Psyllid ID: psy48
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1098 | 2.2.26 [Sep-21-2011] | |||||||
| Q9WTQ1 | 918 | Serine/threonine-protein | yes | N/A | 0.224 | 0.267 | 0.793 | 1e-117 | |
| Q62101 | 918 | Serine/threonine-protein | yes | N/A | 0.224 | 0.267 | 0.793 | 1e-116 | |
| Q15139 | 912 | Serine/threonine-protein | yes | N/A | 0.224 | 0.269 | 0.793 | 1e-116 | |
| Q8K1Y2 | 889 | Serine/threonine-protein | no | N/A | 0.224 | 0.276 | 0.793 | 1e-116 | |
| O94806 | 890 | Serine/threonine-protein | no | N/A | 0.224 | 0.276 | 0.785 | 1e-116 | |
| Q5XIS9 | 875 | Serine/threonine-protein | no | N/A | 0.229 | 0.288 | 0.763 | 1e-113 | |
| Q8BZ03 | 875 | Serine/threonine-protein | no | N/A | 0.229 | 0.288 | 0.763 | 1e-113 | |
| Q9BZL6 | 878 | Serine/threonine-protein | no | N/A | 0.229 | 0.287 | 0.759 | 1e-113 | |
| A8XQD5 | 1191 | Serine/threonine-protein | N/A | N/A | 0.224 | 0.206 | 0.677 | 1e-102 | |
| O45818 | 1070 | Serine/threonine-protein | yes | N/A | 0.224 | 0.229 | 0.673 | 1e-100 |
| >sp|Q9WTQ1|KPCD1_RAT Serine/threonine-protein kinase D1 OS=Rattus norvegicus GN=Prkd1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 204/257 (79%), Positives = 222/257 (86%), Gaps = 11/257 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G HRK+GR VAIK+IDKLRFPTKQE+QL+NEVAILQNL HPGVVNLE MFETP R+FVVM
Sbjct: 606 GKHRKTGRDVAIKIIDKLRFPTKQESQLRNEVAILQNLHHPGVVNLECMFETPERVFVVM 665
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL GDMLEMILSSEKGRL E TKF+ITQILVAL+HLH KNIVHCDLKPENVLL++
Sbjct: 666 EKLHGDMLEMILSSEKGRLPEHITKFLITQILVALRHLHFKNIVHCDLKPENVLLASADP 725
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
PQVKLCDFGFARIIGEKSF PEVLRNKGYNRSLDMWSVGVI+YVSLSG
Sbjct: 726 FPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG 785
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNEDEDI++QIQNAAFMYPP PW++IS +AIDLINNLLQVK RKR SVDK+L+HPWL
Sbjct: 786 TFPFNEDEDIHDQIQNAAFMYPPNPWKEISHEAIDLINNLLQVKMRKRYSVDKTLSHPWL 845
Query: 1060 QDPATWSDLRGLERQIG 1076
QD TW DLR LE +IG
Sbjct: 846 QDYQTWLDLRELECRIG 862
|
Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of MAPK8/JNK1 and Ras signaling, Golgi membrane integrity and trafficking, cell survival through NF-kappa-B activation, cell migration, cell differentiation by mediating HDAC7 nuclear export, cell proliferation via MAPK1/3 (ERK1/2) signaling, and plays a role in cardiac hypertrophy, VEGFA-induced angiogenesis, genotoxic-induced apoptosis and flagellin-stimulated inflammatory response. Phosphorylates the epidermal growth factor receptor (EGFR) on dual threonine residues, which leads to the suppression of epidermal growth factor (EGF)-induced MAPK8/JNK1 activation and subsequent JUN phosphorylation. Phosphorylates RIN1, inducing RIN1 binding to 14-3-3 proteins YWHAB, YWHAE and YWHAZ and increased competition with RAF1 for binding to GTP-bound form of Ras proteins (NRAS, HRAS and KRAS). Acts downstream of the heterotrimeric G-protein beta/gamma-subunit complex to maintain the structural integrity of the Golgi membranes, and is required for protein transport along the secretory pathway. In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane. May act by activating the lipid kinase phosphatidylinositol 4-kinase beta (PI4KB) at the TGN for the local synthesis of phosphorylated inositol lipids, which induces a sequential production of DAG, phosphatidic acid (PA) and lyso-PA (LPA) that are necessary for membrane fission and generation of specific transport carriers to the cell surface. Under oxidative stress, is phosphorylated at Tyr-469 via SRC-ABL1 and contributes to cell survival by activating IKK complex and subsequent nuclear translocation and activation of NFKB1. Involved in cell migration by regulating integrin alpha-5/beta-3 recycling and promoting its recruitment in newly forming focal adhesion. In osteoblast differentiation, mediates the bone morphogenic protein 2 (BMP2)-induced nuclear export of HDAC7, which results in the inhibition of HDAC7 transcriptional repression of RUNX2. In neurons, plays an important role in neuronal polarity by regulating the biogenesis of TGN-derived dendritic vesicles, and is involved in the maintenance of dendritic arborization and Golgi structure in hippocampal cells. May potentiate mitogenesis induced by the neuropeptide bombesin or vasopressin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression. Plays an important role in the proliferative response induced by low calcium in keratinocytes, through sustained activation of MAPK1/3 (ERK1/2) pathway. Downstream of novel PKC signaling, plays a role in cardiac hypertrophy by phosphorylating HDAC5, which in turn triggers XPO1/CRM1-dependent nuclear export of HDAC5, MEF2A transcriptional activation and induction of downstream target genes that promote myocyte hypertrophy and pathological cardiac remodeling. Mediates cardiac troponin I (TNNI3) phosphorylation at the PKA sites, which results in reduced myofilament calcium sensitivity, and accelerated crossbridge cycling kinetics. The PRKD1-HDAC5 pathway is also involved in angiogenesis by mediating VEGFA-induced specific subset of gene expression, cell migration, and tube formation. In response to VEGFA, is necessary and required for HDAC7 phosphorylation which induces HDAC7 nuclear export and endothelial cell proliferation and migration. During apoptosis induced by cytarabine and other genotoxic agents, PRKD1 is cleaved by caspase-3 at Asp-378, resulting in activation of its kinase function and increased sensitivity of cells to the cytotoxic effects of genotoxic agents. In epithelial cells, is required for transducing flagellin-stimulated inflammatory responses by binding and phosphorylating TLR5, which contributes to MAPK14/p38 activation and production of inflammatory cytokines. May play a role in inflammatory response by mediating activation of NF-kappa-B. May be involved in pain transmission by directly modulating TRPV1 receptor. Rattus norvegicus (taxid: 10116) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1EC: 3 |
| >sp|Q62101|KPCD1_MOUSE Serine/threonine-protein kinase D1 OS=Mus musculus GN=Prkd1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 422 bits (1084), Expect = e-116, Method: Compositional matrix adjust.
Identities = 204/257 (79%), Positives = 222/257 (86%), Gaps = 11/257 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G HRK+GR VAIK+IDKLRFPTKQE+QL+NEVAILQNL HPGVVNLE MFETP R+FVVM
Sbjct: 606 GKHRKTGRDVAIKIIDKLRFPTKQESQLRNEVAILQNLHHPGVVNLECMFETPERVFVVM 665
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL GDMLEMILSSEKGRL E TKF+ITQILVAL+HLH KNIVHCDLKPENVLL++
Sbjct: 666 EKLHGDMLEMILSSEKGRLPEHITKFLITQILVALRHLHFKNIVHCDLKPENVLLASADP 725
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
PQVKLCDFGFARIIGEKSF PEVLRNKGYNRSLDMWSVGVI+YVSLSG
Sbjct: 726 FPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG 785
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNEDEDI++QIQNAAFMYPP PW++IS +AIDLINNLLQVK RKR SVDK+L+HPWL
Sbjct: 786 TFPFNEDEDIHDQIQNAAFMYPPNPWKEISHEAIDLINNLLQVKMRKRYSVDKTLSHPWL 845
Query: 1060 QDPATWSDLRGLERQIG 1076
QD TW DLR LE +IG
Sbjct: 846 QDYQTWLDLRELECRIG 862
|
Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of MAPK8/JNK1 and Ras signaling, Golgi membrane integrity and trafficking, cell survival through NF-kappa-B activation, cell migration, cell differentiation by mediating HDAC7 nuclear export, cell proliferation via MAPK1/3 (ERK1/2) signaling, and plays a role in cardiac hypertrophy, VEGFA-induced angiogenesis, genotoxic-induced apoptosis and flagellin-stimulated inflammatory response. Phosphorylates the epidermal growth factor receptor (EGFR) on dual threonine residues, which leads to the suppression of epidermal growth factor (EGF)-induced MAPK8/JNK1 activation and subsequent JUN phosphorylation. Phosphorylates RIN1, inducing RIN1 binding to 14-3-3 proteins YWHAB, YWHAE and YWHAZ and increased competition with RAF1 for binding to GTP-bound form of Ras proteins (NRAS, HRAS and KRAS). Acts downstream of the heterotrimeric G-protein beta/gamma-subunit complex to maintain the structural integrity of the Golgi membranes, and is required for protein transport along the secretory pathway. In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane. May act by activating the lipid kinase phosphatidylinositol 4-kinase beta (PI4KB) at the TGN for the local synthesis of phosphorylated inositol lipids, which induces a sequential production of DAG, phosphatidic acid (PA) and lyso-PA (LPA) that are necessary for membrane fission and generation of specific transport carriers to the cell surface. Under oxidative stress, is phosphorylated at Tyr-469 via SRC-ABL1 and contributes to cell survival by activating IKK complex and subsequent nuclear translocation and activation of NFKB1. Involved in cell migration by regulating integrin alpha-5/beta-3 recycling and promoting its recruitment in newly forming focal adhesion. In osteoblast differentiation, mediates the bone morphogenic protein 2 (BMP2)-induced nuclear export of HDAC7, which results in the inhibition of HDAC7 transcriptional repression of RUNX2. In neurons, plays an important role in neuronal polarity by regulating the biogenesis of TGN-derived dendritic vesicles, and is involved in the maintenance of dendritic arborization and Golgi structure in hippocampal cells. May potentiate mitogenesis induced by the neuropeptide bombesin or vasopressin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression. Plays an important role in the proliferative response induced by low calcium in keratinocytes, through sustained activation of MAPK1/3 (ERK1/2) pathway. Downstream of novel PKC signaling, plays a role in cardiac hypertrophy by phosphorylating HDAC5, which in turn triggers XPO1/CRM1-dependent nuclear export of HDAC5, MEF2A transcriptional activation and induction of downstream target genes that promote myocyte hypertrophy and pathological cardiac remodeling. Mediates cardiac troponin I (TNNI3) phosphorylation at the PKA sites, which results in reduced myofilament calcium sensitivity, and accelerated crossbridge cycling kinetics. The PRKD1-HDAC5 pathway is also involved in angiogenesis by mediating VEGFA-induced specific subset of gene expression, cell migration, and tube formation. In response to VEGFA, is necessary and required for HDAC7 phosphorylation which induces HDAC7 nuclear export and endothelial cell proliferation and migration. During apoptosis induced by cytarabine and other genotoxic agents, PRKD1 is cleaved by caspase-3 at Asp-378, resulting in activation of its kinase function and increased sensitivity of cells to the cytotoxic effects of genotoxic agents. In epithelial cells, is required for transducing flagellin-stimulated inflammatory responses by binding and phosphorylating TLR5, which contributes to MAPK14/p38 activation and production of inflammatory cytokines. May play a role in inflammatory response by mediating activation of NF-kappa-B. May be involved in pain transmission by directly modulating TRPV1 receptor. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|Q15139|KPCD1_HUMAN Serine/threonine-protein kinase D1 OS=Homo sapiens GN=PRKD1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 421 bits (1083), Expect = e-116, Method: Compositional matrix adjust.
Identities = 204/257 (79%), Positives = 222/257 (86%), Gaps = 11/257 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G HRK+GR VAIK+IDKLRFPTKQE+QL+NEVAILQNL HPGVVNLE MFETP R+FVVM
Sbjct: 600 GKHRKTGRDVAIKIIDKLRFPTKQESQLRNEVAILQNLHHPGVVNLECMFETPERVFVVM 659
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL GDMLEMILSSEKGRL E TKF+ITQILVAL+HLH KNIVHCDLKPENVLL++
Sbjct: 660 EKLHGDMLEMILSSEKGRLPEHITKFLITQILVALRHLHFKNIVHCDLKPENVLLASADP 719
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
PQVKLCDFGFARIIGEKSF PEVLRNKGYNRSLDMWSVGVI+YVSLSG
Sbjct: 720 FPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG 779
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNEDEDI++QIQNAAFMYPP PW++IS +AIDLINNLLQVK RKR SVDK+L+HPWL
Sbjct: 780 TFPFNEDEDIHDQIQNAAFMYPPNPWKEISHEAIDLINNLLQVKMRKRYSVDKTLSHPWL 839
Query: 1060 QDPATWSDLRGLERQIG 1076
QD TW DLR LE +IG
Sbjct: 840 QDYQTWLDLRELECKIG 856
|
Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of MAPK8/JNK1 and Ras signaling, Golgi membrane integrity and trafficking, cell survival through NF-kappa-B activation, cell migration, cell differentiation by mediating HDAC7 nuclear export, cell proliferation via MAPK1/3 (ERK1/2) signaling, and plays a role in cardiac hypertrophy, VEGFA-induced angiogenesis, genotoxic-induced apoptosis and flagellin-stimulated inflammatory response. Phosphorylates the epidermal growth factor receptor (EGFR) on dual threonine residues, which leads to the suppression of epidermal growth factor (EGF)-induced MAPK8/JNK1 activation and subsequent JUN phosphorylation. Phosphorylates RIN1, inducing RIN1 binding to 14-3-3 proteins YWHAB, YWHAE and YWHAZ and increased competition with RAF1 for binding to GTP-bound form of Ras proteins (NRAS, HRAS and KRAS). Acts downstream of the heterotrimeric G-protein beta/gamma-subunit complex to maintain the structural integrity of the Golgi membranes, and is required for protein transport along the secretory pathway. In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane. May act by activating the lipid kinase phosphatidylinositol 4-kinase beta (PI4KB) at the TGN for the local synthesis of phosphorylated inositol lipids, which induces a sequential production of DAG, phosphatidic acid (PA) and lyso-PA (LPA) that are necessary for membrane fission and generation of specific transport carriers to the cell surface. Under oxidative stress, is phosphorylated at Tyr-463 via SRC-ABL1 and contributes to cell survival by activating IKK complex and subsequent nuclear translocation and activation of NFKB1. Involved in cell migration by regulating integrin alpha-5/beta-3 recycling and promoting its recruitment in newly forming focal adhesion. In osteoblast differentiation, mediates the bone morphogenic protein 2 (BMP2)-induced nuclear export of HDAC7, which results in the inhibition of HDAC7 transcriptional repression of RUNX2. In neurons, plays an important role in neuronal polarity by regulating the biogenesis of TGN-derived dendritic vesicles, and is involved in the maintenance of dendritic arborization and Golgi structure in hippocampal cells. May potentiate mitogenesis induced by the neuropeptide bombesin or vasopressin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression. Plays an important role in the proliferative response induced by low calcium in keratinocytes, through sustained activation of MAPK1/3 (ERK1/2) pathway. Downstream of novel PKC signaling, plays a role in cardiac hypertrophy by phosphorylating HDAC5, which in turn triggers XPO1/CRM1-dependent nuclear export of HDAC5, MEF2A transcriptional activation and induction of downstream target genes that promote myocyte hypertrophy and pathological cardiac remodeling. Mediates cardiac troponin I (TNNI3) phosphorylation at the PKA sites, which results in reduced myofilament calcium sensitivity, and accelerated crossbridge cycling kinetics. The PRKD1-HDAC5 pathway is also involved in angiogenesis by mediating VEGFA-induced specific subset of gene expression, cell migration, and tube formation. In response to VEGFA, is necessary and required for HDAC7 phosphorylation which induces HDAC7 nuclear export and endothelial cell proliferation and migration. During apoptosis induced by cytarabine and other genotoxic agents, PRKD1 is cleaved by caspase-3 at Asp-378, resulting in activation of its kinase function and increased sensitivity of cells to the cytotoxic effects of genotoxic agents. In epithelial cells, is required for transducing flagellin-stimulated inflammatory responses by binding and phosphorylating TLR5, which contributes to MAPK14/p38 activation and production of inflammatory cytokines. May play a role in inflammatory response by mediating activation of NF-kappa-B. May be involved in pain transmission by directly modulating TRPV1 receptor. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|Q8K1Y2|KPCD3_MOUSE Serine/threonine-protein kinase D3 OS=Mus musculus GN=Prkd3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 421 bits (1083), Expect = e-116, Method: Compositional matrix adjust.
Identities = 204/257 (79%), Positives = 222/257 (86%), Gaps = 11/257 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G HRK+GR VAIKVIDK+RFPTKQE+QL+NEVAILQNL HPG+VNLE MFETP R+FVVM
Sbjct: 592 GKHRKTGRDVAIKVIDKMRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 651
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL GDMLEMILSSEK RL ER TKF++TQILVAL++LH KNIVHCDLKPENVLL++
Sbjct: 652 EKLHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEP 711
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
PQVKLCDFGFARIIGEKSF PEVLR+KGYNRSLDMWSVGVIVYVSLSG
Sbjct: 712 FPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRSKGYNRSLDMWSVGVIVYVSLSG 771
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNEDEDIN+QIQNAAFMYPP PWR+ISS+AIDLINNLLQVK RKR SVDKSL+HPWL
Sbjct: 772 TFPFNEDEDINDQIQNAAFMYPPNPWREISSEAIDLINNLLQVKMRKRYSVDKSLSHPWL 831
Query: 1060 QDPATWSDLRGLERQIG 1076
QD TW DLR E +IG
Sbjct: 832 QDYQTWLDLREFETRIG 848
|
Converts transient diacylglycerol (DAG) signals into prolonged physiological effects, downstream of PKC. Involved in resistance to oxidative stress. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|O94806|KPCD3_HUMAN Serine/threonine-protein kinase D3 OS=Homo sapiens GN=PRKD3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 419 bits (1077), Expect = e-116, Method: Compositional matrix adjust.
Identities = 202/257 (78%), Positives = 221/257 (85%), Gaps = 11/257 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G HRK+GR VAIKVIDK+RFPTKQE+QL+NEVAILQNL HPG+VNLE MFETP R+FVVM
Sbjct: 593 GKHRKTGRDVAIKVIDKMRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 652
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL GDMLEMILSSEK RL ER TKF++TQILVAL++LH KNIVHCDLKPENVLL++
Sbjct: 653 EKLHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEP 712
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
PQVKLCDFGFARIIGEKSF PEVLR+KGYNRSLDMWSVGVI+YVSLSG
Sbjct: 713 FPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRSKGYNRSLDMWSVGVIIYVSLSG 772
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNEDEDIN+QIQNAAFMYPP PWR+IS +AIDLINNLLQVK RKR SVDKSL+HPWL
Sbjct: 773 TFPFNEDEDINDQIQNAAFMYPPNPWREISGEAIDLINNLLQVKMRKRYSVDKSLSHPWL 832
Query: 1060 QDPATWSDLRGLERQIG 1076
QD TW DLR E +IG
Sbjct: 833 QDYQTWLDLREFETRIG 849
|
Converts transient diacylglycerol (DAG) signals into prolonged physiological effects, downstream of PKC. Involved in resistance to oxidative stress. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|Q5XIS9|KPCD2_RAT Serine/threonine-protein kinase D2 OS=Rattus norvegicus GN=Prkd2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 411 bits (1056), Expect = e-113, Method: Compositional matrix adjust.
Identities = 203/266 (76%), Positives = 222/266 (83%), Gaps = 14/266 (5%)
Query: 822 IAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE 881
VV G G HRK+GR VA+KVIDKLRFPTKQE+QL+NEVAILQ+L HPG+VNLE MFE
Sbjct: 563 FGVVYG---GKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQSLRHPGIVNLECMFE 619
Query: 882 TPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
TP ++FVVMEKL GDMLEMILSSEKGRL ER TKF+ITQILVAL+HLH KNIVHCDLKPE
Sbjct: 620 TPEKVFVVMEKLHGDMLEMILSSEKGRLPERLTKFLITQILVALRHLHFKNIVHCDLKPE 679
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVG 990
NVLL++ PQVKLCDFGFARIIGEKSF PEVL N+GYNRSLDMWSVG
Sbjct: 680 NVLLASADPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLLNQGYNRSLDMWSVG 739
Query: 991 VIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV 1050
VI+YVSLSGTFPFNEDEDIN+QIQNAAFMYP PW ISS AIDLINNLLQVK RKR SV
Sbjct: 740 VIMYVSLSGTFPFNEDEDINDQIQNAAFMYPASPWSHISSGAIDLINNLLQVKMRKRYSV 799
Query: 1051 DKSLAHPWLQDPATWSDLRGLERQIG 1076
DKSL+HPWLQ+ TW DLR LE ++G
Sbjct: 800 DKSLSHPWLQEYQTWLDLRELEGKMG 825
|
Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of cell proliferation via MAPK1/3 (ERK1/2) signaling, oxidative stress-induced NF-kappa-B activation, inhibition of HDAC7 transcriptional repression, signaling downstream of T-cell antigen receptor (TCR) and cytokine production, and plays a role in Golgi membrane trafficking, angiogenesis, secretory granule release and cell adhesion. May potentiate mitogenesis induced by the neuropeptide bombesin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression. In response to oxidative stress, is phosphorylated at Tyr-439 by ABL1, which leads to the activation of PRKD2 without increasing its catalytic activity, and mediates activation of NF-kappa-B. In response to the activation of the gastrin receptor CCKBR, is phosphorylated at Ser-244 by CSNK1D and CSNK1E, translocates to the nucleus, phosphorylates HDAC7, leading to nuclear export of HDAC7 and inhibition of HDAC7 transcriptional repression of NR4A1/NUR77. Upon TCR stimulation, is activated independently of ZAP70, translocates from the cytoplasm to the nucleus and is required for interleukin-2 (IL2) promoter up-regulation. During adaptive immune responses, is required in peripheral T-lymphocytes for the production of the effector cytokines IL2 and IFNG after TCR engagement and for optimal induction of antibody responses to antigens. In epithelial cells stimulated with lysophosphatidic acid (LPA), is activated through a PKC-dependent pathway and mediates LPA-stimulated interleukin-8 (IL8) secretion via a NF-kappa-B-dependent pathway. During TCR-induced T-cell activation, interacts with and is activated by the tyrosine kinase LCK, which results in the activation of the NFAT transcription factors. In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane and in polarized cells is involved in the transport of proteins from the TGN to the basolateral membrane. Plays an important role in endothelial cell proliferation and migration prior to angiogenesis, partly through modulation of the expression of KDR/VEGFR2 and FGFR1, two key growth factor receptors involved in angiogenesis. In secretory pathway, is required for the release of chromogranin-A (CHGA)-containing secretory granules from the TGN. Downstream of PRKCA, plays important roles in angiotensin-2-induced monocyte adhesion to endothelial cells. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|Q8BZ03|KPCD2_MOUSE Serine/threonine-protein kinase D2 OS=Mus musculus GN=Prkd2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 411 bits (1056), Expect = e-113, Method: Compositional matrix adjust.
Identities = 203/266 (76%), Positives = 222/266 (83%), Gaps = 14/266 (5%)
Query: 822 IAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE 881
VV G G HRK+GR VA+KVIDKLRFPTKQE+QL+NEVAILQ+L HPG+VNLE MFE
Sbjct: 563 FGVVYG---GKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQSLRHPGIVNLECMFE 619
Query: 882 TPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
TP ++FVVMEKL GDMLEMILSSEKGRL ER TKF+ITQILVAL+HLH KNIVHCDLKPE
Sbjct: 620 TPEKVFVVMEKLHGDMLEMILSSEKGRLPERLTKFLITQILVALRHLHFKNIVHCDLKPE 679
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVG 990
NVLL++ PQVKLCDFGFARIIGEKSF PEVL N+GYNRSLDMWSVG
Sbjct: 680 NVLLASADPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLLNQGYNRSLDMWSVG 739
Query: 991 VIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV 1050
VI+YVSLSGTFPFNEDEDIN+QIQNAAFMYP PW ISS AIDLINNLLQVK RKR SV
Sbjct: 740 VIMYVSLSGTFPFNEDEDINDQIQNAAFMYPASPWSHISSGAIDLINNLLQVKMRKRYSV 799
Query: 1051 DKSLAHPWLQDPATWSDLRGLERQIG 1076
DKSL+HPWLQ+ TW DLR LE ++G
Sbjct: 800 DKSLSHPWLQEYQTWLDLRELEGKMG 825
|
Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of cell proliferation via MAPK1/3 (ERK1/2) signaling, oxidative stress-induced NF-kappa-B activation, inhibition of HDAC7 transcriptional repression, signaling downstream of T-cell antigen receptor (TCR) and cytokine production, and plays a role in Golgi membrane trafficking, angiogenesis, secretory granule release and cell adhesion. May potentiate mitogenesis induced by the neuropeptide bombesin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression. In response to oxidative stress, is phosphorylated at Tyr-439 by ABL1, which leads to the activation of PRKD2 without increasing its catalytic activity, and mediates activation of NF-kappa-B. In response to the activation of the gastrin receptor CCKBR, is phosphorylated at Ser-244 by CSNK1D and CSNK1E, translocates to the nucleus, phosphorylates HDAC7, leading to nuclear export of HDAC7 and inhibition of HDAC7 transcriptional repression of NR4A1/NUR77. Upon TCR stimulation, is activated independently of ZAP70, translocates from the cytoplasm to the nucleus and is required for interleukin-2 (IL2) promoter up-regulation. During adaptive immune responses, is required in peripheral T-lymphocytes for the production of the effector cytokines IL2 and IFNG after TCR engagement and for optimal induction of antibody responses to antigens. In epithelial cells stimulated with lysophosphatidic acid (LPA), is activated through a PKC-dependent pathway and mediates LPA-stimulated interleukin-8 (IL8) secretion via a NF-kappa-B-dependent pathway. During TCR-induced T-cell activation, interacts with and is activated by the tyrosine kinase LCK, which results in the activation of the NFAT transcription factors. In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane and in polarized cells is involved in the transport of proteins from the TGN to the basolateral membrane. Plays an important role in endothelial cell proliferation and migration prior to angiogenesis, partly through modulation of the expression of KDR/VEGFR2 and FGFR1, two key growth factor receptors involved in angiogenesis. In secretory pathway, is required for the release of chromogranin-A (CHGA)-containing secretory granules from the TGN. Downstream of PRKCA, plays important roles in angiotensin-2-induced monocyte adhesion to endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|Q9BZL6|KPCD2_HUMAN Serine/threonine-protein kinase D2 OS=Homo sapiens GN=PRKD2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 410 bits (1055), Expect = e-113, Method: Compositional matrix adjust.
Identities = 202/266 (75%), Positives = 222/266 (83%), Gaps = 14/266 (5%)
Query: 822 IAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE 881
VV G G HRK+GR VA+KVIDKLRFPTKQE+QL+NEVAILQ+L HPG+VNLE MFE
Sbjct: 562 FGVVYG---GKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQSLRHPGIVNLECMFE 618
Query: 882 TPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
TP ++FVVMEKL GDMLEMILSSEKGRL ER TKF+ITQILVAL+HLH KNIVHCDLKPE
Sbjct: 619 TPEKVFVVMEKLHGDMLEMILSSEKGRLPERLTKFLITQILVALRHLHFKNIVHCDLKPE 678
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVG 990
NVLL++ PQVKLCDFGFARIIGEKSF PEVL N+GYNRSLDMWSVG
Sbjct: 679 NVLLASADPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLLNQGYNRSLDMWSVG 738
Query: 991 VIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV 1050
VI+YVSLSGTFPFNEDEDIN+QIQNAAFMYP PW IS+ AIDLINNLLQVK RKR SV
Sbjct: 739 VIMYVSLSGTFPFNEDEDINDQIQNAAFMYPASPWSHISAGAIDLINNLLQVKMRKRYSV 798
Query: 1051 DKSLAHPWLQDPATWSDLRGLERQIG 1076
DKSL+HPWLQ+ TW DLR LE ++G
Sbjct: 799 DKSLSHPWLQEYQTWLDLRELEGKMG 824
|
Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of cell proliferation via MAPK1/3 (ERK1/2) signaling, oxidative stress-induced NF-kappa-B activation, inhibition of HDAC7 transcriptional repression, signaling downstream of T-cell antigen receptor (TCR) and cytokine production, and plays a role in Golgi membrane trafficking, angiogenesis, secretory granule release and cell adhesion. May potentiate mitogenesis induced by the neuropeptide bombesin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression. In response to oxidative stress, is phosphorylated at Tyr-438 by ABL1, which leads to the activation of PRKD2 without increasing its catalytic activity, and mediates activation of NF-kappa-B. In response to the activation of the gastrin receptor CCKBR, is phosphorylated at Ser-244 by CSNK1D and CSNK1E, translocates to the nucleus, phosphorylates HDAC7, leading to nuclear export of HDAC7 and inhibition of HDAC7 transcriptional repression of NR4A1/NUR77. Upon TCR stimulation, is activated independently of ZAP70, translocates from the cytoplasm to the nucleus and is required for interleukin-2 (IL2) promoter up-regulation. During adaptive immune responses, is required in peripheral T-lymphocytes for the production of the effector cytokines IL2 and IFNG after TCR engagement and for optimal induction of antibody responses to antigens. In epithelial cells stimulated with lysophosphatidic acid (LPA), is activated through a PKC-dependent pathway and mediates LPA-stimulated interleukin-8 (IL8) secretion via a NF-kappa-B-dependent pathway. During TCR-induced T-cell activation, interacts with and is activated by the tyrosine kinase LCK, which results in the activation of the NFAT transcription factors. In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane and in polarized cells is involved in the transport of proteins from the TGN to the basolateral membrane. Plays an important role in endothelial cell proliferation and migration prior to angiogenesis, partly through modulation of the expression of KDR/VEGFR2 and FGFR1, two key growth factor receptors involved in angiogenesis. In secretory pathway, is required for the release of chromogranin-A (CHGA)-containing secretory granules from the TGN. Downstream of PRKCA, plays important roles in angiotensin-2-induced monocyte adhesion to endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|A8XQD5|DKF2_CAEBR Serine/threonine-protein kinase dkf-2 OS=Caenorhabditis briggsae GN=dkf-2 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 374 bits (961), Expect = e-102, Method: Compositional matrix adjust.
Identities = 174/257 (67%), Positives = 211/257 (82%), Gaps = 11/257 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G+HR++G+ VA+K+IDKL+FP +E L+ EV IL+ + HPGVV+ +M ET RIFVVM
Sbjct: 908 GIHRRNGQHVAVKLIDKLKFPPNKEDLLRAEVQILEQVDHPGVVHFMQMLETTDRIFVVM 967
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL+GDMLEMILSSEKGRLSERTT+F++ QIL AL++LH +NIVHCDLKPEN+LL++NS+
Sbjct: 968 EKLKGDMLEMILSSEKGRLSERTTQFLVAQILEALRYLHHQNIVHCDLKPENILLNSNSD 1027
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
PQVKLCDFGFARIIGEKSF PEVLRNKG+NRSLDMWSVGVIVYVSLSG
Sbjct: 1028 FPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGFNRSLDMWSVGVIVYVSLSG 1087
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNEDEDIN+QIQNA FMYPP PW++IS +AI+ IN LLQVK KR +V K+ +H W+
Sbjct: 1088 TFPFNEDEDINDQIQNAEFMYPPSPWKEISENAIEFINGLLQVKMSKRYTVAKAQSHIWM 1147
Query: 1060 QDPATWSDLRGLERQIG 1076
Q+ WSDLR LE+ +G
Sbjct: 1148 QNYTIWSDLRVLEKAVG 1164
|
Converts transient diacylglycerol (DAG) signals into prolonged physiological effects, downstream of PKC. Acts in the intestine to regulate both innate immunity by promoting activation of pmk-1 and also stress response and life span by acting as an upstream, negative regulator of the daf-16 transcription factor. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|O45818|DKF2_CAEEL Serine/threonine-protein kinase dkf-2 OS=Caenorhabditis elegans GN=dkf-2 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 368 bits (944), Expect = e-100, Method: Compositional matrix adjust.
Identities = 173/257 (67%), Positives = 209/257 (81%), Gaps = 11/257 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G+HR++G+ VA+K+IDKL+FP +E L+ EV IL+ + HPGVV+ +M ET RIFVVM
Sbjct: 787 GIHRRNGQHVAVKLIDKLKFPPNKEDLLRAEVQILEKVDHPGVVHFMQMLETTDRIFVVM 846
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL+GDMLEMILSSEKGRLSERTT+F++ QIL AL++LH NIVHCDLKPEN+LL++NS+
Sbjct: 847 EKLKGDMLEMILSSEKGRLSERTTQFLVAQILEALRYLHHLNIVHCDLKPENILLNSNSD 906
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
PQVKLCDFGFARIIGEKSF PEVLRNKG+NRSLDMWSVGVIVYVSLSG
Sbjct: 907 FPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGFNRSLDMWSVGVIVYVSLSG 966
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNEDEDIN+QIQNA FMYPP PW++IS +AI+ IN LLQVK KR +V K+ + W+
Sbjct: 967 TFPFNEDEDINDQIQNAEFMYPPTPWKEISENAIEFINGLLQVKMSKRYTVTKAQSQIWM 1026
Query: 1060 QDPATWSDLRGLERQIG 1076
Q+ WSDLR LE+ +G
Sbjct: 1027 QNYTLWSDLRVLEKAVG 1043
|
Converts transient diacylglycerol (DAG) signals into prolonged physiological effects, downstream of PKC. Acts in the intestine to regulate both innate immunity by promoting activation of PMK-1 and also stress response and life span by acting as an upstream, negative regulator of the daf-16 transcription factor. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1098 | ||||||
| 242010805 | 483 | serine/threonine-protein kinase D1, puta | 0.238 | 0.542 | 0.798 | 1e-123 | |
| 148710130 | 981 | protein kinase D2, isoform CRA_b [Mus mu | 0.426 | 0.477 | 0.520 | 1e-123 | |
| 189239432 | 900 | PREDICTED: similar to protein kinase c, | 0.224 | 0.274 | 0.841 | 1e-123 | |
| 270010532 | 805 | hypothetical protein TcasGA2_TC009940 [T | 0.224 | 0.306 | 0.841 | 1e-123 | |
| 383864763 | 841 | PREDICTED: serine/threonine-protein kina | 0.238 | 0.311 | 0.802 | 1e-122 | |
| 345480434 | 866 | PREDICTED: serine/threonine-protein kina | 0.224 | 0.284 | 0.852 | 1e-122 | |
| 345480436 | 851 | PREDICTED: serine/threonine-protein kina | 0.224 | 0.289 | 0.852 | 1e-122 | |
| 307210993 | 852 | Serine/threonine-protein kinase D3 [Harp | 0.238 | 0.307 | 0.791 | 1e-122 | |
| 307178486 | 732 | Serine/threonine-protein kinase D3 [Camp | 0.238 | 0.357 | 0.791 | 1e-122 | |
| 340727626 | 828 | PREDICTED: serine/threonine-protein kina | 0.224 | 0.297 | 0.840 | 1e-121 |
| >gi|242010805|ref|XP_002426149.1| serine/threonine-protein kinase D1, putative [Pediculus humanus corporis] gi|212510196|gb|EEB13411.1| serine/threonine-protein kinase D1, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 451 bits (1159), Expect = e-123, Method: Compositional matrix adjust.
Identities = 218/273 (79%), Positives = 234/273 (85%), Gaps = 11/273 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G HRKSGR VAIKVIDKLRFPTKQEAQLKNEVAILQNL H GVVNLERMFETP RIFVVM
Sbjct: 206 GTHRKSGRAVAIKVIDKLRFPTKQEAQLKNEVAILQNLSHQGVVNLERMFETPERIFVVM 265
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL+GDMLEMILSSEKGRLSER TKF+ITQIL+ALKHLHSKNIVHCDLKPENVLLS++ +
Sbjct: 266 EKLKGDMLEMILSSEKGRLSERITKFLITQILIALKHLHSKNIVHCDLKPENVLLSSDGD 325
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
PQVKLCDFGFARIIGEKSF PEVLRNKGYNRSLDMWSVGVIVYVSLSG
Sbjct: 326 FPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIVYVSLSG 385
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNEDEDIN+QIQNAAFMYPP PW++IS DAIDLI+NLLQVKQRKR +VDK+LAH WL
Sbjct: 386 TFPFNEDEDINDQIQNAAFMYPPNPWKEISGDAIDLISNLLQVKQRKRYTVDKTLAHIWL 445
Query: 1060 QDPATWSDLRGLERQIGTNKKKNPKRTAQLLSY 1092
QD TW DLR LE+QIG + A+ S+
Sbjct: 446 QDYQTWCDLRELEKQIGVRYLTHESDDARWASF 478
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|148710130|gb|EDL42076.1| protein kinase D2, isoform CRA_b [Mus musculus] | Back alignment and taxonomy information |
|---|
Score = 451 bits (1159), Expect = e-123, Method: Compositional matrix adjust.
Identities = 272/523 (52%), Positives = 324/523 (61%), Gaps = 55/523 (10%)
Query: 586 NNKSNNYCKLKSEVASLVSLESSASASYSCLVRSTS-HCFILKTNNLDYYVGEDTHSPSD 644
NN +N Y K E+ L + ++S + T+ HCF + T N+ Y+VGE
Sbjct: 432 NNTTNRYYK---EIPLSEILAVEPAQNFSLVPPGTNPHCFEIITANVTYFVGETPGGAPG 488
Query: 645 GVETPVTAPESGLGARAWELSLRQALMPV---QEPSG---------TKCEDVSESEESRV 692
G T R WE ++RQALMPV PS + VS S+
Sbjct: 489 GPSGQGTE-----AVRGWETAIRQALMPVILQDAPSAPGHTPHRQASLSISVSNSQIQEN 543
Query: 693 TDMSQLYQISPDEVLGSGQFGIVYGAS--MVGIFFLAALYEGVKY--YREYLFWKTYNDL 748
D++ +YQI PDEVLGSGQFG+VYG G + + +++ +E L
Sbjct: 544 VDIATVYQIFPDEVLGSGQFGVVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAIL 603
Query: 749 HYRSIPAQQRISSVEENKDTAKVVPVCDVLQKQPPSMLMLS----MPHFIQTLLHVLQIT 804
P + + E + KV V + L M++ S +P + L + Q
Sbjct: 604 QSLRHPGIVNLECMFETPE--KVFVVMEKLHGDMLEMILSSEKGRLPERLTKFL-ITQFP 660
Query: 805 MSFLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAI 864
L F VV G G HRK+GR VA+KVIDKLRFPTKQE+QL+NEVAI
Sbjct: 661 DEVLGSGQF---------GVVYG---GKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAI 708
Query: 865 LQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVA 924
LQ+L HPG+VNLE MFETP ++FVVMEKL GDMLEMILSSEKGRL ER TKF+ITQILVA
Sbjct: 709 LQSLRHPGIVNLECMFETPEKVFVVMEKLHGDMLEMILSSEKGRLPERLTKFLITQILVA 768
Query: 925 LKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPE 973
L+HLH KNIVHCDLKPENVLL++ PQVKLCDFGFARIIGEKSF PE
Sbjct: 769 LRHLHFKNIVHCDLKPENVLLASADPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPE 828
Query: 974 VLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAI 1033
VL N+GYNRSLDMWSVGVI+YVSLSGTFPFNEDEDIN+QIQNAAFMYP PW ISS AI
Sbjct: 829 VLLNQGYNRSLDMWSVGVIMYVSLSGTFPFNEDEDINDQIQNAAFMYPASPWSHISSGAI 888
Query: 1034 DLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQIG 1076
DLINNLLQVK RKR SVDKSL+HPWLQ+ TW DLR LE ++G
Sbjct: 889 DLINNLLQVKMRKRYSVDKSLSHPWLQEYQTWLDLRELEGKMG 931
|
Source: Mus musculus Species: Mus musculus Genus: Mus Family: Muridae Order: Rodentia Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|189239432|ref|XP_001815003.1| PREDICTED: similar to protein kinase c, mu [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1154), Expect = e-123, Method: Compositional matrix adjust.
Identities = 217/258 (84%), Positives = 229/258 (88%), Gaps = 11/258 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G+HRK+ R VAIKVIDKLRFPTKQEAQLKNEVAILQNL HPGVVNLERMFETP RIFVVM
Sbjct: 624 GIHRKTSRPVAIKVIDKLRFPTKQEAQLKNEVAILQNLSHPGVVNLERMFETPERIFVVM 683
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL+GDMLEMILS EKGRL+ER TKF+ITQIL+ALKHLHSKNIVHCDLKPENVLLS+++E
Sbjct: 684 EKLKGDMLEMILSHEKGRLTERVTKFLITQILIALKHLHSKNIVHCDLKPENVLLSSDAE 743
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
PQVKLCDFGFARIIGEKSF PEVLRNKGYNRSLDMWSVGVIVYVSLSG
Sbjct: 744 FPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIVYVSLSG 803
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNEDEDINEQIQNAAFMYPP PW++ISSDAIDLINNLLQVKQRKR +VDKSL H WL
Sbjct: 804 TFPFNEDEDINEQIQNAAFMYPPNPWKEISSDAIDLINNLLQVKQRKRYTVDKSLQHIWL 863
Query: 1060 QDPATWSDLRGLERQIGT 1077
QD TW DLR LE QIG
Sbjct: 864 QDYQTWCDLRALENQIGV 881
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270010532|gb|EFA06980.1| hypothetical protein TcasGA2_TC009940 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 448 bits (1152), Expect = e-123, Method: Compositional matrix adjust.
Identities = 217/258 (84%), Positives = 229/258 (88%), Gaps = 11/258 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G+HRK+ R VAIKVIDKLRFPTKQEAQLKNEVAILQNL HPGVVNLERMFETP RIFVVM
Sbjct: 529 GIHRKTSRPVAIKVIDKLRFPTKQEAQLKNEVAILQNLSHPGVVNLERMFETPERIFVVM 588
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL+GDMLEMILS EKGRL+ER TKF+ITQIL+ALKHLHSKNIVHCDLKPENVLLS+++E
Sbjct: 589 EKLKGDMLEMILSHEKGRLTERVTKFLITQILIALKHLHSKNIVHCDLKPENVLLSSDAE 648
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
PQVKLCDFGFARIIGEKSF PEVLRNKGYNRSLDMWSVGVIVYVSLSG
Sbjct: 649 FPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIVYVSLSG 708
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNEDEDINEQIQNAAFMYPP PW++ISSDAIDLINNLLQVKQRKR +VDKSL H WL
Sbjct: 709 TFPFNEDEDINEQIQNAAFMYPPNPWKEISSDAIDLINNLLQVKQRKRYTVDKSLQHIWL 768
Query: 1060 QDPATWSDLRGLERQIGT 1077
QD TW DLR LE QIG
Sbjct: 769 QDYQTWCDLRALENQIGV 786
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383864763|ref|XP_003707847.1| PREDICTED: serine/threonine-protein kinase D3 [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 448 bits (1152), Expect = e-122, Method: Compositional matrix adjust.
Identities = 219/273 (80%), Positives = 235/273 (86%), Gaps = 11/273 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
GVHRKSGR VAIKVIDKLRFPTKQEAQLKNEVAILQNL H GVVNLERMFETP RIFVVM
Sbjct: 564 GVHRKSGRAVAIKVIDKLRFPTKQEAQLKNEVAILQNLSHSGVVNLERMFETPERIFVVM 623
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL+GDMLEMILSSE+GRLSER TKF+ITQILVALKHLH+KNIVHCDLKPENVLLS++SE
Sbjct: 624 EKLKGDMLEMILSSERGRLSERITKFLITQILVALKHLHNKNIVHCDLKPENVLLSSDSE 683
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
QVKLCDFGFARIIGEKSF PEVLRNKGYNRSLDMWSVGVI+YVSLSG
Sbjct: 684 FTQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG 743
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNE+EDINEQIQNAAFMYPP PW++ISSDAIDLINNLLQVKQRKR +VDKSL H WL
Sbjct: 744 TFPFNEEEDINEQIQNAAFMYPPNPWQEISSDAIDLINNLLQVKQRKRFTVDKSLQHVWL 803
Query: 1060 QDPATWSDLRGLERQIGTNKKKNPKRTAQLLSY 1092
QD TW DLR LE ++G + A+ L+Y
Sbjct: 804 QDYQTWCDLRELEAKVGYRYLTHESDDARWLAY 836
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345480434|ref|XP_003424145.1| PREDICTED: serine/threonine-protein kinase D3-like isoform 1 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1148), Expect = e-122, Method: Compositional matrix adjust.
Identities = 219/257 (85%), Positives = 228/257 (88%), Gaps = 11/257 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
GVHRK+ R VAIKVIDKLRFPTKQEAQLKNEVAILQNL H GVVNLERMFETP RIFVVM
Sbjct: 568 GVHRKTSRTVAIKVIDKLRFPTKQEAQLKNEVAILQNLSHQGVVNLERMFETPERIFVVM 627
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL+GDMLEMILSSEKGRLSER TKF+ITQILVALKHLHSKNIVHCDLKPENVLLS+NS+
Sbjct: 628 EKLKGDMLEMILSSEKGRLSERITKFLITQILVALKHLHSKNIVHCDLKPENVLLSSNSD 687
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
QVKLCDFGFARIIGEKSF PEVLRNKGYNRSLDMWSVGVIVYVSLSG
Sbjct: 688 FTQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIVYVSLSG 747
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNEDEDINEQIQNAAFMYPP PW++ISSDAIDLINNLLQVKQRKR SVDKSL H WL
Sbjct: 748 TFPFNEDEDINEQIQNAAFMYPPNPWKEISSDAIDLINNLLQVKQRKRFSVDKSLLHFWL 807
Query: 1060 QDPATWSDLRGLERQIG 1076
QD TW DLR LE ++G
Sbjct: 808 QDYQTWCDLRELETRVG 824
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345480436|ref|XP_003424146.1| PREDICTED: serine/threonine-protein kinase D3-like isoform 2 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1146), Expect = e-122, Method: Compositional matrix adjust.
Identities = 219/257 (85%), Positives = 228/257 (88%), Gaps = 11/257 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
GVHRK+ R VAIKVIDKLRFPTKQEAQLKNEVAILQNL H GVVNLERMFETP RIFVVM
Sbjct: 553 GVHRKTSRTVAIKVIDKLRFPTKQEAQLKNEVAILQNLSHQGVVNLERMFETPERIFVVM 612
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL+GDMLEMILSSEKGRLSER TKF+ITQILVALKHLHSKNIVHCDLKPENVLLS+NS+
Sbjct: 613 EKLKGDMLEMILSSEKGRLSERITKFLITQILVALKHLHSKNIVHCDLKPENVLLSSNSD 672
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
QVKLCDFGFARIIGEKSF PEVLRNKGYNRSLDMWSVGVIVYVSLSG
Sbjct: 673 FTQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIVYVSLSG 732
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNEDEDINEQIQNAAFMYPP PW++ISSDAIDLINNLLQVKQRKR SVDKSL H WL
Sbjct: 733 TFPFNEDEDINEQIQNAAFMYPPNPWKEISSDAIDLINNLLQVKQRKRFSVDKSLLHFWL 792
Query: 1060 QDPATWSDLRGLERQIG 1076
QD TW DLR LE ++G
Sbjct: 793 QDYQTWCDLRELETRVG 809
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307210993|gb|EFN87279.1| Serine/threonine-protein kinase D3 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1143), Expect = e-122, Method: Compositional matrix adjust.
Identities = 216/273 (79%), Positives = 235/273 (86%), Gaps = 11/273 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
GVHRK+GR VAIKVIDKLRFPTKQEAQLKNEVAILQNL H GVVNLERMFETP RIFVVM
Sbjct: 575 GVHRKTGRAVAIKVIDKLRFPTKQEAQLKNEVAILQNLSHSGVVNLERMFETPERIFVVM 634
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL+GDMLEMIL+SE+GRLSER TKF+ITQILVALKHLHSKNIVHCDLKPENVLLS++++
Sbjct: 635 EKLKGDMLEMILNSERGRLSERITKFLITQILVALKHLHSKNIVHCDLKPENVLLSSDAD 694
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
QVKLCDFGFARIIGEKSF PEVLRNKGYNRSLDMWSVGVI+YVSLSG
Sbjct: 695 FTQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG 754
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNE+EDINEQIQNAAFMYPP PW++ISSDAIDLINNLLQVKQRKR SVDKSL H WL
Sbjct: 755 TFPFNEEEDINEQIQNAAFMYPPTPWKEISSDAIDLINNLLQVKQRKRYSVDKSLQHVWL 814
Query: 1060 QDPATWSDLRGLERQIGTNKKKNPKRTAQLLSY 1092
QD TW DLR LE ++G + A+ ++Y
Sbjct: 815 QDYQTWCDLRKLEAKVGYRYLTHESDDARWMAY 847
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307178486|gb|EFN67175.1| Serine/threonine-protein kinase D3 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1143), Expect = e-122, Method: Compositional matrix adjust.
Identities = 216/273 (79%), Positives = 236/273 (86%), Gaps = 11/273 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
GVHRKSGR VAIKVIDKLRFPTKQEAQLKNEVAILQNL H GVVNLERMFETP RIFVVM
Sbjct: 455 GVHRKSGRAVAIKVIDKLRFPTKQEAQLKNEVAILQNLSHSGVVNLERMFETPERIFVVM 514
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL+GDMLEMILSSE+GRLSER TKF+ITQILVALKHLHSKNIVHCDLKPENVLLS++++
Sbjct: 515 EKLKGDMLEMILSSERGRLSERITKFLITQILVALKHLHSKNIVHCDLKPENVLLSSDTD 574
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
QVKLCDFGFARIIGEKSF PEVLRNKGYNRSLDMWSVGVI+YVSLSG
Sbjct: 575 FTQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG 634
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNE+EDINEQIQNAAFMYPP PW++IS+DAIDLINNLLQVKQRKR +VDKSL H WL
Sbjct: 635 TFPFNEEEDINEQIQNAAFMYPPTPWKEISNDAIDLINNLLQVKQRKRYTVDKSLQHVWL 694
Query: 1060 QDPATWSDLRGLERQIGTNKKKNPKRTAQLLSY 1092
QD TW DLR LE+++G + A+ ++Y
Sbjct: 695 QDYQTWCDLRKLEQKVGYRYLTHESDDARWMAY 727
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340727626|ref|XP_003402141.1| PREDICTED: serine/threonine-protein kinase D3-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1143), Expect = e-121, Method: Compositional matrix adjust.
Identities = 216/257 (84%), Positives = 229/257 (89%), Gaps = 11/257 (4%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
GVHRKSGR VAIKVIDKLRFPTKQEAQLKNEVAILQNL H GVVNLERMFETP RIFVVM
Sbjct: 551 GVHRKSGRAVAIKVIDKLRFPTKQEAQLKNEVAILQNLSHSGVVNLERMFETPERIFVVM 610
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
EKL+GDMLEMILSSE+GRLSER TKF+ITQIL+ALKHLHSKNIVHCDLKPENVLLS++SE
Sbjct: 611 EKLKGDMLEMILSSERGRLSERVTKFLITQILIALKHLHSKNIVHCDLKPENVLLSSDSE 670
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
QVKLCDFGFARIIGEKSF PEVLRNKGYNRSLDMWSVGVI+YVSLSG
Sbjct: 671 FTQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG 730
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
TFPFNE+EDINEQIQNAAFMYPP PW++ISSDAIDLINNLLQVKQRKR +VDKSL H WL
Sbjct: 731 TFPFNEEEDINEQIQNAAFMYPPIPWQEISSDAIDLINNLLQVKQRKRYTVDKSLQHVWL 790
Query: 1060 QDPATWSDLRGLERQIG 1076
QD TW DLR LE ++G
Sbjct: 791 QDYQTWCDLRELETKVG 807
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1098 | ||||||
| FB|FBgn0038603 | 836 | PKD "Protein Kinase D" [Drosop | 0.224 | 0.295 | 0.790 | 1.2e-179 | |
| MGI|MGI:1922542 | 889 | Prkd3 "protein kinase D3" [Mus | 0.222 | 0.274 | 0.8 | 3.2e-174 | |
| UNIPROTKB|E1B7L9 | 893 | PRKD3 "Serine/threonine-protei | 0.222 | 0.273 | 0.796 | 6.6e-174 | |
| UNIPROTKB|O94806 | 890 | PRKD3 "Serine/threonine-protei | 0.222 | 0.274 | 0.792 | 6.6e-174 | |
| UNIPROTKB|F1S4P5 | 892 | PRKD3 "Serine/threonine-protei | 0.222 | 0.273 | 0.796 | 1.1e-173 | |
| UNIPROTKB|E1C6T4 | 890 | PRKD3 "Serine/threonine-protei | 0.222 | 0.274 | 0.796 | 2.2e-173 | |
| UNIPROTKB|D4A229 | 890 | Prkd3 "Serine/threonine-protei | 0.222 | 0.274 | 0.8 | 5.8e-173 | |
| UNIPROTKB|E2R428 | 890 | PRKD3 "Serine/threonine-protei | 0.222 | 0.274 | 0.796 | 5.8e-173 | |
| RGD|620964 | 918 | Prkd1 "protein kinase D1" [Rat | 0.222 | 0.265 | 0.8 | 2.6e-168 | |
| UNIPROTKB|Q9WTQ1 | 918 | Prkd1 "Serine/threonine-protei | 0.222 | 0.265 | 0.8 | 2.6e-168 |
| FB|FBgn0038603 PKD "Protein Kinase D" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1035 (369.4 bits), Expect = 1.2e-179, Sum P(5) = 1.2e-179
Identities = 204/258 (79%), Positives = 227/258 (87%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
H+K+ R VAIKVIDKLRFPTKQEAQLKNEVAILQN+ H GVVNLERMFETP RIFVVMEK
Sbjct: 562 HKKTQREVAIKVIDKLRFPTKQEAQLKNEVAILQNISHCGVVNLERMFETPERIFVVMEK 621
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
L+GDMLEMILS +GRLSER TKF+ITQIL+ALK+LHS+NIVHCDLKPENVLLS+++E P
Sbjct: 622 LKGDMLEMILSHARGRLSERVTKFLITQILIALKYLHSQNIVHCDLKPENVLLSSDAEFP 681
Query: 953 QVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
QVKLCDFG+ARIIGEKSF P PEVLRNKGYNRSLDMWSVGVI+YVSLSGTF
Sbjct: 682 QVKLCDFGYARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTF 741
Query: 1002 PFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
PFNE+EDIN+QIQNAAFMYPP PW++ISS+AIDLINNLLQVKQRKR +VDKSL H WLQD
Sbjct: 742 PFNEEEDINDQIQNAAFMYPPNPWKEISSNAIDLINNLLQVKQRKRYTVDKSLLHYWLQD 801
Query: 1062 PATWSDLRGLERQIGTNK 1079
T+ DLR LE Q+G +
Sbjct: 802 KQTYRDLRNLEAQVGAGR 819
|
|
| MGI|MGI:1922542 Prkd3 "protein kinase D3" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1032 (368.3 bits), Expect = 3.2e-174, Sum P(6) = 3.2e-174
Identities = 204/255 (80%), Positives = 222/255 (87%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
HRK+GR VAIKVIDK+RFPTKQE+QL+NEVAILQNL HPG+VNLE MFETP R+FVVMEK
Sbjct: 594 HRKTGRDVAIKVIDKMRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK 653
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
L GDMLEMILSSEK RL ER TKF++TQILVAL++LH KNIVHCDLKPENVLL++ P
Sbjct: 654 LHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEPFP 713
Query: 953 QVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
QVKLCDFGFARIIGEKSF P PEVLR+KGYNRSLDMWSVGVIVYVSLSGTF
Sbjct: 714 QVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRSKGYNRSLDMWSVGVIVYVSLSGTF 773
Query: 1002 PFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
PFNEDEDIN+QIQNAAFMYPP PWR+ISS+AIDLINNLLQVK RKR SVDKSL+HPWLQD
Sbjct: 774 PFNEDEDINDQIQNAAFMYPPNPWREISSEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 833
Query: 1062 PATWSDLRGLERQIG 1076
TW DLR E +IG
Sbjct: 834 YQTWLDLREFETRIG 848
|
|
| UNIPROTKB|E1B7L9 PRKD3 "Serine/threonine-protein kinase D" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1028 (366.9 bits), Expect = 6.6e-174, Sum P(6) = 6.6e-174
Identities = 203/255 (79%), Positives = 221/255 (86%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
HRK+GR VAIKVIDK+RFPTKQE+QL+NEVAILQNL HPG+VNLE MFETP R+FVVMEK
Sbjct: 598 HRKTGRDVAIKVIDKMRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK 657
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
L GDMLEMILSSEK RL ER TKF++TQILVAL++LH KNIVHCDLKPENVLL++ P
Sbjct: 658 LHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEPFP 717
Query: 953 QVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
QVKLCDFGFARIIGEKSF P PEVLR+KGYNRSLDMWSVGVIVYVSLSGTF
Sbjct: 718 QVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRSKGYNRSLDMWSVGVIVYVSLSGTF 777
Query: 1002 PFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
PFNEDEDIN+QIQNAAFMYPP PWR+IS +AIDLINNLLQVK RKR SVDKSL+HPWLQD
Sbjct: 778 PFNEDEDINDQIQNAAFMYPPNPWREISGEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 837
Query: 1062 PATWSDLRGLERQIG 1076
TW DLR E +IG
Sbjct: 838 YQTWLDLREFETRIG 852
|
|
| UNIPROTKB|O94806 PRKD3 "Serine/threonine-protein kinase D3" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1027 (366.6 bits), Expect = 6.6e-174, Sum P(6) = 6.6e-174
Identities = 202/255 (79%), Positives = 221/255 (86%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
HRK+GR VAIKVIDK+RFPTKQE+QL+NEVAILQNL HPG+VNLE MFETP R+FVVMEK
Sbjct: 595 HRKTGRDVAIKVIDKMRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK 654
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
L GDMLEMILSSEK RL ER TKF++TQILVAL++LH KNIVHCDLKPENVLL++ P
Sbjct: 655 LHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEPFP 714
Query: 953 QVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
QVKLCDFGFARIIGEKSF P PEVLR+KGYNRSLDMWSVGVI+YVSLSGTF
Sbjct: 715 QVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRSKGYNRSLDMWSVGVIIYVSLSGTF 774
Query: 1002 PFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
PFNEDEDIN+QIQNAAFMYPP PWR+IS +AIDLINNLLQVK RKR SVDKSL+HPWLQD
Sbjct: 775 PFNEDEDINDQIQNAAFMYPPNPWREISGEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 834
Query: 1062 PATWSDLRGLERQIG 1076
TW DLR E +IG
Sbjct: 835 YQTWLDLREFETRIG 849
|
|
| UNIPROTKB|F1S4P5 PRKD3 "Serine/threonine-protein kinase D" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1028 (366.9 bits), Expect = 1.1e-173, Sum P(6) = 1.1e-173
Identities = 203/255 (79%), Positives = 221/255 (86%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
HRK+GR VAIKVIDK+RFPTKQE+QL+NEVAILQNL HPG+VNLE MFETP R+FVVMEK
Sbjct: 597 HRKTGRDVAIKVIDKMRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK 656
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
L GDMLEMILSSEK RL ER TKF++TQILVAL++LH KNIVHCDLKPENVLL++ P
Sbjct: 657 LHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEPFP 716
Query: 953 QVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
QVKLCDFGFARIIGEKSF P PEVLR+KGYNRSLDMWSVGVIVYVSLSGTF
Sbjct: 717 QVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRSKGYNRSLDMWSVGVIVYVSLSGTF 776
Query: 1002 PFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
PFNEDEDIN+QIQNAAFMYPP PWR+IS +AIDLINNLLQVK RKR SVDKSL+HPWLQD
Sbjct: 777 PFNEDEDINDQIQNAAFMYPPNPWREISGEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 836
Query: 1062 PATWSDLRGLERQIG 1076
TW DLR E +IG
Sbjct: 837 YQTWLDLREFETRIG 851
|
|
| UNIPROTKB|E1C6T4 PRKD3 "Serine/threonine-protein kinase D" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1030 (367.6 bits), Expect = 2.2e-173, Sum P(6) = 2.2e-173
Identities = 203/255 (79%), Positives = 222/255 (87%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
HRK+GR VAIKVIDK+RFPTKQE+QL+NEVAILQNL HPG+VNLE MFETP R+FVVMEK
Sbjct: 595 HRKTGRDVAIKVIDKMRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK 654
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
L GDMLEMILSSEK RL ER TKF++TQILVAL++LH KNIVHCDLKPENVLL++ P
Sbjct: 655 LHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEPFP 714
Query: 953 QVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
QVKLCDFGFARIIGEKSF P PEVLR+KGYNRSLDMWSVGVIVYVSLSGTF
Sbjct: 715 QVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRSKGYNRSLDMWSVGVIVYVSLSGTF 774
Query: 1002 PFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
PFNEDEDIN+QIQNAAFMYPP PW++ISS+AIDLINNLLQVK RKR SVDKSL+HPWLQD
Sbjct: 775 PFNEDEDINDQIQNAAFMYPPNPWKEISSEAIDLINNLLQVKMRKRFSVDKSLSHPWLQD 834
Query: 1062 PATWSDLRGLERQIG 1076
TW DLR E +IG
Sbjct: 835 YQTWLDLREFETRIG 849
|
|
| UNIPROTKB|D4A229 Prkd3 "Serine/threonine-protein kinase D" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1032 (368.3 bits), Expect = 5.8e-173, Sum P(6) = 5.8e-173
Identities = 204/255 (80%), Positives = 222/255 (87%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
HRK+GR VAIKVIDK+RFPTKQE+QL+NEVAILQNL HPG+VNLE MFETP R+FVVMEK
Sbjct: 595 HRKTGRDVAIKVIDKMRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK 654
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
L GDMLEMILSSEK RL ER TKF++TQILVAL++LH KNIVHCDLKPENVLL++ P
Sbjct: 655 LHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEPFP 714
Query: 953 QVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
QVKLCDFGFARIIGEKSF P PEVLR+KGYNRSLDMWSVGVIVYVSLSGTF
Sbjct: 715 QVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRSKGYNRSLDMWSVGVIVYVSLSGTF 774
Query: 1002 PFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
PFNEDEDIN+QIQNAAFMYPP PWR+ISS+AIDLINNLLQVK RKR SVDKSL+HPWLQD
Sbjct: 775 PFNEDEDINDQIQNAAFMYPPNPWREISSEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 834
Query: 1062 PATWSDLRGLERQIG 1076
TW DLR E +IG
Sbjct: 835 YQTWLDLREFETRIG 849
|
|
| UNIPROTKB|E2R428 PRKD3 "Serine/threonine-protein kinase D" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1028 (366.9 bits), Expect = 5.8e-173, Sum P(6) = 5.8e-173
Identities = 203/255 (79%), Positives = 221/255 (86%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
HRK+GR VAIKVIDK+RFPTKQE+QL+NEVAILQNL HPG+VNLE MFETP R+FVVMEK
Sbjct: 595 HRKTGRDVAIKVIDKMRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK 654
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
L GDMLEMILSSEK RL ER TKF++TQILVAL++LH KNIVHCDLKPENVLL++ P
Sbjct: 655 LHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEPFP 714
Query: 953 QVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
QVKLCDFGFARIIGEKSF P PEVLR+KGYNRSLDMWSVGVIVYVSLSGTF
Sbjct: 715 QVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRSKGYNRSLDMWSVGVIVYVSLSGTF 774
Query: 1002 PFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
PFNEDEDIN+QIQNAAFMYPP PWR+IS +AIDLINNLLQVK RKR SVDKSL+HPWLQD
Sbjct: 775 PFNEDEDINDQIQNAAFMYPPNPWREISGEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 834
Query: 1062 PATWSDLRGLERQIG 1076
TW DLR E +IG
Sbjct: 835 YQTWLDLREFETRIG 849
|
|
| RGD|620964 Prkd1 "protein kinase D1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1034 (369.0 bits), Expect = 2.6e-168, Sum P(5) = 2.6e-168
Identities = 204/255 (80%), Positives = 222/255 (87%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
HRK+GR VAIK+IDKLRFPTKQE+QL+NEVAILQNL HPGVVNLE MFETP R+FVVMEK
Sbjct: 608 HRKTGRDVAIKIIDKLRFPTKQESQLRNEVAILQNLHHPGVVNLECMFETPERVFVVMEK 667
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
L GDMLEMILSSEKGRL E TKF+ITQILVAL+HLH KNIVHCDLKPENVLL++ P
Sbjct: 668 LHGDMLEMILSSEKGRLPEHITKFLITQILVALRHLHFKNIVHCDLKPENVLLASADPFP 727
Query: 953 QVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
QVKLCDFGFARIIGEKSF P PEVLRNKGYNRSLDMWSVGVI+YVSLSGTF
Sbjct: 728 QVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTF 787
Query: 1002 PFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
PFNEDEDI++QIQNAAFMYPP PW++IS +AIDLINNLLQVK RKR SVDK+L+HPWLQD
Sbjct: 788 PFNEDEDIHDQIQNAAFMYPPNPWKEISHEAIDLINNLLQVKMRKRYSVDKTLSHPWLQD 847
Query: 1062 PATWSDLRGLERQIG 1076
TW DLR LE +IG
Sbjct: 848 YQTWLDLRELECRIG 862
|
|
| UNIPROTKB|Q9WTQ1 Prkd1 "Serine/threonine-protein kinase D1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1034 (369.0 bits), Expect = 2.6e-168, Sum P(5) = 2.6e-168
Identities = 204/255 (80%), Positives = 222/255 (87%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
HRK+GR VAIK+IDKLRFPTKQE+QL+NEVAILQNL HPGVVNLE MFETP R+FVVMEK
Sbjct: 608 HRKTGRDVAIKIIDKLRFPTKQESQLRNEVAILQNLHHPGVVNLECMFETPERVFVVMEK 667
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
L GDMLEMILSSEKGRL E TKF+ITQILVAL+HLH KNIVHCDLKPENVLL++ P
Sbjct: 668 LHGDMLEMILSSEKGRLPEHITKFLITQILVALRHLHFKNIVHCDLKPENVLLASADPFP 727
Query: 953 QVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
QVKLCDFGFARIIGEKSF P PEVLRNKGYNRSLDMWSVGVI+YVSLSGTF
Sbjct: 728 QVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTF 787
Query: 1002 PFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
PFNEDEDI++QIQNAAFMYPP PW++IS +AIDLINNLLQVK RKR SVDK+L+HPWLQD
Sbjct: 788 PFNEDEDIHDQIQNAAFMYPPNPWKEISHEAIDLINNLLQVKMRKRYSVDKTLSHPWLQD 847
Query: 1062 PATWSDLRGLERQIG 1076
TW DLR LE +IG
Sbjct: 848 YQTWLDLRELECRIG 862
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1098 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-76 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-62 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-48 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-47 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-46 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-45 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-43 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-43 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-41 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-40 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-40 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-36 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-33 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-33 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-33 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-32 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-32 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-31 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-31 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-31 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-31 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-31 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-30 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-30 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-30 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-29 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-29 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-28 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-28 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-28 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-28 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-27 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-27 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-27 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-27 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-27 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-27 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-27 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-26 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-26 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-25 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-25 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-25 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-25 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-25 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-25 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-24 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-23 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-23 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-23 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-23 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-22 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-22 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-22 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-22 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-22 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-22 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-21 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-21 | |
| cd01239 | 127 | cd01239, PH_PKD, Protein kinase D (PKD/PKCmu) plec | 2e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-21 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-21 | |
| pfam04145 | 102 | pfam04145, Ctr, Ctr copper transporter family | 3e-21 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-21 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-21 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-20 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-20 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-20 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-19 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-19 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-19 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-19 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-18 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-18 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-18 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-18 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-17 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-17 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-16 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-16 | |
| cd00029 | 50 | cd00029, C1, Protein kinase C conserved region 1 ( | 2e-16 | |
| cd00029 | 50 | cd00029, C1, Protein kinase C conserved region 1 ( | 2e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-16 | |
| smart00109 | 50 | smart00109, C1, Protein kinase C conserved region | 6e-16 | |
| smart00109 | 50 | smart00109, C1, Protein kinase C conserved region | 6e-16 | |
| pfam00130 | 53 | pfam00130, C1_1, Phorbol esters/diacylglycerol bin | 7e-16 | |
| pfam00130 | 53 | pfam00130, C1_1, Phorbol esters/diacylglycerol bin | 7e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-14 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| cd01239 | 127 | cd01239, PH_PKD, Protein kinase D (PKD/PKCmu) plec | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-12 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd01239 | 127 | cd01239, PH_PKD, Protein kinase D (PKD/PKCmu) plec | 5e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-07 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-07 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-05 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-05 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-05 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-04 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-04 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 8e-04 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 0.001 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 0.001 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.001 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.002 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.002 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.002 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 0.003 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.003 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 250 bits (642), Expect = 3e-76
Identities = 97/244 (39%), Positives = 140/244 (57%), Gaps = 20/244 (8%)
Query: 830 CGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
+K+G+ VAIKVI K + K ++ E+ IL+ L HP +V L +FE ++++V
Sbjct: 17 LARDKKTGKLVAIKVIKK-KKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLV 75
Query: 890 MEKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
ME GD+ +++ ++GRLSE +F + QIL AL++LHSK IVH DLKPEN+LL +
Sbjct: 76 MEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDED 133
Query: 949 SELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSL 997
VKL DFG AR + PEVL KGY +++D+WS+GVI+Y L
Sbjct: 134 G---HVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELL 190
Query: 998 SGTFPFNEDEDINEQIQNAAFMYP--PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055
+G PF D+ + E + P P P DIS +A DLI LL KRL+ +++L
Sbjct: 191 TGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
Query: 1056 HPWL 1059
HP+
Sbjct: 251 HPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 2e-62
Identities = 85/248 (34%), Positives = 130/248 (52%), Gaps = 24/248 (9%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
H+ +G+ VA+K++ K +K++ + E+ IL+ L HP +V L FE +++VM
Sbjct: 18 AKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVM 77
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E + GD+ + + S G LSE K I QIL L++LHS I+H DLKPEN+LL N
Sbjct: 78 EYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDEN- 134
Query: 950 ELPQVKLCDFGFARIIGE-----KSF-------PPEVLR-NKGYNRSLDMWSVGVIVYVS 996
VK+ DFG A+ + + +F PEVL GY +D+WS+GVI+Y
Sbjct: 135 --GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYEL 192
Query: 997 LSGTFPFNEDEDINE-----QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVD 1051
L+G PF+ + +++ +I + W S +A DLI L KR + +
Sbjct: 193 LTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAE 252
Query: 1052 KSLAHPWL 1059
+ L HPW
Sbjct: 253 EILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-49
Identities = 81/246 (32%), Positives = 130/246 (52%), Gaps = 30/246 (12%)
Query: 833 HRKSGRGVAIKVIDKLR-FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ +G+ A+KV+ K + K+ E IL + HP +V L F+T ++++V+E
Sbjct: 14 KKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLE 73
Query: 892 KLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
G++ + S++GR SE +F +I++AL++LHS I++ DLKPEN+LL +
Sbjct: 74 YAPGGELFSHL--SKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG- 130
Query: 951 LPQVKLCDFGFARIIGEKSF------------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+KL DFG A+ + + PEVL KGY +++D WS+GV++Y L+
Sbjct: 131 --HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT 188
Query: 999 GTFPFNEDEDINE---QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL---SVDK 1052
G PF ED E +I +P +S +A DLI+ LLQ KRL ++
Sbjct: 189 GKPPF-YAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLLQKDPTKRLGSGGAEE 243
Query: 1053 SLAHPW 1058
AHP+
Sbjct: 244 IKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 3e-48
Identities = 78/240 (32%), Positives = 117/240 (48%), Gaps = 49/240 (20%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+K+G+ VAIK+I K + E +L E+ IL+ L HP +V L +FE +++VM
Sbjct: 12 ARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGVFEDENHLYLVM 70
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E +G L+ +L +G+LSE I+ QIL L++LHS I+H DLKPEN+LL +++
Sbjct: 71 EYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN- 129
Query: 951 LPQVKLCDFGFARIIGEKS------------FPPEVLRNKG-YNRSLDMWSVGVIVYVSL 997
+VKL DFG ++++ PEVL KG Y+ D+WS+GVI+Y
Sbjct: 130 -GKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILY--- 185
Query: 998 SGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
+ + DLI +LQ KR S + L H
Sbjct: 186 --------------------EL----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 7e-47
Identities = 86/249 (34%), Positives = 139/249 (55%), Gaps = 31/249 (12%)
Query: 833 HRKSGRGVAIKVIDK---LRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
H+ SG+ A+K++ K ++ KQ + NE ILQ++ HP +VNL F+ +++V
Sbjct: 22 HKGSGKYYALKILSKAKIVK--LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79
Query: 890 MEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
ME + G++ + S GR E +F Q+++AL++LHS +IV+ DLKPEN+LL ++
Sbjct: 80 MEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD 137
Query: 949 SELPQVKLCDFGFARIIGEKSF---------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
+ K+ DFGFA+ + +++ PE++ +KGY +++D W++G+++Y L+G
Sbjct: 138 GYI---KITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
Query: 1000 TFPFNEDEDIN--EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA-- 1055
PF +D I E+I +P S DA DLI NLLQV KRL K+
Sbjct: 195 YPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVND 250
Query: 1056 ---HPWLQD 1061
HPW
Sbjct: 251 IKNHPWFAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 9e-46
Identities = 82/257 (31%), Positives = 130/257 (50%), Gaps = 41/257 (15%)
Query: 833 HRKSGRGVAIKVIDKLR-FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ R A+K + K T Q+ + +E IL+ HP +V L R F+ I+++ME
Sbjct: 14 VKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLME 73
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
G L IL ++G E T +F I +++A ++LH++ I++ DLKPEN+LL +N
Sbjct: 74 YCLGGELWTILR-DRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-- 130
Query: 952 PQVKLCDFGFARII--GEKSF---------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
VKL DFGFA+ + G+K++ PE++ NKGY+ S+D WS+G+++Y L+G
Sbjct: 131 -YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
Query: 1001 FPFNEDED-----------INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS 1049
PF ED++ N +++ +P I A DLI LL+ +RL
Sbjct: 190 PPFGEDDEDPMEIYNDILKGNGKLE-----FPNY----IDKAAKDLIKQLLRRNPEERLG 240
Query: 1050 VDKSLA-----HPWLQD 1061
K H W
Sbjct: 241 NLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 8e-45
Identities = 86/255 (33%), Positives = 132/255 (51%), Gaps = 32/255 (12%)
Query: 833 HRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ +G AIKVI K K Q Q+ E IL P VV L F+ +++VME
Sbjct: 14 KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVME 73
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
L G L +L + G L E + I +I++AL++LHS I+H DLKP+N+L+ +N L
Sbjct: 74 YLPGGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHL 132
Query: 952 PQVKLCDFGFA-------------------RIIGEKSF-PPEVLRNKGYNRSLDMWSVGV 991
KL DFG + RI+G + PEV+ +G+++++D WS+G
Sbjct: 133 ---KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGC 189
Query: 992 IVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL- 1048
I+Y L G PF+ + E+I + I N +P ++S +AIDLI+ LL KRL
Sbjct: 190 ILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV--EVSDEAIDLISKLLVPDPEKRLG 247
Query: 1049 --SVDKSLAHPWLQD 1061
S+++ HP+ +
Sbjct: 248 AKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 83/268 (30%), Positives = 133/268 (49%), Gaps = 54/268 (20%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQ--EAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVM 890
+++ + AIK++DK R K+ +K E +L L HPG++ L F+ ++ V+
Sbjct: 23 KETNKEYAIKILDK-RQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81
Query: 891 EKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E G++L+ I + G L E+ T+F +IL+AL++LHSK I+H DLKPEN+LL +
Sbjct: 82 EYAPNGELLQYIR--KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM 139
Query: 950 ELPQVKLCDFGFARIIGE-------------------------KSF-------PPEVLRN 977
+K+ DFG A+++ SF PE+L
Sbjct: 140 ---HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE 196
Query: 978 KGYNRSLDMWSVGVIVYVSLSGTFPF---NEDEDINEQIQNAAFMYPPRPWRDISSDAID 1034
K +S D+W++G I+Y L+G PF NE ++I + +PP + DA D
Sbjct: 197 KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-TFQKILKLEYSFPP----NFPPDAKD 251
Query: 1035 LINNLLQVKQRKRLSVDKSL----AHPW 1058
LI LL + + RL V++ AHP+
Sbjct: 252 LIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-43
Identities = 86/292 (29%), Positives = 146/292 (50%), Gaps = 68/292 (23%)
Query: 827 GAAC-GVHRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMFETP 883
G C V +++GR VAIK I + F +A+ L+ E+ +L++L H ++ L + P
Sbjct: 14 GVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILR-EIKLLRHLRHENIIGLLDILRPP 71
Query: 884 GR-----IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDL 938
+++V E ++ D+ ++I S + L++ ++ + QIL LK+LHS N++H DL
Sbjct: 72 SPEDFNDVYIVTELMETDLHKVIKSPQP--LTDDHIQYFLYQILRGLKYLHSANVIHRDL 129
Query: 939 KPENVLLSTNSELPQVKLCDFGFARIIG----EKSF-----------PPEVLRN-KGYNR 982
KP N+L+++N +L K+CDFG AR + EK F PE+L + Y +
Sbjct: 130 KPSNILVNSNCDL---KICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTK 186
Query: 983 SLDMWSVGVIV--------------Y-------VSLSGTFPFNEDEDINEQIQNAAFM-- 1019
++D+WSVG I Y V + GT +ED+ + I +
Sbjct: 187 AIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS---EEDL-KFITSEKARNY 242
Query: 1020 ------YPPRPWRDI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
P +P + S +AIDL+ +L +KR++ D++LAHP+L
Sbjct: 243 LKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 4e-41
Identities = 73/242 (30%), Positives = 120/242 (49%), Gaps = 23/242 (9%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
+ G+ +K ID K+ NEV IL+ L HP ++ FE G++ +VME
Sbjct: 21 RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80
Query: 893 L-QGDMLEMILSSEKGR--LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
GD+ + I +K E Q+ +ALK+LHS+ I+H D+KP+N+ L++N
Sbjct: 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN- 139
Query: 950 ELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVSL 997
VKL DFG ++++ PE+ +NK YN D+WS+G ++Y
Sbjct: 140 --GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELC 197
Query: 998 SGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055
+ PF + ++ +I YPP P + SS+ +L+++LLQ +R S+ + L
Sbjct: 198 TLKHPFEGENLLELALKILKGQ--YPPIPSQ-YSSELRNLVSSLLQKDPEERPSIAQILQ 254
Query: 1056 HP 1057
P
Sbjct: 255 SP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 87/253 (34%), Positives = 131/253 (51%), Gaps = 28/253 (11%)
Query: 827 GAACGV-HRKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLCHPGVVNLERMFETPG 884
G C V R + + A+K ++K + K + + NE ILQ L HP +VNL F+
Sbjct: 14 GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE 73
Query: 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944
+++V++ L G L LS +K + SE KF I +I++AL++LHSK I+H D+KP+N+L
Sbjct: 74 NMYLVVDLLLGGDLRYHLS-QKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNIL 132
Query: 945 LSTNSELPQVKLCDFGFARII--GEKSF---------PPEVLRNKGYNRSLDMWSVGVIV 993
L E V + DF A + + PEVL +GY+ ++D WS+GV
Sbjct: 133 L---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTA 189
Query: 994 YVSLSGTFPF-NEDEDINEQIQN----AAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
Y L G P+ I +QI+ A +YP W S++AID IN LL+ +KRL
Sbjct: 190 YECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT-W---STEAIDAINKLLERDPQKRL 245
Query: 1049 S--VDKSLAHPWL 1059
+ HP+
Sbjct: 246 GDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 79/269 (29%), Positives = 126/269 (46%), Gaps = 47/269 (17%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLK-NEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ +G VAIK I KLRF ++ + E+ +L+ L HP ++ L +F G +++V E
Sbjct: 20 DKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ D+ ++I ++G L E K + Q+L L HS I+H DLKPEN+L++T
Sbjct: 79 FMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-- 135
Query: 952 PQVKLCDFGFARIIGEKSFP------------PEVL-RNKGYNRSLDMWSVGVIVY--VS 996
+KL DFG AR G P PE+L +KGY+ +D+WSVG I +S
Sbjct: 136 -VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194
Query: 997 LSGTFPFNED----------------EDINEQIQNAAFMYPPRP----------WRDISS 1030
FP + E + A P + + S
Sbjct: 195 RRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASP 254
Query: 1031 DAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
A+DL++ +L KR++ +++LAHP+
Sbjct: 255 QALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 8e-39
Identities = 77/273 (28%), Positives = 127/273 (46%), Gaps = 50/273 (18%)
Query: 830 CGVHRKSGRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFETPGRI 886
+K+G VA+K I R ++E E+++L+ L HP +V L + T ++
Sbjct: 17 KARDKKTGEIVALKKI---RLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKL 73
Query: 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
++V E D L+ L G LS K I+ Q+L L + HS I+H DLKP+N+L++
Sbjct: 74 YLVFEYCDMD-LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN 132
Query: 947 TNSELPQVKLCDFGFARIIG--EKSF----------PPEVL-RNKGYNRSLDMWSVGVIV 993
+ L KL DFG AR G +++ PE+L +K Y+ ++D+WSVG I
Sbjct: 133 RDGVL---KLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIF 189
Query: 994 YVSLSGTFPFNEDEDI-------------NEQI----------QNAAFMYPPRPWRDI-- 1028
++G F D +I E+ + +PP+ +
Sbjct: 190 AEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLP 249
Query: 1029 --SSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
+ IDL++ +LQ KR+S ++L HP+
Sbjct: 250 RLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 71/246 (28%), Positives = 120/246 (48%), Gaps = 21/246 (8%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
H+ +G+ A+K I ++ QL E+ L++ P VV F G I +V+
Sbjct: 20 VRHKPTGKIYALKKIHVDGDEEFRK-QLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNS 949
E + G L +L G++ E +I QIL L +LH+K +I+H D+KP N+L+++
Sbjct: 79 EYMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG 137
Query: 950 ELPQVKLCDFGFARII-----GEKSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSL 997
E VK+ DFG ++++ +F PE ++ + Y+ + D+WS+G+ +
Sbjct: 138 E---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECA 194
Query: 998 SGTFPF--NEDEDINEQIQNAAFMYPPR-PWRDISSDAIDLINNLLQVKQRKRLSVDKSL 1054
G FPF E +Q PP P + S + D I+ LQ +KR S + L
Sbjct: 195 LGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELL 254
Query: 1055 AHPWLQ 1060
HP+++
Sbjct: 255 QHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 70/257 (27%), Positives = 118/257 (45%), Gaps = 49/257 (19%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF-----ETPGRIFV 888
+ +G +A+K ++ ++ L+ E+ IL +L HP +V R + E + +
Sbjct: 22 KDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV---RYYGSERDEEKNTLNI 78
Query: 889 VMEKLQG----DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944
+E + G +L+ G+L E + QIL L +LHS IVH D+K N+L
Sbjct: 79 FLEYVSGGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANIL 133
Query: 945 LSTNSELPQVKLCDFGFARIIGEKSFP--------------PEVLRNKGYNRSLDMWSVG 990
+ ++ VKL DFG A+ +G+ PEV+R + Y R+ D+WS+G
Sbjct: 134 VDSDG---VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLG 190
Query: 991 VIVYVSLSGTFPFNEDEDINEQIQNAAFMY--------PPRPWRDISSDAIDLINNLLQV 1042
V +G P++E + A +Y P P +S +A D + L+
Sbjct: 191 CTVIEMATGKPPWSELGN------PMAALYKIGSSGEPPEIP-EHLSEEAKDFLRKCLRR 243
Query: 1043 KQRKRLSVDKSLAHPWL 1059
+KR + D+ L HP+L
Sbjct: 244 DPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 74/239 (30%), Positives = 123/239 (51%), Gaps = 19/239 (7%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
H+++G+ VAIKVI KL K+E ++ NE+ IL+ HP +V + +++VME
Sbjct: 21 HKRTGKEVAIKVI-KLESKEKKE-KIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
G L+ +L S L+E ++ ++L L++LHS I+H D+K N+LL+++ E
Sbjct: 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE-- 136
Query: 953 QVKLCDFGFA----------RIIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLS-GT 1000
VKL DFG + ++G + PEV+ K Y+ D+WS+G I + L+ G
Sbjct: 137 -VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLG-ITAIELAEGK 194
Query: 1001 FPFNEDEDINEQIQNAAFMYPPRPWRDISSDAI-DLINNLLQVKQRKRLSVDKSLAHPW 1058
P++E + + A P + SD D + LQ KR + ++ L HP+
Sbjct: 195 PPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 78/230 (33%), Positives = 125/230 (54%), Gaps = 24/230 (10%)
Query: 833 HRKSGRGVAIKVIDK---LRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
H+ +G AIK + K L+ KQ + E +IL L HP +VN+ F+ R++ +
Sbjct: 39 HKGTGEYYAIKCLKKREILKM--KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
+E + G L L GR KF ++++A ++LHSK+I++ DLKPEN+LL
Sbjct: 97 LEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG 155
Query: 950 ELPQVKLCDFGFARIIGEKSF---------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
VK+ DFGFA+ + +++F PEV+++KG+ +++D W++GV++Y ++G
Sbjct: 156 ---HVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGY 212
Query: 1001 FPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
PF +D I E+I +P W D A DL+ LLQ KRL
Sbjct: 213 PPFFDDTPFRIYEKILAGRLKFP--NWFD--GRARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 72/264 (27%), Positives = 127/264 (48%), Gaps = 33/264 (12%)
Query: 827 GAACGV----HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET 882
GA+ V R +G+ VAIK + R + + + NE+ I+++ HP +V+ +
Sbjct: 30 GASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 883 PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
++VVME + G L I++ R++E ++ ++L L++LHS+N++H D+K +N
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN 146
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSF------------PPEVLRNKGYNRSLDMWSVG 990
+LLS + VKL DFGFA + ++ PEV++ K Y +D+WS+G
Sbjct: 147 ILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLG 203
Query: 991 VIVYVSLSGTFPFNEDEDINEQIQNAAFMY------PPRPWRDISSDAIDLINNLLQVKQ 1044
++ G P+ + E A F+ P + S + D +N L
Sbjct: 204 IMCIEMAEGEPPY-----LREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDP 258
Query: 1045 RKRLSVDKSLAHPWLQDPATWSDL 1068
KR S ++ L HP+L+ +
Sbjct: 259 EKRPSAEELLQHPFLKKACPKEEF 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 78/257 (30%), Positives = 126/257 (49%), Gaps = 33/257 (12%)
Query: 827 GAACGVHRKS-GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVN-LERMFETPG 884
G V RKS G+ + K ID K++ QL +EV IL+ L HP +V +R+ +
Sbjct: 14 GTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73
Query: 885 -RIFVVMEKLQGDMLEMILS---SEKGRLSERTTKFIITQILVALKHLH-----SKNIVH 935
+++VME +G L ++ E+ + E I+TQ+L+AL H ++H
Sbjct: 74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLH 133
Query: 936 CDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF------------PPEVLRNKGYNRS 983
DLKP N+ L N VKL DFG A+I+G S PE L + Y+
Sbjct: 134 RDLKPANIFLDAN---NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK 190
Query: 984 LDMWSVGVIVYVSLSGTFPF---NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040
D+WS+G ++Y + + PF N+ + + +I+ + P+R SS+ ++I ++L
Sbjct: 191 SDIWSLGCLIYELCALSPPFTARNQLQ-LASKIKEG--KFRRIPYR-YSSELNEVIKSML 246
Query: 1041 QVKQRKRLSVDKSLAHP 1057
V KR S ++ L P
Sbjct: 247 NVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 84/254 (33%), Positives = 134/254 (52%), Gaps = 30/254 (11%)
Query: 833 HRKSGRGVAIKVI---DKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
R S A+KV+ + +R KQE + NE +L+ + HP ++ L ++++
Sbjct: 22 DRISEHYYALKVMAIPEVIRL--KQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
ME + G L L + GR S T F ++I+ AL++LHSK IV+ DLKPEN+LL
Sbjct: 80 MEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG 138
Query: 950 ELPQVKLCDFGFARIIGEKSF---------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
+KL DFGFA+ + ++++ PEV+++KG+N+++D W++G+++Y L G
Sbjct: 139 ---HIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
Query: 1001 FPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA--- 1055
PF +D I E+I +P R + A DLI LL V + +RL K+ A
Sbjct: 196 PPFFDDNPFGIYEKILAGKLEFP----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDV 251
Query: 1056 --HPWLQDPATWSD 1067
H W + W D
Sbjct: 252 KNHRWFKS-VDWDD 264
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 88/291 (30%), Positives = 141/291 (48%), Gaps = 61/291 (20%)
Query: 827 GAAC-GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL-----ERMF 880
G C H+ +G VAIK I T + L+ E+ IL+ H ++ + F
Sbjct: 19 GMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHENIIGILDIIRPPSF 77
Query: 881 ETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKP 940
E+ +++V E ++ D+ ++I + LS ++ + QIL LK++HS N++H DLKP
Sbjct: 78 ESFNDVYIVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKP 134
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGEKSFP---------------PEV-LRNKGYNRSL 984
N+LL+TN +L K+CDFG ARI + PE+ L +KGY +++
Sbjct: 135 SNLLLNTNCDL---KICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAI 191
Query: 985 DMWSVGVIVYVSLSGT--FPFNE----------------DEDINEQIQNAAF-------M 1019
D+WSVG I+ LS FP + ED+N I A
Sbjct: 192 DIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPF 251
Query: 1020 YPPRPWRDI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ---DPA 1063
P PW + A+DL++ +L KR++V+++LAHP+L+ DP+
Sbjct: 252 KPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS 302
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 86/292 (29%), Positives = 139/292 (47%), Gaps = 63/292 (21%)
Query: 822 IAVVAGAACGV-----HRKSGRGVAIKVIDKLRFPTKQEAQ-LKN----EVAILQNLCHP 871
+ VV A GV ++ +G VAIK +F ++ + +K EV +L+ L H
Sbjct: 6 LGVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 872 GVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK 931
+VNL+ F GR+++V E ++ +LE++ +S G L + I Q+L A+ + HS
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG-LPPDAVRSYIWQLLQAIAYCHSH 119
Query: 932 NIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSFP-------------PEVL-RN 977
NI+H D+KPEN+L+S + L KLCDFGFAR + + PE+L +
Sbjct: 120 NIIHRDIKPENILVSESGVL---KLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 978 KGYNRSLDMWSVGVIVYVSLSGT--FPFNEDEDINEQIQN-------------------A 1016
Y + +D+W++G I+ L G FP + D D IQ A
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 1017 AFMYPP---------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
+P R +SS A+D + L++ ++RL+ D+ L HP+
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 78/272 (28%), Positives = 133/272 (48%), Gaps = 49/272 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVV 889
++++G VAIK + K +F + +E EV L+ L HP +V L+ +F ++ V
Sbjct: 18 ARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E ++G++ +++ + SE + II QIL L H+H H DLKPEN+L+S
Sbjct: 77 FEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS-GP 135
Query: 950 ELPQVKLCDFGFARIIGEKSFP-------------PEV-LRNKGYNRSLDMWSVGVIVY- 994
E+ VK+ DFG AR I +S P PE+ LR+ Y+ +D+W++G I+
Sbjct: 136 EV--VKIADFGLAREI--RSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAE 191
Query: 995 -VSLSGTFP-FNEDEDIN---------------EQIQNAAFM------YPPRPWRDI--- 1028
+L FP +E + + E + A+ + + P +
Sbjct: 192 LYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPN 251
Query: 1029 -SSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
S +AIDLI ++L+ +KR + ++L HP+
Sbjct: 252 ASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 4e-32
Identities = 85/264 (32%), Positives = 125/264 (47%), Gaps = 38/264 (14%)
Query: 840 VAIKVIDK-LRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGDM 897
VA+KV+ K L +K+ + E+ IL +L P +V L F+ G +++VME + G
Sbjct: 25 VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGS 84
Query: 898 LEMILSS--EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVK 955
LE +L KG LSE FI+ QIL AL++LHSK I+H D+KPEN+LL + + VK
Sbjct: 85 LEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL--DRDGRVVK 142
Query: 956 LCDFGFARIIGEKSF------------------PPEVLR---NKGYNRSLDMWSVGVIVY 994
L DFG A+++ + PEVL + S D+WS+G+ +Y
Sbjct: 143 LIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLY 202
Query: 995 VSLSGTFPFNEDEDINEQIQ-----------NAAFMYPPRPWRDISSDAIDLINNLLQVK 1043
L+G PF +++ + Q + A P IS A DL+ LL
Sbjct: 203 ELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKD 262
Query: 1044 QRKRLSVDKSLAHPWLQDPATWSD 1067
+ RLS L+H L
Sbjct: 263 PKNRLSSSSDLSHDLLAHLKLKES 286
|
Length = 384 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 7e-32
Identities = 93/285 (32%), Positives = 137/285 (48%), Gaps = 62/285 (21%)
Query: 830 CGVHRKSGRGVAIKVI-DKLRFPTKQEAQLK-NEVAILQNL-CHPGVVNLERMF--ETPG 884
+ R++ VA+K I D R T +AQ E+ LQ L HP +V L + E
Sbjct: 25 KAIDRRTKEVVALKKIFDAFRNAT--DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82
Query: 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944
I++V E ++ D+ +I L + ++I+ Q+L ALK++HS N++H DLKP N+L
Sbjct: 83 DIYLVFEYMETDLHAVI---RANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNIL 139
Query: 945 LSTNSELPQVKLCDFGFARII----GEKSFP-------------PEVL-RNKGYNRSLDM 986
L NS+ +VKL DFG AR + P PE+L + Y + +DM
Sbjct: 140 L--NSDC-RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDM 196
Query: 987 WSVGVIVYVSLSGT--FP----FNE------------DEDINEQIQN--AAFM---YPPR 1023
WSVG I+ L G FP N+ EDI E I++ AA M P R
Sbjct: 197 WSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI-ESIKSPFAATMLDSLPSR 255
Query: 1024 PWR-------DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
P + S DA+DL+ LL KRL+ +++L HP++
Sbjct: 256 PRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 31/248 (12%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G++ ++G VAIK I + + + E+ +L+NL HP +V ET +++++
Sbjct: 19 GLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E + L I+ + G E + Q+L L +LH + ++H D+K N+L + +
Sbjct: 79 EYAENGSLRQII-KKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV 137
Query: 951 LPQVKLCDFGFARIIGEKSFP------------PEVLRNKGYNRSLDMWSVGVIVYVSLS 998
VKL DFG A + + S PEV+ G + + D+WS+G V L+
Sbjct: 138 ---VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT 194
Query: 999 GTFPFNEDEDINEQIQNAAFMY-------PPRPWRDISSDAIDLINNLLQVKQRKRLSVD 1051
G P+ + + A ++ PP P IS + D + Q R +
Sbjct: 195 GNPPYYD-------LNPMAALFRIVQDDHPPLP-EGISPELKDFLMQCFQKDPNLRPTAK 246
Query: 1052 KSLAHPWL 1059
+ L HPW+
Sbjct: 247 QLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 63/208 (30%), Positives = 108/208 (51%), Gaps = 26/208 (12%)
Query: 869 CHPGVVNLERMFETPGRIFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKH 927
+P + L T ++M+ ++ GD+ +++ +G+LSE K II Q++ AL
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALND 124
Query: 928 LHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS--------FPPEVLRNKG 979
LH NI+H D+K ENVL + ++ LCD+G +IIG S F PE ++
Sbjct: 125 LHKHNIIHNDIKLENVLY--DRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIKGHN 182
Query: 980 YNRSLDMWSVGVIVYVSLSGTFPF--NEDEDIN-----EQIQNAAFMYPPRPWRDISSDA 1032
Y+ S D W+VGV+ Y L+G PF +EDE+++ ++ Q +++S +A
Sbjct: 183 YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-----KLPFIKNVSKNA 237
Query: 1033 IDLINNLLQVKQRKRLSVDKSLA-HPWL 1059
D + ++L+ RL+ + HP+L
Sbjct: 238 NDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 71/243 (29%), Positives = 116/243 (47%), Gaps = 19/243 (7%)
Query: 834 RKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCH-PGVVNLERMFETPGRIFVVME 891
R +G AIKV+ K K Q +K E AI+ P V L F++ +++VME
Sbjct: 18 RSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVME 77
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
L G ++ + G L E K I ++++ ++ LH + I+H D+KPEN+L+ L
Sbjct: 78 YLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHL 136
Query: 952 PQVKLCDFGFARIIGEKS--------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPF 1003
KL DFG +R E PE + G ++ D WS+G +++ L G PF
Sbjct: 137 ---KLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPF 193
Query: 1004 NED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS---VDKSLAHPW 1058
+ + + + + I + +P S +A+DLIN LL + KRL + +HP+
Sbjct: 194 HAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253
Query: 1059 LQD 1061
+
Sbjct: 254 FKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 7e-31
Identities = 84/264 (31%), Positives = 132/264 (50%), Gaps = 34/264 (12%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE--AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+G+ A+KV+ K Q+ A K E IL+ + HP +V+L F+T G++++++E
Sbjct: 21 ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
L G L M L E G E T F +++I +AL+HLH + I++ DLKPEN+LL
Sbjct: 81 YLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-- 137
Query: 952 PQVKLCDFGFAR---IIGEKS---------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
VKL DFG + G + PE+L G+ +++D WS+G ++Y L+G
Sbjct: 138 -HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
Query: 1000 TFPF---NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA- 1055
PF N + I ++I PP ++ +A DL+ LL+ RL A
Sbjct: 197 APPFTAENRKKTI-DKILKGKLNLPPY----LTPEARDLLKKLLKRNPSSRLGAGPGDAA 251
Query: 1056 ----HPWLQDPATWSDLRGLERQI 1075
HP+ + W DL L R++
Sbjct: 252 EVQSHPFFRH-VNWDDL--LARKV 272
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 55/274 (20%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEA---QLKNEVAILQNLCHPGVVNLERMFETPGR--IF 887
++K+G VA+K K+R ++E E+ +LQ L HP +V L+ + + G+ I+
Sbjct: 20 NKKTGELVALK---KIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY 76
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+V E + D L +L S + + +E K + Q+L L++LHS I+H D+K N+L++
Sbjct: 77 MVFEYMDHD-LTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN 135
Query: 948 NSELPQVKLCDFGFARII-GEKSF------------PPEVLRN-KGYNRSLDMWSVGVIV 993
+ L KL DFG AR S PPE+L Y +DMWSVG I+
Sbjct: 136 DGVL---KLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCIL 192
Query: 994 YVSLSGTFPF---NE--------------DEDINEQIQNAAFMYPPRP-------WRD-- 1027
G F E ++ + + +P R+
Sbjct: 193 AELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFF 252
Query: 1028 ---ISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
I A+DL++ LL + +KR+S D++L H +
Sbjct: 253 KHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 78/274 (28%), Positives = 120/274 (43%), Gaps = 54/274 (19%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEA---QLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888
R++G VA+K K+ + Q E+ LQ HP VV L +F +
Sbjct: 20 KDRETGETVALK---KVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVL 76
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
VME + D+ E++ E+ L E K + +L + ++H+ I+H DLKP N+L+S +
Sbjct: 77 VMEYMPSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD 135
Query: 949 SELPQVKLCDFGFARIIGEKSFP-------------PEVLRNK-GYNRSLDMWSVGVIVY 994
L K+ DFG AR+ E+ PE+L Y+ +D+W+VG I
Sbjct: 136 GVL---KIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFA 192
Query: 995 VSLSGTFPFNEDEDINEQI---------QNA---------------AFMY-PPRPWRDI- 1028
L+G+ F + DI EQ+ N F P P +I
Sbjct: 193 ELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIF 251
Query: 1029 ---SSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
S +A+DL+ LL KRLS ++L HP+
Sbjct: 252 PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 71/260 (27%), Positives = 126/260 (48%), Gaps = 36/260 (13%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCH-PGVVNLERMFETPGRIFVVMEKL 893
G+ A+KV+ K K + + E +L+ + P +V L F+T ++ ++++ +
Sbjct: 28 GKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYV 87
Query: 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953
G L L + +E + I +I++AL HLH I++ D+K EN+LL +
Sbjct: 88 NGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG---H 143
Query: 954 VKLCDFGFARII----GEKSF---------PPEVLRNK--GYNRSLDMWSVGVIVYVSLS 998
V L DFG ++ E+++ PEV+R G+++++D WS+GV+ + L+
Sbjct: 144 VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
Query: 999 GTFPF------NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL---S 1049
G PF N +I+ +I + +P +S++A D I LL+ +KRL
Sbjct: 204 GASPFTVDGEQNSQSEISRRILKSKPPFPK----TMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 1050 VDKSLAHPWLQDPATWSDLR 1069
D+ HP+ Q W DL
Sbjct: 260 ADEIKNHPFFQG-IDWDDLA 278
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 82/275 (29%), Positives = 137/275 (49%), Gaps = 59/275 (21%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFETPGR----- 885
K+GR VAIK KL P + K E+ +L+++ H V+ L +F TP
Sbjct: 37 TKTGRKVAIK---KLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF-TPASSLEDF 92
Query: 886 --IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
+++V + D L I+ +K LS+ +F++ QIL LK++HS I+H DLKP N+
Sbjct: 93 QDVYLVTHLMGAD-LNNIVKCQK--LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI 149
Query: 944 LLSTNSELPQVKLCDFGFARIIGEKSF---------PPEVLRNKG-YNRSLDMWSVGVIV 993
++ + EL K+ DFG AR ++ PE++ N YN+++D+WSVG I+
Sbjct: 150 AVNEDCEL---KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206
Query: 994 YVSLSGT--FPFNE---------------DEDINEQIQNAAF-----MYPPRPWRDI--- 1028
L+G FP ++ DE++ ++I + + P P +D
Sbjct: 207 AELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEV 266
Query: 1029 ----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
+ AIDL+ +L + KR++ ++LAHP+L
Sbjct: 267 FSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 80/275 (29%), Positives = 129/275 (46%), Gaps = 56/275 (20%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQ-------LKNEVAILQNLCHPGVVNLERMFETP 883
+++GR VAIK K++ ++EA+ L+ E+ +LQ L HP ++ L +F
Sbjct: 19 ARDKETGRIVAIK---KIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIGLLDVFGHK 74
Query: 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
I +V E ++ D LE ++ + L+ K + L L++LHS I+H DLKP N+
Sbjct: 75 SNINLVFEFMETD-LEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNL 133
Query: 944 LLSTNSELPQVKLCDFGFARIIGEKSF------------PPEVLRN-KGYNRSLDMWSVG 990
L++++ +KL DFG AR G + PE+L + Y +DMWSVG
Sbjct: 134 LIASDG---VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVG 190
Query: 991 VIVYVSLSGTFPFNEDEDINEQI------------QNAAFM-----------YPPRPWRD 1027
I L D DI +Q+ +N + +PP P +
Sbjct: 191 CIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQ 249
Query: 1028 I----SSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
I S DA+DL+ LL + KR++ ++L HP+
Sbjct: 250 IFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 76/252 (30%), Positives = 119/252 (47%), Gaps = 35/252 (13%)
Query: 831 GVHRKSGRGVAIKVID-KLRFPTKQEA--QLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
G++ G A+K + T QEA QL+ E+A+L L HP +V ++
Sbjct: 19 GLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLY 78
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+ +E + G L +L + G E + QIL+ L++LH +N VH D+K N+L+ T
Sbjct: 79 IFLELVPGGSLAKLLK-KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT 137
Query: 948 NSELPQVKLCDFGFARIIGE----KSF-------PPEVLRNKG-YNRSLDMWSVGVIVYV 995
N VKL DFG A+ + E KSF PEV+ +G Y + D+WS+G V
Sbjct: 138 NG---VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLE 194
Query: 996 SLSGTFPFNEDEDINEQIQNAAFMY--------PPRPWRDISSDAIDLINNLLQVKQRKR 1047
+G P+++ E + A ++ PP P +S +A D I LQ R
Sbjct: 195 MATGKPPWSQLEGV-------AAVFKIGRSKELPPIP-DHLSDEAKDFILKCLQRDPSLR 246
Query: 1048 LSVDKSLAHPWL 1059
+ + L HP++
Sbjct: 247 PTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 71/232 (30%), Positives = 116/232 (50%), Gaps = 21/232 (9%)
Query: 841 AIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDMLE 899
A+K +D K+ NE+ IL ++ HP +++ + F ++ +VME GD+ +
Sbjct: 29 ALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSK 88
Query: 900 MILSSEKGR--LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957
I +K R + E+ I Q+L L+ LH + I+H DLK N+LL N VK+
Sbjct: 89 AISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND---LVKIG 145
Query: 958 DFGFARI---------IGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED- 1006
D G +++ IG + PEV + + Y+ D+WS+G ++Y + PF
Sbjct: 146 DLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205
Query: 1007 -EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
+D+ ++Q YPP P S D + I ++LQVK + R + DK LA P
Sbjct: 206 MQDLRYKVQRGK--YPPIPPI-YSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 78/275 (28%), Positives = 120/275 (43%), Gaps = 55/275 (20%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE----AQLKNEVAILQNLC---HPGVVNLERMFETPGR 885
+GR VA+K K+R P +E + L+ E+A+L+ L HP +V L + P
Sbjct: 20 DLNTGRFVALK---KVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVRLLDVCHGPRT 75
Query: 886 -----IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKP 940
+ +V E + D+ + K L T K ++ Q+L + LHS IVH DLKP
Sbjct: 76 DRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKP 135
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSV 989
+N+L++++ QVK+ DFG ARI + PEVL Y +DMWSV
Sbjct: 136 QNILVTSDG---QVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSV 192
Query: 990 GVIVY--VSLSGTFPFNEDED----INEQI---------QNAAFM---YPPRPWRD---- 1027
G I F + D I + I +N + +P R
Sbjct: 193 GCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSF 252
Query: 1028 ---ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
I + +DL+ +L KR+S ++L HP+
Sbjct: 253 VPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 80/254 (31%), Positives = 119/254 (46%), Gaps = 25/254 (9%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
H+ G+ A+KV+ K K+E + + +L+N+ HP +V L F+T +++ V+
Sbjct: 16 HKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL 75
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ + G L L E+ E +F +I AL +LHS NI++ DLKPEN+LL +
Sbjct: 76 DYVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG- 133
Query: 951 LPQVKLCDFGFAR--IIGEKS----------FPPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
V L DFG + I K+ PEVLR + Y+R++D W +G ++Y L
Sbjct: 134 --HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191
Query: 999 GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSL---- 1054
G PF D E N P R +IS A L+ LLQ + KRL
Sbjct: 192 GLPPFYS-RDTAEMYDN-ILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIK 249
Query: 1055 AHPWLQDPATWSDL 1068
H + W DL
Sbjct: 250 NHVFFS-SINWDDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 80/290 (27%), Positives = 138/290 (47%), Gaps = 66/290 (22%)
Query: 827 GAAC-GVHRKSGRGVAIKVI-DKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG 884
G C + +SG+ VAIK I PT + L+ E+ IL++ H ++ + + PG
Sbjct: 19 GVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIRDILRPPG 77
Query: 885 R----IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKP 940
++VVM+ ++ D+ +I S + L+E ++ + Q+L LK++HS N++H DLKP
Sbjct: 78 ADFKDVYVVMDLMESDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKP 135
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGEKSF----------------PPEVLRN-KGYNRS 983
N+L++ + EL ++ DFG AR + PE+L + Y +
Sbjct: 136 SNLLVNEDCEL---RIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTA 192
Query: 984 LDMWSVGVI---------------------VYVSLSGTFPFNEDEDINE--------QIQ 1014
+DMWSVG I + +S+ G+ +E +N IQ
Sbjct: 193 IDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS---EEVLNRIGSDRVRKYIQ 249
Query: 1015 NAAFMYPPRPW----RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060
N P PW S +A+DL++ +LQ +R++V+++L HP+L
Sbjct: 250 NLP-RKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 69/248 (27%), Positives = 125/248 (50%), Gaps = 26/248 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF----ETPGRI 886
G H +GR VA+K+I+ L P + ++ EVA+L L N+ + + + P R+
Sbjct: 20 GKHVPTGRVVALKIIN-LDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP-RL 77
Query: 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
+++ME +G + ++ + G ++E+ II ++LVALK++H ++H D+K N+L++
Sbjct: 78 WIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT 135
Query: 947 TNSELPQVKLCDFGFARIIGEKS------------FPPEVLRN-KGYNRSLDMWSVGVIV 993
VKLCDFG A ++ + S PEV+ K Y+ D+WS+G+ +
Sbjct: 136 NTG---NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITI 192
Query: 994 YVSLSGTFPFNEDEDINEQIQNAAFMYPPR-PWRDISSDAIDLINNLLQVKQRKRLSVDK 1052
Y +G P++ D D + PPR S + + L + ++RLS ++
Sbjct: 193 YEMATGNPPYS-DVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEE 251
Query: 1053 SLAHPWLQ 1060
L W++
Sbjct: 252 LLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 77/245 (31%), Positives = 122/245 (49%), Gaps = 20/245 (8%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+HR +G+ +A+K I +L + Q+ E+ IL P +V F G I + ME
Sbjct: 21 LHRPTGKIMAVKTI-RLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNSE 950
+ G L+ IL +GR+ ER I +L L +LH K I+H D+KP N+L+++
Sbjct: 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG- 138
Query: 951 LPQVKLCDFGFAR---------IIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
Q+KLCDFG + +G S+ PE ++ Y+ D+WS+G+ + +G
Sbjct: 139 --QIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
Query: 1001 FPF-NEDED---INEQIQNAAFMYPPR-PWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055
FP+ E++ I E +Q PPR P S D D +N L R+R S + L
Sbjct: 197 FPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256
Query: 1056 HPWLQ 1060
HP+++
Sbjct: 257 HPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 74/254 (29%), Positives = 117/254 (46%), Gaps = 43/254 (16%)
Query: 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL-------ERMFETPGRIFV 888
+G +A+K I K ++ +E+ +L+ L HP +V E+++ IF
Sbjct: 24 TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVY-----IF- 77
Query: 889 VMEKLQGDMLEMILSSEKGR-LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
ME G LE +L E GR L E + Q+L L +LHS IVH D+KP N+ L
Sbjct: 78 -MEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH 134
Query: 948 NSELPQVKLCDFGFARIIGEKSFP----------------PEVLRN---KGYNRSLDMWS 988
N + KL DFG A + + PEV+ KG+ R+ D+WS
Sbjct: 135 NGVI---KLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWS 191
Query: 989 VGVIVYVSLSGTFPFNEDEDINEQI--QNAAFMYPPRPWRD-ISSDAIDLINNLLQVKQR 1045
+G +V +G P++E ++ QI A PP P +S + D ++ L+ +
Sbjct: 192 LGCVVLEMATGKRPWSELDN-EFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPK 250
Query: 1046 KRLSVDKSLAHPWL 1059
KR + + L HP++
Sbjct: 251 KRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-28
Identities = 83/286 (29%), Positives = 138/286 (48%), Gaps = 68/286 (23%)
Query: 830 CGVHRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMFETPGR-- 885
+ ++ VAIK I F + +A+ L+ E+ +L++L H V+ ++ + P R
Sbjct: 23 SAKNSETNEKVAIKKIANA-FDNRIDAKRTLR-EIKLLRHLDHENVIAIKDIMPPPHREA 80
Query: 886 ---IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
+++V E + D+ ++I SS+ LS+ ++ + Q+L LK++HS N++H DLKP N
Sbjct: 81 FNDVYIVYELMDTDLHQIIRSSQT--LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN 138
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKS------------FPPEVLRN-KGYNRSLDMWSV 989
+LL+ N +L K+CDFG AR EK PE+L N Y ++D+WSV
Sbjct: 139 LLLNANCDL---KICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSV 195
Query: 990 GVI---------------------VYVSLSGTFPFNEDEDI--NEQI------------Q 1014
G I + L G+ P ED NE+ Q
Sbjct: 196 GCIFAELLGRKPLFPGKDYVHQLKLITELLGS-PSEEDLGFIRNEKARRYIRSLPYTPRQ 254
Query: 1015 NAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060
+ A ++P + AIDL+ +L KR++V+++LAHP+L
Sbjct: 255 SFARLFP-----HANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 68/240 (28%), Positives = 119/240 (49%), Gaps = 17/240 (7%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
++ G+ IK I+ + K+ + + EVA+L N+ HP +V + FE G +++VM+
Sbjct: 21 SKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80
Query: 893 LQGDMLEMILSSEKGRL-SERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+G L +++++G L E QI +ALKH+H + I+H D+K +N+ L+ +
Sbjct: 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-- 138
Query: 952 PQVKLCDFGFARI-----------IGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
+KL DFG AR+ IG + PE+ N+ YN D+W++G ++Y +
Sbjct: 139 -TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTL 197
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
F N ++ YPP S D +L++ L + R R SV+ L ++
Sbjct: 198 KHAFEAGNMKNLVLKIIRGSYPPVSSH-YSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 72/252 (28%), Positives = 121/252 (48%), Gaps = 21/252 (8%)
Query: 834 RKSGRGVAIKVIDK-LRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
+ +G VA+K + K L F + + E IL +V L F+ +++ ME
Sbjct: 23 KDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
+ G +L++ G LSE +F + ++ A+ LH +H DLKPEN L+
Sbjct: 83 VPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID---ASG 138
Query: 953 QVKLCDFGFAR--------IIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPF 1003
+KL DFG ++ ++G + PEVLR KGY+ ++D WS+G ++Y L G PF
Sbjct: 139 HIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF 198
Query: 1004 NED--EDINEQIQNAAFMYP-PR---PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
+ + E ++ P P ++S +A DLI L+ R+ S++ HP
Sbjct: 199 SGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258
Query: 1058 WLQDPATWSDLR 1069
+ + W++LR
Sbjct: 259 FFK-EVDWNELR 269
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 71/249 (28%), Positives = 112/249 (44%), Gaps = 60/249 (24%)
Query: 870 HPGVVNLERM-FETPGR---IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVAL 925
H + L M PG +++ E ++ D+ ++I S + L++ + I QIL L
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ--PLTDAHFQSFIYQILCGL 118
Query: 926 KHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF--------------- 970
K++HS N++H DLKP N+L++ + EL K+CDFG AR E
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCEL---KICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 971 -PPEV-LRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI--------------- 1013
PE+ L + Y +++D+WSVG I+ L P + +D +Q+
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGTPDEETL 234
Query: 1014 --------QNAAFMYPPRPWRDISS-------DAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
QN P P + S A+DL+ LL KR+SV+++L HP+
Sbjct: 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294
Query: 1059 LQDPATWSD 1067
L A W D
Sbjct: 295 L---AIWHD 300
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 77/221 (34%), Positives = 113/221 (51%), Gaps = 26/221 (11%)
Query: 870 HPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLH 929
HP + +L F+T +F VME L G L M GR E +F +I+ L+ LH
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDL-MFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 930 SKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR--IIGEK---SF-------PPEVLRN 977
K I++ DLK +NVLL + +K+ DFG + + GE +F PE+L+
Sbjct: 114 KKGIIYRDLKLDNVLLDKDG---HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170
Query: 978 KGYNRSLDMWSVGVIVYVSLSGTFPFN-EDED-INEQIQNAAFMYPPRPWRDISSDAIDL 1035
+ YN S+D WS GV++Y L G PF+ EDED + + I N +P R IS +A D
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDC 226
Query: 1036 INNLLQVKQRKRLSVDKSLA-HPWLQDPATWSDLRGLERQI 1075
++ L + KRL VD + HP+ + W L +R+I
Sbjct: 227 LSKLFERDPTKRLGVDGDIRQHPFFR-GIDWERLE--KREI 264
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 61/287 (21%)
Query: 833 HRKSGRGVAIKVIDK---LRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
+ +G+ A+KV+ K ++ Q A ++ E IL + P +V L F+ +++V
Sbjct: 22 DKDTGQVYAMKVLRKSDMIK--RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79
Query: 890 MEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
ME + G D+ M L K E T +F I ++++AL +H +H D+KP+N+L+ +
Sbjct: 80 MEYMPGGDL--MNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD 137
Query: 949 SELPQVKLCDFGFARIIGEKSFP------------------------------------- 971
+KL DFG + + +
Sbjct: 138 G---HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTP 194
Query: 972 ----PEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE---QIQN--AAFMYPP 1022
PEVLR Y D WS+GVI+Y L G PF D + E +I N + +PP
Sbjct: 195 DYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD-TLQETYNKIINWKESLRFPP 253
Query: 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLR 1069
P +S +AIDLI LL + + S ++ +HP+ + W +LR
Sbjct: 254 DP--PVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKG-IDWENLR 297
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 73/251 (29%), Positives = 119/251 (47%), Gaps = 23/251 (9%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEA-QLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
R + R A+K I K ++ E E +L + P +V L+ F++P ++++V+
Sbjct: 15 RDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAF 74
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
+ G L L E GR +F ++L AL++LH N+++ DLKPEN+LL
Sbjct: 75 INGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG--- 130
Query: 953 QVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
+ LCDFG ++ + PE+L GY +++D W++GV++Y L+G
Sbjct: 131 HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGL 190
Query: 1001 FPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV---DKSLAHP 1057
PF DE++NE + P R DA DL+ LL +RL + HP
Sbjct: 191 PPF-YDENVNEMYRK-ILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248
Query: 1058 WLQDPATWSDL 1068
+ +W L
Sbjct: 249 FFSQ-LSWKKL 258
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 76/233 (32%), Positives = 114/233 (48%), Gaps = 20/233 (8%)
Query: 842 IKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMI 901
IK ID + P K++ K EV +L + HP +V F+ GR+F+VME G L
Sbjct: 30 IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKR 89
Query: 902 LSSEKGRL-SERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFG 960
++ ++G L SE QI + LKH+H + I+H D+K +N+ LS N + KL DFG
Sbjct: 90 INRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMV--AKLGDFG 147
Query: 961 FARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFPFNED 1006
AR + + PE+ +N+ YN D+WS+G ++Y +L F N
Sbjct: 148 IARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207
Query: 1007 EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
+ +I F P P + S D LI+ L +V R R S+ L P+L
Sbjct: 208 HQLVLKICQGYF-APISP--NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 76/228 (33%), Positives = 120/228 (52%), Gaps = 24/228 (10%)
Query: 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895
+G+ A+KV+ K + + K E IL + HP +V L F+T G+++++++ L+G
Sbjct: 23 AGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG 82
Query: 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVK 955
L LS E +E KF + ++ +AL HLHS I++ DLKPEN+LL E +K
Sbjct: 83 GDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIK 138
Query: 956 LCDFGFAR--IIGEK---SF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPF 1003
L DFG ++ I EK SF PEV+ +G+ +S D WS GV+++ L+G+ PF
Sbjct: 139 LTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
Query: 1004 NEDEDINE---QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
+ +D E I A P + +S +A L+ L + RL
Sbjct: 199 -QGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRALFKRNPANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 79/259 (30%), Positives = 123/259 (47%), Gaps = 33/259 (12%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQ---NLCHPGVVNLERMFETPGRIFV 888
++K+G AIK + K + E + L E I + + HP +VNL F+T +
Sbjct: 20 YKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
VME G L M + ++ SE F +++ L++LH IV+ DLK +N+LL T
Sbjct: 80 VMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE 137
Query: 949 SELPQVKLCDFGFAR-----------IIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVS 996
VK+ DFG + G F PEVL Y R++D W +GV++Y
Sbjct: 138 G---FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194
Query: 997 LSGTFPF--NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSL 1054
L G PF +++E++ + I N YP R +S +AI ++ LL+ +RL +
Sbjct: 195 LVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISIMRRLLRRNPERRLGSGEKD 250
Query: 1055 A-----HPWLQDPATWSDL 1068
A P+ +D W DL
Sbjct: 251 AEDVKKQPFFRD-INWDDL 268
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 79/278 (28%), Positives = 125/278 (44%), Gaps = 57/278 (20%)
Query: 830 CGVHRKSGRGVAIKVIDKLRFPTKQEA----QLKNEVAILQNLCHPGVVNLERMF--ETP 883
+K+G VA+K KL+ ++E L+ E+ IL L HP +V ++ +
Sbjct: 23 RARDKKTGEIVALK---KLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKEVVVGSNL 78
Query: 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
+I++VME ++ D L+ ++ + K + K ++ Q+L + HLH I+H DLK N+
Sbjct: 79 DKIYMVMEYVEHD-LKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNL 137
Query: 944 LLSTNSELPQVKLCDFGFARIIGE--KSF----------PPEVLRN-KGYNRSLDMWSVG 990
LL+ L K+CDFG AR G K + PE+L K Y+ ++DMWSVG
Sbjct: 138 LLNNRGIL---KICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG 194
Query: 991 VIVYVSLSGTFPFNEDEDI-------------NEQI----------QNAAFMYPPR---- 1023
I L+ F +I E+I + F P
Sbjct: 195 CIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLR 254
Query: 1024 ---PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
P +S + DL+N LL KR+S + +L HP+
Sbjct: 255 KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-26
Identities = 75/256 (29%), Positives = 115/256 (44%), Gaps = 26/256 (10%)
Query: 822 IAVVAGAACGV-----HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL 876
I VV A G+ + + V IK I + + +NE +L+ L HP ++
Sbjct: 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 877 ERMFETPGRIFVVMEKLQGDML-EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVH 935
F + +VME G L E I L E T QIL+AL H+H+K I+H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILH 124
Query: 936 CDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS-----------FPPEVLRNKGYNRSL 984
DLK +N+LL + + VK+ DFG ++I+ KS PE+ K YN+
Sbjct: 125 RDLKTQNILLDKHKMV--VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKS 182
Query: 985 DMWSVGVIVY--VSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRD-ISSDAIDLINNLLQ 1041
D+W++G ++Y SL F + +I + F P D S D LI ++L
Sbjct: 183 DIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF----APISDRYSPDLRQLILSMLN 238
Query: 1042 VKQRKRLSVDKSLAHP 1057
+ KR + + +A P
Sbjct: 239 LDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 79/249 (31%), Positives = 119/249 (47%), Gaps = 26/249 (10%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCH---PGVVNLERMFETPGRIFVV 889
+ + R A+KV+ K K+E A E IL P +V L+ F+T +++V
Sbjct: 15 KDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV 74
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
+ + G L L E GR SE KF I ++++AL+HLH +IV+ DLKPEN+LL
Sbjct: 75 TDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG 133
Query: 950 ELPQVKLCDFGFAR-----------IIGEKSF-PPEV-LRNKGYNRSLDMWSVGVIVYVS 996
+ LCDFG ++ G + PEV L KGY + +D WS+GV+V+
Sbjct: 134 ---HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190
Query: 997 LSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL-SVDKSLA 1055
G PF ED + +N AF P +S + + LL + RL + ++
Sbjct: 191 CCGWSPFYA-EDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVE 249
Query: 1056 ---HPWLQD 1061
HP+ D
Sbjct: 250 LKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 79/260 (30%), Positives = 119/260 (45%), Gaps = 32/260 (12%)
Query: 827 GAACGVHRK-SGRGVAIKVIDKLRFPTKQEAQLK-NEVAILQNLCHPGVVNLERMFETPG 884
G C K +G+ A K +DK R ++ Q+ NE IL+ + +V+L FET
Sbjct: 7 GEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD 66
Query: 885 RIFVVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
+ +VM + G D+ I + + E F QI+ L+HLH + IV+ DLKPENV
Sbjct: 67 DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENV 126
Query: 944 LLSTNSELPQVKLCDFGFARIIGEKSFP-----------PEVLRNKGYNRSLDMWSVGVI 992
LL + V++ D G A + PEVL+ + Y+ S+D +++G
Sbjct: 127 LL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCT 183
Query: 993 VYVSLSGTFPFN------EDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRK 1046
+Y ++G PF E E++ + A YP S +A DL LLQ K
Sbjct: 184 LYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP----DKFSPEAKDLCEALLQKDPEK 239
Query: 1047 RL-----SVDKSLAHPWLQD 1061
RL S D+ HP +D
Sbjct: 240 RLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 74/291 (25%), Positives = 129/291 (44%), Gaps = 71/291 (24%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG------- 884
V + VA+K I L P + L+ E+ I++ L H +V +++E G
Sbjct: 25 VDSDCDKRVAVKKI-VLTDPQSVKHALR-EIKIIRRLDHDNIV---KVYEVLGPSGSDLT 79
Query: 885 ----------RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIV 934
+++V E ++ D+ ++ E+G LSE + + Q+L LK++HS N++
Sbjct: 80 EDVGSLTELNSVYIVQEYMETDLANVL---EQGPLSEEHARLFMYQLLRGLKYIHSANVL 136
Query: 935 HCDLKPENVLLSTNSELPQVKLCDFGFARII----GEKSF------------PPEVLRNK 978
H DLKP NV ++T + +K+ DFG ARI+ K + P +L
Sbjct: 137 HRDLKPANVFINTEDLV--LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN 194
Query: 979 GYNRSLDMWSVGVIVYVSLSG------------------TFPFNEDEDINEQIQNAAFM- 1019
Y +++DMW+ G I L+G + P +ED NE +
Sbjct: 195 NYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFV 254
Query: 1020 -----YPPRPWRD----ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
P RP RD ++ +A+D + +L RL+ +++L HP++
Sbjct: 255 RNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 75/230 (32%), Positives = 120/230 (52%), Gaps = 23/230 (10%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
+ +GR A+K++ K K E A E +LQN HP + L+ F+T R+ VME
Sbjct: 17 KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 76
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
G L LS E+ +E +F +I+ AL++LHS+++V+ D+K EN++L +
Sbjct: 77 ANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--- 132
Query: 953 QVKLCDFGFAR--IIGE---KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
+K+ DFG + I K+F PEVL + Y R++D W +GV++Y + G
Sbjct: 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
Query: 1001 FPF-NED-EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
PF N+D E + E I +P R +S +A L+ LL+ ++RL
Sbjct: 193 LPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 67/247 (27%), Positives = 112/247 (45%), Gaps = 18/247 (7%)
Query: 827 GAACGVHRKS-GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885
G V RK+ R A+K ID + ++ + +E +L L ++ F G+
Sbjct: 14 GVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGK 73
Query: 886 IFVVMEKLQGDMLEMILSSEKGR-LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944
+ +VME + L +L ++GR L E QIL+ L HLHSK I+H D+K N+
Sbjct: 74 LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLF 133
Query: 945 LSTNSELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVI 992
L VK+ D G A+++ + + PE+ +K YN D+W++GV+
Sbjct: 134 L---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVV 190
Query: 993 VYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDK 1052
+Y +G PF+ + ++ ++PP S LI+ L R+R +
Sbjct: 191 LYECCTGKHPFDANNQGALILKIIRGVFPPVSQM-YSQQLAQLIDQCLTKDYRQRPDTFQ 249
Query: 1053 SLAHPWL 1059
L +P L
Sbjct: 250 LLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 870 HPGVVNLERMFETPGRIFVVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHL 928
HP + L F+T R+F VME + G D++ I S GR E +F +I++ L+ L
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFL 112
Query: 929 HSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR--IIG---EKSF-------PPEVLR 976
H + I++ DLK +NVLL + +K+ DFG + I+G +F PE+L
Sbjct: 113 HERGIIYRDLKLDNVLLDSEG---HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS 169
Query: 977 NKGYNRSLDMWSVGVIVYVSLSGTFPFN-EDED-INEQIQNAAFMYPPRPWRDISSDAID 1034
+ Y ++D W++GV++Y L+G PF +DED + + I YP R +S +A
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKS 225
Query: 1035 LINNLLQVKQRKRLSVDKSLAHPWLQDP 1062
++ + L KRL + P
Sbjct: 226 ILKSFLTKNPEKRLGCLPTGEQDIKGHP 253
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 74/230 (32%), Positives = 115/230 (50%), Gaps = 23/230 (10%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
+ +G+ A+K++ K K E A E +LQN HP + L+ F+T R+ VME
Sbjct: 17 KATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEY 76
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
G L LS E SE +F +I+ AL +LHS ++V+ DLK EN++L +
Sbjct: 77 ANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG--- 132
Query: 953 QVKLCDFGFAR-----------IIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
+K+ DFG + G + PEVL + Y R++D W +GV++Y + G
Sbjct: 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
Query: 1001 FPF-NED-EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
PF N+D E + E I +P R +S +A L+ LL+ ++RL
Sbjct: 193 LPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 79/230 (34%), Positives = 119/230 (51%), Gaps = 23/230 (10%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
+ SG+ A+K++ K K E A E +L+N HP + +L+ F+T R+ VME
Sbjct: 17 KASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEY 76
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
+ G L LS E+ SE T+F +I+ AL +LHS IV+ DLK EN++L +
Sbjct: 77 VNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG--- 132
Query: 953 QVKLCDFGFAR-----IIGEKSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
+K+ DFG + K+F PEVL + Y R++D W +GV++Y + G
Sbjct: 133 HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
Query: 1001 FPF-NED-EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
PF N+D E + E I +P R +S+DA L++ LL KRL
Sbjct: 193 LPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 75/269 (27%), Positives = 122/269 (45%), Gaps = 45/269 (16%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G +R +G VA+K I L + E+++++ L H +V L + T ++ +V
Sbjct: 19 GRNRTTGEIVALKEI-HLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77
Query: 891 EKLQGDMLE-MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E + D+ + M +G L T K Q+L + H ++H DLKP+N+L++
Sbjct: 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG 137
Query: 950 ELPQVKLCDFGFARIIG--EKSF----------PPEVLR-NKGYNRSLDMWSVGVIVYVS 996
EL KL DFG AR G +F P+VL ++ Y+ S+D+WSVG I+
Sbjct: 138 EL---KLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEM 194
Query: 997 LSGT--FPFNEDEDINEQI---------------------QNAAFMYPPRPWRDI----S 1029
++G FP +ED +I + YPP+ + +
Sbjct: 195 ITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHAD 254
Query: 1030 SDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
IDL++ LLQ+ R+S +L HPW
Sbjct: 255 PLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 83/296 (28%), Positives = 124/296 (41%), Gaps = 71/296 (23%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQLKNEVA-------ILQNLCHPGVVNLERMFETPGRI 886
+ +G+ A+KV+DK +E +N+V IL L HP + L F+T +
Sbjct: 23 KGTGKLFALKVLDK------KEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYL 76
Query: 887 FVVMEKLQGDMLEMILSSEKG-RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
+VM+ G L +L + G LSE +F ++L+AL++LH IV+ DLKPEN+LL
Sbjct: 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL 136
Query: 946 -----------------------------------STNSELPQVKLCDFGFARIIGEKSF 970
S NS + + F SF
Sbjct: 137 HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR----SNSF 192
Query: 971 -------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPF---NEDEDINEQIQNAAFMY 1020
PEV+ G+ ++D W++G+++Y L GT PF N DE I +
Sbjct: 193 VGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF-SNILKKEVTF 251
Query: 1021 PPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA----HPWLQDPATWSDLRGLE 1072
P P +SS A DLI LL KRL + A HP+ + W+ +R
Sbjct: 252 PGSP--PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG-VNWALIRHTT 304
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 73/222 (32%), Positives = 116/222 (52%), Gaps = 28/222 (12%)
Query: 870 HPGVVNLERMFETPGRIFVVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHL 928
HP + +L F+T +F VME L G D++ I S K L T F +I+ L+ L
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRAT--FYAAEIICGLQFL 112
Query: 929 HSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR--IIGEKS----------FPPEVLR 976
HSK IV+ DLK +N+LL T+ +K+ DFG + ++G+ PE+L
Sbjct: 113 HSKGIVYRDLKLDNILLDTDG---HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 977 NKGYNRSLDMWSVGVIVYVSLSGTFPFN--EDEDINEQIQNAAFMYPPRPWRDISSDAID 1034
+ YN S+D WS GV++Y L G PF+ ++E++ + I+ YP R ++ +A D
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKD 225
Query: 1035 LINNLLQVKQRKRLSVDKSL-AHPWLQDPATWSDLRGLERQI 1075
++ L + +RL V + HP+ ++ WS L ER+I
Sbjct: 226 ILVKLFVREPERRLGVKGDIRQHPFFRE-IDWSALE--EREI 264
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 76/259 (29%), Positives = 135/259 (52%), Gaps = 32/259 (12%)
Query: 836 SGRGVAIKVIDKLRFPTKQEA--QLKNEVAILQNLCH-PGVVNLERMFETPGRIFVVMEK 892
SG+ A+KV+ K K + + E +L+++ P +V L F+T ++ ++++
Sbjct: 27 SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDY 86
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
+ G L LS ++ R E+ + +I++AL+HLH I++ D+K EN+LL +N
Sbjct: 87 INGGELFTHLS-QRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--- 142
Query: 953 QVKLCDFG----FARIIGEKSF---------PPEVLR--NKGYNRSLDMWSVGVIVYVSL 997
V L DFG F E+++ P+++R + G+++++D WS+GV++Y L
Sbjct: 143 HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202
Query: 998 SGTFPFNEDEDINEQIQNAAFMY---PPRPWRDISSDAIDLINNLLQVKQRKRL-----S 1049
+G PF D + N Q + + + PP P +++S+ A D+I LL +KRL
Sbjct: 203 TGASPFTVDGEKNSQAEISRRILKSEPPYP-QEMSALAKDIIQRLLMKDPKKRLGCGPSD 261
Query: 1050 VDKSLAHPWLQDPATWSDL 1068
D+ HP+ Q W DL
Sbjct: 262 ADEIKKHPFFQK-INWDDL 279
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 76/271 (28%), Positives = 129/271 (47%), Gaps = 54/271 (19%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNL-ERMFE-TPGRIFVV 889
RK+G+ AIK + K F + ++ E+ L+ L HP ++ L E +F+ GR+ +V
Sbjct: 20 SRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78
Query: 890 MEKLQGDMLEMILSSEKGR---LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
E + ++ E+I KGR L E+ K + Q+L +L H+H I H D+KPEN+L+
Sbjct: 79 FELMDMNLYELI----KGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK 134
Query: 947 TNSELPQVKLCDFGFARIIGEKS-----------FPPEVLRNKG-YNRSLDMWSVGVIVY 994
+ +KL DFG R I K PE L G Y +D+W+VG + +
Sbjct: 135 DDI----LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFF 190
Query: 995 --VSLSGTFP-FNE--------------DEDINEQIQNAAFM---YPPRPWRDI------ 1028
+SL FP NE D ++ ++ + + M +P + +
Sbjct: 191 EILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPN 250
Query: 1029 -SSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
S++ +DL+ LL +R++ ++L HP+
Sbjct: 251 ASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 27/255 (10%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+ G A+KV+ K K+E + +L+NL HP +V L F+T +++ V+
Sbjct: 16 RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL 75
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ + G L L E+ E +F ++ A+ +LHS NI++ DLKPEN+LL +
Sbjct: 76 DYVNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG- 133
Query: 951 LPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
V L DFG + E PEVLR + Y+R++D W +G ++Y L
Sbjct: 134 --HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY 191
Query: 999 GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAI-DLINNLLQVKQRKRLSVDKSLA-- 1055
G PF D+++ N ++ P + A DL+ LL QR+RL
Sbjct: 192 GLPPFYS-RDVSQMYDN--ILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEI 248
Query: 1056 --HPWLQDPATWSDL 1068
H + P W DL
Sbjct: 249 KNHVFFS-PINWDDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 53/275 (19%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLK--NEVAILQNLCHPGVVNLERMFETPGRIFV 888
G + +G+ VA+K I R ++ A E ++L++L H +V L + T + +
Sbjct: 24 GRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
V E L D L+ + G LS + + Q+L L + H + ++H DLKP+N+L+S
Sbjct: 81 VFEYLDTD-LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER 139
Query: 949 SELPQVKLCDFGFARI--IGEKSF----------PPEVLR-NKGYNRSLDMWSVGVIVYV 995
EL KL DFG AR + K++ PP+VL + Y+ SLDMW VG I Y
Sbjct: 140 GEL---KLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYE 196
Query: 996 SLSGTFPFNEDEDINEQIQ-------------------NAAF------MYPPRPWR---- 1026
+G F D+ +Q+ N F YPPRP
Sbjct: 197 MATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAP 256
Query: 1027 --DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
D +L LQ + +KR+S +++ HP+
Sbjct: 257 RLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 86/271 (31%), Positives = 130/271 (47%), Gaps = 51/271 (18%)
Query: 836 SGRGVAIKVIDKLRFPTKQEA-QLKNEVAILQNLCHPGVVNLERMFETPGR-IFVVMEKL 893
+G+ VAIK I K F T A + E+ +L++L H +++L +F +P I+ V E L
Sbjct: 34 TGQNVAIKKIMK-PFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE-L 91
Query: 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953
G L +L+S L ++ ++ + QIL LK++HS +VH DLKP N+L++ N +L
Sbjct: 92 LGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDL-- 147
Query: 954 VKLCDFGFARI-----IGEKSF----PPEV-LRNKGYNRSLDMWSVGVIVYVSLSGTFPF 1003
K+CDFG ARI G S PE+ L + Y+ +D+WS G I L G F
Sbjct: 148 -KICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
Query: 1004 NEDEDIN--------------EQIQNAA------FM--YPPRPWRDISS-------DAID 1034
+ +N + I F+ P R S AID
Sbjct: 207 PGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAID 266
Query: 1035 LINNLLQVKQRKRLSVDKSLAHPWL---QDP 1062
L+ +L +KR+S ++LAHP+L DP
Sbjct: 267 LLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 70/248 (28%), Positives = 125/248 (50%), Gaps = 23/248 (9%)
Query: 827 GAACGVHRKS-GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885
G C KS GR VA+K +D LR ++E L NEV I+++ HP +V + +
Sbjct: 33 GIVCIATDKSTGRQVAVKKMD-LRKQQRREL-LFNEVVIMRDYQHPNIVEMYSSYLVGDE 90
Query: 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
++VVME L+G L I++ R++E + +L AL LH++ ++H D+K +++LL
Sbjct: 91 LWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL 148
Query: 946 STNSELPQVKLCDFGFARIIGE-----KSF-------PPEVLRNKGYNRSLDMWSVGVIV 993
+++ +VKL DFGF + + KS PEV+ Y +D+WS+G++V
Sbjct: 149 TSDG---RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 205
Query: 994 YVSLSGTFPFNEDEDINEQIQNAAFMYPP--RPWRDISSDAIDLINNLLQVKQRKRLSVD 1051
+ G P+ + + + ++ PP + +S ++ +L +R +
Sbjct: 206 IEMVDGEPPYFNEPPL-QAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAA 264
Query: 1052 KSLAHPWL 1059
+ L HP+L
Sbjct: 265 ELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 65/197 (32%), Positives = 106/197 (53%), Gaps = 27/197 (13%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKN-----EVAILQNLCHPGVVNLERMFETPGRIF 887
H+++G+ VAIK +F ++ ++ E+ +L+ L H +VNL +F R++
Sbjct: 22 HKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLY 76
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+V E + +L+ + G L E + + QIL ++ HS NI+H D+KPEN+L+S
Sbjct: 77 LVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135
Query: 948 NSELPQVKLCDFGFARII---GEKSF---------PPEVL-RNKGYNRSLDMWSVGVIVY 994
+ VKLCDFGFAR + GE PE+L + Y R++D+W+VG +V
Sbjct: 136 SG---VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVT 192
Query: 995 VSLSGTFPFNEDEDINE 1011
L+G F D DI++
Sbjct: 193 EMLTGEPLFPGDSDIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 78/273 (28%), Positives = 130/273 (47%), Gaps = 56/273 (20%)
Query: 833 HRKSGRGVAIKVIDKLRF-PTKQEAQLKN----EVAILQNLCHPGVVNLERMFETPGRIF 887
+R++G+ VAIK +F ++ + +K E+ +L+ L HP +VNL +F ++
Sbjct: 22 NRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLH 76
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+V E +L + + +G + E K II Q L A+ H N +H D+KPEN+L++
Sbjct: 77 LVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK 135
Query: 948 NSELPQVKLCDFGFARII--GEKSF----------PPEVL-RNKGYNRSLDMWSVGVIVY 994
Q+KLCDFGFARI+ + PE+L + Y +D+W++G +
Sbjct: 136 QG---QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFA 192
Query: 995 VSLSGT--FPFNEDEDI--------------NEQI--QNAAF--MYPPRP---------W 1025
L+G +P D D ++QI N F + P P +
Sbjct: 193 ELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKF 252
Query: 1026 RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
+ISS A+ + LQ+ +RLS ++ L HP+
Sbjct: 253 PNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 80/271 (29%), Positives = 124/271 (45%), Gaps = 37/271 (13%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
H+ + A+KV+ K K+E + + +L+N+ HP +V L F+T +++ V+
Sbjct: 16 HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 75
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ + G L L E+ L R +F +I AL +LHS NIV+ DLKPEN+LL +
Sbjct: 76 DYINGGELFYHLQRERCFLEPRA-RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG- 133
Query: 951 LPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+ L DFG + E + PEVL + Y+R++D W +G ++Y L
Sbjct: 134 --HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 191
Query: 999 GTFPF--NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSL-- 1054
G PF ++ + I N P +I++ A L+ LLQ + KRL
Sbjct: 192 GLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARHLLEGLLQKDRTKRLGAKDDFME 247
Query: 1055 --AHPWLQDPATWSDLRGLERQIGTNKKKNP 1083
H + P W DL NKK P
Sbjct: 248 IKNHIFFS-PINWDDL--------INKKITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 67/255 (26%), Positives = 116/255 (45%), Gaps = 46/255 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
+H+++G+ VAIKV+ P +++ Q + E++IL+ P +V + +++V
Sbjct: 22 AIHKETGQVVAIKVV-----PVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76
Query: 890 MEKLQG----DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
ME D++++ + L+E I+ Q L L++LHS +H D+K N+LL
Sbjct: 77 MEYCGAGSVSDIMKITNKT----LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL 132
Query: 946 STNSELPQVKLCDFGFARIIGEKSF--------P----PEVLRNKGYNRSLDMWSVGVIV 993
+E Q KL DFG + + + P PEV++ GYN D+WS+G I
Sbjct: 133 ---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLG-IT 188
Query: 994 YVSLSGTFPFNEDEDINEQIQNAAFMYPPRP---------WRDISSDAIDLINNLLQVKQ 1044
+ ++ P + A FM P +P W S + D + L
Sbjct: 189 AIEMAEGKPPY----SDIHPMRAIFMIPNKPPPTLSDPEKW---SPEFNDFVKKCLVKDP 241
Query: 1045 RKRLSVDKSLAHPWL 1059
+R S + L HP++
Sbjct: 242 EERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 68/268 (25%), Positives = 116/268 (43%), Gaps = 30/268 (11%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+ +++ + VAIKVID L + ++ E+ L P + F +++++M
Sbjct: 20 AIDKRTNQVVAIKVID-LEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78
Query: 891 EKLQG----DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
E G D+L+ G+L E FI+ ++L+ L++LH + +H D+K N+LLS
Sbjct: 79 EYCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS 132
Query: 947 TNSELPQVKLCDFGFA-----RIIGEKSF---P----PEVLRNKGYNRSLDMWSVGVIVY 994
+ VKL DFG + + +F P PEV++ GY+ D+WS+G+
Sbjct: 133 EEGD---VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAI 189
Query: 995 VSLSGTFPFNEDEDINEQIQNAAFMYPPR-PWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053
G P D + PP S D ++ L ++R S +
Sbjct: 190 ELAKGEPP-LSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKEL 248
Query: 1054 LAHPWLQDPATWSDLRGLERQIGTNKKK 1081
L H +++ S L L +I K K
Sbjct: 249 LKHKFIKKAKKTSYLTLLIERI--KKWK 274
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 78/280 (27%), Positives = 124/280 (44%), Gaps = 63/280 (22%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE----AQLKNEVAILQNLCHPGVVNLERMFETPGR---- 885
SG VA+K K+R +++ + L+ E+ +L NL HP +V L+ + G+
Sbjct: 29 TTSGEIVALK---KVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKEV--VVGKHLDS 82
Query: 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
IF+VME + D L +L + SE K ++ Q+L L++LH I+H DLK N+LL
Sbjct: 83 IFLVMEYCEQD-LASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL 141
Query: 946 STNSELPQVKLCDFGFARIIGEKSFP------------PEVLRN-KGYNRSLDMWSVGVI 992
+ L K+ DFG AR G + P PE+L Y ++DMW+VG I
Sbjct: 142 TDKGCL---KIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCI 198
Query: 993 VYVSLSGT--FPFN-EDEDI----------NEQI-----------------QNAAFMYPP 1022
+ L+ P E E + NE I Q +
Sbjct: 199 LAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHK 258
Query: 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062
PW +S + L+N LL +KR + +++L + ++
Sbjct: 259 FPW--LSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 17/233 (7%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
V K ++ R K+ NE+ IL L HP ++ F + + ME G L
Sbjct: 28 VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLY 87
Query: 900 MILSSEKGRL-SERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
+ +KG+L E + + QI+ A+ ++H I+H D+K N+ L T + L +KL D
Sbjct: 88 DKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL-TKAGL--IKLGD 144
Query: 959 FGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED 1006
FG ++I+G + PE+ + YN D+W++G ++Y L+ F+
Sbjct: 145 FGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204
Query: 1007 EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
+N ++ Y P SS+ I L+++LLQ KR + D+ L P L
Sbjct: 205 NPLNLVVKIVQGNYTPVVSV-YSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-22
Identities = 87/266 (32%), Positives = 124/266 (46%), Gaps = 37/266 (13%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQLK-NEVAILQNLC-HPGVVNLERMFETPGRIFVVME 891
++SGR A+KV+ K + + E IL HP + L F+TP R+F VME
Sbjct: 17 KESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVME 76
Query: 892 KLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ G D++ I S R E +F +I AL LH K I++ DLK +NVLL
Sbjct: 77 FVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG- 133
Query: 951 LPQVKLCDFGF-----------ARIIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
KL DFG + G + PE+L+ Y S+D W++GV++Y L
Sbjct: 134 --HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191
Query: 999 GTFPF---NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL-SVDKS- 1053
G PF NED D+ E I N +YP W +S DA+D++ + RL S+
Sbjct: 192 GHAPFEAENED-DLFEAILNDEVVYP--TW--LSQDAVDILKAFMTKNPTMRLGSLTLGG 246
Query: 1054 ----LAHPWLQDPATWSDLRGLERQI 1075
L HP+ ++ W L RQI
Sbjct: 247 EEAILRHPFFKE-LDWEKLN--RRQI 269
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-22
Identities = 77/262 (29%), Positives = 121/262 (46%), Gaps = 48/262 (18%)
Query: 832 VHRKSGRGVAIKVI-----DKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886
+HR +GR A+KVI D +R Q+ E+ IL+++ HP VV MF+ G I
Sbjct: 94 IHRPTGRLYALKVIYGNHEDTVR------RQICREIEILRDVNHPNVVKCHDMFDHNGEI 147
Query: 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
V++E + G LE +++ L++ + QIL + +LH ++IVH D+KP N+L++
Sbjct: 148 QVLLEFMDGGSLEGTHIADEQFLAD-----VARQILSGIAYLHRRHIVHRDIKPSNLLIN 202
Query: 947 TNSELPQVKLCDFGFARIIGEKSFP------------PEVLRNKGYNRSL------DMWS 988
+ VK+ DFG +RI+ + P PE + N N D+WS
Sbjct: 203 SAK---NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERI-NTDLNHGAYDGYAGDIWS 258
Query: 989 VGVIVYVSLSGTFPFNEDEDINEQIQNAAFM------YPPRPWRDISSDAIDLINNLLQV 1042
+GV + G FPF + Q A+ M PP S + I+ LQ
Sbjct: 259 LGVSILEFYLGRFPFG----VGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQR 314
Query: 1043 KQRKRLSVDKSLAHPWLQDPAT 1064
+ KR S + L HP++
Sbjct: 315 EPAKRWSAMQLLQHPFILRAQP 336
|
Length = 353 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 78/278 (28%), Positives = 131/278 (47%), Gaps = 48/278 (17%)
Query: 833 HRKSGRGVAIKVIDK----LRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888
H+++ + A+K I+K LR Q Q+ E IL +P VV++ FET + +
Sbjct: 22 HKETRQRFAMKKINKQNLILR---NQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
VME ++G +L + G L + + ++AL++LH+ IVH DLKP+N+L+++
Sbjct: 79 VMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS- 136
Query: 949 SELPQVKLCDFGFARI---------------IGEKSF------------PPEVLRNKGYN 981
+ +KL DFG ++I + F PEV+ +GY
Sbjct: 137 --MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG 194
Query: 982 RSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039
+ +D W++G+I+Y L G PF D E++ Q+ + +P + +DA DLI+ L
Sbjct: 195 KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD-EALPADAQDLISRL 253
Query: 1040 LQVKQRKRLSVDKSL---AHPWLQDPATWSDLRGLERQ 1074
L+ +RL + H + D GL RQ
Sbjct: 254 LRQNPLERLGTGGAFEVKQHRFFLG----LDWNGLLRQ 287
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 31/262 (11%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+ +G A+KV+ K ++ + + E IL P + L+ F+ +++VM
Sbjct: 21 REKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E G L +L+ + + E +F + ++++A+ +H VH D+KPENVL+
Sbjct: 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG- 139
Query: 951 LPQVKLCDFG-FARIIGEKS------------FPPEVLR------NKGYNRSLDMWSVGV 991
+KL DFG AR+ K PEVL Y D WS+GV
Sbjct: 140 --HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGV 197
Query: 992 IVYVSLSGTFPFNED---EDINEQIQNAAFM-YPPRPWRDISSDAIDLINNLLQVKQRKR 1047
I Y + G PF+E + N + F+ +P P +SSD +DLI +LL Q++R
Sbjct: 198 IAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP--KVSSDFLDLIQSLL-CGQKER 254
Query: 1048 LSVDKSLAHPWLQDPATWSDLR 1069
L + HP+ W+++R
Sbjct: 255 LGYEGLCCHPFFSK-IDWNNIR 275
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 71/244 (29%), Positives = 109/244 (44%), Gaps = 30/244 (12%)
Query: 836 SGRGVAIKVI--DKLRFPTKQEA-QLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
+GR +A+K + D TK+E L+ E+ +L+NL H +V + + ME
Sbjct: 26 TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
+ G ++ L + G L+E T+ QIL +++LHS IVH D+K N+L +
Sbjct: 86 MPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG--- 141
Query: 953 QVKLCDFGFAR--------IIGEKSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSL 997
VKL DFG ++ G KS PEV+ +GY R D+WSVG V L
Sbjct: 142 NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEML 201
Query: 998 SGTFPFNEDEDI----NEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053
+ P+ E E + Q P +S DA + + +KR S ++
Sbjct: 202 TEKPPWAEFEAMAAIFKIATQPTNPQLPS----HVSPDARNFLRRTFVENAKKRPSAEEL 257
Query: 1054 LAHP 1057
L H
Sbjct: 258 LRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 73/249 (29%), Positives = 112/249 (44%), Gaps = 30/249 (12%)
Query: 823 AVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMF 880
+VV A C GR VA+K + + Q LK E+ +L+ L HP V+ F
Sbjct: 16 SVVYKAIC---LLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDHPNVIKYLASF 71
Query: 881 ETPGRIFVVMEKLQ-GDMLEMILSSEKGR--LSERTTKFIITQILVALKHLHSKNIVHCD 937
+ +V+E GD+ MI +K + + ERT Q+ AL+H+HSK I+H D
Sbjct: 72 IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRD 131
Query: 938 LKPENVLLSTNSELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLD 985
+KP NV ++ VKL D G R K+ PE + GYN D
Sbjct: 132 IKPANVFITATG---VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 188
Query: 986 MWSVGVIVYVSLSGTFPFNEDE----DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041
+WS+G ++Y + PF D+ + ++I+ YPP P S + DL++ +
Sbjct: 189 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPLPADHYSEELRDLVSRCIN 246
Query: 1042 VKQRKRLSV 1050
KR +
Sbjct: 247 PDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-22
Identities = 81/285 (28%), Positives = 128/285 (44%), Gaps = 54/285 (18%)
Query: 822 IAVVAGAACGV-----HRKSGRGVAIKVI-DKLRFPTKQEAQLKNEVAILQNLCHPGVVN 875
+ VV A GV H+++ VAIK D +E L+ E+ +L+ L +V
Sbjct: 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQENIVE 64
Query: 876 LERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVH 935
L+ F G++++V E ++ +MLE++ G E+ +I Q++ A+ H +IVH
Sbjct: 65 LKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY-QLIKAIHWCHKNDIVH 123
Query: 936 CDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS-------------FPPEVLRNKGYNR 982
D+KPEN+L+S N L KLCDFGFAR + E S PE+L Y +
Sbjct: 124 RDIKPENLLISHNDVL---KLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 983 SLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQNAAFMYPPRPWR-------------- 1026
++DMWSVG I+ G F + +I++ IQ P +
Sbjct: 181 AVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240
Query: 1027 --------------DISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
+S +DL+ NLL++ R ++ L HP
Sbjct: 241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 3e-22
Identities = 76/230 (33%), Positives = 118/230 (51%), Gaps = 22/230 (9%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
+ +GR A+K++ K K E A E +LQN HP + L+ F+T R+ VME
Sbjct: 17 KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 76
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSEL 951
G L LS E+ SE +F +I+ AL +LHS KN+V+ DLK EN++L +
Sbjct: 77 ANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-- 133
Query: 952 PQVKLCDFGFAR-----------IIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
+K+ DFG + G + PEVL + Y R++D W +GV++Y + G
Sbjct: 134 -HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192
Query: 1000 TFPF-NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
PF N+D +E++ M R R +S +A L++ LL+ ++RL
Sbjct: 193 RLPFYNQD---HEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 4e-22
Identities = 77/251 (30%), Positives = 131/251 (52%), Gaps = 29/251 (11%)
Query: 827 GAACGVHRK-SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885
G C K SGR VA+K++D LR ++E L NEV I+++ H VV + + +
Sbjct: 35 GIVCIAREKHSGRQVAVKMMD-LRKQQRREL-LFNEVVIMRDYQHQNVVEMYKSYLVGEE 92
Query: 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
++V+ME LQG L I+S + RL+E + +L AL +LHS+ ++H D+K +++LL
Sbjct: 93 LWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL 150
Query: 946 STNSELPQVKLCDFGFARIIGEKSFP-------------PEVLRNKGYNRSLDMWSVGVI 992
+ + +VKL DFGF I K P PEV+ Y +D+WS+G++
Sbjct: 151 TLDG---RVKLSDFGFCAQI-SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIM 206
Query: 993 VYVSLSGTFPFNEDEDIN--EQIQNAAFMYPP--RPWRDISSDAIDLINNLLQVKQRKRL 1048
V + G P+ D + ++++++ PP + IS D + +L + ++R
Sbjct: 207 VIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKLKNAHKISPVLRDFLERMLTREPQERA 263
Query: 1049 SVDKSLAHPWL 1059
+ + L HP+L
Sbjct: 264 TAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 6e-22
Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 62/279 (22%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQE---AQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
G ++K+G+ VA+K K+R +++E + E+++L+ L HP +V L+ + R++
Sbjct: 19 GRNKKTGQIVAMK---KIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLY 75
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTT-KFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
++ E L D+ + + S KG+ + K + QIL + HS+ ++H DLKP+N+L+
Sbjct: 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID 135
Query: 947 TNSELPQVKLCDFGFARIIGEKSFP---------------PEVLRNKG-YNRSLDMWSVG 990
+KL DFG AR G P PEVL Y+ +D+WS+G
Sbjct: 136 NKG---VIKLADFGLARAFG---IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIG 189
Query: 991 VIVYVSLSGTFP-FNEDEDIN--------------------EQIQNAAFMYPPRPWR--- 1026
I + ++ P F+ D +I+ + + +P W+
Sbjct: 190 TI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP--KWKKGS 246
Query: 1027 ------DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
++ D +DL+ +L KR+S K+L HP+
Sbjct: 247 LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-22
Identities = 72/262 (27%), Positives = 124/262 (47%), Gaps = 32/262 (12%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
H+ S + A+K++ K + + A E I+ + +V L F+ +++VME
Sbjct: 64 HKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ G L ++S+ + E+ +F ++++AL +HS +H D+KP+N+LL + L
Sbjct: 124 YMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 181
Query: 952 PQVKLCDFGFARIIGEKS-------------FPPEVLRNKG----YNRSLDMWSVGVIVY 994
KL DFG + PEVL+++G Y R D WSVGV +Y
Sbjct: 182 ---KLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 995 VSLSGTFPFNEDEDIN--EQIQN--AAFMYPPRPWRDISSDAIDLINNLLQVKQRK--RL 1048
L G PF D + +I + + +P +IS A DLI L ++ + R
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI--EISKQAKDLICAFLTDREVRLGRN 296
Query: 1049 SVDKSLAHPWLQ-DPATWSDLR 1069
VD+ +HP+ + D T+ ++R
Sbjct: 297 GVDEIKSHPFFKNDQWTFDNIR 318
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 9e-22
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 22/200 (11%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL-QGDML 898
VA+K + K +Q + E I++ L HP VV L + +++VME + GD+L
Sbjct: 31 VAVKTL-KEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLL 89
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
L + +LS QI +++L SKN +H DL N L+ N VK+ D
Sbjct: 90 S-YLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN---LVVKISD 145
Query: 959 FGFARIIGEKS-------------FPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFN 1004
FG +R + + PE L+ + D+WS GV+++ + G P+
Sbjct: 146 FGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP 205
Query: 1005 E--DEDINEQIQNAAFMYPP 1022
+E++ E ++N + P
Sbjct: 206 GMSNEEVLEYLKNGYRLPQP 225
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-21
Identities = 73/251 (29%), Positives = 123/251 (49%), Gaps = 21/251 (8%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ G+ A+KV+ K ++E + + +L+N+ HP +V L F+T +++ V++
Sbjct: 17 KLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLD 76
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE- 950
+ G L L E+ E +F +I AL +LHS NIV+ DLKPEN+LL +
Sbjct: 77 FVNGGELFFHLQRERS-FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHV 135
Query: 951 -LPQVKLCDFGFARIIGEKSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFP 1002
L LC G A+ +F PEV+R + Y+ ++D W +G ++Y L G P
Sbjct: 136 VLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
Query: 1003 FNEDEDINEQIQNAAFMYPPRPWR-DISSDAIDLINNLLQVKQRKRLSVDKSL----AHP 1057
F D+ E N ++ P R S A ++ LL+ +++RL + HP
Sbjct: 196 F-YCRDVAEMYDN--ILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHP 252
Query: 1058 WLQDPATWSDL 1068
+ + +W+DL
Sbjct: 253 FFES-LSWTDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 73/257 (28%), Positives = 113/257 (43%), Gaps = 35/257 (13%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF--ETPGRIFVVM 890
+ +G A+K I P Q+ Q+ E+ I ++ P +V F E+ I + M
Sbjct: 22 LKNTGMIFALKTITTDPNPDLQK-QILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80
Query: 891 EKLQGDMLEMI---LSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
E +G L+ I + GR+ E+ I +L L +LHS+ I+H D+KP N+LL+
Sbjct: 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140
Query: 948 NSELPQVKLCDFG--------FARIIGEKSF--PPEVLRNKGYNRSLDMWSVGVIVYVSL 997
QVKLCDFG A SF PE ++ K Y+ + D+WS+G+ +
Sbjct: 141 KG---QVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVA 197
Query: 998 SGTFPFNEDE-------DINEQIQNAAFMYPPR----PWRDIS-SDAI-DLINNLLQVKQ 1044
FPF + ++ I N M P P I S+ D I L+
Sbjct: 198 QNRFPFPPEGEPPLGPIELLSYIVN---MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDP 254
Query: 1045 RKRLSVDKSLAHPWLQD 1061
+R + L HPW++
Sbjct: 255 TRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 1e-21
Identities = 82/284 (28%), Positives = 135/284 (47%), Gaps = 61/284 (21%)
Query: 827 GAAC-GVHRKSGRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFET 882
G+ C + +++G VAIK KL P + E K E+ +L+++ H V+ L +F T
Sbjct: 29 GSVCSAIDKRTGEKVAIK---KLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVF-T 84
Query: 883 PGRIF-------VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVH 935
+VM +Q D L+ I+ LSE ++++ Q+L LK++HS I+H
Sbjct: 85 SAVSGDEFQDFYLVMPYMQTD-LQKIMGHP---LSEDKVQYLVYQMLCGLKYIHSAGIIH 140
Query: 936 CDLKPENVLLSTNSELPQVKLCDFGFAR---------IIGEKSFPPEVLRN-KGYNRSLD 985
DLKP N+ ++ + EL K+ DFG AR ++ PEV+ N YN+++D
Sbjct: 141 RDLKPGNLAVNEDCEL---KILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVD 197
Query: 986 MWSVGVIVYVSLSGTFPFNEDEDINEQIQ------------------NAAFMY----PPR 1023
+WSVG I+ L+G F + +++ Q AA Y P
Sbjct: 198 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKY 257
Query: 1024 PWRDIS-------SDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060
P +D S A+DL+ +L++ KRL+ ++L HP+
Sbjct: 258 PRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 20/176 (11%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+G VAIKVI KL P ++ E+++L+ HP +V + ++++VM
Sbjct: 22 ARDIATGELVAIKVI-KLE-PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E G L+ I +G LSE ++ + L L +LH +H D+K N+LL+ + +
Sbjct: 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD 139
Query: 951 LPQVKLCDFGFARIIGE-----KSF-------PPEVL---RNKGYNRSLDMWSVGV 991
VKL DFG + + KSF PEV R GY+ D+W++G+
Sbjct: 140 ---VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 49/200 (24%), Positives = 86/200 (43%), Gaps = 21/200 (10%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL-QGDML 898
VA+K + K +Q + E I++ L HP +V L + + +VME + GD+L
Sbjct: 31 VAVKTL-KEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLL 89
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
+ + + LS QI +++L SKN +H DL N L+ N VK+ D
Sbjct: 90 DYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN---LVVKISD 146
Query: 959 FGFARIIGEKS-------------FPPEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFPF 1003
FG +R + + PE L+ + D+WS GV+++ +L
Sbjct: 147 FGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP 206
Query: 1004 N-EDEDINEQIQNAAFMYPP 1022
+ ++ E ++ + P
Sbjct: 207 GMSNAEVLEYLKKGYRLPKP 226
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 57/186 (30%), Positives = 90/186 (48%), Gaps = 21/186 (11%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEA--QLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
H S + A+K I R P A + E +L + HP +V + FE G +++VM
Sbjct: 21 HVNSDQKYAMKEI---RLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM 77
Query: 891 EKLQGDMLEMILSSEKGRL-SERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E G L + ++G+L E T Q+ + ++H+H K ++H D+K +N+ L+ N
Sbjct: 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG 137
Query: 950 ELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVSL 997
+VKL DFG AR++ PPE+ N YN D+WS+G I+Y
Sbjct: 138 ---KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELC 194
Query: 998 SGTFPF 1003
+ PF
Sbjct: 195 TLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|241272 cd01239, PH_PKD, Protein kinase D (PKD/PKCmu) pleckstrin homology (PH) domain | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-21
Identities = 30/43 (69%), Positives = 37/43 (86%)
Query: 60 RKRHYWRLDSKCLTLFQSESGSKYYKEIPLSEILGIEPCKPLT 102
RKRHYWRLD+KC+TLFQ+E+ S+YYKEIPLSEIL +EP +
Sbjct: 24 RKRHYWRLDTKCITLFQNETTSRYYKEIPLSEILAVEPADNPS 66
|
Protein Kinase C family is composed of three members, PKD1 (PKCmu), PKD2 and PKD3 (PKCnu). Like the C-type protein kinases (PKCs), PKDs are activated by diacylglycerol (DAG). They are involved in vesicular transport, cell proliferation, survival, migration and immune responses. PKD consists of tandem C1 domains, followed by a PH domain and a kinase domain. While the PKD PH domain has not been shown to bind phosphorylated inositol lipids and is not required for membrane translocation, it is required for nuclear export. PH domains have diverse functions, but in general are involved in targeting proteins to the appropriate cellular location or in the interaction with a binding partner. They share little sequence conservation, but all have a common fold, which is electrostatically polarized. Less than 10% of PH domains bind phosphoinositide phosphates (PIPs) with high affinity and specificity. PH domains are distinguished from other PIP-binding domains by their specific high-affinity binding to PIPs with two vicinal phosphate groups: PtdIns(3,4)P2, PtdIns(4,5)P2 or PtdIns(3,4,5)P3 which results in targeting some PH domain proteins to the plasma membrane. A few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes. Length = 127 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 51/272 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFETPGRIF 887
+R++ VA+K ++R E + E+ +L+ L H +V L + + ++
Sbjct: 19 AKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLT 75
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+V E D L+ S G + K + Q+L L HS N++H DLKP+N+L++
Sbjct: 76 LVFEYCDQD-LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK 134
Query: 948 NSELPQVKLCDFGFARIIG--EKSF----------PPEVLRN-KGYNRSLDMWSVGVIVY 994
N EL KL DFG AR G + + PP+VL K Y+ S+DMWS G I
Sbjct: 135 NGEL---KLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 191
Query: 995 VSLSGTFPFNEDEDINEQIQNAAFM-----------------YPPRP-------WRDI-- 1028
+ P D+++Q++ + Y P P ++
Sbjct: 192 ELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVP 251
Query: 1029 --SSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
+S DL+ NLL +R+S +++L HP+
Sbjct: 252 KLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-21
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 870 HPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLH 929
+P + +L F+T +F VME L G L M +KGR F +I+ L+ LH
Sbjct: 55 NPFLTHLYCTFQTKEHLFFVMEFLNGGDL-MFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113
Query: 930 SKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR--IIGEKS----------FPPEVLRN 977
SK I++ DLK +NV+L + +K+ DFG + + G+ PE+L+
Sbjct: 114 SKGIIYRDLKLDNVMLDRDG---HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 978 KGYNRSLDMWSVGVIVYVSLSGTFPFN-EDED-INEQIQNAAFMYPPRPWRDISSDAIDL 1035
Y S+D WS GV++Y L G PF+ +DED + E I+ YP R I+ ++ D+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDI 226
Query: 1036 INNLLQVKQRKRLSVDKSL-AHPWLQDPATWSDLRGLE 1072
+ L + +RL V ++ HP+ + W+ L E
Sbjct: 227 LEKLFERDPTRRLGVVGNIRGHPFFKT-INWTALEKRE 263
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|217925 pfam04145, Ctr, Ctr copper transporter family | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 3e-21
Identities = 38/116 (32%), Positives = 46/116 (39%), Gaps = 44/116 (37%)
Query: 716 YGASMVGIFFLAALYEGVKYYREYLFWKTYNDLHYRSIPAQQRISSVEENKDTAKVVPVC 775
Y S + IF LA LYEG+K R L
Sbjct: 27 YAGSCIAIFLLAILYEGLKRVRRKLER--------------------------------- 53
Query: 776 DVLQKQPPSMLMLSMPHFIQTLLHVLQITMSFLLMLVFMTYNVALCIAVVAGAACG 831
M H I+ LLH LQ+ +S+LLML+ MTYN L +AVV GAA G
Sbjct: 54 -----------MSLFQHLIRALLHFLQVGLSYLLMLIVMTYNGGLFLAVVLGAALG 98
|
The redox active metal copper is an essential cofactor in critical biological processes such as respiration, iron transport, oxidative stress protection, hormone production, and pigmentation. A widely conserved family of high-affinity copper transport proteins (Ctr proteins) mediates copper uptake at the plasma membrane. A series of clustered methionine residues in the hydrophilic extracellular domain, and an MXXXM motif in the second transmembrane domain, are important for copper uptake. These methionine probably coordinate copper during the process of metal transport. Length = 102 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 70/257 (27%), Positives = 110/257 (42%), Gaps = 32/257 (12%)
Query: 829 ACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
AC V R +G+ A K ++K R K EA NE IL+ + VV+L +ET +
Sbjct: 18 ACQV-RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 76
Query: 888 VVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
+V+ + G D+ I + E F +I L+ LH + IV+ DLKPEN+LL
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL- 135
Query: 947 TNSELPQVKLCDFGFARIIGEKS-----------FPPEVLRNKGYNRSLDMWSVGVIVYV 995
+ +++ D G A I E PEV++N+ Y S D W +G ++Y
Sbjct: 136 --DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYE 193
Query: 996 SLSGTFPFNED------EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS 1049
+ G PF + E++ +++ Y + S A + LL RL
Sbjct: 194 MIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK----FSEAARSICRQLLTKDPGFRLG 249
Query: 1050 VDKSLA-----HPWLQD 1061
A HP+ +
Sbjct: 250 CRGEGAEEVKAHPFFRT 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 4e-21
Identities = 77/292 (26%), Positives = 119/292 (40%), Gaps = 79/292 (27%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+ +G A+K + K K Q A ++ E IL +P VV L F+ ++++M
Sbjct: 21 QKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80
Query: 891 EKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E L G DM M L +K +E T+F I + ++A+ +H +H D+KP+N+LL
Sbjct: 81 EYLPGGDM--MTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG 138
Query: 950 ELPQVKLCDFG------------FARIIGE------KSFP-------------------- 971
+KL DFG F RI+ F
Sbjct: 139 ---HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRAL 195
Query: 972 ------------PEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAA 1017
PEV GYN+ D WS+GVI+Y L G PF D + +I N
Sbjct: 196 AYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIIN-- 253
Query: 1018 FMYPPRPWRD---------ISSDAIDLINNLL-QVKQR-KRLSVDKSLAHPW 1058
W++ +S +A DLI L + ++R V++ +HP+
Sbjct: 254 -------WKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 6e-21
Identities = 68/268 (25%), Positives = 123/268 (45%), Gaps = 49/268 (18%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE---AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+ +G VA+K K+R T+ E + E+++L+ L HP +V L + T ++++V
Sbjct: 22 KLTGEVVALK---KIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E L D+ + + +S + K + Q+L L HS ++H DLKP+N+L++T
Sbjct: 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 138
Query: 951 LPQVKLCDFGFARIIG--EKSFPPEV-----------LRNKGYNRSLDMWSVGVIVYVSL 997
+KL DFG AR G +++ EV L K Y+ ++D+WS+G I +
Sbjct: 139 ---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
Query: 998 SGTFPFNEDEDINEQIQ----------------------NAAF-MYPPRPWRDI----SS 1030
+ F D +I++ + +F + + + +
Sbjct: 196 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDE 255
Query: 1031 DAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
D DL++ +L KR+S +LAHP+
Sbjct: 256 DGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 7e-21
Identities = 72/239 (30%), Positives = 115/239 (48%), Gaps = 25/239 (10%)
Query: 840 VAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDML 898
VAIK +K + KQ + +E IL + HP VNL F+ +++V+E + G
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
L K R F QI++ ++L S NIV+ DLKPEN+LL + +K+ D
Sbjct: 119 FTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG---FIKMTD 174
Query: 959 FGFARIIGEKSF---------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPF--NEDE 1007
FGFA+++ +++ PE+L N G+ ++ D W++G+ +Y L G PF NE
Sbjct: 175 FGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234
Query: 1008 DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA-----HPWLQD 1061
I ++I +P + + ++ L+ LL KR K A HPW +
Sbjct: 235 LIYQKILEGIIYFP----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289
|
Length = 340 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 74/242 (30%), Positives = 116/242 (47%), Gaps = 20/242 (8%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE-TPGRIFVVME 891
HR G+ IK ++ ++ + E +L L HP +V +E G +++VM
Sbjct: 21 HRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80
Query: 892 KLQGDMLEMILSSEKGRL-SERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+G L L +KG+L E QI +AL++LH K+I+H DLK +NV L T +
Sbjct: 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL-TRTN 139
Query: 951 LPQVKLCDFGFARI-----------IGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+ +K+ D G AR+ IG + PE+ NK YN D+W++G VY +
Sbjct: 140 I--IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
Query: 999 GTFPFNEDEDINEQIQN-AAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
FN +D+N + PP P +D S + +LI +L + KR SV L P
Sbjct: 198 LKHAFNA-KDMNSLVYRIIEGKLPPMP-KDYSPELGELIATMLSKRPEKRPSVKSILRQP 255
Query: 1058 WL 1059
++
Sbjct: 256 YI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-20
Identities = 70/248 (28%), Positives = 113/248 (45%), Gaps = 25/248 (10%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
HR +G +A+K I +L + Q+ E+ IL P +V+ F G +++ ME
Sbjct: 22 HRPTGVTMAMKEI-RLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80
Query: 893 LQGDMLEMIL--SSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNS 949
+ L+ + + E + I ++ LK L + NI+H D+KP NVL++ N
Sbjct: 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG 140
Query: 950 ELPQVKLCDFGF-----ARI----IGEKSF-PPEVLRNKG------YNRSLDMWSVGVIV 993
QVKLCDFG A + IG +S+ PE +++ G Y D+WS+G+ +
Sbjct: 141 ---QVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSI 197
Query: 994 YVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVD 1051
G +P+ + +I Q+ PP S DA D + L +R +
Sbjct: 198 LEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYA 257
Query: 1052 KSLAHPWL 1059
+ L HPWL
Sbjct: 258 QLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 67/273 (24%), Positives = 120/273 (43%), Gaps = 55/273 (20%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE---AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
+ +G VA+K K+R T+ E + E+++L+ L HP +V L + + ++++V
Sbjct: 20 DKLTGEIVALK---KIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLV 76
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E L D+ + + SS L K + Q+L + + HS ++H DLKP+N+L+
Sbjct: 77 FEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG 136
Query: 950 ELPQVKLCDFGFARIIGEKSFP---------------PEVLR-NKGYNRSLDMWSVGVIV 993
L KL DFG AR G P PE+L ++ Y+ +D+WS+G I
Sbjct: 137 AL---KLADFGLARAFG---VPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIF 190
Query: 994 YVSLSGTFPFNEDEDINE--------------------QIQN--AAF-MYPPRPWRDI-- 1028
++ F D +I++ + + F + + +
Sbjct: 191 AEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVP 250
Query: 1029 --SSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
D +DL++ +L KR+S +L HP+
Sbjct: 251 NLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 70/243 (28%), Positives = 119/243 (48%), Gaps = 30/243 (12%)
Query: 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895
+G+ VAIK ++ + P K+ + NE+ +++ HP +VN + ++VVME L G
Sbjct: 43 TGQEVAIKQMNLQQQPKKE--LIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVK 955
L +++ + + E + + L AL+ LHS ++H D+K +N+LL + VK
Sbjct: 101 GSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG---SVK 155
Query: 956 LCDFGF-ARIIGEKS-----------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPF 1003
L DFGF A+I E+S PEV+ K Y +D+WS+G++ + G P+
Sbjct: 156 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
Query: 1004 NEDEDINEQIQNAAFMY-----PPRPWRDISSDAI-DLINNLLQVKQRKRLSVDKSLAHP 1057
+NE A ++ P + S D +N L++ KR S + L HP
Sbjct: 216 -----LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270
Query: 1058 WLQ 1060
+L+
Sbjct: 271 FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 860 NEVAIL-QNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSS---EKGRLSERTTK 915
+EV I+ + L HP +V + F R+++VM+ ++G L +S +K R +E
Sbjct: 57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 916 FIITQILVALKHLH-SKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSFP--- 971
I Q+++AL++LH K IVH DL P N++L + +V + DFG A+ +S
Sbjct: 117 NIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD---KVTITDFGLAKQKQPESKLTSV 173
Query: 972 --------PEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFPFNEDEDINEQIQNAAFMYP 1021
PE+++N+ Y D+W+ G I+Y +L F + +I A +Y
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA--VYE 231
Query: 1022 PRPWRDISSDAIDLINNLLQVKQRKR 1047
P P S D D+I + L R
Sbjct: 232 PLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 24/223 (10%)
Query: 856 AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTK 915
L++E+ L++L H +V T + + +E + G + L + GR E+ +
Sbjct: 53 KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVR 111
Query: 916 FIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR----IIGEKS-- 969
F Q+L L +LHSK I+H DLK +N+L+ + K+ DFG ++ I
Sbjct: 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG---ICKISDFGISKKSDDIYDNDQNM 168
Query: 970 --------FPPEVLRN--KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI----QN 1015
PEV+ + +GY+ +D+WS+G +V +G P++++E I +
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR 228
Query: 1016 AAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
+A PP ++S A+D +N + R + + L HP+
Sbjct: 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 71/257 (27%), Positives = 116/257 (45%), Gaps = 32/257 (12%)
Query: 829 ACGVHRKSGRGVAIKVIDKLRFPTKQ-EAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
AC V R +G+ A K ++K R ++ E+ NE IL+ + VVNL +ET +
Sbjct: 18 ACQV-RATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALC 76
Query: 888 VVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
+V+ + G D+ I + E F +IL L+ LH +N V+ DLKPEN+LL
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD 136
Query: 947 TNSELPQVKLCDFGFARIIGEKS-----------FPPEVLRNKGYNRSLDMWSVGVIVYV 995
+++ D G A I E PEVL N+ Y S D W +G ++Y
Sbjct: 137 DYG---HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYE 193
Query: 996 SLSGTFPFN------EDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS 1049
+ G PF + E+++ ++ +Y + S +A + LL ++RL
Sbjct: 194 MIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK----FSEEAKSICKMLLTKDPKQRLG 249
Query: 1050 VDKSLA-----HPWLQD 1061
+ A HP+ ++
Sbjct: 250 CQEEGAGEVKRHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 4e-20
Identities = 70/240 (29%), Positives = 117/240 (48%), Gaps = 45/240 (18%)
Query: 861 EVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQ 920
EV++L+NL H +V L + T + +V E L D L+ L + +S K + Q
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSD-LKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 921 ILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI--IGEKSF-------- 970
+L L + H + I+H DLKP+N+L++ EL KL DFG AR + K++
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLLINEKGEL---KLADFGLARAKSVPTKTYSNEVVTLW 168
Query: 971 --PPEVLR-NKGYNRSLDMWSVGVIVYVSLSG--TFPFNE-DEDI--------------- 1009
PP+VL + Y+ +DMW VG I+Y +G FP + E++
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228
Query: 1010 -----NEQIQNAAF-MYPPRPWRD----ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
NE+ ++ F Y +P + + +D IDL+++LL + + R+S + +L H +
Sbjct: 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 5e-20
Identities = 68/241 (28%), Positives = 115/241 (47%), Gaps = 45/241 (18%)
Query: 861 EVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQ 920
EV++L++L H +V L + T + +V E L D L+ + +S K + Q
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKD-LKQYMDDCGNIMSMHNVKIFLYQ 112
Query: 921 ILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI--IGEKSF-------- 970
IL L + H + ++H DLKP+N+L++ EL KL DFG AR + K++
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGEL---KLADFGLARAKSVPTKTYSNEVVTLW 169
Query: 971 --PPEVLRNKG-YNRSLDMWSVGVIVYVSLSGT--FPFNEDED----------------- 1008
PP+VL Y+ +DMW VG I + SG FP + ED
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
Query: 1009 ----INEQIQNAAF-MYPPRPWRD----ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
N++ +N F Y P+P + + ++ I+L+ LQ + +KR+S ++++ H +
Sbjct: 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289
Query: 1060 Q 1060
+
Sbjct: 290 R 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-20
Identities = 77/289 (26%), Positives = 132/289 (45%), Gaps = 81/289 (28%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFETPGR-------I 886
G+ VAIK KL P + K E+ +++ + H ++ L +F TP + +
Sbjct: 41 GQNVAIK---KLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF-TPQKSLEEFQDV 96
Query: 887 FVVMEKLQGDMLEMI---LSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
++VME + ++ ++I L E R+S +++ Q+L +KHLHS I+H DLKP N+
Sbjct: 97 YLVMELMDANLCQVIQMDLDHE--RMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNI 149
Query: 944 LLSTNSELPQVKLCDFGFARIIGEKSF------------PPEVLRNKGYNRSLDMWSVGV 991
++ ++ L K+ DFG AR G SF PEV+ GY ++D+WSVG
Sbjct: 150 VVKSDCTL---KILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 205
Query: 992 IVYVSLSGT--FPFNE---------------DEDINEQIQNAAFMY-------PPRPWRD 1027
I+ + GT FP + ++ ++Q Y + +
Sbjct: 206 IMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEE 265
Query: 1028 I-----------------SSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
+ +S A DL++ +L + KR+SVD +L HP++
Sbjct: 266 LFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 6e-20
Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 22/192 (11%)
Query: 871 PGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS 930
P + L F+T R++ VME + G L M + G+ E F +I + L LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDL-MYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 931 KNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR--IIGEKS----------FPPEVLRNK 978
K I++ DLK +NV+L +K+ DFG + I G K+ PE++ +
Sbjct: 120 KGIIYRDLKLDNVMLDAEG---HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQ 176
Query: 979 GYNRSLDMWSVGVIVYVSLSGTFPFN-EDED-INEQIQNAAFMYPPRPWRDISSDAIDLI 1036
Y +S+D W+ GV++Y L+G PF+ EDED + + I YP + +S +A+ +
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSIC 232
Query: 1037 NNLLQVKQRKRL 1048
LL KRL
Sbjct: 233 KGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 7e-20
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 33/211 (15%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL-QGDML 898
VA+K + K ++ E +++ L HP VV L + +++V+E + GD+L
Sbjct: 26 VAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLL 84
Query: 899 EMILSS-------EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ + S EK LS + QI +++L SK VH DL N L+ +
Sbjct: 85 DYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED--- 141
Query: 952 PQVKLCDFGFARIIGEKSF--------------PPEVLRNKGYNRSLDMWSVGVIVY--V 995
VK+ DFG +R + + + PE L++ + D+WS GV+++
Sbjct: 142 LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF 201
Query: 996 SLSGTFPFNE--DEDINEQIQNAAFMYPPRP 1024
+L G P+ +E++ E ++ + P+P
Sbjct: 202 TL-GATPYPGLSNEEVLEYLRKGYRL--PKP 229
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 9e-20
Identities = 68/293 (23%), Positives = 111/293 (37%), Gaps = 74/293 (25%)
Query: 831 GVHRKSGRGVAIKVI----DKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMF----- 880
K+GR VA+K I +K FP T E+ IL+ L HP VV L M
Sbjct: 27 ARQIKTGRVVALKKILMHNEKDGFPITALR-----EIKILKKLKHPNVVPLIDMAVERPD 81
Query: 881 ---ETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCD 937
G +++V + D L +L + +L+E K + Q+L + +LH +I+H D
Sbjct: 82 KSKRKRGSVYMVTPYMDHD-LSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRD 140
Query: 938 LKPENVLLSTNSELPQVKLCDFGFARIIGEKSF-----------------------PPE- 973
+K N+L+ +K+ DFG AR PPE
Sbjct: 141 IKAANILIDNQG---ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPEL 197
Query: 974 VLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRP-----WRDI 1028
+L + Y ++D+W +G + + DI++ P WR +
Sbjct: 198 LLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSL 257
Query: 1029 -----------------------SSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
+ +DL++ LL + KRL+ +L HP+
Sbjct: 258 PGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 9e-20
Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 20/170 (11%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDML 898
VA+K + K ++ + E +I++ L HP +V L + +++V E + GD+L
Sbjct: 31 VAVKTL-KEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLL 89
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
+ L +L+ + + QI +++L SKN VH DL N L++ N VK+ D
Sbjct: 90 DF-LRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTEN---LVVKISD 145
Query: 959 FGFARIIGEKSF--------------PPEVLRNKGYNRSLDMWSVGVIVY 994
FG +R I E + PE L++ + D+WS GV+++
Sbjct: 146 FGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLW 195
|
Length = 258 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 2e-19
Identities = 74/253 (29%), Positives = 121/253 (47%), Gaps = 30/253 (11%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896
G+ VAIK I+ + P K+ + NE+ +++ L +P +VN F +FVVME L G
Sbjct: 44 GQEVAIKQINLQKQPKKE--LIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101
Query: 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKL 956
L +++ + E + + L AL+ LH+ ++H D+K +NVLL + VKL
Sbjct: 102 SLTDVVTETC--MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG---SVKL 156
Query: 957 CDFGF-ARIIGEKS-----------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFN 1004
DFGF A+I E+S PEV+ K Y +D+WS+G++ + G P+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY- 215
Query: 1005 EDEDINEQIQNAAFMYPPRPWRDISSDAI------DLINNLLQVKQRKRLSVDKSLAHPW 1058
+NE A ++ ++ + D +N L++ KR S + L HP+
Sbjct: 216 ----LNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271
Query: 1059 LQDPATWSDLRGL 1071
L+ S L L
Sbjct: 272 LKLAKPLSSLTPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 67/242 (27%), Positives = 110/242 (45%), Gaps = 47/242 (19%)
Query: 861 EVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQ 920
EV++L++L H +V L + T + +V E L D L+ L ++ K + Q
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNSINMHNVKLFLFQ 112
Query: 921 ILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI--IGEKSF-------- 970
+L L + H + ++H DLKP+N+L++ EL KL DFG AR I K++
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLINERGEL---KLADFGLARAKSIPTKTYSNEVVTLW 169
Query: 971 --PPEVLR-NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ------------- 1014
PP++L + Y+ +DMW VG I Y +G P + EQ+
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRILGTPTEET 228
Query: 1015 ------NAAFM------YPPRPWRD----ISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
N F Y + + SD +L++ LLQ + RKR+S ++++ HP+
Sbjct: 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288
Query: 1059 LQ 1060
Sbjct: 289 FH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-19
Identities = 70/258 (27%), Positives = 129/258 (50%), Gaps = 31/258 (12%)
Query: 836 SGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCH-PGVVNLERMFETPGRIFVVMEK 892
+G+ A+KV+ K K + + E +L+++ P +V L F+T ++ ++++
Sbjct: 27 TGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDY 86
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
+ G + L ++ SE +F +I++AL+HLH IV+ D+K EN+LL +
Sbjct: 87 VSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG--- 142
Query: 953 QVKLCDFGFARII----GEKSFP---------PEVLRNK-GYNRSLDMWSVGVIVYVSLS 998
V L DFG ++ E+++ PE++R K G+ +++D WS+G++++ L+
Sbjct: 143 HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
Query: 999 GTFPFNEDEDINEQIQNAAF---MYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055
G PF + + N Q + + PP P I +A DL++ LL+ +KRL A
Sbjct: 203 GASPFTLEGERNTQSEVSRRILKCDPPFPSF-IGPEAQDLLHKLLRKDPKKRLGAGPQGA 261
Query: 1056 -----HPWLQDPATWSDL 1068
HP+ + W L
Sbjct: 262 SEIKEHPFFKG-LDWEAL 278
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 49/220 (22%)
Query: 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
I+VV E +Q D+ ++I+S + LS K + QIL LK+LHS I+H D+KP N+L+
Sbjct: 79 IYVVTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV 136
Query: 946 STNSELPQVKLCDFGFAR-------------IIGEKSFPPEVLR-NKGYNRSLDMWSVGV 991
++N +K+CDFG AR ++ + PE+L ++ Y ++D+WSVG
Sbjct: 137 NSNC---VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGC 193
Query: 992 IVYVSLSGTFPFNED------------------EDINEQIQNA-AFMY--PPRP------ 1024
I L F E + + A A + P +P
Sbjct: 194 IFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVL 253
Query: 1025 ---WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+ +A+ L+ +L KR+S +LAHP+L +
Sbjct: 254 YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 4e-19
Identities = 79/281 (28%), Positives = 121/281 (43%), Gaps = 51/281 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G + +G+ VA+KVI +L+ E ++L+ L H +V L + T + +V
Sbjct: 24 GKSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E + D+ + + G L K + Q+L L ++H + I+H DLKP+N+L+S E
Sbjct: 83 EYVHTDLCQY-MDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE 141
Query: 951 LPQVKLCDFGFARIIGEKSF------------PPEVLR-NKGYNRSLDMWSVGVIVYVSL 997
L KL DFG AR S PP+VL + Y+ LDMW VG I +
Sbjct: 142 L---KLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
Query: 998 SGTFPFNEDEDINEQIQNAAFMY------------------PPR-----------PWRDI 1028
G F +DI +Q++ + P R W +
Sbjct: 199 QGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKL 258
Query: 1029 S--SDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD--PATW 1065
S + A DL + LLQ + RLS +L+H + D P W
Sbjct: 259 SYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPRLW 299
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 68/250 (27%), Positives = 128/250 (51%), Gaps = 25/250 (10%)
Query: 827 GAAC-GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885
G C + +G+ VA+K +D LR ++E L NEV I+++ H VV++ +
Sbjct: 36 GIVCIATEKHTGKQVAVKKMD-LRKQQRREL-LFNEVVIMRDYHHENVVDMYNSYLVGDE 93
Query: 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
++VVME L+G L I++ R++E + +L AL +LH++ ++H D+K +++LL
Sbjct: 94 LWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL 151
Query: 946 STNSELPQVKLCDFGFARIIGEKSFP-------------PEVLRNKGYNRSLDMWSVGVI 992
+++ ++KL DFGF + K P PEV+ Y +D+WS+G++
Sbjct: 152 TSDG---RIKLSDFGFCAQV-SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 207
Query: 993 VYVSLSGTFPFNEDEDINEQIQNAAFMYPPR--PWRDISSDAIDLINNLLQVKQRKRLSV 1050
V + G P+ + + + ++ PPR +SS ++ +L + +R +
Sbjct: 208 VIEMIDGEPPYFNEPPL-QAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATA 266
Query: 1051 DKSLAHPWLQ 1060
+ L HP+L+
Sbjct: 267 QELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-19
Identities = 64/237 (27%), Positives = 111/237 (46%), Gaps = 25/237 (10%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLC-HPGVVNLERMFETPGRIFVVM 890
+K+ R A+KVI K ++ ++ E + + HP +V L F+T R+F V+
Sbjct: 16 LKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI 75
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E + G L M + +L E +F +I +AL LH + I++ DLK +NVLL
Sbjct: 76 EFVSGGDL-MFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG- 133
Query: 951 LPQVKLCDFGFAR-----------IIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+KL D+G + G ++ PE+LR + Y S+D W++GV+++ ++
Sbjct: 134 --HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191
Query: 999 GTFPF-------NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
G PF N D++ + + R R +S A ++ L ++RL
Sbjct: 192 GRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 6e-19
Identities = 67/255 (26%), Positives = 115/255 (45%), Gaps = 34/255 (13%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
R +G+ A K ++K R ++ + E IL + +V+L F+T + +VM
Sbjct: 15 RATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTI 74
Query: 893 LQG-DMLEMI--LSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
+ G D+ I + E E F QI+ L+HLH + I++ DLKPENVLL +
Sbjct: 75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG 134
Query: 950 ELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVSL 997
V++ D G A + + PE+L+ + Y+ S+D +++GV +Y +
Sbjct: 135 ---NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191
Query: 998 SGTFPFN------EDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL--- 1048
+ PF E++++ ++I N + YP + S + LL KRL
Sbjct: 192 AARGPFRARGEKVENKELKQRILNDSVTYPDK----FSPASKSFCEALLAKDPEKRLGFR 247
Query: 1049 --SVDKSLAHPWLQD 1061
+ D HP +D
Sbjct: 248 DGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-19
Identities = 73/262 (27%), Positives = 123/262 (46%), Gaps = 32/262 (12%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
H+ + + A+K++ K + + A E I+ P VV L F+ +++VME
Sbjct: 64 HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 123
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ G L ++S+ + E+ +F ++++AL +HS +H D+KP+N+LL + L
Sbjct: 124 YMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 181
Query: 952 PQVKLCDFGFARIIGEKSF-------------PPEVLRNKG----YNRSLDMWSVGVIVY 994
KL DFG + ++ PEVL+++G Y R D WSVGV +Y
Sbjct: 182 ---KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 995 VSLSGTFPFNEDEDIN--EQIQN--AAFMYPPRPWRDISSDAIDLINNLLQVKQRK--RL 1048
L G PF D + +I N + +P DIS +A +LI L ++ + R
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKEAKNLICAFLTDREVRLGRN 296
Query: 1049 SVDKSLAHPWLQ-DPATWSDLR 1069
V++ H + + D W LR
Sbjct: 297 GVEEIKRHLFFKNDQWAWETLR 318
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 60/270 (22%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLC-HPGVVNLERMFETPG---- 884
H+K+G+ VAIK++D + +E ++K E IL+ HP + F
Sbjct: 25 ARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80
Query: 885 --RIFVVMEKLQG----DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDL 938
++++VME G D+++ + K RL E +I+ + L L +LH ++H D+
Sbjct: 81 DDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILRETLRGLAYLHENKVIHRDI 139
Query: 939 KPENVLLSTNSELPQVKLCDFGFAR-----------IIGEKSF-PPEVL-----RNKGYN 981
K +N+LL+ N+E VKL DFG + IG + PEV+ + Y+
Sbjct: 140 KGQNILLTKNAE---VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYD 196
Query: 982 RSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAF---------MYPPRPWRDISSD 1031
D+WS+G I + L+ G P + A F + P W +D
Sbjct: 197 ARSDVWSLG-ITAIELADGKPPLCD-----MHPMRALFKIPRNPPPTLKSPENWSKKFND 250
Query: 1032 AID--LINNLLQVKQRKRLSVDKSLAHPWL 1059
I LI N Q R +++ L HP++
Sbjct: 251 FISECLIKNYEQ-----RPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-18
Identities = 80/292 (27%), Positives = 139/292 (47%), Gaps = 77/292 (26%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFETPGR-------I 886
G VA+K KL P + + K E+ +L+ + H +++L +F TP + +
Sbjct: 46 GINVAVK---KLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF-TPQKSLEEFQDV 101
Query: 887 FVVMEKLQGDMLEMI-LSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
++VME + ++ ++I + + R+S +++ Q+L +KHLHS I+H DLKP N+++
Sbjct: 102 YLVMELMDANLCQVIHMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 156
Query: 946 STNSELPQVKLCDFGFAR-----------IIGEKSFPPEVLRNKGYNRSLDMWSVGVIVY 994
++ L K+ DFG AR ++ PEV+ GY ++D+WSVG I+
Sbjct: 157 KSDCTL---KILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 995 VSLSGTFPFNEDEDI---NEQIQ-----NAAFM--------------------------- 1019
+ G+ F + I N+ I+ +A FM
Sbjct: 214 ELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFP 273
Query: 1020 ---YPPRPWRD--ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ---DPA 1063
+P RD +S A DL++ +L + KR+SVD++L HP++ DPA
Sbjct: 274 DWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA 325
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-18
Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 34/228 (14%)
Query: 870 HPGVVNLERMFETPGRIFVVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHL 928
HP + L F+T R+F VME + G D++ I S K E ++F ++ +AL L
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFL 112
Query: 929 HSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR--IIGEKS----------FPPEVLR 976
H +++ DLK +N+LL KL DFG + I+ + PE+L+
Sbjct: 113 HRHGVIYRDLKLDNILLDAEG---HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 977 NKGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAID 1034
Y S+D W++GV++Y ++G PF D +D+ E I + +YP W +S +A+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP--VW--LSKEAVS 225
Query: 1035 LINNLLQVKQRKRLSV-------DKSLAHPWLQDPATWSDLRGLERQI 1075
++ + KRL D HP+ ++ W L +R+I
Sbjct: 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE-IDWVLLE--QRKI 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 77/288 (26%), Positives = 133/288 (46%), Gaps = 50/288 (17%)
Query: 827 GAAC-GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885
G C + +G VAIK I+ + ++ E+ +L+ L HP +V ++ + P R
Sbjct: 14 GVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 73
Query: 886 -----IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKP 940
I+VV E ++ D+ ++I +++ L+ +F + Q+L ALK++H+ N+ H DLKP
Sbjct: 74 REFKDIYVVFELMESDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTANVFHRDLKP 131
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGEKSFPPEVLRN------------------KGYNR 982
+N+L + + +L K+CDFG AR+ + P + Y
Sbjct: 132 KNILANADCKL---KICDFGLARVAFNDT-PTAIFWTDYVATRWYRAPELCGSFFSKYTP 187
Query: 983 SLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ-NAAFMYPPRPWRDISSDAIDLINNLLQ 1041
++D+WS+G I L+G P +++ Q+ + P S + I + N
Sbjct: 188 AIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGTP------SPETISRVRN--- 237
Query: 1042 VKQRKRLS-VDKSLAHPWLQ-----DPATWSDLRGLERQIGTNKKKNP 1083
K R+ LS + K P+ Q DP LR LER + + K P
Sbjct: 238 EKARRYLSSMRKKQPVPFSQKFPNADPLA---LRLLERLLAFDPKDRP 282
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-18
Identities = 79/292 (27%), Positives = 133/292 (45%), Gaps = 77/292 (26%)
Query: 838 RGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFETPGR-------IF 887
R VAIK KL P + + K E+ +++ + H ++ L +F TP + ++
Sbjct: 50 RNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF-TPQKSLEEFQDVY 105
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+VME + ++ ++I + L +++ Q+L +KHLHS I+H DLKP N+++ +
Sbjct: 106 IVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 948 NSELPQVKLCDFGFARIIGEKSF------------PPEVLRNKGYNRSLDMWSVGVIVYV 995
+ L K+ DFG AR G SF PEV+ GY ++D+WSVG I+
Sbjct: 162 DCTL---KILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 996 SLSGTFPFNEDEDIN------EQIQNAA--FMYPPRP--------------------WRD 1027
+ G F + I+ EQ+ FM +P + D
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPD 277
Query: 1028 I------------SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSD 1067
+ +S A DL++ +L + KR+SVD++L HP++ W D
Sbjct: 278 VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN---VWYD 326
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-18
Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 63/289 (21%)
Query: 827 GAACGV-HRKSGRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFET 882
G+ C K+G VA+K KL P + K E+ +L+++ H V+ L +F T
Sbjct: 31 GSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF-T 86
Query: 883 PGRIF------VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHC 936
P R ++ L G L I+ +K L++ +F+I QIL LK++HS +I+H
Sbjct: 87 PARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADIIHR 144
Query: 937 DLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF---------PPEVLRN-KGYNRSLDM 986
DLKP N+ ++ + EL K+ DFG AR ++ PE++ N YN+++D+
Sbjct: 145 DLKPSNLAVNEDCEL---KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDI 201
Query: 987 WSVGVIVYVSLSGTFPFNEDEDINE--------------------------QIQNAAFMY 1020
WSVG I+ L+G F + I++ IQ+ M
Sbjct: 202 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM- 260
Query: 1021 PPRPWRDI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWL---QDP 1062
P + ++ + A+DL+ +L + KR++ ++LAH + DP
Sbjct: 261 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-18
Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 24/193 (12%)
Query: 871 PGVVNLERMFETPGRIFVVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLH 929
P + L F+T R++ VME + G D++ I + GR E F +I + L LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 930 SKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI-----IGEKSF-------PPEVLRN 977
SK I++ DLK +NV+L + +K+ DFG + + K+F PE++
Sbjct: 119 SKGIIYRDLKLDNVMLDSEG---HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175
Query: 978 KGYNRSLDMWSVGVIVYVSLSGTFPFN-EDED-INEQIQNAAFMYPPRPWRDISSDAIDL 1035
+ Y +S+D W+ GV++Y L+G PF EDED + + I YP + +S +A+ +
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI 231
Query: 1036 INNLLQVKQRKRL 1048
L+ KRL
Sbjct: 232 CKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 76/273 (27%), Positives = 129/273 (47%), Gaps = 38/273 (13%)
Query: 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERM 879
+CIA V + SG+ VA+K +D LR ++E L NEV I+++ H VV +
Sbjct: 36 VCIATV--------KSSGKLVAVKKMD-LRKQQRREL-LFNEVVIMRDYQHENVVEMYNS 85
Query: 880 FETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLK 939
+ ++VVME L+G L I++ R++E + +L AL LH++ ++H D+K
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 940 PENVLLSTNSELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMW 987
+++LL+ + +VKL DFGF + ++ PE++ Y +D+W
Sbjct: 144 SDSILLTHDG---RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 988 SVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM----YPPR--PWRDISSDAIDLINNLLQ 1041
S+G++V + G P+ NE A M PP+ +S ++ LL
Sbjct: 201 SLGIMVIEMVDGEPPY-----FNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255
Query: 1042 VKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQ 1074
+R + + L HP+L S + L RQ
Sbjct: 256 RDPAQRATAAELLKHPFLAKAGPPSCIVPLMRQ 288
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-18
Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 30/264 (11%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
+ + R A+K+++K + E A + E +L N + L F+ +++VM+
Sbjct: 23 KHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
G L +LS + RL E +F I ++++A+ +H + VH D+KP+NVLL N
Sbjct: 83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG--- 139
Query: 953 QVKLCDFG------------FARIIGEKSF-PPEVLRNK-----GYNRSLDMWSVGVIVY 994
++L DFG + +G + PE+L+ Y D WS+GV +Y
Sbjct: 140 HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMY 199
Query: 995 VSLSGTFPFNEDEDINE--QIQN--AAFMYPPRPWRDISSDAIDLINNLLQVKQRK--RL 1048
L G PF + + +I N F +P D+S +A DLI L+ ++R+ +
Sbjct: 200 EMLYGETPFYAESLVETYGKIMNHEERFQFPSHI-TDVSEEAKDLIQRLICSRERRLGQN 258
Query: 1049 SVDKSLAHPWLQDPATWSDLRGLE 1072
++ H + + W ++R LE
Sbjct: 259 GIEDFKKHAFFEG-IDWENIRNLE 281
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 5e-18
Identities = 62/236 (26%), Positives = 115/236 (48%), Gaps = 25/236 (10%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLC-HPGVVNLERMFETPGRIFVVME 891
+K+ R A+KV+ K ++ ++ E + + HP +V L F+T R+F V+E
Sbjct: 17 KKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 76
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ G L + ++ +L E +F +I +AL +LH + I++ DLK +NVLL +
Sbjct: 77 YVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-- 133
Query: 952 PQVKLCDFGFAR-----------IIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
+KL D+G + G ++ PE+LR + Y S+D W++GV+++ ++G
Sbjct: 134 -HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
Query: 1000 TFPF-------NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
PF N D++ + + R R +S A ++ + L ++RL
Sbjct: 193 RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-18
Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 60/254 (23%)
Query: 861 EVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQ 920
E+ I+ + H ++ L ++ I +VM+ + D+ +++ K RL+E K I+ Q
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVV--DRKIRLTESQVKCILLQ 127
Query: 921 ILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF---------- 970
IL L LH +H DL P N+ +++ K+ DFG AR G +
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 971 ----------------PPEVL--RNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--- 1009
PE+L K Y+ ++DMWSVG I L+G F + +I
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243
Query: 1010 ----------NEQIQNAAFMYP---------PRPWRDI----SSDAIDLINNLLQVKQRK 1046
NE A P P+ + I S DAIDL+ +LL++ +
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLE 303
Query: 1047 RLSVDKSLAHPWLQ 1060
R+S ++L H + +
Sbjct: 304 RISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 6e-18
Identities = 58/246 (23%), Positives = 112/246 (45%), Gaps = 26/246 (10%)
Query: 835 KSGRGVAIKVIDKLRFPTKQEAQ----LKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
K+G +A+K + +R + ++ + L+ E+ ++ L HP ++ + + +
Sbjct: 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E + G + +LS + G E Q+L L +LH I+H D+K N+L+ + +
Sbjct: 83 EWMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ 141
Query: 951 LPQVKLCDFGFA---------------RIIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVY 994
++++ DFG A +++G +F PEVLR + Y RS D+WSVG ++
Sbjct: 142 --RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVII 199
Query: 995 VSLSGTFPFNEDEDINEQ---IQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVD 1051
+ P+N ++ N + A+ P +S D+ L+++ R
Sbjct: 200 EMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSR 259
Query: 1052 KSLAHP 1057
+ L HP
Sbjct: 260 ELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 6e-18
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 866 QNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVAL 925
Q +P +V L F+T R+F+V+E + G L M + +L E +F +I +AL
Sbjct: 51 QASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL-MFHMQRQRKLPEEHARFYAAEICIAL 109
Query: 926 KHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR-----------IIGEKSF-PPE 973
LH + I++ DLK +NVLL + +KL D+G + G ++ PE
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDADG---HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPE 166
Query: 974 VLRNKGYNRSLDMWSVGVIVYVSLSGTFPF-----NEDEDINEQIQNAAFMYPPRPWRDI 1028
+LR + Y S+D W++GV+++ ++G PF N D + + + P R R +
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFL 226
Query: 1029 SSDAIDLINNLLQVKQRKRL 1048
S A ++ L ++RL
Sbjct: 227 SVKASHVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-18
Identities = 56/186 (30%), Positives = 90/186 (48%), Gaps = 24/186 (12%)
Query: 836 SGRGVAIKVIDKLRFPT--KQEAQLKNEVAILQNLCHPGVVNLERMFET-PGRIFVVMEK 892
+G VAIK++ P Q A+ + E A+ L HP +V L E PG +F V E
Sbjct: 2 TGHEVAIKLLRTDA-PEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
+ G L +L+++ G L T ++ Q+L AL H++ IVH DLKP+N+++S P
Sbjct: 61 VPGRTLREVLAAD-GALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 953 QVKLCDFGFA------------------RIIGEKSF-PPEVLRNKGYNRSLDMWSVGVIV 993
K+ DFG ++G ++ PE LR + + D+++ G+I
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 994 YVSLSG 999
L+G
Sbjct: 180 LECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 66/259 (25%), Positives = 117/259 (45%), Gaps = 40/259 (15%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQ-------LKNEVAILQNLCHPGVVNL--ERMFE 881
G++ SG +A+K ++ + + L E+A+L+ L H +V +
Sbjct: 19 GMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA 78
Query: 882 TPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
IF +E + G + +L+ G E + + QIL L +LH++ I+H D+K
Sbjct: 79 DHLNIF--LEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGA 135
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKS------------------FPPEVLRNKGYNRS 983
N+L+ +K+ DFG ++ + S PEV++ Y R
Sbjct: 136 NILVDNKG---GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK 192
Query: 984 LDMWSVGVIVYVSLSGTFPF---NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040
D+WS+G +V L+G PF + + I + +NA+ P +ISS+AID +
Sbjct: 193 ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS----PEIPSNISSEAIDFLEKTF 248
Query: 1041 QVKQRKRLSVDKSLAHPWL 1059
++ KR + + L HP+L
Sbjct: 249 EIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 67/285 (23%)
Query: 833 HRKSGRGVAIKVI----DKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP----- 883
H+K+ + VA+K + +K FP L+ E+ ILQ L H VVNL + T
Sbjct: 33 HKKTKQIVALKKVLMENEKEGFPI---TALR-EIKILQLLKHENVVNLIEICRTKATPYN 88
Query: 884 ---GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKP 940
G ++V E + D L +LS++ + + K ++ +L L ++H I+H D+K
Sbjct: 89 RYKGSFYLVFEFCEHD-LAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKA 147
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGEKSF----------------PPEVLRN-KGYNRS 983
N+L++ + L KL DFG AR PPE+L + Y
Sbjct: 148 ANILITKDGIL---KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPP 204
Query: 984 LDMWSVGVIV---------------------YVSLSGTF-----PFNEDEDINEQI---Q 1014
+DMW G I+ L G+ P + ++ +++ Q
Sbjct: 205 IDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQ 264
Query: 1015 NAAFMYPPRPWRDISS-DAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
R + A+DLI+ LL + KR+ D +L H +
Sbjct: 265 GQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-17
Identities = 72/251 (28%), Positives = 118/251 (47%), Gaps = 56/251 (22%)
Query: 861 EVAILQNLCHPGVVNLERMFETPG-------RIFVVMEKLQGDMLEMILSSEKGRLSERT 913
E+ +L+++ H V+ L +F TP +++V L G L I+ +K LS+
Sbjct: 64 ELRLLKHMKHENVIGLLDVF-TPATSIENFNEVYLVT-NLMGADLNNIVKCQK--LSDEH 119
Query: 914 TKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF--- 970
+F+I Q+L LK++HS I+H DLKP NV ++ + EL ++ DFG AR ++
Sbjct: 120 VQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCEL---RILDFGLARQADDEMTGYV 176
Query: 971 ------PPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN------------- 1010
PE++ N YN+++D+WSVG I+ L G F ++ I+
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236
Query: 1011 ---------EQIQNAAFMYPPRPWRDISSD-------AIDLINNLLQVKQRKRLSVDKSL 1054
E + P P +D+ AIDL+ +L + KR+S ++L
Sbjct: 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296
Query: 1055 AHPWL---QDP 1062
AHP+ DP
Sbjct: 297 AHPYFSQYHDP 307
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-17
Identities = 79/291 (27%), Positives = 133/291 (45%), Gaps = 77/291 (26%)
Query: 838 RGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFETPGR-------IF 887
R VAIK KL P + + K E+ +++ + H +++L +F TP + ++
Sbjct: 43 RNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF-TPQKSLEEFQDVY 98
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+VME + ++ ++I + L +++ Q+L +KHLHS I+H DLKP N+++ +
Sbjct: 99 LVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 948 NSELPQVKLCDFGFARIIGEKSF------------PPEVLRNKGYNRSLDMWSVGVIV-- 993
+ L K+ DFG AR G SF PEV+ GY ++D+WSVG I+
Sbjct: 155 DCTL---KILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 994 YVSLSGTFPFNEDED-------------------INEQIQNAAFMYP-------PRPWRD 1027
V FP + D + ++N P P+ + D
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270
Query: 1028 I------------SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ---DPA 1063
+S A DL++ +L + KR+SVD++L HP++ DPA
Sbjct: 271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPA 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-17
Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 32/255 (12%)
Query: 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895
+G+ VAIK ++ + P K+ + NE+ +++ +P +VN + ++VVME L G
Sbjct: 43 TGQEVAIKQMNLQQQPKKE--LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVK 955
L +++ + E + + L AL LHS ++H D+K +N+LL + VK
Sbjct: 101 GSLTDVVTETC--MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG---SVK 155
Query: 956 LCDFGF-ARIIGEKS-----------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPF 1003
L DFGF A+I E+S PEV+ K Y +D+WS+G++ + G P+
Sbjct: 156 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
Query: 1004 NEDEDINEQIQNAAFMYPP-------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
+NE A ++ P R +S+ D +N L++ +R S + L H
Sbjct: 216 -----LNENPLRALYLIATNGTPELQNPER-LSAVFRDFLNRCLEMDVDRRGSAKELLQH 269
Query: 1057 PWLQDPATWSDLRGL 1071
P+L+ S L L
Sbjct: 270 PFLKLAKPLSSLTPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 24/231 (10%)
Query: 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCH----PGVVNLERMFETPGRIFVVME 891
+G+ A+K +DK R KQ L I+ +L P +V + F TP ++ +++
Sbjct: 18 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ G L LS + G SE +F +I++ L+H+H++ +V+ DLKP N+LL E
Sbjct: 78 LMNGGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEH 133
Query: 952 PQVKLCDFGFARIIGEKS----------FPPEVLRNKG--YNRSLDMWSVGVIVYVSLSG 999
V++ D G A +K PEVL+ KG Y+ S D +S+G +++ L G
Sbjct: 134 GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRG 192
Query: 1000 TFPFNE--DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
PF + +D +E + M P S + L+ LLQ +RL
Sbjct: 193 HSPFRQHKTKDKHEIDRMTLTMAVELP-DSFSPELRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 72/264 (27%), Positives = 124/264 (46%), Gaps = 30/264 (11%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
+ +G+ A+K+++K + E A + E +L N + NL F+ +++VM+
Sbjct: 23 KNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
G L +LS + RL E +F + ++++A+ +H VH D+KP+NVLL N
Sbjct: 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG--- 139
Query: 953 QVKLCDFGFA-RIIGEKS------------FPPEVLR----NKG-YNRSLDMWSVGVIVY 994
++L DFG R++ + + PE+L+ KG Y D WS+GV +Y
Sbjct: 140 HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMY 199
Query: 995 VSLSGTFPFNEDE--DINEQIQN--AAFMYPPRPWRDISSDAIDLINNLLQVKQRK--RL 1048
L G PF + + +I N F +PP D+S +A DLI L+ + + R
Sbjct: 200 EMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-TDVSEEAKDLIRRLICSPETRLGRN 258
Query: 1049 SVDKSLAHPWLQDPATWSDLRGLE 1072
+ HP+ + W ++R
Sbjct: 259 GLQDFKDHPFFEG-IDWDNIRNST 281
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 66/227 (29%), Positives = 99/227 (43%), Gaps = 25/227 (11%)
Query: 853 KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSER 912
K+ +L+ EV +L++L H +V I + ME + G + IL+ G L E
Sbjct: 44 KEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEP 102
Query: 913 TTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------G 966
QIL + +LH+ +VH D+K NV+L N +KL DFG AR + G
Sbjct: 103 VFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG---IIKLIDFGCARRLAWVGLHG 159
Query: 967 EKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ-- 1012
S PEV+ GY R D+WS+G V+ +G P + +
Sbjct: 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY 219
Query: 1013 IQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
I + P P S+ AID + + L Q +R S + L H +L
Sbjct: 220 IGAHRGLMPRLPDS-FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 853 KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDMLEMILSSEKGR--L 909
K A E+ +L+ L HP V+ F + +V+E GD+ MI +K + +
Sbjct: 44 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 103
Query: 910 SERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS 969
E+T Q+ AL+H+HS+ ++H D+KP NV ++ VKL D G R K+
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160
Query: 970 ------------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE----DINEQI 1013
PE + GYN D+WS+G ++Y + PF D+ + ++I
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI 220
Query: 1014 QNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV 1050
+ YPP P S + L+N + KR +
Sbjct: 221 EQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 61/232 (26%), Positives = 106/232 (45%), Gaps = 26/232 (11%)
Query: 825 VAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG 884
V A C + RK +++ + + +Q+ E+ +L+ L HP V+ F
Sbjct: 18 VYRATCLLDRKPVALKKVQIFEMMDAKARQDCV--KEIDLLKQLNHPNVIKYLDSFIEDN 75
Query: 885 RIFVVMEKLQ-GDMLEMILSSEKGR--LSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
+ +V+E GD+ +MI +K + + ERT Q+ A++H+HS+ ++H D+KP
Sbjct: 76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPA 135
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSV 989
NV ++ VKL D G R K+ PE + GYN D+WS+
Sbjct: 136 NVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192
Query: 990 GVIVYVSLSGTFPFNEDE----DINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037
G ++Y + PF D+ + ++I+ YPP P S +L++
Sbjct: 193 GCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSEKLRELVS 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 67/254 (26%), Positives = 119/254 (46%), Gaps = 35/254 (13%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFETPGRIFV 888
H+++G A K+I + E +L++ E+ IL HP +V L + ++++
Sbjct: 25 QHKETGLFAAAKIIQ-----IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI 79
Query: 889 VMEKLQGDMLE-MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
++E G L+ ++L E+G L+E +++ Q+L AL LHS ++H DLK N+LL+
Sbjct: 80 LIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL 138
Query: 948 NSELPQVKLCDFGF-ARIIGEK----SF-------PPEVL-----RNKGYNRSLDMWSVG 990
+ VKL DFG A+ +F PEV+ ++ Y+ D+WS+G
Sbjct: 139 DG---DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLG 195
Query: 991 VIVYVSLSGTFPFNEDEDINEQIQNAAFMYPP---RPWRDISSDAIDLINNLLQVKQRKR 1047
I + L+ P + + + + PP +P SS D + + L R
Sbjct: 196 -ITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQP-SKWSSSFNDFLKSCLVKDPDDR 253
Query: 1048 LSVDKSLAHPWLQD 1061
+ + L HP++ D
Sbjct: 254 PTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 66/264 (25%)
Query: 861 EVAILQNLCHPGVVNLERMF--ETPGRIFVVMEKLQGDMLEMI---LSSEKGRLSERTTK 915
E+A+L+ L H VV+L +F ++++ + + D+ ++I +++ + K
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 916 FIITQILVALKHLHSKNIVHCDLKPENVLL-STNSELPQVKLCDFGFARIIGEKSFP--- 971
++ QIL + +LHS ++H DLKP N+L+ E VK+ D G AR+ P
Sbjct: 112 SLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 972 ------------PEVLRN-KGYNRSLDMWSVGVIV--YVSLSGTFPFNEDE--------- 1007
PE+L + Y +++D+W++G I ++L F E +
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231
Query: 1008 DINEQIQNAAFMYPPRPWRDI---------------------------------SSDAID 1034
D E+I + W DI S D
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291
Query: 1035 LINNLLQVKQRKRLSVDKSLAHPW 1058
L+ LL+ KR++ +++L HP+
Sbjct: 292 LLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-17
Identities = 74/254 (29%), Positives = 118/254 (46%), Gaps = 31/254 (12%)
Query: 830 CGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-------CHPGVVNL-ERMFE 881
C G A+KV+D + + + EV L N CH R E
Sbjct: 50 CAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109
Query: 882 TPGRIFVVMEKLQ-GDMLEMILSSEK-GR-LSERTTKFIITQILVALKHLHSKNIVHCDL 938
I +V++ GD+ + I S K R E + Q+L+A+ H+HSK+++H D+
Sbjct: 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDI 169
Query: 939 KPENVLLSTNSELPQVKLCDFGFARIIGE-------KSF-------PPEVLRNKGYNRSL 984
K N+LL +N VKL DFGF+++ ++F PE+ R K Y++
Sbjct: 170 KSANILLCSNG---LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKA 226
Query: 985 DMWSVGVIVYVSLSGTFPFNEDEDINEQIQNA-AFMYPPRPWRDISSDAIDLINNLLQVK 1043
DM+S+GV++Y L+ PF + E++ E + A Y P P IS + +++ LL
Sbjct: 227 DMFSLGVLLYELLTLKRPF-DGENMEEVMHKTLAGRYDPLP-PSISPEMQEIVTALLSSD 284
Query: 1044 QRKRLSVDKSLAHP 1057
++R S K L P
Sbjct: 285 PKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-17
Identities = 72/262 (27%), Positives = 122/262 (46%), Gaps = 32/262 (12%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
H+ S + A+K++ K + + A E I+ P VV L F+ +++VME
Sbjct: 64 HKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ G L ++S+ + E+ KF ++++AL +HS ++H D+KP+N+LL + L
Sbjct: 124 YMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL 181
Query: 952 PQVKLCDFGFARIIGEKSF-------------PPEVLRNKG----YNRSLDMWSVGVIVY 994
KL DFG + E PEVL+++G Y R D WSVGV ++
Sbjct: 182 ---KLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238
Query: 995 VSLSGTFPFNEDEDINEQIQ----NAAFMYPPRPWRDISSDAIDLINNLLQVKQRK--RL 1048
L G PF D + + + +P +IS A +LI L ++ + R
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV--EISKHAKNLICAFLTDREVRLGRN 296
Query: 1049 SVDKSLAHPWLQ-DPATWSDLR 1069
V++ HP+ + D W ++R
Sbjct: 297 GVEEIKQHPFFKNDQWNWDNIR 318
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-17
Identities = 78/289 (26%), Positives = 123/289 (42%), Gaps = 59/289 (20%)
Query: 820 LCIAVVAGAACGVHRKSGRGVAIKVI-----DKLRFPTKQEAQLKNEVAILQNLCHPGVV 874
L A G+ R +G+ VA+KVI + + F +EA L L+ L H +V
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASL------LKGLKHANIV 66
Query: 875 NLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIV 934
L + T + V E + D L + G L + + Q+L L ++H ++I+
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 935 HCDLKPENVLLSTNSELPQVKLCDFGFARI--IGEKSF----------PPEVLRNK-GYN 981
H DLKP+N+L+S EL KL DFG AR I +++ PP+VL Y+
Sbjct: 126 HRDLKPQNLLISYLGEL---KLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182
Query: 982 RSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ-----------------------NAAF 1018
+LD+W G I L G F D+ EQ++ +
Sbjct: 183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242
Query: 1019 MYPPRP------WRDISS--DAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
P +P W+ +S A DL + +L + + R+S +L HP+
Sbjct: 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 68/274 (24%), Positives = 126/274 (45%), Gaps = 52/274 (18%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE---AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
R + +A+K K+R + E + E+++L+ + H +V L+ + + R+++V
Sbjct: 23 DRVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL--ST 947
E L D+ + + SS + R K + QIL + + HS ++H DLKP+N+L+ T
Sbjct: 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT 139
Query: 948 NSELPQVKLCDFGFARIIG--EKSFPPEV-----------LRNKGYNRSLDMWSVGVIVY 994
N+ +KL DFG AR G ++F EV L ++ Y+ +D+WSVG I
Sbjct: 140 NA----LKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFA 195
Query: 995 VSLSGTFPFNEDEDINEQIQNAAFMYPP--RPWRDISS---------------------- 1030
++ F D +I+E + + P W ++S
Sbjct: 196 EMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPT 255
Query: 1031 ---DAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+DL++ +L++ KR++ +L H + +D
Sbjct: 256 LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289
|
Length = 294 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-17
Identities = 77/285 (27%), Positives = 132/285 (46%), Gaps = 60/285 (21%)
Query: 827 GAAC-GVHRKSGRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFET 882
G C + R++G VAIK KL P + E K E+ +L+++ H V+ L +F T
Sbjct: 29 GTVCSALDRRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF-T 84
Query: 883 PGR-------IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVH 935
P ++VM G L ++ EK LSE +F++ Q+L LK++H+ I+H
Sbjct: 85 PDLSLDRFHDFYLVM-PFMGTDLGKLMKHEK--LSEDRIQFLVYQMLKGLKYIHAAGIIH 141
Query: 936 CDLKPENVLLSTNSELPQVKLCDFGFAR---------IIGEKSFPPEVLRN-KGYNRSLD 985
DLKP N+ ++ + EL K+ DFG AR ++ PEV+ N Y +++D
Sbjct: 142 RDLKPGNLAVNEDCEL---KILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVD 198
Query: 986 MWSVGVIVYVSLSGTFPFNEDEDIN----------------------EQIQNAAFMYPPR 1023
+WSVG I+ L+G F + ++ E +N P
Sbjct: 199 IWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRF 258
Query: 1024 PWRDISS-------DAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+D S A++++ +L + R++ ++LAHP+ ++
Sbjct: 259 RKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-17
Identities = 66/239 (27%), Positives = 110/239 (46%), Gaps = 27/239 (11%)
Query: 829 ACGVHRKSGRGVAIKVIDKLRFPTKQ-EAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
AC V R +G+ A K ++K R ++ E+ NE IL+ + VV+L +ET +
Sbjct: 18 ACQV-RATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALC 76
Query: 888 VVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
+V+ + G D+ I + E F +I L+ LH + IV+ DLKPEN+LL
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD 136
Query: 947 TNSELPQVKLCDFGFARIIGEKS-----------FPPEVLRNKGYNRSLDMWSVGVIVYV 995
+ +++ D G A + E PEV++N+ Y S D W++G ++Y
Sbjct: 137 DHG---HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 193
Query: 996 SLSGTFPFNE------DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
++G PF + E++ ++ Y + S DA L LL ++RL
Sbjct: 194 MIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK----FSPDARSLCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-16
Identities = 57/192 (29%), Positives = 95/192 (49%), Gaps = 22/192 (11%)
Query: 871 PGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS 930
P + L F+T R++ VME + G L M + G+ E F +I V L LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL-MYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 931 KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI-----IGEKSF-------PPEVLRNK 978
+ I++ DLK +NV+L + +K+ DFG + + ++F PE++ +
Sbjct: 120 RGIIYRDLKLDNVMLDSEG---HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 979 GYNRSLDMWSVGVIVYVSLSGTFPFN-EDED-INEQIQNAAFMYPPRPWRDISSDAIDLI 1036
Y +S+D W+ GV++Y L+G PF+ EDED + + I YP + +S +A+ +
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSIC 232
Query: 1037 NNLLQVKQRKRL 1048
L+ KRL
Sbjct: 233 KGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 60/194 (30%), Positives = 95/194 (48%), Gaps = 19/194 (9%)
Query: 827 GAACGVHRK-SGRGVAIKVIDKLRFPTKQ-EAQLKNEVAILQNLCHPGVVNLERMFETPG 884
G C V K +G+ A K +DK R K E E IL+ + P +VNL FE+
Sbjct: 7 GEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT 66
Query: 885 RIFVVMEKLQGDMLEMILSS--EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
+ +VM + G L+ + + E+G ER QI + HLHS +IV+ D+KPEN
Sbjct: 67 HLCLVMSLMNGGDLKYHIYNVGERGLEMERVI-HYSAQITCGILHLHSMDIVYRDMKPEN 125
Query: 943 VLLSTNSELPQVKLCDFGFA------RIIGEKS-----FPPEVLRNKGYNRSLDMWSVGV 991
VLL +L D G A + I +++ PE+L+ + Y+ +D +++G
Sbjct: 126 VLLDDQG---NCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGC 182
Query: 992 IVYVSLSGTFPFNE 1005
+Y ++G PF +
Sbjct: 183 SIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-16
Identities = 68/257 (26%), Positives = 120/257 (46%), Gaps = 30/257 (11%)
Query: 841 AIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
A+K+++K + E A + E +L N + + L F+ +++VM+ G L
Sbjct: 30 AMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLL 89
Query: 900 MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959
+LS + RL E +F + ++++A+ +H + VH D+KP+N+L+ N ++L DF
Sbjct: 90 TLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG---HIRLADF 146
Query: 960 GFARIIGEKS-------------FPPEVLR----NKG-YNRSLDMWSVGVIVYVSLSGTF 1001
G + E PE+L+ KG Y D WS+GV +Y L G
Sbjct: 147 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET 206
Query: 1002 PFNEDEDINE--QIQN--AAFMYPPRPWRDISSDAIDLINNLLQVKQRK--RLSVDKSLA 1055
PF + + +I N F +P + D+S DA DLI L+ ++ + + ++
Sbjct: 207 PFYAESLVETYGKIMNHKERFQFPAQV-TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265
Query: 1056 HPWLQDPATWSDLRGLE 1072
HP+ W ++R E
Sbjct: 266 HPFFTG-IDWDNIRNCE 281
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|237996 cd00029, C1, Protein kinase C conserved region 1 (C1) | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-16
Identities = 25/50 (50%), Positives = 32/50 (64%)
Query: 266 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315
H F ++ +PT C +C+K + GLFKQGL+C C HKKC DKVP C
Sbjct: 1 HRFVRKSFFKPTFCDVCRKSIWGLFKQGLRCSWCKVKCHKKCADKVPPSC 50
|
Cysteine-rich zinc binding domain. Some members of this domain family bind phorbol esters and diacylglycerol, some are reported to bind RasGTP. May occur in tandem arrangement. Diacylglycerol (DAG) is a second messenger, released by activation of Phospholipase D. Phorbol Esters (PE) can act as analogues of DAG and mimic its downstream effects in, for example, tumor promotion. Protein Kinases C are activated by DAG/PE, this activation is mediated by their N-terminal conserved region (C1). DAG/PE binding may be phospholipid dependent. C1 domains may also mediate DAG/PE signals in chimaerins (a family of Rac GTPase activating proteins), RasGRPs (exchange factors for Ras/Rap1), and Munc13 isoforms (scaffolding proteins involved in exocytosis). Length = 50 |
| >gnl|CDD|237996 cd00029, C1, Protein kinase C conserved region 1 (C1) | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-16
Identities = 25/50 (50%), Positives = 32/50 (64%)
Query: 530 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579
H F ++ +PT C +C+K + GLFKQGL+C C HKKC DKVP C
Sbjct: 1 HRFVRKSFFKPTFCDVCRKSIWGLFKQGLRCSWCKVKCHKKCADKVPPSC 50
|
Cysteine-rich zinc binding domain. Some members of this domain family bind phorbol esters and diacylglycerol, some are reported to bind RasGTP. May occur in tandem arrangement. Diacylglycerol (DAG) is a second messenger, released by activation of Phospholipase D. Phorbol Esters (PE) can act as analogues of DAG and mimic its downstream effects in, for example, tumor promotion. Protein Kinases C are activated by DAG/PE, this activation is mediated by their N-terminal conserved region (C1). DAG/PE binding may be phospholipid dependent. C1 domains may also mediate DAG/PE signals in chimaerins (a family of Rac GTPase activating proteins), RasGRPs (exchange factors for Ras/Rap1), and Munc13 isoforms (scaffolding proteins involved in exocytosis). Length = 50 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 80/248 (32%), Positives = 116/248 (46%), Gaps = 42/248 (16%)
Query: 840 VAIKVIDKLRFPTK--QEAQ-LKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896
+AIK I P + + Q L E+A+ L H +V G + ME++ G
Sbjct: 36 IAIKEI-----PERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90
Query: 897 MLEMILSSEKGRLS--ERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQV 954
L +L S+ G L E+T F QIL LK+LH IVH D+K +NVL++T S + V
Sbjct: 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGV--V 148
Query: 955 KLCDFGFA-RIIG----EKSF-------PPEVLRN--KGYNRSLDMWSVGVIVYVSLSGT 1000
K+ DFG + R+ G ++F PEV+ +GY D+WS+G + +G
Sbjct: 149 KISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
Query: 1001 FPFNEDEDINEQIQNAAF---MY---PPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSL 1054
PF E + Q A F M+ P P +S++A + I + KR S
Sbjct: 209 PPFIE----LGEPQAAMFKVGMFKIHPEIP-ESLSAEAKNFILRCFEPDPDKRAS----- 258
Query: 1055 AHPWLQDP 1062
AH LQDP
Sbjct: 259 AHDLLQDP 266
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 68/282 (24%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEA----QLKNEVAILQNLCH-PGVVNL---ERMFETPGR 885
+ +G+ VA+K K R +E L+ E+++LQ L +V L E + E G+
Sbjct: 23 KNTGKLVALK---KTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRLLDVEHVEEKNGK 78
Query: 886 --IFVVMEKLQGDMLEMILSSEKGR---LSERTTKFIITQILVALKHLHSKNIVHCDLKP 940
+++V E L D+ + + S+ +G L +T K + Q+L + H H ++H DLKP
Sbjct: 79 PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKP 138
Query: 941 ENVLLSTNSELPQVKLCDFGFAR--IIGEKSF----------PPEVLR-NKGYNRSLDMW 987
+N+L+ L +K+ D G R I KS+ PEVL + Y+ +D+W
Sbjct: 139 QNLLVDKQKGL--LKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIW 196
Query: 988 SVGVIVYVSLSGTFPFNEDEDI-------------NEQI------------------QNA 1016
SVG I F D ++ EQ+ Q+
Sbjct: 197 SVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDL 256
Query: 1017 AFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
+ P D+S + +DL+ +L+ KR+S +L HP+
Sbjct: 257 SRAVP-----DLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-16
Identities = 70/254 (27%), Positives = 121/254 (47%), Gaps = 30/254 (11%)
Query: 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895
+G+ VAI+ ++ + P K+ + NE+ +++ +P +VN + ++VVME L G
Sbjct: 44 TGQEVAIRQMNLQQQPKKE--LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVK 955
L +++ + E + + L AL+ LHS ++H D+K +N+LL + VK
Sbjct: 102 GSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG---SVK 156
Query: 956 LCDFGF-ARIIGEKS-----------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPF 1003
L DFGF A+I E+S PEV+ K Y +D+WS+G++ + G P+
Sbjct: 157 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
Query: 1004 NEDEDINEQIQNAAFMYPPRPWRDISS----DAI--DLINNLLQVKQRKRLSVDKSLAHP 1057
+NE A ++ ++ + AI D +N L + KR S + L H
Sbjct: 217 -----LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271
Query: 1058 WLQDPATWSDLRGL 1071
+L+ S L L
Sbjct: 272 FLKIAKPLSSLTPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 56/185 (30%), Positives = 94/185 (50%), Gaps = 19/185 (10%)
Query: 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPG----VVNLERMFETPGRIFVVME 891
+G+ A+K +DK R KQ L I+ +L G +V + F TP ++ +++
Sbjct: 18 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ G L LS + G SE+ +F T+I++ L+H+H++ +V+ DLKP N+LL E
Sbjct: 78 LMNGGDLHYHLS-QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEH 133
Query: 952 PQVKLCDFGFARIIGEKS----------FPPEVL-RNKGYNRSLDMWSVGVIVYVSLSGT 1000
V++ D G A +K PEVL + Y+ S D +S+G +++ L G
Sbjct: 134 GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193
Query: 1001 FPFNE 1005
PF +
Sbjct: 194 SPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 81/292 (27%), Positives = 116/292 (39%), Gaps = 62/292 (21%)
Query: 822 IAVVAGAACGV-----HRKSGRGVAIKVIDKLRFPTKQEA---QLKNEVAILQNL---CH 870
+A + A G SG VA+K +R T ++ EVA+L+ L H
Sbjct: 5 VAEIGVGAYGTVYKARDPHSGHFVALK---SVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 871 PGVVNLERMFET-----PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVAL 925
P +V L + T ++ +V E + D+ + L T K ++ Q L L
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 926 KHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEV 974
LH+ IVH DLKPEN+L+++ QVKL DFG ARI + PEV
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGG---QVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
Query: 975 LRNKGYNRSLDMWSVGVIVYV---------------SLSGTF-----PFNEDEDINEQIQ 1014
L Y +DMWSVG I L F P +D + +
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 1015 NAAFMYPPRPWR-------DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
AF PR R +I L+ +L KR+S ++L HP+
Sbjct: 239 RGAF--SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 68/257 (26%), Positives = 114/257 (44%), Gaps = 32/257 (12%)
Query: 829 ACGVHRKSGRGVAIKVIDKLRFPTKQ-EAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
AC V R +G+ A K ++K R ++ EA NE IL+ + VV+L +ET +
Sbjct: 18 ACQV-RATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALC 76
Query: 888 VVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
+V+ + G D+ I + E+ F ++ L+ L + IV+ DLKPEN+LL
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD 136
Query: 947 TNSELPQVKLCDFGFARIIGEKS-----------FPPEVLRNKGYNRSLDMWSVGVIVYV 995
+++ D G A I E PEV+ N+ Y S D W +G ++Y
Sbjct: 137 DRG---HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYE 193
Query: 996 SLSGTFPFNED------EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS 1049
+ G PF + E+++ +++ Y + S DA + LL ++RL
Sbjct: 194 MIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK----FSEDAKSICRMLLTKNPKERLG 249
Query: 1050 VDKSLA-----HPWLQD 1061
+ A HP ++
Sbjct: 250 CRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|197519 smart00109, C1, Protein kinase C conserved region 1 (C1) domains (Cysteine-rich domains) | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-16
Identities = 26/50 (52%), Positives = 33/50 (66%)
Query: 266 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315
H T+T+PT C +C+K + G FKQGL+C +C HKKC DKVPK C
Sbjct: 1 HKHVFRTFTKPTFCCVCRKSIWGSFKQGLRCSECKVKCHKKCADKVPKAC 50
|
Some bind phorbol esters and diacylglycerol. Some bind RasGTP. Zinc-binding domains. Length = 50 |
| >gnl|CDD|197519 smart00109, C1, Protein kinase C conserved region 1 (C1) domains (Cysteine-rich domains) | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-16
Identities = 26/50 (52%), Positives = 33/50 (66%)
Query: 530 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579
H T+T+PT C +C+K + G FKQGL+C +C HKKC DKVPK C
Sbjct: 1 HKHVFRTFTKPTFCCVCRKSIWGSFKQGLRCSECKVKCHKKCADKVPKAC 50
|
Some bind phorbol esters and diacylglycerol. Some bind RasGTP. Zinc-binding domains. Length = 50 |
| >gnl|CDD|215738 pfam00130, C1_1, Phorbol esters/diacylglycerol binding domain (C1 domain) | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-16
Identities = 25/50 (50%), Positives = 30/50 (60%)
Query: 266 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315
H F T+ PT C C + L GL KQGL+C CG NVHK+C VP +C
Sbjct: 1 HHFVHRTFKSPTFCDHCGEFLWGLGKQGLKCSWCGLNVHKRCHSLVPPEC 50
|
This domain is also known as the Protein kinase C conserved region 1 (C1) domain. Length = 53 |
| >gnl|CDD|215738 pfam00130, C1_1, Phorbol esters/diacylglycerol binding domain (C1 domain) | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-16
Identities = 25/50 (50%), Positives = 30/50 (60%)
Query: 530 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579
H F T+ PT C C + L GL KQGL+C CG NVHK+C VP +C
Sbjct: 1 HHFVHRTFKSPTFCDHCGEFLWGLGKQGLKCSWCGLNVHKRCHSLVPPEC 50
|
This domain is also known as the Protein kinase C conserved region 1 (C1) domain. Length = 53 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 71/262 (27%), Positives = 118/262 (45%), Gaps = 38/262 (14%)
Query: 823 AVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET 882
AVV A C + VAIK ID + T + +L+ EV + HP VV F
Sbjct: 15 AVVYAAIC---LPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVKYYTSFVV 70
Query: 883 PGRIFVVMEKL-QGDMLEMILSS-EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKP 940
+++VM L G +L+++ SS +G L E ++ ++L L++LHS +H D+K
Sbjct: 71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKA 130
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGE---------KSF-------PPEVLRNK-GYNRS 983
N+LL + VK+ DFG + + + K+F PEV+ GY+
Sbjct: 131 GNILLGEDGS---VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK 187
Query: 984 LDMWSVGVIVYVSLSGTFPFNE---DEDINEQIQNAAFMYPP-----RPWRDISSDAIDL 1035
D+WS G+ +G P+++ + + +QN PP ++ S +
Sbjct: 188 ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND----PPSLETGADYKKYSKSFRKM 243
Query: 1036 INNLLQVKQRKRLSVDKSLAHP 1057
I+ LQ KR + ++ L H
Sbjct: 244 ISLCLQKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 64/251 (25%), Positives = 108/251 (43%), Gaps = 56/251 (22%)
Query: 861 EVAILQNLCHPGVVNLERMF----------ETPGRIFVVMEKLQGDMLEMILSSEKGRLS 910
E+ IL+ L H +VNL+ + + G ++V E + D++ +L S S
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG-LLESGLVHFS 114
Query: 911 ERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF 970
E K + Q+L L + H KN +H D+K N+LL+ Q+KL DFG AR+ +
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG---QIKLADFGLARLYNSEES 171
Query: 971 -------------PPEVLR-NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQ 1014
PPE+L + Y ++D+WS G I+ + F ++++ E I
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231
Query: 1015 NAAFMYPPRPWRD--------------------------ISSDAIDLINNLLQVKQRKRL 1048
P W D I + A+DL++++L + KR
Sbjct: 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291
Query: 1049 SVDKSLAHPWL 1059
+ +++L PWL
Sbjct: 292 TAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 61/276 (22%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEA---QLKNEVAILQNLC---HPGVVNLERMFET----- 882
+ GR VA+K ++R T +E EVA+L++L HP VV R+F+
Sbjct: 24 KNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV---RLFDVCTVSR 77
Query: 883 ---PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLK 939
++ +V E + D+ + + + T K ++ Q+L L LHS +VH DLK
Sbjct: 78 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137
Query: 940 PENVLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWS 988
P+N+L++++ Q+KL DFG ARI + PEVL Y +D+WS
Sbjct: 138 PQNILVTSSG---QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWS 194
Query: 989 VGVIVYVSLSGTFPF-------------------NEDEDINEQIQNAAFMYPPRPWR--- 1026
VG I + + P +ED + + + +
Sbjct: 195 VGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE 253
Query: 1027 ----DISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
DI DL+ L KR+S +L+HP+
Sbjct: 254 KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 45/177 (25%), Positives = 81/177 (45%), Gaps = 21/177 (11%)
Query: 835 KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR--IFVVMEK 892
+G VA+K + + + + E+ IL+ L H +V + + E PG + ++ME
Sbjct: 31 NTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
L L L + +++ + +QI + +L S+ +H DL N+L+ +
Sbjct: 90 LPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--- 146
Query: 953 QVKLCDFGFARIIGEKS----------FP-----PEVLRNKGYNRSLDMWSVGVIVY 994
VK+ DFG A+++ E P PE LR ++ + D+WS GV +Y
Sbjct: 147 LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLY 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 71/244 (29%), Positives = 112/244 (45%), Gaps = 31/244 (12%)
Query: 836 SGRGVAIKVIDKLRF------PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR--IF 887
+GR +A+K +++F +K+ L+ E+ +L+NL H +V P +
Sbjct: 26 TGRELAVK---QVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+ ME + G ++ L S G L+E T+ QIL + +LHS IVH D+K N+L +
Sbjct: 83 IFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDS 141
Query: 948 NSELPQVKLCDFGFARII--------GEKS-------FPPEVLRNKGYNRSLDMWSVGVI 992
VKL DFG ++ + G KS PEV+ +GY R D+WSVG
Sbjct: 142 VG---NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCT 198
Query: 993 VYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDK 1052
V L+ P+ E E + + A P +S D + + V+ + R S D+
Sbjct: 199 VVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADE 257
Query: 1053 SLAH 1056
L H
Sbjct: 258 LLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 72/263 (27%), Positives = 121/263 (46%), Gaps = 35/263 (13%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFETPGRIFVV 889
++++G A KVI+ TK E +L++ E+ IL HP +V L F G+++++
Sbjct: 33 NKETGALAAAKVIE-----TKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
+E G ++ I+ L+E + I Q+L AL++LHS I+H DLK NVLL+ +
Sbjct: 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG 147
Query: 950 ELPQVKLCDFGFA-----------RIIGEKSF-PPEV-----LRNKGYNRSLDMWSVGVI 992
+ +KL DFG + IG + PEV +++ Y+ D+WS+G+
Sbjct: 148 D---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGIT 204
Query: 993 VYVSLSGTFPFNEDEDINEQIQNAAFMYP----PRPWRDISSDAIDLINNLLQVKQRKRL 1048
+ P +E + ++ A P P W S + D + L R
Sbjct: 205 LIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW---SMEFRDFLKTALDKHPETRP 261
Query: 1049 SVDKSLAHPWLQDPATWSDLRGL 1071
S + L HP++ + LR L
Sbjct: 262 SAAQLLEHPFVSSVTSNRPLREL 284
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 5e-15
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 15/159 (9%)
Query: 861 EVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQ 920
E +LQN+ HP V+ ++ + +V+ D L L+ L I Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSD-LYTYLTKRSRPLPIDQALIIEKQ 165
Query: 921 ILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI-IGEKSF--------- 970
IL L++LH++ I+H D+K EN+ ++ QV + D G A+ + +F
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVD---QVCIGDLGAAQFPVVAPAFLGLAGTVET 222
Query: 971 -PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED 1008
PEVL YN D+WS G++++ L+ ED
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPP 261
|
Length = 357 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 9e-15
Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 22/226 (9%)
Query: 852 TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR--IFVVMEKLQGDMLEMILSSEKGRL 909
+K+ + L+ E+ +L+NL H +V + + ME + G ++ L + G L
Sbjct: 45 SKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA-YGAL 103
Query: 910 SERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965
+E T+ QIL + +LHS IVH D+K N+L + VKL DFG ++ +
Sbjct: 104 TESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG---NVKLGDFGASKRLQTIC 160
Query: 966 ----GEKS-------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ 1014
G +S PEV+ +GY R D+WS+G V L+ P+ E E + +
Sbjct: 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK 220
Query: 1015 NAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060
A P+ IS A D + + V+ R R S ++ L HP+ Q
Sbjct: 221 IATQPTNPQLPSHISEHARDFLGCIF-VEARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-15
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 40/252 (15%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
H + R +A+KVI L + + Q+ +E+ IL P ++ F RI + E
Sbjct: 21 YHLLTRRILAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ G L++ ++ E I ++ L +L S I+H D+KP N+L++T
Sbjct: 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-- 132
Query: 952 PQVKLCDFGFAR---------IIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
QVKLCDFG + +G ++ PE + + Y D+WS+G+ G F
Sbjct: 133 -QVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF 191
Query: 1002 PFNEDEDINEQIQ-NAAFMYP------------PR-PWRDISSDAIDLINNLLQVKQRKR 1047
P+ QIQ N + P P P S + I ++ + ++R
Sbjct: 192 PY-------PQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKER 244
Query: 1048 LSVDKSLAHPWL 1059
+ + + HP++
Sbjct: 245 PAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 41/259 (15%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCH-PGVVNLERMF---ETPG-- 884
G H K+G+ AIKV+D +E ++K E+ +L+ H + F PG
Sbjct: 35 GRHVKTGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91
Query: 885 -RIFVVMEKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
++++VME G + +++ +++ L E +I +IL L HLH+ ++H D+K +N
Sbjct: 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQN 151
Query: 943 VLLSTNSELPQVKLCDFGFA----RIIGEKS--------FPPEVLR-----NKGYNRSLD 985
VLL+ N+E VKL DFG + R +G ++ PEV+ + Y+ D
Sbjct: 152 VLLTENAE---VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSD 208
Query: 986 MWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRP-----WRDISSDAIDLINNLL 1040
+WS+G+ G P + A F+ P P + S ID I L
Sbjct: 209 IWSLGITAIEMAEGAPPL-----CDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCL 263
Query: 1041 QVKQRKRLSVDKSLAHPWL 1059
R S ++ L HP++
Sbjct: 264 VKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 68/259 (26%), Positives = 118/259 (45%), Gaps = 41/259 (15%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCH-PGVVNLERMF---ETPG-- 884
G H K+G+ AIKV+D +E ++K E+ +L+ H + F PG
Sbjct: 25 GRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81
Query: 885 -RIFVVMEKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
++++VME G + ++I +++ L E +I +IL L HLH ++H D+K +N
Sbjct: 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQN 141
Query: 943 VLLSTNSELPQVKLCDFGFA----RIIGEKS--------FPPEVLR-----NKGYNRSLD 985
VLL+ N+E VKL DFG + R +G ++ PEV+ + Y+ D
Sbjct: 142 VLLTENAE---VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSD 198
Query: 986 MWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAI-----DLINNLL 1040
+WS+G+ G P + + A F+ P P + S I + L
Sbjct: 199 LWSLGITAIEMAEGAPPLCDMHPM-----RALFLIPRNPAPRLKSKKWSKKFQSFIESCL 253
Query: 1041 QVKQRKRLSVDKSLAHPWL 1059
+R + ++ + HP++
Sbjct: 254 VKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 20/188 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G+ ++ + VAIK+ID L + ++ E+ +L P V + +++++M
Sbjct: 23 GIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81
Query: 891 EKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E L G L+++ E G L E I+ +IL L +LHS+ +H D+K NVLLS +
Sbjct: 82 EYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG 138
Query: 950 ELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVSL 997
E VKL DFG A + + PEV++ Y+ D+WS+G+
Sbjct: 139 E---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 195
Query: 998 SGTFPFNE 1005
G P +E
Sbjct: 196 KGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 63/253 (24%), Positives = 113/253 (44%), Gaps = 27/253 (10%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEV-AILQNLCHPGVVNLERMFETPGRIFVVM 890
+H+ SG +A+K I + K++ +L ++ ++++ P +V G ++ M
Sbjct: 24 LHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82
Query: 891 E--KLQGDMLEMIL-SSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLS 946
E + D + K + E I + AL +L + I+H D+KP N+LL
Sbjct: 83 ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD 142
Query: 947 TNSELPQVKLCDFGFA----------RIIGEKSF-PPEVL---RNKGYNRSLDMWSVGVI 992
N +KLCDFG + R G + + PE + GY+ D+WS+G+
Sbjct: 143 RNG---NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGIT 199
Query: 993 VYVSLSGTFPFNEDEDINEQIQNAAFMYPPR----PWRDISSDAIDLINNLLQVKQRKRL 1048
+Y +G FP+ + + +Q+ PP R+ S ++ IN L + KR
Sbjct: 200 LYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRP 259
Query: 1049 SVDKSLAHPWLQD 1061
+ L HP+++D
Sbjct: 260 KYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-14
Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 65/292 (22%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
+ +G A+K++ K K++ A ++ E IL VV + F+ ++++ME
Sbjct: 23 KDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82
Query: 893 LQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
L G DM+ +++ +K LSE T+F I + ++A+ +H +H D+KP+N+LL
Sbjct: 83 LPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-- 138
Query: 952 PQVKLCDFG------------FAR----------------------------------II 965
VKL DFG F R +
Sbjct: 139 -HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV 197
Query: 966 GEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQN--AAFMY 1020
G + PEV GYN+ D WS+GVI+Y L G PF + ++ ++ N ++
Sbjct: 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVF 257
Query: 1021 PPRPWRDISSDAIDLINNLLQVKQRKRL---SVDKSLAHPWLQDPATWSDLR 1069
PP IS A DLI R+ V++ +HP+ + W +R
Sbjct: 258 PPEV--PISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG-VDWGHIR 305
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 25/202 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
VA+K P+ +E L+ E I++ HP +V L + +++VME L
Sbjct: 37 VAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELR 94
Query: 900 MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ-VKLCD 958
L K L + Q+ AL +L SK VH D+ NVL+S+ P VKL D
Sbjct: 95 SYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS----PDCVKLGD 150
Query: 959 FGFARIIGEKSF-------------PPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFN 1004
FG +R + ++S+ PE + + + + D+W GV ++ L G PF
Sbjct: 151 FGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210
Query: 1005 --EDEDINEQIQNAAFMYPPRP 1024
++ D+ +I+N P P
Sbjct: 211 GVKNNDVIGRIENGE--RLPMP 230
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 60/258 (23%), Positives = 107/258 (41%), Gaps = 27/258 (10%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
H +G +A KV+ + + Q+ E+ I+ P +V+ F I + ME
Sbjct: 26 HIPTGTVMAKKVV-HIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN-IVHCDLKPENVLLSTNSEL 951
+ L+ I + G + I ++ L +L++ + I+H D+KP N+L+++
Sbjct: 85 MDCGSLDRIYK-KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-- 141
Query: 952 PQVKLCDFGFA---------RIIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
Q+KLCDFG + +G ++ PE ++ Y D+WS+G+ + G F
Sbjct: 142 -QIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKF 200
Query: 1002 PFNEDED----------INEQIQNAAFMYPPR-PWRDISSDAIDLINNLLQVKQRKRLSV 1050
PF I + +Q PPR P D D D ++ L +R +
Sbjct: 201 PFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTP 260
Query: 1051 DKSLAHPWLQDPATWSDL 1068
+ A P S++
Sbjct: 261 QQLCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 838 RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDM 897
R VAIK I R E E ++ L HP +V L + I +V E ++
Sbjct: 29 RKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85
Query: 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957
L L +++G+ S+ T + + + +L S N++H DL N L+ N VK+
Sbjct: 86 LSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ---VVKVS 142
Query: 958 DFGFARII---------GEKSFP-----PEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFP 1002
DFG R + G K FP PEV Y+ D+WS GV+++ S G P
Sbjct: 143 DFGMTRFVLDDQYTSSTGTK-FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201
Query: 1003 FNE--DEDINEQIQNAAFMYPPR 1023
+ + ++ E I +Y PR
Sbjct: 202 YENRSNSEVVETINAGFRLYKPR 224
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 66/250 (26%), Positives = 122/250 (48%), Gaps = 33/250 (13%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFETPGRIFVV 889
++++G A KVID TK E +L++ E+ IL + HP +V L F ++++
Sbjct: 26 NKETGVLAAAKVID-----TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 80
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
+E G ++ ++ + L+E + + Q L AL +LH I+H DLK N+L + +
Sbjct: 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG 140
Query: 950 ELPQVKLCDFGFA----RIIGEK-SF-------PPEVL-----RNKGYNRSLDMWSVGVI 992
+ +KL DFG + R I + SF PEV+ +++ Y+ D+WS+G+
Sbjct: 141 D---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT 197
Query: 993 VYVSLSGTFPFNEDEDINEQIQNAAFMYPP---RPWRDISSDAIDLINNLLQVKQRKRLS 1049
+ + ++ P + + + + A PP +P R SS+ D + L+ R +
Sbjct: 198 L-IEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR-WSSEFKDFLKKCLEKNVDARWT 255
Query: 1050 VDKSLAHPWL 1059
+ L HP++
Sbjct: 256 TTQLLQHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (184), Expect = 1e-13
Identities = 69/263 (26%), Positives = 121/263 (46%), Gaps = 40/263 (15%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVN-LERMFETPG-RIFVVM 890
H+++ K I ++++QL EV +++ L H +V ++R +++++M
Sbjct: 34 HKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM 93
Query: 891 EKLQ-GDMLEMILSSEK--GRLSERTTKFIITQILVALKHLHS-------KNIVHCDLKP 940
E GD+ I K G++ E I Q+L AL + H+ + ++H DLKP
Sbjct: 94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKP 153
Query: 941 ENVLLSTN--------------SELPQVKLCDFGFARIIGEKS-----------FPPEVL 975
+N+ LST + P K+ DFG ++ IG +S + PE+L
Sbjct: 154 QNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELL 213
Query: 976 --RNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAI 1033
K Y+ DMW++G I+Y SG PF++ + ++ I P P + S +
Sbjct: 214 LHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELK-RGPDLPIKGKSKELN 272
Query: 1034 DLINNLLQVKQRKRLSVDKSLAH 1056
LI NLL + ++R S + L +
Sbjct: 273 ILIKNLLNLSAKERPSALQCLGY 295
|
Length = 1021 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-13
Identities = 65/256 (25%), Positives = 110/256 (42%), Gaps = 60/256 (23%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
+ +G A+K++ K K++ ++ E IL VV + F+ ++++ME
Sbjct: 23 KDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82
Query: 893 LQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
L G DM+ +++ +K L+E T+F I + ++A+ +H +H D+KP+N+LL +
Sbjct: 83 LPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-- 138
Query: 952 PQVKLCDFG-----------------------------------------------FARI 964
VKL DFG F+ +
Sbjct: 139 -HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTV 197
Query: 965 IGEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQN--AAFMY 1020
PEV GYN+ D WS+GVI+Y L G PF + ++ +++ N ++
Sbjct: 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIF 257
Query: 1021 PPRPWRDISSDAIDLI 1036
PP IS A DLI
Sbjct: 258 PPEV--PISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 52/276 (18%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+HR SG +A K+I L Q+ E+ +L P +V F + G I + ME
Sbjct: 21 LHRPSGLIMARKLI-HLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNSE 950
+ G L+ +L + GR+ E I +L L +L K I+H D+KP N+L+++ E
Sbjct: 80 HMDGGSLDQVLK-KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE 138
Query: 951 LPQVKLCDFGFA---------RIIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
+KLCDFG + +G +S+ PE L+ Y D+WS+G+ + G
Sbjct: 139 ---IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
Query: 1001 FP------------FNEDED-----------------------INEQIQNAAFMYPPR-P 1024
+P F I E + PP+ P
Sbjct: 196 YPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP 255
Query: 1025 WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060
S + D ++ L+ ++R + + HP+++
Sbjct: 256 SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-13
Identities = 66/251 (26%), Positives = 113/251 (45%), Gaps = 66/251 (26%)
Query: 873 VVNLERMFET-PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK 931
++ ++R F+ G + +VM K +L+ I+ + G S R II Q VAL + H++
Sbjct: 193 LMKIQRYFQNETGHMCIVMPKYGPCLLDWIM--KHGPFSHRHLAQIIFQTGVALDYFHTE 250
Query: 932 -NIVHCDLKPENVLLS---------TNSELP----QVKLCDFG------FAR--IIGEKS 969
+++H DLKPEN+L+ TN LP +V++CD G +R I+ +
Sbjct: 251 LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRH 310
Query: 970 F-PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN------------------ 1010
+ PEV+ G+ S DMWS+G I+Y +G ++ +++
Sbjct: 311 YRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAG 370
Query: 1011 -------EQIQNAAFMYPP-------------RPWRDISSDAI--DLINNLLQVKQRKRL 1048
+ N+A P RP R++ D + DLI LL ++KRL
Sbjct: 371 RCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430
Query: 1049 SVDKSLAHPWL 1059
+ + HP++
Sbjct: 431 NARQMTTHPYV 441
|
Length = 467 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 70/245 (28%), Positives = 113/245 (46%), Gaps = 31/245 (12%)
Query: 836 SGRGVAIKVIDKLRF-PTKQEAQ-----LKNEVAILQNLCHPGVVNLERMFETP--GRIF 887
+GR +A+K ++ F P QE L+ E+ +L+NL H +V P ++
Sbjct: 26 TGRELAVK---QVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+ +E + G ++ L + G L+E T+ QIL + +LHS IVH D+K N+L +
Sbjct: 83 IFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDS 141
Query: 948 NSELPQVKLCDFGFARII--------GEKS-------FPPEVLRNKGYNRSLDMWSVGVI 992
VKL DFG ++ I G KS PEV+ +GY R D+WSV
Sbjct: 142 AG---NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACT 198
Query: 993 VYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDK 1052
V L+ P+ E E + + A P +S D + + V++++R + +
Sbjct: 199 VVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIF-VEEKRRPTAEF 257
Query: 1053 SLAHP 1057
L HP
Sbjct: 258 LLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 72/247 (29%), Positives = 111/247 (44%), Gaps = 36/247 (14%)
Query: 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895
+G AIKVI KL P + A ++ E+ ++++ H +V + ++++ ME G
Sbjct: 33 TGELAAIKVI-KLE-PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90
Query: 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVK 955
L+ I G LSE ++ + L L +LHSK +H D+K N+LL+ N VK
Sbjct: 91 GSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG---HVK 146
Query: 956 LCDFGF-----ARIIGEKSF-------PPEVL---RNKGYNRSLDMWSVGVIVYVSLSGT 1000
L DFG A I KSF PEV R GYN+ D+W+VG I + L+
Sbjct: 147 LADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVG-ITAIELAEL 205
Query: 1001 FP--FNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNL-------LQVKQRKRLSVD 1051
P F+ + + PP+ D + N+ L +KR + +
Sbjct: 206 QPPMFDLHPMRALFLMTKSNFQPPK-----LKDKMKWSNSFHHFVKMALTKNPKKRPTAE 260
Query: 1052 KSLAHPW 1058
K L HP+
Sbjct: 261 KLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 27/224 (12%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
H+ SG +A K+I L Q+ E+ +L P +V F + G I + ME
Sbjct: 26 HKPSGLIMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN-IVHCDLKPENVLLSTNSEL 951
+ G L+ +L + GR+ E+ + ++ L +L K+ I+H D+KP N+L+++ E
Sbjct: 85 MDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE- 142
Query: 952 PQVKLCDFGFA---------RIIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
+KLCDFG + +G +S+ PE L+ Y+ D+WS+G+ + G +
Sbjct: 143 --IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRY 200
Query: 1002 PF-NEDEDINEQI-------QNAAFMYPPR---PWRDISSDAID 1034
P D E + A PR P R +SS D
Sbjct: 201 PIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPD 244
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-13
Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 16/181 (8%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
H+ SG +A K+I L Q+ E+ +L P +V F + G I + ME
Sbjct: 26 HKPSGLIMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN-IVHCDLKPENVLLSTNSEL 951
+ G L+ +L K R+ E + +L L +L K+ I+H D+KP N+L+++ E
Sbjct: 85 MDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE- 142
Query: 952 PQVKLCDFGFA---------RIIGEKSF-PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
+KLCDFG + +G +S+ PE L+ Y+ D+WS+G+ + G +
Sbjct: 143 --IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRY 200
Query: 1002 P 1002
P
Sbjct: 201 P 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G+ ++ VAIK+ID L + ++ E+ +L P + + +++++M
Sbjct: 23 GIDNRTKEVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81
Query: 891 EKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E L G L+++ + G L E I+ +IL L +LHS+ +H D+K NVLL S
Sbjct: 82 EYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---S 135
Query: 950 ELPQVKLCDFGFA-----RIIGEKSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSL 997
E VKL DFG A I +F PEV++ Y+ D+WS+G I + L
Sbjct: 136 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLG-ITAIEL 194
Query: 998 SGTFPFNED 1006
+ P N D
Sbjct: 195 AKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 19/188 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G+ ++ + VAIK+ID L + ++ E+ +L P V + +++++M
Sbjct: 23 GIDNRTQQVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E L G +L + G E ++ +IL L +LHS+ +H D+K NVLL SE
Sbjct: 82 EYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SE 136
Query: 951 LPQVKLCDFGFA-----RIIGEKSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
VKL DFG A I +F PEV++ Y+ D+WS+G I + L+
Sbjct: 137 QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLG-ITAIELA 195
Query: 999 GTFPFNED 1006
P N D
Sbjct: 196 KGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|241272 cd01239, PH_PKD, Protein kinase D (PKD/PKCmu) pleckstrin homology (PH) domain | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 38/93 (40%), Positives = 52/93 (55%), Gaps = 11/93 (11%)
Query: 586 NNKSNNYCK--LKSEVASLVSLESSASASYSCLVRSTSHCFILKTNNLDYYVGEDTHSPS 643
N ++ Y K SE+ +++E + + S + HCF +KT NL YYVGED S
Sbjct: 41 NETTSRYYKEIPLSEI---LAVEPADNPSL--PPGTPPHCFEIKTANLVYYVGEDPDGFS 95
Query: 644 DGVETPVTAPESGLG---ARAWELSLRQALMPV 673
G + PESG G AR+WE ++RQALMPV
Sbjct: 96 -GGPPLIPDPESGSGTEIARSWETAIRQALMPV 127
|
Protein Kinase C family is composed of three members, PKD1 (PKCmu), PKD2 and PKD3 (PKCnu). Like the C-type protein kinases (PKCs), PKDs are activated by diacylglycerol (DAG). They are involved in vesicular transport, cell proliferation, survival, migration and immune responses. PKD consists of tandem C1 domains, followed by a PH domain and a kinase domain. While the PKD PH domain has not been shown to bind phosphorylated inositol lipids and is not required for membrane translocation, it is required for nuclear export. PH domains have diverse functions, but in general are involved in targeting proteins to the appropriate cellular location or in the interaction with a binding partner. They share little sequence conservation, but all have a common fold, which is electrostatically polarized. Less than 10% of PH domains bind phosphoinositide phosphates (PIPs) with high affinity and specificity. PH domains are distinguished from other PIP-binding domains by their specific high-affinity binding to PIPs with two vicinal phosphate groups: PtdIns(3,4)P2, PtdIns(4,5)P2 or PtdIns(3,4,5)P3 which results in targeting some PH domain proteins to the plasma membrane. A few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes. Length = 127 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 52/161 (32%), Positives = 85/161 (52%), Gaps = 20/161 (12%)
Query: 917 IITQILVALKHLHSK-NIVHCDLKPENVLLSTNSELPQVKLCDFG--------FARII-- 965
I I+ AL++LHSK +++H D+KP NVL++ N QVKLCDFG A+ I
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG---QVKLCDFGISGYLVDSVAKTIDA 164
Query: 966 GEKSF-PPE----VLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY 1020
G K + PE L KGY+ D+WS+G+ + +G FP++ + +Q++
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP 224
Query: 1021 PPR-PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060
P+ P S + D +N L+ ++R + + L HP+ +
Sbjct: 225 SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 67/260 (25%), Positives = 113/260 (43%), Gaps = 37/260 (14%)
Query: 830 CGV-----HRKSGRGVAIKVIDKLRFPTKQEAQLKN-----EVAILQNLCHPGVVNLERM 879
CG +K+G +A+K + + T + + K +V + + C P +V
Sbjct: 28 CGQVYKMRFKKTGHVMAVKQMRR----TGNKEENKRILMDLDVVLKSHDC-PYIVKCYGY 82
Query: 880 FETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDL 938
F T +F+ ME L L+ +L +G + E + I+ AL +L K ++H D+
Sbjct: 83 FITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDV 141
Query: 939 KPENVLLSTNSELPQVKLCDFGFA-RIIGEKS----------FPPEVL----RNKGYNRS 983
KP N+LL + VKLCDFG + R++ K+ PE + N Y+
Sbjct: 142 KPSNILLDASG---NVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIR 198
Query: 984 LDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPR--PWRDISSDAIDLINNLLQ 1041
D+WS+G+ + +G FP+ + E + PP P S D ++ L
Sbjct: 199 ADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLT 258
Query: 1042 VKQRKRLSVDKSLAHPWLQD 1061
RKR + L HP+++
Sbjct: 259 KDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-12
Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 55/262 (20%)
Query: 854 QEAQLKN-EVAILQNLCHPGVVNLERMFETPG------RIF--VVMEKLQGDMLEMI--L 902
Q+ Q KN E+ I++NL H ++ L+ + T IF VVME + + + +
Sbjct: 101 QDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHY 160
Query: 903 SSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962
+ L K Q+ AL ++HSK I H DLKP+N+L+ N+ +KLCDFG A
Sbjct: 161 ARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH--TLKLCDFGSA 218
Query: 963 R--IIGEKSF----------PPEVLRNKGYNRSLDMWSVGVIV------YVSLSGTFPFN 1004
+ + G++S P +L Y +D+WS+G I+ Y SG +
Sbjct: 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278
Query: 1005 E------------DEDINEQIQN-AAFMYPPRPWRDIS--------SDAIDLINNLLQVK 1043
+ ++ + E N A +P +D+ DAI+ I+ L+ +
Sbjct: 279 QLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYE 338
Query: 1044 QRKRLSVDKSLAHPW---LQDP 1062
KRL+ ++LA P+ L+DP
Sbjct: 339 PLKRLNPIEALADPFFDDLRDP 360
|
Length = 440 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 832 VHRKSGRG---VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888
VH RG VAIK+I R E E ++ L HP +V L + IF+
Sbjct: 20 VHLGKWRGKIDVAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI 76
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
V E + L L KG+L + + + A+++L S +H DL N L+ +
Sbjct: 77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED 136
Query: 949 SELPQVKLCDFGFARII---------GEKSFP-----PEVLRNKGYNRSLDMWSVGVIVY 994
+ VK+ DFG AR + G K FP PEV ++ D+WS GV+++
Sbjct: 137 N---VVKVSDFGLARYVLDDQYTSSQGTK-FPVKWAPPEVFDYSRFSSKSDVWSFGVLMW 192
Query: 995 -VSLSGTFPFN--EDEDINEQIQNAAFMYPPR 1023
V G P+ + ++ E + +Y P+
Sbjct: 193 EVFSEGKMPYERFSNSEVVESVSAGYRLYRPK 224
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-12
Identities = 48/187 (25%), Positives = 88/187 (47%), Gaps = 24/187 (12%)
Query: 835 KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894
K R +A +V + ++ QL+NE+ L L H ++ +E + + +++ +K
Sbjct: 191 KCERLIAKRV----KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD 246
Query: 895 GDMLEMILSSE---KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
D+ + K R + T+ I+ Q+L A++++H K ++H D+K EN+ L+ +
Sbjct: 247 FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG-- 304
Query: 952 PQVKLCDFGFARIIGEKSFP-------------PEVLRNKGYNRSLDMWSVGVIVYVSLS 998
++ L DFG A ++ PE+L GY D+WS G+I+ LS
Sbjct: 305 -KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
Query: 999 GTF-PFN 1004
F P
Sbjct: 364 HDFCPIG 370
|
Length = 501 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 20/190 (10%)
Query: 850 FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRL 909
P +A+ E IL+ HP +V L + I++VME +QG L +E RL
Sbjct: 32 LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRL 91
Query: 910 SERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR------ 963
+ ++ +++L SK+ +H DL N L++ + L K+ DFG +R
Sbjct: 92 KVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVL---KISDFGMSREEEDGV 148
Query: 964 ---IIGEKSFP-----PEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFN--EDEDINEQ 1012
G K P PE L Y+ D+WS G++++ + S G P+ ++ E
Sbjct: 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA 208
Query: 1013 IQNAAFMYPP 1022
I+ + P
Sbjct: 209 IEQGVRLPCP 218
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 18/173 (10%)
Query: 835 KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL- 893
K+ VAIK++ +Q+ Q EV L+ L H +++L + ++++ E +
Sbjct: 28 KNRVRVAIKILKSDDLLKQQDFQK--EVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85
Query: 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953
+G +L + S E L + + Q+ + +L +N +H DL N+L+ +
Sbjct: 86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL---V 142
Query: 954 VKLCDFGFARIIGE-------KSFP-----PEVLRNKGYNRSLDMWSVGVIVY 994
K+ DFG AR+I E K P PE + ++ D+WS G+++Y
Sbjct: 143 CKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLY 195
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-12
Identities = 75/310 (24%), Positives = 116/310 (37%), Gaps = 71/310 (22%)
Query: 841 AIKVIDKLR-FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG-DML 898
A+K + K Q A +K E IL + VV L F+ ++ VM+ + G DM
Sbjct: 30 AMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDM- 88
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
M L G E +F I ++ A++ +H +H D+KP+N+L+ + +KL D
Sbjct: 89 -MSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG---HIKLTD 144
Query: 959 FG------------------------------FARIIGEKSFPPEVLRNKGYNRSL---- 984
FG ++ I + P E R + + R L
Sbjct: 145 FGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSL 204
Query: 985 ---------------------DMWSVGVIVYVSLSGTFPFNEDEDINEQ---IQNAAFMY 1020
D WSVGVI+Y L G PF D Q I ++
Sbjct: 205 VGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLH 264
Query: 1021 PPRPWRDISSDAIDLINNLLQVKQRKRL---SVDKSLAHPWLQDPATWSDLRGLERQIGT 1077
P +S +A DLI L RL D+ AHP+ + ++ L ++
Sbjct: 265 IP-SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG-IDFASLIRRQKAPYI 321
Query: 1078 NKKKNPKRTA 1087
K +P T+
Sbjct: 322 PKITHPTDTS 331
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-12
Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 24/170 (14%)
Query: 853 KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG-DMLEMILSSEKGRL-- 909
+Q A ++E+ L H G+V F++ ++ ++ME G D+ + I K L
Sbjct: 107 RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF 166
Query: 910 SERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ--VKLCDFGFARIIGE 967
E + QI++AL +HS+ ++H DLK N+ L +P +KL DFGF++ +
Sbjct: 167 QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL-----MPTGIIKLGDFGFSKQYSD 221
Query: 968 K-------SF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPF 1003
SF PE+ K Y++ DMWS+GVI+Y L+ PF
Sbjct: 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 55/185 (29%), Positives = 90/185 (48%), Gaps = 32/185 (17%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETP-----GRI 886
++K G A+K++D + + +++ E ILQ+L HP VV MF G++
Sbjct: 43 NKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99
Query: 887 FVVMEKLQG-DMLEMI--LSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
++V+E G + E++ L RL E +I+ L+ L+HLH+ I+H D+K N+
Sbjct: 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNI 159
Query: 944 LLSTNSELPQVKLCDFGF------ARIIGEKS------FPPEVLR-----NKGYNRSLDM 986
LL+T VKL DFG R+ S PEV+ + Y+ D+
Sbjct: 160 LLTTEG---GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDV 216
Query: 987 WSVGV 991
WS+G+
Sbjct: 217 WSLGI 221
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 835 KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894
K VA+K + P + + E IL+ HP +V L + I++VME +
Sbjct: 17 KGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75
Query: 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQV 954
G L L +K RL+ + + +++L SKN +H DL N L+ N+ +
Sbjct: 76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN---VL 132
Query: 955 KLCDFGFAR---------IIGEKSFP-----PEVLRNKGYNRSLDMWSVGVIVYVSLS-- 998
K+ DFG +R G K P PE L Y D+WS G++++ + S
Sbjct: 133 KISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLG 192
Query: 999 -GTFPFNEDEDINEQIQNAAFMYPP 1022
+P ++ E+I++ M P
Sbjct: 193 DTPYPGMSNQQTRERIESGYRMPAP 217
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 21/188 (11%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
GV +K VA+K L+ T + + E A+++ + HP +V L + +++
Sbjct: 25 GVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81
Query: 891 EKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E + G++L+ + + ++ ++ TQI A+++L KN +H DL N L+ N
Sbjct: 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH 141
Query: 950 ELPQVKLCDFGFARIIGEKS--------FP-----PEVLRNKGYNRSLDMWSVGVIVY-V 995
VK+ DFG +R++ + FP PE L ++ D+W+ GV+++ +
Sbjct: 142 ---LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198
Query: 996 SLSGTFPF 1003
+ G P+
Sbjct: 199 ATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 68/250 (27%), Positives = 108/250 (43%), Gaps = 36/250 (14%)
Query: 835 KSGRGVAIKVIDKLRFPTKQEAQ----LKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
++ VAIK K+ + KQ + + EV LQ L HP + + + ++VM
Sbjct: 38 RTNEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94
Query: 891 EKLQG---DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
E G D+LE+ K L E I L L +LHS +H D+K N+LL+
Sbjct: 95 EYCLGSASDILEV----HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE 150
Query: 948 NSELPQVKLCDFGFARIIG-EKSF-------PPEVL--RNKG-YNRSLDMWSVGVIVYVS 996
VKL DFG A ++ SF PEV+ ++G Y+ +D+WS+G I +
Sbjct: 151 PG---TVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIE 206
Query: 997 LSGT----FPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDK 1052
L+ F N + QN + W S + +++ LQ + R S ++
Sbjct: 207 LAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW---SDYFRNFVDSCLQKIPQDRPSSEE 263
Query: 1053 SLAHPWLQDP 1062
L H ++
Sbjct: 264 LLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 51/205 (24%), Positives = 98/205 (47%), Gaps = 37/205 (18%)
Query: 861 EVAILQNLCHPGVVNLERMFETPG--RIFVVMEKLQGDMLEMILSSEKGRLSER------ 912
E+A+L+ L HP V++L+++F + +++++ + + D+ +I + +++
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 913 -TTKFIITQILVALKHLHSKNIVHCDLKPENVL-LSTNSELPQVKLCDFGFARIIGEKSF 970
K ++ QIL + +LH+ ++H DLKP N+L + E +VK+ D GFAR+
Sbjct: 108 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 971 P---------------PEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFN-EDEDIN--- 1010
P PE+L + Y +++D+W++G I L+ F+ EDI
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 227
Query: 1011 -------EQIQNAAFMYPPRPWRDI 1028
++I N + W DI
Sbjct: 228 PYHHDQLDRIFNVMGFPADKDWEDI 252
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 51/177 (28%), Positives = 87/177 (49%), Gaps = 24/177 (13%)
Query: 836 SGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLCHPGVVNLERMFETPGR--IFVVMEK 892
+G VA+K KL+ T + + + E+ IL++L H +V + + + GR + +VME
Sbjct: 32 TGEVVAVK---KLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY 88
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
L L L + RL R +QI +++L SK VH DL N+L+ + +
Sbjct: 89 LPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN--- 145
Query: 953 QVKLCDFGFARII------------GEKS---FPPEVLRNKGYNRSLDMWSVGVIVY 994
+VK+ DFG +++ GE + PE L ++ + D+WS GV++Y
Sbjct: 146 RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 42/158 (26%), Positives = 82/158 (51%), Gaps = 26/158 (16%)
Query: 861 EVAILQNLCHPGVVNLERMF--ETPGRIFVVMEKLQGDMLEMI-------LSSEKGRLSE 911
E+A+L+ L HP V+ L+++F + +++++ + + D+ +I + + +L
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 912 RTTKFIITQILVALKHLHSKNIVHCDLKPENVL-LSTNSELPQVKLCDFGFARIIGEKSF 970
K ++ QIL + +LH+ ++H DLKP N+L + E +VK+ D GFAR+
Sbjct: 108 SMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 971 P---------------PEVLRN-KGYNRSLDMWSVGVI 992
P PE+L + Y +++D+W++G I
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 54/172 (31%), Positives = 86/172 (50%), Gaps = 21/172 (12%)
Query: 835 KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894
+G A+K+I KL P + ++ E+ +++ H +V + + ++++ ME
Sbjct: 32 HTGELAAVKII-KLE-PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89
Query: 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQV 954
G L+ I G LSE ++ + L L +LHSK +H D+K N+LL+ N + V
Sbjct: 90 GGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD---V 145
Query: 955 KLCDFGF-----ARIIGEKSF-------PPEVL---RNKGYNRSLDMWSVGV 991
KL DFG A I KSF PEV +N GYN+ D+W+VG+
Sbjct: 146 KLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-11
Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 860 NEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIIT 919
+E +L+ L HP V+ L + G +V+ K + D L L + L +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD-LYTYLGARLRPLGLAQVTAVAR 267
Query: 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFG---FARIIGEKSFP----- 971
Q+L A+ ++H + I+H D+K ENVL++ + + L DFG FAR G S P
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFAR--GSWSTPFHYGI 322
Query: 972 --------PEVLRNKGYNRSLDMWSVGVIVY 994
PEVL Y S+D+WS G++++
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 27/195 (13%)
Query: 831 GVHR-KSGR--GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
GV+ KSG+ VA+K + + + + E +++ L HP +V L + + +
Sbjct: 14 GVYLMKSGKEVEVAVKTLKQEHIAA-GKKEFLREASVMAQLDHPCIVRLIGVCKGEP-LM 71
Query: 888 VVMEKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
+VME G +L+ + ++ + K + Q+ + + +L SK+ VH DL NVLL
Sbjct: 72 LVMELAPLGPLLKYLK--KRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV 129
Query: 947 TNSELPQVKLCDFGFARIIGEKS---------------FPPEVLRNKGYNRSLDMWSVGV 991
Q K+ DFG +R +G S + PE + ++ D+WS GV
Sbjct: 130 NRH---QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGV 186
Query: 992 IVYVSLS-GTFPFNE 1005
++ + S G P+ E
Sbjct: 187 TLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 831 GVHRKSGR---GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
G+ + GR VAIK + K + KQ +E +I+ H ++ LE +
Sbjct: 24 GILKMPGRKEVAVAIKTL-KPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
++ E ++ L+ L G S ++ I +K+L N VH DL N+L+++
Sbjct: 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS 142
Query: 948 NSELPQVKLCDFGFARIIGEKSFP-----------------PEVLRNKGYNRSLDMWSVG 990
N E K+ DFG +R++ + P PE + + + + D+WS G
Sbjct: 143 NLE---CKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFG 197
Query: 991 VIVYVSLS-GTFPFNE--DEDINEQIQNAAFMYP 1021
++++ +S G P+ + + ++ + I N F P
Sbjct: 198 IVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 67/245 (27%), Positives = 106/245 (43%), Gaps = 30/245 (12%)
Query: 835 KSGRGVAIKVIDKLRFPTKQEAQ----LKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
++ VAIK K+ + KQ + + EV LQ L HP + + ++VM
Sbjct: 38 RNSEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E G ++ L K L E + L L +LHS N++H D+K N+LL SE
Sbjct: 95 EYCLGSASDL-LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SE 150
Query: 951 LPQVKLCDFGFARIIG-EKSF-------PPEVL--RNKG-YNRSLDMWSVGVIVYVSLSG 999
VKL DFG A I+ F PEV+ ++G Y+ +D+WS+G I + L+
Sbjct: 151 PGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAE 209
Query: 1000 TFP----FNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055
P N + QN + W + + +D + LQ + R + + L
Sbjct: 210 RKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
Query: 1056 HPWLQ 1060
H ++
Sbjct: 267 HRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 66/263 (25%), Positives = 114/263 (43%), Gaps = 51/263 (19%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMF-----ETPGRI 886
++K+G A+K++D + + +++ E IL+ L HP VV M+ + ++
Sbjct: 39 NKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95
Query: 887 FVVMEKLQG----DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
++V+E G D+++ L + R+ E +I+ + L+ L+HLH +H D+K N
Sbjct: 96 WLVLELCNGGSVTDLVKGFLKRGE-RMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNN 154
Query: 943 VLLSTNSELPQVKLCDFGFA------RIIGEKS------FPPEVLR-----NKGYNRSLD 985
+LL+T VKL DFG + R+ S PEV+ + Y+ D
Sbjct: 155 ILLTTEG---GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCD 211
Query: 986 MWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRP---------WRDISSDAIDLI 1036
+WS+G+ G P + + A F P P W S++ D I
Sbjct: 212 VWSLGITAIELGDGDPPLADLHPM-----RALFKIPRNPPPTLHQPELW---SNEFNDFI 263
Query: 1037 NNLLQVKQRKRLSVDKSLAHPWL 1059
L KR +V L H ++
Sbjct: 264 RKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 51/181 (28%), Positives = 79/181 (43%), Gaps = 21/181 (11%)
Query: 835 KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG--RIFVVMEK 892
+G VA+K + K A LK E+ IL+NL H +V + + G I ++ME
Sbjct: 31 NTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 89
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
L L+ L K +++ + QI + +L S+ VH DL NVL+ +
Sbjct: 90 LPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--- 146
Query: 953 QVKLCDFGFARIIGEKS---------------FPPEVLRNKGYNRSLDMWSVGVIVYVSL 997
QVK+ DFG + I + PE L + + D+WS GV +Y L
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
Query: 998 S 998
+
Sbjct: 207 T 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
VA+K + + + LK E AI+ +L H ++ L + T + V G +L+
Sbjct: 26 VAVKCLKSDKLSDIMDDFLK-EAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLD 84
Query: 900 MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959
+ G T QI +++L SK +H DL N+LL+++ +VK+ DF
Sbjct: 85 RLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD---KVKIGDF 141
Query: 960 GFARIIGEKS---------------FPPEVLRNKGYNRSLDMWSVGV 991
G R + + PE LR + ++ + D+W GV
Sbjct: 142 GLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGV 188
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 16/168 (9%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL-QG 895
G+ VA+K L+ + E +++ L HP +V L + +++V E + +G
Sbjct: 29 GQKVAVK---CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85
Query: 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVK 955
+++ + S + ++ + +++L KN VH DL NVL+ SE K
Sbjct: 86 SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAK 142
Query: 956 LCDFGFARIIGEK----SFP-----PEVLRNKGYNRSLDMWSVGVIVY 994
+ DFG A+ + P PE LR K ++ D+WS G++++
Sbjct: 143 VSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 861 EVAILQNLCHPGVVNLERMFETPGRIFVVMEKL-QGDMLEMILSSEKGRLSERTTKFIIT 919
E +++ L H +V L + I+++ E + +G +L+ + S E G++
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS--------FP 971
QI + ++ KN +H DL+ NVL+ SE K+ DFG AR+I + FP
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYTAREGAKFP 167
Query: 972 -----PEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPF--NEDEDINEQIQNAAFMYPPR 1023
PE + + D+WS G+++Y ++ G P+ + D+ +Q M PR
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM--PR 225
Query: 1024 P 1024
Sbjct: 226 M 226
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 22/200 (11%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
VAIK I E E ++ L HP +V L + +++V E ++ L
Sbjct: 31 VAIKAI---NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87
Query: 900 MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959
L +G+LS+ + + +++L + +H DL N L+ S VK+ DF
Sbjct: 88 NYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDF 144
Query: 960 GFARIIGEKSF-------------PPEVLRNKGYNRSLDMWSVGVIVY-VSLSGTFPFNE 1005
G R + + + PPEV Y+ D+WS GV+++ V G PF +
Sbjct: 145 GMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204
Query: 1006 DE--DINEQIQNAAFMYPPR 1023
++ E I +Y P+
Sbjct: 205 KSNYEVVEMISRGFRLYRPK 224
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 21/186 (11%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893
RK VAIKV+ + ++ ++ E I+ L +P +V + + E + +VME
Sbjct: 19 RKKQIDVAIKVLKNENEKSVRDEMMR-EAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMA 76
Query: 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953
G L LS +K ++ ++ Q+ + +K+L KN VH DL NVLL
Sbjct: 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH---Y 133
Query: 954 VKLCDFGFARIIGE---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
K+ DFG ++ +G K + PE + + ++ D+WS G+ ++ + S
Sbjct: 134 AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
Query: 999 -GTFPF 1003
G P+
Sbjct: 194 YGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 37/210 (17%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GD-- 896
VA+KV+ +E LK EV IL L P + L + + ++ME ++ GD
Sbjct: 49 VAVKVLRPDASDNAREDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 897 -------MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
L+ LS T ++ TQI +++L S N VH DL N L+ N
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY 167
Query: 950 ELPQVKLCDFG---------FARIIGEKSFP------PEVLRNKGYNRSLDMWSVGVIVY 994
+K+ DFG + R+ G P VL K + D+W+ GV ++
Sbjct: 168 ---TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLW 223
Query: 995 --VSLSGTFPFNE--DEDINEQIQNAAFMY 1020
++L P+ D+ + I+NA +
Sbjct: 224 EILTLCREQPYEHLTDQQV---IENAGHFF 250
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 47/179 (26%), Positives = 82/179 (45%), Gaps = 22/179 (12%)
Query: 834 RKSGRGVAIKVIDKL---RFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+K+ +KV+ ++ + Q E +L L HP +V F ++
Sbjct: 22 KKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81
Query: 891 EKLQGDMLEMILSSEK---GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
E +G L+ L K LSE Q+L+ + ++H + I+H DLK +N+ L
Sbjct: 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN 141
Query: 948 NSELPQVKLCDFGFARII-----------GEKSF-PPEVLRNKGYNRSLDMWSVGVIVY 994
N +K+ DFG +R++ G + PE L+++GY+ D+WS+G I+Y
Sbjct: 142 N----LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILY 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 25/201 (12%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL-QG 895
G+ VA+K I + +A L E A++ L H +V L + G +++VME + +G
Sbjct: 29 GQKVAVKNI---KCDVTAQAFL-EETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKG 83
Query: 896 DMLEMILSSEKGRLSERTTKFIITQILVA--LKHLHSKNIVHCDLKPENVLLSTNSELPQ 953
+++ + + +GR + + + VA +++L SK +VH DL N+L+S +
Sbjct: 84 NLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG---V 138
Query: 954 VKLCDFGFARI---------IGEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS---GTF 1001
K+ DFG AR+ + K PE L++K ++ D+WS GV+++ S +
Sbjct: 139 AKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
Query: 1002 PFNEDEDINEQIQNAAFMYPP 1022
P +++ E ++ M PP
Sbjct: 199 PKMSLKEVKECVEKGYRMEPP 219
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 20/169 (11%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL-QGDML 898
VA+K L+ T E I++ L HP ++ L + I++V E + G +L
Sbjct: 33 VAVK---TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
E + L + Q+ + +L ++N +H DL NVL+ N+ K+ D
Sbjct: 90 EYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN---ICKVAD 146
Query: 959 FGFARIIGEK--------SFP-----PEVLRNKGYNRSLDMWSVGVIVY 994
FG AR+I E FP PE ++ D+WS G+++
Sbjct: 147 FGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 56/170 (32%), Positives = 82/170 (48%), Gaps = 28/170 (16%)
Query: 840 VAIKVIDKLRFPTKQEAQ----LKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895
VA+K K+ + KQ + + EV LQ L HP + + + ++VME G
Sbjct: 49 VAVK---KMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG 105
Query: 896 ---DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
D+LE+ K L E I L L +LHS N++H D+K N+LL +E
Sbjct: 106 SASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPG 158
Query: 953 QVKLCDFGFARIIG-EKSF-------PPEVL--RNKG-YNRSLDMWSVGV 991
QVKL DFG A SF PEV+ ++G Y+ +D+WS+G+
Sbjct: 159 QVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 824 VVAGAACGV-HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFE 881
VV A G+ + VA+K++ +++EA L +E+ I+ +L H +VNL
Sbjct: 51 VVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREA-LMSELKIMSHLGNHENIVNLLGACT 109
Query: 882 TPGRIFVVMEK-LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKP 940
G I V+ E GD+L + + L+ Q+ + L SKN +H DL
Sbjct: 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 169
Query: 941 ENVLLSTNSELPQVKLCDFGFARII---------GEKSFP-----PEVLRNKGYNRSLDM 986
NVLL T+ ++ VK+CDFG AR I G P PE + N Y D+
Sbjct: 170 RNVLL-THGKI--VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 226
Query: 987 WSVGVIVY--VSLSGT 1000
WS G++++ SL
Sbjct: 227 WSYGILLWEIFSLGSN 242
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 20/200 (10%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
VA+K K P + + + +E IL+ HP +V L + I++VME + G
Sbjct: 22 VAVKTC-KEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80
Query: 900 MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959
L +K L + + +L SKN +H DL N L+ N+ L K+ DF
Sbjct: 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVL---KISDF 137
Query: 960 GFAR--------IIGEKSFP-----PEVLRNKGYNRSLDMWSVGVIVYVSLS---GTFPF 1003
G +R G K P PE L Y+ D+WS G++++ + S +P
Sbjct: 138 GMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197
Query: 1004 NEDEDINEQIQNAAFMYPPR 1023
++ EQ++ M P+
Sbjct: 198 MTNQQAREQVEKGYRMSCPQ 217
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 67/238 (28%), Positives = 104/238 (43%), Gaps = 27/238 (11%)
Query: 838 RGVAIKVIDKLRFPTKQEAQ----LKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893
R + I K+ + KQ + + EV LQ + HP + + + ++VME
Sbjct: 48 RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC 107
Query: 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953
G ++ L K L E I L L +LHS N++H D+K N+LL +E Q
Sbjct: 108 LGSASDL-LEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQ 163
Query: 954 VKLCDFGFARIIG-EKSF-------PPEVL--RNKG-YNRSLDMWSVGVIVYVSLSGTFP 1002
VKL DFG A I SF PEV+ ++G Y+ +D+WS+G I + L+ P
Sbjct: 164 VKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKP 222
Query: 1003 ----FNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
N + QN + W D + +D + LQ + R + ++ L H
Sbjct: 223 PLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD---SCLQKIPQDRPTSEELLKH 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 38/129 (29%), Positives = 70/129 (54%), Gaps = 7/129 (5%)
Query: 836 SGRGVAIKVIDKLR-FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894
+G+ A+K + K F Q A +K E +L P VV+L F+ ++++ME L
Sbjct: 25 TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84
Query: 895 G-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953
G D++ M++ + SE T+F + + ++A++ +H +H D+KP+N+L+
Sbjct: 85 GGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG---H 139
Query: 954 VKLCDFGFA 962
+KL DFG +
Sbjct: 140 IKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-09
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 50/213 (23%)
Query: 835 KSGRGVAIKVIDKLRFPTKQEAQLKN----EVAILQNLCHPGVVNLERMFETPGRIFVVM 890
R VA+K K+R + LK E I +L HPG+V + + ++ M
Sbjct: 25 VCSRRVALK---KIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81
Query: 891 EKLQGDMLEMILSSE------KGRLSERTT--KF--IITQILVALKHLHSKNIVHCDLKP 940
++G L+ +L S L+E+T+ F I +I ++++HSK ++H DLKP
Sbjct: 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKP 141
Query: 941 ENVLLSTNSELPQVKLCDFGFA-----------------------------RIIGEKSF- 970
+N+LL E V + D+G A +I+G +
Sbjct: 142 DNILLGLFGE---VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYM 198
Query: 971 PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPF 1003
PE L + S D++++GVI+Y L+ +FP+
Sbjct: 199 APERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 47/201 (23%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
VAIK + K + KQ +E +I+ HP +++LE + + +V E ++ L+
Sbjct: 35 VAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93
Query: 900 MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959
L G+ + ++ I +K+L VH DL N+L+++N K+ DF
Sbjct: 94 AFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL---VCKVSDF 150
Query: 960 GFARIIGEK----------SFP-----PEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPF 1003
G +R++ + P PE + + + + D+WS G++++ +S G P+
Sbjct: 151 GLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210
Query: 1004 NE--DEDINEQIQNAAFMYPP 1022
E ++D+ + I+ + P
Sbjct: 211 WEMSNQDVIKAIEEGYRLPAP 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-09
Identities = 38/130 (29%), Positives = 67/130 (51%), Gaps = 5/130 (3%)
Query: 836 SGRGVAIKVIDKLRFPTKQ-EAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894
+ + A+KV+ K K Q++ E L P +V+L ++ +++VME L
Sbjct: 28 NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLI 87
Query: 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQV 954
G ++ +L G E I+++ +AL +LH I+H DLKP+N+L+S +
Sbjct: 88 GGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG---HI 143
Query: 955 KLCDFGFARI 964
KL DFG +++
Sbjct: 144 KLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 46/200 (23%), Positives = 81/200 (40%), Gaps = 22/200 (11%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
VAIK+I + + E + E ++ L H +V L + I++V E + L
Sbjct: 31 VAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87
Query: 900 MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959
L R + + + +L SK +H DL N L+ VK+ DF
Sbjct: 88 NYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG---CVKVSDF 144
Query: 960 GFARIIGEKSF-------------PPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFN- 1004
G +R + + + PPEVL ++ D+W+ GV+++ S G P+
Sbjct: 145 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204
Query: 1005 -EDEDINEQIQNAAFMYPPR 1023
+ + E++ +Y P
Sbjct: 205 FNNSETVEKVSQGLRLYRPH 224
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 21/170 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDML 898
VAIKV+ + P + L +E ++ ++ HP VV L + + ++ ++ + + G +L
Sbjct: 39 VAIKVLREETSPKANKEIL-DEAYVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLL 96
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
+ + + K + + QI + +L K +VH DL NVL+ T VK+ D
Sbjct: 97 DY-VRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ---HVKITD 152
Query: 959 FGFARII--GEKSF------------PPEVLRNKGYNRSLDMWSVGVIVY 994
FG A+++ EK + E + ++ Y D+WS GV V+
Sbjct: 153 FGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVW 202
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 44/219 (20%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
VAIK + K + KQ +E +I+ HP +++LE + + ++ E ++ L+
Sbjct: 35 VAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALD 93
Query: 900 MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959
L G+ + ++ I +K+L N VH DL N+L+++N K+ DF
Sbjct: 94 SFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL---VCKVSDF 150
Query: 960 GFARIIGEKS------------FP-----PEVLRNKGYNRSLDMWSVGVIVYVSLSGTFP 1002
G +R + + + P PE + + + + D+WS G++++ +S
Sbjct: 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS---- 206
Query: 1003 FNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041
Y RP+ D+S+ D+IN + Q
Sbjct: 207 -----------------YGERPYWDMSNQ--DVINAIEQ 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 50/194 (25%), Positives = 79/194 (40%), Gaps = 47/194 (24%)
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVA--LKHLHSKNIVHCDLKPENVLLS 946
+ +K D+ E E + I VA ++ L S+ +H DL N+LLS
Sbjct: 148 IEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS 207
Query: 947 TNSELPQVKLCDFGFARII---------GEKSFP-----PEVLRNKGYNRSLDMWSVGVI 992
N+ VK+CDFG AR I G+ P PE + +K Y D+WS GV+
Sbjct: 208 ENN---VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVL 264
Query: 993 VYVSLS-GTFPF---NEDEDINEQIQNAAFMYPP---------------------RPWRD 1027
++ S G P+ DE+ +++ M P RP
Sbjct: 265 LWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT-- 322
Query: 1028 ISSDAIDLINNLLQ 1041
S+ ++++ +LLQ
Sbjct: 323 -FSELVEILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 47/170 (27%), Positives = 72/170 (42%), Gaps = 22/170 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
VA+K L+ T E I++ L H +V L + I++V E + L
Sbjct: 33 VAVKT---LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89
Query: 900 MILSSEKGR-LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
L S +G+ L + QI + +L S+N +H DL N+L+ E K+ D
Sbjct: 90 DFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIAD 146
Query: 959 FGFARII---------GEKSFP-----PEVLRNKGYNRSLDMWSVGVIVY 994
FG AR+I G K FP PE + D+WS G+++
Sbjct: 147 FGLARLIEDDEYTAREGAK-FPIKWTAPEAANYGRFTIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 48/195 (24%), Positives = 87/195 (44%), Gaps = 25/195 (12%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
H+ + VA+K I+ + L+ E+ + L HP ++ F ++VV
Sbjct: 21 HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80
Query: 893 LQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ G +++ + L E FI+ +L AL ++HSK +H +K ++LLS +
Sbjct: 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-- 138
Query: 952 PQVKLCDFGFARII---GEKS-----FP-----------PEVLRN--KGYNRSLDMWSVG 990
+V L ++ + G++ FP PEVL+ +GYN D++SVG
Sbjct: 139 -KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVG 197
Query: 991 VIVYVSLSGTFPFNE 1005
+ +G PF +
Sbjct: 198 ITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 53/222 (23%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893
+KS + VA+K++ + +L E ++Q L +P +V + + E +VME
Sbjct: 19 KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAES-WMLVMELA 77
Query: 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953
+ L L K ++E+ ++ Q+ + +K+L N VH DL NVLL T
Sbjct: 78 ELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH---Y 133
Query: 954 VKLCDFGFARIIGE---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
K+ DFG ++ +G K + PE + ++ D+WS GV+++ + S
Sbjct: 134 AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
Query: 999 -GTFPFN--EDEDINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037
G P+ + ++ + I++ M P + + DL+
Sbjct: 194 YGQKPYKGMKGNEVTQMIESGERMECP---QRCPPEMYDLMK 232
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|241272 cd01239, PH_PKD, Protein kinase D (PKD/PKCmu) pleckstrin homology (PH) domain | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 17/23 (73%), Positives = 20/23 (86%)
Query: 471 TKRRGSKVIKEGWMIHYTSKDSM 493
TKRR SKV+KEGWM+HYT+KD
Sbjct: 1 TKRRSSKVLKEGWMVHYTNKDPQ 23
|
Protein Kinase C family is composed of three members, PKD1 (PKCmu), PKD2 and PKD3 (PKCnu). Like the C-type protein kinases (PKCs), PKDs are activated by diacylglycerol (DAG). They are involved in vesicular transport, cell proliferation, survival, migration and immune responses. PKD consists of tandem C1 domains, followed by a PH domain and a kinase domain. While the PKD PH domain has not been shown to bind phosphorylated inositol lipids and is not required for membrane translocation, it is required for nuclear export. PH domains have diverse functions, but in general are involved in targeting proteins to the appropriate cellular location or in the interaction with a binding partner. They share little sequence conservation, but all have a common fold, which is electrostatically polarized. Less than 10% of PH domains bind phosphoinositide phosphates (PIPs) with high affinity and specificity. PH domains are distinguished from other PIP-binding domains by their specific high-affinity binding to PIPs with two vicinal phosphate groups: PtdIns(3,4)P2, PtdIns(4,5)P2 or PtdIns(3,4,5)P3 which results in targeting some PH domain proteins to the plasma membrane. A few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes. Length = 127 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 48/193 (24%), Positives = 82/193 (42%), Gaps = 35/193 (18%)
Query: 830 CGVHRKSGRG---VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886
G + G+ VAIK + K KQ E +I+ HP ++ LE + +
Sbjct: 22 RGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80
Query: 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVAL-------KHLHSKNIVHCDLK 939
++ E ++ L+ L E KF + Q++ L K+L N VH DL
Sbjct: 81 MIITEYMENGSLD-------KFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLA 133
Query: 940 PENVLLSTNSELPQVKLCDFGFARIIGEKS---------FP-----PEVLRNKGYNRSLD 985
N+L+ NS L K+ DFG +R + + P PE + + + + D
Sbjct: 134 ARNILV--NSNL-VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASD 190
Query: 986 MWSVGVIVYVSLS 998
+WS G++++ +S
Sbjct: 191 VWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 23/174 (13%)
Query: 835 KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894
VAIK L+ + E +++ L HP +V L + T I+++ E ++
Sbjct: 28 NGHTKVAIK---SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYME 83
Query: 895 -GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953
G +++ + + E +L+ + QI + + KN +H DL+ N+L+ SE
Sbjct: 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLC 140
Query: 954 VKLCDFGFARII---------GEKSFP-----PEVLRNKGYNRSLDMWSVGVIV 993
K+ DFG AR+I G K FP PE + + D+WS G+++
Sbjct: 141 CKIADFGLARLIEDNEYTAREGAK-FPIKWTAPEAINYGTFTIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 28/159 (17%)
Query: 860 NEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL-QGDMLEMILSSEK-------GRLSE 911
NE ++++ VV L + T VVME + +GD L+ L S + G
Sbjct: 58 NEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGD-LKSYLRSRRPEAENNPGLGPP 116
Query: 912 RTTKFI--ITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS 969
KFI +I + +L +K VH DL N ++ +L VK+ DFG R I E
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV--AEDL-TVKIGDFGMTRDIYETD 173
Query: 970 F--------------PPEVLRNKGYNRSLDMWSVGVIVY 994
+ PE L++ + D+WS GV+++
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 43/182 (23%), Positives = 76/182 (41%), Gaps = 40/182 (21%)
Query: 854 QEAQLKNEVAILQNLCHPGVVNLERM-FETPGRIFVVMEKLQGDMLEMILSSEKGRLSER 912
Q L E +L L H ++ + + E FV+ + L++ L ++ RL E
Sbjct: 51 QVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL--QQCRLGEA 108
Query: 913 TTKFIIT---------QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963
++ QI + +LH + ++H D+ N ++ E QVK+ D +R
Sbjct: 109 NNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSR 165
Query: 964 IIGEKSFP------------------PEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFPF 1003
+ FP E L NK Y+ + D+WS GV+++ ++L T P+
Sbjct: 166 DL----FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQT-PY 220
Query: 1004 NE 1005
E
Sbjct: 221 VE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 839 GVAIKVIDKLRFPTKQEAQLK--NEVAILQNLCHPGVVNLERM-FETPGRIFVVMEKLQG 895
VA+K L ++ + E I+ H +V L + FE R F+++E + G
Sbjct: 38 QVAVKT---LPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR-FILLELMAG 93
Query: 896 DMLEMILSSEKGR------LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
L+ L + R L+ + F + K+L + +H D+ N LL+
Sbjct: 94 GDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG 153
Query: 950 ELPQVKLCDFGFARIIGEKSF--------------PPEVLRNKGYNRSLDMWSVGVIVYV 995
K+ DFG AR I S+ PPE + + D+WS GV+++
Sbjct: 154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWE 213
Query: 996 SLS-GTFPF--NEDEDINEQIQNAAFMYPPR 1023
S G P+ ++++ E + + PP+
Sbjct: 214 IFSLGYMPYPGRTNQEVMEFVTGGGRLDPPK 244
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 31/123 (25%), Positives = 54/123 (43%), Gaps = 16/123 (13%)
Query: 847 KLRFPTKQEAQLKNEVAILQNLC-HPGVV-NLERMFETPGRIFVVMEKLQGDMLEMILSS 904
K+ ++ A + EVAILQ L V + E+ G +++ME ++G+ L+
Sbjct: 27 KINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD----- 81
Query: 905 EKGRLSERTTKFIITQILVALKHLHSKNI---VHCDLKPENVLLSTNSELPQVKLCDFGF 961
+SE + I Q+ L LH + H DL P N+L+ + + D+ +
Sbjct: 82 ---EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK---ILGIIDWEY 135
Query: 962 ARI 964
A
Sbjct: 136 AGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 37/121 (30%), Positives = 59/121 (48%), Gaps = 21/121 (17%)
Query: 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSF 970
Q+ ++ L S+ +H DL N+LLS N+ VK+CDFG AR I G
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 971 P-----PEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPF---NEDEDINEQIQNAAFMYP 1021
P PE + +K Y D+WS GV+++ S G P+ +E+ +++++ M
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA 298
Query: 1022 P 1022
P
Sbjct: 299 P 299
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-07
Identities = 32/109 (29%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 854 QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG-DMLEMILSSEKGRLSER 912
Q A +K E IL + VV L F+ ++ VM+ + G DM+ +++ E E
Sbjct: 44 QVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV--FPEV 101
Query: 913 TTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGF 961
+F I ++ +A++ +H +H D+KP+N+L+ + +KL DFG
Sbjct: 102 LARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG---HIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 55/254 (21%), Positives = 99/254 (38%), Gaps = 58/254 (22%)
Query: 861 EVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQ 920
E IL+ + HP ++ L+ F +++ + + D+ + + K ++ I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYL--AAKRNIAICDILAIERS 190
Query: 921 ILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA----RIIGEKSF------ 970
+L A+++LH I+H D+K EN+ ++ + V L DFG A I K +
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGD---VCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 971 ---PPEVLRNKGYNRSLDMWSVGVIVY----------------------------VSLSG 999
PE+L Y ++D+WS G++++ + SG
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSG 307
Query: 1000 T----FPFNEDEDINEQIQNAAFMYPPRP-----WRDISSDAID---LINNLLQVKQRKR 1047
T FP + +++E A +P W ++ ID LI +L R
Sbjct: 308 THPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHR 367
Query: 1048 LSVDKSLAHPWLQD 1061
S + L QD
Sbjct: 368 PSAEALLDFAAFQD 381
|
Length = 391 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 42/218 (19%)
Query: 840 VAIKVIDKLRFPTKQEAQL--KNEVAILQNLCHPGVVNLERMF---ETPGRIFVVMEKLQ 894
VA+K L+ +A+ + E +L N H +V + + P +F ME
Sbjct: 38 VAVKT---LKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYME--H 92
Query: 895 GDMLEMILS------------SEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
GD+ + + S S G L+ I QI + +L S++ VH DL N
Sbjct: 93 GDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRN 152
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSF--------------PPEVLRNKGYNRSLDMWS 988
L+ + VK+ DFG +R + + PPE + + + D+WS
Sbjct: 153 CLVGYDL---VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 209
Query: 989 VGVIVYVSLS-GTFPFNE--DEDINEQIQNAAFMYPPR 1023
GV+++ + G P+ +E++ E I + PR
Sbjct: 210 FGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-07
Identities = 32/109 (29%), Positives = 56/109 (51%), Gaps = 6/109 (5%)
Query: 854 QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG-DMLEMILSSEKGRLSER 912
Q A +K E IL + VV L F+ ++ VM+ + G DM+ +++ G E
Sbjct: 44 QVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFPED 101
Query: 913 TTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGF 961
+F I ++ A++ +H +H D+KP+N+L+ + +KL DFG
Sbjct: 102 LARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG---HIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 23/176 (13%)
Query: 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR--IFVVMEKL 893
+G VA+K + K + + K E+ IL+ L H +V + G + ++ME +
Sbjct: 32 TGEMVAVKTL-KRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953
L L K L++ QI + +LHS++ +H DL NVLL N L
Sbjct: 91 PLGSLRDYLPKHKLNLAQ--LLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD-NDRL-- 145
Query: 954 VKLCDFGFARIIGEKS---------------FPPEVLRNKGYNRSLDMWSVGVIVY 994
VK+ DFG A+ + E + E L+ ++ + D+WS GV +Y
Sbjct: 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 42/169 (24%), Positives = 78/169 (46%), Gaps = 19/169 (11%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
VAIK++++ P K + +E I+ ++ HP +V L + +P V G +L+
Sbjct: 39 VAIKILNETTGP-KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLD 97
Query: 900 MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959
+ + S+ + + QI + +L + +VH DL NVL+ + + VK+ DF
Sbjct: 98 YVHEHKDNIGSQLLLNWCV-QIAKGMMYLEERRLVHRDLAARNVLVKSPN---HVKITDF 153
Query: 960 GFARII--GEKSFPP------------EVLRNKGYNRSLDMWSVGVIVY 994
G AR++ EK + E + + + D+WS GV ++
Sbjct: 154 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIW 202
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 21/121 (17%)
Query: 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSF 970
Q+ ++ L S+ +H DL N+LLS N+ VK+CDFG AR I G+
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 971 P-----PEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPF---NEDEDINEQIQNAAFMYP 1021
P PE + ++ Y D+WS GV+++ S G P+ DE+ +++ M
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 303
Query: 1022 P 1022
P
Sbjct: 304 P 304
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-07
Identities = 39/148 (26%), Positives = 64/148 (43%), Gaps = 19/148 (12%)
Query: 861 EVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQ 920
E+ IL+ + H ++NL + + +VM K + D+ + G L I +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV--DRSGPLPLEQAITIQRR 193
Query: 921 ILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF---------- 970
+L AL +LH + I+H D+K EN+ L E L DFG A +
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 971 ----PPEVLRNKGYNRSLDMWSVGVIVY 994
PE+L Y D+WS G++++
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLF 278
|
Length = 392 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 8e-07
Identities = 15/39 (38%), Positives = 21/39 (53%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ + R IL L +LHS IVH D+K N+ S +K
Sbjct: 104 RKYTRQILEGLAYLHSNGIVHRDIKGA-NILVDSDGVVK 141
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-07
Identities = 41/113 (36%), Positives = 56/113 (49%), Gaps = 21/113 (18%)
Query: 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSF 970
Q+ ++ L SKN VH DL NVL+ E VK+CDFG AR I G
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 971 P-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFPFNEDEDINEQIQNA 1016
P PE + N Y D+WS G++++ +L GT P+ + +NEQ NA
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGT-PY-PELPMNEQFYNA 354
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 9e-07
Identities = 19/39 (48%), Positives = 25/39 (64%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ + R IL AL++LHSK IVH DLKPE N+ +K
Sbjct: 100 RFYLRQILSALEYLHSKGIVHRDLKPE-NILLDEDGHVK 137
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 51/189 (26%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNL-ERMFETPGRI 886
G +R G VA+K I K +A + E +++ L H +V L + E G +
Sbjct: 25 GDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75
Query: 887 FVVMEKL-QGDMLEMILSSEKGRLS-ERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944
++V E + +G +++ + S + L + KF + + A+++L + N VH DL NVL
Sbjct: 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCEAMEYLEANNFVHRDLAARNVL 134
Query: 945 LSTNSELPQVKLCDFGFARIIGE---------KSFPPEVLRNKGYNRSLDMWSVGVIVYV 995
+S ++ K+ DFG + K PE LR K ++ D+WS G++++
Sbjct: 135 VSEDN---VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 191
Query: 996 SLS-GTFPF 1003
S G P+
Sbjct: 192 IYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 50/190 (26%), Positives = 80/190 (42%), Gaps = 33/190 (17%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893
R S VAIK + + P Q+ + + E ++ +L HP +V L + ++ E L
Sbjct: 32 RLSATSVAIKTLKENAEPKVQQ-EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYL 90
Query: 894 -QGDMLEMILS----SEKGRLSERTTKF----------IITQILVALKHLHSKNIVHCDL 938
GD+ E ++ S+ G S T I QI +++L S + VH DL
Sbjct: 91 AHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDL 150
Query: 939 KPENVLLSTNSELPQVKLCDFGFARIIGEKSF--------------PPEVLRNKGYNRSL 984
N L+ E VK+ DFG +R I + PPE + +
Sbjct: 151 AARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTES 207
Query: 985 DMWSVGVIVY 994
D+WS GV+++
Sbjct: 208 DIWSFGVVLW 217
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 37/204 (18%)
Query: 824 VVAGAACGVHR---KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERM 879
VV A G+ + K VA+K++ K K + L +E+ +++ + H ++NL
Sbjct: 31 VVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89
Query: 880 FETPGRIFVVME-KLQGDM---------LEMILSSEKGRLSERTTKF-----IITQILVA 924
G ++V++E +G++ M S + R+ + F Q+
Sbjct: 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARG 149
Query: 925 LKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE--------------KSF 970
+++L S+ +H DL NVL++ N+ + K+ DFG AR + K
Sbjct: 150 MEYLASQKCIHRDLAARNVLVTENNVM---KIADFGLARDVNNIDYYKKTTNGRLPVKWM 206
Query: 971 PPEVLRNKGYNRSLDMWSVGVIVY 994
PE L ++ Y D+WS GV+++
Sbjct: 207 APEALFDRVYTHQSDVWSFGVLMW 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 42/222 (18%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL-QGDML 898
VAIK + + P +Q + + E +++ L HP +V L + + ++ E L QGD+
Sbjct: 37 VAIKTLKDINNP-QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLH 95
Query: 899 EMIL-----------SSEKGRLSERTTK----FIITQILVALKHLHSKNIVHCDLKPENV 943
E ++ S E G + I QI +++L S VH DL N+
Sbjct: 96 EFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNI 155
Query: 944 LLSTNSELPQVKLCDFGFARIIGEKSF--------------PPEVLRNKGYNRSLDMWSV 989
L+ E VK+ D G +R I + PPE + ++ D+WS
Sbjct: 156 LIG---EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212
Query: 990 GVIVYVSLS-GTFPFN--EDEDINEQIQNAAFM-----YPPR 1023
GV+++ S G P+ ++++ E ++ + PPR
Sbjct: 213 GVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPR 254
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
VAIK + + P K ++ +E ++ ++ +P V L + T + G +L+
Sbjct: 39 VAIKELREATSP-KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLD 97
Query: 900 MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ-VKLCD 958
+ K + + QI + +L + +VH DL NVL+ T PQ VK+ D
Sbjct: 98 YV-REHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT----PQHVKITD 152
Query: 959 FGFARIIG--EKSFPP------------EVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPF 1003
FG A+++G EK + E + ++ Y D+WS GV V+ ++ G+ P+
Sbjct: 153 FGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
Query: 1004 N 1004
+
Sbjct: 213 D 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 19/159 (11%)
Query: 860 NEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFII 918
E +++ L H +V L + T I+++ E + G +L+ + S E +
Sbjct: 50 AEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 108
Query: 919 TQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS--------F 970
QI + + +N +H DL+ N+L+ S K+ DFG AR+I + F
Sbjct: 109 AQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKF 165
Query: 971 P-----PEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPF 1003
P PE + + D+WS G+++ ++ G P+
Sbjct: 166 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-06
Identities = 58/225 (25%), Positives = 86/225 (38%), Gaps = 70/225 (31%)
Query: 899 EMILSSEKG--RLSERTTKFIIT---QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953
+L + + ER K I T QIL AL LHS IVH D+KP+N++ S S
Sbjct: 237 PYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG--S 294
Query: 954 VKLCDFGFA---RIIGEKSFPPEVL---RNKG---YNRS--------------------- 983
K+ D G A R +G P E L R Y S
Sbjct: 295 FKIIDLGAAADLR-VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353
Query: 984 ------LDMWSVGVI----VYVSL---SGTFPFNE-----DEDINEQIQNAAFMYPPRPW 1025
D++S G+I + +L S FN D D+ + PR
Sbjct: 354 LNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV----EPRAS 409
Query: 1026 RDISS--DAID--------LINNLLQVKQRKRLSVDKSLAHPWLQ 1060
D+ + +D L+ ++++ K R+R+S +LAHP+
Sbjct: 410 PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454
|
Length = 566 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 55/252 (21%), Positives = 99/252 (39%), Gaps = 53/252 (21%)
Query: 861 EVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDM--------LEMILSSEKGRLSE 911
E +L NL H +V + + +V E ++ GD+ + +L +E R +E
Sbjct: 57 EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116
Query: 912 RTTK---FIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK 968
T I QI + +L S++ VH DL N L+ N VK+ DFG +R +
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL---LVKIGDFGMSRDVYST 173
Query: 969 SF--------------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ 1014
+ PPE + + + D+WS+GV+++
Sbjct: 174 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW-------------------- 213
Query: 1015 NAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL---SVDKSLAHPWLQDPATWSDLRGL 1071
F Y +PW +S++ + +V QR R V + W ++P +++ +
Sbjct: 214 -EIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEI 272
Query: 1072 ERQIGTNKKKNP 1083
+ K +P
Sbjct: 273 HSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 52/223 (23%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL-ERMFETPGRIFVVMEKLQ-GDM 897
A+K ++++ ++ Q E I+++ HP V++L + G VV+ ++ GD+
Sbjct: 26 CAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDL 84
Query: 898 LEMILSSEKGRLSERTTKFIIT---QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQV 954
I S T K +I Q+ +++L SK VH DL N +L E V
Sbjct: 85 RNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD---ESFTV 137
Query: 955 KLCDFGFARIIGEKSFPP----------------EVLRNKGYNRSLDMWSVGVIVYVSLS 998
K+ DFG AR I +K + E L+ + + D+WS GV+++ ++
Sbjct: 138 KVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
Query: 999 GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041
P P+ D+ D+ D+ LLQ
Sbjct: 198 RGAP---------------------PYPDV--DSFDITVYLLQ 217
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 51/204 (25%), Positives = 83/204 (40%), Gaps = 24/204 (11%)
Query: 869 CHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHL 928
C P +V L + + +F+V++ +G L +S + E K +++VAL L
Sbjct: 43 CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDAL 101
Query: 929 HSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS---------FPPEVLRNKG 979
H + IV DL P N+LL ++L F + + PEV
Sbjct: 102 HREGIVCRDLNPNNILLDDRG---HIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISE 158
Query: 980 YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039
+ D WS+G I++ L+G E I + P W +S +A L+ L
Sbjct: 159 ETEACDWWSLGAILFELLTGK---TLVECHPSGINTHTTLNIPE-W--VSEEARSLLQQL 212
Query: 1040 LQVKQRKRL-----SVDKSLAHPW 1058
LQ +RL V+ +HP+
Sbjct: 213 LQFNPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 34/184 (18%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDML 898
VA+K + +++ Q E +L NL H +V + + +V E ++ GD+
Sbjct: 38 VAVKALKDPTLAARKDFQ--REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 899 E---------MIL-----SSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944
+ MIL KG L I +QI + +L S++ VH DL N L
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155
Query: 945 LSTNSELPQVKLCDFGFARIIGEKSF--------------PPEVLRNKGYNRSLDMWSVG 990
+ N VK+ DFG +R + + PPE + + + D+WS G
Sbjct: 156 VGANL---LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 212
Query: 991 VIVY 994
VI++
Sbjct: 213 VILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 39/170 (22%)
Query: 865 LQNLC----HPGVVNLERMFETPGRIFVVMEKLQ-GDMLEMILSS-----------EKGR 908
L+ LC HP ++NL E G +++ +E G++L+ + S E G
Sbjct: 53 LEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT 112
Query: 909 LSERTTKFII---TQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965
S T++ ++ + + +++L K +H DL NVL+ N K+ DFG +R
Sbjct: 113 ASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL---ASKIADFGLSR-- 167
Query: 966 GEKSFPP-------------EVLRNKGYNRSLDMWSVGVIVY--VSLSGT 1000
GE+ + E L Y D+WS GV+++ VSL GT
Sbjct: 168 GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGT 217
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 35/208 (16%)
Query: 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGV-----VNLERMFETPGRIFVVM 890
S + VA+K++ F + + E A ++ HP V V+L GR+ + M
Sbjct: 26 SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRS--RAKGRLPIPM 83
Query: 891 EKL----QGDMLEMILSSEKGR----LSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
L GD+ +L S G L +T + I +++L SKN +H DL N
Sbjct: 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARN 143
Query: 943 VLLSTNSELPQVKLCDFGFARII--------GEKSFPP------EVLRNKGYNRSLDMWS 988
+L+ N V + DFG ++ I G S P E L + Y D+W+
Sbjct: 144 CMLNENM---TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWA 200
Query: 989 VGVIVY-VSLSGTFPFNEDEDINEQIQN 1015
GV ++ + G P+ E N +I N
Sbjct: 201 FGVTMWEIMTRGQTPYAGVE--NSEIYN 226
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 35/97 (36%), Positives = 47/97 (48%), Gaps = 19/97 (19%)
Query: 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSF 970
Q+ ++ L SKN VH DL NVLL+ VK+CDFG AR I G
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGK---IVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 971 P-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGT 1000
P PE + + Y D+WS G++++ SL GT
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGT 338
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-05
Identities = 22/48 (45%), Positives = 32/48 (66%), Gaps = 3/48 (6%)
Query: 915 KFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962
K ++ Q+L L+ LH IVH D+KPEN+L++ + QVK+ DFG A
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG---QVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 19/97 (19%)
Query: 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE------------ 967
Q+ ++ L SK +H DL NVL++ + + K+ DFG AR I
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVM---KIADFGLARDIHHIDYYRKTTNGRL 196
Query: 968 --KSFPPEVLRNKGYNRSLDMWSVGVIVY--VSLSGT 1000
K PE L ++ Y D+WS GV+++ +L G+
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-05
Identities = 16/39 (41%), Positives = 22/39 (56%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
K IL L++LHS I+H DLKPE N+ + +K
Sbjct: 101 KKIALQILRGLEYLHSNGIIHRDLKPE-NILLDENGVVK 138
|
Length = 260 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 8/104 (7%)
Query: 972 PEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ----NAAFMYPPRPWRD 1027
PEVL GY + D WSVGVI+Y L G PF + Q++ + PP+
Sbjct: 217 PEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQA--K 274
Query: 1028 ISSDAIDLINNLLQVKQRK--RLSVDKSLAHPWLQDPATWSDLR 1069
+S +A DLI L + + + + D+ AHP+ + SDLR
Sbjct: 275 LSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLR 318
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 39/190 (20%), Positives = 79/190 (41%), Gaps = 25/190 (13%)
Query: 853 KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSER 912
KQ E L H +V LE + + +V E + L+ L +G+L
Sbjct: 48 KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAG 107
Query: 913 TTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF-GFARIIGEKS-- 969
++ + +K+L VH L VL++++ +C GF R+ +KS
Sbjct: 108 QLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD------LVCKISGFRRLQEDKSEA 161
Query: 970 -------------FPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNE--DEDINEQI 1013
PE ++ ++ + D+WS G++++ +S G P+ + +D+ + +
Sbjct: 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221
Query: 1014 QNAAFMYPPR 1023
++ + PR
Sbjct: 222 EDGFRLPAPR 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 23/203 (11%)
Query: 819 ALCIAVVAGAAC--GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL 876
+L + V G C V + G I L+ T E +++ L H +V L
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 66
Query: 877 ERMF-ETPGRIFVVMEKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIV 934
+ E P I++V E + +G +L+ + L + QI + ++ N V
Sbjct: 67 YAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124
Query: 935 HCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS--------FP-----PEVLRNKGYN 981
H DL+ N+L+ N K+ DFG AR+I + FP PE +
Sbjct: 125 HRDLRAANILVGENL---VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 982 RSLDMWSVGV-IVYVSLSGTFPF 1003
D+WS G+ + ++ G P+
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 46/222 (20%)
Query: 838 RGVAIKVI-DKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF--ETPGRI-------- 886
+ VAIK + DK P ++E K+E + L HP +V L + E P +
Sbjct: 36 QAVAIKTLKDKAEGPLREE--FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 887 ----FVVMEKLQGDMLEMILSSEKGRLSERTTK-----FIITQILVALKHLHSKNIVHCD 937
F+VM D + S++ + + T + I+TQI ++ L S ++VH D
Sbjct: 94 DLHEFLVMRSPHSD----VGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKD 149
Query: 938 LKPENVLLSTNSELPQVKLCDFGFAR---------IIGEKSFP-----PEVLRNKGYNRS 983
L NVL+ VK+ D G R ++G P PE + ++
Sbjct: 150 LATRNVLVFDKL---NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID 206
Query: 984 LDMWSVGVIVYVSLS-GTFPF--NEDEDINEQIQNAAFMYPP 1022
D+WS GV+++ S G P+ ++D+ E I+N + P
Sbjct: 207 SDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 32/212 (15%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDML 898
VA+K + K +++ LK E ++ N HP +V L + +++ME ++ GD+L
Sbjct: 29 VAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLL 87
Query: 899 EMILSSEKGRLSERTTKFIITQILVAL--------KHLHSKNIVHCDLKPENVLLS--TN 948
+ R+ + + L+ + +L + +H DL N L+S
Sbjct: 88 SYL---RDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGY 144
Query: 949 SELPQVKLCDFGFARII---------GEKSFP-----PEVLRNKGYNRSLDMWSVGVIVY 994
VK+ DFG AR I GE P PE L + + D+WS GV+++
Sbjct: 145 DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMW 204
Query: 995 VSLS---GTFPFNEDEDINEQIQNAAFMYPPR 1023
L+ +P ++++ + + + P
Sbjct: 205 EILTLGQQPYPALNNQEVLQHVTAGGRLQKPE 236
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 42/170 (24%), Positives = 70/170 (41%), Gaps = 39/170 (22%)
Query: 865 LQNLC----HPGVVNLERMFETPGRIFVVMEKLQ-GDMLEMILSS-----------EKGR 908
L+ LC HP ++NL E G +++ +E G++L+ + S
Sbjct: 46 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 105
Query: 909 ---LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965
LS + + + +L K +H DL N+L+ N K+ DFG +R
Sbjct: 106 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY---VAKIADFGLSR-- 160
Query: 966 GEKSFPP-------------EVLRNKGYNRSLDMWSVGVIVY--VSLSGT 1000
G++ + E L Y + D+WS GV+++ VSL GT
Sbjct: 161 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 210
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 6e-05
Identities = 21/55 (38%), Positives = 32/55 (58%), Gaps = 7/55 (12%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK------SNTEEEDEDEERGSTD 438
IL LK+LHS N++H DLKP N+ S+ ++K + + DEDE+ T+
Sbjct: 112 ILRGLKYLHSANVIHRDLKP-SNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-05
Identities = 35/104 (33%), Positives = 49/104 (47%), Gaps = 8/104 (7%)
Query: 972 PEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ----NAAFMYPPRPWRD 1027
PEVL KGY + D WSVGVI++ L G PF Q++ PP+
Sbjct: 217 PEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQV--K 274
Query: 1028 ISSDAIDLINNLLQVKQRK--RLSVDKSLAHPWLQDPATWSDLR 1069
+S +A+DLI L + + R D AHP+ + SD+R
Sbjct: 275 LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIR 318
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 47/202 (23%), Positives = 86/202 (42%), Gaps = 26/202 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF-ETPGRIFVVMEKL-QGDM 897
VA+K L+ T E I++ L H +V L + E P I++V E + +G +
Sbjct: 33 VAVKT---LKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEP--IYIVTEYMSKGSL 87
Query: 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957
L+ + E L + Q+ + ++ N +H DL+ N+L+ K+
Sbjct: 88 LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL---VCKIA 144
Query: 958 DFGFARIIGEKS--------FP-----PEVLRNKGYNRSLDMWSVGVIVYVSLSG---TF 1001
DFG AR+I + FP PE + D+WS G+++ ++ +
Sbjct: 145 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
Query: 1002 PFNEDEDINEQIQNAAFMYPPR 1023
P + ++ EQ++ M P+
Sbjct: 205 PGMNNREVLEQVERGYRMPCPQ 226
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 7e-05
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 17/168 (10%)
Query: 860 NEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLS-ERTTKFII 918
+E+A + L HP +V L + + +++ E ++G L +L + LS ER K I
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRK-IA 786
Query: 919 TQILVALKHLH---SKNIVHCDLKPENVLLSTNSE------LPQVKLCDFGFARIIGEKS 969
I AL+ LH S +V +L PE +++ E LP + D I
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTD--TKCFISSAY 844
Query: 970 FPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAA 1017
PE K D++ G+I+ L+G P + + ++ I A
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA 892
|
Length = 968 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 45/218 (20%)
Query: 840 VAIKVIDKLRFPTKQEAQ-LKNEVAILQNLCHPGVVNL---------ERMFETPGRIFVV 889
VA+K + K+ T+ E + +E ++ HP V+ L + +P I
Sbjct: 29 VAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPF 87
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILV--------ALKHLHSKNIVHCDLKPE 941
M+ GD+ +L S G +++ TQ+LV +++L SK+ +H DL
Sbjct: 88 MK--HGDLHSFLLYSRLGD----CPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAAR 141
Query: 942 NVLLSTNSELPQVKLCDFGFARII--------GEKSFPP------EVLRNKGYNRSLDMW 987
N +L+ N V + DFG ++ I G + P E L ++ Y D+W
Sbjct: 142 NCMLNENM---NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVW 198
Query: 988 SVGVIVY-VSLSGTFPFN--EDEDINEQIQNAAFMYPP 1022
S GV ++ ++ G P+ E+ +I + ++ + P
Sbjct: 199 SFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 9e-05
Identities = 14/27 (51%), Positives = 18/27 (66%), Gaps = 1/27 (3%)
Query: 388 RSILVALKHLHSKNIVHCDLKPERNLF 414
IL L++LHS I+H DLKPE N+
Sbjct: 99 LQILEGLEYLHSNGIIHRDLKPE-NIL 124
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 47/210 (22%), Positives = 89/210 (42%), Gaps = 34/210 (16%)
Query: 840 VAIKVIDKLRFPTKQEAQL---KNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-G 895
V +K + K TK E + E+ + + L H VV L + ++++E G
Sbjct: 38 VLVKALQK----TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLG 93
Query: 896 DMLEMILSSEKGR-------LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
D+ + + +++ LS + + TQI + + HL + VH DL N L+S+
Sbjct: 94 DLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ 153
Query: 949 SELPQVKLCDFGFAR-------------IIGEKSFPPEVLRNKGYNRSLDMWSVGVIVY- 994
+VK+ ++ +I + PE ++ ++ D+WS GV+++
Sbjct: 154 R---EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210
Query: 995 VSLSGTFPFNE--DEDINEQIQNAAFMYPP 1022
V G PF DE++ ++Q P
Sbjct: 211 VFTQGELPFYGLSDEEVLNRLQAGKLELPV 240
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 1e-04
Identities = 16/33 (48%), Positives = 26/33 (78%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ +ALK+LHS+ I+H D+KP+ N+F TS+ +K
Sbjct: 112 LCLALKYLHSRKILHRDIKPQ-NIFLTSNGLVK 143
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 42/185 (22%), Positives = 87/185 (47%), Gaps = 34/185 (18%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVME-KLQGDM 897
VA+K++ K K A L +E+ +++ + H ++NL + G ++V++E +G++
Sbjct: 47 VAVKML-KDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105
Query: 898 LEMI---------LSSEKGRLSERTTKF-----IITQILVALKHLHSKNIVHCDLKPENV 943
E + + + ++ E F Q+ +++L S+ +H DL NV
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165
Query: 944 LLSTNSELPQVKLCDFGFARIIGE--------------KSFPPEVLRNKGYNRSLDMWSV 989
L++ ++ + K+ DFG AR + + K PE L ++ Y D+WS
Sbjct: 166 LVTEDNVM---KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 990 GVIVY 994
G++++
Sbjct: 223 GILMW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 45/198 (22%), Positives = 86/198 (43%), Gaps = 31/198 (15%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
++ +G V ++ I+ L T + L+ E+ + + HP +V F ++VV
Sbjct: 21 YKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79
Query: 892 KLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ G ++I + +SE +I+ +L AL ++H VH +K ++L+S +
Sbjct: 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG- 138
Query: 951 LPQVKLCDFGFARII-----GEK-----SFP-----------PEVLRN--KGYNRSLDMW 987
K+ G + G++ FP PEVL+ +GY+ D++
Sbjct: 139 ----KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 194
Query: 988 SVGVIVYVSLSGTFPFNE 1005
SVG+ +G PF +
Sbjct: 195 SVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 2e-04
Identities = 15/21 (71%), Positives = 19/21 (90%)
Query: 390 ILVALKHLHSKNIVHCDLKPE 410
IL+AL++LHSK I+H DLKPE
Sbjct: 111 ILLALEYLHSKGIIHRDLKPE 131
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 46/181 (25%), Positives = 80/181 (44%), Gaps = 22/181 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
VAIKV+ + P K ++ +E ++ + P V L + T V G +L+
Sbjct: 39 VAIKVLRENTSP-KANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLD 97
Query: 900 MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959
+ K R+ + QI + +L +VH DL NVL+ + + VK+ DF
Sbjct: 98 YV-RENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN---HVKITDF 153
Query: 960 GFARI--IGEKSFPPE-------------VLRNKGYNRSLDMWSVGVIVYVSLS-GTFPF 1003
G AR+ I E + + +L + ++S D+WS GV V+ ++ G P+
Sbjct: 154 GLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQS-DVWSYGVTVWELMTFGAKPY 212
Query: 1004 N 1004
+
Sbjct: 213 D 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 18/99 (18%)
Query: 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSF 970
Q+ + L SKN +H DL N+LL T+ + K+CDFG AR I G
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILL-THGRI--TKICDFGLARDIRNDSNYVVKGNARL 278
Query: 971 P-----PEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPF 1003
P PE + N Y D+WS G++++ S G+ P+
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 18/39 (46%), Positives = 25/39 (64%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+SF IL LK++HS N++H DLKP NL + E+K
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKP-GNLLVNADCELK 145
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 39/170 (22%)
Query: 865 LQNLC----HPGVVNLERMFETPGRIFVVME-KLQGDMLEMILSSE------KGRLSERT 913
L+ LC HP ++NL E G +++ +E G++L+ + S ++ T
Sbjct: 58 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 117
Query: 914 TKFIITQILVA--------LKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965
+ +Q L+ + +L K +H DL N+L+ N K+ DFG +R
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY---VAKIADFGLSR-- 172
Query: 966 GEKSFPP-------------EVLRNKGYNRSLDMWSVGVIVY--VSLSGT 1000
G++ + E L Y + D+WS GV+++ VSL GT
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 222
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 38/154 (24%), Positives = 68/154 (44%), Gaps = 32/154 (20%)
Query: 870 HPGVVNLERMFETPGRIFVVME-KLQGDMLE---------MILSSEKGRLSERTTKF--- 916
H ++NL G ++V++E +G++ E M S + +L E F
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 917 --IITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE------- 967
Q+ +++L S+ +H DL NVL++ ++ + K+ DFG AR +
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVM---KIADFGLARDVHNIDYYKKT 193
Query: 968 -------KSFPPEVLRNKGYNRSLDMWSVGVIVY 994
K PE L ++ Y D+WS GV+++
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 17/89 (19%)
Query: 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE------------ 967
Q+ +++L SK +H DL NVL++ ++ + K+ DFG AR I
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVM---KIADFGLARDIHHIDYYKKTTNGRL 204
Query: 968 --KSFPPEVLRNKGYNRSLDMWSVGVIVY 994
K PE L ++ Y D+WS GV+++
Sbjct: 205 PVKWMAPEALFDRIYTHQSDVWSFGVLLW 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 29/179 (16%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKL-QGDM 897
VA+K +++ ++ + NE ++++ CH VV L + VVME + GD+
Sbjct: 39 VAVKTVNE-SASLRERIEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDL 96
Query: 898 LEMILS------SEKGRLSERTTKFI--ITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
+ S + GR + I +I + +L++K VH DL N +++ +
Sbjct: 97 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 156
Query: 950 ELPQVKLCDFGFARIIGEKSF--------------PPEVLRNKGYNRSLDMWSVGVIVY 994
VK+ DFG R I E + PE L++ + S DMWS GV+++
Sbjct: 157 ---TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 29/163 (17%)
Query: 861 EVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILS----------SEKGRLS 910
E+ I+ L P ++ L + T + ++ E ++ L LS ++ +S
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 911 ERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFG---------F 961
T F+ TQI +K+L S N VH DL N L+ N +K+ DFG +
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY---TIKIADFGMSRNLYSGDY 185
Query: 962 ARIIGEKSFP------PEVLRNKGYNRSLDMWSVGVIVYVSLS 998
RI G P +L K + + D+W+ GV ++ L+
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 48/200 (24%), Positives = 85/200 (42%), Gaps = 43/200 (21%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDML 898
VA+K++ + ++ L +E +L+ + HP V+ L G + +++E + G +
Sbjct: 33 VAVKMLKENASSSELRDLL-SEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 91
Query: 899 EMILSSEK------GRLSER-------------TTKFIIT---QILVALKHLHSKNIVHC 936
+ S K G R T +I+ QI +++L +VH
Sbjct: 92 SFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151
Query: 937 DLKPENVLLSTNSELPQVKLCDFGFARIIGE--------------KSFPPEVLRNKGYNR 982
DL NVL+ +E ++K+ DFG +R + E K E L + Y
Sbjct: 152 DLAARNVLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT 208
Query: 983 SLDMWSVGVIVY--VSLSGT 1000
D+WS GV+++ V+L G
Sbjct: 209 QSDVWSFGVLLWEIVTLGGN 228
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-04
Identities = 28/89 (31%), Positives = 42/89 (47%), Gaps = 17/89 (19%)
Query: 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSF 970
Q+ + L SKN +H D+ NVLL ++ K+CDFG AR I G
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 971 P-----PEVLRNKGYNRSLDMWSVGVIVY 994
P PE + + Y D+WS G++++
Sbjct: 277 PVKWMAPESIFDCVYTVQSDVWSYGILLW 305
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 26/202 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF-ETPGRIFVVMEKL-QGDM 897
VAIK L+ T E I++ L H +V L + E P I++V E + +G +
Sbjct: 33 VAIKT---LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEP--IYIVTEFMGKGSL 87
Query: 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957
L+ + + L + QI + ++ N +H DL+ N+L+ N K+
Sbjct: 88 LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL---VCKIA 144
Query: 958 DFGFARIIGEKS--------FP-----PEVLRNKGYNRSLDMWSVGVIVY-VSLSGTFPF 1003
DFG AR+I + FP PE + D+WS G+++ + G P+
Sbjct: 145 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
Query: 1004 NE--DEDINEQIQNAAFMYPPR 1023
+ ++ EQ++ M P+
Sbjct: 205 PGMVNREVLEQVERGYRMPCPQ 226
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 7e-04
Identities = 14/39 (35%), Positives = 20/39 (51%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
KS +L L + HS I+H DLKP+ N+ +K
Sbjct: 101 KSIMYQLLRGLAYCHSHRILHRDLKPQ-NILINRDGVLK 138
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 28/107 (26%), Positives = 45/107 (42%), Gaps = 14/107 (13%)
Query: 859 KNEVAILQNLCHPGVVNLERMFET-PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFI 917
+ E IL GV + +++ P +VME ++G++L+ L + L +
Sbjct: 47 RREARILAKAREAGV-PVPIVYDVDPDNGLIVMEYIEGELLKDALEEARPDLLREVGR-- 103
Query: 918 ITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964
LV LH IVH DL N++LS ++ DFG
Sbjct: 104 ----LVGK--LHKAGIVHGDLTTSNIILSGG----RIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (99), Expect = 0.001
Identities = 12/21 (57%), Positives = 18/21 (85%)
Query: 390 ILVALKHLHSKNIVHCDLKPE 410
I++AL++LHS I++ DLKPE
Sbjct: 102 IVLALEYLHSLGIIYRDLKPE 122
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 0.001
Identities = 15/33 (45%), Positives = 24/33 (72%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
I++AL++LHS I+H DLKP+ N+ S+ +K
Sbjct: 102 IVLALEYLHSNGIIHRDLKPD-NILIDSNGHLK 133
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 55/229 (24%), Positives = 90/229 (39%), Gaps = 61/229 (26%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE--TPGR-IFVVMEKLQGD 896
VA+K + + +Q+ Q E +L L H +V R + T GR + +V E ++
Sbjct: 38 VAVKALKEASESARQDFQ--REAELLTVLQHQHIV---RFYGVCTEGRPLLMVFEYMRHG 92
Query: 897 MLEMILSSEK--------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
L L S G+L+ I +QI + +L S + VH DL N
Sbjct: 93 DLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRN 152
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSF--------------PPEVLRNKGYNRSLDMWS 988
L+ + VK+ DFG +R I + PPE + + + D+WS
Sbjct: 153 CLVG---QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWS 209
Query: 989 VGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDIS-SDAIDLI 1036
GV+++ F Y +PW +S ++AI+ I
Sbjct: 210 FGVVLW---------------------EIFTYGKQPWYQLSNTEAIECI 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 29/179 (16%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKL-QGDM 897
VAIK +++ ++ + NE ++++ CH VV L + V+ME + +GD+
Sbjct: 39 VAIKTVNE-AASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDL 96
Query: 898 ---LEMILSSEKGR--LSERTTKFIIT---QILVALKHLHSKNIVHCDLKPENVLLSTNS 949
L + + + + K +I +I + +L++ VH DL N +++ +
Sbjct: 97 KSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 156
Query: 950 ELPQVKLCDFGFARIIGEKSF--------------PPEVLRNKGYNRSLDMWSVGVIVY 994
VK+ DFG R I E + PE L++ + D+WS GV+++
Sbjct: 157 ---TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 42/181 (23%), Positives = 76/181 (41%), Gaps = 31/181 (17%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
VA+K++ T + LK E+ I+ L +P ++ L + + + ++ E ++ L
Sbjct: 47 VAVKMLRADVTKTARNDFLK-EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 900 MILSSEKGR-----------LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
LS + +S ++ QI +K+L S N VH DL N L+ +
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH 165
Query: 949 SELPQVKLCDFG---------FARIIGEKSFP------PEVLRNKGYNRSLDMWSVGVIV 993
+K+ DFG + RI G P +L K + + D+W+ GV +
Sbjct: 166 Y---TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTL 221
Query: 994 Y 994
+
Sbjct: 222 W 222
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 33/147 (22%), Positives = 54/147 (36%), Gaps = 44/147 (29%)
Query: 837 GRGVAIKV----------ID-KLR-FPTKQEAQLKNEVAILQNLCHPGV-------VNLE 877
G IK +D ++R T+ EA+L + GV V+ +
Sbjct: 17 GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKA------GVNTPVVYDVDPD 70
Query: 878 RMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCD 937
I VME ++G L+ ++ L + LV LH IVH D
Sbjct: 71 NK-----TI--VMEYIEGKPLKDVIEEGNDELLREIGR------LVGK--LHKAGIVHGD 115
Query: 938 LKPENVLLSTNSELPQVKLCDFGFARI 964
L N+++ + ++ L DFG +
Sbjct: 116 LTTSNIIVRDD----KLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 41/181 (22%), Positives = 80/181 (44%), Gaps = 30/181 (16%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL------ERMFETPGRIFVVMEKL 893
VA+K + + + +E A +++ HP V+ L + + V++ +
Sbjct: 30 VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFM 89
Query: 894 Q-GDMLEMILSSEKGRLSERTT-----KFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+ GD+ +L S G L E+ KF++ I + +++L ++N +H DL N +L
Sbjct: 90 KHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV-DIALGMEYLSNRNFIHRDLAARNCMLRE 148
Query: 948 NSELPQVKLCDFGFARII--------GEKSFPP------EVLRNKGYNRSLDMWSVGVIV 993
+ V + DFG ++ I G + P E L ++ Y D+W+ GV +
Sbjct: 149 DM---TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 205
Query: 994 Y 994
+
Sbjct: 206 W 206
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.003
Identities = 14/35 (40%), Positives = 22/35 (62%), Gaps = 1/35 (2%)
Query: 388 RSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ +L L++LHS I+H D+K N+ TS E+K
Sbjct: 105 KELLKGLEYLHSNGIIHRDIKA-ANILLTSDGEVK 138
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.003
Identities = 37/143 (25%), Positives = 59/143 (41%), Gaps = 39/143 (27%)
Query: 842 IKVIDKLRFPTK----------QEAQLKNEVAILQNLCHPGV-------VNLERMFETPG 884
IK + K R P + + + + E I+ GV V+ E
Sbjct: 20 IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFI---- 75
Query: 885 RIFVVMEKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
+VME ++G+ L+ +++S E+ LS + LV LHS I+H DL
Sbjct: 76 ---IVMEYIEGEPLKDLINSNGMEELELSREIGR------LVGK--LHSAGIIHGDLTTS 124
Query: 942 NVLLSTNSELPQVKLCDFGFARI 964
N++LS ++ L DFG A
Sbjct: 125 NMILSGG----KIYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 29/116 (25%), Positives = 52/116 (44%), Gaps = 21/116 (18%)
Query: 887 FVVMEKL---QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
F+++EKL ++ + I K + K I+ +L L+++H I H D+KPEN+
Sbjct: 103 FILLEKLVENTKEIFKRIKCKNK-----KLIKNIMKDMLTTLEYIHEHGISHGDIKPENI 157
Query: 944 LLSTNSELPQVKLCDFGFAR--IIGEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSL 997
++ N+ + + D+G A II K Y++ G + Y L
Sbjct: 158 MVDGNN---RGYIIDYGIASHFIIHGKHIE--------YSKEQKDLHRGTLYYAGL 202
|
Length = 294 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 44/192 (22%), Positives = 80/192 (41%), Gaps = 19/192 (9%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
H +G V +++ D + L+NEV + HP ++ +F T ++V+
Sbjct: 21 HTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80
Query: 893 LQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ G ++ + +SE I+ L L +LH +H ++K ++L+S + +
Sbjct: 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLV 140
Query: 952 PQVKLCDFGFARIIGEKS-----FP-----------PEVLRNK--GYNRSLDMWSVGVIV 993
L G+K+ FP PE+LR GYN D++SVG+
Sbjct: 141 SLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITA 200
Query: 994 YVSLSGTFPFNE 1005
+G PF +
Sbjct: 201 CELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1098 | |||
| KOG4236|consensus | 888 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG4236|consensus | 888 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| KOG0986|consensus | 591 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0614|consensus | 732 | 100.0 | ||
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| KOG0574|consensus | 502 | 100.0 | ||
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.98 | |
| KOG1095|consensus | 1025 | 99.98 | ||
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.98 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| KOG4645|consensus | 1509 | 99.97 | ||
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0666|consensus | 438 | 99.97 | ||
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG1989|consensus | 738 | 99.97 | ||
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| KOG0596|consensus | 677 | 99.97 | ||
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG2345|consensus | 302 | 99.97 | ||
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0603|consensus | 612 | 99.97 | ||
| KOG0983|consensus | 391 | 99.97 | ||
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0662|consensus | 292 | 99.97 | ||
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0199|consensus | 1039 | 99.97 | ||
| KOG4257|consensus | 974 | 99.97 | ||
| KOG0669|consensus | 376 | 99.97 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG4278|consensus | 1157 | 99.97 | ||
| KOG0196|consensus | 996 | 99.97 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0671|consensus | 415 | 99.96 | ||
| KOG1094|consensus | 807 | 99.96 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| KOG1035|consensus | 1351 | 99.96 | ||
| KOG1006|consensus | 361 | 99.96 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0200|consensus | 609 | 99.96 | ||
| KOG0587|consensus | 953 | 99.96 | ||
| KOG1025|consensus | 1177 | 99.95 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0670|consensus | 752 | 99.95 | ||
| KOG4250|consensus | 732 | 99.95 | ||
| KOG0668|consensus | 338 | 99.95 | ||
| KOG1027|consensus | 903 | 99.95 | ||
| KOG0665|consensus | 369 | 99.95 | ||
| KOG1151|consensus | 775 | 99.95 | ||
| KOG1290|consensus | 590 | 99.94 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| KOG0695|consensus | 593 | 99.94 | ||
| KOG3653|consensus | 534 | 99.94 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0664|consensus | 449 | 99.93 | ||
| KOG0984|consensus | 282 | 99.93 | ||
| KOG0576|consensus | 829 | 99.92 | ||
| KOG1024|consensus | 563 | 99.92 | ||
| KOG2052|consensus | 513 | 99.92 | ||
| KOG1167|consensus | 418 | 99.91 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG1345|consensus | 378 | 99.9 | ||
| KOG0603|consensus | 612 | 99.9 | ||
| KOG1152|consensus | 772 | 99.9 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0590|consensus | 601 | 99.83 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG0606|consensus | 1205 | 99.81 | ||
| KOG1164|consensus | 322 | 99.78 | ||
| KOG1163|consensus | 341 | 99.77 | ||
| KOG0195|consensus | 448 | 99.77 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.74 | |
| KOG1165|consensus | 449 | 99.74 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.69 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG1240|consensus | 1431 | 99.67 | ||
| KOG4158|consensus | 598 | 99.67 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.62 | |
| KOG1023|consensus | 484 | 99.59 | ||
| KOG0193|consensus | 678 | 99.59 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.57 | |
| KOG1166|consensus | 974 | 99.54 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.53 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.52 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.51 | |
| KOG1033|consensus | 516 | 99.45 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.44 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.43 | |
| KOG0590|consensus | 601 | 99.41 | ||
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.39 | |
| KOG0606|consensus | 1205 | 99.38 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.34 | |
| KOG1011|consensus | 1283 | 99.26 | ||
| KOG0598|consensus | 357 | 99.24 | ||
| PF00130 | 53 | C1_1: Phorbol esters/diacylglycerol binding domain | 99.23 | |
| PF00130 | 53 | C1_1: Phorbol esters/diacylglycerol binding domain | 99.22 | |
| KOG0601|consensus | 524 | 99.19 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.16 | |
| KOG1243|consensus | 690 | 99.12 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.05 | |
| KOG0690|consensus | 516 | 99.04 | ||
| cd00029 | 50 | C1 Protein kinase C conserved region 1 (C1) . Cyst | 99.02 | |
| KOG0616|consensus | 355 | 99.02 | ||
| cd00029 | 50 | C1 Protein kinase C conserved region 1 (C1) . Cyst | 99.01 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.0 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.98 | |
| KOG1266|consensus | 458 | 98.94 | ||
| KOG0601|consensus | 524 | 98.92 | ||
| KOG0592|consensus | 604 | 98.91 | ||
| cd01239 | 117 | PH_PKD Protein kinase D (PKD/PKCmu) pleckstrin hom | 98.88 | |
| smart00109 | 49 | C1 Protein kinase C conserved region 1 (C1) domain | 98.84 | |
| smart00109 | 49 | C1 Protein kinase C conserved region 1 (C1) domain | 98.83 | |
| KOG3741|consensus | 655 | 98.79 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.77 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.71 | |
| KOG0605|consensus | 550 | 98.69 | ||
| KOG3087|consensus | 229 | 98.68 | ||
| KOG0576|consensus | 829 | 98.65 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.62 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.57 | |
| KOG0610|consensus | 459 | 98.54 | ||
| KOG2137|consensus | 700 | 98.52 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| KOG0595|consensus | 429 | 98.42 | ||
| KOG0615|consensus | 475 | 98.42 | ||
| KOG1011|consensus | 1283 | 98.33 | ||
| KOG0986|consensus | 591 | 98.29 | ||
| KOG0667|consensus | 586 | 98.27 | ||
| KOG0580|consensus | 281 | 98.25 | ||
| KOG0585|consensus | 576 | 98.25 | ||
| KOG0575|consensus | 592 | 98.22 | ||
| KOG4239|consensus | 348 | 98.21 | ||
| KOG0612|consensus | 1317 | 98.21 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.2 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 98.18 | |
| KOG0614|consensus | 732 | 98.17 | ||
| cd08685 | 119 | C2_RGS-like C2 domain of the Regulator Of G-Protei | 98.15 | |
| cd04028 | 146 | C2B_RIM1alpha C2 domain second repeat contained in | 98.13 | |
| KOG4239|consensus | 348 | 98.11 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.08 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 98.06 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 98.05 | |
| KOG0658|consensus | 364 | 98.03 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 98.02 | |
| cd08381 | 122 | C2B_PI3K_class_II C2 domain second repeat present | 98.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 98.0 | |
| KOG0591|consensus | 375 | 97.99 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 97.99 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 97.98 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 97.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 97.96 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 97.96 |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-129 Score=1088.61 Aligned_cols=781 Identities=52% Similarity=0.795 Sum_probs=627.6
Q ss_pred ecccccccCCC-----CCceEEEEEeccceeeeeeecccccHHHHHHHHHHHHHhhhhc----------cceeccccccc
Q psy48 9 AIVGHSLLRME-----SPEVTFIFQFGLIRDTVSAEVCSLNLKSIKELACNFINAKRKR----------HYWRLDSKCLT 73 (1098)
Q Consensus 9 ~~~~~~~~~~~-----~~~~~~~~q~g~~re~v~~~~~~~~l~~~~~~a~~~~~~~~~~----------~~~~~~~~~~~ 73 (1098)
.+|...+|.|+ +.++||.+|||++||.|+|++++++|+.+|++||+||+||+|+ .+||||.+..|
T Consensus 32 ~~~~~p~p~l~~s~~s~~g~sf~lq~Gltre~V~l~~~e~~l~~v~~~a~s~v~q~~pe~G~~~~~dkilLfrHd~~S~n 111 (888)
T KOG4236|consen 32 VWGPYPPPNLDGSQGSVGGVSFHLQIGLTRESVLLEAHEISLAHVRDMACSIVDQKFPECGFYGLYDKILLFRHDPNSEN 111 (888)
T ss_pred cCCCCCCCCCCCCCCCCCceEEEEEecccccceeecchhhHHHHHHHHHHHHHHHhccCcCcccccceeEEEecCCCCcc
Confidence 67788888888 7899999999999999999999999999999999999999986 67999999999
Q ss_pred ccccccCCccccccccceeecccCCCCCcccceeEEeeeeeeeEeeccCCccccccccCCccchhhhhhhhhccccCCCh
Q psy48 74 LFQSESGSKYYKEIPLSEILGIEPCKPLTHELQQVQIRPHTLTVHSYKAPTFSLKTIIPNHGLTRLLDRLMLFRHDYTYP 153 (1098)
Q Consensus 74 ~~~~~~~~~~~~~~~l~e~~~~~~~~~~~~~~~~~~~~~h~~~~~~~~~p~f~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 153 (1098)
|+|-++++.++.+|+|+||++ ...++.|+++||||+|+|||||+||||||| | |||||
T Consensus 112 iLqlitsasdI~eG~lvEvvl-----~~~at~ed~~i~PH~l~vhSY~~PtFCD~C-----G-------EmL~G------ 168 (888)
T KOG4236|consen 112 ILQLITSASDITEGDLVEVVL-----SASATFEDFQIRPHTLFVHSYKAPTFCDFC-----G-------EMLFG------ 168 (888)
T ss_pred hheeeccccccccCceEEEEe-----eccccccceeeecceeeeecccCchHHHHH-----H-------HHHHH------
Confidence 999999999999999999986 566789999999999999999999999999 4 99999
Q ss_pred hHHHhhhcccccccceEEEEeeccCCccccccccccccCCCCCCcccccCCccccCCCCC-cCCC-CC-cccCCCCCc-c
Q psy48 154 NVLLIINAVSDIVDETVVEIVLAGCSLNFHKRCVVKIPNNCSSGYKHRRSSTLHVPHSTS-ETGS-NS-SIASDDSNY-T 229 (1098)
Q Consensus 154 ~~~~~~~~~~~~~~~~l~g~~c~~C~~~~HKrC~~~i~~~C~~~~~~~~~s~~~~~~~~~-~~~~-~~-~~~~~~~~~-~ 229 (1098)
+++| |++|+|||+||||||++||||||+|.++ ||.|++++.++.| ..+. .+ ......... +
T Consensus 169 -----------LvrQ---GlKC~gCglNyHKRCa~kipNNCsG~r~-rr~sa~~l~~~~s~~l~~s~~~p~~p~~~~~ps 233 (888)
T KOG4236|consen 169 -----------LVRQ---GLKCEGCGLNYHKRCAFKIPNNCSGVRK-RRLSAVSLQPSRSNRLNLSPSSPLEPLLPARPS 233 (888)
T ss_pred -----------HHHc---cccccCCCCcHhhhhhhcCCCCCCcccc-cCCCCCCCCCCCccccccCCCCCCCccccCCCc
Confidence 9999 9999999999999999999999997655 5555554444332 1110 00 011111112 2
Q ss_pred CCCc-cCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCeeeeeeccCCCCcccccccccccccccceecCCCCCCcccccc
Q psy48 230 SSSF-STKPSSRSPSLTSRTDALSPTSPGAPSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCL 308 (1098)
Q Consensus 230 ~~~~-~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~ 308 (1098)
++.+ ...|+..++++++|+.+ +.......+.+||+|.+|+|++||.|.+|.++|.||+|||+||++|++||||||+
T Consensus 234 t~~~~~~~p~~~~~S~sgrpi~---~ek~~~~rvkvPHTf~vHSY~rpTVCq~CkkLLkGL~rQGlqCkDCk~NcHkrCa 310 (888)
T KOG4236|consen 234 TELGGPREPSSAILSWSGRPIW---MEKMLMSRVKVPHTFIVHSYTRPTVCQYCKKLLKGLFRQGLQCKDCKFNCHKRCA 310 (888)
T ss_pred ccccCCCCCCcccccccCCCch---hhhhhhhcccCCeeEEEeeccCchHHHHHHHHHHHHHhcCcccccCCcchhhhhh
Confidence 2233 24456777788888864 4555666788999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCCCccCCCCCCccccccccccccccccccccccccCCCCCCCCCCCCCCCCCCccCCCccceee-cCCCChh
Q psy48 309 DKVPKDCVGEPVTNNKSNNYCKLKSEVASLVSLESSASASYSCLVPKGEGRQDITNSELPQVKLCDFGFARI-IGEKSFR 387 (1098)
Q Consensus 309 ~~v~~~C~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~DF~~lkV-lGkGSfg 387 (1098)
.+||++|.++...+..... +.+.+.++++..++.+...+. +++|-+---| -++|++|
T Consensus 311 ~~v~~dClge~~~n~~~l~--------------------~~~~d~~~e~~~dd~~~~~~~--g~d~~e~~~~~~~~~~~~ 368 (888)
T KOG4236|consen 311 MKVPNDCLGEVTANGFFLS--------------------GQADDVPMEERDDDVNSDSSS--GMDDAEEPGVAPLQMSEG 368 (888)
T ss_pred hhcccccccceeecccccc--------------------ccccccccccccccccccCcc--cccccccCCCCccccccc
Confidence 9999999988765442211 001111222221111100000 0111110000 0112211
Q ss_pred hHHHHhhccccccccccccCCCCCccCCCCcccccCCCccchhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCchhhhhhh
Q psy48 388 RSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIKSNTEEEDEDEERGSTDGGGPSPRSEPRTATATPSNNIPLMRVVQS 467 (1098)
Q Consensus 388 KV~la~lk~LH~k~IihRDLK~dNvLld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~~~~ 467 (1098)
. ..| .||. ++|| .......+|.|+||||||++|+
T Consensus 369 ~--------------------~~~-~~~~----------~~~e---------------~~~~~~s~S~s~nIPLmRvv~s 402 (888)
T KOG4236|consen 369 S--------------------GSN-SLDA----------NADE---------------EADDTISSSTSNNIPLMRVVQS 402 (888)
T ss_pred C--------------------Ccc-cccc----------cchh---------------cccccccccccCCCceeeechh
Confidence 0 000 0111 1111 1234456788999999999999
Q ss_pred hhcccccCccccccCeEEeccCCCCCCCCCCCCCCCCCCCCcccCCCCCCCCCCCCCCCCcCceeeeeecCCCccccccc
Q psy48 468 IKHTKRRGSKVIKEGWMIHYTSKDSMSSSFSTKPSSRSPSLTSRTDALSPTSPGAPSSVNIPHTFNLHTYTRPTLCGLCK 547 (1098)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~H~F~~~~~~~~t~C~~C~ 547 (1098)
+|+++|+.++.+||+||.++.++.+... +.|++. .|
T Consensus 403 vkhtkRksst~~kEGWmvHyt~~d~lRk---------------------------------------rHYWrl----ds- 438 (888)
T KOG4236|consen 403 VKHTKRKSSTKLKEGWMVHYTSKDNLRK---------------------------------------RHYWRL----DS- 438 (888)
T ss_pred hccccccchhhhhcceEEEEechhhhhh---------------------------------------hhhhee----cc-
Confidence 9999999999999999999988665543 444443 23
Q ss_pred cchhcccccceecCCCCccccccccccCCCCCCCCCccCCCCccchhh--hhhHhhccccCCCccccccccccCCcceee
Q psy48 548 KLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPVTNNKSNNYCKL--KSEVASLVSLESSASASYSCLVRSTSHCFI 625 (1098)
Q Consensus 548 ~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~~~~~~~~~~~~~~--~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (1098)
+|...-. +...+.|+++ ++|+.++.+..... ..+...++|||+
T Consensus 439 ----------------------k~itlfq---------n~s~~ryYkeIPLsEIl~v~~~~~~~----~vp~~~~phcFE 483 (888)
T KOG4236|consen 439 ----------------------KCITLFQ---------NESTNRYYKEIPLSEILSVSSNNGFS----LVPAGTNPHCFE 483 (888)
T ss_pred ----------------------ceeEeee---------cCCCceeEEeecHHHhheeeccCCcc----cCCCCCCCceEE
Confidence 5655332 3334566666 67777766554322 334567899999
Q ss_pred ecccCccccccCCCCCCCCCCCCCCCCCCCCC---CCccccccccccCCCCCCCCCC------------CcCCCCccccc
Q psy48 626 LKTNNLDYYVGEDTHSPSDGVETPVTAPESGL---GARAWELSLRQALMPVQEPSGT------------KCEDVSESEES 690 (1098)
Q Consensus 626 ~~~~~~~~~~~~~~~~~sd~~~~~~~~~~~~~---~~~~~~~~~~~~l~p~~~~~~~------------~~~~~~~~~~~ 690 (1098)
+.|.+..|+|++++.+++ . .++|. .+..|+..++++|||+...... ..+.+++....
T Consensus 484 I~T~~~vyfVge~p~~~~------~--~~~g~g~d~a~~w~~ai~~alMpV~pqsss~~~g~~~~k~~~~s~s~s~~qiq 555 (888)
T KOG4236|consen 484 IRTATTVYFVGENPSSTP------G--GESGVGLDAAQGWETAIQQALMPVTPQSSSVGMGKQFHKDSSQSISVSNCQIQ 555 (888)
T ss_pred EEeeeEEEEecCCCCCCc------c--ccccccchhhccCchhhhhcccccccCCCCCCccccchhhccCCccccchhhh
Confidence 999999999999854332 1 12222 3678999999999999654411 11223344445
Q ss_pred cccccccccCCCCCCeecccccEEEEeeeehhhhhhhhhhccccchhhhhhhccccCcccCCCchhhhchhhhhcccccc
Q psy48 691 RVTDMSQLYQISPDEVLGSGQFGIVYGASMVGIFFLAALYEGVKYYREYLFWKTYNDLHYRSIPAQQRISSVEENKDTAK 770 (1098)
Q Consensus 691 ~~~~~~~~~~~~~~~~lG~gsFG~v~k~~~~g~~~l~~~~e~~~y~~~~~~w~~~~~~~~~~ip~~~~~~~~~~~~~~~~ 770 (1098)
..+|+..++++..+++||+|.||+||.
T Consensus 556 e~vd~stvYQif~devLGSGQFG~VYg----------------------------------------------------- 582 (888)
T KOG4236|consen 556 ENVDISTVYQIFADEVLGSGQFGTVYG----------------------------------------------------- 582 (888)
T ss_pred hhhhHHHHHHhhhHhhccCCcceeeec-----------------------------------------------------
Confidence 678889999999999999999999995
Q ss_pred ccccccccccCCCcccccCCchhHhhHHHHHHHHHHHHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC
Q psy48 771 VVPVCDVLQKQPPSMLMLSMPHFIQTLLHVLQITMSFLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF 850 (1098)
Q Consensus 771 ~~~~~~i~~~~~~~~~~~~~p~~~~~ll~~~~~~~~~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~ 850 (1098)
++++++|+.||||++.|.++
T Consensus 583 ------------------------------------------------------------g~hRktGrdVAvKvIdKlrF 602 (888)
T KOG4236|consen 583 ------------------------------------------------------------GKHRKTGRDVAVKVIDKLRF 602 (888)
T ss_pred ------------------------------------------------------------ceecccCceeeeeeeecccC
Confidence 36789999999999999999
Q ss_pred ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh
Q psy48 851 PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS 930 (1098)
Q Consensus 851 ~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs 930 (1098)
+..++.++++|++||+.+.||.||.|..+|++.+++|+|||.+.|+.|++++.+..+++++....+++.||+.||.|||.
T Consensus 603 p~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~ 682 (888)
T KOG4236|consen 603 PTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHF 682 (888)
T ss_pred CCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----------CCCChhhhccCCCCchhHHHHHHHHHHHHHcC
Q psy48 931 KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE-----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999 (1098)
Q Consensus 931 ~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~-----------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG 999 (1098)
++|+|+||||+|||+.+.....++||+|||+|++++. .|+|||+++++.|+.+-|+||+||++|--+.|
T Consensus 683 knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSG 762 (888)
T KOG4236|consen 683 KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG 762 (888)
T ss_pred cceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecc
Confidence 9999999999999999988888999999999997754 45799999999999999999999999999999
Q ss_pred CCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHHHHhhhCCCC
Q psy48 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQIGTNK 1079 (1098)
Q Consensus 1000 ~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~~~~~~~~ 1079 (1098)
.+||..++++.++|++..+.||+.+|+.++.++.+||..+|+..-.+|.|++..+.|||+++++.|.||+.||.+++..+
T Consensus 763 TFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRy 842 (888)
T KOG4236|consen 763 TFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERY 842 (888)
T ss_pred cccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcchhhhhhhhhhhccC
Q psy48 1080 KKNPKRTAQLLSYQLTQML 1098 (1098)
Q Consensus 1080 ~~~~~~~~~~~~~~~~~~~ 1098 (1098)
.++++|+..|..+..++||
T Consensus 843 iThesDD~~~~~~~~~~~l 861 (888)
T KOG4236|consen 843 ITHESDDARWEQLANEHFL 861 (888)
T ss_pred ecCcchhhhhhhhcCcccc
Confidence 9999999999888888775
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-109 Score=901.99 Aligned_cols=497 Identities=26% Similarity=0.419 Sum_probs=429.8
Q ss_pred cCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCCCccCC---------CCccchhhhhh
Q psy48 528 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPVTNN---------KSNNYCKLKSE 598 (1098)
Q Consensus 528 ~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~~~~~~---------~~~~~~~~~~e 598 (1098)
..|.|..++|.+||||||||.+|+|+.+||++|..|.||||++|...||+.||.+.+++| ..+.+++.+.|
T Consensus 109 ~kHkf~~~tYssPTFCDhCGsLLyGl~HQGmKC~~C~mNVH~rCv~nVPslCG~DhtE~RGrl~l~~~~~~~~l~v~i~e 188 (683)
T KOG0696|consen 109 SKHKFKIHTYSSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHHRCVENVPSLCGTDHTERRGRLYLEAHIKRDVLTVTIKE 188 (683)
T ss_pred cccceeeeecCCCchhhhHHHHHHHHHhcccccccccchHHHHHhhcCCcccCCcchhhcceEEEEEEecCceEEEEehh
Confidence 369999999999999999999999999999999999999999999999999999987776 34456677888
Q ss_pred HhhccccCCCccccccccccCCcceeeecccCccccccCCCCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCC
Q psy48 599 VASLVSLESSASASYSCLVRSTSHCFILKTNNLDYYVGEDTHSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSG 678 (1098)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~ 678 (1098)
|+||||||+ +|+||||++.+.+|+++..++++|++++.+|||+||+++
T Consensus 189 a~NLiPMDp--------------------------------NGlSDPYvk~kliPD~~~~sKqKTkTik~~LNP~wNEtf 236 (683)
T KOG0696|consen 189 AKNLIPMDP--------------------------------NGLSDPYVKLKLIPDPKNESKQKTKTIKATLNPVWNETF 236 (683)
T ss_pred hccccccCC--------------------------------CCCCCcceeEEeccCCcchhhhhhhhhhhhcCcccccee
Confidence 999999987 568999999999999999999999999999999999999
Q ss_pred CCcCCCCccccccccccccccCCCCCCeecccccEE--EEeeeehhhhhhhhhhccccchhhhhhhccccCcccCCCchh
Q psy48 679 TKCEDVSESEESRVTDMSQLYQISPDEVLGSGQFGI--VYGASMVGIFFLAALYEGVKYYREYLFWKTYNDLHYRSIPAQ 756 (1098)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~gsFG~--v~k~~~~g~~~l~~~~e~~~y~~~~~~w~~~~~~~~~~ip~~ 756 (1098)
++.++++|+++++++++||||+++||||||+.|||+ ++|++++||||||+++|||+| |||+.
T Consensus 237 tf~Lkp~DkdrRlsiEvWDWDrTsRNDFMGslSFgisEl~K~p~~GWyKlLsqeEGEyy----------------Nvp~~ 300 (683)
T KOG0696|consen 237 TFKLKPSDKDRRLSIEVWDWDRTSRNDFMGSLSFGISELQKAPVDGWYKLLSQEEGEYY----------------NVPVP 300 (683)
T ss_pred EEecccccccceeEEEEecccccccccccceecccHHHHhhcchhhHHHHhhhhcCcee----------------ccCCC
Confidence 999999999999999999999999999999999999 999999999999999999998 77764
Q ss_pred hhc----hhhhhccccccccccccccccCCCcccccCCchhHhhHHHHHHHHHHHHHHhhheeeeeeeeeeeeeceEEEE
Q psy48 757 QRI----SSVEENKDTAKVVPVCDVLQKQPPSMLMLSMPHFIQTLLHVLQITMSFLLMLVFMTYNVALCIAVVAGAACGV 832 (1098)
Q Consensus 757 ~~~----~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~p~~~~~ll~~~~~~~~~~~~l~~~~~~~~Lg~G~~g~v~~a~ 832 (1098)
... ...++..+..++-+.... ..+......+++++.+...++...+++|+ .+||.|.||.|.++.
T Consensus 301 ~~~~e~~~~lr~k~~~~~~~~~~s~--p~~~~~~~~~~~~~~~~~d~i~~tDFnFl---------~VlGKGSFGKVlLae 369 (683)
T KOG0696|consen 301 DEDSEDNEELRQKFERARIGPGSSK--PEKKTMPTDSKFHNSSKRDRIKATDFNFL---------MVLGKGSFGKVLLAE 369 (683)
T ss_pred CchhhHHHHHHHHHhhcccCCCcCC--CCCCCCCCcccCCCCCcccceeecccceE---------EEeccCccceeeeec
Confidence 432 222222222333332221 12234455566677776666666667765 466788889999999
Q ss_pred eecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccc
Q psy48 833 HRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLS 910 (1098)
Q Consensus 833 ~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~ls 910 (1098)
.+.+.+.||||+++++.+- +++.+.-+.|.++|... +-|++++|+.+|++.+++|+||||++||+| +++.++-++|.
T Consensus 370 rkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDL-MyhiQQ~GkFK 448 (683)
T KOG0696|consen 370 RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDL-MYHIQQVGKFK 448 (683)
T ss_pred ccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchh-hhHHHHhcccC
Confidence 9999999999999997764 44457778899998766 578999999999999999999999999999 77777889999
Q ss_pred hhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc-----------c-CCCCCChhhhccC
Q psy48 911 ERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI-----------I-GEKSFPPEVLRNK 978 (1098)
Q Consensus 911 e~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~-----------~-~~~~~APEvl~~~ 978 (1098)
+..+++|+++|+.||-|||++|||+||||.+|||+|.+| +|||+||||++. + ++.|+|||++..+
T Consensus 449 Ep~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG---HiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Yq 525 (683)
T KOG0696|consen 449 EPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG---HIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQ 525 (683)
T ss_pred CchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC---ceEeeecccccccccCCcceeeecCCCcccccceEEec
Confidence 999999999999999999999999999999999999999 999999999963 2 4457899999999
Q ss_pred CCCchhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCH-----H
Q psy48 979 GYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV-----D 1051 (1098)
Q Consensus 979 ~ys~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa-----~ 1051 (1098)
+|+.++|||||||+|||||.|++||+++ +++++.|.+....|| ..+|.++.++++.+|.+.|.+|+++ .
T Consensus 526 PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----KslSkEAv~ickg~ltK~P~kRLGcg~~ge~ 601 (683)
T KOG0696|consen 526 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----KSLSKEAVAICKGLLTKHPGKRLGCGPEGER 601 (683)
T ss_pred ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc----ccccHHHHHHHHHHhhcCCccccCCCCcccc
Confidence 9999999999999999999999999975 577888888888887 4689999999999999999999976 7
Q ss_pred HHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCc--chhhhhhhhhhh
Q psy48 1052 KSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNP--KRTAQLLSYQLT 1095 (1098)
Q Consensus 1052 eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~--~~~~~~~~~~~~ 1095 (1098)
+|.+||||+. +||++||++ ++|||++.. ....++++-.++
T Consensus 602 di~~H~FFR~----iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft 644 (683)
T KOG0696|consen 602 DIREHPFFRR----IDWEKLERREIQPPFKPKIKCGRDAENFDKFFT 644 (683)
T ss_pred chhhCcchhh----ccHHHHhhccCCCCCCCccccCCchhhhhHHHh
Confidence 9999999997 999999999 999998766 334555555443
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-72 Score=656.38 Aligned_cols=411 Identities=29% Similarity=0.453 Sum_probs=302.0
Q ss_pred CcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCCCccCCCCccchhhhhhHhhccccC
Q psy48 527 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPVTNNKSNNYCKLKSEVASLVSLE 606 (1098)
Q Consensus 527 ~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~~~~~~~~~~~~~~~~e~~~~~~~~ 606 (1098)
.+||+|..+++.+++||+|||.++||..+||++|..|+++||++|..+|+++||.+.. ...++...+...
T Consensus 228 ~~Phrf~~~~~q~ptFc~hCGs~L~r~~qqGlkCs~Cg~n~H~~c~~~va~~CG~s~t----------~~~~~~~~~~~~ 297 (694)
T KOG0694|consen 228 RNPHRFVKLNRQRPTFCDHCGSVLYRLRQQGLKCSTCGRNVHNRCVENLAPNCGGSRT----------FSPEILEEIGTS 297 (694)
T ss_pred cCCCcchhhhccCccHHHhcchhhhhhcccCeeehhhhccccHHHHHhcccCCCCchh----------hhhhhhhhcccC
Confidence 4579999999999999999999999999999999999999999999999999998753 233444333333
Q ss_pred CCccccccccccCCcceeeecccCccccccCCCCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCc
Q psy48 607 SSASASYSCLVRSTSHCFILKTNNLDYYVGEDTHSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSE 686 (1098)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~ 686 (1098)
+......+....+.. ..-+ .+...+.+ .+...+.......+ ..+......|.... .....
T Consensus 298 ~~~~~~~~~~~~~~~-------~~~~-----~~~~~~~~--~~~~~~~~~~~p~~-~~~~~~~~~~~~~~-----~~~~~ 357 (694)
T KOG0694|consen 298 PRAQSELKPKLPSVE-------KLFD-----PPQLSPRP--GPPSSPASLVSPIQ-ESTAPEFPQPTFEN-----SGPPE 357 (694)
T ss_pred CCCccccCCCCcchh-------hccc-----CccccCCC--CCCCCcccccCCcc-cccCCCCCCccccC-----CCccc
Confidence 322111111000000 0000 00000000 00000000000000 00000000010000 00000
Q ss_pred cccccccccccccCCCCCCeecccccEEEEeeeehhhhhhhhhhccccchhhhhhhccccCcccCCCchhhhchhhhhcc
Q psy48 687 SEESRVTDMSQLYQISPDEVLGSGQFGIVYGASMVGIFFLAALYEGVKYYREYLFWKTYNDLHYRSIPAQQRISSVEENK 766 (1098)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~lG~gsFG~v~k~~~~g~~~l~~~~e~~~y~~~~~~w~~~~~~~~~~ip~~~~~~~~~~~~ 766 (1098)
...+. ..-.+++|....+||+|+||+||+|
T Consensus 358 ~~~~~--~~~~l~~F~~l~vLGkGsFGkV~la------------------------------------------------ 387 (694)
T KOG0694|consen 358 FPPRR--GPLTLDDFRLLAVLGRGSFGKVLLA------------------------------------------------ 387 (694)
T ss_pred CCCCC--CcccccceEEEEEeccCcCceEEEE------------------------------------------------
Confidence 00000 1223456666677888888888875
Q ss_pred ccccccccccccccCCCcccccCCchhHhhHHHHHHHHHHHHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEe
Q psy48 767 DTAKVVPVCDVLQKQPPSMLMLSMPHFIQTLLHVLQITMSFLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVID 846 (1098)
Q Consensus 767 ~~~~~~~~~~i~~~~~~~~~~~~~p~~~~~ll~~~~~~~~~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlk 846 (1098)
..+.+++.||||+++
T Consensus 388 -----------------------------------------------------------------e~k~~~e~yAIK~LK 402 (694)
T KOG0694|consen 388 -----------------------------------------------------------------ELKGTNEYYAIKVLK 402 (694)
T ss_pred -----------------------------------------------------------------EEcCCCcEEEEEEee
Confidence 345678899999999
Q ss_pred ccCCC-hHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHH
Q psy48 847 KLRFP-TKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVA 924 (1098)
Q Consensus 847 k~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~g 924 (1098)
|..+- .++.+..+.|.+|+... +||+|++|+++|++++++|+||||+.||+ +++.+..+.|++..+++|+++|+.|
T Consensus 403 K~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggd--m~~~~~~~~F~e~rarfyaAev~l~ 480 (694)
T KOG0694|consen 403 KGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGD--LMHHIHTDVFSEPRARFYAAEVVLG 480 (694)
T ss_pred ccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCc--EEEEEecccccHHHHHHHHHHHHHH
Confidence 97764 45568899999999866 59999999999999999999999999999 4555667889999999999999999
Q ss_pred HHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------------CCCCCChhhhccCCCCchhHHHHHHHH
Q psy48 925 LKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------------GEKSFPPEVLRNKGYNRSLDMWSVGVI 992 (1098)
Q Consensus 925 L~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------------~~~~~APEvl~~~~ys~~sDVwSLGvl 992 (1098)
|+|||++||||||||.+|||||.+| ++||+|||||+.. ++.+||||++.+..|+.++|||||||+
T Consensus 481 L~fLH~~~IIYRDlKLdNiLLD~eG---h~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVL 557 (694)
T KOG0694|consen 481 LQFLHENGIIYRDLKLDNLLLDTEG---HVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVL 557 (694)
T ss_pred HHHHHhcCceeeecchhheEEcccC---cEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHH
Confidence 9999999999999999999999999 9999999999742 344689999999999999999999999
Q ss_pred HHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCH-----HHHHcCCCcCCCCCc
Q psy48 993 VYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV-----DKSLAHPWLQDPATW 1065 (1098)
Q Consensus 993 LyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa-----~eIL~HpfFk~~~~~ 1065 (1098)
|||||.|+.||.++ +++++.|......||. .+|.++.++|+++|.+||++|+++ .+|.+||||+.
T Consensus 558 lyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~---- 629 (694)
T KOG0694|consen 558 LYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS---- 629 (694)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc----
Confidence 99999999999865 5788999988888874 599999999999999999999975 79999999999
Q ss_pred chhHHHHhh-hCCCCCCCcchh--hhhhhhhhh
Q psy48 1066 SDLRGLERQ-IGTNKKKNPKRT--AQLLSYQLT 1095 (1098)
Q Consensus 1066 ~~~~~l~~~-~~~~~~~~~~~~--~~~~~~~~~ 1095 (1098)
+||++|+++ +.|||.+..+.. +.+++.+++
T Consensus 630 i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt 662 (694)
T KOG0694|consen 630 IDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFT 662 (694)
T ss_pred CCHHHHhhccCCCCCCcccCChhhhcccchhhh
Confidence 899999999 999887655544 334444443
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-63 Score=530.91 Aligned_cols=462 Identities=22% Similarity=0.355 Sum_probs=350.5
Q ss_pred CCCCCCchhhhhhhhhcccccCcccc-ccCeEEeccCCCCCCCCCCCCCCCCCCCCcccCCCCCCCCCCCCCCCCcC---
Q psy48 454 TPSNNIPLMRVVQSIKHTKRRGSKVI-KEGWMIHYTSKDSMSSSFSTKPSSRSPSLTSRTDALSPTSPGAPSSVNIP--- 529 (1098)
Q Consensus 454 ~~~~~ip~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 529 (1098)
+....+.+..++..+|.++++..+.. ..+|.++.++|+++++|++++++-|......+.+..++..|+.|..|++|
T Consensus 30 ~~~p~~~~e~~~~~vrd~c~~h~~q~~t~kwideegdp~tv~sqmeleea~r~~~~~~d~el~ihvf~~~pe~pglpc~g 109 (593)
T KOG0695|consen 30 SVDPATTFEELCEEVRDMCRLHQQQPLTLKWIDEEGDPCTVSSQMELEEAFRLARQCRDEELIIHVFPSTPEQPGLPCPG 109 (593)
T ss_pred eccCcccHHHHHHHHHHHHHHhhcCCceeEeecCCCCcceechhhhHHHHHHHHHhccccceEEEEccCCCCCCCCCCCC
Confidence 34456789999999999999987654 49999999999999999999999999999999999999999999999886
Q ss_pred ---------------------ceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCCCccCCC
Q psy48 530 ---------------------HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPVTNNK 588 (1098)
Q Consensus 530 ---------------------H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~~~~~~~ 588 (1098)
|+|+.+.|.+.+.|..|.+.|||++||||+|.+|++.||+||+..|+..||....
T Consensus 110 edksiyrrgarrwrkly~~ngh~fqakr~nrr~~c~ic~d~iwglgrqgyrcinckl~vhkkch~~v~~~cg~~~~---- 185 (593)
T KOG0695|consen 110 EDKSIYRRGARRWRKLYRANGHLFQAKRFNRRAYCGICSDRIWGLGRQGYRCINCKLLVHKKCHGLVPLTCGKHMD---- 185 (593)
T ss_pred CcchHHHhHHHHHHHHHhhcCcchhhhhhccceeeeechhhhhhcccccceeecceeehhhhhcccccchhhhhcc----
Confidence 9999999999999999999999999999999999999999999999999987532
Q ss_pred CccchhhhhhHhhccccCCCccccccccccCCcceeeecccCccccccCCCCCCCCCCCCCCCCCCCCCCCccccccccc
Q psy48 589 SNNYCKLKSEVASLVSLESSASASYSCLVRSTSHCFILKTNNLDYYVGEDTHSPSDGVETPVTAPESGLGARAWELSLRQ 668 (1098)
Q Consensus 589 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~ 668 (1098)
..+.+|+.|..... .....+. ..|....+ -+ +....++-.... +..+.
T Consensus 186 ----------~~~~~p~~p~~~s~-~~~~~~s-----~~t~~~~~---------i~----~~~~he~~~~~~---~~~~~ 233 (593)
T KOG0695|consen 186 ----------SVMPSPEPPVDDSN-EDADLPS-----EETDGIAY---------IS----SSRKHESIKDDS---EDLKP 233 (593)
T ss_pred ----------CCCCCCCCCCCCcc-ccCCCCc-----hhcCcccc---------cC----ccccchhhhcCc---cchhh
Confidence 12223333211000 0000000 00000000 00 000000000000 00000
Q ss_pred cCCCCCCCCCCCcCCCCccccccccccccccCCCCCCeecccccEEEEeeeehhhhhhhhhhccccchhhhhhhccccCc
Q psy48 669 ALMPVQEPSGTKCEDVSESEESRVTDMSQLYQISPDEVLGSGQFGIVYGASMVGIFFLAALYEGVKYYREYLFWKTYNDL 748 (1098)
Q Consensus 669 ~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~gsFG~v~k~~~~g~~~l~~~~e~~~y~~~~~~w~~~~~~ 748 (1098)
+.+-. .+.+ ..+. -.+.+|....+||.|||..|.
T Consensus 234 a~~~m----------~g~~---~~~~-l~l~df~ll~vigrgsyakvl-------------------------------- 267 (593)
T KOG0695|consen 234 AIDGM----------DGIK---ISQG-LGLQDFDLLRVIGRGSYAKVL-------------------------------- 267 (593)
T ss_pred hhhhc----------cccc---cccc-cccccceeeeeecCcchhhhh--------------------------------
Confidence 00000 0000 0000 012233333456666666554
Q ss_pred ccCCCchhhhchhhhhccccccccccccccccCCCcccccCCchhHhhHHHHHHHHHHHHHHhhheeeeeeeeeeeeece
Q psy48 749 HYRSIPAQQRISSVEENKDTAKVVPVCDVLQKQPPSMLMLSMPHFIQTLLHVLQITMSFLLMLVFMTYNVALCIAVVAGA 828 (1098)
Q Consensus 749 ~~~~ip~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~p~~~~~ll~~~~~~~~~~~~l~~~~~~~~Lg~G~~g~v 828 (1098)
T Consensus 268 -------------------------------------------------------------------------------- 267 (593)
T KOG0695|consen 268 -------------------------------------------------------------------------------- 267 (593)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred EEEEeecCCceeEEEEEeccCCChH-HHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhcc
Q psy48 829 ACGVHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEK 906 (1098)
Q Consensus 829 ~~a~~k~tg~~VAVKvlkk~~~~~~-~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~ 906 (1098)
.+.++++.+.||+|+++|+.++++ +...++.|..++.+. +||++|.|+.+|++..++|+|.||++||+| +++.++.
T Consensus 268 -~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdl-mfhmqrq 345 (593)
T KOG0695|consen 268 -LVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQ 345 (593)
T ss_pred -heehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcce-eeehhhh
Confidence 356778899999999999877654 458899999998755 799999999999999999999999999999 7777788
Q ss_pred CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------------CCCCCChhh
Q psy48 907 GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------------GEKSFPPEV 974 (1098)
Q Consensus 907 ~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------------~~~~~APEv 974 (1098)
++++++.+++|..+|+.||.|||++|||+||||.+|+|+|.+| ++||+|+||++.. +++|+|||+
T Consensus 346 rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg---hikltdygmcke~l~~gd~tstfcgtpnyiapei 422 (593)
T KOG0695|consen 346 RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG---HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEI 422 (593)
T ss_pred hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC---ceeecccchhhcCCCCCcccccccCCCcccchhh
Confidence 8999999999999999999999999999999999999999999 9999999999632 445689999
Q ss_pred hccCCCCchhHHHHHHHHHHHHHcCCCCCCC------ChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCC
Q psy48 975 LRNKGYNRSLDMWSVGVIVYVSLSGTFPFNE------DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048 (1098)
Q Consensus 975 l~~~~ys~~sDVwSLGvlLyELltG~~Pf~~------~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRP 1048 (1098)
+++..|++++|||+|||+++|||.|+.||+- +....+++.+.......+.++.+|-.+..+++..|++||.+|+
T Consensus 423 lrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 423 LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 9999999999999999999999999999951 1222333333333334444567889999999999999999998
Q ss_pred C------HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcchh
Q psy48 1049 S------VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPKRT 1086 (1098)
Q Consensus 1049 S------a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~~~ 1086 (1098)
+ ++++..|+||+. +||+.||.+ +.|||.++-.+.
T Consensus 503 gc~~~~g~~dik~h~ffr~----idwd~leqk~v~ppf~p~i~~d 543 (593)
T KOG0695|consen 503 GCRPQTGFSDIKSHAFFRS----IDWDLLEQKQVLPPFQPQITDD 543 (593)
T ss_pred CCCcccchhhhhcchhhhh----CCHHHHhhcccCCCCCCccccc
Confidence 5 689999999997 888889888 888988766554
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=447.44 Aligned_cols=212 Identities=25% Similarity=0.367 Sum_probs=182.6
Q ss_pred eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHH
Q psy48 839 GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFII 918 (1098)
Q Consensus 839 ~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia 918 (1098)
.||||+++.+..++++.+.|++|+.+|++.+|.||+-++|++..++. .||+.||+|.+|+.+++....+|+..+.+.|+
T Consensus 416 dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIA 494 (678)
T KOG0193|consen 416 DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIA 494 (678)
T ss_pred ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHH
Confidence 69999999998888899999999999999999999999999988876 99999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC--------------CCCChhhhcc---CCCC
Q psy48 919 TQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE--------------KSFPPEVLRN---KGYN 981 (1098)
Q Consensus 919 ~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~--------------~~~APEvl~~---~~ys 981 (1098)
.||++||.|||.++|||||||..||++.+++ +|||+|||++...+. -|||||+++. .+|+
T Consensus 495 qQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~---kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS 571 (678)
T KOG0193|consen 495 QQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL---KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFS 571 (678)
T ss_pred HHHHHhhhhhhhhhhhhhhccccceEEccCC---cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCC
Confidence 9999999999999999999999999999988 899999999964321 2489999974 5699
Q ss_pred chhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccC----CCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 982 RSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY----PPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 982 ~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~----p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.+||||||+++|||++|..||..... .+.|-..-..+ ......+.++++.+|+..||.+++++||.+.+|+.
T Consensus 572 ~qSDVYaFGiV~YELltg~lPysi~~~-dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 572 FQSDVYAFGIVWYELLTGELPYSIQNR-DQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cccchhhhhHHHHHHHhCcCCcCCCCh-hheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 999999999999999999999983321 12111111111 11123467789999999999999999999999986
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=414.59 Aligned_cols=264 Identities=30% Similarity=0.507 Sum_probs=233.8
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH-HHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..+.+-.++|.|+||.|+.+..+.+++.||+|+++|...... +...+..|..+|..++||+||.++-.|++.+.+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 356778999999999999999999999999999998766544 5578999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||++||.|..++. +.+.|++..+++|+++|+.||.|||++|||||||||+|||||.+| |++|+|||+|+..
T Consensus 105 d~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G---Hi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 105 DYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG---HIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred eccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC---cEEEeccccchhcccCCC
Confidence 9999999977765 677899999999999999999999999999999999999999999 9999999999732
Q ss_pred -------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 966 -------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 966 -------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
+..|||||++.+.+|+..+||||||+++|||++|.+||.+.+ ...+.+.......++ .-++.++++++
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ardll 257 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARDLL 257 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHHHH
Confidence 345799999999999999999999999999999999998753 555555555433332 34889999999
Q ss_pred HHhhhhcccCCC----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcchh
Q psy48 1037 NNLLQVKQRKRL----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPKRT 1086 (1098)
Q Consensus 1037 ~~cL~~dP~kRP----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~~~ 1086 (1098)
+++|..||++|. ++.+|.+||||+. +||++|..+ +.|||+++....
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~----inW~~l~~k~l~PpF~P~~~~~ 308 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKG----INWEKLLAKKLSPPFKPNVTGL 308 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCccccc----CCHHHHHhcCCCCCeecCCCCc
Confidence 999999999997 5789999999999 899999998 999987665443
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=396.01 Aligned_cols=274 Identities=34% Similarity=0.567 Sum_probs=242.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
+..+.+...+|.|.||.|.++.++.+|..||+|++++..+ ...+.+...+|..+|+.+.||++++|++.|.+.+.+|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3455667899999999999999999999999999988554 344568899999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||++||-|..+++ +.++|++..+++|++||+.||+|||+.+|++|||||+|||+|.+| ++||+|||+|+..
T Consensus 123 meyv~GGElFS~Lr-k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G---~iKitDFGFAK~v~~rT 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR-KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG---HIKITDFGFAKRVSGRT 198 (355)
T ss_pred EeccCCccHHHHHH-hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC---cEEEEeccceEEecCcE
Confidence 99999999988886 667899999999999999999999999999999999999999999 9999999999754
Q ss_pred -----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 966 -----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 966 -----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
++.|+|||++++++|+.++|||||||++|||+.|.+||..+. .+.+.|......+|. -++.++.+||++
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLLKK 274 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHHHH
Confidence 445689999999999999999999999999999999998765 556677777777774 588999999999
Q ss_pred hhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC----Ccchhhhhhhhhhhc
Q psy48 1039 LLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK----NPKRTAQLLSYQLTQ 1096 (1098)
Q Consensus 1039 cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~----~~~~~~~~~~~~~~~ 1096 (1098)
+|+.|-.+|. +..+|..||||+. ++|+++..| +++|+.+ .+.|+....+|+.+.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~----v~W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y~e~~ 338 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG----VDWEAILQRKIEPPFEPPNIHGPGDTSNFDDYEEED 338 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccc----ccHHHHhhccccCCCCCccccCCccccccccccccc
Confidence 9999999994 5689999999998 888888888 8888754 666777777776554
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=405.72 Aligned_cols=253 Identities=36% Similarity=0.642 Sum_probs=226.0
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHH-----HHHHHHHHHHHhccCCCCceeeeeeeecCC
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQ-----EAQLKNEVAILQNLCHPGVVNLERMFETPG 884 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~-----~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~ 884 (1098)
....|..+..+|.|.||.|-.|..+.+|+.||||++++....... ...+.+|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345788899999999999999999999999999999886544322 234689999999999999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
..|+||||++||.|.+.+. ..+.+.+..-..++.|++.|+.|||++||+||||||+|||+..+.+...+||+|||+|+.
T Consensus 250 s~YmVlE~v~GGeLfd~vv-~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV-ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred ceEEEEEEecCccHHHHHH-hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999988876 456789999999999999999999999999999999999999886666999999999987
Q ss_pred cC-----------CCCCChhhhccCC---CCchhHHHHHHHHHHHHHcCCCCCCCC---hhHHHHHHHhhccCCCCCCCc
Q psy48 965 IG-----------EKSFPPEVLRNKG---YNRSLDMWSVGVIVYVSLSGTFPFNED---EDINEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 965 ~~-----------~~~~APEvl~~~~---ys~~sDVwSLGvlLyELltG~~Pf~~~---~~~~~~i~~~~~~~p~~~~~~ 1027 (1098)
.+ +.|.|||++.+.. |..++|+||+||+||-+++|.+||.+. ..+.+++....+.+-+..|..
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~ 408 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR 408 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence 63 3456999998765 345889999999999999999999854 347889999999998899999
Q ss_pred CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1028 ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
+|+++.+||.+||..||++|||++++|+||||+...
T Consensus 409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 999999999999999999999999999999999844
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=389.47 Aligned_cols=263 Identities=27% Similarity=0.402 Sum_probs=229.2
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc-EEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR-IFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~-l~LVmE 891 (1098)
.......||.|.+|.|+.+.|+.+++.+|+|++ ..........++.+|+++++..+||+||.+|++|..++. +.|+||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 334556899999999999999999999999999 344556667899999999999999999999999999995 999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||+||+|+.++.. .+++++....+++.++++||.|||. ++||||||||+|||++..| .|||+|||.++.+
T Consensus 159 YMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG---eVKicDFGVS~~lvnS~a 234 (364)
T KOG0581|consen 159 YMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG---EVKICDFGVSGILVNSIA 234 (364)
T ss_pred hcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC---CEEeccccccHHhhhhhc
Confidence 9999999988864 4789999999999999999999995 9999999999999999999 8999999987643
Q ss_pred -----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC----hhHHHHHHHhhccCCCCCCCc-CcHHHHHH
Q psy48 966 -----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED----EDINEQIQNAAFMYPPRPWRD-ISSDAIDL 1035 (1098)
Q Consensus 966 -----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~----~~~~~~i~~~~~~~p~~~~~~-is~el~~L 1035 (1098)
+..|||||.+.+..|+.++||||||+.|+|+++|++||... ....+.+.......|+..+.. +|+++++|
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F 314 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF 314 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 44579999999999999999999999999999999999863 466677777777677777776 99999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCCCCC-cchhHHHHhhhCCCCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQDPAT-WSDLRGLERQIGTNKK 1080 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~~~~-~~~~~~l~~~~~~~~~ 1080 (1098)
+..||++||.+||++.|+++|||+++... -.|+...-.++..+..
T Consensus 315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~~~~~~~~~~~~~ 360 (364)
T KOG0581|consen 315 VSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDMASFVRKALSPPR 360 (364)
T ss_pred HHHHhcCCcccCCCHHHHhcCHHHhhcccccccHHHHHHHhcccCC
Confidence 99999999999999999999999986433 4455555555544443
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=403.45 Aligned_cols=257 Identities=30% Similarity=0.500 Sum_probs=229.5
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHH-HHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQ-EAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~-~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LV 889 (1098)
..+.|+.+||.|.|+.|++|.++.+++.|||||+.|..+..+. ...+..|..+|.+| .||+|++|+..|++...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 4578999999999999999999999999999999887654443 36788999999999 899999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC--
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE-- 967 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~-- 967 (1098)
+||+++|+|..++. +-+.|++..+++|++||+.||+|||++|||||||||+|||||.++ +++|+|||.|+.+++
T Consensus 153 Le~A~nGdll~~i~-K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm---hikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIK-KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG---HIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEecCCCcHHHHHH-HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC---cEEEeeccccccCChhh
Confidence 99999999988886 557899999999999999999999999999999999999999999 999999999976532
Q ss_pred -----------------------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCC
Q psy48 968 -----------------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPP 1022 (1098)
Q Consensus 968 -----------------------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~ 1022 (1098)
.|.+||++.....++.+|+|+|||+||+|+.|++||.+..+ .++.|+.....+|+
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~ 308 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE 308 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence 23599999999999999999999999999999999987654 56777777777764
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHHHHhhhCCCCC
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQIGTNKK 1080 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~~~~~~~~~ 1080 (1098)
++++.+.+|++++|..||.+|+|+.+|.+||||.+ +||+.|..+-+|+..
T Consensus 309 ----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~----Vdw~nlw~~~PP~l~ 358 (604)
T KOG0592|consen 309 ----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG----VDWENLWQQTPPKLQ 358 (604)
T ss_pred ----CCCHHHHHHHHHHHccCccccccHHHHhhCccccc----CChhhhhhcCCCccc
Confidence 57899999999999999999999999999999999 777777777555443
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=399.72 Aligned_cols=265 Identities=26% Similarity=0.414 Sum_probs=230.2
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.+..+..-..||.|+||.||++..+.||..||+|+++|... ...+...+..|..+|....+|+||+|+-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 44555667889999999999999999999999999998654 44566889999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
||||++||++..+|. +.+.|++..+++|+++++.|+..||+.|||||||||+|+|||..| |+||+|||||..+
T Consensus 219 iMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G---HiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG---HIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC---CEeeccccccchhhhh
Confidence 999999999988876 567899999999999999999999999999999999999999999 9999999998411
Q ss_pred --------------------------------------------------------CCCCCChhhhccCCCCchhHHHHH
Q psy48 966 --------------------------------------------------------GEKSFPPEVLRNKGYNRSLDMWSV 989 (1098)
Q Consensus 966 --------------------------------------------------------~~~~~APEvl~~~~ys~~sDVwSL 989 (1098)
++.|||||++.++.|+..+|||||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 111369999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCC---HHHHHcCCCcCCCCC
Q psy48 990 GVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS---VDKSLAHPWLQDPAT 1064 (1098)
Q Consensus 990 GvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPS---a~eIL~HpfFk~~~~ 1064 (1098)
||||||||.|.+||.+++ +..+.+..+...+....-..+++++.+||.+||. ||++|.+ ++||.+||||++
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~--- 450 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG--- 450 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc---
Confidence 999999999999998764 5566777776444333335688999999999999 9999995 899999999999
Q ss_pred cchhHHHHhhhCCCCCCCcc
Q psy48 1065 WSDLRGLERQIGTNKKKNPK 1084 (1098)
Q Consensus 1065 ~~~~~~l~~~~~~~~~~~~~ 1084 (1098)
+||+.|.... |||.+..+
T Consensus 451 -v~W~~l~~~~-apfvP~v~ 468 (550)
T KOG0605|consen 451 -VDWDHLREMP-APFVPQVN 468 (550)
T ss_pred -CCcchhhcCC-CCCCCCCC
Confidence 8888887775 66554433
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=403.46 Aligned_cols=242 Identities=31% Similarity=0.508 Sum_probs=222.2
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
.+|..+..||.|+|+.+|.+.+..+|+.||+|++.+..+ ...+.+.+.+||++.+.++|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 468889999999999999999999999999999987544 4556788999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
|+|..++|..++. ....++|.+++.|++||+.||.|||+++|||||||..||+++.+- +|||+|||||..+
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~---~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM---NVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC---cEEecccceeeeecCccc
Confidence 9999999977665 777899999999999999999999999999999999999999998 8999999999754
Q ss_pred -------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 966 -------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 966 -------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
+++|+|||++....+++.+||||+||+||.||.|++||... .+....+.......|. .+|.++.+||
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI 249 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI 249 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence 34568999999999999999999999999999999999876 5777888888777774 6999999999
Q ss_pred HHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1037 NNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.++|+.||.+|||+++||.|+||+.
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhhhC
Confidence 9999999999999999999999953
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=403.31 Aligned_cols=273 Identities=40% Similarity=0.727 Sum_probs=209.1
Q ss_pred eecccCCCCCcccceeEEeeeeeeeEeeccCCccc-cccccCCccchhhhhhhhhccccCCChhHHHhhhcccccccceE
Q psy48 92 ILGIEPCKPLTHELQQVQIRPHTLTVHSYKAPTFS-LKTIIPNHGLTRLLDRLMLFRHDYTYPNVLLIINAVSDIVDETV 170 (1098)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~h~~~~~~~~~p~f~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 170 (1098)
+.++++.+++.-++|.|.+..|.+++...|+-+.. ..-+||+|||++|||+|+||+||++|+||||+|+++.|+.+++|
T Consensus 48 ~~g~sf~lq~Gltre~V~l~~~e~~l~~v~~~a~s~v~q~~pe~G~~~~~dkilLfrHd~~S~niLqlitsasdI~eG~l 127 (888)
T KOG4236|consen 48 VGGVSFHLQIGLTRESVLLEAHEISLAHVRDMACSIVDQKFPECGFYGLYDKILLFRHDPNSENILQLITSASDITEGDL 127 (888)
T ss_pred CCceEEEEEecccccceeecchhhHHHHHHHHHHHHHHHhccCcCcccccceeEEEecCCCCcchheeeccccccccCce
Confidence 67788899999999999999999999999988876 77789999999999999999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccccCCCCCCcccccCCccccCCCCCcCCCCCcccCCCCCccCCCccCCCCCCCCCCCCCCCC
Q psy48 171 VEIVLAGCSLNFHKRCVVKIPNNCSSGYKHRRSSTLHVPHSTSETGSNSSIASDDSNYTSSSFSTKPSSRSPSLTSRTDA 250 (1098)
Q Consensus 171 ~g~~c~~C~~~~HKrC~~~i~~~C~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~ 250 (1098)
+++|...|-. . +.|
T Consensus 128 vEvvl~~~at-----------------------------------------~--------ed~----------------- 141 (888)
T KOG4236|consen 128 VEVVLSASAT-----------------------------------------F--------EDF----------------- 141 (888)
T ss_pred EEEEeecccc-----------------------------------------c--------cce-----------------
Confidence 9999844210 0 000
Q ss_pred CCCCCCCCCCCCCCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCCCCccCCCCCCccc
Q psy48 251 LSPTSPGAPSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPVTNNKSNNYCK 330 (1098)
Q Consensus 251 ~~~~~~~~~~~~~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~~~~~~~~~~~~~~ 330 (1098)
..+||...+|+|+.|||||+||++||||+|||+||..||+|.||||+.++|++|.|.-......
T Consensus 142 -----------~i~PH~l~vhSY~~PtFCD~CGEmL~GLvrQGlKC~gCglNyHKRCa~kipNNCsG~r~rr~sa----- 205 (888)
T KOG4236|consen 142 -----------QIRPHTLFVHSYKAPTFCDFCGEMLFGLVRQGLKCEGCGLNYHKRCAFKIPNNCSGVRKRRLSA----- 205 (888)
T ss_pred -----------eeecceeeeecccCchHHHHHHHHHHHHHHccccccCCCCcHhhhhhhcCCCCCCcccccCCCC-----
Confidence 1269999999999999999999999999999999999999999999999999996532111000
Q ss_pred cccccccccccccccccccccCCCCCCCCCCCCCCCCCCccCCCccceeecCCCChhhHHHHhhccccccccccccCCCC
Q psy48 331 LKSEVASLVSLESSASASYSCLVPKGEGRQDITNSELPQVKLCDFGFARIIGEKSFRRSILVALKHLHSKNIVHCDLKPE 410 (1098)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~DF~~lkVlGkGSfgKV~la~lk~LH~k~IihRDLK~d 410 (1098)
.++.++. +
T Consensus 206 --------~~l~~~~---------------------s------------------------------------------- 213 (888)
T KOG4236|consen 206 --------VSLQPSR---------------------S------------------------------------------- 213 (888)
T ss_pred --------CCCCCCC---------------------c-------------------------------------------
Confidence 0000000 0
Q ss_pred CccCCCCcccccCCCccchhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCchhhhhhhhhcccccCccccccCeEEeccCC
Q psy48 411 RNLFPTSSLEIKSNTEEEDEDEERGSTDGGGPSPRSEPRTATATPSNNIPLMRVVQSIKHTKRRGSKVIKEGWMIHYTSK 490 (1098)
Q Consensus 411 NvLld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 490 (1098)
|+ |. +....+.+.++..++++..+|+. .++....| ++-|..|++.
T Consensus 214 ~~-l~-----~s~~~p~~p~~~~~pst~~~~~~---~p~~~~~S----------------------~sgrpi~~ek---- 258 (888)
T KOG4236|consen 214 NR-LN-----LSPSSPLEPLLPARPSTELGGPR---EPSSAILS----------------------WSGRPIWMEK---- 258 (888)
T ss_pred cc-cc-----cCCCCCCCccccCCCcccccCCC---CCCccccc----------------------ccCCCchhhh----
Confidence 00 00 11223455666666666555552 11111111 3334444431
Q ss_pred CCCCCCCCCCCCCCCCCCcccCCCCCCCCCCCCCCCCcCceeeeeecCCCccccccccchhcccccceecCCCCcccccc
Q psy48 491 DSMSSSFSTKPSSRSPSLTSRTDALSPTSPGAPSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKK 570 (1098)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~ 570 (1098)
. .-...++||+|.+|.|++||.|.+|.++|.||+|||++|++|++|||+|
T Consensus 259 ~------------------------------~~~rvkvPHTf~vHSY~rpTVCq~CkkLLkGL~rQGlqCkDCk~NcHkr 308 (888)
T KOG4236|consen 259 M------------------------------LMSRVKVPHTFIVHSYTRPTVCQYCKKLLKGLFRQGLQCKDCKFNCHKR 308 (888)
T ss_pred h------------------------------hhhcccCCeeEEEeeccCchHHHHHHHHHHHHHhcCcccccCCcchhhh
Confidence 0 0112468999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCC
Q psy48 571 CLDKVPKDCVGEP 583 (1098)
Q Consensus 571 C~~~v~~~C~~~~ 583 (1098)
|..+||++|.++.
T Consensus 309 Ca~~v~~dClge~ 321 (888)
T KOG4236|consen 309 CAMKVPNDCLGEV 321 (888)
T ss_pred hhhhcccccccce
Confidence 9999999998764
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=374.40 Aligned_cols=261 Identities=30% Similarity=0.428 Sum_probs=224.4
Q ss_pred eeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEecc
Q psy48 816 YNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894 (1098)
Q Consensus 816 ~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ 894 (1098)
.-..||.|..|.||++..+.++..+|+|++.+..+. .....+++.|.+||..+.||+++.||+.|+++...|+|||||+
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 345789999999999999999999999999886654 3334778899999999999999999999999999999999999
Q ss_pred CchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--------
Q psy48 895 GDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-------- 965 (1098)
Q Consensus 895 ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-------- 965 (1098)
||+|..+.+.+ ...|++..+++|+++++.||+|||..|||+|||||+||||.++| ||-|+||.++..+
T Consensus 161 GGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG---HIMLsDFDLS~~~~~~Pt~~~ 237 (459)
T KOG0610|consen 161 GGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG---HIMLSDFDLSLRCPVSPTLVK 237 (459)
T ss_pred CccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC---cEEeeeccccccCCCCCeeec
Confidence 99997776644 45799999999999999999999999999999999999999999 9999999976311
Q ss_pred ---------------------------C-C--------------------------------CCCChhhhccCCCCchhH
Q psy48 966 ---------------------------G-E--------------------------------KSFPPEVLRNKGYNRSLD 985 (1098)
Q Consensus 966 ---------------------------~-~--------------------------------~~~APEvl~~~~ys~~sD 985 (1098)
. . .|+|||++.|...+.++|
T Consensus 238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVD 317 (459)
T KOG0610|consen 238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVD 317 (459)
T ss_pred cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhh
Confidence 0 0 124999999999999999
Q ss_pred HHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCC----HHHHHcCCCc
Q psy48 986 MWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS----VDKSLAHPWL 1059 (1098)
Q Consensus 986 VwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPS----a~eIL~HpfF 1059 (1098)
||+|||+|||||.|..||.+. ++....+......+|... .++..+++||+++|.+||.+|.+ ++||.+||||
T Consensus 318 WWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 318 WWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFF 395 (459)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhhcCccc
Confidence 999999999999999999865 344444444444555433 68899999999999999999998 9999999999
Q ss_pred CCCCCcchhHHHHhhhCCCCCCCcchh
Q psy48 1060 QDPATWSDLRGLERQIGTNKKKNPKRT 1086 (1098)
Q Consensus 1060 k~~~~~~~~~~l~~~~~~~~~~~~~~~ 1086 (1098)
+. ++|. |.+-..||+.+.+.+.
T Consensus 396 ~g----VnWa-Lir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 396 EG----VNWA-LIRCARPPEIPKPVDG 417 (459)
T ss_pred cC----CChh-heeccCCCcCCCcccc
Confidence 99 8888 7777888877666554
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=383.88 Aligned_cols=122 Identities=31% Similarity=0.700 Sum_probs=109.7
Q ss_pred EeeeeeeeEeeccCCccccccccCCccchhhhhhhhhccccCCChhHHHhhhcccccccceEEEEeeccCCccccccccc
Q psy48 109 QIRPHTLTVHSYKAPTFSLKTIIPNHGLTRLLDRLMLFRHDYTYPNVLLIINAVSDIVDETVVEIVLAGCSLNFHKRCVV 188 (1098)
Q Consensus 109 ~~~~h~~~~~~~~~p~f~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~g~~c~~C~~~~HKrC~~ 188 (1098)
.|..|.+.+.+||+||||-|| +-++|| +.+| |..|+.|.+|||||||+
T Consensus 42 evk~HkF~aRFFKqPTfCsHC------------kDFiwG-----------------fgKQ---GfQCqvC~fvvHkrChe 89 (683)
T KOG0696|consen 42 EVKSHKFIARFFKQPTFCSHC------------KDFIWG-----------------FGKQ---GFQCQVCCFVVHKRCHE 89 (683)
T ss_pred hhccceeeehhccCCchhhhh------------hhheec-----------------cccC---ceeeeEEeehhhhhhcc
Confidence 457899999999999999999 789999 9999 99999999999999999
Q ss_pred cccCCCCCCcccccCCccccCCCCCcCCCCCcccCCCCCccCCCccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCeee
Q psy48 189 KIPNNCSSGYKHRRSSTLHVPHSTSETGSNSSIASDDSNYTSSSFSTKPSSRSPSLTSRTDALSPTSPGAPSSVNIPHTF 268 (1098)
Q Consensus 189 ~i~~~C~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~H~f 268 (1098)
+|.+.|||+++. +.+++ ....|.|
T Consensus 90 fVtF~CPGadkg--------------------~dtDd------------------------------------pr~kHkf 113 (683)
T KOG0696|consen 90 FVTFSCPGADKG--------------------PDTDD------------------------------------PRSKHKF 113 (683)
T ss_pred eEEEECCCCCCC--------------------CCCCC------------------------------------cccccce
Confidence 999999987641 22221 2267999
Q ss_pred eeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCCC
Q psy48 269 NLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGE 318 (1098)
Q Consensus 269 ~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~~ 318 (1098)
..++|.+||||||||++|+|++.||+||..|.||||++|..+||+.|+.+
T Consensus 114 ~~~tYssPTFCDhCGsLLyGl~HQGmKC~~C~mNVH~rCv~nVPslCG~D 163 (683)
T KOG0696|consen 114 KIHTYSSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHHRCVENVPSLCGTD 163 (683)
T ss_pred eeeecCCCchhhhHHHHHHHHHhcccccccccchHHHHHhhcCCcccCCc
Confidence 99999999999999999999999999999999999999999999999654
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=369.26 Aligned_cols=250 Identities=34% Similarity=0.547 Sum_probs=222.5
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
..+.|.+...||.|.|+.||.+.++.++..||||.+.+........+.+..|+.+|+.++|||||+|++++.+++.+|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 45678888889999999999999999999999999998877788889999999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-CCC--CcEEEeecCcccccC
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN-SEL--PQVKLCDFGFARIIG 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~-g~~--~~vKL~DFGla~~~~ 966 (1098)
||||+||+|.++++ ..+.+++..++.++.||+.||++||+++||||||||+||||+.. +.. ..+||+|||+|+.+.
T Consensus 88 MEyC~gGDLs~yi~-~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIR-RRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEeCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999987 45589999999999999999999999999999999999999876 322 579999999998764
Q ss_pred C-----------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 967 E-----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 967 ~-----------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
+ -|||||++..+.|+.++|+||+|++||+|++|..||... .++...++......+. ....++....
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~-~~~~~s~~~~ 245 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV-LPAELSNPLR 245 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc-hhhhccCchh
Confidence 3 368999999999999999999999999999999999864 5666666655544433 2245677788
Q ss_pred HHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+++...+..+|..|.++.+-+.|+|...
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhhhhccc
Confidence 9999999999999999999999999975
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=363.54 Aligned_cols=257 Identities=32% Similarity=0.480 Sum_probs=227.5
Q ss_pred eeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEecc
Q psy48 816 YNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894 (1098)
Q Consensus 816 ~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ 894 (1098)
|-..||.|.||.|.+...+.+++.||||+++|+.+-. +.......|-++|+..+||++..|.-.|++.+++++||||++
T Consensus 172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyan 251 (516)
T KOG0690|consen 172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYAN 251 (516)
T ss_pred HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEcc
Confidence 3345677888899999999999999999999977644 344677889999999999999999999999999999999999
Q ss_pred CchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc----------
Q psy48 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI---------- 964 (1098)
Q Consensus 895 ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~---------- 964 (1098)
||.|..++. ....|++..+++|.++|+.||.|||+++||+||||.+|+|+|.+| +|||+|||+|+.
T Consensus 252 GGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG---HIKitDFGLCKE~I~~g~t~kT 327 (516)
T KOG0690|consen 252 GGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG---HIKITDFGLCKEEIKYGDTTKT 327 (516)
T ss_pred CceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC---ceEeeecccchhcccccceecc
Confidence 999966654 566799999999999999999999999999999999999999999 999999999963
Q ss_pred -c-CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 965 -I-GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 965 -~-~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
+ ++.|+|||++....|+.++|||.+||++|||++|+.||... +.+++.|......+| +.+++++..|+..+|
T Consensus 328 FCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP----r~ls~eAktLLsGLL 403 (516)
T KOG0690|consen 328 FCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP----RTLSPEAKTLLSGLL 403 (516)
T ss_pred ccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC----ccCCHHHHHHHHHHh
Confidence 2 34467999999999999999999999999999999999864 567888887777777 468999999999999
Q ss_pred hhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcc
Q psy48 1041 QVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPK 1084 (1098)
Q Consensus 1041 ~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~ 1084 (1098)
.+||.+|++ +.+|.+|+||.. +||++..++ +.|||+++-.
T Consensus 404 ~kdP~kRLGgGpdDakEi~~h~FF~~----v~W~~~~~Kki~PPfKPqVt 449 (516)
T KOG0690|consen 404 KKDPKKRLGGGPDDAKEIMRHRFFAS----VDWEATYRKKIEPPFKPQVT 449 (516)
T ss_pred hcChHhhcCCCchhHHHHHhhhhhcc----CCHHHHHHhccCCCCCCCcc
Confidence 999999985 689999999998 788877766 9999987643
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=373.70 Aligned_cols=273 Identities=28% Similarity=0.432 Sum_probs=241.2
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH-HHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
++.-.+||.|+||.|+....+.||+.||.|.+.|.++... .+....+|..+|.++..++||.|--.|++++.++|||..
T Consensus 187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtl 266 (591)
T KOG0986|consen 187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTL 266 (591)
T ss_pred eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEe
Confidence 3456789999999999999999999999999977655433 345678999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 893 LQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+||+|..++.+-. ..|++.++++|+++|+.||++||+++||+|||||+|||+|+.| +++|+|+|+|..+
T Consensus 267 MNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G---hvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 267 MNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG---HVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred ecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC---CeEeeccceEEecCCCCcc
Confidence 99999966655333 3699999999999999999999999999999999999999999 9999999999643
Q ss_pred -----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC------hhHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 966 -----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED------EDINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 -----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~------~~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
+..|||||++.+..|+++.|||||||+||||+.|+.||... +++.+.+......++ ...|+++.+
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~kFS~eaks 419 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----DKFSEEAKS 419 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----cccCHHHHH
Confidence 34579999999999999999999999999999999999643 344444444444444 578999999
Q ss_pred HHHHhhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcchhhhhhhhhhhcc
Q psy48 1035 LINNLLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPKRTAQLLSYQLTQM 1097 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1098)
+++.+|++||++|++ ++++.+||||++ +||..||.. +.||+.+.|+.++.++.++++||
T Consensus 420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~----lnw~rleagml~PPfiPdp~aVyakDv~DIeqF 484 (591)
T KOG0986|consen 420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD----LNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQF 484 (591)
T ss_pred HHHHHHccCHHHhccCCCcCcchhhhCccccc----CCHhHHhccCCCCCCCCCccccchhhhhhhhhc
Confidence 999999999999996 479999999999 999999999 99999999999999999999998
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=359.21 Aligned_cols=263 Identities=25% Similarity=0.379 Sum_probs=222.5
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
|.....||.|.||.||.+.+..+++.||||++.+..... .....+.+|+.+++.++|+||+++++++.+.+.+++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 456788999999999999999999999999997654322 2335678999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 893 LQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 893 ~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
+.+++|..++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG---HIRISDLGLAVQIPEGETV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC---CEEEeeCCCcEEcCCCCee
Confidence 9999997776533 34689999999999999999999999999999999999999888 8999999998643
Q ss_pred -----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 966 -----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 966 -----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
...|+|||++.+..|+.++|||||||++|||++|+.||....+ ....+..............++.++.+||.+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence 2346899999999999999999999999999999999986432 112222222222223345689999999999
Q ss_pred hhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCc
Q psy48 1039 LLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNP 1083 (1098)
Q Consensus 1039 cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~ 1083 (1098)
||+.||++||+ ++++++||||++ ++|+.++.+ ++||+++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h~~~~~----~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQHPIFKN----INFKRLEANMLEPPFCPDP 285 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcCHhhcC----CCHHHHHhCcCCcCCCCCC
Confidence 99999999997 899999999999 889999998 888988764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=378.13 Aligned_cols=250 Identities=32% Similarity=0.549 Sum_probs=223.9
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEecc-CCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKL-RFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~-~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
..+=++.+..||.|.-|.|-.|.|..||+.+|||++.+. .........+.+|+.+|+.+.|||+++||+.|.++.++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 345578899999999999999999999999999999876 4555666889999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
|.||++||-|.+++. ..++|++.+++++++||+.|+.|+|..+|+||||||+|+|||..+ .|||+|||||...
T Consensus 90 vlEyv~gGELFdylv-~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~---nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLV-RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN---NIKIADFGMASLEVPG 165 (786)
T ss_pred EEEecCCchhHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc---CEeeeccceeecccCC
Confidence 999999999988886 567899999999999999999999999999999999999999998 7999999999643
Q ss_pred -------C-CCCCChhhhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 966 -------G-EKSFPPEVLRNKGYN-RSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 -------~-~~~~APEvl~~~~ys-~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
| +.|.|||++.|.+|. .++||||-|||||.||||..||+++ ..+...++...+..| .++|.++++
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQd 241 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQD 241 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHH
Confidence 2 235699999999985 8999999999999999999999965 355666677777766 579999999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCCCCCcch
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQDPATWSD 1067 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~ 1067 (1098)
||.+||+.||++|.|.++|++|||++.+.....
T Consensus 242 LLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 242 LLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred HHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence 999999999999999999999999998665444
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.73 Aligned_cols=244 Identities=26% Similarity=0.404 Sum_probs=208.4
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|..-..+|.|.||.|+...++.||+.||||.+.....++...+..++|+++|++++|+|+|.|+++|..+..+++|+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 44456789999999999999999999999999765545555677899999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC------
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE------ 967 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~------ 967 (1098)
+...|..+-. ....++...+..|++|++.|+.|+|++++|||||||+||||..+| .+||+|||+|+.+..
T Consensus 84 dhTvL~eLe~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g---vvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 84 DHTVLHELER-YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG---VVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred chHHHHHHHh-ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC---cEEeccchhhHhhcCCcchhh
Confidence 9998865543 445689999999999999999999999999999999999999999 999999999987652
Q ss_pred ------CCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccC--------------------
Q psy48 968 ------KSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY-------------------- 1020 (1098)
Q Consensus 968 ------~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~-------------------- 1020 (1098)
.|.|||.+.| -+|+..+||||+||++.||++|++.|.+..++.+.........
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 2359999988 7899999999999999999999999998876655442221110
Q ss_pred -CC--------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1021 -PP--------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1021 -p~--------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
|. ..+.+++.-+.+|+++||..||++|++.++++.|+||.+
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 00 012356778999999999999999999999999999954
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=367.38 Aligned_cols=214 Identities=25% Similarity=0.428 Sum_probs=186.3
Q ss_pred eEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC-cEEEEEEeccCchHHHHHhh-ccCccchhHHHHH
Q psy48 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG-RIFVVMEKLQGDMLEMILSS-EKGRLSERTTKFI 917 (1098)
Q Consensus 840 VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~-~l~LVmEy~~ggsL~~~l~~-~~~~lse~~~~~i 917 (1098)
||||++.....+......|.+|+.+|.+++|||||+++|++.... .+++||||+++|+|..+++. ....++...++.+
T Consensus 68 vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~ 147 (362)
T KOG0192|consen 68 VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRI 147 (362)
T ss_pred EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHH
Confidence 999999876666666789999999999999999999999999887 79999999999999999987 3778999999999
Q ss_pred HHHHHHHHHHHHhCC-ccccCCCCCceeecCCCCCCcEEEeecCcccccC------------CCCCChhhhc--cCCCCc
Q psy48 918 ITQILVALKHLHSKN-IVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------------EKSFPPEVLR--NKGYNR 982 (1098)
Q Consensus 918 a~qIa~gL~~LHs~g-IvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------------~~~~APEvl~--~~~ys~ 982 (1098)
+.||+.||.|||+++ ||||||||+|||++.++. ++||+|||+++... ..|||||++. ...|+.
T Consensus 148 aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~--~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~ 225 (362)
T KOG0192|consen 148 ALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGK--TLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTE 225 (362)
T ss_pred HHHHHHHHHHHhcCCCeeecccChhhEEEcCCCC--EEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCc
Confidence 999999999999999 999999999999998852 89999999996443 2479999999 569999
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 983 SLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 983 ~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
++|||||||+||||+||+.||.+................+.....+++.+..++.+||..||++||++.+|+.
T Consensus 226 K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 226 KSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred cchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999999877633222232233334444568999999999999999999999988875
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=368.52 Aligned_cols=245 Identities=36% Similarity=0.632 Sum_probs=216.5
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC---hHHHHHHHHHHHHHhccC-CCCceeeeeeeecCC
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP---TKQEAQLKNEVAILQNLC-HPGVVNLERMFETPG 884 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~---~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~ 884 (1098)
...+.|.....||.|.||.|+.+.+..+++.||||++.+.... ......+.+|+.+++.++ ||||++++.++.+..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3467899999999999999999999999999999988775322 123467789999999999 999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-CCCCcEEEeecCccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN-SELPQVKLCDFGFAR 963 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~-g~~~~vKL~DFGla~ 963 (1098)
.+|+||||+.||.|.+++.. .+++.+..++++++||+.|++|||++||+||||||+|||++.+ + .+||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~---~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEG---NLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC---CEEEecccccc
Confidence 99999999999999999886 8899999999999999999999999999999999999999998 6 89999999997
Q ss_pred cc------------CCCCCChhhhccCC-CC-chhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCc
Q psy48 964 II------------GEKSFPPEVLRNKG-YN-RSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 964 ~~------------~~~~~APEvl~~~~-ys-~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~ 1027 (1098)
.. .+.|+|||++.+.. |+ .++||||+||+||.|++|..||.... .+...+....+.+|. .
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----~ 245 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----Y 245 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----C
Confidence 55 22357999999988 86 89999999999999999999998754 344445555555553 3
Q ss_pred C-cHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1028 I-SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1028 i-s~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+ |+++.+|+.+||..||.+|+++.+|++||||+.
T Consensus 246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 246 LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 5 999999999999999999999999999999997
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=365.38 Aligned_cols=247 Identities=30% Similarity=0.427 Sum_probs=209.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCC-cEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPG-RIFV 888 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~-~l~L 888 (1098)
..+|+....+|-|+||.||+|+.+.+|+.||||.+++....- ++..-.+|+..|+++. ||||++|.+.+.+.+ .+||
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 456777788999999999999999999999999998876653 3444568999999998 999999999998887 8999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
|||||+.. |+.++..+...|++..++.|+.||++||+|+|.+|+.||||||+|||+.... .|||+|||+|+.+.
T Consensus 88 VfE~Md~N-LYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~---~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMDCN-LYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND---VIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhhhh-HHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc---eeEecccccccccccC
Confidence 99999876 4467776788899999999999999999999999999999999999999665 79999999998652
Q ss_pred ---------CCCCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHh--------------------
Q psy48 967 ---------EKSFPPEVLR-NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNA-------------------- 1016 (1098)
Q Consensus 967 ---------~~~~APEvl~-~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~-------------------- 1016 (1098)
..|.|||++. ..-|+..+|+||+||+++|+++-++.|.+..++.+..+.-
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 2346999985 6679999999999999999999999998876655443322
Q ss_pred -hccCCCCC-------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1017 -AFMYPPRP-------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1017 -~~~~p~~~-------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.+.+|.-. ....+.++.++|.+|+.+||++||||.++++||||+..
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 22222211 23468899999999999999999999999999999863
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=361.29 Aligned_cols=251 Identities=28% Similarity=0.440 Sum_probs=214.6
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCch
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDM 897 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggs 897 (1098)
.||.|.||.||.+.++.+|+.||||++++... .......+.+|+.+++.++||||+++++++...+.+++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 58999999999999999999999999986432 23344678899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------------
Q psy48 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------------ 965 (1098)
Q Consensus 898 L~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------------ 965 (1098)
|..++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 82 LFFHLS-RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG---HIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred HHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC---CEEEeeCCCCcccccCCCcccceec
Confidence 988876 345789999999999999999999999999999999999999988 8999999998642
Q ss_pred CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhc
Q psy48 966 GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVK 1043 (1098)
Q Consensus 966 ~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~d 1043 (1098)
+..|+|||++.+..|+.++|||||||++|||++|..||...+. ....+..... ..+..+++++.+||.+||+.|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~----~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI----RFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC----CCCCCCCHHHHHHHHHHccCC
Confidence 2346899999999999999999999999999999999976532 2233332222 223568999999999999999
Q ss_pred ccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1044 QRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1044 P~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
|++|| ++.++++||||+. .+|+.+..+ +.+|+.+
T Consensus 234 P~~R~~~~~~~~~~ll~h~~f~~----~~~~~~~~~~~~~~~~~ 273 (323)
T cd05571 234 PKQRLGGGPEDAKEIMEHRFFAS----INWQDVVQKKLEPPFKP 273 (323)
T ss_pred HHHcCCCCCCCHHHHHcCCCcCC----CCHHHHHhCCCCCCcCC
Confidence 99999 8999999999998 577777766 6566543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=368.76 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=226.2
Q ss_pred HHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 808 LLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 808 ~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
..-..+|.....+|.|.-|+||.|....+++.||||.+.... ....+.+.+|+.+|+..+|+|||.++..|...+.++
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 344567788889999999999999999999999999997654 333577899999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-- 965 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-- 965 (1098)
+||||++||+|.++.. ...++|.++..+.+++++||+|||.+||+|||||.+|||++.+| .+||+|||+|..+
T Consensus 347 VVMEym~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g---~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG---SVKLTDFGFCAQISE 421 (550)
T ss_pred EEEeecCCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC---cEEEeeeeeeecccc
Confidence 9999999999988875 34599999999999999999999999999999999999999999 7999999998643
Q ss_pred ----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccC-CCCCCCcCcHHHHH
Q psy48 966 ----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY-PPRPWRDISSDAID 1034 (1098)
Q Consensus 966 ----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~-p~~~~~~is~el~~ 1034 (1098)
++.|||||++..+.|++++||||||++++||+-|++||..+..+........-.. ....+..+|+++++
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence 3446999999999999999999999999999999999998776655544443333 33446689999999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
||.+||+.|+++|+++.++|+||||+......+|..|...
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~pLi~~ 541 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPFLKMAKPESSLNPLILA 541 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChhhhhcCCHHHhHHHHHH
Confidence 9999999999999999999999999876666666555443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=357.62 Aligned_cols=257 Identities=31% Similarity=0.500 Sum_probs=218.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
...|.+...||.|.+|.||.+.++.+++.||||++++... .......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 3567889999999999999999999999999999976432 223346789999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||+.|++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 97 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG---HVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC---CEEEeeccCceEcCCCc
Confidence 999999999888764 45789999999999999999999999999999999999999998 89999999987542
Q ss_pred ------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 967 ------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 967 ------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
..|+|||++.+..++.++|||||||++|||++|..||.+... ..+.+......+ ...++.++.+||.+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~----p~~~~~~~~~li~~ 248 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF----PNWFDGRARDLVKG 248 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCC----CCCCCHHHHHHHHH
Confidence 236799999999999999999999999999999999986543 223333332222 23588999999999
Q ss_pred hhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCC
Q psy48 1039 LLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNK 1079 (1098)
Q Consensus 1039 cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~ 1079 (1098)
||+.||.+|++ +++++.||||++ .+|+.+..+ +.+|.
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~----~~~~~~~~~~~~~~~ 291 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNHPYFHG----ANWDKLYARYYPAPI 291 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCccCC----CCHHHHHhCCCCCCc
Confidence 99999999997 799999999998 566666655 44443
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=356.42 Aligned_cols=245 Identities=29% Similarity=0.441 Sum_probs=208.4
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC--cEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG--RIFVV 889 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~--~l~LV 889 (1098)
..+.....||.|.||.|+.+.+.++|+..|||.+.... ....+.+.+|+.+|.+++|||||++++...... .++++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 34667888999999999999999999999999997652 222677999999999999999999999865555 69999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCCCCcEEEeecCcccccC--
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST-NSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~-~g~~~~vKL~DFGla~~~~-- 966 (1098)
|||+++|+|..++....++|++..++++++||++||.|||++|||||||||+|||++. ++ .+||+|||+++...
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~---~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG---DVKLADFGLAKKLESK 171 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC---eEEeccCccccccccc
Confidence 9999999999998866668999999999999999999999999999999999999999 67 89999999886443
Q ss_pred -------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC-hhHHHHHHHhhccCCCCCCCcCcHH
Q psy48 967 -------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNED-EDINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 967 -------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~-~~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
+.|||||++.+ ....+++|||||||++.||+||..||... ......+........+..+..+|.+
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~ 251 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDE 251 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHH
Confidence 23589999995 33446999999999999999999999873 3333333333333333556779999
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+.+||.+|+..||++||||+++|+|||.+.
T Consensus 252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 252 AKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 999999999999999999999999999987
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=356.17 Aligned_cols=241 Identities=25% Similarity=0.415 Sum_probs=209.5
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcEEEEEEecc
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRIFVVMEKLQ 894 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l~LVmEy~~ 894 (1098)
...||.|+||.||.|.+..+|+.||+|.++.+...........+||.||+++.||||++|.+..... ..+|+|+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 4579999999999999999999999999998877777778889999999999999999999998777 68999999998
Q ss_pred CchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCC------
Q psy48 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK------ 968 (1098)
Q Consensus 895 ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~------ 968 (1098)
.++. -++....-.|++.++..|+.||+.||.|+|.+||+|||||..|||||.+| .+||+|||||+++...
T Consensus 202 hDL~-GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G---~LKiaDFGLAr~y~~~~~~~~T 277 (560)
T KOG0600|consen 202 HDLS-GLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG---VLKIADFGLARFYTPSGSAPYT 277 (560)
T ss_pred chhh-hhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC---CEEeccccceeeccCCCCcccc
Confidence 7654 67766677899999999999999999999999999999999999999999 8999999999865332
Q ss_pred -------CCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc--CCCCCC-------------
Q psy48 969 -------SFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM--YPPRPW------------- 1025 (1098)
Q Consensus 969 -------~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~--~p~~~~------------- 1025 (1098)
|.|||++.|. .|+.++|+||.||||.||++|++.|.+..++.+.-...... .....|
T Consensus 278 ~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp 357 (560)
T KOG0600|consen 278 SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKP 357 (560)
T ss_pred cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCC
Confidence 3599999874 59999999999999999999999999987765543322221 111112
Q ss_pred ------------CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1026 ------------RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1026 ------------~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..++..+.+|+..||..||.+|.|+.++|+++||..
T Consensus 358 ~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 358 QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 246788999999999999999999999999999954
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=358.65 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=210.9
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.....||.|.+|.||.+.+..+++.||||++++.... ......+.+|+.++..++|+||+++++.+.+...+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 467788999999999999999999999999999764322 2334678899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|++|++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 82 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~---~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 82 FLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG---HVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC---CEEEeeccCcccccccccc
Confidence 9999999888764 45799999999999999999999999999999999999999988 8999999998532
Q ss_pred -----------------------------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q psy48 966 -----------------------------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFN 1004 (1098)
Q Consensus 966 -----------------------------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~ 1004 (1098)
+..|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 224689999999999999999999999999999999998
Q ss_pred CChh--HHHHHHHhh--ccCCCCCCCcCcHHHHHHHHHhhhhccc---CCCCHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1005 EDED--INEQIQNAA--FMYPPRPWRDISSDAIDLINNLLQVKQR---KRLSVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1005 ~~~~--~~~~i~~~~--~~~p~~~~~~is~el~~LL~~cL~~dP~---kRPSa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
+... ....+.... ..+|. ...+++++.++|.+|+. +|. .||++++|++||||++ .+|+.+..+
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~----~~~~~~~~~ 307 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPP--EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG----VDWEHIRER 307 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCC--cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC----CCHHHHHhC
Confidence 6543 333333221 22232 23478999999999775 444 4589999999999998 677777655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=350.22 Aligned_cols=254 Identities=31% Similarity=0.490 Sum_probs=215.6
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.+...||.|.+|.||.+.+..+++.||||+++..... ......+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 467788999999999999999999999999999764322 2345678899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+.+++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~---~~kl~Dfg~~~~~~~~~~~ 157 (291)
T cd05612 82 YVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG---HIKLTDFGFAKKLRDRTWT 157 (291)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC---CEEEEecCcchhccCCccc
Confidence 9999999888764 45789999999999999999999999999999999999999988 8999999998743
Q ss_pred ---CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 966 ---GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 966 ---~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
...|+|||++.+..++.++|||||||++|+|++|..||.+... ..+.+......+ ...++..+.+||++||
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l 233 (291)
T cd05612 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF----PRHLDLYAKDLIKKLL 233 (291)
T ss_pred ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCC----CccCCHHHHHHHHHHc
Confidence 2346899999999999999999999999999999999986543 333333333222 2457899999999999
Q ss_pred hhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCC
Q psy48 1041 QVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTN 1078 (1098)
Q Consensus 1041 ~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~ 1078 (1098)
+.||.+|++ ++++++||||+. .+|..+..+ ..+|
T Consensus 234 ~~dp~~R~~~~~~~~~~~l~h~~~~~----~~~~~~~~~~~~~~ 273 (291)
T cd05612 234 VVDRTRRLGNMKNGADDVKNHRWFKS----VDWDDVPQRKLKPP 273 (291)
T ss_pred CCCHHHccCCccCCHHHHhcCccccC----CCHHHHhcCCCCCC
Confidence 999999995 999999999997 555555555 4443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=331.38 Aligned_cols=251 Identities=29% Similarity=0.418 Sum_probs=216.9
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
+|.....+|.|.||.||.|.+..+|+.||||.++.....+.......+|+..|+.++|+||+.|+++|...+.+.||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 45667789999999999999999999999999998776666667888999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCC----
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK---- 968 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~---- 968 (1098)
++ .+|+..++.+...|+..++..|+.++++||+|||++.|+||||||+|+|++++| .+||+|||+|+.++.+
T Consensus 83 m~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g---~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG---QLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred cc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC---cEEeecccchhccCCCCccc
Confidence 96 458888888888999999999999999999999999999999999999999999 9999999999877543
Q ss_pred --------CCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc--CCCCCC------------
Q psy48 969 --------SFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM--YPPRPW------------ 1025 (1098)
Q Consensus 969 --------~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~--~p~~~~------------ 1025 (1098)
|.|||++.| +.|+..+|+||.||++.||+.|.+-|.++.++.+.-...... ..++.|
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 359999986 569999999999999999999999998887765543322211 111122
Q ss_pred ------------CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcch
Q psy48 1026 ------------RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSD 1067 (1098)
Q Consensus 1026 ------------~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~ 1067 (1098)
...+.++.+|+.+||.+||.+|+++.|+++|+||+.......
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP 292 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence 234678999999999999999999999999999997544444
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=352.40 Aligned_cols=252 Identities=31% Similarity=0.473 Sum_probs=212.7
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|.+|.||.+.++.+++.||||++++... .......+..|+.++..+ +||||+++++++.+.+.+|+||||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 58999999999999999999999999976432 223346677888888766 6999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||+++..
T Consensus 82 ~L~~~i~-~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~---~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 82 DLMFHIQ-KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG---HCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred hHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC---cEEEeeCCCCeecCcCCCcccccc
Confidence 9987775 445799999999999999999999999999999999999999998 8999999997642
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
+..|+|||++.+..++.++|||||||++|+|++|+.||..... ..+.+....... ...++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY----PTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHccc
Confidence 2346899999999999999999999999999999999986543 333333322222 245889999999999999
Q ss_pred cccCCCCH------HHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCC
Q psy48 1043 KQRKRLSV------DKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKN 1082 (1098)
Q Consensus 1043 dP~kRPSa------~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~ 1082 (1098)
||++||++ +++++||||++ .+|+.+.++ +.+|+.+.
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f~~----~~~~~~~~~~~~~~~~~~ 276 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFFKE----LDWEKLNRRQIEPPFRPR 276 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCcCC----CCHHHHHhCCCCCCcCCC
Confidence 99999998 89999999998 677777776 66665433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=359.79 Aligned_cols=240 Identities=32% Similarity=0.504 Sum_probs=215.4
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|-....+|.|.||.||.+..+.+.+.||+|.+.|......+...+.+|+++++.++||||+.++++|++..++++|+||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 33445689999999999999999999999999998878888899999999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--------
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-------- 965 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-------- 965 (1098)
.| +|..++. ..+.++++.++.++.+++.||.|||+.+|+|||+||.|||++.++ ++|++|||+|+..
T Consensus 84 ~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~---~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 84 VG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG---TLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC---ceeechhhhhhhcccCceeee
Confidence 98 7777776 567899999999999999999999999999999999999999999 9999999999854
Q ss_pred ----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 966 ----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 966 ----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
++-|||||++.+++|+..+|+|||||++|||++|++||.... .+.+.|......+| ..++.++.+||..+
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p----~~~S~~f~nfl~gL 234 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP----STASSSFVNFLQGL 234 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc----ccccHHHHHHHHHH
Confidence 334689999999999999999999999999999999998653 44444444433333 47899999999999
Q ss_pred hhhcccCCCCHHHHHcCCCcCCC
Q psy48 1040 LQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
|.+||.+|.+-.+++.|||.+..
T Consensus 235 L~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 235 LIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hhcChhhcccHHHHhcChHHhhh
Confidence 99999999999999999999974
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=352.64 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=218.2
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.+...||.|.+|.||.+.+..+++.||||++++.... ......+.+|+.++..++||||+++++++...+.+|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 477889999999999999999999999999999865332 2334678899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|++|++|..++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 82 ~~~g~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kL~Dfg~a~~~~~~~~~ 157 (333)
T cd05600 82 YVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG---HIKLTDFGLSKGIVTYANS 157 (333)
T ss_pred CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC---CEEEEeCcCCcccccccCC
Confidence 999999988886 345789999999999999999999999999999999999999988 8999999998643
Q ss_pred ---CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCC----CcCcHHHHHHH
Q psy48 966 ---GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPW----RDISSDAIDLI 1036 (1098)
Q Consensus 966 ---~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~----~~is~el~~LL 1036 (1098)
+..|+|||++.+..++.++|||||||++|||++|..||.... +....+...........+ ..++.++.++|
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li 237 (333)
T cd05600 158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237 (333)
T ss_pred cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence 234689999999999999999999999999999999998653 333333332221111111 25689999999
Q ss_pred HHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHHHHhhhCCCCCC
Q psy48 1037 NNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQIGTNKKK 1081 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~~~~~~~~~~ 1081 (1098)
.+||..+|++||++.++++||||++ .+|+.+. +..+|+.+
T Consensus 238 ~~~l~~~~~rr~s~~~ll~h~~~~~----~~~~~~~-~~~~~~~~ 277 (333)
T cd05600 238 TKLINDPSRRFGSLEDIKNHPFFKE----VDWNELR-ELKPPFVP 277 (333)
T ss_pred HHHhhChhhhcCCHHHHHhCcccCC----CCHHHHh-hCCCCCCC
Confidence 9999999999999999999999998 5666665 44455433
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=357.56 Aligned_cols=253 Identities=28% Similarity=0.441 Sum_probs=213.9
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.....||.|.+|.||.+.+..+++.||||++++... .......+.+|+.++..++||||++++++|.+.+.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 46778899999999999999999999999999986432 23344678899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+.|++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||+++..
T Consensus 82 ~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~---~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 82 YLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG---HIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC---CEEEeecccceeccccccc
Confidence 9999999888764 45799999999999999999999999999999999999999998 8999999998532
Q ss_pred --------------------------------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCC
Q psy48 966 --------------------------------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001 (1098)
Q Consensus 966 --------------------------------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~ 1001 (1098)
+..|+|||++.+..++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 234689999999999999999999999999999999
Q ss_pred CCCCChhHH--HHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCC---HHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1002 PFNEDEDIN--EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS---VDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1002 Pf~~~~~~~--~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPS---a~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
||....... ..+..............+++++.++|.+||. +|.+|++ +.++++||||++ .+|+.+..+
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~----~~~~~~~~~ 310 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG----VDWEHIRER 310 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC----CCHHHHhhc
Confidence 998764332 2222222112211223578999999999997 9999998 999999999998 567766655
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=343.42 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=221.2
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH-HHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
|.....||.|.+|.||.+.+..+++.||||++.+...... ....+.+|+.+++.++|+||+++++++.+.+.+++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 5567889999999999999999999999999976433222 235678899999999999999999999999999999999
Q ss_pred ccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 893 LQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 893 ~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
+.+++|..++... ...+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG---HIRISDLGLAVEIPEGETI 158 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC---CEEEeeCCCceecCCCCcc
Confidence 9999998777543 34699999999999999999999999999999999999999888 8999999998753
Q ss_pred -----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 966 -----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 966 -----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
...++|||++.+..++.++||||+||++|||++|+.||.+... ..+.+.......+...+..++..+.+||.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence 2246799999999999999999999999999999999986532 112222222222233345688999999999
Q ss_pred hhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCc
Q psy48 1039 LLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNP 1083 (1098)
Q Consensus 1039 cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~ 1083 (1098)
||..||++|| +++++++||||+. .+|++++++ +.||+++.|
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAHPFFRT----ANFKRLEAGMLEPPFCPDP 285 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcCcCccC----CCHHHHhhCCCCCCCCCCC
Confidence 9999999999 8999999999998 788888888 777877754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=354.70 Aligned_cols=263 Identities=27% Similarity=0.451 Sum_probs=221.2
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCC-ceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSG-RGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg-~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
....|.+...||.|.+|.||.+.++.++ ..||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.++
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3456888999999999999999977665 6899999976432 2334467889999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
+||||+.+++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 108 lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~---~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG---FIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC---CEEEecCCCCeecCC
Confidence 99999999999888763 45799999999999999999999999999999999999999988 89999999987542
Q ss_pred --------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 967 --------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 967 --------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
..|+|||++.+..++.++|||||||++|||++|..||...... .+.+......+| ..+++++.++|
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li 259 (340)
T PTZ00426 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKHLM 259 (340)
T ss_pred CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHH
Confidence 2468999999999999999999999999999999999876433 333333332222 45789999999
Q ss_pred HHhhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcc
Q psy48 1037 NNLLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPK 1084 (1098)
Q Consensus 1037 ~~cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~ 1084 (1098)
++||+.||++|+ +++++++||||++ .+|..+..+ +.+|+.+..+
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~----~~~~~~~~~~~~~~~~p~~~ 309 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGN----IDWVSLLHKNVEVPYKPKYK 309 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHcCCCcCC----CCHHHHHhCCCCCCcCCCCC
Confidence 999999999995 8999999999998 566666666 6666655443
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=350.47 Aligned_cols=249 Identities=28% Similarity=0.479 Sum_probs=211.1
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchH
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDML 898 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL 898 (1098)
||.|+||.||.+.+..+++.||+|++++... .......+.+|+.++..++||||+++++++...+.+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 5889999999999999999999999976432 233456788999999999999999999999999999999999999999
Q ss_pred HHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------------C
Q psy48 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------------G 966 (1098)
Q Consensus 899 ~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------------~ 966 (1098)
..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++.. +
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG---HIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC---cEEEEECcccccCccCCCccccccCC
Confidence 888764 45799999999999999999999999999999999999999988 8999999998642 2
Q ss_pred CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcc
Q psy48 967 EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQ 1044 (1098)
Q Consensus 967 ~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP 1044 (1098)
..|+|||++.+..++.++|||||||++|||++|..||..... ..+.+.. .+...+..+++++.++|.+||+.||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----EPLRFPDGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc----CCCCCCCcCCHHHHHHHHHHcCCCH
Confidence 346899999999999999999999999999999999976532 2222222 2233345688999999999999999
Q ss_pred cCCC---CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCC
Q psy48 1045 RKRL---SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKK 1080 (1098)
Q Consensus 1045 ~kRP---Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~ 1080 (1098)
++|| ++.+++.||||++ .++..+..+ +.+++.
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~----~~~~~~~~~~~~~~~~ 268 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQ----LSWKKLLMKGIQPPFK 268 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCC----CCHHHHHhCCCCCCcC
Confidence 9997 5799999999998 466666655 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=352.62 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=209.9
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|.+|.||.+.+..+++.||||++++..... .....+.+|+.++..+ +||||++++++|.+.+.+|+||||++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 5899999999999999999999999998754332 3346688999999888 6999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~---~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 82 DLMFHMQ-RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG---HIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC---CEEECcCccccccccCCCcccccc
Confidence 9977765 346799999999999999999999999999999999999999988 8999999998631
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-------hhHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED-------EDINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~-------~~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
+..|+|||++.+..++.++|||||||++|+|++|+.||... ....+.+...........+..++.++.++|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 23468999999999999999999999999999999999621 1111112111112222233468899999999
Q ss_pred HhhhhcccCCCC------HHHHHcCCCcCCCCCcchhHHHHhh-hCCCC
Q psy48 1038 NLLQVKQRKRLS------VDKSLAHPWLQDPATWSDLRGLERQ-IGTNK 1079 (1098)
Q Consensus 1038 ~cL~~dP~kRPS------a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~ 1079 (1098)
+||+.||.+|++ ++++++||||++ .+|..++.+ +.+++
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~----~~~~~~~~~~~~~~~ 282 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN----IDWDLLEQKQVLPPY 282 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC----CCHHHHHhCCCCCCc
Confidence 999999999997 789999999988 567777665 55554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=351.08 Aligned_cols=251 Identities=27% Similarity=0.447 Sum_probs=212.2
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|++|.||.+.+..+++.||||++++... .......+..|..++..+ +||||++++++|.+.+.+++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 58999999999999999999999999986533 233446677888888765 7999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 82 ~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~---~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 82 DLMFQIQ-RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG---HCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC---CEEEeecccceecccCCccccccc
Confidence 9987775 445799999999999999999999999999999999999999998 8999999998642
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
...|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+......+| ..++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcc
Confidence 2346899999999999999999999999999999999986543 3333333322222 34789999999999999
Q ss_pred cccCCC-------CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1043 KQRKRL-------SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1043 dP~kRP-------Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
||++|+ ++.++++||||.. .+|+.++.+ +.+|+.+
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~----~~~~~~~~~~~~~~~~~ 276 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKE----IDWVLLEQRKIKPPFKP 276 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCC----CCHHHHHhCCCCCCCCC
Confidence 999999 8999999999988 677777776 5555543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=358.20 Aligned_cols=260 Identities=26% Similarity=0.378 Sum_probs=213.5
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.....||.|.||.||.+.+..+++.||||++++... .......+.+|+.+++.++|+||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 46678899999999999999999999999999976543 23445778999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc-------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI------- 964 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~------- 964 (1098)
|++|++|..++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++ ++||+|||+++.
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~---~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG---HIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC---CEEEeeCcCCccccccccc
Confidence 9999999888764 45689999999999999999999999999999999999999988 899999998642
Q ss_pred ----------------------------------------------------cCCCCCChhhhccCCCCchhHHHHHHHH
Q psy48 965 ----------------------------------------------------IGEKSFPPEVLRNKGYNRSLDMWSVGVI 992 (1098)
Q Consensus 965 ----------------------------------------------------~~~~~~APEvl~~~~ys~~sDVwSLGvl 992 (1098)
.+..|+|||++.+..|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 1234689999999999999999999999
Q ss_pred HHHHHcCCCCCCCChhHHH--HHHHhhccCCCCCCCcCcHHHHHHHHHhhh--hcccCCCCHHHHHcCCCcCCCCCcchh
Q psy48 993 VYVSLSGTFPFNEDEDINE--QIQNAAFMYPPRPWRDISSDAIDLINNLLQ--VKQRKRLSVDKSLAHPWLQDPATWSDL 1068 (1098)
Q Consensus 993 LyELltG~~Pf~~~~~~~~--~i~~~~~~~p~~~~~~is~el~~LL~~cL~--~dP~kRPSa~eIL~HpfFk~~~~~~~~ 1068 (1098)
+|||++|..||........ .+...........+..+++++.+||.+|+. .++..|+++++++.||||++ .+|
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~----~~~ 313 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE----VDF 313 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC----CCh
Confidence 9999999999986543322 222222222222234689999999999654 45556999999999999998 455
Q ss_pred HHHHhhhCCCCC
Q psy48 1069 RGLERQIGTNKK 1080 (1098)
Q Consensus 1069 ~~l~~~~~~~~~ 1080 (1098)
....+...+|+.
T Consensus 314 ~~~~~~~~~~~~ 325 (381)
T cd05626 314 SSDIRTQPAPYV 325 (381)
T ss_pred hHHhhcCCCCcc
Confidence 554444444443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=359.25 Aligned_cols=258 Identities=28% Similarity=0.401 Sum_probs=215.1
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.....||.|.+|.||.+.+..+++.||||++.+... .......+.+|+.+++.++|+||+++++.|.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 46778899999999999999999999999999976432 23345678999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc-------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI------- 964 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~------- 964 (1098)
|+++++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||++..
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g---~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG---HIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---CEEEeECCCCccccccccc
Confidence 9999999888764 45789999999999999999999999999999999999999998 899999998641
Q ss_pred ----------------------------------------------------cCCCCCChhhhccCCCCchhHHHHHHHH
Q psy48 965 ----------------------------------------------------IGEKSFPPEVLRNKGYNRSLDMWSVGVI 992 (1098)
Q Consensus 965 ----------------------------------------------------~~~~~~APEvl~~~~ys~~sDVwSLGvl 992 (1098)
.+..|+|||++.+..|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 1234789999999999999999999999
Q ss_pred HHHHHcCCCCCCCChhHHHHHHHhh--ccCCCCCCCcCcHHHHHHHHHhhhhcccCCCC---HHHHHcCCCcCCCCCcch
Q psy48 993 VYVSLSGTFPFNEDEDINEQIQNAA--FMYPPRPWRDISSDAIDLINNLLQVKQRKRLS---VDKSLAHPWLQDPATWSD 1067 (1098)
Q Consensus 993 LyELltG~~Pf~~~~~~~~~i~~~~--~~~p~~~~~~is~el~~LL~~cL~~dP~kRPS---a~eIL~HpfFk~~~~~~~ 1067 (1098)
||||++|+.||.............. ...+......+++++.++|.+|+ .+|++|++ ++++++||||+. .+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~----~~ 312 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT----ID 312 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC----cC
Confidence 9999999999987654333322222 22222233568999999999976 59999997 999999999998 55
Q ss_pred hHHHHhhhCCCC
Q psy48 1068 LRGLERQIGTNK 1079 (1098)
Q Consensus 1068 ~~~l~~~~~~~~ 1079 (1098)
|.....+..+|+
T Consensus 313 ~~~~~~~~~~~~ 324 (382)
T cd05625 313 FSSDLRQQSAPY 324 (382)
T ss_pred hHHHHhcCCCCc
Confidence 655445544443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=341.96 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=212.2
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchH
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDML 898 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL 898 (1098)
||.|+||.||.+.++.+++.||||++.+..... .....+..|+.+++.++|+||+++.+++...+.+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 578999999999999999999999997654322 2335678899999999999999999999999999999999999999
Q ss_pred HHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----------
Q psy48 899 EMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------- 965 (1098)
Q Consensus 899 ~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---------- 965 (1098)
..++.. ....+++..+..++.||+.||+|||++||+||||||+||+++.++ .++|+|||++...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG---NVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEeeCccceecCCCCcccccc
Confidence 777643 234689999999999999999999999999999999999999888 8999999998643
Q ss_pred --CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhh
Q psy48 966 --GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041 (1098)
Q Consensus 966 --~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~ 1041 (1098)
...++|||++.+..++.++|+||||+++|||++|+.||..... ....+.......+...+..++.++.+++.+||+
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 1246899999999999999999999999999999999975422 111222222222333345689999999999999
Q ss_pred hcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1042 VKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1042 ~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
.||++|| +++++++||||+. .+|..++.. +.+|+.+
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~----~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD----LNWRQLEAGMLPPPFVP 279 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc----CCHhHHhhccCCCCCCC
Confidence 9999999 7899999999998 677888777 5556543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=360.09 Aligned_cols=258 Identities=27% Similarity=0.397 Sum_probs=215.9
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|++...||.|.+|.||.+.+..+++.||||++.+... .......+.+|+.+|+.++|+||+++++.|.+.+.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 47788999999999999999999999999999975432 12234678899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc-------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI------- 964 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~------- 964 (1098)
|+++++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||+|..
T Consensus 82 ~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~---~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG---HIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC---CEEEEeCCCCccccccccc
Confidence 9999999888864 45789999999999999999999999999999999999999988 899999999731
Q ss_pred ------------------------------------------------cCCCCCChhhhccCCCCchhHHHHHHHHHHHH
Q psy48 965 ------------------------------------------------IGEKSFPPEVLRNKGYNRSLDMWSVGVIVYVS 996 (1098)
Q Consensus 965 ------------------------------------------------~~~~~~APEvl~~~~ys~~sDVwSLGvlLyEL 996 (1098)
.+..|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 12347899999999999999999999999999
Q ss_pred HcCCCCCCCChhHH--HHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCC---CHHHHHcCCCcCCCCCcchhHHH
Q psy48 997 LSGTFPFNEDEDIN--EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL---SVDKSLAHPWLQDPATWSDLRGL 1071 (1098)
Q Consensus 997 ltG~~Pf~~~~~~~--~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRP---Sa~eIL~HpfFk~~~~~~~~~~l 1071 (1098)
++|..||....... ..+...........+..+++++.++|.+|+ .+|.+|+ ++.++++||||+. .+|..+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~----~~~~~~ 312 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG----IDFASL 312 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC----CCHHHH
Confidence 99999998764332 222222222232334568999999999976 5999999 9999999999998 566666
Q ss_pred HhhhCCCC
Q psy48 1072 ERQIGTNK 1079 (1098)
Q Consensus 1072 ~~~~~~~~ 1079 (1098)
.++..+|.
T Consensus 313 ~~~~~~~~ 320 (376)
T cd05598 313 IRRQKAPY 320 (376)
T ss_pred hhcCCCCC
Confidence 55544443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=350.56 Aligned_cols=250 Identities=27% Similarity=0.452 Sum_probs=211.9
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCch
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDM 897 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggs 897 (1098)
.||.|.||.||.+.+..+|+.||+|++++... .......+.+|+.+++.++||||++++++|...+.+++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 58999999999999999999999999986432 23344677889999999999999999999999999999999999999
Q ss_pred HHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------------
Q psy48 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------------ 965 (1098)
Q Consensus 898 L~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------------ 965 (1098)
|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 82 L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 82 LFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG---HIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred HHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC---CEEecccHHhccccCCCCccccccC
Confidence 977775 345799999999999999999999999999999999999999988 8999999987642
Q ss_pred CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhc
Q psy48 966 GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVK 1043 (1098)
Q Consensus 966 ~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~d 1043 (1098)
+..|+|||++.+..++.++|||||||++|||++|..||..... ....+......+ +..+++++.++|.+||..|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~----p~~~~~~~~~li~~~L~~d 233 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHccCC
Confidence 2346899999999999999999999999999999999976532 223332222222 3468999999999999999
Q ss_pred ccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCC
Q psy48 1044 QRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKK 1080 (1098)
Q Consensus 1044 P~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~ 1080 (1098)
|++|+ ++.++++|+||.. .+|..+..+ +.+|+.
T Consensus 234 P~~R~~~~~~~~~~~l~h~~~~~----~~~~~~~~~~~~~~~~ 272 (323)
T cd05595 234 PKQRLGGGPSDAKEVMEHRFFLS----INWQDVVQKKLLPPFK 272 (323)
T ss_pred HHHhCCCCCCCHHHHHcCCCcCC----CCHHHHHhCCCCCCcC
Confidence 99998 8999999999998 566666655 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=333.49 Aligned_cols=248 Identities=32% Similarity=0.556 Sum_probs=226.3
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|..-..||.|.|+-|+...++.+|+.+|+|++....+...+-+.+.+|+.|-+.++||||++|+..+...+..|+|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 35556778999999999999999999999999987777777778999999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------- 965 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------- 965 (1098)
+.|+.|-.-+.++ --+++..+-.+++||+.||.|+|.+||||||+||.|+|+-+.....-+||+|||+|..+
T Consensus 92 m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~ 170 (355)
T KOG0033|consen 92 VTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWH 170 (355)
T ss_pred ccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccc
Confidence 9999986555433 46899999999999999999999999999999999999987666668999999999654
Q ss_pred ----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 966 ----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 966 ----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
++.+||||++...+|+..+|||+-||+||-|+.|.+||.+. ..+++.+......++...|..+++++.+|+++|
T Consensus 171 G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrM 250 (355)
T KOG0033|consen 171 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRM 250 (355)
T ss_pred cccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHH
Confidence 34468999999999999999999999999999999999873 578999999999999999999999999999999
Q ss_pred hhhcccCCCCHHHHHcCCCcCC
Q psy48 1040 LQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
|..||.+|.|+.|.|+|||+++
T Consensus 251 L~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 251 LTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred hccChhhhccHHHHhCCchhcc
Confidence 9999999999999999999987
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=351.27 Aligned_cols=250 Identities=29% Similarity=0.446 Sum_probs=211.9
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCch
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDM 897 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggs 897 (1098)
.||.|++|.||.+.+..+++.||||++++... .......+.+|+.+++.++||||+++++++...+.+++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 58999999999999999999999999986533 23345678899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------------
Q psy48 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------------ 965 (1098)
Q Consensus 898 L~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------------ 965 (1098)
|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~---~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 82 LFFHLS-RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG---HIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred HHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC---cEEEecCcCCccCCCcccccccccC
Confidence 987775 345799999999999999999999999999999999999999988 8999999998642
Q ss_pred CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhc
Q psy48 966 GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVK 1043 (1098)
Q Consensus 966 ~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~d 1043 (1098)
+..|+|||++.+..++.++|||||||++|+|++|..||..... ....+..... ..+..++.++.++|.+||..|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~----~~p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI----KFPRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc----cCCCCCCHHHHHHHHHHcCCC
Confidence 2346899999999999999999999999999999999976532 2222222222 223468899999999999999
Q ss_pred ccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCC
Q psy48 1044 QRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKK 1080 (1098)
Q Consensus 1044 P~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~ 1080 (1098)
|++|+ ++.++++||||.. .+|..+.+. +.+|+.
T Consensus 234 P~~R~~~~~~~~~~il~h~~~~~----~~~~~~~~~~~~~~~~ 272 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRHSFFTG----VNWQDVYDKKLVPPFK 272 (328)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCC----CCHHHHHhCCCCCCcC
Confidence 99997 8999999999998 566666655 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=340.62 Aligned_cols=243 Identities=28% Similarity=0.438 Sum_probs=204.6
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|.+...||.|.+|.||.+.++.+++.||||+++...........+.+|+.+++.++||||+++++++...+.+++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 57788899999999999999999999999999987544444557788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------ 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------ 966 (1098)
++++++..+. .....+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus 82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 82 VEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC---cEEEeeccCccccccccccc
Confidence 9999886554 3445789999999999999999999999999999999999999888 89999999986432
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHH--HHhhc-------------------
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI--QNAAF------------------- 1018 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i--~~~~~------------------- 1018 (1098)
..++|||++.+..++.++|||||||++|||++|+.||.......... .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 23579999999999999999999999999999999998653322111 11000
Q ss_pred cCCC---------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1019 MYPP---------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1019 ~~p~---------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
..+. ..+..+|.++.+||.+||+.||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 0012368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=347.22 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=215.4
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCC-CCceeeeeeeecCCcEEEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCH-PGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~H-pnIv~L~~~f~~~~~l~LVmE 891 (1098)
|.+...||.|++|.||.+.+..+++.||||++++... .......+..|+.++..+.| ++|+.+++++...+.+|+|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 5678899999999999999999999999999986533 23345678889999998876 568889999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|++|++|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 82 ~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~---~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 82 YVNGGDLMYHIQ-QVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG---HIKIADFGMCKENIFGGKT 157 (324)
T ss_pred CCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC---CEEEeecCcceecCCCCCc
Confidence 999999987775 345789999999999999999999999999999999999999988 8999999998632
Q ss_pred ------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 966 ------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
...|+|||++.+..++.++|||||||++|||++|+.||.+... ....+..... ..+..++.++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~li~ 233 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV----SYPKSLSKEAVSICK 233 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----CCCCCCCHHHHHHHH
Confidence 3346899999999999999999999999999999999986543 3333333222 223468999999999
Q ss_pred HhhhhcccCCCCH-----HHHHcCCCcCCCCCcchhHHHHhh-hCCCCC
Q psy48 1038 NLLQVKQRKRLSV-----DKSLAHPWLQDPATWSDLRGLERQ-IGTNKK 1080 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa-----~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~ 1080 (1098)
+||..||.+|+++ +++++||||+. .+|..++.+ +.+|..
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~----~~~~~~~~~~~~~~~~ 278 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRR----IDWEKLERREIQPPFK 278 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCC----CCHHHHHhCCCCCCcc
Confidence 9999999999986 89999999998 677777766 555543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=352.73 Aligned_cols=251 Identities=29% Similarity=0.450 Sum_probs=213.8
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.....||.|++|.||.+.+..+++.||||++++..... .....+.+|+.++..++|+||+++++++.+.+.+++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 4778889999999999999999999999999998654322 445678999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
|+.+++|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~---~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG---HIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC---CEEeecCCCCccCcccCcc
Confidence 99999998888754 6799999999999999999999999999999999999999998 89999999986432
Q ss_pred ------------------------------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH-
Q psy48 967 ------------------------------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI- 1009 (1098)
Q Consensus 967 ------------------------------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~- 1009 (1098)
..|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2357999999999999999999999999999999999876432
Q ss_pred -HHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCC-HHHHHcCCCcCCCCCcchhHHHH
Q psy48 1010 -NEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS-VDKSLAHPWLQDPATWSDLRGLE 1072 (1098)
Q Consensus 1010 -~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPS-a~eIL~HpfFk~~~~~~~~~~l~ 1072 (1098)
...+..............+++++.++|.+||. ||.+|++ ++++++||||++ .+|+...
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~----~~~~~~~ 297 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG----IDWENLR 297 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC----CCHHHHh
Confidence 22232211112222223479999999999997 9999999 999999999998 5666655
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=349.60 Aligned_cols=258 Identities=25% Similarity=0.408 Sum_probs=214.7
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|.+|.||.+.+..+++.||||++++.... ......+.+|+.++..+ +||||+.+++++.+.+.+++||||++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 589999999999999999999999999875432 23346788999999887 6999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~L~~~~~-~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 82 DLMFHMQ-RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG---HIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC---CEEEeccccceeccCCCCceeccc
Confidence 9977765 345799999999999999999999999999999999999999998 8999999998642
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----hhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED-----EDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~-----~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
+..|+|||++.+..++.++|||||||+||||++|..||... ....+.+.......+...+..++..+.++|.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 23467999999999999999999999999999999999531 111122222222233334456889999999999
Q ss_pred hhhcccCCCC------HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcc
Q psy48 1040 LQVKQRKRLS------VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPK 1084 (1098)
Q Consensus 1040 L~~dP~kRPS------a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~ 1084 (1098)
|+.||++|++ +.++++||||+. ++|+.++.+ +.+|+++...
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~----~~~~~~~~~~~~~~~~~~~~ 285 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRS----IDWDLLEKKQVTPPFKPQIT 285 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCC----CCHHHHHhCCCCCCccCCCC
Confidence 9999999997 579999999998 678888877 6666655433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=357.51 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=212.8
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.....||.|.||.||.+.+..+++.||||++.+... .......+.+|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 46778899999999999999999999999999976432 23344678899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc-------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI------- 964 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~------- 964 (1098)
|++|++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 82 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~---~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 82 FLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG---HIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC---CEEEeeccccccccccccc
Confidence 9999999888763 45789999999999999999999999999999999999999988 899999999852
Q ss_pred ----------------------------------------------------cCCCCCChhhhccCCCCchhHHHHHHHH
Q psy48 965 ----------------------------------------------------IGEKSFPPEVLRNKGYNRSLDMWSVGVI 992 (1098)
Q Consensus 965 ----------------------------------------------------~~~~~~APEvl~~~~ys~~sDVwSLGvl 992 (1098)
.+..|+|||++.+..|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 1234789999999999999999999999
Q ss_pred HHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCC---CCHHHHHcCCCcCCCCCcch
Q psy48 993 VYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKR---LSVDKSLAHPWLQDPATWSD 1067 (1098)
Q Consensus 993 LyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kR---PSa~eIL~HpfFk~~~~~~~ 1067 (1098)
||||++|..||...... ...+..............++.++.+||.+||. +|.+| +++.+++.||||++ .+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~----~~ 312 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG----VD 312 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC----CC
Confidence 99999999999865432 22232221112211223578999999999998 67665 59999999999998 56
Q ss_pred hHHHHhhhCCCCC
Q psy48 1068 LRGLERQIGTNKK 1080 (1098)
Q Consensus 1068 ~~~l~~~~~~~~~ 1080 (1098)
|+.+. ++.+|+.
T Consensus 313 ~~~~~-~~~~~~~ 324 (377)
T cd05629 313 WDTIR-QIRAPFI 324 (377)
T ss_pred HHHHc-cCCCCcc
Confidence 66663 4444443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=347.71 Aligned_cols=252 Identities=31% Similarity=0.457 Sum_probs=209.5
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhc-cCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQN-LCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~-l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|.||.||.+.+..+++.||||++++.... ......+..|..++.. .+||||+++++++...+.+++||||++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 589999999999999999999999999865322 2233555667777764 48999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~---~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 82 DLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG---HIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC---CEEEccCcCCeECCCCCCcccccc
Confidence 99877753 45799999999999999999999999999999999999999988 8999999998642
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
+..|+|||++.+..++.++|||||||++|||++|..||.+... ....+.... +.....++.++.++|.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR----PHFPRWISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----CCCCCCCCHHHHHHHHHHccC
Confidence 2346899999999999999999999999999999999986543 222222221 222345889999999999999
Q ss_pred cccCCCCH-HHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCC
Q psy48 1043 KQRKRLSV-DKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKN 1082 (1098)
Q Consensus 1043 dP~kRPSa-~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~ 1082 (1098)
||++||++ .++++||||+. .+|+.++++ +.+++.+.
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~----~~~~~~~~~~~~~~~~~~ 271 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFFRG----IDWERLEKREIPPPFKPK 271 (316)
T ss_pred CHHHcCCChHHHHcCcccCC----CCHHHHHhCCCCCCcCCC
Confidence 99999986 58999999998 677777776 66665443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=350.07 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=210.9
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|++|.||.+.++.+++.||+|++++.... ......+.+|+.++..+ +||||+++++++.+.+.+++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 589999999999999999999999999875433 23446688899888766 7999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~L~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~---~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 82 DLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG---HIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC---CEEEeeCCccccccCCCCcccccc
Confidence 9977765 445799999999999999999999999999999999999999998 8999999998642
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-------hhHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED-------EDINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~-------~~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
+..|+|||++.+..++.++|||||||++|||++|..||... ......+...........+..++.++.++|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 23467999999999999999999999999999999999521 1111122222222222234568899999999
Q ss_pred HhhhhcccCCCC------HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1038 NLLQVKQRKRLS------VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1038 ~cL~~dP~kRPS------a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
+||+.||++||+ ++++++||||++ .+|..++.+ +.+|+++
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~----~~~~~~~~~~~~~~~~~ 284 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN----VDWDLMEQKQVVPPFKP 284 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC----CCHHHHHcCCCCcCccC
Confidence 999999999998 589999999998 577777666 6666544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=347.44 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=208.6
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhc-cCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQN-LCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~-l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|++|.||.+.++.+|+.||||++++.... ......+..|..++.. .+||||+++++++.+.+.+|+||||+.++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 589999999999999999999999999864321 2334566778888765 48999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||+++..
T Consensus 82 ~L~~~i~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 82 DLMFHIQ-DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG---HIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC---CEEeCccCCCeecccCCCceeccC
Confidence 9987775 346799999999999999999999999999999999999999988 8999999988632
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
+..|+|||++.+..++.++|||||||++|||++|..||..... ..+.+.... +.....++.++.++|.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT----PHYPRWITKESKDILEKLFER 233 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----CCCCCCCCHHHHHHHHHHccC
Confidence 3346899999999999999999999999999999999986543 233333222 222345889999999999999
Q ss_pred cccCCCCH-HHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1043 KQRKRLSV-DKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1043 dP~kRPSa-~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
||++|+++ +++++||||+. .+|..++.+ +.+|+.+
T Consensus 234 dP~~R~~~~~~~~~h~~f~~----~~~~~~~~~~~~~~~~~ 270 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFFKT----INWTALEKRELDPPFKP 270 (316)
T ss_pred CHHHcCCChHHHHcCCCcCC----CCHHHHHhCCCCCCcCC
Confidence 99999998 58999999998 566666655 5555443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=346.33 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=216.2
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
|.+...||.|++|.||.+.+..+++.||||++++.... ......+..|..++..+ .|++|+.+++++.+.+.+++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 56778999999999999999999999999999875332 22345667788888776 58999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+++++|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~---~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 82 YVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG---HIKIADFGMCKENMWDGVT 157 (323)
T ss_pred CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC---cEEEccCCCceecCCCCCc
Confidence 999999987775 345799999999999999999999999999999999999999998 8999999998642
Q ss_pred ------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 966 ------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
...|+|||++.+..++.++|||||||++|||++|+.||.... .....+......+ +..++.++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~ 233 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY----PKSMSKEAVAICK 233 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----CCcCCHHHHHHHH
Confidence 234689999999999999999999999999999999998654 3333333333222 3468999999999
Q ss_pred HhhhhcccCCCCH-----HHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1038 NLLQVKQRKRLSV-----DKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa-----~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
+||+.||++|+++ .++++||||+. .||+.++++ +.+|+.+
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~----~~~~~~~~~~~~~~~~~ 279 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRY----IDWEKLERKEVQPPYKP 279 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCC----CCHHHHHhCCCCCCcCC
Confidence 9999999999984 89999999998 788888877 6666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=345.92 Aligned_cols=250 Identities=28% Similarity=0.451 Sum_probs=211.6
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|++|.||.+.+..+++.||||++++.... ......+.+|+.+++.+ +||||+++++++.+.+.+++||||+.|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 589999999999999999999999999875322 23346678888998877 6999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||+++..
T Consensus 82 ~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 82 DLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG---HIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC---cEEecccCCCeecCcCCCccccee
Confidence 9977765 345799999999999999999999999999999999999999998 8999999988531
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
...|+|||++.+..++.++|+|||||++|+|++|+.||..... ....+...... .+..++.++.+||.+||..
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR----YPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC----CCCcCCHHHHHHHHHHccC
Confidence 2346899999999999999999999999999999999986542 22333322222 2345889999999999999
Q ss_pred cccCCCCH-----HHHHcCCCcCCCCCcchhHHHHhh-hCCCCC
Q psy48 1043 KQRKRLSV-----DKSLAHPWLQDPATWSDLRGLERQ-IGTNKK 1080 (1098)
Q Consensus 1043 dP~kRPSa-----~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~ 1080 (1098)
||++||++ .++++||||+. .+|..++++ +.+|++
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~----~~~~~~~~~~~~~~~~ 273 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFRE----IDWDKLERKEIKPPFK 273 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCC----CCHHHHHhCCCCCCcC
Confidence 99999999 99999999998 566666666 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.55 Aligned_cols=244 Identities=28% Similarity=0.392 Sum_probs=201.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
+..|.....||.|.+|.||.+.++.+++.||+|+++.... ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 4568889999999999999999999999999999975432 223356778999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||+.+ +|..++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~---~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG---ELKLADFGLARAKSVPTK 158 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC---CEEECcCcceeeccCCCc
Confidence 99987 56666665555689999999999999999999999999999999999999988 8999999998643
Q ss_pred -------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhc-----------------
Q psy48 966 -------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAF----------------- 1018 (1098)
Q Consensus 966 -------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~----------------- 1018 (1098)
...++|||++.+ ..++.++|||||||++|+|++|+.||.+.... ...+.....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 223579999875 56899999999999999999999999765322 111111100
Q ss_pred --cCCC-------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1019 --MYPP-------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1019 --~~p~-------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
.++. .....++.++.+||.+||..||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0010 0012467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=353.54 Aligned_cols=251 Identities=28% Similarity=0.462 Sum_probs=212.8
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.....||.|.+|.||.+.++.+++.||||++++... .......+.+|+.++..++|+||+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 35677899999999999999999999999999976432 23345678899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|++|++|..++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++ +++|+|||++...
T Consensus 82 ~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~---~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG---HVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC---CEEEeeccCCccccccccc
Confidence 999999988876 345799999999999999999999999999999999999999988 8999999987532
Q ss_pred -----------------------------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q psy48 966 -----------------------------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFN 1004 (1098)
Q Consensus 966 -----------------------------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~ 1004 (1098)
+..|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 234689999999999999999999999999999999998
Q ss_pred CChhH--HHHHHHhh--ccCCCCCCCcCcHHHHHHHHHhhhhcccCCC---CHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1005 EDEDI--NEQIQNAA--FMYPPRPWRDISSDAIDLINNLLQVKQRKRL---SVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1005 ~~~~~--~~~i~~~~--~~~p~~~~~~is~el~~LL~~cL~~dP~kRP---Sa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
..... ...+.... ..+|. ...+++++.++|.+++. ||.+|+ ++.++++||||++ .+|+.+..+
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~----~~~~~~~~~ 307 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPP--EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG----VDWGHIRER 307 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCC--CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC----CCHHHHhcC
Confidence 65432 23333221 22222 23478999999999874 999998 4799999999999 788888776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=348.81 Aligned_cols=251 Identities=29% Similarity=0.430 Sum_probs=211.3
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCch
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDM 897 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggs 897 (1098)
.||.|.||.||.+.+..+++.||+|++++.... ......+.+|+.+++.++||||+++++++...+.+++||||+++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 589999999999999999999999999875432 2334677889999999999999999999999999999999999999
Q ss_pred HHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 898 L~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
|..++. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~---~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 82 LFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG---HIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred HHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC---CEEEecCCCCeecCCCCccccccc
Confidence 987775 34579999999999999999999997 7999999999999999998 8999999998632
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
+..|+|||++.+..++.++|||||||++|+|++|..||..... ....+...... ....+++++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~----~p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR----FPRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC----CCCCCCHHHHHHHHHHhhc
Confidence 2346899999999999999999999999999999999976532 23333222222 2346889999999999999
Q ss_pred cccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1043 KQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1043 dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
||++|+ ++.++++||||++ .+|.....+ +.+|+.+
T Consensus 234 dP~~R~~~~~~~~~~il~h~~~~~----~~~~~~~~~~~~~~~~~ 274 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQHKFFAG----IVWQDVYEKKLVPPFKP 274 (325)
T ss_pred CHHHhCCCCCCCHHHHhcCCCcCC----CCHHHHHhCCCCCCcCC
Confidence 999997 8999999999998 455555554 5555543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=344.32 Aligned_cols=251 Identities=28% Similarity=0.403 Sum_probs=210.0
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhc-cCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQN-LCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~-l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|.||.||.+.+..+++.||||++++.... ......+..|..++.. ++||||+++++++.+.+.+++||||++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 589999999999999999999999999864321 2234556677778775 48999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 82 DLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG---HIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC---CEEEccCCcceECCCCCCceeeec
Confidence 99888763 45789999999999999999999999999999999999999988 8999999998642
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
+..|+|||++.+..++.++|||||||++|||++|..||.... +..+.+...... ....++.++.++|.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC----YPRWLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----CCccCCHHHHHHHHHHhcc
Confidence 234689999999999999999999999999999999997653 233333322222 2235889999999999999
Q ss_pred cccCCCCHH-HHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1043 KQRKRLSVD-KSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1043 dP~kRPSa~-eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
||++||++. ++++||||+. .+|+.++.+ +.+|+.+
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~----~~~~~~~~~~~~~~~~~ 270 (316)
T cd05619 234 EPERRLGVKGDIRQHPFFRE----IDWSALEEREIEPPFKP 270 (316)
T ss_pred CHhhcCCChHHHHcCcccCC----CCHHHHHhCCCCCCcCC
Confidence 999999996 9999999998 677777666 5565543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=344.54 Aligned_cols=254 Identities=29% Similarity=0.425 Sum_probs=211.7
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHH---hccCCCCceeeeeeeecCCcEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAIL---QNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL---~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
|.+...||.|.+|.||.+.+..+++.||||++++.... ......+.+|+.++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45678899999999999999999999999999864322 23345677777665 466799999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||++|++|..++. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~---~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG---FVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC---cEEeCcccCCccCCCCC
Confidence 99999999987764 35699999999999999999999999999999999999999998 8999999988642
Q ss_pred --------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 966 --------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 966 --------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
...|+|||++.+..++.++|||||||++|||++|..||.+... ....+......+ +..++.++.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~----p~~~~~~~~~l 231 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRY----PRFLSREAISI 231 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----CCCCCHHHHHH
Confidence 2346899999999999999999999999999999999986542 333333332222 34588999999
Q ss_pred HHHhhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCC
Q psy48 1036 INNLLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKK 1080 (1098)
Q Consensus 1036 L~~cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~ 1080 (1098)
|.+||..||++|| ++.++++||||++ .+|..+..+ +.+|+.
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~----~~~~~~~~~~~~~~~~ 278 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRD----INWDDLLARKIKPPFV 278 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC----CCHHHHHhCCCCcCcc
Confidence 9999999999999 6899999999998 566665555 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=332.95 Aligned_cols=236 Identities=28% Similarity=0.408 Sum_probs=203.9
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeee-eeecCCc-EE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLER-MFETPGR-IF 887 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~-~f~~~~~-l~ 887 (1098)
.+..|.+...||.|.||.||.+.+..+|..||.|.+.-...+.........|+.+|++++|||||++++ .|..++. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 344566677899999999999999999999999999877777778889999999999999999999998 5655554 99
Q ss_pred EEEEeccCchHHHHHh---hccCccchhHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 888 VVMEKLQGDMLEMILS---SEKGRLSERTTKFIITQILVALKHLHS--KN--IVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~---~~~~~lse~~~~~ia~qIa~gL~~LHs--~g--IvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
||||||.+|+|..+++ ++...+++..+|+++.|++.||..+|+ .. |+||||||.||+|+.+| .+||+|||
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g---vvKLGDfG 173 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG---VVKLGDFG 173 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC---ceeeccch
Confidence 9999999999988765 345679999999999999999999998 45 99999999999999999 89999999
Q ss_pred ccccc------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCC
Q psy48 961 FARII------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWR 1026 (1098)
Q Consensus 961 la~~~------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~ 1026 (1098)
+++++ ++-||+||++.+.+|++++||||+||++|||..-++||.++. ++.+.|.+. .+|+-+-.
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg--d~~~~p~~ 251 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG--DYPPLPDE 251 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC--CCCCCcHH
Confidence 99754 334589999999999999999999999999999999999884 333334333 44443335
Q ss_pred cCcHHHHHHHHHhhhhcccCCCCH
Q psy48 1027 DISSDAIDLINNLLQVKQRKRLSV 1050 (1098)
Q Consensus 1027 ~is~el~~LL~~cL~~dP~kRPSa 1050 (1098)
.+|.++..+|..|+..||+.||+.
T Consensus 252 ~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 252 HYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HhhhHHHHHHHHHccCCcccCCCc
Confidence 689999999999999999999984
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=339.04 Aligned_cols=245 Identities=30% Similarity=0.456 Sum_probs=201.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|.....||.|.+|.||.+.++.+++.||||+++.... ......+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 567888999999999999999999999999999975432 2223467789999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+.++++ .++....+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 84 ~~~~~l~-~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 84 YVHTDLC-QYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG---ELKLADFGLARAKSVPSHT 159 (303)
T ss_pred CCCcCHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---CEEECCCCcceeccCCCcc
Confidence 9987655 55555556789999999999999999999999999999999999999988 8999999998642
Q ss_pred ------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc--CC---------------
Q psy48 966 ------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM--YP--------------- 1021 (1098)
Q Consensus 966 ------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~--~p--------------- 1021 (1098)
+..++|||++.+ ..++.++|||||||++|+|++|..||.+..+....+...... .+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 223689999875 458999999999999999999999998754433322211100 00
Q ss_pred CCC------------C--CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1022 PRP------------W--RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1022 ~~~------------~--~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+.. | ..+++++.+||.+||+.||++|||+.++++||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 000 0 124578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=345.21 Aligned_cols=253 Identities=30% Similarity=0.465 Sum_probs=209.0
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHH-HHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVA-ILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~-iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|.+|.||.+.+..+|+.||||++.+.... ......+.+|.. +++.++||||+++++++...+.+++||||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 589999999999999999999999999764322 222344555555 567889999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 82 ELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG---HVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC---cEEEeccCCCcccccCCCcccccc
Confidence 9987775 355799999999999999999999999999999999999999998 8999999998642
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
...|+|||++.+..++.++|||||||++|||++|..||...+ +..+.+.... ......++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP----LRLKPNISVSARHLLEGLLQK 233 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC----CCCCCCCCHHHHHHHHHHhhc
Confidence 224689999999999999999999999999999999998653 2333333222 222345789999999999999
Q ss_pred cccCCCCH----HHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCc
Q psy48 1043 KQRKRLSV----DKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNP 1083 (1098)
Q Consensus 1043 dP~kRPSa----~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~ 1083 (1098)
||.+||++ .++++||||+. .+|..+..+ +.+|+.+..
T Consensus 234 ~p~~R~~~~~~~~~il~~~~~~~----~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05575 234 DRTKRLGAKDDFLEIKNHVFFSS----INWDDLVNKKITPPFNPNV 275 (323)
T ss_pred CHHhCCCCCCCHHHHHcCCCcCC----CCHHHHhhccCCCCcCCCC
Confidence 99999987 69999999998 566666655 666655443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=346.62 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=214.1
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.+...||.|.+|.||.+.++.+++.||||++++... .......+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 46778899999999999999999999999999987543 23345678899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+++++|..++......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~---~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG---HIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC---CEEeccCCCCeECCCCCce
Confidence 9999999999876667899999999999999999999999999999999999999988 8999999998643
Q ss_pred -------CCCCCChhhhc------cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcCcH
Q psy48 966 -------GEKSFPPEVLR------NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 966 -------~~~~~APEvl~------~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
+..|+|||++. +..++.++|||||||++|||++|..||...... ...+..............++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 22468999997 456889999999999999999999999865432 222222211111111235789
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHHHHhhh
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQI 1075 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~~~~ 1075 (1098)
++.+||..||. ||.+||++.++++||||+. .+|..+....
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~----~~~~~~~~~~ 278 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCCHPFFSK----IDWNNIRNSL 278 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC----CCHHHHhhCC
Confidence 99999999998 9999999999999999998 5666666543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=350.86 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=208.7
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
.....|.....||.|.+|.||.+.+..+++.||||++++.... ......+.+|+.+++.++||||+++++++.+.+.++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 3456788999999999999999999999999999999764322 233456789999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-- 965 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-- 965 (1098)
+||||++|++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~---~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG---HLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC---CEEEEeccceeeccC
Confidence 99999999999888753 3589999999999999999999999999999999999999998 8999999998643
Q ss_pred -----------CCCCCChhhhccC----CCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcC
Q psy48 966 -----------GEKSFPPEVLRNK----GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDI 1028 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~----~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~i 1028 (1098)
+..|+|||++.+. .++.++|||||||++|||++|..||...... ...+..............+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 2236799999754 4889999999999999999999999876432 2333222111111122358
Q ss_pred cHHHHHHHHHhhhhcccC--CCCHHHHHcCCCcCC
Q psy48 1029 SSDAIDLINNLLQVKQRK--RLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~k--RPSa~eIL~HpfFk~ 1061 (1098)
|.++.+||.+||+.+|.+ |++++++++||||++
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 999999999999999988 999999999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=342.63 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=215.3
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
+.+...||.|.+|.||.+.++.+++.||||++++... .......+..|+.++..+. |++|+++++++.+.+.+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 4567889999999999999999999999999986432 2233466788888888775 5788889999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|++|++|..++. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||+++..
T Consensus 82 y~~~g~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~---~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 82 YVNGGDLMYHIQ-QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG---HIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred CCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC---CEEEeccccccccCCCCcc
Confidence 999999987775 445799999999999999999999999999999999999999998 8999999998642
Q ss_pred ------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 966 ------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
+..|+|||++.+..++.++|||||||++|+|++|..||..... ..+.+...... .+..++.++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~----~p~~~~~~~~~li~ 233 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS----YPKSLSKEAVSICK 233 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----CCccCCHHHHHHHH
Confidence 2346899999999999999999999999999999999987543 23333333222 23468899999999
Q ss_pred HhhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1038 NLLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1038 ~cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
+||..||.+|++ ..++++||||+. .+|..++.+ +.+|+.+
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~----~~~~~~~~~~~~~~~~~ 279 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRR----IDWDKLENREIQPPFKP 279 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCC----CCHHHHhcCCCCcCccC
Confidence 999999999997 479999999998 678888777 6666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.87 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=217.8
Q ss_pred HHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 807 FLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 807 ~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
+......|.+...||.|.-+.||.|....+++.||||++..+..+.+ ...+.+|++.|..++||||++++..|..+..+
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 33456789999999999999999999999999999999987765444 78899999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc-
Q psy48 887 FVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI- 964 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~- 964 (1098)
++||.||.+|++.+++... ...|+|..+..++++++.||.|||.+|.||||||+.||||+.+| .|||+|||.+..
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG---~VkLadFgvsa~l 176 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG---TVKLADFGVSASL 176 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC---cEEEcCceeeeee
Confidence 9999999999998887643 23599999999999999999999999999999999999999999 899999986531
Q ss_pred ---------------cCCCCCChhhhc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCC-----
Q psy48 965 ---------------IGEKSFPPEVLR--NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPP----- 1022 (1098)
Q Consensus 965 ---------------~~~~~~APEvl~--~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~----- 1022 (1098)
..+.|||||++. ...|++++||||||++..||.+|..||.........++...-..|.
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 234579999964 4669999999999999999999999998877665555554444431
Q ss_pred ---CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1023 ---RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1023 ---~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.....++..+..++..||.+||.+|||++++++|+||+..
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 1123467789999999999999999999999999999864
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=334.52 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=218.3
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH-HHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
|.....||.|.||.||.+.+..+++.||||.+.+...... ....+.+|+.+++.++|++++.+++.+.+.+.+++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 3456789999999999999999999999999976543322 235677899999999999999999999999999999999
Q ss_pred ccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 893 LQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 893 ~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
+.|++|..++... ...+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++...
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~---~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG---HIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC---CEEEeeccceeecCCCccc
Confidence 9999998877543 33589999999999999999999999999999999999999988 8999999998643
Q ss_pred -----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 966 -----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 966 -----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
...++|||++.+..++.++||||||+++|+|++|+.||...... ...........+...+..+++++.+|+.+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHH
Confidence 22467999999999999999999999999999999999864211 11111111111222345688999999999
Q ss_pred hhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCc
Q psy48 1039 LLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNP 1083 (1098)
Q Consensus 1039 cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~ 1083 (1098)
||+.||++||| +.++++||||+. .+|..++.. ..||+++.|
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~h~~~~~----~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKEHPLFKQ----INFKRLEAGMLEPPFKPDP 285 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHcChhhhc----cCHHHHhcCCCCCCCCCCC
Confidence 99999999999 899999999998 678878776 667777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=342.30 Aligned_cols=244 Identities=25% Similarity=0.479 Sum_probs=198.6
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC-----CcEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP-----GRIF 887 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~-----~~l~ 887 (1098)
+|.....||.|.+|.||.+.+..+++.||||+++...........+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 47788999999999999999999999999999975433344456788999999999999999999987543 3589
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-- 965 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-- 965 (1098)
+||||+++ +|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 81 lv~e~~~~-~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~---~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELMES-DLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCCC-CHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC---cEEEccCcccccccc
Confidence 99999975 5656654 345699999999999999999999999999999999999999998 8999999998632
Q ss_pred -------------CCCCCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH--HH--------------
Q psy48 966 -------------GEKSFPPEVLRN--KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ--IQ-------------- 1014 (1098)
Q Consensus 966 -------------~~~~~APEvl~~--~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~--i~-------------- 1014 (1098)
+..|+|||++.+ ..++.++|||||||++|||++|+.||.+....... +.
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 123579999876 67899999999999999999999999764322110 00
Q ss_pred ----------HhhccCCC---CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1015 ----------NAAFMYPP---RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1015 ----------~~~~~~p~---~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
......+. ..+..+++++.++|.+||+.||++||+++++++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 00000000 112356788999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=332.63 Aligned_cols=254 Identities=25% Similarity=0.355 Sum_probs=208.6
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchH
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDML 898 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL 898 (1098)
||.|+||.||.+..+.+|+.||+|.+.+..... .....+..|+++++.++||||+++++++.+...+++||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 588999999999999999999999997643322 2234566799999999999999999999999999999999999999
Q ss_pred HHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------C
Q psy48 899 EMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-----------G 966 (1098)
Q Consensus 899 ~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-----------~ 966 (1098)
..++... ...+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++... .
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG---NCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC---CEEEeeceeeeecCCCceeeccCCC
Confidence 7776533 33588999999999999999999999999999999999999988 8999999998643 2
Q ss_pred CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh---HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhc
Q psy48 967 EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED---INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVK 1043 (1098)
Q Consensus 967 ~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~---~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~d 1043 (1098)
..++|||++.+..++.++|||||||++|||++|..||....+ ..+................++.++.++|.+||+.|
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 237 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKK 237 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccC
Confidence 346799999998899999999999999999999999975321 11111111111111122468899999999999999
Q ss_pred ccCCCCH----HHHHcCCCcCCCCCcchhHHHHhh-hCCCCC
Q psy48 1044 QRKRLSV----DKSLAHPWLQDPATWSDLRGLERQ-IGTNKK 1080 (1098)
Q Consensus 1044 P~kRPSa----~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~ 1080 (1098)
|++||++ ++++.|+||+. .+|..++.+ +.+|+.
T Consensus 238 P~~R~~~~~~~~~~~~h~~f~~----~~~~~~~~~~~~~~~~ 275 (277)
T cd05607 238 PEDRLGSREKNDDPRKHEFFKT----INFPRLEAGLIPPPFV 275 (277)
T ss_pred HhhCCCCccchhhhhcChhhcC----CCHHHHhcCcCCCCCC
Confidence 9999999 67889999998 788888887 555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=373.36 Aligned_cols=267 Identities=28% Similarity=0.436 Sum_probs=224.3
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.-..|-+-.+||.|.||.|.++.++.+++.||+|+++|.... ..+...|+.|..+|..-+.+-|++|+-.|+++.++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 344555667899999999999999999999999999884332 3445789999999998889999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
||||++||+|-.++.... ++++..+++|+++|+.||..||+.|+|||||||+|||||..| ||||+|||.|-.+
T Consensus 153 VMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G---HikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG---HIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC---cEeeccchhHHhcCCC
Confidence 999999999988887555 899999999999999999999999999999999999999999 9999999987432
Q ss_pred ----------CCCCCChhhhc----c-CCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHh--hccCCCCCCC
Q psy48 966 ----------GEKSFPPEVLR----N-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNA--AFMYPPRPWR 1026 (1098)
Q Consensus 966 ----------~~~~~APEvl~----~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~--~~~~p~~~~~ 1026 (1098)
++.|++||++. + ..|+...||||+||++|||+.|..||..+. +.+..|... .+.+|.. .
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~--~ 306 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE--T 306 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc--c
Confidence 45678999996 3 569999999999999999999999998764 344455444 5566632 3
Q ss_pred cCcHHHHHHHHHhhhhcccCCCC---HHHHHcCCCcCCCCCcchhHHHHhhhCCCCC---CCcchhhh
Q psy48 1027 DISSDAIDLINNLLQVKQRKRLS---VDKSLAHPWLQDPATWSDLRGLERQIGTNKK---KNPKRTAQ 1088 (1098)
Q Consensus 1027 ~is~el~~LL~~cL~~dP~kRPS---a~eIL~HpfFk~~~~~~~~~~l~~~~~~~~~---~~~~~~~~ 1088 (1098)
.+|.++.+||.+++. +|+.|.+ ++++..||||.+ +||+.|.. ..||+. .++.|+..
T Consensus 307 ~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g----~~W~~iR~-~~pP~vPevssd~DTsn 368 (1317)
T KOG0612|consen 307 DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG----IDWDNIRE-SVPPVVPEVSSDDDTSN 368 (1317)
T ss_pred ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC----CChhhhhh-cCCCCCCcCCCCCcccc
Confidence 599999999999888 8889998 999999999999 66655544 446654 34444443
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=343.59 Aligned_cols=252 Identities=30% Similarity=0.471 Sum_probs=210.9
Q ss_pred eeeeeeeeeceEEEEe---ecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEecc
Q psy48 818 VALCIAVVAGAACGVH---RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~---k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ 894 (1098)
..||.|++|.||.+.+ +.+|+.||+|++++..........+.+|+.+|+.++||||+++++++.+.+.+|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 3689999999998876 4678999999998754444445667889999999999999999999999999999999999
Q ss_pred CchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--------
Q psy48 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-------- 966 (1098)
Q Consensus 895 ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-------- 966 (1098)
+++|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||+++...
T Consensus 82 ~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 82 GGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG---HIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC---cEEEeeccCCcccCCCCCceec
Confidence 999988875 345799999999999999999999999999999999999999988 89999999986432
Q ss_pred ----CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 967 ----EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 967 ----~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
..|+|||++.+..++.++|||||||++|||++|+.||...... ...+....... ...+++++.++|.+||
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~----p~~~~~~~~~li~~~l 233 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM----PQFLSPEAQSLLRALF 233 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHHh
Confidence 2367999999999999999999999999999999999865432 22232222222 2458899999999999
Q ss_pred hhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1041 QVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1041 ~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
+.||++||+ +.+++.||||+. .+|..+.++ +.+|+..
T Consensus 234 ~~~P~~R~~a~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 276 (318)
T cd05582 234 KRNPANRLGAGPDGVEEIKRHPFFST----IDWNKLYRREIKPPFKP 276 (318)
T ss_pred hcCHhHcCCCCCCCHHHHhCCCCcCC----CCHHHHHhcCCCCCcCC
Confidence 999999999 778999999998 566666665 5455433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=341.40 Aligned_cols=251 Identities=30% Similarity=0.476 Sum_probs=208.7
Q ss_pred eeeeeeeeeceEEEEee---cCCceeEEEEEeccCCC--hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 818 VALCIAVVAGAACGVHR---KSGRGVAIKVIDKLRFP--TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k---~tg~~VAVKvlkk~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
..||.|+||.||.+.+. .+++.||||++++.... ......+.+|+.+|+.++||||++++++|..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 46899999999999863 57899999999764321 22335678999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------- 965 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------- 965 (1098)
+.+++|..++.. .+.+.+..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG---HVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC---CEEEeeCcCCeecccCCCcc
Confidence 999999888763 45788999999999999999999999999999999999999988 8999999998632
Q ss_pred -----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 966 -----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 966 -----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
...|+|||++.+..++.++|||||||++|||++|..||...... ...+...... .+..+++++.++|.+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~ 233 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN----LPPYLTPEARDLLKK 233 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----CCCCCCHHHHHHHHH
Confidence 23468999999999999999999999999999999999875432 2222222222 234578999999999
Q ss_pred hhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCC
Q psy48 1039 LLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKK 1080 (1098)
Q Consensus 1039 cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~ 1080 (1098)
||+.||++|| ++.++++||||+. .+|..+..+ +.+|+.
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~----~~~~~~~~~~~~~~~~ 277 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRH----VNWDDLLARKVEPPFK 277 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCC----CCHHHHhcCCCCCCcC
Confidence 9999999999 8999999999997 455555544 555543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=341.07 Aligned_cols=247 Identities=28% Similarity=0.499 Sum_probs=212.3
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh------------HHHHHHHHHHHHHhccCCCCceee
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT------------KQEAQLKNEVAILQNLCHPGVVNL 876 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~------------~~~~~~~~Ei~iL~~l~HpnIv~L 876 (1098)
..++.|+....||.|.||.|-+|.+..+++.||||++.+..... ...+.+.+||.+|+++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45778999999999999999999999999999999997643211 113578999999999999999999
Q ss_pred eeeeecC--CcEEEEEEeccCchHHHHHhhccCc-cchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCc
Q psy48 877 ERMFETP--GRIFVVMEKLQGDMLEMILSSEKGR-LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953 (1098)
Q Consensus 877 ~~~f~~~--~~l~LVmEy~~ggsL~~~l~~~~~~-lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~ 953 (1098)
+++..+. +.+|||+|||..|.+ ++.- .... +++.++++|+++++.||+|||.+|||||||||+|+||+.+| +
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v-~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g---~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEV-KWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG---T 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCcc-ccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC---c
Confidence 9999776 579999999998877 3332 2334 89999999999999999999999999999999999999999 9
Q ss_pred EEEeecCccccc-----------------CCCCCChhhhccCC----CCchhHHHHHHHHHHHHHcCCCCCCCCh--hHH
Q psy48 954 VKLCDFGFARII-----------------GEKSFPPEVLRNKG----YNRSLDMWSVGVIVYVSLSGTFPFNEDE--DIN 1010 (1098)
Q Consensus 954 vKL~DFGla~~~-----------------~~~~~APEvl~~~~----ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~ 1010 (1098)
+||+|||.+... ++..||||...+.. .+++.||||+||+||.|+.|+.||.++. +++
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 999999987533 33458999997632 4689999999999999999999999874 567
Q ss_pred HHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1011 EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1011 ~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+.|.+....+|... .+.+++.+||++||.+||++|.+..+|..|||....
T Consensus 329 ~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 329 DKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 77777777777643 578999999999999999999999999999999864
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=347.63 Aligned_cols=251 Identities=38% Similarity=0.617 Sum_probs=226.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~ 887 (1098)
...+|.+...+|.|.||.|+.+.++.+|+.||+|++++..... .....+.+|+++|+.+. ||||+.+++.|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3467888899999999999999999999999999998865533 34578999999999998 999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCC-CCcEEEeecCcccccC
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE-LPQVKLCDFGFARIIG 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~-~~~vKL~DFGla~~~~ 966 (1098)
+|||++.||.|.+.+... .+++..+..++.||+.|+.|||+.||+||||||+|+|+..... ...+|++|||++....
T Consensus 113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 999999999998888765 3999999999999999999999999999999999999986543 2379999999997654
Q ss_pred C-----------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 967 E-----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 967 ~-----------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
. .|+|||++....|+..+||||+||++|.|++|.+||.+.. .....+....+.++...|..++..+.
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ak 270 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAK 270 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHH
Confidence 3 3469999999999999999999999999999999998765 56667788888889999999999999
Q ss_pred HHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
++++.||..||.+|+++.++|+|||++..
T Consensus 271 d~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 271 DFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999974
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=341.94 Aligned_cols=260 Identities=25% Similarity=0.439 Sum_probs=210.6
Q ss_pred eeeeeeeeeeeeeceEEEEee---cCCceeEEEEEeccCCC--hHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEE
Q psy48 814 MTYNVALCIAVVAGAACGVHR---KSGRGVAIKVIDKLRFP--TKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k---~tg~~VAVKvlkk~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~ 887 (1098)
|.+...||.|.+|.||.+.+. .+++.||+|++++.... ......+.+|+.+++.+ +|+||+++++++...+.++
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 567889999999999998764 57899999999764321 22345688899999999 4899999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-- 965 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-- 965 (1098)
+||||+.+++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~---~~kl~DfG~~~~~~~ 157 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG---HVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC---CEEEeeCcCCccccc
Confidence 99999999999888763 45689999999999999999999999999999999999999998 8999999998642
Q ss_pred -----------CCCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHH
Q psy48 966 -----------GEKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
...|+|||++.+. .++.++|||||||++|||++|..||.... .....+........+..+..++.+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 2346799999875 48899999999999999999999996421 111112221222223334568999
Q ss_pred HHHHHHHhhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1032 AIDLINNLLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
+.++|.+||+.||++|| +++++++||||++ .+|+.+..+ +.+|+.+
T Consensus 238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~----~~~~~~~~~~~~~~~~~ 289 (332)
T cd05614 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG----LDWEALALRKVNPPFRP 289 (332)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC----CCHHHHHhCCCCCCcCC
Confidence 99999999999999999 7889999999998 455555554 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=327.86 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=209.0
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcEEEEEEecc
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRIFVVMEKLQ 894 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l~LVmEy~~ 894 (1098)
-..|+.|+||.||.|.++++++.||+|.++.+.........-.+||.+|.+.+|||||.+..+.... +.+|+|||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 3568999999999999999999999999987654444456678999999999999999999887544 57999999998
Q ss_pred CchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCC------
Q psy48 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK------ 968 (1098)
Q Consensus 895 ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~------ 968 (1098)
.+ |..++.....+|...++..++.|++.|++|||...|+|||||++|+|+...| .+||+|||+|+.++.+
T Consensus 161 hD-Lksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G---~lKiaDFGLAR~ygsp~k~~T~ 236 (419)
T KOG0663|consen 161 HD-LKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG---ILKIADFGLAREYGSPLKPYTP 236 (419)
T ss_pred hh-HHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC---cEEecccchhhhhcCCcccCcc
Confidence 75 5577777777899999999999999999999999999999999999999999 8999999999987665
Q ss_pred ------CCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc-CCC-CCC--------------
Q psy48 969 ------SFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM-YPP-RPW-------------- 1025 (1098)
Q Consensus 969 ------~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~-~p~-~~~-------------- 1025 (1098)
|.|||++.+. .|+.++|+||+|||+.||+++.+.|.+..++.+.-+..... +|. ..|
T Consensus 237 lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f 316 (419)
T KOG0663|consen 237 LVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTF 316 (419)
T ss_pred eEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcccc
Confidence 3599999874 59999999999999999999999999876654433322211 111 111
Q ss_pred --------------CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhH
Q psy48 1026 --------------RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLR 1069 (1098)
Q Consensus 1026 --------------~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~ 1069 (1098)
..+++...+|+..+|.+||.+|.|+.+.|+|.||.+.....+.+
T Consensus 317 ~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~ 374 (419)
T KOG0663|consen 317 SEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPS 374 (419)
T ss_pred CCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChh
Confidence 12568899999999999999999999999999999866555543
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=346.62 Aligned_cols=207 Identities=26% Similarity=0.396 Sum_probs=181.3
Q ss_pred eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhh-ccCccchhHHHHH
Q psy48 839 GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSS-EKGRLSERTTKFI 917 (1098)
Q Consensus 839 ~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~-~~~~lse~~~~~i 917 (1098)
.||+|.++... .....|.+|+++|++|+|++||++++++...+.++|||||+..|+|.++|.. ....+...+.+.+
T Consensus 232 ~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~ 308 (468)
T KOG0197|consen 232 KVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDF 308 (468)
T ss_pred cccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHH
Confidence 68999997542 3346788999999999999999999999998899999999999999999986 5567999999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCC-------------CCChhhhccCCCCchh
Q psy48 918 ITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK-------------SFPPEVLRNKGYNRSL 984 (1098)
Q Consensus 918 a~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~-------------~~APEvl~~~~ys~~s 984 (1098)
+.|||+||+||.++++|||||..+||||+.+. .+||+|||||+..... |+|||.+....|+.++
T Consensus 309 a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~---~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kS 385 (468)
T KOG0197|consen 309 AAQIAEGMAYLESKNYIHRDLAARNILVDEDL---VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKS 385 (468)
T ss_pred HHHHHHHHHHHHhCCccchhhhhhheeeccCc---eEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCccccc
Confidence 99999999999999999999999999999998 9999999999965433 3699999999999999
Q ss_pred HHHHHHHHHHHHHc-CCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHH
Q psy48 985 DMWSVGVIVYVSLS-GTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSL 1054 (1098)
Q Consensus 985 DVwSLGvlLyELlt-G~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL 1054 (1098)
|||||||+||||+| |+.||.+. .+..+.+... +....+..+|+++.+++..||..+|++|||++.+.
T Consensus 386 DVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G---yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 386 DVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG---YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc---CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999999998 88998764 3455555544 33334567999999999999999999999998654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=346.46 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=208.4
Q ss_pred HHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 807 FLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 807 ~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
.......|.....||.|++|.||.+.+..+++.||+|++++... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 33445788999999999999999999999999999999976332 23344668899999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+++||||++|++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~---~~kL~DFG~a~~~ 192 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG---HLKLADFGTCMKM 192 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC---CEEEEecccceec
Confidence 9999999999999888753 3589999999999999999999999999999999999999988 8999999998643
Q ss_pred -------------CCCCCChhhhccCC----CCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCC
Q psy48 966 -------------GEKSFPPEVLRNKG----YNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWR 1026 (1098)
Q Consensus 966 -------------~~~~~APEvl~~~~----ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~ 1026 (1098)
+..|+|||++.+.. ++.++|||||||+||||++|..||..... ....+.............
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence 22368999997643 78999999999999999999999986543 223333222222222223
Q ss_pred cCcHHHHHHHHHhhhhcccC--CCCHHHHHcCCCcCC
Q psy48 1027 DISSDAIDLINNLLQVKQRK--RLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1027 ~is~el~~LL~~cL~~dP~k--RPSa~eIL~HpfFk~ 1061 (1098)
.++..+.+++.+||..++.+ |+++.++++||||+.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 57999999999999866644 899999999999997
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=339.98 Aligned_cols=251 Identities=28% Similarity=0.437 Sum_probs=207.2
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHH-HHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVA-ILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~-iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|.+|.||.+.+..+++.||+|++.+.... ......+.+|.. +++.++||||+++++++.+.+.+++||||++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 589999999999999999999999999764322 222344555554 578889999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++. ....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..
T Consensus 82 ~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 82 ELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG---HVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC---CEEEccCCCCccCCCCCCcccccc
Confidence 9977765 345789999999999999999999999999999999999999998 8999999998642
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
...|+|||++.+..++.++|||||||++|||++|..||...+. ..+.+... +...+...+.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK----PLQLPGGKTVAACDLLVGLLHK 233 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC----CCCCCCCCCHHHHHHHHHHccC
Confidence 2346899999999999999999999999999999999986542 22222222 2233345789999999999999
Q ss_pred cccCCCCH----HHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1043 KQRKRLSV----DKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1043 dP~kRPSa----~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
||.+|+++ .++++|+||.. .+|..+..+ +.+|+.+
T Consensus 234 ~p~~R~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 273 (321)
T cd05603 234 DQRRRLGAKADFLEIKNHVFFSP----INWDDLYHKRITPPYNP 273 (321)
T ss_pred CHhhcCCCCCCHHHHhCCCCcCC----CCHHHHhcCCCCCCcCC
Confidence 99999975 59999999998 566666655 5565543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=329.41 Aligned_cols=263 Identities=26% Similarity=0.402 Sum_probs=220.1
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH-HHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
|+....||.|+||.||.+.+..+++.||+|++.+...... ....+.+|+++++.++|+||+.+++++...+.+++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 4566789999999999999999999999999976543322 235678899999999999999999999999999999999
Q ss_pred ccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 893 LQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 893 ~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
+.+++|..++... ...+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~---~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG---HIRISDLGLAVKIPEGESI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC---CEEEecCCcceecCCCCcc
Confidence 9999998776543 34699999999999999999999999999999999999999888 8999999988543
Q ss_pred -----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 966 -----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 966 -----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
...++|||++.+..++.++|+||||+++|+|++|..||....+.. +.+...........+..++.++.+|+.+
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 234679999999999999999999999999999999998653321 2222222222223345688999999999
Q ss_pred hhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCc
Q psy48 1039 LLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNP 1083 (1098)
Q Consensus 1039 cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~ 1083 (1098)
||..||++||+ +.++++|+||+. .++++++.+ +.|++.+.|
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKRHPFFRN----MNFKRLEAGMLDPPFVPDP 285 (285)
T ss_pred HccCCHhHcCCCcccChHHHHcChhhhc----CCHHHHhcCcCCCCCCCCC
Confidence 99999999999 889999999999 688888877 777776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=341.12 Aligned_cols=251 Identities=27% Similarity=0.459 Sum_probs=206.9
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHH-HHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVA-ILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~-iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|.+|.||.+.+..+|+.||||++.+... .......+..|.. +++.++||||+++++++...+.+++||||+.++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 58999999999999999999999999976432 2223345555655 467789999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~---~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 82 ELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG---HVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC---CEEEeecCCcccCCCCCCCccccc
Confidence 9977765 456799999999999999999999999999999999999999998 8999999998642
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
+..|+|||++.+..++.++|||||||++|||++|..||...+ +..+.+....... ...++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL----RPGASLTAWSILEELLEK 233 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC----CCCCCHHHHHHHHHHhcc
Confidence 223689999999999999999999999999999999998653 2333333222222 235789999999999999
Q ss_pred cccCCCCH----HHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1043 KQRKRLSV----DKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1043 dP~kRPSa----~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
||.+||++ .++++||||+. .+|..++.+ +.+|+.+
T Consensus 234 ~p~~R~~~~~~~~~i~~h~~f~~----~~~~~~~~~~~~~~~~~ 273 (325)
T cd05604 234 DRQRRLGAKEDFLEIQEHPFFES----LSWTDLEQKKIPPPFNP 273 (325)
T ss_pred CHHhcCCCCCCHHHHhcCCCcCC----CCHHHHHhCCCCCCcCC
Confidence 99999976 59999999997 455556655 5555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=345.40 Aligned_cols=279 Identities=25% Similarity=0.381 Sum_probs=233.8
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEec-cCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDK-LRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk-~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
+.-..+.....||.|.||.|-++....|...||+|.++| +.+...+...++.|..||.....+.||+||-.|++++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 334455667899999999999999999999999999976 4445566788999999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-- 965 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-- 965 (1098)
|||||++||++-.+|. +.+.|.|..+++|++++.+|+++.|.-|+|||||||+|||||.+| +|||+|||||+-+
T Consensus 706 FVMdYIPGGDmMSLLI-rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG---HIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLI-RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG---HIKLTDFGLCTGFRW 781 (1034)
T ss_pred EEEeccCCccHHHHHH-HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC---ceeeeecccccccee
Confidence 9999999999977777 567899999999999999999999999999999999999999999 9999999998521
Q ss_pred ----------------------------------------------------CCCCCChhhhccCCCCchhHHHHHHHHH
Q psy48 966 ----------------------------------------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIV 993 (1098)
Q Consensus 966 ----------------------------------------------------~~~~~APEvl~~~~ys~~sDVwSLGvlL 993 (1098)
+..|+|||++....|+...||||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 1223699999999999999999999999
Q ss_pred HHHHcCCCCCCCChhHH--HHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCC---HHHHHcCCCcCCCCCcchh
Q psy48 994 YVSLSGTFPFNEDEDIN--EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS---VDKSLAHPWLQDPATWSDL 1068 (1098)
Q Consensus 994 yELltG~~Pf~~~~~~~--~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPS---a~eIL~HpfFk~~~~~~~~ 1068 (1098)
|||+.|+.||..+.... ..+.++.-......-.++|+++.++|.++.. +++.|++ +++|..||||+. +||
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg----IDf 936 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG----IDF 936 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc----cch
Confidence 99999999998764332 2333333333333346799999999998765 7888984 678999999998 666
Q ss_pred HHHHhh--hCCCCCCCcchhhhhhhhhhhc
Q psy48 1069 RGLERQ--IGTNKKKNPKRTAQLLSYQLTQ 1096 (1098)
Q Consensus 1069 ~~l~~~--~~~~~~~~~~~~~~~~~~~~~~ 1096 (1098)
..|.++ -..|-.++|-|+..+...++++
T Consensus 937 sslRkq~ApYIP~ItHptDTSNFdpvdpek 966 (1034)
T KOG0608|consen 937 SSLRKQRAPYIPRITHPTDTSNFDPVDPEK 966 (1034)
T ss_pred HhhhhccCCcCccccCCCccccCCcCCccc
Confidence 666666 4557788898888877777654
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=338.72 Aligned_cols=249 Identities=29% Similarity=0.454 Sum_probs=204.5
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHH-HHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVA-ILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~-iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|+||.||.+.+..+++.||+|++.+.... ......+.+|.. +++.++|+||+++++++...+.+++||||+.++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 589999999999999999999999999764322 122234444444 567889999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~---~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 82 ELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG---HIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC---CEEEccCCCCcccccCCCCccccc
Confidence 99888763 45688999999999999999999999999999999999999988 8999999998632
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
+..|+|||++.+..++.++|||||||++|+|++|..||..... ....+... +......++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----PLQLKPNITNSARHLLEGLLQK 233 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC----CcCCCCCCCHHHHHHHHHHccc
Confidence 2346899999999999999999999999999999999986543 22333222 2223346899999999999999
Q ss_pred cccCCCCHH----HHHcCCCcCCCCCcchhHHHHhh-hCCCC
Q psy48 1043 KQRKRLSVD----KSLAHPWLQDPATWSDLRGLERQ-IGTNK 1079 (1098)
Q Consensus 1043 dP~kRPSa~----eIL~HpfFk~~~~~~~~~~l~~~-~~~~~ 1079 (1098)
||.+|+++. ++++|+||.. .+|+.+..+ +.+|+
T Consensus 234 ~p~~R~~~~~~~~~i~~~~~~~~----~~~~~~~~~~~~~~~ 271 (325)
T cd05602 234 DRTKRLGAKDDFMEIKNHIFFSP----INWDDLINKKITPPF 271 (325)
T ss_pred CHHHCCCCCCCHHHHhcCcccCC----CCHHHHHhCCCCcCc
Confidence 999999875 8999999987 455555544 44443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.99 Aligned_cols=240 Identities=32% Similarity=0.554 Sum_probs=212.7
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH-HHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
.+|.+...||.|+||.|-.|.....|+.||||.++++.+.+. +.-.+.+|++||..++||||+.+|.+|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 455566788999999999999999999999999999877544 4578999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc------
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI------ 964 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~------ 964 (1098)
||..+|.|++++. ..+.|++..++.+++||..|+.|+|.++++|||||.+|||+|.++ .+||+|||++..
T Consensus 133 EYaS~GeLYDYiS-er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~---NiKIADFGLSNly~~~kf 208 (668)
T KOG0611|consen 133 EYASGGELYDYIS-ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN---NIKIADFGLSNLYADKKF 208 (668)
T ss_pred EecCCccHHHHHH-HhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC---CeeeeccchhhhhccccH
Confidence 9999999999986 567899999999999999999999999999999999999999999 799999999853
Q ss_pred ----cCCC-CCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 965 ----IGEK-SFPPEVLRNKGY-NRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 965 ----~~~~-~~APEvl~~~~y-s~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
++.+ |.+||++.|.+| ++.+|-|||||+||.|+.|..||++.+ .+..+|......-|. -+.++..||
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~PSdA~gLI 283 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----TPSDASGLI 283 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----CCchHHHHH
Confidence 3443 458999999998 489999999999999999999999864 445555555554444 457899999
Q ss_pred HHhhhhcccCCCCHHHHHcCCCcC
Q psy48 1037 NNLLQVKQRKRLSVDKSLAHPWLQ 1060 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~HpfFk 1060 (1098)
++||..||++|.|+.+|-.|=|.+
T Consensus 284 RwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 284 RWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHhcCcccchhHHHHhhhheee
Confidence 999999999999999999998876
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=342.56 Aligned_cols=266 Identities=26% Similarity=0.391 Sum_probs=214.6
Q ss_pred chhHhhHHHHHHHHHHHHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccC
Q psy48 791 PHFIQTLLHVLQITMSFLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLC 869 (1098)
Q Consensus 791 p~~~~~ll~~~~~~~~~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~ 869 (1098)
-.+.+.+................|.....||.|++|.||.+.++.+++.||+|++.+... .......+.+|+.+++.++
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~ 101 (371)
T cd05622 22 DNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101 (371)
T ss_pred HHHHHHhhhHhhHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC
Confidence 344444444443333344456789999999999999999999999999999999976332 2333456889999999999
Q ss_pred CCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy48 870 HPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949 (1098)
Q Consensus 870 HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g 949 (1098)
||||+++++++.+.+.+++||||++|++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 102 hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred CCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC
Confidence 99999999999999999999999999999888753 3589999999999999999999999999999999999999988
Q ss_pred CCCcEEEeecCccccc-------------CCCCCChhhhccCC----CCchhHHHHHHHHHHHHHcCCCCCCCChh--HH
Q psy48 950 ELPQVKLCDFGFARII-------------GEKSFPPEVLRNKG----YNRSLDMWSVGVIVYVSLSGTFPFNEDED--IN 1010 (1098)
Q Consensus 950 ~~~~vKL~DFGla~~~-------------~~~~~APEvl~~~~----ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~ 1010 (1098)
.+||+|||+++.. +..|+|||++.+.. ++.++|||||||++|||++|..||..... ..
T Consensus 180 ---~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~ 256 (371)
T cd05622 180 ---HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 256 (371)
T ss_pred ---CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH
Confidence 8999999998643 22368999997643 88999999999999999999999987643 22
Q ss_pred HHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccC--CCCHHHHHcCCCcCC
Q psy48 1011 EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRK--RLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1011 ~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~k--RPSa~eIL~HpfFk~ 1061 (1098)
..+.......+......++.++.++|.+||..++.+ |++++++++|+||++
T Consensus 257 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 257 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 333322222222223468999999999999854443 789999999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=341.51 Aligned_cols=253 Identities=30% Similarity=0.491 Sum_probs=206.4
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhcc---CCCCceeeeeeeecCCcEEEEEEeccC
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNL---CHPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l---~HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
||.|+||.||.+.+..+++.||||++.+.... ......+..|..++... .||||++++.++.+.+.+++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 58899999999999999999999999764322 22234455677776654 699999999999999999999999999
Q ss_pred chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----------
Q psy48 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------- 965 (1098)
Q Consensus 896 gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---------- 965 (1098)
++|..++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 81 g~L~~~l~-~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~---~~kl~Dfg~a~~~~~~~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQ-KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG---HIALCDFGLSKANLTDNKTTNTF 156 (330)
T ss_pred ChHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC---CEEEecCCcCcCCCCCCCCccCc
Confidence 99987775 456799999999999999999999999999999999999999988 8999999998642
Q ss_pred --CCCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 966 --GEKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 966 --~~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
+..|+|||++.+. .++.++|||||||++|+|++|..||.... +....+.......+. ..+++++.++|.+||
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L 233 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLL 233 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHc
Confidence 2246899999764 58999999999999999999999998653 223333332222222 347899999999999
Q ss_pred hhcccCCC----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCc
Q psy48 1041 QVKQRKRL----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNP 1083 (1098)
Q Consensus 1041 ~~dP~kRP----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~ 1083 (1098)
..||++|| ++.++++||||++ .+|..+.++ +.+|+++..
T Consensus 234 ~~~P~~R~~~~~~~~~ll~h~~~~~----~~~~~~~~~~~~~~~~~~~ 277 (330)
T cd05586 234 NRNPQHRLGAHRDAVELKEHPFFAD----IDWDLLSKKQITPPFKPIV 277 (330)
T ss_pred CCCHHHCCCCCCCHHHHhcCccccC----CCHHHHHhCCCCCCccCCC
Confidence 99999998 6899999999998 456666665 666655443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=335.62 Aligned_cols=254 Identities=27% Similarity=0.458 Sum_probs=210.1
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.+...||.|.+|.||.+.+..+++.||||++++... .......+.+|+.++..++|+||++++++|.+.+.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 46788899999999999999999999999999976322 23344668899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+.|++|..++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG---HIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC---CEEEEECCceeecCCCCCc
Confidence 9999999998876566799999999999999999999999999999999999999988 8999999998532
Q ss_pred -------CCCCCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhh--ccCCCCCCCcCc
Q psy48 966 -------GEKSFPPEVLRN-----KGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAA--FMYPPRPWRDIS 1029 (1098)
Q Consensus 966 -------~~~~~APEvl~~-----~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~--~~~p~~~~~~is 1029 (1098)
+..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ....+.... ...+. ....++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~ 237 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP-DVTDVS 237 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCC-ccCCCC
Confidence 234689999973 4578899999999999999999999976532 222232211 11222 234589
Q ss_pred HHHHHHHHHhhhhcccC--CCCHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1030 SDAIDLINNLLQVKQRK--RLSVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~k--RPSa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
.++.++|.+||..++++ |+++.++++||||.+ .+|..+...
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~----~~~~~~~~~ 280 (331)
T cd05597 238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG----IDWDNIRNS 280 (331)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC----CCHHHHhhC
Confidence 99999999998765444 789999999999998 566666554
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=327.11 Aligned_cols=243 Identities=29% Similarity=0.373 Sum_probs=194.2
Q ss_pred heeeeeeeeeeeeeceEEEEeec-CCceeEEEEEeccCCChHHHHHHHHHHHHHhcc---CCCCceeeeeeee-----cC
Q psy48 813 FMTYNVALCIAVVAGAACGVHRK-SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL---CHPGVVNLERMFE-----TP 883 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~-tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~L~~~f~-----~~ 883 (1098)
.|.+...||.|.+|.||.+.+.. +++.||||+++...........+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 46778899999999999999865 478899999976544333345566777777655 6999999999875 34
Q ss_pred CcEEEEEEeccCchHHHHHhh-ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 884 GRIFVVMEKLQGDMLEMILSS-EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~-~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
..+++||||+++ +|..++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~---~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG---QIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC---CEEEccccce
Confidence 569999999986 45556543 234589999999999999999999999999999999999999988 8999999998
Q ss_pred ccc-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCC-------
Q psy48 963 RII-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPP------- 1022 (1098)
Q Consensus 963 ~~~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~------- 1022 (1098)
+.. +..|+|||++.+..++.++|||||||++|||++|.+||.+..+. ...+........+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 643 23467999999999999999999999999999999999865432 2222211100000
Q ss_pred ----------------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1023 ----------------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1023 ----------------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
.....++..+.+++.+||+.||++|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=328.35 Aligned_cols=249 Identities=28% Similarity=0.495 Sum_probs=205.7
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC-----CcEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP-----GRIFV 888 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~-----~~l~L 888 (1098)
|.....+|.|.+|.|..|.++.+|+.||||.+.......-...+..+|+.+|+.++|+||+.+++++..+ +.+|+
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence 3335779999999999999999999999999976555566678899999999999999999999998652 45999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE- 967 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~- 967 (1098)
|+|+| +.+|..+++ .+..++..++..++.||+.||.|+|+.+|+||||||.|++++.+. .+||+|||+|+....
T Consensus 104 V~elM-etDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c---~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 104 VFELM-ETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC---DLKICDFGLARYLDKF 178 (359)
T ss_pred ehhHH-hhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC---CEEeccccceeecccc
Confidence 99999 566766665 334599999999999999999999999999999999999999988 799999999987731
Q ss_pred -------------CCCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc---------------
Q psy48 968 -------------KSFPPEVLR-NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF--------------- 1018 (1098)
Q Consensus 968 -------------~~~APEvl~-~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~--------------- 1018 (1098)
.|.|||++. ...|+.++||||+||+|.||++|++.|.+.+.+.+.-.....
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 234999985 577999999999999999999999999876543322111111
Q ss_pred ----------cCCCCC----CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcch
Q psy48 1019 ----------MYPPRP----WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSD 1067 (1098)
Q Consensus 1019 ----------~~p~~~----~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~ 1067 (1098)
..|+.+ +.+.++++.+|+.+||..||.+|+|++|+|+||||...-+..|
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 112211 3467899999999999999999999999999999997544443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=332.93 Aligned_cols=246 Identities=23% Similarity=0.349 Sum_probs=206.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|.+|.||.+.+..++..||+|+++... .......+.+|+++|+.++||||+++++++...+.+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 346777889999999999999999999999999997542 3344577999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~-gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
||+++++|..++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .++|+|||++...
T Consensus 83 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 83 EHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG---EIKLCDFGVSGQLIDSM 158 (331)
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC---cEEEccCcccccccccc
Confidence 99999999888764 44689999999999999999999986 699999999999999998 8999999998643
Q ss_pred ------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHH----------------------
Q psy48 966 ------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQN---------------------- 1015 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~---------------------- 1015 (1098)
...|+|||++.+..++.++|||||||++|||++|+.||.... ++...+..
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence 234679999999999999999999999999999999996432 11111100
Q ss_pred ---------------------hh-ccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1016 ---------------------AA-FMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1016 ---------------------~~-~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.. ...+......+++++.+||.+||..||++|||+.+|++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 00 00111112246889999999999999999999999999999986
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=337.04 Aligned_cols=247 Identities=26% Similarity=0.458 Sum_probs=203.1
Q ss_pred HHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC---
Q psy48 808 LLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG--- 884 (1098)
Q Consensus 808 ~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~--- 884 (1098)
.....+|.....||.|.+|.||.+.+..+|+.||||++.+..........+.+|+.+++.++||||+++++++...+
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 17 FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 34568899999999999999999999999999999999766544555677889999999999999999999986543
Q ss_pred ---cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCc
Q psy48 885 ---RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGF 961 (1098)
Q Consensus 885 ---~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGl 961 (1098)
.+|+||||++++++..+ . ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~-~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~---~~kl~Dfg~ 169 (359)
T cd07876 97 EFQDVYLVMELMDANLCQVI-H---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGL 169 (359)
T ss_pred ccceeEEEEeCCCcCHHHHH-h---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC---CEEEecCCC
Confidence 47999999988765433 2 2488899999999999999999999999999999999999998 899999999
Q ss_pred cccc-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHH-----------------
Q psy48 962 ARII-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI----------------- 1013 (1098)
Q Consensus 962 a~~~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i----------------- 1013 (1098)
++.. +..|+|||++.+..++.++|||||||++|+|++|+.||.+.+......
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 8643 234689999999999999999999999999999999997653221100
Q ss_pred ----HH---hhccCCC----------------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1014 ----QN---AAFMYPP----------------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1014 ----~~---~~~~~p~----------------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.. ....++. ......++++.+||.+||..||++|||+.|+++||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00 0000000 001124678999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=356.08 Aligned_cols=210 Identities=21% Similarity=0.339 Sum_probs=142.5
Q ss_pred eccceeeeeeecccccHHHHHHHHHHHHHhhh-----hccceecccccccccccccCCccccccccceeeccc------C
Q psy48 29 FGLIRDTVSAEVCSLNLKSIKELACNFINAKR-----KRHYWRLDSKCLTLFQSESGSKYYKEIPLSEILGIE------P 97 (1098)
Q Consensus 29 ~g~~re~v~~~~~~~~l~~~~~~a~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~e~~~~~------~ 97 (1098)
=|-.++.|++....+ -.++-+.-++++..+- ..+.|-.....-+++....-+.......-.-+...+ .
T Consensus 65 ~~~~~~i~v~~~~~~-~~~~~~a~~~~~~e~~k~~~~~~~~w~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (694)
T KOG0694|consen 65 AGGAKNIIVLLKSPD-PKALSEAQLSLQEESQKLLALEQRLWVLIEELGTLLKPAALTGTLEPGRTKSVFSPEPFFSKPR 143 (694)
T ss_pred cCCceEEEEEecCCc-chhhHHHhHHHHHHHHHHHhhhhhhccccccccceeeeecccCcCCcCccccccccCccccCcc
Confidence 355567777766633 3335555555555332 236666654443333322222111111100000011 1
Q ss_pred CCCCcccceeEEeeeeeeeEeeccCCccccccccCCccchhhhhhhhhccccCCChhHHHhhhcccccccceEEEEeecc
Q psy48 98 CKPLTHELQQVQIRPHTLTVHSYKAPTFSLKTIIPNHGLTRLLDRLMLFRHDYTYPNVLLIINAVSDIVDETVVEIVLAG 177 (1098)
Q Consensus 98 ~~~~~~~~~~~~~~~h~~~~~~~~~p~f~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~g~~c~~ 177 (1098)
...+....+-.+|..|.+-.+++++||||.+| +.++|| +..| |+.|++
T Consensus 144 rrga~~~~kVhei~gH~F~aT~l~Qpt~Cs~C------------~kFi~g-----------------L~kq---GyQCqv 191 (694)
T KOG0694|consen 144 RRGAISQSKVHEIDGHKFGATSLRQPTFCSWC------------QKFIWG-----------------LRKQ---GYQCQV 191 (694)
T ss_pred cccccccceeEEeeCcEEEEeeccCcchhhhh------------hhheec-----------------cCCC---ceEEee
Confidence 11122223447899999999999999999998 789999 7777 999999
Q ss_pred CCccccccccccccCCCCCCcccccCCccccCCCCCcCCCCCcccCCCCCccCCCccCCCCCCCCCCCCCCCCCCCCCCC
Q psy48 178 CSLNFHKRCVVKIPNNCSSGYKHRRSSTLHVPHSTSETGSNSSIASDDSNYTSSSFSTKPSSRSPSLTSRTDALSPTSPG 257 (1098)
Q Consensus 178 C~~~~HKrC~~~i~~~C~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~ 257 (1098)
|.+++||+||.||+..|.+.... ++..+ ....
T Consensus 192 C~~vvHKkCh~kvv~~C~~~~~~---------------------n~e~q---------------------------~~~~ 223 (694)
T KOG0694|consen 192 CWRVVHKKCHVKVVTLCDFLDNL---------------------NSEPQ---------------------------GFLF 223 (694)
T ss_pred eeehHhhhhHHHHHHhccCcCcc---------------------CcCCc---------------------------cccc
Confidence 99999999999999999854320 00000 0111
Q ss_pred CCCCCCCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCCCCc
Q psy48 258 APSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPV 320 (1098)
Q Consensus 258 ~~~~~~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~~~~ 320 (1098)
+ ..+.+||+|..++|.+|+||+|||+++||+.+||++|..|++|||.+|..+|+++|+....
T Consensus 224 ~-~~~~~Phrf~~~~~q~ptFc~hCGs~L~r~~qqGlkCs~Cg~n~H~~c~~~va~~CG~s~t 285 (694)
T KOG0694|consen 224 E-FTFRNPHRFVKLNRQRPTFCDHCGSVLYRLRQQGLKCSTCGRNVHNRCVENLAPNCGGSRT 285 (694)
T ss_pred c-ccccCCCcchhhhccCccHHHhcchhhhhhcccCeeehhhhccccHHHHHhcccCCCCchh
Confidence 2 4467899999999999999999999999999999999999999999999999999976543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=339.41 Aligned_cols=240 Identities=29% Similarity=0.417 Sum_probs=199.9
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
+.....||.|.+|.||.+.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+++||||+
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 344567999999999999999999999999996532 2344577899999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-------
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------- 966 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------- 966 (1098)
.+++|... ....+..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 155 ~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kL~DfG~~~~~~~~~~~~~ 226 (353)
T PLN00034 155 DGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK---NVKIADFGVSRILAQTMDPCN 226 (353)
T ss_pred CCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC---CEEEcccccceeccccccccc
Confidence 99988543 2356788889999999999999999999999999999999988 89999999986432
Q ss_pred -----CCCCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 967 -----EKSFPPEVLRN-----KGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 967 -----~~~~APEvl~~-----~~ys~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
..|+|||++.. ..++.++|||||||++|||++|+.||... .+....+.......+......++.++.+
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 306 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRH 306 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHH
Confidence 24679998843 33457899999999999999999999742 2333333333333334444568899999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
||.+||..||++||++.++++||||...
T Consensus 307 li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 307 FISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccccC
Confidence 9999999999999999999999999984
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=317.62 Aligned_cols=243 Identities=27% Similarity=0.353 Sum_probs=207.6
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH---HHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK---QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
.|.....+|.|.++.+|.+.+..+++.||+|++........ ....+.+|+.+++.++||||+++++++...+.+++|
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 35678899999999999999999999999999876443222 235788999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||+++++|..++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++ .++|+|||+++...
T Consensus 83 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~---~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 83 MEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG---NVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEeecccceeccccc
Confidence 999999999888763 45689999999999999999999999999999999999999888 89999999986431
Q ss_pred ------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 967 ------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 967 ------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
..++|||++.+..++.++||||||+++|||++|+.||...+....................++.++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 23579999999999999999999999999999999997654443333322222333334568899999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
+|.+||..+|++||++.++++|+||
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=324.09 Aligned_cols=242 Identities=30% Similarity=0.432 Sum_probs=194.2
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc---CCCCceeeeeeeec-----CCc
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL---CHPGVVNLERMFET-----PGR 885 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~L~~~f~~-----~~~ 885 (1098)
|.....||.|++|.||.+.++.+++.||+|+++...........+.+|+.+++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 6677899999999999999999999999999976443333334566777777655 69999999998854 345
Q ss_pred EEEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 886 IFVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
+++||||+.++ |..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 82 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~---~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVDQD-LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG---QVKLADFGLARI 157 (288)
T ss_pred EEEEEcccccC-HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---CEEECccCcccc
Confidence 89999999874 54555433 34589999999999999999999999999999999999999988 899999999865
Q ss_pred cC-----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhcc-----CC-----
Q psy48 965 IG-----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFM-----YP----- 1021 (1098)
Q Consensus 965 ~~-----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~-----~p----- 1021 (1098)
.. ..++|||++.+..++.++|||||||++|+|++|.+||....... ..+...... ++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 42 23689999999999999999999999999999999997653321 111111000 00
Q ss_pred ------C-------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1022 ------P-------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1022 ------~-------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
. .....++.++.++|.+||+.||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.57 Aligned_cols=260 Identities=35% Similarity=0.542 Sum_probs=220.1
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|++...||.|.++.+|.+.+..+++.||+|++++.... ......+.+|+++++++.||||+++++++...+.+++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 477889999999999999999999999999999764332 2345678999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
|+++++|..++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++ .++|+|||++....
T Consensus 82 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~---~~kl~dfg~~~~~~~~~~~ 157 (290)
T cd05580 82 YVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG---YIKITDFGFAKRVKGRTYT 157 (290)
T ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC---CEEEeeCCCccccCCCCCC
Confidence 9999999888764 36799999999999999999999999999999999999999998 89999999987542
Q ss_pred ----CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 967 ----EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 967 ----~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
..++|||.+.+..++.++|+||||+++|+|++|..||...... .+.+.... ......++..+.++|.+||
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l 233 (290)
T cd05580 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK----VRFPSFFSPDAKDLIRNLL 233 (290)
T ss_pred CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----ccCCccCCHHHHHHHHHHc
Confidence 2367999999888999999999999999999999999765422 22222222 2223457899999999999
Q ss_pred hhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcc
Q psy48 1041 QVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPK 1084 (1098)
Q Consensus 1041 ~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~ 1084 (1098)
+.||.+|+ +++++++||||+. .+|..++.. +.+|+.+..+
T Consensus 234 ~~~p~~R~~~~~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 279 (290)
T cd05580 234 QVDLTKRLGNLKNGVNDIKNHPWFAG----IDWIALLQRKIEAPFIPKVK 279 (290)
T ss_pred cCCHHHccCcccCCHHHHHcCccccc----CCHHHHhhccCCCCccCCCC
Confidence 99999999 8999999999998 555666655 7777766543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=333.06 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=208.5
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.+...||.|.+|.||.+.++.+++.||||++.+... .......+.+|+.++..++|+||+++++++.+.+.+|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 46788899999999999999999999999999976322 22334568889999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+.|++|..++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~---~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG---HIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC---CEEEEeccceeeccCCCce
Confidence 9999999999876566899999999999999999999999999999999999999888 8999999998543
Q ss_pred -------CCCCCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCC-CCCCCcCcH
Q psy48 966 -------GEKSFPPEVLRN-----KGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYP-PRPWRDISS 1030 (1098)
Q Consensus 966 -------~~~~~APEvl~~-----~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p-~~~~~~is~ 1030 (1098)
...|+|||++.+ ..++.++|||||||+||||++|+.||..... ....+.......+ +..+..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 234689999976 5688999999999999999999999986543 2222222111111 222346789
Q ss_pred HHHHHHHHhhhhcccC--CCCHHHHHcCCCcCCCCCcchhHHH
Q psy48 1031 DAIDLINNLLQVKQRK--RLSVDKSLAHPWLQDPATWSDLRGL 1071 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~k--RPSa~eIL~HpfFk~~~~~~~~~~l 1071 (1098)
++.++|.+||..++.+ |++++++++|+||+. .+|+.+
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~----~~~~~~ 277 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG----IDWENI 277 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC----CCHHHH
Confidence 9999999999876654 468999999999998 455544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=315.73 Aligned_cols=246 Identities=32% Similarity=0.575 Sum_probs=216.5
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC------hHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCC
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP------TKQEAQLKNEVAILQNL-CHPGVVNLERMFETPG 884 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~------~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~ 884 (1098)
..|.-...+|.|..+.|....++.+|..+|+|++...... ..-.++..+|+.+|+++ .||+|+.+.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3455567888999999999999999999999999653211 12235678899999988 6999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
.+|+|+|.++.|-|.+++. ..-.++++.++.+++|++.|+.|||.++||||||||+|||++++- .++|+|||++..
T Consensus 97 F~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~---~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM---NIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc---ceEEeccceeec
Confidence 9999999999999999986 445799999999999999999999999999999999999999988 899999999974
Q ss_pred c-----------CCCCCChhhhc------cCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCC
Q psy48 965 I-----------GEKSFPPEVLR------NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPW 1025 (1098)
Q Consensus 965 ~-----------~~~~~APEvl~------~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~ 1025 (1098)
+ ++.|.|||.+. ...|+..+|+||.||+||.|+.|.+||-.... ....++...+.+....|
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 4 44568999985 35699999999999999999999999987654 34667788888988999
Q ss_pred CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1026 RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1026 ~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.++|.+..+||.+||..||.+|.|++++|.||||..
T Consensus 253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 999999999999999999999999999999999964
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=332.25 Aligned_cols=255 Identities=24% Similarity=0.426 Sum_probs=209.9
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.+...||.|.||.||.+.++.+++.||+|++.+... .......+.+|+.++..++|+||+++++++.+.+.+++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 46778899999999999999999999999999975322 22234568889999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+.+++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~---~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG---HIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC---CEEEeecchheecccCCcc
Confidence 9999999999876667899999999999999999999999999999999999999888 8999999988532
Q ss_pred -------CCCCCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccC-CCCCCCcCcH
Q psy48 966 -------GEKSFPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMY-PPRPWRDISS 1030 (1098)
Q Consensus 966 -------~~~~~APEvl~-----~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~-p~~~~~~is~ 1030 (1098)
+..|+|||++. ...++.++|||||||++|||++|+.||...... ...+....... .+..+..+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 23468999986 346889999999999999999999999865432 22222211111 1122346899
Q ss_pred HHHHHHHHhhhhcccC--CCCHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1031 DAIDLINNLLQVKQRK--RLSVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~k--RPSa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
++.+||.+||..++++ |++++++++||||++ ++|+.+.+.
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~----~~~~~~~~~ 280 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG----IDWDNIRNC 280 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC----CCHHHHhhC
Confidence 9999999999765544 689999999999998 566666543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=320.79 Aligned_cols=242 Identities=35% Similarity=0.612 Sum_probs=215.8
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccC
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
...||.|.++.|...+...+|..||||++.|. ....+..+.+|++++... .|+||++|+++|+++.++|||||.+.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 45689999999999999999999999999875 355678899999999887 599999999999999999999999999
Q ss_pred chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----------
Q psy48 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------- 965 (1098)
Q Consensus 896 gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---------- 965 (1098)
|.|...+. +...|.+..+..+..+|+.||.|||.+||.||||||+|||-...+.-.-|||+||.+..-+
T Consensus 161 GplLshI~-~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 161 GPLLSHIQ-KRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred chHHHHHH-HhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 99877765 4557999999999999999999999999999999999999987665457999999987422
Q ss_pred ---------CCCCCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----------------hhHHHHHH
Q psy48 966 ---------GEKSFPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSGTFPFNED-----------------EDINEQIQ 1014 (1098)
Q Consensus 966 ---------~~~~~APEvl~-----~~~ys~~sDVwSLGvlLyELltG~~Pf~~~-----------------~~~~~~i~ 1014 (1098)
...+||||+.. ...|+.+.|.|||||+||-||.|.+||.+. +.+++.|+
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 11248999874 345999999999999999999999999642 35889999
Q ss_pred HhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1015 NAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1015 ~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+..+.+|...|..+|.++.+++..+|..|+..|.++.++++|||++.
T Consensus 320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 99999999999999999999999999999999999999999999997
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=321.46 Aligned_cols=255 Identities=30% Similarity=0.423 Sum_probs=212.9
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchH
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDML 898 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL 898 (1098)
||.|.+|.||.+.+..+|+.||+|++.+.... ......+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 57899999999999999999999999764332 22345677899999999999999999999999999999999999999
Q ss_pred HHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----------
Q psy48 899 EMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----------- 966 (1098)
Q Consensus 899 ~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----------- 966 (1098)
..++.... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++ .++|+|||++....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG---NVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC---CEEEccCcchhhhccCCccccccCC
Confidence 88876543 3689999999999999999999999999999999999999988 89999999886432
Q ss_pred CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcc
Q psy48 967 EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQ 1044 (1098)
Q Consensus 967 ~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP 1044 (1098)
..++|||.+.+..++.++|+||||+++|+|++|+.||..... ....+.......+...+..+++++.++|.+||+.||
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence 245799999988899999999999999999999999975432 222233333333334445678999999999999999
Q ss_pred cCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1045 RKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1045 ~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
++|| ++.++++||||++ .+|+.+... ..+|+.+
T Consensus 238 ~~R~~~~~~~~~~ll~h~~~~~----~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 238 EKRLGCRGGSADEVREHPLFKD----LNWRRLEAGMLEPPFIP 276 (277)
T ss_pred hHccCCCcccHHHHHhChhhhc----CChhhhhcCCCCCCCCC
Confidence 9999 8888999999998 677777665 5555544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=332.91 Aligned_cols=246 Identities=25% Similarity=0.447 Sum_probs=202.0
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC-----
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP----- 883 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~----- 883 (1098)
....+|.....||.|++|.||.+.+..+++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 456789999999999999999999999999999999976554455567788999999999999999999998644
Q ss_pred -CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 884 -GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 884 -~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
..+++||||++++.+. .+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~~~~lv~e~~~~~l~~-~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~---~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcccHHH-HHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC---CEEEeeCccc
Confidence 3579999999886553 432 2488999999999999999999999999999999999999988 8999999998
Q ss_pred cccC-----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHH---HHhh-----------
Q psy48 963 RIIG-----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI---QNAA----------- 1017 (1098)
Q Consensus 963 ~~~~-----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i---~~~~----------- 1017 (1098)
+..+ ..|+|||++.+..++.++|||||||++|+|++|+.||.+........ ....
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 7542 24679999999999999999999999999999999998654221111 0000
Q ss_pred -------c---c-----CC-----------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1018 -------F---M-----YP-----------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1018 -------~---~-----~p-----------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
. . .+ .......+.++.+||.+||..||++|||+.++++||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 0 0 00 0011224568899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=327.18 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=202.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|++|.||.+.++.+++.||||+++.... ......+.+|+.+++.++|+||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 3567888999999999999999999999999999975432 223346778999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||++++ |..++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 84 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 84 EYLDKD-LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG---ELKLADFGLARAKSVPTK 159 (309)
T ss_pred eCCCCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---CEEECccccceecCCCcc
Confidence 999875 5456555555689999999999999999999999999999999999999988 8999999998642
Q ss_pred -------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHh-------------------
Q psy48 966 -------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNA------------------- 1016 (1098)
Q Consensus 966 -------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~------------------- 1016 (1098)
+..++|||++.+ ..++.++||||||+++|+|++|+.||.+... ....+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 223579999865 5689999999999999999999999976432 11111110
Q ss_pred hccCCCC-------CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1017 AFMYPPR-------PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1017 ~~~~p~~-------~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
...++.. ....++.++.+||.+||..||.+|||+.++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 0011110 11247889999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.13 Aligned_cols=243 Identities=19% Similarity=0.286 Sum_probs=198.3
Q ss_pred eeeeee--eeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccC
Q psy48 818 VALCIA--VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 818 ~~Lg~G--~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
..||.| .++.||.+.++.+|+.||||+++...........+.+|+.+++.++||||++++++|..++..++||||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 456777 678899999999999999999977655555567888999999999999999999999999999999999999
Q ss_pred chHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---------
Q psy48 896 DMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--------- 965 (1098)
Q Consensus 896 gsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--------- 965 (1098)
++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .++++||+.+...
T Consensus 84 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~---~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 84 GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG---KVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC---cEEEcccchhhccccccccccc
Confidence 9998887643 34589999999999999999999999999999999999999988 8999999754211
Q ss_pred ----------CCCCCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCC------------
Q psy48 966 ----------GEKSFPPEVLRN--KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYP------------ 1021 (1098)
Q Consensus 966 ----------~~~~~APEvl~~--~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p------------ 1021 (1098)
...|+|||++.+ ..|+.++|||||||++|||++|..||.................+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 123689999976 46899999999999999999999999754322111111100000
Q ss_pred --------------------------------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1022 --------------------------------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1022 --------------------------------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
......+++++.+||.+||+.||++|||++++++||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 000123567899999999999999999999999999998743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.61 Aligned_cols=242 Identities=28% Similarity=0.439 Sum_probs=199.8
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|+....||.|.++.||.+.+..+++.||||+++...........+.+|+.+++.++||||+++++++..++.+++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 56778899999999999999999999999999765444444567889999999999999999999999999999999999
Q ss_pred cCchHHHHHhhc--cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 894 QGDMLEMILSSE--KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 894 ~ggsL~~~l~~~--~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
.++ |..++... ...+++..++.++.||+.||+|||++||+||||||+||+++.++ .++|+|||++...
T Consensus 82 ~~~-l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 82 SMD-LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG---VIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CCC-HHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC---cEEECcccceeecCCCccc
Confidence 864 54555432 25689999999999999999999999999999999999999988 8999999998643
Q ss_pred ------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc--------------------
Q psy48 966 ------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF-------------------- 1018 (1098)
Q Consensus 966 ------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~-------------------- 1018 (1098)
...++|||++.+ ..++.++||||||+++|+|++|+.||.+..+..........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 234679999875 45789999999999999999999999866433222111000
Q ss_pred cCC-------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1019 MYP-------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1019 ~~p-------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
..+ ...+..+++++.++|.+||..||++|||+.+|++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000 01123578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=333.06 Aligned_cols=246 Identities=26% Similarity=0.444 Sum_probs=201.4
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC-----
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP----- 883 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~----- 883 (1098)
....+|.....||.|++|.||.+.+..+++.||||++.+..........+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 456789999999999999999999999999999999976554455567788999999999999999999987543
Q ss_pred -CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 884 -GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 884 -~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
..+|+||||++++.+ ..+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 101 ~~~~~lv~e~~~~~l~-~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~~kL~DfG~a 173 (364)
T cd07875 101 FQDVYIVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLA 173 (364)
T ss_pred cCeEEEEEeCCCCCHH-HHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC---cEEEEeCCCc
Confidence 357999999988655 4443 2478899999999999999999999999999999999999988 8999999998
Q ss_pred cccC-----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc-------------
Q psy48 963 RIIG-----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF------------- 1018 (1098)
Q Consensus 963 ~~~~-----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~------------- 1018 (1098)
+..+ ..|+|||++.+..++.++|||||||++|+|++|+.||.+.+...........
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 6432 2357999999999999999999999999999999999765432111100000
Q ss_pred --------cCC-------------------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1019 --------MYP-------------------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1019 --------~~p-------------------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..+ .......+.++.+||.+||..||.+|||+.++++||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000 0001123567899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=311.32 Aligned_cols=242 Identities=25% Similarity=0.376 Sum_probs=208.7
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.+...++.|.++.+|.+.+..+++.||+|.+............+.+|+.+++.++||||+++++++...+.+++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 56778899999999999999999999999999876555666788999999999999999999999999999999999999
Q ss_pred cCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----
Q psy48 894 QGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----- 967 (1098)
Q Consensus 894 ~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----- 967 (1098)
++++|..++... ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++ .++|+|||+++....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~---~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD---NVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC---CEEEcccccceeccCccchh
Confidence 999999988754 45789999999999999999999999999999999999999988 899999998875422
Q ss_pred -------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 968 -------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 968 -------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
.++|||++.+..++.++|+||||+++|+|++|+.||.................+ .....++.++.+++.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l 237 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQCL 237 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCccccCHHHHHHHHHHc
Confidence 257999999999999999999999999999999999865432221111111222 222367899999999999
Q ss_pred hhcccCCCCHHHHHcCCCc
Q psy48 1041 QVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1041 ~~dP~kRPSa~eIL~HpfF 1059 (1098)
+.+|++||++.++++|||+
T Consensus 238 ~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 238 TKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred cCCcccCcCHHHHhhCCCC
Confidence 9999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=323.87 Aligned_cols=256 Identities=28% Similarity=0.369 Sum_probs=214.1
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.....+|.|.+|.+|.+.+..+++.||||.+.+..... .....+.+|+++++.++|+||+++++.+......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 4667788999999999999999999999999998755433 345678999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 892 KLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
|+.|++|..++... ...+++..+..++.||+.||+|||+.|++|+||||+||+++.++ .++|+|||++...
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG---HIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC---CEEEeecchhhccccccc
Confidence 99999998887643 35699999999999999999999999999999999999999988 8999999987532
Q ss_pred ------------------------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH
Q psy48 966 ------------------------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI 1009 (1098)
Q Consensus 966 ------------------------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~ 1009 (1098)
...|+|||++.+..++.++||||||+++|+|++|..||.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 12368999999999999999999999999999999999765433
Q ss_pred HHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCC----HHHHHcCCCcCCCCCcchhHHHHhhh
Q psy48 1010 NEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS----VDKSLAHPWLQDPATWSDLRGLERQI 1075 (1098)
Q Consensus 1010 ~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPS----a~eIL~HpfFk~~~~~~~~~~l~~~~ 1075 (1098)
..................++.++.++|.+||..||++||+ ++++++||||+. .+|..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~----~~~~~~~~~~ 304 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG----VNWALIRHTT 304 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc----CChhhcccCC
Confidence 2222111111111112237899999999999999999999 999999999998 5566555543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.08 Aligned_cols=243 Identities=30% Similarity=0.479 Sum_probs=216.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH-HHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..+-.+..||.|-||.||.|..++++-.||+|++.|..+... ...++.+|++|-..++||||+++|++|-+..++|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 344567889999999999999999999999999988654333 3478999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhh-ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 891 EKLQGDMLEMILSS-EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~-~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
||...|.+...+.. ...+|++..+..|+.|++.||.|+|.+++|||||||+|+|++..+ .+||+|||.+...+
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~---~lkiAdfGwsV~~p~~k 178 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG---ELKIADFGWSVHAPSNK 178 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC---CeeccCCCceeecCCCC
Confidence 99998888877763 445799999999999999999999999999999999999999999 89999999875432
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
-.|.+||...+..++..+|+|++|++.||++.|.+||... .+..+.+......+| ..++.++.++|.
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dlI~ 254 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADLIS 254 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHHHH
Confidence 2346999999999999999999999999999999999854 566777888777777 468999999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+||.++|.+|.+..|+++|||...
T Consensus 255 ~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 255 RLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHhccCccccccHHHHhhhHHHHh
Confidence 999999999999999999999875
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=343.66 Aligned_cols=241 Identities=26% Similarity=0.364 Sum_probs=193.2
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--------
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP-------- 883 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~-------- 883 (1098)
..|.....||.|+||.||.+.+..+++.||||++.... ....+|+.+|+.++||||++++++|...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 46889999999999999999999999999999985432 2345799999999999999998887432
Q ss_pred CcEEEEEEeccCchHHHHHh---hccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 884 GRIFVVMEKLQGDMLEMILS---SEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~---~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
..+++||||++++.. .++. .....+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||
T Consensus 140 ~~l~lvmE~~~~~l~-~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~--~vkL~DFG 216 (440)
T PTZ00036 140 IFLNVVMEFIPQTVH-KYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH--TLKLCDFG 216 (440)
T ss_pred eEEEEEEecCCccHH-HHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC--ceeeeccc
Confidence 247799999998654 3332 23457999999999999999999999999999999999999987652 69999999
Q ss_pred ccccc-----------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhh-----------
Q psy48 961 FARII-----------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAA----------- 1017 (1098)
Q Consensus 961 la~~~-----------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~----------- 1017 (1098)
+|+.. +..|+|||++.+ ..|+.++|||||||+||||++|.+||.+............
T Consensus 217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 99743 233689999876 4699999999999999999999999987543221111110
Q ss_pred --------ccCCCC--------CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1018 --------FMYPPR--------PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1018 --------~~~p~~--------~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..++.. .....++++.+||.+||.+||.+|||+.++++||||++
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 001110 01246789999999999999999999999999999986
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.29 Aligned_cols=243 Identities=27% Similarity=0.402 Sum_probs=199.2
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
+|.+...||.|.++.||.+.+..+|+.||+|+++...........+.+|+.+++.++|+||+++++++.+...+++||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 36677889999999999999999999999999976544333446678899999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------ 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------ 966 (1098)
++++.+ .++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||+++..+
T Consensus 81 ~~~~l~-~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 81 CDQDLK-KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG---ELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred CCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC---cEEECccchhhccCCCCCCc
Confidence 987544 55554556799999999999999999999999999999999999999988 89999999987432
Q ss_pred ------CCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHh---hc-----------------c
Q psy48 967 ------EKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNA---AF-----------------M 1019 (1098)
Q Consensus 967 ------~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~---~~-----------------~ 1019 (1098)
..++|||++.+. .++.++|||||||++|+|++|..|+....+..+.+... .. .
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 235799998764 47999999999999999999998865432221111110 00 0
Q ss_pred CCC--------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1020 YPP--------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1020 ~p~--------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
++. .....++.++.++|.+||..||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000 0112468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=334.46 Aligned_cols=242 Identities=29% Similarity=0.450 Sum_probs=198.5
Q ss_pred eeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC-----cEEEE
Q psy48 815 TYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG-----RIFVV 889 (1098)
Q Consensus 815 ~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~-----~l~LV 889 (1098)
.....||.|++|.||.+.+..+++.||||++............+.+|+.+++.++|+||+++++++...+ .+|+|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 4567899999999999999999999999999764433445567889999999999999999999998776 79999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||+.++.+ .++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 83 ~e~~~~~l~-~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~---~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 83 TELMQSDLH-KIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC---VLKICDFGLARVEEPDE 157 (372)
T ss_pred eeccccCHH-HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC---CEEeccccceeecccCc
Confidence 999986544 4443 345799999999999999999999999999999999999999988 8999999998643
Q ss_pred ---------CCCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHh-----------------
Q psy48 966 ---------GEKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNA----------------- 1016 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~----------------- 1016 (1098)
+..|+|||++.+. .++.++|||||||++|||++|+.||.+..... ..+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 2236899999874 48999999999999999999999997653221 111100
Q ss_pred --h---ccCCC------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1017 --A---FMYPP------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1017 --~---~~~p~------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
. ...++ ......++++.+||.+||+.||++|||+.++++||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 0 00010 112346789999999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.82 Aligned_cols=247 Identities=30% Similarity=0.463 Sum_probs=203.3
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCC-ceeeeeeeecCC------cEEEE
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPG-VVNLERMFETPG------RIFVV 889 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~L~~~f~~~~------~l~LV 889 (1098)
-..+|.|+||.||.|+.+.+|+.||+|.++.+...........+|+.+|+.++|+| |+.|++++.+.+ .+++|
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 34589999999999999999999999999875433334466789999999999999 999999998877 89999
Q ss_pred EEeccCchHHHHHhhcc---CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 890 MEKLQGDMLEMILSSEK---GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~---~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
+||+.-+ |..++.... ..++...+..+++||+.||+|||++||+||||||+||||+++| .+||+|||+|+...
T Consensus 96 fe~~d~D-L~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G---~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 96 FEFLDRD-LKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG---VLKLADFGLARAFS 171 (323)
T ss_pred EEeeccc-HHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC---cEeeeccchHHHhc
Confidence 9999765 556665443 3577789999999999999999999999999999999999998 89999999998553
Q ss_pred C------------CCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCC--CCC------
Q psy48 967 E------------KSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPP--RPW------ 1025 (1098)
Q Consensus 967 ~------------~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~--~~~------ 1025 (1098)
- .|.|||++.+. .|+..+||||+||+++||++++..|.++.+..+..........+ ..|
T Consensus 172 ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~ 251 (323)
T KOG0594|consen 172 IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSL 251 (323)
T ss_pred CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccc
Confidence 2 23599999886 79999999999999999999999999887654444322222111 111
Q ss_pred --------------------CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcch
Q psy48 1026 --------------------RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSD 1067 (1098)
Q Consensus 1026 --------------------~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~ 1067 (1098)
...+.++.+++.+||+++|.+|.|+..++.||||+....+..
T Consensus 252 ~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~ 313 (323)
T KOG0594|consen 252 PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS 313 (323)
T ss_pred ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence 123358999999999999999999999999999998544443
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.15 Aligned_cols=242 Identities=36% Similarity=0.554 Sum_probs=204.0
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.+...||.|.+|.||.+.+..+++.||+|++..............+|+.+++.++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 67789999999999999999999999999999876544444445567999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--------
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-------- 965 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-------- 965 (1098)
.+++|..++. ....+++..+..++.||+.||.+||+.||+|+||||+||+++.++ .++|+|||++...
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~---~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG---EVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS---EEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccc-ccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence 9999988887 556799999999999999999999999999999999999999888 8999999998642
Q ss_pred ----CCCCCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHh---hccCCCCCCCcCcHHHHHH
Q psy48 966 ----GEKSFPPEVLR-NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNA---AFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 966 ----~~~~~APEvl~-~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~---~~~~p~~~~~~is~el~~L 1035 (1098)
...++|||++. +..++.++||||||+++|+|++|..||.... +....+... ........+...+.++.++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence 12247999998 8889999999999999999999999998761 221222111 1111111112234899999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
|.+||+.||++||++.++++||||
T Consensus 237 i~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHccCChhHCcCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=328.53 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=205.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|.....||.|.+|.||.+.+..++..+|+|+++... .......+.+|+++++.++|+||++++++|.+.+.+++|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 56778889999999999999999999999999987642 34445779999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~-gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
|+.+++|..++.. .+.+++..+..++.+|+.||.|||+. +|+||||||+|||++.++ .+||+|||++...
T Consensus 84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~---~~kL~Dfg~~~~~~~~~~ 159 (333)
T cd06650 84 HMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG---EIKLCDFGVSGQLIDSMA 159 (333)
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC---CEEEeeCCcchhhhhhcc
Confidence 9999999888864 45689999999999999999999975 799999999999999988 8999999998643
Q ss_pred -----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHH------------------------
Q psy48 966 -----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQ------------------------ 1014 (1098)
Q Consensus 966 -----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~------------------------ 1014 (1098)
...|+|||++.+..++.++|||||||++|+|++|+.||..... +...+.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 2346899999999999999999999999999999999975321 111000
Q ss_pred -----------------HhhccC-CCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1015 -----------------NAAFMY-PPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1015 -----------------~~~~~~-p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
...... +......++.++.+||.+||++||++||++.++++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000000 000112357889999999999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=329.57 Aligned_cols=237 Identities=24% Similarity=0.357 Sum_probs=195.8
Q ss_pred hheeeeeeeeeeeeeceEEEEe-----ecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecC-C
Q psy48 812 VFMTYNVALCIAVVAGAACGVH-----RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETP-G 884 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~-----k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~-~ 884 (1098)
.+|.+...||.|+||.||.+.+ ..+++.||||+++... .......+.+|+.+|..+ +||||+++++++... +
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 4678889999999999999975 3456789999997532 234456789999999999 899999999988664 4
Q ss_pred cEEEEEEeccCchHHHHHhhcc----------------------------------------------------------
Q psy48 885 RIFVVMEKLQGDMLEMILSSEK---------------------------------------------------------- 906 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~---------------------------------------------------------- 906 (1098)
.+++||||+++|+|..++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6899999999999988886431
Q ss_pred ---CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--------------CCC
Q psy48 907 ---GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--------------EKS 969 (1098)
Q Consensus 907 ---~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--------------~~~ 969 (1098)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~---~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC---cEEEeecccccccccCcchhcccCCCCCccc
Confidence 2377788899999999999999999999999999999999888 89999999986431 247
Q ss_pred CChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh---hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhccc
Q psy48 970 FPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE---DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQR 1045 (1098)
Q Consensus 970 ~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~---~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~ 1045 (1098)
+|||++.+..++.++|||||||+||||++ |..||.... .....+... ........+++++.+++.+||..||+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~ 319 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG---TRMRAPENATPEIYRIMLACWQGDPK 319 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHccCChh
Confidence 89999999999999999999999999997 999997643 222222222 12223356889999999999999999
Q ss_pred CCCCHHHHHc
Q psy48 1046 KRLSVDKSLA 1055 (1098)
Q Consensus 1046 kRPSa~eIL~ 1055 (1098)
+||++.++++
T Consensus 320 ~RPs~~el~~ 329 (338)
T cd05102 320 ERPTFSALVE 329 (338)
T ss_pred hCcCHHHHHH
Confidence 9999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=309.71 Aligned_cols=242 Identities=27% Similarity=0.390 Sum_probs=205.7
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC-CcEEEEEEe
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP-GRIFVVMEK 892 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~-~~l~LVmEy 892 (1098)
|.+...+|.|.++.+|.+.++.+++.||+|.+............+.+|+.+++.++|+|++++++.+... ..+++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 6788899999999999999999999999999977655555667789999999999999999999988644 468999999
Q ss_pred ccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 893 LQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
+++++|..++... ...+++.+++.++.+++.||++||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~---~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN---IIKVGDLGIARVLENQCDM 158 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC---cEEEecccceEEecccCCc
Confidence 9999998887653 34589999999999999999999999999999999999999888 89999999986432
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
..++|||++.+..++.++||||||+++|+|++|+.||...+....... ......+.....+++++.+++.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR-IIEGKLPPMPKDYSPELGELIATM 237 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHhcCCCCCccccCHHHHHHHHHH
Confidence 235799999999999999999999999999999999976543222111 111122223356889999999999
Q ss_pred hhhcccCCCCHHHHHcCCCc
Q psy48 1040 LQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfF 1059 (1098)
|+.||++||++.++++||||
T Consensus 238 l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 238 LSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred hccCcccCCCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=336.47 Aligned_cols=238 Identities=23% Similarity=0.318 Sum_probs=195.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|++|.||.+.+..+++.||||.... ..+.+|+++|+.++||||++++++|......++||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 3568899999999999999999999999999997532 34678999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
|++.+. |..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 163 e~~~~~-L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~---~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 163 PRYKTD-LYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG---DVCLGDFGAACFPVDINA 237 (391)
T ss_pred ecCCCC-HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC---CEEEEeCCcccccccccc
Confidence 999765 5455543 35689999999999999999999999999999999999999988 8999999998532
Q ss_pred --------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh---------HHHHHHHhh-----------
Q psy48 966 --------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED---------INEQIQNAA----------- 1017 (1098)
Q Consensus 966 --------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~---------~~~~i~~~~----------- 1017 (1098)
+..++|||++.+..|+.++|||||||++|||++|..||..... ....+....
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2235799999999999999999999999999999988753210 000010000
Q ss_pred ------------c---cCC--CCCC---CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1018 ------------F---MYP--PRPW---RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1018 ------------~---~~p--~~~~---~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
. ..+ ...| ..++.++.+||.+||+.||++|||+.++++||||+.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 0 000 0001 135678999999999999999999999999999986
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=327.83 Aligned_cols=247 Identities=30% Similarity=0.454 Sum_probs=218.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
-+.|-....||.|-|+-|-+|.|..+|+.||||++.|..++......+..|++-|+.++|||||+||++..+...+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 35566678899999999999999999999999999998887777788999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC---
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE--- 967 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~--- 967 (1098)
|+-.+|+|.+++......+.+..+.+|++||+.|+.|+|+..+|||||||+||.+...-. -|||+|||++..+.+
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlG--lVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLG--LVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecC--ceEeeeccccccCCCcch
Confidence 999999999999888888999999999999999999999999999999999998865432 799999999865433
Q ss_pred --------CCCChhhhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 968 --------KSFPPEVLRNKGYN-RSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 968 --------~~~APEvl~~~~ys-~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
.|-|||++.|..|+ +++|||||||+||.|++|++||..-.+.+..-+.....|.. +..+|.+.++||..
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv--PshvS~eCrdLI~s 252 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV--PSHVSKECRDLIQS 252 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC--chhhhHHHHHHHHH
Confidence 23599999999887 79999999999999999999998655444444444444432 35689999999999
Q ss_pred hhhhcccCCCCHHHHHcCCCcCC
Q psy48 1039 LLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1039 cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
||..||.+|.+.++|..|+|++.
T Consensus 253 MLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred HHhcCchhhccHHHHhccccccC
Confidence 99999999999999999999997
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=344.09 Aligned_cols=244 Identities=26% Similarity=0.392 Sum_probs=209.5
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC-------
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG------- 884 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~------- 884 (1098)
.+|.+...||.|.||.||.+.+..+++.||||+++...........+.+|+.++..++|+||++++..+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 5899999999999999999999999999999999877666667788999999999999999999988875432
Q ss_pred -cEEEEEEeccCchHHHHHhhc---cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 885 -RIFVVMEKLQGDMLEMILSSE---KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 885 -~l~LVmEy~~ggsL~~~l~~~---~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
.+++||||+++++|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~---~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG---LVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC---CEEEEecc
Confidence 378999999999998887643 34689999999999999999999999999999999999999988 89999999
Q ss_pred ccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCC
Q psy48 961 FARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRP 1024 (1098)
Q Consensus 961 la~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~ 1024 (1098)
+++.. +..|+|||++.+..|+.++|||||||+||||++|..||..... ....+... .+ ...
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~--~~-~~~ 265 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG--RY-DPL 265 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--CC-CCC
Confidence 98643 2236899999999999999999999999999999999986532 22222211 11 122
Q ss_pred CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1025 WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1025 ~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
...+++++.+++.+||..||.+||++.++++|||++.
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 3568899999999999999999999999999999986
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=314.56 Aligned_cols=243 Identities=28% Similarity=0.437 Sum_probs=202.5
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|.+...+|.|.++.+|.+.++.+++.||+|++............+.+|+.+++.++|+||+++++++.....+++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 57788899999999999999999999999999976543333345688999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------ 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------ 966 (1098)
+++++|..+.. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 82 CDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG---QIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred cCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC---cEEECccccceecCCCcccc
Confidence 99999977764 344689999999999999999999999999999999999999988 89999999987542
Q ss_pred ------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHH--HHhh-------------------c
Q psy48 967 ------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI--QNAA-------------------F 1018 (1098)
Q Consensus 967 ------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i--~~~~-------------------~ 1018 (1098)
..++|||++.+ ..++.++||||||+++|+|++|..||.+........ .... .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 23479999876 558899999999999999999999998654322111 1100 0
Q ss_pred cCCC--------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1019 MYPP--------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1019 ~~p~--------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
..+. ..+..++..+.+||.+||..||++||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 0023568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.89 Aligned_cols=246 Identities=32% Similarity=0.539 Sum_probs=214.5
Q ss_pred Hhhheee-eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHh-ccCCCCceeeeeeeec----C
Q psy48 810 MLVFMTY-NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQ-NLCHPGVVNLERMFET----P 883 (1098)
Q Consensus 810 ~l~~~~~-~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~-~l~HpnIv~L~~~f~~----~ 883 (1098)
++..|++ ..+||.|..|.|....++.+++.+|+|++.. ....++|+++.- .-.|||||.++++|.. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3444555 4678999999999999999999999999842 244667777654 3469999999999854 4
Q ss_pred CcEEEEEEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
..+.+|||.++||.|...+.++. ..|++.++..|+.||+.|+.|||+.+|.||||||+|+|....+....+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 57899999999999977776443 36999999999999999999999999999999999999998777778999999999
Q ss_pred cccC-----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC------hhHHHHHHHhhccCCCCCC
Q psy48 963 RIIG-----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED------EDINEQIQNAAFMYPPRPW 1025 (1098)
Q Consensus 963 ~~~~-----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~------~~~~~~i~~~~~~~p~~~~ 1025 (1098)
+... +-|.|||++..+.|+.+.|+||+||++|-||+|.+||... ......|....+.+|...|
T Consensus 212 K~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW 291 (400)
T KOG0604|consen 212 KETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW 291 (400)
T ss_pred cccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence 8654 2245999999999999999999999999999999999754 4677889999999999999
Q ss_pred CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1026 RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1026 ~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
..+|+++.++|+.+|..+|.+|.|+.++++|||+..+
T Consensus 292 s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 292 SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 9999999999999999999999999999999999864
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=312.16 Aligned_cols=241 Identities=25% Similarity=0.443 Sum_probs=206.0
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH-------HHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK-------QEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~-------~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
+++...+|.|.++.+|.+.+..+++.||+|.+........ ....+.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 5667889999999999999999999999999876433221 235688999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
++||||+++++|..++.. .+.+++..+..++.|++.||+|||+.||+||||+|+||+++.++ .++|+|||+++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~---~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG---GIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC---CEEecccCCCcccc
Confidence 999999999999888864 45789999999999999999999999999999999999999888 89999999886543
Q ss_pred ------------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcC
Q psy48 967 ------------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDI 1028 (1098)
Q Consensus 967 ------------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~i 1028 (1098)
..++|||.+.+..++.++|+||||+++|+|++|..||.............. ...+.....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCccc
Confidence 135699999998899999999999999999999999987654332222222 2223334568
Q ss_pred cHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1029 SSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
+.++.++|.+||+.||++||++.++++||||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 8999999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=319.78 Aligned_cols=246 Identities=28% Similarity=0.393 Sum_probs=202.7
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
+..|.....||.|.+|.||.+.++.+++.||+|.++.... ......+.+|+.+++.++||||+++++++...+.+++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4568888999999999999999999999999999975432 222346778999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||+.+ +|..++......+++..+..++.||+.||.|||+.||+|+||||+||+++.++ .++|+|||++...
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG---ELKLADFGLARAKSIPTK 159 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC---cEEECcCcchhccCCCCC
Confidence 99986 56566665556789999999999999999999999999999999999999988 8999999998643
Q ss_pred -------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhc-----------------
Q psy48 966 -------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAF----------------- 1018 (1098)
Q Consensus 966 -------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~----------------- 1018 (1098)
...++|||++.+ ..++.++|||||||++|+|++|+.||...+.. ...+.....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 223579999875 45889999999999999999999999765322 111111100
Q ss_pred --cCCC-------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1019 --MYPP-------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1019 --~~p~-------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.++. .....+++++.+||.+||..||.+|||++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0010 011347889999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=334.99 Aligned_cols=218 Identities=24% Similarity=0.299 Sum_probs=177.6
Q ss_pred cCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhcc-------
Q psy48 835 KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEK------- 906 (1098)
Q Consensus 835 ~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~------- 906 (1098)
.++..||||+++... .......+.+|+.+|..+ +||||+++++++...+..++||||+++|+|..++....
T Consensus 63 ~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~ 141 (375)
T cd05104 63 DAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPK 141 (375)
T ss_pred ccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhccccccccc
Confidence 345689999996533 233456788999999999 89999999999999999999999999999988876432
Q ss_pred -------------------------------------------------------------------CccchhHHHHHHH
Q psy48 907 -------------------------------------------------------------------GRLSERTTKFIIT 919 (1098)
Q Consensus 907 -------------------------------------------------------------------~~lse~~~~~ia~ 919 (1098)
..+++..+..++.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 221 (375)
T cd05104 142 HEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSY 221 (375)
T ss_pred ccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHH
Confidence 1467888999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--------------CCCCChhhhccCCCCchhH
Q psy48 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLD 985 (1098)
Q Consensus 920 qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sD 985 (1098)
||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ..|+|||++.+..++.++|
T Consensus 222 qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~---~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sD 298 (375)
T cd05104 222 QVAKGMSFLASKNCIHRDLAARNILLTHGR---ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 298 (375)
T ss_pred HHHHHHHHHHHCCeeccCCchhhEEEECCC---cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCC
Confidence 999999999999999999999999999877 89999999986431 1368999999999999999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 986 MWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 986 VwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
||||||++|||++ |..||.....................+...+.++.+||.+||+.||++||++.+|++.
T Consensus 299 i~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 299 VWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999998 8999976432222222222222222234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=314.01 Aligned_cols=242 Identities=24% Similarity=0.384 Sum_probs=201.4
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecC------C
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETP------G 884 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~------~ 884 (1098)
+.|.....+|.|.+|.||.+....+++.||+|++.... .....+.+|+.+++.+ +|+||+++++++... .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 44556677899999999999999999999999997542 3345788899999988 699999999998653 4
Q ss_pred cEEEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
.+++||||+.+++|..++... ...+++..+..++.||+.||+|||++||+|+||||+||+++.++ .++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~---~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA---EVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC---CEEEccCCCce
Confidence 689999999999998888753 34689999999999999999999999999999999999999988 89999999986
Q ss_pred ccC------------CCCCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCC
Q psy48 964 IIG------------EKSFPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWR 1026 (1098)
Q Consensus 964 ~~~------------~~~~APEvl~-----~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~ 1026 (1098)
... ..|+|||++. +..++.++|||||||++|||++|..||.................+.....
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCC
Confidence 432 1357999986 34688999999999999999999999976544433333332222333334
Q ss_pred cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1027 DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1027 ~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
.++.++.+||.+||..||.+||++.++++||||
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 678999999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=314.02 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=211.4
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
+|.+...+|.|.++.+|.+.+..+++.||+|++.... .......+.+|+.+++.++|+||+++++++.....+++|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3455677899999999999999999999999997543 233456788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----- 967 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----- 967 (1098)
+.+++|..++... ++++..+..++.||+.||.|||+.+++||||+|+||+++.++ .++|+|||+++....
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~---~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG---DVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC---CEEEcccccceeeccccccc
Confidence 9999998887643 789999999999999999999999999999999999999988 899999999865432
Q ss_pred -------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCc-CcHHHHHHHHHh
Q psy48 968 -------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRD-ISSDAIDLINNL 1039 (1098)
Q Consensus 968 -------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~-is~el~~LL~~c 1039 (1098)
.++|||.+.+..++.++||||||+++|+|++|..||........ +.......++..... ++.++.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-LFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-HHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 25799999998899999999999999999999999976543222 222222222222223 789999999999
Q ss_pred hhhcccCCCCHHHHHcCCCcCCCCCcchhHHHHh
Q psy48 1040 LQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLER 1073 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~~ 1073 (1098)
|..+|++||+++++++||||++...-.=+..+..
T Consensus 235 l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~~~~~ 268 (274)
T cd06609 235 LNKDPKERPSAKELLKHKFIKKAKKTSYLTLLIE 268 (274)
T ss_pred hhCChhhCcCHHHHhhChhhcCCCcccHHHHHHH
Confidence 9999999999999999999998544433333433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.75 Aligned_cols=255 Identities=29% Similarity=0.435 Sum_probs=215.5
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.+...++.|.++.+|.+.+..+++.||||.+.+.... ......+.+|+.+++.++||||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 366778899999999999999999999999999765332 2334678899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|++|++|..++.. .+.+++..+..++.|++.||+|||+.||+||||||+||+++.++ .++|+|||+++..
T Consensus 82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~---~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG---HIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC---CEEEeeCCCccccCcCccc
Confidence 9999999888864 45789999999999999999999999999999999999999988 8999999987631
Q ss_pred ---------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCC
Q psy48 966 ---------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPP 1022 (1098)
Q Consensus 966 ---------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~ 1022 (1098)
...++|||.+.+..++.++|+||||+++|||++|..||.+.. +............+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 123679999998889999999999999999999999998653 223333333333333
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCC---HHHHHcCCCcCCCCCcchhHHHHhhhC
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLS---VDKSLAHPWLQDPATWSDLRGLERQIG 1076 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPS---a~eIL~HpfFk~~~~~~~~~~l~~~~~ 1076 (1098)
... .++.++.++|.+||..||++||+ +.++++||||+. .+|..+-+++.
T Consensus 238 ~~~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~----~~~~~~~~~~~ 289 (305)
T cd05609 238 GDE-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG----LDWNGLLRQKA 289 (305)
T ss_pred ccc-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC----CCHHHHhhcCC
Confidence 222 57899999999999999999998 789999999988 67777777743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=333.49 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=218.4
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|+....||.|.||.||.|.+..+++.||+|++..+.. .+..+.+++|+.+|..++++||.++|+.|..+..++++|||+
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4555789999999999999999999999999976542 445678999999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc---------
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI--------- 964 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~--------- 964 (1098)
.||++...+. ....+++..+..++++++.||.|||.++.+|||||+.|||+..+| .+||+|||.+..
T Consensus 94 ~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g---~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 94 GGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG---DVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred cCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC---cEEEEecceeeeeechhhccc
Confidence 9999988886 344569999999999999999999999999999999999999998 899999998842
Q ss_pred --c-CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhh
Q psy48 965 --I-GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041 (1098)
Q Consensus 965 --~-~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~ 1041 (1098)
. ++-|||||++....|+.++||||||++.|||++|.+|+...... ..+.......|+..-..+|+.+.+|+..||+
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-rvlflIpk~~PP~L~~~~S~~~kEFV~~CL~ 248 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-RVLFLIPKSAPPRLDGDFSPPFKEFVEACLD 248 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-eEEEeccCCCCCccccccCHHHHHHHHHHhh
Confidence 2 33469999999999999999999999999999999999876653 2222223333444445789999999999999
Q ss_pred hcccCCCCHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1042 VKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1042 ~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
+||+.||+|.++|+|+|++....-..+..+.+|
T Consensus 249 k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r 281 (467)
T KOG0201|consen 249 KNPEFRPSAKELLKHKFIKRAKKTSELKELIDR 281 (467)
T ss_pred cCcccCcCHHHHhhhHHHHhcCCchHHHHHHHH
Confidence 999999999999999999987655555555544
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=314.75 Aligned_cols=244 Identities=24% Similarity=0.339 Sum_probs=205.5
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
+|.....||.|.+|.+|.+.+..++..+|+|.+.... ......+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 3455677999999999999999999999999986532 44557788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------- 965 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------- 965 (1098)
+.+++|..++......+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++...
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~---~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG---DIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC---CEEEcccccccccccccccc
Confidence 999999888766566799999999999999999999999999999999999999988 8999999998543
Q ss_pred -----CCCCCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCC-CCCCCcCcHHHHH
Q psy48 966 -----GEKSFPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYP-PRPWRDISSDAID 1034 (1098)
Q Consensus 966 -----~~~~~APEvl~-----~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p-~~~~~~is~el~~ 1034 (1098)
...|+|||++. +..++.++|||||||++|||++|..||.................+ ......++.++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 22367999984 456788999999999999999999999865433222222111111 1123457899999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+|.+||..||++||+++++++||||+.
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEec
Confidence 999999999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=313.44 Aligned_cols=245 Identities=30% Similarity=0.468 Sum_probs=209.1
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
+.+...||.|.++.+|.+.++.+++.||+|++..... ......+.+|+.+++.++||||+++++.+...+.+++||||+
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 3455678999999999999999999999999976532 345577899999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCccccc-------
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------- 965 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------- 965 (1098)
++++|..++......+++..+..++.||+.||+|||+ .|++|+||||+||+++.++ .++|+|||.+...
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~---~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG---QIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC---CEEEeecccchhhHHHHhhc
Confidence 9999999887655789999999999999999999999 9999999999999999988 8999999998643
Q ss_pred ---CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC----hhHHHHHHHhhccCCCCCCCc-CcHHHHHHHH
Q psy48 966 ---GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED----EDINEQIQNAAFMYPPRPWRD-ISSDAIDLIN 1037 (1098)
Q Consensus 966 ---~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~----~~~~~~i~~~~~~~p~~~~~~-is~el~~LL~ 1037 (1098)
...++|||.+.+..++.++||||||+++|+|++|..||... ....+.+.......++..... ++.++.++|.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHH
Confidence 23468999999999999999999999999999999999754 233333333322222222233 7899999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+||..||++||++.+++.||||+.+
T Consensus 239 ~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 239 LCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=341.15 Aligned_cols=241 Identities=25% Similarity=0.361 Sum_probs=205.3
Q ss_pred heeeeeeeeeeeeeceEEEEeecC-CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKS-GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~t-g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.+...+|.|.+|.||.+.+..+ ++.||+|.+... .......+.+|+.+|+.++||||++++++|...+.+|+|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 378899999999999999998888 788999987443 23444678889999999999999999999999999999999
Q ss_pred eccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 892 KLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
|++|++|..++.+ ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~---~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG---IIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC---cEEEEeCcCceecCCc
Confidence 9999999887753 234689999999999999999999999999999999999999988 8999999998743
Q ss_pred -----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHH
Q psy48 966 -----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
+..|+|||++.+..++.++|||||||++|||++|..||..... ....+.... . ...+..++.++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~--~-~~~~~~~s~~~ 299 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK--Y-DPFPCPVSSGM 299 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C-CCCCccCCHHH
Confidence 2236799999999999999999999999999999999976533 222222221 1 12234688999
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.++|.+||..||++||++++++.|+|++.
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999874
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=314.78 Aligned_cols=245 Identities=24% Similarity=0.351 Sum_probs=206.1
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.....+|.|.+|.||.+.+..++..||+|+++.. .......+.+|+.+++.++|+||+++++.+.....+++||||+
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45566789999999999999999999999999653 2444577889999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-------
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------- 966 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------- 966 (1098)
++++|..++......+++..++.++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++....
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~---~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG---DVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC---CEEEccCccchhhcccccccc
Confidence 99999988876666799999999999999999999999999999999999999988 89999999875332
Q ss_pred -----CCCCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCC-CCCCCcCcHHHHHH
Q psy48 967 -----EKSFPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYP-PRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 -----~~~~APEvl~-----~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p-~~~~~~is~el~~L 1035 (1098)
..++|||.+. ...++.++|+||||+++|+|++|..||.................+ ......++.++.++
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF 241 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence 2357999985 345788999999999999999999999865433222222111111 11234578999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
|.+||..+|.+||++.++++||||++..
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 242 LKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HHHHhccChhhCcCHHHHhcChhhcccc
Confidence 9999999999999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=326.56 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=201.2
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC------
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP------ 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~------ 883 (1098)
+..+|.....||.|.+|.||.+.+..+++.||||++++..........+.+|+.+|+.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 34678888999999999999999999999999999976543334456788999999999999999999988543
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
...+++|+++ +++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~---~~kl~Dfg~~~ 166 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC---ELRILDFGLAR 166 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC---CEEEcCCccce
Confidence 3579999998 556766654 35699999999999999999999999999999999999999988 89999999987
Q ss_pred cc---------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhc-------------
Q psy48 964 II---------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAF------------- 1018 (1098)
Q Consensus 964 ~~---------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~------------- 1018 (1098)
.. +..|+|||++.+ ..++.++|||||||++|+|++|..||....... ..+.....
T Consensus 167 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 167 QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred ecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 53 234689999977 568999999999999999999999997643221 11111000
Q ss_pred ----------cCCC----CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCC
Q psy48 1019 ----------MYPP----RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPAT 1064 (1098)
Q Consensus 1019 ----------~~p~----~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~ 1064 (1098)
..+. ..+...++.+.+||.+||..||++|||+.++++||||....+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 0000 012345678899999999999999999999999999987443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=336.71 Aligned_cols=244 Identities=28% Similarity=0.390 Sum_probs=201.4
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-C-----CCceeeeeeeecCCcE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-H-----PGVVNLERMFETPGRI 886 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-H-----pnIv~L~~~f~~~~~l 886 (1098)
+|.....||.|.||.|..+.+.+|++.||||+++.. ..-..+-..|+.+|..++ | -|+|+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 677799999999999999999999999999999763 334466778999999886 3 4899999999999999
Q ss_pred EEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 887 FVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
|||+|+++.. |++++.+. -..|+...++.++.||+.||.+||+.||||+||||+||||..-+.. .|||+|||.+...
T Consensus 264 ciVfELL~~N-LYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~-~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 264 CIVFELLSTN-LYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS-RIKVIDFGSSCFE 341 (586)
T ss_pred eeeehhhhhh-HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC-ceeEEeccccccc
Confidence 9999999654 55777644 3469999999999999999999999999999999999999876644 8999999999766
Q ss_pred CCC---------CCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc-cCCCCC-----------
Q psy48 966 GEK---------SFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF-MYPPRP----------- 1024 (1098)
Q Consensus 966 ~~~---------~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~-~~p~~~----------- 1024 (1098)
+.. |.|||++.|.+|+.+.||||||||++||++|.+.|.++.+..+....... ..|+..
T Consensus 342 ~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kf 421 (586)
T KOG0667|consen 342 SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKF 421 (586)
T ss_pred CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccccee
Confidence 443 35999999999999999999999999999999989887654433221111 111100
Q ss_pred --------------------------------------C----------C-cCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1025 --------------------------------------W----------R-DISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1025 --------------------------------------~----------~-~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+ . .-...+.+||++||+.||.+|+|+.++++
T Consensus 422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0 01235789999999999999999999999
Q ss_pred CCCcCC
Q psy48 1056 HPWLQD 1061 (1098)
Q Consensus 1056 HpfFk~ 1061 (1098)
||||..
T Consensus 502 Hpfl~~ 507 (586)
T KOG0667|consen 502 HPFLTG 507 (586)
T ss_pred Cccccc
Confidence 999996
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=315.36 Aligned_cols=242 Identities=26% Similarity=0.413 Sum_probs=199.5
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.....+|.|.++.+|.+.+..+++.||||.++...........+.+|+++++.++||||+++++++...+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 56678899999999999999999999999999765444444567889999999999999999999999999999999999
Q ss_pred cCchHHHHHhh-ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------
Q psy48 894 QGDMLEMILSS-EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------ 966 (1098)
Q Consensus 894 ~ggsL~~~l~~-~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------ 966 (1098)
.+ +|..++.. ....+++..+..++.||+.||+|||+.|++||||+|+||+++.++ .++|+|||++...+
T Consensus 82 ~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~---~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 82 HQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG---AIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---CEEEeeccchhhcccCcccc
Confidence 76 45555543 345689999999999999999999999999999999999999998 89999999986432
Q ss_pred ------CCCCChhhhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc--------------------c
Q psy48 967 ------EKSFPPEVLRNKG-YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF--------------------M 1019 (1098)
Q Consensus 967 ------~~~~APEvl~~~~-ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~--------------------~ 1019 (1098)
..++|||.+.+.. ++.++||||||+++|+|+||..||....+.......... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 2357999887644 688999999999999999999999866443222211110 0
Q ss_pred CCC-------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1020 YPP-------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1020 ~p~-------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
++. .....++.++.++|.+||+.||++||+++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000 0012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=311.49 Aligned_cols=243 Identities=28% Similarity=0.377 Sum_probs=202.3
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC---hHHHHHHHHHHHHHhccCCCCceeeeeeeec--CCcEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP---TKQEAQLKNEVAILQNLCHPGVVNLERMFET--PGRIF 887 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~--~~~l~ 887 (1098)
.|.....+|.|.+|.+|.+.+..++..||+|+++..... ......+.+|+.+++.++||||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 366788999999999999999999999999998764322 2334678999999999999999999999865 35789
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
++|||+++++|..++.. ...+++...+.++.||+.||.|||+.||+||||+|+||+++.++ .++|+|||++....
T Consensus 83 l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~---~~~l~dfg~~~~~~~ 158 (266)
T cd06651 83 IFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG---NVKLGDFGASKRLQT 158 (266)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC---CEEEccCCCcccccc
Confidence 99999999999888764 34689999999999999999999999999999999999999888 89999999886331
Q ss_pred --------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHH
Q psy48 967 --------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 967 --------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
..|+|||.+.+..++.++||||||+++|||++|+.||..................+.....+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 135799999999999999999999999999999999986544333332222222233334577889
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcCCCcC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~HpfFk 1060 (1098)
.+++ +||..+|++||++++|++||||+
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 9998 68888999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.47 Aligned_cols=247 Identities=27% Similarity=0.425 Sum_probs=200.2
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCCChHH-HHHHHHHHHHHh---ccCCCCceeeeeeeecCCcEEEEEEeccC
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQ-EAQLKNEVAILQ---NLCHPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~-~~~~~~Ei~iL~---~l~HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
||.|++|.||.+.+..+++.||||++.+....... ...+.+|..+++ ...||||+.+++++...+..++||||+.+
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 78999999999999999999999999765433222 233445554443 34799999999999999999999999999
Q ss_pred chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----------
Q psy48 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------- 965 (1098)
Q Consensus 896 gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---------- 965 (1098)
++|..++. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 82 ~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~ 157 (279)
T cd05633 82 GDLHYHLS-QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG---HVRISDLGLACDFSKKKPHASVG 157 (279)
T ss_pred CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC---CEEEccCCcceeccccCccCcCC
Confidence 99988776 345699999999999999999999999999999999999999888 8999999998533
Q ss_pred CCCCCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhc
Q psy48 966 GEKSFPPEVLR-NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVK 1043 (1098)
Q Consensus 966 ~~~~~APEvl~-~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~d 1043 (1098)
...++|||.+. +..++.++|+|||||++|+|++|..||.... .....+.......+...+..++.++.++|.+||..|
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 237 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCC
Confidence 23467999986 4668999999999999999999999997532 111223333333343444568899999999999999
Q ss_pred ccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1044 QRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1044 P~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
|++|+ ++.++++||||++ .+|.....+
T Consensus 238 p~~R~~~~~~~~~~~~~h~~~~~----~~~~~~~~~ 269 (279)
T cd05633 238 VSKRLGCLGRGAQEVKEHVFFKG----IDWQQVYLQ 269 (279)
T ss_pred HHHhcCCCCCCHHHHHhCccccC----CCHhHHhcC
Confidence 99999 6999999999998 455555444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.32 Aligned_cols=243 Identities=26% Similarity=0.441 Sum_probs=208.0
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
+|++...+|.|.+|.+|.+.+..+++.||+|.+............+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 47788999999999999999999999999999976555555567899999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 893 LQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
+.+++|..++.... ..+++.++..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG---TIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC---CEEEeeccceeecCcchhh
Confidence 99999988876433 3688999999999999999999999999999999999999888 89999999986432
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
..++|||++.+..++.++|+||||+++|+|++|..||...+.............+ .....++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-PVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-CCcccCCHHHHHHHHHH
Confidence 2367999999999999999999999999999999999765432222111111222 22346789999999999
Q ss_pred hhhcccCCCCHHHHHcCCCc
Q psy48 1040 LQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfF 1059 (1098)
|+.+|++||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=317.73 Aligned_cols=257 Identities=25% Similarity=0.359 Sum_probs=214.9
Q ss_pred HHHHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC
Q psy48 805 MSFLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG 884 (1098)
Q Consensus 805 ~~~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~ 884 (1098)
...-.....|+....||.|.+|.+|.+.+..+++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3334455788899999999999999999999999999999975432 23466889999999999999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
..++||||+++++|..++.. ..+++.++..++.|++.||.|||+.||+||||||+|||++.++ .++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~---~~~l~Dfg~~~~ 164 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG---SVKLTDFGFCAQ 164 (297)
T ss_pred EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEECcCccceE
Confidence 99999999999999888753 4588999999999999999999999999999999999999888 899999998864
Q ss_pred cC------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccC-CCCCCCcCcHH
Q psy48 965 IG------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY-PPRPWRDISSD 1031 (1098)
Q Consensus 965 ~~------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~-p~~~~~~is~e 1031 (1098)
.. ..++|||.+.+..++.++|+|||||++|+|++|..||...+............. +......++..
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06656 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244 (297)
T ss_pred ccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHH
Confidence 32 235699999999999999999999999999999999976544322221111111 11223457889
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchh
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDL 1068 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~ 1068 (1098)
+.+++.+||..||++||++.++++||||+....+..+
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~ 281 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSL 281 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhccccccccc
Confidence 9999999999999999999999999999986665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=316.12 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=212.8
Q ss_pred HHHHHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC
Q psy48 804 TMSFLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP 883 (1098)
Q Consensus 804 ~~~~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~ 883 (1098)
-+.+.....+|+....+|.|.+|.+|.+.+..+++.||+|.+..... .....+.+|+.+++.++|+||+++++.|...
T Consensus 12 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred ccccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 34445556788889999999999999999999999999999976442 2346788999999999999999999999999
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
...++||||+.+++|..++.. ..+++.++..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++.
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~---~~kl~dfg~~~ 164 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG---SVKLTDFGFCA 164 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC---CEEECccccch
Confidence 999999999999999888753 4589999999999999999999999999999999999999888 89999999876
Q ss_pred ccC------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccC-CCCCCCcCcH
Q psy48 964 IIG------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY-PPRPWRDISS 1030 (1098)
Q Consensus 964 ~~~------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~-p~~~~~~is~ 1030 (1098)
... ..|+|||.+.+..++.++|||||||++|+|++|+.||................. +......++.
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06654 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244 (296)
T ss_pred hccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCH
Confidence 421 236799999998899999999999999999999999986654332222222111 2122346788
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.+.+++.+||..||++||++.++++||||...
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 99999999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=310.26 Aligned_cols=238 Identities=34% Similarity=0.516 Sum_probs=202.6
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchH
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDML 898 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL 898 (1098)
||.|.++.+|.+.+..+++.||+|++.+.... ......+.+|+.+++.++||||+++++.+.++..+++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 57899999999999999999999999765433 33457899999999999999999999999999999999999999999
Q ss_pred HHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----------
Q psy48 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----------- 967 (1098)
Q Consensus 899 ~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----------- 967 (1098)
..++.. ...+++..+..++.||+.||+|||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG---YVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC---CEEEeeCCcccccCcccccccccCCc
Confidence 888864 34689999999999999999999999999999999999999988 899999999875433
Q ss_pred CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-hHHHHHHHhh-ccCCCCCCCcCcHHHHHHHHHhhhhccc
Q psy48 968 KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-DINEQIQNAA-FMYPPRPWRDISSDAIDLINNLLQVKQR 1045 (1098)
Q Consensus 968 ~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-~~~~~i~~~~-~~~p~~~~~~is~el~~LL~~cL~~dP~ 1045 (1098)
.++|||.+.+..++.++|+||||+++|+|++|..||.... +..+...... ..........+++++.++|.+||..||+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 3679999998889999999999999999999999997654 1222222211 1112222234589999999999999999
Q ss_pred CCCC-----HHHHHcCCCcCC
Q psy48 1046 KRLS-----VDKSLAHPWLQD 1061 (1098)
Q Consensus 1046 kRPS-----a~eIL~HpfFk~ 1061 (1098)
+||+ +.++++||||++
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999997
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=320.91 Aligned_cols=244 Identities=27% Similarity=0.468 Sum_probs=197.5
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--C---cE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--G---RI 886 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~---~l 886 (1098)
..|.....+|.|.||.||.+....+++.||||.+-.+. .--.+|+++|+.+.|||||+|..+|... . .+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 35677889999999999999999999999999984322 1223699999999999999999888433 2 46
Q ss_pred EEEEEeccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 887 FVVMEKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
.+||||++.... ..++. .+.+++...++-|.+||++||+|||+.||+||||||.|||+|.+.. .+||+|||.|+
T Consensus 98 nlVleymP~tL~-~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg--~LKicDFGSAK 174 (364)
T KOG0658|consen 98 NLVLEYMPETLY-RVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG--VLKICDFGSAK 174 (364)
T ss_pred HHHHHhchHHHH-HHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC--eEEeccCCcce
Confidence 789999987655 45442 3567899999999999999999999999999999999999998753 89999999998
Q ss_pred ccCCC-----------CCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccC-C---------
Q psy48 964 IIGEK-----------SFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY-P--------- 1021 (1098)
Q Consensus 964 ~~~~~-----------~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~-p--------- 1021 (1098)
.+... |.|||.+.| ..|+.+.||||.||++.||+.|++.|.++....+......... |
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 66332 359999986 5699999999999999999999999998754433332221111 1
Q ss_pred ------------CCCC-----CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCC
Q psy48 1022 ------------PRPW-----RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPAT 1064 (1098)
Q Consensus 1022 ------------~~~~-----~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~ 1064 (1098)
...| ..+++++.+|+.++|.++|.+|.++.+++.||||..-.+
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 0112 356899999999999999999999999999999986443
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=332.35 Aligned_cols=275 Identities=28% Similarity=0.452 Sum_probs=233.6
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.+........||.|+||.|-++........+|+|+++|..+ ...+.+.+..|.++|...+.|+||+||-.|.+...+|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 34445556789999999999998877777899999988554 45567889999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
+||-|-||.++.++. ..+.|++..+++|+..+++|++|||++|||+|||||+|.|++.+| -+||.|||+|+.++
T Consensus 498 LmEaClGGElWTiLr-dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G---y~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 498 LMEACLGGELWTILR-DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG---YLKLVDFGFAKKIGSG 573 (732)
T ss_pred hHHhhcCchhhhhhh-hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC---ceEEeehhhHHHhccC
Confidence 999999999999987 567899999999999999999999999999999999999999999 89999999998653
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--HHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
+.|.|||++.++..+.++|.||||+++||||+|.+||.+.+.+.. .|......+ ..++.++..+.+|
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--EFPRRITKTATDL 651 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--hcccccchhHHHH
Confidence 345799999999999999999999999999999999998765433 333222111 1225688999999
Q ss_pred HHHhhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCC---CCcchhhhhhhhhh
Q psy48 1036 INNLLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKK---KNPKRTAQLLSYQL 1094 (1098)
Q Consensus 1036 L~~cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~---~~~~~~~~~~~~~~ 1094 (1098)
|+++...+|.+|++ +.+|.+|.||.. -||++|..+ +.||+. .+|-|...+..|.+
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g----fdweglr~~~L~pPi~~~va~ptD~s~Fd~~p~ 715 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEG----FDWEGLRSRTLPPPIIPSVANPTDVSNFDNFPP 715 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhhc----CChhhhhhccCCCCccccCCCcccchhccCCCc
Confidence 99999999999996 799999999999 699999998 888874 45555554444443
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.74 Aligned_cols=243 Identities=30% Similarity=0.452 Sum_probs=204.1
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.+...+|.|.++.+|.+.+..+|+.||||++............+.+|+.+++.++|+||+++++++.....+++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 67788899999999999999999999999999876554555678999999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC------
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE------ 967 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~------ 967 (1098)
+++|..++......+++..++.++.||+.||+|||+.||+|+||||+||+++.++ .++|+|||++.....
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~---~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG---VLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC---cEEEeeeeecccccCCCCCcc
Confidence 8999888876667799999999999999999999999999999999999999988 899999998865422
Q ss_pred -------CCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH--HHHhh-------------------c
Q psy48 968 -------KSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ--IQNAA-------------------F 1018 (1098)
Q Consensus 968 -------~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~--i~~~~-------------------~ 1018 (1098)
.++|||.+.+. .++.++||||||+++|||++|.+||.+..+.... +.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 35799998754 4689999999999999999998888765432211 11100 0
Q ss_pred cCCC-------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcC
Q psy48 1019 MYPP-------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060 (1098)
Q Consensus 1019 ~~p~-------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk 1060 (1098)
.++. ....+++.++.++|.+||..||++||+++++++||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 01134678999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.62 Aligned_cols=244 Identities=25% Similarity=0.325 Sum_probs=208.8
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
+|.....+|.|.+|.+|.+.+..+++.||||.+............+.+|+.+++.++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 36778899999999999999999999999999987666666678899999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 893 LQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
+++++|..++.... ..+++..+..++.+++.||+|||++||+|+||+|+||+++.++. .++|+|||++....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM--VVKIGDFGISKILSSKSKA 158 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEccCCCceecCCCccc
Confidence 99999999987543 35899999999999999999999999999999999999986552 68999999987443
Q ss_pred ------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 967 ------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 967 ------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
..|+|||.+.+..++.++||||||+++|+|++|..||...+........ ...........++.++.+++.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI-MSGTFAPISDRYSPDLRQLILSML 237 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH-HhcCCCCCCCCcCHHHHHHHHHHc
Confidence 2468999999888999999999999999999999999765432222221 111222223458899999999999
Q ss_pred hhcccCCCCHHHHHcCCCc
Q psy48 1041 QVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1041 ~~dP~kRPSa~eIL~HpfF 1059 (1098)
..||++|||+.++++||||
T Consensus 238 ~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 238 NLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred cCChhhCCCHHHHhhCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=307.93 Aligned_cols=241 Identities=29% Similarity=0.409 Sum_probs=203.2
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC----hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP----TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
|+....+|.|.++.||.+.. .+++.+|||.++..... ......+.+|+.+++.++|+||+++++++...+.+++|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred ccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 56678899999999999975 57889999998754322 22235689999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||+.+++|..++.. ...+++..+..++.||+.||+|||+.||+|+||+|+||+++.++ .++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG---IIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC---eEEeccchhhHhhhhcc
Confidence 999999999888864 35689999999999999999999999999999999999999888 89999999886431
Q ss_pred ---------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc-cCCCCCCCcCcH
Q psy48 967 ---------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF-MYPPRPWRDISS 1030 (1098)
Q Consensus 967 ---------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~-~~p~~~~~~is~ 1030 (1098)
..++|||.+.+..++.++|+||||+++|+|++|..||...+........... ...+.....++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 1257999999999999999999999999999999999865443333222221 112223456889
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
++.++|.+||..+|++||++.+++.||||
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.85 Aligned_cols=245 Identities=25% Similarity=0.336 Sum_probs=206.1
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|++...+|.|.+|.||.+.+..+++.||+|++... .......+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 4566777899999999999999999999999999753 24455778899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+++++|..++.+....+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++...
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG---DIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC---CEEEccCccceeccccccc
Confidence 9999999888766667799999999999999999999999999999999999999888 8999999987642
Q ss_pred ------CCCCCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCC-CCCCCcCcHHHH
Q psy48 966 ------GEKSFPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYP-PRPWRDISSDAI 1033 (1098)
Q Consensus 966 ------~~~~~APEvl~-----~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p-~~~~~~is~el~ 1033 (1098)
...|+|||.+. ...++.++|||||||++|||++|..||.................+ ......++.++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 12357999985 345788999999999999999999999765432222222111111 112245788999
Q ss_pred HHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
++|.+||..||++||++.++++||||+.
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 9999999999999999999999999987
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=312.67 Aligned_cols=240 Identities=24% Similarity=0.364 Sum_probs=201.2
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
+.+...||.|.+|.||.+.+..+++.||+|++.... .......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 456678999999999999999999999999997642 2344567999999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-------
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------- 966 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------- 966 (1098)
++++|..+ ..+++..+..++.||+.||+|||+.||+|+||||+|||++.++ .++|+|||++....
T Consensus 82 ~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~---~~~l~dfg~~~~~~~~~~~~~ 153 (279)
T cd06619 82 DGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG---QVKLCDFGVSTQLVNSIAKTY 153 (279)
T ss_pred CCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC---CEEEeeCCcceecccccccCC
Confidence 99999654 2478889999999999999999999999999999999999988 89999999986432
Q ss_pred ---CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh------HHHHHHHhh-ccCCCCCCCcCcHHHHHHH
Q psy48 967 ---EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED------INEQIQNAA-FMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 967 ---~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~------~~~~i~~~~-~~~p~~~~~~is~el~~LL 1036 (1098)
..++|||.+.+..++.++|+||||+++|+|++|..||..... ......... ...+......+++++.+++
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence 245799999999999999999999999999999999964211 111111111 1112222345788999999
Q ss_pred HHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1037 NNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.+||..||++||+++++++||||+..
T Consensus 234 ~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 234 TQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=320.46 Aligned_cols=238 Identities=25% Similarity=0.428 Sum_probs=182.5
Q ss_pred eeeeeeeeeeceEEEEee--cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec--CCcEEEEEEe
Q psy48 817 NVALCIAVVAGAACGVHR--KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET--PGRIFVVMEK 892 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k--~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~--~~~l~LVmEy 892 (1098)
+..||.|+||.||.+.++ .+++.||+|.++.... ...+.+|+.+|+.++||||+++++++.. ...+++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 457999999999999965 4778999999965432 2456789999999999999999999854 4568999999
Q ss_pred ccCchHHHHHhhc--------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC-CCCcEEEeecCccc
Q psy48 893 LQGDMLEMILSSE--------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS-ELPQVKLCDFGFAR 963 (1098)
Q Consensus 893 ~~ggsL~~~l~~~--------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g-~~~~vKL~DFGla~ 963 (1098)
++++ |..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ ....+||+|||+++
T Consensus 82 ~~~~-l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cCCC-HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 9875 44454321 22588999999999999999999999999999999999994321 11279999999986
Q ss_pred ccC---------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChh-----------HHHHHHHh
Q psy48 964 IIG---------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDED-----------INEQIQNA 1016 (1098)
Q Consensus 964 ~~~---------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~-----------~~~~i~~~ 1016 (1098)
... ..|+|||++.+ ..++.++||||+||++|||++|++||....+ ....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 432 23689999987 4589999999999999999999999964321 01111000
Q ss_pred hcc-----------CCC-----------------------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1017 AFM-----------YPP-----------------------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1017 ~~~-----------~p~-----------------------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
... .+. ......+.++.+||.+||+.||++|||++|+++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 000 0001235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.17 Aligned_cols=240 Identities=25% Similarity=0.360 Sum_probs=206.2
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|.+...++.|.++.+|.+....+++.||+|.++.. .....+.+|+.+++.++|+||+++++++.+...++++|||
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 466777899999999999999999999999999653 2267899999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----- 967 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----- 967 (1098)
+++++|..++......+++..+..++.||+.||.|||+.||+||||+|+||+++.++ .++|+|||++.....
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~---~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG---QAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC---cEEEcccccchhcccCcccc
Confidence 999999999876667899999999999999999999999999999999999999988 899999999865422
Q ss_pred -------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCC-CCCCCcCcHHHHHHHHHh
Q psy48 968 -------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYP-PRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 968 -------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p-~~~~~~is~el~~LL~~c 1039 (1098)
.++|||++.+..++.++||||||+++|+|++|+.||.................+ ......++.++.++|.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 357999999999999999999999999999999999865443322222111111 111234678999999999
Q ss_pred hhhcccCCCCHHHHHcCCCc
Q psy48 1040 LQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfF 1059 (1098)
|+.||++||++.++++||||
T Consensus 237 l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 237 LVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=303.98 Aligned_cols=243 Identities=26% Similarity=0.376 Sum_probs=209.2
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
+|+....+|.|.+|.++.+....+++.+++|.+............+.+|++++++++|+||+++++++...+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47788899999999999999999999999999987666666677889999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 893 LQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
+++++|..++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~---~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG---LIKLGDFGISKILGSEYSM 157 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC---CEEECcCcceEEccccccc
Confidence 9999999888754 45689999999999999999999999999999999999999988 89999999886432
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
..|.|||.+.+..++.++|+||||+++|+|++|..||................++. ....++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHH
Confidence 23469999998889999999999999999999999998654322221111111222 2245789999999999
Q ss_pred hhhcccCCCCHHHHHcCCCc
Q psy48 1040 LQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfF 1059 (1098)
|..+|++||++.++++|+|+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.99 Aligned_cols=241 Identities=24% Similarity=0.352 Sum_probs=205.5
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|.+...+|.|.++.+|.+.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++++...+.++++|||
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 5778889999999999999999999999999997643 23457899999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------ 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------ 966 (1098)
+++++|..++......+++..+..++.|++.||+|||++||+|+||+|+||+++.++ .++|+|||++....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~---~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG---DVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC---CEEECccccchhhhhhhhcc
Confidence 999999988876657899999999999999999999999999999999999999988 89999999886432
Q ss_pred ------CCCCChhhhccC---CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCC---CCCcCcHHHHH
Q psy48 967 ------EKSFPPEVLRNK---GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPR---PWRDISSDAID 1034 (1098)
Q Consensus 967 ------~~~~APEvl~~~---~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~---~~~~is~el~~ 1034 (1098)
..++|||.+.+. .++.++|+||||+++|+|++|..||................+... ....++.++.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHH
Confidence 135799999877 899999999999999999999999986543332222222211111 12245788999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPW 1058 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~Hpf 1058 (1098)
++.+||..+|++||++.+++.|+|
T Consensus 239 li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 239 FIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.80 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=205.2
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh----HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT----KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
|+....+|.|.+|.+|.+.+..+++.||+|+++...... .....+.+|+.+++.++|+||+++++++...+.+++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 566788999999999999999999999999997543211 2346789999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||+.+++|..++.. .+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++. .++|+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~--~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 82 VEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ--RLRIADFGAAARLAAKG 158 (268)
T ss_pred EeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEccccccccccccc
Confidence 999999999888864 457899999999999999999999999999999999999987652 59999999986432
Q ss_pred -------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHh-hccCCCCCCCcCcH
Q psy48 967 -------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNA-AFMYPPRPWRDISS 1030 (1098)
Q Consensus 967 -------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~-~~~~p~~~~~~is~ 1030 (1098)
..++|||.+.+..++.++|+||||+++|+|++|..||.... .....+... .....+.....+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 13579999999899999999999999999999999997432 222222221 12223333346789
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHcCCCcC
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~HpfFk 1060 (1098)
++.+++.+||..+|++||++.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=307.82 Aligned_cols=238 Identities=18% Similarity=0.240 Sum_probs=201.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEee---cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHR---KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k---~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
...+++...||.|.||.||.+..+ ..+..||+|+++... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 346888999999999999999765 456789999997642 2344567899999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-- 965 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-- 965 (1098)
+||||+++++|..++......+++..++.++.||+.||+|||++|++||||||+|||++.++ .++|+|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~---~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL---VCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC---cEEECCCcccccccc
Confidence 99999999999999876666899999999999999999999999999999999999999988 8999999986532
Q ss_pred -----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHH
Q psy48 966 -----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
...++|||.+.+..++.++|||||||++|||++ |..||..... ..+.+.. ......+..++..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 236 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED---GFRLPAPRNCPNL 236 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC---CCCCCCCCCCCHH
Confidence 123689999999999999999999999999875 9999976532 2222222 2222334678899
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.+++.+||+.+|++||++++|++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=316.45 Aligned_cols=248 Identities=27% Similarity=0.382 Sum_probs=201.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRIFV 888 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l~L 888 (1098)
...|.....||.|.++.||.+.+..+|+.||+|+++...........+.+|+.+++.++|+||+++++++... +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 3467888899999999999999999999999999976543333334567899999999999999999998655 56899
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE- 967 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~- 967 (1098)
||||+++ +|..++......+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~---~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG---CLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---CEEECccceeeecCCc
Confidence 9999987 45566655556799999999999999999999999999999999999999988 899999999875432
Q ss_pred -----------CCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--HHHHhh----------------
Q psy48 968 -----------KSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQNAA---------------- 1017 (1098)
Q Consensus 968 -----------~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~i~~~~---------------- 1017 (1098)
.|+|||++.+ ..++.++||||||+++|||++|..||........ .+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 2679999875 5689999999999999999999999986543322 121110
Q ss_pred ---ccCCCCC-------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1018 ---FMYPPRP-------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1018 ---~~~p~~~-------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
...+... ...+++++.++|.+||..||++|||+.+++.||||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0000000 12357889999999999999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=303.24 Aligned_cols=242 Identities=27% Similarity=0.407 Sum_probs=205.9
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC---ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF---PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
|+....+|.|.+|.+|.+....+++.||+|++..... .......+.+|+.+++.++|+||+++++++.....+++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 5667889999999999999999999999999876432 2334578999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+++++|..++.. ...+++..+..++.||+.||+|||+.||+|+||+|+||+++.++ .+||+|||++....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~---~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 82 ELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG---VVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEccCccceecccccc
Confidence 99999999888764 34689999999999999999999999999999999999999888 89999999886432
Q ss_pred -------CCCCChhhhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 967 -------EKSFPPEVLRNKG-YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 967 -------~~~~APEvl~~~~-ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
..++|||.+.... ++.++|+||||+++|+|++|+.||..................+..+..+++++.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 2257999998776 89999999999999999999999976553333333222122233345688999999999
Q ss_pred hhhhcccCCCCHHHHHcCCCc
Q psy48 1039 LLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1039 cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
||..+|++||++.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=313.37 Aligned_cols=245 Identities=31% Similarity=0.429 Sum_probs=202.4
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC---hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP---TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
|.+...||.|.++.+|.+.+..+++.||||.++..... ......+.+|+.+++.++|+||+++++++.+.+.+++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 56677899999999999999999999999999875443 233456788999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC---
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE--- 967 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~--- 967 (1098)
||+ +++|..++......+++..++.++.||+.||+|||++||+|+||+|+||+++.++ .++|+|||++.....
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~---~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG---VLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC---CEEEccceeeeeccCCCc
Confidence 999 8888888865444799999999999999999999999999999999999999988 899999999875432
Q ss_pred ---------CCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--HHHHhhccC---------------
Q psy48 968 ---------KSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQNAAFMY--------------- 1020 (1098)
Q Consensus 968 ---------~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~i~~~~~~~--------------- 1020 (1098)
.++|||.+.+ ..++.++|+|||||++|||++|.+||....+... .+.......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 2579999864 5689999999999999999999888875543221 111100000
Q ss_pred -----CC----CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1021 -----PP----RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1021 -----p~----~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+. ..+..++.++.++|.+||..||++|||+.++++|+||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 00 0113457889999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.67 Aligned_cols=241 Identities=31% Similarity=0.454 Sum_probs=207.6
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
|.+...+|.|.++.+|.+.+..+++.||+|++.+..... .....+.+|++++++++||||+++++++.....+++||||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 677889999999999999999999999999998654333 4457899999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----- 967 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----- 967 (1098)
+.|++|..++... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++ .++|+|||++.....
T Consensus 82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG---HVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC---CEEEeecccccccCCCcccc
Confidence 9999998888654 5799999999999999999999999999999999999999988 899999999865432
Q ss_pred ------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 968 ------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 968 ------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
.++|||.+.+..++.++|+||||+++|+|++|..||..... ......... ......+..++.++.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-TADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-cccccCcccCcHHHHHHHHHH
Confidence 24699999988899999999999999999999999986432 222222111 122233456789999999999
Q ss_pred hhhcccCCCCH--HHHHcCCCc
Q psy48 1040 LQVKQRKRLSV--DKSLAHPWL 1059 (1098)
Q Consensus 1040 L~~dP~kRPSa--~eIL~HpfF 1059 (1098)
|..||.+||++ .++++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.96 Aligned_cols=239 Identities=33% Similarity=0.556 Sum_probs=201.8
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchH
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDML 898 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL 898 (1098)
+|.|.+|.+|.+.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++.+......++||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 47799999999999999999999999765432 23457789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------------
Q psy48 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------------ 966 (1098)
Q Consensus 899 ~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------------ 966 (1098)
..++... +.+++..+..++.||+.||+|||+.||+|+||+|+||+++.++ .++|+|||++....
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG---HLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC---CEEEEecccchhcccCcccccccccc
Confidence 8888643 4789999999999999999999999999999999999999998 89999999876432
Q ss_pred --------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 967 --------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 967 --------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
..++|||.+.+..++.++|+||||+++|+|++|..||.... +....+.......+. ...++.++.+++
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--DVEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc--cccCCHHHHHHH
Confidence 13579999988889999999999999999999999997553 223333322222221 123589999999
Q ss_pred HHhhhhcccCCCCH---HHHHcCCCcCCCCCc
Q psy48 1037 NNLLQVKQRKRLSV---DKSLAHPWLQDPATW 1065 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa---~eIL~HpfFk~~~~~ 1065 (1098)
.+||+.+|.+||++ .++++||||++ .+|
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~-~~~ 265 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG-IDW 265 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccC-CCC
Confidence 99999999999999 99999999986 444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=312.66 Aligned_cols=230 Identities=18% Similarity=0.218 Sum_probs=191.9
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHH-HHHHHHHHHHHhccCCCCceeeeeeeec----CCcEEEEEEe
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQ-EAQLKNEVAILQNLCHPGVVNLERMFET----PGRIFVVMEK 892 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~L~~~f~~----~~~l~LVmEy 892 (1098)
..++.|+++.+|.+.. +|+.||||++++....... ...+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 4678899999999876 7899999999875433322 4678899999999999999999999876 3578999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
+++|+|..++.. ...+++.....++.+++.||.|||+ .+++||||||+|||++.++ .+||+|||+++..
T Consensus 104 ~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~---~~kl~dfg~~~~~~~~~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY---KLKIICHGLEKILSSPPFK 179 (283)
T ss_pred CCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC---cEEEcccchHhhhcccccc
Confidence 999999999864 4578999999999999999999998 4999999999999999998 8999999998742
Q ss_pred ---CCCCCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 966 ---GEKSFPPEVLRN--KGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 966 ---~~~~~APEvl~~--~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
...|+|||++.+ ..|+.++|||||||++|||++|..||.... +....+..... .......+++++.+++.+
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN--SLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC--CCCCCCcCcHHHHHHHHH
Confidence 234689999976 689999999999999999999999998653 33333322221 222223578999999999
Q ss_pred hhhhcccCCCCHHHHHc
Q psy48 1039 LLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1039 cL~~dP~kRPSa~eIL~ 1055 (1098)
||+.||++|||+.++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999985
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=312.63 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=209.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|+....+|.|.+|.+|.+.+..+++.||||.+.... ......+.+|+.+++.++|+||+++++++...+.+++||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 345888899999999999999999999999999986543 233567889999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+.+++|..++.. ..+++.++..++.+|+.||+|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~---~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 96 EYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG---SVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEccCccchhcccccc
Confidence 99999999888753 3589999999999999999999999999999999999999888 89999999876431
Q ss_pred --------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc-cCCCCCCCcCcHHHHHHHH
Q psy48 967 --------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF-MYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 --------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~-~~p~~~~~~is~el~~LL~ 1037 (1098)
..|+|||.+.+..++.++|+|||||++|+|++|..||............... ......+..+++.+.++|.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN 250 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence 2357999999999999999999999999999999999876544332222211 1122234568899999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+||..||++||++.+++.||||+..
T Consensus 251 ~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 251 RCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHhhcChhhCCCHHHHhhChHhhhc
Confidence 9999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=337.15 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=190.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC------CCCceeeeeeeecC-
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC------HPGVVNLERMFETP- 883 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~------HpnIv~L~~~f~~~- 883 (1098)
...|.+...||.|.||.||.+.+..+++.||||+++.. ......+..|+.++..++ |.+++.++++|...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 36788999999999999999999999999999999642 122334556777766554 45688899998765
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCC------------
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSE------------ 950 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~------------ 950 (1098)
.++++|||++.+.++ .++. +.+.+++..+..++.||+.||.|||+ .|||||||||+|||++.++.
T Consensus 205 ~~~~iv~~~~g~~l~-~~l~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 205 GHMCIVMPKYGPCLL-DWIM-KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred ceEEEEEeccCCCHH-HHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 578999999865555 5554 34579999999999999999999998 59999999999999987652
Q ss_pred -CCcEEEeecCccccc---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhc
Q psy48 951 -LPQVKLCDFGFARII---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAF 1018 (1098)
Q Consensus 951 -~~~vKL~DFGla~~~---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~ 1018 (1098)
...+||+|||++... +..|+|||++.+..|+.++|||||||+||||++|+.||.+..... ..+.....
T Consensus 283 ~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g 362 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362 (467)
T ss_pred CCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Confidence 114999999987532 335789999999999999999999999999999999998654321 11111100
Q ss_pred cCC------------------------CC------------CCC--cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcC
Q psy48 1019 MYP------------------------PR------------PWR--DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060 (1098)
Q Consensus 1019 ~~p------------------------~~------------~~~--~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk 1060 (1098)
..| .. .+. ..++.+.+||.+||.+||++|||++|+|+||||+
T Consensus 363 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVL 442 (467)
T ss_pred CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccc
Confidence 000 00 000 0135678999999999999999999999999998
Q ss_pred C
Q psy48 1061 D 1061 (1098)
Q Consensus 1061 ~ 1061 (1098)
.
T Consensus 443 ~ 443 (467)
T PTZ00284 443 K 443 (467)
T ss_pred c
Confidence 6
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.19 Aligned_cols=240 Identities=25% Similarity=0.333 Sum_probs=199.6
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|.+...||.|.+|.+|.+.+..+++.||+|+++... ......+.+|+.+++.++||||+++++.+...+.+++||||
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 4566677899999999999999999999999997542 23345688899999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------ 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------ 966 (1098)
+++++|..++. ..+.+++.++..++.||+.||.|||+.||+|+||||+||+++.++ .++|+|||++....
T Consensus 88 ~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~---~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 88 CGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG---HVKLADFGVSAQITATIAKR 163 (267)
T ss_pred cCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---CEEECcceeeeEccCccccc
Confidence 99999988875 345799999999999999999999999999999999999999888 89999999986432
Q ss_pred ------CCCCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCC---CCcCcHHHHH
Q psy48 967 ------EKSFPPEVLR---NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRP---WRDISSDAID 1034 (1098)
Q Consensus 967 ------~~~~APEvl~---~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~---~~~is~el~~ 1034 (1098)
..++|||++. ...++.++|+|||||++|+|++|..||..................+.. ...++..+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 2357999985 456889999999999999999999999754332222111111111111 1246789999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPW 1058 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~Hpf 1058 (1098)
+|.+||..||++||+++++++|||
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=305.08 Aligned_cols=243 Identities=28% Similarity=0.383 Sum_probs=202.2
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC---hHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP---TKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRIF 887 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l~ 887 (1098)
.|+....+|.|.+|.||.+.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 467789999999999999999999999999998643221 23346789999999999999999999998764 4688
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
+||||+++++|..++.. ...+++..+..++.|++.||+|||++||+|+||||+||+++.++ .++|+|||++....
T Consensus 83 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~---~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 83 IFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG---NVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC---CEEECcCcccccccc
Confidence 99999999999888764 35688999999999999999999999999999999999999888 89999999886321
Q ss_pred --------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHH
Q psy48 967 --------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 967 --------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
..|+|||.+.+..++.++||||||+++|+|++|+.||..................+..+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 135799999998899999999999999999999999986544333322222222222334577889
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcCCCcC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~HpfFk 1060 (1098)
.++|.+||. +|++||+++++++|||++
T Consensus 239 ~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 239 RDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 999999995 999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=315.13 Aligned_cols=244 Identities=24% Similarity=0.386 Sum_probs=204.0
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|.+...||.|.+|.||.+.+..++..||+|.++... .......+.+|+++++.++||||++++++|.+.+.+++||||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3677889999999999999999999999999987542 234456788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
+++++|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .++|+|||++...
T Consensus 81 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 81 MDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG---EIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC---cEEEccCCCcccccccccc
Confidence 999999888864 3678999999999999999999997 5999999999999999988 8999999988643
Q ss_pred ----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHh-----------------------
Q psy48 966 ----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNA----------------------- 1016 (1098)
Q Consensus 966 ----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~----------------------- 1016 (1098)
...++|||.+.+..++.++|+||||+++|+|++|..||...+.. ...+...
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 23467999999888999999999999999999999999643211 1111000
Q ss_pred ----------h-ccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1017 ----------A-FMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1017 ----------~-~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
. ...+..+...++.++.+++.+||..||++||++.++++||||.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 0 00011111236788999999999999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=312.15 Aligned_cols=245 Identities=27% Similarity=0.419 Sum_probs=205.4
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.+...||.|.+|.+|.+.+..++..||+|.++.. ........+.+|+.+++.++|+||+++++++...+.+++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 45567889999999999999999999999998653 23444577899999999999999999999999999999999999
Q ss_pred cCchHHHHHhhc--cCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 894 QGDMLEMILSSE--KGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 894 ~ggsL~~~l~~~--~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
++++|..++... ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG---QVKLCDFGVSGNLVASLA 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC---CEEEeecCCcccccCCcc
Confidence 999998887643 2378999999999999999999996 5999999999999999987 89999999986431
Q ss_pred ------CCCCChhhhccC------CCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHH
Q psy48 967 ------EKSFPPEVLRNK------GYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 967 ------~~~~APEvl~~~------~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
..++|||.+.+. .++.++|+|||||++|+|++|..||.... .....+.......+...+..++.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence 246799998643 35889999999999999999999997542 2223333332333334445689999
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.++|.+||..+|++||++.++++||||...
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=306.65 Aligned_cols=239 Identities=29% Similarity=0.394 Sum_probs=199.3
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
...+|.|.+|.||.+.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..++||||+.++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 457899999999999999999999999986543 344578999999999999999999999999999999999999999
Q ss_pred hHHHHHhhccCcc--chhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---------
Q psy48 897 MLEMILSSEKGRL--SERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~l--se~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--------- 965 (1098)
+|..++......+ ++..+..++.||+.||+|||++||+||||||+||+++.+.. .++|+|||++...
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~--~~~l~dfg~~~~~~~~~~~~~~ 168 (268)
T cd06624 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGINPCTET 168 (268)
T ss_pred CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--eEEEecchhheecccCCCcccc
Confidence 9999887655556 88899999999999999999999999999999999986332 7999999988643
Q ss_pred ---CCCCCChhhhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHH-HHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 966 ---GEKSFPPEVLRNKG--YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI-QNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 966 ---~~~~~APEvl~~~~--ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i-~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
...++|||.+.+.. ++.++|+||||+++|+|++|..||.......... ........+..+..+++++.+++.+|
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 248 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRC 248 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHH
Confidence 22457999987643 8899999999999999999999997543221111 11111122223456889999999999
Q ss_pred hhhcccCCCCHHHHHcCCCc
Q psy48 1040 LQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfF 1059 (1098)
|..+|++||++.+++.||||
T Consensus 249 l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 249 FEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred cCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.83 Aligned_cols=242 Identities=24% Similarity=0.309 Sum_probs=200.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.+...+|.|.+|.||.+.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++...+.+++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 345778889999999999999999999999999996532 233456889999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+++++|..++.. ...+++..+..++.|++.||+|||+.||+||||+|+||+++.++ .++|+|||++....
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~---~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 86 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG---DVKLADFGVAAKITATIA 161 (267)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC---CEEECcCccceeeccccc
Confidence 99999999888763 45789999999999999999999999999999999999999888 89999999986432
Q ss_pred --------CCCCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCC---CCcCcHHH
Q psy48 967 --------EKSFPPEVLR---NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRP---WRDISSDA 1032 (1098)
Q Consensus 967 --------~~~~APEvl~---~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~---~~~is~el 1032 (1098)
..++|||.+. ...++.++|||||||++|||++|..||................+.... ...++.++
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 2357999985 445788999999999999999999999654322221111111111111 12468899
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcCCC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAHPW 1058 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~Hpf 1058 (1098)
.++|.+||..||++||++++|++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=324.37 Aligned_cols=238 Identities=24% Similarity=0.320 Sum_probs=193.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|.....||.|.+|.||.+.+..+++.||+|+..+. ....|+.+++.++|+||+++++++...+..++|||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4588899999999999999999999999999986432 23468999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
++.+. |..++......+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++..
T Consensus 138 ~~~~~-l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~---~~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 138 HYSSD-LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD---QVCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred ccCCc-HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---CEEEecCccccccccCccc
Confidence 99765 4466665667899999999999999999999999999999999999999988 8999999998642
Q ss_pred -----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-h------------hHHHHHHHhh---ccCCC--
Q psy48 966 -----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED-E------------DINEQIQNAA---FMYPP-- 1022 (1098)
Q Consensus 966 -----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~-~------------~~~~~i~~~~---~~~p~-- 1022 (1098)
+..|+|||++.+..++.++|||||||++|||+++..|+... . .+...+.... ..++.
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 22467999999999999999999999999999865554221 0 0111111000 00110
Q ss_pred ------------------------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1023 ------------------------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1023 ------------------------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
....+++.++.+||.+||+.||++|||+.|+++||||++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 001245677888999999999999999999999999986
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=304.49 Aligned_cols=243 Identities=25% Similarity=0.385 Sum_probs=204.9
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|++...+|.|.+|.+|.+....++..||+|++....... ....+.+|+.+++.++|+||+++++.+...+..++|||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4677889999999999999999999999999997654433 567899999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhc--cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 893 LQGDMLEMILSSE--KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~--~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
+.+++|..++... ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++ .++|+|||++....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~---~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG---SVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC---CEEEcccchHHHhccCcc
Confidence 9999998888654 24689999999999999999999999999999999999999988 89999999875332
Q ss_pred ------------CCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc---CCC-CCCCcCc
Q psy48 967 ------------EKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM---YPP-RPWRDIS 1029 (1098)
Q Consensus 967 ------------~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~---~p~-~~~~~is 1029 (1098)
..++|||++... .++.++|+||||+++|+|++|..||................ .+. ..+..++
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccccc
Confidence 125799999876 78999999999999999999999997654322211111111 111 1123678
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
.++.+++.+||..||++||++.+|++||||
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 238 KSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=309.63 Aligned_cols=243 Identities=26% Similarity=0.384 Sum_probs=201.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeec------C
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFET------P 883 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~------~ 883 (1098)
.+.|.....+|.|.++.+|.+.+..+++.||+|++... ......+..|+.+++.+ +|+||+++++++.. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 35667778999999999999999999999999998653 23446688899999888 69999999999853 4
Q ss_pred CcEEEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
..++++|||+++++|..++... ...+++..+..++.||+.||+|||+.||+|+||+|+||+++.++ .++|+|||++
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~---~~~l~dfg~~ 168 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA---EVKLVDFGVS 168 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEeeCcch
Confidence 5789999999999998887653 34588889999999999999999999999999999999999988 8999999998
Q ss_pred cccC------------CCCCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCC
Q psy48 963 RIIG------------EKSFPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPW 1025 (1098)
Q Consensus 963 ~~~~------------~~~~APEvl~-----~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~ 1025 (1098)
.... ..|+|||.+. +..++.++|+|||||++|||++|..||.................+....
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence 6432 2367999986 3568889999999999999999999997654333322222222222223
Q ss_pred CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1026 RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1026 ~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
..++.++.++|.+||..||.+||++.+|++||||
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 4578999999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=327.70 Aligned_cols=245 Identities=26% Similarity=0.390 Sum_probs=218.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc-EEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR-IFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~-l~LV 889 (1098)
+..|-+...+|.|.||.++...++..+..|++|.+..............+|+.++.+++|||||.+.+.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 345677789999999999999999999999999999888777777889999999999999999999999999998 9999
Q ss_pred EEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-
Q psy48 890 MEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE- 967 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~- 967 (1098)
|+|++||++...+..++ .-|+++++..|+.||+.|+.|||+++|+|||||+.||+++.++ .|+|+|||+|+..++
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~---~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK---KVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC---ceeecchhhhhhcCCc
Confidence 99999999998887666 5699999999999999999999999999999999999999998 899999999986543
Q ss_pred -----------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 968 -----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 968 -----------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
.||.||++.+.+|+.++|||||||++|||++-+++|.+.+ .+...+.... +.+ .+..++.++..
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~--~~P-lp~~ys~el~~ 236 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL--YSP-LPSMYSSELRS 236 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc--CCC-CCccccHHHHH
Confidence 3579999999999999999999999999999999998764 4444444333 222 23568999999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+|+.||..+|+.||++.++|.+|..+.
T Consensus 237 lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 237 LVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 999999999999999999999998885
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=303.11 Aligned_cols=230 Identities=23% Similarity=0.347 Sum_probs=196.8
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchH
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDML 898 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL 898 (1098)
.||.|.+|.||.+.++.+++.||+|.+... ...+....+.+|+++++.++||||+++++++.....+++||||+.+++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 578999999999999999999999998643 3344557899999999999999999999999999999999999999999
Q ss_pred HHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------------
Q psy48 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------------ 966 (1098)
Q Consensus 899 ~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------------ 966 (1098)
..++......+++..++.++.|++.||+|||++||+||||||+||+++.++ .++|+|||++....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN---VLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC---cEEECccccCcccccccccccCCCCC
Confidence 988876566789999999999999999999999999999999999999888 89999999986422
Q ss_pred --CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhh
Q psy48 967 --EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041 (1098)
Q Consensus 967 --~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~ 1041 (1098)
..|+|||.+.+..++.++||||||+++|||++ |..||..... ....+. ...+...+..++..+.+++.+||.
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---QGVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---cCCCCCCcccCCHHHHHHHHHHcC
Confidence 13679999999889999999999999999997 8899875432 222222 122223345678999999999999
Q ss_pred hcccCCCCHHHHHc
Q psy48 1042 VKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1042 ~dP~kRPSa~eIL~ 1055 (1098)
.||++||++.++++
T Consensus 235 ~~p~~Rps~~~~~~ 248 (252)
T cd05084 235 YDPGQRPSFSTVHQ 248 (252)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=303.22 Aligned_cols=243 Identities=25% Similarity=0.366 Sum_probs=206.1
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
+|.....||.|.++.+|.+.+..+++.||+|+++...........+.+|+.+++.++|+||+++++.+.+.+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 46778899999999999999999999999999987655445678899999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------ 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------ 966 (1098)
+.+++|.+++.. ...+++..+..++.+|+.||.|||+.||+|+||+|+||+++.++ .++|+|||++....
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~---~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG---VIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEcccccccccCCCCCcc
Confidence 999999988764 34689999999999999999999999999999999999999988 89999999886432
Q ss_pred ----------CCCCChhhhccCC---CCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCC--CCCCCcCcHH
Q psy48 967 ----------EKSFPPEVLRNKG---YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYP--PRPWRDISSD 1031 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~---ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p--~~~~~~is~e 1031 (1098)
..++|||.+.+.. ++.++||||||+++|+|++|+.||.................. ...+..++..
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPE 236 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHH
Confidence 2457999998766 899999999999999999999999754322222211111111 1122345899
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
+.++|.+||..+|++||++.+++.|||+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 237 GKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=301.90 Aligned_cols=242 Identities=28% Similarity=0.396 Sum_probs=205.3
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec--CCcEEEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET--PGRIFVVME 891 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~--~~~l~LVmE 891 (1098)
|.+...+|.|++|.+|.+.+..+++.||+|+++...........+.+|+.+++.++|+||+++++++.. ...++++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 566788999999999999999999999999998766666667889999999999999999999998754 456899999
Q ss_pred eccCchHHHHHhhc---cCccchhHHHHHHHHHHHHHHHHH-----hCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 892 KLQGDMLEMILSSE---KGRLSERTTKFIITQILVALKHLH-----SKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 892 y~~ggsL~~~l~~~---~~~lse~~~~~ia~qIa~gL~~LH-----s~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
|+++++|..++... ..++++..++.++.||+.||.||| +.+|+|+||+|+||+++.++ .++|+|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~---~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN---NVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC---CEEEecccccc
Confidence 99999998887643 457899999999999999999999 88999999999999999988 89999999987
Q ss_pred ccC------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHH
Q psy48 964 IIG------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 964 ~~~------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
... ..++|||.+.+..++.++|+||||+++|+|++|..||..... ............+.....++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIKEGKFRRIPYRYSSE 237 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-HHHHHHHhcCCCCCCccccCHH
Confidence 542 234799999998899999999999999999999999986542 1222222222222233467899
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
+.+++.+||..+|++||++.+|++|||+
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=309.39 Aligned_cols=243 Identities=29% Similarity=0.431 Sum_probs=201.8
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|.....||.|.++.||.+.+..+++.||+|++.+..........+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 46778899999999999999999999999999876544344456788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------ 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------ 966 (1098)
+.+++|..+.. ....+++..+..++.||+.||+|||+.||+|+||+|+||+++.++ .++|+|||++....
T Consensus 82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~---~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 82 VDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG---VVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred CCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC---cEEEEeeeeeeeccCCcccc
Confidence 99999987765 334589999999999999999999999999999999999999988 89999999986432
Q ss_pred ------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhh---------------------c
Q psy48 967 ------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAA---------------------F 1018 (1098)
Q Consensus 967 ------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~---------------------~ 1018 (1098)
..++|||++.+ ..++.++||||||+++|||++|..||.............. .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 12579999875 4578899999999999999999999976543221111000 0
Q ss_pred cCCC--------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1019 MYPP--------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1019 ~~p~--------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
..+. ..+..++..+.+|+.+||..+|++||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000 0123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=305.97 Aligned_cols=243 Identities=24% Similarity=0.408 Sum_probs=203.1
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh--------HHHHHHHHHHHHHhccCCCCceeeeeeeecCC
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT--------KQEAQLKNEVAILQNLCHPGVVNLERMFETPG 884 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~--------~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~ 884 (1098)
+|.....||.|.+|.||.+.+..+++.||||.++...... ...+.+.+|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999999999999999986432111 11356888999999999999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
.+++||||+.+++|..++... +.+++..+..++.||+.||.|||+.|++||||+|+||+++.++ .++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~---~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG---ICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC---eEEEeecccccc
Confidence 999999999999998888644 6789999999999999999999999999999999999999888 899999999864
Q ss_pred cC--------------CCCCChhhhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHh----hccCCCCC
Q psy48 965 IG--------------EKSFPPEVLRNKG--YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNA----AFMYPPRP 1024 (1098)
Q Consensus 965 ~~--------------~~~~APEvl~~~~--ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~----~~~~p~~~ 1024 (1098)
.. ..++|||.+.+.. ++.++|+||||+++|+|++|..||...+......... ....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 32 1356999988654 8899999999999999999999997654432222211 11122223
Q ss_pred CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1025 WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1025 ~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
...++.++.++|.+||..+|++||++.++++||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 34578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=309.44 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=197.8
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCc-----E
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGR-----I 886 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~-----l 886 (1098)
.|.....||.|.+|.||.+.+..+++.||||+++...........+.+|+.+++.+. |+||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 467788999999999999999999999999998765433333467888999999995 6999999999977665 8
Q ss_pred EEEEEeccCchHHHHHhhc----cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCCCCcEEEeecCc
Q psy48 887 FVVMEKLQGDMLEMILSSE----KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST-NSELPQVKLCDFGF 961 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~----~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~-~g~~~~vKL~DFGl 961 (1098)
|+||||++++ |..++... ...+++..++.++.||+.||.|||++||+||||+|+||+++. ++ .++|+|||+
T Consensus 82 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~---~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG---LLKIADLGL 157 (295)
T ss_pred EEEeeccCcC-HHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC---eEEEeeccc
Confidence 9999999985 54555432 235899999999999999999999999999999999999998 66 899999999
Q ss_pred ccccC------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc---------
Q psy48 962 ARIIG------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM--------- 1019 (1098)
Q Consensus 962 a~~~~------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~--------- 1019 (1098)
+.... ..++|||++.+ ..++.++||||||+++|+|++|..||.+..+...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 87432 23679998865 557999999999999999999999998765443322111100
Q ss_pred ----------CCC-------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcC
Q psy48 1020 ----------YPP-------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060 (1098)
Q Consensus 1020 ----------~p~-------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk 1060 (1098)
++. .....++.++.+||.+||..||.+||++.+++.||||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000 00134788999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=310.09 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=200.2
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|.....||.|.++.+|.+.+..+++.||||.++...........+.+|+++++.++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 45778889999999999999999999999999987654434445678899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
|++++.+..+.......+++..+..++.||+.||+|||++||+||||+|+||+++.++. .+||+|||++...+
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~--~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC--EEEEcccccccccCCCccc
Confidence 99875444333323334688899999999999999999999999999999999986542 79999999986432
Q ss_pred -------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc-c------------------
Q psy48 967 -------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF-M------------------ 1019 (1098)
Q Consensus 967 -------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~-~------------------ 1019 (1098)
..++|||.+.+ ..++.++||||||+++|+|++|..||............... .
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 23579999876 45899999999999999999999999765433222111100 0
Q ss_pred -CC---CC----CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1020 -YP---PR----PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1020 -~p---~~----~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+ .. ....++.++.+++.+||+.||++||++.++++||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 00 00 01346889999999999999999999999999999997
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=329.74 Aligned_cols=207 Identities=23% Similarity=0.333 Sum_probs=173.2
Q ss_pred CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHH
Q psy48 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKF 916 (1098)
Q Consensus 837 g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ 916 (1098)
++.||||.++. .-..+|.-|++|+|+||+.+.++|.....++||||||..|-|+.+|. ....+.....+.
T Consensus 147 netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk-a~~~itp~llv~ 216 (904)
T KOG4721|consen 147 NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK-AGRPITPSLLVD 216 (904)
T ss_pred CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh-ccCccCHHHHHH
Confidence 56899998742 22347888999999999999999999999999999999999999987 445678888999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------CCCCCChhhhccCCCCchhH
Q psy48 917 IITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-----------GEKSFPPEVLRNKGYNRSLD 985 (1098)
Q Consensus 917 ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-----------~~~~~APEvl~~~~ys~~sD 985 (1098)
|..+|+.||+|||.+.|||||||.-||||..+. .|||+|||.++.. +-.|||||++++.+.+.++|
T Consensus 217 Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d---~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVD 293 (904)
T KOG4721|consen 217 WSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD---VVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVD 293 (904)
T ss_pred HHHHhhhhhHHHHHhhHhhhccCCCceEeeccc---eEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccc
Confidence 999999999999999999999999999999988 8999999988644 23469999999999999999
Q ss_pred HHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 986 MWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 986 VwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
||||||+|||||||..||..-+...-..-..........+..+++-+.-||+.||.-.|..||+|.+|+.|
T Consensus 294 IwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 294 IWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred eehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 99999999999999999976432211111111111112235688999999999999999999999999988
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=304.98 Aligned_cols=239 Identities=28% Similarity=0.467 Sum_probs=198.4
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHH-hccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAIL-QNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL-~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.+|.|.+|.||.+.+..+++.||||++++..... .....+..|..++ ...+|+|++++++++...+.+++||||++++
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 5789999999999999999999999997643322 2223445555544 4558999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--------CCC
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--------GEK 968 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--------~~~ 968 (1098)
+|..++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++ .++|+|||++... ...
T Consensus 83 ~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~ 158 (260)
T cd05611 83 DCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG---HLKLTDFGLSRNGLENKKFVGTPD 158 (260)
T ss_pred CHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC---cEEEeecccceeccccccCCCCcC
Confidence 99888763 45689999999999999999999999999999999999999888 8999999988643 234
Q ss_pred CCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccC
Q psy48 969 SFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRK 1046 (1098)
Q Consensus 969 ~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~k 1046 (1098)
++|||.+.+..++.++||||||+++|+|++|..||.... .....+......++......+++++.++|.+||+.||++
T Consensus 159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 238 (260)
T cd05611 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238 (260)
T ss_pred ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHH
Confidence 679999998889999999999999999999999997653 223333333333444444468999999999999999999
Q ss_pred CCC---HHHHHcCCCcCC
Q psy48 1047 RLS---VDKSLAHPWLQD 1061 (1098)
Q Consensus 1047 RPS---a~eIL~HpfFk~ 1061 (1098)
||+ +++++.||||++
T Consensus 239 R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 239 RLGANGYQEIKSHPFFKS 256 (260)
T ss_pred ccCCCcHHHHHcChHhhc
Confidence 995 579999999987
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=309.87 Aligned_cols=245 Identities=29% Similarity=0.426 Sum_probs=199.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
.+..|.....+|.|.+|.||.+.++.+++.||||.+...... .....+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 346788899999999999999999999999999999754321 2234567899999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||+.+ +|..++......+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||+++..
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~---~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG---ELKLADFGLARAKSVPS 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC---CEEECccccccccCCCC
Confidence 999987 67677765556789999999999999999999999999999999999999998 8999999988643
Q ss_pred --------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHh---hcc--------------
Q psy48 966 --------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNA---AFM-------------- 1019 (1098)
Q Consensus 966 --------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~---~~~-------------- 1019 (1098)
...++|||++.+ ..++.++||||||+++|+|++|..||.......+.+... ...
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 223579999875 558999999999999999999999997554221111100 000
Q ss_pred -----CC---C----CCCCcCc--HHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1020 -----YP---P----RPWRDIS--SDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1020 -----~p---~----~~~~~is--~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
.+ . .....++ .++.+++.+||+.||++|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0 0011234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=332.25 Aligned_cols=239 Identities=26% Similarity=0.343 Sum_probs=196.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.+...||.|.+|.||.+.+..+++.||||.... ..+.+|+++|+.++|+||+++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 4468889999999999999999999999999996432 23568999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
|++.+. |..++......+++.+++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++..
T Consensus 240 e~~~~~-L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~---~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 240 PKYRSD-LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE---DICLGDFGAACFARGSWS 315 (461)
T ss_pred EccCCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC---CEEEcccCCceecccccc
Confidence 999764 5566655556799999999999999999999999999999999999999888 8999999998642
Q ss_pred ---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC----------hhHHHHHHHhhcc---CC--
Q psy48 966 ---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED----------EDINEQIQNAAFM---YP-- 1021 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~----------~~~~~~i~~~~~~---~p-- 1021 (1098)
+..|+|||++.+..++.++|||||||+||||++|..|+... ..+.+.+...... ++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 23468999999999999999999999999999987655321 1222222221110 11
Q ss_pred ----------------------CCCCC---cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1022 ----------------------PRPWR---DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1022 ----------------------~~~~~---~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
...|. .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 01121 35668999999999999999999999999999985
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=311.98 Aligned_cols=259 Identities=23% Similarity=0.275 Sum_probs=209.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..|.....+|.|.+|.+|.+.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 446677889999999999999999999999999865432 2344467899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+.|+.+ .++......+++..+..++.||+.||.|||+.||+||||+|+||+++.++ .++|+|||++....
T Consensus 95 e~~~g~l~-~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~---~~kL~dfg~~~~~~~~~~ 170 (307)
T cd06607 95 EYCLGSAS-DILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG---TVKLADFGSASLVSPANS 170 (307)
T ss_pred HhhCCCHH-HHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC---CEEEeecCcceecCCCCC
Confidence 99987655 45444455799999999999999999999999999999999999999988 89999999986542
Q ss_pred ----CCCCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 967 ----EKSFPPEVLR---NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 967 ----~~~~APEvl~---~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
..++|||++. ...++.++||||||+++|||++|..||...+.............+......++.++.++|.+|
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 250 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC 250 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHH
Confidence 2368999884 456889999999999999999999999865443322222111222222234678999999999
Q ss_pred hhhcccCCCCHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1040 LQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
|..||++||++.+++.||||+..........+.++
T Consensus 251 l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~ 285 (307)
T cd06607 251 LQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQR 285 (307)
T ss_pred hcCChhhCcCHHHHhcChhhcccCCcHHHHHHHHH
Confidence 99999999999999999999875443333333333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=310.75 Aligned_cols=249 Identities=25% Similarity=0.338 Sum_probs=199.7
Q ss_pred HHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC--
Q psy48 807 FLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG-- 884 (1098)
Q Consensus 807 ~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~-- 884 (1098)
+......|.....+|.|.++.||.+.+..+++.||||.+............+.+|+.+++.++||||+++++++...+
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 445567889999999999999999999999999999998765433333456678999999999999999999886543
Q ss_pred ------cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEee
Q psy48 885 ------RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958 (1098)
Q Consensus 885 ------~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~D 958 (1098)
..++||||+.++ |..++......+++..++.++.||+.||+|||++||+|+||||+||+++.++ .+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~---~~kl~d 162 (310)
T cd07865 87 YNRYKGSFYLVFEFCEHD-LAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG---ILKLAD 162 (310)
T ss_pred ccCCCceEEEEEcCCCcC-HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC---cEEECc
Confidence 459999999874 5566655555799999999999999999999999999999999999999988 899999
Q ss_pred cCcccccC----------------CCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhcc
Q psy48 959 FGFARIIG----------------EKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFM 1019 (1098)
Q Consensus 959 FGla~~~~----------------~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~ 1019 (1098)
||++.... ..++|||.+.+. .++.++|+||||+++|||++|..||....... ..+......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99886431 236799998764 47899999999999999999999997654321 111111111
Q ss_pred CCCCC----------------------------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1020 YPPRP----------------------------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1020 ~p~~~----------------------------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
.+... ....+..+.++|.+||..||++||+++++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 11000 01135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=330.72 Aligned_cols=241 Identities=28% Similarity=0.419 Sum_probs=211.4
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
..++|.|+||.||.+.+..+....|||-+.... ....+-+.+|+.+.+.++|.|||+++|.+..++.+-|.||-++||
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 457899999999999999999999999986432 344577999999999999999999999999999999999999999
Q ss_pred hHHHHHhhccCcc--chhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCCCCcEEEeecCccccc--------
Q psy48 897 MLEMILSSEKGRL--SERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST-NSELPQVKLCDFGFARII-------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~l--se~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~-~g~~~~vKL~DFGla~~~-------- 965 (1098)
+|..++..+.+++ .+..+-+|.+||++||.|||+..|||||||-+||||+. .| .+||+|||.++.+
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySG---vlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSG---VLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccc---eEEecccccchhhccCCcccc
Confidence 9999999999998 78999999999999999999999999999999999974 45 8999999998754
Q ss_pred ----CCCCCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHH-HHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 966 ----GEKSFPPEVLRN--KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI-QNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 966 ----~~~~~APEvl~~--~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i-~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
+-.|||||++.. ..|+.++|||||||++.||.||++||..-.....++ +...+..-+..+..+|.++.+||.+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence 235799999974 459999999999999999999999998765443333 3334444455567899999999999
Q ss_pred hhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1039 LLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1039 cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
|++.||..||++.++|++||++..
T Consensus 815 cFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999873
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.27 Aligned_cols=242 Identities=28% Similarity=0.431 Sum_probs=209.1
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.....+|.|.++.+|.+.+..+++.||+|++............+.+|+++++.++|+|++++++.+...+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 56778899999999999999999999999999876655566778999999999999999999999999999999999999
Q ss_pred cCchHHHHHhhc---cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC---
Q psy48 894 QGDMLEMILSSE---KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE--- 967 (1098)
Q Consensus 894 ~ggsL~~~l~~~---~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~--- 967 (1098)
++++|..++... ...+++..+..++.+|+.||.+||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~---~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG---LVKLGDFGISKVLSSTVD 158 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC---cEEECCccceeecccCcc
Confidence 999998888754 36799999999999999999999999999999999999999888 899999999865432
Q ss_pred ---------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 968 ---------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 968 ---------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
.++|||.+.+..++.++|+||+|+++|+|++|..||...+.. +................++.++.+++.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-ELALKILKGQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 257999999999999999999999999999999999765421 2222222222222234688999999999
Q ss_pred hhhhcccCCCCHHHHHcCCCc
Q psy48 1039 LLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1039 cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
||..+|++||++.++++||||
T Consensus 238 ~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 238 LLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HcCCChhhCcCHHHHhcCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=301.09 Aligned_cols=244 Identities=29% Similarity=0.443 Sum_probs=206.4
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
+|.+...+|.|.++.+|.+..+.++..||+|.+............+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 36778899999999999999999999999999977554445567788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC----
Q psy48 893 LQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE---- 967 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~---- 967 (1098)
+.+++|..++.... ..+++..+..++.||+.||.|||+.+|+|+||||+||+++.++. .++|+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM--VAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC--eEEecccccchhccCCccc
Confidence 99999988876543 35899999999999999999999999999999999999998763 579999998864422
Q ss_pred --------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 968 --------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 968 --------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
.++|||.+.+..++.++|+||||+++|+|++|..||....... .+..............++.++.++|.+|
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-LVLKICQGYFAPISPNFSRDLRSLISQL 237 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHhcccCCCCCCCCCHHHHHHHHHH
Confidence 3579999998889999999999999999999999997653222 2222222222222335788999999999
Q ss_pred hhhcccCCCCHHHHHcCCCc
Q psy48 1040 LQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfF 1059 (1098)
|..+|++|||+.++++||||
T Consensus 238 l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 238 FKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred hccChhhCcCHHHHhhCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=312.89 Aligned_cols=238 Identities=24% Similarity=0.418 Sum_probs=181.8
Q ss_pred eeeeeeeeeeceEEEEeec--CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeee--cCCcEEEEEEe
Q psy48 817 NVALCIAVVAGAACGVHRK--SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE--TPGRIFVVMEK 892 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~--tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~--~~~~l~LVmEy 892 (1098)
+..||.|+||.||.+.++. ++..||+|.++... ....+.+|+.+++.++||||+++++++. ....+++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 4579999999999998654 66889999986532 2345778999999999999999999984 35678999999
Q ss_pred ccCchHHHHHhh--------ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC-CCCcEEEeecCccc
Q psy48 893 LQGDMLEMILSS--------EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS-ELPQVKLCDFGFAR 963 (1098)
Q Consensus 893 ~~ggsL~~~l~~--------~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g-~~~~vKL~DFGla~ 963 (1098)
++++.+ .++.. ....+++..++.++.||+.||.|||++||+||||||+|||+..++ ....+||+|||+++
T Consensus 82 ~~~~l~-~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEHDLW-HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCCcHH-HHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 987655 44321 122488899999999999999999999999999999999994321 11279999999997
Q ss_pred ccC---------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhH-----------HHHHHHh
Q psy48 964 IIG---------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI-----------NEQIQNA 1016 (1098)
Q Consensus 964 ~~~---------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~-----------~~~i~~~ 1016 (1098)
... ..|+|||++.+ ..++.++|||||||++|||++|.+||....+. ...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 542 23689999976 45899999999999999999999999643210 0000000
Q ss_pred hcc--------------CC--------------------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1017 AFM--------------YP--------------------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1017 ~~~--------------~p--------------------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
... ++ .......+..+.+||.+||+.||.+|||+.|+++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 00 00001235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=307.68 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=196.5
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHH-HhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAI-LQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.+...+|.|.+|.||.+.+..+|+.||||+++....... ...+..|+.+ ++.+.||||+++++++...+.+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 35677889999999999999999999999999976543333 3445556554 566789999999999999999999999
Q ss_pred eccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 892 KLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~-gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
|+++ +|..++.. ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||++....
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~---~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG---QVKLCDFGISGYLVD 156 (283)
T ss_pred hhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC---CEEEeeccccccccc
Confidence 9985 45455432 234689999999999999999999997 999999999999999988 89999999986432
Q ss_pred ----------CCCCChhhhcc----CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc-CCCCCCCcCcHH
Q psy48 967 ----------EKSFPPEVLRN----KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM-YPPRPWRDISSD 1031 (1098)
Q Consensus 967 ----------~~~~APEvl~~----~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~-~p~~~~~~is~e 1031 (1098)
..++|||.+.+ ..++.++|+||||+++|+|++|+.||.......+.+...... .+......+|.+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHH
Confidence 23579999865 557899999999999999999999997533222222222111 121112357899
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+.++|.+||..+|++||++.++++||||+.
T Consensus 237 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 237 FQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 999999999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=302.77 Aligned_cols=237 Identities=22% Similarity=0.290 Sum_probs=202.0
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..+.+...+|.|.++.||.+..+.+++.||+|+++.. ......+.+|+++++.++|+||+++++++...+.+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 3467888999999999999999999999999998753 2335678899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC---
Q psy48 892 KLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE--- 967 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~--- 967 (1098)
|+++++|..++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .++|+|||++.....
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~---~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH---LVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC---cEEeCCCcccccccccee
Confidence 999999988876433 4589999999999999999999999999999999999999888 899999999875422
Q ss_pred ----------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 968 ----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 968 ----------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
.|+|||.+.+..++.++||||||+++|||++ |..||.+... .+........+.......++.++.+++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKGYRMERPEGCPPKVYELM 238 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 3689999999999999999999999999998 9999976432 122222222233334456889999999
Q ss_pred HHhhhhcccCCCCHHHHHc
Q psy48 1037 NNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.+||..||++||++.++++
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=306.08 Aligned_cols=244 Identities=25% Similarity=0.473 Sum_probs=203.6
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC---CCCceeeeeeeecCCcEEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC---HPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~L~~~f~~~~~l~LVm 890 (1098)
|+....+|.|.+|.+|.+.+..+++.||||+++... .......+.+|+.+++.++ |||++++++++......++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 455677999999999999999999999999987542 2344567889999999886 999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC---
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE--- 967 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~--- 967 (1098)
||+.+++|..++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++ .++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~---~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG---NVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC---CEEEccCCceeecCCCcc
Confidence 99999999888754 3789999999999999999999999999999999999999988 899999998865422
Q ss_pred ---------CCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 968 ---------KSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 968 ---------~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
.|+|||.+.+ ..++.++|+||||+++|+|++|..||.................+......++.++.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence 2569999875 557899999999999999999999998664432222111111222222247889999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
+||+.||++||++.+++.|+||++..
T Consensus 237 ~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 237 ACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999998743
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=319.99 Aligned_cols=215 Identities=27% Similarity=0.377 Sum_probs=176.5
Q ss_pred cCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeec-CCcEEEEEEeccCchHHHHHhhcc------
Q psy48 835 KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFET-PGRIFVVMEKLQGDMLEMILSSEK------ 906 (1098)
Q Consensus 835 ~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~-~~~l~LVmEy~~ggsL~~~l~~~~------ 906 (1098)
.+++.||+|+++... .......+.+|+.++.++ +|+||+++++++.. ...++++|||+.+++|..++....
T Consensus 35 ~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~ 113 (337)
T cd05054 35 ASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPY 113 (337)
T ss_pred cccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccc
Confidence 456789999997543 233446788899999999 79999999998764 467899999999999988875321
Q ss_pred ------------------------------------------------------CccchhHHHHHHHHHHHHHHHHHhCC
Q psy48 907 ------------------------------------------------------GRLSERTTKFIITQILVALKHLHSKN 932 (1098)
Q Consensus 907 ------------------------------------------------------~~lse~~~~~ia~qIa~gL~~LHs~g 932 (1098)
..+++..+..++.||+.||+|||++|
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ 193 (337)
T cd05054 114 RNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK 193 (337)
T ss_pred ccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 25788999999999999999999999
Q ss_pred ccccCCCCCceeecCCCCCCcEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc
Q psy48 933 IVHCDLKPENVLLSTNSELPQVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS 998 (1098)
Q Consensus 933 IvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt 998 (1098)
|+||||||+|||++.++ .++|+|||++..+ ...|+|||++.+..++.++|||||||+||||++
T Consensus 194 ivHrDikp~Nill~~~~---~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t 270 (337)
T cd05054 194 CIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270 (337)
T ss_pred eecCCCCcceEEEeCCC---cEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHH
Confidence 99999999999999888 8999999999753 124789999999999999999999999999997
Q ss_pred -CCCCCCCC---hhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 999 -GTFPFNED---EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 999 -G~~Pf~~~---~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
|..||.+. +.....+..... ......+++++.+++.+||+.+|++||++.++++|
T Consensus 271 ~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 271 LGASPYPGVQIDEEFCRRLKEGTR---MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred cCCCCCCCCCccHHHHHHHhccCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999753 223233322221 12224578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=306.98 Aligned_cols=243 Identities=30% Similarity=0.484 Sum_probs=203.5
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|.+...+|.|.++.+|.+.+..+++.||||+++...........+.+|+++++.++|+||+++++++...+.+++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 57788899999999999999999999999999976544444557899999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----- 967 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----- 967 (1098)
++++++..+.. ....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++ .++|+|||++.....
T Consensus 82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~---~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 82 VERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG---VLKLCDFGFARALRARPASP 157 (288)
T ss_pred CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC---CEEEEeeecccccCCCcccc
Confidence 99988866554 445689999999999999999999999999999999999999988 899999999864322
Q ss_pred --------CCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhh--c------------------
Q psy48 968 --------KSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAA--F------------------ 1018 (1098)
Q Consensus 968 --------~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~--~------------------ 1018 (1098)
.++|||++.+. .++.++|+||||+++|+|++|+.||.............. .
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 25799999888 899999999999999999999999976533221111000 0
Q ss_pred -cCCC---------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1019 -MYPP---------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1019 -~~p~---------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
..+. .....++.++.+||++||..+|++||+++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 0112348899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=300.93 Aligned_cols=243 Identities=28% Similarity=0.429 Sum_probs=210.0
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
+.+...+|.|+++.+|.+.+..+++.||||++...... .....+.+|+.++..++|+||+++++++...+.+++||||+
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 55678899999999999999999999999999765432 45678999999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCcccccC------
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------ 966 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------ 966 (1098)
++++|..++... ..+++..+..++.||+.||+|||+ .|++||||+|+||+++.++ .++|+|||++....
T Consensus 82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~---~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG---EVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC---CEEEccCccceecccCCCcc
Confidence 999999888643 679999999999999999999999 9999999999999999988 89999999887542
Q ss_pred ------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCc-CcHHHHHHHH
Q psy48 967 ------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRD-ISSDAIDLIN 1037 (1098)
Q Consensus 967 ------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~-is~el~~LL~ 1037 (1098)
..++|||.+.+..++.++|+||||+++|+|++|..||.... ...+................ ++..+.++|.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 23579999999999999999999999999999999997654 33333333332222222334 7899999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+||..+|++||++.++++||||+.
T Consensus 238 ~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 238 ACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHccCChhhCCCHHHHHhCHHHHh
Confidence 999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=347.32 Aligned_cols=251 Identities=26% Similarity=0.373 Sum_probs=209.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec--CCcEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET--PGRIF 887 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~--~~~l~ 887 (1098)
.+..|.+...||.|.||.||.+.+..++..||+|++............+..|+.+|+.++||||++++++|.. ...+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3567899999999999999999999999999999998766666667889999999999999999999999854 45699
Q ss_pred EEEEeccCchHHHHHhhc---cCccchhHHHHHHHHHHHHHHHHHhC-------CccccCCCCCceeecCCC--------
Q psy48 888 VVMEKLQGDMLEMILSSE---KGRLSERTTKFIITQILVALKHLHSK-------NIVHCDLKPENVLLSTNS-------- 949 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~---~~~lse~~~~~ia~qIa~gL~~LHs~-------gIvHrDLKp~NILld~~g-------- 949 (1098)
|||||+.+++|..++... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999998887642 35699999999999999999999984 499999999999996532
Q ss_pred ------CCCcEEEeecCccccc-----------CCCCCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH
Q psy48 950 ------ELPQVKLCDFGFARII-----------GEKSFPPEVLRN--KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN 1010 (1098)
Q Consensus 950 ------~~~~vKL~DFGla~~~-----------~~~~~APEvl~~--~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~ 1010 (1098)
....+||+|||++... +..|+|||++.+ ..++.++|||||||+||||++|..||.......
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 1125899999998643 334689999964 458999999999999999999999998665444
Q ss_pred HHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1011 EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1011 ~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..+..... .+..+....+.++.+||..||..+|.+||++.++|.|+||+.
T Consensus 251 qli~~lk~-~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 251 QLISELKR-GPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HHHHHHhc-CCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 44333222 222233457899999999999999999999999999999985
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=308.38 Aligned_cols=248 Identities=27% Similarity=0.451 Sum_probs=210.7
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|.....++.|.++.+|.+.+..+++.||+|+++.... ....+.+|+.+++.++|+|++++++++...+..++||||
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 45566778999999999999999999999999975432 457788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------ 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------ 966 (1098)
+++++|.+++......+++..+..++.||+.||+|||+.||+|+||+|+||+++.++ .++|+|||++....
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~---~~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG---SVKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC---CEEECccchhhhhccchhhh
Confidence 999999999876544799999999999999999999999999999999999999988 89999999875432
Q ss_pred ------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCC-CCCCcCcHHHHHHHHHh
Q psy48 967 ------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPP-RPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 967 ------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~-~~~~~is~el~~LL~~c 1039 (1098)
..|+|||.+.+..++.++|+||||+++|+|++|..||.................+. .....++.++.++|.+|
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKC 253 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHH
Confidence 23689999999899999999999999999999999998765443333222222221 22234789999999999
Q ss_pred hhhcccCCCCHHHHHcCCCcCCCCCcc
Q psy48 1040 LQVKQRKRLSVDKSLAHPWLQDPATWS 1066 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfFk~~~~~~ 1066 (1098)
|+.+|.+||++.++++|+||+....+.
T Consensus 254 l~~~p~~Rpt~~~il~~~~~~~~~~~~ 280 (286)
T cd06614 254 LVKDPEKRPSAEELLQHPFLKKACPKE 280 (286)
T ss_pred hccChhhCcCHHHHhhChHhhccCchH
Confidence 999999999999999999999844443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=306.24 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=199.3
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCCChH-HHHHHHHHHH---HHhccCCCCceeeeeeeecCCcEEEEEEeccC
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVA---ILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~-~~~~~~~Ei~---iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
||.|.+|.||.+.+..+++.||||++.+...... ....+..|.. +++...||+|+.+++++...+.+++||||+.|
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 6899999999999999999999999976543322 2223344443 34445799999999999999999999999999
Q ss_pred chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----------
Q psy48 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------- 965 (1098)
Q Consensus 896 gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---------- 965 (1098)
++|..++. ..+.+++..+..++.|++.||.|||+.+|+||||||+||+++.++ .++|+|||++...
T Consensus 82 ~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~---~~kl~dfg~~~~~~~~~~~~~~~ 157 (278)
T cd05606 82 GDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG---HVRISDLGLACDFSKKKPHASVG 157 (278)
T ss_pred CcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC---CEEEccCcCccccCccCCcCcCC
Confidence 99987775 445799999999999999999999999999999999999999988 8999999998643
Q ss_pred CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChh-HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhc
Q psy48 966 GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDED-INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVK 1043 (1098)
Q Consensus 966 ~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~-~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~d 1043 (1098)
...++|||.+.+ ..++.++|+||+|+++|+|++|..||..... ....+.......+...+..++.++.+++.+||..+
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~ 237 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 237 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcC
Confidence 234579999975 4689999999999999999999999975421 11111122222233334457899999999999999
Q ss_pred ccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1044 QRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1044 P~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
|.+|| ++.++++||||++ .+|..+..+
T Consensus 238 p~~R~~~~~~~~~~ll~~~~~~~----~~~~~~~~~ 269 (278)
T cd05606 238 VNRRLGCLGRGAQEVKEHPFFRS----LDWQMVFLQ 269 (278)
T ss_pred HHhccCCCCCCHHHHHhCccccC----CCchHhhhc
Confidence 99999 9999999999998 556655554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=306.59 Aligned_cols=243 Identities=24% Similarity=0.356 Sum_probs=206.7
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|+....+|.|.+|.+|.+.+..+++.||||+++... .......+.+|+.+++.+.|+||+++++++.+....++||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 4555667999999999999999999999999997543 234457889999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----- 967 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----- 967 (1098)
++|++|..++.. .++++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|||++.....
T Consensus 84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~---~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG---DVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC---CEEEcccccceeccCCcccc
Confidence 999999888753 4689999999999999999999999999999999999999888 899999999854322
Q ss_pred -------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 968 -------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 968 -------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
.++|||++.+..++.++|+||||+++|||++|..||......... .......++.....++..+.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-FLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-hhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 247999999989999999999999999999999999765432211 111222233334467889999999999
Q ss_pred hhcccCCCCHHHHHcCCCcCCC
Q psy48 1041 QVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1041 ~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
..+|++||++.+++.|+||.+.
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=311.99 Aligned_cols=236 Identities=23% Similarity=0.335 Sum_probs=194.9
Q ss_pred eeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHH
Q psy48 823 AVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMIL 902 (1098)
Q Consensus 823 G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l 902 (1098)
|.++.++.+....+++.||||+++...........+.+|+.+++.++|+||+++++++...+..+++|||+++++|..++
T Consensus 11 ~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 11 EDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred cCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 45566788888889999999999876555666788999999999999999999999999999999999999999998888
Q ss_pred hhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---------------
Q psy48 903 SSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--------------- 966 (1098)
Q Consensus 903 ~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--------------- 966 (1098)
... ...+++..+..++.||+.||+|||++||+||||||+||+++.++ .++|+|||.+....
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~---~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG---KVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC---ceEEecCccceeecccccccccccccccc
Confidence 753 34689999999999999999999999999999999999999888 89999999875321
Q ss_pred ----CCCCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCC-------------------
Q psy48 967 ----EKSFPPEVLRN--KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYP------------------- 1021 (1098)
Q Consensus 967 ----~~~~APEvl~~--~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p------------------- 1021 (1098)
..++|||++.+ ..|+.++|+|||||++|||++|..||.........+.......+
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSR 247 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccc
Confidence 13579999976 45889999999999999999999999865433322221110000
Q ss_pred -------------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1022 -------------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1022 -------------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
......++.++.+|+.+||..||++|||+.++++||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 248 SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 0001123567899999999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=324.44 Aligned_cols=239 Identities=22% Similarity=0.318 Sum_probs=194.7
Q ss_pred hhheeeeeeeeeeeeeceEEEEee--cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHR--KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k--~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
...|.+...||.|.+|.||.+... .++..||||.+... ..+.+|+.+|+.++||||+++++++.....+++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 346888999999999999998754 45678999998642 235679999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
|||++.++.+ .++ .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 164 v~e~~~~~l~-~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~---~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 164 VMPKYKCDLF-TYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE---NAVLGDFGAACKLDAH 238 (392)
T ss_pred EehhcCCCHH-HHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC---CEEEccCccccccCcc
Confidence 9999986554 555 3456799999999999999999999999999999999999999988 8999999998543
Q ss_pred -----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-----hHHHHHHHh----hccCCC---
Q psy48 966 -----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-----DINEQIQNA----AFMYPP--- 1022 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-----~~~~~i~~~----~~~~p~--- 1022 (1098)
+..|+|||++.+..|+.++|||||||++|||++|+.||.+.. .....+... ...++.
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 223579999999999999999999999999999999996532 111111110 000000
Q ss_pred -----------------CC------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1023 -----------------RP------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1023 -----------------~~------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.. ...++.++.++|.+||..||++||++.+++.||||+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 00 0134678999999999999999999999999999987
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=302.20 Aligned_cols=243 Identities=25% Similarity=0.405 Sum_probs=200.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCC-----
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPG----- 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~----- 884 (1098)
.+.|.+...++.|.++.+|.+.++.+++.||+|++.... .....+.+|+.+++++ .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 467888999999999999999999999999999987543 2346789999999998 6999999999996644
Q ss_pred -cEEEEEEeccCchHHHHHhhc---cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 885 -RIFVVMEKLQGDMLEMILSSE---KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 885 -~l~LVmEy~~ggsL~~~l~~~---~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
.+++||||+++++|..++... ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~---~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA---EVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC---eEEECCCc
Confidence 489999999999998887543 35789999999999999999999999999999999999999988 89999999
Q ss_pred cccccC------------CCCCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCC-
Q psy48 961 FARIIG------------EKSFPPEVLRN-----KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPP- 1022 (1098)
Q Consensus 961 la~~~~------------~~~~APEvl~~-----~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~- 1022 (1098)
++.... ..++|||++.. ..++.++||||||++||+|++|..||.................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 886432 23679999864 347889999999999999999999997543332222221111111
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
.....++.++.++|.+||..||++|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 1112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.27 Aligned_cols=241 Identities=23% Similarity=0.380 Sum_probs=203.1
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..|.+...+|.|.++.||.+.+..+++.||||.++.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 467888999999999999999999999999999875332 3444567899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 891 EKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
||+++++|..++.. ....+++..+..++.||+.||.|||++||+|+||||+||+++.++ .++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~---~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC---CEEECccccceeccc
Confidence 99999999877653 234588999999999999999999999999999999999999988 89999999886432
Q ss_pred -----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-hHHHHHHHh-hccCCCCCCCcCcHHHH
Q psy48 967 -----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-DINEQIQNA-AFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 967 -----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-~~~~~i~~~-~~~~p~~~~~~is~el~ 1033 (1098)
..++|||.+.+..++.++|+||||+++|||++|..||.... +........ ....++.....++.++.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 23579999999889999999999999999999999997542 222222221 12234333446788999
Q ss_pred HHHHHhhhhcccCCCCHHHHHc
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+++.+||..+|++||++.++++
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHH
Confidence 9999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=307.13 Aligned_cols=244 Identities=29% Similarity=0.429 Sum_probs=198.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
+..|.....||.|.++.||.+.+..+++.||||+++.... ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678889999999999999999999999999999965432 222346778999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||+.++.+. ++......+++..+..++.||+.||.|||+.||+|+||||+||+++.++ .++|+|||+++..
T Consensus 83 e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~---~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMHTDLAQ-YMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG---ELKLADFGLARAKSIPSQ 158 (291)
T ss_pred ecccCCHHH-HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC---cEEEeccccccccCCCCC
Confidence 999866554 4444445678889999999999999999999999999999999999888 8999999988643
Q ss_pred -------CCCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc--c---------------C
Q psy48 966 -------GEKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF--M---------------Y 1020 (1098)
Q Consensus 966 -------~~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~--~---------------~ 1020 (1098)
...++|||.+.+. .++.++||||||+++|+|++|..||....+..+.+..... . +
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2235799998764 5889999999999999999999999865433332221100 0 0
Q ss_pred C--------C----CCCC--cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1021 P--------P----RPWR--DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1021 p--------~----~~~~--~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
. + ..|. ..+.++.+++.+||..||++|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 0 0011 125689999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=339.40 Aligned_cols=211 Identities=25% Similarity=0.389 Sum_probs=186.5
Q ss_pred CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhcc----------
Q psy48 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEK---------- 906 (1098)
Q Consensus 837 g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~---------- 906 (1098)
...||||.++.. ...+...+|++|+++|..++|||||+|+|.|..++.+++|+|||..|+|..||....
T Consensus 516 ~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~ 594 (774)
T KOG1026|consen 516 EQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQ 594 (774)
T ss_pred ceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCC
Confidence 347999999754 334466899999999999999999999999999999999999999999999987432
Q ss_pred ---CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--------------CCCC
Q psy48 907 ---GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--------------GEKS 969 (1098)
Q Consensus 907 ---~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--------------~~~~ 969 (1098)
.+++..+.+.|+.|||.||.||-++.+|||||..+|+||.++- .|||+||||++.+ .-+|
T Consensus 595 ~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l---~VKIsDfGLsRdiYssDYYk~~~~t~lPIRW 671 (774)
T KOG1026|consen 595 DTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL---VVKISDFGLSRDIYSSDYYKVRGNTLLPIRW 671 (774)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce---EEEecccccchhhhhhhhhcccCCceeeeec
Confidence 2388899999999999999999999999999999999999887 9999999999743 3456
Q ss_pred CChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCC--ChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccC
Q psy48 970 FPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNE--DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRK 1046 (1098)
Q Consensus 970 ~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~--~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~k 1046 (1098)
|+||.|...+|+.++|||||||+|||+++ |..||.+ +++..+.+++..... .++++|.++.+||..||+.+|.+
T Consensus 672 MppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~---~Pe~CP~~vY~LM~~CW~~~P~~ 748 (774)
T KOG1026|consen 672 MPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLS---CPENCPTEVYSLMLECWNENPKR 748 (774)
T ss_pred CCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCccc---CCCCCCHHHHHHHHHHhhcCccc
Confidence 89999999999999999999999999998 8999985 567778887776622 24689999999999999999999
Q ss_pred CCCHHHHH
Q psy48 1047 RLSVDKSL 1054 (1098)
Q Consensus 1047 RPSa~eIL 1054 (1098)
||++.||-
T Consensus 749 RPsF~eI~ 756 (774)
T KOG1026|consen 749 RPSFKEIH 756 (774)
T ss_pred CCCHHHHH
Confidence 99999874
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=308.72 Aligned_cols=240 Identities=20% Similarity=0.223 Sum_probs=194.3
Q ss_pred hheeeeeeeeeeeeeceEEEEeec----------------CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCcee
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRK----------------SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVN 875 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~----------------tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~ 875 (1098)
..|.+...||.|+||.||.+.+.. ++..||||+++... .......+.+|+.++..++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 568889999999999999997532 34579999997542 3444578999999999999999999
Q ss_pred eeeeeecCCcEEEEEEeccCchHHHHHhhcc------------------CccchhHHHHHHHHHHHHHHHHHhCCccccC
Q psy48 876 LERMFETPGRIFVVMEKLQGDMLEMILSSEK------------------GRLSERTTKFIITQILVALKHLHSKNIVHCD 937 (1098)
Q Consensus 876 L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~------------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrD 937 (1098)
+++++...+..++||||+.+++|..++.... ..+++..+..++.||+.||.|||+.||+|||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 9999999999999999999999988875421 2367788999999999999999999999999
Q ss_pred CCCCceeecCCCCCCcEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc--CCC
Q psy48 938 LKPENVLLSTNSELPQVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS--GTF 1001 (1098)
Q Consensus 938 LKp~NILld~~g~~~~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt--G~~ 1001 (1098)
|||+|||++.++ .+||+|||+++.. ...|+|||++.+..++.++||||||+++|||++ +..
T Consensus 164 lkp~Nill~~~~---~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 164 LATRNCLVGENL---TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cchhheEEcCCc---cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999988 8999999998643 224689999999899999999999999999986 567
Q ss_pred CCCCCh--hHHHHHHHh----hccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1002 PFNEDE--DINEQIQNA----AFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1002 Pf~~~~--~~~~~i~~~----~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
||.... +....+... ...........++..+.+++.+||..||++|||+.+|.+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 886532 222211111 011111112357899999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.40 Aligned_cols=242 Identities=28% Similarity=0.426 Sum_probs=208.8
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcEEEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRIFVVME 891 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l~LVmE 891 (1098)
|.....++.|.+|.+|.+.+..+++.|++|++............+.+|+.++++++|+||+++++.+... ..+++|||
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 5677889999999999999999999999999987654445678899999999999999999999999888 88999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE---- 967 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~---- 967 (1098)
|+++++|..++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~---~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 82 YVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG---VVKLADFGCAKRLGDIETG 157 (260)
T ss_pred ecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC---CEEEcccccEEeccccccc
Confidence 999999998887544 899999999999999999999999999999999999999988 899999998864422
Q ss_pred ----------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc-cCCCCCCCcCcHHHHHHH
Q psy48 968 ----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF-MYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 968 ----------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~-~~p~~~~~~is~el~~LL 1036 (1098)
.++|||.+.+..++.++|+||||+++|+|++|..||....+....+..... .........++.++.++|
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 246999999888999999999999999999999999876533333322221 122223345789999999
Q ss_pred HHhhhhcccCCCCHHHHHcCCCc
Q psy48 1037 NNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
.+||+.||++||++.++++||||
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHhCcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=324.54 Aligned_cols=216 Identities=25% Similarity=0.317 Sum_probs=175.9
Q ss_pred CCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhcc--------
Q psy48 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEK-------- 906 (1098)
Q Consensus 836 tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~-------- 906 (1098)
++..||||+++... .......+.+|+.+|+.+. ||||+++++++...+.+++||||+++++|..++.+..
T Consensus 66 ~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~ 144 (400)
T cd05105 66 PVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHP 144 (400)
T ss_pred CceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhcccc
Confidence 34579999996542 2344577999999999996 9999999999999999999999999999988875421
Q ss_pred --------------------------------------------------------------------------------
Q psy48 907 -------------------------------------------------------------------------------- 906 (1098)
Q Consensus 907 -------------------------------------------------------------------------------- 906 (1098)
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 224 (400)
T cd05105 145 EKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKN 224 (400)
T ss_pred ccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHH
Confidence
Q ss_pred -------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-------------
Q psy48 907 -------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------------- 966 (1098)
Q Consensus 907 -------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------------- 966 (1098)
..+++..+..++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+++...
T Consensus 225 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~---~~kL~DfGla~~~~~~~~~~~~~~~~~ 301 (400)
T cd05105 225 LLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK---IVKICDFGLARDIMHDSNYVSKGSTFL 301 (400)
T ss_pred HHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC---EEEEEeCCcceeccccccccccCCcCC
Confidence 2367788899999999999999999999999999999999888 89999999986431
Q ss_pred -CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcc
Q psy48 967 -EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQ 1044 (1098)
Q Consensus 967 -~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP 1044 (1098)
..|+|||.+.+..++.++|||||||++|||++ |..||........................++.++.+++.+||+.||
T Consensus 302 ~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 381 (400)
T cd05105 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEP 381 (400)
T ss_pred CcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCH
Confidence 23679999999999999999999999999997 9999975422111111122222222335688999999999999999
Q ss_pred cCCCCHHHHHc
Q psy48 1045 RKRLSVDKSLA 1055 (1098)
Q Consensus 1045 ~kRPSa~eIL~ 1055 (1098)
++||++.+|.+
T Consensus 382 ~~RPt~~~l~~ 392 (400)
T cd05105 382 EKRPSFLHLSD 392 (400)
T ss_pred hHCcCHHHHHH
Confidence 99999988876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=303.19 Aligned_cols=240 Identities=26% Similarity=0.456 Sum_probs=193.0
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecC--CcEEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETP--GRIFVVM 890 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~--~~l~LVm 890 (1098)
|++...+|.|.++.+|.+.+..+++.||+|++++...... .....+|+.++.++. |+||+++++++.+. +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 4567789999999999999999999999999976432222 234457888888885 99999999999887 8899999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||++++.+ .++......+++..+..++.||+.||.|||+.||+||||+|+||+++. + .++|+|||++....
T Consensus 80 e~~~~~l~-~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~---~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 80 ELMDMNLY-ELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D---ILKLADFGSCRGIYSKPP 154 (282)
T ss_pred ecCCccHH-HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C---CeEEEecccccccccCCC
Confidence 99987555 555544567899999999999999999999999999999999999999 6 89999999986442
Q ss_pred -------CCCCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhh------------------c
Q psy48 967 -------EKSFPPEVLR-NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAA------------------F 1018 (1098)
Q Consensus 967 -------~~~~APEvl~-~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~------------------~ 1018 (1098)
..++|||.+. +..++.++|||||||++|||++|..||.+.+... ..+.... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 2357999875 4557899999999999999999999997653221 1111100 0
Q ss_pred cCCCCC-------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1019 MYPPRP-------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1019 ~~p~~~-------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
.++... ...++.++.++|.+||..||++||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 111100 12467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=322.62 Aligned_cols=239 Identities=22% Similarity=0.253 Sum_probs=196.7
Q ss_pred heeeeeeeeeeeeeceEEEEeecC-----CceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKS-----GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~t-----g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l 886 (1098)
.+.+...||.|+||.||.+.+... +..||||+++.... ......+.+|+.+++.+ +|+||+++++++...+.+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 567788999999999999986544 35799999976432 33456788999999999 899999999999999999
Q ss_pred EEEEEeccCchHHHHHhhcc------------------------------------------------------------
Q psy48 887 FVVMEKLQGDMLEMILSSEK------------------------------------------------------------ 906 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~------------------------------------------------------------ 906 (1098)
++||||+.+++|..++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999988875321
Q ss_pred ---------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----------
Q psy48 907 ---------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----------- 966 (1098)
Q Consensus 907 ---------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----------- 966 (1098)
.++++..+++++.||+.||+|||++||+||||||+|||++.++ .++|+|||+++...
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~---~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR---VAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC---eEEEeeceeeeeccCCcceeeccCC
Confidence 2477888999999999999999999999999999999999887 89999999986421
Q ss_pred ---CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 967 ---EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 967 ---~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
..|+|||++.+..++.++|||||||++|||++ |..||........................+++++.+++.+||+.
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 354 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNL 354 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCC
Confidence 23789999999999999999999999999997 99999764322221121222222222345789999999999999
Q ss_pred cccCCCCHHHHHc
Q psy48 1043 KQRKRLSVDKSLA 1055 (1098)
Q Consensus 1043 dP~kRPSa~eIL~ 1055 (1098)
||++||++.++++
T Consensus 355 dp~~RPs~~~l~~ 367 (374)
T cd05106 355 EPTERPTFSQISQ 367 (374)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=316.59 Aligned_cols=247 Identities=26% Similarity=0.465 Sum_probs=200.9
Q ss_pred HHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC----
Q psy48 808 LLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP---- 883 (1098)
Q Consensus 808 ~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~---- 883 (1098)
......|.....||.|.+|.||.+.+..+++.||||++.+..........+.+|+.+++.++|+||++++++|...
T Consensus 12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 3456789999999999999999999999999999999976544445556788899999999999999999998644
Q ss_pred --CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCc
Q psy48 884 --GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGF 961 (1098)
Q Consensus 884 --~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGl 961 (1098)
...|+||||+.+..+ ..+.. .+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||+
T Consensus 92 ~~~~~~lv~e~~~~~l~-~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~---~~kL~Dfg~ 164 (353)
T cd07850 92 EFQDVYLVMELMDANLC-QVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGL 164 (353)
T ss_pred ccCcEEEEEeccCCCHH-HHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC---CEEEccCcc
Confidence 357999999987544 44432 289999999999999999999999999999999999999998 899999999
Q ss_pred ccccCC-----------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--HHHH-------------
Q psy48 962 ARIIGE-----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQN------------- 1015 (1098)
Q Consensus 962 a~~~~~-----------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~i~~------------- 1015 (1098)
++..+. .++|||.+.+..++.++|||||||++|+|++|..||...+.... .+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 875422 35799999999999999999999999999999999975532111 1100
Q ss_pred ------hhccCC------------CC--------CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1016 ------AAFMYP------------PR--------PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1016 ------~~~~~p------------~~--------~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.....+ .. .....++++.++|.+||..||++|||+.++|+||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 000000 00 01134667899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=305.10 Aligned_cols=240 Identities=26% Similarity=0.480 Sum_probs=202.9
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
-..||.|.+|.+|.+.+..+++.||+|+++... ......+.+|+.+++.++|+||+++++++...+..++|+||+.++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~ 101 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCC
Confidence 468999999999999999999999999986432 334566889999999999999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++.. .++++..+..++.||+.||+|||++||+||||+|+||+++.++ .++|+|||++...
T Consensus 102 ~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~---~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 102 ALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG---RVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC---cEEEcccccchhhccCCccccccc
Confidence 99888765 5689999999999999999999999999999999999999988 8999999987532
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCC--CCCcCcHHHHHHHHHhhhh
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPR--PWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~--~~~~is~el~~LL~~cL~~ 1042 (1098)
...++|||.+.+..++.++|+||||+++|+|++|+.||.......... ......++. ....++..+.+++.+||..
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 255 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK-RIRDNLPPKLKNLHKVSPRLRSFLDRMLVR 255 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH-HHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence 123679999999899999999999999999999999997654332211 111111111 1223788999999999999
Q ss_pred cccCCCCHHHHHcCCCcCCCCC
Q psy48 1043 KQRKRLSVDKSLAHPWLQDPAT 1064 (1098)
Q Consensus 1043 dP~kRPSa~eIL~HpfFk~~~~ 1064 (1098)
+|++||++.++++|+||+...+
T Consensus 256 ~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 256 DPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999988544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=308.10 Aligned_cols=240 Identities=25% Similarity=0.351 Sum_probs=202.4
Q ss_pred eeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEecc
Q psy48 815 TYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894 (1098)
Q Consensus 815 ~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ 894 (1098)
+....||.|.++.||.+.+..+++.||+|+++... .......+.+|+.+++.++|+||+++++++...+.+++||||++
T Consensus 7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 33455789999999999999999999999987543 23345678999999999999999999999999999999999999
Q ss_pred CchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--------
Q psy48 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-------- 966 (1098)
Q Consensus 895 ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-------- 966 (1098)
+++|..++. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++....
T Consensus 86 ~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~---~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 86 GGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG---DVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC---CEEEccccccccccCcchhhhc
Confidence 999988875 35689999999999999999999999999999999999999888 89999999986432
Q ss_pred ----CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 967 ----EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 967 ----~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
..++|||.+.+..++.++|+||||+++|||++|..||.......... ......++.....++.++.+++.+||..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-LIPKNSPPTLEGQYSKPFKEFVEACLNK 239 (277)
T ss_pred ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-hhhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 23579999999999999999999999999999999997543222111 1111222222345788999999999999
Q ss_pred cccCCCCHHHHHcCCCcCC
Q psy48 1043 KQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1043 dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+|++||++.++++||||+.
T Consensus 240 ~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 240 DPRFRPTAKELLKHKFITR 258 (277)
T ss_pred CcccCcCHHHHHHhHHHHH
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=308.01 Aligned_cols=243 Identities=28% Similarity=0.434 Sum_probs=198.9
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRIFVVM 890 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l~LVm 890 (1098)
.|.....||.|.+|.||.+.+..+++.||||.++...........+.+|+.+++.++||||+++++++... +.+++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 46667789999999999999999999999999976544433345678899999999999999999998777 8899999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC---
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE--- 967 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~--- 967 (1098)
||+.+ +|..++......+++..++.++.||+.||+|||+.||+|+||||+||+++.++ .++|+|||++.....
T Consensus 86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~---~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG---ILKICDFGLAREYGSPLK 161 (293)
T ss_pred hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC---cEEEeecCceeeccCCcc
Confidence 99986 67677765555799999999999999999999999999999999999999988 899999998875433
Q ss_pred ---------CCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhc-----------cCC---
Q psy48 968 ---------KSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAF-----------MYP--- 1021 (1098)
Q Consensus 968 ---------~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~-----------~~p--- 1021 (1098)
.++|||.+.+. .++.++|+||||+++|+|++|..||....... ..+..... ..+
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 26899998764 46899999999999999999999997653321 11111000 000
Q ss_pred ------------CCCCCc--CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1022 ------------PRPWRD--ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1022 ------------~~~~~~--is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
...... +++.+.++|.+||..||++|||+.|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 000111 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.92 Aligned_cols=242 Identities=25% Similarity=0.389 Sum_probs=199.1
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.+...+|.|.++.+|.+.+..+|..||||++............+.+|+.+++.++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 34567899999999999999999999999999765444444467889999999999999999999999999999999999
Q ss_pred cCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------
Q psy48 894 QGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------ 966 (1098)
Q Consensus 894 ~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------ 966 (1098)
++ +|..++.... ..+++..+..++.||+.||+|||+++++||||+|+||+++.++ .++|+|||++....
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 81 DL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG---ALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred Cc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC---cEEEeecccccccCCCcccc
Confidence 75 5666665333 3689999999999999999999999999999999999999988 89999999986432
Q ss_pred ------CCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc--------------------c
Q psy48 967 ------EKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF--------------------M 1019 (1098)
Q Consensus 967 ------~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~--------------------~ 1019 (1098)
..++|||++.+. .++.++||||||+++|+|++|..||...++..+....... .
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 235799988654 5789999999999999999999999866443222111100 0
Q ss_pred C-------CCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1020 Y-------PPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1020 ~-------p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
. .......++.++.++|.+||+.||++||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 001123577899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=297.64 Aligned_cols=238 Identities=26% Similarity=0.386 Sum_probs=201.0
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.+...+|.|.+|.+|.+.+..+++.||+|.++.... ......+.+|+.+++.++|+||+++++.+.+.+.+++||||+
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5678899999999999999999999999999875432 334567889999999999999999999999999999999999
Q ss_pred cCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----
Q psy48 894 QGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----- 967 (1098)
Q Consensus 894 ~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----- 967 (1098)
++++|..++... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++ .++|+|||++.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~---~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG---KVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC---cEEEcccCcceeeccccccc
Confidence 999998877643 34689999999999999999999999999999999999999988 899999999864422
Q ss_pred -------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 968 -------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 968 -------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
.++|||++.+..++.++|+||||+++|+|++|..||.................+ .....++..+.++|.+||
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l 236 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMF 236 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHH
Confidence 257999999999999999999999999999999999865432221111111121 123457889999999999
Q ss_pred hhcccCCCCHHHHHcC
Q psy48 1041 QVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1041 ~~dP~kRPSa~eIL~H 1056 (1098)
+.||++||++.+++.-
T Consensus 237 ~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 237 KRNPRSRPSATTILSR 252 (255)
T ss_pred hCCcccCCCHHHHhhc
Confidence 9999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=303.23 Aligned_cols=238 Identities=22% Similarity=0.293 Sum_probs=199.9
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCC-----ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSG-----RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg-----~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
..+++...||.|.+|.||.+.+...+ ..||+|.++... .......+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 45677788999999999999876655 689999986432 334456789999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC
Q psy48 887 FVVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~ 951 (1098)
+++|||+++++|..++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~-- 161 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL-- 161 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC--
Confidence 99999999999988886431 4578889999999999999999999999999999999999988
Q ss_pred CcEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHH
Q psy48 952 PQVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQ 1014 (1098)
Q Consensus 952 ~~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~ 1014 (1098)
.++|+|||+++.. +..|+|||.+.+..++.++|||||||++|||++ |..||.+.. +....+.
T Consensus 162 -~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 -TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred -cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 8999999998643 123689999998899999999999999999998 999997643 3333332
Q ss_pred HhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1015 NAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1015 ~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
. .........++.++.+|+.+||+.||++||++.+|+++
T Consensus 241 ~---~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 S---RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred c---CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2 22222345689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=292.61 Aligned_cols=240 Identities=27% Similarity=0.443 Sum_probs=205.3
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.....+|.|.++.+|.+.+..+++.|++|++..... .....+.+|+.+++.++|++++++++++......++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 5667889999999999999999999999999976432 35578999999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCC-----
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK----- 968 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~----- 968 (1098)
++++|..++......+++..+..++.|++.||.+||+.|++||||+|+||+++.++ .++|+|||++......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~---~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG---EVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC---eEEEeeccccccccccccccc
Confidence 99999988876556799999999999999999999999999999999999999988 8999999998765432
Q ss_pred ------CCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCC-CcCcHHHHHHHHHhhh
Q psy48 969 ------SFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPW-RDISSDAIDLINNLLQ 1041 (1098)
Q Consensus 969 ------~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~-~~is~el~~LL~~cL~ 1041 (1098)
++|||.+.+..++.++|+||||+++|+|++|..||.................+.... ..++.++.++|.+||.
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence 479999998889999999999999999999999998663332222222222222111 1248899999999999
Q ss_pred hcccCCCCHHHHHcCCC
Q psy48 1042 VKQRKRLSVDKSLAHPW 1058 (1098)
Q Consensus 1042 ~dP~kRPSa~eIL~Hpf 1058 (1098)
.||++||++.++++|||
T Consensus 237 ~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 237 KNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 99999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=301.06 Aligned_cols=234 Identities=32% Similarity=0.472 Sum_probs=192.7
Q ss_pred eeeeeeeeeeeeceEEEEee----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 815 TYNVALCIAVVAGAACGVHR----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 815 ~~~~~Lg~G~~g~v~~a~~k----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
.....||.|.||.|+.|... ..+..|+||+++. .........+.+|++.+++++||||+++++++...+.+++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 45678999999999999988 5567899999954 334455788999999999999999999999999888899999
Q ss_pred EeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 891 EKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
||+.+++|..++... ...+++..+..++.||+.||.|||+++|+|+||+++||+++.++ .+||+|||++....
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~---~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG---QVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT---EEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc
Confidence 999999999998876 56799999999999999999999999999999999999999998 89999999987652
Q ss_pred -----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHH
Q psy48 967 -----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 967 -----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
..++|||.+.+..++.++||||||+++|||++ |+.||.... ++...+..... ......++..+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 234 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR---LPIPDNCPKDI 234 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE---TTSBTTSBHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ceeccchhHHH
Confidence 12479999999889999999999999999999 789987653 22333322222 22345689999
Q ss_pred HHHHHHhhhhcccCCCCHHHHHc
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.++|.+||+.||++||++.+|++
T Consensus 235 ~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 235 YSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=302.71 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=201.4
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRIFVVM 890 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l~LVm 890 (1098)
.+.....+|.|.+|.+|.+.+..+++.||+|++..... ......+.+|+++++.++||||++++++|... +.+++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35567789999999999999999999999999975432 24457789999999999999999999998553 4789999
Q ss_pred EeccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 891 EKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
||+++++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~---~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG---QVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC---eEEEeeccccccccc
Confidence 99999999877542 345689999999999999999999999999999999999999888 89999999986432
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-------hHHHHHHHhhcc-CCCCCC--Cc
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-------DINEQIQNAAFM-YPPRPW--RD 1027 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-------~~~~~i~~~~~~-~p~~~~--~~ 1027 (1098)
..++|||.+.+..++.++||||||+++|+|++|..||.... +....+...... .+.... ..
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd06621 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237 (287)
T ss_pred cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence 23579999999999999999999999999999999997551 122222111110 111101 23
Q ss_pred CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1028 ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+++++.++|.+||..||++|||+.|+++||||++.
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred hHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 46789999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=303.60 Aligned_cols=244 Identities=25% Similarity=0.383 Sum_probs=200.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecC-----C
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETP-----G 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~-----~ 884 (1098)
...|.+...+|.|.++.+|.+....+++.||+|++.... .....+.+|+.+++++ +|||++++++++... +
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 456888899999999999999999999999999986532 2345678899999988 799999999998653 3
Q ss_pred cEEEEEEeccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCc
Q psy48 885 RIFVVMEKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGF 961 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGl 961 (1098)
.+++||||+++++|..++.. ....+++..++.++.||+.||+|||++||+||||||+||+++.++ .++|+|||+
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~---~~kl~dfg~ 174 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG---GVKLVDFGV 174 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC---CEEEeeccc
Confidence 68999999999999887753 345689999999999999999999999999999999999999988 899999998
Q ss_pred ccccC------------CCCCChhhhccC-----CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCC-CC
Q psy48 962 ARIIG------------EKSFPPEVLRNK-----GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYP-PR 1023 (1098)
Q Consensus 962 a~~~~------------~~~~APEvl~~~-----~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p-~~ 1023 (1098)
+.... ..++|||.+... .++.++|||||||++|||++|+.||.................+ ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (291)
T cd06639 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254 (291)
T ss_pred chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 86432 235799998643 3689999999999999999999999866443332221111111 11
Q ss_pred CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcC
Q psy48 1024 PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060 (1098)
Q Consensus 1024 ~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk 1060 (1098)
....++.++.++|.+||..||++||++.++++||||+
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 1234677899999999999999999999999999996
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=303.46 Aligned_cols=243 Identities=24% Similarity=0.376 Sum_probs=198.7
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeee-----cCC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFE-----TPG 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~-----~~~ 884 (1098)
...|.+...||.|.++.||.+.+..+++.||+|+++... .....+.+|+.+++.+ +|+||+++++++. ..+
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 356778889999999999999999999999999986432 2235678899999998 6999999999873 446
Q ss_pred cEEEEEEeccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCc
Q psy48 885 RIFVVMEKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGF 961 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGl 961 (1098)
.+++||||++|++|..++.. ....+++..+..++.||+.||.|||+.+|+||||||+||+++.++ .++|+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~---~~kl~dfg~ 170 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG---GVKLVDFGV 170 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC---CEEEccCCc
Confidence 79999999999999887652 235688999999999999999999999999999999999999988 799999999
Q ss_pred ccccC------------CCCCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCC-C
Q psy48 962 ARIIG------------EKSFPPEVLRN-----KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPP-R 1023 (1098)
Q Consensus 962 a~~~~------------~~~~APEvl~~-----~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~-~ 1023 (1098)
+.... ..++|||++.. ..++.++|||||||++|||++|+.||.................+. .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (286)
T cd06638 171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250 (286)
T ss_pred eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCccc
Confidence 86432 23679999853 458899999999999999999999998664433222211111111 1
Q ss_pred CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1024 PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1024 ~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
....++.++.++|.+||..||++||++.++++|+||
T Consensus 251 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 123357899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=322.49 Aligned_cols=256 Identities=25% Similarity=0.341 Sum_probs=216.5
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.++-+...||-|.||.||.|+.+.++-..|-|++... .....+.+.-||.||....||+||+|++.|...+.++|+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 3444556789999999999999999999999998643 24556789999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc--------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR-------- 963 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~-------- 963 (1098)
||+||-.+.++-.-...|.+.++.-+.+|++.||.|||+++|||||||..|||++-+| .|+|+|||.+.
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG---dirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG---DIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC---cEeeecccccccchhHHhh
Confidence 9999999888877778899999999999999999999999999999999999999999 89999999863
Q ss_pred ---ccCC-CCCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCC-CCCCcCcHHHH
Q psy48 964 ---IIGE-KSFPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPP-RPWRDISSDAI 1033 (1098)
Q Consensus 964 ---~~~~-~~~APEvl~-----~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~-~~~~~is~el~ 1033 (1098)
++|+ .|||||++. ..+|+.++||||||++|.||..+.+|-..-......+....-..|. ..+..++..+.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFS 266 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence 3444 469999975 6789999999999999999999999987766665544444333322 12456788999
Q ss_pred HHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHHHH
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLE 1072 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~ 1072 (1098)
+||++||.+||..||+++++++||||++...--.+..|-
T Consensus 267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ireLl 305 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIRELL 305 (1187)
T ss_pred HHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHHHHH
Confidence 999999999999999999999999999743333344443
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=308.04 Aligned_cols=243 Identities=28% Similarity=0.439 Sum_probs=203.4
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCch
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDM 897 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggs 897 (1098)
..+|.|.+|.+|.+.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 36899999999999999999999999996543 2234668899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------------
Q psy48 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------------ 965 (1098)
Q Consensus 898 L~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------------ 965 (1098)
|..++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++...
T Consensus 105 L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~---~~kL~dfg~~~~~~~~~~~~~~~~~ 179 (297)
T cd06659 105 LTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG---RVKLSDFGFCAQISKDVPKRKSLVG 179 (297)
T ss_pred HHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC---cEEEeechhHhhcccccccccceec
Confidence 9887643 4689999999999999999999999999999999999999988 8999999998533
Q ss_pred CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHh-hccCCCCCCCcCcHHHHHHHHHhhhhcc
Q psy48 966 GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNA-AFMYPPRPWRDISSDAIDLINNLLQVKQ 1044 (1098)
Q Consensus 966 ~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~-~~~~p~~~~~~is~el~~LL~~cL~~dP 1044 (1098)
...|+|||++.+..++.++||||||+++|||++|..||............. ........+..++.++.++|.+||+.+|
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P 259 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREP 259 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCc
Confidence 123679999999899999999999999999999999997654332221111 1111122234578899999999999999
Q ss_pred cCCCCHHHHHcCCCcCCCCCcch
Q psy48 1045 RKRLSVDKSLAHPWLQDPATWSD 1067 (1098)
Q Consensus 1045 ~kRPSa~eIL~HpfFk~~~~~~~ 1067 (1098)
++||++.++++||||.+...-..
T Consensus 260 ~~Rps~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 260 QERATAQELLDHPFLLQTGLPEC 282 (297)
T ss_pred ccCcCHHHHhhChhhccCCCccc
Confidence 99999999999999997544333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=298.98 Aligned_cols=238 Identities=21% Similarity=0.373 Sum_probs=202.9
Q ss_pred hheeeeeeeeeeeeeceEEEEeecC---CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKS---GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~t---g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
..+++...+|.|+||.||.+....+ ...||||+++... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4678899999999999999988654 4579999986543 34445678899999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||+.+++|..++....+.+++..+..++.|++.||+|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~---~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL---VCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC---CEEECccchhhccccc
Confidence 9999999999999877667899999999999999999999999999999999999999988 89999999987652
Q ss_pred ------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHH
Q psy48 967 ------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 967 ------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
..++|||.+.+..++.++||||||+++|+|++ |..||.... .....+.. .........+++.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 236 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED---GYRLPPPMDCPSA 236 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHH
Confidence 23679999999999999999999999999998 999996543 22222222 2222223568899
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.+++.+||+.+|++||++.+++++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=301.59 Aligned_cols=241 Identities=22% Similarity=0.302 Sum_probs=201.4
Q ss_pred hheeeeeeeeeeeeeceEEEEeec-----CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRK-----SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~-----tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
..+.....||.|.+|.||.+.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+.+..
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 457788899999999999999987 78889999886432 233456789999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhcc------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 887 FVVMEKLQGDMLEMILSSEK------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
++||||+.|++|..++.... ..+++..++.++.||+.||+|||++|++||||||+||+++.++....+||+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999998886543 258899999999999999999999999999999999999876644479999999
Q ss_pred cccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCC
Q psy48 961 FARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPR 1023 (1098)
Q Consensus 961 la~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~ 1023 (1098)
+++... ..++|||++.+..++.++|||||||++|||++ |..||.... .....+.. .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~---~~~~~ 241 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG---GGRLD 241 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---CCcCC
Confidence 987431 13689999999999999999999999999997 999997643 22222221 11222
Q ss_pred CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1024 PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1024 ~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
....++..+.+++.+||+.||++||++.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 234678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=305.03 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=201.5
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC-----
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG----- 884 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~----- 884 (1098)
....|.+...+|.|.+|.||.+.++.+++.||||+++...........+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 355678889999999999999999999999999999765433344467788999999999999999999987654
Q ss_pred -----cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeec
Q psy48 885 -----RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959 (1098)
Q Consensus 885 -----~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DF 959 (1098)
.+++||||++++.+ .++......+++..++.++.||+.||+|||+.||+|+||||+||+++.++ .+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~~l~-~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~---~~kl~df 160 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLM-GLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG---QIKLADF 160 (302)
T ss_pred cccCCcEEEEEcccCccHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---cEEeCcc
Confidence 79999999998555 55554455799999999999999999999999999999999999999988 8999999
Q ss_pred CcccccC-------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH--HHHhhccCCC-
Q psy48 960 GFARIIG-------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ--IQNAAFMYPP- 1022 (1098)
Q Consensus 960 Gla~~~~-------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~--i~~~~~~~p~- 1022 (1098)
|++.... ..++|||.+.+ ..++.++|||||||++|+|++|+.||...+..... +........+
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 9986432 23579998865 45789999999999999999999999765433222 2221100000
Q ss_pred -------------------------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1023 -------------------------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1023 -------------------------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
..+..++..+.+++.+||..||++||++.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0123468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=296.34 Aligned_cols=234 Identities=24% Similarity=0.375 Sum_probs=197.1
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..+.+...||.|++|.||.+..+ .+..+|+|.++.... ....+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 34677788999999999998765 456799999865432 24568889999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
|+++++|..++....+.+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||+++...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~---~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG---VVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC---eEEECCCCCccccCCCcee
Confidence 9999999888876556789999999999999999999999999999999999999888 89999999886431
Q ss_pred --------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 --------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 --------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..++|||.+.+..++.++|+||||+++|||++ |+.||..... ....+... .........+.++.++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~l 233 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG---FRLYRPKLASMTVYEV 233 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---CCCCCCCCCCHHHHHH
Confidence 13679999999899999999999999999999 8999976542 22333222 1222234567899999
Q ss_pred HHHhhhhcccCCCCHHHHHc
Q psy48 1036 INNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.+||..||++||+++++++
T Consensus 234 i~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 234 MYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=292.04 Aligned_cols=241 Identities=25% Similarity=0.404 Sum_probs=209.1
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.....+|.|.++.+|.+.+..+++.||+|.+............+.+|++++..++|+|++++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 56788999999999999999999999999999876655566688999999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC------
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE------ 967 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~------ 967 (1098)
++++|..++... ..+++..+..++.|++.||.+||+.||+||||+|+||+++.++ .++|+|||++.....
T Consensus 82 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~---~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 82 ENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG---VVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC---CEEEeccccceecCCCccccc
Confidence 999998887643 6799999999999999999999999999999999999999987 899999999875422
Q ss_pred ------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhh
Q psy48 968 ------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041 (1098)
Q Consensus 968 ------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~ 1041 (1098)
.++|||.+.+..++.++||||||+++|+|++|..||................ .......++.++.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-CCCCCCCCCHHHHHHHHHHHh
Confidence 2579999988889999999999999999999999997654333222222222 222345688999999999999
Q ss_pred hcccCCCCHHHHHcCCCc
Q psy48 1042 VKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1042 ~dP~kRPSa~eIL~HpfF 1059 (1098)
.+|++||++.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=306.80 Aligned_cols=237 Identities=25% Similarity=0.478 Sum_probs=200.8
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCch
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDM 897 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggs 897 (1098)
..||.|.+|.||.+.+..++..||||.+.... ......+.+|+.+++.++|+||+++++.+...+..++||||+++++
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 45899999999999999999999999986532 3345678899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------------
Q psy48 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------------ 965 (1098)
Q Consensus 898 L~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------------ 965 (1098)
|..++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++ .++|+|||++...
T Consensus 106 L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~---~~kL~dfg~~~~~~~~~~~~~~~~~ 180 (292)
T cd06658 106 LTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG---RIKLSDFGFCAQVSKEVPKRKSLVG 180 (292)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC---CEEEccCcchhhcccccccCceeec
Confidence 9888743 4689999999999999999999999999999999999999988 8999999988532
Q ss_pred CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCC--CCCCcCcHHHHHHHHHhhhhc
Q psy48 966 GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPP--RPWRDISSDAIDLINNLLQVK 1043 (1098)
Q Consensus 966 ~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~--~~~~~is~el~~LL~~cL~~d 1043 (1098)
...|+|||.+.+..++.++|+||||+++|||++|..||........ +.......+. .....++..+.+++.+||..|
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 259 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCCccccccccCHHHHHHHHHHccCC
Confidence 2236799999998999999999999999999999999986543221 1111111111 112357889999999999999
Q ss_pred ccCCCCHHHHHcCCCcCCC
Q psy48 1044 QRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1044 P~kRPSa~eIL~HpfFk~~ 1062 (1098)
|++|||++++++||||+..
T Consensus 260 P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 260 PSQRATAQELLQHPFLKLA 278 (292)
T ss_pred hhHCcCHHHHhhChhhhcc
Confidence 9999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=312.88 Aligned_cols=238 Identities=21% Similarity=0.291 Sum_probs=195.0
Q ss_pred eeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHH
Q psy48 821 CIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEM 900 (1098)
Q Consensus 821 g~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~ 900 (1098)
|.|+++.||.+.+..+|+.||||++..........+.+.+|+.+++.++||||++++++|...+.+++||||+.++++..
T Consensus 9 g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~ 88 (328)
T cd08226 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANS 88 (328)
T ss_pred cccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHH
Confidence 34588899999999999999999997665555556789999999999999999999999999999999999999999988
Q ss_pred HHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--------------
Q psy48 901 ILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-------------- 965 (1098)
Q Consensus 901 ~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-------------- 965 (1098)
++.+.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++ .++++||+.+...
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (328)
T cd08226 89 LLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG---LVSLSGLSHLYSLVRNGQKAKVVYDFP 165 (328)
T ss_pred HHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC---cEEEechHHHhhhhccCcccccccccc
Confidence 876542 3589999999999999999999999999999999999999888 8999999743211
Q ss_pred -----CCCCCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc-------------------
Q psy48 966 -----GEKSFPPEVLRN--KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM------------------- 1019 (1098)
Q Consensus 966 -----~~~~~APEvl~~--~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~------------------- 1019 (1098)
...|+|||++.+ ..++.++|||||||++|+|++|..||................
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (328)
T cd08226 166 QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKN 245 (328)
T ss_pred ccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhcc
Confidence 123689999976 347899999999999999999999997653222211111000
Q ss_pred --------------------------CCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1020 --------------------------YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1020 --------------------------~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
........++.++.+||.+||..||++|||+.++++||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 246 SQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred chhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 000011235678999999999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=294.87 Aligned_cols=231 Identities=23% Similarity=0.344 Sum_probs=199.3
Q ss_pred eeeeeeeeceEEEEeecC---CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccC
Q psy48 819 ALCIAVVAGAACGVHRKS---GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~t---g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
.||.|.+|.||.+..... +..||+|+++...... ....+.+|+.+++.++|+||+++++++.....+++||||+.+
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 578999999999999876 9999999997654333 467899999999999999999999999999999999999999
Q ss_pred chHHHHHhhc--------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC
Q psy48 896 DMLEMILSSE--------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 896 gsL~~~l~~~--------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~ 967 (1098)
++|..++... ...+++..++.++.||+.||.|||++||+||||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~---~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL---VVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC---cEEEccccccccccc
Confidence 9999998765 46799999999999999999999999999999999999999998 899999999975533
Q ss_pred --------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcH
Q psy48 968 --------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 968 --------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
.++|||.+.+..++.++||||||+++|+|++ |..||..... ..+.+.. .........++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK---GYRLPKPEYCPD 234 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCCccCCh
Confidence 3579999998899999999999999999999 6999986532 2233322 222233356789
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
++.+++.+||..||++||++.+++++
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=303.22 Aligned_cols=245 Identities=24% Similarity=0.333 Sum_probs=205.0
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|++...||.|.+|.+|.+.+..+++.||+|++.... .......+.+|+++++.++||||+++++++...+.+++||||
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4556678999999999999999999999999986542 234457899999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
+++++|..++.. .+.+++..+..++.+++.||.|||+ .||+||||+|+||+++.++ .++|+|||++...
T Consensus 85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~---~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 85 MDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG---QIKLCDFGVSGELINSIAD 160 (284)
T ss_pred CCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC---cEEEccCCcccchhhhccC
Confidence 999999887753 4578999999999999999999997 6999999999999999888 8999999998642
Q ss_pred ----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh----------HHHHHHHhhccCCCCC-CCcCcH
Q psy48 966 ----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED----------INEQIQNAAFMYPPRP-WRDISS 1030 (1098)
Q Consensus 966 ----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~----------~~~~i~~~~~~~p~~~-~~~is~ 1030 (1098)
...++|||++.+..++.++|+|||||++|+|++|..||..... ....+.......++.. ...++.
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence 2345799999888999999999999999999999999975322 1122222221112221 223788
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
++.+|+.+||..||++||++.++++|+||...
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 99999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=297.75 Aligned_cols=236 Identities=25% Similarity=0.376 Sum_probs=198.7
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.+++...+|.|.+|.||.+.++ ++..+|+|++++... ....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 4667788999999999999875 567899999865432 234678899999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----- 967 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----- 967 (1098)
+++++|..++......+++..++.++.||+.||+|||+.||+||||||+||+++.++ .+||+|||+++....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~---~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN---VVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC---cEEECCcccceecccccccc
Confidence 999999998876566789999999999999999999999999999999999999988 899999999864321
Q ss_pred --------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 968 --------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 968 --------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
.++|||.+.+..++.++||||||+++|+|++ |..||....... ................++.++.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 3689999999999999999999999999999 899997543321 122222222333335689999999999
Q ss_pred hhhhcccCCCCHHHHHcC
Q psy48 1039 LLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1039 cL~~dP~kRPSa~eIL~H 1056 (1098)
||..+|++||++.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=300.93 Aligned_cols=241 Identities=28% Similarity=0.449 Sum_probs=196.4
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.....||.|.++.+|.+.+..+|+.||||+++.... ......+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5678899999999999999999999999999976432 223456778999999999999999999999999999999999
Q ss_pred cCchHHHHHhhcc--CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 894 QGDMLEMILSSEK--GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 894 ~ggsL~~~l~~~~--~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
.+ +|..++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~---~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG---ELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC---cEEEeecchhhhhcCCccc
Confidence 97 4555654333 4689999999999999999999999999999999999999988 89999999986432
Q ss_pred -------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhc------------------
Q psy48 967 -------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAF------------------ 1018 (1098)
Q Consensus 967 -------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~------------------ 1018 (1098)
..+++||.+.+ ..++.++||||||+++|+|++|..||.+..... ..+.....
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 23679999866 457899999999999999999999997643221 11111100
Q ss_pred cCCCC-------CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1019 MYPPR-------PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1019 ~~p~~-------~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
.++.. ....++.++.+++.+||+.||++||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00000 011357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=302.04 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=208.8
Q ss_pred eeeeeeeeeeeeeceEEEEee---cCCceeEEEEEeccCCC--hHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEE
Q psy48 814 MTYNVALCIAVVAGAACGVHR---KSGRGVAIKVIDKLRFP--TKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k---~tg~~VAVKvlkk~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~ 887 (1098)
|.+...||.|++|.+|.+.+. .+++.||||++++.... ......+.+|+.++.++ +|+||+++++.+.....++
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 567788999999999998764 46789999999764322 12235688999999999 5999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-- 965 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-- 965 (1098)
+||||+.+++|..++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~ 157 (288)
T cd05583 82 LILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG---HVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC---CEEEEECcccccccc
Confidence 99999999999888763 35689999999999999999999999999999999999999988 8999999988642
Q ss_pred -----------CCCCCChhhhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcH
Q psy48 966 -----------GEKSFPPEVLRNKG--YNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~~--ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
...++|||.+.+.. ++.++|+||||+++|+|++|..||..... ....+..............++.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence 22357999987655 78899999999999999999999964311 1111111111111222345789
Q ss_pred HHHHHHHHhhhhcccCCCC---HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCC
Q psy48 1031 DAIDLINNLLQVKQRKRLS---VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKK 1080 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPS---a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~ 1080 (1098)
++.++|.+||+.||++||| +.++++||||++ .+|..++.+ +.+|++
T Consensus 238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~~ 287 (288)
T cd05583 238 EARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG----IDWDDLAAKRIPAPFK 287 (288)
T ss_pred HHHHHHHHHhcCCHhhccCcchHHHHhcCccccc----CCHHHHhhhccCCCCC
Confidence 9999999999999999998 567899999998 677777777 666664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=303.66 Aligned_cols=242 Identities=24% Similarity=0.376 Sum_probs=198.4
Q ss_pred eeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEEEEecc
Q psy48 816 YNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVMEKLQ 894 (1098)
Q Consensus 816 ~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LVmEy~~ 894 (1098)
....||.|.+|.||.+.+..+++.||||.+.+.... .....+.+|+.++.++. |+||+++++++...+..+++|||+.
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 345689999999999999999999999999764432 44567889999999886 9999999999999999999999987
Q ss_pred Cch--HHHHHh-hccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 895 GDM--LEMILS-SEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 895 ggs--L~~~l~-~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
+.. +...+. .....+++..+..++.+++.||+|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus 87 ~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~---~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG---NIKLCDFGISGQLVDSIA 163 (288)
T ss_pred CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC---cEEEeecchhHHhccCCc
Confidence 632 222222 234579999999999999999999997 4999999999999999888 8999999998643
Q ss_pred ------CCCCCChhhhccC---CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccC----CCCCCCcCcHHH
Q psy48 966 ------GEKSFPPEVLRNK---GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY----PPRPWRDISSDA 1032 (1098)
Q Consensus 966 ------~~~~~APEvl~~~---~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~----p~~~~~~is~el 1032 (1098)
...++|||++.+. .++.++|||||||++|+|++|..||.......+.+....... +...+..++.++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF 243 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHH
Confidence 2246799999866 689999999999999999999999986554444443322211 112223578999
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+||.+||..||++||++.+|+.||||+.
T Consensus 244 ~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 244 VNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred HHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 99999999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=293.98 Aligned_cols=242 Identities=26% Similarity=0.373 Sum_probs=206.8
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.....++.|.++.+|.+.+..+++.||+|.+............+.+|+.+++.++|+||+++++++......++||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 56778899999999999999999999999999876555556678889999999999999999999999999999999999
Q ss_pred cCchHHHHHhhc---cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 894 QGDMLEMILSSE---KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 894 ~ggsL~~~l~~~---~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
++++|..++... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~---~~kl~d~g~~~~~~~~~~ 158 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND---LVKIGDLGISKVLKKNMA 158 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC---cEEEeeccchhhhccCCc
Confidence 999998887542 34689999999999999999999999999999999999999987 89999999986542
Q ss_pred ------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 967 ------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 967 ------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
..++|||.+.+..++.++|+||||+++|+|++|..||...+............++. ....++.++.+++.+||
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l 237 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP-IPPIYSQDLQNFIRSML 237 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CchhhCHHHHHHHHHHc
Confidence 23579999999999999999999999999999999998654322111222222222 22367899999999999
Q ss_pred hhcccCCCCHHHHHcCCCc
Q psy48 1041 QVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1041 ~~dP~kRPSa~eIL~HpfF 1059 (1098)
..+|++||++.++++||++
T Consensus 238 ~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 238 QVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCcccCCCHHHHhcCCCC
Confidence 9999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=301.18 Aligned_cols=241 Identities=29% Similarity=0.465 Sum_probs=200.6
Q ss_pred eeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEecc
Q psy48 815 TYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894 (1098)
Q Consensus 815 ~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ 894 (1098)
.....+|.|.++.+|.+.+..+++.+|+|.++...........+.+|+.+++.++|+||+++++++...+.+++||||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 45567999999999999999999999999997765444456788899999999999999999999999999999999998
Q ss_pred CchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-------
Q psy48 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE------- 967 (1098)
Q Consensus 895 ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~------- 967 (1098)
+ ++..++......+++..+..++.||+.||.|||+.||+|+||||+||+++.++ .++|+|||.+.....
T Consensus 82 ~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~---~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 82 T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG---VLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred C-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC---cEEEeeeeeeEecCCCcccccC
Confidence 7 55566665556899999999999999999999999999999999999999888 899999998864422
Q ss_pred -----CCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc---------------------cC
Q psy48 968 -----KSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF---------------------MY 1020 (1098)
Q Consensus 968 -----~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~---------------------~~ 1020 (1098)
.++|||.+.+. .++.++|+||||+++|+|++|+.||...+........... .+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 24699999876 7899999999999999999999999765432221111000 00
Q ss_pred C-------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1021 P-------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1021 p-------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
+ ...+..++.++.++|.+||+.||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0 00123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=297.68 Aligned_cols=237 Identities=21% Similarity=0.363 Sum_probs=202.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCc---eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGR---GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~---~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
..+.+...+|.|.+|.+|.+..+.+++ .||||+++... .......+..|+.+++.++||||+++++++.....+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 457889999999999999999887765 59999987542 34456789999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||+++++|..++....+.+++.+++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~---~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL---VCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC---cEEECCCccccccccC
Confidence 9999999999999877667799999999999999999999999999999999999999887 89999999886431
Q ss_pred ---------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcC
Q psy48 967 ---------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDI 1028 (1098)
Q Consensus 967 ---------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~i 1028 (1098)
..++|||.+.+..++.++||||||+++|||++ |..||..... ....+. ...+...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~~~~~~~~~~~ 236 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---QDYRLPPPMDC 236 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cCCcCCCcccC
Confidence 13679999999999999999999999999986 9999976432 222222 22222234568
Q ss_pred cHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1029 SSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.++.+++.+||..+|++||++.+|+.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=300.82 Aligned_cols=244 Identities=22% Similarity=0.298 Sum_probs=201.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeec-----CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRK-----SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~-----tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
..+|++...||.|.+|.||.+..+. .+..||+|.++... .......+.+|+.+++.++|+||+++++++...+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678889999999999999987652 35589999986543 23344568899999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhcc---------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEE
Q psy48 886 IFVVMEKLQGDMLEMILSSEK---------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKL 956 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~---------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL 956 (1098)
.++||||+.+++|..++.... ..++...+..++.||+.||.|||++||+||||||+||+++.++ .++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~---~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF---TVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC---cEEE
Confidence 999999999999999986432 2345678899999999999999999999999999999999988 8999
Q ss_pred eecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhcc
Q psy48 957 CDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFM 1019 (1098)
Q Consensus 957 ~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~ 1019 (1098)
+|||+++.. ...++|||.+.+..++.++|+|||||++|||++ |..||.+.. +....+....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-- 238 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG-- 238 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--
Confidence 999998632 123689999999899999999999999999998 788997543 2222222111
Q ss_pred CCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc------CCCcCC
Q psy48 1020 YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA------HPWLQD 1061 (1098)
Q Consensus 1020 ~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~------HpfFk~ 1061 (1098)
. ......+++++.+++.+||+.||++||++.++++ ||||++
T Consensus 239 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 239 Y-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred C-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 1 1122456899999999999999999999999987 999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=306.28 Aligned_cols=243 Identities=24% Similarity=0.390 Sum_probs=193.3
Q ss_pred eeeeeeeeeeeeeceEEEEeec--CCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRK--SGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRIFV 888 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~--tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l~L 888 (1098)
|.+...+|.|.+|.||.+.+.. +++.||||++...... ......+.+|+.+++.++||||+++++++... ..+++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 5677889999999999999988 8999999999764311 22235678899999999999999999999888 78999
Q ss_pred EEEeccCchHHHHHhhc---cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC----CCCCCcEEEeecCc
Q psy48 889 VMEKLQGDMLEMILSSE---KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST----NSELPQVKLCDFGF 961 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~---~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~----~g~~~~vKL~DFGl 961 (1098)
||||++++++..+.... ...+++..++.++.||+.||+|||++||+||||||+||+++. ++ .+||+|||+
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~---~~kl~Dfg~ 158 (316)
T cd07842 82 LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG---VVKIGDLGL 158 (316)
T ss_pred EEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc---eEEECCCcc
Confidence 99999876654332211 236899999999999999999999999999999999999998 66 899999999
Q ss_pred ccccC---------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--------HHHHHh-
Q psy48 962 ARIIG---------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--------EQIQNA- 1016 (1098)
Q Consensus 962 a~~~~---------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--------~~i~~~- 1016 (1098)
+.... ..++|||++.+ ..++.++||||||+++|+|++|+.||....... ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 87531 23579998876 458999999999999999999999997432110 000000
Q ss_pred --h------------------c---cCCCCC------------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1017 --A------------------F---MYPPRP------------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1017 --~------------------~---~~p~~~------------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
. . ...... +...+.++.++|.+||..||++|||+.++++||||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0 0 000000 11466789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=304.77 Aligned_cols=244 Identities=23% Similarity=0.285 Sum_probs=203.5
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
+.....+|.|.+|.+|.+.+..+++.||+|++...... ......+.+|+.+++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55566799999999999999999999999999764432 33346788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------ 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------ 966 (1098)
+.+..+ .++......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++ .++|+|||++....
T Consensus 103 ~~~~l~-~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~---~~kL~dfg~~~~~~~~~~~~ 178 (313)
T cd06633 103 CLGSAS-DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG---QVKLADFGSASKSSPANSFV 178 (313)
T ss_pred CCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC---CEEEeecCCCcccCCCCCcc
Confidence 987544 55555556789999999999999999999999999999999999999888 89999999986432
Q ss_pred --CCCCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhh
Q psy48 967 --EKSFPPEVLR---NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041 (1098)
Q Consensus 967 --~~~~APEvl~---~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~ 1041 (1098)
..++|||.+. +..++.++||||||+++|+|++|..||...+.............+......++..+.+|+.+||+
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 258 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ 258 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence 2367999984 45688999999999999999999999976543332222222223333334577889999999999
Q ss_pred hcccCCCCHHHHHcCCCcCC
Q psy48 1042 VKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1042 ~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+|++||++.+++.||||+.
T Consensus 259 ~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 259 KIPQERPASAELLRHDFVRR 278 (313)
T ss_pred CChhhCcCHHHHhcCcccCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=296.02 Aligned_cols=242 Identities=26% Similarity=0.381 Sum_probs=204.7
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccC---CChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLR---FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRIF 887 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~---~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l~ 887 (1098)
.|.+...+|.|.+|.+|.+.+..+++.||+|++.... ........+.+|+.+++.++|+||+++++++.+. ..++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 5778899999999999999999999999999985432 1233446889999999999999999999998664 4689
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
+||||+++++|..++.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++ .++|+|||+++...
T Consensus 83 ~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~---~~~l~dfg~~~~~~~ 158 (264)
T cd06653 83 IFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG---NVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC---CEEECcccccccccc
Confidence 99999999999888763 34589999999999999999999999999999999999999888 89999999986431
Q ss_pred --------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHH
Q psy48 967 --------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 967 --------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
..++|||.+.+..++.++|+|||||++|+|++|+.||.................++..+..+++++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 135799999998899999999999999999999999987655444443333333344456789999
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
.++|.+||. +|.+||++.+++.|||.
T Consensus 239 ~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 239 RDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=307.09 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=211.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.+...+|.|.+|.+|.+....++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 467788899999999999999999999999999986432 233467889999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+++++|..++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++....
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~---~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG---SVKLTDFGFCAQITPEQS 170 (293)
T ss_pred ecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC---CEEEccCcceeccccccc
Confidence 99999999888753 3588999999999999999999999999999999999999888 89999999875332
Q ss_pred --------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccC-CCCCCCcCcHHHHHHHH
Q psy48 967 --------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY-PPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 --------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~-p~~~~~~is~el~~LL~ 1037 (1098)
..++|||.+.+..++.++|+||||+++|+|++|..||................. ....+..++..+.++|.
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence 126799999988899999999999999999999999986544322221111111 11123457789999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCCCCCcchhHHH
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGL 1071 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l 1071 (1098)
+||..+|++||++.+++.|+||+.-+....|..|
T Consensus 251 ~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~~ 284 (293)
T cd06647 251 RCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPL 284 (293)
T ss_pred HHccCChhhCcCHHHHhcCHHHhcCcccccccch
Confidence 9999999999999999999999986555554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=298.85 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=205.7
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|.....||.|.+|.||.+.+..+++.||||++..... ......+.+|+.++..++||||+++++++..++..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34556789999999999999999999999999865332 33446789999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----- 967 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----- 967 (1098)
+++++|..++. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 84 ~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~---~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 84 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG---EVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC---CEEEeecccceecccchhhh
Confidence 99999988875 34689999999999999999999999999999999999999888 899999998864322
Q ss_pred -------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 968 -------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 968 -------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
.++|||.+.+..++.++|+|||||++|+|++|..||....... .........++.....++.++.+++.+||
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-VLFLIPKNNPPTLEGNYSKPLKEFVEACL 237 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-HHHHHhcCCCCCCCcccCHHHHHHHHHHc
Confidence 2479999998889999999999999999999999997644321 11111122222333457899999999999
Q ss_pred hhcccCCCCHHHHHcCCCcCCCC
Q psy48 1041 QVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1041 ~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
..+|++||++.++++||||++..
T Consensus 238 ~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 238 NKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred cCChhhCcCHHHHHhCHHHhhhh
Confidence 99999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=299.47 Aligned_cols=240 Identities=25% Similarity=0.396 Sum_probs=201.4
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.+...||.|.+|.||.+.+..+++.||||.+.+... .......+.+|+.+++.++|+||+++++++...+.++++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 45667789999999999999999999999999876433 23345688999999999999999999999999999999999
Q ss_pred eccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 892 KLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
|+++++|..++.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.++ .++|+|||++....
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~---~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC---CEEECcchhhhccccC
Confidence 9999999888753 234689999999999999999999999999999999999999888 89999999876432
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh-HHHHHHHh-hccCCCCCCCcCcHHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED-INEQIQNA-AFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~-~~~~i~~~-~~~~p~~~~~~is~el~~ 1034 (1098)
..++|||.+.+..++.++|+||||+++|+|++|..||..... ........ ...+++..+..++.++.+
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 235799999999999999999999999999999999975432 22222211 223344444568899999
Q ss_pred HHHHhhhhcccCCCCHHHHHc
Q psy48 1035 LINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
++.+||..||++|||+.+|++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHH
Confidence 999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=296.15 Aligned_cols=229 Identities=23% Similarity=0.360 Sum_probs=192.5
Q ss_pred eeeeeeeeceEEEEe--ecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVH--RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~--k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|.+|.||.+.. ..++..||+|+++...........+.+|+.+++.+.|+||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 478999999999864 4678899999997655445556789999999999999999999998864 5678999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---------- 966 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---------- 966 (1098)
+|..++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++ .++|+|||++....
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH---YAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC---eEEECCCccccccCCCCCeeeecC
Confidence 99888863 45689999999999999999999999999999999999999887 89999999986431
Q ss_pred -----CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 967 -----EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 967 -----~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
..++|||.+.+..++.++|+||||+++|||++ |..||.... +..+.+... .....+..++.++.++|.+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG---ERMECPQRCPPEMYDLMKL 233 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC---CCCCCCCCCCHHHHHHHHH
Confidence 24679999988889999999999999999998 999997643 233333322 1222335689999999999
Q ss_pred hhhhcccCCCCHHHHHc
Q psy48 1039 LLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1039 cL~~dP~kRPSa~eIL~ 1055 (1098)
||+.||++||++++|.+
T Consensus 234 ~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 234 CWTYGVDERPGFAVVEL 250 (257)
T ss_pred HhccCchhCcCHHHHHH
Confidence 99999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=310.76 Aligned_cols=249 Identities=29% Similarity=0.481 Sum_probs=204.8
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC-----cEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG-----RIF 887 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~-----~l~ 887 (1098)
+|.+...||.|.+|.+|.+.+..+++.||||++............+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 467788999999999999999999999999999765433445578999999999999999999999998775 799
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~ 967 (1098)
+||||+++ +|..++.. ...+++..+..++.||+.||+|||+.||+||||||+|||++.++ .++|+|||++.....
T Consensus 81 lv~e~~~~-~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~---~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELMET-DLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC---DLKICDFGLARGVDP 155 (330)
T ss_pred EEecchhh-hHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEcccCceEeecc
Confidence 99999986 56666653 34799999999999999999999999999999999999999998 899999999875432
Q ss_pred ---------------CCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhccCCC-------
Q psy48 968 ---------------KSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYPP------- 1022 (1098)
Q Consensus 968 ---------------~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~~p~------- 1022 (1098)
.++|||++.+. .++.++|+||||+++|+|++|..||....... ..+.......+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 24799999887 89999999999999999999999997654321 111111000000
Q ss_pred ----------------C----CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcc
Q psy48 1023 ----------------R----PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWS 1066 (1098)
Q Consensus 1023 ----------------~----~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~ 1066 (1098)
. ....++.++.++|.+||+.+|++||++.++++||||++..++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence 0 0123678899999999999999999999999999999855443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=300.89 Aligned_cols=253 Identities=28% Similarity=0.459 Sum_probs=204.5
Q ss_pred eeeeeeeeeeeeeceEEEEee---cCCceeEEEEEeccCCC--hHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEE
Q psy48 814 MTYNVALCIAVVAGAACGVHR---KSGRGVAIKVIDKLRFP--TKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k---~tg~~VAVKvlkk~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~ 887 (1098)
|+....+|.|++|.+|.+.+. .+|+.||+|+++..... ......+.+|+.++..+ +|+||+++++++..+..++
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 567788999999999999875 47899999999764321 22346788899999999 5899999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
+||||+++++|..++.. ...+++..+..++.||+.||.|||+.|++||||+|+|||++.++ .++|+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~---~~kl~dfg~~~~~~~ 157 (290)
T cd05613 82 LILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG---HVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC---CEEEeeCccceeccc
Confidence 99999999999888764 45689999999999999999999999999999999999999988 89999999986432
Q ss_pred ------------CCCCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcH
Q psy48 967 ------------EKSFPPEVLRN--KGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 967 ------------~~~~APEvl~~--~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
..++|||.+.+ ..++.++||||||+++|+|++|..||..... ....+..............++.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence 23579999875 3478899999999999999999999964311 1111111111111222345789
Q ss_pred HHHHHHHHhhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1031 DAIDLINNLLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
.+.+++.+||..||++|| ++++++.||||+. .+|+.+...
T Consensus 238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~----~~~~~~~~~ 282 (290)
T cd05613 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK----INWDDLAAK 282 (290)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc----CCHHHHhhc
Confidence 999999999999999997 8899999999998 456665444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=295.15 Aligned_cols=241 Identities=26% Similarity=0.412 Sum_probs=202.9
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
+.|.+...+|.|.++.+|.+.+..+|+.||+|.++..... ......+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 4688899999999999999999999999999999754332 334678999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC
Q psy48 891 EKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~ 967 (1098)
||+++++|..++.. ....+++.++..++.+|+.||.|||+.||+||||+|+||+++.++ .++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~---~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG---VVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC---cEEEeccceeeeccC
Confidence 99999999888753 234589999999999999999999999999999999999999988 899999999864321
Q ss_pred ------------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-hHHHHHHHhh-ccCCCCCCCcCcHHHH
Q psy48 968 ------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-DINEQIQNAA-FMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 968 ------------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-~~~~~i~~~~-~~~p~~~~~~is~el~ 1033 (1098)
.++|||.+.+..++.++|+|||||++|+|++|..||.... ...+...... ...++.+...++.++.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 2569999999999999999999999999999999997543 2222222211 1223333346788999
Q ss_pred HHHHHhhhhcccCCCCHHHHHc
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
++|.+||..+|++||++.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=299.22 Aligned_cols=238 Identities=21% Similarity=0.304 Sum_probs=198.6
Q ss_pred hheeeeeeeeeeeeeceEEEEee----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHR----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
..+++...||.|+||.||.+... .++..||+|.++... .......+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 45678889999999999999853 456789999997532 2344577899999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhcc----------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC
Q psy48 888 VVMEKLQGDMLEMILSSEK----------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~----------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~ 951 (1098)
+||||+.+++|..++.... ..+++.++..++.||+.||.|||++||+||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~-- 161 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL-- 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC--
Confidence 9999999999988875321 2478889999999999999999999999999999999999887
Q ss_pred CcEEEeecCcccccCC--------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHH
Q psy48 952 PQVKLCDFGFARIIGE--------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQ 1014 (1098)
Q Consensus 952 ~~vKL~DFGla~~~~~--------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~ 1014 (1098)
.++|+|||+++.... .|+|||.+.+..++.++||||||+++|||++ |..||.+... ..+.+.
T Consensus 162 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 -HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred -cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 899999999965421 2679999998889999999999999999998 9999976432 222222
Q ss_pred HhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1015 NAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1015 ~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
. ......+..++.++.+++.+||+.||++||++.+|+++
T Consensus 241 ~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 K---RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred c---CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 2 12222345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=317.57 Aligned_cols=254 Identities=23% Similarity=0.291 Sum_probs=214.8
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccC
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
-..||.|.||.||.|.+..+.+.||||.+....-. ...-..+.+|+.+|+.++|||++.+.+||......+||||||-|
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG 110 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG 110 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc
Confidence 35689999999999999999999999998654322 22236799999999999999999999999999999999999976
Q ss_pred chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc-------cCCC
Q psy48 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI-------IGEK 968 (1098)
Q Consensus 896 gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~-------~~~~ 968 (1098)
+- .+++..-..++.+..+..|..+.+.||+|||+.+.||||||..|||+...| .|||+|||.|.+ ++++
T Consensus 111 SA-sDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g---~VKLaDFGSAsi~~PAnsFvGTP 186 (948)
T KOG0577|consen 111 SA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG---LVKLADFGSASIMAPANSFVGTP 186 (948)
T ss_pred cH-HHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC---eeeeccccchhhcCchhcccCCc
Confidence 53 356655667899999999999999999999999999999999999999999 999999999853 3444
Q ss_pred -CCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcc
Q psy48 969 -SFPPEVLR---NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQ 1044 (1098)
Q Consensus 969 -~~APEvl~---~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP 1044 (1098)
|||||++. .+.|+-++||||||++-.||.-.++|+.........+.......|...-..+|..+.+|+..||.+-|
T Consensus 187 ywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKip 266 (948)
T KOG0577|consen 187 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 266 (948)
T ss_pred cccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCc
Confidence 58999986 46699999999999999999999999988776655444444444544455678999999999999999
Q ss_pred cCCCCHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1045 RKRLSVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1045 ~kRPSa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
.+|||.++++.|+|...+.-..-+-+|..|
T Consensus 267 qeRptse~ll~H~fv~R~Rp~tvi~dLIqR 296 (948)
T KOG0577|consen 267 QERPTSEELLKHRFVLRERPPTVIMDLIQR 296 (948)
T ss_pred ccCCcHHHHhhcchhccCCCchHHHHHHHH
Confidence 999999999999999876655555555544
|
|
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=304.06 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=212.7
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCch
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDM 897 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggs 897 (1098)
..||.|.||+|+.|+|+.+|+.+|||.+.. +.+.+++.+|+.++++.+.+++|++|+.|-....+++|||||+.|+
T Consensus 39 ~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 39 GKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 368999999999999999999999999865 4567889999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------------
Q psy48 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------------ 965 (1098)
Q Consensus 898 L~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------------ 965 (1098)
..++++.++.++++..+..+++..+.||+|||...-||||||..|||++.+| +.||+|||.|..+
T Consensus 115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G---~AKLADFGVAGQLTDTMAKRNTVIG 191 (502)
T KOG0574|consen 115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG---IAKLADFGVAGQLTDTMAKRNTVIG 191 (502)
T ss_pred HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc---hhhhhhccccchhhhhHHhhCcccc
Confidence 9999998888999999999999999999999999999999999999999999 9999999987432
Q ss_pred CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCC--CCCcCcHHHHHHHHHhhhhc
Q psy48 966 GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPR--PWRDISSDAIDLINNLLQVK 1043 (1098)
Q Consensus 966 ~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~--~~~~is~el~~LL~~cL~~d 1043 (1098)
++-|||||++..-.|+..+||||||++..||.-|++||..-......... .-..|+. .+..+|.++.+|++.||.++
T Consensus 192 TPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-PT~PPPTF~KPE~WS~~F~DFi~~CLiK~ 270 (502)
T KOG0574|consen 192 TPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-PTKPPPTFKKPEEWSSEFNDFIRSCLIKK 270 (502)
T ss_pred CcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-cCCCCCCCCChHhhhhHHHHHHHHHhcCC
Confidence 34479999999999999999999999999999999999876544222211 1111111 12356889999999999999
Q ss_pred ccCCCCHHHHHcCCCcCCCCCcchhHHH
Q psy48 1044 QRKRLSVDKSLAHPWLQDPATWSDLRGL 1071 (1098)
Q Consensus 1044 P~kRPSa~eIL~HpfFk~~~~~~~~~~l 1071 (1098)
|++|-|+.++++|+|.++...-.=+..|
T Consensus 271 PE~R~TA~~L~~H~FiknA~g~~I~~~~ 298 (502)
T KOG0574|consen 271 PEERKTALRLCEHTFIKNAPGCDIMQLM 298 (502)
T ss_pred HHHHHHHHHHhhhhhhcCCCcccHHHHH
Confidence 9999999999999999986654444433
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=318.35 Aligned_cols=217 Identities=26% Similarity=0.324 Sum_probs=176.2
Q ss_pred CCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhcc--------
Q psy48 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEK-------- 906 (1098)
Q Consensus 836 tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~-------- 906 (1098)
+++.||||+++.... ......+.+|+.+|.++. ||||+++++++...+.+++||||+.+++|..++....
T Consensus 66 ~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~ 144 (401)
T cd05107 66 STMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYL 144 (401)
T ss_pred CceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhc
Confidence 455799999976432 333457889999999997 9999999999999999999999999999998886431
Q ss_pred --------------------------------------------------------------------------------
Q psy48 907 -------------------------------------------------------------------------------- 906 (1098)
Q Consensus 907 -------------------------------------------------------------------------------- 906 (1098)
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (401)
T cd05107 145 DKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERT 224 (401)
T ss_pred ccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCc
Confidence
Q ss_pred ---------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----------
Q psy48 907 ---------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----------- 966 (1098)
Q Consensus 907 ---------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----------- 966 (1098)
..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||+++...
T Consensus 225 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~---~~kL~DfGla~~~~~~~~~~~~~~~ 301 (401)
T cd05107 225 RRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK---LVKICDFGLARDIMRDSNYISKGST 301 (401)
T ss_pred chhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC---EEEEEecCcceecccccccccCCCc
Confidence 1356677889999999999999999999999999999999887 89999999986431
Q ss_pred ---CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 967 ---EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 967 ---~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
..|+|||.+.+..++.++|||||||++|||++ |..||.....................+..++.++.+++.+||..
T Consensus 302 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~ 381 (401)
T cd05107 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEE 381 (401)
T ss_pred CCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 23689999999899999999999999999998 89999754322111111111222223446789999999999999
Q ss_pred cccCCCCHHHHHcC
Q psy48 1043 KQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1043 dP~kRPSa~eIL~H 1056 (1098)
+|++||++++|++.
T Consensus 382 ~P~~RPs~~ell~~ 395 (401)
T cd05107 382 KFEIRPDFSQLVHL 395 (401)
T ss_pred ChhHCcCHHHHHHH
Confidence 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=296.82 Aligned_cols=236 Identities=19% Similarity=0.276 Sum_probs=196.4
Q ss_pred eeeeeeeeeeeeceEEEEeecC---CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc------
Q psy48 815 TYNVALCIAVVAGAACGVHRKS---GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR------ 885 (1098)
Q Consensus 815 ~~~~~Lg~G~~g~v~~a~~k~t---g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~------ 885 (1098)
.+...+|.|++|.||.+....+ +..||||+++...........+.+|+.+++.++|+||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 4567899999999999987654 4789999998765555566789999999999999999999998765543
Q ss_pred EEEEEEeccCchHHHHHhhc-----cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 886 IFVVMEKLQGDMLEMILSSE-----KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~-----~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
.++||||+.+++|..++... ...+++..+..++.||+.||.|||+.||+||||||+||+++.++ .+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM---TVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC---eEEECCcc
Confidence 79999999999998887432 23588999999999999999999999999999999999999988 89999999
Q ss_pred cccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCC
Q psy48 961 FARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPR 1023 (1098)
Q Consensus 961 la~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~ 1023 (1098)
+++... ..++|||.+.+..++.++||||||+++|||++ |..||.+... ..+.+... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~ 235 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG---NRLK 235 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCC
Confidence 987431 24679999999999999999999999999999 8999976543 22222221 2222
Q ss_pred CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1024 PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1024 ~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
....++.++.+++.+||+.||++||++.+++++
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 335688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=321.51 Aligned_cols=245 Identities=31% Similarity=0.542 Sum_probs=218.3
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
...+.|.....||.|.|+.|.++.+..++..||||++++...+......+.+|+++|..++|||||+++.+..+...+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34577889999999999999999999999999999999988777777779999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||+.++.+.+++. +.+++.+..++.++.|+..|++|||+++|+|||||.+||||+.+- .+||+|||++.++.
T Consensus 133 V~eya~~ge~~~yl~-~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m---nikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLV-KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM---NIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEeccCchhHHHHH-hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc---ceeeeccccceeeccc
Confidence 999999999999987 455677799999999999999999999999999999999999987 79999999997653
Q ss_pred ---------CCCCChhhhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYN-RSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys-~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
.+|.|||++.+..|. +.+|+||+|++||.|+.|.+||++. .++........+..| .-++.+..+
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp----~~ms~dce~ 284 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP----FYMSCDCED 284 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc----ceeechhHH
Confidence 345699999998874 8999999999999999999999965 345444444444443 347899999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+|+++|..+|.+|++++++..|.|...
T Consensus 285 lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 285 LLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred HHHHhhccCccccCCHHHhhhhcccch
Confidence 999999999999999999999999986
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=297.07 Aligned_cols=231 Identities=31% Similarity=0.515 Sum_probs=190.7
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCchH
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGDML 898 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL 898 (1098)
+|.|.+|.||.+.++.++..+|+|++........ |+.+...+ +|+||++++++|...+.+++||||+++++|
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L 96 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDL 96 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcH
Confidence 6999999999999999999999999976432211 22222212 699999999999999999999999999999
Q ss_pred HHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--------CCCC
Q psy48 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--------EKSF 970 (1098)
Q Consensus 899 ~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--------~~~~ 970 (1098)
..++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++. .++|+|||++...+ ..++
T Consensus 97 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~y~ 173 (267)
T PHA03390 97 FDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD--RIYLCDYGLCKIIGTPSCYDGTLDYF 173 (267)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC--eEEEecCccceecCCCccCCCCCccc
Confidence 8888644 48999999999999999999999999999999999999988763 69999999986543 2457
Q ss_pred ChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HH-HHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCC
Q psy48 971 PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--IN-EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKR 1047 (1098)
Q Consensus 971 APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~-~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kR 1047 (1098)
|||++.+..++.++||||||+++|+|++|..||....+ .. ..+.... ..+...+..++..+.++|.+||+.||.+|
T Consensus 174 aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R 252 (267)
T PHA03390 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFVQSMLKYNINYR 252 (267)
T ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHHHHHhccChhhC
Confidence 99999999999999999999999999999999974321 11 1111111 23333445789999999999999999999
Q ss_pred CC-HHHHHcCCCcCC
Q psy48 1048 LS-VDKSLAHPWLQD 1061 (1098)
Q Consensus 1048 PS-a~eIL~HpfFk~ 1061 (1098)
|+ ++++++||||++
T Consensus 253 ~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 253 LTNYNEIIKHPFLKI 267 (267)
T ss_pred CchHHHHhcCCcccC
Confidence 96 699999999974
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=315.78 Aligned_cols=214 Identities=26% Similarity=0.343 Sum_probs=171.8
Q ss_pred CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC-cEEEEEEeccCchHHHHHhhccC-ccchhHH
Q psy48 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG-RIFVVMEKLQGDMLEMILSSEKG-RLSERTT 914 (1098)
Q Consensus 837 g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~-~l~LVmEy~~ggsL~~~l~~~~~-~lse~~~ 914 (1098)
+..||||.+....... ..+|.+|+.++.+++|||||+|+|||.+.+ ..+||+||+..|+|.++++.... .++|.+.
T Consensus 99 ~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R 176 (361)
T KOG1187|consen 99 GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETR 176 (361)
T ss_pred CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHH
Confidence 3689999886543221 455999999999999999999999999888 59999999999999999987766 8999999
Q ss_pred HHHHHHHHHHHHHHHhCC---ccccCCCCCceeecCCCCCCcEEEeecCcccccCC-------------CCCChhhhccC
Q psy48 915 KFIITQILVALKHLHSKN---IVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE-------------KSFPPEVLRNK 978 (1098)
Q Consensus 915 ~~ia~qIa~gL~~LHs~g---IvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~-------------~~~APEvl~~~ 978 (1098)
.+|+.++|.||+|||... |||||||+.|||||.+. .+||+|||+|+.... .|+|||.+...
T Consensus 177 ~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~---~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g 253 (361)
T KOG1187|consen 177 LKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF---NAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTG 253 (361)
T ss_pred HHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC---CEEccCccCcccCCccccceeeecCCCCccCChhhhccC
Confidence 999999999999999754 99999999999999998 899999999975543 35799999988
Q ss_pred CCCchhHHHHHHHHHHHHHcCCCCCCCC-----hhHHHH----HHHh--hccCCCCCC-CcCc-----HHHHHHHHHhhh
Q psy48 979 GYNRSLDMWSVGVIVYVSLSGTFPFNED-----EDINEQ----IQNA--AFMYPPRPW-RDIS-----SDAIDLINNLLQ 1041 (1098)
Q Consensus 979 ~ys~~sDVwSLGvlLyELltG~~Pf~~~-----~~~~~~----i~~~--~~~~p~~~~-~~is-----~el~~LL~~cL~ 1041 (1098)
..+.++|||||||+|+||+||+.+.+.. ..+.+. +... .....+... ...+ ..+..+..+|+.
T Consensus 254 ~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~ 333 (361)
T KOG1187|consen 254 KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLR 333 (361)
T ss_pred CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcC
Confidence 8999999999999999999999887632 112221 1111 111111111 2233 235677889999
Q ss_pred hcccCCCCHHHHHc
Q psy48 1042 VKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1042 ~dP~kRPSa~eIL~ 1055 (1098)
.+|.+||++.++++
T Consensus 334 ~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 334 PDPKERPTMSQVVK 347 (361)
T ss_pred cCCCcCcCHHHHHH
Confidence 99999999999754
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=298.08 Aligned_cols=242 Identities=29% Similarity=0.451 Sum_probs=198.6
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcEEEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRIFVVME 891 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l~LVmE 891 (1098)
|.+...+|.|.+|.+|.+....+++.||+|+++...........+.+|+.+++.++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 3456789999999999999999999999999987543334456788999999999999999999999888 88999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE---- 967 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~---- 967 (1098)
|+++ +|..++......+++..++.++.||+.||+|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~---~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG---VLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC---CEEEccccceeeccCCCcc
Confidence 9986 56667665546799999999999999999999999999999999999999988 899999999874422
Q ss_pred ---------CCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhccCCCCC-----------
Q psy48 968 ---------KSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYPPRP----------- 1024 (1098)
Q Consensus 968 ---------~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~~p~~~----------- 1024 (1098)
.++|||.+.+ ..++.++||||||+++|||++|..||....... ..+...........
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2579998765 458999999999999999999999997654321 11111100000000
Q ss_pred ---------------CCc-CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1025 ---------------WRD-ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1025 ---------------~~~-is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
... ++.++.+++.+||..||++||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 112 37899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=303.18 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=203.4
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
|.....+|.|.++.+|.+.+..++..||+|++...... ......+.+|+++++.++|+|++++++++......++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 44566799999999999999999999999999764332 33446788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----- 967 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----- 967 (1098)
+.|..+ .++......+++..+..++.+|+.||.|||+.||+||||+|+||+++.++ .++|+|||++.....
T Consensus 107 ~~g~l~-~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~ 182 (317)
T cd06635 107 CLGSAS-DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG---QVKLADFGSASIASPANSFV 182 (317)
T ss_pred CCCCHH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC---CEEEecCCCccccCCccccc
Confidence 987544 55554566789999999999999999999999999999999999999988 899999998864432
Q ss_pred ---CCCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhh
Q psy48 968 ---KSFPPEVLR---NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041 (1098)
Q Consensus 968 ---~~~APEvl~---~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~ 1041 (1098)
.|+|||.+. +..++.++|||||||++|||++|..||.................+......+++.+.+++.+||.
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 262 (317)
T cd06635 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 262 (317)
T ss_pred CCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHcc
Confidence 367999984 45688999999999999999999999976543322222222222322334578899999999999
Q ss_pred hcccCCCCHHHHHcCCCcCCCC
Q psy48 1042 VKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1042 ~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
.+|.+||++.++++|+|+....
T Consensus 263 ~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 263 KIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred CCcccCcCHHHHHhChhhhccC
Confidence 9999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=297.32 Aligned_cols=240 Identities=19% Similarity=0.260 Sum_probs=197.5
Q ss_pred HhhheeeeeeeeeeeeeceEEEEee-----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHR-----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG 884 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k-----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~ 884 (1098)
...+|+....+|.|++|.||.+.++ .++..||||+++... .......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3456888999999999999998864 345679999986432 2334567889999999999999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhcc---------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEE
Q psy48 885 RIFVVMEKLQGDMLEMILSSEK---------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVK 955 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~---------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vK 955 (1098)
..++||||+++++|..++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~---~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---TVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC---CEE
Confidence 9999999999999998886432 2356788899999999999999999999999999999999988 899
Q ss_pred EeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhc
Q psy48 956 LCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAF 1018 (1098)
Q Consensus 956 L~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~ 1018 (1098)
|+|||+++.. ...|+|||++.+..++.++|||||||++|||++ |..||.+... ..+.+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-- 237 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-- 237 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--
Confidence 9999998632 123689999999999999999999999999999 7889876532 22222221
Q ss_pred cCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1019 MYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1019 ~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
........++..+.+++.+||+.||++||++.+++++
T Consensus 238 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 -GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1122234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=294.95 Aligned_cols=237 Identities=22% Similarity=0.388 Sum_probs=201.1
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCc---eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGR---GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~---~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
..|.+...+|.|.+|.||.+.+..++. .||+|.++... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 567888999999999999998875554 79999986543 34445788999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE- 967 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~- 967 (1098)
||||+++++|..++......+++.++..++.||+.||+|||++||+||||||+|||++.++ .++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~---~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL---VCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC---eEEeCCCCcccccccc
Confidence 9999999999999877667789999999999999999999999999999999999999888 899999999864321
Q ss_pred --------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcH
Q psy48 968 --------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 968 --------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
.++|||.+.+..++.++|+||||+++|||++ |..||.... +....+... ........+++
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 236 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG---YRLPAPMDCPA 236 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC---CcCCCCCCCCH
Confidence 3579999999899999999999999999886 999997543 233333222 22222346789
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=304.78 Aligned_cols=237 Identities=20% Similarity=0.266 Sum_probs=198.1
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCce----eEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRG----VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~----VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.|.....||.|.+|.||.+.+..+++. ||||+++.. ........+.+|+.+++.++||||+++++++... ..++
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 467788999999999999998777664 899998643 2234457788999999999999999999998765 5789
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
|+||+.+++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~---~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC---cEEEccccccccccCC
Confidence 9999999999999887666789999999999999999999999999999999999999888 89999999997532
Q ss_pred ------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhH-HHHHHHhhccCCCCCCCcCcHHH
Q psy48 967 ------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDI-NEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 967 ------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~-~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
..|+|||.+.+..++.++||||||+++|||++ |..||.+.... ...+.......+. ...++.++
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 240 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ--PPICTIDV 240 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC--CCCCCHHH
Confidence 13689999999999999999999999999998 99999764321 1222222222222 23578899
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.+++.+||..||++||++.+++.+
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=293.58 Aligned_cols=237 Identities=22% Similarity=0.363 Sum_probs=201.1
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCc---eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGR---GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~---~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
..++....+|.|.+|.||.+....++. .+|+|.++... .......+.+|+.+++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356788999999999999999877665 79999986532 23445778999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||+++++|..++....+.+++.++..++.|++.||+|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~---~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL---ECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC---cEEECCCccceecccc
Confidence 9999999999999876667899999999999999999999999999999999999999887 89999999986442
Q ss_pred -------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcH
Q psy48 967 -------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 967 -------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
..++|||.+.+..++.++||||||+++|||++ |..||.... +....+.. .........++.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~ 237 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND---GFRLPAPMDCPS 237 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc---CCCCCCCCCCCH
Confidence 13689999998889999999999999999997 999997543 22223322 122222346789
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
++.+++.+||..+|++||++.+|++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=302.66 Aligned_cols=245 Identities=26% Similarity=0.388 Sum_probs=197.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC-------
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP------- 883 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~------- 883 (1098)
...|.....||.|.++.||.+.++.+++.||||++............+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4678889999999999999999999999999999976543333345678899999999999999999987443
Q ss_pred -CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 884 -GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 884 -~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
..+++||||+.+..+ ..+......+++..+..++.||+.||+|||++||+|+||||+||+++.++ .++|+|||++
T Consensus 87 ~~~~~lv~~~~~~~l~-~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDHDLS-GLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG---ILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCcCHH-HHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---CEEECcCccc
Confidence 347999999987655 45544556799999999999999999999999999999999999999998 8999999998
Q ss_pred cccC-----------------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHh
Q psy48 963 RIIG-----------------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNA 1016 (1098)
Q Consensus 963 ~~~~-----------------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~ 1016 (1098)
.... ..++|||.+.+ ..++.++||||||+++|||++|..||.+..... +.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 6432 12679998865 458999999999999999999999997654322 111111
Q ss_pred hccCCC--------------------------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1017 AFMYPP--------------------------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1017 ~~~~p~--------------------------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
....++ ..+..+++++.++|.+||+.||++|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 100000 0012345788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=295.57 Aligned_cols=235 Identities=20% Similarity=0.269 Sum_probs=193.6
Q ss_pred eeeeeeeeeeeceEEEEeecCCc--eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC------CcEE
Q psy48 816 YNVALCIAVVAGAACGVHRKSGR--GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP------GRIF 887 (1098)
Q Consensus 816 ~~~~Lg~G~~g~v~~a~~k~tg~--~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~------~~l~ 887 (1098)
+...||.|++|.||.+....++. .||+|.++...........+.+|+.+++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 46789999999999999887776 699999977655556668899999999999999999999876321 3578
Q ss_pred EEEEeccCchHHHHHhh-----ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 888 VVMEKLQGDMLEMILSS-----EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~-----~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
+||||+.+++|..++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM---NVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC---CEEECCCCcc
Confidence 99999999999877642 223488999999999999999999999999999999999999888 8999999998
Q ss_pred cccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCC
Q psy48 963 RIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPW 1025 (1098)
Q Consensus 963 ~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~ 1025 (1098)
+... ..++|||.+.+..++.++||||||+++|||++ |+.||..... ..+.+.... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~ 236 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN---RLKQP 236 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---CCCCC
Confidence 7532 23579999999999999999999999999999 8999976432 223332221 11223
Q ss_pred CcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1026 RDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1026 ~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
..++..+.++|.+||+.||++|||+.+|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 4678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=303.31 Aligned_cols=241 Identities=21% Similarity=0.291 Sum_probs=199.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCce--eEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRG--VAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~--VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~ 887 (1098)
...+.+...||.|++|.||.+.++.++.. +|+|.++. .........+.+|+.++.++ +|+||+++++++...+.++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 34678889999999999999999888865 46666643 22344557888999999999 8999999999999999999
Q ss_pred EEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCC
Q psy48 888 VVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~ 952 (1098)
+||||+++++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~--- 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--- 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC---
Confidence 9999999999998886432 2578999999999999999999999999999999999999888
Q ss_pred cEEEeecCccccc-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccC
Q psy48 953 QVKLCDFGFARII-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMY 1020 (1098)
Q Consensus 953 ~vKL~DFGla~~~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~ 1020 (1098)
.++|+|||++... ...++|||.+.+..++.++|||||||++|||+| |..||...... +.........
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~ 240 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKLPQGY 240 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-HHHHHHhcCC
Confidence 8999999998532 124689999998889999999999999999998 99999754322 1122222222
Q ss_pred CCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1021 PPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1021 p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
....+..++.++.+++.+||..+|++||++++++++
T Consensus 241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 223344578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=299.25 Aligned_cols=236 Identities=22% Similarity=0.322 Sum_probs=197.7
Q ss_pred hheeeeeeeeeeeeeceEEEEe-----ecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 812 VFMTYNVALCIAVVAGAACGVH-----RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~-----k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
..+.+...+|.|++|.||.+.. ..++..+|+|.++.. .......+.+|+.++++++|+||+++++++...+.+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4577888999999999999985 334567999998653 244457799999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhcc------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcE
Q psy48 887 FVVMEKLQGDMLEMILSSEK------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQV 954 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~v 954 (1098)
++||||+++++|..++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~---~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL---LV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC---cE
Confidence 99999999999988886432 2489999999999999999999999999999999999999988 89
Q ss_pred EEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhh
Q psy48 955 KLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAA 1017 (1098)
Q Consensus 955 KL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~ 1017 (1098)
+|+|||+++.. ...|+|||.+.+..++.++||||||+++|+|++ |..||.... +....+....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999998643 124689999999999999999999999999998 999997643 2223333222
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1018 FMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1018 ~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.......++.++.+++.+||+.||.+|||+.+++.
T Consensus 240 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 ---VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred ---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 12223457899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=298.09 Aligned_cols=236 Identities=21% Similarity=0.315 Sum_probs=198.2
Q ss_pred heeeeeeeeeeeeeceEEEEee-----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHR-----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k-----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
.|.+...+|.|++|.||.+.+. .+++.||||+++... .......+.+|+++|+.++|+||+++++++......+
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 4556678999999999999875 346889999997543 2334578999999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhcc-------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcE
Q psy48 888 VVMEKLQGDMLEMILSSEK-------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQV 954 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~-------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~v 954 (1098)
+||||+++++|..++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~---~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL---VV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC---eE
Confidence 9999999999999886432 3478899999999999999999999999999999999999998 89
Q ss_pred EEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhh
Q psy48 955 KLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAA 1017 (1098)
Q Consensus 955 KL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~ 1017 (1098)
+|+|||++... ...++|||++.+..++.++||||||+++|||++ |..||.... +....+...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~- 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG- 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-
Confidence 99999998642 123679999999999999999999999999998 999997543 233333322
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1018 FMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1018 ~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
........++.++.+++.+||..||++||++.++++
T Consensus 241 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 --RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred --CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 222233568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=300.99 Aligned_cols=239 Identities=20% Similarity=0.308 Sum_probs=197.6
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCc--eeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGR--GVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~--~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LV 889 (1098)
.|++...||.|++|.||.+..+.++. .+|+|.++.. ........+.+|+.++.++ +||||+++++++...+.+++|
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999887775 4688887632 2334456789999999999 799999999999999999999
Q ss_pred EEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcE
Q psy48 890 MEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQV 954 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~v 954 (1098)
|||+++++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~---~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL---AS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC---eE
Confidence 99999999988886432 2488899999999999999999999999999999999999887 89
Q ss_pred EEeecCccccc-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCC
Q psy48 955 KLCDFGFARII-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPP 1022 (1098)
Q Consensus 955 KL~DFGla~~~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~ 1022 (1098)
||+|||++... ...++|||.+.+..++.++|||||||++|||++ |..||....... ...........
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-~~~~~~~~~~~ 237 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRM 237 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhcCCCC
Confidence 99999998532 123689999999999999999999999999997 999997653221 12222222222
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.....++.++.+|+.+||..+|.+||+++++++.
T Consensus 238 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2334688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=307.91 Aligned_cols=246 Identities=30% Similarity=0.519 Sum_probs=196.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC-----Cc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP-----GR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~-----~~ 885 (1098)
...|.....+|.|++|.||.+.+..+|+.||||+++... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357888999999999999999999999999999986422 223346678899999999999999999886543 35
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+++||||+.+. |..++. ...+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++...
T Consensus 83 ~~lv~e~~~~~-l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~---~~kl~dfg~~~~~ 156 (336)
T cd07849 83 VYIVQELMETD-LYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC---DLKICDFGLARIA 156 (336)
T ss_pred EEEEehhcccC-HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC---CEEECcccceeec
Confidence 89999999874 444543 34699999999999999999999999999999999999999988 8999999998643
Q ss_pred C---------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH--HHHh-----------
Q psy48 966 G---------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ--IQNA----------- 1016 (1098)
Q Consensus 966 ~---------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~--i~~~----------- 1016 (1098)
. ..++|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..... +...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 2 23689998764 56899999999999999999999999754321100 0000
Q ss_pred ---------hccC---CCCC----CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1017 ---------AFMY---PPRP----WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1017 ---------~~~~---p~~~----~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
.... +... ...++.++.++|.+||+.||++||++.++++||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000 0000 124678899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=297.99 Aligned_cols=241 Identities=29% Similarity=0.449 Sum_probs=200.0
Q ss_pred eeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEecc
Q psy48 815 TYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894 (1098)
Q Consensus 815 ~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ 894 (1098)
+....+|.|.++.+|.+....+++.||+|++............+..|+.+++.++|+||+++++++...+.+++||||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 45567899999999999999999999999998754333444678889999999999999999999999999999999998
Q ss_pred CchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--------
Q psy48 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-------- 966 (1098)
Q Consensus 895 ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-------- 966 (1098)
+ +|..++......+++..+..++.+|+.||+|||+.||+||||+|+||+++.++ .++|+|||.+....
T Consensus 82 ~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~---~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 82 M-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG---VLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred c-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC---CEEEecCCcccccCCCccccCc
Confidence 6 67777765545799999999999999999999999999999999999999988 89999999986432
Q ss_pred ----CCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHH--HHh------------------hccCC
Q psy48 967 ----EKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI--QNA------------------AFMYP 1021 (1098)
Q Consensus 967 ----~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i--~~~------------------~~~~p 1021 (1098)
..++|||.+.+. .++.++|+||||+++|||++|..||.......... ... ...++
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 225799999776 78999999999999999999999997654322111 110 00000
Q ss_pred C-------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1022 P-------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1022 ~-------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
. .....++.++.++|.+||..||++||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0 1122357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=319.89 Aligned_cols=239 Identities=21% Similarity=0.272 Sum_probs=206.3
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCc---e-eEEEEEec-cCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGR---G-VAIKVIDK-LRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~---~-VAVKvlkk-~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
..+...||.|.||.||.+..+..+. . ||||..+. ......+..++.+|+++++.++|||||++||+......+++
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 3455899999999999998876533 3 89999985 33567778999999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
|||+|.||+|..++......++..+...++.+.+.||+|||++++|||||-.+|+|++.++ .+||+||||++..
T Consensus 239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~---~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG---VVKISDFGLSRAGSQY 315 (474)
T ss_pred EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC---eEEeCccccccCCcce
Confidence 9999999999999987776799999999999999999999999999999999999999988 7899999998754
Q ss_pred ---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 966 ---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
...|+|||.+....|++++|||||||++||+++ |..||.+.....-......-.++.......+.++..+
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~ 395 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV 395 (474)
T ss_pred eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence 245689999999999999999999999999998 8889998754433222223334444445688999999
Q ss_pred HHHhhhhcccCCCCHHHHHc
Q psy48 1036 INNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.+||..||+.||++.++.+
T Consensus 396 ~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 396 MKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHhccCChhhccCHHHHHH
Confidence 99999999999999988875
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=294.78 Aligned_cols=234 Identities=21% Similarity=0.310 Sum_probs=199.4
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|++...+|.|.+|.||.+.+.. +..+|+|+++... ......+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 46677889999999999999988 8999999997643 22356788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC----
Q psy48 893 LQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE---- 967 (1098)
Q Consensus 893 ~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~---- 967 (1098)
+++++|..++... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++ .++|+|||++.....
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~---~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL---VCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc---eEEEccccchhhcCCcccc
Confidence 9999999888653 34689999999999999999999999999999999999999988 899999999865421
Q ss_pred --------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 968 --------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 968 --------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
.++|||.+.+..++.++||||||+++|+|++ |..||.... +....+. ..+.......+++++.+++
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---AGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---hCCcCCCCCCCCHHHHHHH
Confidence 2579999999999999999999999999998 899997643 2223222 2222223356889999999
Q ss_pred HHhhhhcccCCCCHHHHHc
Q psy48 1037 NNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.+||..||.+|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=293.60 Aligned_cols=231 Identities=24% Similarity=0.350 Sum_probs=191.3
Q ss_pred eeeeeeeeceEEEEee--cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHR--KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k--~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|.+|.||.+..+ ..+..||+|+++... .......+.+|+.+++.++|+||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 4789999999998765 445679999986542 33445679999999999999999999998864 5789999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---------- 966 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---------- 966 (1098)
+|..++......+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH---YAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC---cEEeccCCccccccCCccceeccC
Confidence 99998876667899999999999999999999999999999999999999888 89999999986321
Q ss_pred -----CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 967 -----EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 967 -----~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
..++|||.+.+..++.++||||||+++|||++ |..||....... .........+.......++++.++|.+||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~c~ 235 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-VMSFIEQGKRLDCPAECPPEMYALMKDCW 235 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence 24689999998889999999999999999996 999997653221 11111122222233457899999999999
Q ss_pred hhcccCCCCHHHHHc
Q psy48 1041 QVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1041 ~~dP~kRPSa~eIL~ 1055 (1098)
..||++||++.+|.+
T Consensus 236 ~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 236 IYKWEDRPNFAKVEE 250 (257)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=296.48 Aligned_cols=239 Identities=31% Similarity=0.556 Sum_probs=205.9
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LVm 890 (1098)
.|.+...||.|.++.+|.+..+.+++.||+|++.+.... ......+.+|+.+++.+. |+||+++++++...+.+++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 467788999999999999999999999999999764332 334567889999999998 999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+.+++|..++.. .+.+++..+..++.||+.||.+||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~---~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 82 EYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM---HIKITDFGTAKVLDPNSS 157 (280)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC---CEEecCCccccccCCccc
Confidence 99999999888864 44799999999999999999999999999999999999999988 89999999886432
Q ss_pred ----------------------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHh
Q psy48 967 ----------------------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNA 1016 (1098)
Q Consensus 967 ----------------------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~ 1016 (1098)
..++|||++.+..++.++|+||||+++|+|++|+.||....... +.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 23579999998889999999999999999999999998654332 222222
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCH----HHHHcCCCc
Q psy48 1017 AFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV----DKSLAHPWL 1059 (1098)
Q Consensus 1017 ~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa----~eIL~HpfF 1059 (1098)
.... ...+++.+.++|.+||+.||++||++ .++++||||
T Consensus 238 ~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EYSF----PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCC----CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2222 23578999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=292.31 Aligned_cols=230 Identities=22% Similarity=0.295 Sum_probs=193.8
Q ss_pred eeeeeeeeceEEEEeec-CCc--eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccC
Q psy48 819 ALCIAVVAGAACGVHRK-SGR--GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~-tg~--~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
.+|.|.+|.||.+.+.. .++ .||||.++..... .....+.+|+.++++++|+||+++++.+.. ..+++||||+++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 57899999999998865 333 6999999876543 556789999999999999999999999988 889999999999
Q ss_pred chHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-------
Q psy48 896 DMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE------- 967 (1098)
Q Consensus 896 gsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~------- 967 (1098)
++|..++.+.. ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++.....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD---KVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC---EEEeccccccccccccccceec
Confidence 99998887654 5789999999999999999999999999999999999999998 899999999865432
Q ss_pred --------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 968 --------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 968 --------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
.|+|||.+.+..++.++||||||+++|||++ |..||..... ....+.... ........++..+.+++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li 234 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG--ERLERPEACPQDIYNVM 234 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--CcCCCCccCCHHHHHHH
Confidence 3579999999999999999999999999998 9999975432 222222211 11112245789999999
Q ss_pred HHhhhhcccCCCCHHHHHc
Q psy48 1037 NNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.+||..+|++||++.++++
T Consensus 235 ~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 235 LQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHCCCCcccCCCHHHHHH
Confidence 9999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=292.27 Aligned_cols=235 Identities=22% Similarity=0.319 Sum_probs=197.8
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|++...+|.|.+|.+|.+.... +..||||.++.... ....+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 457888899999999999997653 45699999875432 23568899999999999999999999999899999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
|+.+++|..++......+++..++.++.||+.||+|||++||+|+||||+||+++.++ .+||+|||+++...
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~---~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG---CVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC---CEEECCCccceecCCCcee
Confidence 9999999998876555799999999999999999999999999999999999999888 89999999886431
Q ss_pred --------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 --------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 --------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..++|||.+.+..++.++||||||+++|+|++ |..||.... +....+..... .......+..+.++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l 233 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR---LYRPHLASEKVYAI 233 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC---CCCCCCCCHHHHHH
Confidence 13579999998889999999999999999998 999997543 23333332221 12234568999999
Q ss_pred HHHhhhhcccCCCCHHHHHcC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.+||..||++||++.+|+.+
T Consensus 234 i~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 234 MYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHcCCCcccCCCHHHHHHh
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=300.70 Aligned_cols=241 Identities=23% Similarity=0.287 Sum_probs=199.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEe-----ecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVH-----RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPG 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~-----k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~ 884 (1098)
...+.+...||.|.+|.||.+.+ ..++..||||+++... .......+.+|+.+++++ +|+||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 34678889999999999999875 3456689999987543 233446789999999999 7999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhccC-ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKG-RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~-~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
.+++||||+.+++|..++..... .+++.++..++.||+.||+|||++||+|+||||+|||++.++ .++|+|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC---eEEECCCcccc
Confidence 99999999999999888865433 489999999999999999999999999999999999999887 89999999986
Q ss_pred ccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcC
Q psy48 964 IIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDI 1028 (1098)
Q Consensus 964 ~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~i 1028 (1098)
... ..++|||.+.+..++.++|||||||++|||++ |..||.................+.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA 269 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCC
Confidence 431 23689999999999999999999999999998 999997643322222222222222223457
Q ss_pred cHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1029 SSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.++.+++.+||..+|++||++.++++
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=289.79 Aligned_cols=231 Identities=23% Similarity=0.322 Sum_probs=194.8
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchH
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDML 898 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL 898 (1098)
.||.|++|.||.+... ++..||+|+++... .......+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 5789999999999854 68899999986543 344456788999999999999999999999999999999999999999
Q ss_pred HHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------------
Q psy48 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------------ 966 (1098)
Q Consensus 899 ~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------------ 966 (1098)
..++......+++..+..++.+++.||.|||++|++||||||+||+++.++ .++|+|||++....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN---VLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC---eEEECCCccceeccccccccCCCCCC
Confidence 988876666789999999999999999999999999999999999999888 89999999986321
Q ss_pred -CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcc
Q psy48 967 -EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQ 1044 (1098)
Q Consensus 967 -~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP 1044 (1098)
..++|||++.+..++.++||||||+++|+|++ |..||........ ............+..++.++.+++.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-REQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 13679999998889999999999999999998 9999976532211 11122222223345688999999999999999
Q ss_pred cCCCCHHHHHc
Q psy48 1045 RKRLSVDKSLA 1055 (1098)
Q Consensus 1045 ~kRPSa~eIL~ 1055 (1098)
++||++.++++
T Consensus 236 ~~Rp~~~~l~~ 246 (250)
T cd05085 236 ENRPKFSELQK 246 (250)
T ss_pred ccCCCHHHHHH
Confidence 99999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=308.90 Aligned_cols=247 Identities=28% Similarity=0.451 Sum_probs=200.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC-----Cc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP-----GR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~-----~~ 885 (1098)
..+|.....+|.|++|.+|.+.+..+++.||||.++...........+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3468888899999999999999999999999999976543344456778899999999999999999988654 34
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+++||||+.+ +|..++. ..+.+++..+..++.||+.||.|||++||+||||||+||+++.++ .++|+|||++...
T Consensus 84 ~~lv~e~~~~-~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~---~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMDT-DLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC---DLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCCC-CHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC---CEEECcCcccccc
Confidence 8999999975 4555654 345799999999999999999999999999999999999999988 8999999998754
Q ss_pred CC------------CCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhh-------------
Q psy48 966 GE------------KSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAA------------- 1017 (1098)
Q Consensus 966 ~~------------~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~------------- 1017 (1098)
.. .++|||.+.+ ..++.++||||||+++|+|++|..||.+.+... ..+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 22 3579998865 568999999999999999999999997543211 0010000
Q ss_pred -------ccCC-------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1018 -------FMYP-------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1018 -------~~~p-------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
...+ ...+..+++++.++|.+||+.||++|||+.++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000 00123578999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=295.92 Aligned_cols=242 Identities=30% Similarity=0.445 Sum_probs=194.8
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc---CCCCceeeeeeeecCCc-----
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL---CHPGVVNLERMFETPGR----- 885 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~L~~~f~~~~~----- 885 (1098)
|.....+|.|.+|.+|.+.++.+++.||||+++...........+.+|+.+++.+ .|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 3566789999999999999999999999999976543333345667788777655 59999999999988776
Q ss_pred EEEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 886 IFVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
++++|||+++. |..++... ...+++..++.++.||+.||+|||+.||+|+||+|+||+++.++ .++|+|||++..
T Consensus 81 ~~l~~e~~~~~-l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~---~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQD-LATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG---QVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccC-HHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC---CEEEeccCccee
Confidence 99999999874 55666543 33689999999999999999999999999999999999999998 899999999865
Q ss_pred cC-----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhh-c----c-------
Q psy48 965 IG-----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAA-F----M------- 1019 (1098)
Q Consensus 965 ~~-----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~-~----~------- 1019 (1098)
.. ..++|||++.+..++.++|+||||+++|+|++|..||....+.. ..+.... . .
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 42 22579999999999999999999999999999999997653321 1111100 0 0
Q ss_pred ----CCC-------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1020 ----YPP-------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1020 ----~p~-------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
++. .....++..+.++|.+||+.||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000 0012356788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=308.74 Aligned_cols=251 Identities=27% Similarity=0.451 Sum_probs=202.1
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec----CCcEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET----PGRIF 887 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~----~~~l~ 887 (1098)
..|.....||.|.+|.||.+.+..+++.||+|++............+.+|+.+|+.++||||+++++++.. ...++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 46777889999999999999999999999999997654333445677889999999999999999998853 34689
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
+||||+.+ +|..++.. ...+++..+..++.||+.||+|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus 85 lv~e~~~~-~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~---~~kl~dfg~~~~~~~ 159 (334)
T cd07855 85 VVMDLMES-DLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC---ELRIGDFGMARGLSS 159 (334)
T ss_pred EEEehhhh-hHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC---cEEecccccceeecc
Confidence 99999975 56666653 45699999999999999999999999999999999999999998 89999999986431
Q ss_pred ---------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH--HHH-------------
Q psy48 967 ---------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ--IQN------------- 1015 (1098)
Q Consensus 967 ---------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~--i~~------------- 1015 (1098)
..++|||.+.+ ..++.++||||||+++|||++|+.||......... +..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 13569999865 56899999999999999999999999765322110 000
Q ss_pred -------hhccCC---CCC----CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcch
Q psy48 1016 -------AAFMYP---PRP----WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSD 1067 (1098)
Q Consensus 1016 -------~~~~~p---~~~----~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~ 1067 (1098)
.....+ ... ...++.++.++|.+||+.+|++||++++++.||||+...++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence 000011 111 1346889999999999999999999999999999997544443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=312.04 Aligned_cols=271 Identities=30% Similarity=0.408 Sum_probs=210.2
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecC--CcE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETP--GRI 886 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~--~~l 886 (1098)
....|.+...+|.|.++.+|.+.+..+++.||||.+.+..........+.+|+.+++++ +|+||+++++++... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 34567778889999999999999999999999999865433344456678899999999 999999999998654 368
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
++||||+.+ +|..++... .+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 85 ~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~---~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC---RVKLADFGLARSLS 158 (337)
T ss_pred EEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC---cEEEeeccchhccc
Confidence 999999986 666666432 788999999999999999999999999999999999999998 89999999886431
Q ss_pred -----------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--HHHHhh---------
Q psy48 967 -----------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQNAA--------- 1017 (1098)
Q Consensus 967 -----------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~i~~~~--------- 1017 (1098)
..++|||++.+ ..++.++|+||||+++|+|++|+.||........ .+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 13579998764 5588999999999999999999999975432211 110000
Q ss_pred ------------------ccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHHHHhhhCCCC
Q psy48 1018 ------------------FMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQIGTNK 1079 (1098)
Q Consensus 1018 ------------------~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~~~~~~~~ 1079 (1098)
..........++.++.++|.+||+.||++|||+.++++||||+...+.......-..+.+|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPL 318 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCc
Confidence 00001112346889999999999999999999999999999987544333222223356677
Q ss_pred CCCcchh
Q psy48 1080 KKNPKRT 1086 (1098)
Q Consensus 1080 ~~~~~~~ 1086 (1098)
+.+.+.+
T Consensus 319 ~~~~~~~ 325 (337)
T cd07852 319 DDNVKLS 325 (337)
T ss_pred cccceee
Confidence 6665555
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=322.02 Aligned_cols=246 Identities=21% Similarity=0.374 Sum_probs=212.8
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC--hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc--EE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP--TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR--IF 887 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~--l~ 887 (1098)
-+++|...||.|.|.+||.|.+..+|-.||.-.++...+. ....+.|..|+.+|+.|+||||++++.+|.+..+ +.
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 4568899999999999999999999999998777554443 3445899999999999999999999999977655 89
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~g--IvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+|+|++..|+|..|.. +.++...+.+..|++||+.||.|||++. |||||||-+||+|+.+.. .|||+|+|+|+..
T Consensus 120 ~iTEL~TSGtLr~Y~k-k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G--~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 120 FITELFTSGTLREYRK-KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLG--EVKIGDLGLATLL 196 (632)
T ss_pred eeeecccCCcHHHHHH-HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcC--ceeecchhHHHHh
Confidence 9999999999988876 5667899999999999999999999885 999999999999986553 8999999999643
Q ss_pred ----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcC-cHHHHH
Q psy48 966 ----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDI-SSDAID 1034 (1098)
Q Consensus 966 ----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~i-s~el~~ 1034 (1098)
++..||||++. ..|+..+||||||+.|+||+|+..||.......+.++...-...+..+..+ .+++++
T Consensus 197 r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~ 275 (632)
T KOG0584|consen 197 RKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVRE 275 (632)
T ss_pred hccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHH
Confidence 45568999998 679999999999999999999999999877666666666665555444333 589999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
||.+||.. .+.|||+.|+|+||||...
T Consensus 276 fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 276 FIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999999 9999999999999999973
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=307.38 Aligned_cols=246 Identities=24% Similarity=0.421 Sum_probs=201.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC------
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG------ 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~------ 884 (1098)
..+|+....||.|.+|.||.+.+..+++.||||++++..........+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 45688889999999999999999999999999999765433444567889999999999999999999987654
Q ss_pred cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
.+++||||+ +++|..++. ...+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++..
T Consensus 94 ~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~---~~kl~dfg~~~~ 167 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC---ELKILDFGLARQ 167 (343)
T ss_pred eEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEeecccccc
Confidence 358999999 567766664 34689999999999999999999999999999999999999888 899999999875
Q ss_pred cC---------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc---------------
Q psy48 965 IG---------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM--------------- 1019 (1098)
Q Consensus 965 ~~---------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~--------------- 1019 (1098)
.. ..++|||.+.+ ..++.++|+||||+++|+|++|..||................
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred cccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 42 23579999876 458899999999999999999999998654322111100000
Q ss_pred -------CC-------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1020 -------YP-------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1020 -------~p-------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.+ ...+..+++++.++|.+||..||++|||+.+++.||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00 01124578889999999999999999999999999999973
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=290.16 Aligned_cols=229 Identities=24% Similarity=0.350 Sum_probs=196.1
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchH
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDML 898 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL 898 (1098)
.+|.|.+|.+|.+.+.. ++.||+|.++..... .....+.+|+.+++++.|+||+++++++......++||||+.+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred ccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 57899999999999888 999999998765432 4557899999999999999999999999999999999999999999
Q ss_pred HHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------------
Q psy48 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------------ 966 (1098)
Q Consensus 899 ~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------------ 966 (1098)
..++......+++..+..++.+++.||+|||++||+||||+|+||+++.++ .++|+|||++....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN---VLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC---cEEEeeccccccccCCcceeccccCc
Confidence 998876666789999999999999999999999999999999999999988 89999999986432
Q ss_pred --CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhh
Q psy48 967 --EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041 (1098)
Q Consensus 967 --~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~ 1041 (1098)
..|+|||.+.+..++.++|+||||+++|||++ |..||..... ....+.. ......+..++.++.+++.+||.
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~ 233 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES---GYRMPAPQLCPEEIYRLMLQCWA 233 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc---CCCCCCCccCCHHHHHHHHHHhc
Confidence 12679999998899999999999999999999 8899876532 2222221 12222235678999999999999
Q ss_pred hcccCCCCHHHHHc
Q psy48 1042 VKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1042 ~dP~kRPSa~eIL~ 1055 (1098)
.+|++||++.++++
T Consensus 234 ~~p~~Rp~~~ell~ 247 (251)
T cd05041 234 YDPENRPSFSEIYN 247 (251)
T ss_pred cChhhCcCHHHHHH
Confidence 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=291.38 Aligned_cols=235 Identities=22% Similarity=0.320 Sum_probs=198.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...+++...+|.|.+|.||.+... ++..||+|.+.... .....+.+|+.+++.++|+||+++++++...+..++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 346788899999999999999864 56779999986532 23567899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 891 EKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
||+.+++|..++... ...+++..+..++.||+.||+|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~---~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL---MCKIADFGLARVIEDNE 157 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC---cEEECCCccceecCCCc
Confidence 999999998887643 35688899999999999999999999999999999999999988 89999999986542
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
..++|||.+.+..++.++||||||+++|+|++ |..||.... +....+.. ..+......++.++.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 234 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR---GYRMPRMENCPDELY 234 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHH
Confidence 13689999998889999999999999999998 999997643 22222222 222223356889999
Q ss_pred HHHHHhhhhcccCCCCHHHHHc
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+++.+||..+|++||+++++++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=289.90 Aligned_cols=232 Identities=37% Similarity=0.577 Sum_probs=199.9
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchH
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDML 898 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL 898 (1098)
+|.|.++.+|.+.+..+++.||+|++++..... .....+.+|+.+++.++|+||+++++.+..++.+++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 578999999999999999999999997754332 3456889999999999999999999999999999999999999999
Q ss_pred HHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----------
Q psy48 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----------- 967 (1098)
Q Consensus 899 ~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----------- 967 (1098)
..++... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG---HIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC---cEEEeecCcceecccCCCcccCCcCC
Confidence 8888643 4689999999999999999999999999999999999999988 899999999865432
Q ss_pred -CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcc
Q psy48 968 -KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQ 1044 (1098)
Q Consensus 968 -~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP 1044 (1098)
.++|||.+.+..++.++|+||||+++|+|++|..||...+. ..+.+.. ........++.++.++|.+||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----DPLRFPEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc----CCCCCCCCCCHHHHHHHHHHhcCCH
Confidence 35799999988899999999999999999999999976542 2222222 2222334568999999999999999
Q ss_pred cCCCCH---HHHHcCCCc
Q psy48 1045 RKRLSV---DKSLAHPWL 1059 (1098)
Q Consensus 1045 ~kRPSa---~eIL~HpfF 1059 (1098)
++||++ .++++||||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=290.90 Aligned_cols=236 Identities=20% Similarity=0.276 Sum_probs=198.0
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..+.+...+|.|.+|.||.+.+. +++.||||.++.... ....+.+|+.++++++|+||+++++++...+..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 45788899999999999999865 456899999975432 34668899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC---
Q psy48 892 KLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE--- 967 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~--- 967 (1098)
|+.+++|..++.... ..+++..+..++.|++.||.+||+.||+||||||+||+++.++ .++|+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~---~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN---ICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC---CEEECCcceEEEccCCcc
Confidence 999999988886543 4689999999999999999999999999999999999999988 899999999864321
Q ss_pred ----------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 968 ----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 968 ----------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
.++|||.+.+..++.++|+||||+++|||++ |+.||.+...... +..............++..+.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-LQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCcCCHHHHHHH
Confidence 3679999999999999999999999999999 9999976543211 111111222222346789999999
Q ss_pred HHhhhhcccCCCCHHHHHc
Q psy48 1037 NNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.+||+.+|++||++.++++
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=306.07 Aligned_cols=242 Identities=27% Similarity=0.405 Sum_probs=197.2
Q ss_pred eeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHH------------HHHHHHHHHHHhccCCCCceeeeeeeecC
Q psy48 816 YNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQ------------EAQLKNEVAILQNLCHPGVVNLERMFETP 883 (1098)
Q Consensus 816 ~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~------------~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~ 883 (1098)
....||.|.+|.||.+.+..+++.||||+++........ ...+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 467799999999999999999999999999764322210 12477899999999999999999999999
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
+..++||||+.+ +|..++. ....+++..+..++.||+.||+|||+.||+||||+|+||+++.++ .++|+|||++.
T Consensus 93 ~~~~lv~e~~~~-~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~---~~kl~dfg~~~ 167 (335)
T PTZ00024 93 DFINLVMDIMAS-DLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG---ICKIADFGLAR 167 (335)
T ss_pred CcEEEEEecccc-CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC---CEEECCcccee
Confidence 999999999986 5556664 345689999999999999999999999999999999999999988 89999999986
Q ss_pred ccC--------------------------CCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH--HH
Q psy48 964 IIG--------------------------EKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ--IQ 1014 (1098)
Q Consensus 964 ~~~--------------------------~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~--i~ 1014 (1098)
..+ ..++|||.+.+. .++.++|+||||+++|+|++|..||...++.... +.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 544 135799998764 4799999999999999999999999866443221 11
Q ss_pred HhhccCCC------------------------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1015 NAAFMYPP------------------------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1015 ~~~~~~p~------------------------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
......+. ......+.++.++|.+||+.+|++||++++++.||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 11000000 0012457889999999999999999999999999999974
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=294.01 Aligned_cols=237 Identities=20% Similarity=0.273 Sum_probs=198.7
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCce----eEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRG----VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~----VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
...+.+...||.|++|.||.+.+..+++. ||+|+++... .......+.+|+.++..+.|+||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 34567788999999999999998877774 8999986532 344457788999999999999999999998754 57
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
+++|||+++++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~---~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN---HVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC---cEEECCCCceeecc
Confidence 899999999999988876667799999999999999999999999999999999999999888 89999999986432
Q ss_pred --------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCc
Q psy48 967 --------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDIS 1029 (1098)
Q Consensus 967 --------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is 1029 (1098)
..++|||.+.+..++.++||||||+++|||++ |..||.... .....+... .....+..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~ 237 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG---ERLPQPPICT 237 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---CcCCCCccCC
Confidence 23679999999999999999999999999998 999997543 232322221 1222235688
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.++.+++.+||..||++||++.++++
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=298.37 Aligned_cols=246 Identities=23% Similarity=0.370 Sum_probs=198.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LV 889 (1098)
...+.+...+|.|.++.+|.+.+..+++.||||++++.... .....+.+|+.++... .|+||+++++++.+...+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 45577889999999999999999999999999999764332 2345566677766666 599999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
|||+++ ++..++......+++..+..++.||+.||+|||+ .||+||||+|+||+++.++ .++|+|||++....
T Consensus 93 ~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~---~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG---NVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC---CEEECccccchhccCC
Confidence 999976 4555555445679999999999999999999997 6999999999999999888 89999999986432
Q ss_pred ---------CCCCChhhhccCC----CCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc-CCC-CCCCcCcHH
Q psy48 967 ---------EKSFPPEVLRNKG----YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM-YPP-RPWRDISSD 1031 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~----ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~-~p~-~~~~~is~e 1031 (1098)
..++|||.+.+.. ++.++||||||+++|+|++|..||.......+.+...... .+. .....++.+
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence 2457999997654 8899999999999999999999997643322222221111 111 111247899
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+.+|+.+||..||++||++.++++|+||+.
T Consensus 249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 999999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=297.00 Aligned_cols=239 Identities=21% Similarity=0.323 Sum_probs=200.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCC-----ceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSG-----RGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPG 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg-----~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~ 884 (1098)
...|.....+|.|.+|.||.+.+...+ ..||+|+++... .......+.+|+.+++.+ +|+||+++++++...+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 346778889999999999999887543 789999997543 234456788999999999 7999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhc---------------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy48 885 RIFVVMEKLQGDMLEMILSSE---------------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~---------------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g 949 (1098)
.+++||||+.+++|..++... ...+++..++.++.||+.||+|||+.||+||||||+||+++.++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence 999999999999998888632 34688999999999999999999999999999999999999888
Q ss_pred CCCcEEEeecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHH
Q psy48 950 ELPQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQ 1012 (1098)
Q Consensus 950 ~~~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~ 1012 (1098)
.++|+|||+++... ..|+|||++.+..++.++|||||||++|||++ |..||.... +..+.
T Consensus 170 ---~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 170 ---VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred ---eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 89999999986432 23679999999999999999999999999997 999997653 23232
Q ss_pred HHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1013 IQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1013 i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.. ......+..++.++.+|+.+||..||++|||+.+++++
T Consensus 247 ~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKE---GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHc---CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 222 22222334678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=296.12 Aligned_cols=238 Identities=22% Similarity=0.292 Sum_probs=196.8
Q ss_pred hheeeeeeeeeeeeeceEEEEee-----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHR-----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k-----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
..+.+...+|.|++|.+|.+.+. .++..+|+|.++... ......+.+|+.+++.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 45777889999999999999864 345679999986432 33446789999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC
Q psy48 887 FVVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~ 951 (1098)
++||||+++++|..++.... +.+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~-- 160 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL-- 160 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--
Confidence 99999999999999886432 3478999999999999999999999999999999999999988
Q ss_pred CcEEEeecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHh
Q psy48 952 PQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNA 1016 (1098)
Q Consensus 952 ~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~ 1016 (1098)
.++|+|||++.... ..++|||.+.+..++.++||||||+++|||++ |..||....... .+...
T Consensus 161 -~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~ 238 (291)
T cd05094 161 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VIECI 238 (291)
T ss_pred -cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH
Confidence 89999999986431 23689999999999999999999999999998 999987543221 12212
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1017 AFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1017 ~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
...........++.++.+++.+||+.||++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 222222223457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=305.78 Aligned_cols=244 Identities=28% Similarity=0.477 Sum_probs=197.9
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC------c
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG------R 885 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~------~ 885 (1098)
..|.....||.|.+|.||.+.+..+++.||||++++..........+.+|+.+++.++|+||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 4677889999999999999999999999999999765433334466889999999999999999999986543 4
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+++||||+.. +|..+. ...+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||+++..
T Consensus 95 ~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~---~~kL~dfg~~~~~ 167 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC---ELKILDFGLARHA 167 (342)
T ss_pred EEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEeeCCCCcCC
Confidence 6999999975 454443 23689999999999999999999999999999999999999988 8999999998753
Q ss_pred C---------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH--HHHh-----------------
Q psy48 966 G---------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ--IQNA----------------- 1016 (1098)
Q Consensus 966 ~---------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~--i~~~----------------- 1016 (1098)
. ..++|||++.+ ..++.++|||||||++|||++|+.||.+....... +...
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 2 23579999876 56899999999999999999999999865422111 1110
Q ss_pred ---hc---cCCCCC----CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1017 ---AF---MYPPRP----WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1017 ---~~---~~p~~~----~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.. ..+... +..++.++.+||.+||+.||++||++++++.||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00 001100 12467889999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=295.12 Aligned_cols=238 Identities=20% Similarity=0.275 Sum_probs=194.3
Q ss_pred heeeeeeeeeeeeeceEEEE----eecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec--CCcE
Q psy48 813 FMTYNVALCIAVVAGAACGV----HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET--PGRI 886 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~----~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~--~~~l 886 (1098)
.+++...+|.|++|.||.+. +..+++.||||.++.. .......+.+|+++++.++||||+++++++.. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 56778899999999999987 4567889999998653 24445788999999999999999999998643 3568
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
++||||+++++|..++......+++..+..++.||+.||+|||++||+||||||+||+++.++ .++|+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~---~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN---RVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC---eEEECCCccccccc
Confidence 999999999999999876566789999999999999999999999999999999999999988 89999999987532
Q ss_pred C---------------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH-HHH-------------H-HHh
Q psy48 967 E---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI-NEQ-------------I-QNA 1016 (1098)
Q Consensus 967 ~---------------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~-~~~-------------i-~~~ 1016 (1098)
. .++|||.+.+..++.++||||||+++|||++|..|+...... ... + ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 1 257999999999999999999999999999987765432111 100 0 001
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1017 AFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1017 ~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
...........++.++.+|+.+||..+|++|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111111223467899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=332.46 Aligned_cols=238 Identities=23% Similarity=0.333 Sum_probs=205.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCce-----eEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRG-----VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~-----VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
-...+++..||.|.||.||.+........ ||||.+++. .+.+....|.+|..+|..++|||||+++|++.+...
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 34567789999999999999987655443 899988653 345667899999999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhc------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeec
Q psy48 886 IFVVMEKLQGDMLEMILSSE------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DF 959 (1098)
.+|++|||.||+|..+++.. ...++..+.+.++.+||+|+.||+++++|||||..+|+||+... .+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r---~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR---VVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC---cEEEccc
Confidence 99999999999999999876 55689999999999999999999999999999999999999887 8999999
Q ss_pred Cccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCC
Q psy48 960 GFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPP 1022 (1098)
Q Consensus 960 Gla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~ 1022 (1098)
|||+.+ .-+|||||.+....|+.++|||||||+|||++| |..||.+.. ++...+...- ..
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---RL 923 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---RL 923 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---cc
Confidence 999832 234689999999999999999999999999998 889998653 3333233332 22
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.++..+++.+.++|..||+.+|++||++..|++
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 334679999999999999999999999999987
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=294.70 Aligned_cols=237 Identities=20% Similarity=0.290 Sum_probs=197.0
Q ss_pred heeeeeeeeeeeeeceEEEEe-----ecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 813 FMTYNVALCIAVVAGAACGVH-----RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~-----k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
.+.+...+|.|++|.||.+.. ..++..+|+|.++.. .......+.+|+++++.++|+||+++++++...+..+
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 456678899999999999864 345678999998653 2445578999999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhcc--------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCc
Q psy48 888 VVMEKLQGDMLEMILSSEK--------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~--------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~ 953 (1098)
+||||+.+++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~---~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL---V 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC---C
Confidence 9999999999988886432 2478999999999999999999999999999999999999887 8
Q ss_pred EEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhc
Q psy48 954 VKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAF 1018 (1098)
Q Consensus 954 vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~ 1018 (1098)
++|+|||++... +..|+|||.+.+..++.++|||||||++|||++ |..||....... .+.....
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-AIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-HHHHHHc
Confidence 999999998633 124689999999999999999999999999998 999996543321 1221222
Q ss_pred cCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1019 MYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1019 ~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
..+......+++.+.+++.+||..||++||++.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2222334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=289.57 Aligned_cols=230 Identities=23% Similarity=0.320 Sum_probs=191.7
Q ss_pred eeeeeeeeceEEEEeecCC---ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccC
Q psy48 819 ALCIAVVAGAACGVHRKSG---RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg---~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
.||.|.+|.||.+....++ ..||+|.+...... .....+.+|+.+++.+.|+||+++++++.. +..++||||+.+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 5789999999999876655 78999999765433 455788999999999999999999998764 468999999999
Q ss_pred chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---------
Q psy48 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--------- 966 (1098)
Q Consensus 896 gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--------- 966 (1098)
++|..++... ..+++..+..++.|++.||+|||..|++|+||||+|||++.++ .++|+|||+++...
T Consensus 80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~---~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH---QAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC---cEEeccccccceeecCCcccccc
Confidence 9998888643 3789999999999999999999999999999999999999988 89999999986331
Q ss_pred ------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 967 ------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 967 ------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
..++|||.+.+..++.++||||||+++|+|++ |..||...... +.........+......++..+.++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLESGERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 13679999999999999999999999999998 99999764322 11111112222233456889999999999
Q ss_pred hhhcccCCCCHHHHHc
Q psy48 1040 LQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~ 1055 (1098)
|..||++||++.++++
T Consensus 235 l~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 235 WKYRPEDRPTFSELES 250 (257)
T ss_pred hcCChhhCcCHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=298.21 Aligned_cols=236 Identities=26% Similarity=0.474 Sum_probs=199.8
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCch
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDM 897 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggs 897 (1098)
..+|.|.+|.+|.+..+.+++.||||.+.... ......+.+|+.+++.++|+||+++++++...+..++||||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 45789999999999999999999999985422 3345678999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----------
Q psy48 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----------- 966 (1098)
Q Consensus 898 L~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----------- 966 (1098)
|..++. .+.+++..+..++.|++.||+|||+.||+||||+|+||+++.++ .++|+|||++....
T Consensus 104 L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 104 LTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG---RVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---CEEEcccccceeccccccccccccc
Confidence 988764 34689999999999999999999999999999999999999988 89999999875331
Q ss_pred -CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCC--CCCCcCcHHHHHHHHHhhhhc
Q psy48 967 -EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPP--RPWRDISSDAIDLINNLLQVK 1043 (1098)
Q Consensus 967 -~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~--~~~~~is~el~~LL~~cL~~d 1043 (1098)
..++|||.+.+..++.++|+||||+++|+|++|..||........ +.......+. .....++.++.+++.+||..|
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence 225799999888899999999999999999999999986543221 1111111111 123457899999999999999
Q ss_pred ccCCCCHHHHHcCCCcCC
Q psy48 1044 QRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1044 P~kRPSa~eIL~HpfFk~ 1061 (1098)
|.+||++.+++.||||..
T Consensus 258 P~~R~~~~~ll~~~~~~~ 275 (292)
T cd06657 258 PAQRATAAELLKHPFLAK 275 (292)
T ss_pred cccCcCHHHHhcChHHhc
Confidence 999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-31 Score=288.91 Aligned_cols=235 Identities=22% Similarity=0.302 Sum_probs=195.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeee-ecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF-ETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f-~~~~~l~LV 889 (1098)
...+.+...+|.|+++.+|.+.. .+..||+|.++.. .....+.+|+.+++.++|+|++++++++ ...+..++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 34677889999999999999865 4788999998643 2346788999999999999999999875 556779999
Q ss_pred EEeccCchHHHHHhhccC-ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-
Q psy48 890 MEKLQGDMLEMILSSEKG-RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE- 967 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~-~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~- 967 (1098)
|||+++++|..++..... .+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~---~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN---VAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC---cEEecCCccceecccc
Confidence 999999999888865443 488999999999999999999999999999999999999988 899999999875422
Q ss_pred --------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 968 --------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 968 --------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
.++|||++.+..++.++||||||+++|+|++ |..||..... .+.........+......+++.+.+++.+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05082 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYKMDAPDGCPPVVYDVMKQ 234 (256)
T ss_pred CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 3689999999999999999999999999997 9999975421 12222222223333445688999999999
Q ss_pred hhhhcccCCCCHHHHHc
Q psy48 1039 LLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1039 cL~~dP~kRPSa~eIL~ 1055 (1098)
||..+|++|||+.++++
T Consensus 235 ~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 235 CWHLDAATRPSFLQLRE 251 (256)
T ss_pred HhcCChhhCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=305.74 Aligned_cols=246 Identities=28% Similarity=0.459 Sum_probs=201.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc-----
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR----- 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~----- 885 (1098)
...|.....||.|.+|.+|.+.+..+++.||||++............+.+|+.+++.++|+||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 356888999999999999999999999999999987654334445678889999999999999999998866554
Q ss_pred -EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 886 -IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 886 -l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
.++|+||++ ++|..++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++..
T Consensus 94 ~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~---~~kL~dfg~~~~ 167 (343)
T cd07851 94 DVYLVTHLMG-ADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC---ELKILDFGLARH 167 (343)
T ss_pred cEEEEEecCC-CCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC---CEEEcccccccc
Confidence 899999995 567777653 4699999999999999999999999999999999999999988 899999999875
Q ss_pred cC---------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--HHHHhhccC------------
Q psy48 965 IG---------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQNAAFMY------------ 1020 (1098)
Q Consensus 965 ~~---------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~i~~~~~~~------------ 1020 (1098)
.. ..++|||.+.+ ..++.++||||||+++|+|++|+.||........ .+.......
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 168 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 42 23579999865 4688999999999999999999999976543221 111110000
Q ss_pred --------CC-------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1021 --------PP-------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1021 --------p~-------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+. ..+..++.++.++|.+||+.||++|||+.+|++||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 00 0012468899999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=329.93 Aligned_cols=149 Identities=26% Similarity=0.394 Sum_probs=133.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
+..|.+...||.|.||.||.+.+..+++.||||++++... .......+..|+.++..++|+||++++.++...+.+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 4568889999999999999999999999999999976433 333457789999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
|||+.|++|..++.. .+.+++..++.|+.||+.||.|||.+||+||||||+|||++.++ .++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g---~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG---HIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC---CEEEEeCCCCc
Confidence 999999999888763 45689999999999999999999999999999999999999888 89999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=297.92 Aligned_cols=240 Identities=20% Similarity=0.271 Sum_probs=199.0
Q ss_pred hheeeeeeeeeeeeeceEEEEeec-------CCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecC
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRK-------SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETP 883 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~-------tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~ 883 (1098)
..|.+...||.|+||.||.+.+.. +...||+|+++... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 568899999999999999998653 23569999997542 234456788899999999 799999999999999
Q ss_pred CcEEEEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~ 948 (1098)
+.+++||||+.+++|..++.... ..+++.+++.++.||+.||+|||+.||+||||||+||+++.+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 99999999999999998886432 247889999999999999999999999999999999999988
Q ss_pred CCCCcEEEeecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHH
Q psy48 949 SELPQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQI 1013 (1098)
Q Consensus 949 g~~~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i 1013 (1098)
+ .++|+|||+++... ..++|||++.+..++.++|||||||++|||++ |..||..... .+..
T Consensus 177 ~---~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-~~~~ 252 (307)
T cd05098 177 N---VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELF 252 (307)
T ss_pred C---cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHH
Confidence 8 89999999986431 24689999999999999999999999999998 8889876432 1222
Q ss_pred HHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1014 QNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1014 ~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
...........+..++.++.+++.+||..+|++||++.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 253 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 2222222223345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=292.03 Aligned_cols=232 Identities=22% Similarity=0.307 Sum_probs=191.4
Q ss_pred eeeeeeeeceEEEEeecCCce--eEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccC
Q psy48 819 ALCIAVVAGAACGVHRKSGRG--VAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~--VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
.+|.|++|.||.+....++.. +|+|.++.. ........+.+|+.++.++ +||||+++++++...+.+++||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 578999999999999888764 688887642 2334456788999999999 799999999999999999999999999
Q ss_pred chHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 896 DMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 896 gsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
++|..++.... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++ .+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~---~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY---VAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC---eEEECCCC
Confidence 99988886432 2478899999999999999999999999999999999999988 89999999
Q ss_pred ccccc-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcC
Q psy48 961 FARII-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDI 1028 (1098)
Q Consensus 961 la~~~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~i 1028 (1098)
++... ...|+|||++.+..++.++||||||+++|||++ |..||...... .................+
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKLPQGYRLEKPLNC 236 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-HHHHHHhCCCCCCCCCcC
Confidence 98421 123789999999999999999999999999997 99999754321 112222222222233457
Q ss_pred cHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1029 SSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.++.+++.+||..||.+||++.++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 237 DDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-31 Score=286.71 Aligned_cols=235 Identities=25% Similarity=0.360 Sum_probs=198.5
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..+++...+|.|++|.||.+.+. .+..+|+|+++..... ...+.+|+++++.++|||++++++++......++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 35778899999999999999775 4778999998754332 3568889999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
|+.+++|..++....+.+++..++.++.|++.||++||+.||+|+||||+||+++.++ .++|+|||++....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~---~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ---VVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC---eEEECCCcceeecccCccc
Confidence 9999999988876667789999999999999999999999999999999999999887 89999999986431
Q ss_pred --------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 --------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 --------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..++|||.+.+..++.++||||||+++|||++ |..||.... ...+.+... .........+.++.+|
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l 233 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG---FRLYKPRLASQSVYEL 233 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC---CCCCCCCCCCHHHHHH
Confidence 13579999998899999999999999999998 999997543 233333222 1111223468999999
Q ss_pred HHHhhhhcccCCCCHHHHHcC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.+||..+|++||++.++++.
T Consensus 234 ~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 234 MQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHcccChhhCCCHHHHHHh
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=299.08 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=202.0
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
|.....+|.|.+|.+|.+.+..+++.||||.+..... .......+.+|+.+++.++|+|++++++++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 3334568999999999999999999999999875432 233446788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG------ 966 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~------ 966 (1098)
+.|. +..++......+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++....
T Consensus 97 ~~~~-l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~kl~dfg~~~~~~~~~~~~ 172 (308)
T cd06634 97 CLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG---LVKLGDFGSASIMAPANXFV 172 (308)
T ss_pred cCCC-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC---cEEECCcccceeecCccccc
Confidence 9864 5455554556789999999999999999999999999999999999999988 89999999987543
Q ss_pred --CCCCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhh
Q psy48 967 --EKSFPPEVLR---NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041 (1098)
Q Consensus 967 --~~~~APEvl~---~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~ 1041 (1098)
..++|||.+. ...++.++|||||||++|+|++|..||.................+......++..+.++|.+||.
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 252 (308)
T cd06634 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252 (308)
T ss_pred CCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhh
Confidence 3467999985 35688899999999999999999999976543322222222222222233578899999999999
Q ss_pred hcccCCCCHHHHHcCCCcCCCCC
Q psy48 1042 VKQRKRLSVDKSLAHPWLQDPAT 1064 (1098)
Q Consensus 1042 ~dP~kRPSa~eIL~HpfFk~~~~ 1064 (1098)
.+|++||++.+++.|||+.....
T Consensus 253 ~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 253 KIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred CCcccCCCHHHHhhCccccccCC
Confidence 99999999999999999987433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-31 Score=287.32 Aligned_cols=237 Identities=21% Similarity=0.279 Sum_probs=199.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...+.+...+|.|.+|.||.+... .+..||||.+..... ....+.+|+.+++.++|+||+++++++......++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 456788899999999999999865 557899999975432 3467889999999999999999999999989999999
Q ss_pred EeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 891 EKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
||+.+++|..++.... ..+++..+..++.+|+.||.|||+.||+|+||||+||+++.++ .++|+|||++....
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~---~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL---VCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC---CEEECccccceeccchh
Confidence 9999999988886543 4689999999999999999999999999999999999999998 89999999987543
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..++|||.+.+..++.++|+||||+++|+|++ |+.||.+.... ..+......+........+.++.++
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 24679999999999999999999999999998 99999765322 2222222222222234578999999
Q ss_pred HHHhhhhcccCCCCHHHHHc
Q psy48 1036 INNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.+||..+|++||+++++++
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=303.90 Aligned_cols=243 Identities=26% Similarity=0.415 Sum_probs=196.3
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--------
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP-------- 883 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~-------- 883 (1098)
.+|.....||.|++|.||.+.+..+++.||+|++..... .....+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 578889999999999999999999999999999866432 3456788999999999999999999877554
Q ss_pred ------CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEe
Q psy48 884 ------GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957 (1098)
Q Consensus 884 ------~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~ 957 (1098)
..+++||||+++ +|..++. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++. .++|+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~--~~kl~ 157 (342)
T cd07854 83 GSLTELNSVYIVQEYMET-DLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL--VLKIG 157 (342)
T ss_pred ccccccceEEEEeecccc-cHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc--eEEEC
Confidence 357999999985 6666654 346899999999999999999999999999999999999985542 68999
Q ss_pred ecCcccccC---------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhh----
Q psy48 958 DFGFARIIG---------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAA---- 1017 (1098)
Q Consensus 958 DFGla~~~~---------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~---- 1017 (1098)
|||++.... ..++|||.+.+ ..++.++|||||||++|+|++|+.||....+.........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999986431 23579998754 6688999999999999999999999976533222111100
Q ss_pred --------------------ccCCCC----CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1018 --------------------FMYPPR----PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1018 --------------------~~~p~~----~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
...+.. ....++.++.+||.+||..||++||++.+++.||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 000000 01247789999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=294.07 Aligned_cols=235 Identities=21% Similarity=0.257 Sum_probs=191.0
Q ss_pred eeeeeeeeeeeeceEEEE----eecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcEEE
Q psy48 815 TYNVALCIAVVAGAACGV----HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRIFV 888 (1098)
Q Consensus 815 ~~~~~Lg~G~~g~v~~a~----~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l~L 888 (1098)
+....||.|++|.||.+. ...++..||+|+++... .......+.+|+++|+.++||||+++++++... ..+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 778899999999997754 44678899999997542 233457788999999999999999999987653 45899
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE- 967 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~- 967 (1098)
||||+++++|..++.. ..+++.+++.++.|++.||.|||++||+||||||+|||++.++ .++|+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC---cEEEeecccccccCCc
Confidence 9999999999888754 3599999999999999999999999999999999999999887 899999999875421
Q ss_pred --------------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHH--------------Hhhcc
Q psy48 968 --------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ--------------NAAFM 1019 (1098)
Q Consensus 968 --------------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~--------------~~~~~ 1019 (1098)
.++|||.+.+..++.++||||||+++|||++|..||........... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 25799999988899999999999999999999999864321111000 00000
Q ss_pred CCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1020 YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1020 ~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
........++.++.+++.+||+.||++||+++++++
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111113457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-33 Score=343.07 Aligned_cols=260 Identities=24% Similarity=0.318 Sum_probs=222.9
Q ss_pred HHHHHHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec
Q psy48 803 ITMSFLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET 882 (1098)
Q Consensus 803 ~~~~~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~ 882 (1098)
...+.-.+.-+..++..+|.|.||.||.++...+|+..|+|-++-..........+.+|+.+|..++|||+|+++++=..
T Consensus 1226 la~~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1226 LASSLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred HHHHhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec
Confidence 33445555666777889999999999999999999999999997654443344678999999999999999999999999
Q ss_pred CCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 883 PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 883 ~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
.+..+|.||||.||+|..++. ..+..++.....|..|++.|++|||++|||||||||+||+++.+| .+|++|||.|
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g---~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG---LIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC---cEEeecccce
Confidence 999999999999999998875 455688999999999999999999999999999999999999999 8999999998
Q ss_pred ccc----------------CCCCCChhhhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCC
Q psy48 963 RII----------------GEKSFPPEVLRN---KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPR 1023 (1098)
Q Consensus 963 ~~~----------------~~~~~APEvl~~---~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~ 1023 (1098)
..+ ++.|||||++.+ +.-..+.|||||||+++||+||+.||..-+.-.+.+........+.
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC
Confidence 644 344689999975 4467899999999999999999999987655445555555455555
Q ss_pred CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcc
Q psy48 1024 PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWS 1066 (1098)
Q Consensus 1024 ~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~ 1066 (1098)
.+..+|.+..+||..||+.||.+|+++.|+++|.|-+...+..
T Consensus 1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence 6677999999999999999999999999999999988755443
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=295.38 Aligned_cols=240 Identities=23% Similarity=0.288 Sum_probs=195.2
Q ss_pred heeeeeeeeeeeeeceEEEEe----ecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcE
Q psy48 813 FMTYNVALCIAVVAGAACGVH----RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRI 886 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~----k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l 886 (1098)
.|+....+|.|++|.||.+.. +.++..||+|.++... .......+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 456677899999999999873 5678899999986542 234456799999999999999999999998775 568
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
++||||++|++|..++......+++..+..++.||+.||+|||++||+||||||+||+++.++ .++|+|||+++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~---~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH---QVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC---CEEECCCccccccc
Confidence 999999999999998865555689999999999999999999999999999999999999888 89999999986432
Q ss_pred C---------------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--------------hHHHHHHHhh
Q psy48 967 E---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--------------DINEQIQNAA 1017 (1098)
Q Consensus 967 ~---------------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--------------~~~~~i~~~~ 1017 (1098)
. .++|||.+.+..++.++||||||+++|||+++..|+.... .....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 1 2579999998899999999999999999999876653211 1111111111
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1018 FMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1018 ~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.......+..++.++.+|+.+||+.||++||++.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 111222345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=289.83 Aligned_cols=238 Identities=20% Similarity=0.252 Sum_probs=198.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCC-----ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSG-----RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg-----~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
...+.....+|.|++|.||.+..+... ..||+|.+.... .......+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 346778899999999999999886544 889999986432 23445678899999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhcc---------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEE
Q psy48 886 IFVVMEKLQGDMLEMILSSEK---------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKL 956 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~---------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL 956 (1098)
.++||||+++++|..++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~---~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL---TVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC---CEEE
Confidence 999999999999988886422 2467889999999999999999999999999999999999998 8999
Q ss_pred eecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhcc
Q psy48 957 CDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFM 1019 (1098)
Q Consensus 957 ~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~ 1019 (1098)
+|||+++... ..++|||.+.+..++.++||||||+++|||++ |..||.... ...+.+. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~~ 237 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI---DG 237 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh---cC
Confidence 9999986431 23679999998889999999999999999998 999997543 2222222 11
Q ss_pred CCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1020 YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1020 ~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
........++.++.+++.+||..+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 222223457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=289.88 Aligned_cols=242 Identities=22% Similarity=0.347 Sum_probs=201.4
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC---ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF---PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
+|.+...+|.|++|.+|.+.+..++..+++|+++.... .......+..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999999998888888888865332 233345677899999999999999999999999999999
Q ss_pred EEeccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 890 MEKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
|||+.+++|..++.. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++. + .++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~---~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N---LLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C---CEeecccCceeecC
Confidence 999999999887753 3456899999999999999999999999999999999999975 3 69999999886431
Q ss_pred ------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 967 ------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 967 ------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
..++|||.+.+..++.++|+||||+++|+|++|..||............. ....+.....++.++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNS 235 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHH
Confidence 23579999988889999999999999999999999997654332222221 12222223467899999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
+|.+||..||++||++.++++||||
T Consensus 236 li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 236 IMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=286.99 Aligned_cols=234 Identities=21% Similarity=0.328 Sum_probs=198.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...+.+...+|.|.+|.||.+... |+.||||.++... .....+.+|+.+++.++|+||+++++++...+..++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 345677889999999999999764 8899999997543 24578899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccC-ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 891 EKLQGDMLEMILSSEKG-RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~-~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
||+++++|..++..... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||+++...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~---~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL---VAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC---CEEEccccccccccccc
Confidence 99999999888865432 689999999999999999999999999999999999999988 89999999987542
Q ss_pred ------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 967 ------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 ------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
..++|||.+.+..++.++|+||||+++|+|++ |..||.... ++...+.. .+.......+++++.++|.
T Consensus 157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK---GYRMEAPEGCPPEVYKVMK 233 (256)
T ss_pred ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc---CCCCCCccCCCHHHHHHHH
Confidence 23579999998889999999999999999997 999997653 22222221 2222333457899999999
Q ss_pred HhhhhcccCCCCHHHHHc
Q psy48 1038 NLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~ 1055 (1098)
+||..+|++||++.++++
T Consensus 234 ~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 234 DCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 999999999999999886
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=330.39 Aligned_cols=240 Identities=23% Similarity=0.321 Sum_probs=198.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
++|.....||.|++|.||.+.+..+++.||||+++..... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5688889999999999999999999999999999764332 233467999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhc----------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 891 EKLQGDMLEMILSSE----------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~----------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
||++|++|..++... ...++...++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg---~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG---EVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC---CEEEEecC
Confidence 999999998887532 12355677889999999999999999999999999999999988 89999999
Q ss_pred ccccc------------------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH
Q psy48 961 FARII------------------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN 1010 (1098)
Q Consensus 961 la~~~------------------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~ 1010 (1098)
+++.. +..|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 98644 234689999999999999999999999999999999997643221
Q ss_pred HHHHHhhccCC--CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1011 EQIQNAAFMYP--PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1011 ~~i~~~~~~~p--~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.... .....+ ...+..+++.+.+++.+||+.||++|++..+.+.
T Consensus 239 i~~~-~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 239 ISYR-DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhh-hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 111111 1223568899999999999999999987655443
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=286.04 Aligned_cols=234 Identities=23% Similarity=0.343 Sum_probs=198.7
Q ss_pred eeeeeeeeeeeeceEEEEeecCC----ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 815 TYNVALCIAVVAGAACGVHRKSG----RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 815 ~~~~~Lg~G~~g~v~~a~~k~tg----~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
++...+|.|.+|.+|.+.+...+ ..||+|+++... .......+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 34578899999999999998876 899999996543 2235678999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCc-cchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 891 EKLQGDMLEMILSSEKGR-LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~-lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
||+.+++|..++...... +++.++..++.||+.||++||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~---~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC---eEEEcccCCceeccccc
Confidence 999999999888755444 99999999999999999999999999999999999999998 89999999986432
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
..++|||.+.+..++.++|+||||+++|+|++ |..||.... ...+.+... ........++.++.
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 234 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG---YRLPKPENCPPEIY 234 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---CCCCCCCcCCHHHH
Confidence 24679999988889999999999999999998 788887542 222333222 22223345889999
Q ss_pred HHHHHhhhhcccCCCCHHHHHc
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+++.+||..||++|||+.++++
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 235 KLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=304.58 Aligned_cols=239 Identities=24% Similarity=0.335 Sum_probs=195.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEe-----ecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecC-
Q psy48 811 LVFMTYNVALCIAVVAGAACGVH-----RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETP- 883 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~-----k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~- 883 (1098)
..+|.+...||.|+||.||.+.+ ..+++.||||+++... .......+.+|+.+|..+ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 35688899999999999999984 4567899999997543 233456788999999999 689999999987654
Q ss_pred CcEEEEEEeccCchHHHHHhhcc---------------------------------------------------------
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEK--------------------------------------------------------- 906 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~--------------------------------------------------------- 906 (1098)
..+++||||+++++|..++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56899999999999998876432
Q ss_pred ---------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----------
Q psy48 907 ---------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----------- 966 (1098)
Q Consensus 907 ---------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----------- 966 (1098)
..+++.++..++.||+.||+|||++||+||||||+|||++.++ .++|+|||++....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC---cEEEEecccccccccCcchhhcCCC
Confidence 2367788899999999999999999999999999999999888 89999999986431
Q ss_pred ---CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh---hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 967 ---EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE---DINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 967 ---~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~---~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
..++|||.+.+..++.++||||||+++|+|++ |..||.... .....+.... .......+++++.+++.+|
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---RMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC---CCCCCCCCCHHHHHHHHHH
Confidence 23679999999999999999999999999996 999997543 2222222221 1112234788999999999
Q ss_pred hhhcccCCCCHHHHHcC
Q psy48 1040 LQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~H 1056 (1098)
|..||++||++.+|++|
T Consensus 319 l~~~p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=293.12 Aligned_cols=237 Identities=22% Similarity=0.263 Sum_probs=195.0
Q ss_pred heeeeeeeeeeeeeceEEEEeec-----CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRK-----SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~-----tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
.+.+...||.|++|.||.+.+.. .+..||||+++... .......+.+|+.++..++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34556678999999999998754 35789999997543 2334467889999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhc---------------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCC
Q psy48 888 VVMEKLQGDMLEMILSSE---------------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~---------------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~ 952 (1098)
+++||+.+++|..++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~--- 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL--- 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC---
Confidence 999999999998887522 23478888999999999999999999999999999999999887
Q ss_pred cEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHH
Q psy48 953 QVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQN 1015 (1098)
Q Consensus 953 ~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~ 1015 (1098)
.+||+|||+++.. ...|+|||.+.+..++.++||||||+++|||++ |..||.+... ..+.+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 7999999987643 124689999998889999999999999999998 8889876532 2233322
Q ss_pred hhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1016 AAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1016 ~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.. .......++.++.+++.+||+.+|++||++.+|+..
T Consensus 242 ~~---~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 242 RQ---VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CC---cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 22 112235688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=291.06 Aligned_cols=232 Identities=18% Similarity=0.234 Sum_probs=186.3
Q ss_pred eeeeeeeeceEEEEeecC------------CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 819 ALCIAVVAGAACGVHRKS------------GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~t------------g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
.||.|.+|.||.+..... ...||+|++.... ......+.+|+.+++.++||||+++++++..+...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 578999999999975322 3358888875432 23345788899999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC----CcEEEeecCcc
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL----PQVKLCDFGFA 962 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~----~~vKL~DFGla 962 (1098)
++||||+++++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++.. ..++++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 99999999999988887666779999999999999999999999999999999999999866521 13899999998
Q ss_pred ccc--------CCCCCChhhhc-cCCCCchhHHHHHHHHHHHHH-cCCCCCCCChhHH-HHHHHhhccCCCCCCCcCcHH
Q psy48 963 RII--------GEKSFPPEVLR-NKGYNRSLDMWSVGVIVYVSL-SGTFPFNEDEDIN-EQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 963 ~~~--------~~~~~APEvl~-~~~ys~~sDVwSLGvlLyELl-tG~~Pf~~~~~~~-~~i~~~~~~~p~~~~~~is~e 1031 (1098)
... +..|+|||.+. +..++.++|||||||++|||+ +|..||....... ........ . .....+++
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~--~--~~~~~~~~ 235 (262)
T cd05077 160 ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC--M--LVTPSCKE 235 (262)
T ss_pred ccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCc--c--CCCCChHH
Confidence 643 23478999987 567999999999999999998 5888887543221 11111111 1 11235678
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.+||.+||+.||++||++.+|+++
T Consensus 236 ~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 236 LADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=287.96 Aligned_cols=236 Identities=21% Similarity=0.259 Sum_probs=194.7
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
.+.|++...+|.|.+|.||.+.+..+. .||+|++++... ....+.+|+++++.++|+||+++++.+.. ...++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 467899999999999999999876654 599999976432 23568899999999999999999998754 5689999
Q ss_pred EeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 891 EKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
||+.+++|..++... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~---~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL---VCKVADFGLARLIEDNE 156 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC---cEEeccCCceeeccccc
Confidence 999999998888643 34588999999999999999999999999999999999999988 89999999986431
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..|+|||.+.+..++.++||||||+++|+|++ |..||....... .+.......+......++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMPCPPECPESLHDL 235 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-HHHHHhcCCCCCCccccCHHHHHH
Confidence 13689999999999999999999999999999 888997653221 111111122222234688999999
Q ss_pred HHHhhhhcccCCCCHHHHHc
Q psy48 1036 INNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.+||+.||++||++.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=286.69 Aligned_cols=232 Identities=19% Similarity=0.246 Sum_probs=186.9
Q ss_pred eeeeeeeeceEEEEeec---CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeee-cCCcEEEEEEecc
Q psy48 819 ALCIAVVAGAACGVHRK---SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE-TPGRIFVVMEKLQ 894 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~---tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~-~~~~l~LVmEy~~ 894 (1098)
.||.|.+|.||.+.... .+..||||.+... ........+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 57899999999998654 3457999998542 22344578889999999999999999999765 4556899999999
Q ss_pred CchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--------
Q psy48 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-------- 966 (1098)
Q Consensus 895 ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-------- 966 (1098)
+++|..++......+++..+..++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+++...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~---~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF---TVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC---cEEECCccccccccCCcceeec
Confidence 9999999876556677888899999999999999999999999999999999988 89999999986431
Q ss_pred --------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcC-CCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 967 --------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSG-TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 --------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG-~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
..++|||.+.+..++.++||||||+++|||++| .+||...... +.........+......+++.+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-DITVYLLQGRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence 136799999988999999999999999999995 5566543322 222222111222223457899999999
Q ss_pred HhhhhcccCCCCHHHHHc
Q psy48 1038 NLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~ 1055 (1098)
+||..+|++||++.++++
T Consensus 237 ~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 237 SCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHcCCChhhCCCHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=289.12 Aligned_cols=237 Identities=21% Similarity=0.281 Sum_probs=200.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCc----eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGR----GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~----~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
...+.+...||.|++|.+|.+..+.+++ .||+|++++... ......+.+|+.+++.++|+||+++++++.+ ...
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 3566778899999999999999887765 589998865432 4455778999999999999999999999987 789
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
++||||+.+++|..++......+++..+..++.||+.||+|||++||+||||||+||+++.++ .++|+|||+++...
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~---~~kL~dfg~~~~~~ 160 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLD 160 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC---eEEECCCccccccc
Confidence 999999999999999887667799999999999999999999999999999999999999888 89999999986432
Q ss_pred --------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCc
Q psy48 967 --------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDIS 1029 (1098)
Q Consensus 967 --------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is 1029 (1098)
..|+|||.+.+..++.++|+||||+++|||++ |..||.... ++.+.+... .........+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~ 237 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG---ERLPQPPICT 237 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC---CCCCCCCCCC
Confidence 23689999998899999999999999999998 999998643 333333322 1112223477
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.++.+++.+||..||++||++.++++
T Consensus 238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 238 IDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 89999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=289.27 Aligned_cols=220 Identities=23% Similarity=0.321 Sum_probs=183.9
Q ss_pred eeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHH
Q psy48 823 AVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMIL 902 (1098)
Q Consensus 823 G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l 902 (1098)
|.++.||.+.+..+++.||+|++++.. .+.+|...+....||||+++++++...+..++||||++|++|..++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 889999999999999999999997642 2233444555567999999999999999999999999999998887
Q ss_pred hhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---------CCCCChh
Q psy48 903 SSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---------EKSFPPE 973 (1098)
Q Consensus 903 ~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---------~~~~APE 973 (1098)
.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++ .++|+|||++.... ..++|||
T Consensus 77 ~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~y~aPE 152 (237)
T cd05576 77 SK-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG---HIQLTYFSRWSEVEDSCDGEAVENMYCAPE 152 (237)
T ss_pred HH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC---CEEEecccchhccccccccCCcCccccCCc
Confidence 64 34689999999999999999999999999999999999999988 89999999875432 2368999
Q ss_pred hhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCH---
Q psy48 974 VLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV--- 1050 (1098)
Q Consensus 974 vl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa--- 1050 (1098)
.+.+..++.++|+||+|+++|||++|..|+......... .........+++.+.++|.+||+.||++||++
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT------HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc------ccccCCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 998888999999999999999999999887643211100 00111123478999999999999999999985
Q ss_pred --HHHHcCCCc
Q psy48 1051 --DKSLAHPWL 1059 (1098)
Q Consensus 1051 --~eIL~HpfF 1059 (1098)
+++++||||
T Consensus 227 ~~~~~~~h~~~ 237 (237)
T cd05576 227 GVEDIKSHPFF 237 (237)
T ss_pred chHHHHcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=292.30 Aligned_cols=232 Identities=21% Similarity=0.263 Sum_probs=186.5
Q ss_pred eeeeeeeeceEEEEeecC------------------------CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCce
Q psy48 819 ALCIAVVAGAACGVHRKS------------------------GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVV 874 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~t------------------------g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv 874 (1098)
.||.|+||.||.+....+ ...||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 589999999999875432 2358899886432 23346788899999999999999
Q ss_pred eeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCC----
Q psy48 875 NLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE---- 950 (1098)
Q Consensus 875 ~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~---- 950 (1098)
++++++......++||||+++++|..++....+.+++..+..++.||+.||+|||++||+||||||+|||++..+.
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 9999999999999999999999998888766678999999999999999999999999999999999999986432
Q ss_pred CCcEEEeecCccccc--------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHH-cCCCCCCCChhHH-HHHHHhhcc
Q psy48 951 LPQVKLCDFGFARII--------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSL-SGTFPFNEDEDIN-EQIQNAAFM 1019 (1098)
Q Consensus 951 ~~~vKL~DFGla~~~--------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELl-tG~~Pf~~~~~~~-~~i~~~~~~ 1019 (1098)
...++|+|||++... +..|+|||.+.+ ..++.++||||||+++|||+ +|..||....... .........
T Consensus 160 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 239 (274)
T cd05076 160 SPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHR 239 (274)
T ss_pred cceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccC
Confidence 124899999987532 345789998875 56899999999999999985 7999997643221 111111111
Q ss_pred CCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1020 YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1020 ~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.+ ...++++.++|.+||+.+|++||++.+|+++
T Consensus 240 ~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 240 LP----EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred CC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 12 2356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=292.15 Aligned_cols=235 Identities=20% Similarity=0.276 Sum_probs=194.9
Q ss_pred eeeeeeeeeeeeeceEEEEeec-----CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRK-----SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~-----tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
+.....+|.|+||.||.+.... ....+|+|++.... .......+.+|+.+++.++||||+++++.+...+..++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4566789999999999998754 33579999986543 23445778999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhc-----------------------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q psy48 889 VMEKLQGDMLEMILSSE-----------------------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~-----------------------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILl 945 (1098)
||||+.+++|..++... ...+++..++.++.|++.||.|||+.||+||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999998887532 1347889999999999999999999999999999999999
Q ss_pred cCCCCCCcEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--h
Q psy48 946 STNSELPQVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--D 1008 (1098)
Q Consensus 946 d~~g~~~~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~ 1008 (1098)
+.++ .++|+|||+++.. ...++|||.+.+..++.++||||||+++|||++ |..||.+.. .
T Consensus 161 ~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 161 AEGR---KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred cCCC---cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9888 8999999998643 124679999999999999999999999999998 999997653 2
Q ss_pred HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1009 INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1009 ~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.+.+. ..........++.++.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~---~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLK---TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHh---CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 222222 11222234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=290.05 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=200.5
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCc----eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec-CC
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGR----GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET-PG 884 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~----~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~-~~ 884 (1098)
.+..|.....||.|+||.||.|+.+.++. .+|||.++.+..........-+|+.+++.++|+||+.|..+|.+ +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34556677889999999999998776644 79999997654333334566789999999999999999999977 77
Q ss_pred cEEEEEEeccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC-CcEEEeecC
Q psy48 885 RIFVVMEKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL-PQVKLCDFG 960 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~-~~vKL~DFG 960 (1098)
.+++++||.+.+++..+... ....++...+..+++||+.|+.|||+.-|+||||||.|||+..+|.. ..|||+|||
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 89999999999877544332 23458899999999999999999999999999999999999887321 289999999
Q ss_pred cccccCCC---------------CCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhH-----------HHHH
Q psy48 961 FARIIGEK---------------SFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI-----------NEQI 1013 (1098)
Q Consensus 961 la~~~~~~---------------~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~-----------~~~i 1013 (1098)
+++.+..+ |.|||.+.| ..|++++||||.||++.||+|-++.|.+.++. .+.|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99866432 359999987 45999999999999999999999988765321 1122
Q ss_pred HHhhccCCC-CCC---------------------C------------cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1014 QNAAFMYPP-RPW---------------------R------------DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1014 ~~~~~~~p~-~~~---------------------~------------~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
.+.. ..|. ..| . .-++.+.+|+.+||++||-+|.|+++.++|+||
T Consensus 262 f~vL-G~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 262 FEVL-GTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHc-CCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 1111 1111 111 1 124568999999999999999999999999999
Q ss_pred CCCCCc
Q psy48 1060 QDPATW 1065 (1098)
Q Consensus 1060 k~~~~~ 1065 (1098)
+....|
T Consensus 341 ~~d~lp 346 (438)
T KOG0666|consen 341 TEDPLP 346 (438)
T ss_pred ccCCCC
Confidence 985544
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=301.91 Aligned_cols=247 Identities=26% Similarity=0.437 Sum_probs=199.4
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC------
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP------ 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~------ 883 (1098)
...+|.....||.|.+|.+|.+.+..+++.||||++++..........+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 44678888999999999999999999999999999976543344456788999999999999999999988543
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
...+++++++ +++|..++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++.
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~---~~kl~dfg~~~ 168 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC---ELKILDFGLAR 168 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC---CEEEecccccc
Confidence 3478888887 5667666643 4689999999999999999999999999999999999999988 89999999986
Q ss_pred ccC---------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhh--------------
Q psy48 964 IIG---------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAA-------------- 1017 (1098)
Q Consensus 964 ~~~---------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~-------------- 1017 (1098)
... ..++|||.+.+ ..++.++||||||+++|+|++|+.||....... ..+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 169 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred cccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence 432 23579999876 568999999999999999999999997543221 1111000
Q ss_pred ---------ccCCCC----CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1018 ---------FMYPPR----PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1018 ---------~~~p~~----~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
...+.. .+...++++.++|.+||..||.+||++.+++.||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 000110 112457889999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=295.61 Aligned_cols=238 Identities=19% Similarity=0.298 Sum_probs=198.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEeec-------CCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeec
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRK-------SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFET 882 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~-------tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~ 882 (1098)
..++.+...+|.|.+|.||.+.+.. ....||+|+++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3577889999999999999997642 34579999987532 344456788999999999 69999999999999
Q ss_pred CCcEEEEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC
Q psy48 883 PGRIFVVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947 (1098)
Q Consensus 883 ~~~l~LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~ 947 (1098)
.+.+++||||+.+++|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 999999999999999998886432 34788899999999999999999999999999999999998
Q ss_pred CCCCCcEEEeecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHH
Q psy48 948 NSELPQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DIN 1010 (1098)
Q Consensus 948 ~g~~~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~ 1010 (1098)
++ .+||+|||+++... ..|+|||++.+..++.++||||||+++|+|++ |..||.... +..
T Consensus 170 ~~---~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 170 DN---VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred CC---cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 88 89999999986432 24789999999999999999999999999999 889997643 333
Q ss_pred HHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1011 EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1011 ~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
..+... ........++.++.+++.+||..||++||++.++++
T Consensus 247 ~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREG---HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 333322 222223467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=292.72 Aligned_cols=240 Identities=20% Similarity=0.239 Sum_probs=196.9
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCC----------------ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCcee
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSG----------------RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVN 875 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg----------------~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~ 875 (1098)
..|.+...||.|++|.||.+.+...+ ..||+|++.... .......+.+|+++++.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 45677889999999999998876544 568999987543 2345678999999999999999999
Q ss_pred eeeeeecCCcEEEEEEeccCchHHHHHhhcc----------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q psy48 876 LERMFETPGRIFVVMEKLQGDMLEMILSSEK----------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945 (1098)
Q Consensus 876 L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~----------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILl 945 (1098)
+++++...+..++||||+.+++|..++.... ..+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 9999999999999999999999988886443 268999999999999999999999999999999999999
Q ss_pred cCCCCCCcEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc--CCCCCCCCh--
Q psy48 946 STNSELPQVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS--GTFPFNEDE-- 1007 (1098)
Q Consensus 946 d~~g~~~~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt--G~~Pf~~~~-- 1007 (1098)
+.++ .++|+|||+++.. +..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 164 ~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 164 GKNY---TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred cCCC---ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9988 8999999998743 124689999998889999999999999999998 778886532
Q ss_pred hHHHHHHHh----hccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1008 DINEQIQNA----AFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1008 ~~~~~i~~~----~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+........ ...........++.++.+++.+||+.||++||++.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 222222211 001111112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=286.48 Aligned_cols=235 Identities=19% Similarity=0.254 Sum_probs=194.1
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|.+...+|.|+++.||.+... .+..||+|.++..... ...+.+|+.++++++|+|++++++++.. ...+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence 45667788999999999999765 5667999999764432 3568999999999999999999998854 56899999
Q ss_pred eccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 892 KLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
|+.+++|..++... ...+++..+..++.+|+.||+|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~---~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL---VCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc---eEEeCCceeeeeccCccc
Confidence 99999998887653 34589999999999999999999999999999999999999888 89999999986432
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
..++|||.+.+..++.++|+||||+++|+|++ |..||...... +.........+.......+.++.+++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-EVLEQVERGYRMPCPQDCPISLHELM 236 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 13689999998899999999999999999999 89999764322 12222222223333456889999999
Q ss_pred HHhhhhcccCCCCHHHHHc
Q psy48 1037 NNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.+||..||++|||++++++
T Consensus 237 ~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 237 LQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 9999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=286.01 Aligned_cols=235 Identities=20% Similarity=0.247 Sum_probs=194.1
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..+.....||.|.++.||.+.+..++ .+|+|++.... .....+.+|+.+++.++|+|++++++++.. +..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence 45778889999999999999876554 59999986533 224568889999999999999999998854 56899999
Q ss_pred eccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 892 KLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
|+.+++|..++.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++ .++|+|||++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~---~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL---VCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC---eEEECCCccceEccCCcc
Confidence 999999988886533 3588999999999999999999999999999999999999988 89999999986431
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
..++|||.+.+..++.++|+||||+++|+|++ |..||.+..... .............+..++..+.+++
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-VLEQVERGYRMPCPQGCPESLHELM 236 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCcccCHHHHHHH
Confidence 13679999998899999999999999999999 999997654322 1122222223333456889999999
Q ss_pred HHhhhhcccCCCCHHHHHc
Q psy48 1037 NNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.+||..||++||+++++++
T Consensus 237 ~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 237 KLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=298.35 Aligned_cols=246 Identities=29% Similarity=0.460 Sum_probs=201.0
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec-CCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET-PGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~-~~~l~L 888 (1098)
...+|.+...||.|.+|.||.+.+..+++.||||++.+..........+.+|+.+++.++||||++++++|.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 4567889999999999999999999999999999987654444455778899999999999999999999865 467899
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE- 967 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~- 967 (1098)
||||+++ +|..++. ...+++..+..++.||+.||+|||+.||+||||+|+||+++.++ .++|+|||++.....
T Consensus 88 v~e~~~~-~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~---~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 88 VTELLGT-DLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC---DLKICDFGLARIQDPQ 161 (328)
T ss_pred Eeehhcc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC---CEEeCccccccccCCC
Confidence 9999955 6766664 34688889999999999999999999999999999999999888 899999999865422
Q ss_pred --------CCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHh--------------------
Q psy48 968 --------KSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNA-------------------- 1016 (1098)
Q Consensus 968 --------~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~-------------------- 1016 (1098)
.++|||.+.+ ..++.++||||||+++|+|++|..||....... ..+...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 3579998866 678999999999999999999999997543211 000000
Q ss_pred ----hccC--CC-CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1017 ----AFMY--PP-RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1017 ----~~~~--p~-~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.... +. .....++.++.++|.+||+.+|++||++++++.||||..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 0000 00 011246789999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=321.44 Aligned_cols=236 Identities=27% Similarity=0.362 Sum_probs=201.1
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeee-ec---C---
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMF-ET---P--- 883 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f-~~---~--- 883 (1098)
.+.+...+|..|+|+.||+|.+...|..||+|++-.. +......+.+|+.+|+.|+ |+|||.+++.. .. +
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4678899999999999999999999999999998543 4666789999999999996 99999999932 11 1
Q ss_pred CcEEEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 884 GRIFVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~g--IvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
-.++|+||||.|+.|-+++.++ ..+|++.++++|+.++++|+++||... |||||||-+||||..+| ++||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g---~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG---NYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC---CEEeCccc
Confidence 2478999999976666676533 456999999999999999999999987 99999999999999999 89999999
Q ss_pred ccccc---------------------CCCCCChhhh---ccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHh
Q psy48 961 FARII---------------------GEKSFPPEVL---RNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNA 1016 (1098)
Q Consensus 961 la~~~---------------------~~~~~APEvl---~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~ 1016 (1098)
.|.-. +..|.|||++ .+.+.+.++|||||||+||-|+....||+.... -+|...
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--laIlng 269 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--LAILNG 269 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--eeEEec
Confidence 88421 3345699998 488899999999999999999999999987643 356677
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1017 AFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1017 ~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.+.+|+. ..++..+.+||+.||+.||++||++.+++.+
T Consensus 270 ~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 270 NYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred cccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 7777764 4689999999999999999999999888864
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=288.36 Aligned_cols=240 Identities=19% Similarity=0.247 Sum_probs=199.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeec----CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec-CCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRK----SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET-PGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~----tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~-~~~ 885 (1098)
...|.+...+|.|.+|.||.+.+.. ++..||+|+++. .........+.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4568889999999999999999876 368899999864 3345556788999999999999999999998755 567
Q ss_pred EEEEEEeccCchHHHHHhhcc-------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEee
Q psy48 886 IFVVMEKLQGDMLEMILSSEK-------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~-------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~D 958 (1098)
.+++++|+.+++|..++.... ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++ .+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~---~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL---QVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC---cEEECC
Confidence 899999999999988886432 4588999999999999999999999999999999999999887 899999
Q ss_pred cCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCC
Q psy48 959 FGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPR 1023 (1098)
Q Consensus 959 FGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~ 1023 (1098)
||+++... ..++|||.+.+..++.++||||||+++|||++ |..||....... ............
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHHHcCCCCC
Confidence 99997431 13689999999999999999999999999999 999997653221 111111122222
Q ss_pred CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1024 PWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1024 ~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
....+++++.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 33457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=290.71 Aligned_cols=232 Identities=22% Similarity=0.283 Sum_probs=188.4
Q ss_pred eeeeeeeeceEEEEeecCCce-------eEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 819 ALCIAVVAGAACGVHRKSGRG-------VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~-------VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.||.|+||.||.+.++..+.. ||+|++.... ......+.+|+.+++.+.||||+++++++......++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 579999999999998765544 8888875432 3334678899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC-----CcEEEeecCcccccC
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL-----PQVKLCDFGFARIIG 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~-----~~vKL~DFGla~~~~ 966 (1098)
|+++++|..++......+++..+..++.||+.||+|||++||+||||||+||+++.++.. ..++++|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 999999999987666678999999999999999999999999999999999999877521 137999999986432
Q ss_pred --------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCC-CCCCCChhHHH-HHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 --------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGT-FPFNEDEDINE-QIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 --------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~-~Pf~~~~~~~~-~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..++|||.+.+ ..++.++||||||+++|||++|. .||...+.... .........+ ...+.++.++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l 235 (258)
T cd05078 160 PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLP----APKWTELANL 235 (258)
T ss_pred CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCC----CCCcHHHHHH
Confidence 34689999986 45899999999999999999985 66654433221 1222222222 2356889999
Q ss_pred HHHhhhhcccCCCCHHHHHcC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.+||+.||++|||+++|++.
T Consensus 236 i~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 236 INQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHhccChhhCCCHHHHHHh
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=286.27 Aligned_cols=235 Identities=22% Similarity=0.302 Sum_probs=195.5
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|.+...||.|.+|.||.+... +++.||+|.+..... ....+.+|+.+++.++|+||+++++++. .+..+++||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 45677889999999999999854 577899999975443 2457889999999999999999999874 457899999
Q ss_pred eccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 892 KLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
|+.+++|..++... ...+++.++..++.||+.||+|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~---~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL---CCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC---CEEEccCcceeecCCCCc
Confidence 99999998887643 34689999999999999999999999999999999999999988 89999999986432
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
..++|||.+.+..++.++||||||+++|||++ |..||.+.... +................++.++.+++
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-EVIQNLERGYRMPRPDNCPEELYELM 236 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 23679999998889999999999999999999 99999765322 11222222233333456789999999
Q ss_pred HHhhhhcccCCCCHHHHHc
Q psy48 1037 NNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.+||+.+|++||++++++.
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 237 RLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHccCChhhCCCHHHHHH
Confidence 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=318.95 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=186.7
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCC-ceeEEE--------------EEec-cCCChHHHHHHHHHHHHHhccCCCCce
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSG-RGVAIK--------------VIDK-LRFPTKQEAQLKNEVAILQNLCHPGVV 874 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg-~~VAVK--------------vlkk-~~~~~~~~~~~~~Ei~iL~~l~HpnIv 874 (1098)
+..|.....||.|+||.||.+..+... ..+++| ++.+ ..........+.+|+.+|+.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 467899999999999999998765432 222222 1111 111223346788999999999999999
Q ss_pred eeeeeeecCCcEEEEEEeccCchHHHHHhhc---cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC
Q psy48 875 NLERMFETPGRIFVVMEKLQGDMLEMILSSE---KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951 (1098)
Q Consensus 875 ~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~---~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~ 951 (1098)
++++++...+..|+||+++.+..+..+.... ........++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~-- 304 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG-- 304 (501)
T ss_pred cEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--
Confidence 9999999999999999999877664443211 12234667889999999999999999999999999999999988
Q ss_pred CcEEEeecCccccc-------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCC-CCCC--hh---HHHH
Q psy48 952 PQVKLCDFGFARII-------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFP-FNED--ED---INEQ 1012 (1098)
Q Consensus 952 ~~vKL~DFGla~~~-------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~P-f~~~--~~---~~~~ 1012 (1098)
.+||+|||+++.+ ...|+|||++.+..|+.++|||||||+||||++|..+ +... .. +.+.
T Consensus 305 -~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 -KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred -CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 8999999999643 2235799999999999999999999999999998754 4322 11 1111
Q ss_pred HHHhh---ccCCCC---------------C---------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1013 IQNAA---FMYPPR---------------P---------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1013 i~~~~---~~~p~~---------------~---------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+.... ..++.. . ...++.++.++|.+||..||.+|||+.|++.||||...
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 11000 000000 0 01356678889999999999999999999999999874
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=289.94 Aligned_cols=238 Identities=20% Similarity=0.262 Sum_probs=197.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEee-----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHR-----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k-----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
...+.....+|.|.+|.||.+.+. .++..||+|+++... .......+.+|+.+++.+.||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 345777889999999999999875 367899999987542 33445679999999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhcc---------------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy48 886 IFVVMEKLQGDMLEMILSSEK---------------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~---------------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NIL 944 (1098)
+++||||+++++|..++.... ..+++..++.++.||+.||.|||++|++||||||+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 999999999999988886322 24778889999999999999999999999999999999
Q ss_pred ecCCCCCCcEEEeecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--
Q psy48 945 LSTNSELPQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE-- 1007 (1098)
Q Consensus 945 ld~~g~~~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~-- 1007 (1098)
++.++ .++|+|||++.... ..++|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 163 ~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 163 VGENM---VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred ecCCC---ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99988 89999999986421 13679999999999999999999999999997 888987542
Q ss_pred hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1008 DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1008 ~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+....+..... ......++.++.+||.+||..||++||++.|+++
T Consensus 240 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNV---LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 22222222211 1112457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=293.25 Aligned_cols=240 Identities=19% Similarity=0.298 Sum_probs=198.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEee-------cCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeee
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHR-------KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFE 881 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k-------~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~ 881 (1098)
....+.+...||.|++|.||.+.+. .++..||+|+++.. ........+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3567788999999999999999753 23457999998653 2334457789999999999 7999999999999
Q ss_pred cCCcEEEEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec
Q psy48 882 TPGRIFVVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946 (1098)
Q Consensus 882 ~~~~l~LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld 946 (1098)
.....++||||+.+++|..++.... ..+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 9999999999999999998886532 2477888999999999999999999999999999999999
Q ss_pred CCCCCCcEEEeecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hH
Q psy48 947 TNSELPQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DI 1009 (1098)
Q Consensus 947 ~~g~~~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~ 1009 (1098)
.++ .++|+|||+++... ..|+|||++.+..++.++||||||+++|+|++ |..||.+.. +.
T Consensus 172 ~~~---~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 172 ENN---VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred CCC---cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 888 89999999986432 23679999999999999999999999999998 788887542 33
Q ss_pred HHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1010 NEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1010 ~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.+.+... ........++.++.+++.+||..+|++||++.++++.
T Consensus 249 ~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEG---HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcC---CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 3333222 2222234688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=286.23 Aligned_cols=237 Identities=23% Similarity=0.262 Sum_probs=197.1
Q ss_pred heeeeeeeeeeeeeceEEEEeecC---CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKS---GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~t---g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
.+++...+|.|.+|.||.+.+... ...||||...... .....+.+.+|+.+++.++|+||+++++++.+ +..++|
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 467888999999999999987654 4468999886432 24455789999999999999999999998875 457899
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||+++++|..++......+++..++.++.+|+.||.|||+.|++||||||+||+++.++ .++|+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~---~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC---CeEEccCceeeeccccc
Confidence 999999999999876666789999999999999999999999999999999999999988 89999999986431
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..++|||.+.+..++.++||||||+++|||++ |..||......... ...........+..++.++.++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l 240 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGERLPMPPNCPPTLYSL 240 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHcCCcCCCCCCCCHHHHHH
Confidence 23679999998899999999999999999986 99999765432221 2222222223345688999999
Q ss_pred HHHhhhhcccCCCCHHHHHc
Q psy48 1036 INNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.+||..+|++||++.+++.
T Consensus 241 i~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 241 MTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=289.77 Aligned_cols=241 Identities=29% Similarity=0.466 Sum_probs=193.8
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEEEEe
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
|.+...||.|.+|.||.+....+++.||||.+...... .......+|+..++.++ |+||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 45678899999999999999999999999998764322 23344567899999998 99999999999999999999999
Q ss_pred ccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC----
Q psy48 893 LQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE---- 967 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~---- 967 (1098)
+ +++|..++.... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~---~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPY 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC---CEEEeecccceeccCCCCc
Confidence 9 555656665443 4789999999999999999999999999999999999999988 899999999864432
Q ss_pred -------CCCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc---------------------
Q psy48 968 -------KSFPPEVLR-NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF--------------------- 1018 (1098)
Q Consensus 968 -------~~~APEvl~-~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~--------------------- 1018 (1098)
.++|||++. +..++.++|+||||+++|+|++|..||...............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 247999885 455899999999999999999999999755322111110000
Q ss_pred cCCC-------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1019 MYPP-------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1019 ~~p~-------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
..+. ......+.++.++|.+||..||++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0000 0011236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=288.46 Aligned_cols=236 Identities=19% Similarity=0.223 Sum_probs=193.1
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCce----eEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRG----VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~----VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
..+.+...||.|++|.||.+....+++. ||+|.+... ........+..|+.++..+.||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 3456778899999999999999888875 566665322 122334678888889999999999999998754 5678
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
++|||+.+++|..++......+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+|||+++...
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~---~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS---IVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC---cEEEcCCccceeccC
Confidence 99999999999999887677899999999999999999999999999999999999999888 89999999986431
Q ss_pred -------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcH
Q psy48 967 -------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 967 -------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
..++|||.+.+..++.++||||||+++|||++ |..||.+... ..+.+.... ........+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 238 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE---RLAQPQICTI 238 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---cCCCCCCCCH
Confidence 13679999998899999999999999999998 9999976532 222222221 1122334678
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
++.+++.+||..||++||++.++++
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=291.84 Aligned_cols=240 Identities=21% Similarity=0.257 Sum_probs=193.3
Q ss_pred hheeeeeeeeeeeeeceEEEEee----------------cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCcee
Q psy48 812 VFMTYNVALCIAVVAGAACGVHR----------------KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVN 875 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k----------------~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~ 875 (1098)
.+|++...||.|++|.||.+.+. .++..||+|+++... .......+.+|+.+++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 45788899999999999998543 245579999997542 3444578999999999999999999
Q ss_pred eeeeeecCCcEEEEEEeccCchHHHHHhhcc----------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q psy48 876 LERMFETPGRIFVVMEKLQGDMLEMILSSEK----------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945 (1098)
Q Consensus 876 L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~----------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILl 945 (1098)
+++++...+..++||||+.+++|..++.... ..+++..+..++.||+.||+|||+.||+||||||+|||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999988876432 236678899999999999999999999999999999999
Q ss_pred cCCCCCCcEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc--CCCCCCCChh-
Q psy48 946 STNSELPQVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS--GTFPFNEDED- 1008 (1098)
Q Consensus 946 d~~g~~~~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt--G~~Pf~~~~~- 1008 (1098)
+.++ .++|+|||+++.. ...++|||...+..++.++|||||||++|||++ |..||.....
T Consensus 164 ~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 164 GKNY---TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred cCCC---CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9887 8999999998643 124679999888889999999999999999998 7788865322
Q ss_pred -HHHHHHH----hhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1009 -INEQIQN----AAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1009 -~~~~i~~----~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
....... ............+++.+.+|+.+||..||++||++.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1111111 0000111112357799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=292.60 Aligned_cols=240 Identities=18% Similarity=0.219 Sum_probs=194.3
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCC--------------ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeee
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSG--------------RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLE 877 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg--------------~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~ 877 (1098)
.+|.+...||.|++|.||.+.+..++ ..||||+++.. ........+.+|++++++++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 35677888999999999998875432 35999998754 2344456799999999999999999999
Q ss_pred eeeecCCcEEEEEEeccCchHHHHHhhcc-----------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec
Q psy48 878 RMFETPGRIFVVMEKLQGDMLEMILSSEK-----------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946 (1098)
Q Consensus 878 ~~f~~~~~l~LVmEy~~ggsL~~~l~~~~-----------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld 946 (1098)
+++...+..++||||+.+++|..++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 99999999999999999999998886432 1367888999999999999999999999999999999999
Q ss_pred CCCCCCcEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc--CCCCCCCCh--h
Q psy48 947 TNSELPQVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS--GTFPFNEDE--D 1008 (1098)
Q Consensus 947 ~~g~~~~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt--G~~Pf~~~~--~ 1008 (1098)
.++ .+||+|||++... ...|+|||++.+..++.++||||||+++|+|++ |..||.... +
T Consensus 164 ~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 164 NHY---TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred CCC---cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 887 8999999998643 124689999998899999999999999999988 667886532 2
Q ss_pred HHHHHHH----hhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1009 INEQIQN----AAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1009 ~~~~i~~----~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
....... ............++..+.+|+.+||+.||++||++++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2222111 0011111123357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=302.80 Aligned_cols=259 Identities=27% Similarity=0.360 Sum_probs=203.4
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~L 888 (1098)
....|.+...||.|+-+.||.+.... .+.||+|.+.....+.....-+.+|+..|.+++ |.+|++|++|-.+++.+|+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34456777889999999999987654 456677766555566667788999999999995 9999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
||||=+ .+|..+|.+.....+...+++|..|++.|+.++|++||||.||||.|+|+-.. .+||+|||+|..+
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG----~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG----RLKLIDFGIANAIQPD 512 (677)
T ss_pred Eeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee----eEEeeeechhcccCcc
Confidence 999754 55778888777766666899999999999999999999999999999999765 6999999999643
Q ss_pred -----------CCCCCChhhhccCC-----------CCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCC
Q psy48 966 -----------GEKSFPPEVLRNKG-----------YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPR 1023 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~~-----------ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~ 1023 (1098)
+..||+||.+.... .+.++|||||||+||+|+.|+.||..-......+....-.-..-
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI 592 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence 44579999996332 56899999999999999999999987655444444332110000
Q ss_pred CCCcC--cHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC-CCCcchhHHHHhh
Q psy48 1024 PWRDI--SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD-PATWSDLRGLERQ 1074 (1098)
Q Consensus 1024 ~~~~i--s~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~-~~~~~~~~~l~~~ 1074 (1098)
.+..+ ..++.++++.||..||.+||++.++|+|||++- +....-+.++.+.
T Consensus 593 efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~~~m~~~~~~ 646 (677)
T KOG0596|consen 593 EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPVEQMAKLTTN 646 (677)
T ss_pred cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccchHHHHHHHH
Confidence 01112 234999999999999999999999999999996 4444444444433
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=296.69 Aligned_cols=238 Identities=19% Similarity=0.279 Sum_probs=197.5
Q ss_pred hheeeeeeeeeeeeeceEEEEeecC-------CceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecC
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKS-------GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETP 883 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~t-------g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~ 883 (1098)
.+|++...||.|.||.||.+.+... +..||+|+++.. ........+.+|+.+++++ +|+||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 4678899999999999999986432 236899988643 2334457889999999999 799999999999999
Q ss_pred CcEEEEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~ 948 (1098)
+.++++|||+++++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 99999999999999999886432 247788899999999999999999999999999999999988
Q ss_pred CCCCcEEEeecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHH
Q psy48 949 SELPQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINE 1011 (1098)
Q Consensus 949 g~~~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~ 1011 (1098)
+ .+||+|||+++... ..|+|||++.+..++.++||||||+++|||++ |..||.+.. +...
T Consensus 171 ~---~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 171 N---VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred C---cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 8 89999999986431 13689999999999999999999999999998 889997653 2222
Q ss_pred HHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1012 QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1012 ~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.+. ..........++.++.+++.+||..+|++||++.+++++
T Consensus 248 ~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 248 LLK---EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHH---cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 222 222222334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=281.21 Aligned_cols=240 Identities=22% Similarity=0.236 Sum_probs=203.0
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC-----C
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP-----G 884 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~-----~ 884 (1098)
...+|++...+|.|+|+-|+.+....+++.||+|.+.... .++.+..++|++..++++|||+++++++.... .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4578999999999999999999999999999999997654 56678899999999999999999999887433 3
Q ss_pred cEEEEEEeccCchHHHHHhhc---cCccchhHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecCCCCCCcEEEeec
Q psy48 885 RIFVVMEKLQGDMLEMILSSE---KGRLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVLLSTNSELPQVKLCDF 959 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~---~~~lse~~~~~ia~qIa~gL~~LHs~g--IvHrDLKp~NILld~~g~~~~vKL~DF 959 (1098)
..||+++|...|+|.+.+... +..+++.+++.|+.+|+.||.+||+.. ++||||||.|||+...+ .++|.||
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~---~~vl~D~ 173 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG---LPVLMDL 173 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC---ceEEEec
Confidence 499999999988887776532 346999999999999999999999998 99999999999999988 8999999
Q ss_pred Cccccc---------------------CCCCCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCC----hhHHH
Q psy48 960 GFARII---------------------GEKSFPPEVLR---NKGYNRSLDMWSVGVIVYVSLSGTFPFNED----EDINE 1011 (1098)
Q Consensus 960 Gla~~~---------------------~~~~~APEvl~---~~~ys~~sDVwSLGvlLyELltG~~Pf~~~----~~~~~ 1011 (1098)
|.+... +-+|.|||.+. +...+.++|||||||+||+||.|..||... ..+.-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 988532 33456999996 556789999999999999999999999632 22333
Q ss_pred HHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1012 QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1012 ~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
++......+|... .+|+.+.++|+.||+.||.+||++.+++.+
T Consensus 254 Av~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 254 AVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 3444455555543 389999999999999999999999999874
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=283.56 Aligned_cols=234 Identities=25% Similarity=0.324 Sum_probs=194.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
+..|++...+|.|++|.||.+. .+++.||+|+++.. .....+.+|+.+++.++|||++++++++... ..++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 3567889999999999999875 57889999998653 2346788999999999999999999998765 479999
Q ss_pred EeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 891 EKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
||+.+++|..++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~---~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG---VAKVSDFGLARVGSMGV 154 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC---cEEECCCccceeccccC
Confidence 9999999988886543 3588999999999999999999999999999999999999988 89999999986432
Q ss_pred ------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 967 ------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 967 ------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
..|+|||.+.+..++.++|+||||+++|+|++ |..||...... +................++.++.+++.+|
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-EVKECVEKGYRMEPPEGCPADVYVLMTSC 233 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-HHHHHHhCCCCCCCCCcCCHHHHHHHHHH
Confidence 23579999998899999999999999999997 99999765321 11112222222233456889999999999
Q ss_pred hhhcccCCCCHHHHHc
Q psy48 1040 LQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~ 1055 (1098)
|+.+|++||+++++++
T Consensus 234 l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 234 WETEPKKRPSFHKLRE 249 (254)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=288.77 Aligned_cols=239 Identities=20% Similarity=0.298 Sum_probs=197.1
Q ss_pred heeeeeeeeeeeeeceEEEEee----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec--CCcE
Q psy48 813 FMTYNVALCIAVVAGAACGVHR----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET--PGRI 886 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~--~~~l 886 (1098)
.+++...+|.|++|.||.+... .+++.||||+++..... .....+.+|+.+++.+.|+||+++++++.. ....
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 4556678999999999999864 45889999999765432 346789999999999999999999999877 5579
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
++||||+++++|..++......+++..+..++.||+.||+|||+.||+|+||||+||+++.++ .++|+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED---LVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC---CEEEcccccccccc
Confidence 999999999999999876666799999999999999999999999999999999999999988 89999999987554
Q ss_pred C---------------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH-------------HHH-HHhh
Q psy48 967 E---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN-------------EQI-QNAA 1017 (1098)
Q Consensus 967 ~---------------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~-------------~~i-~~~~ 1017 (1098)
. .++|||.+.+..++.++||||||+++|||++|..|+....... ..+ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 1 2579999998899999999999999999999999986432111 111 1111
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1018 FMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1018 ~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
..........++.++.+++.+||..+|++||++.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111223457789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=283.94 Aligned_cols=229 Identities=23% Similarity=0.280 Sum_probs=186.4
Q ss_pred eeeeeeeeceEEEEeecCC----------ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 819 ALCIAVVAGAACGVHRKSG----------RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg----------~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.||.|+++.||.+.+..++ ..|++|++.... .....+.+|+.+++.++||||+++++++.. ...++
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 5799999999999998877 347888775432 125788899999999999999999999988 77899
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC----CCCcEEEeecCcccc
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS----ELPQVKLCDFGFARI 964 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g----~~~~vKL~DFGla~~ 964 (1098)
||||+.+++|..++......+++..+..++.||+.||+|||++||+||||||+|||++.++ ....++|+|||++..
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 9999999999999876555789999999999999999999999999999999999998765 223599999999876
Q ss_pred c--------CCCCCChhhhccC--CCCchhHHHHHHHHHHHHHc-CCCCCCCChhH-HHHHHHhhccCCCCCCCcCcHHH
Q psy48 965 I--------GEKSFPPEVLRNK--GYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDI-NEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 965 ~--------~~~~~APEvl~~~--~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~-~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
. ...++|||++.+. .++.++||||||+++|+|++ |..||...... ...........+ .....++
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 233 (259)
T cd05037 158 VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP----MPDCAEL 233 (259)
T ss_pred cccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCC----CCCchHH
Confidence 3 3456899999876 78999999999999999999 57888654211 111111111111 1123789
Q ss_pred HHHHHHhhhhcccCCCCHHHHHc
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.+++.+||..+|.+||++.++++
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 234 ANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHhccChhhCCCHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=286.61 Aligned_cols=235 Identities=21% Similarity=0.279 Sum_probs=192.4
Q ss_pred eeeeeeeeceEEEEeecCC------ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 819 ALCIAVVAGAACGVHRKSG------RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg------~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.+|.|.+|.||.+...... +.||||.+.+.. .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 5789999999999876544 789999986532 234456788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhc------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC--CCCcEEEeecCcccc
Q psy48 893 LQGDMLEMILSSE------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS--ELPQVKLCDFGFARI 964 (1098)
Q Consensus 893 ~~ggsL~~~l~~~------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g--~~~~vKL~DFGla~~ 964 (1098)
+++++|..++... ...+++.++..++.||+.||+|||+.+++|+||||+||+++.++ ....++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999998888642 23478899999999999999999999999999999999998765 223699999999863
Q ss_pred c--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCc
Q psy48 965 I--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDIS 1029 (1098)
Q Consensus 965 ~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is 1029 (1098)
. ...++|||.+.+..++.++||||||+++|||++ |..||....... .............+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHVTAGGRLQKPENCP 239 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-HHHHHhcCCccCCcccch
Confidence 3 234679999999999999999999999999998 999997654322 122211122223345688
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.++.++|.+||..+|.+||++.++++
T Consensus 240 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 240 DKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=294.55 Aligned_cols=243 Identities=27% Similarity=0.403 Sum_probs=193.8
Q ss_pred eeeeeeeeeeeeeceEEEEeecC--CceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeec----CCcE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKS--GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFET----PGRI 886 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~t--g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~----~~~l 886 (1098)
|.+...||.|.+|.||.+.+..+ +..||||++............+.+|+.+++.+ .||||+++++++.. ...+
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 56778899999999999999888 99999999875433333456788899999988 59999999987532 2458
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
+++|+|+++ +|..++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||+++...
T Consensus 82 ~~~~e~~~~-~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~---~~kl~Dfg~a~~~~ 156 (332)
T cd07857 82 YLYEELMEA-DLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC---ELKICDFGLARGFS 156 (332)
T ss_pred EEEEecccC-CHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC---CEEeCcCCCceecc
Confidence 899999976 4555654 345799999999999999999999999999999999999999988 89999999986421
Q ss_pred ----------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHh-----------
Q psy48 967 ----------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNA----------- 1016 (1098)
Q Consensus 967 ----------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~----------- 1016 (1098)
..|+|||.+.+ ..++.++|||||||++|+|++|..||...... ...+...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 23579998865 56899999999999999999999999754321 1111000
Q ss_pred ------------hccCCC----CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1017 ------------AFMYPP----RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1017 ------------~~~~p~----~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
....+. ..+..++.++.+|+.+||+.||++|||+.+++.||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 000000 112346789999999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=312.10 Aligned_cols=234 Identities=28% Similarity=0.435 Sum_probs=192.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..|.+...+|.|.|+.+-...+..+++.+|||++.+.. ....+|+.++... +||||+++++.+.+..+.|+||
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 45677777999999999999999999999999997652 2234566555444 7999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec-CCCCCCcEEEeecCcccccCC--
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS-TNSELPQVKLCDFGFARIIGE-- 967 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld-~~g~~~~vKL~DFGla~~~~~-- 967 (1098)
|++.|+.+...+... ..+. ..+..|+++|+.|+.|||++|+|||||||+|||++ +.+ +++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~-~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g---~lrltyFG~a~~~~~~~ 470 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK-PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG---HLRLTYFGFWSELERSC 470 (612)
T ss_pred hhccccHHHHHHHhc-chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC---cEEEEEechhhhCchhh
Confidence 999988776655422 2233 78889999999999999999999999999999994 666 899999999875533
Q ss_pred -------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 968 -------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 968 -------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
.|.|||++....|++++||||||++||+||+|+.||.......+..... ..+ ..-..+|.++++||.+||
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i--~~~-~~s~~vS~~AKdLl~~LL 547 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI--QMP-KFSECVSDEAKDLLQQLL 547 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh--cCC-ccccccCHHHHHHHHHhc
Confidence 3469999999999999999999999999999999998543321211111 111 111569999999999999
Q ss_pred hhcccCCCCHHHHHcCCCc
Q psy48 1041 QVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1041 ~~dP~kRPSa~eIL~HpfF 1059 (1098)
+.||.+||++.+++.||||
T Consensus 548 ~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 548 QVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cCChhhCcChhhhccCcch
Confidence 9999999999999999999
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=281.10 Aligned_cols=240 Identities=24% Similarity=0.376 Sum_probs=200.8
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.-||.|.-|.|+.+.++.+|...|||.+.+.. +.++.+++.+.+.++... ..|+||+.+++|.++..+++.||.|. .
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 35789999999999999999999999997643 344456777777776655 48999999999999999999999984 3
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCcccccC---------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--------- 966 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--------- 966 (1098)
-++.++..-.++++|..+-++...++.||.||-. +||||||+||+|||+|..| .+||+|||++.++.
T Consensus 176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G---niKlCDFGIsGrlvdSkAhtrsA 252 (391)
T KOG0983|consen 176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG---NIKLCDFGISGRLVDSKAHTRSA 252 (391)
T ss_pred HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC---CEEeecccccceeeccccccccc
Confidence 4556666667789999999999999999999995 5899999999999999999 89999999986542
Q ss_pred --CCCCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCC--CcCcHHHHHHHHHh
Q psy48 967 --EKSFPPEVLR---NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPW--RDISSDAIDLINNL 1039 (1098)
Q Consensus 967 --~~~~APEvl~---~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~--~~is~el~~LL~~c 1039 (1098)
..|||||.+. ...|+.++||||||++|+||.||+.||.+.+..++.+.......|+... ...|+++.+|+..|
T Consensus 253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~C 332 (391)
T KOG0983|consen 253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDC 332 (391)
T ss_pred CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHH
Confidence 3469999996 3469999999999999999999999999865555555444334443322 24899999999999
Q ss_pred hhhcccCCCCHHHHHcCCCcCCC
Q psy48 1040 LQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
|.+|+.+||...++|+|||++.+
T Consensus 333 L~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 333 LTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred hhcCcccCcchHHHhcCcceeec
Confidence 99999999999999999999864
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=284.19 Aligned_cols=233 Identities=18% Similarity=0.247 Sum_probs=184.1
Q ss_pred eeeeeeeeceEEEEeec--CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRK--SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~--tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|.||.||.+.... ....+|+|.+.... .......+.+|+.+++.++|+||+++++.+.....+++||||++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 57999999999986433 44578888775432 3344567889999999999999999999999999999999999999
Q ss_pred hHHHHHhhccC----ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-------
Q psy48 897 MLEMILSSEKG----RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~----~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------- 965 (1098)
+|..++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~---~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL---SVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC---cEEEeccccccccccchhee
Confidence 99998865432 346788899999999999999999999999999999999988 8999999998642
Q ss_pred -------CCCCCChhhhcc-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHH---HHHHHhhccCCC-CCCC
Q psy48 966 -------GEKSFPPEVLRN-------KGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDIN---EQIQNAAFMYPP-RPWR 1026 (1098)
Q Consensus 966 -------~~~~~APEvl~~-------~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~---~~i~~~~~~~p~-~~~~ 1026 (1098)
...++|||++.. ..++.++|||||||++|||++ |..||....+.. ..+.......+. ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence 123689999753 457889999999999999999 788987653322 112222111221 1223
Q ss_pred cCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1027 DISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1027 ~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.++..+.+++..|| .||++||++++|++-
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 57888999999998 599999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=284.16 Aligned_cols=240 Identities=26% Similarity=0.388 Sum_probs=195.7
Q ss_pred eeeeeeeeeeeeeceEEEEeec-CCceeEEEEEeccC--------CChHHHHHHHHHHHHHhc-cCCCCceeeeeeeecC
Q psy48 814 MTYNVALCIAVVAGAACGVHRK-SGRGVAIKVIDKLR--------FPTKQEAQLKNEVAILQN-LCHPGVVNLERMFETP 883 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~-tg~~VAVKvlkk~~--------~~~~~~~~~~~Ei~iL~~-l~HpnIv~L~~~f~~~ 883 (1098)
|++...||.|.++.+|.+.+.. +++.+|+|.+.... ........+.+|+.++.. ++|+||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4566789999999999999988 78899999986432 122334567788888864 7899999999999999
Q ss_pred CcEEEEEEeccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeec
Q psy48 884 GRIFVVMEKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDF 959 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DF 959 (1098)
+..++||||+++++|..++.. ....+++..++.++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~---~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD---KVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC---cEEEecc
Confidence 999999999999999877642 34568999999999999999999996 7899999999999999988 8999999
Q ss_pred CcccccCC-----------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcC
Q psy48 960 GFARIIGE-----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDI 1028 (1098)
Q Consensus 960 Gla~~~~~-----------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~i 1028 (1098)
|++..... .++|||.+.+..++.++|+||||+++|+|++|..||................+.+.....+
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence 99864332 3579999999889999999999999999999999997654332222212222222222357
Q ss_pred cHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1029 SSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.++.++|.+||+.||++||++.++..+
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 8999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=283.41 Aligned_cols=239 Identities=20% Similarity=0.328 Sum_probs=196.8
Q ss_pred hheeeeeeeeeeeeeceEEEEeec-----CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRK-----SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~-----tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
..+.....+|.|++|.||.+..+. +.+.||+|.+.... .......+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 456778889999999999999754 45679999885432 122457799999999999999999999999998999
Q ss_pred EEEEEeccCchHHHHHhhcc--------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEee
Q psy48 887 FVVMEKLQGDMLEMILSSEK--------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~--------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~D 958 (1098)
++||||+++++|..++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~---~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR---EVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC---cEEEcc
Confidence 99999999999998886443 1589999999999999999999999999999999999999988 899999
Q ss_pred cCcccccC-------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCC
Q psy48 959 FGFARIIG-------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPP 1022 (1098)
Q Consensus 959 FGla~~~~-------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~ 1022 (1098)
||++.... ..++|||.+.+..++.++||||||+++|+|++ |..||....+ ....+......++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~- 239 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP- 239 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC-
Confidence 99986431 12689999998889999999999999999998 8889965322 2222222222121
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
....++..+.+++.+||..||++||++.+++..
T Consensus 240 -~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 -VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 224578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=282.26 Aligned_cols=232 Identities=19% Similarity=0.253 Sum_probs=183.7
Q ss_pred eeeeeeeeceEEEEee--cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHR--KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k--~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|++|.||.+... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+...+++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 4799999999999754 4567899999865432 333457889999999999999999999999999999999999999
Q ss_pred hHHHHHhhcc----CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-------
Q psy48 897 MLEMILSSEK----GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------- 965 (1098)
Q Consensus 897 sL~~~l~~~~----~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------- 965 (1098)
+|..++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~---~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL---TVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC---cEEECCccccccccCcceee
Confidence 9988886432 2456778889999999999999999999999999999999987 8999999988532
Q ss_pred -------CCCCCChhhhccC-------CCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHH--H-HHHhhccCCC-CCCC
Q psy48 966 -------GEKSFPPEVLRNK-------GYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINE--Q-IQNAAFMYPP-RPWR 1026 (1098)
Q Consensus 966 -------~~~~~APEvl~~~-------~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~--~-i~~~~~~~p~-~~~~ 1026 (1098)
...++|||++.+. .++.++||||||+++|||++ |..||........ . +.......+. ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 1236899998642 35789999999999999996 9999975432211 1 1111111111 1112
Q ss_pred cCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1027 DISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1027 ~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
..++.+.+++.+|| .+|++|||+++|+.
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 46788999999999 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=279.73 Aligned_cols=236 Identities=18% Similarity=0.268 Sum_probs=195.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...+.....+|.|+++.||.+... .+..+|+|.++.. ......+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 456788999999999999999754 4567999998643 2335678899999999999999999999887 7889999
Q ss_pred EeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 891 EKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
||+++++|..++... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~---~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL---VCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC---cEEECCCcceeeccCCC
Confidence 999999998888653 34678889999999999999999999999999999999999988 89999999886432
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..++|||++.+..++.++|+||||+++|+|++ |..||...... .........+.......++.++.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERGYRMPRPENCPEELYNI 235 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHhCCCCCCCcccCCHHHHHH
Confidence 12579999998889999999999999999998 99999765322 1111222222333345688999999
Q ss_pred HHHhhhhcccCCCCHHHHHc
Q psy48 1036 INNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.+||..||++||++.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=262.94 Aligned_cols=243 Identities=27% Similarity=0.403 Sum_probs=201.5
Q ss_pred eeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccC
Q psy48 816 YNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 816 ~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
.-..||.|++|+||.+..+.+++.||+|.++.+..++.......+|+-+|+.++|.|||++++....+..+.+|+|||..
T Consensus 6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq 85 (292)
T KOG0662|consen 6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_pred HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH
Confidence 34678999999999999999999999999987765566668889999999999999999999999999999999999975
Q ss_pred chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCC-------
Q psy48 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK------- 968 (1098)
Q Consensus 896 gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~------- 968 (1098)
. |..+...-++.++...++.++.|++.||.|+|+++++||||||.|.||+.+| .+||+|||+++..+.+
T Consensus 86 d-lkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng---elkladfglarafgipvrcysae 161 (292)
T KOG0662|consen 86 D-LKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG---ELKLADFGLARAFGIPVRCYSAE 161 (292)
T ss_pred H-HHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC---cEEecccchhhhcCCceEeeece
Confidence 5 5567666778899999999999999999999999999999999999999999 8999999999876554
Q ss_pred -----CCChhhhccC-CCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHH--HhhccCCCCCCC-------------
Q psy48 969 -----SFPPEVLRNK-GYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQ--NAAFMYPPRPWR------------- 1026 (1098)
Q Consensus 969 -----~~APEvl~~~-~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~--~~~~~~p~~~~~------------- 1026 (1098)
|.+|.++.|. -|+.+.|+||.||++.|+.. |++.|.+.+-..+... ...-......|.
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ 241 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI 241 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence 3478888764 49999999999999999986 6666666543222221 111111111121
Q ss_pred ------------cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1027 ------------DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1027 ------------~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.++...++++.++|.-+|..|.++++.++||||.+.
T Consensus 242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 234457899999999999999999999999999874
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=281.68 Aligned_cols=237 Identities=22% Similarity=0.275 Sum_probs=192.7
Q ss_pred eeeeeeeeeeeeeceEEEEeec---CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC------
Q psy48 814 MTYNVALCIAVVAGAACGVHRK---SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG------ 884 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~---tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~------ 884 (1098)
|++...||.|++|.||.+..+. +++.||||+++.........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 3456789999999999998654 5789999999876655666778999999999999999999999875432
Q ss_pred cEEEEEEeccCchHHHHHhhc-----cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeec
Q psy48 885 RIFVVMEKLQGDMLEMILSSE-----KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~-----~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DF 959 (1098)
..+++++|+.+++|..++... ...+++..+..++.||+.||+|||++||+||||||+||+++.++ .++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~---~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM---TVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC---CEEECcc
Confidence 247899999999997776422 12478889999999999999999999999999999999999887 8999999
Q ss_pred CcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCC
Q psy48 960 GFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPP 1022 (1098)
Q Consensus 960 Gla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~ 1022 (1098)
|+++... ..+++||.+.+..++.++||||||+++|+|++ |..||..... ....+.... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---~~ 234 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN---RL 234 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC---cC
Confidence 9987542 23468999999899999999999999999999 8899876543 222222211 11
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
......+..+.+++.+||..+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1223577899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=286.90 Aligned_cols=236 Identities=21% Similarity=0.317 Sum_probs=194.5
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCc----eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGR----GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~----~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.+.....||.|++|.||.+.+..+++ .||+|++.... .......+.+|+.+++.++||||+++++++... ..++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 34566789999999999999988887 46888876432 233345788999999999999999999998754 4679
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
++||+++++|..++......+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~---~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN---HVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC---ceEEccccccccccCc
Confidence 9999999999888876666789999999999999999999999999999999999999887 89999999986431
Q ss_pred ------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHH
Q psy48 967 ------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 967 ------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
..++|||.+.+..++.++||||||+++|||++ |..||.+.. +..+.+... ...+ .+...+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~ 239 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG-ERLP--QPPICTID 239 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCC--CCCCCCHH
Confidence 24689999999999999999999999999997 899997642 232333221 1112 23457789
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.+++.+||..+|++||+++++++.
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=307.07 Aligned_cols=215 Identities=25% Similarity=0.344 Sum_probs=183.8
Q ss_pred eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhh-ccCccchhHHHHH
Q psy48 839 GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSS-EKGRLSERTTKFI 917 (1098)
Q Consensus 839 ~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~-~~~~lse~~~~~i 917 (1098)
.||||.++...... ....|.+|+.+|.+++|+|+++||+...+ ..+.+|||++++|+|.+.|+. ....|-...+..|
T Consensus 140 ~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdy 217 (1039)
T KOG0199|consen 140 NVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDY 217 (1039)
T ss_pred eEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHH
Confidence 69999998765443 56889999999999999999999999988 678899999999999888876 4567889999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCC---------------CCChhhhccCCCCc
Q psy48 918 ITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK---------------SFPPEVLRNKGYNR 982 (1098)
Q Consensus 918 a~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~---------------~~APEvl~~~~ys~ 982 (1098)
+.||+.||.||.++++|||||..+||||-... .|||+|||+.+.++.. |.|||.++...++.
T Consensus 218 a~QiA~aM~YLeskrlvHRDLAARNlllaspr---tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSh 294 (1039)
T KOG0199|consen 218 AMQIAKAMQYLESKRLVHRDLAARNLLLASPR---TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSH 294 (1039)
T ss_pred HHHHHHHHHHHhhhhhhhhhhhhhhheecccc---eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccc
Confidence 99999999999999999999999999999876 8999999999866432 35999999999999
Q ss_pred hhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 983 SLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 983 ~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
++|||+|||+||||++ |+.||.+... +.+.+..... .+ .++.+|+++.+++++||..+|++||+|..|.+.-+.
T Consensus 295 aSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er-Lp--RPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 295 ASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER-LP--RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred cchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-CC--CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 9999999999999998 7899987643 3333332222 22 235699999999999999999999999999877666
Q ss_pred CC
Q psy48 1060 QD 1061 (1098)
Q Consensus 1060 k~ 1061 (1098)
+.
T Consensus 372 ~e 373 (1039)
T KOG0199|consen 372 AE 373 (1039)
T ss_pred Hh
Confidence 64
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=298.53 Aligned_cols=209 Identities=27% Similarity=0.383 Sum_probs=180.5
Q ss_pred eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHH
Q psy48 839 GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFII 918 (1098)
Q Consensus 839 ~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia 918 (1098)
-||||..+.+- ..++.+.|..|..+|+.++||||++|+|++... ..+||||+++.|-|..+++++...++......|+
T Consensus 420 aVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~ 497 (974)
T KOG4257|consen 420 AVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYC 497 (974)
T ss_pred eeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHH
Confidence 38999997643 455578899999999999999999999999765 6899999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-------------CCCChhhhccCCCCchhH
Q psy48 919 TQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE-------------KSFPPEVLRNKGYNRSLD 985 (1098)
Q Consensus 919 ~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~-------------~~~APEvl~~~~ys~~sD 985 (1098)
.||+.||+|||++.+|||||..+|||+.+.. -+||+|||+++.+.. .|||||.+.-..++.++|
T Consensus 498 ~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~---CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASD 574 (974)
T KOG4257|consen 498 YQICTALAYLESKRFVHRDIAARNILVSSPQ---CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASD 574 (974)
T ss_pred HHHHHHHHHHHhhchhhhhhhhhheeecCcc---eeeecccchhhhccccchhhccccccceeecCccccchhcccchhh
Confidence 9999999999999999999999999999887 799999999986533 468999999999999999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 986 MWSVGVIVYVSLS-GTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 986 VwSLGvlLyELlt-G~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
||-|||.+||++. |..||.+- .+..-.+.+... ...+.++|+.+..|+.+||+++|.+||.+.+|..
T Consensus 575 VWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR---lP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 575 VWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER---LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHHHHHHHHhcCCccccccccceEEEecCCCC---CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 9999999999875 99999864 333333333332 2224579999999999999999999999876543
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=279.10 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=208.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--------
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP-------- 883 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~-------- 883 (1098)
+.|.....+|.|.||.||.|..+.+|+.||+|++-.++..........+|+.+|..++|+|++.++++|.+.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345556678999999999999999999999998754443333445677899999999999999999988443
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
..+|+||++|+.+. .-++.....+|+..++.+++.+++.||.|+|...|+|||+|+.|+||+.+| .+||+|||+++
T Consensus 97 ~t~ylVf~~cehDL-aGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg---ilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDL-AGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG---ILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhhhH-HHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc---eEEeecccccc
Confidence 34899999998764 467776667899999999999999999999999999999999999999999 89999999996
Q ss_pred ccC----------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH--HHHhhccCCCCC
Q psy48 964 IIG----------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ--IQNAAFMYPPRP 1024 (1098)
Q Consensus 964 ~~~----------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~--i~~~~~~~p~~~ 1024 (1098)
.+. -.|.+||.+.| ..|++..|||+.||++.||.+|.+.+.++.+..+. |....-...++.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 432 22459999986 56999999999999999999999999887655332 222222222222
Q ss_pred CCc-------------------------------CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCc-chhHHHH
Q psy48 1025 WRD-------------------------------ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATW-SDLRGLE 1072 (1098)
Q Consensus 1025 ~~~-------------------------------is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~-~~~~~l~ 1072 (1098)
|.+ -.+++.+|+..+|..||.+|+.++++++|.||....-. .|+.++-
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqanl~~ml 332 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQANLQDML 332 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchhhHHHHH
Confidence 321 13478999999999999999999999999999864443 6676666
Q ss_pred hh
Q psy48 1073 RQ 1074 (1098)
Q Consensus 1073 ~~ 1074 (1098)
.+
T Consensus 333 ~t 334 (376)
T KOG0669|consen 333 ST 334 (376)
T ss_pred HH
Confidence 65
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=269.21 Aligned_cols=231 Identities=41% Similarity=0.664 Sum_probs=193.7
Q ss_pred eeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHh
Q psy48 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILS 903 (1098)
Q Consensus 824 ~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~ 903 (1098)
++|.+|.+....+++.||+|++........ ...+.+|++.++.++|+||+++++++......+++|||+++++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 367899999999999999999976433221 5789999999999999999999999999999999999999999988876
Q ss_pred hccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----------CCCCh
Q psy48 904 SEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE-----------KSFPP 972 (1098)
Q Consensus 904 ~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~-----------~~~AP 972 (1098)
... .+++..+..++.+++.+|.+||+.||+|+||+|+||+++.++ .++|+|||++..... .+++|
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG---HVKLADFGLARQLDPGGLLTTFVGTPEYMAP 155 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC---cEEEccccceeeeccccccccccCCcCCCCH
Confidence 433 389999999999999999999999999999999999999987 899999999875543 35799
Q ss_pred hhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCC--CCCCcCcHHHHHHHHHhhhhcccCCCCH
Q psy48 973 EVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPP--RPWRDISSDAIDLINNLLQVKQRKRLSV 1050 (1098)
Q Consensus 973 Evl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~--~~~~~is~el~~LL~~cL~~dP~kRPSa 1050 (1098)
|.+.+..++.++|+||||+++|+|++|..||....+.............. ..+..++.++.+++.+||..+|++||++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 235 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA 235 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence 99998889999999999999999999999997632222222222111111 1111288999999999999999999999
Q ss_pred HHHHcCCCc
Q psy48 1051 DKSLAHPWL 1059 (1098)
Q Consensus 1051 ~eIL~HpfF 1059 (1098)
.++++||||
T Consensus 236 ~~~~~~~~~ 244 (244)
T smart00220 236 EEALQHPFF 244 (244)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=294.22 Aligned_cols=235 Identities=22% Similarity=0.280 Sum_probs=202.1
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
.+-...||.|.||.||.+++++-.-.||||.++.+ ....++|..|..+|+.++|||+|+|+++|.....+|||+|||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 34456799999999999999999999999999753 345689999999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccC-ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----
Q psy48 894 QGDMLEMILSSEKG-RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----- 967 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~-~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----- 967 (1098)
..|+|.++|+.-++ .++...++.++.||..||.||..+++|||||..+|+|+..+. .||++|||+++.+..
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh---iVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH---IVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc---eEEeeccchhhhhcCCceec
Confidence 99999899875443 467777889999999999999999999999999999999887 899999999987633
Q ss_pred --------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 968 --------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 968 --------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
.|.|||-+..+.++.++|||+|||+|||+.| |..||.+-+-. +.+.-....|....+..+++.+.+|++.
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-qVY~LLEkgyRM~~PeGCPpkVYeLMra 501 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYGLLEKGYRMDGPEGCPPKVYELMRA 501 (1157)
T ss_pred ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHHHhccccccCCCCCCHHHHHHHHH
Confidence 2359999999999999999999999999998 88999875421 2222223344445567899999999999
Q ss_pred hhhhcccCCCCHHHHHc
Q psy48 1039 LLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1039 cL~~dP~kRPSa~eIL~ 1055 (1098)
||+.+|..||++++|-+
T Consensus 502 CW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 502 CWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HhcCCcccCccHHHHHH
Confidence 99999999999988754
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=305.36 Aligned_cols=243 Identities=21% Similarity=0.389 Sum_probs=215.2
Q ss_pred HHHHHhhheeeeeeeeeeeeeceEEEEeecCCc---eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec
Q psy48 806 SFLLMLVFMTYNVALCIAVVAGAACGVHRKSGR---GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET 882 (1098)
Q Consensus 806 ~~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~---~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~ 882 (1098)
.....-...++..+||.|.||.|+.+..+..|+ .||||.+|. .....+...|..|+.||-++.||||++|.+....
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 334445667889999999999999999887764 699999965 4567778999999999999999999999999999
Q ss_pred CCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 883 PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 883 ~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
...+.||+|||+.|+|+.||++..+.|...++.-+++.|+.||.||-+.|+|||||..+|||++.+- .+|++|||++
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL---vCKVsDFGLS 778 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL---VCKVSDFGLS 778 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce---EEEeccccce
Confidence 9999999999999999999999999999999999999999999999999999999999999999998 8999999999
Q ss_pred cccCC---------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCC--ChhHHHHHHHhhccCCCCC
Q psy48 963 RIIGE---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNE--DEDINEQIQNAAFMYPPRP 1024 (1098)
Q Consensus 963 ~~~~~---------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~--~~~~~~~i~~~~~~~p~~~ 1024 (1098)
+.+.. +|.|||.+...+++.++||||||++|||.|+ |..||-+ +.+....+.+.....|
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp--- 855 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP--- 855 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC---
Confidence 86622 2359999999999999999999999999886 9999965 4566666655544333
Q ss_pred CCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1025 WRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1025 ~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+-++|..+..|+..||++|-++||.+.+|+.
T Consensus 856 PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 856 PMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 4579999999999999999999999999986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-29 Score=274.26 Aligned_cols=232 Identities=16% Similarity=0.221 Sum_probs=180.4
Q ss_pred eeeeeeeeceEEEEeecC--CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 819 ALCIAVVAGAACGVHRKS--GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~t--g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
.||.|.+|.||.+..... ...+++|.++... .......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 478999999999875433 2345666665432 2334578999999999999999999999999999999999999999
Q ss_pred hHHHHHhhcc---CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--------
Q psy48 897 MLEMILSSEK---GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-------- 965 (1098)
Q Consensus 897 sL~~~l~~~~---~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-------- 965 (1098)
+|..++.+.. ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++ .++|+|||++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~---~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL---TVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc---cEEecccccccccCcchhhhc
Confidence 9988886532 3466778889999999999999999999999999999999988 8999999987531
Q ss_pred ------CCCCCChhhhcc-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCChhH--HHH-HHHhhccC-CCCCCCc
Q psy48 966 ------GEKSFPPEVLRN-------KGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDI--NEQ-IQNAAFMY-PPRPWRD 1027 (1098)
Q Consensus 966 ------~~~~~APEvl~~-------~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~--~~~-i~~~~~~~-p~~~~~~ 1027 (1098)
...++|||++.. ..++.++||||||+++|||++ |..||....+. ... +....... .+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP 237 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence 124689999853 346789999999999999997 56788654322 222 22211111 1222235
Q ss_pred CcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1028 ISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+++.+.+++..|| .+|++||++++|++
T Consensus 238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 238 YSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 7889999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=285.63 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=196.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC--CCC----ceeeeeeeecCC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC--HPG----VVNLERMFETPG 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~--Hpn----Iv~L~~~f~~~~ 884 (1098)
..+|..-..+|.|.||.|....+..++..||||+++.. ..-.++.+-|+++|+++. .|+ ++++.++|...+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 45677778899999999999999999999999999642 334466778999999884 333 788999999999
Q ss_pred cEEEEEEeccCchHHHHHhh-ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC--------------
Q psy48 885 RIFVVMEKLQGDMLEMILSS-EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS-------------- 949 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~-~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g-------------- 949 (1098)
+.+||+|.++- ++.+++.. .-.+|+..+++.+++||+.+++|||+.+++|-||||+|||+.+..
T Consensus 165 hiCivfellG~-S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 165 HICIVFELLGL-STFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred ceEEEEeccCh-hHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 99999999844 55577764 345799999999999999999999999999999999999984311
Q ss_pred ---CCCcEEEeecCccccc---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--HHHH
Q psy48 950 ---ELPQVKLCDFGFARII---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQN 1015 (1098)
Q Consensus 950 ---~~~~vKL~DFGla~~~---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~i~~ 1015 (1098)
....|+|+|||.|++. +..|.|||++.+-+++..+||||+||||+|+++|...|...++.+. .++.
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer 323 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER 323 (415)
T ss_pred ccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence 1237999999999754 4456799999999999999999999999999999999986543221 1111
Q ss_pred hhccCCC----------------CCCCc--------------------------CcHHHHHHHHHhhhhcccCCCCHHHH
Q psy48 1016 AAFMYPP----------------RPWRD--------------------------ISSDAIDLINNLLQVKQRKRLSVDKS 1053 (1098)
Q Consensus 1016 ~~~~~p~----------------~~~~~--------------------------is~el~~LL~~cL~~dP~kRPSa~eI 1053 (1098)
.....|. ..|.+ --.++.+||++||..||.+|+|+.|+
T Consensus 324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA 403 (415)
T KOG0671|consen 324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA 403 (415)
T ss_pred hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence 1111110 00110 01258999999999999999999999
Q ss_pred HcCCCcCCC
Q psy48 1054 LAHPWLQDP 1062 (1098)
Q Consensus 1054 L~HpfFk~~ 1062 (1098)
|.||||+..
T Consensus 404 L~HpFF~~~ 412 (415)
T KOG0671|consen 404 LSHPFFARL 412 (415)
T ss_pred hcCHHhhcC
Confidence 999999874
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=287.31 Aligned_cols=237 Identities=18% Similarity=0.228 Sum_probs=196.3
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
...+...||.|.||.+-..+... +..||||+++... .......|.+|+++|.+++||||+.|++.|..++.+++||||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecC-ceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 35678899999999999987543 7899999997543 344468899999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCc-cchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 893 LQGDMLEMILSSEKGR-LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~-lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
++.|+|..++.....+ ........++.||+.||+||.+.++|||||.++|+|++.+. ++||+||||++-+
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~---~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF---TIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc---cEEecCcccccccccCCce
Confidence 9999999998755433 46677888999999999999999999999999999999999 9999999999832
Q ss_pred --------CCCCCChhhhccCCCCchhHHHHHHHHHHHHH--cCCCCCCCCh--hHHHHHHHhhc-----cCCCCCCCcC
Q psy48 966 --------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSL--SGTFPFNEDE--DINEQIQNAAF-----MYPPRPWRDI 1028 (1098)
Q Consensus 966 --------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELl--tG~~Pf~~~~--~~~~~i~~~~~-----~~p~~~~~~i 1028 (1098)
..+|||||.+...+++.++|+|+|||+|||++ +.+.||.... ...+.....-. .++. .+.-+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~-~P~~c 772 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS-RPPAC 772 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc-CCCcC
Confidence 34568999999999999999999999999976 4789997532 22222221111 1111 13457
Q ss_pred cHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1029 SSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+..+.++|.+||..|-++||+++++..
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 899999999999999999999999854
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=272.52 Aligned_cols=239 Identities=14% Similarity=0.111 Sum_probs=177.8
Q ss_pred hheeeeeeeeeeeeeceEEEEeecC---CceeEEEEEeccCCChHHH---------HHHHHHHHHHhccCCCCceeeeee
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKS---GRGVAIKVIDKLRFPTKQE---------AQLKNEVAILQNLCHPGVVNLERM 879 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~t---g~~VAVKvlkk~~~~~~~~---------~~~~~Ei~iL~~l~HpnIv~L~~~ 879 (1098)
..|.+...||.|+||.||.+.+..+ +..+|+|+........... .....+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4688899999999999999998887 7778888754332111111 111223344556789999999987
Q ss_pred eecCC----cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEE
Q psy48 880 FETPG----RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVK 955 (1098)
Q Consensus 880 f~~~~----~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vK 955 (1098)
+.... ..+++|+++..... ..+. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++ .++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~---~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTK-EIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN---RGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhccCHH-HHHH-hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---cEE
Confidence 65543 34778888755433 3433 223467888999999999999999999999999999999999887 899
Q ss_pred EeecCccccc-------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh---HHHHH
Q psy48 956 LCDFGFARII-------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED---INEQI 1013 (1098)
Q Consensus 956 L~DFGla~~~-------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~---~~~~i 1013 (1098)
|+|||+|+.. +..|+|||++.+..++.++|||||||+||||++|..||..... .....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 9999998643 1235799999999999999999999999999999999975521 11111
Q ss_pred HH---hhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1014 QN---AAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1014 ~~---~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.. .............++++.+++..|+..+|++||++.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 KCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00 0001111123456899999999999999999999999875
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=306.90 Aligned_cols=235 Identities=25% Similarity=0.369 Sum_probs=188.8
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec----------------
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET---------------- 882 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~---------------- 882 (1098)
.||.|+||.|+.+..+-+|+.||||.|.... +......+.+|+.+|.+++|||||+++..|..
T Consensus 486 lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 486 LLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 5789999999999999999999999997644 45556789999999999999999998766510
Q ss_pred ---------------------------------------C----------------------------------------
Q psy48 883 ---------------------------------------P---------------------------------------- 883 (1098)
Q Consensus 883 ---------------------------------------~---------------------------------------- 883 (1098)
.
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence 0
Q ss_pred ------------------------CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy48 884 ------------------------GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLK 939 (1098)
Q Consensus 884 ------------------------~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLK 939 (1098)
..+||-||||+..+++.++..+...-....+++++++|+.||+|+|++||||||||
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLK 724 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLK 724 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCC
Confidence 12688999999999988876543222578899999999999999999999999999
Q ss_pred CCceeecCCCCCCcEEEeecCccccc------------------------------CCCCCChhhhccC---CCCchhHH
Q psy48 940 PENVLLSTNSELPQVKLCDFGFARII------------------------------GEKSFPPEVLRNK---GYNRSLDM 986 (1098)
Q Consensus 940 p~NILld~~g~~~~vKL~DFGla~~~------------------------------~~~~~APEvl~~~---~ys~~sDV 986 (1098)
|.||++++++ .|||+|||+|+.. +.-|+|||++.+. .|+.++|+
T Consensus 725 P~NIFLd~~~---~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDm 801 (1351)
T KOG1035|consen 725 PRNIFLDSRN---SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDM 801 (1351)
T ss_pred cceeEEcCCC---CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhh
Confidence 9999999888 8999999999751 1113699999764 49999999
Q ss_pred HHHHHHHHHHHcCCCCCCCChhH---HHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcC
Q psy48 987 WSVGVIVYVSLSGTFPFNEDEDI---NEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060 (1098)
Q Consensus 987 wSLGvlLyELltG~~Pf~~~~~~---~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk 1060 (1098)
|||||||+||+. ||...-+- ...++......+...+.+--+.-.++|.+|++.||++||||.|+|++.||-
T Consensus 802 YSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 802 YSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 999999999986 46654332 223333333333222444446778999999999999999999999999998
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=270.06 Aligned_cols=241 Identities=26% Similarity=0.410 Sum_probs=203.2
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHh-ccCCCCceeeeeeeecCCcEEEEEEeccCch
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQ-NLCHPGVVNLERMFETPGRIFVVMEKLQGDM 897 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~-~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggs 897 (1098)
.+|.|.||.|....|+.+|+..|||.++..+. ..+..++..|..+.. .-+.||||++|+..-.++..++.||+|.-+.
T Consensus 71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~Sl 149 (361)
T KOG1006|consen 71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISL 149 (361)
T ss_pred HhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhH
Confidence 58999999999999999999999999987654 344467777877654 4478999999999999999999999996432
Q ss_pred --HHHHH-hhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCccccc--------
Q psy48 898 --LEMIL-SSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-------- 965 (1098)
Q Consensus 898 --L~~~l-~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-------- 965 (1098)
|+.+. ..+...+++..+-.+...++.||.||-. ..|||||+||+|||++..| .+||+|||++..+
T Consensus 150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G---~vKLCDFGIcGqLv~SiAkT~ 226 (361)
T KOG1006|consen 150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG---DVKLCDFGICGQLVDSIAKTV 226 (361)
T ss_pred HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC---CEeeecccchHhHHHHHHhhh
Confidence 22222 2345679999999999999999999994 5899999999999999999 8999999998543
Q ss_pred ---CCCCCChhhhc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCC-----CcCcHHHHHH
Q psy48 966 ---GEKSFPPEVLR--NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPW-----RDISSDAIDL 1035 (1098)
Q Consensus 966 ---~~~~~APEvl~--~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~-----~~is~el~~L 1035 (1098)
-.+|||||.+. +..|+.++|+||||++|||+.||.+||.+-...++++......-|+... ..++..+..+
T Consensus 227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~f 306 (361)
T KOG1006|consen 227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRF 306 (361)
T ss_pred ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHH
Confidence 34689999996 4469999999999999999999999999998888888877766555432 2478899999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
|.-||.+|-+.||...+++++||++.+.
T Consensus 307 intCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 307 INTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred HHHHhhcccccCcchhhhhcCchhhhhh
Confidence 9999999999999999999999999643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=290.57 Aligned_cols=225 Identities=24% Similarity=0.326 Sum_probs=161.8
Q ss_pred ecCCceeEEEEEeccCCCh------------HHHHHHHHHHHHHhccCCCCc-----eeeeeeeec--------CCcEEE
Q psy48 834 RKSGRGVAIKVIDKLRFPT------------KQEAQLKNEVAILQNLCHPGV-----VNLERMFET--------PGRIFV 888 (1098)
Q Consensus 834 k~tg~~VAVKvlkk~~~~~------------~~~~~~~~Ei~iL~~l~HpnI-----v~L~~~f~~--------~~~l~L 888 (1098)
...++.||||.++...... ...+....|+.++.+++|.++ +.++++|.. .+..++
T Consensus 183 ~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~L 262 (507)
T PLN03224 183 EQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWL 262 (507)
T ss_pred cccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEE
Confidence 3456789999986432110 011223346666667766543 666777643 356899
Q ss_pred EEEeccCchHHHHHhhccC-----------------------ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q psy48 889 VMEKLQGDMLEMILSSEKG-----------------------RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~-----------------------~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILl 945 (1098)
||||+++++|.+++....+ .+++..++.++.||+.||.|||+.+|+||||||+|||+
T Consensus 263 V~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl 342 (507)
T PLN03224 263 VWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV 342 (507)
T ss_pred EEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE
Confidence 9999999999888764321 23567788999999999999999999999999999999
Q ss_pred cCCCCCCcEEEeecCccccc-------------CCCCCChhhhccCC--------------------CC--chhHHHHHH
Q psy48 946 STNSELPQVKLCDFGFARII-------------GEKSFPPEVLRNKG--------------------YN--RSLDMWSVG 990 (1098)
Q Consensus 946 d~~g~~~~vKL~DFGla~~~-------------~~~~~APEvl~~~~--------------------ys--~~sDVwSLG 990 (1098)
+.++ .+||+|||++... +..|+|||++.... |+ ...||||+|
T Consensus 343 ~~~~---~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlG 419 (507)
T PLN03224 343 TVDG---QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAG 419 (507)
T ss_pred CCCC---cEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHH
Confidence 9988 8999999998542 34578999986432 11 247999999
Q ss_pred HHHHHHHcCCC-CCCCChhHHHHH-----------HHhhccCCCCCCCcCcHHHHHHHHHhhhhcc---cCCCCHHHHHc
Q psy48 991 VIVYVSLSGTF-PFNEDEDINEQI-----------QNAAFMYPPRPWRDISSDAIDLINNLLQVKQ---RKRLSVDKSLA 1055 (1098)
Q Consensus 991 vlLyELltG~~-Pf~~~~~~~~~i-----------~~~~~~~p~~~~~~is~el~~LL~~cL~~dP---~kRPSa~eIL~ 1055 (1098)
|++|+|++|.. ||.........+ ......+....+..+++++.+|+.+||..+| .+|+|++|+|+
T Consensus 420 vil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 420 VLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 99999999985 765321111111 1111112223356688999999999999876 68999999999
Q ss_pred CCCcCC
Q psy48 1056 HPWLQD 1061 (1098)
Q Consensus 1056 HpfFk~ 1061 (1098)
||||..
T Consensus 500 Hp~f~~ 505 (507)
T PLN03224 500 HRFFLP 505 (507)
T ss_pred CCCcCC
Confidence 999975
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=298.41 Aligned_cols=211 Identities=25% Similarity=0.399 Sum_probs=183.6
Q ss_pred ceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhcc----------
Q psy48 838 RGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEK---------- 906 (1098)
Q Consensus 838 ~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~---------- 906 (1098)
..||||.++..... .+...+..|+.+|+.+ .|+||+.+++++..++.+++|+||+..|+|..++....
T Consensus 329 ~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~ 407 (609)
T KOG0200|consen 329 VTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGV 407 (609)
T ss_pred EEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCC
Confidence 37999999765544 6778999999999988 59999999999999999999999999999999998666
Q ss_pred -----CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---------------C
Q psy48 907 -----GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------------G 966 (1098)
Q Consensus 907 -----~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---------------~ 966 (1098)
..++..+.+.++.||+.||+||+++++|||||-.+|||+..+. .+||+|||+|+.. .
T Consensus 408 ~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~---~~kIaDFGlar~~~~~~~y~~~~~~~~LP 484 (609)
T KOG0200|consen 408 FPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK---VIKIADFGLARDHYNKDYYRTKSSAGTLP 484 (609)
T ss_pred CccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC---EEEEccccceeccCCCCceEecCCCCccc
Confidence 3488999999999999999999999999999999999999997 8999999999732 2
Q ss_pred CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCC---ChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 967 EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNE---DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 967 ~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~---~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
-.|||||.+....|+.++|||||||+||||++ |..||.+ ..++.+.+.... ....+..++.++.++++.||..
T Consensus 485 ~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~---r~~~P~~c~~eiY~iM~~CW~~ 561 (609)
T KOG0200|consen 485 VKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN---RMEQPEHCSDEIYDLMKSCWNA 561 (609)
T ss_pred eeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC---CCCCCCCCCHHHHHHHHHHhCC
Confidence 23799999999999999999999999999998 8899987 445544444443 3334456899999999999999
Q ss_pred cccCCCCHHHHHc
Q psy48 1043 KQRKRLSVDKSLA 1055 (1098)
Q Consensus 1043 dP~kRPSa~eIL~ 1055 (1098)
+|++||++.++.+
T Consensus 562 ~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 562 DPEDRPTFSECVE 574 (609)
T ss_pred CcccCCCHHHHHH
Confidence 9999999998887
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=291.96 Aligned_cols=245 Identities=26% Similarity=0.405 Sum_probs=206.5
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeee-----cCCcE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFE-----TPGRI 886 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~-----~~~~l 886 (1098)
.+.+...+|.|++|.||.+.++++++.+|||++... .+..+++..|.++|+.. .|||++.++++|. .++.+
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 467889999999999999999999999999998653 34456778889999877 5999999999983 34689
Q ss_pred EEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 887 FVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+||||||+||+..++...- ..++.|..+..|+++++.||.+||...++|||||-+|||++.++ .|||+|||.+..+
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~---~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA---EVKLVDFGVSAQL 173 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC---cEEEeeeeeeeee
Confidence 9999999999999887643 45799999999999999999999999999999999999999999 8999999987532
Q ss_pred ------------CCCCCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCC-CCCc
Q psy48 966 ------------GEKSFPPEVLRN-----KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPR-PWRD 1027 (1098)
Q Consensus 966 ------------~~~~~APEvl~~-----~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~-~~~~ 1027 (1098)
++-|||||++.- ..|+..+|+||||++..||.-|.+|+.........++...-..|.. .|..
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence 233699999963 4478899999999999999999999987665544433322222211 2567
Q ss_pred CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1028 ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
.++++.+||..||.+|-++||+..++++|||.++..
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 889999999999999999999999999999999643
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=289.40 Aligned_cols=209 Identities=22% Similarity=0.337 Sum_probs=181.9
Q ss_pred eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHH
Q psy48 839 GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFII 918 (1098)
Q Consensus 839 ~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia 918 (1098)
+||||++.... ......++.+|+-+|..++||||++|++++.... +.||++|+++|.|.++++..+..+-....+.|.
T Consensus 727 pVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~ 804 (1177)
T KOG1025|consen 727 PVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWC 804 (1177)
T ss_pred eeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHH
Confidence 79999986532 3344578999999999999999999999998876 889999999999999999888899999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC--------------CCCChhhhccCCCCchh
Q psy48 919 TQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE--------------KSFPPEVLRNKGYNRSL 984 (1098)
Q Consensus 919 ~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~--------------~~~APEvl~~~~ys~~s 984 (1098)
.||++||.|||.++++||||-.+||||..-. ++||.|||+++.... +|||-|.++...|+.++
T Consensus 805 ~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~---hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqS 881 (1177)
T KOG1025|consen 805 YQIAKGMKYLEEQRLVHRDLAARNVLVKSPN---HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQS 881 (1177)
T ss_pred HHHHHHHHHHHhcchhhhhhhhhheeecCCC---eEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchh
Confidence 9999999999999999999999999999887 999999999986532 24688888999999999
Q ss_pred HHHHHHHHHHHHHc-CCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 985 DMWSVGVIVYVSLS-GTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 985 DVwSLGvlLyELlt-G~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
|||||||++||+|| |..||.+. +++-+.+....... .+..++-++.-++.+||..|++.||+|+++..
T Consensus 882 DVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLs---qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 882 DVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLS---QPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred hhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCC---CCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 99999999999998 99999864 56666666555422 23468999999999999999999999987764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=293.82 Aligned_cols=242 Identities=20% Similarity=0.264 Sum_probs=169.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecC----CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeee------e
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKS----GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERM------F 880 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~t----g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~------f 880 (1098)
...|.....||.|+||.||.+.+..+ +..||||.+.... ..+...+| .++...+.++..+... .
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 45688899999999999999999999 9999999986422 11111111 1112222222222222 2
Q ss_pred ecCCcEEEEEEeccCchHHHHHhhccCc-------------------cchhHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy48 881 ETPGRIFVVMEKLQGDMLEMILSSEKGR-------------------LSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941 (1098)
Q Consensus 881 ~~~~~l~LVmEy~~ggsL~~~l~~~~~~-------------------lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~ 941 (1098)
.....+++||||+++++|..++...... .....+..++.||+.||.|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 4556799999999999998887643211 123446689999999999999999999999999
Q ss_pred ceeecCC-CCCCcEEEeecCccccc-------------CCCCCChhhhccC----------------------CCCchhH
Q psy48 942 NVLLSTN-SELPQVKLCDFGFARII-------------GEKSFPPEVLRNK----------------------GYNRSLD 985 (1098)
Q Consensus 942 NILld~~-g~~~~vKL~DFGla~~~-------------~~~~~APEvl~~~----------------------~ys~~sD 985 (1098)
|||++.+ + .+||+|||+|+.. +..|+|||.+... .++.++|
T Consensus 285 NILl~~~~~---~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 285 NIIFSEGSG---SFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HEEEeCCCC---cEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999864 5 7999999999643 2357899976432 2345669
Q ss_pred HHHHHHHHHHHHcCCCCCCCChhH-HHHHHHhhc-------cCCCCC----------CCcCcHHHHHHHHHhhhhcccCC
Q psy48 986 MWSVGVIVYVSLSGTFPFNEDEDI-NEQIQNAAF-------MYPPRP----------WRDISSDAIDLINNLLQVKQRKR 1047 (1098)
Q Consensus 986 VwSLGvlLyELltG~~Pf~~~~~~-~~~i~~~~~-------~~p~~~----------~~~is~el~~LL~~cL~~dP~kR 1047 (1098)
||||||+||||+++..++...... ...+..... ..+... +...+.++.+||.+||++||++|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 999999999999987776543211 111111100 000000 01123345689999999999999
Q ss_pred CCHHHHHcCCCcCC
Q psy48 1048 LSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1048 PSa~eIL~HpfFk~ 1061 (1098)
||+.++|+||||+.
T Consensus 442 ~ta~e~L~Hpff~~ 455 (566)
T PLN03225 442 ISAKAALAHPYFDR 455 (566)
T ss_pred CCHHHHhCCcCcCC
Confidence 99999999999997
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=277.94 Aligned_cols=246 Identities=24% Similarity=0.397 Sum_probs=199.5
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC------CCCceeeeeeeecC
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC------HPGVVNLERMFETP 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~------HpnIv~L~~~f~~~ 883 (1098)
.-.+|......|.|.|+.|..|.+...|..||||+|..... -...=..|+++|++|. --++++|+..|...
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 34577888889999999999999999999999999975321 1244567999999885 24799999999999
Q ss_pred CcEEEEEEeccCchHHHHHhhcc--CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEK--GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGF 961 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~--~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGl 961 (1098)
+++|||+|-+.- +|..++..-+ ..|....++.|+.|++.||..|-..||+|.||||+|||++.... .+||||||.
T Consensus 507 nHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~--iLKLCDfGS 583 (752)
T KOG0670|consen 507 NHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN--ILKLCDFGS 583 (752)
T ss_pred ceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc--eeeeccCcc
Confidence 999999998854 4666765433 35889999999999999999999999999999999999998764 799999999
Q ss_pred ccccCCCC----------CChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCC-----
Q psy48 962 ARIIGEKS----------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRP----- 1024 (1098)
Q Consensus 962 a~~~~~~~----------~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~----- 1024 (1098)
|...+.+. .|||++.|.+|+...|+||+||+||||+||+..|.+. ..+....+...-.+|...
T Consensus 584 A~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq 663 (752)
T KOG0670|consen 584 ASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ 663 (752)
T ss_pred ccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence 98776542 4999999999999999999999999999999999865 333333333222222110
Q ss_pred ---------------------------------C-C----------cCc-------HHHHHHHHHhhhhcccCCCCHHHH
Q psy48 1025 ---------------------------------W-R----------DIS-------SDAIDLINNLLQVKQRKRLSVDKS 1053 (1098)
Q Consensus 1025 ---------------------------------~-~----------~is-------~el~~LL~~cL~~dP~kRPSa~eI 1053 (1098)
+ . .++ ..+.+||.+||..||++|.|+.++
T Consensus 664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA 743 (752)
T KOG0670|consen 664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA 743 (752)
T ss_pred hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence 0 0 011 257899999999999999999999
Q ss_pred HcCCCcCC
Q psy48 1054 LAHPWLQD 1061 (1098)
Q Consensus 1054 L~HpfFk~ 1061 (1098)
|.||||+.
T Consensus 744 L~HpFi~~ 751 (752)
T KOG0670|consen 744 LKHPFITE 751 (752)
T ss_pred hcCCcccC
Confidence 99999975
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=287.16 Aligned_cols=188 Identities=32% Similarity=0.511 Sum_probs=163.8
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC------cEEEEE
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG------RIFVVM 890 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~------~l~LVm 890 (1098)
...||.|+||.||.+.++.+|+.||||.+++.. .....+...+|+++|++++|+|||+++++=.+.. ...+||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 467899999999999999999999999998754 3344577889999999999999999999875544 578999
Q ss_pred EeccCchHHHHHhhccC--ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCC-CCcEEEeecCcccccCC
Q psy48 891 EKLQGDMLEMILSSEKG--RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE-LPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~--~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~-~~~vKL~DFGla~~~~~ 967 (1098)
|||.||+|+..+.+... .|++..++.++.++..||.|||++||+||||||.||++....+ ....||+|||.|+.+..
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d 176 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDD 176 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCC
Confidence 99999999999986543 5999999999999999999999999999999999999865442 22579999999986533
Q ss_pred -----------CCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q psy48 968 -----------KSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNE 1005 (1098)
Q Consensus 968 -----------~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~ 1005 (1098)
.|++||++.. +.|+..+|.|||||++|+.+||..||..
T Consensus 177 ~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 177 NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 4579999984 8899999999999999999999999964
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=251.50 Aligned_cols=238 Identities=25% Similarity=0.464 Sum_probs=195.5
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecC--CcEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETP--GRIFVV 889 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~--~~l~LV 889 (1098)
.|.....+|-|.++.||.+....+++.++||+++ +.....+.+|+.+|+.++ ||||++|+++..+. ....+|
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4455567888999999999999999999999997 344678999999999996 99999999999776 457899
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCCC
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS 969 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~~ 969 (1098)
+||++..+...+.. .|+..+++.++.+|+.||.|+|+.||+|||+||.|+|||.... .++|+|+|+|.+.-+..
T Consensus 114 FE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r--kLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc--eeeeeecchHhhcCCCc
Confidence 99999998866643 4888999999999999999999999999999999999997764 79999999998764432
Q ss_pred -----------CChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCh----------------hHHHHHHHhhccC-
Q psy48 970 -----------FPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDE----------------DINEQIQNAAFMY- 1020 (1098)
Q Consensus 970 -----------~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~----------------~~~~~i~~~~~~~- 1020 (1098)
--||.+.. +.|+.+-|+|||||+|..|+..+.||.... ++...+..-....
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 27999864 669999999999999999999999996321 2222222211111
Q ss_pred ----------CCCCCC---------cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1021 ----------PPRPWR---------DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1021 ----------p~~~~~---------~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
....|. -+++++.+||.++|.+|-.+|+|+.|++.||||..
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 122232 35799999999999999999999999999999985
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=289.63 Aligned_cols=218 Identities=28% Similarity=0.429 Sum_probs=171.2
Q ss_pred CceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhc--cCcc-chh
Q psy48 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSE--KGRL-SER 912 (1098)
Q Consensus 837 g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~--~~~l-se~ 912 (1098)
|+.||||.+- .+...-..+|+..|+.- .|||||++++.-++...+||..|+|... |.+++... ...+ ...
T Consensus 533 ~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~s-L~dlie~~~~d~~~~~~i 606 (903)
T KOG1027|consen 533 GREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACS-LQDLIESSGLDVEMQSDI 606 (903)
T ss_pred CceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhh-HHHHHhccccchhhcccc
Confidence 4589999874 33345678999999877 5999999999999999999999999764 66777653 1111 125
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---CCCCCcEEEeecCcccccC---------------CCCCChhh
Q psy48 913 TTKFIITQILVALKHLHSKNIVHCDLKPENVLLST---NSELPQVKLCDFGFARIIG---------------EKSFPPEV 974 (1098)
Q Consensus 913 ~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~---~g~~~~vKL~DFGla~~~~---------------~~~~APEv 974 (1098)
..+.++.|++.||++||+.+||||||||.||||.. ++ ..+++|+|||+++.+. ..|+|||+
T Consensus 607 ~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~-~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~ 685 (903)
T KOG1027|consen 607 DPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADG-TLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQ 685 (903)
T ss_pred cHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCc-ceeEEecccccccccCCCcchhhcccCCCCcccccCHHH
Confidence 56889999999999999999999999999999986 33 2389999999998652 23589999
Q ss_pred hccCCCCchhHHHHHHHHHHHHHcC-CCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHH
Q psy48 975 LRNKGYNRSLDMWSVGVIVYVSLSG-TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053 (1098)
Q Consensus 975 l~~~~ys~~sDVwSLGvlLyELltG-~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eI 1053 (1098)
+....-+.++|||||||++|+.++| .+||...-+-...|............ .-..++.+||.+|+..+|..||++.+|
T Consensus 686 L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~-~~d~eA~dLI~~ml~~dP~~RPsa~~V 764 (903)
T KOG1027|consen 686 LREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEP-LPDCEAKDLISRMLNPDPQLRPSATDV 764 (903)
T ss_pred HhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeecc-CchHHHHHHHHHhcCCCcccCCCHHHH
Confidence 9988888899999999999999886 89998765443444333322111000 111289999999999999999999999
Q ss_pred HcCCCcCCC
Q psy48 1054 LAHPWLQDP 1062 (1098)
Q Consensus 1054 L~HpfFk~~ 1062 (1098)
|.||||-+.
T Consensus 765 L~HPlFW~~ 773 (903)
T KOG1027|consen 765 LNHPLFWDS 773 (903)
T ss_pred hCCCccCCh
Confidence 999999753
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=261.89 Aligned_cols=252 Identities=28% Similarity=0.480 Sum_probs=197.0
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC------Cc
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP------GR 885 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~------~~ 885 (1098)
.+|..-.-++.|.- .+..|.+.-.+++||+|.+..............+|..++..+.|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34444445555655 677788999999999999977755555567889999999999999999999999544 34
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
.|+|||++....-...+ ..++-..+..++.|++.|+++||+.||+||||||+||++..+. .+||.|||+|+..
T Consensus 96 ~y~v~e~m~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~---~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC---TLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhhhhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh---heeeccchhhccc
Confidence 89999999766443333 3478889999999999999999999999999999999999998 8999999999755
Q ss_pred CCC-----------CCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc---------------
Q psy48 966 GEK-----------SFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM--------------- 1019 (1098)
Q Consensus 966 ~~~-----------~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~--------------- 1019 (1098)
+.. |.|||++.+..|...+||||+||++.||++|...|.+.+.+.+..+.....
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 443 249999999999999999999999999999999887654333222211111
Q ss_pred ------------------CCCCCCC-------cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1020 ------------------YPPRPWR-------DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1020 ------------------~p~~~~~-------~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
+|...|. .-+..+++++.+||-.||++|.+++++|.||||+ -|-+.+..+..
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~---vw~~~~ev~ap 325 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK---VWYDPDEVEAP 325 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee---eecccccccCC
Confidence 1111111 1134589999999999999999999999999999 47665544443
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=266.23 Aligned_cols=243 Identities=29% Similarity=0.470 Sum_probs=200.2
Q ss_pred eeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHH-----HHHHHHHHHHHhccCCCCceeeeeeeec-CCcEEEE
Q psy48 816 YNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQ-----EAQLKNEVAILQNLCHPGVVNLERMFET-PGRIFVV 889 (1098)
Q Consensus 816 ~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~-----~~~~~~Ei~iL~~l~HpnIv~L~~~f~~-~~~l~LV 889 (1098)
.-..||.|+|+.||.|.+....+.||||+-.....-.+. .....+|..|.+.|.||.||++|++|.- .+.+|-|
T Consensus 467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence 334578999999999999999999999996432211111 2456789999999999999999999954 4678999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC--CccccCCCCCceeecCCCCCCcEEEeecCcccccCC
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK--NIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~--gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~ 967 (1098)
+|||+|.+|+.++. +...+++..++.|+.||+.||.||... .|||-||||.|||+-.......|||+|||++++...
T Consensus 547 LEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdd 625 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDD 625 (775)
T ss_pred eeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccC
Confidence 99999999988886 455789999999999999999999976 599999999999998766555899999999986632
Q ss_pred C-------------------CCChhhhc-c---CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHH------Hhhc
Q psy48 968 K-------------------SFPPEVLR-N---KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ------NAAF 1018 (1098)
Q Consensus 968 ~-------------------~~APEvl~-~---~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~------~~~~ 1018 (1098)
. |++||.+. + ...+.++||||+||++|+.+.|+.||..+....+.++ ....
T Consensus 626 dSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEV 705 (775)
T KOG1151|consen 626 DSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEV 705 (775)
T ss_pred CccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceec
Confidence 2 35899875 3 2368899999999999999999999987754444433 3344
Q ss_pred cCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1019 MYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1019 ~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+|+.+ -++.++.+||++||++--+.|..+.++-.||||.-
T Consensus 706 qFP~KP--vVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 706 QFPPKP--VVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred cCCCCC--ccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 566554 48999999999999999999999999999999975
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=261.83 Aligned_cols=249 Identities=29% Similarity=0.414 Sum_probs=197.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-----C---CCceeeeeeeec
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-----H---PGVVNLERMFET 882 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-----H---pnIv~L~~~f~~ 882 (1098)
.++|-....||+|-|++||++.+..+.+.||+|+.+.. ..-.+....||.+|++++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 37888899999999999999999999999999999742 233467788999999874 2 359999999954
Q ss_pred C----CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCC---------
Q psy48 883 P----GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTN--------- 948 (1098)
Q Consensus 883 ~----~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~--------- 948 (1098)
. .++++|+|+++..+|.-+....-..++...+..|++||+.||.|||. .||||-||||+|||+..+
T Consensus 154 sGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred cCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 3 57999999998887765555555679999999999999999999995 599999999999999110
Q ss_pred -----------------------------------------------------------------------------CC-
Q psy48 949 -----------------------------------------------------------------------------SE- 950 (1098)
Q Consensus 949 -----------------------------------------------------------------------------g~- 950 (1098)
+.
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence 00
Q ss_pred ----------------------------------------------------------------------------CCcE
Q psy48 951 ----------------------------------------------------------------------------LPQV 954 (1098)
Q Consensus 951 ----------------------------------------------------------------------------~~~v 954 (1098)
..++
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 0157
Q ss_pred EEeecCccccc---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCC--------ChhHHHHHHHhh
Q psy48 955 KLCDFGFARII---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNE--------DEDINEQIQNAA 1017 (1098)
Q Consensus 955 KL~DFGla~~~---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~--------~~~~~~~i~~~~ 1017 (1098)
||+|||.|.+. +.+|.|||++.|..|+..+||||++|++|||+||...|.. +++-...+.+..
T Consensus 394 KIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELL 473 (590)
T KOG1290|consen 394 KIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELL 473 (590)
T ss_pred EEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHH
Confidence 99999998764 4456799999999999999999999999999999998852 223333333332
Q ss_pred ccCCCC-------------------------CCC---------cC----cHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1018 FMYPPR-------------------------PWR---------DI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1018 ~~~p~~-------------------------~~~---------~i----s~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
..+|.. +|. .+ ..++.+||.-||+.+|++||||.++|+|||+
T Consensus 474 G~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwL 553 (590)
T KOG1290|consen 474 GKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWL 553 (590)
T ss_pred hhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccc
Confidence 222211 111 11 3468899999999999999999999999999
Q ss_pred CCC
Q psy48 1060 QDP 1062 (1098)
Q Consensus 1060 k~~ 1062 (1098)
+..
T Consensus 554 n~~ 556 (590)
T KOG1290|consen 554 NPV 556 (590)
T ss_pred cCC
Confidence 963
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=305.47 Aligned_cols=231 Identities=20% Similarity=0.283 Sum_probs=181.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..+.....+|.|.+|.||.+.+..++..||||.++.... ...+|++++++++||||+++++++.+.+..++|||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 445667789999999999999999999999999864321 12346888999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHH---hCCccccCCCCCceeecCCCCCCcEEEeecCcccc----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLH---SKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI---- 964 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LH---s~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~---- 964 (1098)
|+++++|.+++. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++ ..++. ||....
T Consensus 764 y~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~---~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 764 YIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD---EPHLR-LSLPGLLCTD 835 (968)
T ss_pred CCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC---ceEEE-eccccccccC
Confidence 999999999885 3889999999999999999999 66999999999999999877 45553 554432
Q ss_pred ----cCCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh----hHHHHHHHhh------ccCCCCC------
Q psy48 965 ----IGEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE----DINEQIQNAA------FMYPPRP------ 1024 (1098)
Q Consensus 965 ----~~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~----~~~~~i~~~~------~~~p~~~------ 1024 (1098)
....|+|||++.+..|+.++|||||||++|||++|+.||.... ...+...... ....+..
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 1256899999999999999999999999999999999985321 1111111100 0000000
Q ss_pred CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1025 WRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1025 ~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
......++.+++.+||+.||++||++.++++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00112357789999999999999999999863
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-28 Score=264.35 Aligned_cols=152 Identities=27% Similarity=0.437 Sum_probs=108.5
Q ss_pred CCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCCCCccCC--CCCCcccccccc-cccc
Q psy48 263 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPVTNN--KSNNYCKLKSEV-ASLV 339 (1098)
Q Consensus 263 ~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~~~~~~~--~~~~~~~~~~~~-~~~~ 339 (1098)
...|+|+++.|.+.++|..|.+.|||++||||+|.+|++.|||||+..|+..|+.+..... +..+........ .+..
T Consensus 128 ~ngh~fqakr~nrr~~c~ic~d~iwglgrqgyrcinckl~vhkkch~~v~~~cg~~~~~~~~~p~~p~~~s~~~~~~~s~ 207 (593)
T KOG0695|consen 128 ANGHLFQAKRFNRRAYCGICSDRIWGLGRQGYRCINCKLLVHKKCHGLVPLTCGKHMDSVMPSPEPPVDDSNEDADLPSE 207 (593)
T ss_pred hcCcchhhhhhccceeeeechhhhhhcccccceeecceeehhhhhcccccchhhhhccCCCCCCCCCCCCccccCCCCch
Confidence 3589999999999999999999999999999999999999999999999999987643222 111111111110 0000
Q ss_pred ------ccccccccccccCCCCCCC-CCCC----CCCCCCCccCCCccceeecCCCChhhH-------------------
Q psy48 340 ------SLESSASASYSCLVPKGEG-RQDI----TNSELPQVKLCDFGFARIIGEKSFRRS------------------- 389 (1098)
Q Consensus 340 ------~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~L~DF~~lkVlGkGSfgKV------------------- 389 (1098)
..++++. .+.....+++ .+.+ ....+..++|.||++|+|||||||+||
T Consensus 208 ~t~~~~~i~~~~~--he~~~~~~~~~~~a~~~m~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkk 285 (593)
T KOG0695|consen 208 ETDGIAYISSSRK--HESIKDDSEDLKPAIDGMDGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKK 285 (593)
T ss_pred hcCcccccCcccc--chhhhcCccchhhhhhhccccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHH
Confidence 0001100 0111111111 1111 122345689999999999999999999
Q ss_pred --------------------------------------------------------------------------HHHhhc
Q psy48 390 --------------------------------------------------------------------------ILVALK 395 (1098)
Q Consensus 390 --------------------------------------------------------------------------~la~lk 395 (1098)
|..+|+
T Consensus 286 el~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~ 365 (593)
T KOG0695|consen 286 ELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALN 365 (593)
T ss_pred HhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHH
Confidence 888999
Q ss_pred cccccccccccCCCCCccCCC
Q psy48 396 HLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 396 ~LH~k~IihRDLK~dNvLld~ 416 (1098)
|||++||||||||+||||||+
T Consensus 366 flh~rgiiyrdlkldnvllda 386 (593)
T KOG0695|consen 366 FLHERGIIYRDLKLDNVLLDA 386 (593)
T ss_pred HHhhcCeeeeeccccceEEcc
Confidence 999999999999999999999
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=262.67 Aligned_cols=205 Identities=23% Similarity=0.359 Sum_probs=158.9
Q ss_pred CceeEEEEEeccCCChHHHHHHHHHHHHHh--ccCCCCceeeeeeeecCC----cEEEEEEeccCchHHHHHhhccCccc
Q psy48 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAILQ--NLCHPGVVNLERMFETPG----RIFVVMEKLQGDMLEMILSSEKGRLS 910 (1098)
Q Consensus 837 g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~--~l~HpnIv~L~~~f~~~~----~l~LVmEy~~ggsL~~~l~~~~~~ls 910 (1098)
++.||||++. ..+.+.+.+|.+|+. .++|+||++++++-.... .+.||++|.+.|+|.++|.. ..++
T Consensus 233 ~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~--ntis 305 (534)
T KOG3653|consen 233 NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA--NTIS 305 (534)
T ss_pred CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh--cccc
Confidence 4689999985 566788999999987 558999999999875554 79999999999999999964 4589
Q ss_pred hhHHHHHHHHHHHHHHHHHhC---------CccccCCCCCceeecCCCCCCcEEEeecCccccc--------------CC
Q psy48 911 ERTTKFIITQILVALKHLHSK---------NIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--------------GE 967 (1098)
Q Consensus 911 e~~~~~ia~qIa~gL~~LHs~---------gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--------------~~ 967 (1098)
+....+++..+++||+|||+. .|+|||||+.||||.+|+ +..|+|||+|..+ +.
T Consensus 306 w~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl---TccIaDFGLAl~~~p~~~~~d~~~qVGT~ 382 (534)
T KOG3653|consen 306 WNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL---TCCIADFGLALRLEPGKPQGDTHGQVGTR 382 (534)
T ss_pred HHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC---cEEeeccceeEEecCCCCCcchhhhhhhh
Confidence 999999999999999999953 599999999999999999 8999999999654 34
Q ss_pred CCCChhhhccCC-CC-----chhHHHHHHHHHHHHHcCC------------CCCC---CChhHHHHHHHhhccCC-----
Q psy48 968 KSFPPEVLRNKG-YN-----RSLDMWSVGVIVYVSLSGT------------FPFN---EDEDINEQIQNAAFMYP----- 1021 (1098)
Q Consensus 968 ~~~APEvl~~~~-ys-----~~sDVwSLGvlLyELltG~------------~Pf~---~~~~~~~~i~~~~~~~p----- 1021 (1098)
+|||||++.+.- +. .+.||||+|.+||||+++- .||. +.....+.++.......
T Consensus 383 RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~ 462 (534)
T KOG3653|consen 383 RYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKI 462 (534)
T ss_pred hhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCC
Confidence 579999997632 22 5799999999999999852 3443 11222222332222211
Q ss_pred CCCCCc--CcHHHHHHHHHhhhhcccCCCCHH
Q psy48 1022 PRPWRD--ISSDAIDLINNLLQVKQRKRLSVD 1051 (1098)
Q Consensus 1022 ~~~~~~--is~el~~LL~~cL~~dP~kRPSa~ 1051 (1098)
+..|.. -..-+.+.+..||..||+.|+|+.
T Consensus 463 p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 463 PDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred hhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 112322 234578999999999999999973
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=224.95 Aligned_cols=201 Identities=39% Similarity=0.600 Sum_probs=179.4
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHH
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~ 899 (1098)
+|.|.++.+|.+....+++.+++|++....... ....+.+|+++++.++|++|+++++++......+++|||+.|++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 478899999999999899999999997643222 3578999999999999999999999999999999999999999998
Q ss_pred HHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCCCCcEEEeecCcccccCC-----------
Q psy48 900 MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST-NSELPQVKLCDFGFARIIGE----------- 967 (1098)
Q Consensus 900 ~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~-~g~~~~vKL~DFGla~~~~~----------- 967 (1098)
.++......++...++.++.+++.+|++||+.|++|+||+|.||+++. ++ .++|+|||++.....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG---KVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC---cEEEecCCceEEccCCcchhhcccCC
Confidence 888754356899999999999999999999999999999999999998 66 899999999875433
Q ss_pred -CCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhccc
Q psy48 968 -KSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQR 1045 (1098)
Q Consensus 968 -~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~ 1045 (1098)
.+++||.+... .++.+.|+|++|+++++| ..+.+++.+|+..||+
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~ 203 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPE 203 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcc
Confidence 24699999877 889999999999999999 5899999999999999
Q ss_pred CCCCHHHHHcCC
Q psy48 1046 KRLSVDKSLAHP 1057 (1098)
Q Consensus 1046 kRPSa~eIL~Hp 1057 (1098)
+||++.++++|+
T Consensus 204 ~R~~~~~l~~~~ 215 (215)
T cd00180 204 KRPSAKEILEHL 215 (215)
T ss_pred cCcCHHHHhhCC
Confidence 999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=244.70 Aligned_cols=239 Identities=28% Similarity=0.460 Sum_probs=188.6
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC-----cEEEEEEe
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG-----RIFVVMEK 892 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~-----~l~LVmEy 892 (1098)
.-||.|.||-||.+.+.++|+.||+|.+......-...+.+.+|+.+|..++|.|++..+++.+-.. .+|+|+|+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 4589999999999999999999999998654333344578999999999999999999988876553 36788888
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCC----
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK---- 968 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~---- 968 (1098)
+.. +|..++. ....++...+.-++.||+.||.|||+.||+||||||.|.|++++- .+||+|||+++.....
T Consensus 139 mQS-DLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC---vLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 139 MQS-DLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC---ILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHh-hhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc---eEEecccccccccchhhhhh
Confidence 854 4434443 344688999999999999999999999999999999999999987 8999999999865432
Q ss_pred ---------CCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc-------------------
Q psy48 969 ---------SFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM------------------- 1019 (1098)
Q Consensus 969 ---------~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~------------------- 1019 (1098)
|.|||++.| ..|+.++||||+||++.||+..+..|.....+.+.-......
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 359999987 459999999999999999999998887554332221111111
Q ss_pred --CCCCCC-----------CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1020 --YPPRPW-----------RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1020 --~p~~~~-----------~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+...+ ..-..+...++..+|..||++|.+.++.+.|++..+
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 111110 112346888999999999999999999999999864
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=229.22 Aligned_cols=201 Identities=25% Similarity=0.399 Sum_probs=168.4
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
..||.|.+|.+-...|..+|...|+|.++... +.+....+.+|+.+..+. ..|++|++|+.......+++.||.+.-
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 35889999999999999999999999997654 344556777888876544 689999999999999999999999964
Q ss_pred hHHHHHh---hccCccchhHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCCCCcEEEeecCccccc-------
Q psy48 897 MLEMILS---SEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------- 965 (1098)
Q Consensus 897 sL~~~l~---~~~~~lse~~~~~ia~qIa~gL~~LHs~-gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------- 965 (1098)
+|+.+.. .+.+..++..+-+++..++.||.|||++ .+||||+||.|||++.+| ++||+|||++..+
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G---qVKiCDFGIsG~L~dSiAkt 206 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG---QVKICDFGISGYLVDSIAKT 206 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC---cEEEcccccceeehhhhHHH
Confidence 3444432 3566799999999999999999999976 799999999999999999 9999999998644
Q ss_pred ----CCCCCChhhhc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCC
Q psy48 966 ----GEKSFPPEVLR----NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPR 1023 (1098)
Q Consensus 966 ----~~~~~APEvl~----~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~ 1023 (1098)
-.+|||||.+. ...|+.++||||||++++||.++++||......++++.+.....++.
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 34679999986 34799999999999999999999999998777777777665554443
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-26 Score=265.76 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=210.1
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|..-+.+|.|++|.||.+.++.+++..|||+++.+. .++..-++.|+-+++..+||||+.+++.+.....+++.|||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 3455688999999999999999999999999998753 45567788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc--------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI-------- 964 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~-------- 964 (1098)
|+||+|.++.+ -.+++++.++....++.++||+|||+.|-+|||||-.|||+.+.| .+|++|||.+..
T Consensus 94 cgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g---DvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 94 CGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG---DVKLADFGVSAQITATIAKR 169 (829)
T ss_pred cCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC---ceeecccCchhhhhhhhhhh
Confidence 99999988765 567899999999999999999999999999999999999999999 899999997632
Q ss_pred ---c-CCCCCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCC---CCcCcHHHHH
Q psy48 965 ---I-GEKSFPPEVLR---NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRP---WRDISSDAID 1034 (1098)
Q Consensus 965 ---~-~~~~~APEvl~---~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~---~~~is~el~~ 1034 (1098)
+ ++.|||||+.. ...|+..+|||++|++..|+---++|...............-.+.+.. ....++.+.+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence 2 34469999974 566999999999999999999888887766555554444443333222 2356788999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
|++.+|.++|.+||+++.+|.|||....
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999999999985
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=241.49 Aligned_cols=210 Identities=20% Similarity=0.317 Sum_probs=174.0
Q ss_pred eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec-CCcEEEEEEeccCchHHHHHhhc-------cCccc
Q psy48 839 GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET-PGRIFVVMEKLQGDMLEMILSSE-------KGRLS 910 (1098)
Q Consensus 839 ~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~-~~~l~LVmEy~~ggsL~~~l~~~-------~~~ls 910 (1098)
.|-+|.++ ...++-+...+..|.-+|..+.|||++.+.+.... ....++++.+.+-++|..++..- ...++
T Consensus 316 ~v~vKTvk-~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvt 394 (563)
T KOG1024|consen 316 EVLVKTVK-QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVT 394 (563)
T ss_pred HHHHHHHH-hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchh
Confidence 34555553 33445566788889999999999999999998754 45688899999999999998722 22477
Q ss_pred hhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--------------CCCCChhhhc
Q psy48 911 ERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--------------EKSFPPEVLR 976 (1098)
Q Consensus 911 e~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--------------~~~~APEvl~ 976 (1098)
..++..++.|++.||+|||++|+||.||..+|.+||+.- ++||+|-.+++.+- -+||+||.+.
T Consensus 395 t~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L---qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~ 471 (563)
T KOG1024|consen 395 TIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL---QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ 471 (563)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe---eEEeccchhccccCcccccccCCCCCCcccccCHHHHh
Confidence 888999999999999999999999999999999999887 99999999987541 2368999999
Q ss_pred cCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHH
Q psy48 977 NKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053 (1098)
Q Consensus 977 ~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eI 1053 (1098)
+..|+.++|+|||||+||||+| |+.||.+-+ +....++. .+....+-++|+++..++.-||+.+|++||+++|+
T Consensus 472 n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd---GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Ql 548 (563)
T KOG1024|consen 472 NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD---GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQL 548 (563)
T ss_pred hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc---cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHH
Confidence 9999999999999999999998 899998654 33344443 34444557899999999999999999999999998
Q ss_pred Hc
Q psy48 1054 LA 1055 (1098)
Q Consensus 1054 L~ 1055 (1098)
..
T Consensus 549 v~ 550 (563)
T KOG1024|consen 549 VI 550 (563)
T ss_pred HH
Confidence 75
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=245.21 Aligned_cols=229 Identities=20% Similarity=0.332 Sum_probs=177.7
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHh--ccCCCCceeeeeeeecC----CcEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQ--NLCHPGVVNLERMFETP----GRIF 887 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~--~l~HpnIv~L~~~f~~~----~~l~ 887 (1098)
.+....+|.|.||.||.+..+ |+.||||++. ..++..+.+|.+|++ .++|+||+.+++.-..+ .+++
T Consensus 213 I~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~-----srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFS-----SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred eEEEEEecCccccceeecccc--CCceEEEEec-----ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 345778999999999999875 8899999985 344667788888887 55999999999886444 2599
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceeecCCCCCCcEEEeec
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK--------NIVHCDLKPENVLLSTNSELPQVKLCDF 959 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~--------gIvHrDLKp~NILld~~g~~~~vKL~DF 959 (1098)
||++|.+.|+|.++|.. ..++....++++..++.||++||.. .|.|||||+.||||.+++ ...|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~---~C~IADL 360 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG---TCCIADL 360 (513)
T ss_pred EeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC---cEEEeec
Confidence 99999999999999964 5699999999999999999999943 499999999999999999 8999999
Q ss_pred Cccccc----------------CCCCCChhhhccCC----C--CchhHHHHHHHHHHHHHcC----------CCCCCC--
Q psy48 960 GFARII----------------GEKSFPPEVLRNKG----Y--NRSLDMWSVGVIVYVSLSG----------TFPFNE-- 1005 (1098)
Q Consensus 960 Gla~~~----------------~~~~~APEvl~~~~----y--s~~sDVwSLGvlLyELltG----------~~Pf~~-- 1005 (1098)
|+|... +.+|||||++...- + -..+||||||+++||+... ++||.+
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 998432 34579999997532 1 2579999999999999752 578863
Q ss_pred -ChhHHHHHHHhhcc---CC--CCCCCcCc--HHHHHHHHHhhhhcccCCCCHHHHH
Q psy48 1006 -DEDINEQIQNAAFM---YP--PRPWRDIS--SDAIDLINNLLQVKQRKRLSVDKSL 1054 (1098)
Q Consensus 1006 -~~~~~~~i~~~~~~---~p--~~~~~~is--~el~~LL~~cL~~dP~kRPSa~eIL 1054 (1098)
.+..++.+.+.... .| +..|...+ ..+..+++.||..||..|.|+-.|.
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 22223333322221 12 22343322 3467889999999999999986554
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=246.43 Aligned_cols=250 Identities=24% Similarity=0.411 Sum_probs=199.4
Q ss_pred HHHHHHHHHhhheeeeeeeeeeeeeceEEEEeec---CCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeee
Q psy48 802 QITMSFLLMLVFMTYNVALCIAVVAGAACGVHRK---SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLE 877 (1098)
Q Consensus 802 ~~~~~~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~---tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~ 877 (1098)
+..-.+......|.....+|.|.|+.||.+.+.. ..+.||+|.+... .....+.+|+++|..+ .+.||+++.
T Consensus 26 ~l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~ 101 (418)
T KOG1167|consen 26 QLRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLN 101 (418)
T ss_pred HHHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcch
Confidence 3444566677888889999999999999999887 7889999998653 3346789999999988 599999999
Q ss_pred eeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEe
Q psy48 878 RMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957 (1098)
Q Consensus 878 ~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~ 957 (1098)
+++..++...+||||++.....+++. .++...+..|++.++.||.++|..|||||||||.|+|.+.... +-.|+
T Consensus 102 ~~~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~--rg~Lv 175 (418)
T KOG1167|consen 102 GCFRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ--RGVLV 175 (418)
T ss_pred hhhccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC--CceEE
Confidence 99999999999999999998888865 3778999999999999999999999999999999999987654 78999
Q ss_pred ecCccccc-----------------CC---------------------------------------CCCChhhhcc-CCC
Q psy48 958 DFGFARII-----------------GE---------------------------------------KSFPPEVLRN-KGY 980 (1098)
Q Consensus 958 DFGla~~~-----------------~~---------------------------------------~~~APEvl~~-~~y 980 (1098)
|||+|... .+ .+.|||++.. ...
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 99998511 00 0138999865 447
Q ss_pred CchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHH------------Hhhcc-----------------------------
Q psy48 981 NRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ------------NAAFM----------------------------- 1019 (1098)
Q Consensus 981 s~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~------------~~~~~----------------------------- 1019 (1098)
+.++||||.||+++-++++++||....+....+. +....
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 8899999999999999999999963321111110 00000
Q ss_pred -CC-------CCCCCc-CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1020 -YP-------PRPWRD-ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1020 -~p-------~~~~~~-is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
++ ...|.+ .+..+.+|+.+||+.||.+|.|+++.|+||||.+
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00 001111 2457899999999999999999999999999996
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=279.14 Aligned_cols=191 Identities=18% Similarity=0.191 Sum_probs=146.8
Q ss_pred cCC-CCceeeeeee-------ecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy48 868 LCH-PGVVNLERMF-------ETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLK 939 (1098)
Q Consensus 868 l~H-pnIv~L~~~f-------~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLK 939 (1098)
++| .||..++++| .....++++|||++ ++|..++......+++.+++.++.||+.||.|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 345 5777777877 22346788899875 47888887666679999999999999999999999999999999
Q ss_pred CCceeecCCC----------------CCCcEEEeecCccccc----------------------------CCCCCChhhh
Q psy48 940 PENVLLSTNS----------------ELPQVKLCDFGFARII----------------------------GEKSFPPEVL 975 (1098)
Q Consensus 940 p~NILld~~g----------------~~~~vKL~DFGla~~~----------------------------~~~~~APEvl 975 (1098)
|+||||+..+ ....+||+|||+++.. +..|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996422 1126788888887532 1227899999
Q ss_pred ccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 976 RNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 976 ~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.+..|+.++|||||||+||||++|..|+.........+.... .++... ....+..+++.+||..||.+||++.++++
T Consensus 188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRV--LPPQIL-LNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhh--cChhhh-hcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 999999999999999999999999998765433333332221 122111 12356778999999999999999999999
Q ss_pred CCCcCCC
Q psy48 1056 HPWLQDP 1062 (1098)
Q Consensus 1056 HpfFk~~ 1062 (1098)
||||+..
T Consensus 265 h~~~~~~ 271 (793)
T PLN00181 265 SEFINEP 271 (793)
T ss_pred chhhhhh
Confidence 9999874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-23 Score=219.76 Aligned_cols=188 Identities=41% Similarity=0.636 Sum_probs=166.3
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
|.+...++.|.++.+|.+.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 34667899999999999999999999999999765432 24678999999999999999999999999999999999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCC-----
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK----- 968 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~----- 968 (1098)
.+++|..++......+++..+..++.+++.+|.+||+.+++|+||+|.||+++.++ .++|+|||++......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~---~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG---LVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEeeCceeeEecCcccccc
Confidence 99999888765433389999999999999999999999999999999999999887 8999999988755332
Q ss_pred --------CCChhhh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q psy48 969 --------SFPPEVL-RNKGYNRSLDMWSVGVIVYVSLSGTFPFNE 1005 (1098)
Q Consensus 969 --------~~APEvl-~~~~ys~~sDVwSLGvlLyELltG~~Pf~~ 1005 (1098)
+++||.+ ....++.++|+|+||+++|+|++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4799999 677788899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=229.81 Aligned_cols=244 Identities=27% Similarity=0.400 Sum_probs=190.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeee-eecCCcEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERM-FETPGRIFV 888 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~-f~~~~~l~L 888 (1098)
...|.++..+|.|-||.+.++.|+.+...+++|.+.+.. .....|.+|..----| .|.||+.-|+. |++.+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 345677889999999999999999999999999997653 3346788888754444 48899887655 899999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCC
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK 968 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~ 968 (1098)
+|||++.|+|..-+. ...+-+....+++.|+++||.|+|++++||||||.+||||-... ..+|||+|||+.+..+..
T Consensus 100 ~qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eeccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeecccccccCce
Confidence 999999999976654 34588999999999999999999999999999999999996543 238999999999766543
Q ss_pred ---------CCChhhhccC-----CCCchhHHHHHHHHHHHHHcCCCCCCCC----hhHH--HHHHHhhccCCCCCCCcC
Q psy48 969 ---------SFPPEVLRNK-----GYNRSLDMWSVGVIVYVSLSGTFPFNED----EDIN--EQIQNAAFMYPPRPWRDI 1028 (1098)
Q Consensus 969 ---------~~APEvl~~~-----~ys~~sDVwSLGvlLyELltG~~Pf~~~----~~~~--~~i~~~~~~~p~~~~~~i 1028 (1098)
+-+||+.... ...+.+|+|.||+++|..|||.+||... ...- .+.+......-+..+..+
T Consensus 177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f 256 (378)
T KOG1345|consen 177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF 256 (378)
T ss_pred ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence 4588876532 2568999999999999999999999742 1111 111222222233345678
Q ss_pred cHHHHHHHHHhhhhcccCC---CCHHHHHcCCCcC
Q psy48 1029 SSDAIDLINNLLQVKQRKR---LSVDKSLAHPWLQ 1060 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~kR---PSa~eIL~HpfFk 1060 (1098)
++.+..+.++.|..++++| .++.......|..
T Consensus 257 s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 257 SEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred CHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 9999999999999999999 5666666655553
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-25 Score=255.11 Aligned_cols=247 Identities=29% Similarity=0.432 Sum_probs=211.1
Q ss_pred eeeeeeeceEEEE---eecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEEEEeccC
Q psy48 820 LCIAVVAGAACGV---HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 820 Lg~G~~g~v~~a~---~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
+|.|.+|.|+... ....|..||+|++++.............|..++...+ ||+++.++-.|+++..+++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 5778888888753 3466888999999886554444446667888888886 99999999999999999999999999
Q ss_pred chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--------CC
Q psy48 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--------GE 967 (1098)
Q Consensus 896 gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--------~~ 967 (1098)
+.+...+. ....+++.....+..+++.+++++|+.||+|||+|++||+++.+| ++++.|||+++.. +.
T Consensus 82 g~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G---hi~~tdfglske~v~~~~~cgt~ 157 (612)
T KOG0603|consen 82 GDLFTRLS-KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG---HIKLTDFGLSKEAVKEKIACGTY 157 (612)
T ss_pred chhhhccc-cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC---ccccCCchhhhHhHhhhhcccch
Confidence 99876665 455789999999999999999999999999999999999999999 9999999998743 44
Q ss_pred CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCC
Q psy48 968 KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKR 1047 (1098)
Q Consensus 968 ~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kR 1047 (1098)
.|||||++. ....++||||||++++||+||..||.. +....|.......|. .++.++++++..++..+|.+|
T Consensus 158 eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r~p~nr 229 (612)
T KOG0603|consen 158 EYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--DTMKRILKAELEMPR----ELSAEARSLFRQLFKRNPENR 229 (612)
T ss_pred hhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--HHHHHHhhhccCCch----hhhHHHHHHHHHHHhhCHHHH
Confidence 579999998 568899999999999999999999988 566667666666664 577899999999999999999
Q ss_pred CCH-----HHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCC
Q psy48 1048 LSV-----DKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKN 1082 (1098)
Q Consensus 1048 PSa-----~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~ 1082 (1098)
... .++++|+||+. +||.+|+.+ ..+|+++-
T Consensus 230 Lg~~~~~~~eik~h~f~~~----i~~~~l~~r~~~~~fkp~ 266 (612)
T KOG0603|consen 230 LGAGPDGVDEIKQHEFFQS----IDWNELEARSRPPPFKPG 266 (612)
T ss_pred hccCcchhHHHhccchhee----eeHhhHhhcCCCCCCCCc
Confidence 864 79999999999 888888888 77777654
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=247.01 Aligned_cols=189 Identities=30% Similarity=0.448 Sum_probs=166.0
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHH------HHHHHHHHHHHhccC---CCCceeeeeeeecC
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQ------EAQLKNEVAILQNLC---HPGVVNLERMFETP 883 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~------~~~~~~Ei~iL~~l~---HpnIv~L~~~f~~~ 883 (1098)
.|+.-+.||.|.||.|+.++++++...|+||.+.|+++-.+. ...+-.|++||..++ |+||++++.+|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 477788999999999999999999999999999987653221 234678999999997 99999999999999
Q ss_pred CcEEEEEEec-cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 884 GRIFVVMEKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 884 ~~l~LVmEy~-~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
+.+||+||-- +|-+|.+++. ...++++..+..|++|++.|+++||++||||||||-+|+.++.+| -+||+|||.|
T Consensus 642 d~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g---~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG---FVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC---eEEEeeccch
Confidence 9999999987 4677777775 556799999999999999999999999999999999999999999 8999999998
Q ss_pred cccC----------CCCCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q psy48 963 RIIG----------EKSFPPEVLRNKGY-NRSLDMWSVGVIVYVSLSGTFPFNE 1005 (1098)
Q Consensus 963 ~~~~----------~~~~APEvl~~~~y-s~~sDVwSLGvlLyELltG~~Pf~~ 1005 (1098)
.... -.+.|||++.|.+| +..-|||++|++||.++....||.+
T Consensus 718 a~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 6442 23469999999887 5778999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=212.04 Aligned_cols=155 Identities=24% Similarity=0.330 Sum_probs=124.7
Q ss_pred chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-------CCC
Q psy48 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-------GEK 968 (1098)
Q Consensus 896 gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-------~~~ 968 (1098)
|+|.+++......+++.+++.++.||+.||+|||+++ ||+|||++.++ .+++ ||++... +..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~---~~~~--fG~~~~~~~~~~~g~~~ 69 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG---LLKL--DGSVAFKTPEQSRVDPY 69 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc---ceee--ccceEeeccccCCCccc
Confidence 5677888766667999999999999999999999998 99999999988 7888 9998753 445
Q ss_pred CCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCC------CCCcCcH--HHHHHHHHhh
Q psy48 969 SFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPR------PWRDISS--DAIDLINNLL 1040 (1098)
Q Consensus 969 ~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~------~~~~is~--el~~LL~~cL 1040 (1098)
|+|||++.+..|+.++|||||||++|||++|+.||.........+.......... ....++. ++.++|.+||
T Consensus 70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl 149 (176)
T smart00750 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCA 149 (176)
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHH
Confidence 7899999999999999999999999999999999976533322222211111111 1123344 6999999999
Q ss_pred hhcccCCCCHHHHHcCCCcCC
Q psy48 1041 QVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1041 ~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..||++||++.++++|+|+..
T Consensus 150 ~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 150 SRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred hcccccccCHHHHHHHHHHHH
Confidence 999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-21 Score=237.13 Aligned_cols=243 Identities=24% Similarity=0.390 Sum_probs=193.4
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEecc---CCChHH-HHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKL---RFPTKQ-EAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~---~~~~~~-~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
+.....+|.|.+|.++.+......+.++.|..+.. ...... ...+..|+-+-..+.|+|++..+..+.......-+
T Consensus 320 ~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 320 GKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 35577889999999999998888888888876532 111111 12266677777888999998888887777666666
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
||||++ +|..++.. .+.+....+..++.||+.|++|||..||.|||||++|+++..+| .+||+|||.+...
T Consensus 400 mE~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g---~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG---ILKIIDFGAASVFRYPW 474 (601)
T ss_pred hhcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC---ceEEeecCcceeeccCc
Confidence 999999 88777653 35789999999999999999999999999999999999999999 8999999987532
Q ss_pred ------------CCCCCChhhhccCCCCc-hhHHHHHHHHHHHHHcCCCCCCCChhHHHH-------HHHhhccCCCCCC
Q psy48 966 ------------GEKSFPPEVLRNKGYNR-SLDMWSVGVIVYVSLSGTFPFNEDEDINEQ-------IQNAAFMYPPRPW 1025 (1098)
Q Consensus 966 ------------~~~~~APEvl~~~~ys~-~sDVwSLGvlLyELltG~~Pf~~~~~~~~~-------i~~~~~~~p~~~~ 1025 (1098)
..+|+|||++.+..|.+ .+||||.|+++..|++|+.||.......+. ........+...+
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 34578999999999975 789999999999999999999632111110 1111222233446
Q ss_pred CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1026 RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1026 ~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..++.+-+.+|.+||+.||.+|.|+++|++.+||+.
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 678899999999999999999999999999999997
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.9e-19 Score=191.86 Aligned_cols=243 Identities=33% Similarity=0.494 Sum_probs=194.1
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH-HHHHHHHHHHHHhccCCC-CceeeeeeeecCCcEEEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCHP-GVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~-~~~~~~~Ei~iL~~l~Hp-nIv~L~~~f~~~~~l~LVmE 891 (1098)
|.....+|.|.++.+|.+.+. ..+|+|.+........ ....+.+|+.++..+.|+ +++++...+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 456678889999999999888 8899999987654443 567899999999999988 79999999988888899999
Q ss_pred eccCchHHHHHhhcc--CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 892 KLQGDMLEMILSSEK--GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~--~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
++.++.+..++.... ..+....+..++.|++.++.|+|..|++|||+||+||+++..+. .++++|||+++...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~--~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR--VVKLIDFGLAKLLPDPG 156 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC--eEEEeccCcceecCCCC
Confidence 999999986655333 26899999999999999999999999999999999999998762 49999999886332
Q ss_pred ---------------CCCCChhhhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCChh---HHHHHHHhhccC----C
Q psy48 967 ---------------EKSFPPEVLRN---KGYNRSLDMWSVGVIVYVSLSGTFPFNEDED---INEQIQNAAFMY----P 1021 (1098)
Q Consensus 967 ---------------~~~~APEvl~~---~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~---~~~~i~~~~~~~----p 1021 (1098)
..++|||.+.+ ..++...|+||+|++++++++|..||..... ............ .
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 22469999987 5789999999999999999999999876542 222222211111 1
Q ss_pred CCCCCcC----cHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1022 PRPWRDI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1022 ~~~~~~i----s~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
....... ...+.+++..++..+|..|.+..+...++|...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 1111111 257899999999999999999999888877665
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.7e-20 Score=223.81 Aligned_cols=222 Identities=29% Similarity=0.451 Sum_probs=173.9
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
...+..|.||.||.+.|+.+.+.+|+|+= +.++ -+++ ++.....|++| |
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiN-kq~l------ilRn---ilt~a~npfvv---------------------g 136 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL------ILRN---ILTFAGNPFVV---------------------G 136 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhccc-ccch------hhhc---cccccCCccee---------------------c
Confidence 46788999999999999999999999553 3211 0111 33444455554 3
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+-...+. .-+.++.. ++.+++|||+.||+|||+||+|.+|..-| ++|++|||+.+..
T Consensus 137 Dc~tllk-~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mG---hiKlTDfgLsk~GLms~atnl~eg 204 (1205)
T KOG0606|consen 137 DCATLLK-NIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMG---HIKLTDFGLSKKGLMSLATNLKEG 204 (1205)
T ss_pred hhhhhcc-cCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecc---cccccchhhhhhhhhhccchhhhc
Confidence 3323333 22334433 27899999999999999999999999999 9999999987632
Q ss_pred ----------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCc
Q psy48 966 ----------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 966 ----------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~ 1027 (1098)
++.|+|||++..+.|+..+|||++|+++||.+.|..||.++ ++++..+......++... ..
T Consensus 205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d-ea 283 (1205)
T KOG0606|consen 205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED-EA 283 (1205)
T ss_pred chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC-cC
Confidence 22356999999999999999999999999999999999987 678888888888888764 46
Q ss_pred CcHHHHHHHHHhhhhcccCCC---CHHHHHcCCCcCCCCCcchhHHHHhh-h-CCCCCCCcchh
Q psy48 1028 ISSDAIDLINNLLQVKQRKRL---SVDKSLAHPWLQDPATWSDLRGLERQ-I-GTNKKKNPKRT 1086 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRP---Sa~eIL~HpfFk~~~~~~~~~~l~~~-~-~~~~~~~~~~~ 1086 (1098)
++++++++|.++|..+|..|. ++-++.+|.||+. .||..|-+| . ..|-+.+++|.
T Consensus 284 ~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~----LDw~~llRqkaefvpql~~eddt 343 (1205)
T KOG0606|consen 284 LPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL----LDWKSLLRQKAEFVPQLESEDDT 343 (1205)
T ss_pred CCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee----cccchhhhhhccccccccccccc
Confidence 889999999999999999997 5679999999999 899988887 3 33555555554
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.2e-18 Score=193.08 Aligned_cols=241 Identities=22% Similarity=0.208 Sum_probs=181.3
Q ss_pred heeeeeeeeeeeeeceEEEEeecCC-ceeEEEEEeccCCChHHHHHHHHHHHHHhccC----CCCceeeeeee-ecCCcE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSG-RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC----HPGVVNLERMF-ETPGRI 886 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg-~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~----HpnIv~L~~~f-~~~~~l 886 (1098)
.|+....||.|.||.||.+.+..++ ..+|+|+......... ..+..|+.++..+. ..++..++..+ .....-
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 7899999999999999999988775 6899999865432111 26777888888776 26899999999 577789
Q ss_pred EEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCC--CCcEEEeecCccc
Q psy48 887 FVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE--LPQVKLCDFGFAR 963 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~--~~~vKL~DFGla~ 963 (1098)
|+||+.+ |.+|.++.... .+.|+...+..++.|++.+|.+||+.|++||||||+|+++..... ...++|.|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999988 45565665433 478999999999999999999999999999999999999987641 1379999999998
Q ss_pred --cc----C----------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhcc
Q psy48 964 --II----G----------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFM 1019 (1098)
Q Consensus 964 --~~----~----------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~ 1019 (1098)
.. + ..|.++.+..+...+.+.|+||++.++.+|+.|..||...+. ....+......
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 21 0 112366777788889999999999999999999999975432 22222222211
Q ss_pred CCCC-CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1020 YPPR-PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1020 ~p~~-~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.... .....+.++..++..+-..+...+|....+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1111 122345677778777777888888877655543
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=181.43 Aligned_cols=237 Identities=20% Similarity=0.245 Sum_probs=185.0
Q ss_pred HHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCC-CCceeeeeeeecCCcE
Q psy48 808 LLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCH-PGVVNLERMFETPGRI 886 (1098)
Q Consensus 808 ~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~L~~~f~~~~~l 886 (1098)
+...+.|.....||.|.||.+|.+....+|+.||||+-+... .-.++..|..+.+.+++ ..|..+..++.+...-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 455678899999999999999999999999999999975422 12456778889988874 7888888999999999
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
.+|||++ |-+|+++..--.+.|+..+++-++-|++.-++|+|.+++|||||||+|+|..-+....++.|+|||+|+..-
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 566888877677789999999999999999999999999999999999999766544589999999997542
Q ss_pred CC-------------------CCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH-----HHHHHHhhccCCC
Q psy48 967 EK-------------------SFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI-----NEQIQNAAFMYPP 1022 (1098)
Q Consensus 967 ~~-------------------~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~-----~~~i~~~~~~~p~ 1022 (1098)
.. |.+-....+...+.+.|+-|+|.+|.++..|..||.+-... .+.|.+.....+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 11 11233334555678999999999999999999999875322 2333333333333
Q ss_pred CC-CCcCcHHHHHHHHHhhhhcccCCCC
Q psy48 1023 RP-WRDISSDAIDLINNLLQVKQRKRLS 1049 (1098)
Q Consensus 1023 ~~-~~~is~el~~LL~~cL~~dP~kRPS 1049 (1098)
+. -...|.|+.-.|..|=..--++-|.
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 22 2457788888888876666666665
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=8e-19 Score=186.23 Aligned_cols=218 Identities=17% Similarity=0.278 Sum_probs=177.2
Q ss_pred CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccC-ccchhHH
Q psy48 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKG-RLSERTT 914 (1098)
Q Consensus 836 tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~-~lse~~~ 914 (1098)
.|..+++|+++....+......|.+|.-.|+.+.||||+.+++.|..+.++.++..|++.|+|+..++.... ..+..++
T Consensus 212 qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqa 291 (448)
T KOG0195|consen 212 QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQA 291 (448)
T ss_pred cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchH
Confidence 456678899987666655557899999999999999999999999999999999999999999999986544 4788999
Q ss_pred HHHHHHHHHHHHHHHhCC--ccccCCCCCceeecCCCCCCcEEEeecCcc-----cccCCCCCChhhhccCCCC---chh
Q psy48 915 KFIITQILVALKHLHSKN--IVHCDLKPENVLLSTNSELPQVKLCDFGFA-----RIIGEKSFPPEVLRNKGYN---RSL 984 (1098)
Q Consensus 915 ~~ia~qIa~gL~~LHs~g--IvHrDLKp~NILld~~g~~~~vKL~DFGla-----~~~~~~~~APEvl~~~~ys---~~s 984 (1098)
.+++.+|+.|++|||+.. |.---|.+..+++|.+-.. ++..+|--++ +.+.+.+|+||.++.++.+ .++
T Consensus 292 v~faldiargmaflhslep~ipr~~lns~hvmidedlta-rismad~kfsfqe~gr~y~pawmspealqrkped~n~raa 370 (448)
T KOG0195|consen 292 VRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTA-RISMADTKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAA 370 (448)
T ss_pred HHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhh-heecccceeeeeccccccCcccCCHHHHhcCchhcchhhh
Confidence 999999999999999875 4455789999999988622 4555664443 3556778999999877644 689
Q ss_pred HHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHH
Q psy48 985 DMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSL 1054 (1098)
Q Consensus 985 DVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL 1054 (1098)
|+|||+++||||.|...||..-...+--++..........+..++..+..|+.-|++.||.+||.++.|+
T Consensus 371 dmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 371 DMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred hHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 9999999999999999999876554444443333444445567999999999999999999999987664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-18 Score=197.46 Aligned_cols=140 Identities=21% Similarity=0.215 Sum_probs=113.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeec-CCceeEEEEEeccCC---ChHHHHHHHHHHHHHhccCCCCcee-eeeeeecCCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRK-SGRGVAIKVIDKLRF---PTKQEAQLKNEVAILQNLCHPGVVN-LERMFETPGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~-tg~~VAVKvlkk~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~-L~~~f~~~~~ 885 (1098)
...|.....||.|.||.||.+.++. +++.||||++..... .......+.+|+.+|+.++|+|+++ ++.+ +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 4568899999999999999999886 788889998753211 2334567999999999999999985 4432 46
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCC-CCCceeecCCCCCCcEEEeecCcccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDL-KPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDL-Kp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
.|+||||++|++|... . .. . ...++.+++.||.|||++||+|||| ||+|||++.++ .++|+|||+|+.
T Consensus 93 ~~LVmE~~~G~~L~~~-~-~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~---~ikLiDFGlA~~ 161 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-R-PH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG---EAAVIDFQLASV 161 (365)
T ss_pred cEEEEEccCCCCHHHh-C-cc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC---CEEEEECcccee
Confidence 8999999999999632 1 11 1 1467899999999999999999999 99999998887 899999999974
Q ss_pred c
Q psy48 965 I 965 (1098)
Q Consensus 965 ~ 965 (1098)
.
T Consensus 162 ~ 162 (365)
T PRK09188 162 F 162 (365)
T ss_pred c
Confidence 3
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.7e-18 Score=179.82 Aligned_cols=142 Identities=19% Similarity=0.198 Sum_probs=110.2
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHH------------------------HHHHHHHHHHHhccCCCCc
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQ------------------------EAQLKNEVAILQNLCHPGV 873 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~------------------------~~~~~~Ei~iL~~l~HpnI 873 (1098)
..||.|++|.||.|.+. +|+.||||+++........ .....+|+.++..+.++++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 56899999999999997 8999999999765322111 1233459999999987776
Q ss_pred eeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHH-HhCCccccCCCCCceeecCCCCCC
Q psy48 874 VNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHL-HSKNIVHCDLKPENVLLSTNSELP 952 (1098)
Q Consensus 874 v~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~L-Hs~gIvHrDLKp~NILld~~g~~~ 952 (1098)
.....+.. . ..+|||||++|+++..... ....+++..+..++.||+.+|.+| |+.||+||||||+|||++. +
T Consensus 82 ~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--- 154 (190)
T cd05147 82 PCPEPILL-K-SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--- 154 (190)
T ss_pred CCCcEEEe-c-CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C---
Confidence 43332222 2 2389999999987754432 345789999999999999999999 7999999999999999984 4
Q ss_pred cEEEeecCcccccCC
Q psy48 953 QVKLCDFGFARIIGE 967 (1098)
Q Consensus 953 ~vKL~DFGla~~~~~ 967 (1098)
.++|+|||+|.....
T Consensus 155 ~v~LiDFG~a~~~~~ 169 (190)
T cd05147 155 KLYIIDVSQSVEHDH 169 (190)
T ss_pred cEEEEEccccccCCC
Confidence 799999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=181.46 Aligned_cols=239 Identities=17% Similarity=0.232 Sum_probs=182.0
Q ss_pred HHHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCC
Q psy48 806 SFLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPG 884 (1098)
Q Consensus 806 ~~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~ 884 (1098)
+.+++...|+.+..||.|.||..+.+...-++++||||.-.. .....++..|....+.|. .++|..++-+.+..-
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 445677889999999999999999999999999999999644 223456778888888774 689999888888888
Q ss_pred cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCC--CCcEEEeecCcc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE--LPQVKLCDFGFA 962 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~--~~~vKL~DFGla 962 (1098)
+-.||||++ |-+|+++..--.++|+.+.+.-+|.|++.-++++|++.+|+|||||+|+||..-+. ...|.|+|||||
T Consensus 98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 889999998 56677887767788999999999999999999999999999999999999975332 126999999999
Q ss_pred cccCC-------------------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hH---HHHHHHhhc
Q psy48 963 RIIGE-------------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DI---NEQIQNAAF 1018 (1098)
Q Consensus 963 ~~~~~-------------------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~---~~~i~~~~~ 1018 (1098)
+.... +||+-....|...+.+.|+-|||-++++.|.|..||.+.. .. .+.|-+...
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 86532 2356566667888999999999999999999999998653 22 222222222
Q ss_pred cCCCCC-CCcCcHHHHHHHHHhhhhcccCCCC
Q psy48 1019 MYPPRP-WRDISSDAIDLINNLLQVKQRKRLS 1049 (1098)
Q Consensus 1019 ~~p~~~-~~~is~el~~LL~~cL~~dP~kRPS 1049 (1098)
..+.+. ..++|.++..-|.-.=..+-.+-|.
T Consensus 257 ~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 257 STPIEVLCEGFPEEFATYLRYVRRLDFFETPD 288 (449)
T ss_pred cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence 222111 1245566655555544444444454
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.8e-17 Score=179.14 Aligned_cols=173 Identities=13% Similarity=0.153 Sum_probs=136.6
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHH-HHH------HHHHHHHHhccCCCCceeeeeeee
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQ-EAQ------LKNEVAILQNLCHPGVVNLERMFE 881 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~-~~~------~~~Ei~iL~~l~HpnIv~L~~~f~ 881 (1098)
.+.++|+....++.|.++.||.+.. ++..+|||+++........ ... +.+|+..+.++.|++|..+..++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3467889999999999999999655 4778999999754433222 122 679999999999999999988865
Q ss_pred cC--------CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCc
Q psy48 882 TP--------GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953 (1098)
Q Consensus 882 ~~--------~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~ 953 (1098)
.. +..++||||++|.+|..+.. +++ ....+|+.+|..||..|++|||+||.||+++.+|
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---- 172 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---- 172 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC----
Confidence 33 35899999999999977632 333 3466999999999999999999999999998775
Q ss_pred EEEeecCcccccCCCCCChhhhccCCCCchhHHHHHHHHHHHH
Q psy48 954 VKLCDFGFARIIGEKSFPPEVLRNKGYNRSLDMWSVGVIVYVS 996 (1098)
Q Consensus 954 vKL~DFGla~~~~~~~~APEvl~~~~ys~~sDVwSLGvlLyEL 996 (1098)
++|+|||.............++....|+.++|+|+||+++...
T Consensus 173 i~liDfg~~~~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EEEEECCCcccccchhhHHHHHHHhHhcccccccceeEeehHH
Confidence 9999999887664443333345566788899999999998755
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.6e-17 Score=170.76 Aligned_cols=143 Identities=20% Similarity=0.201 Sum_probs=111.4
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH------------------------HHHHHHHHHHHHhccCCCC
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK------------------------QEAQLKNEVAILQNLCHPG 872 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~------------------------~~~~~~~Ei~iL~~l~Hpn 872 (1098)
...||.|.+|.||.+.+. +|+.||||+++....... ....+..|...+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 357899999999999987 999999999986532100 0123468899999999888
Q ss_pred ceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCC
Q psy48 873 VVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSEL 951 (1098)
Q Consensus 873 Iv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~ 951 (1098)
+.....+... ..+|||||++|+++..... ....++...+..++.|++.+|.+||. .||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~-- 154 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG-- 154 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC--
Confidence 7544333322 2489999999885433221 23567888999999999999999999 9999999999999998 55
Q ss_pred CcEEEeecCcccccCC
Q psy48 952 PQVKLCDFGFARIIGE 967 (1098)
Q Consensus 952 ~~vKL~DFGla~~~~~ 967 (1098)
.++|+|||++.....
T Consensus 155 -~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 -KPYIIDVSQAVELDH 169 (190)
T ss_pred -CEEEEEcccceecCC
Confidence 799999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.5e-16 Score=175.13 Aligned_cols=223 Identities=25% Similarity=0.318 Sum_probs=142.1
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCC-----------CCceeeeee--
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCH-----------PGVVNLERM-- 879 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~H-----------pnIv~L~~~-- 879 (1098)
...+..||.|.++.||.+.+..+|+.+|||++....... ...+.+.+|.-....+.+ ..++++ +.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~ 92 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLR 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEE
Confidence 466889999999999999999999999999986654332 234667766655444322 112221 11
Q ss_pred -------eecCC--------cEEEEEEeccCchHHHHHh---hc-cC--ccchhHHHHHHHHHHHHHHHHHhCCccccCC
Q psy48 880 -------FETPG--------RIFVVMEKLQGDMLEMILS---SE-KG--RLSERTTKFIITQILVALKHLHSKNIVHCDL 938 (1098)
Q Consensus 880 -------f~~~~--------~l~LVmEy~~ggsL~~~l~---~~-~~--~lse~~~~~ia~qIa~gL~~LHs~gIvHrDL 938 (1098)
+.... +.+++|+-+.++.. .++. .. .. .+.......+..|+++.+++||.+|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~-~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQ-DLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHH-HHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHH-HHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11111 34778888865543 4432 11 11 1223333455689999999999999999999
Q ss_pred CCCceeecCCCCCCcEEEeecCcccccC---------CCCCChhhhcc--------CCCCchhHHHHHHHHHHHHHcCCC
Q psy48 939 KPENVLLSTNSELPQVKLCDFGFARIIG---------EKSFPPEVLRN--------KGYNRSLDMWSVGVIVYVSLSGTF 1001 (1098)
Q Consensus 939 Kp~NILld~~g~~~~vKL~DFGla~~~~---------~~~~APEvl~~--------~~ys~~sDVwSLGvlLyELltG~~ 1001 (1098)
+|+|++++.+| .++|+||+.....+ ..+.+||.... -.++.+.|.|+||++||.|.+|..
T Consensus 172 ~~~nfll~~~G---~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDG---GVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS----EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCC---CEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999 89999999765332 23457887643 247899999999999999999999
Q ss_pred CCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCC
Q psy48 1002 PFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKR 1047 (1098)
Q Consensus 1002 Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kR 1047 (1098)
||........... . +. .-.++|+.++.||..+|+.||++|
T Consensus 249 Pf~~~~~~~~~~~--~--f~--~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW--D--FS--RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG--G--GT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc--c--ch--hcCCcCHHHHHHHHHHccCCcccC
Confidence 9985432110000 1 11 123688999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.8e-16 Score=165.16 Aligned_cols=174 Identities=17% Similarity=0.108 Sum_probs=131.6
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH--HHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEEEEec
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK--QEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~--~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
...|+.|+||.|+.+.. .+..++.+.++....-.. ....+.+|+++|+++. ++++++++++ +..+++|||+
T Consensus 7 ~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 45788999999996654 778888777754332111 1235889999999995 5889999886 4579999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCC-CCCceeecCCCCCCcEEEeecCcccccCCCC---
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDL-KPENVLLSTNSELPQVKLCDFGFARIIGEKS--- 969 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDL-Kp~NILld~~g~~~~vKL~DFGla~~~~~~~--- 969 (1098)
.|.+|..... .. ...++.|++.+|.++|++||+|||| ||+|||++.++ .++|+|||+|.......
T Consensus 81 ~G~~L~~~~~-------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g---~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 81 AGAAMYQRPP-------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG---SPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred cCccHHhhhh-------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC---CEEEEECCCceecCCcchHH
Confidence 9999864421 11 2357889999999999999999999 79999999888 89999999998544322
Q ss_pred -----------------CChhhhcc------CCCC-chhHHHHHHHHHHHHHcCCCCCCCCh
Q psy48 970 -----------------FPPEVLRN------KGYN-RSLDMWSVGVIVYVSLSGTFPFNEDE 1007 (1098)
Q Consensus 970 -----------------~APEvl~~------~~ys-~~sDVwSLGvlLyELltG~~Pf~~~~ 1007 (1098)
++||.+.- ...+ ...+|++.|.-+|.++|+..+..++.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 24444431 1223 67899999999999999999876543
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.8e-17 Score=200.37 Aligned_cols=226 Identities=22% Similarity=0.268 Sum_probs=170.3
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccC--CChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLR--FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~--~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
.+-+...||.+.|-.+..+.+++. .|+||++-+.. ++-....+-.+|++ ....++||.+++.-.-.+....|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 677888999999999999987643 39999986533 22223333344444 45668999999988888888889999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
+|+...+. +.+. .+.-+...+..+|+.||+.||..+|..||+|||||.+||||++-+ -+.|+||..-+..
T Consensus 101 qyvkhnLy-DRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN---W~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 101 QYVKHNLY-DRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN---WLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHhhhhh-hhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec---hhhhhcccccCCccCCCC
Confidence 99976544 5543 334477888899999999999999999999999999999999887 6999999865422
Q ss_pred ---------CCC-----CCChhhhccC----------C-CCchhHHHHHHHHHHHHHc-CCCCCCCCh---------hHH
Q psy48 966 ---------GEK-----SFPPEVLRNK----------G-YNRSLDMWSVGVIVYVSLS-GTFPFNEDE---------DIN 1010 (1098)
Q Consensus 966 ---------~~~-----~~APEvl~~~----------~-ys~~sDVwSLGvlLyELlt-G~~Pf~~~~---------~~~ 1010 (1098)
++. |+|||.+... + .+++.||||+||+++||++ |++||.-.. +..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP 255 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence 111 3599998541 2 5789999999999999998 688884221 111
Q ss_pred HHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1011 EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1011 ~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.+.+.. -+..++++|..|++.||++|.++++.|+.
T Consensus 256 e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111111 12478999999999999999999999985
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.67 E-value=3e-16 Score=174.34 Aligned_cols=182 Identities=28% Similarity=0.475 Sum_probs=135.0
Q ss_pred CCCCceeeeeeeec---------------------------CCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHH
Q psy48 869 CHPGVVNLERMFET---------------------------PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQI 921 (1098)
Q Consensus 869 ~HpnIv~L~~~f~~---------------------------~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qI 921 (1098)
+|||||+++.+|.+ +..+|+||..+... |..++..+ ..+....+-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~t-Lr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQT-LREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhh-HHHHHhcC--CCchHHHHHHHHHH
Confidence 59999999888733 23589999988765 55665433 36777888899999
Q ss_pred HHHHHHHHhCCccccCCCCCceeecCCC-CCCcEEEeecCcccccC------------------CCCCChhhhccCC---
Q psy48 922 LVALKHLHSKNIVHCDLKPENVLLSTNS-ELPQVKLCDFGFARIIG------------------EKSFPPEVLRNKG--- 979 (1098)
Q Consensus 922 a~gL~~LHs~gIvHrDLKp~NILld~~g-~~~~vKL~DFGla~~~~------------------~~~~APEvl~~~~--- 979 (1098)
++|+.|||.+||.|||||++|||+.-+. ....+.|+|||.|-... ...||||+....+
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 9999999999999999999999985332 23478999999773211 1127999987433
Q ss_pred ---CCchhHHHHHHHHHHHHHcCCCCCCCChhHH---HHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCH---
Q psy48 980 ---YNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN---EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV--- 1050 (1098)
Q Consensus 980 ---ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~---~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa--- 1050 (1098)
--.++|.|+.|.+.||+++...||....+.. ...++.. .|. .+..+++.+++++..+|+.||++|++.
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q--LPa-lp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ--LPA-LPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh--CCC-CcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 1258999999999999999999998743211 1122221 222 235689999999999999999999985
Q ss_pred HHHHcC
Q psy48 1051 DKSLAH 1056 (1098)
Q Consensus 1051 ~eIL~H 1056 (1098)
+.+++.
T Consensus 508 ANvl~L 513 (598)
T KOG4158|consen 508 ANVLNL 513 (598)
T ss_pred HhHHHH
Confidence 455543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-15 Score=161.70 Aligned_cols=138 Identities=20% Similarity=0.211 Sum_probs=108.0
Q ss_pred eeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-----CCCCceeeeeeeecCC---cE
Q psy48 815 TYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-----CHPGVVNLERMFETPG---RI 886 (1098)
Q Consensus 815 ~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-----~HpnIv~L~~~f~~~~---~l 886 (1098)
.-...||.|.++.||. +..++.. +||++.... ......+.+|+.+++.+ .||||++++++++++. .+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 3456899999999995 7777665 699886543 22456799999999998 5799999999998874 43
Q ss_pred E-EEEEe--ccCchHHHHHhhccCccchhHHHHHHHHHHHHH-HHHHhCCccccCCCCCceeecCCC-CCCcEEEeecCc
Q psy48 887 F-VVMEK--LQGDMLEMILSSEKGRLSERTTKFIITQILVAL-KHLHSKNIVHCDLKPENVLLSTNS-ELPQVKLCDFGF 961 (1098)
Q Consensus 887 ~-LVmEy--~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL-~~LHs~gIvHrDLKp~NILld~~g-~~~~vKL~DFGl 961 (1098)
+ +|||| +.+++|..++.+ ..+++. ..++.+++.++ +|||+++|+||||||+|||++..+ ...+++|+||+-
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 4 78999 447999999864 346665 35678888887 999999999999999999998543 123799999443
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.3e-15 Score=174.80 Aligned_cols=188 Identities=25% Similarity=0.310 Sum_probs=153.0
Q ss_pred HhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCc-cccCCCCCce
Q psy48 865 LQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNI-VHCDLKPENV 943 (1098)
Q Consensus 865 L~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gI-vHrDLKp~NI 943 (1098)
|+.+.|.|+.++++.+......++|.+||..|+|.+.+....-.+++.....++++|+.||+|||.-.| .|+.|++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 456789999999999999999999999999999999998777788999999999999999999998766 9999999999
Q ss_pred eecCCCCCCcEEEeecCcccccCC--------------CCCChhhhccCC-------CCchhHHHHHHHHHHHHHcCCCC
Q psy48 944 LLSTNSELPQVKLCDFGFARIIGE--------------KSFPPEVLRNKG-------YNRSLDMWSVGVIVYVSLSGTFP 1002 (1098)
Q Consensus 944 Lld~~g~~~~vKL~DFGla~~~~~--------------~~~APEvl~~~~-------ys~~sDVwSLGvlLyELltG~~P 1002 (1098)
++|... .+||+|||+...... -|.|||++++.. .+.+.|+||||++++|+++...|
T Consensus 81 lvd~~w---~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LVDSRW---VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred eeeeeE---EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 999988 999999999876632 125999998642 46779999999999999999999
Q ss_pred CCCC---h---hHHHHHHH-hhccCCCCCC--CcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1003 FNED---E---DINEQIQN-AAFMYPPRPW--RDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1003 f~~~---~---~~~~~i~~-~~~~~p~~~~--~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
|... . ++...+.. ....+.+..+ ..+.+++..++.+||..+|++||+++++..
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 9742 1 23333333 1111222222 145568999999999999999999987764
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.3e-15 Score=174.07 Aligned_cols=32 Identities=34% Similarity=0.526 Sum_probs=30.5
Q ss_pred HHHhhccccccccccccCCCCCccCCC-Ccccc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT-SSLEI 421 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~-~~~~~ 421 (1098)
+..+|.|||+|||||||||++||||+. ++|+|
T Consensus 497 iaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkI 529 (678)
T KOG0193|consen 497 IAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKI 529 (678)
T ss_pred HHHhhhhhhhhhhhhhhccccceEEccCCcEEE
Confidence 888999999999999999999999999 88888
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=9.9e-15 Score=159.78 Aligned_cols=147 Identities=20% Similarity=0.187 Sum_probs=114.3
Q ss_pred heeeeeeeeeeeeeceEEEE-eecCCceeEEEEEeccCCCh--------------------H--HHHHHHHHHHHHhccC
Q psy48 813 FMTYNVALCIAVVAGAACGV-HRKSGRGVAIKVIDKLRFPT--------------------K--QEAQLKNEVAILQNLC 869 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~-~k~tg~~VAVKvlkk~~~~~--------------------~--~~~~~~~Ei~iL~~l~ 869 (1098)
.|.+...||.|.+|.||.|. +..+|+.||||+++...... . ....+..|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 56678899999999999999 77899999999997543210 0 1134678999999887
Q ss_pred CC--CceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCC-ccccCCCCCceeec
Q psy48 870 HP--GVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN-IVHCDLKPENVLLS 946 (1098)
Q Consensus 870 Hp--nIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~g-IvHrDLKp~NILld 946 (1098)
+. .++.++.. ...++||||++|.+|..... ....+....+..++.||+.+|.+||+.| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 53 23444432 23589999999988755432 2345667778899999999999999999 99999999999999
Q ss_pred CCCCCCcEEEeecCcccccCCC
Q psy48 947 TNSELPQVKLCDFGFARIIGEK 968 (1098)
Q Consensus 947 ~~g~~~~vKL~DFGla~~~~~~ 968 (1098)
++ .++|+|||++...+.+
T Consensus 184 -~~---~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 184 -DG---KVVIIDVSQSVELDHP 201 (237)
T ss_pred -CC---CEEEEEChhhhccCCc
Confidence 55 7999999998866543
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.2e-14 Score=181.67 Aligned_cols=189 Identities=20% Similarity=0.243 Sum_probs=149.2
Q ss_pred HHHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC---CCCceeeeeeeec
Q psy48 806 SFLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC---HPGVVNLERMFET 882 (1098)
Q Consensus 806 ~~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~L~~~f~~ 882 (1098)
.+......+.+...+|.|++|.||.|.+.. |+.||+|+-+....- +|.--.+++.+|+ -+.|..+..++.-
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 344556778889999999999999999988 999999997654321 1221222333333 2456666666667
Q ss_pred CCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC----CCCCCcEEEee
Q psy48 883 PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST----NSELPQVKLCD 958 (1098)
Q Consensus 883 ~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~----~g~~~~vKL~D 958 (1098)
.+.-+||+||.+.|+|.+++. ....+++..+.+++.|++..+..||..||||+||||+|+||.. +.+...++|+|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 777899999999999988876 5667999999999999999999999999999999999999952 22233799999
Q ss_pred cCccccc---CCC-----------CCChhhhccCCCCchhHHHHHHHHHHHHHcCCC
Q psy48 959 FGFARII---GEK-----------SFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001 (1098)
Q Consensus 959 FGla~~~---~~~-----------~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~ 1001 (1098)
||-+..+ ... .-.+|+..|.+++..+|.|.|+.+++-||.|++
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9987432 111 127999999999999999999999999999965
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.3e-14 Score=149.38 Aligned_cols=135 Identities=25% Similarity=0.329 Sum_probs=111.8
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCChH------HHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK------QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.||.|.+|.||.+.. .|..|+||+......... ....+.+|+.++..+.|++++....++...+..++||||
T Consensus 3 ~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 3 LIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred ccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 578999999999986 778899998754332211 124678899999999999888777777777788999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
++|.+|..++.... . ....++.+++.+|.+||+.|++|||++|.|||++ ++ .++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~---~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG---KIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC---CEEEEECCcccC
Confidence 99999988875322 2 7889999999999999999999999999999999 55 799999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.2e-14 Score=147.28 Aligned_cols=132 Identities=22% Similarity=0.284 Sum_probs=105.2
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCCChH------HHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK------QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
||.|.+|.||.+. .++..|++|+......... ....+.+|++++..+.|+++.....++...+..++||||+
T Consensus 2 ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 2 IAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 6889999999998 4678899999654322111 1256788999999998877655555555666789999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+|++|..++..... .++.+++.+|.+||+.|++|||++|.||+++ ++ .++|+|||++...
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~---~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD---KLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC---cEEEEECCCCcCC
Confidence 99999877643211 7899999999999999999999999999999 55 7999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1e-13 Score=147.06 Aligned_cols=139 Identities=19% Similarity=0.191 Sum_probs=108.0
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh--------------------HHHHHHHHHHHHHhccCCCC-
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT--------------------KQEAQLKNEVAILQNLCHPG- 872 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~--------------------~~~~~~~~Ei~iL~~l~Hpn- 872 (1098)
|.....|+.|.+|.||.+... +|+.||||+++...... ........|..++..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 666788999999999999875 89999999986532110 01123677888888887764
Q ss_pred -ceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC
Q psy48 873 -VVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951 (1098)
Q Consensus 873 -Iv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~ 951 (1098)
++..++ ....++||||++|++|..+.. ......++.+|+.++.++|+.||+||||||+||+++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-- 162 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-- 162 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC--
Confidence 444433 235689999999999865532 145677899999999999999999999999999999887
Q ss_pred CcEEEeecCcccccCC
Q psy48 952 PQVKLCDFGFARIIGE 967 (1098)
Q Consensus 952 ~~vKL~DFGla~~~~~ 967 (1098)
.++|+|||++...+.
T Consensus 163 -~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 -KIYIIDWPQMVSTDH 177 (198)
T ss_pred -cEEEEECCccccCCC
Confidence 899999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.2e-14 Score=163.87 Aligned_cols=166 Identities=25% Similarity=0.384 Sum_probs=129.9
Q ss_pred CcEEEEEEeccCchHHHHHhhcc--CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEK--GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGF 961 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~--~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGl 961 (1098)
..+||.|++|.-.+|.+++..+. ...+......++.|++.|+.| +|.+|+|+||.||+...+. .+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~---q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD---QLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch---hhhhhhhhh
Confidence 35899999999999999996432 347788899999999999999 9999999999999999887 899999998
Q ss_pred cccc------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCC
Q psy48 962 ARII------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPP 1022 (1098)
Q Consensus 962 a~~~------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~ 1022 (1098)
.... +..||+||.+.++.|+.++||||||++|+|++. =...+.....+ ..++ ...+|+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~-~d~r--~g~ip~ 479 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL-TDIR--DGIIPP 479 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh-hhhh--cCCCCh
Confidence 7422 334689999999999999999999999999998 33333322111 1111 223343
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
..+.+.+ +-..|+.+++...|.+||++.+.-.|.|.
T Consensus 480 ~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 480 EFLQDYP-EEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHhhcCc-HHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 3443443 45689999999999999988888777775
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.2e-13 Score=162.91 Aligned_cols=136 Identities=20% Similarity=0.233 Sum_probs=108.3
Q ss_pred eeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-h-----HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 815 TYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-T-----KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 815 ~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~-----~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.....||.|.++.||.+..... .+++|+....... . .....+.+|+++++.++|++++....++......++
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred CccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 4467899999999999876443 4444443221111 1 123568899999999999999888777777778899
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
||||++|++|..++. ....++.+|+.+|.+||+.||+||||||+|||+ .++ .++|+|||+++..
T Consensus 414 v~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~---~~~liDFGla~~~ 477 (535)
T PRK09605 414 VMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDD---RLYLIDFGLGKYS 477 (535)
T ss_pred EEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECC---cEEEEeCcccccC
Confidence 999999999988764 356789999999999999999999999999999 444 7999999999764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.4e-13 Score=138.94 Aligned_cols=134 Identities=25% Similarity=0.281 Sum_probs=97.6
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHH----------------------HHHHHHHHhccCCCC--c
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQ----------------------LKNEVAILQNLCHPG--V 873 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~----------------------~~~Ei~iL~~l~Hpn--I 873 (1098)
..||.|.+|.||.+.+. +++.||||+++........... ...|...+..+.+.. +
T Consensus 3 ~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 3 GPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred cccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46899999999999887 8999999998764322211111 135555555554332 3
Q ss_pred eeeeeeeecCCcEEEEEEeccCc-----hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecC
Q psy48 874 VNLERMFETPGRIFVVMEKLQGD-----MLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLST 947 (1098)
Q Consensus 874 v~L~~~f~~~~~l~LVmEy~~gg-----sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~ 947 (1098)
.+.+++ ...++||||++|+ .|..... . ..+..++.+++.++.++|. .||+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~------~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL------L-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhh------c-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-
Confidence 434433 2458999999994 3332211 1 6788999999999999999 9999999999999999
Q ss_pred CCCCCcEEEeecCcccccCC
Q psy48 948 NSELPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 948 ~g~~~~vKL~DFGla~~~~~ 967 (1098)
++ .++|+|||++.....
T Consensus 150 ~~---~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DG---KVYIIDVPQAVEIDH 166 (187)
T ss_pred CC---cEEEEECcccccccC
Confidence 65 799999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.6e-14 Score=176.74 Aligned_cols=245 Identities=22% Similarity=0.363 Sum_probs=194.9
Q ss_pred eeeeeeeeeeeeceEEEEee-cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEEEEe
Q psy48 815 TYNVALCIAVVAGAACGVHR-KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 815 ~~~~~Lg~G~~g~v~~a~~k-~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.....+|.|.++.+...... .....+|+|.+............+..|..+-..+. |.|++++++.....+..+++++|
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 34445788888888887764 34556777777654433444456667777777776 99999999999999999999999
Q ss_pred ccCchHHHHH-hhccCccchhHHHHHHHHHHHHHHHHH-hCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 893 LQGDMLEMIL-SSEKGRLSERTTKFIITQILVALKHLH-SKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 893 ~~ggsL~~~l-~~~~~~lse~~~~~ia~qIa~gL~~LH-s~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
..|+++...+ .......+...+.+++.|+..++.|+| ..++.|+||||+|.+++..+. .++++|||+|...
T Consensus 103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~--~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS--ALKIADFGLATAYRNKNG 180 (601)
T ss_pred ccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC--cccCCCchhhccccccCC
Confidence 9999997777 433336788889999999999999999 999999999999999998774 6899999998643
Q ss_pred -----------CCCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChh---HHHHHHHhhccCCCCCCCcCcH
Q psy48 966 -----------GEKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDED---INEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~---~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
...|+|||...+. -..+..|+||.|+++.-|++|..|+..... .+..............|..++.
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISD 260 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCCh
Confidence 2345799999885 456899999999999999999999974321 1111222222333556889999
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+.+++.+++..+|..|.+.+++..++|+..
T Consensus 261 ~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 261 QAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred hhhhcccccccCCchhccccccccccccccc
Confidence 9999999999999999999999999999987
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.4e-12 Score=141.20 Aligned_cols=140 Identities=17% Similarity=0.187 Sum_probs=104.4
Q ss_pred eeeeee-eeeeeceEEEEeecCCceeEEEEEeccCC-----------ChHHHHHHHHHHHHHhccCCCCc--eeeeeeee
Q psy48 816 YNVALC-IAVVAGAACGVHRKSGRGVAIKVIDKLRF-----------PTKQEAQLKNEVAILQNLCHPGV--VNLERMFE 881 (1098)
Q Consensus 816 ~~~~Lg-~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-----------~~~~~~~~~~Ei~iL~~l~HpnI--v~L~~~f~ 881 (1098)
.+..+| .|+-+++|.+... +..++||.+..... .......+.+|+.++..+.|++| +..+++..
T Consensus 35 ~~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 35 QARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred cCceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 345676 6777777777653 77899998854221 11233568899999999988775 66666643
Q ss_pred cCC----cEEEEEEeccC-chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEE
Q psy48 882 TPG----RIFVVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKL 956 (1098)
Q Consensus 882 ~~~----~l~LVmEy~~g-gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL 956 (1098)
... ..++|||+++| .+|..++.. ..+++. .+.+|+.+|.+||+.||+||||||.|||++.++ .++|
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~---~v~L 183 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG---KFWL 183 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC---CEEE
Confidence 322 23599999997 688777643 345543 357899999999999999999999999999887 8999
Q ss_pred eecCcccccC
Q psy48 957 CDFGFARIIG 966 (1098)
Q Consensus 957 ~DFGla~~~~ 966 (1098)
+|||.+....
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999987643
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=1e-13 Score=169.97 Aligned_cols=247 Identities=28% Similarity=0.352 Sum_probs=194.5
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCch
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDM 897 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggs 897 (1098)
-+..+.++.++.+.-..+|...++|+..+... ...+......+-.++-...+|.++...-.+.-...++|+|+|+++++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 56667888888888888888888888765322 22233444555555544566777776666666778999999999999
Q ss_pred HHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------------
Q psy48 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------------ 965 (1098)
Q Consensus 898 L~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------------ 965 (1098)
|...++ ..+..+..-++.++..+.+++++||...+.|+|++|+|+++..++ +.++.|||.....
T Consensus 891 ~~Skl~-~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g---h~~l~~~~t~~~vg~~~p~~~~sg~ 966 (1205)
T KOG0606|consen 891 LPSKLH-NSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG---HRPLTDFGTLSKVGLIPPTTDLSGP 966 (1205)
T ss_pred chhhhh-cCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC---CcccCccccccccccccCcCCcccc
Confidence 988876 344678888899999999999999999999999999999999999 9999999843211
Q ss_pred -------------------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHH
Q psy48 966 -------------------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQ 1012 (1098)
Q Consensus 966 -------------------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~ 1012 (1098)
++.+.+||++.+......+|||++|++++|.++|..||.... ..++.
T Consensus 967 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~n 1046 (1205)
T KOG0606|consen 967 SSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFEN 1046 (1205)
T ss_pred cccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhc
Confidence 111248999999999999999999999999999999998653 44555
Q ss_pred HHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHH---HHHcCCCcCCCCCcchhHHHHhh
Q psy48 1013 IQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVD---KSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1013 i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~---eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
+......++.- ....+.++++++...+..+|.+|.++. ++-.|+||++ .+|+.|..+
T Consensus 1047 i~~~~~~~p~g-~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~----~~~~~l~~q 1106 (1205)
T KOG0606|consen 1047 ILNRDIPWPEG-PEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQD----VDWENLALQ 1106 (1205)
T ss_pred cccCCCCCCCC-ccccChhhhhhhhhhhccCchhccCcccccccccCCccCC----CCccccccc
Confidence 54444444332 345789999999999999999999886 9999999999 788888888
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.7e-12 Score=125.17 Aligned_cols=130 Identities=25% Similarity=0.284 Sum_probs=108.8
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCC--CCceeeeeeeecCCcEEEEEEeccC
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCH--PGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
..++.|.++.+|.+.... ..++||+...... ...+.+|+.+++.+++ .++++++.++...+..+++|||+.|
T Consensus 4 ~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred eecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 457889999999998754 7899999865432 4678899999999976 5899999988888889999999999
Q ss_pred chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC---CccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK---NIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 896 gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~---gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
..+..+ +......++.+++.+|+.||.. +++|+||+|+||+++..+ .++++|||.+..
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~---~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK---ILGIIDWEYAGY 138 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc---EEEEEecccccC
Confidence 877533 4456677899999999999984 799999999999999866 899999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1011|consensus | Back alignment and domain information |
|---|
Probab=99.26 E-value=1e-12 Score=151.19 Aligned_cols=202 Identities=23% Similarity=0.329 Sum_probs=116.1
Q ss_pred CCCCCCCcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCCCccCC---CCccchhh-h
Q psy48 521 GAPSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPVTNN---KSNNYCKL-K 596 (1098)
Q Consensus 521 ~~~~~~~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~~~~~~---~~~~~~~~-~ 596 (1098)
.-|.+...||+|...+|..||||.-|..+|||+.|||++|..|+..||.+|+..+.++|.+...... +..+.+.. +
T Consensus 164 iypis~ttphnf~~~t~~tpt~cyecegllwglarqglrctqc~vk~hdkc~ell~adclqraaeks~khg~~drtq~lv 243 (1283)
T KOG1011|consen 164 IYPISATTPHNFATTTFQTPTFCYECEGLLWGLARQGLRCTQCQVKVHDKCRELLSADCLQRAAEKSTKHGEADRTQSLV 243 (1283)
T ss_pred eeecccCCCCceeeeeccCCchhhhhhhHHHHHhhcccchhhccccHHHHHHHHhhhHHHHHHHHhhccccchhhHHHHH
Confidence 3445556799999999999999999999999999999999999999999999999999986422111 00000000 0
Q ss_pred ---h---------------hHhhccccCCCccc------cccccccCCc-ceeeecccCccccc-cCCCCCCCCCCCCCC
Q psy48 597 ---S---------------EVASLVSLESSASA------SYSCLVRSTS-HCFILKTNNLDYYV-GEDTHSPSDGVETPV 650 (1098)
Q Consensus 597 ---~---------------e~~~~~~~~~~~~~------~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~sd~~~~~~ 650 (1098)
. .++.+.-.+.+.+. ..+.+.++.. ..-+-.|-.+.... ..|..|.||||++..
T Consensus 244 ~~irdrmki~e~nkpevfq~ir~vf~v~~~~~~e~lktvk~silegsskwsakitltvlcaqgl~akdktg~sdpyvt~q 323 (1283)
T KOG1011|consen 244 NVIRDRMKIQEQNKPEVFQMIRTVFDVDENIQKETLKTVKASILEGSSKWSAKITLTVLCAQGLIAKDKTGKSDPYVTAQ 323 (1283)
T ss_pred HHHHHHHHHHhhcChHHHHHHHHHhhhhhHHHHHHHHHHHHHHhccccccceeeEEeeeecccceecccCCCCCCcEEEe
Confidence 0 00000001100000 0000000000 00001111222222 235688999999754
Q ss_pred CCCCCCCCCccccccccccCCCCCCCCCCCcCC-CCcccccccccccc-c-----cC--CCCCCeecccccEE-EEeeee
Q psy48 651 TAPESGLGARAWELSLRQALMPVQEPSGTKCED-VSESEESRVTDMSQ-L-----YQ--ISPDEVLGSGQFGI-VYGASM 720 (1098)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~-~~~~~~~~~~~~~~-~-----~~--~~~~~~lG~gsFG~-v~k~~~ 720 (1098)
... .+..|+++.+.|||+|+++|.|.-- ..|.-..++||-++ + .+ -..+||||.--..+ ...|.+
T Consensus 324 v~k-----tkrrtrti~~~lnpvw~ekfhfechnstdrikvrvwded~dlksklrqkl~resddflgqtvievrtlsgem 398 (1283)
T KOG1011|consen 324 VGK-----TKRRTRTIHQELNPVWNEKFHFECHNSTDRIKVRVWDEDNDLKSKLRQKLTRESDDFLGQTVIEVRTLSGEM 398 (1283)
T ss_pred ecc-----cchhhHhhhhccchhhhhheeeeecCCCceeEEEEecCcccHHHHHHHHhhhcccccccceeEEEEecccch
Confidence 332 3456788999999999999977532 22322233333221 0 01 13458899766555 566788
Q ss_pred hhhhhhh
Q psy48 721 VGIFFLA 727 (1098)
Q Consensus 721 ~g~~~l~ 727 (1098)
+=||-|-
T Consensus 399 dvwynle 405 (1283)
T KOG1011|consen 399 DVWYNLE 405 (1283)
T ss_pred hhhcchh
Confidence 8887653
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.8e-12 Score=144.89 Aligned_cols=29 Identities=48% Similarity=0.639 Sum_probs=26.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||||||||..-
T Consensus 134 i~lAL~~LH~~gIiyRDlKPENILLd~~G 162 (357)
T KOG0598|consen 134 IVLALGYLHSKGIIYRDLKPENILLDEQG 162 (357)
T ss_pred HHHHHHHHHhCCeeeccCCHHHeeecCCC
Confidence 78889999999999999999999999843
|
|
| >PF00130 C1_1: Phorbol esters/diacylglycerol binding domain (C1 domain); InterPro: IPR002219 Diacylglycerol (DAG) is an important second messenger | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.2e-12 Score=105.76 Aligned_cols=52 Identities=48% Similarity=0.964 Sum_probs=47.6
Q ss_pred ceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCC
Q psy48 530 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 581 (1098)
Q Consensus 530 H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~ 581 (1098)
|+|+..+|..|++|++|+++|||+.+|||+|.+|++.+|++|.+.|+..|+.
T Consensus 1 H~f~~~~~~~~~~C~~C~~~i~g~~~~g~~C~~C~~~~H~~C~~~~~~~C~~ 52 (53)
T PF00130_consen 1 HHFVPTTFSKPTYCDVCGKFIWGLGKQGYRCSWCGLVCHKKCLSKVPPSCGC 52 (53)
T ss_dssp -EEEEEESSSTEB-TTSSSBECSSSSCEEEETTTT-EEETTGGCTSSSBSST
T ss_pred CeEEEccCCCCCCCcccCcccCCCCCCeEEECCCCChHhhhhhhhcCCCCCC
Confidence 8999999999999999999999999999999999999999999999999963
|
Phorbol esters (PE) are analogues of DAG and potent tumour promoters that cause a variety of physiological changes when administered to both cells and tissues. DAG activates a family of serine/threonine protein kinases, collectively known as protein kinase C (PKC) []. Phorbol esters can directly stimulate PKC. The N-terminal region of PKC, known as C1, has been shown [] to bind PE and DAG in a phospholipid and zinc-dependent fashion. The C1 region contains one or two copies (depending on the isozyme of PKC) of a cysteine-rich domain, which is about 50 amino-acid residues long, and which is essential for DAG/PE-binding. The DAG/PE-binding domain binds two zinc ions; the ligands of these metal ions are probably the six cysteines and two histidines that are conserved in this domain.; GO: 0035556 intracellular signal transduction; PDB: 1RFH_A 2FNF_X 3PFQ_A 1PTQ_A 1PTR_A 2VRW_B 1XA6_A 2ENN_A 1TBN_A 1TBO_A .... |
| >PF00130 C1_1: Phorbol esters/diacylglycerol binding domain (C1 domain); InterPro: IPR002219 Diacylglycerol (DAG) is an important second messenger | Back alignment and domain information |
|---|
Probab=99.22 E-value=7e-12 Score=104.98 Aligned_cols=52 Identities=48% Similarity=0.964 Sum_probs=47.5
Q ss_pred eeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCC
Q psy48 266 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 317 (1098)
Q Consensus 266 H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~ 317 (1098)
|.|...+|.+|++|++|+++|||+.+|||+|..|++.+|++|..+|+..|..
T Consensus 1 H~f~~~~~~~~~~C~~C~~~i~g~~~~g~~C~~C~~~~H~~C~~~~~~~C~~ 52 (53)
T PF00130_consen 1 HHFVPTTFSKPTYCDVCGKFIWGLGKQGYRCSWCGLVCHKKCLSKVPPSCGC 52 (53)
T ss_dssp -EEEEEESSSTEB-TTSSSBECSSSSCEEEETTTT-EEETTGGCTSSSBSST
T ss_pred CeEEEccCCCCCCCcccCcccCCCCCCeEEECCCCChHhhhhhhhcCCCCCC
Confidence 8999999999999999999999999999999999999999999999999953
|
Phorbol esters (PE) are analogues of DAG and potent tumour promoters that cause a variety of physiological changes when administered to both cells and tissues. DAG activates a family of serine/threonine protein kinases, collectively known as protein kinase C (PKC) []. Phorbol esters can directly stimulate PKC. The N-terminal region of PKC, known as C1, has been shown [] to bind PE and DAG in a phospholipid and zinc-dependent fashion. The C1 region contains one or two copies (depending on the isozyme of PKC) of a cysteine-rich domain, which is about 50 amino-acid residues long, and which is essential for DAG/PE-binding. The DAG/PE-binding domain binds two zinc ions; the ligands of these metal ions are probably the six cysteines and two histidines that are conserved in this domain.; GO: 0035556 intracellular signal transduction; PDB: 1RFH_A 2FNF_X 3PFQ_A 1PTQ_A 1PTR_A 2VRW_B 1XA6_A 2ENN_A 1TBN_A 1TBO_A .... |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.6e-11 Score=145.14 Aligned_cols=239 Identities=21% Similarity=0.210 Sum_probs=187.3
Q ss_pred eeeeeee--eeeeceEEEEe--ecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEEE
Q psy48 816 YNVALCI--AVVAGAACGVH--RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 816 ~~~~Lg~--G~~g~v~~a~~--k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LVm 890 (1098)
....+|. |.++.+|.+.. +.++..+|+|.-+...........-.+|+...+.++ |++.++.+..+...+.+|+-+
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence 3455666 99999999988 899999999985544333333344455666666664 999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHH----HHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILV----ALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~----gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
|++. .+|..+.+.....++...++.+..+... ||..+|..+|+|-|+||+||++..++. ..+++|||+...++
T Consensus 198 E~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~--s~~~~df~~v~~i~ 274 (524)
T KOG0601|consen 198 ELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWT--SCKLTDFGLVSKIS 274 (524)
T ss_pred cccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccc--eeecCCcceeEEcc
Confidence 9997 4555666656666899999999999999 999999999999999999999999842 79999999886543
Q ss_pred CC-----------------CCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCc
Q psy48 967 EK-----------------SFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 967 ~~-----------------~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~ 1027 (1098)
.. |++||...+. +++..|+|++|.++.+..++..+.... ... ..+.. ...+.+....
T Consensus 275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~r~--~~ip~e~~~~ 350 (524)
T KOG0601|consen 275 DGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQLRQ--GYIPLEFCEG 350 (524)
T ss_pred CCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCc-ccccc--ccCchhhhcC
Confidence 32 4688887665 899999999999999999988776533 111 11111 1134444456
Q ss_pred CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1028 ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+.++...+..|++.+|-.|++++.++.|++...
T Consensus 351 ~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 351 GSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 7788888999999999999999999999999985
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.3e-10 Score=132.46 Aligned_cols=143 Identities=22% Similarity=0.290 Sum_probs=96.4
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH--H------------------------------------HHHHH
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK--Q------------------------------------EAQLK 859 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~--~------------------------------------~~~~~ 859 (1098)
.-++.|.+|.||.|..+ +|+.||||+.+......- + +-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999864 789999999864320000 0 00234
Q ss_pred HHHHHHhcc----CCCCceeeeeee-ecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHH-HHHHHHhCCc
Q psy48 860 NEVAILQNL----CHPGVVNLERMF-ETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILV-ALKHLHSKNI 933 (1098)
Q Consensus 860 ~Ei~iL~~l----~HpnIv~L~~~f-~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~-gL~~LHs~gI 933 (1098)
+|...+..+ ++.+-+.+-..+ ......++||||++|.+|.++.......+ ....++..++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 455444443 222222222222 22345689999999999977754322122 23456666665 4788999999
Q ss_pred cccCCCCCceeecCCCCCCcEEEeecCcccccCC
Q psy48 934 VHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 934 vHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~ 967 (1098)
+|+|+||.||+++.++ +++|+|||++..++.
T Consensus 279 ~H~D~hPgNilv~~~g---~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDG---KIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCC---cEEEEeCCCeeECCH
Confidence 9999999999999888 899999999976653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.1e-09 Score=130.75 Aligned_cols=203 Identities=22% Similarity=0.334 Sum_probs=147.2
Q ss_pred EEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccc
Q psy48 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLS 910 (1098)
Q Consensus 831 a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~ls 910 (1098)
+..+.++.+|.|.+.+...- .......+-+.-|+.++||||++++..+...+.+|||+|.+.- |..++.+ +.
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~----l~ 102 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE----LG 102 (690)
T ss_pred cceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH----hH
Confidence 56788899999999976542 4456677888899999999999999999999999999999854 4444442 33
Q ss_pred hhHHHHHHHHHHHHHHHHH-hCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCCC------------CChhhhcc
Q psy48 911 ERTTKFIITQILVALKHLH-SKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS------------FPPEVLRN 977 (1098)
Q Consensus 911 e~~~~~ia~qIa~gL~~LH-s~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~~------------~APEvl~~ 977 (1098)
.......+.||+.||.||| +.+++|++|.-+.|+|+..| .+||++|.++....... ..|+.+..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G---eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG---EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC---cEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 6667778999999999998 67899999999999999999 89999999875432222 24444432
Q ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHH-----H
Q psy48 978 KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVD-----K 1052 (1098)
Q Consensus 978 ~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~-----e 1052 (1098)
.. -..|.|-||++++|++.| ++....++.. ...+++....+..+-+--.+..||... -
T Consensus 180 s~--~s~D~~~Lg~li~el~ng--~~~~~~~~~~-------------~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~ 242 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG--SLLTKTDLSN-------------TGKIPKALIELYCKKLGATELKRPNKLRFILEC 242 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc--ccCcchhhhc-------------cCccchhHHHHHHHHhccccccccchhhHHHHH
Confidence 22 457999999999999999 3322222110 122444555555555555666666532 2
Q ss_pred HHcCCCcCC
Q psy48 1053 SLAHPWLQD 1061 (1098)
Q Consensus 1053 IL~HpfFk~ 1061 (1098)
.+-|+||++
T Consensus 243 ~~~~gff~n 251 (690)
T KOG1243|consen 243 RLLGGFFRN 251 (690)
T ss_pred Hhccccccc
Confidence 234899987
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-09 Score=131.97 Aligned_cols=143 Identities=22% Similarity=0.376 Sum_probs=90.8
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCC---------------------------Ch-----HHHHHHHHHHHH-
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF---------------------------PT-----KQEAQLKNEVAI- 864 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~---------------------------~~-----~~~~~~~~Ei~i- 864 (1098)
.-++.|.+|.|+.|..+.+|+.||||+++.... .. +....+.+|+..
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 468999999999999998899999999975310 00 111223333333
Q ss_pred -----HhccC----CCCceeeeeee-ecCCcEEEEEEeccCchHHHHHhh-ccC----ccchhHHHHHHHHHHHHHHHHH
Q psy48 865 -----LQNLC----HPGVVNLERMF-ETPGRIFVVMEKLQGDMLEMILSS-EKG----RLSERTTKFIITQILVALKHLH 929 (1098)
Q Consensus 865 -----L~~l~----HpnIv~L~~~f-~~~~~l~LVmEy~~ggsL~~~l~~-~~~----~lse~~~~~ia~qIa~gL~~LH 929 (1098)
+.+++ +...+.+-..+ ......++||||+.|+.+.++..- ..+ .+.+..+..++.|| .
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 33221 22222222222 223456799999999998764221 111 24444444444444 4
Q ss_pred hCCccccCCCCCceeecCCC-CCCcEEEeecCcccccCC
Q psy48 930 SKNIVHCDLKPENVLLSTNS-ELPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 930 s~gIvHrDLKp~NILld~~g-~~~~vKL~DFGla~~~~~ 967 (1098)
..|++|+|+||.||+++.++ ...+++++|||++..++.
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 68999999999999998765 122699999999986654
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.6e-11 Score=130.50 Aligned_cols=28 Identities=50% Similarity=0.548 Sum_probs=26.9
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
|..+|.|||++||||||||++|.|||-+
T Consensus 277 IvsAL~YLHs~~ivYRDlKLENLlLDkD 304 (516)
T KOG0690|consen 277 IVSALGYLHSRNIVYRDLKLENLLLDKD 304 (516)
T ss_pred HHHHhhhhhhCCeeeeechhhhheeccC
Confidence 8999999999999999999999999984
|
|
| >cd00029 C1 Protein kinase C conserved region 1 (C1) | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.2e-10 Score=96.04 Aligned_cols=50 Identities=50% Similarity=1.082 Sum_probs=48.4
Q ss_pred eeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCC
Q psy48 266 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315 (1098)
Q Consensus 266 H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C 315 (1098)
|.|...++.++++|++|++.|||+.+||++|..|++++|++|..+|+..|
T Consensus 1 H~f~~~~~~~~~~C~~C~~~i~~~~~~~~~C~~C~~~~H~~C~~~v~~~C 50 (50)
T cd00029 1 HRFVRKSFFKPTFCDVCRKSIWGLFKQGLRCSWCKVKCHKKCADKVPPSC 50 (50)
T ss_pred CccEEeeCCCCCChhhcchhhhccccceeEcCCCCCchhhhhhccCCCCC
Confidence 88999999999999999999999999999999999999999999999887
|
Cysteine-rich zinc binding domain. Some members of this domain family bind phorbol esters and diacylglycerol, some are reported to bind RasGTP. May occur in tandem arrangement. Diacylglycerol (DAG) is a second messenger, released by activation of Phospholipase D. Phorbol Esters (PE) can act as analogues of DAG and mimic its downstream effects in, for example, tumor promotion. Protein Kinases C are activated by DAG/PE, this activation is mediated by their N-terminal conserved region (C1). DAG/PE binding may be phospholipid dependent. C1 domains may also mediate DAG/PE signals in chimaerins (a family of Rac GTPase activating proteins), RasGRPs (exchange factors for Ras/Rap1), and Munc13 isoforms (scaffolding proteins involved in exocytosis). |
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.1e-11 Score=128.91 Aligned_cols=27 Identities=48% Similarity=0.663 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
+..++.|||+++||||||||||||||.
T Consensus 153 ivlAleylH~~~iiYRDLKPENiLlD~ 179 (355)
T KOG0616|consen 153 IVLALEYLHSLDIIYRDLKPENLLLDQ 179 (355)
T ss_pred HHHHHHHHHhcCeeeccCChHHeeecc
Confidence 788899999999999999999999998
|
|
| >cd00029 C1 Protein kinase C conserved region 1 (C1) | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.5e-10 Score=95.51 Aligned_cols=50 Identities=50% Similarity=1.082 Sum_probs=48.3
Q ss_pred ceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCC
Q psy48 530 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579 (1098)
Q Consensus 530 H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C 579 (1098)
|.|...++..+++|++|.+.|||+.+|||+|.+|++.+|++|..+|+..|
T Consensus 1 H~f~~~~~~~~~~C~~C~~~i~~~~~~~~~C~~C~~~~H~~C~~~v~~~C 50 (50)
T cd00029 1 HRFVRKSFFKPTFCDVCRKSIWGLFKQGLRCSWCKVKCHKKCADKVPPSC 50 (50)
T ss_pred CccEEeeCCCCCChhhcchhhhccccceeEcCCCCCchhhhhhccCCCCC
Confidence 89999999999999999999999989999999999999999999999877
|
Cysteine-rich zinc binding domain. Some members of this domain family bind phorbol esters and diacylglycerol, some are reported to bind RasGTP. May occur in tandem arrangement. Diacylglycerol (DAG) is a second messenger, released by activation of Phospholipase D. Phorbol Esters (PE) can act as analogues of DAG and mimic its downstream effects in, for example, tumor promotion. Protein Kinases C are activated by DAG/PE, this activation is mediated by their N-terminal conserved region (C1). DAG/PE binding may be phospholipid dependent. C1 domains may also mediate DAG/PE signals in chimaerins (a family of Rac GTPase activating proteins), RasGRPs (exchange factors for Ras/Rap1), and Munc13 isoforms (scaffolding proteins involved in exocytosis). |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.00 E-value=1e-09 Score=112.58 Aligned_cols=126 Identities=19% Similarity=0.170 Sum_probs=91.7
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCc-eeeeeeeecCCcEEEEEEeccCch
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGV-VNLERMFETPGRIFVVMEKLQGDM 897 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~L~~~f~~~~~l~LVmEy~~ggs 897 (1098)
.++.|..+.+|..... +..|++|+...... ....+.+|+.+++.+.+.++ .+++.+.. ...++||||++|..
T Consensus 5 ~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 5 PLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred ecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 4567888888887754 77899999754321 12346788888888765444 44554433 23579999999988
Q ss_pred HHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNI-----VHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 898 L~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gI-----vHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
+... ......++.+++.+|+.||..++ +|+|++|.||+++ ++ .++|+|||.+..
T Consensus 78 l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~---~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG---RLWLIDWEYAGM 136 (170)
T ss_pred cccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC---eEEEEecccccC
Confidence 7432 01123457899999999999985 9999999999999 44 699999999763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.8e-09 Score=113.31 Aligned_cols=147 Identities=18% Similarity=0.151 Sum_probs=102.5
Q ss_pred eeeeeeeeeceEEEEeec------CCceeEEEEEeccCC---------------C-----hHHHH----HHHHHHHHHhc
Q psy48 818 VALCIAVVAGAACGVHRK------SGRGVAIKVIDKLRF---------------P-----TKQEA----QLKNEVAILQN 867 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~------tg~~VAVKvlkk~~~---------------~-----~~~~~----~~~~Ei~iL~~ 867 (1098)
..++.|-=+-||.+.... .+..+|||+.+.... . ..... ...+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 456777778888887653 357899999854210 0 01122 23489999988
Q ss_pred cCC--CCceeeeeeeecCCcEEEEEEeccCchHHH-HHhhccCccchhHHHHHHHHHHHHHHHH-HhCCccccCCCCCce
Q psy48 868 LCH--PGVVNLERMFETPGRIFVVMEKLQGDMLEM-ILSSEKGRLSERTTKFIITQILVALKHL-HSKNIVHCDLKPENV 943 (1098)
Q Consensus 868 l~H--pnIv~L~~~f~~~~~l~LVmEy~~ggsL~~-~l~~~~~~lse~~~~~ia~qIa~gL~~L-Hs~gIvHrDLKp~NI 943 (1098)
+.. -+++.++.+ ..-+|||||++++.+.. .+ +...++..++..+..+++.+|..| |..|||||||++.||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L--kd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL--KDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh--hccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 753 456666654 45689999998754321 12 122455667778889999999998 899999999999999
Q ss_pred eecCCCCCCcEEEeecCcccccCCCCCChhhh
Q psy48 944 LLSTNSELPQVKLCDFGFARIIGEKSFPPEVL 975 (1098)
Q Consensus 944 Lld~~g~~~~vKL~DFGla~~~~~~~~APEvl 975 (1098)
|++. + .++|+|||.+..... ..|-|.+
T Consensus 157 L~~~-~---~v~iIDF~qav~~~h-p~a~~~l 183 (197)
T cd05146 157 LWHD-G---KVWFIDVSQSVEPTH-PHGLEFL 183 (197)
T ss_pred EEEC-C---cEEEEECCCceeCCC-CCHHHHH
Confidence 9974 4 699999998876643 2344444
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.5e-09 Score=119.41 Aligned_cols=190 Identities=21% Similarity=0.239 Sum_probs=137.6
Q ss_pred HHHHhccCCCCceeeeeeeecC-----CcEEEEEEeccCchHHHHHhhc---cCccchhHHHHHHHHHHHHHHHHHhC--
Q psy48 862 VAILQNLCHPGVVNLERMFETP-----GRIFVVMEKLQGDMLEMILSSE---KGRLSERTTKFIITQILVALKHLHSK-- 931 (1098)
Q Consensus 862 i~iL~~l~HpnIv~L~~~f~~~-----~~l~LVmEy~~ggsL~~~l~~~---~~~lse~~~~~ia~qIa~gL~~LHs~-- 931 (1098)
..-|..+-|.|||+++.||.+. .+..|++||+..+++..+|+.. ...+.+....+|+.||+.||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 3344556799999999999554 4689999999999999998743 23588888999999999999999987
Q ss_pred CccccCCCCCceeecCCCCCCcEEEeecCcccc----------------cCCCCCChhhhccCCCCchhHHHHHHHHHHH
Q psy48 932 NIVHCDLKPENVLLSTNSELPQVKLCDFGFARI----------------IGEKSFPPEVLRNKGYNRSLDMWSVGVIVYV 995 (1098)
Q Consensus 932 gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~----------------~~~~~~APEvl~~~~ys~~sDVwSLGvlLyE 995 (1098)
-|+|+++..+-|++..+| -|||.--.-... .-..+.|||.=..-.-+-.+|||+||+..++
T Consensus 198 piihgnlTc~tifiq~ng---LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNG---LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred ccccCCcchhheeecCCc---eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 499999999999999887 566542111000 0111236665544455678999999999999
Q ss_pred HHcCCCCCCCCh---hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 996 SLSGTFPFNEDE---DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 996 LltG~~Pf~~~~---~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
|..+..--...+ ...+.+....+... ...-++++..|++-.|+.||++.+++.||-.-+
T Consensus 275 mailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred HHHheeccCCCcceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 998865422221 22333333332221 123457899999999999999999999998765
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.3e-10 Score=132.36 Aligned_cols=240 Identities=19% Similarity=0.163 Sum_probs=180.1
Q ss_pred eeeeeeeeeeeeeceEEEEee-cCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHR-KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k-~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
......|+.+.++.++....+ .++..|++|.+.+......+...-..|+.+...+ .|.++++.+..|....+.|+-.|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 344567788888888887766 7888999999987766655555555677776666 59999999888888888899999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+.++++.... .-...+++...+++..|++.++.++|+..++|+|+||+||++..++. --++.|||.+..+
T Consensus 347 ~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~--~~~~~~~~~~t~~~~~~~~ 423 (524)
T KOG0601|consen 347 FCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGF--FSKLGDFGCWTRLAFSSGV 423 (524)
T ss_pred hhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchh--hhhccccccccccceeccc
Confidence 99988886554 22335888999999999999999999999999999999999988641 6789999987532
Q ss_pred ---CCCCC--ChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhh
Q psy48 966 ---GEKSF--PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLL 1040 (1098)
Q Consensus 966 ---~~~~~--APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL 1040 (1098)
....+ +++......+..+.|++|||..+++.+++..--...... ..++.. ..+. ......++..+.+.++
T Consensus 424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-~~i~~~--~~p~--~~~~~~~~q~~~kv~~ 498 (524)
T KOG0601|consen 424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-LTIRSG--DTPN--LPGLKLQLQVLLKVMI 498 (524)
T ss_pred ccccccccccchhhccccccccccccccccccccccccCcccCcccccc-eeeecc--cccC--CCchHHhhhhhhhhhc
Confidence 22234 444445677889999999999999999986432222111 111111 1111 1234478899999999
Q ss_pred hhcccCCCCHHHHHcCCCcCC
Q psy48 1041 QVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1041 ~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..++..||.+.++..|.-|-.
T Consensus 499 ~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 499 NPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred CCccccchhhhhhcccchhhh
Confidence 999999999999998876653
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.3e-10 Score=132.84 Aligned_cols=29 Identities=52% Similarity=0.709 Sum_probs=27.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
|+-++.|||.+|||||||||||||||.+-
T Consensus 183 IldAleylH~~GIIHRDlKPENILLd~dm 211 (604)
T KOG0592|consen 183 ILDALEYLHSNGIIHRDLKPENILLDKDG 211 (604)
T ss_pred HHHHHHHHHhcCceeccCChhheeEcCCC
Confidence 88999999999999999999999999843
|
|
| >cd01239 PH_PKD Protein kinase D (PKD/PKCmu) pleckstrin homology (PH) domain | Back alignment and domain information |
|---|
Probab=98.88 E-value=9.4e-10 Score=104.35 Aligned_cols=66 Identities=47% Similarity=0.749 Sum_probs=57.0
Q ss_pred hhhhccceecccccccccccccCCccccccccceeecccCCCCCc----ccceeEEeeeeeeeEeeccCC
Q psy48 58 AKRKRHYWRLDSKCLTLFQSESGSKYYKEIPLSEILGIEPCKPLT----HELQQVQIRPHTLTVHSYKAP 123 (1098)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~e~~~~~~~~~~~----~~~~~~~~~~h~~~~~~~~~p 123 (1098)
+.+|+||||+|+|+++||+++++++||+||||+||+.|+.+.... ...|.|+||.-++++.....+
T Consensus 14 ~~rKRhYWrLDsK~Itlf~~e~~skyyKeIPLsEIl~V~~~~~~~~~~~~~~hcFEi~T~~~vY~VG~~~ 83 (117)
T cd01239 14 NRRKKHYWRLDSKAITLYQEESGSRYYKEIPLAEILSVSSNNGDSVLAKHPPHCFEIRTTTNVYFVGGED 83 (117)
T ss_pred cceeeeEEEecCCeEEEEEcCCCCeeeEEeehHHheEEeccCCCcCCCCCCCcEEEEEecCEEEEecccc
Confidence 557899999999999999999999999999999999998665443 678999999988887776544
|
Protein kinase D (PKD/PKCmu) pleckstrin homology (PH) domain. PKD consists of 2 C1 domains, followed by a PH domain and a kinase domain. While the PKD PH domain has not been shown to bind phosphorylated inositol lipids and is not required for membrane translocation, it is required for nuclear export. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. |
| >smart00109 C1 Protein kinase C conserved region 1 (C1) domains (Cysteine-rich domains) | Back alignment and domain information |
|---|
Probab=98.84 E-value=1e-09 Score=89.90 Aligned_cols=49 Identities=47% Similarity=1.009 Sum_probs=46.7
Q ss_pred eeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCC
Q psy48 266 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315 (1098)
Q Consensus 266 H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C 315 (1098)
|.|...++..+++|++|++.|||+. ||++|..|++.+|++|..+|+..|
T Consensus 1 H~~~~~~~~~~~~C~~C~~~i~~~~-~~~~C~~C~~~~H~~C~~~v~~~C 49 (49)
T smart00109 1 HHFVERTFKKPTKCCVCRKSIWGSF-QGLRCSWCKVKCHKKCAEKVPQPC 49 (49)
T ss_pred CceEEeccCCCCCccccccccCcCC-CCcCCCCCCchHHHHHHhhcCCCC
Confidence 7899999999999999999999987 899999999999999999999887
|
Some bind phorbol esters and diacylglycerol. Some bind RasGTP. Zinc-binding domains. |
| >smart00109 C1 Protein kinase C conserved region 1 (C1) domains (Cysteine-rich domains) | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.3e-09 Score=89.19 Aligned_cols=49 Identities=47% Similarity=1.009 Sum_probs=46.7
Q ss_pred ceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCC
Q psy48 530 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579 (1098)
Q Consensus 530 H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C 579 (1098)
|.|...++..+++|++|.+.|||+. ||++|.+|++.+|++|...|+..|
T Consensus 1 H~~~~~~~~~~~~C~~C~~~i~~~~-~~~~C~~C~~~~H~~C~~~v~~~C 49 (49)
T smart00109 1 HHFVERTFKKPTKCCVCRKSIWGSF-QGLRCSWCKVKCHKKCAEKVPQPC 49 (49)
T ss_pred CceEEeccCCCCCccccccccCcCC-CCcCCCCCCchHHHHHHhhcCCCC
Confidence 7899999999999999999999987 899999999999999999999877
|
Some bind phorbol esters and diacylglycerol. Some bind RasGTP. Zinc-binding domains. |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-07 Score=110.69 Aligned_cols=214 Identities=17% Similarity=0.248 Sum_probs=154.7
Q ss_pred eeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC----CcEEEEEEeccC-chH
Q psy48 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP----GRIFVVMEKLQG-DML 898 (1098)
Q Consensus 824 ~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~----~~l~LVmEy~~g-gsL 898 (1098)
.-...|.+....+|..|++|.+.-.+... ......-+++++++.|+|||++.++|.+. ..++||++|.++ .+|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 34567889999999999999994432211 11223456788999999999999999743 468999999974 455
Q ss_pred HHHHhhc--------------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 899 EMILSSE--------------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 899 ~~~l~~~--------------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
.++.-.. ....++..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+- +++|...|+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~---RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM---RIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc---eEEEecccceee
Confidence 4543211 23467899999999999999999999999999999999999876 799988887765
Q ss_pred cCCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH-HHHhhccCCCCCCCcCcHHHHHHHHHhhhhc
Q psy48 965 IGEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ-IQNAAFMYPPRPWRDISSDAIDLINNLLQVK 1043 (1098)
Q Consensus 965 ~~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~-i~~~~~~~p~~~~~~is~el~~LL~~cL~~d 1043 (1098)
+.....+| +.+ ..+-|.-.||.+++.|.||..--...+..... +... ...+|.++++++.-+...+
T Consensus 443 l~~d~~~~--le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I--------~~~yS~D~rn~v~yl~s~~ 509 (655)
T KOG3741|consen 443 LQEDPTEP--LES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI--------TTTYSTDLRNVVEYLESLN 509 (655)
T ss_pred ecCCCCcc--hhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh--------hhhhhHHHHHHHHHHHhcC
Confidence 54433222 222 24679999999999999995432221111111 2221 1347889999999999999
Q ss_pred ccCCCCHHHHHcC
Q psy48 1044 QRKRLSVDKSLAH 1056 (1098)
Q Consensus 1044 P~kRPSa~eIL~H 1056 (1098)
+++ -++.+++.+
T Consensus 510 ~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 510 FRE-KSIQDLLPM 521 (655)
T ss_pred ccc-ccHHHHHHH
Confidence 986 577777654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=6.2e-08 Score=100.61 Aligned_cols=130 Identities=22% Similarity=0.244 Sum_probs=93.0
Q ss_pred eeeeeceEEEEeecCCceeEEEEE-eccCCChHH-----HHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccC
Q psy48 822 IAVVAGAACGVHRKSGRGVAIKVI-DKLRFPTKQ-----EAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 822 ~G~~g~v~~a~~k~tg~~VAVKvl-kk~~~~~~~-----~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
.|.=+.++.+.. -|..+.+|.= +|....+.- .....+|+.++.+++--.|..-.-++.+.+...|+|||++|
T Consensus 6 ~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G 83 (204)
T COG3642 6 QGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEG 83 (204)
T ss_pred CCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCC
Confidence 344444444422 3445666653 332222221 24577899999888765555555556667778899999999
Q ss_pred chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 896 gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
..|.+.+... ...++..+-.-+.-||..||+|+||.++||++..++ +.++||||+.+-
T Consensus 84 ~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~----i~~IDfGLg~~s 141 (204)
T COG3642 84 ELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEFS 141 (204)
T ss_pred hhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc----EEEEECCccccc
Confidence 9998887643 256778888888999999999999999999998774 999999998743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.3e-08 Score=103.86 Aligned_cols=139 Identities=23% Similarity=0.275 Sum_probs=101.7
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCC--CCceeeeeeeecC---CcEEEEEEec
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCH--PGVVNLERMFETP---GRIFVVMEKL 893 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~L~~~f~~~---~~l~LVmEy~ 893 (1098)
.++.|..+.+|..... +|+.|++|+....... .....+..|..+++.+.+ ..+.+++.+.... +..++||||+
T Consensus 5 ~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 5 QLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 4677888889988764 3688999998653221 124568889999998865 3456677776554 3678999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-------------------------------------------
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS------------------------------------------- 930 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs------------------------------------------- 930 (1098)
+|.++...+.. ..++..+...++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99988654321 346666777777777777777773
Q ss_pred -------------CCccccCCCCCceeecC--CCCCCcEEEeecCcccc
Q psy48 931 -------------KNIVHCDLKPENVLLST--NSELPQVKLCDFGFARI 964 (1098)
Q Consensus 931 -------------~gIvHrDLKp~NILld~--~g~~~~vKL~DFGla~~ 964 (1098)
..++|+|++++||+++. ++ .+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~---~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPR---VVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCc---EEEEEecccccc
Confidence 23689999999999998 44 689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.7e-09 Score=123.09 Aligned_cols=28 Identities=25% Similarity=0.548 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.-+|..|||||||||||.|||..
T Consensus 250 ~vlAI~~iH~~gyIHRDIKPdNlLiD~~ 277 (550)
T KOG0605|consen 250 TVLAIESIHQLGYIHRDIKPDNLLIDAK 277 (550)
T ss_pred HHHHHHHHHHcCcccccCChhheeecCC
Confidence 7788899999999999999999999973
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.8e-07 Score=96.68 Aligned_cols=143 Identities=21% Similarity=0.224 Sum_probs=99.8
Q ss_pred eeeeeeceEEEEeecCCceeEEEEE-eccCCChH-----HHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEecc
Q psy48 821 CIAVVAGAACGVHRKSGRGVAIKVI-DKLRFPTK-----QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894 (1098)
Q Consensus 821 g~G~~g~v~~a~~k~tg~~VAVKvl-kk~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ 894 (1098)
-+|.=+.++.+ ...|+...||.= .|...-+. ......+|+++|.++.--.|.--.-+|.+...-.|+|||++
T Consensus 16 kQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~ 93 (229)
T KOG3087|consen 16 KQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFID 93 (229)
T ss_pred eccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEecc
Confidence 34444444443 456788777763 22111111 13567889999988765555544455666667789999998
Q ss_pred C-chHHHHHhhccCc-cchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 895 G-DMLEMILSSEKGR-LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 895 g-gsL~~~l~~~~~~-lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
| .++..++...... ........++.+|-..+.-||..+|+|+||..+||++.+++....+.|+|||++...
T Consensus 94 g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 94 GASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred chhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 8 5566665543322 233333788999999999999999999999999999999988767799999997643
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.6e-09 Score=126.35 Aligned_cols=196 Identities=17% Similarity=0.201 Sum_probs=132.9
Q ss_pred HHHHHHHHHHhccCCCC-ceeeeeeeecCCcEEEEEEeccCc-hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCc
Q psy48 856 AQLKNEVAILQNLCHPG-VVNLERMFETPGRIFVVMEKLQGD-MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNI 933 (1098)
Q Consensus 856 ~~~~~Ei~iL~~l~Hpn-Iv~L~~~f~~~~~l~LVmEy~~gg-sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gI 933 (1098)
....-++++|.+++||| .+..++-++.+....++|+++.++ +.........-.|.+.+...+.+.-+.++++||+.--
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~ 357 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYK 357 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccc
Confidence 34556888999999999 676777777788899999999877 2211111122246666777788888899999998877
Q ss_pred cccCCCCCceeecCCCCCCcEEEeecCcccccC-----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCC
Q psy48 934 VHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFP 1002 (1098)
Q Consensus 934 vHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~P 1002 (1098)
+|+| ||+..++ ..+..||+....++ +.++|||+..+..+....|.|++|+--.+|.-|.+|
T Consensus 358 ~~~d----~~l~s~~----~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 358 VHRD----NILGSEE----EVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred cCcc----ccccccc----ccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 8998 8887765 48999999875432 334799999999999999999999977777777666
Q ss_pred CCCChhHHHHHHHhh---ccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1003 FNEDEDINEQIQNAA---FMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1003 f~~~~~~~~~i~~~~---~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
-..-....-.+-... .......|... +-.++...|+...|..|+....++.|.+|..
T Consensus 430 r~~P~~~~~~~g~~p~s~~L~~~~aw~~~--~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 430 RSSPPAVLPMIGNGPNSPMLTDKSAWSPV--FHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CCCCccccCCCCCCCCccccchhhhcCcc--cccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 432100000000000 00000111111 1124667788889999999888888888874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.1e-07 Score=98.57 Aligned_cols=127 Identities=28% Similarity=0.285 Sum_probs=83.3
Q ss_pred eEEEEeecCCceeEEEEEeccCC----------------------Ch--HHHHHHHHHHHHHhccCCC--Cceeeeeeee
Q psy48 828 AACGVHRKSGRGVAIKVIDKLRF----------------------PT--KQEAQLKNEVAILQNLCHP--GVVNLERMFE 881 (1098)
Q Consensus 828 v~~a~~k~tg~~VAVKvlkk~~~----------------------~~--~~~~~~~~Ei~iL~~l~Hp--nIv~L~~~f~ 881 (1098)
||.|.. .+|..+|||+.+.... .. .......+|.+.|..+..- ++++++.+.
T Consensus 2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 455554 4677999999855210 00 1124678999999988754 466666542
Q ss_pred cCCcEEEEEEecc--CchHHHHHhhccCccchhHHHHHHHHHHHHHHH-HHhCCccccCCCCCceeecCCCCCCcEEEee
Q psy48 882 TPGRIFVVMEKLQ--GDMLEMILSSEKGRLSERTTKFIITQILVALKH-LHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958 (1098)
Q Consensus 882 ~~~~l~LVmEy~~--ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~-LHs~gIvHrDLKp~NILld~~g~~~~vKL~D 958 (1098)
.-+|||||++ |..+..+.. ..++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~---~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~----~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD---VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG----KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH---CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT----CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHh---ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc----eEEEEe
Confidence 3479999999 777754432 123356677788888885555 679999999999999999877 499999
Q ss_pred cCcccccC
Q psy48 959 FGFARIIG 966 (1098)
Q Consensus 959 FGla~~~~ 966 (1098)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99987665
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.5e-07 Score=102.11 Aligned_cols=130 Identities=18% Similarity=0.178 Sum_probs=90.3
Q ss_pred cCCceeEEEEEeccCCCh---------HHHHHHHHHHHHHhccCCCC--ceeeeeeeec-----CCcEEEEEEeccCc-h
Q psy48 835 KSGRGVAIKVIDKLRFPT---------KQEAQLKNEVAILQNLCHPG--VVNLERMFET-----PGRIFVVMEKLQGD-M 897 (1098)
Q Consensus 835 ~tg~~VAVKvlkk~~~~~---------~~~~~~~~Ei~iL~~l~Hpn--Iv~L~~~f~~-----~~~l~LVmEy~~gg-s 897 (1098)
-.|+.|.||......... .-...+.+|...+..+..-+ .+.+++++.. ...-+||||++++. +
T Consensus 43 ~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~s 122 (268)
T PRK15123 43 LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTIS 122 (268)
T ss_pred ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCcc
Confidence 356788899763221100 00114778888887774333 3334445432 23578999999986 7
Q ss_pred HHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC----CCCCcEEEeecCcccc
Q psy48 898 LEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN----SELPQVKLCDFGFARI 964 (1098)
Q Consensus 898 L~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~----g~~~~vKL~DFGla~~ 964 (1098)
|.+++... ....+......++.+++..+.-||..||+|+||++.|||++.+ ++...+.|+||+.+..
T Consensus 123 L~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 123 LEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 87776432 2345666778999999999999999999999999999999852 2223899999998864
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.3e-08 Score=113.43 Aligned_cols=29 Identities=45% Similarity=0.561 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++++|.|||-.|||||||||||||+-.+-
T Consensus 188 vl~ALEYLHmlGivYRDLKPENILvredG 216 (459)
T KOG0610|consen 188 VLLALEYLHMLGIVYRDLKPENILVREDG 216 (459)
T ss_pred HHHHHHHHHhhceeeccCCcceeEEecCC
Confidence 89999999999999999999999997633
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.52 E-value=5.4e-08 Score=116.98 Aligned_cols=140 Identities=21% Similarity=0.338 Sum_probs=107.5
Q ss_pred HHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCcccccCC---------------------CCCChhhhc
Q psy48 919 TQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE---------------------KSFPPEVLR 976 (1098)
Q Consensus 919 ~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~---------------------~~~APEvl~ 976 (1098)
.+.+.||.|+|. .++||+.|.|++|.++.++ .+||+.|+++..... .+.|||++.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~---~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANG---DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCc---ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344599999995 5899999999999999999 899999998754322 124999999
Q ss_pred cCCCCchhHHHHHHHHHHHHH-cCCCCCCCCh-hHHHHHHHhhccCC-CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHH
Q psy48 977 NKGYNRSLDMWSVGVIVYVSL-SGTFPFNEDE-DINEQIQNAAFMYP-PRPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053 (1098)
Q Consensus 977 ~~~ys~~sDVwSLGvlLyELl-tG~~Pf~~~~-~~~~~i~~~~~~~p-~~~~~~is~el~~LL~~cL~~dP~kRPSa~eI 1053 (1098)
+...+.++|+||+|+++|.+. .|+..+.... .+............ .-...+++.++.+-|.+++..++..||++..+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 988899999999999999999 5655554331 11111111111111 11125789999999999999999999999999
Q ss_pred HcCCCcCC
Q psy48 1054 LAHPWLQD 1061 (1098)
Q Consensus 1054 L~HpfFk~ 1061 (1098)
+..+||.+
T Consensus 263 ~~~~ff~D 270 (700)
T KOG2137|consen 263 LSIPFFSD 270 (700)
T ss_pred hcccccCC
Confidence 99999998
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.3e-06 Score=93.84 Aligned_cols=131 Identities=21% Similarity=0.198 Sum_probs=93.2
Q ss_pred cCCceeEEEEEeccCCC-----hHHHHHHHHHHHHHhccCC--CCceeeeeeeecC----CcEEEEEEeccC-chHHHHH
Q psy48 835 KSGRGVAIKVIDKLRFP-----TKQEAQLKNEVAILQNLCH--PGVVNLERMFETP----GRIFVVMEKLQG-DMLEMIL 902 (1098)
Q Consensus 835 ~tg~~VAVKvlkk~~~~-----~~~~~~~~~Ei~iL~~l~H--pnIv~L~~~f~~~----~~l~LVmEy~~g-gsL~~~l 902 (1098)
..++.|-+|.+...... .-......+|...+..+.. -..+..+++.... ...+||||++++ .+|..++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~ 109 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLL 109 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHH
Confidence 44556666654221111 1223567788888776643 2344455555442 245899999988 4788887
Q ss_pred hhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 903 SSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 903 ~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
..... ++......++.+++..++-||..||+|+|+++.|||++.++....+.|+||+-++...
T Consensus 110 ~~~~~-~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 110 QQWEQ-LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred Hhhcc-cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 64222 6677788999999999999999999999999999999988655589999999877543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=98.42 E-value=5e-08 Score=110.69 Aligned_cols=27 Identities=48% Similarity=0.762 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
+.++|++||++|||||||||+||||.+
T Consensus 118 LA~alq~L~~~~IiHRDLKPQNiLLs~ 144 (429)
T KOG0595|consen 118 LASALQFLHENNIIHRDLKPQNILLST 144 (429)
T ss_pred HHHHHHHHHHCCeeeccCCcceEEecc
Confidence 888999999999999999999999998
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=98.42 E-value=5.7e-08 Score=110.17 Aligned_cols=27 Identities=48% Similarity=0.781 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
||.+++|||+.||+|||||||||||-.
T Consensus 285 ll~avkYLH~~GI~HRDiKPeNILl~~ 311 (475)
T KOG0615|consen 285 LLTAVKYLHSQGIIHRDIKPENILLSN 311 (475)
T ss_pred HHHHHHHHHHcCcccccCCcceEEecc
Confidence 999999999999999999999999987
|
|
| >KOG1011|consensus | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.1e-08 Score=112.09 Aligned_cols=59 Identities=41% Similarity=0.857 Sum_probs=54.8
Q ss_pred CCCCCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCCC
Q psy48 260 SSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGE 318 (1098)
Q Consensus 260 ~~~~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~~ 318 (1098)
.+...||+|...+|..||||.-|..+|||+.|||++|..|++.||.+|...+..+|.+.
T Consensus 167 is~ttphnf~~~t~~tpt~cyecegllwglarqglrctqc~vk~hdkc~ell~adclqr 225 (1283)
T KOG1011|consen 167 ISATTPHNFATTTFQTPTFCYECEGLLWGLARQGLRCTQCQVKVHDKCRELLSADCLQR 225 (1283)
T ss_pred cccCCCCceeeeeccCCchhhhhhhHHHHHhhcccchhhccccHHHHHHHHhhhHHHHH
Confidence 34468999999999999999999999999999999999999999999999999999543
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.8e-07 Score=106.99 Aligned_cols=27 Identities=48% Similarity=0.743 Sum_probs=25.7
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
|+..|.+||.++||||||||+|||||-
T Consensus 296 i~cGLehlH~~~iVYRDLKPeNILLDd 322 (591)
T KOG0986|consen 296 IICGLEHLHRRRIVYRDLKPENILLDD 322 (591)
T ss_pred HHhhHHHHHhcceeeccCChhheeecc
Confidence 778899999999999999999999986
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.8e-07 Score=111.78 Aligned_cols=27 Identities=56% Similarity=0.880 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
+|.+|.+||+.||||.|||||||||-.
T Consensus 298 il~~L~~L~~l~IIHcDLKPENILL~~ 324 (586)
T KOG0667|consen 298 ILTALLFLHELGIIHCDLKPENILLKD 324 (586)
T ss_pred HHHHHHHHHhCCeeeccCChhheeecc
Confidence 999999999999999999999999976
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.7e-07 Score=98.51 Aligned_cols=27 Identities=37% Similarity=0.525 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
+.-++.|+|.+++||||+||+|+||++
T Consensus 133 ~A~Al~y~h~k~VIhRdiKpenlLlg~ 159 (281)
T KOG0580|consen 133 LANALLYCHLKRVIHRDIKPENLLLGS 159 (281)
T ss_pred HHHHHHHhccCCcccCCCCHHHhccCC
Confidence 778899999999999999999999998
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.4e-07 Score=106.70 Aligned_cols=30 Identities=30% Similarity=0.605 Sum_probs=27.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCCcc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSL 419 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~~ 419 (1098)
++.+|.|||..||||||+||.|+||+++..
T Consensus 219 vv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 219 VVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred HHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 889999999999999999999999998643
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=98.22 E-value=3e-07 Score=108.93 Aligned_cols=32 Identities=38% Similarity=0.508 Sum_probs=29.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC-cccc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS-SLEI 421 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~-~~~~ 421 (1098)
|+.+++|||++|||||||||=|+||+.+ -+.|
T Consensus 127 Iv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKI 159 (592)
T KOG0575|consen 127 IVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKI 159 (592)
T ss_pred HHHHHHHHHhcCceecccchhheeecCcCcEEe
Confidence 9999999999999999999999999996 4444
|
|
| >KOG4239|consensus | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.8e-07 Score=100.45 Aligned_cols=67 Identities=27% Similarity=0.504 Sum_probs=59.8
Q ss_pred CCCCCCCCCCCCcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCC
Q psy48 516 SPTSPGAPSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGE 582 (1098)
Q Consensus 516 ~~~~~~~~~~~~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~ 582 (1098)
.+..|..+..+...|+|......-|+|||.|+.++||+.++|++|..||++||-+|+..|..+|...
T Consensus 38 ~~~~p~~~lv~~r~~~~~~~g~~~~~~~~~c~~~~~~vl~egL~c~~c~~tch~rcr~lv~ldc~~p 104 (348)
T KOG4239|consen 38 KHIQPLELLVPLRGHNFYTAGLLLPTWCDKCGDFIWGVLREGLLCIHCKFTCHIRCRMLVDLDCRSP 104 (348)
T ss_pred cccCcccceeeccccccccccccccccchhhhHHHHHHHHHHHhhhhcCCccCHHHHhhhhhhhcCC
Confidence 4455666666678899999999999999999999999999999999999999999999999999543
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.1e-07 Score=116.11 Aligned_cols=27 Identities=44% Similarity=0.698 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
|..++.-+|+.|-||||+||||||||.
T Consensus 184 iVlAldslH~mgyVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 184 IVLALDSLHSMGYVHRDIKPDNVLLDK 210 (1317)
T ss_pred HHHHHHHHHhccceeccCCcceeEecc
Confidence 888899999999999999999999998
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.3e-05 Score=91.64 Aligned_cols=164 Identities=21% Similarity=0.270 Sum_probs=117.4
Q ss_pred cEEEEEEeccCch-HHHHHhh-----ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEee
Q psy48 885 RIFVVMEKLQGDM-LEMILSS-----EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958 (1098)
Q Consensus 885 ~l~LVmEy~~ggs-L~~~l~~-----~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~D 958 (1098)
.+.++|..+.|.- ..+++.- ....+.|..+++.++.|+.+.+.||..|.+-+|+.++|+|+.+++ .+.|+|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~---~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS---KVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc---eEEEEc
Confidence 4789999987642 2233321 122478899999999999999999999999999999999999988 788887
Q ss_pred cCcccc-----------cCCCCCChhhhc-----cCCCCchhHHHHHHHHHHHHHcC-CCCCCCC-------hhHHHHHH
Q psy48 959 FGFARI-----------IGEKSFPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSG-TFPFNED-------EDINEQIQ 1014 (1098)
Q Consensus 959 FGla~~-----------~~~~~~APEvl~-----~~~ys~~sDVwSLGvlLyELltG-~~Pf~~~-------~~~~~~i~ 1014 (1098)
-..-.. ....+.+||... +-.-+...|.|.|||+|++++.| ++||.+- ...+..|.
T Consensus 161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 543221 123345888765 44456789999999999999876 9999642 12222333
Q ss_pred HhhccCC------------CCCCCcCcHHHHHHHHHhhhh--cccCCCCHH
Q psy48 1015 NAAFMYP------------PRPWRDISSDAIDLINNLLQV--KQRKRLSVD 1051 (1098)
Q Consensus 1015 ~~~~~~p------------~~~~~~is~el~~LL~~cL~~--dP~kRPSa~ 1051 (1098)
...+.+. ..+|.-+++++..|..+|++. ++.-||+++
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 2222221 123556889999999999986 356899974
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.1e-07 Score=106.55 Aligned_cols=29 Identities=24% Similarity=0.567 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||+|.+.
T Consensus 110 i~~aL~~lH~~givHrDlKp~NILi~~~~ 138 (363)
T cd05628 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKG 138 (363)
T ss_pred HHHHHHHHHhCCeEecCCCHHHeEECCCC
Confidence 78899999999999999999999998743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.5e-07 Score=105.68 Aligned_cols=28 Identities=43% Similarity=0.604 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
.+.++.|||+||||||||||+|.|||..
T Consensus 529 v~EAfeYLH~k~iIYRDLKPENllLd~~ 556 (732)
T KOG0614|consen 529 VLEAFEYLHRKGIIYRDLKPENLLLDNR 556 (732)
T ss_pred HHHHHHHHHhcCceeccCChhheeeccC
Confidence 6778999999999999999999999983
|
|
| >cd08685 C2_RGS-like C2 domain of the Regulator Of G-Protein Signaling (RGS) family | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.2e-07 Score=91.22 Aligned_cols=87 Identities=13% Similarity=0.182 Sum_probs=68.6
Q ss_pred CCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCccccccccccccccCCC-CCCeecccccEE---E
Q psy48 640 HSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSESEESRVTDMSQLYQIS-PDEVLGSGQFGI---V 715 (1098)
Q Consensus 640 ~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~lG~gsFG~---v 715 (1098)
.+.+|||++....|......+.+|++.+.+++|.||++|.|.....+....+.+.+|+.++.. .+++||+.+|+. +
T Consensus 29 ~g~~dpYVkv~l~p~~~~~~~~kT~v~~~t~~P~~nE~F~f~v~~~~~~~~l~v~V~~~~~~~~~~~~lG~~~i~l~~~~ 108 (119)
T cd08685 29 SGTCNSYVKISLSPDKEVRFRQKTSTVPDSANPLFHETFSFDVNERDYQKRLLVTVWNKLSKSRDSGLLGCMSFGVKSIV 108 (119)
T ss_pred CCCCCeeEEEEEEeCCCCcceEeCccccCCCCCccccEEEEEcChHHhCCEEEEEEECCCCCcCCCEEEEEEEecHHHhc
Confidence 456788988777776555556688889999999999999998766665566778899988876 478999999998 4
Q ss_pred Eeeeehhhhhh
Q psy48 716 YGASMVGIFFL 726 (1098)
Q Consensus 716 ~k~~~~g~~~l 726 (1098)
....++|||+|
T Consensus 109 ~~~~~~~Wy~l 119 (119)
T cd08685 109 NQKEISGWYYL 119 (119)
T ss_pred cCccccceEeC
Confidence 44457899875
|
This CD contains members of the regulator of G-protein signaling (RGS) family. RGS is a GTPase activating protein which inhibits G-protein mediated signal transduction. The protein is largely cytosolic, but G-protein activation leads to translocation of this protein to the plasma membrane. A nuclear form of this protein has also been described, but its sequence has not been identified. There are multiple alternatively spliced transcript variants in this family with some members having additional domains (ex. PDZ and RGS) downstream of the C2 domain. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind pho |
| >cd04028 C2B_RIM1alpha C2 domain second repeat contained in Rab3-interacting molecule (RIM) proteins | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.4e-07 Score=92.20 Aligned_cols=91 Identities=9% Similarity=-0.012 Sum_probs=74.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCccccccccccc-cccCCCCCCeecccccEE--E
Q psy48 639 THSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSESEESRVTDMS-QLYQISPDEVLGSGQFGI--V 715 (1098)
Q Consensus 639 ~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~lG~gsFG~--v 715 (1098)
..+.+|||++....+......+.+|++.+.++||+||+++.|... ..+..+.+.+| ++++++++++||+..|.. +
T Consensus 47 ~~g~sDPYVKv~Llp~~~~~~k~KT~v~kktlnPvfNE~F~f~v~--l~~~~L~v~V~~d~~~~~~~~~iG~~~i~L~~l 124 (146)
T cd04028 47 SKVLPAPYVKVYLLEGKKCIAKKKTKIARKTLDPLYQQQLVFDVS--PTGKTLQVIVWGDYGRMDKKVFMGVAQILLDDL 124 (146)
T ss_pred CCCCcCCeEEEEEECCCccccceeceecCCCCCCccCCeEEEEEc--CCCCEEEEEEEeCCCCCCCCceEEEEEEEcccc
Confidence 356789999988887766666789999999999999999999876 45567777888 799999999999999987 3
Q ss_pred -Eeeeehhhhhhhhhhc
Q psy48 716 -YGASMVGIFFLAALYE 731 (1098)
Q Consensus 716 -~k~~~~g~~~l~~~~e 731 (1098)
....+.+||.|+...+
T Consensus 125 ~~~~~~~~Wy~L~~~~~ 141 (146)
T cd04028 125 DLSNLVIGWYKLFPTSS 141 (146)
T ss_pred cCCCCceeEEecCCccc
Confidence 3446678999887654
|
RIMs are believed to organize specialized sites of the plasma membrane called active zones. They also play a role in controlling neurotransmitter release, plasticity processes, as well as memory and learning. RIM contains an N-terminal zinc finger domain, a PDZ domain, and two C-terminal C2 domains (C2A, C2B). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as |
| >KOG4239|consensus | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.8e-07 Score=98.02 Aligned_cols=57 Identities=30% Similarity=0.613 Sum_probs=53.3
Q ss_pred CCCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCCC
Q psy48 262 VNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGE 318 (1098)
Q Consensus 262 ~~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~~ 318 (1098)
....|+|..+...-|++|+.|++++||++++|++|..||+.||.+|+..|..+|.+-
T Consensus 48 ~~r~~~~~~~g~~~~~~~~~c~~~~~~vl~egL~c~~c~~tch~rcr~lv~ldc~~p 104 (348)
T KOG4239|consen 48 PLRGHNFYTAGLLLPTWCDKCGDFIWGVLREGLLCIHCKFTCHIRCRMLVDLDCRSP 104 (348)
T ss_pred eccccccccccccccccchhhhHHHHHHHHHHHhhhhcCCccCHHHHhhhhhhhcCC
Confidence 347899999999999999999999999999999999999999999999999999654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.2e-05 Score=86.31 Aligned_cols=147 Identities=24% Similarity=0.266 Sum_probs=108.1
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC------------------C--hHHHHHHHHHHHHHhccCCC--
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF------------------P--TKQEAQLKNEVAILQNLCHP-- 871 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~------------------~--~~~~~~~~~Ei~iL~~l~Hp-- 871 (1098)
..++..||.|-=+.||.+.+. .|..+|||.=+.... + .......++|.++|..+...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 345678999999999999976 788999998432210 0 11124567899999888644
Q ss_pred CceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC
Q psy48 872 GVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951 (1098)
Q Consensus 872 nIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~ 951 (1098)
.++..+++ ++-.+||||++|-.|... +++...+..++..|+.-+.-+-..||||+|+.+=||+++.+|
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg-- 239 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG-- 239 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC--
Confidence 56655554 567899999999777433 235666777788888888888899999999999999999998
Q ss_pred CcEEEeecCcccccCCCCCChhhh
Q psy48 952 PQVKLCDFGFARIIGEKSFPPEVL 975 (1098)
Q Consensus 952 ~~vKL~DFGla~~~~~~~~APEvl 975 (1098)
.+.++||--+.....+. |+|.+
T Consensus 240 -~~~vIDwPQ~v~~~hp~-a~e~l 261 (304)
T COG0478 240 -DIVVIDWPQAVPISHPD-AEELL 261 (304)
T ss_pred -CEEEEeCcccccCCCCC-HHHHH
Confidence 79999997665444332 55555
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=98.06 E-value=8.1e-07 Score=103.90 Aligned_cols=29 Identities=24% Similarity=0.537 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.++.|||++|||||||||+|||+|.+.
T Consensus 110 i~~aL~~LH~~givHrDlKp~Nili~~~~ 138 (381)
T cd05626 110 LTLAIESVHKMGFIHRDIKPDNILIDLDG 138 (381)
T ss_pred HHHHHHHHHhCCeeecCCcHHHEEECCCC
Confidence 77889999999999999999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=98.05 E-value=8.4e-07 Score=102.83 Aligned_cols=29 Identities=24% Similarity=0.550 Sum_probs=26.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||+|.+.
T Consensus 110 i~~~L~~lH~~givHrDLkp~NIli~~~~ 138 (360)
T cd05627 110 TVLAIDAIHQLGFIHRDIKPDNLLLDAKG 138 (360)
T ss_pred HHHHHHHHHHCCeEccCCCHHHEEECCCC
Confidence 77889999999999999999999998743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.3e-06 Score=98.46 Aligned_cols=35 Identities=31% Similarity=0.426 Sum_probs=32.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCCcccccCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIKSN 424 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~~~~~~~ 424 (1098)
|+-+|.|||+.||.|||+||.|+|+|.++..+|=+
T Consensus 134 lfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKic 168 (364)
T KOG0658|consen 134 LFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKIC 168 (364)
T ss_pred HHHHHHHHHhcCcccCCCChheEEEcCCCCeEEec
Confidence 88999999999999999999999999988888743
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.3e-06 Score=100.74 Aligned_cols=28 Identities=43% Similarity=0.551 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 140 i~~aL~~LH~~~ivHrDLkp~NILl~~~ 167 (340)
T PTZ00426 140 IVLIFEYLQSLNIVYRDLKPENLLLDKD 167 (340)
T ss_pred HHHHHHHHHHCCeEccCCCHHHEEECCC
Confidence 7888999999999999999999999764
|
|
| >cd08381 C2B_PI3K_class_II C2 domain second repeat present in class II phosphatidylinositol 3-kinases (PI3Ks) | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.3e-07 Score=87.48 Aligned_cols=87 Identities=11% Similarity=0.017 Sum_probs=67.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcC-CC-CccccccccccccccCCCCCCeecccccEE--E
Q psy48 640 HSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCE-DV-SESEESRVTDMSQLYQISPDEVLGSGQFGI--V 715 (1098)
Q Consensus 640 ~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~lG~gsFG~--v 715 (1098)
.+.+|||++....|......+.+|++.+.+++|.|++++.|.. .. ......+.+.+|+++.++.+++||+..|+. +
T Consensus 30 ~~~~DpyVkv~l~~~~~~~~~~kT~v~~~~~nP~wnE~F~f~~~~~~~l~~~~L~~~V~d~d~~~~~~~lG~~~i~l~~l 109 (122)
T cd08381 30 GSDPDPYVKTYLLPDPQKTTKRKTKVVRKTRNPTFNEMLVYDGLPVEDLQQRVLQVSVWSHDSLVENEFLGGVCIPLKKL 109 (122)
T ss_pred CCCCCCEEEEEEeeCCccCCceeCCccCCCCCCCcccEEEEecCChHHhCCCEEEEEEEeCCCCcCCcEEEEEEEecccc
Confidence 4567899988877766656678899999999999999999875 32 223456778899999999999999999987 3
Q ss_pred E-eeeehhhhhh
Q psy48 716 Y-GASMVGIFFL 726 (1098)
Q Consensus 716 ~-k~~~~g~~~l 726 (1098)
. .....+||.|
T Consensus 110 ~~~~~~~~W~~L 121 (122)
T cd08381 110 DLSQETEKWYPL 121 (122)
T ss_pred ccCCCccceEEC
Confidence 2 2335778765
|
There are 3 classes of PI3Ks based on structure, regulation, and specificity. All classes contain a N-terminal C2 domain, a PIK domain, and a kinase catalytic domain. Unlike class I and class III, class II PI3Ks have additionally a PX domain and a C-terminal C2 domain containing a nuclear localization signal both of which bind phospholipids though in a slightly different fashion. PI3Ks (AKA phosphatidylinositol (PtdIns) 3-kinases) regulate cell processes such as cell growth, differentiation, proliferation, and motility. PI3Ks work on phosphorylation of phosphatidylinositol, phosphatidylinositide (4)P (PtdIns (4)P),2 or PtdIns(4,5)P2. Specifically they phosphorylate the D3 hydroxyl group of phosphoinositol lipids on the inositol ring. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permut |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=98.00 E-value=1.2e-06 Score=102.39 Aligned_cols=29 Identities=24% Similarity=0.518 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.++.|||++|||||||||+|||+|.+.
T Consensus 110 i~~al~~lH~~~ivHrDlKp~NILl~~~g 138 (382)
T cd05625 110 LTCAVESVHKMGFIHRDIKPDNILIDRDG 138 (382)
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 77889999999999999999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.5e-06 Score=94.59 Aligned_cols=31 Identities=29% Similarity=0.497 Sum_probs=26.8
Q ss_pred HHHhhccccc--cc--cccccCCCCCccCCCCccc
Q psy48 390 ILVALKHLHS--KN--IVHCDLKPERNLFPTSSLE 420 (1098)
Q Consensus 390 ~la~lk~LH~--k~--IihRDLK~dNvLld~~~~~ 420 (1098)
++.+|-..|. +. |||||+||-||+||.+.++
T Consensus 133 L~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvv 167 (375)
T KOG0591|consen 133 LCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVV 167 (375)
T ss_pred HHHHHHHHhccccccceeeccCcchheEEcCCCce
Confidence 7888999999 66 9999999999999975443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.4e-06 Score=107.34 Aligned_cols=25 Identities=48% Similarity=0.752 Sum_probs=22.8
Q ss_pred hhccccccccccccCCCCCccCCCC
Q psy48 393 ALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 393 ~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
+|.|||++|||||||||+|||||.+
T Consensus 267 aL~yLH~~gIiHRDLKP~NILl~~~ 291 (566)
T PLN03225 267 ALDGLHSTGIVHRDVKPQNIIFSEG 291 (566)
T ss_pred HHHHHHHCCEEeCcCCHHHEEEeCC
Confidence 5789999999999999999999863
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.3e-06 Score=99.78 Aligned_cols=29 Identities=31% Similarity=0.445 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.++.|||++|||||||||+|||+|.+.
T Consensus 110 i~~al~~lH~~~ivHrDikp~Nill~~~~ 138 (323)
T cd05615 110 ISVGLFFLHRRGIIYRDLKLDNVMLDSEG 138 (323)
T ss_pred HHHHHHHHHHCCeeccCCCHHHeEECCCC
Confidence 77889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.5e-06 Score=99.24 Aligned_cols=28 Identities=36% Similarity=0.486 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||+|.+
T Consensus 110 i~~al~~lH~~~ivH~dlkp~Nill~~~ 137 (324)
T cd05587 110 IAIGLFFLHSKGIIYRDLKLDNVMLDAE 137 (324)
T ss_pred HHHHHHHHHHCCeEecCCCHHHeEEcCC
Confidence 7889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.9e-06 Score=98.70 Aligned_cols=28 Identities=43% Similarity=0.672 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||+|.+
T Consensus 127 i~~aL~~LH~~~ivH~dlkp~NIll~~~ 154 (329)
T PTZ00263 127 LVLAFEYLHSKDIIYRDLKPENLLLDNK 154 (329)
T ss_pred HHHHHHHHHHCCeeecCCCHHHEEECCC
Confidence 6678999999999999999999999874
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.6e-06 Score=98.92 Aligned_cols=29 Identities=34% Similarity=0.485 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||+|.+.
T Consensus 110 i~~aL~~LH~~~ivHrDlkp~Nill~~~~ 138 (323)
T cd05616 110 IAIGLFFLHSKGIIYRDLKLDNVMLDSEG 138 (323)
T ss_pred HHHHHHHHHHCCEEecCCCHHHeEECCCC
Confidence 78889999999999999999999998743
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1098 | ||||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-40 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-40 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-40 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-40 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-40 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-40 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-39 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-36 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-36 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-36 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-36 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-36 | ||
| 2jam_B | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-36 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-35 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-35 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-34 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-34 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-34 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-34 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-33 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-33 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-32 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-32 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-32 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-32 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-32 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-32 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-32 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-32 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-32 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-30 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-30 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-30 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-30 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-30 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-30 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-30 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-30 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-30 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-30 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-29 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-29 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-29 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-29 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-29 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-29 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-28 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-28 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-28 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-28 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-28 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-28 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-28 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-28 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-28 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-28 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-28 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-28 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-28 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-28 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-28 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-28 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-28 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-28 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-28 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-28 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-28 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-28 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-28 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-28 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-28 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-28 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-28 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-28 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-28 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-28 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-28 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-28 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-27 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-27 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-27 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-27 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-27 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-27 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-27 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-27 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-27 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-27 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-27 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-27 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-27 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-27 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-27 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-27 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-27 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-27 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-27 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-27 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-27 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-27 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-27 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-27 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-27 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-27 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-27 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-27 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-27 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-27 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-27 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-27 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-27 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-27 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-27 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-27 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-27 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-27 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-27 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-27 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-27 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-27 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-26 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-26 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-26 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-26 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-26 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-26 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-26 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-26 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-26 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-26 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-26 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-25 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-25 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-25 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-25 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-25 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-24 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-24 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-24 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-24 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-24 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-24 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-24 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-24 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-24 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-24 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-24 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-23 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-23 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-23 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-23 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-23 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-23 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-23 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-23 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-23 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-23 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-23 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-23 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-23 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-23 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-23 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-23 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-23 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-23 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-23 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-23 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-23 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-23 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-22 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-22 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-22 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-22 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-22 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-22 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-22 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-22 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-22 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-22 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-22 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-22 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-22 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-22 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-22 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-22 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-22 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-22 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-22 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-22 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-21 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-21 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-21 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-21 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-21 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-21 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-21 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-21 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-21 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-21 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-21 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-21 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-21 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-21 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-21 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-21 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-21 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-21 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-21 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-21 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-21 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-21 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-21 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-21 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-21 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-21 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-21 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-21 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-21 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-21 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-21 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-21 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-21 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-21 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-21 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-20 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-20 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-20 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-20 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-20 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-20 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-20 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-20 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-20 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-20 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-20 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-20 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-20 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-20 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-20 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-20 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-20 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-20 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-20 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-20 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-20 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-20 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-20 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-20 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-20 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-20 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-19 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-19 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-19 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-19 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-19 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-19 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-19 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-19 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-19 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-19 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-19 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-19 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-19 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-19 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-18 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-18 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-18 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-18 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-18 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-18 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-18 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-18 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-18 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-17 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-17 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-17 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-17 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-17 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-17 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-16 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-16 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-15 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-15 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-15 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-15 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-14 | ||
| 2d9z_A | 129 | Solution Structure Of The Ph Domain Of Protein Kina | 5e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-12 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-12 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-12 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-11 | ||
| 2coa_A | 125 | Solution Structure Of The Ph Domain Of Protein Kina | 7e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-10 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-09 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 8e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 9e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-06 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-05 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 4e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 4e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 4e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-04 |
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2D9Z|A Chain A, Solution Structure Of The Ph Domain Of Protein Kinase C, Nu Type From Human Length = 129 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2COA|A Chain A, Solution Structure Of The Ph Domain Of Protein Kinase C, D2 Type From Human Length = 125 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 3e-84
Identities = 76/269 (28%), Positives = 126/269 (46%), Gaps = 15/269 (5%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCH-PGVVNLERMFETPGRIFVVM 890
+ + +G+ A K + K R A++ +E+A+L+ P V+NL ++E I +++
Sbjct: 49 ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E G++ + L +SE +I QIL + +LH NIVH DLKP+N+LLS+
Sbjct: 109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY 168
Query: 950 ELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
L +K+ DFG +R IG PE+L + DMW++G+I Y+ L+
Sbjct: 169 PLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228
Query: 999 GTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
T PF +++ I Y + +S A D I +LL KR + + L+H
Sbjct: 229 HTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288
Query: 1057 PWLQDPATWSDLRGLERQIGTNKKKNPKR 1085
WLQ + E + + + R
Sbjct: 289 SWLQQWDFENLFHPEETSSSSQTQDHSVR 317
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 14/65 (21%)
Query: 372 LCDFG--FARIIGEKS----------FRRSILVALKHLHSKNIVHCDLKPERNLF--PTS 417
G F+ + E + + IL + +LH NIVH DLKP+ L
Sbjct: 110 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYP 169
Query: 418 SLEIK 422
+IK
Sbjct: 170 LGDIK 174
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 1e-78
Identities = 76/259 (29%), Positives = 135/259 (52%), Gaps = 16/259 (6%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
VH+ +G A K+I+ + + +L+ E I + L HP +V L + ++V
Sbjct: 25 CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
+ + G++ E I+ + SE I QIL ++ + HS IVH +LKPEN+LL++ +
Sbjct: 85 DLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 142
Query: 950 ELPQVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+ VKL DFG A + + P PEVL+ Y++ +D+W+ GVI+Y+ L
Sbjct: 143 KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 202
Query: 999 GTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
G PF ++ + QI+ A+ YP W ++ +A LI+++L V +KR++ D++L
Sbjct: 203 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262
Query: 1057 PWLQDPATWSDLRGLERQI 1075
PW+ + + + +
Sbjct: 263 PWICNRERVASAIHRQDTV 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 4e-06
Identities = 17/52 (32%), Positives = 25/52 (48%), Gaps = 11/52 (21%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNL 413
L G F I+ + + + IL ++ + HS IVH +LKPE NL
Sbjct: 86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE-NL 136
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 6e-78
Identities = 88/265 (33%), Positives = 146/265 (55%), Gaps = 27/265 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQ------EAQLKNEVAILQNLCHPGVVNLERMFETPG 884
RK+ + VAI++I K +F ++ E+ IL+ L HP ++ ++ F+
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212
Query: 885 RIFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
++V+E ++ G++ + ++ RL E T K Q+L+A+++LH I+H DLKPENV
Sbjct: 213 DYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENV 270
Query: 944 LLSTNSELPQVKLCDFGFARIIGEKSFP-----------PEVLRN---KGYNRSLDMWSV 989
LLS+ E +K+ DFG ++I+GE S PEVL + GYNR++D WS+
Sbjct: 271 LLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 990 GVIVYVSLSGTFPF---NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRK 1046
GVI+++ LSG PF + +QI + + + P W ++S A+DL+ LL V +
Sbjct: 331 GVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKA 390
Query: 1047 RLSVDKSLAHPWLQDPATWSDLRGL 1071
R + +++L HPWLQD + L
Sbjct: 391 RFTTEEALRHPWLQDEDMKRKFQDL 415
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 15/50 (30%), Positives = 26/50 (52%), Gaps = 8/50 (16%)
Query: 377 FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
F +++G K + +L+A+++LH I+H DLKPE L +
Sbjct: 227 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 276
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 6e-78
Identities = 93/290 (32%), Positives = 154/290 (53%), Gaps = 28/290 (9%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQ------EAQLKNEVAILQNLCHPGVVNLERMFETPG 884
RK+ + VAIK+I K +F ++ E+ IL+ L HP ++ ++ F+
Sbjct: 29 AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87
Query: 885 RIFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
++V+E ++ G++ + ++ RL E T K Q+L+A+++LH I+H DLKPENV
Sbjct: 88 DYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENV 145
Query: 944 LLSTNSELPQVKLCDFGFARIIGEKSF-------P----PEVLRN---KGYNRSLDMWSV 989
LLS+ E +K+ DFG ++I+GE S P PEVL + GYNR++D WS+
Sbjct: 146 LLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 205
Query: 990 GVIVYVSLSGTFPF---NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRK 1046
GVI+++ LSG PF + +QI + + + P W ++S A+DL+ LL V +
Sbjct: 206 GVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKA 265
Query: 1047 RLSVDKSLAHPWLQDPATWSDLRGLERQIGTNKKKNPKRTAQLLSYQLTQ 1096
R + +++L HPWLQD + L + P+ AQ + +
Sbjct: 266 RFTTEEALRHPWLQDEDMKRKFQDLLSEE-NESTALPQVLAQPSTSRKRP 314
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 17/52 (32%), Positives = 29/52 (55%), Gaps = 11/52 (21%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNL 413
L + G F +++G K + +L+A+++LH I+H DLKPE N+
Sbjct: 95 LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPE-NV 145
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 3e-77
Identities = 85/267 (31%), Positives = 145/267 (54%), Gaps = 19/267 (7%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
R +G+ A+K I K +++ L+NE+A+L+ + H +V LE ++E+ ++VM+
Sbjct: 29 KQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86
Query: 892 KLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ G++ + IL E+G +E+ +I Q+L A+K+LH IVH DLKPEN+L T E
Sbjct: 87 LVSGGELFDRIL--ERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEE 144
Query: 951 LPQVKLCDFGFARIIGEKSF------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
++ + DFG +++ P PEVL K Y++++D WS+GVI Y+ L G
Sbjct: 145 NSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGY 204
Query: 1001 FPFNE--DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
PF E + + E+I+ + + W DIS A D I +LL+ +R + +K+L+HPW
Sbjct: 205 PPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264
Query: 1059 LQDPATWSDLRGLERQIGTNKKKNPKR 1085
+ R + + +KN +
Sbjct: 265 IDGNTALH--RDIYPSVSLQIQKNFAK 289
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 20/52 (38%), Positives = 26/52 (50%), Gaps = 11/52 (21%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNL 413
L G F RI+ + + +L A+K+LH IVH DLKPE NL
Sbjct: 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPE-NL 137
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-76
Identities = 80/269 (29%), Positives = 139/269 (51%), Gaps = 16/269 (5%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
VH+ +G A K+I+ + + +L+ E I + L HP +V L + ++V +
Sbjct: 49 VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108
Query: 892 KLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ G++ E I+ + SE I QIL ++ + HS IVH +LKPEN+LL++ ++
Sbjct: 109 LVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK 166
Query: 951 LPQVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
VKL DFG A + + P PEVL+ Y++ +D+W+ GVI+Y+ L G
Sbjct: 167 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
Query: 1000 TFPFNE--DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
PF + + QI+ A+ YP W ++ +A LI+++L V +KR++ D++L P
Sbjct: 227 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286
Query: 1058 WLQDPATWSDLRGLERQIGTNKKKNPKRT 1086
W+ + + + + KK N +R
Sbjct: 287 WICNRERVASAIHRQDTVDCLKKFNARRK 315
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 16/57 (28%), Positives = 26/57 (45%), Gaps = 10/57 (17%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
L G F I+ + + + IL ++ + HS IVH +LKPE L + +
Sbjct: 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 165
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 4e-76
Identities = 83/274 (30%), Positives = 137/274 (50%), Gaps = 19/274 (6%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQ---EAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888
++R++G+ A+K++D +F + LK E +I L HP +V L + + G +++
Sbjct: 44 INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103
Query: 889 VMEKLQG-DMLEMILS--SEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
V E + G D+ I+ SE + QIL AL++ H NI+H D+KP VLL
Sbjct: 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLL 163
Query: 946 STNSELPQVKLCDFGFARIIGEKSFP------------PEVLRNKGYNRSLDMWSVGVIV 993
++ VKL FG A +GE PEV++ + Y + +D+W GVI+
Sbjct: 164 ASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
Query: 994 YVSLSGTFPFN-EDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDK 1052
++ LSG PF E + E I + PR W IS A DL+ +L + +R++V +
Sbjct: 224 FILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYE 283
Query: 1053 SLAHPWLQDPATWSDLRGLERQIGTNKKKNPKRT 1086
+L HPWL++ ++ L + +K N +R
Sbjct: 284 ALNHPWLKERDRYAYKIHLPETVEQLRKFNARRK 317
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 13/31 (41%), Positives = 18/31 (58%)
Query: 388 RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
R IL AL++ H NI+H D+KP L +
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKE 167
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 4e-76
Identities = 79/247 (31%), Positives = 128/247 (51%), Gaps = 17/247 (6%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
R + + A+KVI+K K + + EV +L+ L HP ++ L + E ++V E
Sbjct: 42 KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101
Query: 892 KLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
G++ + I+ ++ R SE II Q+ + ++H NIVH DLKPEN+LL + +
Sbjct: 102 LYTGGELFDEII--KRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159
Query: 951 LPQVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
+K+ DFG + + + PEVLR Y+ D+WS GVI+Y+ LSG
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
Query: 1000 TFPFNE--DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
T PF + DI ++++ + + WR IS DA DLI +L R++ + L HP
Sbjct: 219 TPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278
Query: 1058 WLQDPAT 1064
W+Q ++
Sbjct: 279 WIQKYSS 285
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 18/57 (31%), Positives = 24/57 (42%), Gaps = 10/57 (17%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
L G F II K F + + + ++H NIVH DLKPE L +
Sbjct: 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 5e-75
Identities = 77/281 (27%), Positives = 132/281 (46%), Gaps = 23/281 (8%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQ----LKNEVAILQNLCHPGVVNLERMFETPGRIF 887
+ +G A K I K R + + ++ EV+IL+ + HP V+ L ++E +
Sbjct: 31 REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 888 VVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL- 945
+++E + G ++ + + EK L+E + QIL + +LHS I H DLKPEN++L
Sbjct: 91 LILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 946 STNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVY 994
N P++K+ DFG A I + PE++ + DMWS+GVI Y
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 995 VSLSGTFPF--NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDK 1052
+ LSG PF + ++ + + + + + S+ A D I LL +KR+++
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268
Query: 1053 SLAHPWLQDPATWSDLRGLERQIGTN--KKKNPKRTAQLLS 1091
SL HPW++ T L + KK ++ + S
Sbjct: 269 SLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGS 309
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 16/59 (27%), Positives = 25/59 (42%), Gaps = 10/59 (16%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSSLE 420
L G F + ++S + IL + +LHS I H DLKPE + ++
Sbjct: 95 LVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVP 153
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 1e-74
Identities = 83/247 (33%), Positives = 136/247 (55%), Gaps = 21/247 (8%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ + + A+KV+ K T + ++ E+ +L L HP ++ L+ +FETP I +V+E
Sbjct: 73 KQKGTQKPYALKVLKK----TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128
Query: 892 KLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ G++ + I+ EKG SER + QIL A+ +LH IVH DLKPEN+L +T +
Sbjct: 129 LVTGGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAP 186
Query: 951 LPQVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
+K+ DFG ++I+ + P PE+LR Y +DMWSVG+I Y+ L G
Sbjct: 187 DAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
Query: 1000 TFPF---NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
PF D+ + +I N + + W ++S +A DL+ L+ + +KRL+ ++L H
Sbjct: 247 FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306
Query: 1057 PWLQDPA 1063
PW+ A
Sbjct: 307 PWVTGKA 313
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 20/57 (35%), Positives = 28/57 (49%), Gaps = 10/57 (17%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
L G F RI+ + + + IL A+ +LH IVH DLKPE L+ T +
Sbjct: 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA 185
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 3e-74
Identities = 73/249 (29%), Positives = 121/249 (48%), Gaps = 21/249 (8%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQ----LKNEVAILQNLCHPGVVNLERMFETPGRIF 887
+ +G+ A K I K R + + ++ EV IL+ + HP ++ L +FE +
Sbjct: 25 RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84
Query: 888 VVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL- 945
+++E + G++ + + EK L+E + QIL + +LHSK I H DLKPEN++L
Sbjct: 85 LILELVSGGELFDFLA--EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL 142
Query: 946 STNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVY 994
N P++KL DFG A I + PE++ + DMWS+GVI Y
Sbjct: 143 DKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 202
Query: 995 VSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDK 1052
+ LSG PF + I + + + + S A D I LL ++R+++ +
Sbjct: 203 ILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQ 262
Query: 1053 SLAHPWLQD 1061
SL H W++
Sbjct: 263 SLEHSWIKA 271
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 6e-06
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 10/59 (16%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSSLE 420
L G F + ++S + IL + +LHSK I H DLKPE + ++
Sbjct: 89 LVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVP 147
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 5e-74
Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 21/270 (7%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQ----LKNEVAILQNLCHPGVVNLERMFETPGRIF 887
+ +G A K I K + + ++ EV+IL+ + H V+ L ++E +
Sbjct: 32 REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 888 VVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL- 945
+++E + G++ + + +K LSE I QIL + +LH+K I H DLKPEN++L
Sbjct: 92 LILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149
Query: 946 STNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVY 994
N +P +KL DFG A I + PE++ + DMWS+GVI Y
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 995 VSLSGTFPF--NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDK 1052
+ LSG PF + ++ I + ++ + + S A D I LL + RKRL++ +
Sbjct: 210 ILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQE 269
Query: 1053 SLAHPWLQDPATWSDLRGLERQIGTNKKKN 1082
+L HPW+ + E + +
Sbjct: 270 ALRHPWITPVDNQQAMVRRESVVNLENFRK 299
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 8e-06
Identities = 16/59 (27%), Positives = 26/59 (44%), Gaps = 10/59 (16%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSSLE 420
L G F + ++S + IL + +LH+K I H DLKPE + ++
Sbjct: 96 LVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 7e-74
Identities = 80/270 (29%), Positives = 138/270 (51%), Gaps = 17/270 (6%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
V +G+ A +I+ + + +L+ E I + L HP +V L G +++ +
Sbjct: 31 VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90
Query: 892 KLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ G ++ E I+ + SE I QIL A+ H H +VH +LKPEN+LL++ +
Sbjct: 91 LVTGGELFEDIV--AREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLK 148
Query: 951 LPQVKLCDFGFARII--GEKSF------P----PEVLRNKGYNRSLDMWSVGVIVYVSLS 998
VKL DFG A + ++++ P PEVLR Y + +D+W+ GVI+Y+ L
Sbjct: 149 GAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208
Query: 999 GTFPFNE--DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
G PF + + +QI+ A+ +P W ++ +A DLIN +L + KR++ ++L H
Sbjct: 209 GYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268
Query: 1057 PWLQDPATWSDLRGLERQIGTNKKKNPKRT 1086
PW+ +T + + + KK N +R
Sbjct: 269 PWISHRSTVASCMHRQETVDCLKKFNARRK 298
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 16/57 (28%), Positives = 24/57 (42%), Gaps = 10/57 (17%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
L G F I+ + + + IL A+ H H +VH +LKPE L +
Sbjct: 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL 147
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 4e-73
Identities = 75/252 (29%), Positives = 118/252 (46%), Gaps = 19/252 (7%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
V + + A K I K + + K E+ I+++L HP ++ L FE I++VM
Sbjct: 28 AVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E G++ E ++ K E I+ +L A+ + H N+ H DLKPEN L T+S
Sbjct: 86 ELCTGGELFERVV--HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS 143
Query: 950 ELPQVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+KL DFG A P P+VL Y D WS GV++YV L
Sbjct: 144 PDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLC 202
Query: 999 GTFPFNE--DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
G PF+ D ++ +I+ F +P + W ++S A LI LL ++R++ ++L H
Sbjct: 203 GYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262
Query: 1057 PWLQDPATWSDL 1068
W + + S
Sbjct: 263 EWFEKQLSSSPR 274
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 21/57 (36%), Positives = 30/57 (52%), Gaps = 10/57 (17%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
LC G F R++ ++ FR + +L A+ + H N+ H DLKPE LF T S
Sbjct: 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS 143
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 6e-73
Identities = 87/259 (33%), Positives = 135/259 (52%), Gaps = 30/259 (11%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVM 890
VH+KS + A+K+I K + EA + E+ L+ HP +V L +F F+VM
Sbjct: 31 VHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85
Query: 891 EKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E L G ++ E I +K SE +I+ +++ A+ H+H +VH DLKPEN+L + +
Sbjct: 86 ELLNGGELFERIK--KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN 143
Query: 950 ELPQVKLCDFGFARIIGEKSFP------------PEVLRNKGYNRSLDMWSVGVIVYVSL 997
+ ++K+ DFGFAR+ + P PE+L GY+ S D+WS+GVI+Y L
Sbjct: 144 DNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTML 203
Query: 998 SGTFPFNED---------EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
SG PF +I ++I+ F + W+++S +A DLI LL V KRL
Sbjct: 204 SGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL 263
Query: 1049 SVDKSLAHPWLQDPATWSD 1067
+ + WLQD + S
Sbjct: 264 KMSGLRYNEWLQDGSQLSS 282
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 24/63 (38%), Positives = 32/63 (50%), Gaps = 12/63 (19%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLF--PTSSL 419
L + G F RI +K F R ++ A+ H+H +VH DLKPE LF +L
Sbjct: 87 LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNL 146
Query: 420 EIK 422
EIK
Sbjct: 147 EIK 149
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 6e-73
Identities = 79/274 (28%), Positives = 130/274 (47%), Gaps = 22/274 (8%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQ----LKNEVAILQNLCHPGVVNLERMFETPGRIF 887
+ +G A K I K + + ++ EV+IL+ + HP ++ L ++E +
Sbjct: 32 REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91
Query: 888 VVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL- 945
+++E + G++ + + +K LSE I QIL + +LH+K I H DLKPEN++L
Sbjct: 92 LILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149
Query: 946 STNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVY 994
N +P +KL DFG A I + PE++ + DMWS+GVI Y
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 995 VSLSGTFPF--NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDK 1052
+ LSG PF + ++ I ++ + + S A D I LL + RKRL++ +
Sbjct: 210 ILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQE 269
Query: 1053 SLAHPWLQDPATWSDLRGLERQIGTNK-KKNPKR 1085
+L HPW+ T + E + KK R
Sbjct: 270 ALRHPWITPVDTQQAMVRRESVVNLENFKKQYVR 303
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 16/59 (27%), Positives = 26/59 (44%), Gaps = 10/59 (16%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSSLE 420
L G F + ++S + IL + +LH+K I H DLKPE + ++
Sbjct: 96 LVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 1e-71
Identities = 78/267 (29%), Positives = 132/267 (49%), Gaps = 34/267 (12%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQ-------EAQLKNEVAILQNLC-HPGVVNLERMFET 882
+H+ + + A+K+ID + EV IL+ + HP ++ L+ +ET
Sbjct: 36 CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95
Query: 883 PGRIFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
F+V + ++ G++ + + EK LSE+ T+ I+ +L + LH NIVH DLKPE
Sbjct: 96 NTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE 153
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKSF-------P----PEVLR------NKGYNRSL 984
N+LL + + KL DFGF+ + P PE++ + GY + +
Sbjct: 154 NILLDDDMNI---KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 210
Query: 985 DMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042
DMWS GVI+Y L+G+ PF + I + + + W D S DL++ L V
Sbjct: 211 DMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV 270
Query: 1043 KQRKRLSVDKSLAHPWLQDPATWSDLR 1069
+ +KR + +++LAHP+ Q ++R
Sbjct: 271 QPQKRYTAEEALAHPFFQQ-YVVEEVR 296
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 19/61 (31%), Positives = 27/61 (44%), Gaps = 11/61 (18%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSSLEI 421
L G F + + + R++L + LH NIVH DLKPE N+ + I
Sbjct: 105 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE-NILLDDDMNI 163
Query: 422 K 422
K
Sbjct: 164 K 164
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 1e-71
Identities = 78/251 (31%), Positives = 136/251 (54%), Gaps = 17/251 (6%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+ + AIK+I K T ++L EVA+L+ L HP ++ L FE ++VM
Sbjct: 56 CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115
Query: 891 EKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E +G ++ + I+ + + +E II Q+L + +LH NIVH DLKPEN+LL +
Sbjct: 116 ECYKGGELFDEII--HRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE 173
Query: 950 ELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+ +K+ DFG + + + PEVLR K Y+ D+WS+GVI+++ L+
Sbjct: 174 KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232
Query: 999 GTFPFNE--DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
G PF D++I +++ + + W+++S A DLI +LQ ++R+S ++L H
Sbjct: 233 GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292
Query: 1057 PWLQDPATWSD 1067
PW+++ + +
Sbjct: 293 PWIKEMCSKKE 303
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 18/57 (31%), Positives = 23/57 (40%), Gaps = 10/57 (17%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
G F II F + +L + +LH NIVH DLKPE L +
Sbjct: 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE 173
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-71
Identities = 79/245 (32%), Positives = 126/245 (51%), Gaps = 17/245 (6%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
R + + A+KVI+K K + + EV +L+ L HP ++ L + E ++V
Sbjct: 41 CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100
Query: 891 EKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E G ++ + I+ ++ R SE II Q+ + ++H NIVH DLKPEN+LL +
Sbjct: 101 ELYTGGELFDEII--KRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158
Query: 950 ELPQVKLCDFGFARIIGEKSFP-----------PEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+ +K+ DFG + + + PEVLR Y+ D+WS GVI+Y+ LS
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLS 217
Query: 999 GTFPFNE--DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
GT PF + DI ++++ + + WR IS DA DLI +L R++ + L H
Sbjct: 218 GTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277
Query: 1057 PWLQD 1061
PW+Q
Sbjct: 278 PWIQK 282
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 18/57 (31%), Positives = 24/57 (42%), Gaps = 10/57 (17%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
L G F II K F + + + ++H NIVH DLKPE L +
Sbjct: 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 3e-71
Identities = 71/270 (26%), Positives = 127/270 (47%), Gaps = 19/270 (7%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
V S + K + + +K E++IL H +++L FE+ + ++ E
Sbjct: 25 VETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81
Query: 892 KLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ G D+ E I + L+ER + Q+ AL+ LHS NI H D++PEN++ T
Sbjct: 82 FISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS 140
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
+K+ +FG AR + PEV ++ + + DMWS+G +VYV LSG
Sbjct: 141 -STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
Query: 1000 TFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
PF + + I E I NA + + +++IS +A+D ++ LL +++ R++ ++L HP
Sbjct: 200 INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259
Query: 1058 WLQDPATWSDLRGLERQIGTNKKKNPKRTA 1087
WL+ + + +
Sbjct: 260 WLKQKIERVSTKVIRTLKHRRYYHTLIKKD 289
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 7e-05
Identities = 19/63 (30%), Positives = 26/63 (41%), Gaps = 12/63 (19%)
Query: 372 LCDFG--FARIIGEK---------SFRRSILVALKHLHSKNIVHCDLKPERNLFPT-SSL 419
F RI S+ + AL+ LHS NI H D++PE ++ T S
Sbjct: 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS 141
Query: 420 EIK 422
IK
Sbjct: 142 TIK 144
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 1e-70
Identities = 72/247 (29%), Positives = 121/247 (48%), Gaps = 19/247 (7%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
R SG IK I+K R E Q++ E+ +L++L HP ++ + +FE +++VM
Sbjct: 41 VEERSSGLERVIKTINKDRSQVPME-QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99
Query: 891 EKLQ-GDMLEMILS--SEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
E + G++LE I+S + LSE ++ Q++ AL + HS+++VH DLKPEN+L
Sbjct: 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQD 159
Query: 948 NSELPQVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGVIVYVS 996
S +K+ DFG A + PEV + + D+WS GV++Y
Sbjct: 160 TSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFL 218
Query: 997 LSGTFPFNE--DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSL 1054
L+G PF E++ ++ Y ++ A+DL+ +L +R S + L
Sbjct: 219 LTGCLPFTGTSLEEVQQKATYKEPNYAVECR-PLTPQAVDLLKQMLTKDPERRPSAAQVL 277
Query: 1055 AHPWLQD 1061
H W +
Sbjct: 278 HHEWFKQ 284
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 8e-05
Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 14/61 (22%)
Query: 372 LCDFG--FARIIGEKSFR------------RSILVALKHLHSKNIVHCDLKPERNLFPTS 417
C+ G RI+ ++ + ++ AL + HS+++VH DLKPE LF +
Sbjct: 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDT 160
Query: 418 S 418
S
Sbjct: 161 S 161
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 2e-70
Identities = 78/268 (29%), Positives = 130/268 (48%), Gaps = 19/268 (7%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
V + +GR K I+ + +KNE++I+ L HP ++NL FE + +++E
Sbjct: 71 VEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128
Query: 892 KLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
L G ++ + I + E ++SE + Q LKH+H +IVH D+KPEN++ T
Sbjct: 129 FLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA 187
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
VK+ DFG A + PE++ + DMW++GV+ YV LSG
Sbjct: 188 -SSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
Query: 1000 TFPF--NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
PF +D + + ++ + + + +S +A D I NLLQ + RKRL+V +L HP
Sbjct: 247 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306
Query: 1058 WLQDPATWSDLRGLERQIGTNKKKNPKR 1085
WL+ + R + ++ K
Sbjct: 307 WLKGDHSNLTSR-IPSSRYNKIRQKIKE 333
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 18/56 (32%), Positives = 26/56 (46%), Gaps = 10/56 (17%)
Query: 377 FARIIGEK---------SFRRSILVALKHLHSKNIVHCDLKPERNLFPT-SSLEIK 422
F RI E ++ R LKH+H +IVH D+KPE + T + +K
Sbjct: 136 FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVK 191
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 2e-70
Identities = 77/246 (31%), Positives = 123/246 (50%), Gaps = 18/246 (7%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
+ +G+ A+KVI K + K + + L EV +L+ L HP ++ L FE G ++V
Sbjct: 45 CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104
Query: 890 MEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
E G ++ + I+ + R SE II Q+L + ++H IVH DLKPEN+LL +
Sbjct: 105 GEVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK 162
Query: 949 SELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSL 997
S+ +++ DFG + PEVL Y+ D+WS GVI+Y+ L
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILL 221
Query: 998 SGTFPF--NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055
SG PF + DI ++++ + + W+ +S A DLI +L R+S +L
Sbjct: 222 SGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281
Query: 1056 HPWLQD 1061
H W+Q
Sbjct: 282 HEWIQT 287
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 19/57 (33%), Positives = 25/57 (43%), Gaps = 10/57 (17%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
+ G F II K F R +L + ++H IVH DLKPE L + S
Sbjct: 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS 163
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-70
Identities = 84/271 (30%), Positives = 131/271 (48%), Gaps = 25/271 (9%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+G +A K+I K + ++KNE++++ L H ++ L FE+ I +VME
Sbjct: 109 EETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166
Query: 892 KLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ G ++ + I+ E L+E T + QI ++H+H I+H DLKPEN+L
Sbjct: 167 YVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDA 225
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
Q+K+ DFG AR + PEV+ + DMWSVGVI Y+ LSG
Sbjct: 226 -KQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
Query: 1000 TFPF--NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
PF + D + I + ++DIS +A + I+ LL ++ R+S ++L HP
Sbjct: 285 LSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHP 344
Query: 1058 WLQDPATWSDLRGLERQIGTNKKKNPKRTAQ 1088
WL D L ++ KKKN AQ
Sbjct: 345 WLSD-------HKLHSRLSAQKKKNRGSDAQ 368
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 21/63 (33%), Positives = 28/63 (44%), Gaps = 12/63 (19%)
Query: 372 LCDFG--FARIIGEK---------SFRRSILVALKHLHSKNIVHCDLKPERNLFPT-SSL 419
D G F RII E F + I ++H+H I+H DLKPE L +
Sbjct: 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK 226
Query: 420 EIK 422
+IK
Sbjct: 227 QIK 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 6e-69
Identities = 78/257 (30%), Positives = 132/257 (51%), Gaps = 32/257 (12%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQE------AQLKNEVAILQNLC-HPGVVNLERMFETP 883
VHR +G A+K+++ E + E IL+ + HP ++ L +E+
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172
Query: 884 GRIFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
+F+V + ++ G++ + + EK LSE+ T+ I+ +L A+ LH+ NIVH DLKPEN
Sbjct: 173 SFMFLVFDLMRKGELFDYLT--EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSF-------P----PEVLR------NKGYNRSLD 985
+LL N ++ +L DFGF+ + P PE+L+ + GY + +D
Sbjct: 231 ILLDDNMQI---RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 986 MWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVK 1043
+W+ GVI++ L+G+ PF + I + + W D SS DLI+ LLQV
Sbjct: 288 LWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVD 347
Query: 1044 QRKRLSVDKSLAHPWLQ 1060
RL+ +++L HP+ +
Sbjct: 348 PEARLTAEQALQHPFFE 364
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 20/61 (32%), Positives = 31/61 (50%), Gaps = 11/61 (18%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSSLEI 421
L G F + + + RS+L A+ LH+ NIVH DLKPE N+ +++I
Sbjct: 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPE-NILLDDNMQI 239
Query: 422 K 422
+
Sbjct: 240 R 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 9e-69
Identities = 72/268 (26%), Positives = 115/268 (42%), Gaps = 18/268 (6%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
R +G A K + + ++ E+ + L HP +VNL FE + ++ E
Sbjct: 177 TERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 892 KLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ G ++ E + E ++SE + Q+ L H+H N VH DLKPEN++ +T
Sbjct: 235 FMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS 293
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
++KL DFG + K PEV K DMWSVGV+ Y+ LSG
Sbjct: 294 -NELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
Query: 1000 TFPFNE--DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
PF D++ +++ + + IS D D I LL R+++ ++L HP
Sbjct: 353 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412
Query: 1058 WLQDPATWSDLRGLERQIGTNKKKNPKR 1085
WL + T + + K
Sbjct: 413 WLTPGNAPGRDSQIPSSRYTKIRDSIKT 440
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 20/63 (31%), Positives = 27/63 (42%), Gaps = 12/63 (19%)
Query: 372 LCDFG--FARIIGEK---------SFRRSILVALKHLHSKNIVHCDLKPERNLFPT-SSL 419
G F ++ E + R + L H+H N VH DLKPE +F T S
Sbjct: 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN 294
Query: 420 EIK 422
E+K
Sbjct: 295 ELK 297
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 2e-68
Identities = 78/259 (30%), Positives = 130/259 (50%), Gaps = 28/259 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPT-----------KQEAQLKNEVAILQNLCHPGVVNLERM 879
+ AIKVI K +F K ++ NE+++L++L HP ++ L +
Sbjct: 55 CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114
Query: 880 FETPGRIFVVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDL 938
FE ++V E +G ++ E I+ + + E I+ QIL + +LH NIVH D+
Sbjct: 115 FEDKKYFYLVTEFYEGGELFEQII--NRHKFDECDAANIMKQILSGICYLHKHNIVHRDI 172
Query: 939 KPENVLLSTNSELPQVKLCDFGFARIIGEKSFP-----------PEVLRNKGYNRSLDMW 987
KPEN+LL + L +K+ DFG + + PEVL+ K YN D+W
Sbjct: 173 KPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVW 231
Query: 988 SVGVIVYVSLSGTFPFNE--DEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQR 1045
S GVI+Y+ L G PF D+DI ++++ + + W++IS +A +LI +L
Sbjct: 232 SCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYN 291
Query: 1046 KRLSVDKSLAHPWLQDPAT 1064
KR + +++L W++ A
Sbjct: 292 KRCTAEEALNSRWIKKYAN 310
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 18/57 (31%), Positives = 25/57 (43%), Gaps = 10/57 (17%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
+ G F +II F + IL + +LH NIVH D+KPE L +
Sbjct: 127 FYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 3e-68
Identities = 78/271 (28%), Positives = 137/271 (50%), Gaps = 29/271 (10%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVM 890
+H+ + A+K+IDK + +E + IL HP ++ L+ +++ ++VV
Sbjct: 42 IHKATNMEFAVKIIDKSKRDPTEE------IEILLRYGQHPNIITLKDVYDDGKYVYVVT 95
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E ++ G++L+ IL + SER ++ I +++LH++ +VH DLKP N+L S
Sbjct: 96 ELMKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES 153
Query: 950 ELPQ-VKLCDFGFARIIGEKSFP------------PEVLRNKGYNRSLDMWSVGVIVYVS 996
P+ +++CDFGFA+ + ++ PEVL +GY+ + D+WS+GV++Y
Sbjct: 154 GNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTM 213
Query: 997 LSGTFPF-----NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVD 1051
L+G PF + E+I +I + F W +S A DL++ +L V +RL+
Sbjct: 214 LTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273
Query: 1052 KSLAHPWLQDPATWSDLRGLERQIGTNKKKN 1082
L HPW+ L RQ + K
Sbjct: 274 LVLRHPWIVHWDQLPQ-YQLNRQDAPHLVKG 303
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 16/57 (28%), Positives = 27/57 (47%), Gaps = 10/57 (17%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
L G +I+ +K F +I +++LH++ +VH DLKP L+ S
Sbjct: 97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES 153
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 4e-68
Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 29/288 (10%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETP----GRI 886
HR++G+ A+K++ + + EV P +V + ++E +
Sbjct: 49 FHRRTGQKCALKLLYD-------SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101
Query: 887 FVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
++ME ++ G++ I +ER I+ I A++ LHS NI H D+KPEN+L
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLY 161
Query: 946 STNSELPQVKLCDFGFARIIGEKSF----------PPEVLRNKGYNRSLDMWSVGVIVYV 995
++ + +KL DFGFA+ + + PEVL + Y++S DMWS+GVI+Y+
Sbjct: 162 TSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 221
Query: 996 SLSGTFPFNED------EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS 1049
L G PF + + +I+ + +P W ++S DA LI LL+ +RL+
Sbjct: 222 LLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT 281
Query: 1050 VDKSLAHPWLQDPATWSDLRGLERQIGTNKKKNPKRTAQLLSYQLTQM 1097
+ + + HPW+ ++ K + + ++ L M
Sbjct: 282 ITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEEMTSALATM 329
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 21/65 (32%), Positives = 31/65 (47%), Gaps = 14/65 (21%)
Query: 372 LCDFG--FARII--GEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLF--PTS 417
+ G F+RI G+++F R I A++ LHS NI H D+KPE L+
Sbjct: 107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEK 166
Query: 418 SLEIK 422
+K
Sbjct: 167 DAVLK 171
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 6e-67
Identities = 68/278 (24%), Positives = 126/278 (45%), Gaps = 29/278 (10%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFET----PGRI 886
++++ A+K++ + + EV + P +V + ++E +
Sbjct: 38 FNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90
Query: 887 FVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
+VME L G++ I +ER I+ I A+++LHS NI H D+KPEN+L
Sbjct: 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 150
Query: 946 STNSELPQVKLCDFGFARIIGEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPF-- 1003
++ +KL DFGFA E + Y++S DMWS+GVI+Y+ L G PF
Sbjct: 151 TSKRPNAILKLTDFGFA---------KETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYS 200
Query: 1004 ----NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
+ +I+ + +P W ++S + LI NLL+ + +R+++ + + HPW+
Sbjct: 201 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260
Query: 1060 QDPATWSDLRGLERQIGTNKKKNPKRTAQLLSYQLTQM 1097
++ K+ + + ++ L M
Sbjct: 261 MQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATM 298
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 21/59 (35%), Positives = 32/59 (54%), Gaps = 12/59 (20%)
Query: 372 LCDFG--FARII--GEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
D G F+RI G+++F +SI A+++LHS NI H D+KPE L+ +
Sbjct: 96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 154
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 5e-66
Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 47/275 (17%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVM 890
++ + + A+K+I+K P +++ EV +L H V+ L FE R ++V
Sbjct: 33 INLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
EK++ G +L I ++ +E ++ + AL LH+K I H DLKPEN+L +
Sbjct: 91 EKMRGGSILSHIH--KRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN 148
Query: 950 ELPQVKLCDFGFARIIGEKSFP-------------------PEVLR-----NKGYNRSLD 985
++ VK+CDF I PEV+ Y++ D
Sbjct: 149 QVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCD 208
Query: 986 MWSVGVIVYVSLSGTFPFNED-----------------EDINEQIQNAAFMYPPRPWRDI 1028
+WS+GVI+Y+ LSG PF + E IQ + +P + W I
Sbjct: 209 LWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI 268
Query: 1029 SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063
S A DLI+ LL ++RLS + L HPW+Q A
Sbjct: 269 SCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 16/57 (28%), Positives = 22/57 (38%), Gaps = 10/57 (17%)
Query: 372 LCDFG--FARIIGEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
G + I + F + + AL LH+K I H DLKPE L +
Sbjct: 92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN 148
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 2e-64
Identities = 68/259 (26%), Positives = 121/259 (46%), Gaps = 30/259 (11%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFET----PGRI 886
++++ A+K++ + + EV + P +V + ++E +
Sbjct: 82 FNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134
Query: 887 FVVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
+VME L G ++ I +ER I+ I A+++LHS NI H D+KPEN+L
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 194
Query: 946 STNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVY 994
++ +KL DFGFA+ + PEVL + Y++S DMWS+GVI+Y
Sbjct: 195 TSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 254
Query: 995 VSLSGTFPF------NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
+ L G PF + +I+ + +P W ++S + LI NLL+ + +R+
Sbjct: 255 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 314
Query: 1049 SVDKSLAHPWLQDPATWSD 1067
++ + + HPW+
Sbjct: 315 TITEFMNHPWIMQSTKVPQ 333
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 21/59 (35%), Positives = 32/59 (54%), Gaps = 12/59 (20%)
Query: 372 LCDFG--FARII--GEKSFR--------RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418
D G F+RI G+++F +SI A+++LHS NI H D+KPE L+ +
Sbjct: 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 198
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-64
Identities = 71/242 (29%), Positives = 122/242 (50%), Gaps = 23/242 (9%)
Query: 833 HRKSGRGVAIKVIDKLR-FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
++S +A+KV+ K + E QL+ EV I +L HP ++ L F R+++++E
Sbjct: 30 EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ L + + E+ T IT++ AL + HSK ++H D+KPEN+LL + EL
Sbjct: 90 YAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGEL 148
Query: 952 PQVKLCDFGFA-RIIGEKSF---------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
K+ DFG++ + PPE++ + ++ +D+WS+GV+ Y L G
Sbjct: 149 ---KIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
Query: 1002 PFNEDEDINE---QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
PF E E +I F +P + ++ A DLI+ LL+ +R + + L HPW
Sbjct: 206 PF-EANTYQETYKRISRVEFTFP--DF--VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260
Query: 1059 LQ 1060
+
Sbjct: 261 IT 262
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 8e-04
Identities = 15/39 (38%), Positives = 24/39 (61%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
++ + AL + HSK ++H D+KPE NL S+ E+K
Sbjct: 112 ATYITELANALSYCHSKRVIHRDIKPE-NLLLGSAGELK 149
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 4e-64
Identities = 74/293 (25%), Positives = 119/293 (40%), Gaps = 63/293 (21%)
Query: 831 GVHRKSGRGVAIKVIDK--LRFPTKQEAQ-LKNEVAILQNLCHPGVVNLERMFETPGRIF 887
+ ++ AIK+++K +R ++ + +K EV +++ L HP + L ++E I
Sbjct: 45 AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104
Query: 888 VVMEKLQG---------------------------------------DMLEMILSSEKGR 908
+VME G + S
Sbjct: 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFV 164
Query: 909 LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK 968
E+ I+ QI AL +LH++ I H D+KPEN L STN +KL DFG ++ +
Sbjct: 165 QREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE-IKLVDFGLSKEFYKL 223
Query: 969 SFP----------------PEVLR--NKGYNRSLDMWSVGVIVYVSLSGTFPFNE--DED 1008
+ PEVL N+ Y D WS GV++++ L G PF D D
Sbjct: 224 NNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD 283
Query: 1009 INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
Q+ N + + +S A DL++NLL +R ++L HPW+
Sbjct: 284 TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 19/36 (52%), Positives = 24/36 (66%), Gaps = 1/36 (2%)
Query: 388 RSILVALKHLHSKNIVHCDLKPERNLFPTS-SLEIK 422
R I AL +LH++ I H D+KPE LF T+ S EIK
Sbjct: 175 RQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 2e-63
Identities = 66/246 (26%), Positives = 119/246 (48%), Gaps = 25/246 (10%)
Query: 830 CGVHRKSGRGVAIKVIDKLR-FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888
+++ +A+KV+ K + E QL+ E+ I +L HP ++ + F RI++
Sbjct: 32 LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
++E L L GR E+ + + ++ AL + H + ++H D+KPEN+L+
Sbjct: 92 MLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK 150
Query: 949 SELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSL 997
EL K+ DFG++ + PPE++ K ++ +D+W GV+ Y L
Sbjct: 151 GEL---KIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206
Query: 998 SGTFPFNEDEDINE---QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSL 1054
G PF + E +I N +P P+ +S + DLI+ LL+ +RL + +
Sbjct: 207 VGMPPF-DSPSHTETHRRIVNVDLKFP--PF--LSDGSKDLISKLLRYHPPQRLPLKGVM 261
Query: 1055 AHPWLQ 1060
HPW++
Sbjct: 262 EHPWVK 267
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 12/33 (36%), Positives = 19/33 (57%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ AL + H + ++H D+KPE NL E+K
Sbjct: 123 LADALHYCHERKVIHRDIKPE-NLLMGYKGELK 154
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 2e-63
Identities = 58/257 (22%), Positives = 102/257 (39%), Gaps = 34/257 (13%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHP--GVVNLERMFETPGRIFVV 889
V + + AIK ++ + +NE+A L L ++ L T I++V
Sbjct: 47 VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
ME D+ + +K + K +L A+ +H IVH DLKP N L+
Sbjct: 107 MECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG- 163
Query: 950 ELPQVKLCDFGFARIIGEKSF--------------PPEVLRNKG-----------YNRSL 984
+KL DFG A + + PPE +++ +
Sbjct: 164 ---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220
Query: 985 DMWSVGVIVYVSLSGTFPFNEDEDINEQIQN-AAFMYPPRPWRDISSDAIDLINNLLQVK 1043
D+WS+G I+Y G PF + + ++ + D D++ L+
Sbjct: 221 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRD 280
Query: 1044 QRKRLSVDKSLAHPWLQ 1060
++R+S+ + LAHP++Q
Sbjct: 281 PKQRISIPELLAHPYVQ 297
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 11/25 (44%), Positives = 14/25 (56%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLF 414
+L A+ +H IVH DLKP L
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLI 160
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 3e-62
Identities = 64/300 (21%), Positives = 113/300 (37%), Gaps = 44/300 (14%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHP--GVVNLERMFETPGRIFVV 889
V + + AIK ++ + +NE+A L L ++ L T I++V
Sbjct: 28 VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
ME D+ + +K + K +L A+ +H IVH DLKP N L+
Sbjct: 88 MECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG- 144
Query: 950 ELPQVKLCDFGFARIIGEKSF--------------PPEVLRNKG-----------YNRSL 984
+KL DFG A + + PPE +++ +
Sbjct: 145 ---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201
Query: 985 DMWSVGVIVYVSLSGTFPFNEDEDINEQIQN-AAFMYPPRPWRDISSDAIDLINNLLQVK 1043
D+WS+G I+Y G PF + + ++ + D D++ L+
Sbjct: 202 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRD 261
Query: 1044 QRKRLSVDKSLAHPWLQ----------DPATWSDLRGLERQIGTNKKKNPKRTAQLLSYQ 1093
++R+S+ + LAHP++Q T L + +G N + + A+ L
Sbjct: 262 PKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEH 321
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 13/31 (41%), Positives = 19/31 (61%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLF 414
KS+ +++L A+ +H IVH DLKP L
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 141
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 7e-61
Identities = 59/254 (23%), Positives = 98/254 (38%), Gaps = 29/254 (11%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVME 891
R VA+K I + + EV +L+ HP V+ + ++ +E
Sbjct: 44 GMFDNRDVAVKRILP-----ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE- 950
+ E + + ++ Q L HLHS NIVH DLKP N+L+S +
Sbjct: 99 LCAATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAH 157
Query: 951 -LPQVKLCDFGFARII--GEKSF-------------PPEVLR---NKGYNRSLDMWSVGV 991
+ + DFG + + G SF PE+L + ++D++S G
Sbjct: 158 GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGC 217
Query: 992 IVYVSLS-GTFPFNEDEDINEQIQNAAFMYP-PRPWRDISSDAIDLINNLLQVKQRKRLS 1049
+ Y +S G+ PF + I A P + A +LI ++ + +KR S
Sbjct: 218 VFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS 277
Query: 1050 VDKSLAHPWLQDPA 1063
L HP+
Sbjct: 278 AKHVLKHPFFWSLE 291
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 17/49 (34%), Positives = 19/49 (38%), Gaps = 10/49 (20%)
Query: 372 LCDFGFARIIGEKSFRRS----------ILVALKHLHSKNIVHCDLKPE 410
LC + +K F L HLHS NIVH DLKP
Sbjct: 99 LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPH 147
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 8e-61
Identities = 67/247 (27%), Positives = 110/247 (44%), Gaps = 24/247 (9%)
Query: 830 CGVHRKSGRGVAIKVIDKLR-FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888
+G VAIK+IDK + +++NEV I L HP ++ L FE +++
Sbjct: 29 RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
V+E + L + SE + + QI+ + +LHS I+H DL N+LL+ N
Sbjct: 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN 148
Query: 949 SELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVS 996
+ K+ DFG A + PE+ + D+WS+G + Y
Sbjct: 149 MNI---KIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTL 205
Query: 997 LSGTFPFNEDEDINE---QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053
L G PF + + + ++ A + P +S +A DLI+ LL+ RLS+
Sbjct: 206 LIGRPPF-DTDTVKNTLNKVVLADYEMPS----FLSIEAKDLIHQLLRRNPADRLSLSSV 260
Query: 1054 LAHPWLQ 1060
L HP++
Sbjct: 261 LDHPFMS 267
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 4e-05
Identities = 14/37 (37%), Positives = 20/37 (54%), Gaps = 1/37 (2%)
Query: 386 FRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
F I+ + +LHS I+H DL NL T ++ IK
Sbjct: 117 FMHQIITGMLYLHSHGILHRDLTLS-NLLLTRNMNIK 152
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-60
Identities = 65/247 (26%), Positives = 112/247 (45%), Gaps = 27/247 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
+ A K++ K Q ++ E++I ++L H VV FE +FVV
Sbjct: 34 ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93
Query: 890 MEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
+E + +LE+ + L+E ++ + QI++ ++LH ++H DLK N+ L+ +
Sbjct: 94 LELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED 151
Query: 949 SELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVS 996
E VK+ DFG A + PEVL KG++ +D+WS+G I+Y
Sbjct: 152 LE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 208
Query: 997 LSGTFPFNEDEDINE---QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053
L G PF E + E +I+ + P I+ A LI +LQ R ++++
Sbjct: 209 LVGKPPF-ETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARPTINEL 263
Query: 1054 LAHPWLQ 1060
L +
Sbjct: 264 LNDEFFT 270
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 8e-05
Identities = 14/37 (37%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 386 FRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ R I++ ++LH ++H DLK NLF LE+K
Sbjct: 120 YLRQIVLGCQYLHRNRVIHRDLKLG-NLFLNEDLEVK 155
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 3e-60
Identities = 65/300 (21%), Positives = 113/300 (37%), Gaps = 44/300 (14%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHP--GVVNLERMFETPGRIFVV 889
V + + AIK ++ + +NE+A L L ++ L T I++V
Sbjct: 75 VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
ME D+ + +K + K +L A+ +H IVH DLKP N L+
Sbjct: 135 MECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG- 191
Query: 950 ELPQVKLCDFGFARIIGE-------KSF-------PPEVLRNKG-----------YNRSL 984
+KL DFG A + S PPE +++ +
Sbjct: 192 ---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 985 DMWSVGVIVYVSLSGTFPFNEDEDINEQIQN-AAFMYPPRPWRDISSDAIDLINNLLQVK 1043
D+WS+G I+Y G PF + + ++ + D D++ L+
Sbjct: 249 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRD 308
Query: 1044 QRKRLSVDKSLAHPWLQ----------DPATWSDLRGLERQIGTNKKKNPKRTAQLLSYQ 1093
++R+S+ + LAHP++Q T L + +G N + + A+ L
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEH 368
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 13/30 (43%), Positives = 19/30 (63%), Gaps = 1/30 (3%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNL 413
KS+ +++L A+ +H IVH DLKP N
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPA-NF 186
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 7e-60
Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 20/244 (8%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVV 889
++ GR A+K K A+ EV + + HP V LE+ +E G +++
Sbjct: 76 VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E L+ + L E + L+AL HLHS+ +VH D+KP N+ L
Sbjct: 136 TELCGPS-LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG 194
Query: 950 ELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+ KL DFG +G PE+L+ Y + D++S+G+ +
Sbjct: 195 ---RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVAC 250
Query: 999 GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
+ E + Q PP +SS+ ++ +L+ + R + + LA P
Sbjct: 251 NMELPHGGEGWQQLRQG---YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307
Query: 1059 LQDP 1062
L+ P
Sbjct: 308 LRQP 311
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 15/33 (45%), Positives = 20/33 (60%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
L+AL HLHS+ +VH D+KP N+F K
Sbjct: 166 TLLALAHLHSQGLVHLDVKPA-NIFLGPRGRCK 197
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-59
Identities = 64/247 (25%), Positives = 112/247 (45%), Gaps = 27/247 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
+ A K++ K Q ++ E++I ++L H VV FE +FVV
Sbjct: 60 ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119
Query: 890 MEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
+E + +LE+ + L+E ++ + QI++ ++LH ++H DLK N+ L+ +
Sbjct: 120 LELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED 177
Query: 949 SELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVS 996
E+ K+ DFG A + PEVL KG++ +D+WS+G I+Y
Sbjct: 178 LEV---KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 234
Query: 997 LSGTFPFNEDEDINE---QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053
L G PF E + E +I+ + P I+ A LI +LQ R ++++
Sbjct: 235 LVGKPPF-ETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARPTINEL 289
Query: 1054 LAHPWLQ 1060
L +
Sbjct: 290 LNDEFFT 296
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 14/37 (37%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 386 FRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ R I++ ++LH ++H DLK NLF LE+K
Sbjct: 146 YLRQIVLGCQYLHRNRVIHRDLKLG-NLFLNEDLEVK 181
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 5e-59
Identities = 70/250 (28%), Positives = 121/250 (48%), Gaps = 31/250 (12%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQE----AQLKNEVAILQNLCH--PGVVNLERMFETPG 884
G+ VAIK ++K R E ++ EV +L+ + GV+ L FE P
Sbjct: 62 GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121
Query: 885 RIFVVME--KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
+++E + D+ + I +E+G L E + Q+L A++H H+ ++H D+K EN
Sbjct: 122 SFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 179
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSF----------PPEVLRNKGYN-RSLDMWSVGV 991
+L+ N ++KL DFG ++ + + PPE +R Y+ RS +WS+G+
Sbjct: 180 ILIDLNRG--ELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237
Query: 992 IVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVD 1051
++Y + G PF D E+I + R +SS+ LI L ++ R + +
Sbjct: 238 LLYDMVCGDIPFEHD----EEIIRGQVFFRQR----VSSECQHLIRWCLALRPSDRPTFE 289
Query: 1052 KSLAHPWLQD 1061
+ HPW+QD
Sbjct: 290 EIQNHPWMQD 299
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 5e-59
Identities = 57/281 (20%), Positives = 102/281 (36%), Gaps = 52/281 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE--TPGRIFV 888
G H+K+G AIKV + + F + E +L+ L H +V L + E T +
Sbjct: 28 GRHKKTGDLFAIKVFNNISFLRPVD-VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86
Query: 889 VMEKLQ-GDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
+ME G + ++ L E ++ ++ + HL IVH ++KP N++
Sbjct: 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV 146
Query: 947 TNS-ELPQVKLCDFGFARIIGEKSF-------P----PEVLR--------NKGYNRSLDM 986
KL DFG AR + + P++ K Y ++D+
Sbjct: 147 IGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 987 WSVGVIVYVSLSGTFPF------NEDEDINEQIQNAAFM--------------------- 1019
WS+GV Y + +G+ PF ++++ +I
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 1020 YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060
R + ++ N+L+ Q K D+ A
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 13/46 (28%), Positives = 21/46 (45%), Gaps = 4/46 (8%)
Query: 371 KLCDFGFARIIGEKSFR---RSILVALKHLHSKNIVHCDLKPERNL 413
L + A + E F R ++ + HL IVH ++KP N+
Sbjct: 99 VLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPG-NI 143
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 7e-59
Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 33/253 (13%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPT----KQEAQLKNEVAILQNL----CHPGVVNLERMFET 882
G VAIKVI + R EVA+L + HPGV+ L FET
Sbjct: 50 GHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109
Query: 883 PGRIFVVMEKLQ--GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKP 940
+V+E+ D+ + I +EKG L E ++ Q++ A++H HS+ +VH D+K
Sbjct: 110 QEGFMLVLERPLPAQDLFDYI--TEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKD 167
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGEKSF----------PPEVLRNKGYN-RSLDMWSV 989
EN+L+ + KL DFG ++ ++ + PPE + Y+ +WS+
Sbjct: 168 ENILI--DLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSL 225
Query: 990 GVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS 1049
G+++Y + G PF D ++I A +P +S D LI L K R S
Sbjct: 226 GILLYDMVCGDIPFERD----QEILEAELHFPAH----VSPDCCALIRRCLAPKPSSRPS 277
Query: 1050 VDKSLAHPWLQDP 1062
+++ L PW+Q P
Sbjct: 278 LEEILLDPWMQTP 290
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-58
Identities = 63/274 (22%), Positives = 107/274 (39%), Gaps = 48/274 (17%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVME 891
GR VA+K + E+ +L HP V+ T +++ +E
Sbjct: 35 GSFQGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89
Query: 892 KLQGDMLEMI-----LSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
++ +++ E ++ QI + HLHS I+H DLKP+N+L+S
Sbjct: 90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVS 149
Query: 947 TNSELP----------QVKLCDFGFARII--GEKSF--------------PPEVLRN--- 977
T+S ++ + DFG + + G+ SF PE+L
Sbjct: 150 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNN 209
Query: 978 ----KGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAF---MYPPRPWRDIS 1029
+ RS+D++S+G + Y LS G PF + I F R +
Sbjct: 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLI 269
Query: 1030 SDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063
++A DLI+ ++ KR + K L HP +
Sbjct: 270 AEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 1/44 (2%)
Query: 388 RSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIKSNTEEEDED 431
R I + HLHS I+H DLKP+ N+ ++S ++ + E+
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQ-NILVSTSSRFTADQQTGAEN 164
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-57
Identities = 69/249 (27%), Positives = 117/249 (46%), Gaps = 27/249 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+ + VA+K I++ + ++ E+ ++L HP +V + + TP + ++M
Sbjct: 39 MRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E G++ E I GR SE +F Q+L + + HS I H DLK EN LL +
Sbjct: 96 EYASGGELYERI--CNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS- 152
Query: 950 ELPQVKLCDFGFARIIGEKSFP-----------PEVLRNKGYN-RSLDMWSVGVIVYVSL 997
P++K+CDFG+++ S P PEVL + Y+ + D+WS GV +YV L
Sbjct: 153 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVML 212
Query: 998 SGTFPFNEDEDIN------EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVD 1051
G +PF + E+ ++I + + P IS + LI+ + R+S+
Sbjct: 213 VGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPECCHLISRIFVADPATRISIP 270
Query: 1052 KSLAHPWLQ 1060
+ H W
Sbjct: 271 EIKTHSWFL 279
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 7e-57
Identities = 71/246 (28%), Positives = 126/246 (51%), Gaps = 26/246 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
H +GR VAIK+IDK + +L EV I++ L HP +V L + ET ++++M
Sbjct: 34 ARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E G++ + + GR+ E+ + QI+ A+++ H K IVH DLK EN+LL +
Sbjct: 94 EYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM 151
Query: 950 ELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYN-RSLDMWSVGVIVYVSL 997
+K+ DFGF+ PE+ + K Y+ +D+WS+GVI+Y +
Sbjct: 152 ---NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208
Query: 998 SGTFPFNEDEDINE---QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSL 1054
SG+ PF + +++ E ++ + P +S+D +L+ L + KR ++++ +
Sbjct: 209 SGSLPF-DGQNLKELRERVLRGKYRIPFY----MSTDCENLLKRFLVLNPIKRGTLEQIM 263
Query: 1055 AHPWLQ 1060
W+
Sbjct: 264 KDRWIN 269
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-56
Identities = 54/249 (21%), Positives = 104/249 (41%), Gaps = 27/249 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
V+R + VA+K++D R +K E+ I + L H VV ++ +
Sbjct: 26 AVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E G++ + I + E + Q++ + +LH I H D+KPEN+LL
Sbjct: 85 EYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER- 141
Query: 950 ELPQVKLCDFGFARIIGEKSFP--------------PEVLRNKGYN-RSLDMWSVGVIVY 994
+K+ DFG A + + PE+L+ + ++ +D+WS G+++
Sbjct: 142 --DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 995 VSLSGTFPFNEDEDINE---QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVD 1051
L+G P+++ D + + PW+ I S + L++ +L R+++
Sbjct: 200 AMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSAPLALLHKILVENPSARITIP 257
Query: 1052 KSLAHPWLQ 1060
W
Sbjct: 258 DIKKDRWYN 266
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-56
Identities = 73/246 (29%), Positives = 126/246 (51%), Gaps = 26/246 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
H K+ + VA+K I + + +++ E++ L+ L HP ++ L + TP I +V
Sbjct: 28 ATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
+E G++ + I EK R++E + QI+ A+++ H IVH DLKPEN+LL N
Sbjct: 88 IEYAGGELFDYI--VEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL 145
Query: 950 ELPQVKLCDFGFARIIGEKSF-------P----PEVLRNKGYN-RSLDMWSVGVIVYVSL 997
VK+ DFG + I+ + +F P PEV+ K Y +D+WS G+++YV L
Sbjct: 146 ---NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVML 202
Query: 998 SGTFPFNEDEDIN---EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSL 1054
G PF +DE I +++ + ++ P +S A LI ++ +R+++ +
Sbjct: 203 VGRLPF-DDEFIPNLFKKVNSCVYVMPD----FLSPGAQSLIRRMIVADPMQRITIQEIR 257
Query: 1055 AHPWLQ 1060
PW
Sbjct: 258 RDPWFN 263
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-56
Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 33/252 (13%)
Query: 831 GVHRKSGRGVAIKVIDKLR------FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG 884
V ++ + V +K I K + + ++ E+AIL + H ++ + +FE G
Sbjct: 43 AVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102
Query: 885 RIFVVMEKLQ--GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
+VMEK D+ I RL E +I Q++ A+ +L K+I+H D+K EN
Sbjct: 103 FFQLVMEKHGSGLDLFAFI--DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDEN 160
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYN-RSLDMWSVG 990
++++ + +KL DFG A + PEVL Y L+MWS+G
Sbjct: 161 IVIAEDF---TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLG 217
Query: 991 VIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV 1050
V +Y + PF E E+ AA P +S + + L++ LLQ +R ++
Sbjct: 218 VTLYTLVFEENPFCEL----EETVEAAIHPP--YL--VSKELMSLVSGLLQPVPERRTTL 269
Query: 1051 DKSLAHPWLQDP 1062
+K + PW+ P
Sbjct: 270 EKLVTDPWVTQP 281
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-56
Identities = 63/302 (20%), Positives = 119/302 (39%), Gaps = 57/302 (18%)
Query: 833 HRKSGRGVAIKVIDKLRF---------------PTKQEAQLKNEVAILQNLCHPGVVNLE 877
K + A+K +K + KNE+ I+ ++ + + E
Sbjct: 50 CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109
Query: 878 RMFETPGRIFVVMEKLQ-GDMLEMILS------SEKGRLSERTTKFIITQILVALKHLHS 930
+ ++++ E ++ +L+ + + + K II +L + ++H+
Sbjct: 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN 169
Query: 931 -KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF----------PPEVLRNKG 979
KNI H D+KP N+L+ N VKL DFG + + +K PPE N+
Sbjct: 170 EKNICHRDVKPSNILMDKNGR---VKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNES 226
Query: 980 --YNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN---EQIQNAAFMYPPRP---------- 1024
+D+WS+G+ +YV PF+ + I+ YP
Sbjct: 227 SYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNK 286
Query: 1025 -----WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQIGTNK 1079
+S++ ID + L+ +R++ + +L H WL D DLR +++ +
Sbjct: 287 KSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD-TNIEDLREFSKELYKKR 345
Query: 1080 KK 1081
KK
Sbjct: 346 KK 347
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-56
Identities = 74/247 (29%), Positives = 127/247 (51%), Gaps = 27/247 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
G H+ +G VA+K++++ + ++K E+ L+ HP ++ L ++ TP F+V
Sbjct: 30 GEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89
Query: 890 MEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
ME + G++ + I + GR+ E + + QIL A+ + H +VH DLKPENVLL +
Sbjct: 90 MEYVSGGELFDYI--CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH 147
Query: 949 SELPQVKLCDFGFARIIGEKSF-------P----PEVLRNKGYN-RSLDMWSVGVIVYVS 996
K+ DFG + ++ + F P PEV+ + Y +D+WS GVI+Y
Sbjct: 148 M---NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 997 LSGTFPFNEDEDIN---EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053
L GT PF +DE + ++I+ F P + ++ L+ ++LQV KR ++
Sbjct: 205 LCGTLPF-DDEHVPTLFKKIRGGVFYIP--EY--LNRSVATLLMHMLQVDPLKRATIKDI 259
Query: 1054 LAHPWLQ 1060
H W +
Sbjct: 260 REHEWFK 266
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-55
Identities = 61/271 (22%), Positives = 105/271 (38%), Gaps = 48/271 (17%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF---------- 880
+ R AIK I ++ + + +EV +L +L H VV +
Sbjct: 25 ARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81
Query: 881 ---ETPGRIFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHC 936
+ +F+ ME + G + ++I SE + QIL AL ++HS+ I+H
Sbjct: 82 TAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHR 140
Query: 937 DLKPENVLLSTNSELPQVKLCDFGFARIIGEKSFP------------------------- 971
DLKP N+ + + VK+ DFG A+ +
Sbjct: 141 DLKPMNIFIDESR---NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYV 197
Query: 972 -PEVLRNKG-YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDIS 1029
EVL G YN +DM+S+G+I + + E +I +++++ + +PP +
Sbjct: 198 ATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKM 257
Query: 1030 SDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060
+I L+ KR L WL
Sbjct: 258 KVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 17/35 (48%), Positives = 23/35 (65%), Gaps = 1/35 (2%)
Query: 388 RSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
R IL AL ++HS+ I+H DLKP N+F S +K
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPM-NIFIDESRNVK 156
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-55
Identities = 54/249 (21%), Positives = 104/249 (41%), Gaps = 27/249 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
V+R + VA+K++D R +K E+ I + L H VV ++ +
Sbjct: 26 AVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E G++ + I + E + Q++ + +LH I H D+KPEN+LL
Sbjct: 85 EYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER- 141
Query: 950 ELPQVKLCDFGFARIIGEKSFP--------------PEVLRNKGYN-RSLDMWSVGVIVY 994
+K+ DFG A + + PE+L+ + ++ +D+WS G+++
Sbjct: 142 --DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 995 VSLSGTFPFNEDEDINE---QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVD 1051
L+G P+++ D + + PW+ I S + L++ +L R+++
Sbjct: 200 AMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSAPLALLHKILVENPSARITIP 257
Query: 1052 KSLAHPWLQ 1060
W
Sbjct: 258 DIKKDRWYN 266
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 5e-55
Identities = 67/253 (26%), Positives = 118/253 (46%), Gaps = 31/253 (12%)
Query: 831 GVHRKSGRGVAIKVIDK--LRFPTKQEAQLKNEVAILQNLCHPGVVNL-ERMF-ETPGRI 886
+ ++ A+K++ K LR EA +K E+ +L+ L H V+ L + ++ E ++
Sbjct: 24 VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83
Query: 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
++VME M EM+ S + R Q++ L++LHS+ IVH D+KP N+LL+
Sbjct: 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143
Query: 947 TNSELPQVKLCDFGFARIIGEKSF--------------PPEVLRN-KGYN-RSLDMWSVG 990
T +K+ G A + + PPE+ ++ +D+WS G
Sbjct: 144 TGG---TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAG 200
Query: 991 VIVYVSLSGTFPFNEDEDIN---EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKR 1047
V +Y +G +PF E ++I E I ++ P D DL+ +L+ + KR
Sbjct: 201 VTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPG----DCGPPLSDLLKGMLEYEPAKR 255
Query: 1048 LSVDKSLAHPWLQ 1060
S+ + H W +
Sbjct: 256 FSIRQIRQHSWFR 268
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-54
Identities = 68/245 (27%), Positives = 116/245 (47%), Gaps = 23/245 (9%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
+ GR IK I+ R +K+ + + EVA+L N+ HP +V FE G +++VM+
Sbjct: 45 STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104
Query: 893 LQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ GD+ + I + + E QI +ALKH+H + I+H D+K +N+ L+ +
Sbjct: 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-- 162
Query: 952 PQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
V+L DFG AR++ PE+ NK YN D+W++G ++Y +
Sbjct: 163 -TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL 221
Query: 1000 TFPFNEDEDINE---QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
F E + +I + + +PP S D L++ L + R R SV+ L
Sbjct: 222 KHAF-EAGSMKNLVLKIISGS--FPPVS-LHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277
Query: 1057 PWLQD 1061
++
Sbjct: 278 GFIAK 282
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 13/33 (39%), Positives = 22/33 (66%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
I +ALKH+H + I+H D+K + N+F T ++
Sbjct: 134 ICLALKHVHDRKILHRDIKSQ-NIFLTKDGTVQ 165
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-53
Identities = 57/279 (20%), Positives = 103/279 (36%), Gaps = 52/279 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE--TPGRIFV 888
G H+K+G AIKV + + F + E +L+ L H +V L + E T +
Sbjct: 28 GRHKKTGDLFAIKVFNNISFLRPVD-VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86
Query: 889 VMEKLQ-GDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
+ME G + ++ L E ++ ++ + HL IVH ++KP N++
Sbjct: 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV 146
Query: 947 TNSELP-QVKLCDFGFARIIGEKSF-------P----PEVLR--------NKGYNRSLDM 986
+ KL DFG AR + + P++ K Y ++D+
Sbjct: 147 IGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 987 WSVGVIVYVSLSGTFPF------NEDEDINEQIQNAAFM--------------------- 1019
WS+GV Y + +G+ PF ++++ +I
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 1020 YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
R + ++ N+L+ Q K D+ A
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 13/46 (28%), Positives = 21/46 (45%), Gaps = 4/46 (8%)
Query: 371 KLCDFGFARIIGEKSFR---RSILVALKHLHSKNIVHCDLKPERNL 413
L + A + E F R ++ + HL IVH ++KP N+
Sbjct: 99 VLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPG-NI 143
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-53
Identities = 66/253 (26%), Positives = 116/253 (45%), Gaps = 30/253 (11%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF--ETPGRIFVVM 890
+ G+ + K +D ++ L +EV +L+ L HP +V T +++VM
Sbjct: 27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86
Query: 891 EKLQ-GDMLEMI--LSSEKGRLSERTTKFIITQILVALKHLHSKN-----IVHCDLKPEN 942
E + GD+ +I + E+ L E ++TQ+ +ALK H ++ ++H DLKP N
Sbjct: 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVG 990
V L VKL DFG ARI+ + PE + YN D+WS+G
Sbjct: 147 VFLDGKQ---NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG 203
Query: 991 VIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
++Y + PF +++ +I+ + P S + ++I +L +K R
Sbjct: 204 CLLYELCALMPPFTAFSQKELAGKIREGK--FRRIP-YRYSDELNEIITRMLNLKDYHRP 260
Query: 1049 SVDKSLAHPWLQD 1061
SV++ L +P + +
Sbjct: 261 SVEEILENPLILE 273
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 6e-53
Identities = 82/260 (31%), Positives = 135/260 (51%), Gaps = 28/260 (10%)
Query: 833 HRKSGRGVAIKVIDKLR-FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
H++SG A+K++DK + KQ NE ILQ + P +V LE F+ +++VME
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ G + L GR SE +F QI++ ++LHS ++++ DLKPEN+L+
Sbjct: 122 YVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-- 178
Query: 952 PQVKLCDFGFARIIGEKSF---------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFP 1002
+++ DFGFA+ + +++ PE++ +KGYN+++D W++GV++Y +G P
Sbjct: 179 -YIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 1003 FNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS-----LA 1055
F D I E+I + +P SSD DL+ NLLQV KR K+
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
Query: 1056 HPWLQDPATWSDLRGLERQI 1075
H W W + +R++
Sbjct: 294 HKWFAT-TDWIAI--YQRKV 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 189 bits (480), Expect = 7e-53
Identities = 37/280 (13%), Positives = 75/280 (26%), Gaps = 53/280 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEA-QLKNEVAILQNLCHPGVVNLERMF--------- 880
+ A+KV ++ E +L L
Sbjct: 81 VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140
Query: 881 -----------------ETPGRIFVVMEKLQGDMLEMI-----LSSEKGRLSERTTKFII 918
++M D+ + + +G +
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200
Query: 919 TQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF-------- 970
Q++ +L SK +VH P+N+ + + ++ L D +G +
Sbjct: 201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDG---RLMLGDVSALWKVGTRGPASSVPVTY 257
Query: 971 -PPEVLRNKG--YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRP--- 1024
P E L + +L+ W +G+ +Y PF + + P
Sbjct: 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSL 317
Query: 1025 ----WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060
+ LI L +R+RL +++ P
Sbjct: 318 AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 9/39 (23%), Positives = 15/39 (38%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
++ +L SK +VH P+ NLF +
Sbjct: 197 HILTAQLIRLAANLQSKGLVHGHFTPD-NLFIMPDGRLM 234
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 196 bits (498), Expect = 1e-52
Identities = 122/581 (20%), Positives = 206/581 (35%), Gaps = 84/581 (14%)
Query: 520 PGAPSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579
A H F +HTY+ PT C C LL GL QG++C C NVHK+C+ VP C
Sbjct: 93 GPASDDPRSKHKFKIHTYSSPTFCDHCGSLLYGLIHQGMKCDTCMMNVHKRCVMNVPSLC 152
Query: 580 VGEPVTNNKSNNYCKLKSEVASLVSLESSASASYSCLVRSTSHCFILKTNNLDYYVGEDT 639
+ + +++ + V + A + + Y +
Sbjct: 153 ---GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDP-------NGLSDPYVKLKLI 202
Query: 640 HSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSESEESRVTDMSQLY 699
P + +S L E ++E + V + + +
Sbjct: 203 PDPKSESKQKTKTIKSSLNPEWNE----TFRFQLKESDKDRRLSVEIWDWDLTSRNDFMG 258
Query: 700 QIS--PDEVLGSGQFGIV-YGASMVGIFFLAALYEGVKYYREYLFWKTYNDLHYRSIPAQ 756
+S E+ +G G + G +F + E L K + A
Sbjct: 259 SLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAP 318
Query: 757 QRISSVEENKDTAKVVPVCDVLQKQPPSMLMLSMPHFIQTLLHVLQITMSF-LLMLVFMT 815
+ ++ +K + + + F L VL SF +ML
Sbjct: 319 EEKTANTISK------------FDNNGNRDRMKLTDF--NFLMVLG-KGSFGKVMLS--- 360
Query: 816 YNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLC-HPGV 873
+ + A+K++ K + E +L P +
Sbjct: 361 ----------------ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 874 VNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNI 933
L F+T R++ VME + G L + GR E F +I + L L SK I
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGI 463
Query: 934 VHCDLKPENVLLSTNSELPQVKLCDFGFAR--IIGE---KSF-------PPEVLRNKGYN 981
++ DLK +NV+L + +K+ DFG + I K+F PE++ + Y
Sbjct: 464 IYRDLKLDNVMLDSEG---HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG 520
Query: 982 RSLDMWSVGVIVYVSLSGTFPF-NEDED-INEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039
+S+D W+ GV++Y L+G PF EDED + + I YP + +S +A+ + L
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICKGL 576
Query: 1040 LQVKQRKRLSVDKS-----LAHPWLQDPATWSDLRGLERQI 1075
+ KRL H + + W L ++I
Sbjct: 577 MTKHPGKRLGCGPEGERDIKEHAFFRY-IDWEKL--ERKEI 614
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 4e-14
Identities = 23/79 (29%), Positives = 31/79 (39%), Gaps = 15/79 (18%)
Query: 266 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGE------- 318
H F + +PT C C + G KQG QC+ C F VHK+C + V C G
Sbjct: 38 HKFTARFFKQPTFCSHCTDFIWGFGKQGFQCQVCSFVVHKRCHEFVTFSCPGADKGPASD 97
Query: 319 --------PVTNNKSNNYC 329
+ S +C
Sbjct: 98 DPRSKHKFKIHTYSSPTFC 116
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 4e-14
Identities = 23/79 (29%), Positives = 31/79 (39%), Gaps = 15/79 (18%)
Query: 530 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGE------- 582
H F + +PT C C + G KQG QC+ C F VHK+C + V C G
Sbjct: 38 HKFTARFFKQPTFCSHCTDFIWGFGKQGFQCQVCSFVVHKRCHEFVTFSCPGADKGPASD 97
Query: 583 --------PVTNNKSNNYC 593
+ S +C
Sbjct: 98 DPRSKHKFKIHTYSSPTFC 116
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 74.3 bits (182), Expect = 1e-13
Identities = 26/72 (36%), Positives = 33/72 (45%)
Query: 256 PGAPSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315
A H F +HTY+ PT C C LL GL QG++C C NVHK+C+ VP C
Sbjct: 93 GPASDDPRSKHKFKIHTYSSPTFCDHCGSLLYGLIHQGMKCDTCMMNVHKRCVMNVPSLC 152
Query: 316 VGEPVTNNKSNN 327
+
Sbjct: 153 GTDHTERRGRIY 164
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-52
Identities = 74/247 (29%), Positives = 128/247 (51%), Gaps = 27/247 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
G H +G VA+K++++ + +++ E+ L+ HP ++ L ++ TP IF+V
Sbjct: 35 GKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94
Query: 890 MEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
ME + G++ + I + GRL E+ ++ + QIL + + H +VH DLKPENVLL +
Sbjct: 95 MEYVSGGELFDYI--CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH 152
Query: 949 SELPQVKLCDFGFARIIGEKSF-------P----PEVLRNKGYN-RSLDMWSVGVIVYVS 996
K+ DFG + ++ + F P PEV+ + Y +D+WS GVI+Y
Sbjct: 153 M---NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYAL 209
Query: 997 LSGTFPFNEDEDIN---EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053
L GT PF +D+ + ++I + F P ++ I L+ ++LQV KR ++
Sbjct: 210 LCGTLPF-DDDHVPTLFKKICDGIFYTPQ----YLNPSVISLLKHMLQVDPMKRATIKDI 264
Query: 1054 LAHPWLQ 1060
H W +
Sbjct: 265 REHEWFK 271
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 6e-52
Identities = 68/263 (25%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
G VA+K + + A E+ +L+ L HP V+ F + +V
Sbjct: 51 AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110
Query: 890 MEKLQ-GDMLEMI--LSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
+E GD+ MI +K + ERT Q+ AL+H+HS+ ++H D+KP NV ++
Sbjct: 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT 170
Query: 947 TNSELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVY 994
VKL D G R K+ PE + GYN D+WS+G ++Y
Sbjct: 171 ATG---VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 227
Query: 995 VSLSGTFPFNEDE----DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV 1050
+ PF D+ + ++I+ YPP P S + L+N + KR V
Sbjct: 228 EMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285
Query: 1051 DKSLAHPWLQDPATWSDLRGLER 1073
T S L
Sbjct: 286 TYVYDVAKRMHACTASSLEHHHH 308
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 13/33 (39%), Positives = 24/33 (72%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ AL+H+HS+ ++H D+KP N+F T++ +K
Sbjct: 145 LCSALEHMHSRRVMHRDIKPA-NVFITATGVVK 176
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 6e-52
Identities = 69/262 (26%), Positives = 122/262 (46%), Gaps = 36/262 (13%)
Query: 833 HRKSGRGVAIKVIDK---LRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
+ R AIK+++K ++ + + E ++ L HP V L F+ +++
Sbjct: 51 ELATSREYAIKILEKRHIIK--ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 108
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
+ + L + G E T+F +I+ AL++LH K I+H DLKPEN+LL+ +
Sbjct: 109 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 167
Query: 950 ELPQVKLCDFGFARIIGEKSFP--------------PEVLRNKGYNRSLDMWSVGVIVYV 995
+++ DFG A+++ +S PE+L K +S D+W++G I+Y
Sbjct: 168 ---HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224
Query: 996 SLSGTFPF-NEDED-INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053
++G PF +E I ++I + +P A DL+ LL + KRL ++
Sbjct: 225 LVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKARDLVEKLLVLDATKRLGCEEM 280
Query: 1054 ------LAHPWLQDPATWSDLR 1069
AHP+ + TW +L
Sbjct: 281 EGYGPLKAHPFFES-VTWENLH 301
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 14/24 (58%), Positives = 19/24 (79%), Gaps = 1/24 (4%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNL 413
I+ AL++LH K I+H DLKPE N+
Sbjct: 139 IVSALEYLHGKGIIHRDLKPE-NI 161
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 8e-52
Identities = 82/262 (31%), Positives = 136/262 (51%), Gaps = 32/262 (12%)
Query: 833 HRKSGRGVAIKVIDK---LRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
R +GR A+KV+ K +R KQ +E +L + HP ++ + F+ +IF++
Sbjct: 27 SRHNGRYYAMKVLKKEIVVR--LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
M+ ++G L +L R KF ++ +AL++LHSK+I++ DLKPEN+LL N
Sbjct: 85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG 143
Query: 950 ELPQVKLCDFGFARIIGEKSF---------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
+K+ DFGFA+ + + ++ PEV+ K YN+S+D WS G+++Y L+G
Sbjct: 144 ---HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
Query: 1001 FPF-NEDED-INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS----- 1053
PF + + E+I NA +PP + D DL++ L+ +RL ++
Sbjct: 201 TPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 256
Query: 1054 LAHPWLQDPATWSDLRGLERQI 1075
HPW ++ W L L R I
Sbjct: 257 KNHPWFKE-VVWEKL--LSRNI 275
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 5e-04
Identities = 13/24 (54%), Positives = 21/24 (87%), Gaps = 1/24 (4%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNL 413
+ +AL++LHSK+I++ DLKPE N+
Sbjct: 115 VCLALEYLHSKDIIYRDLKPE-NI 137
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 9e-52
Identities = 57/271 (21%), Positives = 113/271 (41%), Gaps = 42/271 (15%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI---- 886
+H+ +G VAIK + P +E + E+ I++ L HP VV+ + + ++
Sbjct: 33 WIHQDTGEQVAIKQCRQELSPKNRE-RWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91
Query: 887 --FVVMEKLQ-GDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
+ ME + GD+ + + E L E + +++ I AL++LH I+H DLKPEN
Sbjct: 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 151
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSF-------P----PEVLRNKGYNRSLDMWSVGV 991
++L + K+ D G+A+ + + PE+L K Y ++D WS G
Sbjct: 152 IVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 992 IVYVSLSGTFPFNED---EDINEQIQNAAFMYPPRPW-------------------RDIS 1029
+ + ++G PF + + +++ + + ++
Sbjct: 212 LAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILA 271
Query: 1030 SDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060
+ +L QR+R + ++ Q
Sbjct: 272 GKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 17/46 (36%), Positives = 22/46 (47%), Gaps = 4/46 (8%)
Query: 371 KLCDFGFARIIGEKSFR---RSILVALKHLHSKNIVHCDLKPERNL 413
L F + E R I AL++LH I+H DLKPE N+
Sbjct: 108 YLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPE-NI 152
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-50
Identities = 46/283 (16%), Positives = 86/283 (30%), Gaps = 61/283 (21%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLC-------------------- 869
+++G + V P Q+K EV L+ L
Sbjct: 92 ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151
Query: 870 -----HPGVVNLERMFETPG--RIFVVMEKLQGDMLEMI-----LSSEKGRLSERTTKFI 917
++ + F + ++Q ++ SS L +
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211
Query: 918 ITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF------- 970
Q++ L LH +VH L+P +++L V L F G +
Sbjct: 212 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG---VFLTGFEHLVRDGARVVSSVSRGF 268
Query: 971 -PPEVL-----------RNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF 1018
PPE+ R S D W++G+++Y P +D + F
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG--GSEWIF 326
Query: 1019 MYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
R ++I L+ L+ + RL +++ P +
Sbjct: 327 ----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 7/35 (20%), Positives = 14/35 (40%), Gaps = 1/35 (2%)
Query: 388 RSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
++ L LH +VH L+P ++ +
Sbjct: 213 LQVIRLLASLHHYGLVHTYLRPV-DIVLDQRGGVF 246
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-50
Identities = 48/257 (18%), Positives = 91/257 (35%), Gaps = 43/257 (16%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE----------- 881
HR G+ IK + + + EV L L H +V+ ++
Sbjct: 32 HRIDGKTYVIKRVKY------NNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85
Query: 882 -----TPGRIFVVMEKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVH 935
+F+ ME +G + + I +L + + QI + ++HSK +++
Sbjct: 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIN 145
Query: 936 CDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSL 984
DLKP N+ L QVK+ DFG + PE + ++ Y + +
Sbjct: 146 RDLKPSNIFLVDTK---QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEV 202
Query: 985 DMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQ 1044
D++++G+I+ L E +++ L+ LL K
Sbjct: 203 DLYALGLILAELLHVCDTAFETSKFFTDLRDGII--SDI----FDKKEKTLLQKLLSKKP 256
Query: 1045 RKRLSVDKSLAHPWLQD 1061
R + + L +
Sbjct: 257 EDRPNTSEILRTLTVWK 273
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 11/33 (33%), Positives = 21/33 (63%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
I + ++HSK +++ DLKP N+F + ++K
Sbjct: 131 ITKGVDYIHSKKLINRDLKPS-NIFLVDTKQVK 162
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-50
Identities = 70/275 (25%), Positives = 120/275 (43%), Gaps = 54/275 (19%)
Query: 831 GVHRKSGRGVAIKVIDKLRF------------------------PTKQEAQLKNEVAILQ 866
+ A+KV+ K + P Q+ E+AIL+
Sbjct: 32 AYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91
Query: 867 NLCHPGVVNLERMFETPGR--IFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILV 923
L HP VV L + + P +++V E + G ++E+ LSE +F ++
Sbjct: 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIK 148
Query: 924 ALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-GEKSF-----------P 971
+++LH + I+H D+KP N+L+ + +K+ DFG + G +
Sbjct: 149 GIEYLHYQKIIHRDIKPSNLLVGEDG---HIKIADFGVSNEFKGSDALLSNTVGTPAFMA 205
Query: 972 PEVLRN--KGYN-RSLDMWSVGVIVYVSLSGTFPFNEDEDIN---EQIQNAAFMYPPRPW 1025
PE L K ++ ++LD+W++GV +Y + G PF DE I +I++ A +P
Sbjct: 206 PESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF-MDERIMCLHSKIKSQALEFP--DQ 262
Query: 1026 RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060
DI+ D DLI +L R+ V + HPW+
Sbjct: 263 PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-47
Identities = 63/264 (23%), Positives = 119/264 (45%), Gaps = 32/264 (12%)
Query: 833 HRKSGRGVAIKVIDKLR-FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ + A+K ++K + + + E+ I+Q L HP +VNL F+ +F+V++
Sbjct: 36 KNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
L G L L E T K I ++++AL +L ++ I+H D+KP+N+LL +
Sbjct: 96 LLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-- 152
Query: 952 PQVKLCDFGFARIIGE----KSF-------PPEVLRNK---GYNRSLDMWSVGVIVYVSL 997
V + DF A ++ + PE+ ++ GY+ ++D WS+GV Y L
Sbjct: 153 -HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211
Query: 998 SGTFPF-----NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDK 1052
G P+ ++I + YP S + + L+ LL+ +R S
Sbjct: 212 RGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWSQEMVSLLKKLLEPNPDQRFSQLS 267
Query: 1053 SL-AHPWLQDPATWSDLRGLERQI 1075
+ P++ D W + ++++
Sbjct: 268 DVQNFPYMND-INWDAV--FQKRL 288
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 8/21 (38%), Positives = 17/21 (80%)
Query: 390 ILVALKHLHSKNIVHCDLKPE 410
+++AL +L ++ I+H D+KP+
Sbjct: 124 LVMALDYLQNQRIIHRDMKPD 144
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-45
Identities = 53/266 (19%), Positives = 94/266 (35%), Gaps = 42/266 (15%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL----ERMFETPGRIFV 888
G A+K I + + + E + + HP ++ L R ++
Sbjct: 50 GLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107
Query: 889 VMEKLQ-GDMLEMI--LSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
++ + G + I L + L+E +++ I L+ +H+K H DLKP N+LL
Sbjct: 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL 167
Query: 946 STNSELPQVKLCDFGFARIIGEKSF---------------------PPEVLRNKGY---N 981
Q L D G PE+ + + +
Sbjct: 168 GDEG---QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID 224
Query: 982 RSLDMWSVGVIVYVSLSGTFPF---NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINN 1038
D+WS+G ++Y + G P+ + D P P SS L+N+
Sbjct: 225 ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSP--RHSSALWQLLNS 282
Query: 1039 LLQVKQRKRLSVDKSLAHPW-LQDPA 1063
++ V +R + L+ LQ PA
Sbjct: 283 MMTVDPHQRPHIPLLLSQLEALQPPA 308
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 10/33 (30%), Positives = 15/33 (45%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
I L+ +H+K H DLKP N+ +
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPT-NILLGDEGQPV 174
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-45
Identities = 79/263 (30%), Positives = 132/263 (50%), Gaps = 31/263 (11%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ +GR A+K++ K K E A E +LQN HP + L+ F+T R+ VME
Sbjct: 26 EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
G L LS E +E +F +I+ AL++LHS+++V+ D+K EN++L +
Sbjct: 86 YANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-- 142
Query: 952 PQVKLCDFGFARI-IGE----KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
+K+ DFG + I + K+F PEVL + Y R++D W +GV++Y + G
Sbjct: 143 -HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
Query: 1000 TFPF-NEDED-INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA-- 1055
PF N+D + + E I +P R +S +A L+ LL+ ++RL S A
Sbjct: 202 RLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
Query: 1056 ---HPWLQDPATWSDLRGLERQI 1075
H + W D+ +++++
Sbjct: 258 VMEHRFFLS-INWQDV--VQKKL 277
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 7e-04
Identities = 10/21 (47%), Positives = 18/21 (85%)
Query: 390 ILVALKHLHSKNIVHCDLKPE 410
I+ AL++LHS+++V+ D+K E
Sbjct: 114 IVSALEYLHSRDVVYRDIKLE 134
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 78/261 (29%), Positives = 122/261 (46%), Gaps = 30/261 (11%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893
+ + A+KV+ K + + K E IL + HP +V L F+T G+++++++ L
Sbjct: 49 SDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL 108
Query: 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953
+G L LS E +E KF + ++ +AL HLHS I++ DLKPEN+LL
Sbjct: 109 RGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG---H 164
Query: 954 VKLCDFGFAR--IIGE---KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001
+KL DFG ++ I E SF PEV+ +G+ +S D WS GV+++ L+GT
Sbjct: 165 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
Query: 1002 PF-NEDED-INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS-----L 1054
PF +D I A P +S +A L+ L + RL
Sbjct: 225 PFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK 280
Query: 1055 AHPWLQDPATWSDLRGLERQI 1075
H + W+ L R+I
Sbjct: 281 RHSFFST-IDWNKL--YRREI 298
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 5e-04
Identities = 12/21 (57%), Positives = 16/21 (76%)
Query: 390 ILVALKHLHSKNIVHCDLKPE 410
+ +AL HLHS I++ DLKPE
Sbjct: 135 LALALDHLHSLGIIYRDLKPE 155
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 51/259 (19%), Positives = 91/259 (35%), Gaps = 33/259 (12%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVV 889
V R G AIK K + E EV L H VV + + +
Sbjct: 30 CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89
Query: 890 MEKLQ-GDMLEMILSSEK--GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
E G + + I + + E K ++ Q+ L+++HS ++VH D+KP N+ +S
Sbjct: 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 149
Query: 947 TNSELPQ----------------VKLCDFGFARIIGE-KSF-------PPEVLR-NKGYN 981
S K+ D G I + EVL+ N +
Sbjct: 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHL 209
Query: 982 RSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041
D++++ + V + + +E Q P P + +S + +L+ ++
Sbjct: 210 PKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGR---LPRIP-QVLSQEFTELLKVMIH 265
Query: 1042 VKQRKRLSVDKSLAHPWLQ 1060
+R S + H L
Sbjct: 266 PDPERRPSAMALVKHSVLL 284
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 19/74 (25%), Positives = 35/74 (47%), Gaps = 7/74 (9%)
Query: 388 RSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIKSNTEEEDEDEERGST------DGGG 441
+ L+++HS ++VH D+KP N+F + + + +EE DED+ + D G
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPS-NIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 442 PSPRSEPRTATATP 455
+ S P+
Sbjct: 181 VTRISSPQVEEGDS 194
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-44
Identities = 65/291 (22%), Positives = 124/291 (42%), Gaps = 60/291 (20%)
Query: 827 GAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKN---------EVAILQNLCHPGVVNLE 877
GA C G VAIK + + L + E+ +L + HP ++ L
Sbjct: 36 GAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95
Query: 878 RMFETPGR-----IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN 932
+F +++V E ++ D L ++ ++ +S + ++ + IL+ L LH
Sbjct: 96 DIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG 154
Query: 933 IVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRN-KGY 980
+VH DL P N+LL+ N+++ +CDF AR + PE++ KG+
Sbjct: 155 VVHRDLHPGNILLADNNDI---TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGF 211
Query: 981 NRSLDMWSVGVIVYVSLSGT--FPFN----------------EDEDIN--------EQIQ 1014
+ +DMWS G ++ + F + + ED+ + ++
Sbjct: 212 TKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLR 271
Query: 1015 NAAFMYPPRPWRDI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
N+ P R W + A+DLI +L+ ++R+S +++L HP+ +
Sbjct: 272 NSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 12/33 (36%), Positives = 17/33 (51%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
IL+ L LH +VH DL P N+ + +I
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPG-NILLADNNDIT 174
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 47/268 (17%), Positives = 96/268 (35%), Gaps = 47/268 (17%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET---------- 882
++ AIK I ++ EV L L HPG+V +
Sbjct: 26 NKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84
Query: 883 --PGRIFVVMEKL--QGDMLEMI-LSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCD 937
+++ M+ L + ++ + + I QI A++ LHSK ++H D
Sbjct: 85 SPKVYLYIQMQ-LCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRD 143
Query: 938 LKPENVLLSTNSELPQVKLCDFGFARIIGEKS------------------------FPPE 973
LKP N+ + + VK+ DFG + + PE
Sbjct: 144 LKPSNIFFTMDD---VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE 200
Query: 974 VLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAI 1033
+ Y+ +D++S+G+I++ L +PF+ + + + + P +
Sbjct: 201 QIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEY 257
Query: 1034 DLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
++ ++L +R + + +D
Sbjct: 258 VMVQDMLSPSPMERPEAINIIENAVFED 285
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 15/33 (45%), Positives = 21/33 (63%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
I A++ LHSK ++H DLKP N+F T +K
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPS-NIFFTMDDVVK 158
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 71/276 (25%), Positives = 115/276 (41%), Gaps = 52/276 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFETPGRIF 887
+R +G+ VAIK K K E+ +L+ L HP +VNL +F R+
Sbjct: 22 CRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+V E + L + + E K I Q L A+ H N +H D+KPEN+L++
Sbjct: 79 LVFEYCDHT-VLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK 137
Query: 948 NSELPQVKLCDFGFARIIG--EKSF----------PPEVL-RNKGYNRSLDMWSVGVIVY 994
+S + KLCDFGFAR++ + PE+L + Y +D+W++G +
Sbjct: 138 HSVI---KLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFA 194
Query: 995 VSLSGT--FPFNEDED-----------INEQI-----QNAAF-------MYPPRPWRDI- 1028
LSG +P D D + + N F P
Sbjct: 195 ELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKF 254
Query: 1029 ---SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
S A+ L+ L + +RL+ ++ L HP+ ++
Sbjct: 255 PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 84/263 (31%), Positives = 132/263 (50%), Gaps = 32/263 (12%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE--AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+G+ A+KV+ K + A K E IL+ + HP +V+L F+T G++++++E
Sbjct: 42 ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILE 101
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
L G L M L E G E T F + +I +AL HLH K I++ DLKPEN++L+
Sbjct: 102 YLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-- 158
Query: 952 PQVKLCDFGFARI-IGE----KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
VKL DFG + I + +F PE+L G+NR++D WS+G ++Y L+G
Sbjct: 159 -HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
Query: 1000 TFPF-NEDED-INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS---- 1053
PF E+ ++I PP ++ +A DL+ LL+ RL
Sbjct: 218 APPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGE 273
Query: 1054 -LAHPWLQDPATWSDLRGLERQI 1075
AHP+ + W +L L R++
Sbjct: 274 VQAHPFFRH-INWEEL--LARKV 293
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 6e-04
Identities = 13/21 (61%), Positives = 16/21 (76%)
Query: 390 ILVALKHLHSKNIVHCDLKPE 410
I +AL HLH K I++ DLKPE
Sbjct: 130 ISMALGHLHQKGIIYRDLKPE 150
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 3e-43
Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 34/267 (12%)
Query: 833 HRKSGRGVAIKVIDKLR-FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ + + A+K+++K + A + E +L N + L F+ +++VM+
Sbjct: 95 LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
G L +LS + RL E +F + ++++A+ +H + VH D+KP+N+L+ N
Sbjct: 155 YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-- 212
Query: 952 PQVKLCDFGFARIIGE------KSF-------PPEVLR-----NKGYNRSLDMWSVGVIV 993
++L DFG + E PE+L+ Y D WS+GV +
Sbjct: 213 -HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271
Query: 994 YVSLSGTFPFNEDEDINEQIQN-----AAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
Y L G PF E + E F +P + D+S +A DLI L+ + RL
Sbjct: 272 YEMLYGETPF-YAESLVETYGKIMNHKERFQFPTQV-TDVSENAKDLIRRLIC-SREHRL 328
Query: 1049 SVDKSL---AHPWLQDPATWSDLRGLE 1072
+ HP+ W ++R E
Sbjct: 329 GQNGIEDFKKHPFFSG-IDWDNIRNCE 354
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 162 bits (410), Expect = 4e-43
Identities = 47/285 (16%), Positives = 86/285 (30%), Gaps = 60/285 (21%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLC-------------------- 869
+++G + V P Q+K EV L+ L
Sbjct: 97 ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156
Query: 870 --HPGVVNLERMFETPGRI-----FVVMEKLQGDMLEMI-----LSSEKGRLSERTTKFI 917
P + R+ + F + ++Q ++ SS L +
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216
Query: 918 ITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF------- 970
Q++ L LH +VH L+P +++L V L F G +
Sbjct: 217 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG---GVFLTGFEHLVRDGASAVSPIGRGF 273
Query: 971 -PPEVL----------RNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM 1019
PPE + D W++G+ +Y P +D + F
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL--GGSEWIF- 330
Query: 1020 YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPAT 1064
R ++I L+ L+ + RL +++ P + T
Sbjct: 331 ---RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 7/33 (21%), Positives = 14/33 (42%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
++ L LH +VH L+P ++ +
Sbjct: 220 VIRLLASLHHYGLVHTYLRPV-DIVLDQRGGVF 251
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 52/276 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKN---EVAILQNLCHPGVVNLERMFETPGRIF 887
++ +GR VAIK K + K E+ +L+ L H +VNL + + R +
Sbjct: 44 CRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+V E + +L+ L L + + + QI+ + HS NI+H D+KPEN+L+S
Sbjct: 101 LVFEFVDHTILD-DLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ 159
Query: 948 NSELPQVKLCDFGFARIIGE--KSF----------PPEVL-RNKGYNRSLDMWSVGVIVY 994
+ + KLCDFGFAR + + + PE+L + Y +++D+W++G +V
Sbjct: 160 SGVV---KLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVT 216
Query: 995 VSLSGT--FPFNEDED-----------INEQI-----QNAAFM-------YPPRPWRD-- 1027
G FP + D D + + +N F P
Sbjct: 217 EMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRY 276
Query: 1028 --ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+S IDL L + KR + L H + Q
Sbjct: 277 PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-42
Identities = 40/259 (15%), Positives = 84/259 (32%), Gaps = 39/259 (15%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
K+ + +KV E + L+ + +V E
Sbjct: 91 DAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147
Query: 892 KLQG----DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+ + + ++ + + + ++L ++ +H I+H D+KP+N +L
Sbjct: 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207
Query: 948 NSELPQ--------VKLCDFGFARIIGEKSFP----------------PEVLRNKGYNRS 983
+ L D G + + K FP E+L NK +N
Sbjct: 208 GFLEQDDEDDLSAGLALIDLGQSIDM--KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ 265
Query: 984 LDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWR-DISSDAIDLINNLLQV 1042
+D + V VY L GT+ ++E + + R D+ ++ ++ N+
Sbjct: 266 IDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL----FRRLPHLDMWNEFFHVMLNIPDC 321
Query: 1043 KQRKRLSVDKSLAHPWLQD 1061
L + + Q
Sbjct: 322 HHLPSLDLLRQKLKKVFQQ 340
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 10/46 (21%), Positives = 22/46 (47%), Gaps = 1/46 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIKSNTEEED 429
SF +L ++ +H I+H D+KP+ N + + + ++
Sbjct: 175 ISFAMRMLYMIEQVHDCEIIHGDIKPD-NFILGNGFLEQDDEDDLS 219
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-42
Identities = 74/260 (28%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQ-NLCHPGVVNLERMFETPGRIFVVM 890
+K+ + AIK + K + E +L HP + ++ F+T +F VM
Sbjct: 38 FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E L G L + S + F +I++ L+ LHSK IV+ DLK +N+LL +
Sbjct: 98 EYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG- 155
Query: 951 LPQVKLCDFGFAR--IIGE---KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+K+ DFG + ++G+ +F PE+L + YN S+D WS GV++Y L
Sbjct: 156 --HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213
Query: 999 GTFPF-NEDED-INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL-SVDKSLA 1055
G PF +DE+ + I+ YP R + +A DL+ L + KRL
Sbjct: 214 GQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269
Query: 1056 HPWLQDPATWSDLRGLERQI 1075
HP ++ W +L ++I
Sbjct: 270 HPLFRE-INWEEL--ERKEI 286
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-42
Identities = 69/267 (25%), Positives = 116/267 (43%), Gaps = 34/267 (12%)
Query: 833 HRKSGRGVAIKVIDKLR-FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
H+ + + A+K++ K A E I+ P VV L F+ +++VME
Sbjct: 90 HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ G L ++S + E+ +F ++++AL +HS +H D+KP+N+LL +
Sbjct: 150 YMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-- 205
Query: 952 PQVKLCDFGFARIIGEKSFP-------------PEVLRNKG----YNRSLDMWSVGVIVY 994
+KL DFG + ++ PEVL+++G Y R D WSVGV +Y
Sbjct: 206 -HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 264
Query: 995 VSLSGTFPFNEDEDIN---EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL--- 1048
L G PF + + +I N DIS +A +LI L + RL
Sbjct: 265 EMLVGDTPF-YADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRN 322
Query: 1049 SVDKSLAHPWLQDPATWSDLRGLERQI 1075
V++ H + ++ W+ R
Sbjct: 323 GVEEIKRHLFFKN-DQWAWE--TLRDT 346
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-42
Identities = 77/263 (29%), Positives = 124/263 (47%), Gaps = 31/263 (11%)
Query: 833 HRKSGRGVAIKVIDK-LRFPTKQEAQLKNEVAIL-QNLCHPGVVNLERMFETPGRIFVVM 890
H+ A+KV+ K K+E + +E +L +N+ HP +V L F+T +++ V+
Sbjct: 59 HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ + G L L E E +F +I AL +LHS NIV+ DLKPEN+LL +
Sbjct: 119 DYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG- 176
Query: 951 LPQVKLCDFGFAR--IIGE---KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+ L DFG + I +F PEVL + Y+R++D W +G ++Y L
Sbjct: 177 --HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234
Query: 999 GTFPF-NEDED-INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSL-- 1054
G PF + + + + I N P +I++ A L+ LLQ + KRL
Sbjct: 235 GLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARHLLEGLLQKDRTKRLGAKDDFME 290
Query: 1055 --AHPWLQDPATWSDLRGLERQI 1075
+H + W DL + ++I
Sbjct: 291 IKSHVFFSL-INWDDL--INKKI 310
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 6e-04
Identities = 14/21 (66%), Positives = 16/21 (76%)
Query: 390 ILVALKHLHSKNIVHCDLKPE 410
I AL +LHS NIV+ DLKPE
Sbjct: 148 IASALGYLHSLNIVYRDLKPE 168
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 3e-42
Identities = 61/269 (22%), Positives = 102/269 (37%), Gaps = 36/269 (13%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+++G+ A+K+++K + E + + E +L N + L F+ +++VME
Sbjct: 82 MKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
G L +LS R+ +F + +I++A+ +H VH D+KP+N+LL
Sbjct: 142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-- 199
Query: 952 PQVKLCDFGFARIIGE------KSF-------PPEVLRNKG-------YNRSLDMWSVGV 991
++L DFG + PE+L+ G Y D W++GV
Sbjct: 200 -HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258
Query: 992 IVYVSLSGTFPFNEDEDINEQIQN-----AAFMYPPRPWRDISSDAIDLINNLLQVKQRK 1046
Y G PF + E P + +A D I LL
Sbjct: 259 FAYEMFYGQTPF-YADSTAETYGKIVHYKEHLSLPLVD-EGVPEEARDFIQRLLC-PPET 315
Query: 1047 RLSVDKSL---AHPWLQDPATWSDLRGLE 1072
RL + HP+ W LR
Sbjct: 316 RLGRGGAGDFRTHPFFFG-LDWDGLRDSV 343
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 70/305 (22%), Positives = 130/305 (42%), Gaps = 77/305 (25%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMFE 881
+V A V + VAIK K+ Q + L+ E+ I++ L H +V + +
Sbjct: 26 LVFSA---VDNDCDKRVAIK---KIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEILG 78
Query: 882 TPGR--------------IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKH 927
G +++V E ++ D+ ++ G L E + + Q+L LK+
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLLEEHARLFMYQLLRGLKY 135
Query: 928 LHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSFP---------------P 972
+HS N++H DLKP N+ + N+E +K+ DFG ARI+ P
Sbjct: 136 IHSANVLHRDLKPANLFI--NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSP 193
Query: 973 EVLRN-KGYNRSLDMWSVGVIVYVSLSGT--FPFN----------------EDEDINEQI 1013
+L + Y +++DMW+ G I L+G F +ED +++
Sbjct: 194 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR-QEL 252
Query: 1014 QNAAFMY-------PPRPWRDI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062
+ +Y P +P + S +A+D + +L RL+ +++L+HP++
Sbjct: 253 LSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM--- 309
Query: 1063 ATWSD 1067
+ +S
Sbjct: 310 SIYSF 314
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 65/265 (24%), Positives = 104/265 (39%), Gaps = 48/265 (18%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNL--------ERMFETP 883
SGR A+K + ++ + EV ++ L HP +V E
Sbjct: 49 DVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106
Query: 884 GRIFVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKN--IVHCDLKP 940
++ E +G ++E + E +G LS T I Q A++H+H + I+H DLK
Sbjct: 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKV 166
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGEKSF------------------------PPEVL- 975
EN+LLS +KLCDFG A I PE++
Sbjct: 167 ENLLLSNQG---TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223
Query: 976 --RNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAI 1033
N D+W++G I+Y+ PF ++ +I N + PP +
Sbjct: 224 LYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGAKLRIVNGKYSIPPHD--TQYTVFH 279
Query: 1034 DLINNLLQVKQRKRLSVDKSLAHPW 1058
LI +LQV +RLS+ + +
Sbjct: 280 SLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-41
Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 73/296 (24%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMFETPGR---- 885
R VAIK + + F + A+ + E+ +++ + H ++ L +F
Sbjct: 45 YDAILERNVAIKKLSRP-FQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102
Query: 886 --IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
+++VME + ++ ++I + L +++ Q+L +KHLHS I+H DLKP N+
Sbjct: 103 QDVYIVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158
Query: 944 LLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVI 992
++ ++ L K+ DFG AR G PEV+ GY ++D+WSVG I
Sbjct: 159 VVKSDCTL---KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 215
Query: 993 VYVSLSGT--FPFN----------------EDEDINEQIQNAAFMY-------PPRPWRD 1027
+ + G FP E + +++Q Y +
Sbjct: 216 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM-KKLQPTVRTYVENRPKYAGYSFEK 274
Query: 1028 I----------------SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSD 1067
+ +S A DL++ +L + KR+SVD++L HP++ W D
Sbjct: 275 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI---NVWYD 327
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 15/33 (45%), Positives = 20/33 (60%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+L +KHLHS I+H DLKP N+ S +K
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPS-NIVVKSDCTLK 167
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-41
Identities = 79/247 (31%), Positives = 122/247 (49%), Gaps = 29/247 (11%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ +GR A+K++ K K E A E +LQN HP + L+ F+T R+ VME
Sbjct: 169 EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSE 950
G L LS E SE +F +I+ AL +LHS KN+V+ DLK EN++L +
Sbjct: 229 YANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG- 286
Query: 951 LPQVKLCDFGFARI-IGE----KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+K+ DFG + I + K+F PEVL + Y R++D W +GV++Y +
Sbjct: 287 --HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344
Query: 999 GTFPF-NEDED-INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA- 1055
G PF N+D + + E I +P R + +A L++ LL+ ++RL A
Sbjct: 345 GRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAK 400
Query: 1056 ----HPW 1058
H +
Sbjct: 401 EIMQHRF 407
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-41
Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 74/299 (24%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLR-FPTKQEAQ--LKNEVAILQNLCHPGVVNLERMF 880
VV A H+ +G VAIK K+ F A L+ E+ IL++ H ++ + +
Sbjct: 26 VVCSA---THKPTGEIVAIK---KIEPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQ 78
Query: 881 ETPGR-----IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVH 935
++++ E +Q D L ++S++ LS+ ++ I Q L A+K LH N++H
Sbjct: 79 RPDSFENFNEVYIIQELMQTD-LHRVISTQM--LSDDHIQYFIYQTLRAVKVLHGSNVIH 135
Query: 936 CDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSFP----------------------PE 973
DLKP N+L+++N +L K+CDFG ARII E + PE
Sbjct: 136 RDLKPSNLLINSNCDL---KVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 974 VLRN-KGYNRSLDMWSVGVIVYVSLSGT--FPFN-----------------EDEDINEQI 1013
V+ Y+R++D+WS G I+ FP D D+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIE 252
Query: 1014 QNAAFMY-------PPRPWRDI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
A Y P P + + IDL+ +L KR++ ++L HP+LQ
Sbjct: 253 SPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-04
Identities = 15/33 (45%), Positives = 21/33 (63%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
L A+K LH N++H DLKP NL S+ ++K
Sbjct: 121 TLRAVKVLHGSNVIHRDLKP-SNLLINSNCDLK 152
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 71/277 (25%), Positives = 131/277 (47%), Gaps = 56/277 (20%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMFETPGR---- 885
+ ++SG VAIK + + F ++ A+ + E+ +L+++ H V+ L +F
Sbjct: 44 IDKRSGEKVAIKKLSRP-FQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNF 101
Query: 886 --IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
++VM +Q D+ +++ + SE ++++ Q+L LK++HS +VH DLKP N+
Sbjct: 102 YDFYLVMPFMQTDLQKIM----GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL 157
Query: 944 LLSTNSELPQVKLCDFGFARIIGEKSFP---------PEVLRN-KGYNRSLDMWSVGVIV 993
++ + EL K+ DFG AR + PEV+ + YN+++D+WSVG I+
Sbjct: 158 AVNEDCEL---KILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 214
Query: 994 YVSLSGT--FPFN----------------EDEDINEQIQNAAFMY-------PPRPWRDI 1028
L+G F E + + AA Y P + + +
Sbjct: 215 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQL 274
Query: 1029 ----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
S A DL+ +L++ KRL+ ++L HP+ +
Sbjct: 275 FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 15/33 (45%), Positives = 20/33 (60%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+L LK++HS +VH DLKP NL E+K
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPG-NLAVNEDCELK 166
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-41
Identities = 70/270 (25%), Positives = 112/270 (41%), Gaps = 37/270 (13%)
Query: 833 HRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ +G+ A K ++K R + E IL + +V+L FET + +VM
Sbjct: 206 MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265
Query: 892 KLQGDMLEM---ILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
+ G + + + E F QI+ L+HLH +NI++ DLKPENVLL +
Sbjct: 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD 325
Query: 949 SELPQVKLCDFGFARIIGE-----KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVS 996
V++ D G A + K + PE+L + Y+ S+D +++GV +Y
Sbjct: 326 G---NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEM 382
Query: 997 LSGTFPF-NEDEDINEQ-----IQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL-- 1048
++ PF E + + + A YP S + D LLQ KRL
Sbjct: 383 IAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASKDFCEALLQKDPEKRLGF 438
Query: 1049 ---SVDKSLAHPWLQDPATWSDLRGLERQI 1075
S D HP +D +W L +
Sbjct: 439 RDGSCDGLRTHPLFRD-ISWRQL--EAGML 465
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-41
Identities = 72/271 (26%), Positives = 131/271 (48%), Gaps = 40/271 (14%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE--AQLKNEVAILQNLCH-PGVVNLERMFETPGRIFVVM 890
+G+ A+KV+ K K + + E +L+++ P +V L F+T ++ +++
Sbjct: 79 HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ + G L LS R +E + + +I++AL+HLH I++ D+K EN+LL +N
Sbjct: 139 DYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG- 196
Query: 951 LPQVKLCDFGFAR--IIGE----KSF-------PPEVLR--NKGYNRSLDMWSVGVIVYV 995
V L DFG ++ + E F P+++R + G+++++D WS+GV++Y
Sbjct: 197 --HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
Query: 996 SLSGTFPF-NEDEDIN-----EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS 1049
L+G PF + E + +I + YP ++S+ A DLI LL +KRL
Sbjct: 255 LLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ----EMSALAKDLIQRLLMKDPKKRLG 310
Query: 1050 VDKS-----LAHPWLQDPATWSDLRGLERQI 1075
H + Q W DL +++
Sbjct: 311 CGPRDADEIKEHLFFQK-INWDDL--AAKKV 338
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 10/21 (47%), Positives = 16/21 (76%)
Query: 390 ILVALKHLHSKNIVHCDLKPE 410
I++AL+HLH I++ D+K E
Sbjct: 168 IVLALEHLHKLGIIYRDIKLE 188
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-41
Identities = 68/264 (25%), Positives = 113/264 (42%), Gaps = 32/264 (12%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVM 890
+ + A+K++ K + E +L P + L F+T R++ VM
Sbjct: 41 RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E + G L + GR E F +I + L L SK I++ DLK +NV+L +
Sbjct: 101 EYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG- 158
Query: 951 LPQVKLCDFGFAR--IIGE---KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+K+ DFG + I K+F PE++ + Y +S+D W+ GV++Y L+
Sbjct: 159 --HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216
Query: 999 GTFPF-NEDED-INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS--- 1053
G PF EDED + + I YP + +S +A+ + L+ KRL
Sbjct: 217 GQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGER 272
Query: 1054 --LAHPWLQDPATWSDLRGLERQI 1075
H + + W L ++I
Sbjct: 273 DIKEHAFFRY-IDWEKL--ERKEI 293
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-41
Identities = 77/265 (29%), Positives = 116/265 (43%), Gaps = 33/265 (12%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVM 890
+++G A+KV+ K + E IL HP + L F+TP R+F VM
Sbjct: 44 VKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E + G L + R E +F +I+ AL LH K I++ DLK +NVLL
Sbjct: 104 EFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG- 161
Query: 951 LPQVKLCDFGFARI-IGE----KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
KL DFG + I +F PE+L+ Y ++D W++GV++Y L
Sbjct: 162 --HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219
Query: 999 GTFPF-NEDED-INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA- 1055
G PF E+ED + E I N +YP + DA ++ + + RL
Sbjct: 220 GHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATGILKSFMTKNPTMRLGSLTQGGE 275
Query: 1056 -----HPWLQDPATWSDLRGLERQI 1075
HP+ ++ W+ L RQI
Sbjct: 276 HAILRHPFFKE-IDWAQL--NHRQI 297
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-40
Identities = 70/292 (23%), Positives = 131/292 (44%), Gaps = 60/292 (20%)
Query: 822 IAVVAGAACGV-----HRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVV 874
+ V A G ++G VAIK + + F ++ A+ + E+ +L+++ H V+
Sbjct: 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYR-ELRLLKHMRHENVI 87
Query: 875 NLERMFETPGR------IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHL 928
L +F ++VM + D L ++ EK L E +F++ Q+L L+++
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLMKHEK--LGEDRIQFLVYQMLKGLRYI 144
Query: 929 HSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSFP---------PEVLRN-K 978
H+ I+H DLKP N+ ++ + EL K+ DFG AR + PEV+ N
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCEL---KILDFGLARQADSEMTGYVVTRWYRAPEVILNWM 201
Query: 979 GYNRSLDMWSVGVIVYVSLSGT--FPFN----------------EDEDINEQIQNAAFMY 1020
Y +++D+WSVG I+ ++G F + E + + A Y
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261
Query: 1021 -------PPRPWRDI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+ + I S A++L+ +L + +R++ ++LAHP+ +
Sbjct: 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 13/33 (39%), Positives = 20/33 (60%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+L L+++H+ I+H DLKP NL E+K
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPG-NLAVNEDCELK 168
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-40
Identities = 69/256 (26%), Positives = 111/256 (43%), Gaps = 24/256 (9%)
Query: 833 HRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
R +G+ A K ++K R + EA NE IL+ + VV+L +ET + +V+
Sbjct: 205 VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 264
Query: 892 KLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ GD+ I + E F +I L+ LH + IV+ DLKPEN+LL +
Sbjct: 265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG- 323
Query: 951 LPQVKLCDFGFARIIGE----KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
+++ D G A + E K PEV++N+ Y S D W++G ++Y ++G
Sbjct: 324 --HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381
Query: 1000 TFPF-NEDEDI-NEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA-- 1055
PF + I E+++ P S A L + LL +RL A
Sbjct: 382 QSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSARE 441
Query: 1056 ---HPWLQDPATWSDL 1068
HP + + L
Sbjct: 442 VKEHPLFKK-LNFKRL 456
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-40
Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 61/282 (21%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMFETPGR---- 885
+ VAIK I F + Q L+ E+ IL H ++ + + P
Sbjct: 47 YDNLNKVRVAIKKIS--PFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMK 103
Query: 886 -IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944
+++V + ++ D+ +++ + LS + + QIL LK++HS N++H DLKP N+L
Sbjct: 104 DVYIVQDLMETDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 160
Query: 945 LSTNSELPQVKLCDFGFARIIGEKSFP---------------PEVLRN-KGYNRSLDMWS 988
L+T +L K+CDFG AR+ PE++ N KGY +S+D+WS
Sbjct: 161 LNTTCDL---KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 217
Query: 989 VGVIVYVSLSGT--FPFN----------------EDEDINEQIQNAAFMY-------PPR 1023
VG I+ LS FP ED+N I A Y
Sbjct: 218 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 1024 PWRDI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
PW + S A+DL++ +L KR+ V+++LAHP+L+
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 15/33 (45%), Positives = 23/33 (69%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
IL LK++HS N++H DLKP NL ++ ++K
Sbjct: 137 ILRGLKYIHSANVLHRDLKPS-NLLLNTTCDLK 168
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-40
Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 42/274 (15%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAIL-QNLCHPGVVNLERMFETPGRIFVVM 890
+K+ R A+KV+ K ++ ++ E + Q HP +V L F+T R+F V+
Sbjct: 30 LKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E + G L + + +L E +F +I +AL +LH + I++ DLK +NVLL +
Sbjct: 90 EYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG- 147
Query: 951 LPQVKLCDFGFARI-IGE----KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+KL D+G + + +F PE+LR + Y S+D W++GV+++ ++
Sbjct: 148 --HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205
Query: 999 GTFPFN--------EDEDINE---QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKR 1047
G PF+ + + I P R +S A ++ + L ++R
Sbjct: 206 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKER 261
Query: 1048 LSVDKSLA------HPWLQDPATWSDLRGLERQI 1075
L HP+ ++ W + ++Q+
Sbjct: 262 LGCHPQTGFADIQGHPFFRN-VDWDMM--EQKQV 292
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 50/270 (18%)
Query: 835 KSGRGVAIKVIDKLRFPTKQE---AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
G A+K K+R + E + E++IL+ L H +V L + T R+ +V E
Sbjct: 24 NYGETFALK---KIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
L D L+ +L +G L T K + Q+L + + H + ++H DLKP+N+L++ EL
Sbjct: 81 HLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL 139
Query: 952 PQVKLCDFGFARIIG--EKSF----------PPEVL-RNKGYNRSLDMWSVGVIVYVSLS 998
K+ DFG AR G + + P+VL +K Y+ ++D+WSVG I ++
Sbjct: 140 ---KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 999 GT--FPFNEDED----I-------NEQI---------QNAAF-MYPPRPWRDI----SSD 1031
GT FP + D I N + + F +Y P PW
Sbjct: 197 GTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256
Query: 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
IDL++ +L++ +R++ ++L H + ++
Sbjct: 257 GIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-40
Identities = 74/292 (25%), Positives = 135/292 (46%), Gaps = 60/292 (20%)
Query: 822 IAVVAGAACGV-----HRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVV 874
++ V A G K+G VA+K + + F + A+ + E+ +L+++ H V+
Sbjct: 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYR-ELRLLKHMKHENVI 91
Query: 875 NLERMFETPGR------IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHL 928
L +F +++V + D L I+ +K L++ +F+I QIL LK++
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQK--LTDDHVQFLIYQILRGLKYI 148
Query: 929 HSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSFP---------PEVLRN-K 978
HS +I+H DLKP N+ ++ + EL K+ DFG AR ++ PE++ N
Sbjct: 149 HSADIIHRDLKPSNLAVNEDCEL---KILDFGLARHTADEMTGYVATRWYRAPEIMLNWM 205
Query: 979 GYNRSLDMWSVGVIVYVSLSGT--FPFN----------------EDEDINEQIQNAAFMY 1020
YN+++D+WSVG I+ L+G FP E + + +A Y
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 1021 -------PPRPWRDI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
P + ++ + A+DL+ +L + KR++ ++LAH +
Sbjct: 266 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 16/33 (48%), Positives = 21/33 (63%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
IL LK++HS +I+H DLKP NL E+K
Sbjct: 141 ILRGLKYIHSADIIHRDLKPS-NLAVNEDCELK 172
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-40
Identities = 69/296 (23%), Positives = 125/296 (42%), Gaps = 73/296 (24%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMFETPGR---- 885
R VAIK + + F + A+ + E+ +++ + H +++L +F
Sbjct: 82 YDAVLDRNVAIKKLSRP-FQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEF 139
Query: 886 --IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
+++VME + ++ ++I + L +++ Q+L +KHLHS I+H DLKP N+
Sbjct: 140 QDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
Query: 944 LLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVI 992
++ ++ L K+ DFG AR G PEV+ GY ++D+WSVG I
Sbjct: 196 VVKSDCTL---KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
Query: 993 VYVSLSGT--FPFN----------------EDEDINEQIQNAAFMY-------PPRPWRD 1027
+ + FP E + +++Q Y +
Sbjct: 253 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVENRPKYAGLTFPK 311
Query: 1028 I----------------SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSD 1067
+ +S A DL++ +L + KR+SVD +L HP++ W D
Sbjct: 312 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI---NVWYD 364
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-40
Identities = 64/268 (23%), Positives = 113/268 (42%), Gaps = 36/268 (13%)
Query: 833 HRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQ---NLCHPGVVNLERMFETPGRIFV 888
+G+ A+K +DK R K E NE +L P +V + F TP ++
Sbjct: 210 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
+++ + G L LS G SE +F +I++ L+H+H++ +V+ DLKP N+LL +
Sbjct: 270 ILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 328
Query: 949 SELPQVKLCDFGFARIIGE---KSF-------PPEVL-RNKGYNRSLDMWSVGVIVYVSL 997
V++ D G A + + PEVL + Y+ S D +S+G +++ L
Sbjct: 329 G---HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 998 SGTFPFNEDEDINEQ-----IQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL---- 1048
G PF + + ++ A P S + L+ LLQ +RL
Sbjct: 386 RGHSPFRQHKTKDKHEIDRMTLTMAVELPDS----FSPELRSLLEGLLQRDVNRRLGCLG 441
Query: 1049 -SVDKSLAHPWLQDPATWSDLRGLERQI 1075
+ P+ + W + ++
Sbjct: 442 RGAQEVKESPFFRS-LDWQMV--FLQKY 466
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-40
Identities = 77/307 (25%), Positives = 125/307 (40%), Gaps = 57/307 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQ-------LKNEVAILQNLCHPGVVNLERMFETP 883
+ + + VAIK K++ + EA+ L+ E+ +LQ L HP ++ L F
Sbjct: 29 ARDKNTNQIVAIK---KIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAFGHK 84
Query: 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
I +V + ++ D LE+I+ L+ K + L L++LH I+H DLKP N+
Sbjct: 85 SNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 143
Query: 944 LLSTNSELPQVKLCDFGFARIIGE--KSF----------PPEVLRN-KGYNRSLDMWSVG 990
LL N L KL DFG A+ G +++ PE+L + Y +DMW+VG
Sbjct: 144 LLDENGVL---KLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVG 200
Query: 991 VIVYVSLSGT--FPFNEDED----I-------NEQI-----QNAAF----MYPPRPWRDI 1028
I+ L P + D D I E+ + +P P I
Sbjct: 201 CILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHI 260
Query: 1029 ----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD---PATWSDLRGLERQIGTNKKK 1081
D +DLI L R++ ++L + + P L + T K++
Sbjct: 261 FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRPNCPVETLKEQ 320
Query: 1082 NPKRTAQ 1088
+ A
Sbjct: 321 SNPALAI 327
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 9e-40
Identities = 77/271 (28%), Positives = 132/271 (48%), Gaps = 51/271 (18%)
Query: 835 KSGRGVAIKVIDKLRFPTKQE---AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
GR VA+K ++R + E + E+++L+ L HP +V+L + + + +V E
Sbjct: 43 SQGRIVALK---RIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
++ D L+ +L K L + K + Q+L + H H I+H DLKP+N+L++++ L
Sbjct: 100 FMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGAL 158
Query: 952 PQVKLCDFGFARIIG--EKSF----------PPEVL-RNKGYNRSLDMWSVGVIVYVSLS 998
KL DFG AR G +S+ P+VL +K Y+ S+D+WS+G I ++
Sbjct: 159 ---KLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
Query: 999 GT--FPFNEDED----I-------NEQI----------QNAAF-MYPPRPWRDI----SS 1030
G FP D+D I N + + F ++ +PW I
Sbjct: 216 GKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQ 275
Query: 1031 DAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+ IDL++N+L KR+S ++ HP+ +D
Sbjct: 276 EGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 54/255 (21%), Positives = 107/255 (41%), Gaps = 35/255 (13%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL----ERMFETPGRI 886
G+ ++ VA + + + + K E +L+ L HP +V E + I
Sbjct: 45 GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104
Query: 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVL 944
+V E + L+ L + + + QIL L+ LH++ I+H DLK +N+
Sbjct: 105 VLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163
Query: 945 LSTNSELPQVKLCDFGFARIIGE---KSF-------PPEVLRNKGYNRSLDMWSVGVIVY 994
++ + VK+ D G A + K+ PE+ Y+ S+D+++ G+ +
Sbjct: 164 ITGPTG--SVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML 220
Query: 995 VSLSGTFPFNEDEDINEQIQNAAFMY--------PPRPWRDISSDAIDLINNLLQVKQRK 1046
+ +P++E QNAA +Y P + + ++I ++ + +
Sbjct: 221 EMATSEYPYSE-------CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDE 273
Query: 1047 RLSVDKSLAHPWLQD 1061
R S+ L H + Q+
Sbjct: 274 RYSIKDLLNHAFFQE 288
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 56/260 (21%), Positives = 97/260 (37%), Gaps = 38/260 (14%)
Query: 830 CGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
+++G A+K + E E+ L P +V L + +
Sbjct: 76 RMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
ME L+G L ++ + G L E + + Q L L++LH++ I+H D+K +NVLLS++
Sbjct: 129 MELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG 187
Query: 950 ELPQVKLCDFGFARIIGE----------KSFP-------PEVLRNKGYNRSLDMWSVGVI 992
+ LCDFG A + P PEV+ K + +D+WS +
Sbjct: 188 S--RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245
Query: 993 VYVSLSGTFPFNEDEDINEQIQNAAFMYP--PRPWRDI----SSDAIDLINNLLQVKQRK 1046
+ L+G P+ + + P P R+I + I L+ +
Sbjct: 246 MLHMLNGCHPWTQY----FRGP-LCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVH 300
Query: 1047 RLSVDKSLAHPWLQDPATWS 1066
R S +
Sbjct: 301 RASAMELRRKVGKALQEVGG 320
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 70/262 (26%), Positives = 120/262 (45%), Gaps = 31/262 (11%)
Query: 830 CGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
G + +AIK I + ++ L E+A+ ++L H +V F G I +
Sbjct: 40 AGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97
Query: 890 MEKLQGDMLEMILSSEKGRL--SERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
ME++ G L +L S+ G L +E+T F QIL LK+LH IVH D+K +NVL++T
Sbjct: 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 157
Query: 948 NSELPQVKLCDFGFARIIGE-----KSFP-------PEVLR--NKGYNRSLDMWSVGVIV 993
S +K+ DFG ++ + ++F PE++ +GY ++ D+WS+G +
Sbjct: 158 YSG--VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTI 215
Query: 994 YVSLSGTFPFNEDEDINEQIQNAAFM------YPPRPWRDISSDAIDLINNLLQVKQRKR 1047
+G PF ++ E A F +P P +S++A I + KR
Sbjct: 216 IEMATGKPPFY---ELGEPQA-AMFKVGMFKVHPEIP-ESMSAEAKAFILKCFEPDPDKR 270
Query: 1048 LSVDKSLAHPWLQDPATWSDLR 1069
+ L +L+ + +
Sbjct: 271 ACANDLLVDEFLKVSSKKKKTQ 292
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-39
Identities = 64/274 (23%), Positives = 123/274 (44%), Gaps = 42/274 (15%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVM 890
+K+ R A++V+ K ++ ++ E + + HP +V L F+T R+F V+
Sbjct: 73 LKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E + G L + + +L E +F +I +AL +LH + I++ DLK +NVLL +
Sbjct: 133 EYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG- 190
Query: 951 LPQVKLCDFGFAR--IIGE---KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+KL D+G + + +F PE+LR + Y S+D W++GV+++ ++
Sbjct: 191 --HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248
Query: 999 GTFPFN--------EDEDINE---QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKR 1047
G PF+ + + I P R +S A ++ + L ++R
Sbjct: 249 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKER 304
Query: 1048 LSVDKSLA------HPWLQDPATWSDLRGLERQI 1075
L HP+ ++ W + ++Q+
Sbjct: 305 LGCHPQTGFADIQGHPFFRN-VDWDMM--EQKQV 335
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-39
Identities = 72/282 (25%), Positives = 118/282 (41%), Gaps = 66/282 (23%)
Query: 831 GVHRKSGRGVAIKVI--DK--------LRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF 880
G + + VA+K I + +R EV++L++L H +V L +
Sbjct: 21 GKSKLTDNLVALKEIRLEHEEGAPCTAIR-----------EVSLLKDLKHANIVTLHDII 69
Query: 881 ETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKP 940
T + +V E L D L+ L ++ K + Q+L L + H + ++H DLKP
Sbjct: 70 HTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKP 128
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGE--KSF----------PPEVL-RNKGYNRSLDMW 987
+N+L++ EL KL DFG AR K++ PP++L + Y+ +DMW
Sbjct: 129 QNLLINERGEL---KLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMW 185
Query: 988 SVGVIVYVSLSGT--FPFNEDED----I-------NEQI----------QNAAF-MYPPR 1023
VG I Y +G FP + E+ I E+ + + Y
Sbjct: 186 GVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAE 245
Query: 1024 PWRDI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
SD DL+ LLQ + R R+S + ++ HP+
Sbjct: 246 ALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 9e-39
Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 59/279 (21%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKN-EVAILQNLCHPGVVNLERMFETPGR----- 885
SG VAIK + Q+ + KN E+ I++ L H +V L F + G
Sbjct: 74 KLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126
Query: 886 -IFVVMEKLQGDMLEMI--LSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
+ +V++ + + + S K L K + Q+ +L ++HS I H D+KP+N
Sbjct: 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEV-LRNKGYNRSLDMWSVG 990
+LL + + +KLCDFG A+ + PE+ Y S+D+WS G
Sbjct: 187 LLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 244
Query: 991 VIV--------------YV-------SLSGTFPFNED-EDINEQIQNAAF-MYPPRPWRD 1027
++ V + GT P E ++N F PW
Sbjct: 245 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGT-PTREQIREMNPNYTEFKFPQIKAHPWTK 303
Query: 1028 I-----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+ +AI L + LL+ RL+ ++ AH + +
Sbjct: 304 VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 70/275 (25%), Positives = 119/275 (43%), Gaps = 51/275 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQE---AQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
+R++ VA+K ++R E + E+ +L+ L H +V L + + ++
Sbjct: 21 AKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+V E D L+ S G L K + Q+L L HS+N++H DLKP+N+L++
Sbjct: 78 LVFEFCDQD-LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136
Query: 948 NSELPQVKLCDFGFARIIG--EKSF----------PPEVL-RNKGYNRSLDMWSVGVIVY 994
N EL KL +FG AR G + + PP+VL K Y+ S+DMWS G I
Sbjct: 137 NGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193
Query: 995 VSLSGTFP-FNEDEDI-------------NEQI----------QNAAFMYPPRPWRDI-- 1028
+ P F ++ E+ + ++
Sbjct: 194 ELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVP 253
Query: 1029 --SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
++ DL+ NLL+ +R+S +++L HP+ D
Sbjct: 254 KLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 76/281 (27%), Positives = 109/281 (38%), Gaps = 56/281 (19%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKN------EVAILQNL---CHPGVVNLERMF- 880
SG VA+K +R P EVA+L+ L HP VV L +
Sbjct: 28 ARDPHSGHFVALK---SVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84
Query: 881 ----ETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHC 936
+ ++ +V E + D+ + + L T K ++ Q L L LH+ IVH
Sbjct: 85 TSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR 144
Query: 937 DLKPENVLLSTNSELPQVKLCDFGFARIIG-EKSF----------PPEVLRNKGYNRSLD 985
DLKPEN+L+++ + KL DFG ARI + + PEVL Y +D
Sbjct: 145 DLKPENILVTSGGTV---KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVD 201
Query: 986 MWSVGVIVYVSLSGT--FPFNEDED----I-------NEQI-------QNAAFM-YPPRP 1024
MWSVG I F N + D I E AF PRP
Sbjct: 202 MWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRP 261
Query: 1025 WRDI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+ + L+ +L KR+S ++L H +L
Sbjct: 262 VQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 58/284 (20%), Positives = 115/284 (40%), Gaps = 64/284 (22%)
Query: 830 CGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGR--- 885
++ + V +K++ ++ K++ K E+ IL+NL P ++ L + + P
Sbjct: 54 EAINITNNEKVVVKILKPVK---KKKI--KREIKILENLRGGPNIITLADIVKDPVSRTP 108
Query: 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
V D ++ L++ +F + +IL AL + HS I+H D+KP NV++
Sbjct: 109 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 163
Query: 946 STNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRN-KGYNRSLDMWSVGVIV 993
+ E +++L D+G A PE+L + + Y+ SLDMWS+G ++
Sbjct: 164 --DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 221
Query: 994 YVSLSGTFPF-------------------NEDEDINEQIQNAAF--------MYPPRPWR 1026
+ PF + D ++ + + W
Sbjct: 222 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 281
Query: 1027 DI---------SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
S +A+D ++ LL+ + RL+ +++ HP+
Sbjct: 282 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 9e-38
Identities = 67/277 (24%), Positives = 125/277 (45%), Gaps = 51/277 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQE---AQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
+ + VAIK ++R ++E EV++L+ L H ++ L+ + R+
Sbjct: 53 AIDTVTNETVAIK---RIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
++ E + D L+ + +S R K + Q++ + HS+ +H DLKP+N+LLS
Sbjct: 110 LIFEYAEND-LKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV 167
Query: 948 N--SELPQVKLCDFGFARIIG--EKSF----------PPEVL-RNKGYNRSLDMWSVGVI 992
+ SE P +K+ DFG AR G + F PPE+L ++ Y+ S+D+WS+ I
Sbjct: 168 SDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACI 227
Query: 993 VYVSLSGT--FPFNEDED----I-------NEQI----------QNAAFMYPPRPWRD-- 1027
L T FP + + D I ++ + + + + +
Sbjct: 228 WAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL 287
Query: 1028 ---ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+ + +DL+ +L++ KR+S +L HP+
Sbjct: 288 GALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 55/276 (19%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQE----AQLKNEVAILQNL---CHPGVVNLERMFETP--- 883
+ GR VA+K ++R T +E + ++ EVA+L++L HP VV L +
Sbjct: 34 KNGGRFVALK---RVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDVCTVSRTD 89
Query: 884 --GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
++ +V E + D+ + + + T K ++ Q+L L LHS +VH DLKP+
Sbjct: 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ 149
Query: 942 NVLLSTNSELPQVKLCDFGFARIIG-EKSF----------PPEVLRNKGYNRSLDMWSVG 990
N+L++++ ++ KL DFG ARI + + PEVL Y +D+WSVG
Sbjct: 150 NILVTSSGQI---KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 206
Query: 991 VIVYVSLSGT--FPFNEDED----I-------NEQI-------QNAAFM-YPPRPWRDI- 1028
I F + D D I E+ AF +P
Sbjct: 207 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV 266
Query: 1029 ---SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
DL+ L KR+S +L+HP+ QD
Sbjct: 267 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-36
Identities = 73/279 (26%), Positives = 121/279 (43%), Gaps = 58/279 (20%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKN-EVAILQNLCHPGVVNLERMFETPGR---- 885
+S VAIK + Q+ + KN E+ I++ + HP VV+L+ F + G
Sbjct: 59 AKLVESDE-VAIKKV-------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110
Query: 886 --IFVVMEKLQGDMLEMI--LSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
+ +V+E + + + K + K + Q+L +L ++HS I H D+KP+
Sbjct: 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQ 170
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEV-LRNKGYNRSLDMWSV 989
N+LL + +KL DFG A+I+ PE+ Y ++D+WS
Sbjct: 171 NLLL--DPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWST 228
Query: 990 GVIVYVSLSGT--FPFNEDED----I--------NEQIQ--NAAFM------YPPRPWRD 1027
G ++ + G FP D I EQI+ N +M P P+
Sbjct: 229 GCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSK 288
Query: 1028 I-----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+ DAIDLI+ LL+ RL+ ++L HP+ +
Sbjct: 289 VFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 73/290 (25%), Positives = 122/290 (42%), Gaps = 73/290 (25%)
Query: 831 GVHRKSGRGVAIKVI--DK--------LRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF 880
G+++ +G VA+K + D +R E+++++ L H +V L +
Sbjct: 24 GLNKTTGVYVALKEVKLDSEEGTPSTAIR-----------EISLMKELKHENIVRLYDVI 72
Query: 881 ETPGRIFVVMEKLQGD----MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHC 936
T ++ +V E + D M + + L K+ Q+L L H I+H
Sbjct: 73 HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHR 132
Query: 937 DLKPENVLLSTNSELPQVKLCDFGFARIIG--EKSF----------PPEVL-RNKGYNRS 983
DLKP+N+L++ +L KL DFG AR G +F P+VL ++ Y+ S
Sbjct: 133 DLKPQNLLINKRGQL---KLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTS 189
Query: 984 LDMWSVGVIVYVSLSGT--FPFNEDED-----------INEQI----------QNAAFMY 1020
+D+WS G I+ ++G FP DE+ NE +
Sbjct: 190 IDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQR 249
Query: 1021 PPRPWRDI---------SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
PPR R + + +D ++ LLQ+ RLS ++L HPW +
Sbjct: 250 PPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 37/235 (15%), Positives = 81/235 (34%), Gaps = 32/235 (13%)
Query: 853 KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGR--LS 910
++ + V + +++ M+ + + L+ ++
Sbjct: 103 SPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162
Query: 911 ERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF 970
I QI A++ LHSK ++H DLKP N+ + + VK+ DFG + +
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD---VVKVGDFGLVTAMDQDEE 219
Query: 971 P------------------------PEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED 1006
PE + Y+ +D++S+G+I++ L E
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER 279
Query: 1007 EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
I ++N F P + ++ ++L +R + + ++
Sbjct: 280 VRIITDVRNLKF---PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 15/33 (45%), Positives = 21/33 (63%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
I A++ LHSK ++H DLKP N+F T +K
Sbjct: 173 IAEAVEFLHSKGLMHRDLKPS-NIFFTMDDVVK 204
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 67/259 (25%), Positives = 118/259 (45%), Gaps = 30/259 (11%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+ +G+ VAI+ ++ + P K+ NE+ +++ +P +VN + ++VVM
Sbjct: 39 AMDVATGQEVAIRQMNLQQQPKKELII--NEILVMRENKNPNIVNYLDSYLVGDELWVVM 96
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E L G L +++ + + E + + L AL+ LHS ++H D+K +N+LL +
Sbjct: 97 EYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG- 153
Query: 951 LPQVKLCDFGFARIIGE-----KSF---P----PEVLRNKGYNRSLDMWSVGVIVYVSLS 998
VKL DFGF I + P PEV+ K Y +D+WS+G++ +
Sbjct: 154 --SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211
Query: 999 GTFPFNEDEDINEQIQNAAFMYPPRP------WRDISSDAIDLINNLLQVKQRKRLSVDK 1052
G P+ +NE A ++ +S+ D +N L++ KR S +
Sbjct: 212 GEPPY-----LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266
Query: 1053 SLAHPWLQDPATWSDLRGL 1071
L H +L+ S L L
Sbjct: 267 LLQHQFLKIAKPLSSLTPL 285
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 30/259 (11%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+ SGR VA+K++D + ++ L NEV I+++ H VV + + + ++V+M
Sbjct: 64 AREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E LQG L I+S RL+E + +L AL +LH++ ++H D+K +++LL+ +
Sbjct: 122 EFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR 179
Query: 951 LPQVKLCDFGFARIIGE-----KSF---P----PEVLRNKGYNRSLDMWSVGVIVYVSLS 998
VKL DFGF I + KS P PEV+ Y +D+WS+G++V +
Sbjct: 180 ---VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD 236
Query: 999 GTFPFNEDEDINEQIQNAAFMYPPRP------WRDISSDAIDLINNLLQVKQRKRLSVDK 1052
G P+ ++ A P +S D + +L ++R + +
Sbjct: 237 GEPPY-----FSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQE 291
Query: 1053 SLAHPWLQDPATWSDLRGL 1071
L HP+L L L
Sbjct: 292 LLDHPFLLQTGLPECLVPL 310
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 65/259 (25%), Positives = 108/259 (41%), Gaps = 30/259 (11%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+H+++G+ VAIK + ++ E++I+Q P VV + +++VM
Sbjct: 48 AIHKETGQIVAIKQVP----VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E + I+ L+E I+ L L++LH +H D+K N+LL+T
Sbjct: 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH 163
Query: 951 LPQVKLCDFGFARIIGE-----KSF---P----PEVLRNKGYNRSLDMWSVGVIVYVSLS 998
KL DFG A + + + P PEV++ GYN D+WS+G+
Sbjct: 164 ---AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220
Query: 999 GTFPFNEDEDINEQIQNAAFMYPPRP------WRDISSDAIDLINNLLQVKQRKRLSVDK 1052
G P+ + A FM P P S + D + L +R + +
Sbjct: 221 GKPPY-----ADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
Query: 1053 SLAHPWLQDPATWSDLRGL 1071
L HP+++ S LR L
Sbjct: 276 LLQHPFVRSAKGVSILRDL 294
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-34
Identities = 68/337 (20%), Positives = 128/337 (37%), Gaps = 109/337 (32%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMFE 881
V A + + + VAIK ++++ F + + L+ E+ IL L ++ L +
Sbjct: 41 YVYLA---YDKNTEKNVAIKKVNRM-FEDLIDCKRILR-EITILNRLKSDYIIRLYDLII 95
Query: 882 TPGR-----IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHC 936
+++V+E D+ ++ + L+E K I+ +L+ +H I+H
Sbjct: 96 PDDLLKFDELYIVLEIADSDLKKLFKTPIF--LTEEHIKTILYNLLLGENFIHESGIIHR 153
Query: 937 DLKPENVLLSTNSELPQVKLCDFGFARIIGEKSFP------------------------- 971
DLKP N LL+ + + K+CDFG AR I +
Sbjct: 154 DLKPANCLLNQDCSV---KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
Query: 972 ---------PEV-LRNKGYNRSLDMWSVGVIVYVSLSGT-------------FPFNE--- 1005
PE+ L + Y +S+D+WS G I L+ FP +
Sbjct: 211 HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFP 270
Query: 1006 ------------------------------DEDI----NEQIQNAAFMYPPR---PWRDI 1028
++D+ ++ ++P R +
Sbjct: 271 LSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK 330
Query: 1029 ----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
S D I+L+ ++L+ KR+++D++L HP+L+D
Sbjct: 331 YPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 10/33 (30%), Positives = 15/33 (45%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+L+ +H I+H DLKP N +K
Sbjct: 138 LLLGENFIHESGIIHRDLKP-ANCLLNQDCSVK 169
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVV 889
VH+ SG+ +A+K I +Q+ QL ++ ++ P +V G ++
Sbjct: 41 MVHKPSGQIMAVKRIRSTVDEKEQK-QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99
Query: 890 MEKLQG---DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLL 945
ME + + + S + E I + AL HL I+H D+KP N+LL
Sbjct: 100 MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL 159
Query: 946 STNSELPQVKLCDFGFA----------RIIGEKSF-PPEVL----RNKGYNRSLDMWSVG 990
+ +KLCDFG + R G + + PE + +GY+ D+WS+G
Sbjct: 160 DRSG---NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216
Query: 991 VIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPR----PWRDISSDAIDLINNLLQVKQRK 1046
+ +Y +G FP+ + + +Q+ PP+ R+ S I+ +N L + K
Sbjct: 217 ITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESK 276
Query: 1047 RLSVDKSLAHPWLQD 1061
R + L HP++
Sbjct: 277 RPKYKELLKHPFILM 291
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 59/251 (23%), Positives = 109/251 (43%), Gaps = 24/251 (9%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVV 889
H SG+ +A+K I +Q+ +L ++ I P V G +++
Sbjct: 26 MRHVPSGQIMAVKRIRATVNSQEQK-RLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84
Query: 890 MEKLQG--DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLS 946
ME + D + + + E I I+ AL+HLHSK +++H D+KP NVL++
Sbjct: 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN 144
Query: 947 TNSELPQVKLCDFGFARI----IGEKSF-------PPEV----LRNKGYNRSLDMWSVGV 991
+ VK+CDFG + + + PE L KGY+ D+WS+G+
Sbjct: 145 ALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGI 201
Query: 992 IVYVSLSGTFPFNEDEDINEQIQNAAFMYPPR-PWRDISSDAIDLINNLLQVKQRKRLSV 1050
+ FP++ +Q++ P+ P S++ +D + L+ ++R +
Sbjct: 202 TMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTY 261
Query: 1051 DKSLAHPWLQD 1061
+ + HP+
Sbjct: 262 PELMQHPFFTL 272
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 62/281 (22%), Positives = 108/281 (38%), Gaps = 30/281 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
++ VAIK + + ++ Q + EV LQ L HP + + ++V
Sbjct: 73 ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
ME G +++ K L E + L L +LHS N++H D+K N+LLS
Sbjct: 133 MEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG 191
Query: 950 ELPQVKLCDFGFARIIGEK-SF---P----PEV---LRNKGYNRSLDMWSVGVIVYVSLS 998
VKL DFG A I+ SF P PEV + Y+ +D+WS+G+
Sbjct: 192 L---VKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 248
Query: 999 GTFPFNEDEDINEQIQNAAFMYPPRP-----WRDISSDAIDLINNLLQVKQRKRLSVDKS 1053
P N +A + S + +++ LQ + R + +
Sbjct: 249 RKPPL-----FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 303
Query: 1054 LAHPWLQDPATWSDLRGL----ERQIGTNKKKNPKRTAQLL 1090
L H ++ + + L + + ++ ++L
Sbjct: 304 LKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKIL 344
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 74/345 (21%), Positives = 125/345 (36%), Gaps = 117/345 (33%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNLERMFE 881
V A + R VAIK I ++ F + + L+ E+AIL L H VV + +
Sbjct: 68 HVCEA---YDKLEKRVVAIKKILRV-FEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVI 122
Query: 882 TPGR-----IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHC 936
++VV+E D ++ + L+E K ++ +LV +K++HS I+H
Sbjct: 123 PKDVEKFDELYVVLEIADSDFKKLFRTPVY--LTELHIKTLLYNLLVGVKYVHSAGILHR 180
Query: 937 DLKPENVLLSTNSELPQVKLCDFGFARIIGEKSFP------------------------- 971
DLKP N L++ + + K+CDFG AR +
Sbjct: 181 DLKPANCLVNQDCSV---KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
Query: 972 --------------PEV-LRNKGYNRSLDMWSVGVIV----------------------- 993
PE+ L + Y ++D+WS+G I
Sbjct: 238 RQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPG 297
Query: 994 --YVSLSGTFPFNE------------------------DEDI----NEQIQNAAFMYPPR 1023
LS +EDI E + ++P R
Sbjct: 298 SSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357
Query: 1024 ---PWRDI----SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+ S+DAI L+ +L KR+++++ LAHP+ ++
Sbjct: 358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 61/264 (23%), Positives = 106/264 (40%), Gaps = 33/264 (12%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
++++G A KVI+ ++ E+ IL HP +V L + G++++++
Sbjct: 38 AKNKETGALAAAKVIETKSEEELED--YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E G ++ I+ L+E + + Q+L AL LHSK I+H DLK NVL++ +
Sbjct: 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD 155
Query: 951 LPQVKLCDFGFARIIGE-----KSF---P----PEV-----LRNKGYNRSLDMWSVGVIV 993
++L DFG + + SF P PEV +++ Y+ D+WS+G+ +
Sbjct: 156 ---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212
Query: 994 YVSLSGTFPFNEDEDINEQIQNAAFMYPPRP------WRDISSDAIDLINNLLQVKQRKR 1047
P S + D + L R
Sbjct: 213 IEMAQIEPPH-----HELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETR 267
Query: 1048 LSVDKSLAHPWLQDPATWSDLRGL 1071
S + L HP++ + LR L
Sbjct: 268 PSAAQLLEHPFVSSITSNKALREL 291
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-33
Identities = 70/322 (21%), Positives = 126/322 (39%), Gaps = 95/322 (29%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLC-HPGVVNLERMF 880
+V + + R++G VA+K I F +AQ + E+ IL L H +VNL +
Sbjct: 24 IVWKS---IDRRTGEVVAVKKIFDA-FQNSTDAQRTFR-EIMILTELSGHENIVNLLNVL 78
Query: 881 ETPGR--IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDL 938
+++V + ++ D L ++ + L ++++ Q++ +K+LHS ++H D+
Sbjct: 79 RADNDRDVYLVFDYMETD-LHAVIRANI--LEPVHKQYVVYQLIKVIKYLHSGGLLHRDM 135
Query: 939 KPENVLLSTNSELPQVKLCDFGFARIIGEKSFP--------------------------- 971
KP N+LL+ + K+ DFG +R
Sbjct: 136 KPSNILLNAECHV---KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVA 192
Query: 972 ------PEV-LRNKGYNRSLDMWSVGVIVYVSLSGT--FPFN----------------ED 1006
PE+ L + Y + +DMWS+G I+ L G FP + +
Sbjct: 193 TRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSN 252
Query: 1007 EDINEQIQNAAFMY----PPR-----------------------PWRDISSDAIDLINNL 1039
ED+ A + P D + +A+DL++ L
Sbjct: 253 EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312
Query: 1040 LQVKQRKRLSVDKSLAHPWLQD 1061
LQ KR+S + +L HP++
Sbjct: 313 LQFNPNKRISANDALKHPFVSI 334
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 10/33 (30%), Positives = 20/33 (60%), Gaps = 1/33 (3%)
Query: 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
++ +K+LHS ++H D+KP N+ + +K
Sbjct: 118 LIKVIKYLHSGGLLHRDMKP-SNILLNAECHVK 149
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 71/292 (24%), Positives = 118/292 (40%), Gaps = 63/292 (21%)
Query: 824 VVAGAACGVHRKSGRGVAIK-VIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET 882
V + +G VAIK VI RF +E Q + L L HP +V L+ F T
Sbjct: 38 TVQLG---KEKSTGMSVAIKKVIQDPRF-RNRELQ---IMQDLAVLHHPNIVQLQSYFYT 90
Query: 883 PGR-------IFVVMEKLQGDMLEMILSSEKGR--LSERTTKFIITQILVALK--HLHSK 931
G + VVME + + + + + K + Q++ ++ HL S
Sbjct: 91 LGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV 150
Query: 932 NIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRN-KG 979
N+ H D+KP NVL+ N +KLCDFG A+ + PE++ +
Sbjct: 151 NVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQH 208
Query: 980 YNRSLDMWSVGVIVYVSLSGT--FP-------FNE---------DEDINEQIQNAAFMY- 1020
Y ++D+WSVG I + G F +E E + + + +
Sbjct: 209 YTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDL 268
Query: 1021 ---PPRPWRDI--------SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
PW ++ + +A DL++ LLQ +R+ ++L HP+ +
Sbjct: 269 YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 69/289 (23%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQE-----AQLKNEVAILQNLCHPGVVNLERMF------- 880
HRK+G+ VA+K K+ ++E A E+ ILQ L H VVNL +
Sbjct: 38 HRKTGQKVALK---KVLMENEKEGFPITAL--REIKILQLLKHENVVNLIEICRTKASPY 92
Query: 881 -ETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLK 939
G I++V + + D L +LS+ + + K ++ +L L ++H I+H D+K
Sbjct: 93 NRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 151
Query: 940 PENVLLSTNSELPQVKLCDFGFARIIGEKSF----------------PPEVLR-NKGYNR 982
NVL++ + L KL DFG AR PPE+L + Y
Sbjct: 152 AANVLITRDGVL---KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP 208
Query: 983 SLDMWSVGVIVYVSLSGT--FPFNEDED-----------INEQI----------QNAAF- 1018
+D+W G I+ + + N ++ I ++ +
Sbjct: 209 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 268
Query: 1019 MYPPRPWRDI------SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
R +D A+DLI+ LL + +R+ D +L H +
Sbjct: 269 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 63/310 (20%), Positives = 114/310 (36%), Gaps = 89/310 (28%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKN-EVAILQNLCHPGVVNLERMFETPGR----- 885
+SG+ A+K + Q+ + KN E+ I++ L H ++ L F T G
Sbjct: 27 FDIESGKRFALKKV-------LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79
Query: 886 ---------------------------------IFVVMEKLQGDMLEMI--LSSEKGRLS 910
+ V+ME + + +++ +
Sbjct: 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIP 139
Query: 911 ERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF 970
I Q+ A+ +HS I H D+KP+N+L+ NS+ +KLCDFG A+ +
Sbjct: 140 MNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV--NSKDNTLKLCDFGSAKKLIPSEP 197
Query: 971 -----------PPEVLRN-KGYNRSLDMWSVGVIVYVSLSGT--FP-------FNE---- 1005
PE++ Y S+D+WS+G + + G F
Sbjct: 198 SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQI 257
Query: 1006 -----DEDINEQIQNAAFMY----PPRPWRDI-----SSDAIDLINNLLQVKQRKRLSVD 1051
E + + + + WR I S AIDL+ +L+ + R++
Sbjct: 258 MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317
Query: 1052 KSLAHPWLQD 1061
+++AHP+
Sbjct: 318 EAMAHPFFDH 327
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 65/250 (26%), Positives = 107/250 (42%), Gaps = 27/250 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G+ ++ + VAIK+ID L + ++ E+ +L P V + +++++M
Sbjct: 41 GIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E L G +L E G L E I+ +IL L +LHS+ +H D+K NVLLS + E
Sbjct: 100 EYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE 157
Query: 951 LPQVKLCDFGFARIIGE-----KSF---P----PEVLRNKGYNRSLDMWSVGVIVYVSLS 998
VKL DFG A + + +F P PEV++ Y+ D+WS+G+
Sbjct: 158 ---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR 214
Query: 999 GTFPFNEDEDINEQIQNAAFM----YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSL 1054
G P F+ PP + S + + L + R + + L
Sbjct: 215 GEPPH-----SELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 269
Query: 1055 AHPWLQDPAT 1064
H ++ A
Sbjct: 270 KHKFILRNAK 279
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 58/251 (23%), Positives = 105/251 (41%), Gaps = 25/251 (9%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVV 889
RK+G +A+K + + + + ++ ++ ++ P +V F T +F+
Sbjct: 44 MRFRKTGHVIAVKQMRRSGNKEENK-RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTN 948
ME L G E + +G + ER + I+ AL +L K ++H D+KP N+LL
Sbjct: 103 ME-LMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER 161
Query: 949 SELPQVKLCDFGFA----RIIGEKSF-------PPEVL-----RNKGYNRSLDMWSVGVI 992
+ +KLCDFG + + PE + Y+ D+WS+G+
Sbjct: 162 GQ---IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218
Query: 993 VYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDI--SSDAIDLINNLLQVKQRKRLSV 1050
+ +G FP+ + E + PP + S D + + L RKR
Sbjct: 219 LVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKY 278
Query: 1051 DKSLAHPWLQD 1061
+K L H +++
Sbjct: 279 NKLLEHSFIKR 289
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 68/324 (20%), Positives = 118/324 (36%), Gaps = 77/324 (23%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL--------CHPG---VVNLERMFET 882
+ VA+K++ R ++E+ +LQ + G ++ L F
Sbjct: 41 MVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97
Query: 883 PGR----IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCD 937
G + +V E L ++L +I E + K I Q+L+ L ++H + I+H D
Sbjct: 98 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTD 157
Query: 938 LKPENVLLS---TNSELPQVKLCDFGFARIIGEKSFP---------PEVLRNKGYNRSLD 985
+KPENVL+ + L Q+K+ D G A E PEVL + D
Sbjct: 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGAD 217
Query: 986 MWSVGVIVYVSLSGTFPF---NEDEDINEQIQNAAFM----YPPR--------------- 1023
+WS +++ ++G F F + A + P
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 277
Query: 1024 --PWRDISSDA----------------------IDLINNLLQVKQRKRLSVDKSLAHPWL 1059
R+IS D ++ +LQ+ RKR + HPWL
Sbjct: 278 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
Query: 1060 QDPATWSDLRGLERQIGTNKKKNP 1083
+D ++R +R++ + P
Sbjct: 338 KDTLGMEEIRVPDRELYGSGSDIP 361
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 11/43 (25%), Positives = 19/43 (44%), Gaps = 1/43 (2%)
Query: 384 KSFRRSILVALKHLHSK-NIVHCDLKPERNLFPTSSLEIKSNT 425
K + +L+ L ++H + I+H D+KPE L
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 44/222 (19%), Positives = 85/222 (38%), Gaps = 33/222 (14%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
HR++G + +K + +RF + + EV +++ L HP V+ + R+ +
Sbjct: 29 VTHRETGEVMVMKEL--IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E ++G L I+ S + I + +LHS NI+H DL N L+ N
Sbjct: 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN 146
Query: 951 LPQVKLCDFGFARIIGEKSFP--------------------------PEVLRNKGYNRSL 984
V + DFG AR++ ++ PE++ + Y+ +
Sbjct: 147 ---VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKV 203
Query: 985 DMWSVGVIVYVSLSGTFPFNEDEDINEQIQNA--AFMYPPRP 1024
D++S G+++ + + F+ P
Sbjct: 204 DVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-31
Identities = 47/187 (25%), Positives = 73/187 (39%), Gaps = 26/187 (13%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQ--LKNEVAILQNLCHPGVVNL-----ERMFETPGR 885
+GR V +K L EAQ E L + HP +V +
Sbjct: 102 RNVNGRPVVLKG---LVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158
Query: 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
++VME + G L+ +L + +IL AL +LHS +V+ DLKPEN++L
Sbjct: 159 GYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML 215
Query: 946 STNSELPQVKLCDFGFARIIGEKS--------FPPEVLRNKGYNRSLDMWSVGVIVYVSL 997
+ Q+KL D G I PE++R + D+++VG +
Sbjct: 216 TEE----QLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRTGPTVAT-DIYTVGRTLAALT 270
Query: 998 SGTFPFN 1004
N
Sbjct: 271 LDLPTRN 277
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 13/21 (61%), Positives = 16/21 (76%)
Query: 390 ILVALKHLHSKNIVHCDLKPE 410
IL AL +LHS +V+ DLKPE
Sbjct: 191 ILPALSYLHSIGLVYNDLKPE 211
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 70/317 (22%), Positives = 121/317 (38%), Gaps = 70/317 (22%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
H+ SG +A K+I P + Q+ E+ +L P +V F + G I + M
Sbjct: 52 VSHKPSGLVMARKLIHLEIKPAIRN-QIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNS 949
E + G L+ +L + GR+ E+ + ++ L +L K I+H D+KP N+L+++
Sbjct: 111 EHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 169
Query: 950 ELPQVKLCDFGFARIIGE---KSF-------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
E +KLCDFG + + + SF PE L+ Y+ D+WS+G+ + G
Sbjct: 170 E---IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
Query: 1000 TFPFNEDEDINEQIQNAAFMYPP----------------------RPWRDI--------- 1028
+P + ++ + RP I
Sbjct: 227 RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVN 286
Query: 1029 -----------SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQ-------DPATWSDLRG 1070
S + D +N L +R + + + H +++ D A W
Sbjct: 287 EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGW----- 341
Query: 1071 LERQIGTNKKKNPKRTA 1087
L IG N+ P A
Sbjct: 342 LCSTIGLNQPSTPTHAA 358
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 74/290 (25%), Positives = 125/290 (43%), Gaps = 50/290 (17%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLC-HPGVVNL------ERMFET 882
G H K+G+ AIKV+D T E + +K E+ +L+ H + +
Sbjct: 43 GRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98
Query: 883 PGRIFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
++++VME G + ++I +++ L E +I +IL L HLH ++H D+K +
Sbjct: 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 158
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGE-----KSF---P----PEVLRNK-----GYNRSL 984
NVLL+ N+E VKL DFG + + +F P PEV+ Y+
Sbjct: 159 NVLLTENAE---VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKS 215
Query: 985 DMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRP--------WRDISSDAIDLI 1036
D+WS+G+ G P + A F+ P P W S I
Sbjct: 216 DLWSLGITAIEMAEGAPPL-----CDMHPMRALFLIPRNPAPRLKSKKW---SKKFQSFI 267
Query: 1037 NNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRG-LERQIGTNKKKNPKR 1085
+ L +R + ++ + HP+++D +R L+ I KKK ++
Sbjct: 268 ESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEK 317
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-30
Identities = 54/306 (17%), Positives = 106/306 (34%), Gaps = 78/306 (25%)
Query: 830 CGVHRKSGRGVAIKVI-DKLRFPTKQEAQLKNEVAILQNLCHPG------VVNLERMFET 882
C H + VA+K+I + ++ + A+L E+ +L+ + V + F
Sbjct: 38 CLDHARGKSQVALKIIRNVGKY-REA-ARL--EINVLKKIKEKDKENKFLCVLMSDWFNF 93
Query: 883 PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
G + + E L + E + + + + Q+ AL+ LH + H DLKPEN
Sbjct: 94 HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPEN 153
Query: 943 VLLSTNSEL----------------PQVKLCDFGFARIIGEKSFP---------PEVLRN 977
+L + +++ DFG A E PEV+
Sbjct: 154 ILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILE 213
Query: 978 KGYNRSLDMWSVGVIVY---------------------VSLSGTFP-----------FNE 1005
G+ + D+WS+G I++ + G P +
Sbjct: 214 LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFY 273
Query: 1006 DEDINEQIQNAAFMYPPRPWRDISS----------DAIDLINNLLQVKQRKRLSVDKSLA 1055
+ ++ Y + + S DL+ +L+ +R+++ ++L
Sbjct: 274 KGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333
Query: 1056 HPWLQD 1061
HP+
Sbjct: 334 HPFFAG 339
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 17/55 (30%), Positives = 25/55 (45%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIKSNTEEEDEDEERGSTD 438
+ + AL+ LH + H DLKPE LF S E N + E++ +T
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-30
Identities = 61/301 (20%), Positives = 105/301 (34%), Gaps = 78/301 (25%)
Query: 834 RKSGRGVAIKVI-DKLRFPTKQEAQLKNEVAILQNLCHPG------VVNLERMFETPGRI 886
K + VA+K++ ++ RF Q E+ IL++L V+++ F I
Sbjct: 119 HKVHQHVALKMVRNEKRF----HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174
Query: 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
+ E L ++ E+I ++ S + IL L LH I+HCDLKPEN+LL
Sbjct: 175 CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL- 233
Query: 947 TNSELPQVKLCDFGFARIIGEKSFP---------PEVLRNKGYNRSLDMWSVGVIVY--- 994
+K+ DFG + ++ + PEV+ Y +DMWS+G I+
Sbjct: 234 KQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 995 ------------------VSLSGTFP-------------FNEDED-----INEQIQNAAF 1018
+ L G + + +
Sbjct: 294 TGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVV 353
Query: 1019 MYPPRPWRDISSDA------------------IDLINNLLQVKQRKRLSVDKSLAHPWLQ 1060
+ R R +D + L+ R++ ++L HPWL+
Sbjct: 354 LNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
Query: 1061 D 1061
Sbjct: 414 R 414
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 15/27 (55%), Positives = 17/27 (62%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPE 410
+ F SIL L LH I+HCDLKPE
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPE 229
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 53/246 (21%), Positives = 93/246 (37%), Gaps = 33/246 (13%)
Query: 832 VHRKSGRG-VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
V+ G VAI++ID R Q K EV + H VV +P + ++
Sbjct: 49 VYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+G L ++ K L T+ I +I+ + +LH+K I+H DLK +NV
Sbjct: 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGK- 167
Query: 951 LPQVKLCDFGFARIIGEKSFP-----------------PEVLRN---------KGYNRSL 984
V + DFG I G PE++R +++
Sbjct: 168 ---VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHS 224
Query: 985 DMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY-PPRPWRDISSDAIDLINNLLQVK 1043
D++++G I Y + +PF + + I P + + D++ +
Sbjct: 225 DVFALGTIWYELHAREWPF-KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFE 283
Query: 1044 QRKRLS 1049
Q +R +
Sbjct: 284 QEERPT 289
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-30
Identities = 58/304 (19%), Positives = 120/304 (39%), Gaps = 75/304 (24%)
Query: 829 ACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF--ETPGRI 886
A K + A+K I+ A E+A+L+ L HP V++L+++F ++
Sbjct: 40 AKRKDGKDDKDYALKQIEGTGIS--MSAC--REIALLRELKHPNVISLQKVFLSHADRKV 95
Query: 887 FVVMEKLQGDMLEMI-------LSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLK 939
+++ + + D+ +I + + +L K ++ QIL + +LH+ ++H DLK
Sbjct: 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLK 155
Query: 940 PENVLLSTNS-ELPQVKLCDFGFARIIGE--KSF-------------PPEVL-RNKGYNR 982
P N+L+ E +VK+ D GFAR+ K PE+L + Y +
Sbjct: 156 PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTK 215
Query: 983 SLDMWSVGVIVYVSLSGTFPFNEDEDI----------------------NEQI------- 1013
++D+W++G I L+ F+ ++ ++
Sbjct: 216 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKM 275
Query: 1014 ---QNAAFMYPPRPWRD-------------ISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
+ + + S A L+ LL + KR++ ++++ P
Sbjct: 276 PEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335
Query: 1058 WLQD 1061
+ +
Sbjct: 336 YFLE 339
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 47/193 (24%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 832 VHRKSGRG-VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE---TPGRIF 887
V++ G VA+K+++ +Q KNEV +L+ H ++ +F T ++
Sbjct: 40 VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL----LFMGYSTAPQLA 95
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+V + +G L L + + + + I Q + +LH+K+I+H DLK N+ L
Sbjct: 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE 155
Query: 948 NSELPQVKLCDFGFARIIGEKSFP--------------PEVLRNKG---YNRSLDMWSVG 990
+ VK+ DFG A S PEV+R + Y+ D+++ G
Sbjct: 156 D---NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 991 VIVYVSLSGTFPF 1003
+++Y ++G P+
Sbjct: 213 IVLYELMTGQLPY 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 837 GRGVAIKVID---------KLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
VAIK I RF ++E + L H +V++ + E +
Sbjct: 36 NIKVAIKAIFIPPREKEETLKRF--EREVH---NSS---QLSHQNIVSMIDVDEEDDCYY 87
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+VME ++G L + G LS T QIL +KH H IVH D+KP+N+L+ +
Sbjct: 88 LVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS 146
Query: 948 NSELPQVKLCDFGFARIIGEKS-------------FPPEVLRNKGYNRSLDMWSVGVIVY 994
N +K+ DFG A+ + E S F PE + + + D++S+G+++Y
Sbjct: 147 NK---TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLY 203
Query: 995 VSLSGTFPFNEDEDIN---EQIQNAAFMYPPRPWRDISSD 1031
L G PFN + ++ + IQ++ P D+ D
Sbjct: 204 EMLVGEPPFNGETAVSIAIKHIQDS----VPNVTTDVRKD 239
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 27/189 (14%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF----ETPGRIFVVMEK 892
G VA+K++ + F ++ + EVAI++ L HP +V +F P + +V E
Sbjct: 60 GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----LFMGAVTQPPNLSIVTEY 115
Query: 893 LQGDMLEMIL--SSEKGRLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVLLSTN 948
L L +L S + +L ER + + + +LH++N IVH +LK N+L+
Sbjct: 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK 175
Query: 949 SELPQVKLCDFGFARIIGEKSF------------PPEVLRNKGYNRSLDMWSVGVIVYVS 996
VK+CDFG +R+ PEVLR++ N D++S GVI++
Sbjct: 176 ---YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232
Query: 997 LSGTFPFNE 1005
+ P+
Sbjct: 233 ATLQQPWGN 241
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 8e-29
Identities = 52/222 (23%), Positives = 85/222 (38%), Gaps = 48/222 (21%)
Query: 831 GVHRKSGRGVAIKVID---------KLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE 881
R VA+K++ + R ++EA+ LQ P VV + E
Sbjct: 53 AEDTVRERIVALKLMSETLSSDPVFRTRM--QREART---AGRLQ---EPHVVPIHDFGE 104
Query: 882 TPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
G+++V M + G L +L +G L+ I+ QI AL H+ H D+KPE
Sbjct: 105 IDGQLYVDMRLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPE 163
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKS-------------FPPEVLRNKGYNRSLDMWS 988
N+L+S + L DFG A ++ PE D+++
Sbjct: 164 NILVSADD---FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYA 220
Query: 989 VGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY------PPRP 1024
+ ++Y L+G+ P+ D + M PRP
Sbjct: 221 LTCVLYECLTGSPPYQGD--------QLSVMGAHINQAIPRP 254
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 8e-29
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 28/200 (14%)
Query: 834 RKSGRGVAIKVI-DKLRFPTKQEAQLKNEVAILQNLCHPG------VVNLERMFETPGRI 886
R VAIK+I +K F Q + EV +L+ + +V+L+R F +
Sbjct: 76 RVEQEWVAIKIIKNKKAF----LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131
Query: 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK--NIVHCDLKPENVL 944
+V E L ++ +++ ++ +S T+ Q+ AL L + +I+HCDLKPEN+L
Sbjct: 132 CLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENIL 191
Query: 945 LSTNSELPQVKLCDFGFARIIGEKSFP---------PEVLRNKGYNRSLDMWSVGVIVYV 995
L N + +K+ DFG + +G++ + PEVL Y+ ++DMWS+G I+
Sbjct: 192 L-CNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
Query: 996 SLSGT--FPFNEDEDINEQI 1013
+G F +E +Q+
Sbjct: 251 MHTGEPLFS-GANE--VDQM 267
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 12/29 (41%), Positives = 18/29 (62%), Gaps = 2/29 (6%)
Query: 384 KSFRRSILVALKHLHSK--NIVHCDLKPE 410
+ F + + AL L + +I+HCDLKPE
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPE 188
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 63/304 (20%), Positives = 112/304 (36%), Gaps = 78/304 (25%)
Query: 830 CGVHRKSGRGVAIKVI-DKLRFPTKQEAQLKNEVAILQNLCHPG------VVNLERMFET 882
C H+ GR VA+K++ + R+ ++E+ +L++L V + FE
Sbjct: 33 CIDHKAGGRHVAVKIVKNVDRY----CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88
Query: 883 PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
G I +V E L + I + + + QI ++ LHS + H DLKPEN
Sbjct: 89 HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPEN 148
Query: 943 VLLSTNSEL----------------PQVKLCDFGFARIIGEKSFP---------PEVLRN 977
+L + P +K+ DFG A E PEV+
Sbjct: 149 ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILA 208
Query: 978 KGYNRSLDMWSVGVIVY---------------------VSLSGTFP-------------F 1003
G+++ D+WS+G I+ + G P
Sbjct: 209 LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFH 268
Query: 1004 NEDEDINEQIQNAAFMYPP-RPWRDI-------SSDAIDLINNLLQVKQRKRLSVDKSLA 1055
++ D +E ++ +P ++ DLI +L+ KR+++ ++L
Sbjct: 269 HDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328
Query: 1056 HPWL 1059
HP+
Sbjct: 329 HPFF 332
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 15/55 (27%), Positives = 24/55 (43%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIKSNTEEEDEDEERGSTD 438
+ I ++ LHS + H DLKPE LF S N + + ++ + D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 61/308 (19%), Positives = 104/308 (33%), Gaps = 85/308 (27%)
Query: 834 RKSGRGVAIKVI-DKLRFPTKQEAQLKNEVAILQNLCH--PG---VVNLERMFETPGRIF 887
+ + A+KV+ + ++ K E IL+ + + +V F +
Sbjct: 57 IDNKKYYAVKVVRNIKKY----TRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
++ E L + E+I + K +IL AL +L ++ H DLKPEN+LL
Sbjct: 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172
Query: 948 NSEL----------------------PQVKLCDFGFARIIGEKSFP---------PEVLR 976
+KL DFG A + PEV+
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVIL 232
Query: 977 NKGYNRSLDMWSVGVIVY---------------------VSLSGTFP------------- 1002
N G++ S DMWS G ++ S+ P
Sbjct: 233 NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGS 292
Query: 1003 --FNEDEDINEQIQNAAFMYPPRPWR------DISSDA--IDLINNLLQVKQRKRLSVDK 1052
N+DE +NA+ + + + I D + ++LQ+ R S +
Sbjct: 293 KYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352
Query: 1053 SLAHPWLQ 1060
L H +L+
Sbjct: 353 LLKHKFLE 360
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 12/27 (44%), Positives = 16/27 (59%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPE 410
K + IL AL +L ++ H DLKPE
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPE 166
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 61/264 (23%), Positives = 110/264 (41%), Gaps = 39/264 (14%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
VAIK I+ + T + +L E+ + HP +V+ F +++VM
Sbjct: 34 AYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92
Query: 891 EKLQG----DMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
+ L G D+++ I++ + G L E T I+ ++L L++LH +H D+K N+
Sbjct: 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNI 152
Query: 944 LLSTNSELPQVKLCDFGFARIIGE----------KSF---P----PEVL-RNKGYNRSLD 985
LL + V++ DFG + + K+F P PEV+ + +GY+ D
Sbjct: 153 LLGEDGS---VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 209
Query: 986 MWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPR---------PWRDISSDAIDLI 1036
+WS G+ +G P++ + + PP + +I
Sbjct: 210 IWSFGITAIELATGAAPYH-KYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMI 268
Query: 1037 NNLLQVKQRKRLSVDKSLAHPWLQ 1060
+ LQ KR + + L H + Q
Sbjct: 269 SLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 24/231 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQE-----AQLKNEVAILQNLCHPGVVNLERMFETPGR 885
G K VAIK + + E + + EV I+ NL HP +V L + P R
Sbjct: 38 GRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97
Query: 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENV 943
+ VME + L L + + ++ I + ++++ ++N IVH DL+ N+
Sbjct: 98 M--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNI 155
Query: 944 LLSTNSELPQ--VKLCDFGFARIIGEKSF---------PPEVL--RNKGYNRSLDMWSVG 990
L + E K+ DFG ++ PE + + Y D +S
Sbjct: 156 FLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFA 215
Query: 991 VIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041
+I+Y L+G PF+E + N RP I D + N+++
Sbjct: 216 MILYTILTGEGPFDEYSYGKIKFINMIREEGLRP--TIPEDCPPRLRNVIE 264
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 22/189 (11%)
Query: 837 GRGVAIKVI--DKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894
G VA+K D ++ ++ E + L HP ++ L + + +VME +
Sbjct: 30 GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89
Query: 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN---IVHCDLKPENVLLSTNSEL 951
G L +LS ++ + QI + +LH + I+H DLK N+L+ E
Sbjct: 90 GGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147
Query: 952 PQ-----VKLCDFGFARIIGEKSF----------PPEVLRNKGYNRSLDMWSVGVIVYVS 996
+K+ DFG AR + PEV+R +++ D+WS GV+++
Sbjct: 148 GDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWEL 207
Query: 997 LSGTFPFNE 1005
L+G PF
Sbjct: 208 LTGEVPFRG 216
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 40/198 (20%)
Query: 837 GRGVAIKVID---------KLRFPTKQEAQLKNEVAILQNLCHPGVVNL----ERMFETP 883
R VA+KV+ LRF ++EAQ A L HP +V + E
Sbjct: 37 HRDVAVKVLRADLARDPSFYLRF--RREAQ---NAA---ALNHPAIVAVYDTGEAETPAG 88
Query: 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
++VME + G L I+ +G ++ + +I AL H I+H D+KP N+
Sbjct: 89 PLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 147
Query: 944 LLSTNSELPQVKLCDFGFARIIGEKSFP---------------PEVLRNKGYNRSLDMWS 988
++S + VK+ DFG AR I + PE R + D++S
Sbjct: 148 MISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 989 VGVIVYVSLSGTFPFNED 1006
+G ++Y L+G PF D
Sbjct: 205 LGCVLYEVLTGEPPFTGD 222
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 59/240 (24%), Positives = 94/240 (39%), Gaps = 27/240 (11%)
Query: 826 AGAACGVHRKSGRG--VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP 883
GA V + R VAIK I+ + E+ L + HP +V L P
Sbjct: 18 RGAFGVVCKAKWRAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGACLNP 73
Query: 884 GRIFVVMEKLQGDMLEMILSSEKGR--LSERTTKFIITQILVALKHLHS---KNIVHCDL 938
+ +VME +G L +L + + Q + +LHS K ++H DL
Sbjct: 74 --VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL 131
Query: 939 KPENVLLSTNSELPQVKLCDFGFARIIGEKS---------FPPEVLRNKGYNRSLDMWSV 989
KP N+LL + +K+CDFG A I PEV Y+ D++S
Sbjct: 132 KPPNLLL--VAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSW 189
Query: 990 GVIVYVSLSGTFPFNEDEDINEQIQNAAF--MYPPRPWRDISSDAIDLINNLLQVKQRKR 1047
G+I++ ++ PF+E +I A PP +++ L+ +R
Sbjct: 190 GIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI-KNLPKPIESLMTRCWSKDPSQR 248
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 38/183 (20%), Positives = 76/183 (41%), Gaps = 25/183 (13%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
++ +G V ++ I+ + L+ E+ + + HP +V F ++VV
Sbjct: 46 ARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
+ G ++I + ++E +I+ +L AL ++H VH +K ++L+S +
Sbjct: 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG 165
Query: 950 ELPQVKLCDFGFARIIGE--------KSFP-----------PEVLR--NKGYNRSLDMWS 988
+ V L + FP PEVL+ +GY+ D++S
Sbjct: 166 K---VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 222
Query: 989 VGV 991
VG+
Sbjct: 223 VGI 225
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 29/188 (15%), Positives = 60/188 (31%), Gaps = 26/188 (13%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF------ETPGRIFVVM 890
G + +KV+ + T++ E L+ HP V+ ++
Sbjct: 33 GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL----PVLGACQSPPAPHPTLIT 88
Query: 891 EKLQGDMLEMILSSEKGR-LSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVLLST 947
+ L +L + + + + LH+ I L +V++
Sbjct: 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE 148
Query: 948 NSELPQVKLCDFGFARIIGEKSF-------PPEVLRNKGYN---RSLDMWSVGVIVYVSL 997
+ ++ PE L+ K + RS DMWS V+++ +
Sbjct: 149 DM---TARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205
Query: 998 SGTFPFNE 1005
+ PF +
Sbjct: 206 TREVPFAD 213
|
| >1y8f_A UNC-13 homolog A, MUNC13-1; cysteine-rich domain, C1-domain, zinc-binding domain, endocytosis/exocytosis,signaling protein complex; NMR {Rattus norvegicus} Length = 66 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-25
Identities = 26/62 (41%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 255 SPGA-PSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK 313
SPG I H F + T T PT C C+ LL G+ +QG++C +CG H+KC D +
Sbjct: 2 SPGISGGGGGIQHNFEVWTATTPTYCYECEGLLWGIARQGMRCTECGVKCHEKCQDLLNA 61
Query: 314 DC 315
DC
Sbjct: 62 DC 63
|
| >1y8f_A UNC-13 homolog A, MUNC13-1; cysteine-rich domain, C1-domain, zinc-binding domain, endocytosis/exocytosis,signaling protein complex; NMR {Rattus norvegicus} Length = 66 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-25
Identities = 26/62 (41%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 519 SPGA-PSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK 577
SPG I H F + T T PT C C+ LL G+ +QG++C +CG H+KC D +
Sbjct: 2 SPGISGGGGGIQHNFEVWTATTPTYCYECEGLLWGIARQGMRCTECGVKCHEKCQDLLNA 61
Query: 578 DC 579
DC
Sbjct: 62 DC 63
|
| >2eli_A Protein kinase C alpha type; PKC-alpha, PKC-A, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 85 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 4e-25
Identities = 34/87 (39%), Positives = 45/87 (51%), Gaps = 5/87 (5%)
Query: 252 SPTSPGAPSSVN--IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLD 309
S S G P + + H F +HTY PT C C LL GL QG++C C NVHK+C+
Sbjct: 2 SSGSSGGPDTDDPRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVI 61
Query: 310 KVPKDCVGEPVTNNKSNNYCKLKSEVA 336
VP C + + + LK+EVA
Sbjct: 62 NVPSLC---GMDHTEKRGRIYLKAEVA 85
|
| >2eli_A Protein kinase C alpha type; PKC-alpha, PKC-A, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 85 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 4e-25
Identities = 34/87 (39%), Positives = 45/87 (51%), Gaps = 5/87 (5%)
Query: 516 SPTSPGAPSSVN--IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLD 573
S S G P + + H F +HTY PT C C LL GL QG++C C NVHK+C+
Sbjct: 2 SSGSSGGPDTDDPRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVI 61
Query: 574 KVPKDCVGEPVTNNKSNNYCKLKSEVA 600
VP C + + + LK+EVA
Sbjct: 62 NVPSLC---GMDHTEKRGRIYLKAEVA 85
|
| >2enz_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} Length = 65 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 9e-25
Identities = 27/61 (44%), Positives = 36/61 (59%)
Query: 255 SPGAPSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKD 314
S G+ +++PH F ++ Y PT C C LL GL +QGL+C CG NVH +C KV
Sbjct: 2 SSGSSGKIDMPHRFKVYNYKSPTFCEHCGTLLWGLARQGLKCDACGMNVHHRCQTKVANL 61
Query: 315 C 315
C
Sbjct: 62 C 62
|
| >2enz_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} Length = 65 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 9e-25
Identities = 27/61 (44%), Positives = 36/61 (59%)
Query: 519 SPGAPSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKD 578
S G+ +++PH F ++ Y PT C C LL GL +QGL+C CG NVH +C KV
Sbjct: 2 SSGSSGKIDMPHRFKVYNYKSPTFCEHCGTLLWGLARQGLKCDACGMNVHHRCQTKVANL 61
Query: 579 C 579
C
Sbjct: 62 C 62
|
| >2yuu_A NPKC-delta, protein kinase C delta type; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 83 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-24
Identities = 22/61 (36%), Positives = 33/61 (54%)
Query: 265 PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPVTNNK 324
H F + +PT C +CK + GL KQG +C+ C +HKKC+DK+ C G +
Sbjct: 17 NHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRD 76
Query: 325 S 325
+
Sbjct: 77 T 77
|
| >2yuu_A NPKC-delta, protein kinase C delta type; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 83 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-24
Identities = 22/61 (36%), Positives = 33/61 (54%)
Query: 529 PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPVTNNK 588
H F + +PT C +CK + GL KQG +C+ C +HKKC+DK+ C G +
Sbjct: 17 NHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRD 76
Query: 589 S 589
+
Sbjct: 77 T 77
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 29/177 (16%), Positives = 52/177 (29%), Gaps = 22/177 (12%)
Query: 831 GVHRKSGRGVAIKVID-KLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
+ R VA+ +D + P + + L + PGV + + T VV
Sbjct: 50 ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E ++G L+ + S + + A H + P V +S +
Sbjct: 110 AEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG 166
Query: 950 ELPQVKLCDFGFARIIGEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED 1006
V L + D+ +G +Y L +P E
Sbjct: 167 ---DVVLAYPATMPDANPQD---------------DIRGIGASLYALLVNRWPLPEA 205
|
| >2enn_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} Length = 77 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-23
Identities = 23/53 (43%), Positives = 31/53 (58%)
Query: 265 PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 317
H F + +PT C +C + + GL KQG QC+ C +HKKC+DKV C G
Sbjct: 23 CHEFTATFFPQPTFCSVCHEFVWGLNKQGYQCRQCNAAIHKKCIDKVIAKCTG 75
|
| >2enn_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} Length = 77 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-23
Identities = 23/53 (43%), Positives = 31/53 (58%)
Query: 529 PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 581
H F + +PT C +C + + GL KQG QC+ C +HKKC+DKV C G
Sbjct: 23 CHEFTATFFPQPTFCSVCHEFVWGLNKQGYQCRQCNAAIHKKCIDKVIAKCTG 75
|
| >2db6_A SH3 and cysteine rich domain 3; STAC3, C1 domain, cystein-rich domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 74 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 3e-23
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 3/70 (4%)
Query: 252 SPTSPGAPSSVNI--PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLD 309
S S G P + PH F H + +P C +C +++ K GL+CK+C N+H+ C
Sbjct: 2 SSGSSGEPPKLVNDKPHKFKDHFFKKPKFCDVCARMIVLNNKFGLRCKNCKTNIHEHCQS 61
Query: 310 KVP-KDCVGE 318
V + C G
Sbjct: 62 YVEMQRCSGP 71
|
| >2db6_A SH3 and cysteine rich domain 3; STAC3, C1 domain, cystein-rich domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 74 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 3e-23
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 3/70 (4%)
Query: 516 SPTSPGAPSSVNI--PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLD 573
S S G P + PH F H + +P C +C +++ K GL+CK+C N+H+ C
Sbjct: 2 SSGSSGEPPKLVNDKPHKFKDHFFKKPKFCDVCARMIVLNNKFGLRCKNCKTNIHEHCQS 61
Query: 574 KVP-KDCVGE 582
V + C G
Sbjct: 62 YVEMQRCSGP 71
|
| >1ptq_A Protein kinase C delta type; phosphotransferase; 1.95A {Mus musculus} SCOP: g.49.1.1 PDB: 1ptr_A* Length = 50 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-22
Identities = 27/50 (54%), Positives = 32/50 (64%)
Query: 266 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315
H F ++ Y PT C C LL GL KQGL+C+DCG NVH KC +KV C
Sbjct: 1 HRFKVYNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLC 50
|
| >1ptq_A Protein kinase C delta type; phosphotransferase; 1.95A {Mus musculus} SCOP: g.49.1.1 PDB: 1ptr_A* Length = 50 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-22
Identities = 27/50 (54%), Positives = 32/50 (64%)
Query: 530 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579
H F ++ Y PT C C LL GL KQGL+C+DCG NVH KC +KV C
Sbjct: 1 HRFKVYNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLC 50
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 2e-21
Identities = 74/341 (21%), Positives = 116/341 (34%), Gaps = 117/341 (34%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-----HPG---VVNLERMFETPG 884
+ + VA+KV+ T+ +E+ +L+++ P VV L F+ G
Sbjct: 58 DIQGKKFVAMKVVKSAEHYTETA---LDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114
Query: 885 R----IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLK 939
I +V E L +L+ I+ S L K II Q+L L +LH+K I+H D+K
Sbjct: 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIK 174
Query: 940 PENVLLS----------------------------------------------TNSELPQ 953
PEN+LLS N+E +
Sbjct: 175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLK 234
Query: 954 VKLCDFGFARIIGEKSF---------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFN 1004
VK+ D G A + + EVL GYN D+WS + + +G + F
Sbjct: 235 VKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
Query: 1005 --------EDEDINEQIQ-----------------------NAAFMYPP--RPWR----- 1026
DED I + +PW
Sbjct: 295 PHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354
Query: 1027 ----DISSD----AIDLINNLLQVKQRKRLSVDKSLAHPWL 1059
+ S + D + +L++ KR + + L HPWL
Sbjct: 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 22/81 (27%), Positives = 35/81 (43%), Gaps = 1/81 (1%)
Query: 384 KSFRRSILVALKHLHSK-NIVHCDLKPERNLFPTSSLEIKSNTEEEDEDEERGSTDGGGP 442
K + +L L +LH+K I+H D+KPE L + I+ E E + G+ G
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 443 SPRSEPRTATATPSNNIPLMR 463
+ + P TA N +
Sbjct: 209 AVSTAPATAGNFLVNPLEPKN 229
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 8e-20
Identities = 49/210 (23%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
GV +K VA+K + K +E E A+++ + HP +V L + +++
Sbjct: 239 GVWKKYSLTVAVKTL-KEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E + G++L+ + + +S ++ TQI A+++L KN +H +L N L+ N
Sbjct: 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH 355
Query: 950 ELPQVKLCDFGFARII--------GEKSFP-----PEVLRNKGYNRSLDMWSVGVIVY-- 994
VK+ DFG +R++ FP PE L ++ D+W+ GV+++
Sbjct: 356 ---LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412
Query: 995 VSLSGT-FPFNEDEDINEQIQNAAFMYPPR 1023
+ + +P + + E ++ M P
Sbjct: 413 ATYGMSPYPGIDLSQVYELLEKDYRMERPE 442
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 39/208 (18%), Positives = 71/208 (34%), Gaps = 46/208 (22%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAI--LQNLCHPGVVNL----ERMFETPGRIFVVM 890
G VA+K+ F ++ E E + L H ++ + +++++
Sbjct: 31 GENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK--------NIVHCDLKPEN 942
+ L L L + I+ I L HLH + I H DLK +N
Sbjct: 86 HYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSFP----------------PEVLRNK------GY 980
+L+ N Q + D G A + + + PEVL
Sbjct: 144 ILVKKNG---QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 200
Query: 981 NRSLDMWSVGVIVYVSLSGTFPFNEDED 1008
+ +D+W+ G++++ ED
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 52/189 (27%), Positives = 79/189 (41%), Gaps = 23/189 (12%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP 883
V +G VA+K + K A LK E+ IL+NL H +V + +
Sbjct: 37 VELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95
Query: 884 GR--IFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKP 940
G I ++ME L G + E L K +++ + QI + +L S+ VH DL
Sbjct: 96 GGNGIKLIMEFLPSGSLKEY-LPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAA 154
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGEKS----------FP-----PEVLRNKGYNRSLD 985
NVL+ + QVK+ DFG + I P PE L + + D
Sbjct: 155 RNVLVESEH---QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASD 211
Query: 986 MWSVGVIVY 994
+WS GV ++
Sbjct: 212 VWSFGVTLH 220
|
| >1faq_A RAF-1; transferase, serine/threonine-protein kinase, proto- oncogene, zinc, ATP-binding, phorbol-ester binding; NMR {Homo sapiens} SCOP: g.49.1.1 PDB: 1far_A Length = 52 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-19
Identities = 18/53 (33%), Positives = 26/53 (49%), Gaps = 4/53 (7%)
Query: 264 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCV 316
H F T+ + C +C+K L G +C+ CG+ H+ C KVP CV
Sbjct: 2 TTHNFARKTFLKLAFCDICQKFLL----NGFRCQTCGYKFHEHCSTKVPTMCV 50
|
| >1faq_A RAF-1; transferase, serine/threonine-protein kinase, proto- oncogene, zinc, ATP-binding, phorbol-ester binding; NMR {Homo sapiens} SCOP: g.49.1.1 PDB: 1far_A Length = 52 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-19
Identities = 18/53 (33%), Positives = 26/53 (49%), Gaps = 4/53 (7%)
Query: 528 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCV 580
H F T+ + C +C+K L G +C+ CG+ H+ C KVP CV
Sbjct: 2 TTHNFARKTFLKLAFCDICQKFLL----NGFRCQTCGYKFHEHCSTKVPTMCV 50
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 47/190 (24%), Positives = 89/190 (46%), Gaps = 26/190 (13%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLCHPGVVNLERMFET 882
V + +G VA+K KL+ T++ + + E+ IL++L H +V + + +
Sbjct: 26 VEMCRYDPLQDNTGEVVAVK---KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82
Query: 883 PGR--IFVVMEKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLK 939
GR + ++ME L G + + L K R+ +QI +++L +K +H DL
Sbjct: 83 AGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 141
Query: 940 PENVLLSTNSELPQVKLCDFGFARIIGEKS----------FP-----PEVLRNKGYNRSL 984
N+L+ + +VK+ DFG +++ + P PE L ++ +
Sbjct: 142 TRNILVENEN---RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVAS 198
Query: 985 DMWSVGVIVY 994
D+WS GV++Y
Sbjct: 199 DVWSFGVVLY 208
|
| >2coa_A Protein kinase C, D2 type; protein kinase D2, PH domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1 Length = 125 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 7e-19
Identities = 30/54 (55%), Positives = 37/54 (68%), Gaps = 2/54 (3%)
Query: 60 RKRHYWRLDSKCLTLFQSESGSKYYKEIPLSEILGIEPCKPLTHELQQVQIRPH 113
RKRHYWRLD KC+TLFQ+ + ++YYKEIPLSEIL +E + L PH
Sbjct: 24 RKRHYWRLDCKCITLFQNNTTNRYYKEIPLSEILTVESAQ--NFSLVPPGTNPH 75
|
| >2coa_A Protein kinase C, D2 type; protein kinase D2, PH domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1 Length = 125 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 4e-12
Identities = 29/94 (30%), Positives = 41/94 (43%), Gaps = 17/94 (18%)
Query: 586 NNKSNNYCK--LKSEVASLVSLESSASASYSCLVRSTSHCFILKTNNLDYYVGEDTHSPS 643
NN +N Y K SE+ ++ S ++ + + HCF + T N Y+VGE
Sbjct: 41 NNTTNRYYKEIPLSEILTVESAQNFSLVPPG----TNPHCFEIVTANATYFVGEMPGGTP 96
Query: 644 DGVETPVTAPESGLG---ARAWELSLRQALMPVQ 674
SG G AR WE ++RQALM
Sbjct: 97 G--------GPSGQGAEAARGWETAIRQALMSGP 122
|
| >2coa_A Protein kinase C, D2 type; protein kinase D2, PH domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1 Length = 125 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 16/86 (18%), Positives = 31/86 (36%), Gaps = 17/86 (19%)
Query: 475 GSKVIKEGWMIHYTSKDSM----------------SSSFSTKPSSRSPSLTSRTDALSPT 518
S ++EGW++HY++KD++ ++ + + P L+ S
Sbjct: 5 SSGTLREGWVVHYSNKDTLRKRHYWRLDCKCITLFQNNTTNRYYKEIP-LSEILTVESAQ 63
Query: 519 SPGAPSSVNIPHTFNLHTYTRPTLCG 544
+ PH F + T G
Sbjct: 64 NFSLVPPGTNPHCFEIVTANATYFVG 89
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 24/189 (12%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP 883
V + +G VA+K + + P +Q + E+ IL+ L +V + P
Sbjct: 39 VELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQR-EIQILKALHSDFIVKYRGVSYGP 96
Query: 884 GR--IFVVMEKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKP 940
GR + +VME L G + + L + RL +QI +++L S+ VH DL
Sbjct: 97 GRQSLRLVMEYLPSGCLRDF-LQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAA 155
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGEKS----------FP-----PEVLRNKGYNRSLD 985
N+L+ + + VK+ DFG A+++ P PE L + ++R D
Sbjct: 156 RNILVESEA---HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 212
Query: 986 MWSVGVIVY 994
+WS GV++Y
Sbjct: 213 VWSFGVVLY 221
|
| >2fnf_X Putative RAS effector NORE1; zinc, signal transduction, apoptosis, cysteine rich domain; NMR {Mus musculus} Length = 72 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 1e-18
Identities = 18/70 (25%), Positives = 27/70 (38%), Gaps = 4/70 (5%)
Query: 247 RTDALSPTSPGAPSSVNIPHTFNLHT-YTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHK 305
R+ P P + H F P C LC + + +Q L+C +C F H
Sbjct: 5 RSIFEQPQDPRVLAERGEGHRFVELALRGGPGWCDLCGR---EVLRQALRCANCKFTCHS 61
Query: 306 KCLDKVPKDC 315
+C + DC
Sbjct: 62 ECRSLIQLDC 71
|
| >2fnf_X Putative RAS effector NORE1; zinc, signal transduction, apoptosis, cysteine rich domain; NMR {Mus musculus} Length = 72 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 1e-18
Identities = 18/70 (25%), Positives = 27/70 (38%), Gaps = 4/70 (5%)
Query: 511 RTDALSPTSPGAPSSVNIPHTFNLHT-YTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHK 569
R+ P P + H F P C LC + + +Q L+C +C F H
Sbjct: 5 RSIFEQPQDPRVLAERGEGHRFVELALRGGPGWCDLCGR---EVLRQALRCANCKFTCHS 61
Query: 570 KCLDKVPKDC 579
+C + DC
Sbjct: 62 ECRSLIQLDC 71
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 47/190 (24%), Positives = 89/190 (46%), Gaps = 26/190 (13%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLCHPGVVNLERMFET 882
V + +G VA+K KL+ T++ + + E+ IL++L H +V + + +
Sbjct: 57 VEMCRYDPLQDNTGEVVAVK---KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113
Query: 883 PGR--IFVVMEKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLK 939
GR + ++ME L G + + L K R+ +QI +++L +K +H DL
Sbjct: 114 AGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172
Query: 940 PENVLLSTNSELPQVKLCDFGFARIIGEKS----------FP-----PEVLRNKGYNRSL 984
N+L+ + +VK+ DFG +++ + P PE L ++ +
Sbjct: 173 TRNILVENEN---RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVAS 229
Query: 985 DMWSVGVIVY 994
D+WS GV++Y
Sbjct: 230 DVWSFGVVLY 239
|
| >2d9z_A Protein kinase C, NU type; PH domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 129 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 2e-18
Identities = 35/43 (81%), Positives = 37/43 (86%)
Query: 60 RKRHYWRLDSKCLTLFQSESGSKYYKEIPLSEILGIEPCKPLT 102
RKRHYWRLDSKCLTLFQ+ESGSKYYKEIPLSEIL I + T
Sbjct: 24 RKRHYWRLDSKCLTLFQNESGSKYYKEIPLSEILRISSPRDFT 66
|
| >2d9z_A Protein kinase C, NU type; PH domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 129 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 3e-13
Identities = 29/98 (29%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 586 NNKSNNYCK--LKSEVASLVSLESSASASYSCLVRSTSHCFILKTNNLDYYVGEDTHSPS 643
N + Y K SE+ + S + S S HCF + T+ + Y+VGE+ S
Sbjct: 41 NESGSKYYKEIPLSEILRISSPRDFTNISQG----SNPHCFEIITDTMVYFVGENNGDSS 96
Query: 644 DGVETPVTAPESGLG---ARAWELSLRQALMPVQEPSG 678
+G+G A++WE ++RQALM SG
Sbjct: 97 ----HNPVLAATGVGLDVAQSWEKAIRQALMSGP-SSG 129
|
| >2d9z_A Protein kinase C, NU type; PH domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 129 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 11/19 (57%), Positives = 17/19 (89%)
Query: 475 GSKVIKEGWMIHYTSKDSM 493
S ++KEGWM+HYTS+D++
Sbjct: 5 SSGMVKEGWMVHYTSRDNL 23
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-18
Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 27/211 (12%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERM-FETPGRIFVV 889
G + R VAIK L+ T E +++ L H +V L + E P I++V
Sbjct: 203 GTWNGTTR-VAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP--IYIV 256
Query: 890 MEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
E + G +L+ + L + QI + ++ N VH DL+ N+L+ N
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 316
Query: 949 SELPQVKLCDFGFARIIGE--------KSFP-----PEVLRNKGYNRSLDMWSVGVIVY- 994
K+ DFG AR+I + FP PE + D+WS G+++
Sbjct: 317 L---VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 373
Query: 995 -VSLSGT-FPFNEDEDINEQIQNAAFMYPPR 1023
+ +P + ++ +Q++ M P
Sbjct: 374 LTTKGRVPYPGMVNREVLDQVERGYRMPCPP 404
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-18
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G R VA+K + P +A+ E IL+ HP +V L + I++VM
Sbjct: 133 GRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E +QG L +E RL +T ++ +++L SK +H DL N L++ +
Sbjct: 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV 251
Query: 951 LPQVKLCDFGFARII---------GEKSFP-----PEVLRNKGYNRSLDMWSVGVIVY-- 994
+K+ DFG +R G + P PE L Y+ D+WS G++++
Sbjct: 252 ---LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWET 308
Query: 995 VSLSGTFPF----NEDEDINEQIQNAAFMYPP 1022
SL G P+ N + E ++ + P
Sbjct: 309 FSL-GASPYPNLSN--QQTREFVEKGGRLPCP 337
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 41/208 (19%), Positives = 72/208 (34%), Gaps = 46/208 (22%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAI--LQNLCHPGVVNL----ERMFETPGRIFVVM 890
G VA+KV F T +EA E I + H ++ + + +++++
Sbjct: 60 GEKVAVKV-----FFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT 114
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN--------IVHCDLKPEN 942
+ + L L S L ++ + + L HLH++ I H DLK +N
Sbjct: 115 DYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSFP----------------PEVL------RNKGY 980
+L+ N + D G A + PEVL +
Sbjct: 173 ILVKKN---GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229
Query: 981 NRSLDMWSVGVIVYVSLSGTFPFNEDED 1008
DM+S G+I++ E+
Sbjct: 230 YIMADMYSFGLILWEVARRCVSGGIVEE 257
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
GV +K VA+K L+ T + + E A+++ + HP +V L + +++
Sbjct: 32 GVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E + G++L+ + + +S ++ TQI A+++L KN +H DL N L+ N
Sbjct: 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH 148
Query: 950 ELPQVKLCDFGFARII--------GEKSFP-----PEVLRNKGYNRSLDMWSVGVIVY-- 994
VK+ DFG +R++ FP PE L ++ D+W+ GV+++
Sbjct: 149 L---VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 995 VSLSGT-FPFNEDEDINEQIQNAAFMYPP 1022
+ + +P + + E ++ M P
Sbjct: 206 ATYGMSPYPGIDLSQVYELLEKDYRMERP 234
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 8e-18
Identities = 35/192 (18%), Positives = 67/192 (34%), Gaps = 46/192 (23%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAI--LQNLCHPGVVNL----ERMFETPGRIFVVM 890
G VA+K+ F +++E E I L H ++ + T ++++V
Sbjct: 65 GEEVAVKI-----FSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 119
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK--------NIVHCDLKPEN 942
+ + L L+ ++ + L HLH + I H DLK +N
Sbjct: 120 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 177
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSFP----------------PEVLRNKG------Y 980
+L+ N + D G A + PEVL +
Sbjct: 178 ILVKKN---GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234
Query: 981 NRSLDMWSVGVI 992
+ D++++G++
Sbjct: 235 FKRADIYAMGLV 246
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-17
Identities = 48/210 (22%), Positives = 85/210 (40%), Gaps = 25/210 (11%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G + R VAIK L+ T E +++ L H +V L + + I++V
Sbjct: 286 GTWNGTTR-VAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVT 340
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E + G +L+ + L + QI + ++ N VH DL+ N+L+ N
Sbjct: 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 400
Query: 950 ELPQVKLCDFGFARIIGE--------KSFP-----PEVLRNKGYNRSLDMWSVGVIVY-- 994
K+ DFG AR+I + FP PE + D+WS G+++
Sbjct: 401 ---VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457
Query: 995 VSLSGT-FPFNEDEDINEQIQNAAFMYPPR 1023
+ +P + ++ +Q++ M P
Sbjct: 458 TTKGRVPYPGMVNREVLDQVERGYRMPCPP 487
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 46/219 (21%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERM-FET 882
V G K VAIK + + K ++ +E ++ ++ +P V L + +
Sbjct: 31 VYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89
Query: 883 PGRIFVVMEKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
+ ++ + + G +L+ + K + + QI + +L + +VH DL
Sbjct: 90 T--VQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 146
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKS---------FP-----PEVLRNKGYNRSLDMW 987
NVL+ T VK+ DFG A+++G + P E + ++ Y D+W
Sbjct: 147 NVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVW 203
Query: 988 SVGVIVY--VSLSGTFPFNE--DEDINEQIQNAAFMYPP 1022
S GV V+ ++ G+ P++ +I+ ++ + P
Sbjct: 204 SYGVTVWELMTF-GSKPYDGIPASEISSILEKGERLPQP 241
|
| >1rfh_A RAS association (ralgds/AF-6) domain family 5; zinc, signal transduction, apoptosis, cysteine rich domain, metal binding protein; NMR {Mus musculus} Length = 59 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-17
Identities = 16/61 (26%), Positives = 24/61 (39%), Gaps = 4/61 (6%)
Query: 256 PGAPSSVNIPHTFNLHT-YTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKD 314
P + H F P C LC + + +Q L+C +C F H +C + D
Sbjct: 1 PRVLAERGEGHRFVELALRGGPGWCDLCGREV---LRQALRCANCKFTCHSECRSLIQLD 57
Query: 315 C 315
C
Sbjct: 58 C 58
|
| >1rfh_A RAS association (ralgds/AF-6) domain family 5; zinc, signal transduction, apoptosis, cysteine rich domain, metal binding protein; NMR {Mus musculus} Length = 59 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-17
Identities = 16/61 (26%), Positives = 24/61 (39%), Gaps = 4/61 (6%)
Query: 520 PGAPSSVNIPHTFNLHT-YTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKD 578
P + H F P C LC + + +Q L+C +C F H +C + D
Sbjct: 1 PRVLAERGEGHRFVELALRGGPGWCDLCGREV---LRQALRCANCKFTCHSECRSLIQLD 57
Query: 579 C 579
C
Sbjct: 58 C 58
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 48/200 (24%), Positives = 85/200 (42%), Gaps = 21/200 (10%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERM-FETPGRIFVVMEKLQ- 894
G VA+K I K E +++ L H +V L + E G +++V E +
Sbjct: 44 GNKVAVKCI-K---NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99
Query: 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQV 954
G +++ + S + L + A+++L N VH DL NVL+S ++
Sbjct: 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN---VA 156
Query: 955 KLCDFGFARIIGEKS----FP-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGT-FP 1002
K+ DFG + P PE LR K ++ D+WS G++++ S +P
Sbjct: 157 KVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 216
Query: 1003 FNEDEDINEQIQNAAFMYPP 1022
+D+ +++ M P
Sbjct: 217 RIPLKDVVPRVEKGYKMDAP 236
|
| >2row_A RHO-associated protein kinase 2; ATP-binding, coiled coil, cytoplasm, membrane, metal-binding, nucleotide-binding, phorbol-ester binding; NMR {Rattus norvegicus} Length = 84 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 2e-17
Identities = 19/66 (28%), Positives = 26/66 (39%), Gaps = 2/66 (3%)
Query: 252 SPTSPGAPSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFK--QGLQCKDCGFNVHKKCLD 309
P + + H F Y PT C C K L +FK L+C+ C HK +D
Sbjct: 11 EPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMD 70
Query: 310 KVPKDC 315
K +
Sbjct: 71 KKEEII 76
|
| >2row_A RHO-associated protein kinase 2; ATP-binding, coiled coil, cytoplasm, membrane, metal-binding, nucleotide-binding, phorbol-ester binding; NMR {Rattus norvegicus} Length = 84 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 2e-17
Identities = 19/66 (28%), Positives = 26/66 (39%), Gaps = 2/66 (3%)
Query: 516 SPTSPGAPSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFK--QGLQCKDCGFNVHKKCLD 573
P + + H F Y PT C C K L +FK L+C+ C HK +D
Sbjct: 11 EPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMD 70
Query: 574 KVPKDC 579
K +
Sbjct: 71 KKEEII 76
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 43/187 (22%), Positives = 74/187 (39%), Gaps = 23/187 (12%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERM-FET 882
V G V IKVI + + + + + + + +L H +V L + +
Sbjct: 29 VHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS 87
Query: 883 PGRIFVVMEKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
+ +V + L G +L+ + +G L + QI + +L +VH +L
Sbjct: 88 S--LQLVTQYLPLGSLLDH-VRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAAR 144
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKS---------FP-----PEVLRNKGYNRSLDMW 987
NVLL + S QV++ DFG A ++ P E + Y D+W
Sbjct: 145 NVLLKSPS---QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVW 201
Query: 988 SVGVIVY 994
S GV V+
Sbjct: 202 SYGVTVW 208
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 45/217 (20%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERM-FET 882
V G G + VA+K L+ + E +++ L H +V L + +
Sbjct: 29 VWMGYYNGHTK-----VAVKS---LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 883 PGRIFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
P I+++ E ++ G +++ + + +L+ + QI + + +N +H DL+
Sbjct: 81 P--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKS--------FP-----PEVLRNKGYNRSLDMWS 988
N+L+S K+ DFG AR+I + FP PE + + D+WS
Sbjct: 139 NILVSDTL---SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 989 VGVIVY--VSLSGT-FPFNEDEDINEQIQNAAFMYPP 1022
G+++ V+ +P + ++ + ++ M P
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 43/204 (21%), Positives = 89/204 (43%), Gaps = 26/204 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDML 898
VAIK + K + +Q +E +I+ HP ++ LE + +V E ++ G +
Sbjct: 80 VAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
L + G+ + ++ + +++L VH DL NVL+ +N K+ D
Sbjct: 139 TF-LRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL---VCKVSD 194
Query: 959 FGFARIIGEKS----------FP-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGTF 1001
FG +R++ + P PE + + ++ + D+WS GV+++ ++ G
Sbjct: 195 FGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAY-GER 253
Query: 1002 PFNE--DEDINEQIQNAAFMYPPR 1023
P+ + D+ ++ + P
Sbjct: 254 PYWNMTNRDVISSVEEGYRLPAPM 277
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 25/189 (13%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP 883
V + +G VA+K + K + + K E+ IL+ L H ++ + E
Sbjct: 47 VSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105
Query: 884 GR--IFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKP 940
G + +VME + G + + + + + QI + +LH+++ +H DL
Sbjct: 106 GAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAA 162
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGEKS----------FP-----PEVLRNKGYNRSLD 985
NVLL + VK+ DFG A+ + E P PE L+ + + D
Sbjct: 163 RNVLLDNDR---LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASD 219
Query: 986 MWSVGVIVY 994
+WS GV +Y
Sbjct: 220 VWSFGVTLY 228
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-17
Identities = 48/201 (23%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERM-FETPGRIFVVMEKLQ- 894
G VA+K ++ +A L E +++ L H +V L + E G +++V E +
Sbjct: 216 GNKVAVKC---IKNDATAQAFLA-EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271
Query: 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQV 954
G +++ + S + L + A+++L N VH DL NVL+S ++
Sbjct: 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN---VA 328
Query: 955 KLCDFGFARIIGEKS----FP-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGT-FP 1002
K+ DFG + P PE LR K ++ D+WS G++++ S +P
Sbjct: 329 KVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388
Query: 1003 FNEDEDINEQIQNAAFMYPPR 1023
+D+ +++ M P
Sbjct: 389 RIPLKDVVPRVEKGYKMDAPD 409
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-17
Identities = 44/210 (20%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+ K + VA+K ++ + E +++ L H +V L + T I+++
Sbjct: 207 ATYNKHTK-VAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIIT 261
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E + G +L+ + S E + QI + + +N +H DL+ N+L+S +
Sbjct: 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL 321
Query: 950 ELPQVKLCDFGFARIIGEKS--------FP-----PEVLRNKGYNRSLDMWSVGVIVY-- 994
K+ DFG AR+I + FP PE + + D+WS G+++
Sbjct: 322 ---VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 378
Query: 995 VSLSGT-FPFNEDEDINEQIQNAAFMYPPR 1023
V+ +P + ++ ++ M P
Sbjct: 379 VTYGRIPYPGMSNPEVIRALERGYRMPRPE 408
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 25/202 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDML 898
VA+K K + + +E I++NL HP +V L + E +++ME G++
Sbjct: 43 VAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELG 100
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
L K L T QI A+ +L S N VH D+ N+L+++ VKL D
Sbjct: 101 HY-LERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGD 156
Query: 959 FGFARIIGEKS--------FP-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFPF 1003
FG +R I ++ P PE + + + + D+W V ++ +S G PF
Sbjct: 157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSF-GKQPF 215
Query: 1004 NE--DEDINEQIQNAAFMYPPR 1023
++D+ ++ + P
Sbjct: 216 FWLENKDVIGVLEKGDRLPKPD 237
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 27/203 (13%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF-ETPGRIFVVMEKL-QGDM 897
VAIK K + E ++ HP +V L + E P ++++ME G++
Sbjct: 46 VAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGEL 102
Query: 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957
L K L + Q+ AL +L SK VH D+ NVL+S+N VKL
Sbjct: 103 RSF-LQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLG 158
Query: 958 DFGFARIIGEKS--------FP-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFP 1002
DFG +R + + + P PE + + + + D+W GV ++ + G P
Sbjct: 159 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKP 217
Query: 1003 FNE--DEDINEQIQNAAFMYPPR 1023
F + D+ +I+N + P
Sbjct: 218 FQGVKNNDVIGRIENGERLPMPP 240
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 39/204 (19%), Positives = 75/204 (36%), Gaps = 23/204 (11%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL-QGDML 898
V +KV+DK +++ L H +V + +V E + G +
Sbjct: 43 VLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD 100
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ----- 953
L K ++ + Q+ A+ L ++H ++ +N+LL +
Sbjct: 101 TY-LKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 954 VKLCDFGFARIIGEKSF--------PPEVLRN-KGYNRSLDMWSVGVIVY--VSLSGTFP 1002
+KL D G + + K PPE + N K N + D WS G ++ S G P
Sbjct: 160 IKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG-GDKP 218
Query: 1003 FNE--DEDINEQIQNAAFMYPPRP 1024
+ + + ++ + P+
Sbjct: 219 LSALDSQRKLQFYEDRHQLPAPKA 242
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 48/220 (21%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP 883
V G K VAIK + K + KQ E I+ H ++ LE +
Sbjct: 60 VYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118
Query: 884 GRIFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
+ ++ E ++ G + + L + G S ++ I +K+L + N VH DL N
Sbjct: 119 KPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN 177
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKS----------FP-----PEVLRNKGYNRSLDMW 987
+L+++N K+ DFG +R++ + P PE + + + + D+W
Sbjct: 178 ILVNSNL---VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVW 234
Query: 988 SVGVIVY--VSLSGTFPFNE--DEDINEQIQNAAFMYPPR 1023
S G++++ ++ G P+ E + ++ + I + + P
Sbjct: 235 SFGIVMWEVMTY-GERPYWELSNHEVMKAINDGFRLPTPM 273
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 25/210 (11%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G + VAIK +R E E ++ L HP +V L + I +V
Sbjct: 27 GYWLNKDK-VAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82
Query: 891 EKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E ++ G + + L +++G + T + + + +L ++H DL N L+ N
Sbjct: 83 EFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ 141
Query: 950 ELPQVKLCDFGFARIIGEKS--------FP-----PEVLRNKGYNRSLDMWSVGVIVY-- 994
+K+ DFG R + + FP PEV Y+ D+WS GV+++
Sbjct: 142 ---VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 198
Query: 995 VSLSGT-FPFNEDEDINEQIQNAAFMYPPR 1023
S + + ++ E I +Y PR
Sbjct: 199 FSEGKIPYENRSNSEVVEDISTGFRLYKPR 228
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 45/202 (22%), Positives = 81/202 (40%), Gaps = 26/202 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDML 898
VA+K+ ++ + E + E + L HP +V + I++V E + G +L
Sbjct: 35 VAVKM---IKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
L S L + + + L S +H DL N L+ + VK+ D
Sbjct: 92 NY-LRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL---CVKVSD 147
Query: 959 FGFARIIGEKS--------FP-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFPF 1003
FG R + + FP PEV Y+ D+W+ G++++ SL G P+
Sbjct: 148 FGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSL-GKMPY 206
Query: 1004 --NEDEDINEQIQNAAFMYPPR 1023
+ ++ ++ +Y P
Sbjct: 207 DLYTNSEVVLKVSQGHRLYRPH 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 22/171 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDML 898
VAIKV+ K ++ E I+ L +P +V L + + + +VME G +
Sbjct: 40 VAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLH 97
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
+ L ++ + ++ Q+ + +K+L KN VH DL NVLL K+ D
Sbjct: 98 KF-LVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH---YAKISD 153
Query: 959 FGFARIIGEKS----------FP-----PEVLRNKGYNRSLDMWSVGVIVY 994
FG ++ +G +P PE + + ++ D+WS GV ++
Sbjct: 154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 204
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 42/187 (22%), Positives = 79/187 (42%), Gaps = 23/187 (12%)
Query: 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERM-FET 882
V G K VAIK + + K ++ +E ++ ++ +P V L + +
Sbjct: 31 VYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89
Query: 883 PGRIFVVMEKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
+ ++ + + G +L+ + K + + QI + +L + +VH DL
Sbjct: 90 T--VQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 146
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKS---------FP-----PEVLRNKGYNRSLDMW 987
NVL+ T VK+ DFG A+++G + P E + ++ Y D+W
Sbjct: 147 NVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVW 203
Query: 988 SVGVIVY 994
S GV V+
Sbjct: 204 SYGVTVW 210
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 3e-16
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 27/202 (13%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERM-FETPGRIFVVMEKL-QGDM 897
VAIK K + E ++ HP +V L + E P ++++ME G++
Sbjct: 421 VAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGEL 477
Query: 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957
L K L + Q+ AL +L SK VH D+ NVL+S+N VKL
Sbjct: 478 RSF-LQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLG 533
Query: 958 DFGFARIIGEKS--------FP-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFP 1002
DFG +R + + + P PE + + + + D+W GV ++ + G P
Sbjct: 534 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKP 592
Query: 1003 FN--EDEDINEQIQNAAFMYPP 1022
F ++ D+ +I+N + P
Sbjct: 593 FQGVKNNDVIGRIENGERLPMP 614
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 26/202 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDML 898
VAIK+ ++ + E + E ++ NL H +V L + IF++ E + G +L
Sbjct: 51 VAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
L + R + + + A+++L SK +H DL N L++ VK+ D
Sbjct: 108 NY-LREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV---VKVSD 163
Query: 959 FGFARIIGEKS--------FP-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFPF 1003
FG +R + + FP PEVL ++ D+W+ GV+++ SL G P+
Sbjct: 164 FGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL-GKMPY 222
Query: 1004 --NEDEDINEQIQNAAFMYPPR 1023
+ + E I +Y P
Sbjct: 223 ERFTNSETAEHIAQGLRLYRPH 244
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 45/233 (19%), Positives = 77/233 (33%), Gaps = 43/233 (18%)
Query: 811 LVFMTYNVALCIAVVAGAACGVHRKSGRG--VAIKVIDKLRFPTKQEAQLKNEVAILQNL 868
L F + + L G V + VA+K+ KQ Q + EV L +
Sbjct: 19 LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKI---FPIQDKQSWQNEYEVYSLPGM 75
Query: 869 CHPGVVNL----ERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVA 924
H ++ +R ++++ + L L + +S I +
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARG 133
Query: 925 LKHLHSK----------NIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS----- 969
L +LH I H D+K +NVLL N + DFG A
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL---TACIADFGLALKFEAGKSAGDT 190
Query: 970 ---------FPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED 1008
PEVL + +DM+++G++++ S + D
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 8e-16
Identities = 43/170 (25%), Positives = 75/170 (44%), Gaps = 20/170 (11%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLE 899
VAIKV+ K ++ E I+ L +P +V L + + + +VME G L
Sbjct: 366 VAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLH 423
Query: 900 MILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959
L ++ + ++ Q+ + +K+L KN VH +L NVLL K+ DF
Sbjct: 424 KFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH---YAKISDF 480
Query: 960 GFARIIGEKS----------FP-----PEVLRNKGYNRSLDMWSVGVIVY 994
G ++ +G +P PE + + ++ D+WS GV ++
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 26/174 (14%)
Query: 840 VAIKVI--DKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERM-FETPGRIFVVMEKL-QG 895
VA+K + D L P + ++ EV + +L H ++ L + P + +V E G
Sbjct: 49 VAVKCLKPDVLSQPEAMDDFIR-EVNAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLG 105
Query: 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVK 955
+L+ L +G T Q+ + +L SK +H DL N+LL+T VK
Sbjct: 106 SLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVK 161
Query: 956 LCDFGFARIIGEKS----------FP-----PEVLRNKGYNRSLDMWSVGVIVY 994
+ DFG R + + P PE L+ + ++ + D W GV ++
Sbjct: 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 215
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 43/278 (15%), Positives = 80/278 (28%), Gaps = 65/278 (23%)
Query: 837 GRGVAIKVIDKLRFPTKQEAQLKNEVAI--LQNLCHPGVVNL-----ERMFETPGRIFVV 889
R VA+KV F NE I + + H + + +V
Sbjct: 36 ERPVAVKV-----FSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS---------KNIVHCDLKP 940
ME L LS ++ + + L +LH+ I H DL
Sbjct: 91 MEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNS 148
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGEKSF--------------------PPEVLRN--- 977
NVL+ + + DFG + + PEVL
Sbjct: 149 RNVLVKNDG---TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN 205
Query: 978 ----KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAI 1033
+ + +DM+++G+I + E + E P + +
Sbjct: 206 LRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV 265
Query: 1034 DLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGL 1071
++++R ++ W ++ L+
Sbjct: 266 --------SREKQRPKFPEA----WKENSLAVRSLKET 291
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDML 898
VAIK + K+ + KQ E +I+ HP ++ LE + + +V E ++ G +
Sbjct: 76 VAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
L + + ++ I +K+L VH DL N+L+++N K+ D
Sbjct: 135 SF-LRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL---VCKVSD 190
Query: 959 FGFARIIGEKS----------FP-----PEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFP 1002
FG R++ + P PE + + + + D+WS G++++ +S G P
Sbjct: 191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
Query: 1003 FNE--DEDINEQIQNAAFMYPPR 1023
+ E ++D+ + + + PP
Sbjct: 251 YWEMSNQDVIKAVDEGYRLPPPM 273
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 45/205 (21%), Positives = 83/205 (40%), Gaps = 26/205 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLE-RMFETPGRIFVVMEKLQ-GDM 897
A+K + + +Q E I+++ HP V++L + G VV+ ++ GD+
Sbjct: 56 CAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 114
Query: 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957
+ +E + + Q+ +K+L SK VH DL N +L VK+
Sbjct: 115 RNF-IRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF---TVKVA 170
Query: 958 DFGFARIIGEKSF----------------PPEVLRNKGYNRSLDMWSVGVIVY--VSLSG 999
DFG AR + +K + E L+ + + D+WS GV+++ ++
Sbjct: 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 230
Query: 1000 T-FPFNEDEDINEQIQNAAFMYPPR 1023
+P DI + + P
Sbjct: 231 PPYPDVNTFDITVYLLQGRRLLQPE 255
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A Length = 463 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 4e-15
Identities = 31/124 (25%), Positives = 49/124 (39%), Gaps = 5/124 (4%)
Query: 193 NCSSGYKHRRSSTLHVPHSTSETGSNSSIASDDSNYTSSSFSTKPSSRSPSLTSRTDALS 252
+ Y+H +TL+ + + D+ + T ++ S + +
Sbjct: 142 TINPIYEHVGYTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRA-----T 196
Query: 253 PTSPGAPSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVP 312
H F +HT+ P C C + GL QG++C DCG NVHK+C VP
Sbjct: 197 LKENEQIPKYEKIHNFKVHTFRGPHWCEYCANFMWGLIAQGVKCADCGLNVHKQCSKMVP 256
Query: 313 KDCV 316
DC
Sbjct: 257 NDCK 260
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A Length = 463 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 35/134 (26%), Positives = 47/134 (35%), Gaps = 8/134 (5%)
Query: 447 EPRTATATPSNNIPLMRVVQSIKHTKRRGSKVIKEGWMIHYTSKDSMSSSFSTKPSSRSP 506
A T + T R K ++ T + S+ R
Sbjct: 135 AEYIAKMTINPIYE-----HVGYTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLT 189
Query: 507 SLTSRTDALSPTSPGAPSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFN 566
SL R + H F +HT+ P C C + GL QG++C DCG N
Sbjct: 190 SLVRRA---TLKENEQIPKYEKIHNFKVHTFRGPHWCEYCANFMWGLIAQGVKCADCGLN 246
Query: 567 VHKKCLDKVPKDCV 580
VHK+C VP DC
Sbjct: 247 VHKQCSKMVPNDCK 260
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 39/211 (18%), Positives = 89/211 (42%), Gaps = 30/211 (14%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL-----ERMFETPGRIFVVMEKLQ 894
VA+K + ++ + +E A +++ HP V+ L E + + V++ ++
Sbjct: 65 VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 895 -GDMLEMILSS----EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
GD+ +L S + +T + I + +++L ++N +H DL N +L +
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184
Query: 950 ELPQVKLCDFGFARIIGEKSF--------------PPEVLRNKGYNRSLDMWSVGVIVY- 994
V + DFG ++ I + E L ++ Y D+W+ GV ++
Sbjct: 185 ---TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWE 241
Query: 995 -VSLSGT-FPFNEDEDINEQIQNAAFMYPPR 1023
+ T +P ++ ++ + + + + P
Sbjct: 242 IATRGMTPYPGVQNHEMYDYLLHGHRLKQPE 272
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 79.1 bits (194), Expect = 6e-15
Identities = 72/554 (12%), Positives = 153/554 (27%), Gaps = 187/554 (33%)
Query: 629 NNLDYYVGEDTHSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTK---CEDVS 685
+++D+ GE + D ++ V E + C+DV
Sbjct: 5 HHMDFETGEHQYQYKD-------------------------ILSVFEDAFVDNFDCKDVQ 39
Query: 686 ESEESRVT--DMSQLYQISPDEVLGSGQ-FGIV--YGASMVGIFFLAAL---YEGVKYYR 737
+ +S ++ ++ + S D V G+ + F + MV F L Y+
Sbjct: 40 DMPKSILSKEEIDHIIM-SKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK------ 92
Query: 738 EYLFWKTYNDLHYRSI-PAQQRISSVEENKDTAKVVPVCDVLQKQPPSMLMLSMPHFIQT 796
+ + + P+ +E+ D L + +
Sbjct: 93 ----F-LMSPIKTEQRQPSMMTRMYIEQR----------DRLYNDNQVF----AKYNVSR 133
Query: 797 LLHVLQITMSFLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVID----KLRFPT 852
L L++ + LL L + + G K+ VA+ V + +
Sbjct: 134 LQPYLKLRQA-LLELRPAKN-----VLIDGVLGSG---KTW--VALDVCLSYKVQCKMDF 182
Query: 853 K-------QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSE 905
K + + +LQ L + N + I + + +Q L +L S+
Sbjct: 183 KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ-AELRRLLKSK 241
Query: 906 KGRLSERTTKFIITQILVALKHLHSKNIV-----HCDLKPENVLLSTN------------ 948
L+ L ++ + C +LL+T
Sbjct: 242 PYENC-----------LLVLLNVQNAKAWNAFNLSC-----KILLTTRFKQVTDFLSAAT 285
Query: 949 -SELPQVKLCD-FG-------FARIIGEKSF--PPEVL-------------------RNK 978
+ + + + + P EVL
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD 345
Query: 979 GYNRSLDMWSVGVIVYVSLSGTFP------------FNEDEDINEQIQNAAFMYPPRPWR 1026
+ + ++ + I+ SL+ P F I + + + W
Sbjct: 346 NW-KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS---LI----WF 397
Query: 1027 DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQIGTNKKKNPKRT 1086
D+ + ++ N L SL +T S + + ++ K K
Sbjct: 398 DVIKSDVMVVVNKL---------HKYSLVEKQ-PKESTIS-IPSIYLEL---KVKLENEY 443
Query: 1087 A---QLL-SYQLTQ 1096
A ++ Y + +
Sbjct: 444 ALHRSIVDHYNIPK 457
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 5e-12
Identities = 97/708 (13%), Positives = 187/708 (26%), Gaps = 228/708 (32%)
Query: 148 HDYTYPNVLLIINA-------VSDIVDETVVEIVLAGCSLNFHKRCVVKIPNNCSSGYKH 200
H Y Y ++L + D+ D + +L+ ++ ++ + S
Sbjct: 14 HQYQYKDILSVFEDAFVDNFDCKDVQDMP--KSILSKEEIDH----IIMSKDAVSGTL-- 65
Query: 201 RRSSTLHVPHSTSETGSNSSIA-----SDDSNYT--SSSFSTKPSSRSPSLTSRTDALSP 253
R TL + + NY S T+ S +
Sbjct: 66 RLFWTL-------LSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 254 TSPGAPSSVNIPHTFNLHTYTRP-TLCGLCKKLL-----KGLFKQGLQCKDCGFNVHKKC 307
N F + +R L + LL K + G+ G K
Sbjct: 119 LY-------NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV--LGSG----KTW 165
Query: 308 LDKVPKDCVGEPVTNNKSN--------NYCKLKSEVASLVSLESSASASYSCLVPKGEGR 359
+ C+ V N ++ + L L + P R
Sbjct: 166 V--ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL-------LYQIDPNWTSR 216
Query: 360 QDITNSELPQVKLCDFGFARIIGEKSFRRSILVALKHLHSKNIV-----HCD-LKPERNL 413
D +++ ++ R++ K + +LV L ++ + C L R
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV-LLNVQNAKAWNAFNLSCKILLTTRFK 275
Query: 414 FPTSSLEIKSNTEEEDEDEERGSTDGG---------GPSPRSEPRTATATPSNNIPLMRV 464
T L + T + T P+ PR T P
Sbjct: 276 QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT----NPR--R 329
Query: 465 VQSIKHTKRRGSKVIKEGWMIHYTSKDSMSSSFSTKPSSRSPSLTSRTDALSPTSPGA-- 522
+ I + R G + W + + D +++ + SL + L P
Sbjct: 330 LSIIAESIRDGLATW-DNWK--HVNCDKLTTIIES-------SL----NVLEPAEYRKMF 375
Query: 523 ------PSSVNIPHTFNLHTYTRPTLCGL--------CKKLLKGLFKQGL---QCKDCGF 565
P S +IP L + ++ L K L Q K+
Sbjct: 376 DRLSVFPPSAHIP---------TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
Query: 566 NVHKKCLDKVPKDCVGEPVTNNKSNNYCKLKSEVASLVSLESSASASYSCLVRSTSHCFI 625
++ Y +LK ++ + +L S Y+ + T
Sbjct: 427 SIP---------SI------------YLELKVKLENEYALHRSIVDHYN--IPKTFDSDD 463
Query: 626 LKTNNLD-Y---YVGEDTHSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKC 681
L LD Y ++G H L+
Sbjct: 464 LIPPYLDQYFYSHIGH--H-------------------------LKNIEH---------- 486
Query: 682 EDVSESEESRVTDMSQLYQISPDEVLGSGQFG------IVYGASMVGIFFLAALYEGVKY 735
R+T ++ D F + + + +K+
Sbjct: 487 -------PERMTLFRMVFL---D-------FRFLEQKIRHDSTAWNASGSILNTLQQLKF 529
Query: 736 YREYLFWKTYNDLHYRSIPAQQRISSVEEN--KDTAKVV--PVCDVLQ 779
Y+ Y+ ND Y ++ ++++ + K ++ D+L+
Sbjct: 530 YKPYI---CDNDPKY-----ERLVNAILDFLPKIEENLICSKYTDLLR 569
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 3e-08
Identities = 62/395 (15%), Positives = 113/395 (28%), Gaps = 110/395 (27%)
Query: 93 LGIEPCKPLTHELQQVQIRPHTLTVHSYKAPTFSLKTIIPNHGLTRLLDRLMLFRHDYTY 152
L ++ C L+ +Q + + + S + H + L RL+ + Y
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK---PY 243
Query: 153 PNVLLIINAVSDIVDETVVEIVLAGC-------------SLNFHKRCVVKIPNNCSSGYK 199
N LL++ ++ + C L+ + + ++ S
Sbjct: 244 ENCLLVL---LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL-DHHSMTLT 299
Query: 200 HRRSSTL----------HVPHSTSETG--SNSSIA---SDD----SNYTSSSFSTKPSSR 240
+L +P T S IA D N+ + +
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 241 SPSLTSRTDALSPTSPGA--------PSSVNIPHT------FNLHTY-TRPTLCGLCKKL 285
SL + L P P S +IP F++ + L K
Sbjct: 360 ESSL----NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415
Query: 286 LKGLFKQ---------GLQCK-----DCGFNVHKKCLDK--VPKDCVGEPVTNNKSNNYC 329
L + KQ + + + + +H+ +D +PK + + + Y
Sbjct: 416 L--VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY- 472
Query: 330 KLKSEVASLVSLESSASASYSCLVPKG----EGRQDITNSELPQVKLCDFGF--ARIIGE 383
YS + G + V L DF F +I +
Sbjct: 473 ------------------FYSHI---GHHLKNIEHPERMTLFRMVFL-DFRFLEQKIRHD 510
Query: 384 KS---FRRSILVALKHL--HSKNIVHCDLKPERNL 413
+ SIL L+ L + I D K ER +
Sbjct: 511 STAWNASGSILNTLQQLKFYKPYICDNDPKYERLV 545
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 1e-07
Identities = 86/631 (13%), Positives = 177/631 (28%), Gaps = 187/631 (29%)
Query: 546 CKKLLKGL---FKQGLQCKDCGFNVHKKCL-DKVPKDCVGEPVTNNKSNNYC---KLKSE 598
K +L F CKD ++ K L + + + S L S+
Sbjct: 18 YKDILSVFEDAFVDNFDCKDV-QDMPKSILSKEEIDHIIMSK--DAVSGTLRLFWTLLSK 74
Query: 599 VASLVS--LESSASASYSCLVRSTSHCFILKTNNLDYYVGEDTHSPSDGVETP---VTAP 653
+V +E +Y L+ + Y+ + +D V+
Sbjct: 75 QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRL 134
Query: 654 ESGLGARAWELSLRQALMPVQEPSGTKCEDVSESEESRVTDMSQLYQISPDEVLGSGQFG 713
+ L LRQAL ++ P + +
Sbjct: 135 QP-------YLKLRQAL----------------------------LELRPAKNV------ 153
Query: 714 IVYGASMVGI--FFLAA---LYEGVKYYREY-LFWKTY-------------NDLHYRSIP 754
++ G ++G ++A L V+ ++ +FW L Y+ P
Sbjct: 154 LIDG--VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 755 AQQRISSVEENKDTAKVVPVCDVLQKQPPSMLMLSMPHFIQTLLHVL------QITMSFL 808
+ D + + + + L+ S P+ LL VL + +F
Sbjct: 212 ------NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY-ENCLL-VLLNVQNAKAWNAFN 263
Query: 809 L---MLVFMTYNVALCIAVVAGAACGV---HRKSG------RGVAIKVIDKLRFPTKQEA 856
L +L+ T + + A + H + + +K +D +
Sbjct: 264 LSCKILL-TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC------RPQ 316
Query: 857 QLKNEVAILQNLCHPGVVNL--ERMFETPGRI--FVVMEKLQGDMLEMILSSEKGRLSER 912
L EV +P +++ E + + + + + D L I+ S L
Sbjct: 317 DLPREVL----TTNPRRLSIIAESIRDGLATWDNW---KHVNCDKLTTIIESSLNVLEPA 369
Query: 913 TTK--------F-----IITQILVAL-------------KHLHSKNIVHCDLKPENV--- 943
+ F I T +L + LH ++V K +
Sbjct: 370 EYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP 429
Query: 944 -----LLSTNSELPQV--KLCD-FGFARIIGEKSFPPEVLRNKGYN---------RSLDM 986
L + + D + + P L Y+ +
Sbjct: 430 SIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPER 489
Query: 987 WSVGVIVYVSLS--------GTFPFNEDEDINEQIQNAAFMY-------PPRPWRDISSD 1031
++ +V++ + +N I +Q F Y P+ R ++
Sbjct: 490 MTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF-YKPYICDNDPKYERLVN-- 546
Query: 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062
+++ L ++++ S L L
Sbjct: 547 --AILDFLPKIEENLICSKYTDLLRIALMAE 575
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 43/212 (20%), Positives = 82/212 (38%), Gaps = 31/212 (14%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL------ERMFETPGRIFVVMEKL 893
VA+K++ + + E A ++ HP V L R V++ +
Sbjct: 54 VAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFM 113
Query: 894 Q-GDMLEMILSS----EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
+ GD+ +L+S L +T + I +++L S+N +H DL N +L+ +
Sbjct: 114 KHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173
Query: 949 SELPQVKLCDFGFARIIGEKSF--------------PPEVLRNKGYNRSLDMWSVGVIVY 994
V + DFG +R I + E L + Y D+W+ GV ++
Sbjct: 174 M---TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMW 230
Query: 995 --VSLSGT-FPFNEDEDINEQIQNAAFMYPPR 1023
++ T + E+ +I + + P
Sbjct: 231 EIMTRGQTPYAGIENAEIYNYLIGGNRLKQPP 262
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 8/135 (5%)
Query: 831 GVHRKSGRGVAIKV-IDKLRFPTKQEAQLKNEVAILQNLCH-PGVVNLERMFETPGRIFV 888
G +G VAIK+ K + P QL E I + + G+ + +
Sbjct: 28 GTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
VME L G LE + + + S +T + Q++ ++++HSKN +H D+KP+N L+
Sbjct: 83 VME-LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG 141
Query: 949 SELPQVKLCDFGFAR 963
+ V + DFG A+
Sbjct: 142 KKGNLVYIIDFGLAK 156
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 830 CGVHRKSGRGVAIKV-IDKLRFPTKQEAQLKNEVAILQNLCH-PGVVNLERMFETPGRIF 887
G + + VAIK+ K R P QL E + L G+ +
Sbjct: 27 LGKNLYTNEYVAIKLEPMKSRAP-----QLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+V+E L G LE + S +T I Q++ ++++HSKN+++ D+KPEN L+
Sbjct: 82 MVLE-LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR 140
Query: 948 --NSELPQVKLCDFGFAR 963
N + + DF A+
Sbjct: 141 PGNKTQQVIHIIDFALAK 158
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 43/205 (20%), Positives = 81/205 (39%), Gaps = 26/205 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLE-RMFETPGRIFVVMEKLQ-GDM 897
AIK + +Q E +++ L HP V+ L M G V++ + GD+
Sbjct: 52 CAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL 110
Query: 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957
L+ + S + + + Q+ +++L + VH DL N +L + VK+
Sbjct: 111 LQF-IRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF---TVKVA 166
Query: 958 DFGFARIIGEKS-----------FP-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSG 999
DFG AR I ++ P E L+ + D+WS GV+++ ++
Sbjct: 167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA 226
Query: 1000 T-FPFNEDEDINEQIQNAAFMYPPR 1023
+ + D+ + + P
Sbjct: 227 PPYRHIDPFDLTHFLAQGRRLPQPE 251
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 46/205 (22%), Positives = 82/205 (40%), Gaps = 26/205 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLE-RMFETPGRIFVVMEKLQ-GDM 897
A+K + + +Q E I+++ HP V++L + G VV+ ++ GD+
Sbjct: 120 CAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178
Query: 898 LEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957
+ +E + + Q+ +K L SK VH DL N +L VK+
Sbjct: 179 RNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF---TVKVA 234
Query: 958 DFGFARIIGEKSF----------------PPEVLRNKGYNRSLDMWSVGVIVY--VSLSG 999
DFG AR + +K F E L+ + + D+WS GV+++ ++
Sbjct: 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 294
Query: 1000 T-FPFNEDEDINEQIQNAAFMYPPR 1023
+P DI + + P
Sbjct: 295 PPYPDVNTFDITVYLLQGRRLLQPE 319
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 47/224 (20%), Positives = 82/224 (36%), Gaps = 25/224 (11%)
Query: 824 VVAGAACGVHRKSGR-GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET 882
V G G+ VA+K + + E E I+ H +V +
Sbjct: 46 VYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104
Query: 883 PGRIFVVMEKLQ-GDMLEMILSS-----EKGRLSERTTKFIITQILVALKHLHSKNIVHC 936
F++ME + GD+ + + + L+ + I ++L + +H
Sbjct: 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR 164
Query: 937 DLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSFP-----PEVLRNKGYNR 982
D+ N LL+ K+ DFG AR I G P PE +
Sbjct: 165 DIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTS 224
Query: 983 SLDMWSVGVIVY--VSLSGT-FPFNEDEDINEQIQNAAFMYPPR 1023
D WS GV+++ SL +P ++++ E + + M PP+
Sbjct: 225 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 268
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 44/202 (21%), Positives = 88/202 (43%), Gaps = 25/202 (12%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ-GDML 898
VA+K++ + +L E ++Q L +P +V + + E +VME + G +
Sbjct: 47 VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLN 105
Query: 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958
+ + + + ++ ++ Q+ + +K+L N VH DL NVLL T K+ D
Sbjct: 106 KYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISD 160
Query: 959 FGFARIIGEKS----------FP-----PEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFP 1002
FG ++ + +P PE + ++ D+WS GV+++ + S G P
Sbjct: 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
Query: 1003 FNE--DEDINEQIQNAAFMYPP 1022
+ ++ ++ M P
Sbjct: 221 YRGMKGSEVTAMLEKGERMGCP 242
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 30/152 (19%), Positives = 56/152 (36%), Gaps = 25/152 (16%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI---- 886
A V+ + ++ L +E+ Q + + + +
Sbjct: 56 AFPTNKPEKDARHVV---KVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112
Query: 887 ---------------FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK 931
F+VME+L G L+ I + G + T + ++L L+++H
Sbjct: 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISG-QNGTFKKSTVLQLGIRMLDVLEYIHEN 170
Query: 932 NIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963
VH D+K N+LL + QV L D+G +
Sbjct: 171 EYVHGDIKAANLLLGYKNP-DQVYLADYGLSY 201
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 46/224 (20%), Positives = 82/224 (36%), Gaps = 25/224 (11%)
Query: 824 VVAGAACGVHRKSGR-GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET 882
V G G+ VA+K + + E E I+ H +V +
Sbjct: 87 VYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145
Query: 883 PGRIFVVMEKLQ-GDMLEMILSS-----EKGRLSERTTKFIITQILVALKHLHSKNIVHC 936
F+++E + GD+ + + + L+ + I ++L + +H
Sbjct: 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR 205
Query: 937 DLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSFP-----PEVLRNKGYNR 982
D+ N LL+ K+ DFG AR I G P PE +
Sbjct: 206 DIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTS 265
Query: 983 SLDMWSVGVIVY--VSLSGT-FPFNEDEDINEQIQNAAFMYPPR 1023
D WS GV+++ SL +P ++++ E + + M PP+
Sbjct: 266 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 309
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 31/151 (20%), Positives = 53/151 (35%), Gaps = 21/151 (13%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI----- 886
S V ++ L E+ Q P + +
Sbjct: 54 ADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113
Query: 887 --------------FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN 932
F++M++ G L+ I + R S +T + +IL L+++H
Sbjct: 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE 172
Query: 933 IVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963
VH D+K N+LL+ + QV L D+G A
Sbjct: 173 YVHGDIKASNLLLNYKNP-DQVYLVDYGLAY 202
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 33/137 (24%), Positives = 63/137 (45%), Gaps = 10/137 (7%)
Query: 831 GVHRKSGRGVAIKV-IDKLRFPTKQEAQLKNEVAILQNLCH-PGVVNLERMFETPGRIFV 888
G + + + VAIK + P QL++E + L G+ N+ + +
Sbjct: 29 GTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL--S 946
V++ L G LE +L + S +T Q+L ++ +H K++V+ D+KP+N L+
Sbjct: 84 VID-LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP 142
Query: 947 TNSELPQVKLCDFGFAR 963
+ + + DFG +
Sbjct: 143 NSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 8/135 (5%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEA-QLKNEVAILQNL-CHPGVVNLERMFETPGRIFV 888
G + ++ VAIK+ K + QL E I + L G+ N+ +
Sbjct: 26 GTNIQTNEEVAIKLE-----NVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
VM+ L G LE + + +LS +T + Q++ ++ +HSK+ +H D+KP+N L+
Sbjct: 81 VMD-LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139
Query: 949 SELPQVKLCDFGFAR 963
QV + DFG A+
Sbjct: 140 RRANQVYIIDFGLAK 154
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 48/227 (21%), Positives = 88/227 (38%), Gaps = 31/227 (13%)
Query: 824 VVAGAACGVHRKSGRG-VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET 882
V G A GV + VAIK + ++ + NE ++++ VV L +
Sbjct: 41 VYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99
Query: 883 PGRIFVVMEKLQ-GDMLE--------MILSSEKGRLSERTTKFIITQILVALKHLHSKNI 933
V+ME + GD+ M + S + +I + +L++
Sbjct: 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF 159
Query: 934 VHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSFP-----PEVLRNKG 979
VH DL N +++ + VK+ DFG R I G+ P PE L++
Sbjct: 160 VHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 216
Query: 980 YNRSLDMWSVGVIVY--VSLSGT-FPFNEDEDINEQIQNAAFMYPPR 1023
+ D+WS GV+++ +L+ + +E + + + P
Sbjct: 217 FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 263
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 35/141 (24%), Positives = 58/141 (41%), Gaps = 26/141 (18%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI------------- 886
++K+ ++ +L NE Q P VN + + +
Sbjct: 78 FSLKL-------DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQD 130
Query: 887 ---FVVMEKLQGDMLEMIL-SSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
F+V+ L G L+ L S K LSER+ + ++L AL+ LH VH ++ EN
Sbjct: 131 KYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189
Query: 943 VLLSTNSELPQVKLCDFGFAR 963
+ + + QV L +GFA
Sbjct: 190 IFVDPEDQ-SQVTLAGYGFAF 209
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 56/214 (26%), Positives = 85/214 (39%), Gaps = 40/214 (18%)
Query: 824 VVAGAACGVHRKSGR-GVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFE 881
VV A G+ + VA+K++ K + L +E+ +L L H +VNL
Sbjct: 39 VVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97
Query: 882 TPGRIFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIIT----------------QILVA 924
G V+ E GD+L + + +T+ I+ Q+
Sbjct: 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157
Query: 925 LKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSF-------------- 970
+ L SKN +H DL N+LL+ K+CDFG AR I S
Sbjct: 158 MAFLASKNCIHRDLAARNILLTHGRI---TKICDFGLARDIKNDSNYVVKGNARLPVKWM 214
Query: 971 PPEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFP 1002
PE + N Y D+WS G+ ++ SL G+ P
Sbjct: 215 APESIFNCVYTFESDVWSYGIFLWELFSL-GSSP 247
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 35/208 (16%)
Query: 824 VVAGAACGVHRKSG-RGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFE 881
VV A G+ ++ VA+K++ K ++ L +E+ I+ +L H +VNL
Sbjct: 62 VVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120
Query: 882 TPGRIFVVMEKLQ-GDMLE------------MILSSEKGRLSERTTKFIITQILVALKHL 928
G + V+ E GD+L + S R +Q+ + L
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL 180
Query: 929 HSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSFP-----PEV 974
SKN +H D+ NVLL+ K+ DFG AR I G P PE
Sbjct: 181 ASKNCIHRDVAARNVLLTNGHV---AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPES 237
Query: 975 LRNKGYNRSLDMWSVGVIVY--VSLSGT 1000
+ + Y D+WS G++++ SL
Sbjct: 238 IFDCVYTVQSDVWSYGILLWEIFSLGLN 265
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 54/235 (22%), Positives = 88/235 (37%), Gaps = 42/235 (17%)
Query: 824 VVAGAACGVHRKSGR-GVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFE 881
V + + VA+K L+ PT + E +L NL H +V +
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKA---LKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG 87
Query: 882 TPGRIFVVMEKL-QGDMLE--------------MILSSEKGRLSERTTKFIITQILVALK 926
+ +V E + GD+ + KG L I +QI +
Sbjct: 88 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMV 147
Query: 927 HLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSFP-----P 972
+L S++ VH DL N L+ N VK+ DFG +R + G P P
Sbjct: 148 YLASQHFVHRDLATRNCLVGANL---LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 204
Query: 973 EVLRNKGYNRSLDMWSVGVIVY--VSLSGTFPFN--EDEDINEQIQNAAFMYPPR 1023
E + + + D+WS GVI++ + G P+ + ++ E I + PR
Sbjct: 205 ESIMYRKFTTESDVWSFGVILWEIFTY-GKQPWFQLSNTEVIECITQGRVLERPR 258
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 47/218 (21%)
Query: 824 VVAGAACGVHRKSG-RGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNL----- 876
V+ A G+ + + R VA+K++ K + L +E+ IL ++ H VVNL
Sbjct: 43 VIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101
Query: 877 ERMFETPGRIFVVMEKLQ-GDMLE--------------MILSSEKGRLSERTTKFIITQI 921
+ P + V++E + G++ K L+ Q+
Sbjct: 102 KP--GGP--LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 157
Query: 922 LVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSFP- 971
++ L S+ +H DL N+LLS + VK+CDFG AR I G+ P
Sbjct: 158 AKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLARDIYKDPDYVRKGDARLPL 214
Query: 972 ----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFPF 1003
PE + ++ Y D+WS GV+++ SL G P+
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-GASPY 251
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 45/234 (19%), Positives = 84/234 (35%), Gaps = 41/234 (17%)
Query: 824 VVAGAACGVHRKSGR-GVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFE 881
V + + + VA+K L+ ++ + E +L L H +V +
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKA---LKEASESARQDFQREAELLTMLQHQHIVRFFGVCT 113
Query: 882 TPGRIFVVMEKLQ-GDMLE-------------MILSSEKGRLSERTTKFIITQILVALKH 927
+ +V E ++ GD+ G L + +Q+ + +
Sbjct: 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173
Query: 928 LHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSFP-----PE 973
L + VH DL N L+ VK+ DFG +R I G P PE
Sbjct: 174 LAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 230
Query: 974 VLRNKGYNRSLDMWSVGVIVY--VSLSGTFPFNE--DEDINEQIQNAAFMYPPR 1023
+ + + D+WS GV+++ + G P+ + + + + I + PR
Sbjct: 231 SILYRKFTTESDVWSFGVVLWEIFTY-GKQPWYQLSNTEAIDCITQGRELERPR 283
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 37/204 (18%)
Query: 824 VVAGAACGVHRKSGRG---VAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERM 879
VV A G+ + VA+K++ K K + L +E+ +++ + H ++NL
Sbjct: 85 VVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143
Query: 880 FETPGRIFVVMEKLQ-GDMLEMILSS--------------EKGRLSERTTKFIITQILVA 924
G ++V++E G++ E + + + +LS + Q+
Sbjct: 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 203
Query: 925 LKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSFP---- 971
+++L SK +H DL NVL++ ++ +K+ DFG AR I P
Sbjct: 204 MEYLASKKCIHRDLAARNVLVTEDNV---MKIADFGLARDIHHIDYYKKTTNGRLPVKWM 260
Query: 972 -PEVLRNKGYNRSLDMWSVGVIVY 994
PE L ++ Y D+WS GV+++
Sbjct: 261 APEALFDRIYTHQSDVWSFGVLLW 284
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 40/214 (18%)
Query: 824 VVAGAACGVHRKSGRG---VAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERM 879
VV A G+ + + VA+K++ K K + L +E+ +++ + H ++NL
Sbjct: 51 VVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109
Query: 880 FETPGRIFVVMEKLQ-GDMLE--------------MILSSEKGRLSERTTKFIITQILVA 924
G ++V++E G++ E I + +++ + Q+
Sbjct: 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 169
Query: 925 LKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSFP---- 971
+++L S+ +H DL NVL++ N+ +K+ DFG AR I P
Sbjct: 170 MEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLARDINNIDYYKKTTNGRLPVKWM 226
Query: 972 -PEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFP 1002
PE L ++ Y D+WS GV+++ +L G P
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEIFTL-GGSP 259
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 51/233 (21%), Positives = 86/233 (36%), Gaps = 37/233 (15%)
Query: 824 VVAGAACGVHRKSGRG-VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET 882
V G G VAIK + K + + ++E + L HP VV L +
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 83
Query: 883 PGRIFVVMEKLQ-GDMLE--------------MILSSEKGRLSERTTKFIITQILVALKH 927
+ ++ GD+ E + K L ++ QI +++
Sbjct: 84 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEY 143
Query: 928 LHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSFP-----PE 973
L S ++VH DL NVL+ VK+ D G R + G P PE
Sbjct: 144 LSSHHVVHKDLATRNVLVYDKL---NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE 200
Query: 974 VLRNKGYNRSLDMWSVGVIVY--VSLSGT-FPFNEDEDINEQIQNAAFMYPPR 1023
+ ++ D+WS GV+++ S + ++D+ E I+N + P
Sbjct: 201 AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPD 253
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 49/215 (22%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 824 VVAGAACGVHRKSGRG---VAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERM 879
VV A G+ + + VA+K++ K K + L +E+ +++ + H ++NL
Sbjct: 97 VVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155
Query: 880 FETPGRIFVVMEKLQ-GDMLEMILSS--------------EKGRLSERTTKFIITQILVA 924
G ++V++E G++ E + + + +++ + Q+
Sbjct: 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215
Query: 925 LKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSFP---- 971
+++L S+ +H DL NVL++ N+ +K+ DFG AR I P
Sbjct: 216 MEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLARDINNIDYYKKTTNGRLPVKWM 272
Query: 972 -PEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFPF 1003
PE L ++ Y D+WS GV+++ +L G P+
Sbjct: 273 APEALFDRVYTHQSDVWSFGVLMWEIFTL-GGSPY 306
|
| >2vrw_B P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP-binding, metal-binding, phosphoprotein, exchange factor, RAC, GTPase, membrane domain; 1.85A {Mus musculus} PDB: 3bji_A 1f5x_A Length = 406 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 19/48 (39%), Positives = 27/48 (56%)
Query: 266 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK 313
H F + ++ T C C+ LL+G F QG +C C HK+CL +VP
Sbjct: 347 HDFQMFSFEETTSCKACQMLLRGTFYQGYRCYRCRAPAHKECLGRVPP 394
|
| >2vrw_B P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP-binding, metal-binding, phosphoprotein, exchange factor, RAC, GTPase, membrane domain; 1.85A {Mus musculus} PDB: 3bji_A 1f5x_A Length = 406 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 19/48 (39%), Positives = 27/48 (56%)
Query: 530 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK 577
H F + ++ T C C+ LL+G F QG +C C HK+CL +VP
Sbjct: 347 HDFQMFSFEETTSCKACQMLLRGTFYQGYRCYRCRAPAHKECLGRVPP 394
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 9e-10
Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 44/217 (20%)
Query: 824 VVAGAACGVHRKSGR-GVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFE 881
V+ A G+ + VA+K++ K + + + L +E+ ++ L H +VNL
Sbjct: 61 VMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119
Query: 882 TPGRIFVVMEKLQ-GDMLE------------MILSSEKGRLSERTTKFIIT--------- 919
G I+++ E GD+L I + RL E ++T
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179
Query: 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSF 970
Q+ ++ L K+ VH DL NVL++ VK+CDFG AR I G
Sbjct: 180 QVAKGMEFLEFKSCVHRDLAARNVLVTHGKV---VKICDFGLARDIMSDSNYVVRGNARL 236
Query: 971 P-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGT 1000
P PE L Y D+WS G++++ SL
Sbjct: 237 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 9e-10
Identities = 47/220 (21%), Positives = 88/220 (40%), Gaps = 45/220 (20%)
Query: 824 VVAGAACGVHRKSG-RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET 882
VV A + ++G VA+K++ K + L +E +L+ + HP V+ L
Sbjct: 39 VVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97
Query: 883 PGRIFVVMEKLQ-GDMLE-------------MILSSEKGRLSERTTKFIIT--------- 919
G + +++E + G + S + + +T
Sbjct: 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAW 157
Query: 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSF 970
QI +++L +VH DL N+L++ + +K+ DFG +R + +
Sbjct: 158 QISQGMQYLAEMKLVHRDLAARNILVAEGRK---MKISDFGLSRDVYEEDSYVKRSQGRI 214
Query: 971 P-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGTFPF 1003
P E L + Y D+WS GV+++ V+L G P+
Sbjct: 215 PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL-GGNPY 253
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 47/190 (24%), Positives = 72/190 (37%), Gaps = 33/190 (17%)
Query: 840 VAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVME------- 891
AIK + K E+ +L L HP ++NL E G +++ +E
Sbjct: 55 AAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 113
Query: 892 --------KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943
L+ D I +S LS + + + +L K +H DL N+
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 173
Query: 944 LLSTNSELPQVKLCDFGFARII------GEKSFP-----PEVLRNKGYNRSLDMWSVGVI 992
L+ N K+ DFG +R P E L Y + D+WS GV+
Sbjct: 174 LVGENYV---AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 230
Query: 993 VY--VSLSGT 1000
++ VSL GT
Sbjct: 231 LWEIVSLGGT 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 39/146 (26%), Positives = 62/146 (42%), Gaps = 23/146 (15%)
Query: 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVK 955
+ E K L+ Q+ ++ L S+ +H DL N+LLS + VK
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVK 233
Query: 956 LCDFGFARIIGE--------------KSFPPEVLRNKGYNRSLDMWSVGVIVY--VSLSG 999
+CDFG AR I + K PE + ++ Y D+WS GV+++ SL G
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-G 292
Query: 1000 TFPF---NEDEDINEQIQNAAFMYPP 1022
P+ DE+ +++ M P
Sbjct: 293 ASPYPGVKIDEEFCRRLKEGTRMRAP 318
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 49/241 (20%), Positives = 87/241 (36%), Gaps = 45/241 (18%)
Query: 824 VVAGAACGVHRKSGR-GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET 882
V A G+ VA+K++ K +A + E A++ +P +V L +
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121
Query: 883 PGRIFVVMEKLQ-GDMLE----------------------MILSSEKGRLSERTTKFIIT 919
+ ++ E + GD+ E + S LS I
Sbjct: 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 181
Query: 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---------GEKSF 970
Q+ + +L + VH DL N L+ N VK+ DFG +R I G +
Sbjct: 182 QVAAGMAYLSERKFVHRDLATRNCLVGENM---VVKIADFGLSRNIYSADYYKADGNDAI 238
Query: 971 P-----PEVLRNKGYNRSLDMWSVGVIVY--VSLSGT-FPFNEDEDINEQIQNAAFMYPP 1022
P PE + Y D+W+ GV+++ S + E++ +++ + P
Sbjct: 239 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACP 298
Query: 1023 R 1023
Sbjct: 299 E 299
|
| >3ky9_A Proto-oncogene VAV; calponin homology domain, DBL homology domain, pleckst homology domain, C1 domain, guanine-nucleotide releasing FA metal-binding; 2.73A {Homo sapiens} PDB: 2d86_A Length = 587 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 8e-09
Identities = 19/49 (38%), Positives = 28/49 (57%)
Query: 265 PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK 313
H F + ++ T C C+ LL+G F QG +C C + HK+CL +VP
Sbjct: 518 GHDFQMFSFEETTSCKACQMLLRGTFYQGYRCHRCRASAHKECLGRVPP 566
|
| >3ky9_A Proto-oncogene VAV; calponin homology domain, DBL homology domain, pleckst homology domain, C1 domain, guanine-nucleotide releasing FA metal-binding; 2.73A {Homo sapiens} PDB: 2d86_A Length = 587 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 8e-09
Identities = 19/49 (38%), Positives = 28/49 (57%)
Query: 529 PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK 577
H F + ++ T C C+ LL+G F QG +C C + HK+CL +VP
Sbjct: 518 GHDFQMFSFEETTSCKACQMLLRGTFYQGYRCHRCRASAHKECLGRVPP 566
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 41/189 (21%), Positives = 70/189 (37%), Gaps = 38/189 (20%)
Query: 837 GRGVAIKVIDKLRFPT-KQ-EAQLKNEVAILQNLCHPGVVNL--------ERMFETPGRI 886
VA+K + + T ++ + Q E+ ++ H +V L +
Sbjct: 54 NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLC------- 106
Query: 887 FVVMEKLQGDMLEMILSSEKGR--LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944
+V + L LS G LS I + LH + +H D+K N+L
Sbjct: 107 -LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL 165
Query: 945 LSTNSELPQVKLCDFGFARI--IGEKS------------FPPEVLRNKGYNRSLDMWSVG 990
L K+ DFG AR ++ PE LR + +S D++S G
Sbjct: 166 LDEAFT---AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKS-DIYSFG 221
Query: 991 VIVYVSLSG 999
V++ ++G
Sbjct: 222 VVLLEIITG 230
|
| >2ls3_A High affinity copper uptake protein 1; HCTR1 TMDS, oligomerization, metal transport; NMR {Homo sapiens} Length = 29 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-07
Identities = 15/26 (57%), Positives = 23/26 (88%)
Query: 792 HFIQTLLHVLQITMSFLLMLVFMTYN 817
H +QT+LH++Q+ +S+ LML+FMTYN
Sbjct: 2 HLLQTVLHIIQVVISYFLMLIFMTYN 27
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 7e-07
Identities = 35/156 (22%), Positives = 59/156 (37%), Gaps = 33/156 (21%)
Query: 832 VHR---KSGRGVAIKVIDKLRFPTKQ--EAQLKNEVAILQNLCHPGVVNL--------ER 878
V++ G VA+K +L+ Q E Q + EV ++ H ++ L ER
Sbjct: 46 VYKGRLADGTLVAVK---RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102
Query: 879 MFETPGRIFVVMEKLQGDMLEMIL---SSEKGRLSERTTKFIITQILVALKHLHSK---N 932
+ +V + + L + L + I L +LH
Sbjct: 103 L--------LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154
Query: 933 IVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK 968
I+H D+K N+LL E + DFG A+++ K
Sbjct: 155 IIHRDVKAANILLDEEFE---AVVGDFGLAKLMDYK 187
|
| >1kbe_A Kinase suppressor of RAS; KSR, cysteine-rich domain, zinc- binding protein, signaling protein; NMR {Mus musculus} SCOP: g.49.1.1 PDB: 1kbf_A Length = 49 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 9e-07
Identities = 13/50 (26%), Positives = 24/50 (48%), Gaps = 5/50 (10%)
Query: 264 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK 313
+ H F+ ++ +C +C+K + G++CK C H KC + P
Sbjct: 3 VTHRFSTKSWL-SQVCNVCQKSMI----FGVKCKHCRLKCHNKCTKEAPA 47
|
| >1kbe_A Kinase suppressor of RAS; KSR, cysteine-rich domain, zinc- binding protein, signaling protein; NMR {Mus musculus} SCOP: g.49.1.1 PDB: 1kbf_A Length = 49 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 9e-07
Identities = 13/50 (26%), Positives = 24/50 (48%), Gaps = 5/50 (10%)
Query: 528 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK 577
+ H F+ ++ +C +C+K + G++CK C H KC + P
Sbjct: 3 VTHRFSTKSWL-SQVCNVCQKSMI----FGVKCKHCRLKCHNKCTKEAPA 47
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 5e-06
Identities = 36/207 (17%), Positives = 56/207 (27%), Gaps = 52/207 (25%)
Query: 834 RKSGRGVAIKVI------DKLRFPTKQEAQLKNEVAILQNLC---------HPGVVNLER 878
VAIK+I K ++ E+ I + L G + L
Sbjct: 40 IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99
Query: 879 MFETPGR------------------------------IFVVMEKLQGDMLEMILSSEKGR 908
+ G +F+V+E G + +
Sbjct: 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID--LEQMRTKL 157
Query: 909 LSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE 967
S T K I+ Q+ +L + H DL NVLL + KL +
Sbjct: 158 SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL---KKTSLKKLHYTLNGKSSTI 214
Query: 968 KSFPPEVLRNKGYNRSLDMWSVGVIVY 994
S +V Y S V+
Sbjct: 215 PSCGLQVSIID-YTLSRLERDGIVVFC 240
|
| >1r79_A Diacylglycerol kinase, delta; C1 domain, cystein-rich zinc binding domain, structural genomics, riken structural genomics/proteomics initiative; NMR {Homo sapiens} SCOP: g.49.1.1 Length = 84 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 4e-05
Identities = 15/63 (23%), Positives = 25/63 (39%), Gaps = 7/63 (11%)
Query: 259 PSSVNIPHTF---NLHTYTRPTLCGLCKKLLKGLFK-QGLQCKDCGFNVHKKCLDKVPKD 314
+ +PH + NL + C +C K + + Q +C C VH C + +
Sbjct: 21 ADGIAMPHQWLEGNLPVSAK---CTVCDKTCGSVLRLQDWRCLWCKAMVHTSCKESLLTK 77
Query: 315 CVG 317
C G
Sbjct: 78 CSG 80
|
| >1r79_A Diacylglycerol kinase, delta; C1 domain, cystein-rich zinc binding domain, structural genomics, riken structural genomics/proteomics initiative; NMR {Homo sapiens} SCOP: g.49.1.1 Length = 84 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 4e-05
Identities = 15/63 (23%), Positives = 25/63 (39%), Gaps = 7/63 (11%)
Query: 523 PSSVNIPHTF---NLHTYTRPTLCGLCKKLLKGLFK-QGLQCKDCGFNVHKKCLDKVPKD 578
+ +PH + NL + C +C K + + Q +C C VH C + +
Sbjct: 21 ADGIAMPHQWLEGNLPVSAK---CTVCDKTCGSVLRLQDWRCLWCKAMVHTSCKESLLTK 77
Query: 579 CVG 581
C G
Sbjct: 78 CSG 80
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1098 | |||
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.65 | |
| 2enz_A | 65 | NPKC-theta, protein kinase C theta type; zinc bind | 99.63 | |
| 2enz_A | 65 | NPKC-theta, protein kinase C theta type; zinc bind | 99.6 | |
| 1ptq_A | 50 | Protein kinase C delta type; phosphotransferase; 1 | 99.56 | |
| 2db6_A | 74 | SH3 and cysteine rich domain 3; STAC3, C1 domain, | 99.54 | |
| 2enn_A | 77 | NPKC-theta, protein kinase C theta type; zinc bind | 99.54 | |
| 1y8f_A | 66 | UNC-13 homolog A, MUNC13-1; cysteine-rich domain, | 99.53 | |
| 2eli_A | 85 | Protein kinase C alpha type; PKC-alpha, PKC-A, str | 99.53 | |
| 2eli_A | 85 | Protein kinase C alpha type; PKC-alpha, PKC-A, str | 99.53 | |
| 1ptq_A | 50 | Protein kinase C delta type; phosphotransferase; 1 | 99.51 | |
| 2yuu_A | 83 | NPKC-delta, protein kinase C delta type; metal bin | 99.51 | |
| 2row_A | 84 | RHO-associated protein kinase 2; ATP-binding, coil | 99.51 | |
| 1y8f_A | 66 | UNC-13 homolog A, MUNC13-1; cysteine-rich domain, | 99.51 | |
| 2db6_A | 74 | SH3 and cysteine rich domain 3; STAC3, C1 domain, | 99.5 | |
| 3uej_A | 65 | NPKC-delta, protein kinase C delta type; proteine | 99.5 | |
| 2row_A | 84 | RHO-associated protein kinase 2; ATP-binding, coil | 99.48 | |
| 3uej_A | 65 | NPKC-delta, protein kinase C delta type; proteine | 99.47 | |
| 2enn_A | 77 | NPKC-theta, protein kinase C theta type; zinc bind | 99.46 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.46 | |
| 2yuu_A | 83 | NPKC-delta, protein kinase C delta type; metal bin | 99.45 | |
| 1rfh_A | 59 | RAS association (ralgds/AF-6) domain family 5; zin | 99.43 | |
| 2fnf_X | 72 | Putative RAS effector NORE1; zinc, signal transduc | 99.43 | |
| 1rfh_A | 59 | RAS association (ralgds/AF-6) domain family 5; zin | 99.43 | |
| 2fnf_X | 72 | Putative RAS effector NORE1; zinc, signal transduc | 99.38 | |
| 1faq_A | 52 | RAF-1; transferase, serine/threonine-protein kinas | 99.33 | |
| 1faq_A | 52 | RAF-1; transferase, serine/threonine-protein kinas | 99.28 | |
| 4b6d_A | 61 | RAC GTPase-activating protein 1; signaling protein | 99.24 | |
| 4b6d_A | 61 | RAC GTPase-activating protein 1; signaling protein | 99.24 | |
| 1kbe_A | 49 | Kinase suppressor of RAS; KSR, cysteine-rich domai | 99.16 | |
| 1kbe_A | 49 | Kinase suppressor of RAS; KSR, cysteine-rich domai | 99.14 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 98.93 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 98.91 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 98.89 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 98.83 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.82 | |
| 2vrw_B | 406 | P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP | 98.82 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 98.8 | |
| 3ky9_A | 587 | Proto-oncogene VAV; calponin homology domain, DBL | 98.8 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 98.79 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 98.78 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 98.77 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 98.76 | |
| 2vrw_B | 406 | P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP | 98.76 | |
| 2d9z_A | 129 | Protein kinase C, NU type; PH domain, structural g | 98.74 | |
| 3ky9_A | 587 | Proto-oncogene VAV; calponin homology domain, DBL | 98.71 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 98.7 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 98.69 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 98.67 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 98.64 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 98.63 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.6 | |
| 2coa_A | 125 | Protein kinase C, D2 type; protein kinase D2, PH d | 98.6 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.53 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 98.52 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 98.52 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 98.51 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 98.49 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 98.47 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 98.47 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 98.45 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 98.45 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 98.44 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 98.43 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 98.41 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 98.37 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 98.37 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 98.36 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 98.36 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 98.35 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 98.33 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 98.33 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 98.28 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 98.25 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.24 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.21 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 98.16 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 98.14 | |
| 1r79_A | 84 | Diacylglycerol kinase, delta; C1 domain, cystein-r | 98.11 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 98.11 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 98.11 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 98.11 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 98.11 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 98.09 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 98.09 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 98.08 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 98.05 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 98.04 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 98.03 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.03 | |
| 3rdl_A | 137 | Protein kinase C alpha type; protein kinase PKC, t | 98.02 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 98.01 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 98.01 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 98.01 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 98.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 98.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 98.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 98.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 98.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 98.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 97.99 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 97.99 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 97.98 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 97.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 97.96 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 97.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 97.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 97.95 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 97.95 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 97.95 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 97.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 97.94 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 97.94 | |
| 1a25_A | 149 | CALB, protein kinase C (beta); calcium++/phospholi | 97.94 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 97.93 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 97.93 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 97.92 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 97.91 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 97.91 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 97.91 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 97.91 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 97.91 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 97.91 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 97.91 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 97.91 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 97.9 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 97.9 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 97.9 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 97.89 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 97.89 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 97.88 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 97.88 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 97.88 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 97.86 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 97.86 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 97.85 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 97.85 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 97.85 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 97.85 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 97.85 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 97.84 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 97.84 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 97.83 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 97.83 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 97.82 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 97.82 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 97.82 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 97.82 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 97.82 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 97.81 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 97.81 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 97.8 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 97.8 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 97.8 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 97.79 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 97.79 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 97.79 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 97.79 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 97.79 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 97.79 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 97.78 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 97.78 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 97.77 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 97.77 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 97.77 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 97.77 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 97.77 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 97.76 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 97.76 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 97.76 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 97.75 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 97.75 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 97.75 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 97.75 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 97.75 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 97.74 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 97.74 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 97.74 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 97.73 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 97.73 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 97.73 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 97.73 | |
| 1r79_A | 84 | Diacylglycerol kinase, delta; C1 domain, cystein-r | 97.72 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 97.72 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 97.72 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 97.72 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 97.71 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 97.71 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 97.71 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 97.71 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 97.71 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 97.7 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 97.7 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 97.7 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 97.7 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 97.7 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 97.69 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 97.69 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 97.69 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 97.69 | |
| 3fbk_A | 153 | RGS3, RGP3, regulator of G-protein signaling 3; al | 97.69 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 97.69 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.69 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 97.67 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 97.65 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 97.65 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 97.65 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 97.65 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 97.64 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 97.64 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 97.64 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 97.64 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 97.64 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 97.64 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 97.63 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 97.63 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 97.62 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 97.62 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 97.62 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 97.62 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 97.61 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 97.61 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 97.61 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 97.61 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 97.61 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 97.6 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 97.59 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 97.59 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 97.59 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 97.59 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 97.59 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 97.59 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 97.59 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 97.58 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 97.58 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 97.57 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 97.57 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 97.57 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 97.56 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 97.54 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 97.53 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 97.51 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 97.51 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 97.51 | |
| 1v27_A | 141 | Regulating synaptic membrane exocytosis protein 2; | 97.51 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 97.51 |
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-80 Score=765.51 Aligned_cols=495 Identities=24% Similarity=0.380 Sum_probs=377.3
Q ss_pred cCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCCCccCCCCccchhhhhhHhhccccCC
Q psy48 528 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPVTNNKSNNYCKLKSEVASLVSLES 607 (1098)
Q Consensus 528 ~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 607 (1098)
++|+|..++|..++||++|+++|||+.+|||+|.+|+++||++|...|+..|+.+....++.-.+.. .++
T Consensus 101 ~~h~~~~~~~~~~~~C~~C~~~l~g~~~qg~~C~~C~~~~H~~C~~~v~~~C~~d~~~~~g~i~~~~---------~~~- 170 (674)
T 3pfq_A 101 SKHKFKIHTYSSPTFCDHCGSLLYGLIHQGMKCDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQA---------HID- 170 (674)
T ss_dssp -CCCCCEECCSSCCCCSSSCSCCBBSSSCEECCSSSCCCBCSSTTSSSCCCSSSCSSCCSCEEEEEE---------EEC-
T ss_pred CCcceeecCCCCCCCCCccccccchhhcCccccccCCcchhhhhhhccCcccccccccccccccccc---------eec-
Confidence 4799999999999999999999999999999999999999999999999999987644332100000 000
Q ss_pred CccccccccccCCcceeeecccCccccccCCCCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCcc
Q psy48 608 SASASYSCLVRSTSHCFILKTNNLDYYVGEDTHSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSES 687 (1098)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~ 687 (1098)
.......+..+.++. ..+..+.+|||++....+......+.+|++.+.+++|+|++.+.+.....+.
T Consensus 171 ----------~~~L~V~v~~a~~L~---~~d~~g~sDPyvkv~l~p~~~~~~k~kT~v~~~tlnP~wne~f~f~~~~~~~ 237 (674)
T 3pfq_A 171 ----------REVLIVVVRDAKNLV---PMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDK 237 (674)
T ss_dssp ----------SSEEEEEEEEEESCC---CCSTTSSCCEEEEEEEESCSSCCSCEECCCCSSCSSCEEEEEEEEECCSTTT
T ss_pred ----------cceeeeeeecccccC---CCCcccccCcccccccccCccccccccccccccccCCCccceeeeecccCCc
Confidence 011122233333332 3456788999998877776666667889999999999999999888777777
Q ss_pred ccccccccccccCCCCCCeecccccEE--EEeeeehhhhhhhhhhccccchhhhhhhccccCcccCCCchhhhc----hh
Q psy48 688 EESRVTDMSQLYQISPDEVLGSGQFGI--VYGASMVGIFFLAALYEGVKYYREYLFWKTYNDLHYRSIPAQQRI----SS 761 (1098)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~lG~gsFG~--v~k~~~~g~~~l~~~~e~~~y~~~~~~w~~~~~~~~~~ip~~~~~----~~ 761 (1098)
+..+.+++||||.++.+|+||+.+++. +..+..+|||.|+...+|++| ++|..... ..
T Consensus 238 ~~~L~v~v~d~d~~~~dd~iG~~~i~l~~l~~~~~~~w~~Lls~~~g~~~----------------~~p~~~~~~~~~~~ 301 (674)
T 3pfq_A 238 DRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYF----------------NVPVPPEGSEGNEE 301 (674)
T ss_dssp TCEEEEEEEECCSSSCCEECCBCCCBTTHHHHCCEEEEEECBCTTGGGTC----------------CEECCC--------
T ss_pred cceeeeEEeecccccccccccccccchhhhccCCcccceeecccccceec----------------ccCCCCccccccHH
Confidence 777899999999999999999999886 666778999999999999887 23321110 00
Q ss_pred hhhccccccccccccccccCCCcccccCCchhHhhHHHHHHHHHHHHHHhhheeeeeeeeeeeeeceEEEEeecCCceeE
Q psy48 762 VEENKDTAKVVPVCDVLQKQPPSMLMLSMPHFIQTLLHVLQITMSFLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVA 841 (1098)
Q Consensus 762 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~p~~~~~ll~~~~~~~~~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VA 841 (1098)
.+...+..++... .+.+.... ...+.............+..|.+...||.|.||.||.+.++.+++.||
T Consensus 302 ~~~~~~~~~~~~~----~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vA 370 (674)
T 3pfq_A 302 LRQKFERAKIGQG----TKAPEEKT-------ANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYA 370 (674)
T ss_dssp -------------------------------------------------CTTEEEEEESSBTTTBCEEEEEESSSCCEEE
T ss_pred HHHHHhhccccCC----CCCccccc-------ccccccccccCccccccccceEEEEEEccCCCEEEEEEEECCCCcEEE
Confidence 0000000000000 00000000 000000011111223456789999999999999999999999999999
Q ss_pred EEEEeccCC-ChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHH
Q psy48 842 IKVIDKLRF-PTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIIT 919 (1098)
Q Consensus 842 VKvlkk~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~ 919 (1098)
||++++... .......+..|..+|..+ +||||+.++++|++.+.+||||||++|++|..++.. .+.+++..++.|+.
T Consensus 371 vK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ 449 (674)
T 3pfq_A 371 VKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAA 449 (674)
T ss_dssp EEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHH
T ss_pred EEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHH
Confidence 999986432 122346788899999887 799999999999999999999999999999888864 46799999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------------CCCCCChhhhccCCCCchhHHH
Q psy48 920 QILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------------GEKSFPPEVLRNKGYNRSLDMW 987 (1098)
Q Consensus 920 qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------------~~~~~APEvl~~~~ys~~sDVw 987 (1098)
||+.||+|||++||+||||||+||||+.++ ++||+|||+|+.. +..|+|||++.+..|+.++|||
T Consensus 450 qi~~aL~~LH~~gIiHrDLKp~NILl~~~g---~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~Dvw 526 (674)
T 3pfq_A 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEG---HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 526 (674)
T ss_dssp HHHHHHHHHHHTSEECCCCCSTTEEECSSS---CEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHH
T ss_pred HHHHHHHHHHhCCeEeccCChhhEEEcCCC---cEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEe
Confidence 999999999999999999999999999998 8999999998742 3346899999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCH-----HHHHcCCCcC
Q psy48 988 SVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV-----DKSLAHPWLQ 1060 (1098)
Q Consensus 988 SLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa-----~eIL~HpfFk 1060 (1098)
||||+||||++|+.||.+.. ++.+.+......+| ..+++++.+||.+||++||++||++ ++|++||||+
T Consensus 527 SlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~ 602 (674)
T 3pfq_A 527 AFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602 (674)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred chHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence 99999999999999998754 34444444433333 4689999999999999999999997 9999999999
Q ss_pred CCCCcchhHHHHhh-hCCCCCCCcc
Q psy48 1061 DPATWSDLRGLERQ-IGTNKKKNPK 1084 (1098)
Q Consensus 1061 ~~~~~~~~~~l~~~-~~~~~~~~~~ 1084 (1098)
+ +||+.|+++ +.||+++..+
T Consensus 603 ~----i~w~~l~~~~~~pp~~p~~~ 623 (674)
T 3pfq_A 603 Y----IDWEKLERKEIQPPYKPKAS 623 (674)
T ss_dssp S----CCHHHHTTTCSCCSCCCBCC
T ss_pred C----CCHHHHHhCCCCCCCCCcCC
Confidence 9 899999988 8899877554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=453.30 Aligned_cols=252 Identities=26% Similarity=0.443 Sum_probs=222.2
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..|.+...||.|+||.||.+.++.+|+.||||++++.... ......+.+|+++|+.++|||||+++++|++++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4589999999999999999999999999999999875322 233577999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||++||+|..++. +.+.+++.+++.|+.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+.+
T Consensus 112 Ey~~gG~L~~~i~-~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g---~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS---CEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC---CEEEEEcCCceecCCCCC
Confidence 9999999999886 456899999999999999999999999999999999999999998 8999999999754
Q ss_pred ---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 966 ---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
+..|||||++.+..|+.++|||||||+||||++|+.||.+.. ++...+......+ +..+|+++.+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----p~~~s~~~~d 263 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF----PEKFFPKARD 263 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC----CTTCCHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----CcccCHHHHH
Confidence 223589999999999999999999999999999999998653 4445555544433 3568999999
Q ss_pred HHHHhhhhcccCCCCHHH------HHcCCCcCCCCCcchhHHHHhhh
Q psy48 1035 LINNLLQVKQRKRLSVDK------SLAHPWLQDPATWSDLRGLERQI 1075 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~e------IL~HpfFk~~~~~~~~~~l~~~~ 1075 (1098)
||.+||++||++|||++| |++||||++ +||+.|+++-
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~----idw~~l~~~~ 306 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES----VTWENLHQQT 306 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT----CCCTTGGGSC
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC----CCHHHhcCCC
Confidence 999999999999999987 689999998 6777777664
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=451.98 Aligned_cols=258 Identities=29% Similarity=0.440 Sum_probs=220.4
Q ss_pred hheeeeeeeeeeeeeceEEEEee---cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHR---KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k---~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
..|.+...||.|+||.||.+.+. .+++.||||++++......+...+.+|+.+|+.++|||||+++++|++++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 36889999999999999999874 568899999998765444444578899999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
||||++||+|..++. +.+.+++.+++.|+.||+.||+|||++||+||||||+|||++.+| ++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g---~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG---HIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS---CEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC---CEEecccccceeccCC
Confidence 999999999998886 456799999999999999999999999999999999999999999 8999999999743
Q ss_pred ---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 966 ---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
+..|||||++.+..|+.++|||||||+||||++|+.||.+.. +....+..... ..+..+|+++.+
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~----~~p~~~s~~~~~ 255 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL----GMPQFLSPEAQS 255 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----CCCTTSCHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC----CCCCcCCHHHHH
Confidence 234689999999999999999999999999999999998764 33344443332 234569999999
Q ss_pred HHHHhhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1035 LINNLLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
||.+||++||++||| ++|+++||||++ +||++|+++ +.|||.+
T Consensus 256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~----idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFST----IDWNKLYRREIHPPFKP 304 (304)
T ss_dssp HHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT----CCHHHHHTTCSCCSSCC
T ss_pred HHHHHcccCHHHCCCCCcCCHHHHHcCccccC----CCHHHHHhCCCCcCcCC
Confidence 999999999999998 479999999998 789999887 8899864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=448.20 Aligned_cols=246 Identities=27% Similarity=0.426 Sum_probs=214.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
.+.+|.....||.|+||.||.+.++.+|+.||||++++..........+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 35689999999999999999999999999999999998877777778999999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 890 MEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
||||+||+|..++.... ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+..
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g---~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG---TVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC---CEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC---CEEEcccccceeecCC
Confidence 99999999999886543 4689999999999999999999999999999999999999998 8999999999643
Q ss_pred ---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 966 ---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
+..|||||++.+..|+.++|||||||+||||++|+.||.+.... ...+... .++ ..+..+|+++.+
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~-~~~~~~s~~~~~ 255 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--SFP-PVSLHYSYDLRS 255 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCC-CCCTTSCHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC--CCC-CCCccCCHHHHH
Confidence 45679999999999999999999999999999999999876433 3333332 232 345679999999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
||.+||++||++|||++|+++||||++
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 999999999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=445.30 Aligned_cols=245 Identities=25% Similarity=0.447 Sum_probs=214.5
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|.....||.|+||.||.+.++.+|+.||||++++... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 468888999999999999999999999999999976542 234568899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
||+||+|..++.. +++++.+++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+
T Consensus 152 y~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g---~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 152 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG---RVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---CEEECCCTTCEECCSSSCC
T ss_pred CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC---CEEEecCcCceecCCCCCc
Confidence 9999999988864 5699999999999999999999999999999999999999998 8999999999754
Q ss_pred ------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 966 ------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
+..|||||++.+..|+.++|||||||+||||++|+.||.+..... ..+... .......+..+|+++.+||.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCSCGGGSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCccccCCHHHHHHHH
Confidence 223589999999999999999999999999999999998764332 222221 12233446689999999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCCCCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQDPAT 1064 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~~~~ 1064 (1098)
+||++||++|||++|+++||||++...
T Consensus 306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 306 RLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 999999999999999999999997443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=429.65 Aligned_cols=243 Identities=20% Similarity=0.372 Sum_probs=211.1
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec----CCcEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET----PGRIFVV 889 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~----~~~l~LV 889 (1098)
+.+...||.|+||.||.|.++.++..||||++.+..........|.+|+.+|+.++|||||+++++|.+ .+.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 478889999999999999999999999999998877777777889999999999999999999999865 3568999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecC-CCCCCcEEEeecCccccc-
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVLLST-NSELPQVKLCDFGFARII- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~g--IvHrDLKp~NILld~-~g~~~~vKL~DFGla~~~- 965 (1098)
||||+||+|..++. +.+.+++..++.|+.||+.||+|||++| ||||||||+||||+. ++ .+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g---~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG---SVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS---CEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC---CEEEEeCcCCEeCC
Confidence 99999999999886 4567999999999999999999999998 999999999999985 66 8999999999643
Q ss_pred ---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc-CCCCCCCcCcHHHHHH
Q psy48 966 ---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM-YPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~-~p~~~~~~is~el~~L 1035 (1098)
++.|||||++.+ .|+.++|||||||+||||+||+.||.+.............. .|...+..+++++.+|
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 262 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHH
Confidence 445789999876 59999999999999999999999998654443333333222 2333445678999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
|.+||++||++|||++|+++||||++
T Consensus 263 i~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 263 IEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999997
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=425.45 Aligned_cols=242 Identities=28% Similarity=0.489 Sum_probs=203.7
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH-HHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
+++|.+...||.|+||.||.+.++.+|+.||||++++...... ....+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999987654433 356799999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||++| +|..++. +.+++++.+++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+..
T Consensus 92 mEy~~g-~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~---~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 92 IEYAGN-ELFDYIV-QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL---NVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EECCCE-EHHHHHH-HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC---CEEECCSSCC-------
T ss_pred EeCCCC-CHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC---CEEEeecCCCeecCCCC
Confidence 999955 5556665 356799999999999999999999999999999999999999998 8999999999743
Q ss_pred -------CCCCCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 966 -------GEKSFPPEVLRNKGY-NRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 966 -------~~~~~APEvl~~~~y-s~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
+..|||||++.+..| +.++|||||||++|||++|+.||.+.. .+.+.+...... .+..+|+++.+|
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~----~p~~~s~~~~~l 242 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT----LPKFLSPGAAGL 242 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----CCTTSCHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC----CCCCCCHHHHHH
Confidence 345689999999886 589999999999999999999998653 334444443332 345689999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
|.+||+.||++|||++|+++||||+.
T Consensus 243 i~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHccCChhHCcCHHHHHcCccccc
Confidence 99999999999999999999999985
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=446.59 Aligned_cols=252 Identities=24% Similarity=0.426 Sum_probs=218.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..+|.....||.|+||.||.|.++.+|+.||||++++... ...+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 3568999999999999999999999999999999976542 23456889999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
|||+||+|.+++.. +++++.+++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+
T Consensus 228 Ey~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g---~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 228 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG---RVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp ECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC---CEEECCCTTCEECCSSCC
T ss_pred eCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC---CEEEecCccceECCCCCc
Confidence 99999999988853 5699999999999999999999999999999999999999999 8999999999743
Q ss_pred -------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 966 -------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 966 -------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
+..|||||++.+..|+.++|||||||+||||++|+.||.+..... ..+... .......+..+|+++.+||
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli 381 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFL 381 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCSCTTSSCHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCcccccCCHHHHHHH
Confidence 334689999999999999999999999999999999998765432 222221 1223344668999999999
Q ss_pred HHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHH
Q psy48 1037 NNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRG 1070 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~ 1070 (1098)
.+||++||++|||++|+|+||||++......+..
T Consensus 382 ~~~L~~dP~~R~ta~ell~Hp~~~~~~~p~~l~p 415 (423)
T 4fie_A 382 DRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 415 (423)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGTGG
T ss_pred HHHcCCChhHCcCHHHHhcCHHhcCCCCCccccc
Confidence 9999999999999999999999997544444333
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=458.53 Aligned_cols=268 Identities=24% Similarity=0.365 Sum_probs=226.1
Q ss_pred HHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHH---HHHHHhccCCCCceeeeeeeecC
Q psy48 808 LLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKN---EVAILQNLCHPGVVNLERMFETP 883 (1098)
Q Consensus 808 ~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~---Ei~iL~~l~HpnIv~L~~~f~~~ 883 (1098)
...+..|.+...||.|+||.||.+.++.+|+.||||++++..... .....+.+ ++.+++.++|||||+++++|++.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 345678999999999999999999999999999999998643221 11233334 45666778999999999999999
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
+.+||||||++||+|..++. +.+.|++..+++|++||+.||+|||++|||||||||+||||+.+| ++||+|||+|+
T Consensus 265 ~~lylVmEy~~GGdL~~~l~-~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G---~vKL~DFGlA~ 340 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG---HVRISDLGLAC 340 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS---CEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC---CEEecccceee
Confidence 99999999999999988886 456899999999999999999999999999999999999999999 99999999997
Q ss_pred cc----------CCCCCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcH
Q psy48 964 II----------GEKSFPPEVLR-NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 964 ~~----------~~~~~APEvl~-~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
.. ++.|||||++. +..|+.++|||||||+||||++|.+||.+.. +.. .+.......+...+..+|+
T Consensus 341 ~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~i~~~i~~~~~~~p~~~S~ 419 (689)
T 3v5w_A 341 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSP 419 (689)
T ss_dssp ECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-HHHHHHHHCCCCCCTTSCH
T ss_pred ecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhhcCCCCCCCccCCH
Confidence 54 23468999996 5689999999999999999999999997532 222 2222222333444567999
Q ss_pred HHHHHHHHhhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcc
Q psy48 1031 DAIDLINNLLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPK 1084 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~ 1084 (1098)
++.+||.+||++||++|++ +++|++||||++ +||+.|+.+ +.||+.+...
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~----idW~~l~~~~~~pP~~P~~~ 475 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS----LDWQMVFLQKYPPPLIPPRG 475 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT----CCHHHHHTTCSCCSCCCCTT
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC----CCHHHHHcCCCCcCccCCCC
Confidence 9999999999999999998 799999999999 899999888 8999887554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=426.26 Aligned_cols=240 Identities=24% Similarity=0.343 Sum_probs=208.1
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..+.....||.|+||.||.+.++.+|+.||||++++.... .+|+.+|+.++|||||+++++|.+.+.+|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4678888999999999999999999999999999875432 469999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|++||+|..++.. .+.|++.+++.|+.||+.||+|||++|||||||||+||||+.+|. ++||+|||+|+..
T Consensus 131 y~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS--RAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC--CEEECCCTTCEEC------
T ss_pred ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC--EEEEeeCCCCeEccCCCcc
Confidence 9999999999864 567999999999999999999999999999999999999998873 6999999999743
Q ss_pred -----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHH
Q psy48 966 -----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
+..|||||++.+..|+.++|||||||+||||++|+.||.+.. ++...+....... ...+..+|+++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s~~~ 286 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI-REIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG-GGSCTTSCHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc-hhcCccCCHHH
Confidence 234689999999999999999999999999999999997642 3334443332111 12345799999
Q ss_pred HHHHHHhhhhcccCCCCHHHH-------------HcCCCcCCC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKS-------------LAHPWLQDP 1062 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eI-------------L~HpfFk~~ 1062 (1098)
.+||.+||++||++|||+.|+ ++|||+++.
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 999999999999999999998 568888764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=415.24 Aligned_cols=213 Identities=22% Similarity=0.376 Sum_probs=181.3
Q ss_pred eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHH
Q psy48 839 GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFII 918 (1098)
Q Consensus 839 ~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia 918 (1098)
.||||+++...........|.+|+.+|++++|||||++++++.. +.++||||||+||+|..++.....++++.++..|+
T Consensus 60 ~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~ 138 (307)
T 3omv_A 60 DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIA 138 (307)
T ss_dssp EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHH
T ss_pred cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHH
Confidence 48999998766667777899999999999999999999998754 57899999999999999998777889999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--------------CCCCCChhhhcc---CCCC
Q psy48 919 TQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--------------GEKSFPPEVLRN---KGYN 981 (1098)
Q Consensus 919 ~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--------------~~~~~APEvl~~---~~ys 981 (1098)
.||+.||+|||+++||||||||+||||+.++ .+||+|||+|+.. +..|||||++.+ .+|+
T Consensus 139 ~qia~gL~yLH~~~IiHRDlKp~NILl~~~~---~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~ 215 (307)
T 3omv_A 139 RQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL---TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215 (307)
T ss_dssp HHHHHHHHHHHHTTCBCSCCCSSSEEEETTE---EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCC
T ss_pred HHHHHHHHHHHHCCccCCccCHHHEEECCCC---cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCC
Confidence 9999999999999999999999999999998 8999999999643 345789999974 4699
Q ss_pred chhHHHHHHHHHHHHHcCCCCCCCChhHHHH--HHHhhccCC--CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 982 RSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ--IQNAAFMYP--PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 982 ~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~--i~~~~~~~p--~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.++|||||||+||||+||+.||.+....... +.......| ...+.++|+++.+|+.+||+.||++|||+.+|++
T Consensus 216 ~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 216 FQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred cHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999999999865332222 222111222 2345678999999999999999999999998865
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=413.30 Aligned_cols=244 Identities=20% Similarity=0.296 Sum_probs=201.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC------
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG------ 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~------ 884 (1098)
+..|.....||.|+||.||.+.++.+|+.||||+++... .......+.+|+.+|+.++|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 345888899999999999999999999999999997653 3444578999999999999999999999996544
Q ss_pred ------cEEEEEEeccCchHHHHHhhccC--ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEE
Q psy48 885 ------RIFVVMEKLQGDMLEMILSSEKG--RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKL 956 (1098)
Q Consensus 885 ------~l~LVmEy~~ggsL~~~l~~~~~--~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL 956 (1098)
.+|+||||++|++|..++..... ..++..++.|+.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~---~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD---VVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---CEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC---cEEE
Confidence 37999999999999999874432 244566889999999999999999999999999999999998 8999
Q ss_pred eecCccccc------------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH
Q psy48 957 CDFGFARII------------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ 1012 (1098)
Q Consensus 957 ~DFGla~~~------------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~ 1012 (1098)
+|||+|+.. +..|||||++.+..|+.++|||||||+||||++ ||....+....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 999998642 345789999999999999999999999999996 88765444333
Q ss_pred HHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1013 IQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1013 i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+........+..+...++++.+||.+||+.||++|||+.|+++||||++
T Consensus 237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 3333222222223456678899999999999999999999999999998
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=420.32 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=210.5
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec------CCc
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET------PGR 885 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~------~~~ 885 (1098)
.+|.....||.|+||.||.|.++.+|+.||||++++..........+.+|+.+|+.++|||||++++++.+ .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 46899999999999999999999999999999998776666667889999999999999999999998754 367
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+||||||++|+ |..++. ..+.+++.+++.|++||+.||.|||++|||||||||+|||++.++ .+||+|||+|+.+
T Consensus 134 ~~ivmE~~~g~-L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~---~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLMESD-LHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC---ELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCSEE-HHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC---CEEECCCTTCBCC
T ss_pred EEEEEeCCCCC-HHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC---CEEEeecceeeec
Confidence 99999999865 656665 456899999999999999999999999999999999999999998 8999999999643
Q ss_pred ----------------CCCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhccCC-----
Q psy48 966 ----------------GEKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYP----- 1021 (1098)
Q Consensus 966 ----------------~~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~~p----- 1021 (1098)
+..|||||++.+. .|+.++||||+||++|||++|++||.+..... ..+.......+
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 3346899999875 56999999999999999999999998765432 33322221111
Q ss_pred ---------------CC---C----CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCc
Q psy48 1022 ---------------PR---P----WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATW 1065 (1098)
Q Consensus 1022 ---------------~~---~----~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~ 1065 (1098)
.. . +..+++++.+||.+||.+||++|||++|+|+||||++..+.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 10 0 23578999999999999999999999999999999985443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=403.01 Aligned_cols=236 Identities=21% Similarity=0.300 Sum_probs=202.3
Q ss_pred hheeeeeeeeeeeeeceEEEEee-----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHR-----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k-----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
..+.+...||.|+||.||.|.+. .++..||||+++.. .....+.|.+|+++|++++|||||++++++.+++.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 45788999999999999999865 46889999999753 355568899999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhc------------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcE
Q psy48 887 FVVMEKLQGDMLEMILSSE------------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQV 954 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~------------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~v 954 (1098)
+|||||+++|+|..++... ...+++.+++.++.||+.||+|||+++||||||||+||||+.++ .+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~---~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL---LV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG---CE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC---cE
Confidence 9999999999999998753 24699999999999999999999999999999999999999998 89
Q ss_pred EEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhh
Q psy48 955 KLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAA 1017 (1098)
Q Consensus 955 KL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~ 1017 (1098)
||+|||+|+.. +..|||||++.+..|+.++|||||||+||||+| |+.||.+.. ++...+...
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~- 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG- 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT-
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 99999999632 234799999999999999999999999999998 899998753 333334333
Q ss_pred ccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1018 FMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1018 ~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.....+..+|+++.+||.+||+.||++|||+.+|++
T Consensus 247 --~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 247 --RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 223334679999999999999999999999999953
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=404.36 Aligned_cols=237 Identities=20% Similarity=0.283 Sum_probs=201.0
Q ss_pred hheeeeeeeeeeeeeceEEEEee-----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHR-----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k-----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
..+.+...||.|+||.||.+..+ .+++.||||+++.. .....+.|.+|+++|++++|||||+++++|.+.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34677889999999999999864 46889999999753 355568899999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhc--------------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCC
Q psy48 887 FVVMEKLQGDMLEMILSSE--------------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~--------------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~ 952 (1098)
+|||||+++|+|..++... .+++++.+++.|+.||+.||+|||+++||||||||+||||+.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~--- 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL--- 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT---
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC---
Confidence 9999999999999998643 24689999999999999999999999999999999999999998
Q ss_pred cEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHH
Q psy48 953 QVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQN 1015 (1098)
Q Consensus 953 ~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~ 1015 (1098)
.+||+|||+|+.. +..|||||++.+..|+.++|||||||+||||+| |+.||.+.. +....+..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999999743 223789999999999999999999999999999 899998653 33333333
Q ss_pred hhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1016 AAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1016 ~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
. .....+..+++++.+||.+||+.||++|||+.+|+++
T Consensus 276 g---~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 G---RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp T---CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred C---CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 2 3334456799999999999999999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=409.90 Aligned_cols=243 Identities=23% Similarity=0.386 Sum_probs=203.4
Q ss_pred HHHhhheeeeeeeeeeeeeceEEEEee---cCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecC
Q psy48 808 LLMLVFMTYNVALCIAVVAGAACGVHR---KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETP 883 (1098)
Q Consensus 808 ~~~l~~~~~~~~Lg~G~~g~v~~a~~k---~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~ 883 (1098)
.....+|.+...||.|+||.||.|.++ .+++.||||++.+. .....+.+|+++|+.+ +||||++++++|.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 345678999999999999999999876 46789999998653 2345688999999988 699999999999999
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-CCCCcEEEeecCcc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN-SELPQVKLCDFGFA 962 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~-g~~~~vKL~DFGla 962 (1098)
+++|+||||++|++|..++. .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ + ++||+|||+|
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~---~~kl~DFGla 165 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLK---KYALVDFGLA 165 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT---EEEECCCTTC
T ss_pred CEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCC---eEEECcCCCC
Confidence 99999999999999988873 59999999999999999999999999999999999999876 5 8999999999
Q ss_pred ccc----------------------------------------CCCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCC
Q psy48 963 RII----------------------------------------GEKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTF 1001 (1098)
Q Consensus 963 ~~~----------------------------------------~~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~ 1001 (1098)
+.. +..|+|||++.+. .|+.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 632 3346899999875 58999999999999999999999
Q ss_pred CCCCChhHHHHHHHhh-----------------------------------------c------------cCCCCCCCcC
Q psy48 1002 PFNEDEDINEQIQNAA-----------------------------------------F------------MYPPRPWRDI 1028 (1098)
Q Consensus 1002 Pf~~~~~~~~~i~~~~-----------------------------------------~------------~~p~~~~~~i 1028 (1098)
||....+..+.+.... . ......|..+
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 9965432211111100 0 0011235678
Q ss_pred cHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1029 SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
|+++.+||.+||+.||++|+|++|+|+||||++
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999999999997
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=435.76 Aligned_cols=249 Identities=28% Similarity=0.479 Sum_probs=222.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
+.+|.+...||.|.||.||.+.++.+|+.||||++++.. ..+...+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 467999999999999999999999999999999997643 445678999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||++||+|..++....+.|++.+++.|++||+.||.|||++||+||||||+|||++.+.. .++||+|||+|+.+.
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~-~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS-NELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC-CCEEECCCSSCEECCTTSE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCC-CCEEEeeccceeEccCCCc
Confidence 999999999988767778999999999999999999999999999999999999986521 189999999997542
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
..|||||++.+..|+.++|||||||+||||++|..||.+.. +....+......++...|..+|+++.+||.
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~ 392 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHH
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 34689999999999999999999999999999999998764 344455555555666667889999999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+||..||++|||+.|+|+||||+..
T Consensus 393 ~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 393 KLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp TTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHccCChhHCcCHHHHhcCcCcCCC
Confidence 9999999999999999999999963
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=399.58 Aligned_cols=238 Identities=21% Similarity=0.257 Sum_probs=202.6
Q ss_pred hheeeeeeeeeeeeeceEEEEee-----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHR-----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k-----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
..+++...||.|+||.||.|... .+++.||||+++... .....+.|.+|+.+|++++|||||++++++.+.+.+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 45678899999999999999853 567899999997542 334457899999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhc---------------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC
Q psy48 887 FVVMEKLQGDMLEMILSSE---------------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~---------------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~ 951 (1098)
+|||||+++|+|..++... ...+++.++..++.||+.||+|||+++||||||||+||||+.++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~-- 182 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL-- 182 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC--
Confidence 9999999999999998643 24589999999999999999999999999999999999999998
Q ss_pred CcEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHH
Q psy48 952 PQVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQ 1014 (1098)
Q Consensus 952 ~~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~ 1014 (1098)
.+||+|||+|+.. +..|||||++.+..|+.++|||||||+||||+| |..||.+.. ++.+.+.
T Consensus 183 -~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 183 -NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp -CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred -CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 8999999998643 124789999999999999999999999999998 899998754 3333333
Q ss_pred HhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1015 NAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1015 ~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.. .....+..+|+++.+|+.+||+.||++|||+.+|+++
T Consensus 262 ~~---~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 262 NR---QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC---CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22 2223356799999999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=403.65 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=226.3
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH-HHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK-QEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~-~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~ 887 (1098)
.+..|.+...||.|+||.||.+.++.+++.||||++++...... ....+.+|+.+|..+ +||||++++++|++.+.++
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 45678999999999999999999999999999999987654333 336688999999876 8999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-- 965 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-- 965 (1098)
+||||++|++|..++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+|+..
T Consensus 130 lV~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g---~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG---HIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---CEEECCCTTCBCCCC
T ss_pred EEEEcCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC---CEEEeecceeeeccc
Confidence 9999999999987776 446799999999999999999999999999999999999999998 8999999999742
Q ss_pred ----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----------hhHHHHHHHhhccCCCCC
Q psy48 966 ----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED-----------EDINEQIQNAAFMYPPRP 1024 (1098)
Q Consensus 966 ----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~-----------~~~~~~i~~~~~~~p~~~ 1024 (1098)
+..|+|||++.+..|+.++|||||||++|||++|+.||... ..+.+.+..... ..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----~~ 281 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----RI 281 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----CC
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----CC
Confidence 22368999999999999999999999999999999999632 112333333332 33
Q ss_pred CCcCcHHHHHHHHHhhhhcccCCCCH------HHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcch
Q psy48 1025 WRDISSDAIDLINNLLQVKQRKRLSV------DKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPKR 1085 (1098)
Q Consensus 1025 ~~~is~el~~LL~~cL~~dP~kRPSa------~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~~ 1085 (1098)
+..++.++.+||.+||+.||++||++ ++|++||||++ +||+.|+.+ +.||+++..+.
T Consensus 282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~----i~w~~l~~~~~~pp~~p~~~~ 345 (396)
T 4dc2_A 282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN----VDWDMMEQKQVVPPFKPNISG 345 (396)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT----CCHHHHHTTCSCCSCCCCCCS
T ss_pred CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC----CCHHHHHcCCCCCCCcCCCCC
Confidence 35689999999999999999999985 79999999998 889999887 88888776543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=398.07 Aligned_cols=264 Identities=28% Similarity=0.435 Sum_probs=227.5
Q ss_pred HHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCc
Q psy48 808 LLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGR 885 (1098)
Q Consensus 808 ~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~ 885 (1098)
......|.+...||.|.||.||.+.++.+++.||||++++... .......+.+|+.++..+ +||||++++++|++.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 3456789999999999999999999999999999999986432 122346788999999987 69999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+|+||||++|++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 99 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g---~ikL~DFG~a~~~ 174 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG---HCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---CEEECCCTTCBCS
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC---CEEEccccceeec
Confidence 9999999999999888764 46799999999999999999999999999999999999999998 8999999998742
Q ss_pred ------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHH
Q psy48 966 ------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 966 ------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
+..|+|||++.+..|+.++|||||||++|||++|..||.+.. +..+.+......+| ..++++
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~ 250 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHED 250 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHH
Confidence 234689999999999999999999999999999999998654 44455555444443 358999
Q ss_pred HHHHHHHhhhhcccCCCCH------HHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCc
Q psy48 1032 AIDLINNLLQVKQRKRLSV------DKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNP 1083 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa------~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~ 1083 (1098)
+.+||.+||..||++||++ .++++||||++ +||+.|+.+ +.||+.+..
T Consensus 251 ~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~----~~w~~l~~~~~~~p~~p~~ 305 (353)
T 3txo_A 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE----IDWAQLNHRQIEPPFRPRI 305 (353)
T ss_dssp HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT----CCHHHHHTTCSCCSCCCCC
T ss_pred HHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC----CCHHHHhcCcCCCCccCCC
Confidence 9999999999999999998 89999999998 788888877 888886543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=396.95 Aligned_cols=238 Identities=23% Similarity=0.316 Sum_probs=203.2
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCC-----ceeEEEEEeccCCChHHHHHHHHHHHHHhccCC-CCceeeeeeeec-CC
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSG-----RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCH-PGVVNLERMFET-PG 884 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg-----~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~L~~~f~~-~~ 884 (1098)
..+.+...||.|+||.||.|.+..++ +.||||+++... .......|.+|+.+|..++| ||||+++++|.. .+
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 56889999999999999999987654 679999997543 34456789999999999975 899999999865 46
Q ss_pred cEEEEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy48 885 RIFVVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g 949 (1098)
.++||||||++|+|..+++... ..+++.+++.|+.||+.||+|||+++||||||||+|||++.++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 7999999999999999987532 3488999999999999999999999999999999999999998
Q ss_pred CCCcEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh---hHHH
Q psy48 950 ELPQVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE---DINE 1011 (1098)
Q Consensus 950 ~~~~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~---~~~~ 1011 (1098)
.+||+|||+|+.. +..|||||++.+..|+.++|||||||+||||+| |+.||.+.. .+..
T Consensus 223 ---~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 223 ---VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp ---CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred ---CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 8999999999754 124789999999999999999999999999998 999998643 3333
Q ss_pred HHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1012 QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1012 ~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.+... .....+..+++++.++|.+||+.||++|||+.+|++|
T Consensus 300 ~i~~g---~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEG---TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcC---CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 33332 2333345689999999999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=390.10 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=227.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
...|.+...||.|+||.||.+.++.+|+.||||++++... .......+.+|+.+|+.++||||++++++|++.+.+++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 4678899999999999999999999999999999976432 122346788999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||++|++|..++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 84 ~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g---~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG---HIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---CEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC---CEEEeeccchhhcccCC
Confidence 99999999988876 446799999999999999999999999999999999999999998 8999999998742
Q ss_pred --------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 966 --------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 966 --------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
+..|+|||++.+..|+.++|||||||++|||++|..||.... ...+.+......+ +..+++++.+|
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~l 235 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSL 235 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHH
Confidence 223689999999999999999999999999999999998653 3334444433333 34689999999
Q ss_pred HHHhhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCc
Q psy48 1036 INNLLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNP 1083 (1098)
Q Consensus 1036 L~~cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~ 1083 (1098)
|.+||+.||++|| +++++++||||++ +||+.+..+ +.||+++..
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~----~~~~~~~~~~~~pp~~p~~ 285 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS----INWQDVVQKKLLPPFKPQV 285 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT----CCHHHHHTTCSCCSCCCCC
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC----CCHHHHHhCCCCCCCCCCC
Confidence 9999999999999 8999999999998 788888877 888877654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=386.44 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=225.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~L 888 (1098)
+..|.....||.|.||.||.+.++.+++.||||++++.... ......+.+|+.++..+ +||||++++++|.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 46788999999999999999999999999999999876543 34457789999999887 89999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
||||++|++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g---~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG---HIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---CEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC---CEEEEeccccccccCC
Confidence 9999999999888763 45799999999999999999999999999999999999999998 8999999999742
Q ss_pred ---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----------hhHHHHHHHhhccCCCCCC
Q psy48 966 ---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED-----------EDINEQIQNAAFMYPPRPW 1025 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~-----------~~~~~~i~~~~~~~p~~~~ 1025 (1098)
+..|+|||++.+..|+.++|||||||++|||++|..||... ....+.+...... .+
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----~p 239 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----IP 239 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC----CC
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC----CC
Confidence 22357999999999999999999999999999999999641 1222333333222 23
Q ss_pred CcCcHHHHHHHHHhhhhcccCCCCH------HHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcc
Q psy48 1026 RDISSDAIDLINNLLQVKQRKRLSV------DKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPK 1084 (1098)
Q Consensus 1026 ~~is~el~~LL~~cL~~dP~kRPSa------~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~ 1084 (1098)
..++.++.+||.+||+.||++||++ +++++||||++ .||+.++.+ +.||+++...
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~----~~w~~~~~~~~~~p~~p~~~ 301 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN----VDWDMMEQKQVVPPFKPNIS 301 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT----CCHHHHHTTCSCCSCCCCCC
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC----CCHHHHHhCCCCCCcCCCCC
Confidence 5689999999999999999999995 89999999998 788888877 8888776544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=381.25 Aligned_cols=261 Identities=31% Similarity=0.502 Sum_probs=227.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
+..|.....||.|.+|.||.+.++.+|+.||||++++.... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 46788999999999999999999999999999999764321 12346788999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||++|++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 85 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g---~~kL~Dfg~a~~~~~~~ 160 (318)
T 1fot_A 85 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG---HIKITDFGFAKYVPDVT 160 (318)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS---CEEECCCSSCEECSSCB
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC---CEEEeecCcceecCCcc
Confidence 999999999888864 45799999999999999999999999999999999999999998 8999999999754
Q ss_pred -----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 966 -----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 966 -----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
+..|+|||++.+..|+.++|||||||++|||++|..||..... ....+......+| ..+++++.++|.+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~ 236 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSR 236 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHH
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHH
Confidence 3346899999999999999999999999999999999986543 3334444333333 4688999999999
Q ss_pred hhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCc
Q psy48 1039 LLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNP 1083 (1098)
Q Consensus 1039 cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~ 1083 (1098)
||..||++|| +++++++||||++ ++|+.+..+ +.+|+.+..
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~----~~~~~~~~~~~~~p~~p~~ 283 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE----VVWEKLLSRNIETPYEPPI 283 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS----CCHHHHHTTCSCCSCCCCC
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccC----CCHHHHHhCCCCCCCCCCc
Confidence 9999999999 8999999999998 788888887 888876654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=389.63 Aligned_cols=263 Identities=25% Similarity=0.418 Sum_probs=227.2
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l 886 (1098)
..+..|.+...||.|+||.||.+.++.+++.||||++++... .......+.+|..+|..+ +||||++++++|++.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 356789999999999999999999999999999999986432 122346788999999887 799999999999999999
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII- 965 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~- 965 (1098)
|+||||++|++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 97 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g---~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG---HIKIADFGMCKENI 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---CEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC---cEEEEeCCcccccc
Confidence 999999999999888764 45799999999999999999999999999999999999999998 8999999998752
Q ss_pred -----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHH
Q psy48 966 -----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
+..|+|||++.+..|+.++|||||||++|||++|+.||.+.. +..+.+......+| ..+++++
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 248 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEA 248 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHH
Confidence 223689999999999999999999999999999999998653 34444444433333 4689999
Q ss_pred HHHHHHhhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCc
Q psy48 1033 IDLINNLLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNP 1083 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~ 1083 (1098)
.+||.+||..||++||+ +++|++||||+. +||+.++++ +.||+.+..
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~----~~w~~l~~~~~~~p~~p~~ 301 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY----IDWEKLERKEIQPPYKPKA 301 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT----CCHHHHHTTCSCCSCCCCC
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC----CCHHHHHhCCCCCCcCCCC
Confidence 99999999999999995 699999999998 788999877 888887654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=389.56 Aligned_cols=262 Identities=28% Similarity=0.401 Sum_probs=222.3
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l 886 (1098)
.....|.....||.|+||.||.+.++.+++.||||++++... .......+..|..++..+ +||||+++++++++.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 346789999999999999999999999999999999986432 122346678899999876 899999999999999999
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII- 965 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~- 965 (1098)
|+||||++|++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g---~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG---HIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---CEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC---CEEEeEChhhhhcc
Confidence 999999999999888764 45799999999999999999999999999999999999999998 8999999998743
Q ss_pred -----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHH
Q psy48 966 -----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
+..|+|||++.+..|+.++|||||||++|||++|..||.+.. +....+......+ ...+++++
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~ 245 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEA 245 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC----CcccCHHH
Confidence 223579999999999999999999999999999999998654 3344444433333 34589999
Q ss_pred HHHHHHhhhhcccCCCCHH-HHHcCCCcCCCCCcchhHHHHhh-hCCCCCCC
Q psy48 1033 IDLINNLLQVKQRKRLSVD-KSLAHPWLQDPATWSDLRGLERQ-IGTNKKKN 1082 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~-eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~ 1082 (1098)
.+||.+||..||++||++. +|++||||++ +||+.|+++ +.||+.+.
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~----~~w~~l~~~~~~~p~~p~ 293 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQHPLFRE----INWEELERKEIDPPFRPK 293 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTT----CCHHHHHTTCSCC-----
T ss_pred HHHHHHHhcCCHhHcCCChHHHHcCccccC----CCHHHHhhCCCCCCcCCC
Confidence 9999999999999999998 9999999998 788889887 88887654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=391.50 Aligned_cols=275 Identities=23% Similarity=0.371 Sum_probs=229.5
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
....|.+...||.|+||.||.+.++.+++.||||++.+... .......+.+|+.+|+.++||||++++++|.+.+.+|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 35678999999999999999999999999999999976432 12234678899999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||+.|++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++...
T Consensus 93 v~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g---~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG---HVHITDFNIAAMLPRE 168 (384)
T ss_dssp EECCCTTEEHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC---CEEEeccceeeeccCC
Confidence 999999999988876 456799999999999999999999999999999999999999998 89999999997542
Q ss_pred ---------CCCCChhhhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHH
Q psy48 967 ---------EKSFPPEVLRN---KGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 967 ---------~~~~APEvl~~---~~ys~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
..|+|||++.+ ..|+.++|||||||++|||++|..||... ......+.... ......+..++.++
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~p~~~s~~~ 247 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-TTVVTYPSAWSQEM 247 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-HCCCCCCTTSCHHH
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-hcccCCCCcCCHHH
Confidence 23579999974 56899999999999999999999999743 22222222111 11222235689999
Q ss_pred HHHHHHhhhhcccCCCC-HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcchhhhhhhhh
Q psy48 1033 IDLINNLLQVKQRKRLS-VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPKRTAQLLSYQ 1093 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPS-a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~~ 1093 (1098)
.+||.+||+.||++||+ ++++++||||++ ++|+.++.+ +.||+.+..........++
T Consensus 248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~----~~w~~~~~~~~~p~~~p~~~~~~~~~~~~ 306 (384)
T 4fr4_A 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMND----INWDAVFQKRLIPGFIPNKGRLNCDPTFE 306 (384)
T ss_dssp HHHHHHHSCSSGGGSCCSHHHHHTSGGGTT----CCHHHHHTTCSCCCCCCSCCSSCCCCCCC
T ss_pred HHHHHHHhcCCHhHhcccHHHHHcChhhhc----CCHHHHHhCCCCCCCCCCCCCCCCCCccC
Confidence 99999999999999998 899999999999 788888888 8888887765443333333
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=385.07 Aligned_cols=262 Identities=32% Similarity=0.515 Sum_probs=228.3
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.+..|.....||.|.+|.||.+.++.+|+.||||++++.... ......+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 457899999999999999999999999999999999764321 1234678899999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||++|++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++...
T Consensus 119 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g---~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG---YIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECSSC
T ss_pred EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC---CEEEcccccceeccCC
Confidence 9999999999888864 45799999999999999999999999999999999999999998 89999999997543
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
..|+|||++.+..|+.++|||||||++|||++|..||.... +..+.+......+| ..++.++.++|.
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 270 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHHH
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 34689999999999999999999999999999999998754 33344444433333 468999999999
Q ss_pred HhhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCc
Q psy48 1038 NLLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNP 1083 (1098)
Q Consensus 1038 ~cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~ 1083 (1098)
+||..||++||+ +++|++||||+. .||..+..+ +.+|+.+..
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~----~~w~~~~~~~~~~p~~p~~ 318 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT----TDWIAIYQRKVEAPFIPKF 318 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT----CCHHHHHTTCSCCSCCCCC
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCC----CCHHHHhhccCCCCCCCCC
Confidence 999999999998 999999999998 788888877 888876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=394.51 Aligned_cols=268 Identities=25% Similarity=0.360 Sum_probs=224.7
Q ss_pred HHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 808 LLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 808 ~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
......|.+...||.|+||.||.+.++.+++.||||++++.... ......+.+|+.+++.++||||++++++|++.+.+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 34457899999999999999999999999999999999763211 11224588999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
|+||||++|++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+|+...
T Consensus 145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g---~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG---HLKLADFGTCMKMN 219 (410)
T ss_dssp EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECC
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC---CEEEeccceeEeec
Confidence 999999999999888864 4699999999999999999999999999999999999999998 89999999996432
Q ss_pred -------------CCCCChhhhccCC----CCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCc
Q psy48 967 -------------EKSFPPEVLRNKG----YNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 967 -------------~~~~APEvl~~~~----ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~ 1027 (1098)
..|+|||++.+.. |+.++|||||||+||||++|..||.+.. +....+...........+..
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 299 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCC
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccc
Confidence 2357999998766 8899999999999999999999998764 33444443332222223456
Q ss_pred CcHHHHHHHHHhhhhcccC--CCCHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcc
Q psy48 1028 ISSDAIDLINNLLQVKQRK--RLSVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPK 1084 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~k--RPSa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~ 1084 (1098)
+++++.+||.+||..+|.+ |+++++|++||||++ +||+.++.+ +.||+.+..+
T Consensus 300 ~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~----~~w~~~~~~~~~~p~~p~~~ 355 (410)
T 3v8s_A 300 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN----DQWAWETLRDTVAPVVPDLS 355 (410)
T ss_dssp CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC----SSCCSTTGGGSCCSCCCCCS
T ss_pred ccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC----CCHHHHhhcccCCCCCCcCC
Confidence 9999999999999999998 999999999999998 555555555 7888766543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=385.57 Aligned_cols=261 Identities=28% Similarity=0.416 Sum_probs=218.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHH-HhccCCCCceeeeeeeecCCcEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAI-LQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~i-L~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
...|.+...||.|.||.||.+.++.+++.||||++++.... ......+.+|..+ ++.++||||++++++|++.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 46789999999999999999999999999999999876543 2334567778777 467899999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
||||++|++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g---~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG---HIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---CEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC---CEEEeeCccccccccC
Confidence 9999999999888763 45799999999999999999999999999999999999999998 8999999998742
Q ss_pred ---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 966 ---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
+..|+|||++.+..|+.++|||||||++|||++|..||.+.. +..+.+......+ ...++.++.+
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~ 268 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARH 268 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC----CSSSCHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCC----CCCCCHHHHH
Confidence 334689999999999999999999999999999999998754 3334444433333 3468999999
Q ss_pred HHHHhhhhcccCCCCH----HHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCc
Q psy48 1035 LINNLLQVKQRKRLSV----DKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNP 1083 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa----~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~ 1083 (1098)
||.+||..||++||++ .++++||||+. +||+.|+++ +.||+.+..
T Consensus 269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~----~~w~~l~~~~~~pp~~p~~ 318 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL----INWDDLINKKITPPFNPNV 318 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT----CCHHHHHTTCSCCSCCCSC
T ss_pred HHHHHcccCHHhCCCCCCCHHHHhCCccccC----CCHHHHHhCCCCCCCCCCC
Confidence 9999999999999986 69999999998 788888877 888876643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=373.77 Aligned_cols=246 Identities=30% Similarity=0.512 Sum_probs=217.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
..+.|.....||.|+||.||.+.+..+|+.||||++.+..........+.+|+.+|+.++||||+++++++.+.+.+++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 45789999999999999999999999999999999988776677778899999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||++|++|..++.. .+++++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM---NIKIADFGFSNEFTVGG 168 (328)
T ss_dssp ECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS---CEEECSTTCCGGGSSSC
T ss_pred EECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC---CEEEeeccCceecCCCC
Confidence 999999999888764 45799999999999999999999999999999999999999998 89999999996432
Q ss_pred --------CCCCChhhhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 --------EKSFPPEVLRNKGYN-RSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 --------~~~~APEvl~~~~ys-~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..|+|||++.+..+. .++|||||||++|+|++|..||.+.. +....+.......| ..+++++.+|
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 244 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCENL 244 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 235799999988875 89999999999999999999998764 33444444333333 3589999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
|.+||..||++|||++++++||||+...
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999999743
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=405.93 Aligned_cols=265 Identities=26% Similarity=0.392 Sum_probs=228.9
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
....|.....||.|+||.||.+.++.+|+.||||++++.... ......+.+|+.+|+.++||||++++++|.+.+.+|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 356788899999999999999999999999999999764321 2234668899999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 889 VMEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
||||++|++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g---~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG---HIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS---CEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC---CeEEEecccceeccc
Confidence 999999999988876443 3499999999999999999999999999999999999999998 89999999997542
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh------hHHHHHHHhhccCCCCCCCcCcH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE------DINEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~------~~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
..|+|||++.+..|+.++|||||||++|||++|..||.... .+...+.. .+...+..+++
T Consensus 339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----~~~~~p~~~s~ 414 (576)
T 2acx_A 339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VPEEYSERFSP 414 (576)
T ss_dssp TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----CCCCCCTTSCH
T ss_pred CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----ccccCCccCCH
Confidence 23689999999999999999999999999999999998642 23333332 33333467899
Q ss_pred HHHHHHHHhhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcch
Q psy48 1031 DAIDLINNLLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPKR 1085 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~~ 1085 (1098)
++.+||.+||+.||++|| ++++|++||||++ +||+.|+.+ +.||+.+.+..
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~----i~w~~l~~~~~~pp~~p~~~~ 471 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK----LNFKRLGAGMLEPPFKPDPQA 471 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT----CCHHHHHTTCSCCSCCCCCCC
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc----CCHHHHhcCCCCCCCCCCccc
Confidence 999999999999999999 7899999999998 789999887 88898887653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=379.88 Aligned_cols=251 Identities=31% Similarity=0.518 Sum_probs=219.2
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH----HHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK----QEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~----~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
....|.+...||.|.||.||.+.++.+|+.||||++++...... ....+.+|+.+|+.++||||++++++|.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 34679999999999999999999999999999999987543321 35779999999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCC-CCcEEEeecCcccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE-LPQVKLCDFGFARI 964 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~-~~~vKL~DFGla~~ 964 (1098)
+++||||+.|++|..++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++..
T Consensus 90 ~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEECCCSCBHHHHHT-TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 999999999999988886 3567999999999999999999999999999999999999987652 22699999999975
Q ss_pred cCC-----------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHH
Q psy48 965 IGE-----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 965 ~~~-----------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
... .|+|||++.+..|+.++|||||||++|+|++|..||.+.. +....+......++...|..++++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 248 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 422 3579999999999999999999999999999999998754 344445555555555556789999
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+.+||.+||..||++|||+.++++||||+.
T Consensus 249 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 999999999999999999999999999997
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=394.51 Aligned_cols=264 Identities=24% Similarity=0.423 Sum_probs=223.2
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
....|.....||.|+||.||.+.++.+++.||||++++..... .....+.+|+.++..++||||++++++|.+.+.+|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 3567899999999999999999999999999999997632111 112348899999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
||||+.|++|..++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+|+..
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g---~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG---HIRLADFGSCLKLMED 228 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC---CEEEcchhhhhhcccC
Confidence 9999999999999986667899999999999999999999999999999999999999998 8999999998543
Q ss_pred ----------CCCCCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhh--ccCCCCCCC
Q psy48 966 ----------GEKSFPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAA--FMYPPRPWR 1026 (1098)
Q Consensus 966 ----------~~~~~APEvl~-----~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~--~~~p~~~~~ 1026 (1098)
+..|+|||++. ...|+.++|||||||+||||++|+.||.+.. +....+.... ..+|. .+.
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~ 307 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT-QVT 307 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS-SCC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc-ccc
Confidence 22358999997 5679999999999999999999999998764 3333443322 23332 335
Q ss_pred cCcHHHHHHHHHhhhhcccC--CCCHHHHHcCCCcCCCCCcchhHHHHhhhCCCCCCC
Q psy48 1027 DISSDAIDLINNLLQVKQRK--RLSVDKSLAHPWLQDPATWSDLRGLERQIGTNKKKN 1082 (1098)
Q Consensus 1027 ~is~el~~LL~~cL~~dP~k--RPSa~eIL~HpfFk~~~~~~~~~~l~~~~~~~~~~~ 1082 (1098)
.+++++.+||.+||..+|++ |++++++++||||++ +||+.| +++.||+.+.
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~----i~w~~l-~~~~~p~~P~ 360 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG----IDWDNI-RNCEAPYIPE 360 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT----CCTTTG-GGSCCSCCCC
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC----CCHHHH-hhCCCCCCCc
Confidence 68999999999999999988 999999999999998 566666 4577776554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=369.53 Aligned_cols=262 Identities=30% Similarity=0.465 Sum_probs=216.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEee---cCCceeEEEEEeccCCC--hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHR---KSGRGVAIKVIDKLRFP--TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k---~tg~~VAVKvlkk~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
...|.....||.|++|.||.+.+. .+++.||||++++.... ......+.+|+.+|+.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467899999999999999999885 68999999999875432 2234668899999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+|+||||+.|++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG---HVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS---CEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC---cEEEEeCCccccc
Confidence 9999999999999888863 45789999999999999999999999999999999999999988 8999999998642
Q ss_pred ------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHH
Q psy48 966 ------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 966 ------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
+..|+|||++.+..++.++||||||+++|+|++|..||..... ....+.......+ ..++.+
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~ 247 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQE 247 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSCHH
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHH
Confidence 3346899999999999999999999999999999999986543 3333333333332 458999
Q ss_pred HHHHHHHhhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcc
Q psy48 1032 AIDLINNLLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPK 1084 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~ 1084 (1098)
+.+||.+||..||++|| ++.++++||||++ .+|+.+..+ +.+|+.+..+
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~----~~~~~~~~~~~~~p~~p~~~ 302 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH----INWEELLARKVEPPFKPLLQ 302 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS----CCHHHHHTTCSCCSCCCC--
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC----CCHHHHhhccCCCCCCCCcC
Confidence 99999999999999999 8899999999998 788888777 7788766543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=376.97 Aligned_cols=250 Identities=30% Similarity=0.534 Sum_probs=224.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|.||.||.+.++.+++.||||+++...........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46799999999999999999999999999999999887766667788999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+.|++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++....
T Consensus 108 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 108 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp CCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 99999999888763 4579999999999999999999999999999999999999876643479999999986442
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
..|+|||++.+..|+.++|||||||++|+|++|..||.+.. +....+......++...|..+++++.+||.
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 266 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHH
T ss_pred cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 34689999999999999999999999999999999998653 445556666666677777889999999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+||..||++||++.++++||||+.
T Consensus 267 ~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 267 SMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHcCCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=391.28 Aligned_cols=263 Identities=27% Similarity=0.424 Sum_probs=219.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
...|.+...||.|+||.||.+.++.+++.||||++++... .......+.+|+.+++.++||||++++++|.+.+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4678999999999999999999999999999999986432 233346788999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
|||++|++|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~---~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG---HIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS---CEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC---CEEEccCCCceeccCC
Confidence 999999999888764 4579999999999999999999998 9999999999999999998 8999999998642
Q ss_pred ---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 966 ---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
+..|+|||++.+..|+.++|||||||+||||++|+.||.... .....+......+ +..+++++.+
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~~~~~~~ 378 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF----PRTLGPEAKS 378 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHHHH
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC----CccCCHHHHH
Confidence 223689999999999999999999999999999999998654 3334444333333 3468999999
Q ss_pred HHHHhhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcch
Q psy48 1035 LINNLLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPKR 1085 (1098)
Q Consensus 1035 LL~~cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~~ 1085 (1098)
||.+||+.||++|| +++++++||||++ .+|+.+..+ +.||+++....
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~----~~~~~~~~~~~~pp~~p~~~~ 431 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG----IVWQHVYEKKLSPPFKPQVTS 431 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT----CCHHHHHTTCSCCSCCCSCSS
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHhCccccC----CCHHHHhhCcCCCCccCCCCC
Confidence 99999999999999 9999999999998 788888777 88888776543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=399.81 Aligned_cols=264 Identities=26% Similarity=0.349 Sum_probs=227.4
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
....|.....||.|+||.||.+.++.+|+.||||++++..... .....+.+|+.+|+.++||||++++++|++.+.+|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3467888899999999999999999999999999997643211 224678899999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhc---cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 889 VMEKLQGDMLEMILSSE---KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~---~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
||||++|++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+| ++||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g---~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG---NVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS---CEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC---CEEEeecceeeec
Confidence 99999999998887643 34699999999999999999999999999999999999999998 8999999998643
Q ss_pred ------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh------hHHHHHHHhhccCCCCCCCc
Q psy48 966 ------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE------DINEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 966 ------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~------~~~~~i~~~~~~~p~~~~~~ 1027 (1098)
+..|+|||++.+..|+.++|||||||++|||++|..||.... .+.+.+...... .+..
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~----~p~~ 415 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT----YPDK 415 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC----CCTT
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC----CCcc
Confidence 234689999999999999999999999999999999997642 233333333322 3356
Q ss_pred CcHHHHHHHHHhhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcc
Q psy48 1028 ISSDAIDLINNLLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPK 1084 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~ 1084 (1098)
+++++.+||.+||+.||++||+ +++|++||||++ ++|+.|+.+ +.||+.+...
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~----i~w~~l~~~~~~pp~~P~~~ 474 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD----ISWRQLEAGMLTPPFVPDSR 474 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT----CCHHHHHTTCSCCSCCCCSS
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC----CCHHHHHcCCCCCCCCCCcc
Confidence 8999999999999999999996 489999999998 789999987 8889887654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=362.15 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=208.7
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.+|.....||.|.+|.||.+.++.+++.||||+++...........+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999999999999999998766556666888999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
|++++++..+ ....+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..+
T Consensus 82 ~~~~~l~~~~-~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 82 FCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG---ELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHH-HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECCSCCSC
T ss_pred cCCCCHHHHH-HhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEeecccceecCCcccc
Confidence 9998777554 44567899999999999999999999999999999999999999998 89999999997543
Q ss_pred -------CCCCChhhhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCChhHHH---HHHHhhccCCCC------------
Q psy48 967 -------EKSFPPEVLRNKG-YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE---QIQNAAFMYPPR------------ 1023 (1098)
Q Consensus 967 -------~~~~APEvl~~~~-ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~---~i~~~~~~~p~~------------ 1023 (1098)
..|+|||++.+.. ++.++|||||||++|+|++|..||....+..+ .+.......+..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 2257999998766 89999999999999999999888654432222 222211111111
Q ss_pred -------------CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1024 -------------PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1024 -------------~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
....+++++.+||.+||+.||++|||++|+++||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 11247899999999999999999999999999999997
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=363.83 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=222.2
Q ss_pred HHHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 806 SFLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 806 ~~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
.......+|.....||.|.+|.||.+.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp BSSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CcCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence 333456789999999999999999999999999999999976542 234678899999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+++||||+.|++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 92 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~---~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG---SVKLTDFGFCAQI 166 (297)
T ss_dssp EEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---CEEECCCTTCEEC
T ss_pred EEEEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC---CEEEeeCCCceec
Confidence 9999999999999998864 3699999999999999999999999999999999999999998 8999999998643
Q ss_pred C------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc-cCCCCCCCcCcHHH
Q psy48 966 G------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF-MYPPRPWRDISSDA 1032 (1098)
Q Consensus 966 ~------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~-~~p~~~~~~is~el 1032 (1098)
. ..|+|||++.+..|+.++||||||+++|||++|..||............... ......+..+++++
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T 3fxz_A 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (297)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHH
T ss_pred CCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHH
Confidence 2 2357999999999999999999999999999999999876544333222221 22223345789999
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
.+||.+||+.||++|||++++++||||+.......+..+...
T Consensus 247 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~~p~~~~ 288 (297)
T 3fxz_A 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAA 288 (297)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGGHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHhhChhhcccCcccccchHHHH
Confidence 999999999999999999999999999976655555544443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=383.22 Aligned_cols=252 Identities=29% Similarity=0.526 Sum_probs=223.1
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.....|.....||.|.||.||.+.++.+|+.||+|++.+..........+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34578999999999999999999999999999999998876666667889999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||+.|++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+.....+||+|||++....
T Consensus 88 v~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999888764 4579999999999999999999999999999999999999854322389999999996442
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
..|+|||++.+..|+.++|||||||++|+|++|..||.+.. +....+......++...|..+++++.+
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 246 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 23579999999999999999999999999999999997653 555666677777777778899999999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
||.+||+.||++|||+.++++||||+.
T Consensus 247 li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 247 LINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHcCCChhHCCCHHHHhcCccccC
Confidence 999999999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=371.64 Aligned_cols=246 Identities=28% Similarity=0.474 Sum_probs=218.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.+...||.|.||.||.+.+..+++.||+|+++.. ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 46789999999999999999999999999999999743 345577899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC--CCCCCcEEEeecCcccccC--
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST--NSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~--~g~~~~vKL~DFGla~~~~-- 966 (1098)
||++|++|..++......+++..++.++.||+.||.|||++||+||||||+|||++. ++ .+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~---~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS---TIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCC---CEEECCCTTCEECCTT
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCC---CEEEEECCCCeECCCC
Confidence 999999999998766667999999999999999999999999999999999999997 45 89999999997542
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..|+|||++.+..++.++||||||+++|+|++|..||.+.. +....+......++...|..++.++.+|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 23689999999999999999999999999999999998653 3444555555555544566799999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
|.+||..||++|||+.++++||||++.
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999873
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=385.99 Aligned_cols=265 Identities=23% Similarity=0.355 Sum_probs=220.0
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
.....|.....||.|+||.||.+.++.+++.||||++++.... ......+.+|+.++..++||||++++++|++.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 3457789999999999999999999999999999999763211 122345889999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-- 965 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-- 965 (1098)
+||||++|++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g---~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG---HIRLADFGSCLKLRA 214 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECCT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC---CEEEeechhheeccC
Confidence 99999999999999876656899999999999999999999999999999999999999998 8999999998643
Q ss_pred -----------CCCCCChhhhc-------cCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhh--ccCCCC
Q psy48 966 -----------GEKSFPPEVLR-------NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAA--FMYPPR 1023 (1098)
Q Consensus 966 -----------~~~~~APEvl~-------~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~--~~~p~~ 1023 (1098)
+..|+|||++. +..|+.++|||||||++|||++|+.||.+... ....+.... ..+| .
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~ 293 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP-L 293 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC-c
Confidence 22358999997 35689999999999999999999999987643 333343322 2222 1
Q ss_pred CCCcCcHHHHHHHHHhhhhcccCC---CCHHHHHcCCCcCCCCCcchhHHHHhhhCCCCCCCc
Q psy48 1024 PWRDISSDAIDLINNLLQVKQRKR---LSVDKSLAHPWLQDPATWSDLRGLERQIGTNKKKNP 1083 (1098)
Q Consensus 1024 ~~~~is~el~~LL~~cL~~dP~kR---PSa~eIL~HpfFk~~~~~~~~~~l~~~~~~~~~~~~ 1083 (1098)
....+|+++.+||.+||. +|++| +++++|++||||++ +||+.|. +..||+.+..
T Consensus 294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~----i~w~~l~-~~~~p~~p~~ 350 (412)
T 2vd5_A 294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG----LDWDGLR-DSVPPFTPDF 350 (412)
T ss_dssp ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT----CCSTTST-TSCCSCCCC-
T ss_pred cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC----CCHHHHh-hcCCCCCCcC
Confidence 235689999999999999 99998 58999999999998 5666664 4567776543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=365.01 Aligned_cols=251 Identities=30% Similarity=0.503 Sum_probs=217.3
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh----HHHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT----KQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
....|.....||.|.||.||.+.++.+++.||||++++..... .....+.+|+.+|+.++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3467999999999999999999999999999999998754322 135779999999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC-CCCcEEEeecCcccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS-ELPQVKLCDFGFARI 964 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g-~~~~vKL~DFGla~~ 964 (1098)
+++||||+.+++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+++.
T Consensus 89 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 89 VILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEECCCSCBHHHHHT-TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCHHHHHH-hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 999999999999998886 346799999999999999999999999999999999999998765 223699999999975
Q ss_pred c-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHH
Q psy48 965 I-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 965 ~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
. +..|+|||++.+..++.++|||||||++|+|++|..||.+.. +....+......++...+..++.+
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (326)
T 2y0a_A 168 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247 (326)
T ss_dssp CCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHH
Confidence 4 234689999999999999999999999999999999998654 333344444444444445678999
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+.+||.+||..||++|||+.++++||||+.
T Consensus 248 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 999999999999999999999999999997
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=375.07 Aligned_cols=251 Identities=31% Similarity=0.549 Sum_probs=215.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC---ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF---PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
...|.....||.|.||.||.+.++.+++.||||++++... .......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4679999999999999999999999999999999975321 1123567999999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhc---cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 888 VVMEKLQGDMLEMILSSE---KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~---~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
+||||++|++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++....+||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999997776533 23589999999999999999999999999999999999998776444699999999865
Q ss_pred cC------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-hHHHHHHHhhccCCCCCCCcCcHH
Q psy48 965 IG------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-DINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 965 ~~------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
.. ..|+|||++.+..|+.++|||||||++|+|++|..||.+.. .....+.......++..|..++++
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISES 262 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccccCCHH
Confidence 42 23579999999999999999999999999999999998764 334444444444444445678999
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+.+||.+||..||++|||+.++++||||++
T Consensus 263 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 263 AKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 999999999999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=361.19 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=205.5
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
....+|.....||.|.+|.||.+.+. +++.||||+++...........+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34578999999999999999999985 59999999997655444455788999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
||||++++++ .++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~---~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 97 VFEFMEKDLK-KVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG---ALKLADFGLARAFGIP 172 (311)
T ss_dssp EEECCSEEHH-HHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---CEEECCCTTCEETTSC
T ss_pred EEcCCCCCHH-HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC---CEEEccCcCceecCCC
Confidence 9999997544 56655666799999999999999999999999999999999999999998 8999999999754
Q ss_pred ---------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCC---------
Q psy48 966 ---------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRP--------- 1024 (1098)
Q Consensus 966 ---------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~--------- 1024 (1098)
+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. +....+........+..
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 233679999986 568999999999999999999999997542 33333322221111111
Q ss_pred -----------------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1025 -----------------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1025 -----------------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
...+++++.+||.+||+.||++|||++++++||||++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 1246789999999999999999999999999999997
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=357.41 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=206.3
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.+|.....||.|.+|.||.+.+ .+++.||||+++...........+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 4688899999999999999998 789999999997654333334678899999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+++ +|..++....+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG---ELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS---CEEECCTTHHHHHCC----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC---CEEEeECccccccCccccc
Confidence 9987 56677766667899999999999999999999999999999999999999998 8999999998643
Q ss_pred ------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH--HHHhhccCCC--------------
Q psy48 966 ------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ--IQNAAFMYPP-------------- 1022 (1098)
Q Consensus 966 ------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~--i~~~~~~~p~-------------- 1022 (1098)
+..|+|||++.+ ..++.++||||||+++|||++|..||.+....... +.......+.
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 334689999976 45899999999999999999999999876433222 2111110000
Q ss_pred -----------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1023 -----------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1023 -----------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.....+++++.+||.+||+.||++|||++++++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 012357899999999999999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=351.63 Aligned_cols=251 Identities=30% Similarity=0.531 Sum_probs=223.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|.+|.||.+.++.+++.||+|++............+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46789999999999999999999999999999999887766777788999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+.+++|...+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++....+||+|||++....
T Consensus 85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 99999999777763 4579999999999999999999999999999999999999877644469999999986442
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
..|+|||++.+..++.++||||||+++|+|++|..||.... .....+......++...+..+++++.+||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence 23579999999999999999999999999999999997653 444555566666666667789999999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+||+.||++|||+.++++||||++.
T Consensus 244 ~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 244 SMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHcccChhhCCCHHHHhcCccccCC
Confidence 9999999999999999999999973
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=374.17 Aligned_cols=252 Identities=19% Similarity=0.263 Sum_probs=212.6
Q ss_pred HHHHhhheeeeeeeeee--eeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC
Q psy48 807 FLLMLVFMTYNVALCIA--VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG 884 (1098)
Q Consensus 807 ~~~~l~~~~~~~~Lg~G--~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~ 884 (1098)
+....+.|.....||.| ++|.||.+.++.+++.||||+++...........+.+|+.+++.++||||++++++|.+.+
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 34456789999999999 9999999999999999999999887666666788999999999999999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
.+++||||+.+++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~---~~kl~dfg~~~ 176 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG---KVYLSGLRSNL 176 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---CEEECCGGGCE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEcccccce
Confidence 999999999999999888654 35699999999999999999999999999999999999999988 89999999874
Q ss_pred cc-------------------CCCCCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc---
Q psy48 964 II-------------------GEKSFPPEVLRN--KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM--- 1019 (1098)
Q Consensus 964 ~~-------------------~~~~~APEvl~~--~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~--- 1019 (1098)
.. +..|+|||++.+ ..|+.++|||||||++|||++|+.||.+..............
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 32 122689999987 679999999999999999999999997642211111100000
Q ss_pred -----------------------------------------CCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCC
Q psy48 1020 -----------------------------------------YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058 (1098)
Q Consensus 1020 -----------------------------------------~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~Hpf 1058 (1098)
.....+..+++++.+||.+||+.||++|||++++++|||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 000123457899999999999999999999999999999
Q ss_pred cCC
Q psy48 1059 LQD 1061 (1098)
Q Consensus 1059 Fk~ 1061 (1098)
|+.
T Consensus 337 f~~ 339 (389)
T 3gni_B 337 FKQ 339 (389)
T ss_dssp GGG
T ss_pred HHH
Confidence 997
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=371.76 Aligned_cols=249 Identities=31% Similarity=0.515 Sum_probs=219.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|++|.||.+.++.+++.||+|++.... ......+.+|+.+|+.++||||+++++++.+...+++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 467899999999999999999999999999999997643 344568999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+.|++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++. ..+||+|||+++...
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~-~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA-SSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTC-CCEEECCCTTCEECCTTSC
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCC-CceEEEecccceecCCCcc
Confidence 999999999888766667999999999999999999999999999999999999985431 179999999997543
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
..|+|||++.+..++.++|||||||++|||++|..||.+... ....+.......+...+..+++++.+||.
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 286 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence 235799999999999999999999999999999999987643 33444444445555666789999999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+||..||++|||+.++++||||+..
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 287 NLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp TTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHcCCChhHCcCHHHHhhCccccCC
Confidence 9999999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=370.62 Aligned_cols=249 Identities=27% Similarity=0.440 Sum_probs=200.6
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCC--c
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPG--R 885 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~--~ 885 (1098)
..+.+|.....||.|+||.||.+.++.+++.||||++.+..........+.+|+.+|+.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3567899999999999999999999999999999999776555666788899999999997 999999999997544 7
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+|+||||+++ +|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 86 ~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~---~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYMET-DLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC---HVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCSE-EHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---CEEECCCTTCEES
T ss_pred EEEEecccCc-CHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC---CEEecCCcccccc
Confidence 9999999986 56666653 4699999999999999999999999999999999999999998 8999999999753
Q ss_pred C---------------------------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH
Q psy48 966 G---------------------------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE 1011 (1098)
Q Consensus 966 ~---------------------------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~ 1011 (1098)
. ..|+|||++.+ ..|+.++|||||||++|||++|+.||.+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2 22579999987 6799999999999999999999999987643322
Q ss_pred HHHHh-hccCCC--------------------------------------------CCCCcCcHHHHHHHHHhhhhcccC
Q psy48 1012 QIQNA-AFMYPP--------------------------------------------RPWRDISSDAIDLINNLLQVKQRK 1046 (1098)
Q Consensus 1012 ~i~~~-~~~~p~--------------------------------------------~~~~~is~el~~LL~~cL~~dP~k 1046 (1098)
..... ....|. ..+..+++++.+||.+||..||++
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 21111 111110 011257899999999999999999
Q ss_pred CCCHHHHHcCCCcCCCC
Q psy48 1047 RLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1047 RPSa~eIL~HpfFk~~~ 1063 (1098)
|||++++++||||+...
T Consensus 320 R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 320 RISANDALKHPFVSIFH 336 (388)
T ss_dssp SCCHHHHTTSTTTTTTC
T ss_pred CCCHHHHhCCHHHHHhc
Confidence 99999999999998743
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=355.42 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=211.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..+|.....||.|++|.||.+.+..+++.||||++............+.+|+.+++.++||||+++++++...+.+++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 46788999999999999999999999999999999776555555678899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+++++|..++. ....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 82 e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 82 EYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS---VIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp ECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC---CEEEeeCCCchhccCccc
Confidence 9999999987765 445799999999999999999999999999999999999999988 89999999997543
Q ss_pred --------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH--HHHhhcc----------------
Q psy48 967 --------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ--IQNAAFM---------------- 1019 (1098)
Q Consensus 967 --------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~--i~~~~~~---------------- 1019 (1098)
..|+|||++.+ ..++.++||||||+++|+|++|..||.+....... +......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 12579999986 67899999999999999999999999876433222 1111000
Q ss_pred ---CCCC--------CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1020 ---YPPR--------PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1020 ---~p~~--------~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
.+.. .+..++.++.+||.+||+.||++|||++++++||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 0000 0135788999999999999999999999999999999843
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=364.71 Aligned_cols=233 Identities=16% Similarity=0.176 Sum_probs=183.3
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC----cEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG----RIFV 888 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~----~l~L 888 (1098)
.+.....||.|+||.||.+.+ +|+.||||+++.. ......+..|+..+..++|||||++++++...+ .+||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 467889999999999999976 6899999999653 222233445666667889999999999997653 5899
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK--------NIVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~--------gIvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
||||+++|+|..++.. ..+++..+.+++.|++.||+|||++ +||||||||+||||+.++ .+||+|||
T Consensus 79 V~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~---~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG---TCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS---CEEECCCT
T ss_pred EecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC---CEEEEeCC
Confidence 9999999999999864 4589999999999999999999987 999999999999999998 89999999
Q ss_pred ccccc----------------CCCCCChhhhccC------CCCchhHHHHHHHHHHHHHcCCCCCCCCh-----------
Q psy48 961 FARII----------------GEKSFPPEVLRNK------GYNRSLDMWSVGVIVYVSLSGTFPFNEDE----------- 1007 (1098)
Q Consensus 961 la~~~----------------~~~~~APEvl~~~------~ys~~sDVwSLGvlLyELltG~~Pf~~~~----------- 1007 (1098)
+|+.. +..|||||++.+. .|+.++|||||||+||||+||..||....
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 98632 2346899999765 36789999999999999999977653210
Q ss_pred --hHHHHHHHhh--ccCCCCCCC-----cCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1008 --DINEQIQNAA--FMYPPRPWR-----DISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1008 --~~~~~i~~~~--~~~p~~~~~-----~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.....+.... ....+..+. ..++.+.+|+.+||+.||++|||+.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0111121111 111111111 23457889999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=362.15 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=202.9
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
...+|.....||.|.+|.||.+.+..+++.||||+++...........+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 45789999999999999999999999999999999987654444556788999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC--CCCcEEEeecCccccc--
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS--ELPQVKLCDFGFARII-- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g--~~~~vKL~DFGla~~~-- 965 (1098)
|||+++ +|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+++..
T Consensus 112 ~e~~~~-~L~~~~~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 112 FEYAEN-DLKKYMD-KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EECCSE-EHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EecCCC-CHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 999997 6666665 345699999999999999999999999999999999999995433 1126999999998643
Q ss_pred ----------CCCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHH--HhhccCCCCCC-------
Q psy48 966 ----------GEKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ--NAAFMYPPRPW------- 1025 (1098)
Q Consensus 966 ----------~~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~--~~~~~~p~~~~------- 1025 (1098)
+..|+|||++.+. .++.++|||||||++|||++|..||.+......... ......+...|
T Consensus 190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (329)
T 3gbz_A 190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence 3346899999874 589999999999999999999999987654332222 21111111111
Q ss_pred -------------------CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1026 -------------------RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1026 -------------------~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..+++++.+||.+||+.||++|||++++++||||++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 116789999999999999999999999999999998
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=372.45 Aligned_cols=240 Identities=33% Similarity=0.498 Sum_probs=207.1
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
...||.|.||.||.+.+..+|+.||||+++... ......+.+|+.+|+.++||||+++++++.+.+.+++||||++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 567999999999999999999999999997643 345678999999999999999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceee--cCCCCCCcEEEeecCccccc---------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL--STNSELPQVKLCDFGFARII--------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILl--d~~g~~~~vKL~DFGla~~~--------- 965 (1098)
+|..++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++ .+||+|||+++..
T Consensus 172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~---~~kl~DFG~a~~~~~~~~~~~~ 248 (373)
T 2x4f_A 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK---QIKIIDFGLARRYKPREKLKVN 248 (373)
T ss_dssp EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTT---EEEECCCSSCEECCTTCBCCCC
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCC---cEEEEeCCCceecCCccccccc
Confidence 9988887666779999999999999999999999999999999999999 4455 8999999999754
Q ss_pred --CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhh
Q psy48 966 --GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041 (1098)
Q Consensus 966 --~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~ 1041 (1098)
+..|+|||++.+..++.++|||||||++|||++|..||.+..+ ....+.......+...+..+++++.+||.+||.
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 328 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLI 328 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSC
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcC
Confidence 2346899999999999999999999999999999999987643 334444444444555566799999999999999
Q ss_pred hcccCCCCHHHHHcCCCcCC
Q psy48 1042 VKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1042 ~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.||++|||+.++++||||++
T Consensus 329 ~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 329 KEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp SSGGGSCCHHHHHHSHHHHC
T ss_pred CChhhCCCHHHHhcCcCcCC
Confidence 99999999999999999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=356.62 Aligned_cols=246 Identities=26% Similarity=0.466 Sum_probs=203.8
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh------------------------HHHHHHHHHHHH
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT------------------------KQEAQLKNEVAI 864 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~------------------------~~~~~~~~Ei~i 864 (1098)
..+..|.....||.|.+|.||.+.+..+++.||||++.+..... .....+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34678999999999999999999999999999999997653221 123568899999
Q ss_pred HhccCCCCceeeeeeeec--CCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy48 865 LQNLCHPGVVNLERMFET--PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942 (1098)
Q Consensus 865 L~~l~HpnIv~L~~~f~~--~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~N 942 (1098)
|+.++||||+++++++.+ .+.+++||||+++++|..++ ....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999986 56899999999999987654 34579999999999999999999999999999999999
Q ss_pred eeecCCCCCCcEEEeecCcccccC------------CCCCChhhhccCC---CCchhHHHHHHHHHHHHHcCCCCCCCCh
Q psy48 943 VLLSTNSELPQVKLCDFGFARIIG------------EKSFPPEVLRNKG---YNRSLDMWSVGVIVYVSLSGTFPFNEDE 1007 (1098)
Q Consensus 943 ILld~~g~~~~vKL~DFGla~~~~------------~~~~APEvl~~~~---ys~~sDVwSLGvlLyELltG~~Pf~~~~ 1007 (1098)
||++.++ .+||+|||+++... ..|+|||++.+.. ++.++||||||+++|+|++|..||....
T Consensus 168 il~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 168 LLVGEDG---HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEECTTS---CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCC---CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999998 89999999986542 2357999998765 4789999999999999999999998754
Q ss_pred h--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1008 D--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1008 ~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
. ....+......++ ....+++++.+||.+||+.||++|||+.++++||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFP--DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHHCCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHHhcccCCCC--CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 3 2233333222222 23568999999999999999999999999999999963
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=360.39 Aligned_cols=252 Identities=31% Similarity=0.483 Sum_probs=218.0
Q ss_pred Hhhheeee-eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEE
Q psy48 810 MLVFMTYN-VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 810 ~l~~~~~~-~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~ 887 (1098)
..++|... ..||.|.+|.||.+.+..+++.||||++++..........+.+|+.+++.+. ||||+++++++...+.++
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 35566766 8899999999999999999999999999876655555678999999999885 699999999999999999
Q ss_pred EEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 888 VVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
+||||+.+++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.......+||+|||+++...
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999999998877533 3579999999999999999999999999999999999999982211289999999997542
Q ss_pred -----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 967 -----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 967 -----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
..|+|||++.+..++.++||||||+++|+|++|..||.... +....+......++...+..+++++.
T Consensus 186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 3lm5_A 186 HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLAT 265 (327)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHH
Confidence 23579999999999999999999999999999999998754 33344555555666666778999999
Q ss_pred HHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+||.+||+.||++|||++++++||||++
T Consensus 266 ~li~~~L~~dP~~Rpt~~~ll~h~~~~~ 293 (327)
T 3lm5_A 266 DFIQSLLVKNPEKRPTAEICLSHSWLQQ 293 (327)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred HHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence 9999999999999999999999999998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=361.17 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=214.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec--------
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET-------- 882 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~-------- 882 (1098)
...|.....||.|++|.||.+.++.+|+.||||++............+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 578999999999999999999999999999999997765544445678899999999999999999999976
Q ss_pred CCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 883 PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 883 ~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
.+.+++||||++++++ ..+......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~l~-~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~---~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG---VLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSEEHH-HHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTC
T ss_pred CceEEEEEeccCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC---CEEEccchhc
Confidence 4468999999998655 55555556799999999999999999999999999999999999999998 8999999998
Q ss_pred cccC----------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCC
Q psy48 963 RIIG----------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPR 1023 (1098)
Q Consensus 963 ~~~~----------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~ 1023 (1098)
+... ..|+|||++.+ ..++.++|||||||++|+|++|..||.+... ....+.......+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 6542 22579999986 5589999999999999999999999987643 333343433334433
Q ss_pred CCCc----------------------------CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHHHH
Q psy48 1024 PWRD----------------------------ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLE 1072 (1098)
Q Consensus 1024 ~~~~----------------------------is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~ 1072 (1098)
.|.. .++++.+||.+||+.||++|||++|+++||||+......+++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~ 328 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGML 328 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCSHHHH
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcccccccc
Confidence 3332 267899999999999999999999999999999755555544443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=375.72 Aligned_cols=246 Identities=27% Similarity=0.401 Sum_probs=193.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec-----CCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET-----PGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~-----~~~ 885 (1098)
..+|.....||.|.||.||.+.++.+++.||||++.+..........+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367899999999999999999999999999999997765556667889999999999999999999999943 357
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+|+||||+++ +|..++. ....+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+++..
T Consensus 132 ~~lv~e~~~~-~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~---~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIADS-DFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC---SVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCSE-EHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC---CEEECCCTTCBCT
T ss_pred EEEEEecccc-chhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC---CEeecccccchhc
Confidence 9999999865 5656664 445799999999999999999999999999999999999999998 8999999999754
Q ss_pred ---------------------------------------CCCCCChhhh-ccCCCCchhHHHHHHHHHHHHHc-------
Q psy48 966 ---------------------------------------GEKSFPPEVL-RNKGYNRSLDMWSVGVIVYVSLS------- 998 (1098)
Q Consensus 966 ---------------------------------------~~~~~APEvl-~~~~ys~~sDVwSLGvlLyELlt------- 998 (1098)
+..|+|||++ .+..|+.++|||||||+||||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 2337899987 56779999999999999999999
Q ss_pred ----CCCCCCCChh----------------------HHHHHHHhh--------------------ccCCC-------CCC
Q psy48 999 ----GTFPFNEDED----------------------INEQIQNAA--------------------FMYPP-------RPW 1025 (1098)
Q Consensus 999 ----G~~Pf~~~~~----------------------~~~~i~~~~--------------------~~~p~-------~~~ 1025 (1098)
|.++|.+... ....+.... ...+. ..+
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 6666654321 011111000 00110 113
Q ss_pred CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1026 RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1026 ~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..+++++.+||.+||..||++|||++|+|+||||++
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence 456899999999999999999999999999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=355.39 Aligned_cols=253 Identities=27% Similarity=0.425 Sum_probs=213.5
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.+.....||.|++|.||.+.+..+|+.||||+++... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 4677789999999999999999999999999997643 23356788999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-----
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE----- 967 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~----- 967 (1098)
++|++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~~~~~~~~~~~~ 198 (321)
T 2c30_A 124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG---RVKLSDFGFCAQISKDVPKR 198 (321)
T ss_dssp CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---CEEECCCTTCEECCSSSCCB
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---cEEEeeeeeeeecccCcccc
Confidence 999999988753 4699999999999999999999999999999999999999988 899999999865422
Q ss_pred -------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCC-CCCCCcCcHHHHHHHHHh
Q psy48 968 -------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYP-PRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 968 -------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p-~~~~~~is~el~~LL~~c 1039 (1098)
.|+|||++.+..++.++||||||+++|||++|+.||.................+ ......+++++.++|.+|
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 257999999999999999999999999999999999876433221111111111 122346889999999999
Q ss_pred hhhcccCCCCHHHHHcCCCcCCCCCcchhHHHH
Q psy48 1040 LQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLE 1072 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~ 1072 (1098)
|+.||++|||+.++++||||+.......+..+-
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~ 311 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQTGLPECLVPLI 311 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGCCCGGGGHHHH
T ss_pred ccCChhhCcCHHHHhcChhhccCCCcccchHHH
Confidence 999999999999999999999755555544443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=361.55 Aligned_cols=248 Identities=23% Similarity=0.402 Sum_probs=208.7
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
....|.....||.|.+|.||.+.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35689999999999999999999999999999999975432 22346788999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||++|++|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 84 ~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 84 LEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD---NLKISDFGLATVFRYNN 159 (323)
T ss_dssp EECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC---CEEECCCTTCEECEETT
T ss_pred EEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC---CEEEEEeeccceeccCC
Confidence 99999999988775 445699999999999999999999999999999999999999988 8999999999643
Q ss_pred ----------CCCCCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCChhHHHHH-HHhhccCCCCCCCcCcHHHH
Q psy48 966 ----------GEKSFPPEVLRNKGY-NRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI-QNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 966 ----------~~~~~APEvl~~~~y-s~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i-~~~~~~~p~~~~~~is~el~ 1033 (1098)
+..|+|||++.+..+ +.++||||||+++|+|++|..||.......... ...........+..+++++.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 223579999988775 789999999999999999999997643221111 11122222334577999999
Q ss_pred HHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+||.+||..||++|||+.|+++||||+..
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 99999999999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=358.63 Aligned_cols=247 Identities=31% Similarity=0.542 Sum_probs=207.8
Q ss_pred hheee-eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEE
Q psy48 812 VFMTY-NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 812 ~~~~~-~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LV 889 (1098)
..|.. ...||.|.+|.||.+.+..+++.||||++++.. ......+.+|+.++.++ +||||+++++++.+.+.+++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 34555 467999999999999999999999999997653 33456788999999884 799999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||+.+++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++....+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 999999999888864 457999999999999999999999999999999999999998874345999999998643
Q ss_pred ---------------CCCCCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCh-----------------h
Q psy48 966 ---------------GEKSFPPEVLRN-----KGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-----------------D 1008 (1098)
Q Consensus 966 ---------------~~~~~APEvl~~-----~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-----------------~ 1008 (1098)
+..|+|||++.+ ..++.++||||||+++|||++|..||.+.. .
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 223679999975 558899999999999999999999997542 2
Q ss_pred HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1009 INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1009 ~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+.+.+......++...+..++.++.+||.+||..||++|||++++++||||++
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 33444444444443334568999999999999999999999999999999997
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=354.92 Aligned_cols=244 Identities=19% Similarity=0.275 Sum_probs=202.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC------
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG------ 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~------ 884 (1098)
+..|.....||.|++|.||.+.++.+++.||||+++... .......+.+|+.+|+.++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 467899999999999999999999999999999997644 3445678999999999999999999999985543
Q ss_pred ---------------------------------------------------cEEEEEEeccCchHHHHHhhccC--ccch
Q psy48 885 ---------------------------------------------------RIFVVMEKLQGDMLEMILSSEKG--RLSE 911 (1098)
Q Consensus 885 ---------------------------------------------------~l~LVmEy~~ggsL~~~l~~~~~--~lse 911 (1098)
.+++||||++|++|..++..... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999875432 3455
Q ss_pred hHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC------------------------
Q psy48 912 RTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE------------------------ 967 (1098)
Q Consensus 912 ~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~------------------------ 967 (1098)
..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD---VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---CEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC---CEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 67899999999999999999999999999999999988 899999999875432
Q ss_pred CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCC
Q psy48 968 KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKR 1047 (1098)
Q Consensus 968 ~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kR 1047 (1098)
.|+|||++.+..++.++||||||+++|||++|..|+.........+. ....+..+...++++.+||.+||+.||++|
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVR---NLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHH---TTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhh---ccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 35799999999999999999999999999998777533322222222 122222234567889999999999999999
Q ss_pred CCHHHHHcCCCcCC
Q psy48 1048 LSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1048 PSa~eIL~HpfFk~ 1061 (1098)
||+.++++||||++
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=366.53 Aligned_cols=246 Identities=28% Similarity=0.543 Sum_probs=212.5
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~ 887 (1098)
.....|.....||.|.||.||.+.++.+++.||||++++.... ..+|++++.++ +||||+++++++.+.+.+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 3467899999999999999999999999999999999765422 34678888777 7999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-CCCCcEEEeecCccccc-
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN-SELPQVKLCDFGFARII- 965 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~-g~~~~vKL~DFGla~~~- 965 (1098)
+||||+.|++|..++. ..+.+++..++.++.||+.||+|||++||+||||||+|||+..+ +....+||+|||+++..
T Consensus 93 lv~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 93 VVTELMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEECCCCSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999988876 34579999999999999999999999999999999999998543 32225999999998743
Q ss_pred -----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----hhHHHHHHHhhccCCCCCCCcCc
Q psy48 966 -----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED-----EDINEQIQNAAFMYPPRPWRDIS 1029 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~-----~~~~~~i~~~~~~~p~~~~~~is 1029 (1098)
+..|+|||++.+..|+.++|||||||++|||++|..||... .++...+.......+...|..++
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 23468999999888999999999999999999999999752 24455555666666666678899
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+++.+||.+||..||++|||+.++++||||.+
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 99999999999999999999999999999964
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=356.64 Aligned_cols=246 Identities=26% Similarity=0.392 Sum_probs=192.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|.+|.||.+.++.+++.||||+++... .......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 356778889999999999999999999999999997643 2223467889999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhcc-----CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 891 EKLQGDMLEMILSSEK-----GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~-----~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
||+++ +|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~---~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG---QLKLGDFGLARAF 158 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---CEEECCCSSCEET
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC---CEEECcCccceec
Confidence 99996 5656665332 3589999999999999999999999999999999999999998 8999999998753
Q ss_pred ------------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCC--------
Q psy48 966 ------------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPP-------- 1022 (1098)
Q Consensus 966 ------------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~-------- 1022 (1098)
+..|+|||++.+ ..++.++|||||||++|||++|+.||.+..+. ...+.......+.
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 233689999986 46899999999999999999999999876432 2222221111000
Q ss_pred ----------------------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1023 ----------------------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1023 ----------------------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.....++.++.+||.+||+.||++|||++++++||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 011257889999999999999999999999999999997
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=361.80 Aligned_cols=247 Identities=32% Similarity=0.562 Sum_probs=203.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|.+|.||.+.+..+++.||||+++.. .....+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 45788999999999999999999999999999999753 23467889999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+.+++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.......+||+|||+++...
T Consensus 128 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 128 ELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp CCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 99999999888764 4569999999999999999999999999999999999999862222289999999987542
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh---HHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED---INEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~---~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
..|+|||++.+..++.++|||||||++|||++|..||..... ....+.......+...+..++.++.+||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 286 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHH
Confidence 236899999999999999999999999999999999976532 3344444444444455678999999999
Q ss_pred HHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1037 NNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.+||..||++|||+.++++||||+..
T Consensus 287 ~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 287 RKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp HTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred HHHccCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=361.88 Aligned_cols=239 Identities=36% Similarity=0.621 Sum_probs=195.3
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEEEEeccCc
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVMEKLQGD 896 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LVmEy~~gg 896 (1098)
..||.|+||.||.+.++.+++.||||++.+. ....+.+|+.+++.+. ||||+++++++.+....++||||++|+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 6799999999999999999999999999753 3567789999999997 999999999999999999999999999
Q ss_pred hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----------
Q psy48 897 MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------- 965 (1098)
Q Consensus 897 sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------- 965 (1098)
+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++....+||+|||+++..
T Consensus 92 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 170 (325)
T 3kn6_A 92 ELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170 (325)
T ss_dssp BHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence 99888864 467999999999999999999999999999999999999987665457999999999743
Q ss_pred -CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh---------hHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 966 -GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE---------DINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 966 -~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~---------~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
+..|+|||++.+..|+.++||||||+++|+|++|..||.... +....+......++...|..+++++.+|
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 250 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHH
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHH
Confidence 234689999999999999999999999999999999997542 2333333333344444456789999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
|.+||..||++|||++++++||||++.
T Consensus 251 i~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 251 IQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred HHHHCCCChhHCCCHHHHhcChhhccC
Confidence 999999999999999999999999973
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=354.86 Aligned_cols=251 Identities=31% Similarity=0.500 Sum_probs=215.4
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH----HHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK----QEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~----~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
....|.+...||.|.+|.||.+.+..+|+.||||++++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 35679999999999999999999999999999999987543221 35779999999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC-CcEEEeecCcccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL-PQVKLCDFGFARI 964 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~-~~vKL~DFGla~~ 964 (1098)
+++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.. ..+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999988864 4579999999999999999999999999999999999999877621 2599999999975
Q ss_pred cCC-----------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHH
Q psy48 965 IGE-----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 965 ~~~-----------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
... .|+|||++.+..++.++||||||+++|+|++|..||.+... ....+.......+...+..++.+
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred cCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHH
Confidence 432 35799999999999999999999999999999999987543 33333333333333334568899
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+.+||.+||..||++|||+.++++||||+.
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 999999999999999999999999999997
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=355.99 Aligned_cols=243 Identities=24% Similarity=0.310 Sum_probs=204.4
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..|.....||.|++|.||.+.+..+++.||||++...............|+..+..+ +||||++++++|...+.+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 578899999999999999999999999999999877655555555666666666555 8999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+++ +|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...+
T Consensus 137 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~---~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 137 ELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG---RCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp ECCCC-BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG---CEEECCCTTCEECC----
T ss_pred eccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC---CEEEccceeeeecccCCC
Confidence 99965 55566666667799999999999999999999999999999999999999988 89999999986542
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
..|+|||++.+ .++.++|||||||++|||++|..|+........ +.. ...+...+..+++++.+||.+|
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ-LRQ--GYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH-HTT--TCCCHHHHTTSCHHHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-Hhc--cCCCcccccCCCHHHHHHHHHH
Confidence 24679999987 699999999999999999999877765443322 211 1122222346889999999999
Q ss_pred hhhcccCCCCHHHHHcCCCcCCC
Q psy48 1040 LQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
|+.||++|||++++++||||+++
T Consensus 289 L~~dP~~Rpt~~ell~hp~~~~p 311 (311)
T 3p1a_A 289 LEPDPKLRATAEALLALPVLRQP 311 (311)
T ss_dssp SCSSTTTSCCHHHHHTSGGGSCC
T ss_pred cCCChhhCcCHHHHHhCccccCC
Confidence 99999999999999999999873
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=343.40 Aligned_cols=247 Identities=20% Similarity=0.210 Sum_probs=209.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LV 889 (1098)
...|.....||.|.+|.||.+.+..+++.||||+++...........+.+|+.++..+ +||||+++++++.+.+.+++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 4678999999999999999999999999999999987666666678889999999988 899999999999999999999
Q ss_pred EEeccCchHHHHHhhcc---CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC----------------C
Q psy48 890 MEKLQGDMLEMILSSEK---GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS----------------E 950 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~---~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g----------------~ 950 (1098)
|||+++++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999998886542 5689999999999999999999999999999999999998554 2
Q ss_pred CCcEEEeecCcccccCC--------CCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCC
Q psy48 951 LPQVKLCDFGFARIIGE--------KSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYP 1021 (1098)
Q Consensus 951 ~~~vKL~DFGla~~~~~--------~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p 1021 (1098)
...++|+|||++..... .|+|||++.+. .++.++||||||+++|+|++|..++....... .+.... .
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-~~~~~~---~ 245 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH-EIRQGR---L 245 (289)
T ss_dssp CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH-HHHTTC---C
T ss_pred ceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH-HHHcCC---C
Confidence 33799999999875532 35799999876 67789999999999999999998876654432 222221 2
Q ss_pred CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1022 PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1022 ~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+..+..+++++.++|.+||+.||++|||+.++++||||++
T Consensus 246 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 2334568999999999999999999999999999999997
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=350.75 Aligned_cols=248 Identities=28% Similarity=0.371 Sum_probs=200.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh---HHHHHHHHHHHHHhccC---CCCceeeeeeeecC
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT---KQEAQLKNEVAILQNLC---HPGVVNLERMFETP 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~---~~~~~~~~Ei~iL~~l~---HpnIv~L~~~f~~~ 883 (1098)
...+|.....||.|.+|.||.+.+..+++.||||+++...... .....+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3568999999999999999999999999999999997643221 11245677887777664 99999999999775
Q ss_pred C-----cEEEEEEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEe
Q psy48 884 G-----RIFVVMEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957 (1098)
Q Consensus 884 ~-----~l~LVmEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~ 957 (1098)
. .+++||||+++ +|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~---~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG---TVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS---CEEEC
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC---CEEEe
Confidence 5 58999999986 6666665433 3499999999999999999999999999999999999999988 89999
Q ss_pred ecCccccc-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhccCCCCC
Q psy48 958 DFGFARII-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYPPRP 1024 (1098)
Q Consensus 958 DFGla~~~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~~p~~~ 1024 (1098)
|||+++.. +..|+|||++.+..++.++|||||||++|+|++|..||.+..... ..+.......+...
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred eCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99998643 334689999999999999999999999999999999998764332 22222221111111
Q ss_pred -----------------------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1025 -----------------------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1025 -----------------------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
...+++++.+||.+||+.||++|||+.++++||||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 1357899999999999999999999999999999997
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=376.56 Aligned_cols=245 Identities=26% Similarity=0.442 Sum_probs=203.4
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC------
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP------ 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~------ 883 (1098)
...+|.....||.|+||.||.+.+..+++.||||++.+..........+.+|+.+|+.++||||++++++|...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 35689999999999999999999999999999999987655566678899999999999999999999999655
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
..+|+||||++++++..+ . ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 140 ~~~~lv~E~~~~~l~~~~-~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~---~~kl~DFG~a~ 212 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVI-Q---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLAR 212 (464)
T ss_dssp CEEEEEEECCSEEHHHHH-T---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---CEEECCCCCC-
T ss_pred CeEEEEEeCCCCCHHHHH-h---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC---CEEEEEEEeee
Confidence 357999999998866444 2 2489999999999999999999999999999999999999998 89999999997
Q ss_pred ccC-----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccC------------
Q psy48 964 IIG-----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY------------ 1020 (1098)
Q Consensus 964 ~~~-----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~------------ 1020 (1098)
..+ ..|+|||++.+..|+.++|||||||+||||++|+.||.+...............
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred ecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 542 336899999999999999999999999999999999987654322221111000
Q ss_pred ---------CC---CCC-----C-----------cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1021 ---------PP---RPW-----R-----------DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1021 ---------p~---~~~-----~-----------~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+. ..+ . ..++++.+||.+||..||++|||++|+++||||+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00 000 0 01567999999999999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=377.18 Aligned_cols=249 Identities=31% Similarity=0.553 Sum_probs=214.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|+||.||.+.++.++..||||++++..........+.+|+.+|+.++||||++++++|.+.+.+++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46799999999999999999999999999999999876554555678899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||+.|++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++...
T Consensus 116 e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 116 ECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 99999999777753 457999999999999999999999999999999999999987654447999999998643
Q ss_pred ------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 966 ------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
+..|+|||++.+ .|+.++|||||||++|+|++|..||.+.. +....+......++...|..+++++.+||.
T Consensus 195 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 273 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273 (494)
T ss_dssp BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHH
T ss_pred ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHH
Confidence 334689999874 69999999999999999999999998653 455556666666666667889999999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+||+.||++|||+.++++||||+.
T Consensus 274 ~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 274 QMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHCCCChhhCccHHHHhcCccccc
Confidence 999999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=358.75 Aligned_cols=255 Identities=29% Similarity=0.441 Sum_probs=214.3
Q ss_pred HHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccC---CChHHHHHHHHHHHHHhccCCCCceeeeeeeecC
Q psy48 807 FLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLR---FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP 883 (1098)
Q Consensus 807 ~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~---~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~ 883 (1098)
.......|.....||.|.+|.||.+.+..+++.||||++.+.. ........+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456788999999999999999999999999999999997642 2334557899999999999999999999999999
Q ss_pred CcEEEEEEeccCchHHHHHhhc---------------------------------------cCccchhHHHHHHHHHHHH
Q psy48 884 GRIFVVMEKLQGDMLEMILSSE---------------------------------------KGRLSERTTKFIITQILVA 924 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~---------------------------------------~~~lse~~~~~ia~qIa~g 924 (1098)
+.+++||||++|++|..++... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999998887410 1235778899999999999
Q ss_pred HHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----------------CCCCCChhhhcc--CCCCchhHH
Q psy48 925 LKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----------------GEKSFPPEVLRN--KGYNRSLDM 986 (1098)
Q Consensus 925 L~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----------------~~~~~APEvl~~--~~ys~~sDV 986 (1098)
|+|||++||+||||||+|||++.++. ..+||+|||++... +..|+|||++.+ ..++.++||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKS-FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSS-CCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCCC-ceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999986652 26999999998743 122579999975 679999999
Q ss_pred HHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 987 WSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 987 wSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
||||+++|||++|..||.+.... ...+.......+...+..+++++.+||.+||+.||++||++.++++||||++.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 99999999999999999875433 33333444344444455689999999999999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=367.85 Aligned_cols=248 Identities=26% Similarity=0.438 Sum_probs=203.7
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC-----
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP----- 883 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~----- 883 (1098)
....+|.....||.|.+|.||.+.++.+++.||||++++..........+.+|+.+|+.++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 345789999999999999999999999999999999987655566678899999999999999999999999776
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
..+|+||||+++ +|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~---~~kL~DFGla~ 177 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC---SVKVCDFGLAR 177 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---CEEECCCTTCE
T ss_pred CeEEEEEecCCc-CHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC---CEEEccCCCcc
Confidence 579999999986 6666765 345799999999999999999999999999999999999999998 89999999997
Q ss_pred cc----------------------------------CCCCCChhhh-ccCCCCchhHHHHHHHHHHHHHcCCCC------
Q psy48 964 II----------------------------------GEKSFPPEVL-RNKGYNRSLDMWSVGVIVYVSLSGTFP------ 1002 (1098)
Q Consensus 964 ~~----------------------------------~~~~~APEvl-~~~~ys~~sDVwSLGvlLyELltG~~P------ 1002 (1098)
.. +..|+|||++ .+..|+.++|||||||+||||++|..|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 54 2236899986 566799999999999999999985433
Q ss_pred -----CCCChh----------------HHHHH---HH--------------------hhccCCCC-------CCCcCcHH
Q psy48 1003 -----FNEDED----------------INEQI---QN--------------------AAFMYPPR-------PWRDISSD 1031 (1098)
Q Consensus 1003 -----f~~~~~----------------~~~~i---~~--------------------~~~~~p~~-------~~~~is~e 1031 (1098)
|.+... ....+ .. .....+.. .+..++++
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 332210 00110 00 00001111 12458999
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+.+||.+||..||++|||++++++||||++
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 999999999999999999999999999998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.39 Aligned_cols=246 Identities=20% Similarity=0.369 Sum_probs=211.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec----CCcE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET----PGRI 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~----~~~l 886 (1098)
..+|.+...||.|++|.||.+.+..++..||+|++............+.+|+.+++.++||||+++++++.. ...+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 456888999999999999999999999999999998877777777889999999999999999999999865 4568
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeec-CCCCCCcEEEeecCccc
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVLLS-TNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~g--IvHrDLKp~NILld-~~g~~~~vKL~DFGla~ 963 (1098)
++||||+++++|..++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++ .++ .+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~---~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG---SVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS---CEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC---CEEEeeCCCcc
Confidence 999999999999988864 457999999999999999999999999 99999999999998 566 89999999986
Q ss_pred cc----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc-CCCCCCCcCcHHH
Q psy48 964 II----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM-YPPRPWRDISSDA 1032 (1098)
Q Consensus 964 ~~----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~-~p~~~~~~is~el 1032 (1098)
.. +..|+|||++.+ .++.++||||||+++|+|++|..||................ .+.......++++
T Consensus 181 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (290)
T 1t4h_A 181 LKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp GCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred cccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHH
Confidence 43 334689998875 49999999999999999999999998755444443333322 2222334567899
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.++|.+||+.||++|||+.++++||||++
T Consensus 260 ~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 99999999999999999999999999997
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=363.44 Aligned_cols=267 Identities=26% Similarity=0.427 Sum_probs=219.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEee---cCCceeEEEEEeccCCC--hHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHR---KSGRGVAIKVIDKLRFP--TKQEAQLKNEVAILQNL-CHPGVVNLERMFETPG 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k---~tg~~VAVKvlkk~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~ 884 (1098)
...|.....||.|.||.||.+.+. .+++.||||++++.... ......+.+|+.+|+.+ .||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 457899999999999999999984 58999999999764321 12235577899999998 6999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
.+++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG---HVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---CEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---cEEEeeCCCCee
Confidence 99999999999999888864 45799999999999999999999999999999999999999998 899999999863
Q ss_pred c-------------CCCCCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCc
Q psy48 965 I-------------GEKSFPPEVLRN--KGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 965 ~-------------~~~~~APEvl~~--~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~ 1027 (1098)
. +..|+|||++.+ ..++.++|||||||+||||++|..||.... .....+........+..+..
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence 2 345789999986 457899999999999999999999997431 11112222222222333457
Q ss_pred CcHHHHHHHHHhhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcch
Q psy48 1028 ISSDAIDLINNLLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPKR 1085 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~~ 1085 (1098)
++..+.+||.+||..||++|| +++++++||||++ .+|+.+..+ +.+|+.+..++
T Consensus 289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~----~~~~~l~~~~~~~p~~p~~~~ 348 (355)
T 1vzo_A 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK----INWDDLAAKKVPAPFKPVIRD 348 (355)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT----CCHHHHHTTCSCCSCCCCCCC
T ss_pred cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc----CChhHhhhccCCCCCCCcccc
Confidence 899999999999999999999 9999999999998 678888887 77777665543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=345.54 Aligned_cols=245 Identities=30% Similarity=0.497 Sum_probs=212.2
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
...+|+....||.|.+|.||.+.+..++..||+|++.+... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 45679999999999999999999999999999999976542 2356789999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceee---cCCCCCCcEEEeecCccccc-
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL---STNSELPQVKLCDFGFARII- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILl---d~~g~~~~vKL~DFGla~~~- 965 (1098)
|||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .++|+|||++...
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~---~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 85 MELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS---PLKLIDFGLAARFK 160 (277)
T ss_dssp EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC---CEEECCCTTCEECC
T ss_pred EeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC---cEEEEecccceecc
Confidence 999999999887764 4569999999999999999999999999999999999999 5555 8999999998643
Q ss_pred ----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 966 ----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 966 ----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
+..|+|||++.+. ++.++||||||+++|+|++|..||..... ....+.......+...+..+++++.
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 2346799998765 99999999999999999999999986543 3344444444444434457899999
Q ss_pred HHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
++|.+||+.||++||++.++++||||++
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 9999999999999999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=355.81 Aligned_cols=257 Identities=23% Similarity=0.264 Sum_probs=215.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
...|.....||.|.+|.||.+.+..+++.||||++....... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 355888899999999999999999999999999997654333 3346799999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||+.|+++ .++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 133 ~e~~~g~l~-~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~~kL~DfG~a~~~~~~~ 208 (348)
T 1u5q_A 133 MEYCLGSAS-DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG---LVKLGDFGSASIMAPAN 208 (348)
T ss_dssp EECCSEEHH-HHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT---EEEECCCTTCBSSSSBC
T ss_pred EecCCCCHH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC---CEEEeeccCceecCCCC
Confidence 999986544 56655567899999999999999999999999999999999999999988 89999999997543
Q ss_pred -----CCCCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 967 -----EKSFPPEVLR---NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 967 -----~~~~APEvl~---~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
..|+|||++. +..++.++|||||||++|||++|..||.................+......+++++.+||.+
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 2358999985 56799999999999999999999999987654433332222233333345689999999999
Q ss_pred hhhhcccCCCCHHHHHcCCCcCCCCCcchhHHH
Q psy48 1039 LLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGL 1071 (1098)
Q Consensus 1039 cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l 1071 (1098)
||+.||++|||++++++||||........+..+
T Consensus 289 ~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~~~~ 321 (348)
T 1u5q_A 289 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 321 (348)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHH
T ss_pred HcccChhhCcCHHHHhhChhhhccCCcchhhHH
Confidence 999999999999999999999875444433333
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=355.07 Aligned_cols=249 Identities=27% Similarity=0.360 Sum_probs=212.0
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.....|.....||.|.+|.||.+.+..+++.||||++............+.+|+.+++.++||||+++++++...+.+++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 45678999999999999999999999999999999997766556666788999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
||||+++++|..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 102 v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 102 VFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG---VVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---CEEECCCTTC------
T ss_pred EEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC---cEEEEeCCCceeecCC
Confidence 999999999987754 445799999999999999999999999999999999999999998 8999999998643
Q ss_pred ---------CCCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc-----------------
Q psy48 966 ---------GEKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF----------------- 1018 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~----------------- 1018 (1098)
+..|+|||++.+. .++.++||||||+++|+|++|..||....+..........
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 2336899999875 7899999999999999999999999876543222211110
Q ss_pred ----cCCCC--------CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1019 ----MYPPR--------PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1019 ----~~p~~--------~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..+.. .+..+++++.+||.+||+.||++|||++++++||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 00000 01257899999999999999999999999999999997
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=349.01 Aligned_cols=248 Identities=32% Similarity=0.577 Sum_probs=214.6
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.....|.+...||.|.+|.||.+.+..+|+.||||+++... ......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 45678999999999999999999999999999999997643 2234678899999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceee---cCCCCCCcEEEeecCccccc
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL---STNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILl---d~~g~~~~vKL~DFGla~~~ 965 (1098)
||||+++++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||++ +.++ .++|+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~---~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 84 VMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS---KIMITDFGLSKME 159 (304)
T ss_dssp EECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC---CEEBCSCSTTCCC
T ss_pred EEEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC---CEEEccCCcceec
Confidence 9999999999888753 4579999999999999999999999999999999999999 4555 8999999998643
Q ss_pred ----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 966 ----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 966 ----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
+..|+|||++.+..++.++||||||+++|+|++|..||.... .....+......++...+..+++++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 160 QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp CCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred CCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 334689999999999999999999999999999999998653 34445555544555555678999999
Q ss_pred HHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
++|.+||..||++||++.++++||||++.
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=361.03 Aligned_cols=246 Identities=28% Similarity=0.459 Sum_probs=205.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..+|.+...||.|+||.||.+.++.+++.||||++.+... ....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 4679999999999999999999999999999999976432 2356889999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||+.+++|..++.. .+++++..++.++.||+.||+|||++||+||||||+|||++.++.. ++||+|||+++..
T Consensus 96 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~-~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 96 EYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSC-CEEECCCCCC--------
T ss_pred EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCc-eEEEeecCccccccccCC
Confidence 99999999888763 4579999999999999999999999999999999999999876621 5999999998632
Q ss_pred ------CCCCCChhhhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCh---hHHHHHHHh-hccCCCCCCCcCcHHHHH
Q psy48 966 ------GEKSFPPEVLRNKGYNRS-LDMWSVGVIVYVSLSGTFPFNEDE---DINEQIQNA-AFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~-sDVwSLGvlLyELltG~~Pf~~~~---~~~~~i~~~-~~~~p~~~~~~is~el~~ 1034 (1098)
+..|+|||++.+..++.+ +|||||||++|+|++|+.||.+.. .....+... ...+.......+++++.+
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 253 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHH
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHH
Confidence 345689999998888655 899999999999999999997642 222222221 112222223468999999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
||.+||..||++|||+.++++||||..
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 254 LISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp HHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred HHHHHccCChhHCcCHHHHHhCcchhc
Confidence 999999999999999999999999965
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=375.20 Aligned_cols=251 Identities=32% Similarity=0.532 Sum_probs=219.1
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
...+|.+...||.|.+|.||.+.++.+++.||||++.+..........+.+|+.+|+.++||||+++++++.+.+.+++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 35689999999999999999999999999999999976443334467889999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||+.|++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 100 GELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp ECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 999999999877754 457999999999999999999999999999999999999976554447999999998743
Q ss_pred -------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 966 -------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 966 -------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
+..|+|||++.+. |+.++|||||||++|+|++|..||.+.. +....+......++...|..+|+++.+||
T Consensus 179 ~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 257 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257 (486)
T ss_dssp ---CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHH
T ss_pred ccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHH
Confidence 2235799999874 9999999999999999999999998754 44455555555566666788999999999
Q ss_pred HHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1037 NNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.+||..||++|||+.++++||||+..
T Consensus 258 ~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 258 RKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HHHcCCChhhCcCHHHHhcCHhhccC
Confidence 99999999999999999999999853
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=344.93 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=198.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
....|.....||.|++|.||.+.+..+++.||||+++...........+.++...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 34678999999999999999999999999999999976543344445556666668888999999999999999999999
Q ss_pred EEeccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 890 MEKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~-gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
|||++|+ |..++.. ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus 85 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDTS-LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG---QVKMCDFGISGYL 160 (290)
T ss_dssp EECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC---CEEBCCC------
T ss_pred Eehhccc-hHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC---CEEEeecCCcccc
Confidence 9999874 4444432 456799999999999999999999998 999999999999999988 8999999998643
Q ss_pred -----------CCCCCChhhh----ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-hHHHHHHHhhccCCCCCCCcCc
Q psy48 966 -----------GEKSFPPEVL----RNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-DINEQIQNAAFMYPPRPWRDIS 1029 (1098)
Q Consensus 966 -----------~~~~~APEvl----~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-~~~~~i~~~~~~~p~~~~~~is 1029 (1098)
+..|+|||++ .+..++.++||||||+++|+|++|..||.... .............+......++
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence 3346899996 56679999999999999999999999998643 2222222223333333345689
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+++.++|.+||+.||++|||+.++++||||+.
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 99999999999999999999999999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=365.79 Aligned_cols=244 Identities=28% Similarity=0.499 Sum_probs=207.9
Q ss_pred hheeee-eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHh-ccCCCCceeeeeeeec----CCc
Q psy48 812 VFMTYN-VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQ-NLCHPGVVNLERMFET----PGR 885 (1098)
Q Consensus 812 ~~~~~~-~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~-~l~HpnIv~L~~~f~~----~~~ 885 (1098)
..|... ..||.|.||.||.+.++.+++.||||+++.. ..+.+|+.++. ..+||||++++++|.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 345554 6899999999999999999999999999642 35677888874 5589999999999865 567
Q ss_pred EEEEEEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
+|+||||+.|++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999998887543 3699999999999999999999999999999999999999832222899999999975
Q ss_pred c-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh------hHHHHHHHhhccCCCCCCCc
Q psy48 965 I-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE------DINEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 965 ~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~------~~~~~i~~~~~~~p~~~~~~ 1027 (1098)
. +..|+|||++.+..|+.++|||||||+||||++|..||.... .....+......++...|..
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 293 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293 (400)
T ss_dssp CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence 4 234689999999999999999999999999999999997543 24556666666667667788
Q ss_pred CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1028 ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
++.++.+||.+||..||++|||+.++++||||++.
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=373.66 Aligned_cols=250 Identities=31% Similarity=0.523 Sum_probs=218.4
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
...+|.....||.|.+|.||.+.++.+++.||||++.+.... ......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 356899999999999999999999999999999999775543 3346789999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||+.|++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||+++...
T Consensus 104 v~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 104 VGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EECCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999988776 34579999999999999999999999999999999999999643323389999999986542
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..|+|||++.+ .|+.++|||||||++|+|++|..||.+.. +....+......++...|..+|+++.+|
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 261 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHH
T ss_pred cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHH
Confidence 34689999987 59999999999999999999999998764 3445555555555656678899999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
|.+||+.||++|||+.++++||||+.
T Consensus 262 i~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 262 IRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred HHHHCCCChhHCcCHHHHhhChhhcc
Confidence 99999999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=345.37 Aligned_cols=243 Identities=28% Similarity=0.456 Sum_probs=211.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
+..|.....||.|.+|.||.+.+..+++.||||++.+..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 567899999999999999999999999999999997633211 1246789999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~---~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG---ELKIADFGWSVHAPSSR 163 (279)
T ss_dssp ECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS---CEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC---CEEEEeccccccCCccc
Confidence 999999999888764 45799999999999999999999999999999999999999998 8999999988543
Q ss_pred ------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 966 ------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
+..++|||++.+..++.++||||||+++|+|++|..||..... ....+....... ...+++++.+||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~ 239 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLIS 239 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC----CTTSCHHHHHHHH
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC----CCcCCHHHHHHHH
Confidence 3346899999999999999999999999999999999986543 333333333222 3458899999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+||+.||++|||+.++++||||+.
T Consensus 240 ~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 240 RLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp HHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHhccChhhCCCHHHHhhCccccC
Confidence 999999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.02 Aligned_cols=248 Identities=28% Similarity=0.479 Sum_probs=207.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.+...||.|.+|.||.+.++.++..||+|++..... ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4678999999999999999999999999999999976542 233577899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhc---cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 891 EKLQGDMLEMILSSE---KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~---~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
||+++++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999988877533 3579999999999999999999999999999999999999654333389999999996532
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
..|+|||++. ..++.++||||||+++|+|++|..||.+... ...........++. ....+++++.+
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 257 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-ECRPLTPQAVD 257 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHHHHH
T ss_pred cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc-ccCcCCHHHHH
Confidence 2357999986 4689999999999999999999999987542 22222222222221 22347899999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
||.+||+.||++|||+.++++||||++
T Consensus 258 li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 258 LLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=356.49 Aligned_cols=245 Identities=27% Similarity=0.362 Sum_probs=203.4
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|.....||.|++|.||.+.+..+++.||||+++.... ......+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 468889999999999999999999999999999965331 1112245679999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+++ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~---~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG---ELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC---CEEECSSSEEECC------
T ss_pred cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC---CEEEccCcccccccCCccc
Confidence 9986 55566666666799999999999999999999999999999999999999998 8999999998643
Q ss_pred ------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCC------------
Q psy48 966 ------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRP------------ 1024 (1098)
Q Consensus 966 ------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~------------ 1024 (1098)
+..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.... ...+.......+...
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 223579999986 66899999999999999999999999876432 222222211111111
Q ss_pred --------------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1025 --------------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1025 --------------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+..+++++.+||.+||+.||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 1246889999999999999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=346.51 Aligned_cols=249 Identities=28% Similarity=0.414 Sum_probs=197.6
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
.....|.....||.|.+|.||.+.+..+++.||||++.+..... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 34567999999999999999999999999999999997532111 12367899999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
+||||+++++|..++......+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~---~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM---NIKIADFGLATQLKM 164 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC---CEEECCCTTCEECC-
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC---CEEEEeecceeeccC
Confidence 99999999999999887667899999999999999999999999999999999999999988 89999999987542
Q ss_pred -----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 -----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 -----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..|+|||++.+..++.++||||||+++|+|++|..||........ +... ..........++.++.++
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKV-VLADYEMPSFLSIEAKDL 242 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------C-CSSCCCCCTTSCHHHHHH
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHH-hhcccCCccccCHHHHHH
Confidence 236799999999999999999999999999999999976432111 1111 111112234588999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
|.+||..||++|||++++++||||++.
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHcccCHhhCCCHHHHhcCccccCC
Confidence 999999999999999999999999873
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=364.04 Aligned_cols=242 Identities=28% Similarity=0.467 Sum_probs=204.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
.+.|.....||.|+||.||.+.+..+++.||||++.+..... .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 578999999999999999999999999999999997642211 1135789999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||++|+ |..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 88 ~E~~~g~-l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~---~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYAGGE-LFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL---NVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCCCEE-HHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC---CEEECCSSCTBTTTTSB
T ss_pred EECCCCc-HHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC---CEEEEEeccceeccCCc
Confidence 9999655 5455543 45799999999999999999999999999999999999999998 8999999998643
Q ss_pred -------CCCCCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 966 -------GEKSFPPEVLRNKGY-NRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 966 -------~~~~~APEvl~~~~y-s~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
+..|+|||++.+..+ +.++|||||||++|+|++|..||.+... ....+.. .....+..+++++.+|
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS----CVYVMPDFLSPGAQSL 238 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS----SCCCCCTTSCHHHHHH
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----CCCCCcccCCHHHHHH
Confidence 234689999998876 7899999999999999999999976421 1111111 1112234589999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
|.+||..||.+|||++++++||||+.
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred HHHHcCCChhHCcCHHHHHhChhhcc
Confidence 99999999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=369.07 Aligned_cols=259 Identities=34% Similarity=0.633 Sum_probs=215.2
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC------hHHHHHHHHHHHHHhccCCCCceeeeeeeecC
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP------TKQEAQLKNEVAILQNLCHPGVVNLERMFETP 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~------~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~ 883 (1098)
....|.....||.|+||.||.+.++.+++.||||++.+.... ......+.+|+.+|+.++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 456899999999999999999999999999999999764322 1112358899999999999999999999865
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
+.+++||||+.+++|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++....+||+|||+++
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred CceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 45899999999999977765 44679999999999999999999999999999999999999876644479999999997
Q ss_pred cc-----------CCCCCChhhhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCC---hhHHHHHHHhhccCCCCCCC
Q psy48 964 II-----------GEKSFPPEVLRN---KGYNRSLDMWSVGVIVYVSLSGTFPFNED---EDINEQIQNAAFMYPPRPWR 1026 (1098)
Q Consensus 964 ~~-----------~~~~~APEvl~~---~~ys~~sDVwSLGvlLyELltG~~Pf~~~---~~~~~~i~~~~~~~p~~~~~ 1026 (1098)
.. +..|+|||++.+ ..|+.++|||||||++|+|++|..||... ......+......+.+..|.
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 370 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHT
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhc
Confidence 54 234689999863 67889999999999999999999999754 24455555555444444556
Q ss_pred cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1027 DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1027 ~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
.+++++.+||.+||+.||++||+++++++||||++ .++...-++
T Consensus 371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~----~~~~~~~~~ 414 (419)
T 3i6u_A 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD----EDMKRKFQD 414 (419)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC----HHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC----hhHHHHHHH
Confidence 78999999999999999999999999999999998 455544333
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=351.00 Aligned_cols=251 Identities=35% Similarity=0.649 Sum_probs=210.3
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC------hHHHHHHHHHHHHHhccCCCCceeeeeeeecC
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP------TKQEAQLKNEVAILQNLCHPGVVNLERMFETP 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~------~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~ 883 (1098)
....|.....||.|.+|.||.+.+..+++.||||++.+.... ......+.+|+.+|+.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 456899999999999999999999999999999999764321 12234588999999999999999999999766
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
+ .++||||+.+++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++.
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred c-eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 5 899999999999988775 44579999999999999999999999999999999999999987644469999999997
Q ss_pred cc-----------CCCCCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCh---hHHHHHHHhhccCCCCCCC
Q psy48 964 II-----------GEKSFPPEVLR---NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE---DINEQIQNAAFMYPPRPWR 1026 (1098)
Q Consensus 964 ~~-----------~~~~~APEvl~---~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~---~~~~~i~~~~~~~p~~~~~ 1026 (1098)
.. +..|+|||++. +..++.++||||||+++|+|++|..||.... .+...+........+..+.
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence 54 34578999984 5678999999999999999999999997542 4445555444444333445
Q ss_pred cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1027 DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1027 ~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.++.++.+||.+||..||++||++.++++||||++.
T Consensus 246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 789999999999999999999999999999999983
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=359.74 Aligned_cols=245 Identities=26% Similarity=0.452 Sum_probs=202.5
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC-----
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG----- 884 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~----- 884 (1098)
....|.....||.|++|.||.+.+..+++.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 356799999999999999999999999999999999876555666678999999999999999999999997664
Q ss_pred -cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 885 -RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 885 -~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
.+++||||++++++ .++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 103 ~~~~lv~e~~~~~l~-~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~---~~kl~Dfg~a~ 175 (371)
T 2xrw_A 103 QDVYIVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLAR 175 (371)
T ss_dssp CEEEEEEECCSEEHH-HHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS---CEEECCCCC--
T ss_pred cceEEEEEcCCCCHH-HHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC---CEEEEEeeccc
Confidence 78999999997655 5543 3589999999999999999999999999999999999999998 89999999986
Q ss_pred ccC-----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc-------------
Q psy48 964 IIG-----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM------------- 1019 (1098)
Q Consensus 964 ~~~-----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~------------- 1019 (1098)
..+ ..|+|||++.+..|+.++|||||||++|+|++|..||.+..............
T Consensus 176 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 542 23689999999999999999999999999999999998765432221111100
Q ss_pred --------CCCC---C----------------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1020 --------YPPR---P----------------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1020 --------~p~~---~----------------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+.. . ....+.++.+||.+||..||++|||++++++||||+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0000 0 0012578999999999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=342.95 Aligned_cols=256 Identities=24% Similarity=0.320 Sum_probs=213.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
....|.....||.|.+|.||.+.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4567899999999999999999999999999999997542 33457788999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc-----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI----- 964 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~----- 964 (1098)
|||+++++|..++......+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG---DIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS---CEEECCCHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC---CEEEEECCCCccccccc
Confidence 999999999988876677899999999999999999999999999999999999999888 899999998742
Q ss_pred -------cCCCCCChhhh-----ccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCC-CCCCcCcHH
Q psy48 965 -------IGEKSFPPEVL-----RNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPP-RPWRDISSD 1031 (1098)
Q Consensus 965 -------~~~~~~APEvl-----~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~-~~~~~is~e 1031 (1098)
.+..|+|||++ .+..++.++||||||+++|+|++|..||.................+. .....++.+
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHH
Confidence 13346899998 36778999999999999999999999998764433222222222221 223568899
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHH
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRG 1070 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~ 1070 (1098)
+.++|.+||..||++|||+.++++||||++......+..
T Consensus 252 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~ 290 (302)
T 2j7t_A 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290 (302)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHHHH
T ss_pred HHHHHHHHcccChhhCCCHHHHhcChHHhhhccchhHHH
Confidence 999999999999999999999999999998544333333
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=342.32 Aligned_cols=250 Identities=32% Similarity=0.540 Sum_probs=216.9
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
...+|.....||.|.+|.||.+.+..+++.||||++............+.+|+.+++.++||||+++++++...+.+++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 35789999999999999999999999999999999987655555567899999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC--
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE-- 967 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~-- 967 (1098)
|||+.+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 100 GELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp ECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 999999999777753 35799999999999999999999999999999999999998765444799999999875432
Q ss_pred ---------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 968 ---------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 968 ---------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
.++|||++.+. ++.++||||||+++|+|++|..||.... +....+.......+...+..+++++.++|
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 257 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHH
T ss_pred ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHH
Confidence 35799999865 8999999999999999999999998754 33344444444444444567899999999
Q ss_pred HHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1037 NNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+||..||++|||+.++++||||++
T Consensus 258 ~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 258 RKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHcccChhhCcCHHHHhcCHHHhc
Confidence 9999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=374.57 Aligned_cols=252 Identities=30% Similarity=0.510 Sum_probs=215.3
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-----------HHHHHHHHHHHHHhccCCCCceeeee
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-----------KQEAQLKNEVAILQNLCHPGVVNLER 878 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-----------~~~~~~~~Ei~iL~~l~HpnIv~L~~ 878 (1098)
....|.....||.|+||.||.+.++.+++.||||++++..... .....+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3567999999999999999999999999999999998754332 23467899999999999999999999
Q ss_pred eeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEee
Q psy48 879 MFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCD 958 (1098)
Q Consensus 879 ~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~D 958 (1098)
++.+...+++||||++|++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999887764 45799999999999999999999999999999999999999877545799999
Q ss_pred cCccccc-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCC
Q psy48 959 FGFARII-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPW 1025 (1098)
Q Consensus 959 FGla~~~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~ 1025 (1098)
||++... +..|+|||++.+ .|+.++|||||||++|+|++|..||.+.. +....+......++...|
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 9999653 234679999875 59999999999999999999999998753 445555555555555556
Q ss_pred CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1026 RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1026 ~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
..+|+++.+||.+||..||.+|||++++++||||+...
T Consensus 272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 78999999999999999999999999999999998644
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=356.81 Aligned_cols=247 Identities=24% Similarity=0.425 Sum_probs=202.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC------
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG------ 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~------ 884 (1098)
...|.....||.|.+|.||.+.+..+|+.||||++............+.+|+.+|+.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 45788999999999999999999999999999999765555556678999999999999999999999997663
Q ss_pred cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
.+|+||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC---ELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---CEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC---CEEEEeeecccc
Confidence 469999999 7788888764 5699999999999999999999999999999999999999998 899999999975
Q ss_pred cC---------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--HHHHhhcc-------------
Q psy48 965 IG---------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQNAAFM------------- 1019 (1098)
Q Consensus 965 ~~---------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~i~~~~~~------------- 1019 (1098)
.. ..|+|||++.+ ..|+.++|||||||++|||++|+.||.+...... .+......
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 178 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred cccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 42 23579999987 7899999999999999999999999987643322 11111000
Q ss_pred ----------CCC----CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1020 ----------YPP----RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1020 ----------~p~----~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
.+. ..+..+++++.+||.+||..||++|||++++++||||++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 001 11245789999999999999999999999999999999743
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=338.59 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=213.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeee--ecCCcEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF--ETPGRIFV 888 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f--~~~~~l~L 888 (1098)
...|.....||.|.+|.||.+.+..+++.||+|++............+.+|+.+++.++||||+++++++ .....+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 5678999999999999999999999999999999987766677778899999999999999999999987 44678999
Q ss_pred EEEeccCchHHHHHhhcc---CccchhHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 889 VMEKLQGDMLEMILSSEK---GRLSERTTKFIITQILVALKHLHSKN-----IVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~---~~lse~~~~~ia~qIa~gL~~LHs~g-----IvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
||||+++++|..++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++ .+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~---~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ---NVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS---CEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC---CEEEecCc
Confidence 999999999988886432 34999999999999999999999999 99999999999999988 89999999
Q ss_pred ccccc------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCC
Q psy48 961 FARII------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWR 1026 (1098)
Q Consensus 961 la~~~------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~ 1026 (1098)
++... +..|+|||++.+..++.++||||||+++|+|++|..||..... ....+..... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~ 238 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIPY 238 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---CCCCT
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc---ccCCc
Confidence 98654 3347899999999999999999999999999999999986542 3333333322 22234
Q ss_pred cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1027 DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1027 ~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
.++.++.++|.+||+.||++||++.++++|+|+.++.
T Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 6899999999999999999999999999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=353.23 Aligned_cols=249 Identities=26% Similarity=0.333 Sum_probs=201.5
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH---HHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK---QEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
.....|.....||.|.+|.||.+.+..+|+.||||+++....... ....+.+|+.+++.++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345778999999999999999999999999999999975432221 12468899999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+++||||+++ +|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~---~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG---VLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---CEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC---CEEEEecccceec
Confidence 9999999997 56677766666799999999999999999999999999999999999999998 8999999998754
Q ss_pred C------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--HHHHhhccCCCCC------
Q psy48 966 G------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQNAAFMYPPRP------ 1024 (1098)
Q Consensus 966 ~------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~i~~~~~~~p~~~------ 1024 (1098)
. ..|+|||++.+ ..++.++|||||||++|||++|.+||.+..+... .+...........
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 2 23679999976 4589999999999999999999999987654322 2222211111111
Q ss_pred ------------------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1025 ------------------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1025 ------------------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+..++.++.+||.+||..||++|||+.|+++||||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 1356789999999999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=345.52 Aligned_cols=259 Identities=24% Similarity=0.310 Sum_probs=216.2
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.....|.....||.|.+|.||.+.+..+|+.||||++.... ....+.+|+.+++.++||||+++++++...+.+++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34567888999999999999999999999999999997642 23568899999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE- 967 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~- 967 (1098)
||||+++++|..++......+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++.....
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~---~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG---HAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---CEEECCCTTCEECBTT
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC---CEEEeecccchhhhhh
Confidence 9999999999999876677899999999999999999999999999999999999999988 899999999864422
Q ss_pred -----------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccC-CCCCCCcCcHHHHHH
Q psy48 968 -----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY-PPRPWRDISSDAIDL 1035 (1098)
Q Consensus 968 -----------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~-p~~~~~~is~el~~L 1035 (1098)
.|+|||++.+..++.++||||||+++|+|++|..||................. .......++.++.+|
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 258 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF 258 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence 25799999999999999999999999999999999987654333222211111 112234578999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhHHHHhh
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~~l~~~ 1074 (1098)
|.+||..||++|||+.++++||||+....+..+..+.++
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~ 297 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINE 297 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGGHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHhCHHHhcCCcchHHHHHhhh
Confidence 999999999999999999999999997777777766555
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=338.46 Aligned_cols=246 Identities=23% Similarity=0.412 Sum_probs=210.9
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
....|.....||.|.+|.||.+.+..+++.||||+++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 45789999999999999999999999999999999976432 23457889999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||+++++|..++. ....+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++...
T Consensus 84 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~---~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 84 LEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD---NLKISDFGLATVFRYNN 159 (276)
T ss_dssp EECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC---CEEECCCTTCEECEETT
T ss_pred EEecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC---CEEEeeCCCccccCCCc
Confidence 99999999988775 345799999999999999999999999999999999999999988 8999999998643
Q ss_pred ----------CCCCCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCChhH---HHHHHHhhccCCCCCCCcCcHH
Q psy48 966 ----------GEKSFPPEVLRNKGY-NRSLDMWSVGVIVYVSLSGTFPFNEDEDI---NEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 966 ----------~~~~~APEvl~~~~y-s~~sDVwSLGvlLyELltG~~Pf~~~~~~---~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
...++|||++.+..+ +.++||||||+++|+|++|..||...... ...+... ......+..++++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSA 237 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT--CTTSTTGGGSCHH
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc--ccccCchhhcCHH
Confidence 123579999988775 78999999999999999999999764321 2222221 1122235678999
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+.++|.+||+.||++|||+.++++||||++.
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 238 PLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 9999999999999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=339.44 Aligned_cols=249 Identities=31% Similarity=0.526 Sum_probs=215.2
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC---Ch----HHHHHHHHHHHHHhccC-CCCceeeeeee
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF---PT----KQEAQLKNEVAILQNLC-HPGVVNLERMF 880 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~---~~----~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f 880 (1098)
.....|.....||.|.+|.||.+.++.+++.||||+++.... .. .....+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 346789999999999999999999999999999999976431 11 22367889999999995 99999999999
Q ss_pred ecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 881 ETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 881 ~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
...+..++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~---~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM---NIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC---CEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC---cEEEeccc
Confidence 999999999999999999888864 45799999999999999999999999999999999999999998 89999999
Q ss_pred cccccC-----------CCCCChhhhc------cCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCC
Q psy48 961 FARIIG-----------EKSFPPEVLR------NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYP 1021 (1098)
Q Consensus 961 la~~~~-----------~~~~APEvl~------~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p 1021 (1098)
++.... ..++|||++. ...++.++||||||+++|+|++|..||.... .....+.......+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred chhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence 986542 2357999985 4568999999999999999999999998654 33344445455555
Q ss_pred CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1022 PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1022 ~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
...+..++.++.++|.+||+.||++|||+.++++||||++
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence 5556789999999999999999999999999999999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=340.23 Aligned_cols=242 Identities=25% Similarity=0.349 Sum_probs=208.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec--------
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET-------- 882 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~-------- 882 (1098)
...|.....||.|.+|.||.+.+..+++.||||+++.. ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 46789999999999999999999999999999999653 3455789999999999999999999998754
Q ss_pred -----CCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEe
Q psy48 883 -----PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957 (1098)
Q Consensus 883 -----~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~ 957 (1098)
.+.+++||||+++++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~---~~kl~ 158 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR---NVKIG 158 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS---CEEEC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC---CEEEe
Confidence 4578999999999999999987666788999999999999999999999999999999999999988 89999
Q ss_pred ecCcccccC--------------------------CCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCh---
Q psy48 958 DFGFARIIG--------------------------EKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDE--- 1007 (1098)
Q Consensus 958 DFGla~~~~--------------------------~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~--- 1007 (1098)
|||++.... ..|+|||++.+. .++.++||||||+++|+|++ ||....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 999986542 236799999865 69999999999999999998 665432
Q ss_pred hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1008 DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1008 ~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.....+......++.......+..+.++|.+||+.||++|||+.++++||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 233333344444555555667889999999999999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.63 Aligned_cols=250 Identities=30% Similarity=0.499 Sum_probs=214.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH----HHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK----QEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~----~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
...|.....||.|.+|.||.+.+..+++.||||+++....... ....+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 4578999999999999999999999999999999987544322 357899999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCC-CCcEEEeecCccccc
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE-LPQVKLCDFGFARII 965 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~-~~~vKL~DFGla~~~ 965 (1098)
++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++. ...+||+|||++...
T Consensus 84 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999888864 457999999999999999999999999999999999999987652 226999999998754
Q ss_pred C-----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcCcHHH
Q psy48 966 G-----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 966 ~-----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
. ..|+|||++.+..++.++||||||+++|+|++|..||...... ...+.......+...+..++.++
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHH
Confidence 2 2357999999999999999999999999999999999875432 23333333233333335688999
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.++|.+||..||++||++.++++||||+.
T Consensus 243 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 243 KDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=370.98 Aligned_cols=244 Identities=30% Similarity=0.566 Sum_probs=212.3
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
..+.|.....||.|.||.||.+.+..+|+.||||++++..... .....+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3568999999999999999999999999999999997643211 224678999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
||||++|++|..++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 94 v~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~---~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 94 VMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM---NAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEECCSSEEHHHHTT-SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC---CEEECCCSSCEECCTT
T ss_pred EEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC---CeEEEeccchhhcccc
Confidence 999999999988886 456799999999999999999999999999999999999999998 8999999998754
Q ss_pred --------CCCCCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 966 --------GEKSFPPEVLRNKGY-NRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 --------~~~~~APEvl~~~~y-s~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
+..|+|||++.+..+ +.++|||||||++|+|++|..||.+.. .....+....... +..+++++.+
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~ 245 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT----PQYLNPSVIS 245 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC----CTTCCHHHHH
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC----CccCCHHHHH
Confidence 234679999998876 789999999999999999999998653 3444444333222 2458899999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
||.+||..||++|||+.++++||||+.
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred HHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 999999999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=340.02 Aligned_cols=243 Identities=26% Similarity=0.370 Sum_probs=212.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
...|.....||.|++|.||.+.+..+++.||+|++.+.... ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 46788999999999999999999999999999999775433 44567899999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~---~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL---EVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---CEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC---CEEEEeccCceecccCc
Confidence 999999999887753 45799999999999999999999999999999999999999988 89999999986532
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..++|||++.+..++.++||||||+++|+|++|..||...... ...+...... ....+++++.++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l 245 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS----IPKHINPVAASL 245 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC----CCTTSCHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC----CccccCHHHHHH
Confidence 2368999999999999999999999999999999999876432 2222222222 234688999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
|.+||+.||++|||++++++||||++
T Consensus 246 i~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 246 IQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HHHHcccChhhCcCHHHHhhChheec
Confidence 99999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=347.49 Aligned_cols=245 Identities=25% Similarity=0.369 Sum_probs=213.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
..+|.....||.|.||.||.+.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3578899999999999999999999999999999987543 344567899999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||+.+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~---~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL---EVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC---CEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC---CEEEeeccCceecccCc
Confidence 999999999887753 45799999999999999999999999999999999999999988 89999999987542
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..|+|||++.+..++.++||||||+++|+|++|+.||..... ....+....... ...++.++.+|
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l 271 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI----PKHINPVAASL 271 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC----CTTSCHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC----CccCCHHHHHH
Confidence 236899999999999999999999999999999999987543 223333332222 24688999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
|.+||..||++||++.++++||||+...
T Consensus 272 i~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 272 IQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHccCChhHCcCHHHHhcCccccCCC
Confidence 9999999999999999999999998743
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=350.90 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=209.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc----
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR---- 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~---- 885 (1098)
..+|.....||.|.+|.||.+.+..+++.||||+++..... ......+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999999999999999999875443 3345789999999999999999999999876543
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
.|+||||++|++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS---CEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC---CEEEeeccCcccc
Confidence 4999999999999988864 45799999999999999999999999999999999999999988 8999999998643
Q ss_pred ---------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc--CCCCCCCcC
Q psy48 966 ---------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM--YPPRPWRDI 1028 (1098)
Q Consensus 966 ---------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~--~p~~~~~~i 1028 (1098)
+..|+|||++.+..++.++||||||+++|+|++|+.||.+.............. .+...+..+
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 345689999999999999999999999999999999998765433322222211 111223468
Q ss_pred cHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1029 SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+.++.++|.+||+.||++||++.+++.|+|++.
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 999999999999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=352.00 Aligned_cols=242 Identities=27% Similarity=0.425 Sum_probs=209.2
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH------HHHHHHHHHHHHhccCCCCceeeeeeeecC
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK------QEAQLKNEVAILQNLCHPGVVNLERMFETP 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~ 883 (1098)
....|.....||.|.+|.||.+.++.+++.||||++++...... ....+.+|+.+|+.++||||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45789999999999999999999999999999999987543222 234678899999999999999999999999
Q ss_pred CcEEEEEEeccCc-hHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 884 GRIFVVMEKLQGD-MLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 884 ~~l~LVmEy~~gg-sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
+.+++||||+.++ +|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF---TIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS---CEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC---cEEEeecccc
Confidence 9999999999665 8878775 445799999999999999999999999999999999999999988 8999999999
Q ss_pred cccC-----------CCCCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcH
Q psy48 963 RIIG-----------EKSFPPEVLRNKGY-NRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 963 ~~~~-----------~~~~APEvl~~~~y-s~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
.... ..|+|||++.+..+ +.++||||||+++|+|++|..||....+.. ......+..+++
T Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~~~~~~~~~ 249 (335)
T 3dls_A 178 AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------EAAIHPPYLVSK 249 (335)
T ss_dssp EECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------TTCCCCSSCCCH
T ss_pred eECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------hhccCCCcccCH
Confidence 7542 24679999998887 889999999999999999999997643211 111222345899
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
++.+||.+||+.||++|||+.++++||||++..
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 999999999999999999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=350.71 Aligned_cols=246 Identities=23% Similarity=0.352 Sum_probs=211.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|.+|.||.+.+..+++.||+|+++... .......+.+|+.+++.++||||+++++++...+.+++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 467899999999999999999999999999999997652 3555678999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~-gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
||++|++|..++.. .+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus 111 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 111 EHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG---EIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp CCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC---CEEECCCCCCHHHHHHC
T ss_pred ECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC---CEEEEECCCCccccccc
Confidence 99999999888864 45799999999999999999999996 999999999999999998 8999999998532
Q ss_pred ------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--H-------------------------
Q psy48 966 ------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--Q------------------------- 1012 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~------------------------- 1012 (1098)
+..|+|||++.+..++.++||||||+++|+|++|..||........ .
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 4457899999999999999999999999999999999975432111 0
Q ss_pred --------------HHHh-hccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1013 --------------IQNA-AFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1013 --------------i~~~-~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+... ....+......++.++.+||.+||+.||++|||++++++||||+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 0100 111122223357899999999999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=352.97 Aligned_cols=249 Identities=32% Similarity=0.554 Sum_probs=212.2
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC--ChHH----HHHHHHHHHHHhcc-CCCCceeeeeeee
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF--PTKQ----EAQLKNEVAILQNL-CHPGVVNLERMFE 881 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~--~~~~----~~~~~~Ei~iL~~l-~HpnIv~L~~~f~ 881 (1098)
.....|.....||.|.+|.||.+.++.+|+.||||+++.... ...+ ...+.+|+.+++.+ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 345678999999999999999999999999999999976432 2121 35688999999998 7999999999999
Q ss_pred cCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCc
Q psy48 882 TPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGF 961 (1098)
Q Consensus 882 ~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGl 961 (1098)
..+..++||||+.|++|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||+
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~---~ikl~DfG~ 246 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM---QIRLSDFGF 246 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC---CEEECCCTT
T ss_pred eCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---CEEEEecCc
Confidence 99999999999999999888864 45799999999999999999999999999999999999999998 899999999
Q ss_pred ccccC-----------CCCCChhhhcc------CCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCC
Q psy48 962 ARIIG-----------EKSFPPEVLRN------KGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPP 1022 (1098)
Q Consensus 962 a~~~~-----------~~~~APEvl~~------~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~ 1022 (1098)
+.... ..|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+......++.
T Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 247 SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred ccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 86542 23579999863 3688999999999999999999999986543 23333343333333
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..|..++.++.+||.+||..||++|||+.++++||||+.
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 345678999999999999999999999999999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=348.62 Aligned_cols=243 Identities=25% Similarity=0.364 Sum_probs=202.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-----CCCceeeeeeeecCCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-----HPGVVNLERMFETPGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~L~~~f~~~~~ 885 (1098)
...|.....||.|++|.||.+.+..+++.||||+++.. ......+..|+.+++.+. ||||+++++++...+.
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 46799999999999999999999999999999999642 344567888999999886 9999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-----------------
Q psy48 886 IFVVMEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST----------------- 947 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~----------------- 947 (1098)
+++||||+ +++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 99999999 777777776443 46999999999999999999999999999999999999985
Q ss_pred --------CCCCCcEEEeecCcccccC---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH
Q psy48 948 --------NSELPQVKLCDFGFARIIG---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN 1010 (1098)
Q Consensus 948 --------~g~~~~vKL~DFGla~~~~---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~ 1010 (1098)
++ .+||+|||+++... ..|+|||++.+..|+.++|||||||++|+|++|+.||.......
T Consensus 190 ~~~~~~~~~~---~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 266 (360)
T 3llt_A 190 KIQIYRTKST---GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266 (360)
T ss_dssp EEEEEEESCC---CEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccCCC---CEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHH
Confidence 44 89999999997542 23689999999999999999999999999999999998754332
Q ss_pred --HHHHHhhccCCCC---------------------CC---------------------CcCcHHHHHHHHHhhhhcccC
Q psy48 1011 --EQIQNAAFMYPPR---------------------PW---------------------RDISSDAIDLINNLLQVKQRK 1046 (1098)
Q Consensus 1011 --~~i~~~~~~~p~~---------------------~~---------------------~~is~el~~LL~~cL~~dP~k 1046 (1098)
..+.......+.. .| ...++++.+||.+||+.||++
T Consensus 267 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 346 (360)
T 3llt_A 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTL 346 (360)
T ss_dssp HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhh
Confidence 2222221111100 00 012367889999999999999
Q ss_pred CCCHHHHHcCCCcC
Q psy48 1047 RLSVDKSLAHPWLQ 1060 (1098)
Q Consensus 1047 RPSa~eIL~HpfFk 1060 (1098)
|||++++++||||+
T Consensus 347 Rpta~elL~hp~f~ 360 (360)
T 3llt_A 347 RPSPAELLKHKFLE 360 (360)
T ss_dssp SCCHHHHTTSGGGC
T ss_pred CCCHHHHhcCcccC
Confidence 99999999999996
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=349.07 Aligned_cols=245 Identities=24% Similarity=0.299 Sum_probs=205.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCC--CCceeeeeeeecCCcEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCH--PGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~L~~~f~~~~~l~L 888 (1098)
...|.+...||.|+||.||.+.+ .+++.||||+++...........+.+|+.+|..++| +||+++++++.+.+.+++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 35688999999999999999988 468999999998776666667889999999999976 999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
|||+ .+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||+++..
T Consensus 87 v~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~---~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG---MLKLIDFGIANQMQPD 160 (343)
T ss_dssp EECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT---EEEECCCSSSCCC---
T ss_pred EEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC---cEEEeecccccccCcc
Confidence 9995 56678788764 45799999999999999999999999999999999999997 44 7999999998643
Q ss_pred -----------CCCCCChhhhcc-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHH-hhccCCC
Q psy48 966 -----------GEKSFPPEVLRN-----------KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQN-AAFMYPP 1022 (1098)
Q Consensus 966 -----------~~~~~APEvl~~-----------~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~-~~~~~p~ 1022 (1098)
+..|+|||++.+ ..++.++|||||||++|||++|+.||.........+.. .......
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 334689999975 67899999999999999999999999865333222222 2222222
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
......+.++.+||.+||+.||++|||+.++++||||+..
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 3334567899999999999999999999999999999853
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=342.34 Aligned_cols=240 Identities=23% Similarity=0.328 Sum_probs=204.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|++|.||.+.+ +++.||||++............+.+|+.+++.++||||+++++++...+.+++||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 45788999999999999999975 6889999999877666666788999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccC--ccchhHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecCCCCCCcEEEeecCccccc-
Q psy48 891 EKLQGDMLEMILSSEKG--RLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVLLSTNSELPQVKLCDFGFARII- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~--~lse~~~~~ia~qIa~gL~~LHs~g--IvHrDLKp~NILld~~g~~~~vKL~DFGla~~~- 965 (1098)
||+.+++|..++..... .+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++..
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~---~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY---TVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC---CEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC---cEEECCCCCCcccc
Confidence 99999999998874432 3899999999999999999999999 99999999999999998 8999999998633
Q ss_pred -----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 966 -----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
+..|+|||++.+..++.++||||||+++|+|++|+.||........................+++++.+
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 270 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 334689999999999999999999999999999999998764432222222222333344678999999
Q ss_pred HHHHhhhhcccCCCCHHHHHc
Q psy48 1035 LINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
||.+||+.||++|||++++++
T Consensus 271 li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 271 IIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=344.72 Aligned_cols=247 Identities=24% Similarity=0.388 Sum_probs=208.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeec------C
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFET------P 883 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~------~ 883 (1098)
.+.|.....||.|.+|.||.+.+..+++.||||++.... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 467899999999999999999999999999999997543 2346788999999998 79999999999976 4
Q ss_pred CcEEEEEEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
+.+++||||+++++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~---~~kl~Dfg~~ 176 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA---EVKLVDFGVS 176 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC---CEEECCCTTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC---CEEEeeCcCc
Confidence 67999999999999999887543 5699999999999999999999999999999999999999888 8999999998
Q ss_pred cccC------------CCCCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCC
Q psy48 963 RIIG------------EKSFPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPW 1025 (1098)
Q Consensus 963 ~~~~------------~~~~APEvl~-----~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~ 1025 (1098)
.... ..|+|||++. +..++.++||||||+++|+|++|..||.................+....
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 256 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc
Confidence 6532 2357999997 5678999999999999999999999998765443333333333333334
Q ss_pred CcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1026 RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1026 ~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
..++.++.+||.+||..||++||++.++++||||++..
T Consensus 257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 56899999999999999999999999999999999743
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=354.88 Aligned_cols=247 Identities=26% Similarity=0.430 Sum_probs=195.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC------C
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP------G 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~------~ 884 (1098)
..+|.....||.|.+|.||.+.+..+|+.||||++............+.+|+.+|+.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4678999999999999999999999999999999977555556668899999999999999999999998654 5
Q ss_pred cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
.+++||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~---~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC---ELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---CEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC---CEEEeecccccc
Confidence 689999999 5677677653 5699999999999999999999999999999999999999988 899999999975
Q ss_pred c---------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--HHHHhhc--------------
Q psy48 965 I---------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQNAAF-------------- 1018 (1098)
Q Consensus 965 ~---------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~i~~~~~-------------- 1018 (1098)
. +..|+|||++.+ ..|+.++|||||||++|||++|+.||.+...... .+.....
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 3 334689999987 7799999999999999999999999987643322 1211100
Q ss_pred ---------cCCCCC----CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1019 ---------MYPPRP----WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1019 ---------~~p~~~----~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
..+... +..+++++.+||.+||..||++|||+.++++||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 001111 134688999999999999999999999999999999743
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=338.91 Aligned_cols=243 Identities=26% Similarity=0.458 Sum_probs=210.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
...|.....||.|.+|.||.+.+..+++.||||++.+..... .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467899999999999999999999999999999997532211 1246789999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||+++++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~---~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG---ELKIADFGWSVHAPSLR 168 (284)
T ss_dssp ECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC---CEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC---CEEEecccccccCcccc
Confidence 999999999888764 45799999999999999999999999999999999999999988 89999999986432
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
..++|||++.+..++.++||||||+++|+|++|..||...... ...+......+ ...++.++.++|.
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~ 244 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF----PPFLSDGSKDLIS 244 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC----CTTSCHHHHHHHH
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCC----CCcCCHHHHHHHH
Confidence 2357999999999999999999999999999999999865432 22333322222 3458899999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+||+.||++||++.++++||||+.
T Consensus 245 ~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 245 KLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp HHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHhhcCHhhCCCHHHHhhCHHHHh
Confidence 999999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=350.94 Aligned_cols=245 Identities=27% Similarity=0.441 Sum_probs=205.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE----
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI---- 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l---- 886 (1098)
...|.....||.|++|.||.+.+..+|+.||||+++...........+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3578889999999999999999999999999999987665566668899999999999999999999999877654
Q ss_pred --EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 887 --FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 887 --~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
++||||+.+ +|..++ ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 121 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~---~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQT-DLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC---ELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCCE-EHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC---CEEECSTTCC--
T ss_pred eEEEEEccccc-cHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC---CEEEEecCcccc
Confidence 999999986 455554 23599999999999999999999999999999999999999998 899999999964
Q ss_pred c---------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc---------------
Q psy48 965 I---------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM--------------- 1019 (1098)
Q Consensus 965 ~---------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~--------------- 1019 (1098)
. +..|+|||++.+ ..++.++||||||+++|+|++|..||.+..............
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 194 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred cccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 3 344689999987 789999999999999999999999998764332221111100
Q ss_pred -------CCCC-------CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1020 -------YPPR-------PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1020 -------~p~~-------~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.+.. .+..+++++.+||.+||+.||++|||++++++||||+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0000 023578999999999999999999999999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.36 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=191.3
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.....|.....||.|.+|.||.+.+..+++.||||++..... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999999999999999865432 2334678899999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhh-------ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCc
Q psy48 889 VMEKLQGDMLEMILSS-------EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGF 961 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~-------~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGl 961 (1098)
||||+++++|..++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~---~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG---SVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC---CEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC---CEEEEeccc
Confidence 9999999999888764 245699999999999999999999999999999999999999988 899999998
Q ss_pred cccc-----------------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCC--
Q psy48 962 ARII-----------------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYP-- 1021 (1098)
Q Consensus 962 a~~~-----------------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p-- 1021 (1098)
+... +..|+|||++.+ ..++.++||||||+++|+|++|..||.................+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 8643 233689999976 66899999999999999999999999865432222211111111
Q ss_pred ------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1022 ------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1022 ------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
...+..++.++.++|.+||+.||++||++.++++||||++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 1223567899999999999999999999999999999997
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=342.84 Aligned_cols=240 Identities=23% Similarity=0.410 Sum_probs=201.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeec--CCcEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFET--PGRIF 887 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~--~~~l~ 887 (1098)
...|.....||.|.+|.||.+.+..+++.||||+++.. ....+.+|+.+++.++ ||||+++++++.. ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 46789999999999999999999999999999999642 2467899999999997 9999999999987 56799
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~ 967 (1098)
+||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++....
T Consensus 110 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC--EEEEEeCCCceEcCC
Confidence 9999999999988864 4899999999999999999999999999999999999997663 799999999975422
Q ss_pred -----------CCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHH----------------HHhhcc
Q psy48 968 -----------KSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI----------------QNAAFM 1019 (1098)
Q Consensus 968 -----------~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i----------------~~~~~~ 1019 (1098)
.++|||++.+ ..++.++|||||||++|+|++|..||.......+.+ ......
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2479999987 679999999999999999999999996432211111 111100
Q ss_pred --------------------CCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1020 --------------------YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1020 --------------------~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
........+++++.+||.+||+.||++|||++++++||||++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 111112337899999999999999999999999999999997
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=336.18 Aligned_cols=244 Identities=29% Similarity=0.538 Sum_probs=208.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
..+.|.....||.|.+|.||.+.+..+++.||||++...... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 456899999999999999999999999999999999753211 1224678999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||+.+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~---~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM---NAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS---CEEECCCCGGGCCCC-
T ss_pred EEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC---CEEEeecccccccCCC
Confidence 9999999999888864 45689999999999999999999999999999999999999988 89999999987543
Q ss_pred ---------CCCCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGY-NRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~y-s~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
..++|||++.+..+ +.++||||||+++|+|++|..||.... ...+.+....... ...++.++.+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~ 240 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI----PEYLNRSVAT 240 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHHHH
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC----chhcCHHHHH
Confidence 23679999998776 689999999999999999999998653 2333333322222 2457899999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+|.+||+.||++|||+.++++||||++
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHccCChhhCCCHHHHHhChhhcc
Confidence 999999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=344.06 Aligned_cols=241 Identities=20% Similarity=0.324 Sum_probs=207.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCce---eEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRG---VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~---VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
....|.+...||.|+||.||.+.+..+++. ||||+++.. ........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 356789999999999999999999866654 999999754 2455567899999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
++||||+++++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL---VCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC---CEEECCCSSCEECC
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC---CEEECCCCcccccc
Confidence 999999999999999977777899999999999999999999999999999999999999988 89999999997542
Q ss_pred C---------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcH
Q psy48 967 E---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 967 ~---------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
. .|+|||++.+..++.++||||||+++|||++ |..||....... .+..............+++
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 281 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-VISSVEEGYRLPAPMGCPH 281 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-HHHHHHTTCCCCCCTTCCH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHHHcCCCCCCCCCcCH
Confidence 2 3789999999999999999999999999999 999997654322 1122222222333457899
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
++.+||.+||..||++||++.+|++
T Consensus 282 ~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.70 Aligned_cols=243 Identities=25% Similarity=0.371 Sum_probs=211.0
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|.....||.|.+|.||.+.+..+++.||||+++.... ......+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 468889999999999999999999999999999976543 3345789999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE---- 967 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~---- 967 (1098)
|+++++|..++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++.....
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG---EVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECBTTBCC
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC---CEEEeecccceecCccccc
Confidence 9999999888753 5799999999999999999999999999999999999999988 899999999865422
Q ss_pred --------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 968 --------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 968 --------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
.|+|||++.+..++.++||||||+++|+|++|..||........... .....+......++.++.+||.+|
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-IPKNNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHSCCCCCCSSCCHHHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-hhcCCCCCCccccCHHHHHHHHHH
Confidence 25799999999999999999999999999999999986543322211 112233334457899999999999
Q ss_pred hhhcccCCCCHHHHHcCCCcCC
Q psy48 1040 LQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
|..||++|||+.++++||||..
T Consensus 255 l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHHHHH
T ss_pred cCCChhhCcCHHHHhhChhhhc
Confidence 9999999999999999999964
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=354.66 Aligned_cols=248 Identities=27% Similarity=0.357 Sum_probs=202.7
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC--------CCCceeeeeeee-
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC--------HPGVVNLERMFE- 881 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~--------HpnIv~L~~~f~- 881 (1098)
.++|.....||.|++|.||.+.+..+++.||||+++.. ......+.+|+.+++.++ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 46799999999999999999999999999999999743 345578899999999885 788999999997
Q ss_pred ---cCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCC--------
Q psy48 882 ---TPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNS-------- 949 (1098)
Q Consensus 882 ---~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~-gIvHrDLKp~NILld~~g-------- 949 (1098)
....+++||||++++++..+.......+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 56689999999988888776665556799999999999999999999998 999999999999998764
Q ss_pred --------------------------------------CCCcEEEeecCccccc---------CCCCCChhhhccCCCCc
Q psy48 950 --------------------------------------ELPQVKLCDFGFARII---------GEKSFPPEVLRNKGYNR 982 (1098)
Q Consensus 950 --------------------------------------~~~~vKL~DFGla~~~---------~~~~~APEvl~~~~ys~ 982 (1098)
....+||+|||++... +..|+|||++.+..|+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCc
Confidence 1126999999999654 33468999999999999
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCh------h--HHHHHHHhhccCCC--------------------------------
Q psy48 983 SLDMWSVGVIVYVSLSGTFPFNEDE------D--INEQIQNAAFMYPP-------------------------------- 1022 (1098)
Q Consensus 983 ~sDVwSLGvlLyELltG~~Pf~~~~------~--~~~~i~~~~~~~p~-------------------------------- 1022 (1098)
++|||||||+||||++|+.||.... + ....+.......+.
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 352 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence 9999999999999999999997432 1 11111111110000
Q ss_pred ------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1023 ------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1023 ------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
......+.++.+||.+||+.||++|||++++++||||++
T Consensus 353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 001233567899999999999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=355.59 Aligned_cols=244 Identities=24% Similarity=0.445 Sum_probs=187.5
Q ss_pred hhheee-eeeeeeeeeeceEEEEee--cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeee--cCCc
Q psy48 811 LVFMTY-NVALCIAVVAGAACGVHR--KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE--TPGR 885 (1098)
Q Consensus 811 l~~~~~-~~~Lg~G~~g~v~~a~~k--~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~--~~~~ 885 (1098)
...|.+ +..||.|+||.||.+.++ .+++.||||+++..... ..+.+|+.+|+.++||||++++++|. ....
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 345665 557999999999999966 57899999999764332 45788999999999999999999994 4678
Q ss_pred EEEEEEeccCchHHHHHhhc-------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceee----cCCCCCCcE
Q psy48 886 IFVVMEKLQGDMLEMILSSE-------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL----STNSELPQV 954 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~-------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILl----d~~g~~~~v 954 (1098)
+++||||++++++..+.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~---~~ 171 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG---RV 171 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT---CE
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC---cE
Confidence 99999999886554332211 1248999999999999999999999999999999999999 4455 89
Q ss_pred EEeecCccccc---------------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChh----------
Q psy48 955 KLCDFGFARII---------------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDED---------- 1008 (1098)
Q Consensus 955 KL~DFGla~~~---------------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~---------- 1008 (1098)
||+|||+++.. +..|+|||++.+ ..|+.++|||||||+||||++|..||.+..+
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999999643 233689999987 4599999999999999999999999975422
Q ss_pred -HHHHHHHhhccCCCCCCCc----------------------------------CcHHHHHHHHHhhhhcccCCCCHHHH
Q psy48 1009 -INEQIQNAAFMYPPRPWRD----------------------------------ISSDAIDLINNLLQVKQRKRLSVDKS 1053 (1098)
Q Consensus 1009 -~~~~i~~~~~~~p~~~~~~----------------------------------is~el~~LL~~cL~~dP~kRPSa~eI 1053 (1098)
....+.......+...|.. .++++.+||.+||..||++|||++++
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 2222222211122222221 26789999999999999999999999
Q ss_pred HcCCCcCC
Q psy48 1054 LAHPWLQD 1061 (1098)
Q Consensus 1054 L~HpfFk~ 1061 (1098)
|+||||++
T Consensus 332 L~hp~f~~ 339 (405)
T 3rgf_A 332 MQDPYFLE 339 (405)
T ss_dssp HTSGGGTS
T ss_pred hcChhhcc
Confidence 99999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=358.96 Aligned_cols=239 Identities=18% Similarity=0.252 Sum_probs=193.8
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHH---HhccCCCCceeee-------eee
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAI---LQNLCHPGVVNLE-------RMF 880 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~i---L~~l~HpnIv~L~-------~~f 880 (1098)
..|.....||.|.+|.||.+.+..+|+.||||++++... .......+.+|+.+ |+.++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 468889999999999999999999999999999986533 34456789999954 4555799999998 555
Q ss_pred ecCC-----------------cEEEEEEeccCchHHHHHhhccCccc-------hhHHHHHHHHHHHHHHHHHhCCcccc
Q psy48 881 ETPG-----------------RIFVVMEKLQGDMLEMILSSEKGRLS-------ERTTKFIITQILVALKHLHSKNIVHC 936 (1098)
Q Consensus 881 ~~~~-----------------~l~LVmEy~~ggsL~~~l~~~~~~ls-------e~~~~~ia~qIa~gL~~LHs~gIvHr 936 (1098)
.+.+ ..|+||||++ ++|..++... +.++ +..++.++.||+.||+|||++||+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~-g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECCS-EEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hccCCccccccccCCCceEEEEEEEEEeccC-CCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 5443 3899999994 6887887643 2344 48888899999999999999999999
Q ss_pred CCCCCceeecCCCCCCcEEEeecCccccc--------CCCCCChhhhccC-----------CCCchhHHHHHHHHHHHHH
Q psy48 937 DLKPENVLLSTNSELPQVKLCDFGFARII--------GEKSFPPEVLRNK-----------GYNRSLDMWSVGVIVYVSL 997 (1098)
Q Consensus 937 DLKp~NILld~~g~~~~vKL~DFGla~~~--------~~~~~APEvl~~~-----------~ys~~sDVwSLGvlLyELl 997 (1098)
||||+|||++.++ .+||+|||+++.. +..|+|||++.+. .|+.++|||||||+||||+
T Consensus 231 Dikp~NIll~~~~---~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 231 YLRPVDIVLDQRG---GVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp CCCGGGEEECTTC---CEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCC---CEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 9999999999998 8999999999743 3567899999987 8999999999999999999
Q ss_pred cCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 998 SGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 998 tG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+|+.||........ . ... ...+..+++++.+||.+||+.||++||++.++++||||++
T Consensus 308 tg~~Pf~~~~~~~~-~-~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 308 CADLPITKDAALGG-S-EWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HSSCCC------CC-S-GGG----GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HCCCCCcccccccc-h-hhh----hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999976432110 0 001 1123568999999999999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=349.99 Aligned_cols=246 Identities=25% Similarity=0.435 Sum_probs=207.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH---------------HHHHHHHHHHHHhccCCCCcee
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK---------------QEAQLKNEVAILQNLCHPGVVN 875 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~---------------~~~~~~~Ei~iL~~l~HpnIv~ 875 (1098)
.+.|.....||.|.+|.||.+.+ +++.||||++........ ....+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46799999999999999999998 999999999976432111 1178999999999999999999
Q ss_pred eeeeeecCCcEEEEEEeccCchHHHH------Hhhc-cCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecC
Q psy48 876 LERMFETPGRIFVVMEKLQGDMLEMI------LSSE-KGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLST 947 (1098)
Q Consensus 876 L~~~f~~~~~l~LVmEy~~ggsL~~~------l~~~-~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~ 947 (1098)
+++++.+.+.+++||||+++++|..+ +... ...+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999877 4432 4679999999999999999999999 99999999999999999
Q ss_pred CCCCCcEEEeecCcccccC----------CCCCChhhhccC-CCCc-hhHHHHHHHHHHHHHcCCCCCCCCh---hHHHH
Q psy48 948 NSELPQVKLCDFGFARIIG----------EKSFPPEVLRNK-GYNR-SLDMWSVGVIVYVSLSGTFPFNEDE---DINEQ 1012 (1098)
Q Consensus 948 ~g~~~~vKL~DFGla~~~~----------~~~~APEvl~~~-~ys~-~sDVwSLGvlLyELltG~~Pf~~~~---~~~~~ 1012 (1098)
++ .++|+|||++.... ..++|||++.+. .++. ++||||||+++|+|++|..||.... +....
T Consensus 188 ~~---~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 188 NG---RVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp TS---CEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CC---cEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 98 89999999997542 235799999887 6766 9999999999999999999998653 33333
Q ss_pred HHHhhccCCCCC---------------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1013 IQNAAFMYPPRP---------------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1013 i~~~~~~~p~~~---------------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+......++... ...++.++.+||.+||+.||++|||+.++++||||++
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 333322222110 1468899999999999999999999999999999998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.52 Aligned_cols=239 Identities=28% Similarity=0.414 Sum_probs=202.6
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCch
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDM 897 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggs 897 (1098)
..||.|.+|.||.+.+..+++.||||+++... ......+.+|+.+++.++||||+++++++...+.+++||||+++++
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 105 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS 105 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence 38999999999999999999999999997643 3445779999999999999999999999999999999999999999
Q ss_pred HHHHHhhccC--ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCCCCcEEEeecCcccccC--------
Q psy48 898 LEMILSSEKG--RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST-NSELPQVKLCDFGFARIIG-------- 966 (1098)
Q Consensus 898 L~~~l~~~~~--~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~-~g~~~~vKL~DFGla~~~~-------- 966 (1098)
|..++..... .+++..+..++.||+.||.|||++||+||||||+||+++. ++ .+||+|||++....
T Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~~kl~Dfg~~~~~~~~~~~~~~ 182 (295)
T 2clq_A 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG---VLKISDFGTSKRLAGINPCTET 182 (295)
T ss_dssp HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC---CEEECCTTTCEESCC-----CC
T ss_pred HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC---CEEEeecccccccCCCCCcccc
Confidence 9999876533 4668889999999999999999999999999999999987 66 89999999987542
Q ss_pred ----CCCCChhhhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCChhH-HHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 967 ----EKSFPPEVLRNKG--YNRSLDMWSVGVIVYVSLSGTFPFNEDEDI-NEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 967 ----~~~~APEvl~~~~--ys~~sDVwSLGvlLyELltG~~Pf~~~~~~-~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
..++|||++.+.. ++.++||||||+++|+|++|..||...... ............+..+..+++++.++|.+|
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 262 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKC 262 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHT
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHH
Confidence 2357999997644 899999999999999999999999753222 122222223333444567899999999999
Q ss_pred hhhcccCCCCHHHHHcCCCcCC
Q psy48 1040 LQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
|+.||++||++.++++||||+.
T Consensus 263 l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 263 FEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp TCSSTTTSCCHHHHHTSGGGCC
T ss_pred ccCChhhCCCHHHHhcChhhhh
Confidence 9999999999999999999997
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=337.12 Aligned_cols=245 Identities=24% Similarity=0.329 Sum_probs=209.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
..+|.....||.|++|.||.+.+..+++.||||++...... ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999999999999999999764433 34457899999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||++|++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 90 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK---TLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---CEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEEeCCCcccccccc
Confidence 999999999988864 45799999999999999999999999999999999999999998 8999999998643
Q ss_pred ---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCC---CCCCcCcHHHH
Q psy48 966 ---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPP---RPWRDISSDAI 1033 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~---~~~~~is~el~ 1033 (1098)
+..|+|||++.+..++.++||||||+++|+|++|+.||.+...............+. .....+++.+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 334689999999999999999999999999999999998876544444333322221 12356899999
Q ss_pred HHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
++|.+||+.||++||+..+.+.+.|.
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHH
Confidence 99999999999999955555554443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=355.05 Aligned_cols=245 Identities=23% Similarity=0.337 Sum_probs=200.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc------CCCCceeeeeeeecCC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL------CHPGVVNLERMFETPG 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l------~HpnIv~L~~~f~~~~ 884 (1098)
..+|.....||.|.||.||.+.+..+++.||||+++.. ......+.+|+.+++.+ .|+||+++++++...+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 45789999999999999999999999999999999753 34456778888888766 5779999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
.+++||||+.++++ .++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.. .+||+|||++.
T Consensus 173 ~~~lv~e~~~~~L~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~-~vkL~DFG~a~ 250 (429)
T 3kvw_A 173 HICMTFELLSMNLY-ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRS-GIKVIDFGSSC 250 (429)
T ss_dssp EEEEEECCCCCBHH-HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSC-CEEECCCTTCE
T ss_pred eEEEEEeccCCCHH-HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCc-ceEEeecccce
Confidence 99999999987544 555433 3469999999999999999999999999999999999999988721 39999999986
Q ss_pred ccC---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--HHHHhhccCCCC---------
Q psy48 964 IIG---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQNAAFMYPPR--------- 1023 (1098)
Q Consensus 964 ~~~---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~i~~~~~~~p~~--------- 1023 (1098)
... ..|+|||++.+..|+.++|||||||+||||++|..||.+..+... .+.... ..++.
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~-~~p~~~~~~~~~~~ 329 (429)
T 3kvw_A 251 YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL-GMPSQKLLDASKRA 329 (429)
T ss_dssp ETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-CCCCHHHHHTBTTH
T ss_pred ecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc-CCCCHHHHHhhhhh
Confidence 442 235899999999999999999999999999999999987643322 121110 00000
Q ss_pred ------------------------------------------C-----CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1024 ------------------------------------------P-----WRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1024 ------------------------------------------~-----~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
. ....++++.+||.+||+.||++|||++|+|+|
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence 0 01237889999999999999999999999999
Q ss_pred CCcCC
Q psy48 1057 PWLQD 1061 (1098)
Q Consensus 1057 pfFk~ 1061 (1098)
|||++
T Consensus 410 pw~~~ 414 (429)
T 3kvw_A 410 PWLRR 414 (429)
T ss_dssp TTTC-
T ss_pred hhhcc
Confidence 99997
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.86 Aligned_cols=245 Identities=26% Similarity=0.426 Sum_probs=198.9
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeee-------
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE------- 881 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~------- 881 (1098)
....+|.....||.|.+|.||.+.+..+++.||||++... .......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 3457889999999999999999999999999999999754 2455678999999999999999999998873
Q ss_pred -------cCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCCCCc
Q psy48 882 -------TPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST-NSELPQ 953 (1098)
Q Consensus 882 -------~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~-~g~~~~ 953 (1098)
....+++||||++| +|..++. .+.+++..++.++.||+.||+|||++||+||||||+|||++. ++ .
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~ 159 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYMET-DLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL---V 159 (320)
T ss_dssp C----CCSCSEEEEEEECCSE-EHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT---E
T ss_pred cccccccccCceeEEeeccCC-CHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---e
Confidence 34678999999985 6777774 356999999999999999999999999999999999999974 44 8
Q ss_pred EEEeecCccccc---------------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH--HHH
Q psy48 954 VKLCDFGFARII---------------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ--IQN 1015 (1098)
Q Consensus 954 vKL~DFGla~~~---------------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~--i~~ 1015 (1098)
+||+|||+++.. +..++|||++.+ ..++.++||||||+++|||++|+.||.+....... +..
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999998754 233689999875 77999999999999999999999999876433221 111
Q ss_pred hh----------------------ccCCCC----CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1016 AA----------------------FMYPPR----PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1016 ~~----------------------~~~p~~----~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.. ...+.. .+..++.++.+||.+||+.||++|||++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 10 000111 12357899999999999999999999999999999997
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=346.69 Aligned_cols=258 Identities=25% Similarity=0.425 Sum_probs=206.0
Q ss_pred HHHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC---------hHHHHHHHHHHHHHhccCCCCceeee
Q psy48 807 FLLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP---------TKQEAQLKNEVAILQNLCHPGVVNLE 877 (1098)
Q Consensus 807 ~~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~---------~~~~~~~~~Ei~iL~~l~HpnIv~L~ 877 (1098)
.......|.....||.|++|.||.+.+.. ++.||||++...... ......+.+|+.+++.++||||++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 34556889999999999999999999865 999999999664322 22247899999999999999999999
Q ss_pred eeee-----cCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCC
Q psy48 878 RMFE-----TPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952 (1098)
Q Consensus 878 ~~f~-----~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~ 952 (1098)
+++. ....+++||||++|+++ .++......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--- 171 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMRTDLA-QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN--- 171 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCSEEHH-HHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---
T ss_pred eeEEeccCCCcceEEEEEccCCCCHH-HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC---
Confidence 9984 33468999999997555 55555566799999999999999999999999999999999999999988
Q ss_pred cEEEeecCccccc-----------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhc
Q psy48 953 QVKLCDFGFARII-----------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAF 1018 (1098)
Q Consensus 953 ~vKL~DFGla~~~-----------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~ 1018 (1098)
.+||+|||++... +..|+|||++.+ ..++.++||||||+++|+|++|+.||.+..... ..+.....
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 172 DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 8999999999643 223589999987 779999999999999999999999998764322 22211100
Q ss_pred ------------------------cCCCCC----CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCCcchhH
Q psy48 1019 ------------------------MYPPRP----WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLR 1069 (1098)
Q Consensus 1019 ------------------------~~p~~~----~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~~~~~~ 1069 (1098)
..+... ...+++.+.+||.+||+.||++|||+.++++||||+...+..++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~ 330 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT 330 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGT
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccc
Confidence 001111 124688999999999999999999999999999999865555543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=356.61 Aligned_cols=245 Identities=16% Similarity=0.164 Sum_probs=188.8
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhcc--CCCCceeee-------eeeec
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNL--CHPGVVNLE-------RMFET 882 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l--~HpnIv~L~-------~~f~~ 882 (1098)
.|.....||.|+||.||.+.+..+++.||||+++...... .....+.+|+.+++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4788999999999999999999999999999998865433 3456788885544444 699988755 33332
Q ss_pred C-----------------CcEEEEEEeccCchHHHHHhhccCccchhHH------HHHHHHHHHHHHHHHhCCccccCCC
Q psy48 883 P-----------------GRIFVVMEKLQGDMLEMILSSEKGRLSERTT------KFIITQILVALKHLHSKNIVHCDLK 939 (1098)
Q Consensus 883 ~-----------------~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~------~~ia~qIa~gL~~LHs~gIvHrDLK 939 (1098)
. ..+++||||++ ++|..++......+.+... ..++.||+.||+|||++||+|||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 2 34899999999 7888888765555666666 6778999999999999999999999
Q ss_pred CCceeecCCCCCCcEEEeecCccccc---------CCCCCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCChh
Q psy48 940 PENVLLSTNSELPQVKLCDFGFARII---------GEKSFPPEVLRN--KGYNRSLDMWSVGVIVYVSLSGTFPFNEDED 1008 (1098)
Q Consensus 940 p~NILld~~g~~~~vKL~DFGla~~~---------~~~~~APEvl~~--~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~ 1008 (1098)
|+|||++.++ .+||+|||+++.. +..|+|||++.+ ..|+.++|||||||+||||++|+.||.....
T Consensus 222 p~NIll~~~~---~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 222 PDNLFIMPDG---RLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp GGGEEECTTS---CEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred HHHEEECCCC---CEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 9999999998 8999999998643 344689999987 7899999999999999999999999976521
Q ss_pred HHHH-H------HHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1009 INEQ-I------QNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1009 ~~~~-i------~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.... . ...........+..+++++.+||.+||+.||++|||+.++++||||++
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp TCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred ccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 1000 0 000111122223578999999999999999999999999999999997
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=338.87 Aligned_cols=245 Identities=26% Similarity=0.413 Sum_probs=203.7
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC--hHHHHHHHHHHHHHhccCCCCceeeeeee--ecCCc
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP--TKQEAQLKNEVAILQNLCHPGVVNLERMF--ETPGR 885 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f--~~~~~ 885 (1098)
..+.|.....||.|++|.||.+.+..+++.||||++++.... ......+.+|+.+++.++||||+++++++ .....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 356789999999999999999999999999999999764221 23457899999999999999999999998 45568
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+++||||+.+++...+.......+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++...
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~---~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG---TLKISALGVAEAL 159 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC---CEEECCCTTCEEC
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC---cEEeecccccccc
Confidence 9999999999855444333456799999999999999999999999999999999999999988 8999999998754
Q ss_pred C--------------CCCCChhhhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCc
Q psy48 966 G--------------EKSFPPEVLRNKG--YNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 966 ~--------------~~~~APEvl~~~~--ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~ 1027 (1098)
. ..|+|||++.+.. ++.++||||||+++|+|++|..||..... ..+.+...... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~----~~~~ 235 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA----IPGD 235 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC----CCSS
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC----CCCc
Confidence 2 2357999998754 47899999999999999999999987542 33333333222 2346
Q ss_pred CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1028 ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+++++.++|.+||..||++|||++++++||||++
T Consensus 236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 8899999999999999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=351.59 Aligned_cols=244 Identities=24% Similarity=0.308 Sum_probs=203.2
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC--CCCceeeeeeeecCCcEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC--HPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~L~~~f~~~~~l~LV 889 (1098)
..|.+...||.|.||.||.+.+.. ++.||||++............+.+|+.+|+.++ ||||+++++++...+.+++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 458899999999999999999865 999999999877666667788999999999996 59999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|| +.+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||+++..
T Consensus 135 ~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~---~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G---MLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S---CEEECCCSSSCCC----
T ss_pred Ee-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C---eEEEEecCccccccCCC
Confidence 99 567788788764 457899999999999999999999999999999999999964 5 7999999999643
Q ss_pred ----------CCCCCChhhhcc-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhh-ccCCCC
Q psy48 966 ----------GEKSFPPEVLRN-----------KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAA-FMYPPR 1023 (1098)
Q Consensus 966 ----------~~~~~APEvl~~-----------~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~-~~~p~~ 1023 (1098)
+..|+|||++.+ ..|+.++|||||||+||||++|..||....+....+.... ......
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 223579999975 4689999999999999999999999986533222222221 112222
Q ss_pred CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1024 PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1024 ~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.....+.++.+||.+||+.||++||++.++++||||+..
T Consensus 289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 233467899999999999999999999999999999853
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=346.85 Aligned_cols=245 Identities=29% Similarity=0.465 Sum_probs=203.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC-----Cc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP-----GR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~-----~~ 885 (1098)
..+|+....||.|++|.||.+.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 457999999999999999999999999999999997532 344457889999999999999999999999665 46
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+++||||+++ +|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 105 ~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~---~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC---DLKICDFGLARVA 178 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---CEEECCCTTCEEC
T ss_pred EEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC---CEEEEeCcceEec
Confidence 8999999986 56566643 4699999999999999999999999999999999999999998 8999999998643
Q ss_pred C---------------CCCCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhc---------
Q psy48 966 G---------------EKSFPPEVLR-NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAF--------- 1018 (1098)
Q Consensus 966 ~---------------~~~~APEvl~-~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~--------- 1018 (1098)
. ..|+|||++. +..++.++|||||||++|+|++|+.||.+.. +....+.....
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2 2257999875 4558999999999999999999999998653 22222221100
Q ss_pred -----------cCCCC-------CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1019 -----------MYPPR-------PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1019 -----------~~p~~-------~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
..+.. .+..+++++.+||.+||+.||++|||+.++++||||++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 01100 013578999999999999999999999999999999984
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=340.58 Aligned_cols=245 Identities=20% Similarity=0.276 Sum_probs=192.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCc---eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE-
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGR---GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI- 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~---~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l- 886 (1098)
...|.....||.|++|.||.+.+..++. .||||+++...........+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4578899999999999999999988776 899999987665566678899999999999999999999999877654
Q ss_pred -----EEEEEeccCchHHHHHhhcc-----CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEE
Q psy48 887 -----FVVMEKLQGDMLEMILSSEK-----GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKL 956 (1098)
Q Consensus 887 -----~LVmEy~~ggsL~~~l~~~~-----~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL 956 (1098)
++||||+.+++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~---~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM---TVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS---CEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC---CEEE
Confidence 99999999999988876432 1589999999999999999999999999999999999999988 8999
Q ss_pred eecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhcc
Q psy48 957 CDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFM 1019 (1098)
Q Consensus 957 ~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~ 1019 (1098)
+|||+++... ..|+|||++.+..++.++||||||+++|+|++ |..||.+.. +....+....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-- 256 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-- 256 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC--
Confidence 9999996431 13689999999999999999999999999999 999998653 3333333222
Q ss_pred CCCCCCCcCcHHHHHHHHHhhhhcccCCCC-------HHHHHcCCCcCC
Q psy48 1020 YPPRPWRDISSDAIDLINNLLQVKQRKRLS-------VDKSLAHPWLQD 1061 (1098)
Q Consensus 1020 ~p~~~~~~is~el~~LL~~cL~~dP~kRPS-------a~eIL~HpfFk~ 1061 (1098)
.......+++++.+||.+||+.||++||| ++++++|+|+..
T Consensus 257 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 257 -RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred -CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 22234568999999999999999999999 788889999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=345.46 Aligned_cols=245 Identities=27% Similarity=0.459 Sum_probs=203.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC-----Cc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP-----GR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~-----~~ 885 (1098)
...|.....||.|.+|.||.+.+..+|+.||||+++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 467899999999999999999999999999999996432 344457788999999999999999999987654 67
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
.++||||+.+ +|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 89 ~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~---~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 89 VYIIQELMQT-DLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC---DLKVCDFGLARII 162 (353)
T ss_dssp EEEEECCCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC---CEEECCCTTCEEC
T ss_pred EEEEEeccCc-cHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC---cEEEEeccccccc
Confidence 9999999986 56666653 4699999999999999999999999999999999999999988 8999999998754
Q ss_pred C----------------------CCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhh-cc--
Q psy48 966 G----------------------EKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAA-FM-- 1019 (1098)
Q Consensus 966 ~----------------------~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~-~~-- 1019 (1098)
. ..|+|||++.+ ..++.++||||||+++|+|++|..||.+............ ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 2 22679998864 7799999999999999999999999987643222111100 00
Q ss_pred -----------------------CCCC----CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1020 -----------------------YPPR----PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1020 -----------------------~p~~----~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
++.. .+..+++++.+||.+||..||++|||++++++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0100 123678999999999999999999999999999999973
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=329.15 Aligned_cols=238 Identities=22% Similarity=0.334 Sum_probs=205.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.+...||.|.+|.||.+.+. +++.||||+++.... ....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 457889999999999999999986 577899999976533 2356899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+++++|..++......+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ---VIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG---CEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC---CEEecccccccccccccc
Confidence 99999999999987777899999999999999999999999999999999999999888 89999999997432
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
..|+|||++.+..++.++||||||+++|+|++ |..||...... +................+++++.+++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li 240 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRLYKPRLASTHVYQIM 240 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHHhcCccCCCCCcCCHHHHHHH
Confidence 13689999999999999999999999999999 99999865432 22222222233333456899999999
Q ss_pred HHhhhhcccCCCCHHHHHcC
Q psy48 1037 NNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.+||+.||++||++.++++|
T Consensus 241 ~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 241 NHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCcccCcCHHHHHHH
Confidence 99999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=350.05 Aligned_cols=249 Identities=19% Similarity=0.248 Sum_probs=207.9
Q ss_pred hhheeeeeeeeeeeeeceEEEE-----eecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGV-----HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~-----~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
...|.+...||.|+||.||.+. +..+++.||||+++.. ........+.+|+.+++.++||||+++++++.....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3568889999999999999999 5567889999999643 345556788999999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhcc------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeec
Q psy48 886 IFVVMEKLQGDMLEMILSSEK------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DF 959 (1098)
.++||||+.|++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++....+||+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 999999999999999987543 35899999999999999999999999999999999999997664447999999
Q ss_pred Cccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCC
Q psy48 960 GFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRP 1024 (1098)
Q Consensus 960 Gla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~ 1024 (1098)
|+++.. +..|+|||++.+..++.++|||||||++|||++ |..||....... .+...........
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-~~~~i~~~~~~~~ 307 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-VLEFVTSGGRMDP 307 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCCCCC
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCC
Confidence 998632 224789999999999999999999999999998 999998754321 1222222222233
Q ss_pred CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1025 WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1025 ~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
...++.++.+||.+||+.||++||++.+|+++.++-.
T Consensus 308 ~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 308 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 4568999999999999999999999999999876653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=336.65 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=196.4
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
....|.....||.|.+|.||.+.++.+++.||||++............+.++..+++.++||||+++++++...+.+++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 35678889999999999999999999999999999987654333345555666678888999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~-gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
|||+ ++++..+.......+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~---~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG---QIKLCDFGISGRLVDD 178 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS---CEEECCCTTC------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC---CEEEEECCCchhccCC
Confidence 9999 5666666655567899999999999999999999995 999999999999999988 8999999998643
Q ss_pred --------CCCCCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCC--CCCcCcH
Q psy48 966 --------GEKSFPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPR--PWRDISS 1030 (1098)
Q Consensus 966 --------~~~~~APEvl~-----~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~--~~~~is~ 1030 (1098)
...|+|||++. +..++.++||||||+++|+|++|+.||.......+.+.......+.. ....+++
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence 33468999994 56789999999999999999999999986432222222222222211 1235899
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
++.++|.+||+.||++||+++++++||||++
T Consensus 259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 9999999999999999999999999999984
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=334.62 Aligned_cols=241 Identities=18% Similarity=0.236 Sum_probs=203.4
Q ss_pred HhhheeeeeeeeeeeeeceEEEE----eecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--
Q psy48 810 MLVFMTYNVALCIAVVAGAACGV----HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP-- 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~----~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~-- 883 (1098)
....|++...||.|.+|.||.+. +..+++.||||+++.. .......+.+|+.+++.++||||+++++++...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 35678999999999999999998 6778999999999753 345567899999999999999999999998543
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
..+++||||+++++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~---~~kl~Dfg~~~ 162 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTK 162 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCCCSCC
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC---eEEEccCcccc
Confidence 568999999999999999987777799999999999999999999999999999999999999988 89999999997
Q ss_pred ccCC---------------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH---------------HHH
Q psy48 964 IIGE---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN---------------EQI 1013 (1098)
Q Consensus 964 ~~~~---------------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~---------------~~i 1013 (1098)
.... .|+|||++.+..++.++||||||+++|||++|..|+....... ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 5422 1689999999999999999999999999999999986532111 111
Q ss_pred HHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1014 QNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1014 ~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
...........+..+++++.++|.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 122222233334578999999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=338.01 Aligned_cols=248 Identities=29% Similarity=0.389 Sum_probs=203.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEee-cCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc---CCCCceeeeeeee-----
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHR-KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL---CHPGVVNLERMFE----- 881 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k-~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~L~~~f~----- 881 (1098)
...|.....||.|.+|.||.+.+. .+++.||||+++...........+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 467999999999999999999995 7789999999976543333334566788777766 8999999999987
Q ss_pred cCCcEEEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 882 TPGRIFVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 882 ~~~~l~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
....+++||||++| +|..++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||
T Consensus 90 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~---~~kl~Dfg 165 (326)
T 1blx_A 90 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG---QIKLADFG 165 (326)
T ss_dssp SEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---CEEECSCC
T ss_pred CCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC---CEEEecCc
Confidence 55779999999996 666666543 34599999999999999999999999999999999999999988 89999999
Q ss_pred ccccc-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhcc-----CC-
Q psy48 961 FARII-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFM-----YP- 1021 (1098)
Q Consensus 961 la~~~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~-----~p- 1021 (1098)
++... +..|+|||++.+..++.++||||||+++|+|++|..||.+..... ..+...... ++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 166 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred ccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 98643 234689999999999999999999999999999999998764332 222211100 00
Q ss_pred -----------------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1022 -----------------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1022 -----------------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
...+..++.++.+||.+||+.||++||++.++++||||++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 01124688999999999999999999999999999999973
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=347.94 Aligned_cols=241 Identities=24% Similarity=0.381 Sum_probs=196.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec--------
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET-------- 882 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~-------- 882 (1098)
...|.....||.|+||.||.+.+..+|+.||||++..... ...+|+.+++.++||||++++++|..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4678999999999999999999999999999999965422 23369999999999999999999843
Q ss_pred ------------------------------CCcEEEEEEeccCchHHHHHh---hccCccchhHHHHHHHHHHHHHHHHH
Q psy48 883 ------------------------------PGRIFVVMEKLQGDMLEMILS---SEKGRLSERTTKFIITQILVALKHLH 929 (1098)
Q Consensus 883 ------------------------------~~~l~LVmEy~~ggsL~~~l~---~~~~~lse~~~~~ia~qIa~gL~~LH 929 (1098)
...+++||||++++ |...+. .....+++..++.++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT-LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCcc-HHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 33489999999974 444443 24567999999999999999999999
Q ss_pred hCCccccCCCCCceeec-CCCCCCcEEEeecCccccc-----------CCCCCChhhhccC-CCCchhHHHHHHHHHHHH
Q psy48 930 SKNIVHCDLKPENVLLS-TNSELPQVKLCDFGFARII-----------GEKSFPPEVLRNK-GYNRSLDMWSVGVIVYVS 996 (1098)
Q Consensus 930 s~gIvHrDLKp~NILld-~~g~~~~vKL~DFGla~~~-----------~~~~~APEvl~~~-~ys~~sDVwSLGvlLyEL 996 (1098)
++||+||||||+|||++ .++ .+||+|||+++.. +..|+|||++.+. .|+.++|||||||++|||
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDN---TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTT---EEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCC---cEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 99999999999999998 466 8999999999753 2236799999875 499999999999999999
Q ss_pred HcCCCCCCCChhHHHHHHHhhc-------------------cCCC---C-----CCCcCcHHHHHHHHHhhhhcccCCCC
Q psy48 997 LSGTFPFNEDEDINEQIQNAAF-------------------MYPP---R-----PWRDISSDAIDLINNLLQVKQRKRLS 1049 (1098)
Q Consensus 997 ltG~~Pf~~~~~~~~~i~~~~~-------------------~~p~---~-----~~~~is~el~~LL~~cL~~dP~kRPS 1049 (1098)
++|+.||.+............. .++. . ....+++++.+||.+||..||++|||
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 9999999876443322221110 0110 0 12347889999999999999999999
Q ss_pred HHHHHcCCCcCC
Q psy48 1050 VDKSLAHPWLQD 1061 (1098)
Q Consensus 1050 a~eIL~HpfFk~ 1061 (1098)
+.|+++||||++
T Consensus 316 ~~e~l~hp~f~~ 327 (383)
T 3eb0_A 316 PYEAMAHPFFDH 327 (383)
T ss_dssp HHHHHTSGGGHH
T ss_pred HHHHhcCHHHHH
Confidence 999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=350.39 Aligned_cols=238 Identities=23% Similarity=0.319 Sum_probs=206.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...+.....||.|.||.||.+.++.+++.||||+++.. ........+.+|+.+|+.++||||+++++++...+.+++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 45788899999999999999999999999999999753 33445567899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+++++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~---~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN---VLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC---CEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC---cEEECcCCCceecCCCce
Confidence 99999999999887667799999999999999999999999999999999999999988 89999999986432
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
..|+|||++.+..++.++||||||+++|||++ |..||..... ..+.+.. ......+..+++++.
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~ 345 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK---GGRLPCPELCPDAVF 345 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT---TCCCCCCTTCCHHHH
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHH
Confidence 13789999999999999999999999999998 9999986543 2222222 222223456899999
Q ss_pred HHHHHhhhhcccCCCCHHHHHc
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+||.+||+.||++|||+.++++
T Consensus 346 ~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 346 RLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=343.21 Aligned_cols=244 Identities=27% Similarity=0.452 Sum_probs=204.7
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc------
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR------ 885 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~------ 885 (1098)
..|.....||.|.+|.||.+.++.+|+.||||++............+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56889999999999999999999999999999998765555566789999999999999999999999987654
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+++||||+.+ +|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 104 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~---~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQT-DLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC---ELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCSE-EGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC---CEEECSTTCTTC-
T ss_pred EEEEeccccC-CHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC---cEEEeecccccCC
Confidence 4999999985 5545543 3599999999999999999999999999999999999999988 8999999999753
Q ss_pred ---------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhc---------------
Q psy48 966 ---------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAF--------------- 1018 (1098)
Q Consensus 966 ---------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~--------------- 1018 (1098)
+..|+|||++.+ ..++.++||||||+++|+|++|..||.+..... ..+.....
T Consensus 177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 334689999987 779999999999999999999999998654321 11111100
Q ss_pred --------cCC----CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1019 --------MYP----PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1019 --------~~p----~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
..+ ...+..+++++.+||.+||+.||++|||++++++||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 000 11234678999999999999999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=353.51 Aligned_cols=242 Identities=26% Similarity=0.383 Sum_probs=195.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC------Cc
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP------GR 885 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~------~~ 885 (1098)
..|.....||.|.||.||.+.+..+++.||||++.... ....+|+++|+.++||||++++++|... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 36888999999999999999999999999999996532 1234699999999999999999998432 24
Q ss_pred EEEEEEeccCchHHHHHh--hccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 886 IFVVMEKLQGDMLEMILS--SEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~--~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
+++||||++++.+..+.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~--~~kl~DFG~a~ 205 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA--VLKLCDFGSAK 205 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT--EEEECCCTTCE
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC--eEEeccchhhh
Confidence 789999999865543322 23467999999999999999999999999999999999999996642 68999999997
Q ss_pred cc-----------CCCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhh--------------
Q psy48 964 II-----------GEKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAA-------------- 1017 (1098)
Q Consensus 964 ~~-----------~~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~-------------- 1017 (1098)
.. +..|+|||++.+. .|+.++|||||||+||||++|+.||.+............
T Consensus 206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 43 2346899999765 799999999999999999999999987653322211111
Q ss_pred -----ccCCC---CC-----CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1018 -----FMYPP---RP-----WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1018 -----~~~p~---~~-----~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+.++. .. ...+++++.+||.+||..||++||++.++++||||++
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 01111 00 1246899999999999999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=341.24 Aligned_cols=245 Identities=22% Similarity=0.365 Sum_probs=201.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCC-ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCC------ceeeeeeeecC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSG-RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPG------VVNLERMFETP 883 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg-~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~L~~~f~~~ 883 (1098)
..+|.....||.|.+|.||.+.+..++ +.||||+++.. ......+.+|+.+++.++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 467899999999999999999998877 78999999642 345577889999999887655 89999999999
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec-----------------
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS----------------- 946 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld----------------- 946 (1098)
+.+++||||++++++..+.......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 999999999988877655554445799999999999999999999999999999999999994
Q ss_pred --CCCCCCcEEEeecCcccccC---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHH
Q psy48 947 --TNSELPQVKLCDFGFARIIG---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQI 1013 (1098)
Q Consensus 947 --~~g~~~~vKL~DFGla~~~~---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i 1013 (1098)
.++ .+||+|||+++... ..|+|||++.+..++.++||||||+++|||++|..||....... ..+
T Consensus 175 ~~~~~---~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 175 SVKNT---SIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp EESCC---CEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccCCC---cEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 444 89999999997542 23579999999999999999999999999999999998754322 222
Q ss_pred HHhhccCCC----------------------------------------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHH
Q psy48 1014 QNAAFMYPP----------------------------------------RPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053 (1098)
Q Consensus 1014 ~~~~~~~p~----------------------------------------~~~~~is~el~~LL~~cL~~dP~kRPSa~eI 1053 (1098)
.......|. ......+.++.+||.+||+.||++|||++++
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 221111110 0001124578999999999999999999999
Q ss_pred HcCCCcCC
Q psy48 1054 LAHPWLQD 1061 (1098)
Q Consensus 1054 L~HpfFk~ 1061 (1098)
++||||++
T Consensus 332 l~hp~f~~ 339 (355)
T 2eu9_A 332 LLHPFFAG 339 (355)
T ss_dssp TTSGGGGG
T ss_pred hcChhhcC
Confidence 99999997
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=344.58 Aligned_cols=243 Identities=23% Similarity=0.288 Sum_probs=203.7
Q ss_pred HhhheeeeeeeeeeeeeceEEEE-----eecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecC
Q psy48 810 MLVFMTYNVALCIAVVAGAACGV-----HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETP 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~-----~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~ 883 (1098)
....|.....||.|+||.||.+. +..+++.||||+++.. ........+.+|+.++..+ +||||+++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 35678999999999999999999 5667799999999754 2344557899999999999 789999999998776
Q ss_pred C-cEEEEEEeccCchHHHHHhhccC-------------------------------------------------------
Q psy48 884 G-RIFVVMEKLQGDMLEMILSSEKG------------------------------------------------------- 907 (1098)
Q Consensus 884 ~-~l~LVmEy~~ggsL~~~l~~~~~------------------------------------------------------- 907 (1098)
+ .+++||||+.+++|..++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 5 49999999999999999875432
Q ss_pred ----------ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----------
Q psy48 908 ----------RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----------- 966 (1098)
Q Consensus 908 ----------~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----------- 966 (1098)
.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG---CEEECCCGGGSCTTSCTTCEEC--C
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC---cEEEEeccceeeecccccchhcccc
Confidence 189999999999999999999999999999999999999888 89999999997441
Q ss_pred ---CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhh
Q psy48 967 ---EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042 (1098)
Q Consensus 967 ---~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~ 1042 (1098)
..|+|||++.+..++.++||||||+++|||++ |..||.+......................+++++.++|.+||+.
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 335 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 335 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 13689999999999999999999999999998 99999864322222222222222333456899999999999999
Q ss_pred cccCCCCHHHHHcC
Q psy48 1043 KQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1043 dP~kRPSa~eIL~H 1056 (1098)
||++|||+.++++|
T Consensus 336 dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 336 EPSQRPTFSELVEH 349 (359)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=347.27 Aligned_cols=239 Identities=20% Similarity=0.310 Sum_probs=204.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEee-------cCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeec
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHR-------KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFET 882 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k-------~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~ 882 (1098)
...|.+...||.|.||.||.+.+. .++..||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 357889999999999999999875 34567999999754 2344567899999999999 89999999999999
Q ss_pred CCcEEEEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC
Q psy48 883 PGRIFVVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947 (1098)
Q Consensus 883 ~~~l~LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~ 947 (1098)
.+.+|+||||+.+++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence 999999999999999999987543 34789999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC--hhHH
Q psy48 948 NSELPQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNED--EDIN 1010 (1098)
Q Consensus 948 ~g~~~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~--~~~~ 1010 (1098)
++ .+||+|||+++... ..|+|||++.+..|+.++|||||||++|||++ |..||.+. .+..
T Consensus 239 ~~---~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 239 NN---VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp TC---CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CC---CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 98 89999999997432 13689999999999999999999999999999 99999764 3333
Q ss_pred HHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1011 EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1011 ~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
..+... .....+..++.++.++|.+||..||++||++.+++++
T Consensus 316 ~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcC---CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333322 2233345789999999999999999999999999873
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=340.79 Aligned_cols=233 Identities=20% Similarity=0.291 Sum_probs=204.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|++|.||.+.+..+++.||+|++.. ........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 4678899999999999999999999999999999854 34566688999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||+.+++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK---NVVVADFGLARLMVDEKT 163 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS---CEEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC---CEEEeecccceecccccc
Confidence 99999999999987677899999999999999999999999999999999999999988 8999999998643
Q ss_pred ---------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--------hHHHHHHHh
Q psy48 966 ---------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--------DINEQIQNA 1016 (1098)
Q Consensus 966 ---------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--------~~~~~i~~~ 1016 (1098)
+..|+|||++.+..++.++||||||+++|||++|..||.... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH--
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc--
Confidence 122689999999999999999999999999999999986421 1111111
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1017 AFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1017 ~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
... ...+++++.++|.+||+.||++|||+.++++
T Consensus 242 -~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 -RYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp -HTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -ccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 2457889999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=348.63 Aligned_cols=241 Identities=26% Similarity=0.383 Sum_probs=195.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC------
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG------ 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~------ 884 (1098)
...|+....||.|+||.||.+.+..+++ ||+|.+..... ...+|+.+++.++||||++++++|...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3578999999999999999999988777 88887754321 1236999999999999999999995443
Q ss_pred cEEEEEEeccCchHHHHHh--hccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec-CCCCCCcEEEeecCc
Q psy48 885 RIFVVMEKLQGDMLEMILS--SEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS-TNSELPQVKLCDFGF 961 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~--~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld-~~g~~~~vKL~DFGl 961 (1098)
.+++||||++++++..+.. .....+++..++.++.||+.||+|||++||+||||||+|||++ .++ .+||+|||+
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~---~~kL~DFG~ 188 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG---VLKLIDFGS 188 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT---EEEECCCTT
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC---cEEEeeCCC
Confidence 3889999999987755442 2345799999999999999999999999999999999999998 676 899999999
Q ss_pred ccccC-----------CCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc-----------
Q psy48 962 ARIIG-----------EKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF----------- 1018 (1098)
Q Consensus 962 a~~~~-----------~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~----------- 1018 (1098)
++... ..|+|||++.+. .|+.++|||||||++|||++|+.||.+.............
T Consensus 189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 97542 225799999765 5999999999999999999999999876533222211110
Q ss_pred --------cCCC---C-----CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1019 --------MYPP---R-----PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1019 --------~~p~---~-----~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.++. . ....+++++.+||.+||+.||++|||+.++++||||++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 0110 0 11247899999999999999999999999999999997
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=326.75 Aligned_cols=238 Identities=20% Similarity=0.267 Sum_probs=204.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|++...||.|.+|.||.+.++ ++..||||+++.... ....+.+|+.+++.++||||+++++++...+.+++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 467889999999999999999665 577899999976433 2356899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC---
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE--- 967 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~--- 967 (1098)
||+++++|..++......+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~---~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL---CVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC---CEEECCTTCEEECCTTCE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC---CEEEccCccceecchhhh
Confidence 99999999999887666799999999999999999999999999999999999999998 899999999874422
Q ss_pred ----------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 968 ----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 968 ----------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
.|+|||++.+..++.++||||||+++|+|++ |..||........... ............+++++.++|
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li 238 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK-VSQGHRLYRPHLASDTIYQIM 238 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTTCCCCCCTTSCHHHHHHH
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-HHcCCCCCCCCcChHHHHHHH
Confidence 2689999999999999999999999999999 9999986543322222 222222233356789999999
Q ss_pred HHhhhhcccCCCCHHHHHcC
Q psy48 1037 NNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.+||+.||++|||+.+++++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 239 YSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=344.96 Aligned_cols=246 Identities=30% Similarity=0.502 Sum_probs=188.5
Q ss_pred Hhhheee-eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec----CC
Q psy48 810 MLVFMTY-NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET----PG 884 (1098)
Q Consensus 810 ~l~~~~~-~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~----~~ 884 (1098)
....|.. ...||.|++|.||.+.++.+++.||||++... .. ...+....++.++||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 3456777 45699999999999999999999999999642 11 22222334566789999999999976 45
Q ss_pred cEEEEEEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
.+++||||+.|++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+++
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 5899999999999998887543 369999999999999999999999999999999999999876543479999999996
Q ss_pred cc----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH------HHHHHHhhccCCCCCCCc
Q psy48 964 II----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI------NEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 964 ~~----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~------~~~i~~~~~~~p~~~~~~ 1027 (1098)
.. +..|+|||++.+..++.++||||||+++|+|++|..||...... ...+.......+...+..
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (336)
T 3fhr_A 180 ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259 (336)
T ss_dssp EC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTT
T ss_pred eccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhcc
Confidence 44 23468999999999999999999999999999999999754321 223333444455556678
Q ss_pred CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1028 ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+++++.+||.+||..||++|||+.++++||||++
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 9999999999999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=330.23 Aligned_cols=241 Identities=21% Similarity=0.268 Sum_probs=201.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCc-------eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGR-------GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP 883 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~-------~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~ 883 (1098)
...|.+...||.|.+|.||.+.+..+++ .||+|+++... ......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 4578999999999999999999998884 69999997543 34457899999999999999999999999999
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC-----CcEEEee
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL-----PQVKLCD 958 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~-----~~vKL~D 958 (1098)
+..++||||+.+++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.. ..+||+|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 99999999999999999998766669999999999999999999999999999999999999987721 0199999
Q ss_pred cCccccc--------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCC-CCCCCChhHHHHHHHhhccCCCCCCCcC
Q psy48 959 FGFARII--------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGT-FPFNEDEDINEQIQNAAFMYPPRPWRDI 1028 (1098)
Q Consensus 959 FGla~~~--------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~-~Pf~~~~~~~~~i~~~~~~~p~~~~~~i 1028 (1098)
||++... +..|+|||++.+ ..++.++||||||+++|||++|. +||...... ........ ....+...
T Consensus 165 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~~~~~~~~--~~~~~~~~ 241 (289)
T 4fvq_A 165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-RKLQFYED--RHQLPAPK 241 (289)
T ss_dssp CCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHT--TCCCCCCS
T ss_pred CcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-HHHHHhhc--cCCCCCCC
Confidence 9998644 445789999987 77999999999999999999965 454443322 22221111 11222446
Q ss_pred cHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1029 SSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
++++.++|.+||+.||++|||+.++++|
T Consensus 242 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 242 AAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp SCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7899999999999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=342.76 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=190.3
Q ss_pred HHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc--
Q psy48 808 LLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR-- 885 (1098)
Q Consensus 808 ~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~-- 885 (1098)
...+..|.....||.|+||.||.+.++.+++.||||++..... ......+|+..+..++||||++++++|...+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3556789999999999999999999999999999999865432 22345667788888899999999999965433
Q ss_pred -----EEEEEEeccCchHHHHHh--hccCccchhHHHHHHHHHHHHHHHHH--hCCccccCCCCCceeecC-CCCCCcEE
Q psy48 886 -----IFVVMEKLQGDMLEMILS--SEKGRLSERTTKFIITQILVALKHLH--SKNIVHCDLKPENVLLST-NSELPQVK 955 (1098)
Q Consensus 886 -----l~LVmEy~~ggsL~~~l~--~~~~~lse~~~~~ia~qIa~gL~~LH--s~gIvHrDLKp~NILld~-~g~~~~vK 955 (1098)
+++||||++++++..+.. .....+++..++.++.||+.||.||| ++||+||||||+|||++. ++ .+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~---~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG---TLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT---EEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC---cEE
Confidence 899999999986644432 24557899999999999999999999 999999999999999996 66 899
Q ss_pred EeecCcccccC-----------CCCCChhhhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--HHHHhhccC-
Q psy48 956 LCDFGFARIIG-----------EKSFPPEVLRNKG-YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQNAAFMY- 1020 (1098)
Q Consensus 956 L~DFGla~~~~-----------~~~~APEvl~~~~-ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~i~~~~~~~- 1020 (1098)
|+|||+++... ..|+|||++.+.. ++.++|||||||++|+|++|..||.+...... .+.......
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 99999997542 2257999997654 89999999999999999999999987643322 221110000
Q ss_pred -------------------C--------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1021 -------------------P--------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1021 -------------------p--------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
. .......++++.+||.+||+.||++|||+.++++||||++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 0 00112257899999999999999999999999999999973
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=332.66 Aligned_cols=242 Identities=21% Similarity=0.270 Sum_probs=205.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEe-----ecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVH-----RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPG 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~-----k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~ 884 (1098)
...|.+...||.|++|.||.+.+ ..+++.||||+++... .......+.+|+.+++.+ +||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 45789999999999999999985 4678899999997543 344567899999999999 8999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhccC-----------------ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKG-----------------RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~-----------------~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~ 947 (1098)
..++||||+++++|..++..... .+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 99999999999999999875432 4899999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCcccccCC--------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHH
Q psy48 948 NSELPQVKLCDFGFARIIGE--------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQ 1012 (1098)
Q Consensus 948 ~g~~~~vKL~DFGla~~~~~--------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~ 1012 (1098)
++ .+||+|||++..... .|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 181 ~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 181 GR---ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp TT---EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred CC---CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 88 899999999875422 3689999999999999999999999999999 99999764321111
Q ss_pred HHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1013 IQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1013 i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
...............++.++.++|.+||+.||++|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 11111222233345689999999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.22 Aligned_cols=238 Identities=23% Similarity=0.316 Sum_probs=201.7
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.+...||.|.+|.||.+.+. ++..||||+++..... ...+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 457889999999999999999765 6778999999765332 366889999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+.+++|..++......+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~---~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG---VVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS---CEEECSTTGGGGBCCHHH
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC---CEEEcccccccccccccc
Confidence 99999999999887667899999999999999999999999999999999999999988 89999999997441
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
..|+|||++.+..++.++||||||+++|+|++ |+.||......... ..............+++++.++|
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li 254 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-EHIAQGLRLYRPHLASEKVYTIM 254 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH-HHHhcccCCCCCCcCCHHHHHHH
Confidence 23789999999999999999999999999998 99999865432221 12222222233456789999999
Q ss_pred HHhhhhcccCCCCHHHHHcC
Q psy48 1037 NNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.+||+.||++|||+.++++|
T Consensus 255 ~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 255 YSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=335.41 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=199.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEe-ecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCC------CceeeeeeeecC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVH-RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHP------GVVNLERMFETP 883 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~-k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~Hp------nIv~L~~~f~~~ 883 (1098)
..+|.....||.|.+|.||.+.+ ..+++.||||+++.. ......+.+|+.+++.++|+ +++++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 46799999999999999999998 568999999999642 34457788999999888654 599999999999
Q ss_pred CcEEEEEEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCC------------
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE------------ 950 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~------------ 950 (1098)
+.+++||||+ +++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999999 555556665433 46899999999999999999999999999999999999987321
Q ss_pred ----CCcEEEeecCcccccC---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHH
Q psy48 951 ----LPQVKLCDFGFARIIG---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQN 1015 (1098)
Q Consensus 951 ----~~~vKL~DFGla~~~~---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~ 1015 (1098)
...+||+|||+++... ..|+|||++.+..++.++||||||+++|||++|..||...... ...+..
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 248 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHH
T ss_pred ccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 1179999999987543 2357999999999999999999999999999999999865432 222222
Q ss_pred hhccCCC----------------------------------------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1016 AAFMYPP----------------------------------------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1016 ~~~~~p~----------------------------------------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.....|. ......++++.+||.+||+.||++|||+.++++
T Consensus 249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 1111110 001123577899999999999999999999999
Q ss_pred CCCcCC
Q psy48 1056 HPWLQD 1061 (1098)
Q Consensus 1056 HpfFk~ 1061 (1098)
||||+.
T Consensus 329 hp~f~~ 334 (339)
T 1z57_A 329 HPFFDL 334 (339)
T ss_dssp SGGGGG
T ss_pred CHHHHH
Confidence 999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=324.12 Aligned_cols=240 Identities=16% Similarity=0.231 Sum_probs=205.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRIFV 888 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l~L 888 (1098)
...|.+...||.|.+|.||.+.+. ++.||||+++...........+.+|+.+++.++||||+++++++.+. +.+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 467889999999999999999974 88999999988766677778899999999999999999999999887 78999
Q ss_pred EEEeccCchHHHHHhhccC-ccchhHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 889 VMEKLQGDMLEMILSSEKG-RLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~-~lse~~~~~ia~qIa~gL~~LHs~g--IvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
||||+++++|..++..... .+++..++.++.||+.||+|||++| |+||||||+||+++.++ .++|.|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~---~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM---TARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS---CEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc---ceeEEeccceeee
Confidence 9999999999999875443 5899999999999999999999999 99999999999999988 7899988876432
Q ss_pred -------CCCCCChhhhccCCCCc---hhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 966 -------GEKSFPPEVLRNKGYNR---SLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 966 -------~~~~~APEvl~~~~ys~---~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
+..|+|||++.+..++. ++||||||+++|||++|+.||..................+..+..+++++.++
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (271)
T 3kmu_A 164 QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKL 243 (271)
T ss_dssp SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHH
T ss_pred cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 33468999998765544 89999999999999999999987654433333333334444456789999999
Q ss_pred HHHhhhhcccCCCCHHHHHc
Q psy48 1036 INNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~ 1055 (1098)
|.+||+.||++|||+.++++
T Consensus 244 i~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 244 MKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=337.57 Aligned_cols=243 Identities=26% Similarity=0.386 Sum_probs=199.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC--cEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG--RIFV 888 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~--~l~L 888 (1098)
..+|.....||.|++|.||.+.+..+++.||||+++.... ......+.+|+.+++.++||||+++++++.... .+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 4678999999999999999999999999999999975432 223467789999999999999999999987655 7899
Q ss_pred EEEeccCchHHHHHhhccC--ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceee----cCCCCCCcEEEeecCcc
Q psy48 889 VMEKLQGDMLEMILSSEKG--RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL----STNSELPQVKLCDFGFA 962 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~--~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILl----d~~g~~~~vKL~DFGla 962 (1098)
||||+++++|..++..... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++ .+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~---~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS---VYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE---EEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc---eEEEccCCCc
Confidence 9999999999999875433 38999999999999999999999999999999999998 5555 7999999999
Q ss_pred cccC-----------CCCCChhhhc--------cCCCCchhHHHHHHHHHHHHHcCCCCCCCC---hhHHHHHHHhhccC
Q psy48 963 RIIG-----------EKSFPPEVLR--------NKGYNRSLDMWSVGVIVYVSLSGTFPFNED---EDINEQIQNAAFMY 1020 (1098)
Q Consensus 963 ~~~~-----------~~~~APEvl~--------~~~ys~~sDVwSLGvlLyELltG~~Pf~~~---~~~~~~i~~~~~~~ 1020 (1098)
+... ..|+|||++. +..++.++|||||||++|||++|..||... ....+.+.......
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 7542 2357999986 578999999999999999999999999632 11122222221111
Q ss_pred CC------------------------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCC
Q psy48 1021 PP------------------------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057 (1098)
Q Consensus 1021 p~------------------------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~Hp 1057 (1098)
|. .....++..+.++|.+||+.||++|||++|+++||
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 11 11123567889999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.14 Aligned_cols=243 Identities=23% Similarity=0.251 Sum_probs=202.7
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHH-----HHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQE-----AQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~-----~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
...|.+...||.|.+|.||.+.+..+++.||||++.......... ..+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367899999999999999999999999999999997644332222 67899999999999999999999997765
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecCCCC--CCcEEEeecCc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVLLSTNSE--LPQVKLCDFGF 961 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~g--IvHrDLKp~NILld~~g~--~~~vKL~DFGl 961 (1098)
++||||+.+++|..++......+++..++.++.||+.||+|||++| |+||||||+|||++.++. ...+||+|||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 6999999999998888777778999999999999999999999999 999999999999987661 11399999999
Q ss_pred cccc---------CCCCCChhhhc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcC
Q psy48 962 ARII---------GEKSFPPEVLR--NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDI 1028 (1098)
Q Consensus 962 a~~~---------~~~~~APEvl~--~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~i 1028 (1098)
++.. +..|+|||++. ...++.++||||||+++|+|++|+.||.... ....................+
T Consensus 176 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 4f0f_A 176 SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDC 255 (287)
T ss_dssp CBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTS
T ss_pred cccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCccc
Confidence 8643 33468999994 5568899999999999999999999997542 221122222233344445678
Q ss_pred cHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1029 SSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
++++.++|.+||+.||++|||+.++++
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 256 PPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=336.33 Aligned_cols=239 Identities=20% Similarity=0.242 Sum_probs=205.5
Q ss_pred HhhheeeeeeeeeeeeeceEEEEee-----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHR-----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG 884 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k-----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~ 884 (1098)
....|.+...||.|.+|.||.+.+. .+++.||||+++... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 4567899999999999999999987 456899999997543 3445678999999999999999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhcc-----------------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy48 885 RIFVVMEKLQGDMLEMILSSEK-----------------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~-----------------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~ 941 (1098)
.+++||||+.+++|..++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 9999999999999999987532 56899999999999999999999999999999999
Q ss_pred ceeecCCCCCCcEEEeecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q psy48 942 NVLLSTNSELPQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNED 1006 (1098)
Q Consensus 942 NILld~~g~~~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~ 1006 (1098)
|||++.++ .+||+|||+++... ..|+|||++.+..++.++||||||+++|||++ |..||.+.
T Consensus 204 NIl~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 204 NCLVGENM---VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp GEEECGGG---CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred eEEECCCC---eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999988 89999999986431 13689999999999999999999999999999 99999865
Q ss_pred hh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1007 ED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1007 ~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.. ....+.... .......+++++.++|.+||+.||++||++.++++
T Consensus 281 ~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 281 AHEEVIYYVRDGN---ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp CHHHHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ChHHHHHHHhCCC---cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 32 223332222 22233568999999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=340.46 Aligned_cols=241 Identities=18% Similarity=0.202 Sum_probs=200.7
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~ 887 (1098)
.....|.....||.|.||.||.+.+..+++.||||++..... ...+.+|+.+++.+ +||||+++++++...+..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 345678999999999999999999999999999999975432 23588999999999 8999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC--CcEEEeecCccccc
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL--PQVKLCDFGFARII 965 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~--~~vKL~DFGla~~~ 965 (1098)
+||||+ +++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++.. ..+||+|||+++..
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 888988887666789999999999999999999999999999999999999987721 12999999999743
Q ss_pred -------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--hhH---HHHHHHhhccCC
Q psy48 966 -------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED--EDI---NEQIQNAAFMYP 1021 (1098)
Q Consensus 966 -------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~--~~~---~~~i~~~~~~~p 1021 (1098)
+..|+|||++.+..++.++||||||+++|||++|..||.+. .+. ...+.......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 23467999999999999999999999999999999999863 222 233333332222
Q ss_pred CCC-CCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1022 PRP-WRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1022 ~~~-~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
... ...++ ++.++|..||+.||.+||++++|++
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 211 12345 9999999999999999999988776
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=344.00 Aligned_cols=237 Identities=21% Similarity=0.366 Sum_probs=199.0
Q ss_pred hheeeeeeeeeeeeeceEEEEee---cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHR---KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k---~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
..|.....||.|+||.||.+.++ .++..||||+++... .......+.+|+.+++.++||||+++++++...+.+++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 46788999999999999999887 567789999997542 45556789999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||+++++|..++......+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL---VCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC---CEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC---CEEECcCccccccccC
Confidence 9999999999999987666899999999999999999999999999999999999999988 89999999987532
Q ss_pred -------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcH
Q psy48 967 -------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 967 -------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
..|+|||++.+..++.++||||||+++|||++ |..||..... ....+... ........++.
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~ 277 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG---YRLPPPMDCPA 277 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT---EECCCCTTCBH
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCccccH
Confidence 23789999999999999999999999999998 9999976532 22222222 12222346899
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
++.++|.+||+.||++||++.+|++
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHH
Confidence 9999999999999999999999886
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=331.54 Aligned_cols=239 Identities=19% Similarity=0.245 Sum_probs=205.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEee-----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHR-----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k-----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
...|.....||.|.+|.||.+.+. .+++.||||+++.. ........+.+|+.+++.++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 457889999999999999999884 45689999999754 345556789999999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhcc-----------------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy48 886 IFVVMEKLQGDMLEMILSSEK-----------------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~-----------------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~N 942 (1098)
+++||||+.+++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 999999999999999987532 248999999999999999999999999999999999
Q ss_pred eeecCCCCCCcEEEeecCcccccCC--------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh
Q psy48 943 VLLSTNSELPQVKLCDFGFARIIGE--------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE 1007 (1098)
Q Consensus 943 ILld~~g~~~~vKL~DFGla~~~~~--------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~ 1007 (1098)
|+++.++ .+||+|||++..... .|+|||++.+..++.++||||||+++|||++ |..||.+..
T Consensus 181 Ili~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 181 ILVAEGR---KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp EEEETTT---EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCC---CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999988 899999999864421 2689999999999999999999999999999 999998653
Q ss_pred --hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1008 --DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1008 --~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.....+... .....+..+++++.++|.+||+.||++||++.+++++
T Consensus 258 ~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 258 PERLFNLLKTG---HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGGHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcC---CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 333333322 2233345789999999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=338.26 Aligned_cols=242 Identities=22% Similarity=0.260 Sum_probs=201.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEee-----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHR-----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPG 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k-----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~ 884 (1098)
...|.....||.|.+|.||.+.+. .++..||||+++... .......+.+|+.+++.+ +||||+++++++...+
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 467889999999999999999973 456789999997532 233447899999999999 8999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhccC----------------------ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKG----------------------RLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~----------------------~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~N 942 (1098)
.+++||||+++++|..++..... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 202 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 202 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence 99999999999999999875432 37899999999999999999999999999999999
Q ss_pred eeecCCCCCCcEEEeecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh
Q psy48 943 VLLSTNSELPQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE 1007 (1098)
Q Consensus 943 ILld~~g~~~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~ 1007 (1098)
||++.++ .+||+|||++.... ..|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 203 Ill~~~~---~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 203 VLVTHGK---VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp EEEETTT---EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred EEEcCCC---cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999988 89999999986431 13789999999999999999999999999998 999997643
Q ss_pred hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1008 DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1008 ~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
....................+++++.+||.+||..||++|||+.++++|
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 2111111111222223345689999999999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=342.88 Aligned_cols=244 Identities=27% Similarity=0.385 Sum_probs=198.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CC-----CceeeeeeeecCC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HP-----GVVNLERMFETPG 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIv~L~~~f~~~~ 884 (1098)
...|.....||.|.+|.||.+.+..+++.||||+++.. ......+.+|+.+++.++ |+ +|+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 46789999999999999999999999999999999742 344567888998888775 44 4999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHH--hCCccccCCCCCceeecC--CCCCCcEEEeec
Q psy48 885 RIFVVMEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLH--SKNIVHCDLKPENVLLST--NSELPQVKLCDF 959 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LH--s~gIvHrDLKp~NILld~--~g~~~~vKL~DF 959 (1098)
.+++||||+++ +|..++.... ..+++..++.++.||+.||.||| +.||+||||||+|||++. ++ .+||+||
T Consensus 130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~---~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS---AIKIVDF 205 (382)
T ss_dssp EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC---CEEECCC
T ss_pred ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC---cEEEEec
Confidence 99999999987 5556665443 56999999999999999999999 579999999999999964 44 7999999
Q ss_pred CcccccCC---------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhccC--------
Q psy48 960 GFARIIGE---------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMY-------- 1020 (1098)
Q Consensus 960 Gla~~~~~---------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~~-------- 1020 (1098)
|+++..+. .|+|||++.+..|+.++|||||||++|||++|+.||.+..... ..+.......
T Consensus 206 G~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (382)
T 2vx3_A 206 GSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285 (382)
T ss_dssp TTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred cCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 99975533 3579999999999999999999999999999999998764322 2222111000
Q ss_pred ----------CCCCC-----------------Cc-------------------------CcHHHHHHHHHhhhhcccCCC
Q psy48 1021 ----------PPRPW-----------------RD-------------------------ISSDAIDLINNLLQVKQRKRL 1048 (1098)
Q Consensus 1021 ----------p~~~~-----------------~~-------------------------is~el~~LL~~cL~~dP~kRP 1048 (1098)
+...| .. .++++.+||.+||+.||++||
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp 365 (382)
T 2vx3_A 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI 365 (382)
T ss_dssp TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence 00000 00 014789999999999999999
Q ss_pred CHHHHHcCCCcCC
Q psy48 1049 SVDKSLAHPWLQD 1061 (1098)
Q Consensus 1049 Sa~eIL~HpfFk~ 1061 (1098)
|++++|+||||++
T Consensus 366 ta~e~L~hp~f~~ 378 (382)
T 2vx3_A 366 QPYYALQHSFFKK 378 (382)
T ss_dssp CHHHHTTSGGGCC
T ss_pred CHHHHhcCccccc
Confidence 9999999999997
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=337.80 Aligned_cols=238 Identities=21% Similarity=0.244 Sum_probs=199.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCce----eEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRG----VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~----VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
...|.....||.|+||.||.+.+..+++. ||+|++.... .......+.+|+.+++.++||||+++++++. .+..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 35688899999999999999999999887 5555553321 1222356778999999999999999999986 4578
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
++||||+.+++|..++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++...
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~---~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS---QVQVADFGVADLLP 166 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS---CEEECSCSGGGGSC
T ss_pred EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC---eEEECCCCcccccC
Confidence 999999999999999887667899999999999999999999999999999999999999988 89999999997542
Q ss_pred --------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC--hhHHHHHHHhhccCCCCCCCcCc
Q psy48 967 --------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNED--EDINEQIQNAAFMYPPRPWRDIS 1029 (1098)
Q Consensus 967 --------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is 1029 (1098)
..|+|||++.+..++.++||||||+++|+|++ |..||.+. .+....+..... ......++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 243 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER---LAQPQICT 243 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB---CCCCTTBC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---CCCCCcCc
Confidence 14689999999999999999999999999999 99999864 333333333222 22234578
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.++.++|.+||..||++||++.+++++
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 244 IDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.85 Aligned_cols=239 Identities=23% Similarity=0.301 Sum_probs=197.3
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecC---CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKS---GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~t---g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
....|.....||.|.+|.||.+.+..+ +..||||+++.. ........+.+|+.+++.++||||+++++++. .+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 356889999999999999999998654 456999998653 23445678999999999999999999999985 4678
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
++||||+.+++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC---CEEECccccccccC
Confidence 999999999999999886666799999999999999999999999999999999999999888 89999999986542
Q ss_pred C-------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcH
Q psy48 967 E-------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 967 ~-------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
. .|+|||++.+..++.++||||||+++|||++ |..||.+.. +....+... .....+..+++
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~ 244 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPMPPNCPP 244 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---CCCCCCTTCCH
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC---CCCCCCCCCCH
Confidence 1 3689999999999999999999999999996 999998643 333333322 22223457899
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
++.++|.+||+.||++|||+.+++++
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=328.74 Aligned_cols=240 Identities=22% Similarity=0.273 Sum_probs=201.8
Q ss_pred hheeeeeeeeeeeeeceEEEE----eecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--Cc
Q psy48 812 VFMTYNVALCIAVVAGAACGV----HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GR 885 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~----~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~ 885 (1098)
.+|+....||.|.+|.||.+. +..+++.||||+++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 458889999999999999998 67889999999997543 233457789999999999999999999999876 67
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+++||||+++++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH---QVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC---CEEECcccccccc
Confidence 9999999999999999977777899999999999999999999999999999999999999988 8999999998654
Q ss_pred CC---------------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--------------hhHHHHHHHh
Q psy48 966 GE---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED--------------EDINEQIQNA 1016 (1098)
Q Consensus 966 ~~---------------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~--------------~~~~~~i~~~ 1016 (1098)
.. .|+|||++.+..++.++||||||+++|+|++|..|+... ..........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 22 168999999999999999999999999999999876432 1222222333
Q ss_pred hccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1017 AFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1017 ~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
........+..+++++.+||.+||+.||++|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 333333345678999999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.54 Aligned_cols=238 Identities=21% Similarity=0.328 Sum_probs=204.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.+...||.|.+|.||.+.+. +++.||||+++.... ....+.+|+.+++.++||||+++++++...+.+++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 357889999999999999999886 678899999976533 2367899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+++++|..++......+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~---~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ---VIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG---CEEECCTTGGGGBCCHHH
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC---CEEEcccccccccccccc
Confidence 99999999999887667799999999999999999999999999999999999999888 89999999987542
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
..++|||++.+..++.++||||||+++|+|++ |..||....... ................++.++.+++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li 238 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIM 238 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-HHHHHhcCCcCCCCccCcHHHHHHH
Confidence 13689999999999999999999999999999 899998653321 1222222222333456889999999
Q ss_pred HHhhhhcccCCCCHHHHHcC
Q psy48 1037 NNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.+||+.||++||++.+++++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 239 NHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=338.95 Aligned_cols=239 Identities=20% Similarity=0.296 Sum_probs=205.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCC-------ceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeec
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSG-------RGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFET 882 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg-------~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~ 882 (1098)
...|.....||.|+||.||.+.+..++ ..||||+++.. ........+.+|+++++.+ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 357889999999999999999976443 57999999764 3455567899999999999 89999999999999
Q ss_pred CCcEEEEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC
Q psy48 883 PGRIFVVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947 (1098)
Q Consensus 883 ~~~l~LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~ 947 (1098)
.+.+++||||+.+++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence 999999999999999999987543 35999999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCcccccCC--------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHH
Q psy48 948 NSELPQVKLCDFGFARIIGE--------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DIN 1010 (1098)
Q Consensus 948 ~g~~~~vKL~DFGla~~~~~--------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~ 1010 (1098)
++ .+||+|||+++.... .|+|||++.+..++.++||||||+++|+|++ |..||.+.. +..
T Consensus 227 ~~---~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 227 DN---VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp TC---CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CC---cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 88 899999999975422 2579999999999999999999999999999 999998653 222
Q ss_pred HHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1011 EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1011 ~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.+.. .........+++++.+||.+||+.||++|||+.+++++
T Consensus 304 ~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKE---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHT---TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHc---CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22222 22333345789999999999999999999999999983
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=337.43 Aligned_cols=241 Identities=27% Similarity=0.489 Sum_probs=205.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh----HHHHHHHHHHHHHhccC--CCCceeeeeeeecC
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT----KQEAQLKNEVAILQNLC--HPGVVNLERMFETP 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~----~~~~~~~~Ei~iL~~l~--HpnIv~L~~~f~~~ 883 (1098)
....|.....||.|.+|.||.+.+..+++.||||+++...... .....+.+|+.+++.++ |+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 3567999999999999999999999999999999998754332 12245778999999886 59999999999999
Q ss_pred CcEEEEEEeccC-chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec-CCCCCCcEEEeecCc
Q psy48 884 GRIFVVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS-TNSELPQVKLCDFGF 961 (1098)
Q Consensus 884 ~~l~LVmEy~~g-gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld-~~g~~~~vKL~DFGl 961 (1098)
+..++|||++.+ ++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++ .+||+|||+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~~kL~Dfg~ 196 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG---ELKLIDFGS 196 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT---EEEECCCTT
T ss_pred CcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC---CEEEeeCcc
Confidence 999999999975 888888764 45799999999999999999999999999999999999998 566 899999999
Q ss_pred ccccCC----------CCCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcH
Q psy48 962 ARIIGE----------KSFPPEVLRNKGY-NRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 962 a~~~~~----------~~~APEvl~~~~y-s~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
+..... .|+|||++.+..+ +.++||||||+++|||++|+.||...... ...... ....+++
T Consensus 197 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~~~~~~----~~~~~~~ 268 (320)
T 3a99_A 197 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----IRGQVF----FRQRVSS 268 (320)
T ss_dssp CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----HHCCCC----CSSCCCH
T ss_pred ccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh----hccccc----ccccCCH
Confidence 875432 3579999987765 78899999999999999999999765432 112211 2246889
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
++.+||.+||+.||++|||++++++||||++.
T Consensus 269 ~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 99999999999999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=336.03 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=188.8
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHH-HHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVA-ILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..|.....||.|.+|.||.+.++.+++.||||+++... .......+..|+. +++.++||||+++++++...+..++||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 56788899999999999999999999999999997653 2333445555655 777889999999999999999999999
Q ss_pred EeccCchHHHHHhh----ccCccchhHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 891 EKLQGDMLEMILSS----EKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~----~~~~lse~~~~~ia~qIa~gL~~LHs~-gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
||++++ |..++.. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||+++..
T Consensus 101 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMSTS-FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG---NIKLCDFGISGQL 176 (327)
T ss_dssp CCCSEE-HHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT---EEEECCCSSSCC-
T ss_pred eecCCC-hHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC---CEEEccCCCceec
Confidence 999975 4444432 245789999999999999999999999 999999999999999988 8999999998643
Q ss_pred -----------CCCCCChhhh----ccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccC----CCCCCC
Q psy48 966 -----------GEKSFPPEVL----RNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMY----PPRPWR 1026 (1098)
Q Consensus 966 -----------~~~~~APEvl----~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~----p~~~~~ 1026 (1098)
+..|+|||++ .+..++.++||||||+++|+|++|..||.......+.+....... +...+.
T Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3aln_A 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSC
T ss_pred ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccc
Confidence 2336799999 466799999999999999999999999987544333332222111 122234
Q ss_pred cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1027 DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1027 ~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+++++.+||.+||..||++||++.++++||||..
T Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 68999999999999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=329.61 Aligned_cols=240 Identities=23% Similarity=0.330 Sum_probs=202.9
Q ss_pred HhhheeeeeeeeeeeeeceEEEEe-----ecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecC
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVH-----RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETP 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~-----k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~ 883 (1098)
....|.....||.|.+|.||.+.+ ..+++.||||+++... .......+.+|+.++..+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 356899999999999999999985 4577899999997643 344557899999999999 699999999998765
Q ss_pred C-cEEEEEEeccCchHHHHHhhccCc---------------cchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC
Q psy48 884 G-RIFVVMEKLQGDMLEMILSSEKGR---------------LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947 (1098)
Q Consensus 884 ~-~l~LVmEy~~ggsL~~~l~~~~~~---------------lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~ 947 (1098)
+ .+++||||+++++|..++...... +++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 4 599999999999999998754332 899999999999999999999999999999999999998
Q ss_pred CCCCCcEEEeecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh---hH
Q psy48 948 NSELPQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE---DI 1009 (1098)
Q Consensus 948 ~g~~~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~---~~ 1009 (1098)
++ .+||+|||+++... ..|+|||++.+..++.++||||||+++|+|++ |..||.+.. ..
T Consensus 184 ~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 184 KN---VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp GG---CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CC---CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 88 89999999997542 13689999999999999999999999999998 999997643 23
Q ss_pred HHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1010 NEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1010 ~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
...+... ........+++++.++|.+||+.||++|||+.++++|
T Consensus 261 ~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CRRLKEG---TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccC---ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3333322 2222334588999999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=329.44 Aligned_cols=245 Identities=24% Similarity=0.295 Sum_probs=204.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC--CCCceeeeeeeecCCcEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC--HPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~L~~~f~~~~~l~L 888 (1098)
...|.....||.|.+|.||.+.+. +++.||||++............+.+|+.++..++ |+||+++++++...+.+++
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 356889999999999999999885 5899999999876666667788999999999997 5999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
||| +.+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||++...
T Consensus 106 v~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~---~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G---MLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T---EEEECCCSSSCC----
T ss_pred EEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C---eEEEeeccccccccCc
Confidence 999 567778788764 457899999999999999999999999999999999999964 5 7999999998643
Q ss_pred -----------CCCCCChhhhcc-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHh-hccCCC
Q psy48 966 -----------GEKSFPPEVLRN-----------KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNA-AFMYPP 1022 (1098)
Q Consensus 966 -----------~~~~~APEvl~~-----------~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~-~~~~p~ 1022 (1098)
...|+|||++.+ ..++.++||||||+++|+|++|..||.........+... ......
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 259 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence 223579999976 478999999999999999999999998653322222221 112222
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
......+.++.++|.+||+.||++||++.++++||||+..
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 2234568999999999999999999999999999999873
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=325.50 Aligned_cols=243 Identities=26% Similarity=0.400 Sum_probs=201.0
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCC-ChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRF-PTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.+..|.....||.|.+|.||.+.+..+++.||||+++.... .......+.+|+.+++.++||||+++++++...+.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 45679999999999999999999999999999999976433 34456789999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 889 VMEKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
||||+.+++|..++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~---~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---CEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC---CEEEEeccceeee
Confidence 9999999999888764 345689999999999999999999999999999999999999988 8999999998643
Q ss_pred ------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-hHHHHHH-HhhccCCCCCCCcCcHH
Q psy48 966 ------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-DINEQIQ-NAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 966 ------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-~~~~~i~-~~~~~~p~~~~~~is~e 1031 (1098)
...++|||++.+..++.++||||||+++|+|++|..||.+.. ....... .....++......++++
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence 233679999999999999999999999999999999997542 1111111 12223344344678999
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.++|.+||..||++||++.++++
T Consensus 267 l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 267 LRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=321.12 Aligned_cols=242 Identities=23% Similarity=0.301 Sum_probs=197.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh--HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT--KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
...|.....||.|++|.||.+.+. ++.||||+++...... .....+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 457889999999999999999874 8899999997643222 224678999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceeecCCCC-----CCcEEEeecC
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN---IVHCDLKPENVLLSTNSE-----LPQVKLCDFG 960 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~g---IvHrDLKp~NILld~~g~-----~~~vKL~DFG 960 (1098)
||||+++++|..++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+.. ...+||+|||
T Consensus 84 v~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999988875 457999999999999999999999999 899999999999986221 1279999999
Q ss_pred ccccc----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcH
Q psy48 961 FARII----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 961 la~~~----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
++... +..|+|||++.+..++.++||||||+++|+|++|+.||........................+++
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (271)
T 3dtc_A 162 LAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE 241 (271)
T ss_dssp C-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCH
Confidence 99643 22357999999999999999999999999999999999876554443333333333334467899
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
++.++|.+||+.||++|||+.+++++
T Consensus 242 ~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 242 PFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.46 Aligned_cols=240 Identities=18% Similarity=0.215 Sum_probs=201.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LV 889 (1098)
...|.....||.|.+|.||.+.+..+++.||||++.... ....+.+|+.+++.+ +|+|++++++++......++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 457899999999999999999999999999999996532 234578899999998 799999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCC--CCcEEEeecCcccccC-
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE--LPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~--~~~vKL~DFGla~~~~- 966 (1098)
|||+ +++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++. ...+||+|||+++...
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9999 88998998866667999999999999999999999999999999999999987651 1249999999986432
Q ss_pred ------------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-----hHHHHHHHhhccCC-C
Q psy48 967 ------------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-----DINEQIQNAAFMYP-P 1022 (1098)
Q Consensus 967 ------------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-----~~~~~i~~~~~~~p-~ 1022 (1098)
..|+|||++.+..++.++||||||+++|||++|+.||.... .....+.......+ .
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 33679999999999999999999999999999999997631 22222222222111 1
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.....+++++.++|.+||+.||++||++++|++
T Consensus 244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 112368899999999999999999999999876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=324.42 Aligned_cols=238 Identities=22% Similarity=0.314 Sum_probs=196.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
.+.|+....||.|++|.||.+.+.. .||||+++...........+.+|+.+++.++||||++++++. ..+.+++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 4578999999999999999997643 599999987766677778899999999999999999999965 556789999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||+.+++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN---TVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT---EEEECCCC----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC---CEEEccceeccccccccc
Confidence 99999999999877777899999999999999999999999999999999999999998 8999999998633
Q ss_pred ---------CCCCCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH---HHHHHHhhccCC-CCCCCcCc
Q psy48 966 ---------GEKSFPPEVLR---NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI---NEQIQNAAFMYP-PRPWRDIS 1029 (1098)
Q Consensus 966 ---------~~~~~APEvl~---~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~---~~~i~~~~~~~p-~~~~~~is 1029 (1098)
+..|+|||++. +..++.++||||||+++|+|++|+.||...... .+.+........ ......++
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCC
Confidence 33468999997 677899999999999999999999999864332 222222222221 12234688
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+++.+||.+||+.||++|||+.++++
T Consensus 256 ~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 256 KRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=331.37 Aligned_cols=239 Identities=20% Similarity=0.263 Sum_probs=204.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEee-----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHR-----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k-----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
...|.....||.|.+|.||.+.++ .+++.||||++.... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 467899999999999999999887 468899999997542 34455679999999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhcc---------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEE
Q psy48 886 IFVVMEKLQGDMLEMILSSEK---------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKL 956 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~---------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL 956 (1098)
.++||||+.+++|..++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~---~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---TVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC---CEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC---eEEE
Confidence 999999999999998886432 3568999999999999999999999999999999999999988 8999
Q ss_pred eecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhcc
Q psy48 957 CDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFM 1019 (1098)
Q Consensus 957 ~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~ 1019 (1098)
+|||++... +..|+|||++.+..++.++||||||+++|+|++ |..||..... ....+....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-- 257 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-- 257 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC--
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC--
Confidence 999998643 123789999999999999999999999999999 8999986532 222222221
Q ss_pred CCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1020 YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1020 ~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.......++.++.++|.+||+.||++|||+.+++++
T Consensus 258 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 -LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 122235689999999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=330.37 Aligned_cols=239 Identities=21% Similarity=0.347 Sum_probs=201.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCC----ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSG----RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg----~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
...|+....||.|++|.||.+.+..++ ..||||+++... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 356788899999999999999987654 359999997543 345567899999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
++||||+.+++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~---~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL---VCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC---CEEECCCCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC---cEEECCCCcchhhc
Confidence 999999999999999987667899999999999999999999999999999999999999988 89999999987542
Q ss_pred C---------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcC
Q psy48 967 E---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDI 1028 (1098)
Q Consensus 967 ~---------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~i 1028 (1098)
. .|+|||++.+..++.++||||||+++|||++ |..||..... ....+.. .........+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~ 275 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---GFRLPTPMDC 275 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---TCCCCCCTTC
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC---CCcCCCcccC
Confidence 1 3689999999999999999999999999999 9999976532 2222222 2222234568
Q ss_pred cHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1029 SSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.++.++|.+||+.||++||++.+++++
T Consensus 276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=323.87 Aligned_cols=236 Identities=23% Similarity=0.320 Sum_probs=206.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|+....||.|.+|.||.+.+..++..||||+++.. ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 45788999999999999999999999999999999753 344578899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC--
Q psy48 891 EKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE-- 967 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~-- 967 (1098)
||+.|++|..++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++.....
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~---~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH---LVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG---CEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC---CEEEccCccceeccCCc
Confidence 999999999888753 34599999999999999999999999999999999999999888 899999999975432
Q ss_pred -----------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 968 -----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 968 -----------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
.++|||++.+..++.++||||||+++|+|++ |..||.... ...+.+.. ......+..+++++.
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~ 242 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVY 242 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---TCCCCCCTTCCHHHH
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---cCCCCCCCCCCHHHH
Confidence 3689999999999999999999999999999 999997643 33333322 223333457899999
Q ss_pred HHHHHhhhhcccCCCCHHHHHc
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
++|.+||..||++|||+.++++
T Consensus 243 ~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 243 ELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCCChhhCcCHHHHHH
Confidence 9999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=332.28 Aligned_cols=247 Identities=20% Similarity=0.263 Sum_probs=204.5
Q ss_pred hhheeeeeeeeeeeeeceEEEE-----eecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc
Q psy48 811 LVFMTYNVALCIAVVAGAACGV-----HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~-----~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~ 885 (1098)
...|.+...||.|++|.||.+. +..+++.||||++... ........+.+|+.+++.++||||+++++++...+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 4678899999999999999999 5678889999999643 334556789999999999999999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhcc------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeec
Q psy48 886 IFVVMEKLQGDMLEMILSSEK------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDF 959 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DF 959 (1098)
.++||||+++++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 999999999999999987543 34889999999999999999999999999999999999996654447999999
Q ss_pred Cccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCC
Q psy48 960 GFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPP 1022 (1098)
Q Consensus 960 Gla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~ 1022 (1098)
|++... +..|+|||++.+..++.++||||||+++|+|++ |..||..... ....+.. ....
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---~~~~ 264 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS---GGRM 264 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT---TCCC
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc---CCCC
Confidence 998632 224789999999999999999999999999998 9999986533 2222222 2222
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.....++..+.++|.+||+.||++||++.+++++.++-.
T Consensus 265 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 265 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 334568999999999999999999999999999877643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=332.43 Aligned_cols=244 Identities=20% Similarity=0.248 Sum_probs=207.0
Q ss_pred HHHhhheeeeeeeeeeeeeceEEEE----eecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeee--
Q psy48 808 LLMLVFMTYNVALCIAVVAGAACGV----HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE-- 881 (1098)
Q Consensus 808 ~~~l~~~~~~~~Lg~G~~g~v~~a~----~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~-- 881 (1098)
+.....|++...||.|.+|.||.+. +..+++.||||++... .......+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 3445789999999999999999998 5788999999999754 3455678999999999999999999999886
Q ss_pred cCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCc
Q psy48 882 TPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGF 961 (1098)
Q Consensus 882 ~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGl 961 (1098)
....+++||||+++++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~---~~kl~Dfg~ 173 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA---HVKIADFGL 173 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCGGG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC---CEEEccccc
Confidence 45669999999999999999887667799999999999999999999999999999999999999988 899999999
Q ss_pred ccccCC---------------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--------------HHH
Q psy48 962 ARIIGE---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--------------NEQ 1012 (1098)
Q Consensus 962 a~~~~~---------------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--------------~~~ 1012 (1098)
+..... .|+|||++.+..++.++||||||+++|+|++|..||...... ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 975421 168999999999999999999999999999999998654221 122
Q ss_pred HHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1013 IQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1013 i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
...............+++++.+||.+||+.||++|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22222223333345789999999999999999999999999764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=324.50 Aligned_cols=237 Identities=21% Similarity=0.298 Sum_probs=199.5
Q ss_pred hhheeeee-eeeeeeeeceEEEE--eecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 811 LVFMTYNV-ALCIAVVAGAACGV--HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 811 l~~~~~~~-~Lg~G~~g~v~~a~--~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
...|.... .||.|.+|.||.+. ...+++.||||+++...........+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 34677777 99999999999994 466788999999987654455567899999999999999999999999 567789
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
+||||+.+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC---cEEEccCCcceeecc
Confidence 99999999999988864 45699999999999999999999999999999999999999988 89999999986542
Q ss_pred --------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhH--HHHHHHhhccCCCCCCCcCc
Q psy48 967 --------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDI--NEQIQNAAFMYPPRPWRDIS 1029 (1098)
Q Consensus 967 --------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is 1029 (1098)
..|+|||++.+..++.++||||||+++|+|++ |..||...... ...+.. .........++
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~ 246 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCP 246 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCCCCCTTCC
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCC
Confidence 23689999999999999999999999999999 99999875432 222222 22223345789
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+++.++|.+||+.||++||++.++++
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=322.54 Aligned_cols=236 Identities=18% Similarity=0.220 Sum_probs=197.8
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCc---eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE-EE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGR---GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI-FV 888 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~---~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l-~L 888 (1098)
.+.....||.|++|.||.+.+..+++ .||+|+++.. ........+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 45567899999999999999766655 7999999653 2344567899999999999999999999999876665 99
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||+.+++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~---~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF---TVKVADFGLARDILDR 177 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC---CEEECCTTSSCTTTTG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC---cEEeCcCCCcccccCC
Confidence 9999999999999887677899999999999999999999999999999999999999988 89999999996431
Q ss_pred --------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCC-CCh--hHHHHHHHhhccCCCCCCCcCc
Q psy48 967 --------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFN-EDE--DINEQIQNAAFMYPPRPWRDIS 1029 (1098)
Q Consensus 967 --------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~-~~~--~~~~~i~~~~~~~p~~~~~~is 1029 (1098)
..++|||++.+..++.++||||||+++|+|++|..|+. ... +....+... ........++
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 254 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG---RRLPQPEYCP 254 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT---CCCCCCTTCC
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC---CCCCCCccch
Confidence 13579999999999999999999999999999665544 322 233333222 2223345689
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+++.++|.+||+.||.+|||+.++++
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=323.34 Aligned_cols=236 Identities=24% Similarity=0.358 Sum_probs=200.7
Q ss_pred heeee-eeeeeeeeeceEEEEee--cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 813 FMTYN-VALCIAVVAGAACGVHR--KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 813 ~~~~~-~~Lg~G~~g~v~~a~~k--~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
.+... ..||.|.+|.||.+.++ .++..||||+++... .......+.+|+.+++.++||||+++++++ ..+.+++|
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 44444 49999999999999854 568889999997642 345567899999999999999999999999 45679999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||+.+++|..++......+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT---EEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC---CEEECcccceeeeccCc
Confidence 999999999999876667899999999999999999999999999999999999999888 89999999987542
Q ss_pred ------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHH
Q psy48 967 ------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 967 ------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
..|+|||++.+..++.++||||||+++|+|++ |+.||.... +....+... .....+..++++
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~ 241 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRMECPPECPPE 241 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT---CCCCCCTTCCHH
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC---CcCCCCCCcCHH
Confidence 23689999999999999999999999999998 999998653 333333222 222334578999
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.++|.+||+.||++||++.+++++
T Consensus 242 l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 242 LYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=332.94 Aligned_cols=238 Identities=20% Similarity=0.273 Sum_probs=196.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCcee----EEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGV----AIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~V----AVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
...|+....||.|+||.||.+.+..+++.+ |+|.++.. ........+.+|+.+++.++||||+++++++.+.. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 457889999999999999999998888876 55555432 12334578999999999999999999999998764 7
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
++||||+.+++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCTTHHHHHT
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC---CEEEccCcceeEcc
Confidence 899999999999999887777899999999999999999999999999999999999999988 89999999986532
Q ss_pred C--------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCc
Q psy48 967 E--------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDIS 1029 (1098)
Q Consensus 967 ~--------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is 1029 (1098)
. .|+|||++.+..++.++||||||+++|||++ |..||.+.. +....+.... .......++
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 245 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICT 245 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---CCCCCTTBC
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC---CCCCCccCC
Confidence 1 3689999999999999999999999999999 999998643 3333333222 222235688
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.++.+++.+||+.||++||++.+++++
T Consensus 246 ~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 246 IDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.40 Aligned_cols=242 Identities=30% Similarity=0.474 Sum_probs=197.7
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh----HHHHHHHHHHHHHhcc----CCCCceeeeeee
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT----KQEAQLKNEVAILQNL----CHPGVVNLERMF 880 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~----~~~~~~~~Ei~iL~~l----~HpnIv~L~~~f 880 (1098)
.....|.....||.|++|.||.+.+..+++.||||+++...... .....+.+|+.++..+ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34567999999999999999999999999999999997654322 1234466789998888 899999999999
Q ss_pred ecCCcEEEEEEe-ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec-CCCCCCcEEEee
Q psy48 881 ETPGRIFVVMEK-LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS-TNSELPQVKLCD 958 (1098)
Q Consensus 881 ~~~~~l~LVmEy-~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld-~~g~~~~vKL~D 958 (1098)
...+..++|||| +.+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++ .++ .+||+|
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~~kl~d 183 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG---CAKLID 183 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT---EEEECC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC---eEEEEE
Confidence 999999999999 789999888864 45799999999999999999999999999999999999999 666 899999
Q ss_pred cCccccc----------CCCCCChhhhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCc
Q psy48 959 FGFARII----------GEKSFPPEVLRNKGYN-RSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 959 FGla~~~----------~~~~~APEvl~~~~ys-~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~ 1027 (1098)
||++... ...|+|||++.+..+. .++||||||+++|+|++|+.||...... ...... ....
T Consensus 184 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~----~~~~ 255 (312)
T 2iwi_A 184 FGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI----LEAELH----FPAH 255 (312)
T ss_dssp CSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----HHTCCC----CCTT
T ss_pred cchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH----hhhccC----Cccc
Confidence 9998754 2336799999877664 5999999999999999999999765432 222222 2346
Q ss_pred CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1028 ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
++.++.++|.+||+.||++||+++++++||||+..
T Consensus 256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 88999999999999999999999999999999984
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=331.95 Aligned_cols=239 Identities=21% Similarity=0.274 Sum_probs=202.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCc-----eeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGR-----GVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPG 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~-----~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~ 884 (1098)
...|.+...||.|++|.||.+.+..+++ .||||+++... .......+.+|+.+++.+ +||||+++++++...+
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 4578899999999999999999877665 79999997543 344567899999999999 8999999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhc-------------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC
Q psy48 885 RIFVVMEKLQGDMLEMILSSE-------------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~-------------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~ 951 (1098)
.+++||||+++++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-- 201 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-- 201 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG--
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC--
Confidence 999999999999999988643 23579999999999999999999999999999999999999888
Q ss_pred CcEEEeecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHH
Q psy48 952 PQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQ 1014 (1098)
Q Consensus 952 ~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~ 1014 (1098)
.+||+|||++.... ..|+|||++.+..++.++||||||+++|||++ |..||.+.. .....+.
T Consensus 202 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 202 -VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp -EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred -eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 89999999997431 13689999999999999999999999999998 999997643 2222222
Q ss_pred HhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1015 NAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1015 ~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.. .........+++++.++|.+||+.||.+|||+.++++
T Consensus 281 ~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 281 KD--GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HH--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hc--CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 22 2222233557899999999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=337.01 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=198.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-----------CCCceeeeee
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-----------HPGVVNLERM 879 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~L~~~ 879 (1098)
...|.+...||.|.+|.||.+.+..+++.||||+++.. ......+.+|+.+++.+. |+||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 46799999999999999999999999999999999742 344577889999998776 8999999999
Q ss_pred eecCC----cEEEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCC---C
Q psy48 880 FETPG----RIFVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNS---E 950 (1098)
Q Consensus 880 f~~~~----~l~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~-gIvHrDLKp~NILld~~g---~ 950 (1098)
+...+ .+++||||+ +++|..++... ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 97654 789999999 67777776643 45699999999999999999999998 999999999999995322 1
Q ss_pred CCcEEEeecCcccccC---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--------hHHHHH
Q psy48 951 LPQVKLCDFGFARIIG---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--------DINEQI 1013 (1098)
Q Consensus 951 ~~~vKL~DFGla~~~~---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--------~~~~~i 1013 (1098)
...+||+|||++.... ..|+|||++.+..++.++||||||+++|||++|..||.... +....+
T Consensus 174 ~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253 (373)
T ss_dssp EEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred cceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence 1279999999997543 23579999999999999999999999999999999997542 111111
Q ss_pred HHhhccCCC--------------------------------------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1014 QNAAFMYPP--------------------------------------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1014 ~~~~~~~p~--------------------------------------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.......|. .....+++++.+||.+||+.||++|||++++++
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 111110000 011235678999999999999999999999999
Q ss_pred CCCcCCC
Q psy48 1056 HPWLQDP 1062 (1098)
Q Consensus 1056 HpfFk~~ 1062 (1098)
||||++.
T Consensus 334 hp~f~~~ 340 (373)
T 1q8y_A 334 HPWLKDT 340 (373)
T ss_dssp CGGGTTC
T ss_pred Chhhhcc
Confidence 9999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=327.71 Aligned_cols=243 Identities=21% Similarity=0.251 Sum_probs=199.3
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
..++.|.....||.|.+|.||.+.+..+++.||||+++..... ......+.+|+.+++.++||||+++++++...+.++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 3467899999999999999999999999999999999765332 333478999999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
+||||++|++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 111 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~---~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD---FAYLVDFGIASATTD 186 (309)
T ss_dssp EEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS---CEEECSCCC------
T ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC---CEEEecCccCccccc
Confidence 99999999999988864 45799999999999999999999999999999999999999988 89999999986442
Q ss_pred ------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH-HHHHHhhccCCCCCCCcCcHHHH
Q psy48 967 ------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN-EQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 967 ------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~-~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
..|+|||++.+..++.++||||||+++|+|++|..||....... ..........+...+..++.++.
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHH
Confidence 23579999999999999999999999999999999998765331 11112111222233456899999
Q ss_pred HHHHHhhhhcccCCC-CHHHHHc
Q psy48 1034 DLINNLLQVKQRKRL-SVDKSLA 1055 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRP-Sa~eIL~ 1055 (1098)
++|.+||+.||++|| +++++++
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999 7877775
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=325.24 Aligned_cols=241 Identities=17% Similarity=0.249 Sum_probs=199.1
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeec---CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC--
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRK---SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG-- 884 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~---tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~-- 884 (1098)
....|.....||.|.+|.||.+.+.. +++.||||+++...........+.+|+.+++.++||||+++++++...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 35678999999999999999998765 5568999999876666666788999999999999999999999997654
Q ss_pred ---cEEEEEEeccCchHHHHHhh-----ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEE
Q psy48 885 ---RIFVVMEKLQGDMLEMILSS-----EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKL 956 (1098)
Q Consensus 885 ---~l~LVmEy~~ggsL~~~l~~-----~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL 956 (1098)
..++||||+.+++|..++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~---~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM---TVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS---CEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC---cEEE
Confidence 45999999999999888743 235699999999999999999999999999999999999999988 8999
Q ss_pred eecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhcc
Q psy48 957 CDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFM 1019 (1098)
Q Consensus 957 ~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~ 1019 (1098)
+|||++.... ..|+|||++.+..++.++||||||+++|+|++ |..||.... +....+...
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--- 265 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG--- 265 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC---
Confidence 9999986542 13679999999999999999999999999999 899997643 333333222
Q ss_pred CCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1020 YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1020 ~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.....+..+++++.++|.+||..||++||++.+++++
T Consensus 266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2233346789999999999999999999999999873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=328.94 Aligned_cols=241 Identities=21% Similarity=0.291 Sum_probs=203.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCcee--EEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGV--AIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~V--AVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~ 887 (1098)
...|.+...||.|++|.||.+.+..++..+ |||+++.. ........+.+|+.+++.+ +||||+++++++.+.+.++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 467889999999999999999999999866 99998643 2234456789999999999 8999999999999999999
Q ss_pred EEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCC
Q psy48 888 VVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~ 952 (1098)
+||||+++++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--- 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--- 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG---
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC---
Confidence 9999999999999886543 3689999999999999999999999999999999999999888
Q ss_pred cEEEeecCccccc-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccC
Q psy48 953 QVKLCDFGFARII-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMY 1020 (1098)
Q Consensus 953 ~vKL~DFGla~~~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~ 1020 (1098)
.+||+|||+++.. ...|+|||++.+..++.++||||||+++|+|++ |..||.+..... .........
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-~~~~~~~~~ 258 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGY 258 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHGGGTC
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-HHHHhhcCC
Confidence 8999999998632 234789999999999999999999999999998 999998764322 222222223
Q ss_pred CCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1021 PPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1021 p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.......+++++.+||.+||..||++|||+++++++
T Consensus 259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 333345789999999999999999999999999974
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=322.48 Aligned_cols=238 Identities=21% Similarity=0.292 Sum_probs=198.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCC---ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeee-ecCCcE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSG---RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF-ETPGRI 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg---~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f-~~~~~l 886 (1098)
...|.+...||.|++|.||.+.+..++ ..||||+++.. ........+.+|+.+++.++||||+++++++ ...+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 356888999999999999999865443 45899998653 2344567899999999999999999999985 556789
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
++||||+++++|..++......+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++...
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF---TVKVADFGLARDMY 179 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC---CEEECSCGGGCCCS
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC---CEEECccccccccc
Confidence 999999999999999987677799999999999999999999999999999999999999988 89999999996432
Q ss_pred ----------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCc
Q psy48 967 ----------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 967 ----------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~ 1027 (1098)
..|+|||++.+..++.++||||||+++|+|++ |.+||.... +....+.... .......
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 256 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---RLLQPEY 256 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC---CCCCCTT
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC---CCCCCcc
Confidence 13689999999999999999999999999999 556665432 3333333222 2222356
Q ss_pred CcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1028 ISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+++++.++|.+||+.||++|||+.++++
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8899999999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=328.79 Aligned_cols=239 Identities=20% Similarity=0.310 Sum_probs=202.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEee-------cCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeec
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHR-------KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFET 882 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k-------~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~ 882 (1098)
...|.....||.|.||.||.+.+. .++..||||+++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 467899999999999999999975 467889999997543 345567899999999999 89999999999999
Q ss_pred CCcEEEEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC
Q psy48 883 PGRIFVVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947 (1098)
Q Consensus 883 ~~~l~LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~ 947 (1098)
.+.+++||||+.+++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 999999999999999999987543 24889999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCcccccCC--------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHH
Q psy48 948 NSELPQVKLCDFGFARIIGE--------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DIN 1010 (1098)
Q Consensus 948 ~g~~~~vKL~DFGla~~~~~--------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~ 1010 (1098)
++ .+||+|||++..... .|+|||++.+..++.++||||||+++|+|++ |..||.+.. +..
T Consensus 193 ~~---~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 193 NN---VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp TC---CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CC---CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 88 899999999864422 2689999999999999999999999999999 999998653 233
Q ss_pred HHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1011 EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1011 ~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
..+... ........++.++.++|.+||..||++||++.+++++
T Consensus 270 ~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcC---CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 333222 2223345689999999999999999999999999973
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=325.62 Aligned_cols=238 Identities=19% Similarity=0.256 Sum_probs=199.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeee----cCCcE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE----TPGRI 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~----~~~~l 886 (1098)
...|.+...||.|.+|.||.+.+..+++.||||++... .......+.+|+.+++.++||||+++++++. .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 45789999999999999999999999999999998653 2455678999999999999999999999986 34578
Q ss_pred EEEEEeccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 887 FVVMEKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
++||||+.+++|..++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~---~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG---QPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS---CEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC---CEEEEecCcch
Confidence 999999999999888765 346799999999999999999999999999999999999999988 89999999876
Q ss_pred cc---------------------CCCCCChhhhccCC---CCchhHHHHHHHHHHHHHcCCCCCCCC----hhHHHHHHH
Q psy48 964 II---------------------GEKSFPPEVLRNKG---YNRSLDMWSVGVIVYVSLSGTFPFNED----EDINEQIQN 1015 (1098)
Q Consensus 964 ~~---------------------~~~~~APEvl~~~~---ys~~sDVwSLGvlLyELltG~~Pf~~~----~~~~~~i~~ 1015 (1098)
.. +..|+|||++.+.. ++.++||||||+++|+|++|+.||... ......+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 262 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence 43 34478999998654 789999999999999999999999531 222222222
Q ss_pred hhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1016 AAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1016 ~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
. ........++.++.++|.+||+.||++||++.+++++
T Consensus 263 -~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 -Q--LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -c--CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 1 1222235689999999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=330.03 Aligned_cols=238 Identities=20% Similarity=0.264 Sum_probs=199.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEecc---CCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKL---RFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~---~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
...|.....||.|.||.||.+.+..+++.||+|+..+. .........+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 45788999999999999999999999988755543221 122344678999999999999999999999998764 88
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~ 967 (1098)
+||+|+.+++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~---~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC---CEEEccCcceeEccC
Confidence 99999999999999887777899999999999999999999999999999999999999988 899999999975421
Q ss_pred --------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcH
Q psy48 968 --------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 968 --------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
.|+|||++.+..|+.++||||||+++|||++ |..||.+.. +....+.... .......++.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 246 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICTI 246 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---CCCCCTTBCH
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---CCCCCccCCH
Confidence 3689999999999999999999999999999 999998643 3333333222 2222356899
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
++.++|.+||..||++||++.++++
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999997
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.97 Aligned_cols=238 Identities=24% Similarity=0.279 Sum_probs=202.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecC---CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKS---GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~t---g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
...|.....||.|.+|.||.+.+... +..||||+++... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 46788999999999999999986543 4569999997643 345567899999999999999999999998754 568
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~ 967 (1098)
+||||+.+++|..++......+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT---EEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC---cEEeCccCCCccccc
Confidence 99999999999999887667799999999999999999999999999999999999999988 899999999875421
Q ss_pred -------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHH
Q psy48 968 -------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNED--EDINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 968 -------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
.|+|||++.+..++.++||||||+++|+|++ |..||... .+....+.... .......++++
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 242 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD---RLPKPDLCPPV 242 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC---CCCCCTTCCHH
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC---CCCCCCCCCHH
Confidence 3689999999999999999999999999998 99999743 33433333322 12223468999
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.++|.+||..||++||++.+++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=330.08 Aligned_cols=234 Identities=28% Similarity=0.506 Sum_probs=190.1
Q ss_pred hhheeee-eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHH-hccCCCCceeeeeeeec----CC
Q psy48 811 LVFMTYN-VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAIL-QNLCHPGVVNLERMFET----PG 884 (1098)
Q Consensus 811 l~~~~~~-~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~L~~~f~~----~~ 884 (1098)
...|... ..||.|.+|.||.+.+..+++.||||+++.. ..+.+|+.++ +..+||||+++++++.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3455555 7799999999999999999999999999642 3567788887 56689999999999976 67
Q ss_pred cEEEEEEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
.+++||||++|++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 8999999999999988887543 369999999999999999999999999999999999999984322289999999987
Q ss_pred ccCCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH------HHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 964 IIGEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ------IQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 964 ~~~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~------i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
... +..|+.++||||||+++|||++|..||......... +.......+...+..+++++.+||.
T Consensus 169 ~~~----------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (299)
T 3m2w_A 169 ETT----------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 238 (299)
T ss_dssp ECT----------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHH
T ss_pred ccc----------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHH
Confidence 554 355888999999999999999999999765432111 0011111111112468999999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+||+.||++|||+.++++||||++
T Consensus 239 ~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 239 NLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp HHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHcccChhhCCCHHHHhcChhhcc
Confidence 999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=321.07 Aligned_cols=241 Identities=21% Similarity=0.216 Sum_probs=195.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeec-CCc--eeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRK-SGR--GVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~-tg~--~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
...|.+...||.|.+|.||.+.+.. +++ .||||+++..... ......+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4678999999999999999998654 333 6999999765432 344578999999999999999999999998765 8
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
++||||+.+++|..++......+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~---~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC---CEEEcccccccccc
Confidence 999999999999999887667899999999999999999999999999999999999999888 89999999986542
Q ss_pred C---------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcH
Q psy48 967 E---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISS 1030 (1098)
Q Consensus 967 ~---------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~ 1030 (1098)
. .|+|||++.+..++.++||||||+++|+|++ |+.||........................++.
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 252 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence 2 3689999999999999999999999999999 99999875432222111122222233457899
Q ss_pred HHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1031 DAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1031 el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
++.++|.+||..||++||++.++++
T Consensus 253 ~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 253 DIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999997
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=341.81 Aligned_cols=243 Identities=26% Similarity=0.353 Sum_probs=193.9
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..+.....||.|++|.||.+ ...+|+.||||++... ....+.+|+.+|+.+ +||||+++++++.+.+.+++||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 45666889999999999874 5678999999999653 235678899999876 8999999999999999999999
Q ss_pred EeccCchHHHHHhhccCc------cchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC----------CCCcE
Q psy48 891 EKLQGDMLEMILSSEKGR------LSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS----------ELPQV 954 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~------lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g----------~~~~v 954 (1098)
||++| +|..++...... .++..++.++.||+.||+|||++||+||||||+|||++.++ ....+
T Consensus 89 E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 89 ELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred ecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 99975 787887643221 23446688999999999999999999999999999997542 22379
Q ss_pred EEeecCccccc----------------CCCCCChhhhcc-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHH
Q psy48 955 KLCDFGFARII----------------GEKSFPPEVLRN-------KGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDIN 1010 (1098)
Q Consensus 955 KL~DFGla~~~----------------~~~~~APEvl~~-------~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~ 1010 (1098)
||+|||+++.. +..|+|||++.+ ..++.++|||||||++|||++ |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999998643 224689999976 678999999999999999999 999998654433
Q ss_pred HHHHHhhccCCCCC---CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1011 EQIQNAAFMYPPRP---WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1011 ~~i~~~~~~~p~~~---~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..+.......+... ...+++++.+||.+||+.||++|||+.++++||||+.
T Consensus 248 ~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 44443333322211 2245689999999999999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=349.90 Aligned_cols=235 Identities=22% Similarity=0.314 Sum_probs=205.2
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..+.+...||.|.||.||.+.++.++..||||+++... .....+.+|+.+|+.++||||+++++++...+.+++|||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 46788999999999999999999999999999997643 235679999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 892 KLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
|+.+++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~---~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH---LVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG---CEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC---cEEEeecccceeccCCce
Confidence 99999999998753 34689999999999999999999999999999999999999888 89999999997542
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
..|+|||++.+..++.++|||||||+||||++ |..||.+.. +..+.+.. .+....+..+++++.+
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~ 450 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYE 450 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---TCCCCCCTTCCHHHHH
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHH
Confidence 13689999999999999999999999999999 999998643 33333322 2333344678999999
Q ss_pred HHHHhhhhcccCCCCHHHHHc
Q psy48 1035 LINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
||.+||+.||++|||+.+|++
T Consensus 451 li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 451 LMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=321.39 Aligned_cols=237 Identities=20% Similarity=0.272 Sum_probs=203.0
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec-------
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET------- 882 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~------- 882 (1098)
....|.....||.|.+|.||.+.+..+++.||||+++... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 4567889999999999999999999999999999997542 356789999999999999999998854
Q ss_pred ---------CCcEEEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCC
Q psy48 883 ---------PGRIFVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952 (1098)
Q Consensus 883 ---------~~~l~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~ 952 (1098)
...+++||||+++++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--- 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--- 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC---
Confidence 45589999999999999988754 35799999999999999999999999999999999999999988
Q ss_pred cEEEeecCcccccC-----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCC
Q psy48 953 QVKLCDFGFARIIG-----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYP 1021 (1098)
Q Consensus 953 ~vKL~DFGla~~~~-----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p 1021 (1098)
.+||+|||++.... ..|+|||++.+..++.++||||||+++|+|++|..|+.........+....
T Consensus 160 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~---- 235 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI---- 235 (284)
T ss_dssp EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTC----
T ss_pred CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhccc----
Confidence 89999999986542 246799999999999999999999999999999998864433333332211
Q ss_pred CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1022 PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1022 ~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
....++.++.++|.+||..||++||++.++++|.+.-.
T Consensus 236 --~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 --ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 12457899999999999999999999999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=341.87 Aligned_cols=235 Identities=22% Similarity=0.321 Sum_probs=201.7
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC-cEE
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG-RIF 887 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~-~l~ 887 (1098)
.....+.+...||.|.||.||.+.+. ++.||||+++... ....+.+|+.+|+.++||||+++++++.... .++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 34567889999999999999999864 7799999997542 3467899999999999999999999976654 799
Q ss_pred EEEEeccCchHHHHHhhccC-ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-
Q psy48 888 VVMEKLQGDMLEMILSSEKG-RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII- 965 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~-~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~- 965 (1098)
+||||+.+++|..++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~---~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN---VAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS---CEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC---CEEEeeCCCccccc
Confidence 99999999999999876543 379999999999999999999999999999999999999988 8999999998643
Q ss_pred --------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 966 --------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 --------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
+..|+|||++.+..++.++||||||++||||++ |..||... .+....+... +....+..+++++.+
T Consensus 341 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~p~~~~~~l~~ 417 (450)
T 1k9a_A 341 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVYD 417 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT---CCCCCCTTCCHHHHH
T ss_pred ccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCHHHHH
Confidence 234789999999999999999999999999998 99999754 3333333322 233344678999999
Q ss_pred HHHHhhhhcccCCCCHHHHHc
Q psy48 1035 LINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
||.+||..||++|||+.++++
T Consensus 418 li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 418 VMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999885
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=342.02 Aligned_cols=234 Identities=18% Similarity=0.278 Sum_probs=200.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...+.+...||.|.||.||.+.+. ++..||||+++... .....+.+|+.+|+.++||||+++++++. .+.+++||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 457888999999999999999875 46789999997643 23578999999999999999999999986 56789999
Q ss_pred EeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 891 EKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
||+.+++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~---~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL---VCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC---CEEECSTTGGGGBCCHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC---cEEEeeCCCceEcCCCc
Confidence 9999999999987443 3688999999999999999999999999999999999999988 89999999997542
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
..|+|||++.+..++.++|||||||+||||++ |+.||.+.. +....+.. .+....+..+++++.
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~ 415 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER---GYRMPRPENCPEELY 415 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH---TCCCCCCTTSCHHHH
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHH
Confidence 23689999999999999999999999999999 999998653 23333332 222233457899999
Q ss_pred HHHHHhhhhcccCCCCHHHHHc
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+||.+||..||++|||+.+|++
T Consensus 416 ~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 416 NIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=343.82 Aligned_cols=242 Identities=24% Similarity=0.318 Sum_probs=193.1
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.|.....||.|++|.|+. ....+++.||||++..... ..+.+|+.+|+.+ +||||+++++++.+...+|+|||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 467788999999999864 5567899999999965332 2356799999988 79999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC--CCCcEEEeecCccccc----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS--ELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g--~~~~vKL~DFGla~~~---- 965 (1098)
|++| +|..++......+.+..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+++..
T Consensus 99 ~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 99 LCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp CCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 9986 67678776666677778899999999999999999999999999999996432 1226889999998643
Q ss_pred -----------CCCCCChhhhc---cCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCC-CCCCCcCc
Q psy48 966 -----------GEKSFPPEVLR---NKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYP-PRPWRDIS 1029 (1098)
Q Consensus 966 -----------~~~~~APEvl~---~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p-~~~~~~is 1029 (1098)
+..|+|||++. +..++.++|||||||++|||++ |..||.........+........ .......+
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHH
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccccc
Confidence 33467999998 4668889999999999999999 99999765433322222221111 11123346
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..+.+||.+||+.||++|||+.++++||||+.
T Consensus 258 ~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 258 VIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred HHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 67899999999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=336.49 Aligned_cols=238 Identities=17% Similarity=0.157 Sum_probs=191.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecC-----CceeEEEEEeccCCChHHH---------HHHHHHHHHHhccCCCCceee
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKS-----GRGVAIKVIDKLRFPTKQE---------AQLKNEVAILQNLCHPGVVNL 876 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~t-----g~~VAVKvlkk~~~~~~~~---------~~~~~Ei~iL~~l~HpnIv~L 876 (1098)
...|.....||.|+||.||.+.+..+ ++.||||++.........+ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34788999999999999999998765 5889999997643111111 123445566778889999999
Q ss_pred eeeeecC----CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec--CCCC
Q psy48 877 ERMFETP----GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS--TNSE 950 (1098)
Q Consensus 877 ~~~f~~~----~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld--~~g~ 950 (1098)
++++... ..+++||||+ |++|..++......+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~- 191 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD- 191 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT-
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC-
Confidence 9998765 4589999999 9999999887667899999999999999999999999999999999999999 666
Q ss_pred CCcEEEeecCcccc-------------------cCCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh---h
Q psy48 951 LPQVKLCDFGFARI-------------------IGEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE---D 1008 (1098)
Q Consensus 951 ~~~vKL~DFGla~~-------------------~~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~---~ 1008 (1098)
.+||+|||+++. .+..|+|||++.+..++.++|||||||+||||++|+.||.+.. .
T Consensus 192 --~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 192 --QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp --CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred --eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 899999999954 2335689999999999999999999999999999999998531 1
Q ss_pred HHHHHHHh---------hccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1009 INEQIQNA---------AFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1009 ~~~~i~~~---------~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
........ ...++ ...+++++.++|..||..||++||++.+|++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 11111100 00011 1357899999999999999999999988775
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.54 Aligned_cols=238 Identities=20% Similarity=0.203 Sum_probs=193.4
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeee-ecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF-ETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f-~~~~~l~L 888 (1098)
....|.....||.|.+|.||.+.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 4467999999999999999999999999999999976532 223578899999999887766665555 66778899
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceee---cCCCCCCcEEEeecCccccc
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL---STNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILl---d~~g~~~~vKL~DFGla~~~ 965 (1098)
||||+ +++|..++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||+++..
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~---~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN---LVYIIDFGLAKKY 158 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT---CEEECCCTTCEEC
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC---eEEEecCccceec
Confidence 99999 888888887666789999999999999999999999999999999999999 5666 8999999999643
Q ss_pred C-------------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-----hHHHHHHHhhccCC
Q psy48 966 G-------------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-----DINEQIQNAAFMYP 1021 (1098)
Q Consensus 966 ~-------------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-----~~~~~i~~~~~~~p 1021 (1098)
. ..|+|||++.+..++.++|||||||++|+|++|+.||.... .....+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 2 23479999999999999999999999999999999997531 22233322222222
Q ss_pred C-CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1022 P-RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1022 ~-~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
. .....+++++.++|.+||+.||++||++.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1 112457899999999999999999999998886
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=313.55 Aligned_cols=236 Identities=20% Similarity=0.287 Sum_probs=199.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|.+|.||.+.+. ++..||||+++.... ....+.+|+.+++.++||||+++++++.. +..++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 357889999999999999999865 567899999976432 34678999999999999999999999864 5689999
Q ss_pred EeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 891 EKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
||+.+++|..++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL---SCKIADFGLARLIEDNE 163 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS---CEEECCCTTCEECSSSC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC---CEEECCCcccccccCcc
Confidence 9999999999886433 2699999999999999999999999999999999999999888 89999999987542
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..++|||++.+..++.++||||||+++|||++ |..||.+.... +.+..............+++++.++
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l 242 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGYRMVRPDNCPEELYQL 242 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-HHHHHHhcccCCCCcccccHHHHHH
Confidence 23689999999999999999999999999999 99999865432 1222222223333345789999999
Q ss_pred HHHhhhhcccCCCCHHHHHc
Q psy48 1036 INNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~ 1055 (1098)
|.+||..||++|||+.++++
T Consensus 243 i~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 243 MRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHHH
Confidence 99999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=352.31 Aligned_cols=231 Identities=24% Similarity=0.371 Sum_probs=199.0
Q ss_pred eeeeeeeeeeceEEEEee--cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEecc
Q psy48 817 NVALCIAVVAGAACGVHR--KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k--~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ 894 (1098)
...||.|.||.||.+.++ .++..||||+++... .......+.+|+.+|+.++||||+++++++.. +.+++||||+.
T Consensus 341 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~ 418 (613)
T 2ozo_A 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG 418 (613)
T ss_dssp EEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCC
Confidence 447999999999999876 356679999997642 33456789999999999999999999999976 56999999999
Q ss_pred CchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--------
Q psy48 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-------- 966 (1098)
Q Consensus 895 ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-------- 966 (1098)
+++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 419 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 419 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH---YAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp TCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCCSTTTTCC--------
T ss_pred CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC---cEEEeeccCcccccCCCceeee
Confidence 9999999877777799999999999999999999999999999999999999988 89999999997542
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
..|+|||++.+..|+.++|||||||+||||++ |+.||.+.. +....+... .....+..+++++.+||
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~---~~~~~p~~~~~~l~~li 572 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRMECPPECPPELYALM 572 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT---CCCCCCTTCCHHHHHHH
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCHHHHHHH
Confidence 24789999999999999999999999999998 999998653 333333332 22333456899999999
Q ss_pred HHhhhhcccCCCCHHHHHc
Q psy48 1037 NNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.+||..||++||++.+|++
T Consensus 573 ~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 573 SDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHTTCSSTTTSCCHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHH
Confidence 9999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=324.52 Aligned_cols=236 Identities=20% Similarity=0.252 Sum_probs=197.6
Q ss_pred eeeeeeeeeeeeeceEEEE----eecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC--CcEE
Q psy48 814 MTYNVALCIAVVAGAACGV----HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP--GRIF 887 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~----~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~--~~l~ 887 (1098)
++....||.|.+|.||.+. +..+++.||||+++.. ........+.+|+.+|+.++||||+++++++.+. ..++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 4889999999999997764 5568999999999764 3345567899999999999999999999999874 6789
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~ 967 (1098)
+||||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~---~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC---CEEECCGGGCEECCT
T ss_pred EEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC---CEEECCccccccccc
Confidence 99999999999998854 3499999999999999999999999999999999999999988 899999999975432
Q ss_pred ---------------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--------------HHHHHHhhc
Q psy48 968 ---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--------------NEQIQNAAF 1018 (1098)
Q Consensus 968 ---------------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--------------~~~i~~~~~ 1018 (1098)
.|+|||++.+..++.++||||||+++|+|++|..||...... .........
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 168999999999999999999999999999999999754211 111111122
Q ss_pred cCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1019 MYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1019 ~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.........++.++.+||.+||+.||++|||+.++++
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2233334578999999999999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=324.58 Aligned_cols=240 Identities=19% Similarity=0.251 Sum_probs=201.8
Q ss_pred hhheeeeeeeeeeeeeceEEEE----eecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC--
Q psy48 811 LVFMTYNVALCIAVVAGAACGV----HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG-- 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~----~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~-- 884 (1098)
...|.+...||.|.+|.||.+. +..+++.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 4678899999999999999998 5678999999999753 3455678999999999999999999999986654
Q ss_pred cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
.+++||||+++++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~---~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKV 194 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCCTTCEE
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC---cEEEecCcchhh
Confidence 78999999999999999987667799999999999999999999999999999999999999988 899999999875
Q ss_pred cCC---------------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH-H--------------HHHH
Q psy48 965 IGE---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI-N--------------EQIQ 1014 (1098)
Q Consensus 965 ~~~---------------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~-~--------------~~i~ 1014 (1098)
... .++|||++.+..++.++||||||+++|+|++|..||...... . ....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 422 167999999999999999999999999999999998643111 0 1111
Q ss_pred HhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1015 NAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1015 ~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.............+++++.++|.+||+.||++|||+.++++
T Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111222234568999999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=334.03 Aligned_cols=237 Identities=21% Similarity=0.291 Sum_probs=195.2
Q ss_pred heeeeeeeeeeeeeceEEEEeecCC---ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeee-ecCCcEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSG---RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF-ETPGRIFV 888 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg---~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f-~~~~~l~L 888 (1098)
.|.+...||.|.||.||.+.+..++ ..||||+++.. ........+.+|+.+++.++||||+++++++ ...+..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4677899999999999999876543 46899998653 2345567899999999999999999999986 45568899
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||+.+++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF---TVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC---CEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC---CEEEeecccccccccc
Confidence 9999999999999987677799999999999999999999999999999999999999988 89999999996431
Q ss_pred --------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC--hhHHHHHHHhhccCCCCCCCcCc
Q psy48 967 --------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNED--EDINEQIQNAAFMYPPRPWRDIS 1029 (1098)
Q Consensus 967 --------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is 1029 (1098)
..|+|||++.+..++.++||||||+++|||++ |.+||... .+....+.... .......++
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~---~~~~p~~~~ 322 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---RLLQPEYCP 322 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC---CCCCCTTCC
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC---CCCCCCCCC
Confidence 13689999999999999999999999999999 67888654 23333333322 222235689
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.++.++|.+||+.||++||++.+++++
T Consensus 323 ~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 323 DPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.40 Aligned_cols=242 Identities=17% Similarity=0.127 Sum_probs=190.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeec---CCceeEEEEEeccCCChHH---------HHHHHHHHHHHhccCCCCceeeee
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRK---SGRGVAIKVIDKLRFPTKQ---------EAQLKNEVAILQNLCHPGVVNLER 878 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~---tg~~VAVKvlkk~~~~~~~---------~~~~~~Ei~iL~~l~HpnIv~L~~ 878 (1098)
...|.+...||.|.+|.||.+.+.. ++..||||++......... ...+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3578999999999999999999987 8899999999764321111 123667888899999999999999
Q ss_pred eeec----CCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcE
Q psy48 879 MFET----PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQV 954 (1098)
Q Consensus 879 ~f~~----~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~v 954 (1098)
++.. ...+++||||+ +++|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.. .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~-~~ 192 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QV 192 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT-SE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC-cE
Confidence 9977 77899999999 89998887644 389999999999999999999999999999999999999876532 79
Q ss_pred EEeecCccccc-------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC---hh-HHH
Q psy48 955 KLCDFGFARII-------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED---ED-INE 1011 (1098)
Q Consensus 955 KL~DFGla~~~-------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~---~~-~~~ 1011 (1098)
||+|||+++.. +..|+|||++.+..++.++|||||||++|||++|+.||... .. ...
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999999643 33468999999999999999999999999999999999642 11 111
Q ss_pred HHHHhhccCCCC-----CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1012 QIQNAAFMYPPR-----PWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1012 ~i~~~~~~~p~~-----~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.........+.. ....+++++.++|.+||..||++||++.+|++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 111111111110 01268899999999999999999999998876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=319.14 Aligned_cols=235 Identities=23% Similarity=0.303 Sum_probs=195.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|++|.||.+.+. ++.||||++.. ......+.+|+.+++.++||||+++++++.+ ..++||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 356888999999999999999864 78899999864 3445789999999999999999999999874 489999
Q ss_pred EeccCchHHHHHhhccC--ccchhHHHHHHHHHHHHHHHHHh---CCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 891 EKLQGDMLEMILSSEKG--RLSERTTKFIITQILVALKHLHS---KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~--~lse~~~~~ia~qIa~gL~~LHs---~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
||+++++|..++..... .+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|||++...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT--VLKICDFGTACDI 156 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT--EEEECCCCC----
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC--EEEEccccccccc
Confidence 99999999999875432 47889999999999999999999 89999999999999998772 4899999998643
Q ss_pred ---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-hHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 966 ---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-DINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
+..|+|||++.+..++.++||||||+++|||++|+.||.... ..............+.....++..+.++
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (307)
T 2eva_A 157 QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHH
T ss_pred ccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHH
Confidence 344689999999999999999999999999999999997532 2222222222233334456789999999
Q ss_pred HHHhhhhcccCCCCHHHHHc
Q psy48 1036 INNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~ 1055 (1098)
|.+||+.||++|||++++++
T Consensus 237 i~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 237 MTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=315.34 Aligned_cols=237 Identities=20% Similarity=0.194 Sum_probs=196.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeee-ecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF-ETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f-~~~~~l~LV 889 (1098)
...|.....||.|.+|.||.+.+..+++.||||++..... ...+.+|+.+++.++|++++..+..+ ...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 4678999999999999999999999999999999876432 23588999999999988766655554 666788999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec---CCCCCCcEEEeecCccccc-
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS---TNSELPQVKLCDFGFARII- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld---~~g~~~~vKL~DFGla~~~- 965 (1098)
|||+ +++|..++......+++..++.++.||+.||+|||++||+||||||+|||++ .++ .+||+|||++...
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~---~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN---LVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT---CEEECCCTTCEECB
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC---eEEEeeCCCccccc
Confidence 9999 8888888876667899999999999999999999999999999999999995 555 8999999998643
Q ss_pred ------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----hhHHHHHHHhhccCCC
Q psy48 966 ------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED-----EDINEQIQNAAFMYPP 1022 (1098)
Q Consensus 966 ------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~-----~~~~~~i~~~~~~~p~ 1022 (1098)
+..|+|||++.+..++.++||||||+++|||++|+.||... ......+.......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 22367999999999999999999999999999999999753 1233333333222221
Q ss_pred -CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1023 -RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1023 -~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.....+++++.++|.+||+.||++||++.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 112458899999999999999999999998876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=315.00 Aligned_cols=234 Identities=22% Similarity=0.303 Sum_probs=195.1
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec-CCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET-PGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~-~~~l~L 888 (1098)
....|.+...||.|.+|.||.+.+ +++.||||+++.. .....+.+|+.+++.++||||+++++++.. .+.+++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 356899999999999999999976 4889999999753 245678999999999999999999998654 457999
Q ss_pred EEEeccCchHHHHHhhccC-ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--
Q psy48 889 VMEKLQGDMLEMILSSEKG-RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~-~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-- 965 (1098)
||||+++++|..++..... .+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN---VAKVSDFGLTKEASS 169 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS---CEEECCCCC------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC---cEEEeeccccccccc
Confidence 9999999999888865432 389999999999999999999999999999999999999988 8999999998643
Q ss_pred -------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 966 -------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 966 -------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
...++|||++.+..++.++||||||+++|+|++ |..||.... +....+. ..........+++++.++
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~l 246 (278)
T 1byg_A 170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---KGYKMDAPDGCPPAVYEV 246 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT---TTCCCCCCTTCCHHHHHH
T ss_pred cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---cCCCCCCcccCCHHHHHH
Confidence 234789999999999999999999999999998 999997643 3322222 222333446789999999
Q ss_pred HHHhhhhcccCCCCHHHHHc
Q psy48 1036 INNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~ 1055 (1098)
|.+||..||++||++.++++
T Consensus 247 i~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 247 MKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=329.59 Aligned_cols=240 Identities=19% Similarity=0.203 Sum_probs=198.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|.+|.||.+.+ .+++.||||++.... ......+.+|+.+++.++||||+++++++...+.+++||
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 45678888999999999999996 478999999986543 344678999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhcc---CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--
Q psy48 891 EKLQGDMLEMILSSEK---GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII-- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~---~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~-- 965 (1098)
||+.+++|..++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF---VPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC---CEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC---CEEEeeccccccccc
Confidence 9999999988875432 2589999999999999999999999999999999999999988 8999999998642
Q ss_pred ------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-----hHHHHHHHh--hcc-------
Q psy48 966 ------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-----DINEQIQNA--AFM------- 1019 (1098)
Q Consensus 966 ------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-----~~~~~i~~~--~~~------- 1019 (1098)
+..|+|||++.+..++.++||||||+++|||++|+.||.... ......... ...
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 234689999999999999999999999999999999997532 111111100 000
Q ss_pred -CCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1020 -YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1020 -~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
........++.++.+++.+||+.||++|||+.+++++
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0111112346779999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=323.02 Aligned_cols=235 Identities=28% Similarity=0.413 Sum_probs=185.3
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeee--------ec
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMF--------ET 882 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f--------~~ 882 (1098)
.+|.....||.|.+|.||.+.+..+++.||||++.... ......+.+|+.+++.+. ||||+++++++ ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 47888999999999999999999999999999986542 455678899999999996 99999999998 34
Q ss_pred CCcEEEEEEeccCchHHHHHhh--ccCccchhHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecCCCCCCcEEEee
Q psy48 883 PGRIFVVMEKLQGDMLEMILSS--EKGRLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVLLSTNSELPQVKLCD 958 (1098)
Q Consensus 883 ~~~l~LVmEy~~ggsL~~~l~~--~~~~lse~~~~~ia~qIa~gL~~LHs~g--IvHrDLKp~NILld~~g~~~~vKL~D 958 (1098)
...+++||||++|+ |..++.. ..+.+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|
T Consensus 106 ~~~~~lv~e~~~g~-L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~---~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCKGQ-LVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG---TIKLCD 181 (337)
T ss_dssp SEEEEEEEECCSEE-HHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS---CEEBCC
T ss_pred CceEEEEEEecCCC-HHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC---CEEEec
Confidence 45689999999865 5455543 3456999999999999999999999999 99999999999999988 899999
Q ss_pred cCcccccC------------------------CCCCChhhh---ccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH
Q psy48 959 FGFARIIG------------------------EKSFPPEVL---RNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE 1011 (1098)
Q Consensus 959 FGla~~~~------------------------~~~~APEvl---~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~ 1011 (1098)
||+++... ..|+|||++ .+..++.++||||||+++|+|++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 99987542 236899999 57778999999999999999999999997654321
Q ss_pred HHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1012 QIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1012 ~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+....... ......+..+.+||.+||+.||++||++.+++++
T Consensus 261 -~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 261 -IVNGKYSI--PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ------CCC--CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred -hhcCcccC--CcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11122222 2234577889999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=352.70 Aligned_cols=231 Identities=22% Similarity=0.324 Sum_probs=198.6
Q ss_pred eeeeeeeeeeceEEEEe--ecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEecc
Q psy48 817 NVALCIAVVAGAACGVH--RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~--k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ 894 (1098)
...||.|.||.||.+.+ +.+++.||||+++...........+.+|+.+|+.++||||+++++++.. +.+++||||+.
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 45799999999999954 4667899999998765555567889999999999999999999999965 46899999999
Q ss_pred CchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--------
Q psy48 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-------- 966 (1098)
Q Consensus 895 ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-------- 966 (1098)
+++|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 453 ~g~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 453 LGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp TEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCTTHHHHTTC-------
T ss_pred CCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC---CEEEEEcCCccccccCcccccc
Confidence 999999886 455799999999999999999999999999999999999999988 89999999987542
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
..|+|||++.+..|+.++|||||||+||||++ |+.||.+... ..+.+... ........+++++.+||
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~---~~~~~p~~~~~~l~~li 605 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPAGCPREMYDLM 605 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHH
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHH
Confidence 12689999999999999999999999999998 9999987543 33333322 22333457899999999
Q ss_pred HHhhhhcccCCCCHHHHHc
Q psy48 1037 NNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.+||..||++||++++|++
T Consensus 606 ~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=338.48 Aligned_cols=234 Identities=22% Similarity=0.271 Sum_probs=198.7
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...+.....||.|.||.||.+.+.. +..||||+++.... ....+.+|+.+|+.++||||+++++++.. +.+++||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 3568889999999999999999865 45699999976432 24678999999999999999999999876 6789999
Q ss_pred EeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 891 EKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
||+.+++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~---~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL---VCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG---CEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC---CEEECCCccceecCCCc
Confidence 999999999998753 34589999999999999999999999999999999999999888 89999999997542
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
..|+|||++.+..++.++||||||++||||++ |+.||.+... ....+. ..........+++++.
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~~~~~~~~~~~~~~l~ 411 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RGYRMPCPPECPESLH 411 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCCCCCTTSCHHHH
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCCCCCCCCHHHH
Confidence 23689999999999999999999999999999 9999986542 222222 2222333457899999
Q ss_pred HHHHHhhhhcccCCCCHHHHHc
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+||.+||+.||++|||+++|++
T Consensus 412 ~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 412 DLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=324.45 Aligned_cols=236 Identities=18% Similarity=0.150 Sum_probs=190.2
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC----c
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG----R 885 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~----~ 885 (1098)
....|.+...||.|+||.||.+.+. ++.||||+++.. ........+|+.+++.++||||+++++++.... .
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 4567899999999999999999765 799999999653 334456677999999999999999999997754 4
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC----------CccccCCCCCceeecCCCCCCcEE
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK----------NIVHCDLKPENVLLSTNSELPQVK 955 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~----------gIvHrDLKp~NILld~~g~~~~vK 955 (1098)
+++||||+++++|..++.. ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+|
T Consensus 97 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~---~~k 171 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL---TAC 171 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC---CEE
T ss_pred EEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC---eEE
Confidence 7999999999999999864 4599999999999999999999999 999999999999999988 899
Q ss_pred EeecCccccc--------------CCCCCChhhhccC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCh---------
Q psy48 956 LCDFGFARII--------------GEKSFPPEVLRNK-----GYNRSLDMWSVGVIVYVSLSGTFPFNEDE--------- 1007 (1098)
Q Consensus 956 L~DFGla~~~--------------~~~~~APEvl~~~-----~ys~~sDVwSLGvlLyELltG~~Pf~~~~--------- 1007 (1098)
|+|||+++.. +..|+|||++.+. .++.++|||||||++|||++|+.||.+..
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999543 2235799999873 46678999999999999999999996431
Q ss_pred ------hHHHHHHHhhccCCCCCC------CcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1008 ------DINEQIQNAAFMYPPRPW------RDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1008 ------~~~~~i~~~~~~~p~~~~------~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.................. ...++++.+||.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111111111111111111 123456999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=316.51 Aligned_cols=234 Identities=20% Similarity=0.275 Sum_probs=187.2
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhc--cCCCCceeeeeeeec----C
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQN--LCHPGVVNLERMFET----P 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~L~~~f~~----~ 883 (1098)
....|.+...||.|++|.||.+.+ +++.||||++... ....+.+|.+++.. ++||||+++++++.. .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 356789999999999999999976 6899999999642 34556667777665 789999999998644 3
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceeecCCCCCCcEE
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLH--------SKNIVHCDLKPENVLLSTNSELPQVK 955 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LH--------s~gIvHrDLKp~NILld~~g~~~~vK 955 (1098)
..+++||||+++++|..++. ...+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+|
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~---~~k 153 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG---QCC 153 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS---CEE
T ss_pred ceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC---CEE
Confidence 56899999999999999984 356999999999999999999999 99999999999999999988 899
Q ss_pred EeecCccccc----------------CCCCCChhhhccC------CCCchhHHHHHHHHHHHHHcC----------CCCC
Q psy48 956 LCDFGFARII----------------GEKSFPPEVLRNK------GYNRSLDMWSVGVIVYVSLSG----------TFPF 1003 (1098)
Q Consensus 956 L~DFGla~~~----------------~~~~~APEvl~~~------~ys~~sDVwSLGvlLyELltG----------~~Pf 1003 (1098)
|+|||+++.. +..|+|||++.+. .++.++||||||+++|||++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999998532 2245799999876 456799999999999999999 8888
Q ss_pred CCC---hhHHHHHHH---hhccCCCCC----CCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1004 NED---EDINEQIQN---AAFMYPPRP----WRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1004 ~~~---~~~~~~i~~---~~~~~p~~~----~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
... ......+.. .....+... ...+++++.+||.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 642 111111111 111111111 1125578999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=335.12 Aligned_cols=241 Identities=26% Similarity=0.387 Sum_probs=196.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC--cEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG--RIFV 888 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~--~l~L 888 (1098)
..+|.....||.|++|.||.+.+..+++.||||+++.... ......+.+|+.+++.++||||+++++++...+ ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4578999999999999999999999999999999975432 223467789999999999999999999997655 7899
Q ss_pred EEEeccCchHHHHHhhccC--ccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceee----cCCCCCCcEEEeecCcc
Q psy48 889 VMEKLQGDMLEMILSSEKG--RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL----STNSELPQVKLCDFGFA 962 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~--~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILl----d~~g~~~~vKL~DFGla 962 (1098)
||||+.+++|..++..... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++ .+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~---~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS---VYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE---EEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce---eEEEecCCCc
Confidence 9999999999999875433 38999999999999999999999999999999999998 5555 7999999999
Q ss_pred ccc-----------CCCCCChhhhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCCCC---hhHHHHHHHhhccC
Q psy48 963 RII-----------GEKSFPPEVLRN--------KGYNRSLDMWSVGVIVYVSLSGTFPFNED---EDINEQIQNAAFMY 1020 (1098)
Q Consensus 963 ~~~-----------~~~~~APEvl~~--------~~ys~~sDVwSLGvlLyELltG~~Pf~~~---~~~~~~i~~~~~~~ 1020 (1098)
+.. +..|+|||++.+ ..++.++|||||||++|||++|+.||... ....+.+.......
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 653 335689999875 56789999999999999999999999632 11112222221112
Q ss_pred CCC------------------------CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1021 PPR------------------------PWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1021 p~~------------------------~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
|.. ....++..+.++|.+||+.||++||++.++++
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 211 11235667899999999999999999998854
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=323.23 Aligned_cols=246 Identities=18% Similarity=0.182 Sum_probs=198.5
Q ss_pred HHHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 808 LLMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 808 ~~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
......|.....||.|++|.||.+.+ .+++.||||+++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 34567788899999999999999974 4689999999976432 122236899999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhcc---CccchhHHHHHHHHHHHHHHHHHhC---CccccCCCCCceeecCCCCCCcEEEeecCc
Q psy48 888 VVMEKLQGDMLEMILSSEK---GRLSERTTKFIITQILVALKHLHSK---NIVHCDLKPENVLLSTNSELPQVKLCDFGF 961 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~---~~lse~~~~~ia~qIa~gL~~LHs~---gIvHrDLKp~NILld~~g~~~~vKL~DFGl 961 (1098)
+||||+.+++|..++.... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~---~~kl~Dfg~ 180 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGL 180 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC---CEEECCCSS
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC---CEEeccCcc
Confidence 9999999999999887543 2489999999999999999999999 999999999999999988 899999999
Q ss_pred ccccC-------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-------hhHHHHHHHhhccC-
Q psy48 962 ARIIG-------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNED-------EDINEQIQNAAFMY- 1020 (1098)
Q Consensus 962 a~~~~-------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~-------~~~~~~i~~~~~~~- 1020 (1098)
+.... ..|+|||++.+..++.++||||||+++|+|++|..||... ....+.+.......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 3uim_A 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260 (326)
T ss_dssp CEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred ccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence 97542 2357999999999999999999999999999999999521 11112111111000
Q ss_pred ---------CCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCC
Q psy48 1021 ---------PPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058 (1098)
Q Consensus 1021 ---------p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~Hpf 1058 (1098)
........+.++.+++.+||+.||++|||+.++++|-.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00111233478999999999999999999999998743
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=322.79 Aligned_cols=238 Identities=23% Similarity=0.300 Sum_probs=198.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|.+|.||.+.+.. .||||+++...........+.+|+.+++.++||||+++++++...+.+++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 4578889999999999999998754 5999999876544444566888999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||+.|++|..++......+++..++.++.||+.||+|||++||+||||||+||+++ ++ .++|+|||++....
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~---~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG---KVVITDFGLFSISGVLQA 184 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC-------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC---CEEEeecCCccccccccc
Confidence 99999999999876666799999999999999999999999999999999999998 45 79999999875431
Q ss_pred -------------CCCCChhhhcc---------CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCC
Q psy48 967 -------------EKSFPPEVLRN---------KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRP 1024 (1098)
Q Consensus 967 -------------~~~~APEvl~~---------~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~ 1024 (1098)
..|+|||++.+ ..++.++||||||+++|||++|..||.................+...
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 264 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS 264 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC
Confidence 23579999974 45899999999999999999999999875433222222222233333
Q ss_pred CCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1025 WRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1025 ~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
...++.++.++|.+||..||++|||+.++++
T Consensus 265 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3468899999999999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=341.84 Aligned_cols=234 Identities=22% Similarity=0.272 Sum_probs=200.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...+.+...||.|.||.||.+.+.. +..||||+++.... ..+.+.+|+.+|+.++|+||+++++++.. +.++|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 4568889999999999999998865 45699999976442 24678999999999999999999999876 6789999
Q ss_pred EeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 891 EKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
||+.+++|..++... ...+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~---~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL---VCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG---CEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC---cEEEcccccceecCCCc
Confidence 999999999998753 34589999999999999999999999999999999999999888 89999999997542
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
..|+|||++.+..++.++|||||||+||||++ |+.||.+.. +..+.+. ..+.......++.++.
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~---~~~~~~~~~~~~~~l~ 494 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RGYRMPCPPECPESLH 494 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH---TTCCCCCCTTCCHHHH
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCCCCCCCCHHHH
Confidence 23689999999999999999999999999999 999998653 2333332 2222233457899999
Q ss_pred HHHHHhhhhcccCCCCHHHHHc
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+||.+||+.||++|||+++|++
T Consensus 495 ~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 495 DLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999886
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=323.91 Aligned_cols=235 Identities=21% Similarity=0.209 Sum_probs=192.2
Q ss_pred hheeeeeeeeeeeeeceEEEEeec--------CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCcee--------
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRK--------SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVN-------- 875 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~--------tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~-------- 875 (1098)
..|.....||.|.+|.||.+.+.. .++.||||++... ..+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 578999999999999999999988 4899999999753 35788999999999999887
Q ss_pred -------eeeeeec-CCcEEEEEEeccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec
Q psy48 876 -------LERMFET-PGRIFVVMEKLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946 (1098)
Q Consensus 876 -------L~~~f~~-~~~l~LVmEy~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld 946 (1098)
+++++.. ...+++||||+ +++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 4556654 67899999999 89998988754 36799999999999999999999999999999999999999
Q ss_pred CCCCCCcEEEeecCccccc-------------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh
Q psy48 947 TNSELPQVKLCDFGFARII-------------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE 1007 (1098)
Q Consensus 947 ~~g~~~~vKL~DFGla~~~-------------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~ 1007 (1098)
.++. ..+||+|||+++.. +..|+|||++.+..++.++||||||++||||++|+.||....
T Consensus 194 ~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 PEDQ-SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TTEE-EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCC-ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 7752 16999999999532 224679999999999999999999999999999999997542
Q ss_pred ---h-HHHHHHHhhccC-----CCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1008 ---D-INEQIQNAAFMY-----PPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1008 ---~-~~~~i~~~~~~~-----p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
. ............ ....+..+++++.+||.+||+.||++||+++++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 1 222222111111 11123457899999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=335.53 Aligned_cols=252 Identities=20% Similarity=0.205 Sum_probs=203.9
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCC-CCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCH-PGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~L~~~f~~~~~l~LV 889 (1098)
...|.+...||.|.||.||.+.+..+++.||||+++.... ...+.+|+.+++.++| +++..+..++...+..+||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 4678999999999999999999999999999999875432 2347889999999986 5566666667778889999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec---CCCCCCcEEEeecCcccccC
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS---TNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld---~~g~~~~vKL~DFGla~~~~ 966 (1098)
|||+ +++|..++......+++..++.++.||+.||.|||++||+||||||+||||+ .++ .+||+|||+++...
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~---~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAKKYR 157 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT---CEEECCCTTCEECB
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC---eEEEEeCCcceecc
Confidence 9999 8888888876677899999999999999999999999999999999999994 555 89999999986432
Q ss_pred -------------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-----hHHHHHHHhhccCCC
Q psy48 967 -------------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-----DINEQIQNAAFMYPP 1022 (1098)
Q Consensus 967 -------------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-----~~~~~i~~~~~~~p~ 1022 (1098)
..|+|||++.+..++.++|||||||+||||++|+.||.+.. .....+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 23679999999999999999999999999999999997532 122222222211111
Q ss_pred -CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc----------CCCcCCCCCcchhHHHHhh
Q psy48 1023 -RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA----------HPWLQDPATWSDLRGLERQ 1074 (1098)
Q Consensus 1023 -~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~----------HpfFk~~~~~~~~~~l~~~ 1074 (1098)
.....++.++.+||.+||..||++||++.+|++ ++|+.. .||+.+..+
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~----~dW~~~~~~ 296 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYV----FDWTILKYQ 296 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSC----CHHHHHTC-
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCC----cCchhhccc
Confidence 112457899999999999999999999987764 667666 567766554
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=328.02 Aligned_cols=230 Identities=16% Similarity=0.156 Sum_probs=187.8
Q ss_pred hheeeeeeeeeeeeeceEEE-----EeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC---CCCceeeeeeeecC
Q psy48 812 VFMTYNVALCIAVVAGAACG-----VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC---HPGVVNLERMFETP 883 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a-----~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~L~~~f~~~ 883 (1098)
..|.....||.|+||.||.+ .+..+++.||||+++.. ....+.+|+.++..++ |+||+.+++++...
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 56888999999999999999 47788999999999753 2456777888887776 89999999999999
Q ss_pred CcEEEEEEeccCchHHHHHhh----ccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-----------C
Q psy48 884 GRIFVVMEKLQGDMLEMILSS----EKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST-----------N 948 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~----~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~-----------~ 948 (1098)
+..++||||++|++|..++.. ....+++..++.++.||+.||+|||++||+||||||+|||++. +
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999999864 3456999999999999999999999999999999999999987 5
Q ss_pred CCCCcEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHH
Q psy48 949 SELPQVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ 1014 (1098)
Q Consensus 949 g~~~~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~ 1014 (1098)
+ .+||+|||+|+.. +..|+|||++.+..|+.++|||||||++|||++|+.||.........
T Consensus 220 ~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-- 294 (365)
T 3e7e_A 220 A---GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-- 294 (365)
T ss_dssp T---TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred C---CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence 6 8999999999532 34578999999999999999999999999999999999643221000
Q ss_pred HhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1015 NAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1015 ~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
....++. ...++.+.+++..||+.+|.+|++..+.+.
T Consensus 295 -~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 295 -PEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp -ECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred -echhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 0011111 125678999999999999999975544433
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=312.37 Aligned_cols=236 Identities=21% Similarity=0.285 Sum_probs=188.4
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhc--cCCCCceeeeeeeecC---
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQN--LCHPGVVNLERMFETP--- 883 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~L~~~f~~~--- 883 (1098)
.....|.....||.|.+|.||.+.+. ++.||||++... ....+.+|.+++.. ++||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 34578999999999999999999875 899999999642 23445556666654 4899999999999777
Q ss_pred -CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceeecCCCCCCcE
Q psy48 884 -GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK--------NIVHCDLKPENVLLSTNSELPQV 954 (1098)
Q Consensus 884 -~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~--------gIvHrDLKp~NILld~~g~~~~v 954 (1098)
..+++||||+.+++|..++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~---~~ 181 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG---TC 181 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS---CE
T ss_pred CCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC---CE
Confidence 689999999999999999854 4699999999999999999999999 999999999999999988 89
Q ss_pred EEeecCccccc----------------CCCCCChhhhccCCCCch------hHHHHHHHHHHHHHcC----------CCC
Q psy48 955 KLCDFGFARII----------------GEKSFPPEVLRNKGYNRS------LDMWSVGVIVYVSLSG----------TFP 1002 (1098)
Q Consensus 955 KL~DFGla~~~----------------~~~~~APEvl~~~~ys~~------sDVwSLGvlLyELltG----------~~P 1002 (1098)
||+|||+++.. +..|+|||++.+..+... +|||||||++|||++| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999998532 223679999988776654 9999999999999999 777
Q ss_pred CCCC---hhHHHHHHH---hhccCCCCC----CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1003 FNED---EDINEQIQN---AAFMYPPRP----WRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1003 f~~~---~~~~~~i~~---~~~~~p~~~----~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
|... ......+.. .....+... ...+++++.+||.+||+.||++|||+.++++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 7542 111111111 111111111 12466789999999999999999999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=351.73 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=204.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec------CC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET------PG 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~------~~ 884 (1098)
.+.|.....||.|++|.||.+.+..+|+.||||+++.. ........+.+|+.+++.++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 47889999999999999999999999999999999754 345566789999999999999999999999765 67
Q ss_pred cEEEEEEeccCchHHHHHhhcc--CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEK--GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~--~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
..++||||++|++|..++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++....+||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999999999999987533 26999999999999999999999999999999999999998875546999999999
Q ss_pred cccC-----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHH--------HH--------
Q psy48 963 RIIG-----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI--------QN-------- 1015 (1098)
Q Consensus 963 ~~~~-----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i--------~~-------- 1015 (1098)
.... ..|+|||++.+..++.++||||||+++|+|++|..||.......... ..
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~ 251 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence 7542 24579999999999999999999999999999999997643221110 00
Q ss_pred hhc------cCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1016 AAF------MYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1016 ~~~------~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
... ..+......+++++.++|.+||..||++|||+.++++||||+.
T Consensus 252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 000 0111122346789999999999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=309.49 Aligned_cols=235 Identities=21% Similarity=0.239 Sum_probs=192.2
Q ss_pred eeeeeeeeeeeceEEEEeecCCceeEEEEEeccC--CChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEec
Q psy48 816 YNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLR--FPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893 (1098)
Q Consensus 816 ~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~--~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~ 893 (1098)
....||.|++|.||.+.+ +++.||||++.... ........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 347899999999999986 68899999997543 22344578999999999999999999999999999999999999
Q ss_pred cCchHHHHHhhc--cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 894 QGDMLEMILSSE--KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 894 ~ggsL~~~l~~~--~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
++++|..++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF---TAKISDFGLARASEKFAQT 189 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC---CEEECCCTTCEECCSCSSC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC---cEEEeeccccccccccccc
Confidence 999998888643 34589999999999999999999999999999999999999988 89999999986432
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh------hHHHHHHHhhc-------cCCCCC
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE------DINEQIQNAAF-------MYPPRP 1024 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~------~~~~~i~~~~~-------~~p~~~ 1024 (1098)
..|+|||++.+. ++.++||||||+++|+|++|..||.... .....+..... ......
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred ccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 235799998764 8999999999999999999999997542 11121111100 001111
Q ss_pred CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1025 WRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1025 ~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
....+..+.+++.+||..||++||++.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 23356789999999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=339.63 Aligned_cols=237 Identities=22% Similarity=0.291 Sum_probs=202.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecC---CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKS---GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~t---g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
...|.+...||.|+||.||.+.+..+ +..||||+++.. ........+.+|+.+++.++||||+++++++. .+.++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 46788999999999999999998654 456999998653 23445578999999999999999999999985 45789
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
+||||+++++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~---~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC---CEEEEecCCCeecCC
Confidence 99999999999999886666799999999999999999999999999999999999999988 89999999997542
Q ss_pred ------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHH
Q psy48 967 ------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 967 ------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
..|+|||++.+..++.++||||||+++|||++ |..||.+... ....+... .....+..++++
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~ 620 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPMPPNCPPT 620 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT---CCCCCCTTCCHH
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---CCCCCCccccHH
Confidence 24789999999999999999999999999997 9999986533 22333222 222234578999
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.++|.+||..||++||++.++++
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=313.30 Aligned_cols=234 Identities=19% Similarity=0.214 Sum_probs=180.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHH--HhccCCCCceeeeeee-----ec
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAI--LQNLCHPGVVNLERMF-----ET 882 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~i--L~~l~HpnIv~L~~~f-----~~ 882 (1098)
....|.+...||.|.||.||.+.+ +++.||||+++.. ....+..|.++ +..++||||+++++.+ ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 356789999999999999999965 7899999999753 23334444444 4468999999999754 33
Q ss_pred CCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC---------CccccCCCCCceeecCCCCCCc
Q psy48 883 PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK---------NIVHCDLKPENVLLSTNSELPQ 953 (1098)
Q Consensus 883 ~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~---------gIvHrDLKp~NILld~~g~~~~ 953 (1098)
...+++||||+++++|..++... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~---~ 158 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG---T 158 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS---C
T ss_pred CceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC---c
Confidence 34689999999999999988643 468899999999999999999999 999999999999999988 8
Q ss_pred EEEeecCcccccC--------------------CCCCChhhhcc-------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q psy48 954 VKLCDFGFARIIG--------------------EKSFPPEVLRN-------KGYNRSLDMWSVGVIVYVSLSGTFPFNED 1006 (1098)
Q Consensus 954 vKL~DFGla~~~~--------------------~~~~APEvl~~-------~~ys~~sDVwSLGvlLyELltG~~Pf~~~ 1006 (1098)
+||+|||+++... ..|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999996432 24579999987 45678999999999999999997776422
Q ss_pred hh-------------------HHHHHHHhhccCCC--CCC---CcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1007 ED-------------------INEQIQNAAFMYPP--RPW---RDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1007 ~~-------------------~~~~i~~~~~~~p~--~~~---~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.. ............+. ..+ ..+++++.+||.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 10 00111111111111 111 124568999999999999999999999965
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=326.40 Aligned_cols=239 Identities=19% Similarity=0.251 Sum_probs=186.2
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCC-CCceee--------------
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCH-PGVVNL-------------- 876 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~H-pnIv~L-------------- 876 (1098)
.++....||.|+||.||.+.+..+|+.||||+++..... ......+.+|+.+++.++| .|...+
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 367788999999999999999999999999999743322 2234779999999999876 321111
Q ss_pred -------eeeeec-----CCcEEEEEEeccCchHHHHHh------hccCccchhHHHHHHHHHHHHHHHHHhCCccccCC
Q psy48 877 -------ERMFET-----PGRIFVVMEKLQGDMLEMILS------SEKGRLSERTTKFIITQILVALKHLHSKNIVHCDL 938 (1098)
Q Consensus 877 -------~~~f~~-----~~~l~LVmEy~~ggsL~~~l~------~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDL 938 (1098)
+.++.. ...++++|+++. ++|..++. .....+++..++.++.||+.||+|||++||+||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp CCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 111111 224677888765 55666663 22446888999999999999999999999999999
Q ss_pred CCCceeecCCCCCCcEEEeecCccccc--------CCCCCChhhh----------ccCCCCchhHHHHHHHHHHHHHcCC
Q psy48 939 KPENVLLSTNSELPQVKLCDFGFARII--------GEKSFPPEVL----------RNKGYNRSLDMWSVGVIVYVSLSGT 1000 (1098)
Q Consensus 939 Kp~NILld~~g~~~~vKL~DFGla~~~--------~~~~~APEvl----------~~~~ys~~sDVwSLGvlLyELltG~ 1000 (1098)
||+|||++.++ .+||+|||+++.. +..|+|||++ .+..|+.++|||||||++|||++|+
T Consensus 238 Kp~NILl~~~~---~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 238 RPVDIVLDQRG---GVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp CGGGEEECTTC---CEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred ccceEEEecCC---eEEEEeccceeecCCccccCCCCceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 99999999998 8999999998632 4568899999 5566889999999999999999999
Q ss_pred CCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1001 FPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1001 ~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.||........ ... .+ ..+..+|+++.+||.+||+.||++||++.++++||||+.
T Consensus 315 ~Pf~~~~~~~~--~~~--~~--~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 315 LPNTDDAALGG--SEW--IF--RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp CCCCTTGGGSC--SGG--GG--SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCCCCcchhhh--HHH--HH--hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99986543210 000 11 123468899999999999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=310.90 Aligned_cols=235 Identities=17% Similarity=0.225 Sum_probs=190.8
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhc--cCCCCceeeeeeeecCC---
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQN--LCHPGVVNLERMFETPG--- 884 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~L~~~f~~~~--- 884 (1098)
....|.+...||.|.+|.||.+.+ +++.||||+++. .....+.+|++++.. ++||||+++++++....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 456899999999999999999987 589999999964 234667788888876 78999999999998776
Q ss_pred -cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceeecCCCCCCcEE
Q psy48 885 -RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLH--------SKNIVHCDLKPENVLLSTNSELPQVK 955 (1098)
Q Consensus 885 -~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LH--------s~gIvHrDLKp~NILld~~g~~~~vK 955 (1098)
.+++||||+++++|..++.. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+|
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~---~~k 187 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG---TCC 187 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS---CEE
T ss_pred ceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC---CEE
Confidence 79999999999999999864 46999999999999999999999 89999999999999999988 899
Q ss_pred EeecCcccccC----------------CCCCChhhhccCC------CCchhHHHHHHHHHHHHHcC----------CCCC
Q psy48 956 LCDFGFARIIG----------------EKSFPPEVLRNKG------YNRSLDMWSVGVIVYVSLSG----------TFPF 1003 (1098)
Q Consensus 956 L~DFGla~~~~----------------~~~~APEvl~~~~------ys~~sDVwSLGvlLyELltG----------~~Pf 1003 (1098)
|+|||++.... ..|+|||++.+.. ++.++||||||+++|||++| +.||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999985432 2357999998762 34789999999999999999 7888
Q ss_pred CCCh----hHHHHHHHhh-ccCCCCCC-----CcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1004 NEDE----DINEQIQNAA-FMYPPRPW-----RDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1004 ~~~~----~~~~~i~~~~-~~~p~~~~-----~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.... .......... ....+... ..+++.+.+||.+||+.||++|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 6531 1111111111 11111111 1345689999999999999999999999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=307.78 Aligned_cols=224 Identities=17% Similarity=0.112 Sum_probs=186.5
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
..++|.....||.|.+|.||.+.+..+++.||||+++..... ......+.+|+.++..++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 346799999999999999999999999999999999875543 3445789999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCC
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK 968 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~ 968 (1098)
||||++|++|..++.. + ....++..++.||+.||+|||++||+||||||+|||++.++ .+||+++|..
T Consensus 109 v~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g---~~kl~~~~~~------ 176 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG---DVVLAYPATM------ 176 (286)
T ss_dssp EEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS---CEEECSCCCC------
T ss_pred EEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC---CEEEEecccc------
Confidence 9999999999999853 2 35557889999999999999999999999999999999998 8999876542
Q ss_pred CCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH---HHH--HhhccCCCCCCCcCcHHHHHHHHHhhhhc
Q psy48 969 SFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE---QIQ--NAAFMYPPRPWRDISSDAIDLINNLLQVK 1043 (1098)
Q Consensus 969 ~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~---~i~--~~~~~~p~~~~~~is~el~~LL~~cL~~d 1043 (1098)
+ +++.++||||||+++|||++|+.||.+...... ... ......+......+++++.++|.+||+.|
T Consensus 177 --~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 247 (286)
T 3uqc_A 177 --P-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGD 247 (286)
T ss_dssp --T-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTT
T ss_pred --C-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccC
Confidence 2 479999999999999999999999986532110 000 00000001112468999999999999999
Q ss_pred ccCCCCHHHHHc
Q psy48 1044 QRKRLSVDKSLA 1055 (1098)
Q Consensus 1044 P~kRPSa~eIL~ 1055 (1098)
|++| |+.++++
T Consensus 248 P~~R-s~~el~~ 258 (286)
T 3uqc_A 248 GGIR-SASTLLN 258 (286)
T ss_dssp SSCC-CHHHHHH
T ss_pred CccC-CHHHHHH
Confidence 9999 9999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=321.66 Aligned_cols=239 Identities=18% Similarity=0.208 Sum_probs=185.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC------hHHHHHHHHHHHHHhccC---------------
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP------TKQEAQLKNEVAILQNLC--------------- 869 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~------~~~~~~~~~Ei~iL~~l~--------------- 869 (1098)
...|.....||.|+||.||.+.+ +|+.||||++++.... ......+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46678889999999999999987 7899999999875421 223467888999888775
Q ss_pred -----------CCCceeeeeeeec-------------CCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHH
Q psy48 870 -----------HPGVVNLERMFET-------------PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVAL 925 (1098)
Q Consensus 870 -----------HpnIv~L~~~f~~-------------~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL 925 (1098)
||||++++++|.+ .+.+|+||||+.++++...+. ...+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHH
Confidence 4555555555554 788999999998885434443 25689999999999999999
Q ss_pred HHHH-hCCccccCCCCCceeecCCCC-----------------CCcEEEeecCccccc-------CCCCCChhhhccCCC
Q psy48 926 KHLH-SKNIVHCDLKPENVLLSTNSE-----------------LPQVKLCDFGFARII-------GEKSFPPEVLRNKGY 980 (1098)
Q Consensus 926 ~~LH-s~gIvHrDLKp~NILld~~g~-----------------~~~vKL~DFGla~~~-------~~~~~APEvl~~~~y 980 (1098)
+||| ++||+||||||+|||++.++. ...+||+|||+|+.. +..|+|||++.+..
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~~- 253 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG- 253 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCCS-
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCCC-
Confidence 9999 999999999999999997751 127999999999754 44578999999876
Q ss_pred CchhHHHHHHHH-HHHHHcCCCCCCCChh---HHHHHHHhhccCCCC----CCCcCcHHHHHHHHHhhhhcccCCCCHHH
Q psy48 981 NRSLDMWSVGVI-VYVSLSGTFPFNEDED---INEQIQNAAFMYPPR----PWRDISSDAIDLINNLLQVKQRKRLSVDK 1052 (1098)
Q Consensus 981 s~~sDVwSLGvl-LyELltG~~Pf~~~~~---~~~~i~~~~~~~p~~----~~~~is~el~~LL~~cL~~dP~kRPSa~e 1052 (1098)
+.++||||||++ .+++++|..||..... ..+.+... ...... .+..+++++.+||.+||+.| |+++
T Consensus 254 ~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e 327 (336)
T 2vuw_A 254 DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ-MTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATD 327 (336)
T ss_dssp SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHT-CCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHH
T ss_pred ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhh-hccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHH
Confidence 999999998776 7788999999955322 22222211 111111 13357899999999999977 9999
Q ss_pred HH-cCCCcC
Q psy48 1053 SL-AHPWLQ 1060 (1098)
Q Consensus 1053 IL-~HpfFk 1060 (1098)
++ +||||+
T Consensus 328 ~l~~Hp~f~ 336 (336)
T 2vuw_A 328 LLCQHSLFK 336 (336)
T ss_dssp HHHHCGGGC
T ss_pred HHhcCCCcC
Confidence 99 999996
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=332.11 Aligned_cols=231 Identities=23% Similarity=0.260 Sum_probs=192.9
Q ss_pred hheeeeeeeeeeeeeceEEEEeec-CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCc-----
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRK-SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR----- 885 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~-tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~----- 885 (1098)
+.|.....||.|++|.||.+.+.. +++.||||++... ........+.+|+.++..++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 679999999999999999999976 7999999998653 234455778999999999999999999999987665
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
.||||||++|++|..++.. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~----~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE----QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS----CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC----cEEEEecccchhc
Confidence 7999999999999877643 69999999999999999999999999999999999999874 6999999999754
Q ss_pred --------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCC-CCCCCcCcHHHHHHH
Q psy48 966 --------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYP-PRPWRDISSDAIDLI 1036 (1098)
Q Consensus 966 --------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p-~~~~~~is~el~~LL 1036 (1098)
+..|+|||++.+. ++.++|||||||+||+|++|..||.+.... ..+ ......+++.+.+||
T Consensus 232 ~~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li 301 (681)
T 2pzi_A 232 NSFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPEDDPVLKTYDSYGRLL 301 (681)
T ss_dssp TCCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCTTCHHHHHCHHHHHHH
T ss_pred ccCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc---------cccccccccccCHHHHHHH
Confidence 3356899999876 489999999999999999999988652100 001 011112467899999
Q ss_pred HHhhhhcccCCCCHHHHHcCCCcC
Q psy48 1037 NNLLQVKQRKRLSVDKSLAHPWLQ 1060 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~HpfFk 1060 (1098)
.+||+.||++||+..+.+.|+|+.
T Consensus 302 ~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 302 RRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hhhccCChhhCCCHHHHHHHHHHH
Confidence 999999999999999999888875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=337.85 Aligned_cols=122 Identities=33% Similarity=0.667 Sum_probs=52.3
Q ss_pred EeeeeeeeEeeccCCccccccccCCccchhhhhhhhhccccCCChhHHHhhhcccccccceEEEEeeccCCccccccccc
Q psy48 109 QIRPHTLTVHSYKAPTFSLKTIIPNHGLTRLLDRLMLFRHDYTYPNVLLIINAVSDIVDETVVEIVLAGCSLNFHKRCVV 188 (1098)
Q Consensus 109 ~~~~h~~~~~~~~~p~f~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~g~~c~~C~~~~HKrC~~ 188 (1098)
.+.+|.+.+++|+.||||++| ..+||| +..| |+.|..|++++||||+.
T Consensus 34 ~~~~H~f~~~~~~~p~~C~~C------------~~~i~g-----------------~~~q---g~~C~~C~~~~H~~C~~ 81 (674)
T 3pfq_A 34 EVKNHKFTARFFKQPTFCSHC------------TDFIWG-----------------FGKQ---GFQCQVCSFVVHKRCHE 81 (674)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCceEEeeeCCCCCccccc------------cccccc-----------------cCCc---eeECCCCCCCcChhhcC
Confidence 468999999999999999999 478999 8788 99999999999999999
Q ss_pred cccCCCCCCcccccCCccccCCCCCcCCCCCcccCCCCCccCCCccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCeee
Q psy48 189 KIPNNCSSGYKHRRSSTLHVPHSTSETGSNSSIASDDSNYTSSSFSTKPSSRSPSLTSRTDALSPTSPGAPSSVNIPHTF 268 (1098)
Q Consensus 189 ~i~~~C~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~H~f 268 (1098)
++++.|++.....+. ....++|+|
T Consensus 82 ~v~~~c~~~~~~~~~--------------------------------------------------------~~~~~~h~~ 105 (674)
T 3pfq_A 82 FVTFSCPGADKGPAS--------------------------------------------------------DDPRSKHKF 105 (674)
T ss_dssp ----------------------------------------------------------------------------CCCC
T ss_pred cCcccCCCccccccc--------------------------------------------------------ccccCCcce
Confidence 999999854220000 001268999
Q ss_pred eeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCCC
Q psy48 269 NLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGE 318 (1098)
Q Consensus 269 ~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~~ 318 (1098)
..++|..+|+|++|+++|||+.+||++|..|+++||++|..+|+..|+.+
T Consensus 106 ~~~~~~~~~~C~~C~~~l~g~~~qg~~C~~C~~~~H~~C~~~v~~~C~~d 155 (674)
T 3pfq_A 106 KIHTYSSPTFCDHCGSLLYGLIHQGMKCDTCMMNVHKRCVMNVPSLCGTD 155 (674)
T ss_dssp CEECCSSCCCCSSSCSCCBBSSSCEECCSSSCCCBCSSTTSSSCCCSSSC
T ss_pred eecCCCCCCCCCccccccchhhcCccccccCCcchhhhhhhccCcccccc
Confidence 99999999999999999999999999999999999999999999999654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-26 Score=277.41 Aligned_cols=177 Identities=18% Similarity=0.148 Sum_probs=126.4
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC--------hHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEE
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP--------TKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~--------~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~ 887 (1098)
......|.++....+.....|+.||||++.+.... .....+|.+|+++|+++ .|+||+++++++++++.+|
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 33455566666667777888999999999875321 12236799999999999 6999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~ 967 (1098)
|||||++|++|.+++.. .+++++. .|+.||+.||+|||++|||||||||+|||++.+| ++||+|||+|+....
T Consensus 319 LVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg---~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ---HARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS---CEEECCCTTEESCC-
T ss_pred EEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC---CEEEeecccCeeCCC
Confidence 99999999999999874 4567654 5889999999999999999999999999999998 899999999986543
Q ss_pred C------------CCChhhhccCCCCchhHHHHHHHHHHHHHcCCC
Q psy48 968 K------------SFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTF 1001 (1098)
Q Consensus 968 ~------------~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~ 1001 (1098)
. |||||++.+. +...+|+||+|+++++|.++..
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 2 4799999875 6778999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.5e-22 Score=237.78 Aligned_cols=154 Identities=17% Similarity=0.247 Sum_probs=127.3
Q ss_pred CceeEEEEEeccCCChH------HHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccc
Q psy48 837 GRGVAIKVIDKLRFPTK------QEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLS 910 (1098)
Q Consensus 837 g~~VAVKvlkk~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~ls 910 (1098)
++.+|+|.......... ....+.+|+.+|+.++||||+++..++...+..++||||++|++|..++..
T Consensus 359 ~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~------ 432 (540)
T 3en9_A 359 DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED------ 432 (540)
T ss_dssp SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT------
T ss_pred CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH------
Confidence 34678887644332211 134589999999999999999766666677788999999999999888753
Q ss_pred hhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-------------------CCCC
Q psy48 911 ERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE-------------------KSFP 971 (1098)
Q Consensus 911 e~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~-------------------~~~A 971 (1098)
+..++.||+.||.|||++||+||||||+|||++. .+||+|||+++.... .|||
T Consensus 433 ---~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~A 504 (540)
T 3en9_A 433 ---NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-----DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKF 504 (540)
T ss_dssp ---CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGH
T ss_pred ---HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCC
Confidence 5689999999999999999999999999999987 599999999976543 3579
Q ss_pred hhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q psy48 972 PEVLRN--KGYNRSLDMWSVGVIVYVSLSGTFPFN 1004 (1098)
Q Consensus 972 PEvl~~--~~ys~~sDVwSLGvlLyELltG~~Pf~ 1004 (1098)
||++.+ ..|+...|+|+..+-.++.+.++.+|.
T Consensus 505 PEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 505 DEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred HHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 999987 668889999999999998888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=6.8e-20 Score=203.63 Aligned_cols=151 Identities=18% Similarity=0.132 Sum_probs=122.0
Q ss_pred HHhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh----------------HHHHHHHHHHHHHhccCCCC
Q psy48 809 LMLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT----------------KQEAQLKNEVAILQNLCHPG 872 (1098)
Q Consensus 809 ~~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~----------------~~~~~~~~Ei~iL~~l~Hpn 872 (1098)
.....|.....||.|.+|.||.+.+ .+|+.||||+++...... .....+.+|+.+|+.++ |
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred hCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 3445666789999999999999999 889999999996533211 13567899999999998 5
Q ss_pred ceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCC
Q psy48 873 VVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952 (1098)
Q Consensus 873 Iv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~ 952 (1098)
+++.+++.. +..++||||++|++|.. + .......++.||+.||.|||++||+||||||+|||++ ++
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l-------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~--- 229 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-V-------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE--- 229 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-C-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT---
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-c-------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC---
Confidence 667776644 56799999999999965 3 2244667999999999999999999999999999999 77
Q ss_pred cEEEeecCcccccCCCCCChhhhcc
Q psy48 953 QVKLCDFGFARIIGEKSFPPEVLRN 977 (1098)
Q Consensus 953 ~vKL~DFGla~~~~~~~~APEvl~~ 977 (1098)
.+||+|||+|+... .++|||.+..
T Consensus 230 ~vkl~DFG~a~~~~-~~~a~e~l~r 253 (282)
T 1zar_A 230 GIWIIDFPQSVEVG-EEGWREILER 253 (282)
T ss_dssp EEEECCCTTCEETT-STTHHHHHHH
T ss_pred cEEEEECCCCeECC-CCCHHHHHHH
Confidence 89999999998654 3578998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-16 Score=173.91 Aligned_cols=148 Identities=18% Similarity=0.153 Sum_probs=113.0
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCce--eEEEEEeccCCCh----------------------HHHHHHHHHHHHHhcc
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRG--VAIKVIDKLRFPT----------------------KQEAQLKNEVAILQNL 868 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~--VAVKvlkk~~~~~----------------------~~~~~~~~Ei~iL~~l 868 (1098)
.|.+...||.|.+|.||.+.+..+|+. ||||+++...... .....+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467789999999999999999889999 9999986532110 1124688999999999
Q ss_pred CCCCc--eeeeeeeecCCcEEEEEEeccC-c----hHHHHHhhccCccchhHHHHHHHHHHHHHHHHH-hCCccccCCCC
Q psy48 869 CHPGV--VNLERMFETPGRIFVVMEKLQG-D----MLEMILSSEKGRLSERTTKFIITQILVALKHLH-SKNIVHCDLKP 940 (1098)
Q Consensus 869 ~HpnI--v~L~~~f~~~~~l~LVmEy~~g-g----sL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LH-s~gIvHrDLKp 940 (1098)
.|+++ +.++.. +..+|||||+++ | .|..+.. .+++..+..++.||+.||.||| +.||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 87754 333332 356899999943 2 6655532 1346688999999999999999 99999999999
Q ss_pred CceeecCCCCCCcEEEeecCcccccCCCCCChhh
Q psy48 941 ENVLLSTNSELPQVKLCDFGFARIIGEKSFPPEV 974 (1098)
Q Consensus 941 ~NILld~~g~~~~vKL~DFGla~~~~~~~~APEv 974 (1098)
+|||++. .++|+|||+|.....+ .+++.
T Consensus 200 ~NILl~~-----~~~liDFG~a~~~~~~-~~~~~ 227 (258)
T 1zth_A 200 YNIMYID-----KVYFIDMGQAVTLRHP-MAESY 227 (258)
T ss_dssp TSEEESS-----SEEECCCTTCEETTST-THHHH
T ss_pred HHEEEcC-----cEEEEECcccccCCCc-cHHHH
Confidence 9999986 4999999999876432 34443
|
| >2enz_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-16 Score=136.57 Aligned_cols=58 Identities=43% Similarity=0.943 Sum_probs=54.9
Q ss_pred CCCCCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCC
Q psy48 260 SSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 317 (1098)
Q Consensus 260 ~~~~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~ 317 (1098)
..+.++|+|.+++|.+||+|++|+++|||+++|||+|++|+++||++|..+|+..|+.
T Consensus 7 ~~~~~~H~F~~~~~~~pt~C~~C~~~l~Gl~~qg~~C~~C~~~~Hk~C~~~v~~~C~~ 64 (65)
T 2enz_A 7 GKIDMPHRFKVYNYKSPTFCEHCGTLLWGLARQGLKCDACGMNVHHRCQTKVANLCGI 64 (65)
T ss_dssp CCCCCCCCEEECCCCSCCBCSSSCCBCCCSSSCSEEESSSCCEECTTTTTTSCSCTTT
T ss_pred CCCCCCCccEeEcCCCCcCchhcChhheecCCcccccCCCCCccCHhHHhhCcCcCCC
Confidence 3466899999999999999999999999999999999999999999999999999964
|
| >2enz_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=5.8e-16 Score=134.00 Aligned_cols=60 Identities=42% Similarity=0.919 Sum_probs=56.0
Q ss_pred CCCCCcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCC
Q psy48 523 PSSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGE 582 (1098)
Q Consensus 523 ~~~~~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~ 582 (1098)
......+|+|+.++|.+||||++|+++|||+.+|||+|+.|+++||++|..+|+..|+.+
T Consensus 6 ~~~~~~~H~F~~~~~~~pt~C~~C~~~l~Gl~~qg~~C~~C~~~~Hk~C~~~v~~~C~~~ 65 (65)
T 2enz_A 6 SGKIDMPHRFKVYNYKSPTFCEHCGTLLWGLARQGLKCDACGMNVHHRCQTKVANLCGIN 65 (65)
T ss_dssp CCCCCCCCCEEECCCCSCCBCSSSCCBCCCSSSCSEEESSSCCEECTTTTTTSCSCTTTC
T ss_pred cCCCCCCCccEeEcCCCCcCchhcChhheecCCcccccCCCCCccCHhHHhhCcCcCCCC
Confidence 445578999999999999999999999999999999999999999999999999999753
|
| >1ptq_A Protein kinase C delta type; phosphotransferase; 1.95A {Mus musculus} SCOP: g.49.1.1 PDB: 1ptr_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1e-15 Score=125.46 Aligned_cols=50 Identities=54% Similarity=1.115 Sum_probs=49.2
Q ss_pred eeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCC
Q psy48 266 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315 (1098)
Q Consensus 266 H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C 315 (1098)
|+|.+++|.+||+|++|+++|||+++||++|++|++++|++|..+||..|
T Consensus 1 H~F~~~~~~~pt~C~~C~~~l~g~~~qg~~C~~C~~~~H~~C~~~v~~~C 50 (50)
T 1ptq_A 1 HRFKVYNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLC 50 (50)
T ss_dssp CCEEEECCSSCCBCTTTCCBCCSSSSCEEEETTTCCEECHHHHTTSCSCC
T ss_pred CCCEeecCCCCCCcCCCCceeeccCCccCEeCCCCCeECHHHhhhcCCCC
Confidence 89999999999999999999999999999999999999999999999988
|
| >2db6_A SH3 and cysteine rich domain 3; STAC3, C1 domain, cystein-rich domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.3e-15 Score=133.52 Aligned_cols=57 Identities=33% Similarity=0.795 Sum_probs=53.2
Q ss_pred CCCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCC-CCCCC
Q psy48 262 VNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK-DCVGE 318 (1098)
Q Consensus 262 ~~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~-~C~~~ 318 (1098)
...+|+|..++|.+||+|++|+++|||+++|||+|++|+++||++|..+|+. .|.+.
T Consensus 14 ~~~~H~F~~~~f~~pt~C~~C~~~lwGl~kqG~~C~~C~~~~Hk~C~~~v~~~~C~~~ 71 (74)
T 2db6_A 14 NDKPHKFKDHFFKKPKFCDVCARMIVLNNKFGLRCKNCKTNIHEHCQSYVEMQRCSGP 71 (74)
T ss_dssp CSSBCCEEEEECSSCEECSSSCCEECHHHHEEEEESSSCCEECTTTTGGGSSSBCCCC
T ss_pred cCCCCceEEeeCCCCcCchhcChhhccccCCccccCCCCCccChhHHhhCCCCcCCCC
Confidence 4579999999999999999999999999999999999999999999999996 69653
|
| >2enn_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=5.1e-15 Score=132.33 Aligned_cols=55 Identities=42% Similarity=0.922 Sum_probs=53.0
Q ss_pred CCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCC
Q psy48 263 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 317 (1098)
Q Consensus 263 ~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~ 317 (1098)
..+|+|.+++|.+||+|++|+++|||+++|||+|++|+++||++|..+|+..|.+
T Consensus 21 ~~~H~F~~~~f~~pt~C~~C~~~lwGl~kqG~~C~~C~~~~Hk~C~~~v~~~C~~ 75 (77)
T 2enn_A 21 VKCHEFTATFFPQPTFCSVCHEFVWGLNKQGYQCRQCNAAIHKKCIDKVIAKCTG 75 (77)
T ss_dssp SSSCEEEEECCSSCEECSSSCCEECCTTCCEEECSSSCCEEESGGGSSCCSCCCC
T ss_pred CCCCccEEEcCCCCcCccccChhhccccccccCcCCCCCcCCHhHHhhCcCCCCC
Confidence 4689999999999999999999999999999999999999999999999999965
|
| >1y8f_A UNC-13 homolog A, MUNC13-1; cysteine-rich domain, C1-domain, zinc-binding domain, endocytosis/exocytosis,signaling protein complex; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.7e-15 Score=131.48 Aligned_cols=56 Identities=41% Similarity=0.833 Sum_probs=50.6
Q ss_pred CCCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCC
Q psy48 262 VNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 317 (1098)
Q Consensus 262 ~~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~ 317 (1098)
...+|+|.+++|.+||+|++|+++|||+++|||+|++|+++||++|..+|+..|..
T Consensus 10 ~~~~H~F~~~~~~~pt~C~~C~~~l~Gl~~qg~~C~~C~~~~Hk~C~~~v~~~C~~ 65 (66)
T 1y8f_A 10 GGIQHNFEVWTATTPTYCYECEGLLWGIARQGMRCTECGVKCHEKCQDLLNADCKL 65 (66)
T ss_dssp ---CCCEEEEECSSCCCCTTTCCCCCSSCCEEEEETTTCCEECTTHHHHSCCCC--
T ss_pred CCCCcccEeeeCCCCcChhhcChhhcccCcceeEcCCCCCeeCHHHHhhCcCcCCC
Confidence 34789999999999999999999999999999999999999999999999999963
|
| >2eli_A Protein kinase C alpha type; PKC-alpha, PKC-A, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=7.8e-15 Score=133.67 Aligned_cols=58 Identities=43% Similarity=0.911 Sum_probs=54.7
Q ss_pred CCCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCCCC
Q psy48 262 VNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEP 319 (1098)
Q Consensus 262 ~~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~~~ 319 (1098)
...+|+|..++|.+||||++|+++|||+++|||+|.+|+++||++|..+|+..|....
T Consensus 14 ~~~~H~F~~~~~~~pt~C~~C~~~l~Gl~kqG~~C~~C~~~~Hk~C~~~v~~~C~~~~ 71 (85)
T 2eli_A 14 PRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGMDH 71 (85)
T ss_dssp TTTSCCCEEECCSSCCBCSSSCCBCCCSSSCEEECSSSCCEEETTTTTTSCSCCCCCC
T ss_pred CCCCcccEeeeCCCCcCCcccCccccccccCCCcCCCcCCccCHhHHhhcCCcCCcch
Confidence 4478999999999999999999999999999999999999999999999999997654
|
| >2eli_A Protein kinase C alpha type; PKC-alpha, PKC-A, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=6.4e-15 Score=134.22 Aligned_cols=61 Identities=41% Similarity=0.868 Sum_probs=56.9
Q ss_pred CCCcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCCCcc
Q psy48 525 SVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPVT 585 (1098)
Q Consensus 525 ~~~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~~~~ 585 (1098)
.+..+|+|+.++|.+||||++|+++|||+.+|||+|..|+++||++|...|+..|+.+...
T Consensus 13 ~~~~~H~F~~~~~~~pt~C~~C~~~l~Gl~kqG~~C~~C~~~~Hk~C~~~v~~~C~~~~~e 73 (85)
T 2eli_A 13 DPRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGMDHTE 73 (85)
T ss_dssp CTTTSCCCEEECCSSCCBCSSSCCBCCCSSSCEEECSSSCCEEETTTTTTSCSCCCCCCCC
T ss_pred CCCCCcccEeeeCCCCcCCcccCccccccccCCCcCCCcCCccCHhHHhhcCCcCCcchhh
Confidence 4567899999999999999999999999999999999999999999999999999876544
|
| >1ptq_A Protein kinase C delta type; phosphotransferase; 1.95A {Mus musculus} SCOP: g.49.1.1 PDB: 1ptr_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=3.9e-15 Score=121.98 Aligned_cols=50 Identities=54% Similarity=1.115 Sum_probs=49.1
Q ss_pred ceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCC
Q psy48 530 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579 (1098)
Q Consensus 530 H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C 579 (1098)
|+|+.++|.+||+|++|+++|||+.+||++|++|++++|++|..+||..|
T Consensus 1 H~F~~~~~~~pt~C~~C~~~l~g~~~qg~~C~~C~~~~H~~C~~~v~~~C 50 (50)
T 1ptq_A 1 HRFKVYNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLC 50 (50)
T ss_dssp CCEEEECCSSCCBCTTTCCBCCSSSSCEEEETTTCCEECHHHHTTSCSCC
T ss_pred CCCEeecCCCCCCcCCCCceeeccCCccCEeCCCCCeECHHHhhhcCCCC
Confidence 89999999999999999999999999999999999999999999999987
|
| >2yuu_A NPKC-delta, protein kinase C delta type; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.1e-14 Score=132.18 Aligned_cols=58 Identities=38% Similarity=0.853 Sum_probs=54.6
Q ss_pred CCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCCCCc
Q psy48 263 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPV 320 (1098)
Q Consensus 263 ~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~~~~ 320 (1098)
..+|+|..++|.+||+|++|+++|||+++|||+|.+|+++||++|..+|+..|.....
T Consensus 15 ~~~H~F~~~~~~~pt~C~~C~~~lwGl~kqg~~C~~C~~~~Hk~C~~~v~~~C~~~~~ 72 (83)
T 2yuu_A 15 IKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAA 72 (83)
T ss_dssp GGGCCEEEECCSSCCCCSSSCCCCCSSSCCEEEETTTCCEECTTGGGTCCSCCSSCCC
T ss_pred cCCCceEeEeCCCCcChhhcChhhccccccccccCCcCCeeChhhhhhCCCcCCCccc
Confidence 3689999999999999999999999999999999999999999999999999976543
|
| >2row_A RHO-associated protein kinase 2; ATP-binding, coiled coil, cytoplasm, membrane, metal-binding, nucleotide-binding, phorbol-ester binding; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.5e-15 Score=134.35 Aligned_cols=57 Identities=32% Similarity=0.584 Sum_probs=53.8
Q ss_pred CCCCeeeeeeccCCCCccccccccccccccc--ceecCCCCCCccccccC---CcCCCCCCC
Q psy48 262 VNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQ--GLQCKDCGFNVHKKCLD---KVPKDCVGE 318 (1098)
Q Consensus 262 ~~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~q--G~kC~~C~~~vHkkC~~---~v~~~C~~~ 318 (1098)
...+|+|.+++|.+||||++|+++|||+++| ||+|+.|+++||++|.. .|+..|+.+
T Consensus 21 ~~~~H~F~~~~~~~PT~Cd~C~~~lWGl~kqp~G~~C~~C~~~~HkrC~~k~~~v~~~C~~~ 82 (84)
T 2row_A 21 CHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVY 82 (84)
T ss_dssp EETTEEEEEECCSSCEECSSSSSEECCSSSCCCEEEESSSCCEEEHHHHHHTCTTCCCCSTT
T ss_pred EcCCcceEeEcCCCCcchhhcCHhhhccccCCCCCEecCCCCccchhHhCCccccccccCcC
Confidence 3478999999999999999999999999998 99999999999999999 799999765
|
| >1y8f_A UNC-13 homolog A, MUNC13-1; cysteine-rich domain, C1-domain, zinc-binding domain, endocytosis/exocytosis,signaling protein complex; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.51 E-value=4e-15 Score=129.12 Aligned_cols=58 Identities=40% Similarity=0.809 Sum_probs=50.6
Q ss_pred CCCCcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCC
Q psy48 524 SSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 581 (1098)
Q Consensus 524 ~~~~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~ 581 (1098)
.....+|+|+.++|.+||||++|+++|||+.+|||+|++|+++||++|..+|+..|+.
T Consensus 8 ~~~~~~H~F~~~~~~~pt~C~~C~~~l~Gl~~qg~~C~~C~~~~Hk~C~~~v~~~C~~ 65 (66)
T 1y8f_A 8 GGGGIQHNFEVWTATTPTYCYECEGLLWGIARQGMRCTECGVKCHEKCQDLLNADCKL 65 (66)
T ss_dssp -----CCCEEEEECSSCCCCTTTCCCCCSSCCEEEEETTTCCEECTTHHHHSCCCC--
T ss_pred CCCCCCcccEeeeCCCCcChhhcChhhcccCcceeEcCCCCCeeCHHHHhhCcCcCCC
Confidence 3445789999999999999999999999999999999999999999999999999964
|
| >2db6_A SH3 and cysteine rich domain 3; STAC3, C1 domain, cystein-rich domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=7.4e-15 Score=130.30 Aligned_cols=59 Identities=32% Similarity=0.751 Sum_probs=54.1
Q ss_pred CCCCcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCC-CCCCC
Q psy48 524 SSVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK-DCVGE 582 (1098)
Q Consensus 524 ~~~~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~-~C~~~ 582 (1098)
.....+|+|+.++|.+||||++|+++|||+.+|||+|+.|+++||++|..+|+. .|.+.
T Consensus 12 ~~~~~~H~F~~~~f~~pt~C~~C~~~lwGl~kqG~~C~~C~~~~Hk~C~~~v~~~~C~~~ 71 (74)
T 2db6_A 12 LVNDKPHKFKDHFFKKPKFCDVCARMIVLNNKFGLRCKNCKTNIHEHCQSYVEMQRCSGP 71 (74)
T ss_dssp CSCSSBCCEEEEECSSCEECSSSCCEECHHHHEEEEESSSCCEECTTTTGGGSSSBCCCC
T ss_pred cccCCCCceEEeeCCCCcCchhcChhhccccCCccccCCCCCccChhHHhhCCCCcCCCC
Confidence 345678999999999999999999999999999999999999999999999996 59653
|
| >3uej_A NPKC-delta, protein kinase C delta type; proteine kinase cdelta, phosphotransferase, anesthetic bindi metal binding protein; 1.30A {Mus musculus} PDB: 3ugi_A 3ugl_A 3uey_A 3ugd_A 3uff_A 1ptq_A 1ptr_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=3.4e-15 Score=129.20 Aligned_cols=54 Identities=50% Similarity=0.964 Sum_probs=52.0
Q ss_pred CCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCC
Q psy48 264 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 317 (1098)
Q Consensus 264 ~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~ 317 (1098)
.+|+|.+++|.+||+|++|+++|||+++|||+|++|+++||++|..+|+..|+.
T Consensus 8 ~~H~F~~~~~~~pt~C~~C~~~l~Gl~~qg~~C~~C~~~~Hk~C~~~v~~~C~~ 61 (65)
T 3uej_A 8 GSHRFKVYNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCEF 61 (65)
T ss_dssp EECCEEEECCSSCCBCTTTCCBCCSSSSCEEEETTTCCEECHHHHTTSCSEEEE
T ss_pred CCceEEeEeCCCCCcccccChhhhccCceeeECCCCCCeEchhHhhhCCCcCCC
Confidence 589999999999999999999999999999999999999999999999999953
|
| >2row_A RHO-associated protein kinase 2; ATP-binding, coiled coil, cytoplasm, membrane, metal-binding, nucleotide-binding, phorbol-ester binding; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.3e-14 Score=130.61 Aligned_cols=56 Identities=32% Similarity=0.595 Sum_probs=53.5
Q ss_pred CcCceeeeeecCCCccccccccchhccccc--ceecCCCCccccccccc---cCCCCCCCC
Q psy48 527 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQ--GLQCKDCGFNVHKKCLD---KVPKDCVGE 582 (1098)
Q Consensus 527 ~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~q--G~~C~~C~~~vH~~C~~---~v~~~C~~~ 582 (1098)
..+|.|.+++|..||||++|+++|||+++| ||+|+.|+++||++|.. .|++.|+.+
T Consensus 22 ~~~H~F~~~~~~~PT~Cd~C~~~lWGl~kqp~G~~C~~C~~~~HkrC~~k~~~v~~~C~~~ 82 (84)
T 2row_A 22 HKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVY 82 (84)
T ss_dssp ETTEEEEEECCSSCEECSSSSSEECCSSSCCCEEEESSSCCEEEHHHHHHTCTTCCCCSTT
T ss_pred cCCcceEeEcCCCCcchhhcCHhhhccccCCCCCEecCCCCccchhHhCCccccccccCcC
Confidence 468999999999999999999999999998 99999999999999999 799999876
|
| >3uej_A NPKC-delta, protein kinase C delta type; proteine kinase cdelta, phosphotransferase, anesthetic bindi metal binding protein; 1.30A {Mus musculus} PDB: 3ugi_A 3ugl_A 3uey_A 3ugd_A 3uff_A 1ptq_A 1ptr_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=7.2e-15 Score=127.17 Aligned_cols=54 Identities=50% Similarity=0.964 Sum_probs=52.1
Q ss_pred cCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCC
Q psy48 528 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 581 (1098)
Q Consensus 528 ~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~ 581 (1098)
.+|+|+.++|.+||||++|+++|||+.+|||+|..|+++||++|..+|+..|+.
T Consensus 8 ~~H~F~~~~~~~pt~C~~C~~~l~Gl~~qg~~C~~C~~~~Hk~C~~~v~~~C~~ 61 (65)
T 3uej_A 8 GSHRFKVYNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCEF 61 (65)
T ss_dssp EECCEEEECCSSCCBCTTTCCBCCSSSSCEEEETTTCCEECHHHHTTSCSEEEE
T ss_pred CCceEEeEeCCCCCcccccChhhhccCceeeECCCCCCeEchhHhhhCCCcCCC
Confidence 479999999999999999999999999999999999999999999999999975
|
| >2enn_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.1e-14 Score=128.40 Aligned_cols=55 Identities=42% Similarity=0.922 Sum_probs=52.8
Q ss_pred CcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCC
Q psy48 527 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 581 (1098)
Q Consensus 527 ~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~ 581 (1098)
..+|.|..++|..||||++|+++|||+.+|||+|..|+++||++|..+|+..|..
T Consensus 21 ~~~H~F~~~~f~~pt~C~~C~~~lwGl~kqG~~C~~C~~~~Hk~C~~~v~~~C~~ 75 (77)
T 2enn_A 21 VKCHEFTATFFPQPTFCSVCHEFVWGLNKQGYQCRQCNAAIHKKCIDKVIAKCTG 75 (77)
T ss_dssp SSSCEEEEECCSSCEECSSSCCEECCTTCCEEECSSSCCEEESGGGSSCCSCCCC
T ss_pred CCCCccEEEcCCCCcCccccChhhccccccccCcCCCCCcCCHhHHhhCcCCCCC
Confidence 4689999999999999999999999999999999999999999999999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.46 E-value=2.9e-14 Score=164.60 Aligned_cols=153 Identities=11% Similarity=0.137 Sum_probs=104.9
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC------------hHHH--------HHHHHHHHHHhccCCC
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP------------TKQE--------AQLKNEVAILQNLCHP 871 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~------------~~~~--------~~~~~Ei~iL~~l~Hp 871 (1098)
..|..+..||.|.++.||.|.+. +|+.||||+++..... .... ....+|...|.++.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34889999999999999999984 6999999998642110 0001 1223455566655443
Q ss_pred CceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCC
Q psy48 872 GVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951 (1098)
Q Consensus 872 nIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~ 951 (1098)
++.-. ..+.. ...+|||||++|..|..+. ....+..++.||+.+|.+||+.|||||||||.|||++.++..
T Consensus 174 gv~vp-~p~~~-~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 174 GFPVP-EPIAQ-SRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp TCSCC-CEEEE-ETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCC-eeeec-cCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 33211 11111 1237999999999885432 234567789999999999999999999999999999877621
Q ss_pred C-------cEEEeecCcccccCCCCCChhhh
Q psy48 952 P-------QVKLCDFGFARIIGEKSFPPEVL 975 (1098)
Q Consensus 952 ~-------~vKL~DFGla~~~~~~~~APEvl 975 (1098)
. .+.|+||+-+.....+ .|.|.+
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~hp-~a~~~l 274 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMDHP-NAEMYF 274 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETTST-THHHHH
T ss_pred ccccccccceEEEEeCCcccCCCC-ChHHHH
Confidence 0 3899999987654432 355544
|
| >2yuu_A NPKC-delta, protein kinase C delta type; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=4.2e-14 Score=128.28 Aligned_cols=58 Identities=38% Similarity=0.846 Sum_probs=54.5
Q ss_pred CCcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCCC
Q psy48 526 VNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEP 583 (1098)
Q Consensus 526 ~~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~~ 583 (1098)
...+|+|..++|..||||++|+++|||+++|||+|..|+++||++|..+|+..|....
T Consensus 14 ~~~~H~F~~~~~~~pt~C~~C~~~lwGl~kqg~~C~~C~~~~Hk~C~~~v~~~C~~~~ 71 (83)
T 2yuu_A 14 YIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTA 71 (83)
T ss_dssp CGGGCCEEEECCSSCCCCSSSCCCCCSSSCCEEEETTTCCEECTTGGGTCCSCCSSCC
T ss_pred ccCCCceEeEeCCCCcChhhcChhhccccccccccCCcCCeeChhhhhhCCCcCCCcc
Confidence 3468999999999999999999999999999999999999999999999999997653
|
| >1rfh_A RAS association (ralgds/AF-6) domain family 5; zinc, signal transduction, apoptosis, cysteine rich domain, metal binding protein; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.43 E-value=4.2e-14 Score=119.79 Aligned_cols=57 Identities=28% Similarity=0.654 Sum_probs=53.4
Q ss_pred CCCCCCCCcCceeee-eecCCCccccccccchhcccccceecCCCCccccccccccCCCCC
Q psy48 520 PGAPSSVNIPHTFNL-HTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579 (1098)
Q Consensus 520 ~~~~~~~~~~H~F~~-~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C 579 (1098)
|+.|.....+|+|.. ++|.+||||++|+++| .+|||+|++|+++||++|..+|+..|
T Consensus 1 ~~~~~~~~~~H~F~~~~~~~~pt~C~~C~~~i---~kqg~kC~~C~~~cH~kC~~~v~~~C 58 (59)
T 1rfh_A 1 PRVLAERGEGHRFVELALRGGPGWCDLCGREV---LRQALRCANCKFTCHSECRSLIQLDC 58 (59)
T ss_dssp CCCCCCCCSSCCCEECCCSSCCEECTTTCSEE---CSCCEECTTTSCEECHHHHTTCCCCC
T ss_pred CCcCCcCCCCCcCeeeeccCCCeEchhcchhh---hhCccEeCCCCCeEehhhhhhCcCCC
Confidence 456677789999999 9999999999999999 59999999999999999999999999
|
| >2fnf_X Putative RAS effector NORE1; zinc, signal transduction, apoptosis, cysteine rich domain; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.43 E-value=4.9e-14 Score=124.08 Aligned_cols=51 Identities=29% Similarity=0.693 Sum_probs=49.0
Q ss_pred CCCCeeeee-eccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCC
Q psy48 262 VNIPHTFNL-HTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315 (1098)
Q Consensus 262 ~~~~H~f~~-~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C 315 (1098)
...+|+|.+ ++|.+||||++|+++| ++|||+|++|+++||++|..+|+..|
T Consensus 20 ~~~~H~F~~~~~~~~pt~C~~C~~~l---~~qG~kC~~C~~~cHkkC~~~V~~~C 71 (72)
T 2fnf_X 20 RGEGHRFVELALRGGPGWCDLCGREV---LRQALRCANCKFTCHSECRSLIQLDC 71 (72)
T ss_dssp GCSSCCCEECCCCSSCCBCTTTSSBC---SSCCEECTTSSCEECTGGGGGCCSCC
T ss_pred cCCCCccceeecCCCCcchhhhhHHH---HhCcCccCCCCCeechhhhccCcCCC
Confidence 568999999 9999999999999999 69999999999999999999999999
|
| >1rfh_A RAS association (ralgds/AF-6) domain family 5; zinc, signal transduction, apoptosis, cysteine rich domain, metal binding protein; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.43 E-value=4.3e-14 Score=119.77 Aligned_cols=54 Identities=28% Similarity=0.648 Sum_probs=50.4
Q ss_pred CCCCCCCeeeee-eccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCC
Q psy48 259 PSSVNIPHTFNL-HTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315 (1098)
Q Consensus 259 ~~~~~~~H~f~~-~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C 315 (1098)
+.+...+|+|.+ ++|.+||||++|+++| ++||++|++|+++||++|..+|+..|
T Consensus 4 ~~~~~~~H~F~~~~~~~~pt~C~~C~~~i---~kqg~kC~~C~~~cH~kC~~~v~~~C 58 (59)
T 1rfh_A 4 LAERGEGHRFVELALRGGPGWCDLCGREV---LRQALRCANCKFTCHSECRSLIQLDC 58 (59)
T ss_dssp CCCCCSSCCCEECCCSSCCEECTTTCSEE---CSCCEECTTTSCEECHHHHTTCCCCC
T ss_pred CCcCCCCCcCeeeeccCCCeEchhcchhh---hhCccEeCCCCCeEehhhhhhCcCCC
Confidence 344568999999 9999999999999999 69999999999999999999999998
|
| >2fnf_X Putative RAS effector NORE1; zinc, signal transduction, apoptosis, cysteine rich domain; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.9e-13 Score=120.34 Aligned_cols=52 Identities=29% Similarity=0.681 Sum_probs=49.5
Q ss_pred CCCcCceeee-eecCCCccccccccchhcccccceecCCCCccccccccccCCCCC
Q psy48 525 SVNIPHTFNL-HTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579 (1098)
Q Consensus 525 ~~~~~H~F~~-~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C 579 (1098)
....+|+|.. ++|..||||++|+++| .+|||+|++|+++||++|..+|+..|
T Consensus 19 ~~~~~H~F~~~~~~~~pt~C~~C~~~l---~~qG~kC~~C~~~cHkkC~~~V~~~C 71 (72)
T 2fnf_X 19 ERGEGHRFVELALRGGPGWCDLCGREV---LRQALRCANCKFTCHSECRSLIQLDC 71 (72)
T ss_dssp GGCSSCCCEECCCCSSCCBCTTTSSBC---SSCCEECTTSSCEECTGGGGGCCSCC
T ss_pred ccCCCCccceeecCCCCcchhhhhHHH---HhCcCccCCCCCeechhhhccCcCCC
Confidence 3568999999 9999999999999999 69999999999999999999999999
|
| >1faq_A RAF-1; transferase, serine/threonine-protein kinase, proto- oncogene, zinc, ATP-binding, phorbol-ester binding; NMR {Homo sapiens} SCOP: g.49.1.1 PDB: 1far_A | Back alignment and structure |
|---|
Probab=99.33 E-value=5.3e-13 Score=110.15 Aligned_cols=49 Identities=37% Similarity=0.998 Sum_probs=47.4
Q ss_pred CeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCC
Q psy48 265 PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 317 (1098)
Q Consensus 265 ~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~ 317 (1098)
+|+|..++|.+||+|++|+++|| ||++|++|++++|++|..+|+..|..
T Consensus 3 ~H~F~~~~~~~pt~C~~C~~~l~----qG~~C~~C~~~~H~~C~~~v~~~C~~ 51 (52)
T 1faq_A 3 THNFARKTFLKLAFCDICQKFLL----NGFRCQTCGYKFHEHCSTKVPTMCVD 51 (52)
T ss_dssp CCCCEEECCSSCEECTTSSSEEC----SEEECTTTTCCBCSTTSSSSSSCCCC
T ss_pred CceeEeEeCCCCcCCCCcccccc----cCCEeCCCCCeEChhHHhhCcCcCCC
Confidence 79999999999999999999999 99999999999999999999999964
|
| >1faq_A RAF-1; transferase, serine/threonine-protein kinase, proto- oncogene, zinc, ATP-binding, phorbol-ester binding; NMR {Homo sapiens} SCOP: g.49.1.1 PDB: 1far_A | Back alignment and structure |
|---|
Probab=99.28 E-value=1.2e-12 Score=108.13 Aligned_cols=49 Identities=37% Similarity=0.998 Sum_probs=47.3
Q ss_pred CceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCC
Q psy48 529 PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 581 (1098)
Q Consensus 529 ~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~ 581 (1098)
+|+|+.++|.+||+|++|+++|| ||++|+.|+++||++|..+|+..|+.
T Consensus 3 ~H~F~~~~~~~pt~C~~C~~~l~----qG~~C~~C~~~~H~~C~~~v~~~C~~ 51 (52)
T 1faq_A 3 THNFARKTFLKLAFCDICQKFLL----NGFRCQTCGYKFHEHCSTKVPTMCVD 51 (52)
T ss_dssp CCCCEEECCSSCEECTTSSSEEC----SEEECTTTTCCBCSTTSSSSSSCCCC
T ss_pred CceeEeEeCCCCcCCCCcccccc----cCCEeCCCCCeEChhHHhhCcCcCCC
Confidence 69999999999999999999999 99999999999999999999999963
|
| >4b6d_A RAC GTPase-activating protein 1; signaling protein, cytokinesis, plasma membrane, phospholipi centralspindlin, spindle midzone, central spindle; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=2e-12 Score=109.91 Aligned_cols=54 Identities=33% Similarity=0.660 Sum_probs=50.6
Q ss_pred CCCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCC
Q psy48 262 VNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCV 316 (1098)
Q Consensus 262 ~~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~ 316 (1098)
...+|+|++++|.+|++|++|++.|| +++|||||++|+++||++|...++..|.
T Consensus 5 ~~~~H~F~~kt~~~~~~C~~Cg~~i~-~gkq~~kC~dC~~~cH~~C~~~~~~~C~ 58 (61)
T 4b6d_A 5 SMRLHDFVSKTVIKPESCVPCGKRIK-FGKLSLKCRDCRVVSHPECRDRCPLPCI 58 (61)
T ss_dssp CBCCCCEEEEECCSCEECTTTCCEEC-TTCEEEEESSSSCEECGGGGGGSCSSCC
T ss_pred cccceeEEeeeccCCcccccccCEEE-EeeEeeECCCCCCeEchhHhhcCCCCCC
Confidence 45789999999999999999999875 8999999999999999999999999995
|
| >4b6d_A RAC GTPase-activating protein 1; signaling protein, cytokinesis, plasma membrane, phospholipi centralspindlin, spindle midzone, central spindle; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.6e-12 Score=109.17 Aligned_cols=55 Identities=33% Similarity=0.651 Sum_probs=51.1
Q ss_pred CCCcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCC
Q psy48 525 SVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCV 580 (1098)
Q Consensus 525 ~~~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~ 580 (1098)
....+|+|+.++|.++++|++|++.|| +++|||+|.+|++.||++|...++..|.
T Consensus 4 ~~~~~H~F~~kt~~~~~~C~~Cg~~i~-~gkq~~kC~dC~~~cH~~C~~~~~~~C~ 58 (61)
T 4b6d_A 4 GSMRLHDFVSKTVIKPESCVPCGKRIK-FGKLSLKCRDCRVVSHPECRDRCPLPCI 58 (61)
T ss_dssp ECBCCCCEEEEECCSCEECTTTCCEEC-TTCEEEEESSSSCEECGGGGGGSCSSCC
T ss_pred CcccceeEEeeeccCCcccccccCEEE-EeeEeeECCCCCCeEchhHhhcCCCCCC
Confidence 345689999999999999999999885 9999999999999999999999999995
|
| >1kbe_A Kinase suppressor of RAS; KSR, cysteine-rich domain, zinc- binding protein, signaling protein; NMR {Mus musculus} SCOP: g.49.1.1 PDB: 1kbf_A | Back alignment and structure |
|---|
Probab=99.16 E-value=1.1e-11 Score=100.40 Aligned_cols=46 Identities=28% Similarity=0.847 Sum_probs=42.6
Q ss_pred CCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCC
Q psy48 263 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK 313 (1098)
Q Consensus 263 ~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~ 313 (1098)
.++|+|..++|. +|+|++|+++|| ||++|++|++++|++|..+||+
T Consensus 2 ~i~HrF~~~t~~-~t~C~~C~k~i~----~G~kC~~Ck~~cH~kC~~~vp~ 47 (49)
T 1kbe_A 2 SVTHRFSTKSWL-SQVCNVCQKSMI----FGVKCKHCRLKCHNKCTKEAPA 47 (49)
T ss_dssp CCCCCEEEECCS-SCCCSSSCCSSC----CEEEETTTTEEESSSCTTTSCC
T ss_pred CCCcccCccCCC-CcCccccCceeE----CcCCCCCCCCccchhhcCcCCC
Confidence 479999999998 599999999999 7999999999999999997764
|
| >1kbe_A Kinase suppressor of RAS; KSR, cysteine-rich domain, zinc- binding protein, signaling protein; NMR {Mus musculus} SCOP: g.49.1.1 PDB: 1kbf_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1.4e-11 Score=99.69 Aligned_cols=46 Identities=28% Similarity=0.843 Sum_probs=42.5
Q ss_pred CcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCC
Q psy48 527 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK 577 (1098)
Q Consensus 527 ~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~ 577 (1098)
.++|+|..++|.. |+|++|+++|| ||++|++|++++|++|..+||+
T Consensus 2 ~i~HrF~~~t~~~-t~C~~C~k~i~----~G~kC~~Ck~~cH~kC~~~vp~ 47 (49)
T 1kbe_A 2 SVTHRFSTKSWLS-QVCNVCQKSMI----FGVKCKHCRLKCHNKCTKEAPA 47 (49)
T ss_dssp CCCCCEEEECCSS-CCCSSSCCSSC----CEEEETTTTEEESSSCTTTSCC
T ss_pred CCCcccCccCCCC-cCccccCceeE----CcCCCCCCCCccchhhcCcCCC
Confidence 4689999999985 99999999999 8999999999999999997774
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=8.5e-10 Score=119.66 Aligned_cols=141 Identities=15% Similarity=0.075 Sum_probs=109.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LV 889 (1098)
+..|+....++.|.++.||.... .++.+++|+...... .....+.+|+.+++.+. +..+.++++++...+..|+|
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 44567777777777888888764 368899999864321 11235888999998884 67788899999888899999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh---------------------------------------
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS--------------------------------------- 930 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs--------------------------------------- 930 (1098)
|||++|.+|...+ .+......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 89 MSEADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EECCSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEecCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 9999999997652 1233455788999999999998
Q ss_pred --------------------CCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 931 --------------------KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 931 --------------------~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
..++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~---~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK---VSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE---EEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc---EEEEEEchhccc
Confidence 4489999999999998654 567999998753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=98.93 E-value=8.6e-11 Score=132.19 Aligned_cols=28 Identities=50% Similarity=0.729 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 141 i~~al~ylH~~~IiHRDlKPeNILl~~~ 168 (311)
T 4aw0_A 141 IVSALEYLHGKGIIHRDLKPENILLNED 168 (311)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCCccCCCCHHHeEEcCC
Confidence 8999999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.2e-10 Score=142.58 Aligned_cols=28 Identities=36% Similarity=0.640 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 301 Il~aL~yLH~~gIiHRDLKPeNILld~~ 328 (689)
T 3v5w_A 301 IILGLEHMHNRFVVYRDLKPANILLDEH 328 (689)
T ss_dssp HHHHHHHHHTTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCccccCCchHHeEEeCC
Confidence 8999999999999999999999999974
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=98.89 E-value=4.2e-10 Score=133.39 Aligned_cols=57 Identities=42% Similarity=0.964 Sum_probs=53.1
Q ss_pred CCCCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCC
Q psy48 261 SVNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVG 317 (1098)
Q Consensus 261 ~~~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~ 317 (1098)
++..+|+|.+++|.+||+|++|+++|||+++||++|.+|+++||++|...++..|..
T Consensus 205 niv~~h~f~~~~~~~pt~C~~C~~~l~g~~~qg~~C~~C~~~~Hk~C~~~vp~~C~~ 261 (463)
T 3cxl_A 205 KYEKIHNFKVHTFRGPHWCEYCANFMWGLIAQGVKCADCGLNVHKQCSKMVPNDCKP 261 (463)
T ss_dssp --CBCCCEEEECCSSCCBCTTTCCBCCSSSCCEEEETTTCCEECHHHHTTSCSBCCG
T ss_pred ccCCCcceEEeecCCCCcchhhhhhhhhHHhcCeeccccCccccccccccccccccc
Confidence 356799999999999999999999999999999999999999999999999999964
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=98.83 E-value=9.1e-10 Score=130.56 Aligned_cols=57 Identities=42% Similarity=0.979 Sum_probs=53.5
Q ss_pred CCcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCC
Q psy48 526 VNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGE 582 (1098)
Q Consensus 526 ~~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~ 582 (1098)
...+|.|.+++|.+||||++|+++|||+.+||++|..|+++||++|...++..|+.+
T Consensus 206 iv~~h~f~~~~~~~pt~C~~C~~~l~g~~~qg~~C~~C~~~~Hk~C~~~vp~~C~~~ 262 (463)
T 3cxl_A 206 YEKIHNFKVHTFRGPHWCEYCANFMWGLIAQGVKCADCGLNVHKQCSKMVPNDCKPD 262 (463)
T ss_dssp -CBCCCEEEECCSSCCBCTTTCCBCCSSSCCEEEETTTCCEECHHHHTTSCSBCCGG
T ss_pred cCCCcceEEeecCCCCcchhhhhhhhhHHhcCeeccccCcccccccccccccccccc
Confidence 456899999999999999999999999999999999999999999999999999754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.82 E-value=4e-09 Score=113.15 Aligned_cols=127 Identities=17% Similarity=0.164 Sum_probs=93.0
Q ss_pred eeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCC--ceeeeeeeecCCcEEEEEEeccCchH
Q psy48 821 CIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPG--VVNLERMFETPGRIFVVMEKLQGDML 898 (1098)
Q Consensus 821 g~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~L~~~f~~~~~l~LVmEy~~ggsL 898 (1098)
+.|..+.+|... ..+|+.++||+.... ....+.+|+.+++.+.+.+ +.+++.+....+..++||||++|..+
T Consensus 29 ~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 29 IGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp CTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 455557777774 456788999997543 1245778999988885434 56688888888889999999999988
Q ss_pred HHHHhhccCccchhHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q psy48 899 EMILSSEKGRLSERTTKFIITQILVALKHLHSKN---------------------------------------------- 932 (1098)
Q Consensus 899 ~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~g---------------------------------------------- 932 (1098)
. .. .. ....++.+++..|..||+..
T Consensus 103 ~--~~----~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 103 L--SS----HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp T--TS----CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred C--cC----cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 4 21 11 12356677777777777643
Q ss_pred ------------ccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 933 ------------IVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 933 ------------IvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
++|+|++|.|||++.++ .+.|+|||.+...
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~---~~~liD~~~a~~g 215 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGR---FSGFIDCGRLGVA 215 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTE---EEEECCCTTCEEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCc---EEEEEcchhcccC
Confidence 99999999999998664 5679999987643
|
| >2vrw_B P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP-binding, metal-binding, phosphoprotein, exchange factor, RAC, GTPase, membrane domain; 1.85A {Mus musculus} PDB: 3bji_A 1f5x_A | Back alignment and structure |
|---|
Probab=98.82 E-value=1.2e-09 Score=127.34 Aligned_cols=55 Identities=36% Similarity=0.809 Sum_probs=49.8
Q ss_pred CCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCCCC
Q psy48 264 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEP 319 (1098)
Q Consensus 264 ~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~~~ 319 (1098)
.+|.|..++|.+||+|++|++++||+++||++|+.||++||++|..+|++ |++..
T Consensus 345 ~~h~f~~~~~~~~t~C~~C~~~~~g~~~qg~~C~~C~~~~h~~C~~~~~~-C~~~~ 399 (406)
T 2vrw_B 345 NGHDFQMFSFEETTSCKACQMLLRGTFYQGYRCYRCRAPAHKECLGRVPP-CGRHG 399 (406)
T ss_dssp GGCCEEEECCSSCCBCTTTCCBCCSSSSCEEEETTTCCEECGGGGGGSCC-C----
T ss_pred CCCCCccccCCCCCCCccccchhceeCCCCCCCCCCcCccchhhhhhCCC-CCCCc
Confidence 57999999999999999999999999999999999999999999999996 97654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=6.1e-10 Score=127.26 Aligned_cols=28 Identities=36% Similarity=0.670 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 134 i~~aL~ylH~~~IiHRDlKp~NILl~~~ 161 (350)
T 4b9d_A 134 ICLALKHVHDRKILHRDIKSQNIFLTKD 161 (350)
T ss_dssp HHHHHHHHHHTTCEETTCCGGGEEECTT
T ss_pred HHHHHHHHHHCCeeeccCCHHHEEECCC
Confidence 8899999999999999999999999874
|
| >3ky9_A Proto-oncogene VAV; calponin homology domain, DBL homology domain, pleckst homology domain, C1 domain, guanine-nucleotide releasing FA metal-binding; 2.73A {Homo sapiens} PDB: 2d86_A | Back alignment and structure |
|---|
Probab=98.80 E-value=1.5e-09 Score=132.52 Aligned_cols=57 Identities=35% Similarity=0.796 Sum_probs=50.1
Q ss_pred CCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCCCCc
Q psy48 263 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPV 320 (1098)
Q Consensus 263 ~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~~~~ 320 (1098)
...|.|..++|.+||+|++|+++|||+++||++|..|+++||++|...|+ .|++.+.
T Consensus 516 ~~~H~F~~~~~~~~t~C~~C~~~l~gl~~qg~~C~~C~~~vHk~C~~~v~-~C~~~~~ 572 (587)
T 3ky9_A 516 ANGHDFQMFSFEETTSCKACQMLLRGTFYQGYRCHRCRASAHKECLGRVP-PCGRHGQ 572 (587)
T ss_dssp GGGCCEEEECCSSCCBCTTTCSBCCSSSCCEEEETTTCCEECSGGGGGSC-CC-----
T ss_pred ccCCceeEEeCCCCcccccccccccccccCCcCCCCCCCccchhhhhcCC-CCCCCCc
Confidence 36899999999999999999999999999999999999999999999995 9987654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=98.79 E-value=7e-10 Score=122.73 Aligned_cols=28 Identities=43% Similarity=0.611 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++|||||||||+|||||.+
T Consensus 121 i~~al~ylH~~~IiHRDiKP~NILl~~~ 148 (275)
T 3hyh_A 121 IISAVEYCHRHKIVHRDLKPENLLLDEH 148 (275)
T ss_dssp HHHHHHHHHHTTCCCCCCCTTTEEECTT
T ss_pred HHHHHHHHHHCCcccccCChHHeEECCC
Confidence 8999999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=6.9e-10 Score=124.50 Aligned_cols=28 Identities=46% Similarity=0.661 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 135 i~~aL~ylH~~~IiHRDlKp~NILl~~~ 162 (304)
T 3ubd_A 135 LALALDHLHSLGIIYRDLKPENILLDEE 162 (304)
T ss_dssp HHHHHHHHHHTTCCCSSCCGGGEEECTT
T ss_pred HHHHHHHHHHCCCcCCCCCHHHeEEcCC
Confidence 8889999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=7.5e-10 Score=125.87 Aligned_cols=29 Identities=31% Similarity=0.560 Sum_probs=27.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||||.+.
T Consensus 159 i~~aL~ylH~~~IiHRDlKp~NILl~~~g 187 (336)
T 4g3f_A 159 ALEGLEYLHTRRILHGDVKADNVLLSSDG 187 (336)
T ss_dssp HHHHHHHHHTTTEECSCCCGGGEEECTTS
T ss_pred HHHHHHHHHHCCceecccCHHHEEEeCCC
Confidence 88999999999999999999999999854
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=5.3e-10 Score=125.13 Aligned_cols=29 Identities=41% Similarity=0.654 Sum_probs=26.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+||||+.+.
T Consensus 127 i~~al~ylH~~~IiHRDlKp~NILl~~~~ 155 (299)
T 4g31_A 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDD 155 (299)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred HHHHHHHHHHCcCccccCcHHHeEECCCC
Confidence 67789999999999999999999998743
|
| >2vrw_B P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP-binding, metal-binding, phosphoprotein, exchange factor, RAC, GTPase, membrane domain; 1.85A {Mus musculus} PDB: 3bji_A 1f5x_A | Back alignment and structure |
|---|
Probab=98.76 E-value=2.6e-09 Score=124.45 Aligned_cols=55 Identities=36% Similarity=0.809 Sum_probs=49.6
Q ss_pred cCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCCC
Q psy48 528 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEP 583 (1098)
Q Consensus 528 ~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~~ 583 (1098)
.+|.|..++|..||+|++|+.++||+.+||++|..||++||++|..+||+ |+++.
T Consensus 345 ~~h~f~~~~~~~~t~C~~C~~~~~g~~~qg~~C~~C~~~~h~~C~~~~~~-C~~~~ 399 (406)
T 2vrw_B 345 NGHDFQMFSFEETTSCKACQMLLRGTFYQGYRCYRCRAPAHKECLGRVPP-CGRHG 399 (406)
T ss_dssp GGCCEEEECCSSCCBCTTTCCBCCSSSSCEEEETTTCCEECGGGGGGSCC-C----
T ss_pred CCCCCccccCCCCCCCccccchhceeCCCCCCCCCCcCccchhhhhhCCC-CCCCc
Confidence 47999999999999999999999999999999999999999999999996 98764
|
| >2d9z_A Protein kinase C, NU type; PH domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.74 E-value=4.1e-09 Score=101.08 Aligned_cols=68 Identities=54% Similarity=0.788 Sum_probs=59.5
Q ss_pred hhhhccceecccccccccccccCCccccccccceeecccCCCCCc-----ccceeEEeeeeeeeEeeccCCcc
Q psy48 58 AKRKRHYWRLDSKCLTLFQSESGSKYYKEIPLSEILGIEPCKPLT-----HELQQVQIRPHTLTVHSYKAPTF 125 (1098)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~e~~~~~~~~~~~-----~~~~~~~~~~h~~~~~~~~~p~f 125 (1098)
..+++||||+|.|+++||+++.++++|+||||+||+.++.+.... +.+|.|+|+.-.+.+....+|..
T Consensus 22 ~~rKRHYWrLD~K~Itlf~~e~~~k~ykeIpLseIL~v~~~~~~~~~~~~~~phcFEi~T~~~~y~Vge~~~~ 94 (129)
T 2d9z_A 22 NLRKRHYWRLDSKCLTLFQNESGSKYYKEIPLSEILRISSPRDFTNISQGSNPHCFEIITDTMVYFVGENNGD 94 (129)
T ss_dssp CCCEEEEEEEESSCEEEESCSSCCSCCCEECTTTCCEECCTTCCCCSSSCSCCCSEEEECSSCEEEECBCCSC
T ss_pred ccccceeeEecCCeEEEEecCCCCceeceeeHHHhcccccccCccccCCCCCCceEEEEECCEEEEEccCCCC
Confidence 347899999999999999999999999999999999999987665 35599999998888888887653
|
| >3ky9_A Proto-oncogene VAV; calponin homology domain, DBL homology domain, pleckst homology domain, C1 domain, guanine-nucleotide releasing FA metal-binding; 2.73A {Homo sapiens} PDB: 2d86_A | Back alignment and structure |
|---|
Probab=98.71 E-value=3.9e-09 Score=128.78 Aligned_cols=56 Identities=36% Similarity=0.819 Sum_probs=49.9
Q ss_pred CcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCCC
Q psy48 527 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEP 583 (1098)
Q Consensus 527 ~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~~ 583 (1098)
..+|.|+.++|.+||+|++|+++|||+.+||++|..|+++||++|...|+ .|++..
T Consensus 516 ~~~H~F~~~~~~~~t~C~~C~~~l~gl~~qg~~C~~C~~~vHk~C~~~v~-~C~~~~ 571 (587)
T 3ky9_A 516 ANGHDFQMFSFEETTSCKACQMLLRGTFYQGYRCHRCRASAHKECLGRVP-PCGRHG 571 (587)
T ss_dssp GGGCCEEEECCSSCCBCTTTCSBCCSSSCCEEEETTTCCEECSGGGGGSC-CC----
T ss_pred ccCCceeEEeCCCCcccccccccccccccCCcCCCCCCCccchhhhhcCC-CCCCCC
Confidence 45799999999999999999999999999999999999999999999995 998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.70 E-value=2.6e-09 Score=120.02 Aligned_cols=28 Identities=29% Similarity=0.477 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 141 ia~gL~yLH~~~IiHRDlKp~NILl~~~ 168 (307)
T 3omv_A 141 TAQGMDYLHAKNIIHRDMKSNNIFLHEG 168 (307)
T ss_dssp HHHHHHHHHHTTCBCSCCCSSSEEEETT
T ss_pred HHHHHHHHHHCCccCCccCHHHEEECCC
Confidence 7889999999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=1.7e-09 Score=123.42 Aligned_cols=28 Identities=32% Similarity=0.598 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 179 i~~aL~ylH~~~IiHRDlKp~NILl~~~ 206 (346)
T 4fih_A 179 VLQALSVLHAQGVIHRDIKSDSILLTHD 206 (346)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCcccccCCHHHEEECCC
Confidence 8899999999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.67 E-value=2.4e-09 Score=125.26 Aligned_cols=28 Identities=32% Similarity=0.598 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 256 il~aL~ylH~~~IiHRDiKp~NILl~~~ 283 (423)
T 4fie_A 256 VLQALSVLHAQGVIHRDIKSDSILLTHD 283 (423)
T ss_dssp HHHHHHHHHHTTEECCCCSTTTEEECTT
T ss_pred HHHHHHHHHHCCeecccCCHHHEEEcCC
Confidence 8999999999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=2.8e-09 Score=122.39 Aligned_cols=29 Identities=38% Similarity=0.587 Sum_probs=27.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+++|||++|||||||||+|||||.+.
T Consensus 126 ll~al~ylH~~gIiHRDiKPeNiLl~~~~ 154 (361)
T 4f9c_A 126 LFKALKRIHQFGIVHRDVKPSNFLYNRRL 154 (361)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEETTT
T ss_pred HHHHHHHHHHCCeEeCcCCHHHeEEeCCC
Confidence 89999999999999999999999998753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.63 E-value=3.5e-09 Score=123.18 Aligned_cols=28 Identities=39% Similarity=0.627 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||||.+
T Consensus 167 il~al~ylH~~~iiHRDlKP~NIl~~~~ 194 (398)
T 4b99_A 167 LLRGLKYMHSAQVIHRDLKPSNLLVNEN 194 (398)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCcCcCCCcCccccccCCC
Confidence 8899999999999999999999999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.60 E-value=7.3e-08 Score=109.69 Aligned_cols=141 Identities=16% Similarity=0.233 Sum_probs=102.2
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEe--ccCCChHHHHHHHHHHHHHhccC--CCCceeeeeeeecC---CcEEEE
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVID--KLRFPTKQEAQLKNEVAILQNLC--HPGVVNLERMFETP---GRIFVV 889 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlk--k~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~L~~~f~~~---~~l~LV 889 (1098)
...++.|....+|..... +..+++|+.. .... ......+.+|..+++.+. +..+++++.++.+. +..|+|
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 455677888888887653 4678888865 2211 112356888999999886 45578888888766 458999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh---------------------------------------
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS--------------------------------------- 930 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs--------------------------------------- 930 (1098)
|||++|..+... ....++..+...++.+++.+|..||+
T Consensus 120 me~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999999877321 12236777888899999999999997
Q ss_pred -------------------CCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 931 -------------------KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 931 -------------------~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
..++|+|+++.|||++.++. ..+.|+||+++..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECcccccc
Confidence 36899999999999997752 1469999998864
|
| >2coa_A Protein kinase C, D2 type; protein kinase D2, PH domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1 | Back alignment and structure |
|---|
Probab=98.60 E-value=1.2e-08 Score=97.61 Aligned_cols=68 Identities=44% Similarity=0.746 Sum_probs=57.9
Q ss_pred hhhhccceecccccccccccccCCccccccccceeecccCCCCCc-----ccceeEEeeeeeeeEeeccCCcc
Q psy48 58 AKRKRHYWRLDSKCLTLFQSESGSKYYKEIPLSEILGIEPCKPLT-----HELQQVQIRPHTLTVHSYKAPTF 125 (1098)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~e~~~~~~~~~~~-----~~~~~~~~~~h~~~~~~~~~p~f 125 (1098)
..+++||||+|.|+++||++++++++|++|+|+||+.++.+.... ...|.|+|+.-.+.+....+|..
T Consensus 22 ~~rKRHYWrLD~K~Itlf~~e~~~~~ykeIpL~eIl~v~~~~~~~~l~~~~~~hcFEi~T~~~~yyVg~~~~~ 94 (125)
T 2coa_A 22 TLRKRHYWRLDCKCITLFQNNTTNRYYKEIPLSEILTVESAQNFSLVPPGTNPHCFEIVTANATYFVGEMPGG 94 (125)
T ss_dssp CCCEEEEEEECSSEEEEESSSSCSSCSEEEETTTCCEEEESCCCSSSCTTSCCEEEEEECSSCCCCEECCSCC
T ss_pred ccccceeeEecCCeEEEEecCCCCceeeeeehhHeecccccccccccCCCCCCceEEEEeCCeEEEEccCCCC
Confidence 346899999999999999999999999999999999999887555 35588999888777777766553
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.53 E-value=1e-07 Score=106.01 Aligned_cols=170 Identities=21% Similarity=0.232 Sum_probs=115.5
Q ss_pred eeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCC--ceeeeeeeecCC---cEEEEEEec
Q psy48 820 LCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPG--VVNLERMFETPG---RIFVVMEKL 893 (1098)
Q Consensus 820 Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-Hpn--Iv~L~~~f~~~~---~l~LVmEy~ 893 (1098)
++.|....+|... ..+++|+... ......+.+|..+|+.+. +.. +..++......+ ..|+||+++
T Consensus 28 ~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 28 SGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp EEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred cCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 5666666666542 5689998642 234577899999998773 322 344444443333 358999999
Q ss_pred cCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-------------------------------------------
Q psy48 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS------------------------------------------- 930 (1098)
Q Consensus 894 ~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs------------------------------------------- 930 (1098)
+|..+..... ..++..+...++.+++..|..||+
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988854322 236677777888888888888885
Q ss_pred ---------------CCccccCCCCCceeecCC-CCCCcEEEeecCcccccCCC--------C---CChhhhcc-----C
Q psy48 931 ---------------KNIVHCDLKPENVLLSTN-SELPQVKLCDFGFARIIGEK--------S---FPPEVLRN-----K 978 (1098)
Q Consensus 931 ---------------~gIvHrDLKp~NILld~~-g~~~~vKL~DFGla~~~~~~--------~---~APEvl~~-----~ 978 (1098)
..++|+|+++.||+++.+ +. .+.|+||+.+....+. . +.|+.... .
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~--~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNT--ICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTE--EEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCC--EEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 137999999999999984 21 6789999998654321 1 34443221 1
Q ss_pred CC---------CchhHHHHHHHHHHHHHcCCCCC
Q psy48 979 GY---------NRSLDMWSVGVIVYVSLSGTFPF 1003 (1098)
Q Consensus 979 ~y---------s~~sDVwSLGvlLyELltG~~Pf 1003 (1098)
.. ....+.|+++.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 12368999999999999998776
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.1e-08 Score=114.57 Aligned_cols=29 Identities=28% Similarity=0.313 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||||.+-
T Consensus 137 ia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 137 IAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred HHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 45679999999999999999999999853
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.52 E-value=1e-08 Score=117.17 Aligned_cols=28 Identities=39% Similarity=0.514 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 133 i~~aL~~LH~~givHrDlkp~NILl~~~ 160 (353)
T 3txo_A 133 IISALMFLHDKGIIYRDLKLDNVLLDHE 160 (353)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCCcccCCCHHHEEECCC
Confidence 7888999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.51 E-value=1.1e-08 Score=118.88 Aligned_cols=28 Identities=36% Similarity=0.502 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 162 i~~aL~~LH~~givHrDLKp~NILl~~~ 189 (396)
T 4dc2_A 162 ISLALNYLHERGIIYRDLKLDNVLLDSE 189 (396)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCEEeccCCHHHEEECCC
Confidence 7888999999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=2.2e-08 Score=115.31 Aligned_cols=28 Identities=54% Similarity=0.589 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 148 i~~aL~~LH~~givHrDlkp~NIll~~~ 175 (373)
T 2r5t_A 148 IASALGYLHSLNIVYRDLKPENILLDSQ 175 (373)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCceecCCCHHHEEECCC
Confidence 7888999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=98.47 E-value=1.7e-08 Score=113.38 Aligned_cols=27 Identities=26% Similarity=0.331 Sum_probs=24.6
Q ss_pred HHhhccccccccccccCCCCCccCCCC
Q psy48 391 LVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 391 la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
+.+|.|||++||||||||++|||||.+
T Consensus 155 a~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 155 AAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred HHHHHHHHhCCCCCCCccccceEECCC
Confidence 456999999999999999999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=98.47 E-value=1.8e-08 Score=114.37 Aligned_cols=28 Identities=36% Similarity=0.517 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 114 i~~aL~~LH~~~ivHrDlkp~NIll~~~ 141 (337)
T 1o6l_A 114 IVSALEYLHSRDVVYRDIKLENLMLDKD 141 (337)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCeecCcCCHHHEEECCC
Confidence 7888999999999999999999999863
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.45 E-value=2.1e-08 Score=113.72 Aligned_cols=28 Identities=21% Similarity=0.208 Sum_probs=25.1
Q ss_pred HHhhccccccccccccCCCCCccCCCCc
Q psy48 391 LVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 391 la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
+.+|.|||++|||||||||+|||||.+-
T Consensus 168 a~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 168 AAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp HHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred HHHHHHHhcCCeecccccHhhEEECCCC
Confidence 4578999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.45 E-value=2.1e-08 Score=111.71 Aligned_cols=32 Identities=38% Similarity=0.609 Sum_probs=28.0
Q ss_pred HHHhhccccccc--cccccCCCCCccCCC--Ccccc
Q psy48 390 ILVALKHLHSKN--IVHCDLKPERNLFPT--SSLEI 421 (1098)
Q Consensus 390 ~la~lk~LH~k~--IihRDLK~dNvLld~--~~~~~ 421 (1098)
++.+|.|||++| ||||||||+|||||. |.+.|
T Consensus 138 i~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl 173 (290)
T 3fpq_A 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp HHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEE
T ss_pred HHHHHHHHHHCCCCEEecccChhheeEECCCCCEEE
Confidence 888999999999 999999999999985 34444
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=2.3e-08 Score=114.27 Aligned_cols=28 Identities=32% Similarity=0.440 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 130 i~~aL~~LH~~givHrDlkp~NIll~~~ 157 (353)
T 2i0e_A 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSE 157 (353)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCEEeccCCHHHEEEcCC
Confidence 7888999999999999999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=98.43 E-value=2.2e-08 Score=121.73 Aligned_cols=28 Identities=46% Similarity=0.732 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+||||+++
T Consensus 264 i~~al~ylH~~~iiHRDlKp~Nill~~~ 291 (573)
T 3uto_A 264 VCKGLCHMHENNYVHLDLKPENIMFTTK 291 (573)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESSS
T ss_pred HHHHHHHHHHCCeeeccCChhhccccCC
Confidence 7889999999999999999999999873
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2.6e-08 Score=113.98 Aligned_cols=26 Identities=23% Similarity=0.390 Sum_probs=24.1
Q ss_pred HhhccccccccccccCCCCCccCCCC
Q psy48 392 VALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 392 a~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
.+|.|||++||||||||++|||||.+
T Consensus 196 ~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 196 KGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred HHHHhHhhCCeecCccCccceeeCCC
Confidence 47899999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.37 E-value=5.6e-08 Score=112.46 Aligned_cols=28 Identities=32% Similarity=0.634 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 124 i~~aL~~LH~~givHrDlkp~NIll~~~ 151 (384)
T 4fr4_A 124 LVMALDYLQNQRIIHRDMKPDNILLDEH 151 (384)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCceeccCcHHHeEECCC
Confidence 7889999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=4.7e-08 Score=111.34 Aligned_cols=28 Identities=43% Similarity=0.584 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 127 i~~aL~~LH~~~ivHrDlkp~NIll~~~ 154 (345)
T 1xjd_A 127 IILGLQFLHSKGIVYRDLKLDNILLDKD 154 (345)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCeEeCCCChhhEEECCC
Confidence 7788999999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.36 E-value=4.5e-08 Score=110.01 Aligned_cols=28 Identities=46% Similarity=0.667 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 115 i~~aL~~LH~~~ivHrDlkp~NIll~~~ 142 (318)
T 1fot_A 115 VCLALEYLHSKDIIYRDLKPENILLDKN 142 (318)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCccccCCChheEEEcCC
Confidence 7888999999999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=5.2e-08 Score=110.77 Aligned_cols=28 Identities=36% Similarity=0.502 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 119 i~~aL~~LH~~~ivHrDlkp~NIll~~~ 146 (345)
T 3a8x_A 119 ISLALNYLHERGIIYRDLKLDNVLLDSE 146 (345)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCceecCCCHHHEEECCC
Confidence 7888999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=5.1e-08 Score=113.79 Aligned_cols=28 Identities=36% Similarity=0.672 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 177 i~~aL~~LH~~givHrDLKp~NILl~~~ 204 (410)
T 3v8s_A 177 VVLALDAIHSMGFIHRDVKPDNMLLDKS 204 (410)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCeEeccCCHHHeeECCC
Confidence 7788999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.33 E-value=5.8e-08 Score=113.39 Aligned_cols=28 Identities=32% Similarity=0.584 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 171 i~~aL~~LH~~giiHrDLKp~NILld~~ 198 (412)
T 2vd5_A 171 IVMAIDSVHRLGYVHRDIKPDNILLDRC 198 (412)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCeeecccCHHHeeecCC
Confidence 7888999999999999999999999873
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=6.1e-08 Score=114.06 Aligned_cols=28 Identities=29% Similarity=0.598 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 184 i~~aL~~LH~~giiHrDLKp~NILl~~~ 211 (437)
T 4aw2_A 184 MVIAIDSVHQLHYVHRDIKPDNILMDMN 211 (437)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHhCCeEecccCHHHeeEcCC
Confidence 7888999999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=8.6e-08 Score=107.26 Aligned_cols=28 Identities=36% Similarity=0.479 Sum_probs=25.8
Q ss_pred HHHhhcccccc--------ccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSK--------NIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k--------~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++ |||||||||+|||||.+
T Consensus 109 ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~ 144 (303)
T 3hmm_A 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp HHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred HHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC
Confidence 77889999987 99999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=98.25 E-value=1.4e-07 Score=107.39 Aligned_cols=28 Identities=36% Similarity=0.571 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 150 i~~aL~~LH~~~ivHrDlkp~NIll~~~ 177 (350)
T 1rdq_E 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQ 177 (350)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCcccccCccceEEECCC
Confidence 7788999999999999999999999864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=1.1e-05 Score=87.32 Aligned_cols=129 Identities=16% Similarity=0.209 Sum_probs=94.1
Q ss_pred eeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEEEEeccCchHHHHH
Q psy48 824 VVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVMEKLQGDMLEMIL 902 (1098)
Q Consensus 824 ~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l 902 (1098)
....+|.......+..+.+|+-.. .....+.+|..+|+.+. +--+.+++.++.+.+..++|||+++|..+....
T Consensus 37 S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~ 111 (272)
T 4gkh_A 37 SGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVL 111 (272)
T ss_dssp SSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHH
T ss_pred cCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccc
Confidence 334577777777788899998752 34567888999998774 334677888888889999999999998886654
Q ss_pred hhccCccchhHHHHHHHHHHHHHHHHHhC---------------------------------------------------
Q psy48 903 SSEKGRLSERTTKFIITQILVALKHLHSK--------------------------------------------------- 931 (1098)
Q Consensus 903 ~~~~~~lse~~~~~ia~qIa~gL~~LHs~--------------------------------------------------- 931 (1098)
.. .......+..+++..|..||..
T Consensus 112 ~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 186 (272)
T 4gkh_A 112 EE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKL 186 (272)
T ss_dssp HH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTT
T ss_pred cC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhc
Confidence 31 1223344566666666666631
Q ss_pred -------CccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 932 -------NIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 932 -------gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
.++|+|+.+.|||++.++ .+-|+||+.+...
T Consensus 187 ~~~~~~~~l~HGDl~~~Nil~~~~~---~~~viDwe~a~~g 224 (272)
T 4gkh_A 187 LPFSPDSVVTHGDFSLDNLIFDEGK---LIGCIDVGRVGIA 224 (272)
T ss_dssp CCCCCCEEEECSCCCTTSEEEETTE---EEEECCCTTCEEE
T ss_pred ccccCCcEEEcCCCCCCeEEEECCe---EEEEEECcccccC
Confidence 168999999999998765 5679999987643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.16 E-value=2.5e-07 Score=108.77 Aligned_cols=29 Identities=41% Similarity=0.631 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|+|||++|||||||||+|||||.+.
T Consensus 165 i~~aL~~LH~~~iiHrDlKp~NILl~~~~ 193 (458)
T 3rp9_A 165 LLVGVKYVHSAGILHRDLKPANCLVNQDC 193 (458)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTTC
T ss_pred HHHHHHHHHhCCcCCCCCChhhEEECCCC
Confidence 77889999999999999999999998753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=98.14 E-value=2.9e-07 Score=111.20 Aligned_cols=28 Identities=46% Similarity=0.749 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 298 i~~aL~~LH~~gIvHrDLKP~NILl~~~ 325 (543)
T 3c4z_A 298 IVSGLEHLHQRNIIYRDLKPENVLLDDD 325 (543)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred HHHHHHHHHHcCCcccCCChHHEEEeCC
Confidence 7788999999999999999999999874
|
| >1r79_A Diacylglycerol kinase, delta; C1 domain, cystein-rich zinc binding domain, structural genomics, riken structural genomics/proteomics initiative; NMR {Homo sapiens} SCOP: g.49.1.1 | Back alignment and structure |
|---|
Probab=98.11 E-value=1.2e-06 Score=79.08 Aligned_cols=55 Identities=22% Similarity=0.482 Sum_probs=50.3
Q ss_pred CCcCceeeeeecCCCccccccccchhcc-cccceecCCCCccccccccccCCCCCC
Q psy48 526 VNIPHTFNLHTYTRPTLCGLCKKLLKGL-FKQGLQCKDCGFNVHKKCLDKVPKDCV 580 (1098)
Q Consensus 526 ~~~~H~F~~~~~~~~t~C~~C~~~l~Gl-~~qG~~C~~C~~~vH~~C~~~v~~~C~ 580 (1098)
..+.|.|++.++...++|++|.+.+++. ..+|+||.+|++.||.+|...++..|.
T Consensus 24 ~~~~H~WveGNl~~~s~C~vC~k~c~s~~~L~g~rC~WCq~~VH~~C~~~~~~eC~ 79 (84)
T 1r79_A 24 IAMPHQWLEGNLPVSAKCTVCDKTCGSVLRLQDWRCLWCKAMVHTSCKESLLTKCS 79 (84)
T ss_dssp CCBCCCEEESCCCTTCBCSSSCCBCCCTTTCCCEEESSSCCEECHHHHHHCCSCBC
T ss_pred ccceeeEEccCCCCCCEeCCCCCEeCCccCCCCCCCcccChhHHHHHHHhccCcCC
Confidence 4578999999999999999999999974 559999999999999999999999994
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=98.11 E-value=3.3e-07 Score=103.40 Aligned_cols=28 Identities=43% Similarity=0.562 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+++|||++|||||||||+|||+|.+
T Consensus 123 i~~al~~lH~~~ivHrDlkp~NIll~~~ 150 (328)
T 3fe3_A 123 IVSAVQYCHQKRIVHRDLKAENLLLDAD 150 (328)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCEeccCCCHHHEEEcCC
Confidence 7889999999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=3.1e-07 Score=107.78 Aligned_cols=28 Identities=46% Similarity=0.548 Sum_probs=26.0
Q ss_pred HHHhhccccc-cccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHS-KNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~-k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||+ +|||||||||+|||||.+
T Consensus 257 i~~aL~~LH~~~giiHrDlkp~NIll~~~ 285 (446)
T 4ejn_A 257 IVSALDYLHSEKNVVYRDLKLENLMLDKD 285 (446)
T ss_dssp HHHHHHHHHHHTCCCCCCCCGGGEEECSS
T ss_pred HHHHHHHHhhcCCEEECCCCHHHEEECCC
Confidence 7889999998 999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=3.2e-07 Score=111.49 Aligned_cols=28 Identities=43% Similarity=0.579 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 295 Il~aL~yLH~~gIvHrDLKPeNILld~~ 322 (576)
T 2acx_A 295 ICCGLEDLHRERIVYRDLKPENILLDDH 322 (576)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCEeccCCchheEEEeCC
Confidence 7788999999999999999999999873
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=98.11 E-value=3.7e-07 Score=100.25 Aligned_cols=28 Identities=39% Similarity=0.638 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++|||||||||+|||+|.+
T Consensus 110 l~~~l~~lH~~~ivH~dikp~Nil~~~~ 137 (292)
T 3o0g_A 110 LLKGLGFCHSRNVLHRDLKPQNLLINRN 137 (292)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 7889999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=98.09 E-value=4e-07 Score=104.56 Aligned_cols=29 Identities=31% Similarity=0.572 Sum_probs=26.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|+|||++|||||||||+|||+|.+.
T Consensus 118 i~~~L~~LH~~~ivHrDlkp~NIll~~~~ 146 (388)
T 3oz6_A 118 LIKVIKYLHSGGLLHRDMKPSNILLNAEC 146 (388)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred HHHHHHHHHhCCEEeCCCCHHHeEEcCCC
Confidence 78899999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=6.2e-07 Score=100.34 Aligned_cols=28 Identities=21% Similarity=0.326 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 124 i~~~l~~lH~~~ivH~Dikp~Nil~~~~ 151 (325)
T 3kex_A 124 IAKGMYYLEEHGMVHRNLAARNVLLKSP 151 (325)
T ss_dssp HHHHHHHHHHTTCCCSCCSSTTEEESSS
T ss_pred HHHHHHHHHhCCCCCCccchheEEECCC
Confidence 7889999999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=4.3e-07 Score=102.04 Aligned_cols=28 Identities=46% Similarity=0.663 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 130 i~~al~~lH~~~ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 130 ISMALGHLHQKGIIYRDLKPENIMLNHQ 157 (327)
T ss_dssp HHHHHHHHHHTTCCCCCCCTTTEEECTT
T ss_pred HHHHHHHHHhCCEEcccCCHHHeEECCC
Confidence 7788999999999999999999999763
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.05 E-value=6.4e-07 Score=101.87 Aligned_cols=28 Identities=39% Similarity=0.590 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 168 i~~aL~~LH~~~ivH~Dlkp~NIll~~~ 195 (355)
T 1vzo_A 168 IVLALEHLHKLGIIYRDIKLENILLDSN 195 (355)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 7788999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=98.04 E-value=5.4e-07 Score=98.82 Aligned_cols=29 Identities=28% Similarity=0.516 Sum_probs=26.7
Q ss_pred HHHHhhccccccccccccCCCCCccCCCC
Q psy48 389 SILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 389 V~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
-++.+|.|||++||+||||||+|||+|.+
T Consensus 108 qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 136 (288)
T 1ob3_A 108 QLLNGIAYCHDRRVLHRDLKPQNLLINRE 136 (288)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred HHHHHHHHHHHCCeecCCCCHHHEEEcCC
Confidence 38889999999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.03 E-value=5.8e-07 Score=102.26 Aligned_cols=27 Identities=26% Similarity=0.609 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||||.
T Consensus 181 i~~~L~~lH~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 181 MLYMIEQVHDCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp HHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred HHHHHHHHhhCCeecCCCCHHHEEecc
Confidence 778899999999999999999999987
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=4.1e-05 Score=85.37 Aligned_cols=134 Identities=19% Similarity=0.219 Sum_probs=88.2
Q ss_pred eeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCC---Cceeeeeeee-cCCcEEEEEEecc
Q psy48 819 ALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHP---GVVNLERMFE-TPGRIFVVMEKLQ 894 (1098)
Q Consensus 819 ~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~L~~~f~-~~~~l~LVmEy~~ 894 (1098)
.++.|....+|.. +..++||+-.. ......+.+|..+|+.+.+. .+..++.+.. ..+..++||||++
T Consensus 26 ~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 26 SLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred ecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 3455655566665 57789998532 34457899999999988642 2555666653 4566889999999
Q ss_pred CchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q psy48 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK------------------------------------------- 931 (1098)
Q Consensus 895 ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~------------------------------------------- 931 (1098)
|..+..... ..++..+...++.++...|..||+.
T Consensus 97 G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 988865311 1233344444444444444444432
Q ss_pred -----------------CccccCCCCCceeecC---CCCCCcEEEeecCcccccC
Q psy48 932 -----------------NIVHCDLKPENVLLST---NSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 932 -----------------gIvHrDLKp~NILld~---~g~~~~vKL~DFGla~~~~ 966 (1098)
.++|+|+++.|||++. ++. .+.|+||+.+....
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~--~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTP--LTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCC--EEEECCCTTCEEEC
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCc--eEEEEehhhcCCCC
Confidence 3599999999999987 331 35899999887544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=6.7e-07 Score=105.86 Aligned_cols=28 Identities=43% Similarity=0.745 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||||.+
T Consensus 173 il~aL~~lH~~~iiHrDlkp~NIll~~~ 200 (464)
T 3ttj_A 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSD 200 (464)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCcccCCCChHhEEEeCC
Confidence 7788999999999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=98.01 E-value=7.6e-07 Score=96.93 Aligned_cols=28 Identities=39% Similarity=0.597 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 118 i~~~l~~LH~~~i~H~dlkp~Nili~~~ 145 (279)
T 3fdn_A 118 LANALSYCHSKRVIHRDIKPENLLLGSA 145 (279)
T ss_dssp HHHHHHHHHTTTCEECCCCGGGEEECTT
T ss_pred HHHHHHHHHhCCEecccCChHhEEEcCC
Confidence 7888999999999999999999999764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=6.8e-07 Score=100.31 Aligned_cols=28 Identities=32% Similarity=0.534 Sum_probs=26.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 114 i~~aL~~LH~~givH~Dlkp~NIll~~~ 141 (323)
T 3tki_A 114 LMAGVVYLHGIGITHRDIKPENLLLDER 141 (323)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCccccccchHHEEEeCC
Confidence 8889999999999999999999999873
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=98.00 E-value=1e-06 Score=100.60 Aligned_cols=28 Identities=39% Similarity=0.479 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||+|.+
T Consensus 125 l~~~L~~LH~~~ivH~Dlkp~Nill~~~ 152 (361)
T 3uc3_A 125 LLSGVSYCHSMQICHRDLKLENTLLDGS 152 (361)
T ss_dssp HHHHHHHHHHTTCCSCCCCGGGEEECSS
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEEcCC
Confidence 7889999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.00 E-value=1e-06 Score=100.68 Aligned_cols=27 Identities=19% Similarity=0.341 Sum_probs=24.9
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||||.
T Consensus 190 i~~aL~~LH~~~ivHrDlkp~NIll~~ 216 (367)
T 3l9p_A 190 IACGCQYLEENHFIHRDIAARNCLLTC 216 (367)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred HHHHHHHHHhCCeeCCCCChhhEEEec
Confidence 566789999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=8.4e-07 Score=102.43 Aligned_cols=32 Identities=38% Similarity=0.620 Sum_probs=29.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCCcccc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEI 421 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~~~~ 421 (1098)
++.+|.|||++|||||||||+||||+.+.+.|
T Consensus 164 i~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl 195 (390)
T 2zmd_A 164 MLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 195 (390)
T ss_dssp HHHHHHHHHTTTCCCCCCCGGGEEESSSCEEE
T ss_pred HHHHHHHHHHCCeeecCCCHHHEEEECCeEEE
Confidence 78889999999999999999999998877776
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=1e-06 Score=98.71 Aligned_cols=29 Identities=31% Similarity=0.534 Sum_probs=26.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||+|.+.
T Consensus 114 i~~~l~~LH~~~iiHrDlkp~Nill~~~~ 142 (330)
T 2izr_A 114 LISRMEYVHSKNLIYRDVKPENFLIGRPG 142 (330)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECCGG
T ss_pred HHHHHHHHHhCCeeccCCCHHHeeeccCC
Confidence 78889999999999999999999999854
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.00 E-value=8.8e-07 Score=99.95 Aligned_cols=32 Identities=38% Similarity=0.620 Sum_probs=29.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCCcccc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEI 421 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~~~~ 421 (1098)
++.+|.|||++|||||||||+|||++.+.+.|
T Consensus 117 i~~al~~lH~~~iiHrDikp~NIll~~~~~kl 148 (343)
T 3dbq_A 117 MLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 148 (343)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEEETTEEEE
T ss_pred HHHHHHHHHhCCeecCCCCcceEEEECCcEEE
Confidence 88899999999999999999999999877766
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=97.99 E-value=9.6e-07 Score=99.91 Aligned_cols=27 Identities=44% Similarity=0.614 Sum_probs=25.7
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+||||+.
T Consensus 146 i~~aL~~LH~~~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 146 ILKALNYLRKMSLTHTDLKPENILLDD 172 (360)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred HHHHHHHHHHCCeeeCCCCcccEEEcc
Confidence 788899999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=97.99 E-value=5.7e-07 Score=100.83 Aligned_cols=28 Identities=29% Similarity=0.411 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 126 i~~~l~~LH~~~ivH~Dikp~NIll~~~ 153 (327)
T 3poz_A 126 IAKGMNYLEDRRLVHRDLAARNVLVKTP 153 (327)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEEET
T ss_pred HHHHHHHHhhCCeeCCCCChheEEECCC
Confidence 7888999999999999999999999873
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=97.98 E-value=7.1e-07 Score=104.07 Aligned_cols=29 Identities=31% Similarity=0.528 Sum_probs=26.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||||.+.
T Consensus 165 i~~aL~~LH~~~ivHrDlkp~NILl~~~~ 193 (420)
T 1j1b_A 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDT 193 (420)
T ss_dssp HHHHHHHHHTTTEECSCCSGGGEEEETTT
T ss_pred HHHHHHHHHHCCccccCCChhhEEEeCCC
Confidence 67789999999999999999999999654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=9e-07 Score=98.56 Aligned_cols=28 Identities=36% Similarity=0.625 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||++.+
T Consensus 128 i~~~l~~LH~~~ivH~Dikp~NIl~~~~ 155 (311)
T 3niz_A 128 LLRGVAHCHQHRILHRDLKPQNLLINSD 155 (311)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCcccCCCchHhEEECCC
Confidence 8889999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=97.96 E-value=1e-06 Score=99.95 Aligned_cols=28 Identities=43% Similarity=0.649 Sum_probs=26.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++|||||||||+|||+|.+
T Consensus 117 i~~aL~~LH~~givH~Dlkp~NIll~~~ 144 (336)
T 3h4j_B 117 IICAIEYCHRHKIVHRDLKPENLLLDDN 144 (336)
T ss_dssp HHHHHHHHHHHTCCCCCCSTTTEEECTT
T ss_pred HHHHHHHHHHCCeEecCCchhhEEEcCC
Confidence 7889999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.96 E-value=1.2e-06 Score=97.03 Aligned_cols=29 Identities=34% Similarity=0.471 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||+|.+.
T Consensus 117 i~~al~~lH~~~ivH~dlkp~Nil~~~~~ 145 (310)
T 3s95_A 117 IASGMAYLHSMNIIHRDLNSHNCLVRENK 145 (310)
T ss_dssp HHHHHHHHHHTTEECSCCSTTSEEECTTS
T ss_pred HHHHHHHHHhCCccCCCCCcCeEEECCCC
Confidence 78889999999999999999999998743
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=97.95 E-value=1.2e-06 Score=96.65 Aligned_cols=29 Identities=14% Similarity=0.121 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||++.+.
T Consensus 138 l~~aL~~lH~~givH~Dikp~NIll~~~g 166 (286)
T 3uqc_A 138 LAAAADAAHRAGVALSIDHPSRVRVSIDG 166 (286)
T ss_dssp HHHHHHHHHHTTCCCCCCSGGGEEEETTS
T ss_pred HHHHHHHHHHCCCccCCCCcccEEEcCCC
Confidence 78889999999999999999999998643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.95 E-value=9.2e-07 Score=99.32 Aligned_cols=28 Identities=29% Similarity=0.411 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 126 i~~aL~~LH~~~ivH~Dikp~NIl~~~~ 153 (327)
T 3lzb_A 126 IAKGMNYLEDRRLVHRDLAARNVLVKTP 153 (327)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEEET
T ss_pred HHHHHHHHhhCCCcCCCCCHHHEEEcCC
Confidence 7888999999999999999999999763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=97.95 E-value=7.9e-07 Score=100.84 Aligned_cols=27 Identities=37% Similarity=0.620 Sum_probs=25.0
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.++.|||++|||||||||+|||+..
T Consensus 125 i~~al~~lH~~givHrDlkp~NIl~~~ 151 (342)
T 2qr7_A 125 ITKTVEYLHAQGVVHRDLKPSNILYVD 151 (342)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEESS
T ss_pred HHHHHHHHHHCCcEeccCCHHHEEEec
Confidence 788999999999999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.95 E-value=1.1e-06 Score=98.36 Aligned_cols=28 Identities=32% Similarity=0.528 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 109 i~~aL~~LH~~~ivH~Dikp~NIl~~~~ 136 (324)
T 3mtl_A 109 LLRGLAYCHRQKVLHRDLKPQNLLINER 136 (324)
T ss_dssp HHHHHHHHHHTTEEESSCCGGGEEECTT
T ss_pred HHHHHHHHHHCCccCCCcCHHHEEECCC
Confidence 8889999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=97.94 E-value=1.5e-06 Score=103.38 Aligned_cols=28 Identities=39% Similarity=0.566 Sum_probs=26.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++|||||||||+|||+|.+
T Consensus 125 i~~aL~~LH~~givHrDLkp~NIll~~~ 152 (476)
T 2y94_A 125 ILSGVDYCHRHMVVHRDLKPENVLLDAH 152 (476)
T ss_dssp HHHHHHHHHTTTEECSCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCCCcccccHHHEEEecC
Confidence 8889999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.94 E-value=1.3e-06 Score=97.50 Aligned_cols=28 Identities=29% Similarity=0.403 Sum_probs=26.0
Q ss_pred HHHhhcccccc---------ccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSK---------NIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k---------~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++ |||||||||+|||++.+
T Consensus 120 i~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp HHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred HHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 77889999999 99999999999999873
|
| >1a25_A CALB, protein kinase C (beta); calcium++/phospholipid binding protein, calcium-binding protein; HET: PSE; 2.70A {Rattus norvegicus} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=97.94 E-value=3.7e-07 Score=91.06 Aligned_cols=97 Identities=19% Similarity=0.175 Sum_probs=78.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCccccccccccccccCCCCCCeecccccEE--EE
Q psy48 639 THSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSESEESRVTDMSQLYQISPDEVLGSGQFGI--VY 716 (1098)
Q Consensus 639 ~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~gsFG~--v~ 716 (1098)
..+.+|||++....++.......+|++.+.+++|.|++.+.+.....+....+.+++||++.+..+++||+..+.. +.
T Consensus 48 ~~g~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~v~~~~~~~~L~i~V~d~d~~~~~~~iG~~~i~l~~l~ 127 (149)
T 1a25_A 48 PNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQ 127 (149)
T ss_dssp TTSCCCEEEEEEEESCTTCSSCEECCCCSSCSSCEEEEEEEEECCSGGGGCEEEEEEEECCSSSCCEEEEEEEEEHHHHT
T ss_pred CCCCcCeEEEEEEECCCCCcceEecceeCCCCCCcCCcEEEEEeccccCCCEEEEEEEECCCCCCCCEEEEEEEEHHHhC
Confidence 3456788877655544333456788888999999999999888776666677889999999999999999998876 55
Q ss_pred eeeehhhhhhhhhhccccc
Q psy48 717 GASMVGIFFLAALYEGVKY 735 (1098)
Q Consensus 717 k~~~~g~~~l~~~~e~~~y 735 (1098)
.+..++||.|...+.|+.|
T Consensus 128 ~~~~~~W~~L~~~~~g~~~ 146 (149)
T 1a25_A 128 KAGVDGWFKLLSQEEGEYF 146 (149)
T ss_dssp TCCEEEEEECBCHHHHTTC
T ss_pred cCccCCeEEccCCCCCccc
Confidence 6678899999999999887
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=1.1e-06 Score=102.71 Aligned_cols=28 Identities=32% Similarity=0.608 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||+|.+
T Consensus 138 il~aL~~LH~~givHrDlkp~NILl~~~ 165 (432)
T 3n9x_A 138 LLLGENFIHESGIIHRDLKPANCLLNQD 165 (432)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCCCCCCCCHHHeEECCC
Confidence 7889999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=1.1e-06 Score=97.18 Aligned_cols=28 Identities=36% Similarity=0.574 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 125 i~~~l~~lH~~~i~H~Dlkp~Nil~~~~ 152 (297)
T 3fxz_A 125 CLQALEFLHSNQVIHRDIKSDNILLGMD 152 (297)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHhCCceeCCCCHHHEEECCC
Confidence 7789999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=97.92 E-value=1.4e-06 Score=95.03 Aligned_cols=27 Identities=48% Similarity=0.794 Sum_probs=25.7
Q ss_pred HHHhhcccccc-ccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSK-NIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k-~IihRDLK~dNvLld~ 416 (1098)
++.++.|||++ ||+||||||+|||+|.
T Consensus 118 i~~~l~~lH~~~~i~H~dlkp~Nil~~~ 145 (290)
T 3fme_A 118 IVKALEHLHSKLSVIHRDVKPSNVLINA 145 (290)
T ss_dssp HHHHHHHHHHHSCCCCCCCSGGGCEECT
T ss_pred HHHHHHHHhhcCCeecCCCCHHHEEECC
Confidence 77889999999 9999999999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.91 E-value=7.9e-07 Score=98.95 Aligned_cols=28 Identities=43% Similarity=0.704 Sum_probs=25.9
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 166 i~~aL~~LH~~~ivH~Dikp~NIll~~~ 193 (311)
T 3p1a_A 166 TLLALAHLHSQGLVHLDVKPANIFLGPR 193 (311)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECGG
T ss_pred HHHHHHHHHHCCEecCCCCHHHEEECCC
Confidence 7788999999999999999999999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=1.3e-06 Score=102.17 Aligned_cols=29 Identities=48% Similarity=0.840 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+||||+.+.
T Consensus 209 i~~aL~~LH~~~ivHrDlKp~NILl~~~~ 237 (429)
T 3kvw_A 209 ILQCLDALHKNRIIHCDLKPENILLKQQG 237 (429)
T ss_dssp HHHHHHHHHHHTEECSCCSGGGEEESSTT
T ss_pred HHHHHHHHHHCCeecCCCCHHHeEEccCC
Confidence 77789999999999999999999999743
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.91 E-value=1.4e-06 Score=97.63 Aligned_cols=27 Identities=44% Similarity=0.730 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.++.|||++||+||||||+|||++.
T Consensus 111 i~~al~~lH~~givH~Dlkp~NIl~~~ 137 (321)
T 1tki_A 111 VCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred HHHHHHHHHHCCCCcCCCCHHHEEEcc
Confidence 888999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=97.91 E-value=1.2e-06 Score=101.66 Aligned_cols=27 Identities=48% Similarity=0.653 Sum_probs=25.7
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||||.
T Consensus 170 i~~aL~~LH~~~ivHrDlkp~Nill~~ 196 (400)
T 1nxk_A 170 IGEAIQYLHSINIAHRDVKPENLLYTS 196 (400)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred HHHHHHHHHHCCccccCcCcceEEEec
Confidence 778899999999999999999999997
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=1e-06 Score=96.12 Aligned_cols=29 Identities=14% Similarity=0.312 Sum_probs=26.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||++.+.
T Consensus 122 i~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 150 (289)
T 4fvq_A 122 LAAAMHFLEENTLIHGNVCAKNILLIREE 150 (289)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEEEECC
T ss_pred HHHHHHHHhhCCeECCCcCcceEEEecCC
Confidence 78899999999999999999999998744
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.91 E-value=2.1e-06 Score=95.08 Aligned_cols=32 Identities=31% Similarity=0.529 Sum_probs=28.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCCcccc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEI 421 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~~~~ 421 (1098)
++.++.|||++||+||||||+|||+|.+.+.|
T Consensus 139 i~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l 170 (319)
T 2y4i_B 139 IVKGMGYLHAKGILHKDLKSKNVFYDNGKVVI 170 (319)
T ss_dssp HHHHHHHHHHTTCCCCCCCSTTEEEC--CCEE
T ss_pred HHHHHHHHHhCCccccCCChhhEEEeCCCEEE
Confidence 78899999999999999999999999877666
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=1.3e-06 Score=97.51 Aligned_cols=29 Identities=34% Similarity=0.551 Sum_probs=26.5
Q ss_pred HHHHhhccccccccccccCCCCCccCCCC
Q psy48 389 SILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 389 V~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
-++.+|.|||++|||||||||+|||+|.+
T Consensus 116 qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~ 144 (317)
T 2pmi_A 116 QLLQGLAFCHENKILHRDLKPQNLLINKR 144 (317)
T ss_dssp HHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred HHHHHHHHHHHCCeeeCCCChHHeEEcCC
Confidence 37889999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.91 E-value=1.5e-06 Score=97.47 Aligned_cols=28 Identities=21% Similarity=0.294 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 160 i~~~L~~LH~~~ivH~Dlkp~NIll~~~ 187 (325)
T 3kul_A 160 VGAGMRYLSDLGYVHRDLAARNVLVDSN 187 (325)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCeeCCCCCcceEEECCC
Confidence 6788999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=97.90 E-value=1.2e-06 Score=97.70 Aligned_cols=29 Identities=38% Similarity=0.514 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||++.+.
T Consensus 139 i~~~l~~lH~~~ivH~Dikp~Nil~~~~~ 167 (330)
T 3nsz_A 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEH 167 (330)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred HHHHHHHHHhCCeeeCCCCHHHEEEcCCC
Confidence 78899999999999999999999998643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.90 E-value=1.2e-06 Score=103.29 Aligned_cols=27 Identities=44% Similarity=0.666 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.++.|||++|||||||||+|||++.
T Consensus 119 il~aL~~lH~~givHrDlKp~NIll~~ 145 (444)
T 3soa_A 119 ILEAVLHCHQMGVVHRNLKPENLLLAS 145 (444)
T ss_dssp HHHHHHHHHHTTCBCCCCSSTTEEESB
T ss_pred HHHHHHHHHHCCccccCCCHHHEEEec
Confidence 788999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=97.90 E-value=1.1e-06 Score=101.62 Aligned_cols=27 Identities=37% Similarity=0.582 Sum_probs=25.0
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||+|.
T Consensus 150 i~~aL~~LH~~~ivHrDlkp~Nill~~ 176 (394)
T 4e7w_A 150 LLRSLAYIHSIGICHRDIKPQNLLLDP 176 (394)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEET
T ss_pred HHHHHHHHHHCCccCCCCCHHHEEEcC
Confidence 677899999999999999999999983
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=97.89 E-value=1.8e-06 Score=94.04 Aligned_cols=28 Identities=29% Similarity=0.381 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 129 i~~~l~~lH~~~i~H~dikp~Nili~~~ 156 (283)
T 3gen_A 129 VCEAMEYLESKQFLHRDLAARNCLVNDQ 156 (283)
T ss_dssp HHHHHHHHHHTTCCCSSCSGGGEEECTT
T ss_pred HHHHHHHHHHCCccCCCCccceEEEcCC
Confidence 7788999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=1.4e-06 Score=99.66 Aligned_cols=28 Identities=43% Similarity=0.643 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++|||||||||+||||+.+
T Consensus 124 i~~aL~~LH~~givHrDlkp~NIll~~~ 151 (361)
T 2yab_A 124 ILDGVNYLHTKKIAHFDLKPENIMLLDK 151 (361)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEESCT
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEEeCC
Confidence 8889999999999999999999999764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=2.1e-06 Score=96.81 Aligned_cols=28 Identities=29% Similarity=0.466 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 133 i~~~l~~LH~~~ivH~Dlkp~NIl~~~~ 160 (351)
T 3mi9_A 133 LLNGLYYIHRNKILHRDMKAANVLITRD 160 (351)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCeeCCCCCHHHEEEcCC
Confidence 7788999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=97.88 E-value=1.9e-06 Score=101.49 Aligned_cols=28 Identities=25% Similarity=0.433 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 293 i~~~l~~LH~~~ivHrDlkp~Nill~~~ 320 (454)
T 1qcf_A 293 IAEGMAFIEQRNYIHRDLRAANILVSAS 320 (454)
T ss_dssp HHHHHHHHHHTTCCCSSCSGGGEEECTT
T ss_pred HHHHHHHHHhCCccCCCCCHHHEEECCC
Confidence 7788999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=97.86 E-value=1.5e-06 Score=95.47 Aligned_cols=28 Identities=25% Similarity=0.329 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 123 i~~~l~~lH~~~ivH~Dikp~Nil~~~~ 150 (295)
T 3ugc_A 123 ICKGMEYLGTKRYIHRDLATRNILVENE 150 (295)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEEET
T ss_pred HHHHHHHHhcCCcccCCCCHhhEEEcCC
Confidence 8889999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=1.9e-06 Score=94.43 Aligned_cols=28 Identities=39% Similarity=0.530 Sum_probs=26.1
Q ss_pred HHHhhcccc--------ccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLH--------SKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH--------~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.||| ++|||||||||+|||+|.+
T Consensus 114 i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149 (301)
T ss_dssp HHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred HHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC
Confidence 788999999 9999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.85 E-value=1.9e-06 Score=95.12 Aligned_cols=28 Identities=36% Similarity=0.536 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 111 l~~~l~~lH~~~ivH~dlkp~Nil~~~~ 138 (311)
T 4agu_A 111 TLQAVNFCHKHNCIHRDVKPENILITKH 138 (311)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCCcCCCCChhhEEEcCC
Confidence 7889999999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.85 E-value=1.7e-06 Score=99.93 Aligned_cols=27 Identities=44% Similarity=0.683 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||+|.
T Consensus 158 i~~aL~~LH~~givHrDlkp~NIll~~ 184 (387)
T 1kob_A 158 ACEGLKHMHEHSIVHLDIKPENIMCET 184 (387)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred HHHHHHHHHhCCeeecccchHHeEEec
Confidence 888999999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=1.6e-06 Score=97.19 Aligned_cols=27 Identities=30% Similarity=0.562 Sum_probs=25.5
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||++.
T Consensus 141 l~~~l~~LH~~~ivH~Dlkp~NIll~~ 167 (329)
T 3gbz_A 141 LINGVNFCHSRRCLHRDLKPQNLLLSV 167 (329)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEEC
T ss_pred HHHHHHHHHhCCEECCCCCHHHEEEec
Confidence 788899999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.85 E-value=3.1e-06 Score=93.60 Aligned_cols=28 Identities=46% Similarity=0.666 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||++.+
T Consensus 129 i~~al~~lH~~~ivH~Dlkp~Nil~~~~ 156 (308)
T 3g33_A 129 FLRGLDFLHANCIVHRDLKPENILVTSG 156 (308)
T ss_dssp HHHHHHHHHHTTCCCSCCCTTTEEECTT
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEEcCC
Confidence 8889999999999999999999999763
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=97.85 E-value=3.3e-06 Score=96.66 Aligned_cols=28 Identities=21% Similarity=0.329 Sum_probs=24.9
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 212 i~~aL~~LH~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 212 LARGMEYLASQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred HHHHHHHHHhCCeeccccchhhEEECCC
Confidence 4567899999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=97.84 E-value=1.9e-06 Score=95.05 Aligned_cols=29 Identities=41% Similarity=0.659 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.++.|||++||+||||||+|||+|.+.
T Consensus 120 i~~~l~~lH~~~i~H~Dlkp~Nil~~~~~ 148 (294)
T 4eqm_A 120 ILDGIKHAHDMRIVHRDIKPQNILIDSNK 148 (294)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEECCCC
Confidence 78899999999999999999999997643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=97.84 E-value=2.4e-06 Score=98.03 Aligned_cols=29 Identities=28% Similarity=0.309 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||+|.+.
T Consensus 156 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 184 (373)
T 2qol_A 156 IASGMKYLSDMGYVHRDLAARNILINSNL 184 (373)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred HHHHHHHHHHCCeeCCCCCcceEEEcCCC
Confidence 77889999999999999999999998753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=97.83 E-value=1.9e-06 Score=98.79 Aligned_cols=28 Identities=29% Similarity=0.405 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 137 i~~~l~~LH~~~ivHrDlkp~NIll~~~ 164 (389)
T 3gni_B 137 VLKALDYIHHMGYVHRSVKASHILISVD 164 (389)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 7788999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=97.83 E-value=2.3e-06 Score=93.47 Aligned_cols=26 Identities=35% Similarity=0.675 Sum_probs=24.6
Q ss_pred HHHhhccccccccccccCCCCCccCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFP 415 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld 415 (1098)
++.+|.|||++|||||||||+|||++
T Consensus 114 i~~~l~~LH~~~ivH~Dlkp~NIl~~ 139 (296)
T 4hgt_A 114 MISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred HHHHHHHHHHCCeecCCCCHHHeeee
Confidence 78899999999999999999999993
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=2e-06 Score=92.99 Aligned_cols=28 Identities=18% Similarity=0.282 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 115 i~~~l~~lH~~~i~H~dikp~Nil~~~~ 142 (269)
T 4hcu_A 115 VCEGMAYLEEACVIHRDLAARNCLVGEN 142 (269)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred HHHHHHHHHhCCeecCCcchheEEEcCC
Confidence 7788999999999999999999999764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=2.6e-06 Score=95.26 Aligned_cols=28 Identities=29% Similarity=0.425 Sum_probs=25.8
Q ss_pred HHHhhcccccc----------ccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSK----------NIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k----------~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++ |||||||||+|||+|.+
T Consensus 130 i~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167 (322)
T ss_dssp HHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred HHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence 67789999999 99999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=97.82 E-value=1.7e-06 Score=98.82 Aligned_cols=27 Identities=44% Similarity=0.645 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.++.|||++|||||||||+|||++.
T Consensus 137 i~~al~~lH~~~ivH~Dlkp~NIll~~ 163 (362)
T 2bdw_A 137 ILESIAYCHSNGIVHRNLKPENLLLAS 163 (362)
T ss_dssp HHHHHHHHHHTTCBCCCCSGGGEEESC
T ss_pred HHHHHHHHHHCCeEeccCchHHEEEec
Confidence 788999999999999999999999987
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=2.6e-06 Score=93.22 Aligned_cols=28 Identities=29% Similarity=0.546 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||++.+
T Consensus 115 i~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 142 (298)
T 1csn_A 115 MLARVQSIHEKSLVYRDIKPDNFLIGRP 142 (298)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEECCS
T ss_pred HHHHHHHHHhCCEecCCCCHHHEEeccC
Confidence 8889999999999999999999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=2.2e-06 Score=98.32 Aligned_cols=28 Identities=25% Similarity=0.310 Sum_probs=25.9
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 222 i~~~l~~LH~~~ivHrDlkp~Nil~~~~ 249 (377)
T 3cbl_A 222 AAAGMEYLESKCCIHRDLAARNCLVTEK 249 (377)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCcCCcccCHHHEEEcCC
Confidence 6788999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=97.81 E-value=2.2e-06 Score=102.08 Aligned_cols=26 Identities=31% Similarity=0.620 Sum_probs=24.7
Q ss_pred HHHhhccccccccccccCCCCCccCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFP 415 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld 415 (1098)
++.+|.|||++|||||||||+||||+
T Consensus 112 i~~aL~yLH~~gIvHrDIKP~NILl~ 137 (483)
T 3sv0_A 112 MINRVEFVHSKSFLHRDIKPDNFLMG 137 (483)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred HHHHHHHHHHCCEeecccCcceEEEe
Confidence 78899999999999999999999994
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=97.80 E-value=2.6e-06 Score=100.28 Aligned_cols=28 Identities=29% Similarity=0.400 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 298 i~~~l~~LH~~~ivHrDlkp~Nill~~~ 325 (450)
T 1k9a_A 298 VCEAMEYLEGNNFVHRDLAARNVLVSED 325 (450)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred HHHHHHHHHhCCeeCCCCCHhhEEECCC
Confidence 7788999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=97.80 E-value=2.8e-06 Score=92.65 Aligned_cols=28 Identities=32% Similarity=0.514 Sum_probs=25.9
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 123 i~~~l~~lH~~~i~H~dl~p~Nil~~~~ 150 (284)
T 2vgo_A 123 LADALHYCHERKVIHRDIKPENLLMGYK 150 (284)
T ss_dssp HHHHHHHHHTTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCceecCCCHHHEEEcCC
Confidence 7888999999999999999999999753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=3e-06 Score=94.91 Aligned_cols=28 Identities=43% Similarity=0.653 Sum_probs=25.9
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 133 i~~~l~~LH~~~ivH~dlkp~Nil~~~~ 160 (331)
T 4aaa_A 133 IINGIGFCHSHNIIHRDIKPENILVSQS 160 (331)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCEEccCcChheEEEcCC
Confidence 7788999999999999999999999764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=97.79 E-value=2.8e-06 Score=101.27 Aligned_cols=28 Identities=29% Similarity=0.392 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 327 i~~~L~~LH~~~ivHrDlkp~NIll~~~ 354 (495)
T 1opk_A 327 ISSAMEYLEKKNFIHRNLAARNCLVGEN 354 (495)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred HHHHHHHHHhCCcccCCCChhhEEECCC
Confidence 6778999999999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=97.79 E-value=2.5e-06 Score=92.09 Aligned_cols=28 Identities=21% Similarity=0.352 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 113 i~~~l~~lH~~~i~H~dikp~Nil~~~~ 140 (268)
T 3sxs_A 113 VCEGMAFLESHQFIHRDLAARNCLVDRD 140 (268)
T ss_dssp HHHHHHHHHHTTEEESSCSGGGEEECTT
T ss_pred HHHHHHHHHHCCeecCCcCcceEEECCC
Confidence 7889999999999999999999999764
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=97.79 E-value=3.1e-06 Score=92.83 Aligned_cols=28 Identities=39% Similarity=0.606 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||+|.+
T Consensus 112 i~~~l~~lH~~~i~H~dlkp~Nili~~~ 139 (299)
T 2r3i_A 112 LLQGLAFCHSHRVLHRDLKPQNLLINTE 139 (299)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCccCCCCCHHHeEEcCC
Confidence 7888999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.79 E-value=2.9e-06 Score=93.28 Aligned_cols=28 Identities=29% Similarity=0.551 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 146 i~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 173 (298)
T 2zv2_A 146 LIKGIEYLHYQKIIHRDIKPSNLLVGED 173 (298)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCeeccCCCHHHEEECCC
Confidence 7889999999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=97.79 E-value=3.8e-06 Score=93.51 Aligned_cols=28 Identities=29% Similarity=0.414 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||+|.+
T Consensus 148 i~~~l~~lH~~~ivH~dlkp~Nil~~~~ 175 (321)
T 2qkw_B 148 AARGLHYLHTRAIIHRDVKSINILLDEN 175 (321)
T ss_dssp HHHHHHHHHHTTEECSCCCSTTEEECTT
T ss_pred HHHHHHHhcCCCeecCCCCHHHEEECCC
Confidence 6778999999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=97.79 E-value=2.2e-06 Score=97.34 Aligned_cols=27 Identities=44% Similarity=0.674 Sum_probs=25.7
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||++.
T Consensus 139 i~~al~~lH~~~ivHrDlkp~NIl~~~ 165 (351)
T 3c0i_A 139 ILEALRYCHDNNIIHRDVKPHCVLLAS 165 (351)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECS
T ss_pred HHHHHHHHHHCCceeccCChHHeEEec
Confidence 788899999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=2.5e-06 Score=101.13 Aligned_cols=27 Identities=41% Similarity=0.709 Sum_probs=25.7
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.++.|||++|||||||||+|||+++
T Consensus 130 i~~al~~lH~~~ivH~Dlkp~Nil~~~ 156 (486)
T 3mwu_A 130 VFSGITYMHKHNIVHRDLKPENILLES 156 (486)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEESS
T ss_pred HHHHHHHHHHCCeEeccCchHHEEEec
Confidence 788999999999999999999999976
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.78 E-value=3.7e-06 Score=96.18 Aligned_cols=28 Identities=32% Similarity=0.536 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||+|.+
T Consensus 137 i~~~L~~LH~~~ivH~Dlkp~NIll~~~ 164 (367)
T 1cm8_A 137 MLKGLRYIHAAGIIHRDLKPGNLAVNED 164 (367)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCccccCcCHHHEEEcCC
Confidence 7888999999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=97.77 E-value=3.3e-06 Score=98.34 Aligned_cols=27 Identities=44% Similarity=0.780 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+||||+.
T Consensus 248 i~~~l~~LH~~~ivHrDlkp~NIll~~ 274 (419)
T 3i6u_A 248 MLLAVQYLHENGIIHRDLKPENVLLSS 274 (419)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred HHHHHHHHHHCCccccCCChHhEEEec
Confidence 788999999999999999999999976
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=97.77 E-value=3.1e-06 Score=96.72 Aligned_cols=28 Identities=43% Similarity=0.745 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||++.+
T Consensus 136 i~~al~~lH~~~ivH~Dlkp~NIl~~~~ 163 (371)
T 2xrw_A 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSD 163 (371)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCeecccCCHHHEEEcCC
Confidence 7788999999999999999999999864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=2.8e-06 Score=93.76 Aligned_cols=27 Identities=48% Similarity=0.653 Sum_probs=25.9
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||++.
T Consensus 126 i~~~l~~lH~~~i~H~dlkp~Nil~~~ 152 (299)
T 3m2w_A 126 IGEAIQYLHSINIAHRDVKPENLLYTS 152 (299)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred HHHHHHHHHhCCcccCCCCHHHEEEec
Confidence 788999999999999999999999996
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=3.3e-06 Score=96.23 Aligned_cols=29 Identities=41% Similarity=0.723 Sum_probs=26.3
Q ss_pred HHHhhcccccc-ccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSK-NIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k-~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++ |||||||||+||||+.+.
T Consensus 155 i~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp HHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred HHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 67789999999 999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=2e-06 Score=93.10 Aligned_cols=29 Identities=31% Similarity=0.534 Sum_probs=25.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||++.+.
T Consensus 124 i~~al~~lH~~~ivH~Dikp~NIl~~~~~ 152 (289)
T 1x8b_A 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTS 152 (289)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred HHHHHHHHHhCCEeecCCCHHHEEEcCCC
Confidence 78899999999999999999999999743
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=2.7e-06 Score=92.79 Aligned_cols=27 Identities=33% Similarity=0.429 Sum_probs=25.6
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++||+||||||+|||+|.
T Consensus 125 i~~~l~~lH~~~i~H~dlkp~Nil~~~ 151 (281)
T 1mp8_A 125 LSTALAYLESKRFVHRDIAARNVLVSS 151 (281)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEEE
T ss_pred HHHHHHHHHhCCeecccccHHHEEECC
Confidence 788899999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=97.76 E-value=3.9e-06 Score=91.93 Aligned_cols=29 Identities=28% Similarity=0.447 Sum_probs=26.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++||+||||||+|||+|.+.
T Consensus 129 i~~~L~~lH~~~i~H~Dlkp~Nil~~~~~ 157 (289)
T 3og7_A 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDN 157 (289)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred HHHHHHHHHhCCcccccCccceEEECCCC
Confidence 77889999999999999999999998643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=3.2e-06 Score=93.79 Aligned_cols=28 Identities=29% Similarity=0.484 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 125 i~~~l~~lH~~~ivH~dlkp~Nil~~~~ 152 (311)
T 3ork_A 125 ACQALNFSHQNGIIHRDVKPANIMISAT 152 (311)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEEETT
T ss_pred HHHHHHHHHHCCCCcCCCCHHHEEEcCC
Confidence 7888999999999999999999999763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=3.8e-06 Score=93.57 Aligned_cols=28 Identities=32% Similarity=0.488 Sum_probs=26.1
Q ss_pred HHHhhccccccc--cccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKN--IVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~--IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++| ||||||||+|||+|.+
T Consensus 146 i~~aL~~LH~~~~~ivH~Dikp~NIll~~~ 175 (309)
T 3p86_A 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVDKK 175 (309)
T ss_dssp HHHHHHHHHTSSSCCCCTTCCGGGEEECTT
T ss_pred HHHHHHHHHcCCCCEECCCCChhhEEEeCC
Confidence 777899999999 9999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.75 E-value=3.6e-06 Score=94.95 Aligned_cols=28 Identities=29% Similarity=0.452 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 139 i~~~L~~LH~~~ivH~Dlkp~NIll~~~ 166 (335)
T 3dls_A 139 LVSAVGYLRLKDIIHRDIKDENIVIAED 166 (335)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred HHHHHHHHHhCCeEEeccCHHHEEEcCC
Confidence 8889999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=97.75 E-value=3.6e-06 Score=95.68 Aligned_cols=28 Identities=50% Similarity=0.723 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||++.+
T Consensus 137 i~~aL~~LH~~~ivH~Dikp~NIl~~~~ 164 (364)
T 3qyz_A 137 ILRGLKYIHSANVLHRDLKPSNLLLNTT 164 (364)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCeecCCCChHhEEECCC
Confidence 7888999999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.75 E-value=3.3e-06 Score=95.32 Aligned_cols=28 Identities=39% Similarity=0.548 Sum_probs=26.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 121 i~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 148 (346)
T 1ua2_A 121 TLQGLEYLHQHWILHRDLKPNNLLLDEN 148 (346)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCEECCCCCHHHEEEcCC
Confidence 8889999999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=97.74 E-value=4.6e-06 Score=95.48 Aligned_cols=28 Identities=43% Similarity=0.603 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||++.+
T Consensus 141 i~~aL~~LH~~givH~Dlkp~NIll~~~ 168 (367)
T 2fst_X 141 ILRGLKYIHSADIIHRDLKPSNLAVNED 168 (367)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCeeeCCCCHhhEEECCC
Confidence 7889999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.74 E-value=4e-06 Score=98.25 Aligned_cols=27 Identities=52% Similarity=0.673 Sum_probs=25.4
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+||||+.
T Consensus 127 i~~aL~~LH~~~ivHrDlKp~NIll~~ 153 (432)
T 3p23_A 127 TTSGLAHLHSLNIVHRDLKPHNILISM 153 (432)
T ss_dssp HHHHHHHHHHTTCCCCCCSTTSEEECC
T ss_pred HHHHHHHHHHCcCEeCCCCHHHEEEec
Confidence 778899999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=4.5e-06 Score=89.75 Aligned_cols=28 Identities=14% Similarity=0.243 Sum_probs=26.4
Q ss_pred HHHhhccccccc--cccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKN--IVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~--IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++| |+||||||+|||+|.+
T Consensus 120 i~~~l~~lH~~~~~i~H~dikp~Nil~~~~ 149 (271)
T 3kmu_A 120 MARGMAFLHTLEPLIPRHALNSRSVMIDED 149 (271)
T ss_dssp HHHHHHHHTTSSSCCTTCCCSGGGEEECTT
T ss_pred HHHHHHHHhcCCCceecCCCccceEEEcCC
Confidence 788999999999 9999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=97.73 E-value=4.2e-06 Score=94.42 Aligned_cols=32 Identities=31% Similarity=0.585 Sum_probs=26.9
Q ss_pred HHHhhcccc--ccccccccCCCCCccCCC--Ccccc
Q psy48 390 ILVALKHLH--SKNIVHCDLKPERNLFPT--SSLEI 421 (1098)
Q Consensus 390 ~la~lk~LH--~k~IihRDLK~dNvLld~--~~~~~ 421 (1098)
++.++.||| ++|||||||||+|||+|. +.+.|
T Consensus 138 i~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp HHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred HHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 666789999 999999999999999985 34444
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=3.8e-06 Score=91.39 Aligned_cols=27 Identities=44% Similarity=0.645 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.++.|||++||+||||||+|||++.
T Consensus 114 i~~~l~~lH~~~i~H~dikp~Nil~~~ 140 (284)
T 3kk8_A 114 ILESIAYCHSNGIVHRNLKPENLLLAS 140 (284)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEESS
T ss_pred HHHHHHHHHHCCcCcCCCCHHHEEEec
Confidence 788999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=97.73 E-value=3.6e-06 Score=92.00 Aligned_cols=26 Identities=35% Similarity=0.675 Sum_probs=24.7
Q ss_pred HHHhhccccccccccccCCCCCccCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFP 415 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld 415 (1098)
++.+|.|||++||+||||||+|||++
T Consensus 114 i~~~l~~lH~~~ivH~dlkp~NIl~~ 139 (296)
T 3uzp_A 114 MISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred HHHHHHHHHhCCeeeCCCCHHHeEEe
Confidence 78899999999999999999999994
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=3.6e-06 Score=100.09 Aligned_cols=27 Identities=48% Similarity=0.733 Sum_probs=25.7
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||++.
T Consensus 145 i~~~l~~lH~~~ivH~Dlkp~Nil~~~ 171 (494)
T 3lij_A 145 VLSGVTYLHKHNIVHRDLKPENLLLES 171 (494)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred HHHHHHHHHHCCceeccCChhhEEEeC
Confidence 788999999999999999999999986
|
| >1r79_A Diacylglycerol kinase, delta; C1 domain, cystein-rich zinc binding domain, structural genomics, riken structural genomics/proteomics initiative; NMR {Homo sapiens} SCOP: g.49.1.1 | Back alignment and structure |
|---|
Probab=97.72 E-value=1.2e-05 Score=72.39 Aligned_cols=56 Identities=23% Similarity=0.512 Sum_probs=50.3
Q ss_pred CCCCeeeeeeccCCCCcccccccccccc-cccceecCCCCCCccccccCCcCCCCCC
Q psy48 262 VNIPHTFNLHTYTRPTLCGLCKKLLKGL-FKQGLQCKDCGFNVHKKCLDKVPKDCVG 317 (1098)
Q Consensus 262 ~~~~H~f~~~~~~~pt~C~~C~~~l~Gl-~~qG~kC~~C~~~vHkkC~~~v~~~C~~ 317 (1098)
..++|.|..-++...++|.+|.+.+++. .-+|++|..|++.||.+|..+++..|..
T Consensus 24 ~~~~H~WveGNl~~~s~C~vC~k~c~s~~~L~g~rC~WCq~~VH~~C~~~~~~eC~l 80 (84)
T 1r79_A 24 IAMPHQWLEGNLPVSAKCTVCDKTCGSVLRLQDWRCLWCKAMVHTSCKESLLTKCSG 80 (84)
T ss_dssp CCBCCCEEESCCCTTCBCSSSCCBCCCTTTCCCEEESSSCCEECHHHHHHCCSCBCC
T ss_pred ccceeeEEccCCCCCCEeCCCCCEeCCccCCCCCCCcccChhHHHHHHHhccCcCCC
Confidence 3579999999999999999999998874 3499999999999999999999999953
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.72 E-value=5.4e-06 Score=91.97 Aligned_cols=29 Identities=34% Similarity=0.480 Sum_probs=26.1
Q ss_pred HHHhhccccc---cccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHS---KNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~---k~IihRDLK~dNvLld~~~ 418 (1098)
++.++.|||+ +|||||||||+|||++.+.
T Consensus 111 i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 142 (307)
T 2eva_A 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG 142 (307)
T ss_dssp HHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT
T ss_pred HHHHHHHHHhCCCCCeecCCCChhHEEEeCCC
Confidence 5678999999 9999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=3.1e-06 Score=100.21 Aligned_cols=27 Identities=41% Similarity=0.696 Sum_probs=25.6
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.++.|||++|||||||||+|||+++
T Consensus 135 i~~~l~~lH~~~ivH~Dlkp~Nil~~~ 161 (484)
T 3nyv_A 135 VLSGITYMHKNKIVHRDLKPENLLLES 161 (484)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred HHHHHHHHHHCCeeeCCCCHHHEEEec
Confidence 888999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=4.4e-06 Score=94.00 Aligned_cols=28 Identities=43% Similarity=0.650 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||++.+
T Consensus 121 i~~~L~~LH~~~ivH~Dlkp~Nil~~~~ 148 (353)
T 2b9h_A 121 TLRAVKVLHGSNVIHRDLKPSNLLINSN 148 (353)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCeecCCCCHHHeEEcCC
Confidence 7888999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=4.4e-06 Score=90.94 Aligned_cols=28 Identities=32% Similarity=0.326 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||++.+
T Consensus 122 i~~~l~~lH~~~i~H~dlkp~Nil~~~~ 149 (281)
T 3cc6_A 122 ICKAMAYLESINCVHRDIAVRNILVASP 149 (281)
T ss_dssp HHHHHHHHHHTTCCCCCCSGGGEEEEET
T ss_pred HHHHHHHHHHCCcccCCCccceEEECCC
Confidence 7888999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=97.71 E-value=3.5e-06 Score=92.31 Aligned_cols=27 Identities=48% Similarity=0.752 Sum_probs=25.2
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||++.
T Consensus 133 i~~~L~~LH~~~ivH~dikp~NIl~~~ 159 (285)
T 3is5_A 133 MMNALAYFHSQHVVHKDLKPENILFQD 159 (285)
T ss_dssp HHHHHHHHHHTTCCCCCCSGGGEEESS
T ss_pred HHHHHHHHHhCCEEECCCCHHHEEEec
Confidence 778899999999999999999999964
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=3.8e-06 Score=93.04 Aligned_cols=32 Identities=38% Similarity=0.620 Sum_probs=29.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCCcccc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSLEI 421 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~~~~ 421 (1098)
++.+|.|||++||+||||||+|||++.+.+.|
T Consensus 136 i~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL 167 (313)
T 3cek_A 136 MLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 167 (313)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEEETTEEEE
T ss_pred HHHHHHHHHHCCceecCCCcccEEEECCeEEE
Confidence 78889999999999999999999998877776
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.71 E-value=4.4e-06 Score=91.80 Aligned_cols=29 Identities=41% Similarity=0.631 Sum_probs=26.6
Q ss_pred HHHHhhccccccccccccCCCCCccCCCC
Q psy48 389 SILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 389 V~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
-++.+|.|||++||+||||||+|||++.+
T Consensus 117 qi~~al~~LH~~~i~H~dlkp~NIl~~~~ 145 (305)
T 2wtk_C 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTG 145 (305)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred HHHHHHHHHHHCCeeecCCCcccEEEcCC
Confidence 38889999999999999999999999764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.71 E-value=4.3e-06 Score=90.76 Aligned_cols=28 Identities=32% Similarity=0.470 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 121 i~~~l~~lH~~~i~H~dl~p~Nili~~~ 148 (278)
T 3cok_A 121 IITGMLYLHSHGILHRDLTLSNLLLTRN 148 (278)
T ss_dssp HHHHHHHHHHTTEECSSCCGGGEEECTT
T ss_pred HHHHHHHHHHCCeecCCCCHHHEEEcCC
Confidence 8889999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.70 E-value=3.9e-06 Score=94.08 Aligned_cols=28 Identities=43% Similarity=0.558 Sum_probs=26.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||++.+
T Consensus 123 i~~al~~lH~~~ivH~Dlkp~NIll~~~ 150 (326)
T 2y0a_A 123 ILNGVYYLHSLQIAHFDLKPENIMLLDR 150 (326)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESCS
T ss_pred HHHHHHHHHHCCeEcCCCCHHHEEEecC
Confidence 8889999999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.70 E-value=4.7e-06 Score=94.53 Aligned_cols=27 Identities=56% Similarity=0.773 Sum_probs=25.5
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||++.
T Consensus 157 i~~~L~~LH~~~ivH~Dikp~NIll~~ 183 (349)
T 2w4o_A 157 ILEAVAYLHENGIVHRDLKPENLLYAT 183 (349)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEESS
T ss_pred HHHHHHHHHHCCeEecCCCcccEEEec
Confidence 788899999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=4.2e-06 Score=92.91 Aligned_cols=27 Identities=44% Similarity=0.695 Sum_probs=25.9
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||++.
T Consensus 127 i~~~l~~lH~~~ivH~Dlkp~Nil~~~ 153 (339)
T 1z57_A 127 ICKSVNFLHSNKLTHTDLKPENILFVQ 153 (339)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred HHHHHHHHHHCCCcCCCCCHHHEEEec
Confidence 888999999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=97.70 E-value=5.7e-06 Score=91.53 Aligned_cols=28 Identities=46% Similarity=0.637 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||++.+
T Consensus 120 i~~~l~~lH~~~ivH~dlkp~Nil~~~~ 147 (316)
T 2ac3_A 120 VASALDFLHNKGIAHRDLKPENILCEHP 147 (316)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEESCS
T ss_pred HHHHHHHHHhCCceeCCCCHHHEEEccC
Confidence 7889999999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=97.70 E-value=4.6e-06 Score=90.87 Aligned_cols=28 Identities=32% Similarity=0.421 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 120 i~~~l~~lH~~~i~H~dikp~Nil~~~~ 147 (288)
T 3kfa_A 120 ISSAMEYLEKKNFIHRDLAARNCLVGEN 147 (288)
T ss_dssp HHHHHHHHHHHTCCCSCCSGGGEEECGG
T ss_pred HHHHHHHHHHCCccCCCCCcceEEEcCC
Confidence 7888999999999999999999999764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=4.9e-06 Score=90.40 Aligned_cols=28 Identities=29% Similarity=0.400 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 126 i~~~l~~lH~~~i~H~dlkp~Nil~~~~ 153 (278)
T 1byg_A 126 VCEAMEYLEGNNFVHRDLAARNVLVSED 153 (278)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred HHHHHHHHHhCCccccCCCcceEEEeCC
Confidence 7778999999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.69 E-value=5.5e-06 Score=95.08 Aligned_cols=28 Identities=29% Similarity=0.427 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 201 i~~aL~~LH~~~ivHrDlkp~NIll~~~ 228 (373)
T 3c1x_A 201 VAKGMKFLASKKFVHRDLAARNCMLDEK 228 (373)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCEecCccchheEEECCC
Confidence 7888999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=97.69 E-value=6e-06 Score=92.15 Aligned_cols=27 Identities=33% Similarity=0.543 Sum_probs=25.4
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||+|.
T Consensus 158 i~~~L~~LH~~~ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 158 VLEAVRHCHNCGVLHRDIKDENILIDL 184 (320)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred HHHHHHHHHHCCcEeCCCCHHHEEEeC
Confidence 788899999999999999999999984
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=9.8e-06 Score=88.32 Aligned_cols=27 Identities=26% Similarity=0.524 Sum_probs=25.6
Q ss_pred HHHhhccccccc--cccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKN--IVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~--IihRDLK~dNvLld~ 416 (1098)
++.++.|||++| ||||||||+|||++.
T Consensus 131 l~~~l~~lH~~~~~ivH~dikp~Nil~~~ 159 (287)
T 4f0f_A 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQS 159 (287)
T ss_dssp HHHHHHHHHTSSSCCBCSCCSGGGEEESC
T ss_pred HHHHHHHHHhCCCCeecCCCCcceEEEec
Confidence 778899999999 999999999999986
|
| >3fbk_A RGS3, RGP3, regulator of G-protein signaling 3; all beta-sheet fold, structural genomics, PSI-2, protein structure initiative; 2.00A {Homo sapiens} SCOP: b.7.1.0 | Back alignment and structure |
|---|
Probab=97.69 E-value=1.1e-06 Score=88.01 Aligned_cols=96 Identities=11% Similarity=0.077 Sum_probs=76.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCccccccccccccccCCCC-CCeecccccEE--EE
Q psy48 640 HSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSESEESRVTDMSQLYQISP-DEVLGSGQFGI--VY 716 (1098)
Q Consensus 640 ~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~lG~gsFG~--v~ 716 (1098)
.+.+|||++....+......+.+|.+.+.+++|.|++.+.|.....+....+.+++||++.+.. +++||+..+.. +.
T Consensus 44 ~g~~Dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~v~~~~~~~~L~i~V~d~d~~~~~d~~lG~~~i~l~~l~ 123 (153)
T 3fbk_A 44 PGTCDPYVKISLIPEDSRLRHQKTQTVPDCRDPAFHEHFFFPVQEEDDQKRLLVTVWNRASQSRQSGLIGCMSFGVKSLL 123 (153)
T ss_dssp SSCCCEEEEEEEESCSCCTTCEECCCCTTCSSCEEEEEEEEECCGGGTTSEEEEEEEECCSSGGGCEEEEEEEEEHHHHT
T ss_pred CCCCCEEEEEEEEcCCCCccEEeccccCCCCCCccccEEEEecccHHhCCEEEEEEEeCCCCCCCCcEEEEEEEEHHHhc
Confidence 3678899887666655455667888899999999999998887656665668899999999887 89999998886 33
Q ss_pred --eeeehhhhhhhhhhccccc
Q psy48 717 --GASMVGIFFLAALYEGVKY 735 (1098)
Q Consensus 717 --k~~~~g~~~l~~~~e~~~y 735 (1098)
.....+||.|...++|.+.
T Consensus 124 ~~~~~~~~W~~L~~~~~g~~~ 144 (153)
T 3fbk_A 124 TPDKEISGWYYLLGEHLGRTK 144 (153)
T ss_dssp C--CCEEEEEECBCTTGGGTC
T ss_pred CCCCccccEEECCChhhcccc
Confidence 3678899999999998765
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=4.8e-06 Score=93.23 Aligned_cols=28 Identities=46% Similarity=0.724 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||++.+
T Consensus 132 i~~~L~~lH~~~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 132 LCHALRFLHENQLTHTDLKPENILFVNS 159 (355)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEESCC
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEEecc
Confidence 7888999999999999999999999763
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=97.67 E-value=4.8e-06 Score=91.32 Aligned_cols=28 Identities=29% Similarity=0.402 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 137 l~~~l~~lH~~~i~H~dikp~Nil~~~~ 164 (298)
T 3f66_A 137 VAKGMKYLASKKFVHRDLAARNCMLDEK 164 (298)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred HHHHHHHHHhCCccCCCCchheEEECCC
Confidence 7888999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=5.5e-06 Score=94.09 Aligned_cols=28 Identities=36% Similarity=0.513 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 163 i~~aL~~LH~~~ivH~Dlkp~NIll~~~ 190 (348)
T 1u5q_A 163 ALQGLAYLHSHNMIHRDVKAGNILLSEP 190 (348)
T ss_dssp HHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred HHHHHHHHHhCCeeeCCCCHHHEEECCC
Confidence 7788999999999999999999999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=5e-06 Score=89.42 Aligned_cols=28 Identities=18% Similarity=0.282 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 113 i~~~l~~lH~~~i~H~dl~p~Nili~~~ 140 (267)
T 3t9t_A 113 VCEGMAYLEEACVIHRDLAARNCLVGEN 140 (267)
T ss_dssp HHHHHHHHHHTTCCCSSCCGGGEEECGG
T ss_pred HHHHHHHHHhCCcccCCCchheEEECCC
Confidence 7889999999999999999999999764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=97.65 E-value=6.4e-06 Score=93.23 Aligned_cols=28 Identities=32% Similarity=0.528 Sum_probs=25.6
Q ss_pred HHHhhcccccc-ccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSK-NIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k-~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++ |||||||||+|||+|.+
T Consensus 140 i~~~l~~lh~~~~i~H~dlkp~Nil~~~~ 168 (360)
T 3eqc_A 140 VIKGLTYLREKHKIMHRDVKPSNILVNSR 168 (360)
T ss_dssp HHHHHHHHHHHHCCCCSCCSGGGEEECTT
T ss_pred HHHHHHHHHHhCCEEcCCccHHHEEECCC
Confidence 77889999997 99999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=6.7e-06 Score=91.79 Aligned_cols=28 Identities=21% Similarity=0.324 Sum_probs=25.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 151 i~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 151 VARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred HHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 4567899999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.64 E-value=7.9e-06 Score=90.05 Aligned_cols=28 Identities=43% Similarity=0.655 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||+|..
T Consensus 129 i~~~l~~lH~~~i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 129 LLRGLKYIHSANVLHRDLKPANLFINTE 156 (320)
T ss_dssp HHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred HHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 8889999999999999999999999853
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=97.64 E-value=4.3e-06 Score=90.37 Aligned_cols=28 Identities=32% Similarity=0.534 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||++.+
T Consensus 114 i~~~l~~lH~~~i~H~dl~p~Nil~~~~ 141 (276)
T 2yex_A 114 LMAGVVYLHGIGITHRDIKPENLLLDER 141 (276)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred HHHHHHHHHhCCeeccCCChHHEEEccC
Confidence 8889999999999999999999999873
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=7.6e-06 Score=99.42 Aligned_cols=31 Identities=23% Similarity=0.334 Sum_probs=28.0
Q ss_pred hHHHHhhccccccccccccCCCCCccCCCCc
Q psy48 388 RSILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 388 KV~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
+-++.+|.|+|++|||||||||+|||||.+.
T Consensus 346 ~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg 376 (569)
T 4azs_A 346 GSLLRSLAALEKQGFWHDDVRPWNVMVDARQ 376 (569)
T ss_dssp HHHHHHHHHHHHTTCEESCCCGGGEEECTTS
T ss_pred HHHHHHHHHHHHCCceeccCchHhEEECCCC
Confidence 4589999999999999999999999998643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=97.64 E-value=7e-06 Score=91.05 Aligned_cols=28 Identities=36% Similarity=0.449 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 143 i~~~l~~lH~~~i~H~dlkp~NIl~~~~ 170 (309)
T 2h34_A 143 IGSALDAAHAAGATHRDVKPENILVSAD 170 (309)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred HHHHHHHHHHCcCCcCCCChHHEEEcCC
Confidence 7888999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=6.3e-06 Score=89.22 Aligned_cols=28 Identities=43% Similarity=0.589 Sum_probs=26.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 120 i~~~l~~lH~~~i~H~dl~p~Nil~~~~ 147 (276)
T 2h6d_A 120 ILSAVDYCHRHMVVHRDLKPENVLLDAH 147 (276)
T ss_dssp HHHHHHHHHHHCSSCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCCccCCCChhhEEECCC
Confidence 7888999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=9.2e-06 Score=88.90 Aligned_cols=28 Identities=29% Similarity=0.436 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 130 i~~~l~~lH~~~i~H~dl~p~Nil~~~~ 157 (303)
T 2vwi_A 130 VLEGLEYLHKNGQIHRDVKAGNILLGED 157 (303)
T ss_dssp HHHHHHHHHHTTCCCCCCSGGGEEECTT
T ss_pred HHHHHHHHHhCCCCCCCCChhhEEEcCC
Confidence 6788999999999999999999999863
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=7.6e-06 Score=91.07 Aligned_cols=28 Identities=29% Similarity=0.389 Sum_probs=26.0
Q ss_pred HHHhhcccccc---ccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSK---NIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k---~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++ |||||||||+|||+|.+
T Consensus 140 i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp HHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence 66789999999 99999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=97.63 E-value=6.3e-06 Score=89.46 Aligned_cols=28 Identities=21% Similarity=0.418 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||+|.+
T Consensus 118 i~~~l~~lH~~~i~H~dikp~Nil~~~~ 145 (279)
T 1qpc_A 118 IAEGMAFIEERNYIHRDLRAANILVSDT 145 (279)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCeeccCCCHhhEEEcCC
Confidence 7888999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=8.5e-06 Score=89.41 Aligned_cols=28 Identities=46% Similarity=0.624 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||+|.+
T Consensus 126 i~~~l~~lH~~~i~H~dlkp~Nil~~~~ 153 (302)
T 2j7t_A 126 MLEALNFLHSKRIIHRDLKAGNVLMTLE 153 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCSGGGEEECTT
T ss_pred HHHHHHHHhcCCcccCCCCHHHEEECCC
Confidence 7788999999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.62 E-value=7.7e-06 Score=90.33 Aligned_cols=28 Identities=36% Similarity=0.532 Sum_probs=25.5
Q ss_pred HHHhhcccccc-ccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSK-NIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k-~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++ ||+||||||+|||+|.+
T Consensus 133 i~~~l~~lH~~~~i~H~dlkp~Nil~~~~ 161 (318)
T 2dyl_A 133 IVKALYYLKEKHGVIHRDVKPSNILLDER 161 (318)
T ss_dssp HHHHHHHHHHHHCCCCCCCCGGGEEECTT
T ss_pred HHHHHHHHHhhCCEEeCCCCHHHEEECCC
Confidence 77889999996 99999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.62 E-value=5.4e-06 Score=92.35 Aligned_cols=28 Identities=36% Similarity=0.507 Sum_probs=25.8
Q ss_pred HHHhhcccccc--------ccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSK--------NIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k--------~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++ |||||||||+|||+|.+
T Consensus 143 i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp HHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred HHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 77889999999 99999999999999764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=97.62 E-value=7.3e-06 Score=88.43 Aligned_cols=27 Identities=33% Similarity=0.466 Sum_probs=25.6
Q ss_pred HHHhhccccccc---cccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKN---IVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~---IihRDLK~dNvLld~ 416 (1098)
++.++.|||++| |+||||||+|||++.
T Consensus 114 l~~~l~~lH~~~~~~i~H~dikp~Nil~~~ 143 (271)
T 3dtc_A 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQ 143 (271)
T ss_dssp HHHHHHHHHHSSSSCCCCSCCSGGGEEESS
T ss_pred HHHHHHHHHhCCCCceeecCCchHHEEEec
Confidence 788999999999 999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=6.7e-06 Score=92.01 Aligned_cols=28 Identities=32% Similarity=0.578 Sum_probs=25.9
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||+|.+
T Consensus 150 i~~~L~~LH~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 150 VLQALAYLHAQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 7778999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=5.8e-06 Score=92.09 Aligned_cols=28 Identities=43% Similarity=0.755 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||++.+
T Consensus 123 i~~~l~~lH~~~ivH~dlkp~NIl~~~~ 150 (322)
T 2ycf_A 123 MLLAVQYLHENGIIHRDLKPENVLLSSQ 150 (322)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEESSS
T ss_pred HHHHHHHHHHCCeeccCCCHHHEEEecC
Confidence 8889999999999999999999999873
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=9.6e-06 Score=88.96 Aligned_cols=28 Identities=29% Similarity=0.352 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 135 i~~~l~~lH~~~i~H~dikp~Nil~~~~ 162 (302)
T 4e5w_A 135 ICKGMDYLGSRQYVHRDLAARNVLVESE 162 (302)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred HHHHHHHhhcCCcccCCCchheEEEcCC
Confidence 7889999999999999999999999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=97.61 E-value=8e-06 Score=93.29 Aligned_cols=28 Identities=39% Similarity=0.548 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||++.+
T Consensus 153 i~~aL~~LH~~~ivH~Dikp~NIll~~~ 180 (371)
T 4exu_A 153 MLKGLKYIHSAGVVHRDLKPGNLAVNED 180 (371)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCCcCCCcCHHHeEECCC
Confidence 7888999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=6.2e-06 Score=92.68 Aligned_cols=28 Identities=25% Similarity=0.434 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+|||||++|||+|.+
T Consensus 150 i~~aL~~LH~~~ivH~dlkp~NIl~~~~ 177 (335)
T 2owb_A 150 IVLGCQYLHRNRVIHRDLKLGNLFLNED 177 (335)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCCEecCCCchhEEEcCC
Confidence 7888999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=97.60 E-value=7.2e-06 Score=96.47 Aligned_cols=28 Identities=25% Similarity=0.310 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 289 i~~~l~~LH~~~ivHrDlkp~Nill~~~ 316 (452)
T 1fmk_A 289 IASGMAYVERMNYVHRDLRAANILVGEN 316 (452)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred HHHHHHHHHhCCeeCCCCChhhEEECCC
Confidence 7788999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.59 E-value=9.8e-06 Score=91.03 Aligned_cols=28 Identities=32% Similarity=0.386 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||+|.+
T Consensus 156 i~~aL~~LH~~~ivH~Dikp~NIl~~~~ 183 (333)
T 1mqb_A 156 IAAGMKYLANMNYVHRDLAARNILVNSN 183 (333)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred HHHHHHHHHhCCeeCCCCChheEEECCC
Confidence 7788999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=9.3e-06 Score=93.03 Aligned_cols=27 Identities=44% Similarity=0.691 Sum_probs=23.9
Q ss_pred HHHhhcccc--ccccccccCCCCCccCCC
Q psy48 390 ILVALKHLH--SKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH--~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.||| ++|||||||||+||||+.
T Consensus 166 i~~al~~lH~~~~~ivHrDlkp~NIll~~ 194 (382)
T 2vx3_A 166 MCTALLFLATPELSIIHCDLKPENILLCN 194 (382)
T ss_dssp HHHHHHHHTSTTTCEECCCCSGGGEEESS
T ss_pred HHHHHHHhccCCCCEEcCCCCcccEEEec
Confidence 677899999 589999999999999964
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=97.59 E-value=6.2e-06 Score=91.87 Aligned_cols=29 Identities=41% Similarity=0.631 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++||+||||||+|||++.+.
T Consensus 124 i~~aL~~lH~~~ivH~dikp~NIl~~~~~ 152 (321)
T 2a2a_A 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKN 152 (321)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEESCTT
T ss_pred HHHHHHHHHhCCeecCCCChHHEEEecCC
Confidence 78899999999999999999999998743
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=8.3e-06 Score=100.74 Aligned_cols=28 Identities=32% Similarity=0.425 Sum_probs=25.9
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 500 i~~aL~~LH~~givHrDikp~NILl~~~ 527 (656)
T 2j0j_A 500 LSTALAYLESKRFVHRDIAARNVLVSSN 527 (656)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEEET
T ss_pred HHHHHHHHHhCCccccccchHhEEEeCC
Confidence 7788999999999999999999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=97.59 E-value=7.8e-06 Score=98.44 Aligned_cols=28 Identities=25% Similarity=0.310 Sum_probs=25.9
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||||||||++|||+|.+
T Consensus 372 i~~~L~~LH~~~ivHrDlkp~NIll~~~ 399 (535)
T 2h8h_A 372 IASGMAYVERMNYVHRDLRAANILVGEN 399 (535)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred HHHHHHHHHhCCeeCCCCCHhhEEEcCC
Confidence 7778999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=97.59 E-value=9.1e-06 Score=96.88 Aligned_cols=28 Identities=46% Similarity=0.673 Sum_probs=26.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||++.+
T Consensus 155 i~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 155 ILSGICYLHKHNIVHRDIKPENILLENK 182 (504)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEESST
T ss_pred HHHHHHHHHHCCeEeCCCcHHHEEEecC
Confidence 7889999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=9.2e-06 Score=91.48 Aligned_cols=27 Identities=48% Similarity=0.736 Sum_probs=25.6
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++||+||||||+|||++.
T Consensus 137 l~~~l~~LH~~~ivH~dlkp~NIll~~ 163 (336)
T 3fhr_A 137 IGTAIQFLHSHNIAHRDVKPENLLYTS 163 (336)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEEEe
Confidence 788899999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=97.58 E-value=8.5e-06 Score=88.78 Aligned_cols=28 Identities=29% Similarity=0.393 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||+|.+
T Consensus 130 i~~~l~~lH~~~i~H~dikp~Nili~~~ 157 (291)
T 1u46_A 130 VAEGMGYLESKRFIHRDLAARNLLLATR 157 (291)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEEEET
T ss_pred HHHHHHHHHhCCcccCCCchheEEEcCC
Confidence 7888999999999999999999999763
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=97.58 E-value=4.4e-06 Score=93.73 Aligned_cols=28 Identities=43% Similarity=0.761 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++|||||||||+|||++.+
T Consensus 115 i~~~l~~LH~~~ivH~Dlkp~NIll~~~ 142 (325)
T 3kn6_A 115 LVSAVSHMHDVGVVHRDLKPENLLFTDE 142 (325)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEEEC-
T ss_pred HHHHHHHHHHCCCeecCCCHHHEEEecC
Confidence 8889999999999999999999999763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.57 E-value=8.3e-06 Score=90.24 Aligned_cols=28 Identities=36% Similarity=0.520 Sum_probs=25.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||++.+
T Consensus 143 i~~~L~~LH~~~ivH~dlkp~NIl~~~~ 170 (317)
T 2buj_A 143 ICRGLEAIHAKGYAHRDLKPTNILLGDE 170 (317)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred HHHHHHHHHhCCcccCCCCHHHEEEcCC
Confidence 7788999999999999999999999763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.57 E-value=7.8e-06 Score=90.91 Aligned_cols=25 Identities=28% Similarity=0.547 Sum_probs=24.2
Q ss_pred HHHhhccccccccccccCCCCCccC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLF 414 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLl 414 (1098)
++.+|.|||++|||||||||+|||+
T Consensus 121 i~~~L~~LH~~~ivH~Dlkp~NIll 145 (319)
T 4euu_A 121 VVGGMNHLRENGIVHRNIKPGNIMR 145 (319)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred HHHHHHHHHHCCEecCCCCHHHEEE
Confidence 7889999999999999999999998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=7.4e-06 Score=89.75 Aligned_cols=28 Identities=25% Similarity=0.434 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+|||||++|||+|.+
T Consensus 124 i~~~l~~lH~~~i~H~dl~p~Nil~~~~ 151 (294)
T 2rku_A 124 IVLGCQYLHRNRVIHRDLKLGNLFLNED 151 (294)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCccccCCChHhEEEcCC
Confidence 7888999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=1.1e-05 Score=89.17 Aligned_cols=28 Identities=32% Similarity=0.691 Sum_probs=25.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||+|.+
T Consensus 145 i~~~l~~LH~~~i~H~dl~p~NIl~~~~ 172 (310)
T 2wqm_A 145 LCSALEHMHSRRVMHRDIKPANVFITAT 172 (310)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred HHHHHHHHhhCCeeCCCCcHHHEEEcCC
Confidence 6778999999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=7.8e-06 Score=91.25 Aligned_cols=28 Identities=29% Similarity=0.344 Sum_probs=25.9
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 136 i~~al~~lH~~~ivH~Dikp~NIl~~~~ 163 (327)
T 3lxl_A 136 ICKGMEYLGSRRCVHRDLAARNILVESE 163 (327)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred HHHHHHHHHhCCccCCCCChhhEEECCC
Confidence 7888999999999999999999999653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=1e-05 Score=90.09 Aligned_cols=28 Identities=39% Similarity=0.635 Sum_probs=25.5
Q ss_pred HHHhhcccccc-ccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSK-NIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k-~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++ ||+||||||+|||+|.+
T Consensus 134 i~~~l~~lH~~~~ivH~dlkp~NIll~~~ 162 (327)
T 3aln_A 134 TVKALNHLKENLKIIHRDIKPSNILLDRS 162 (327)
T ss_dssp HHHHHHHHHHHHSCCCSCCCGGGEEEETT
T ss_pred HHHHHHHHhccCCEeECCCCHHHEEEcCC
Confidence 67789999999 99999999999999763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.51 E-value=1.5e-05 Score=88.13 Aligned_cols=28 Identities=32% Similarity=0.377 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++||+||||||+|||+|.+
T Consensus 134 i~~~l~~lH~~~i~H~dl~p~Nil~~~~ 161 (314)
T 3com_A 134 TLKGLEYLHFMRKIHRDIKAGNILLNTE 161 (314)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHhCCCcCCCcCHHHEEECCC
Confidence 7788999999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.51 E-value=1.3e-05 Score=90.51 Aligned_cols=28 Identities=39% Similarity=0.548 Sum_probs=26.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++||+||||||+|||+|.+
T Consensus 135 i~~al~~LH~~~ivH~dlkp~NIl~~~~ 162 (353)
T 3coi_A 135 MLKGLKYIHSAGVVHRDLKPGNLAVNED 162 (353)
T ss_dssp HHHHHHHHHHTTCCCSSCCGGGEEECTT
T ss_pred HHHHHHHHHHCCcccCCCCHHHEeECCC
Confidence 8889999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=1.1e-05 Score=87.43 Aligned_cols=25 Identities=48% Similarity=0.697 Sum_probs=24.3
Q ss_pred HHHhhccccccccccccCCCCCccC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLF 414 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLl 414 (1098)
++.++.|||++||+||||||+|||+
T Consensus 115 i~~~l~~lH~~~i~H~dlkp~Nil~ 139 (277)
T 3f3z_A 115 VLSAVAYCHKLNVAHRDLKPENFLF 139 (277)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HHHHHHHHHHCCccCCCCCHHHEEE
Confidence 8889999999999999999999999
|
| >1v27_A Regulating synaptic membrane exocytosis protein 2; RAB3-interacting molecule, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=97.51 E-value=2.4e-05 Score=76.63 Aligned_cols=96 Identities=11% Similarity=0.061 Sum_probs=72.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcC-CCCc-cccccccccccccCCCC--CCeecccccE
Q psy48 638 DTHSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCE-DVSE-SEESRVTDMSQLYQISP--DEVLGSGQFG 713 (1098)
Q Consensus 638 ~~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~--~~~lG~gsFG 713 (1098)
+..+.+|||++....++.......+|++.+.+++|.|++.+.+.. ...+ ....+.+++||++.+.. +++||+..+.
T Consensus 37 d~~g~~dpyv~v~~~~~~~~~~~~kT~~~~~t~nP~wne~f~f~~~~~~~~~~~~l~i~V~d~d~~~~~~~~~lG~~~i~ 116 (141)
T 1v27_A 37 EDGRPRNPYVKIYFLPDRSDKNKRRTKTVKKTLEPKWNQTFIYSPVHRREFRERMLEITLWDQARVREEESEFLGEILIE 116 (141)
T ss_dssp SSSCCCCEEEECCCSSCCSSSSCCBCCCCSSCSSCCCCCCCEECSCCTTGGGTCEEEEEEEEBCSSSSCCBCCCEEEEEE
T ss_pred CCCCCCCCEEEEEEecCCCCCcceeCccccCCCCCccccEEEEccCCHHHhcCCEEEEEEEECCCCcCCCCceEEEEEEE
Confidence 345677888887776655445677888999999999999998873 3222 34577888999999987 9999998877
Q ss_pred E--EEeeeehhhhhhhhhhccc
Q psy48 714 I--VYGASMVGIFFLAALYEGV 733 (1098)
Q Consensus 714 ~--v~k~~~~g~~~l~~~~e~~ 733 (1098)
. +.......||.|...++|.
T Consensus 117 l~~l~~~~~~~W~~L~~~~~g~ 138 (141)
T 1v27_A 117 LETALLDDEPHWYKLQTHDSGP 138 (141)
T ss_dssp GGGCCCSSEEEEEECBCCSSCC
T ss_pred ccccCCCCCCceEECcccccCC
Confidence 5 4444567899888777663
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=1.7e-05 Score=88.54 Aligned_cols=27 Identities=19% Similarity=0.341 Sum_probs=25.2
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++||+||||||+|||++.
T Consensus 149 i~~al~~LH~~~i~H~dlkp~NIli~~ 175 (327)
T 2yfx_A 149 IACGCQYLEENHFIHRDIAARNCLLTC 175 (327)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred HHHHHHHHhhCCeecCcCCHhHEEEec
Confidence 677899999999999999999999985
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1098 | ||||
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-61 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 0.002 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-05 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-05 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-04 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-04 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-54 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 0.002 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 0.001 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 0.001 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 0.002 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-54 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-53 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 0.001 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-53 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 0.001 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-04 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-46 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-46 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-04 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-46 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 0.003 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-04 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-04 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-45 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-04 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 0.002 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-41 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-39 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-39 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 0.004 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-04 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-34 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 0.001 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-32 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-25 | |
| d1xa6a3 | 62 | g.49.1.1 (A:209-270) Beta-chimaerin, middle domain | 4e-19 | |
| d1xa6a3 | 62 | g.49.1.1 (A:209-270) Beta-chimaerin, middle domain | 4e-19 | |
| d1ptqa_ | 50 | g.49.1.1 (A:) Protein kinase C-delta (PKCdelta) {M | 7e-19 | |
| d1ptqa_ | 50 | g.49.1.1 (A:) Protein kinase C-delta (PKCdelta) {M | 7e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 0.004 | |
| d1tbna_ | 66 | g.49.1.1 (A:) Protein kinase c-gamma {Rat (Rattus | 9e-18 | |
| d1tbna_ | 66 | g.49.1.1 (A:) Protein kinase c-gamma {Rat (Rattus | 9e-18 | |
| d1tbna_ | 66 | g.49.1.1 (A:) Protein kinase c-gamma {Rat (Rattus | 5e-04 | |
| d1r79a_ | 84 | g.49.1.1 (A:) Diacylglycerol kinase delta {Human ( | 2e-17 | |
| d1r79a_ | 84 | g.49.1.1 (A:) Diacylglycerol kinase delta {Human ( | 2e-17 | |
| d1faqa_ | 52 | g.49.1.1 (A:) RAF-1 {Human (Homo sapiens) [TaxId: | 9e-16 | |
| d1faqa_ | 52 | g.49.1.1 (A:) RAF-1 {Human (Homo sapiens) [TaxId: | 9e-16 | |
| d1kbea_ | 49 | g.49.1.1 (A:) Kinase suppressor of Ras, Ksr {Mouse | 1e-15 | |
| d1kbea_ | 49 | g.49.1.1 (A:) Kinase suppressor of Ras, Ksr {Mouse | 1e-15 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 211 bits (539), Expect = 1e-61
Identities = 70/244 (28%), Positives = 109/244 (44%), Gaps = 16/244 (6%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
R +G A K + + ++ E+ + L HP +VNL FE + ++
Sbjct: 45 VTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E + G L ++ E ++SE + Q+ L H+H N VH DLKPEN++ +T
Sbjct: 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS 162
Query: 951 LPQVKLCDFGFARIIGEKS-----------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
++KL DFG + K PEV K DMWSVGV+ Y+ LSG
Sbjct: 163 -NELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
Query: 1000 TFPF--NEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
PF D++ +++ + + IS D D I LL R+++ ++L HP
Sbjct: 222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281
Query: 1058 WLQD 1061
WL
Sbjct: 282 WLTP 285
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 38.9 bits (90), Expect = 0.002
Identities = 13/31 (41%), Positives = 17/31 (54%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLF 414
+ R + L H+H N VH DLKPE +F
Sbjct: 127 VEYMRQVCKGLCHMHENNYVHLDLKPENIMF 157
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 208 bits (531), Expect = 2e-60
Identities = 80/271 (29%), Positives = 131/271 (48%), Gaps = 18/271 (6%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
V + +GR K I+ + +KNE++I+ L HP ++NL FE + +++
Sbjct: 48 CVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E L G L +++E ++SE + Q LKH+H +IVH D+KPEN++ T
Sbjct: 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA 165
Query: 951 LPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
VK+ DFG A + PE++ + DMW++GV+ YV LSG
Sbjct: 166 -SSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224
Query: 1000 TFPFNEDEDIN--EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
PF ++D+ + ++ + + + +S +A D I NLLQ + RKRL+V +L HP
Sbjct: 225 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284
Query: 1058 WLQDPATWSDLRGLERQIGTNKKKNPKRTAQ 1088
WL+ S+L NK + +
Sbjct: 285 WLKG--DHSNLTSRIPSSRYNKIRQKIKEKY 313
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-57
Identities = 67/243 (27%), Positives = 122/243 (50%), Gaps = 21/243 (8%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQ-EAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
++S +A+KV+ K + E QL+ EV I +L HP ++ L F R++++
Sbjct: 25 AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
+E + L + + E+ T IT++ AL + HSK ++H D+KPEN+LL +
Sbjct: 85 LEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG 143
Query: 950 ELPQVKLCDFGFARIIGEKSF----------PPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
++K+ DFG++ PPE++ + ++ +D+WS+GV+ Y L G
Sbjct: 144 ---ELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 200
Query: 1000 TFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
PF + ++ ++I F +P ++ A DLI+ LL+ +R + + L HP
Sbjct: 201 KPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHP 256
Query: 1058 WLQ 1060
W+
Sbjct: 257 WIT 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (106), Expect = 3e-05
Identities = 15/39 (38%), Positives = 24/39 (61%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
++ + AL + HSK ++H D+KPE NL S+ E+K
Sbjct: 109 ATYITELANALSYCHSKRVIHRDIKPE-NLLLGSAGELK 146
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-57
Identities = 70/267 (26%), Positives = 132/267 (49%), Gaps = 20/267 (7%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
V S + K + + +K E++IL H +++L FE+ + ++
Sbjct: 24 CVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E + G + +++ L+ER + Q+ AL+ LHS NI H D++PEN++ T
Sbjct: 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS 140
Query: 951 LPQVKLCDFGFARIIGEKS-----------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
+K+ +FG AR + + PEV ++ + + DMWS+G +VYV LSG
Sbjct: 141 -STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
Query: 1000 TFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
PF + + I E I NA + + +++IS +A+D ++ LL +++ R++ ++L HP
Sbjct: 200 INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259
Query: 1058 WLQ---DPATWSDLRGLERQIGTNKKK 1081
WL+ + + +R L+ + +
Sbjct: 260 WLKQKIERVSTKVIRTLKHRRYYHTLI 286
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (500), Expect = 8e-57
Identities = 85/269 (31%), Positives = 146/269 (54%), Gaps = 17/269 (6%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+++ + VAIK I K + +E ++NE+A+L + HP +V L+ ++E+ G ++++M
Sbjct: 28 AEDKRTQKLVAIKCIAK-KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ + G L + EKG +ER +I Q+L A+K+LH IVH DLKPEN+L + E
Sbjct: 87 QLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDE 145
Query: 951 LPQVKLCDFGFARIIGEKS-----------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
++ + DFG +++ S PEVL K Y++++D WS+GVI Y+ L G
Sbjct: 146 DSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 205
Query: 1000 TFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
PF ++ + EQI A + + W DIS A D I +L++ KR + +++L HP
Sbjct: 206 YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265
Query: 1058 WLQDPATWSDLRGLERQIGTNKKKNPKRT 1086
W+ + + + + KKN ++
Sbjct: 266 WIAGDTALD--KNIHQSVSEQIKKNFAKS 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 1e-56
Identities = 55/248 (22%), Positives = 104/248 (41%), Gaps = 23/248 (9%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
++++ A KVID ++ E+ IL + HP +V L F +++++
Sbjct: 31 AQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E G ++ ++ + L+E + + Q L AL +LH I+H DLK N+L + +
Sbjct: 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG- 147
Query: 951 LPQVKLCDFGFARIIGEKS------------FPPEVL-----RNKGYNRSLDMWSVGVIV 993
+KL DFG + PEV+ +++ Y+ D+WS+G+ +
Sbjct: 148 --DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 205
Query: 994 YVSLSGTFPFNEDEDINEQIQNAAFMYPPRP-WRDISSDAIDLINNLLQVKQRKRLSVDK 1052
P +E + ++ A P SS+ D + L+ R + +
Sbjct: 206 IEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ 265
Query: 1053 SLAHPWLQ 1060
L HP++
Sbjct: 266 LLQHPFVT 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (103), Expect = 6e-05
Identities = 14/39 (35%), Positives = 20/39 (51%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ + L AL +LH I+H DLK N+ T +IK
Sbjct: 113 QVVCKQTLDALNYLHDNKIIHRDLKAG-NILFTLDGDIK 150
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (495), Expect = 5e-56
Identities = 58/257 (22%), Positives = 101/257 (39%), Gaps = 16/257 (6%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
++ VAIK + + ++ Q + EV LQ L HP + + ++V
Sbjct: 34 ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
ME G +++ K L E + L L +LHS N++H D+K N+LLS
Sbjct: 94 MEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG 152
Query: 950 ELPQVKLCDFGFARIIGEKS--------FPPEVLR---NKGYNRSLDMWSVGVIVYVSLS 998
VKL DFG A I+ + PEV+ Y+ +D+WS+G+
Sbjct: 153 L---VKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
Query: 999 GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
P ++ A P S + +++ LQ + R + + L H +
Sbjct: 210 RKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269
Query: 1059 LQDPATWSDLRGLERQI 1075
+ + + L ++
Sbjct: 270 VLRERPPTVIMDLIQRT 286
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.9 bits (98), Expect = 3e-04
Identities = 11/39 (28%), Positives = 19/39 (48%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ L L +LHS N++H D+K N+ + +K
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAG-NILLSEPGLVK 155
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 4e-55
Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 21/248 (8%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
V+R + VA+K++D R E +K E+ I + L H VV ++ +
Sbjct: 24 AVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E G L + + E + Q++ + +LH I H D+KPEN+LL
Sbjct: 83 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD- 140
Query: 951 LPQVKLCDFGFARIIGEKS--------------FPPEVLRNKGYN-RSLDMWSVGVIVYV 995
+K+ DFG A + + PE+L+ + ++ +D+WS G+++
Sbjct: 141 --NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTA 198
Query: 996 SLSGTFPFNEDEDINEQIQNAAFM-YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSL 1054
L+G P+++ D ++ + PW+ I S + L++ +L R+++
Sbjct: 199 MLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 258
Query: 1055 AHPWLQDP 1062
W P
Sbjct: 259 KDRWYNKP 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (97), Expect = 3e-04
Identities = 12/39 (30%), Positives = 19/39 (48%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ F ++ + +LH I H D+KPE NL +K
Sbjct: 106 QRFFHQLMAGVVYLHGIGITHRDIKPE-NLLLDERDNLK 143
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 189 bits (481), Expect = 1e-54
Identities = 77/257 (29%), Positives = 128/257 (49%), Gaps = 31/257 (12%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPT-------KQEAQLKNEVAILQNL-CHPGVVNLERMFET 882
+H+ + + A+K+ID + + EV IL+ + HP ++ L+ +ET
Sbjct: 22 CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81
Query: 883 PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
F+V + ++ L L+ EK LSE+ T+ I+ +L + LH NIVH DLKPEN
Sbjct: 82 NTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 140
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLR------NKGYNRSLD 985
+LL + +KL DFGF+ + PE++ + GY + +D
Sbjct: 141 ILLDDDM---NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 197
Query: 986 MWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVK 1043
MWS GVI+Y L+G+ PF + + I + + + W D S DL++ L V+
Sbjct: 198 MWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ 257
Query: 1044 QRKRLSVDKSLAHPWLQ 1060
+KR + +++LAHP+ Q
Sbjct: 258 PQKRYTAEEALAHPFFQ 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 39.3 bits (91), Expect = 0.002
Identities = 16/39 (41%), Positives = 22/39 (56%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ R++L + LH NIVH DLKPE N+ + IK
Sbjct: 113 RKIMRALLEVICALHKLNIVHRDLKPE-NILLDDDMNIK 150
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-54
Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 37/278 (13%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
+ R AIK+++K + + + E ++ L HP V L F+ +++
Sbjct: 27 ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
+ + L + + G E T+F +I+ AL++LH K I+H DLKPEN+LL+ +
Sbjct: 87 LSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 145
Query: 950 ELPQVKLCDFGFARIIGEKS--------------FPPEVLRNKGYNRSLDMWSVGVIVYV 995
+++ DFG A+++ +S PE+L K +S D+W++G I+Y
Sbjct: 146 ---HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 202
Query: 996 SLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS-- 1053
++G PF + I A DL+ LL + KRL ++
Sbjct: 203 LVAGLPPFRAGNEY--LIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260
Query: 1054 ----LAHPWLQDPATWSDLRGLERQIGTNKKKNPKRTA 1087
AHP+ + TW +L ++ PK TA
Sbjct: 261 YGPLKAHPFFES-VTWENLH---------QQTPPKLTA 288
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (92), Expect = 0.001
Identities = 15/39 (38%), Positives = 24/39 (61%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ + I+ AL++LH K I+H DLKPE N+ + I+
Sbjct: 111 RFYTAEIVSALEYLHGKGIIHRDLKPE-NILLNEDMHIQ 148
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-54
Identities = 49/247 (19%), Positives = 104/247 (42%), Gaps = 21/247 (8%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP----GRI 886
G+ ++ VA + + + + K E +L+ L HP +V +E+ I
Sbjct: 28 GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87
Query: 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVL 944
+V E + L+ L + + + QIL L+ LH++ I+H DLK +N+
Sbjct: 88 VLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 146
Query: 945 LSTNSELPQVKLCDFGFARIIGEKS----------FPPEVLRNKGYNRSLDMWSVGVIVY 994
+ VK+ D G A + PE+ K Y+ S+D+++ G+ +
Sbjct: 147 I--TGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCML 203
Query: 995 VSLSGTFPFNEDEDINEQIQN-AAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053
+ +P++E ++ + + + + P + + ++I ++ + +R S+
Sbjct: 204 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
Query: 1054 LAHPWLQ 1060
L H + Q
Sbjct: 264 LNHAFFQ 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-54
Identities = 65/253 (25%), Positives = 115/253 (45%), Gaps = 22/253 (8%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+ +G+ VAI+ ++ + P K+ + NE+ +++ +P +VN + ++VVM
Sbjct: 39 AMDVATGQEVAIRQMNLQQQPKKE--LIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E L G L ++ + + E + + L AL+ LHS ++H D+K +N+LL +
Sbjct: 97 EYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG- 153
Query: 951 LPQVKLCDFGFARIIGEKSF------------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
VKL DFGF I + PEV+ K Y +D+WS+G++ +
Sbjct: 154 --SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211
Query: 999 GTFPFNEDEDINEQIQNAAFMYPPRP--WRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
G P+ +E+ + A P +S+ D +N L + KR S + L H
Sbjct: 212 GEPPY-LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270
Query: 1057 PWLQDPATWSDLR 1069
+L+ S L
Sbjct: 271 QFLKIAKPLSSLT 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (92), Expect = 0.001
Identities = 12/39 (30%), Positives = 20/39 (51%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ R L AL+ LHS ++H D+K + N+ +K
Sbjct: 119 AAVCRECLQALEFLHSNQVIHRDIKSD-NILLGMDGSVK 156
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 4e-54
Identities = 57/284 (20%), Positives = 107/284 (37%), Gaps = 58/284 (20%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
H+ SG +A K+I Q+ E+ +L P +V F + G I + M
Sbjct: 25 VSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN-IVHCDLKPENVLLSTNS 949
E + G L+ +L + GR+ E+ + ++ L +L K+ I+H D+KP N+L+++
Sbjct: 84 EHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 142
Query: 950 ELPQVKLCDFGFARIIGEKS----------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
E +KLCDFG + + + PE L+ Y+ D+WS+G+ + G
Sbjct: 143 E---IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199
Query: 1000 TFPFNEDEDINEQIQNAAFM---------------------------------------- 1019
+P + ++ +
Sbjct: 200 RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVN 259
Query: 1020 --YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
P P S + D +N L +R + + + H +++
Sbjct: 260 EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (91), Expect = 0.002
Identities = 13/40 (32%), Positives = 21/40 (52%), Gaps = 2/40 (5%)
Query: 384 KSFRRSILVALKHLHSKN-IVHCDLKPERNLFPTSSLEIK 422
+++ L +L K+ I+H D+KP N+ S EIK
Sbjct: 107 GKVSIAVIKGLTYLREKHKIMHRDVKPS-NILVNSRGEIK 145
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 6e-54
Identities = 65/251 (25%), Positives = 108/251 (43%), Gaps = 26/251 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMF--ETPGRIFV 888
+ G+ + K +D ++ L +EV +L+ L HP +V T +++
Sbjct: 23 IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82
Query: 889 VMEKLQGDMLEMIL---SSEKGRLSERTTKFIITQILVALKHLHSKN-----IVHCDLKP 940
VME +G L ++ + E+ L E ++TQ+ +ALK H ++ ++H DLKP
Sbjct: 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKP 142
Query: 941 ENVLLSTNSELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWS 988
NV L VKL DFG ARI+ + PE + YN D+WS
Sbjct: 143 ANVFLDGK---QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWS 199
Query: 989 VGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
+G ++Y + PF E R S + ++I +L +K R
Sbjct: 200 LGCLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRP 258
Query: 1049 SVDKSLAHPWL 1059
SV++ L +P +
Sbjct: 259 SVEEILENPLI 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 6e-53
Identities = 71/290 (24%), Positives = 132/290 (45%), Gaps = 30/290 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETP----GR 885
++++ A+K++ + + EV + P +V + ++E
Sbjct: 31 IFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83
Query: 886 IFVVMEKLQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944
+ +VME L G++ I +ER I+ I A+++LHS NI H D+KPEN+L
Sbjct: 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 143
Query: 945 LSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIV 993
++ +KL DFGFA+ + PEVL + Y++S DMWS+GVI+
Sbjct: 144 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 203
Query: 994 YVSLSGTFPFNED------EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKR 1047
Y+ L G PF + + +I+ + +P W ++S + LI NLL+ + +R
Sbjct: 204 YILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 263
Query: 1048 LSVDKSLAHPWLQDPATWSDLRGLERQIGTNKKKNPKRTAQLLSYQLTQM 1097
+++ + + HPW+ ++ K+ + + ++ L M
Sbjct: 264 MTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATM 313
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (92), Expect = 0.001
Identities = 14/31 (45%), Positives = 20/31 (64%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLF 414
+SI A+++LHS NI H D+KPE L+
Sbjct: 114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLY 144
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 8e-53
Identities = 76/256 (29%), Positives = 123/256 (48%), Gaps = 19/256 (7%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEA----QLKNEVAILQNLCHPGVVNLERMFETPGRI 886
+ +G A K I K R + + ++ EV+IL+ + HP V+ L ++E +
Sbjct: 29 CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88
Query: 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
+++E + G L +EK L+E + QIL + +LHS I H DLKPEN++L
Sbjct: 89 ILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 147
Query: 947 T-NSELPQVKLCDFGFARIIGEKS-----------FPPEVLRNKGYNRSLDMWSVGVIVY 994
N P++K+ DFG A I + PE++ + DMWS+GVI Y
Sbjct: 148 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 995 VSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDK 1052
+ LSG PF D ++ + + + + + S+ A D I LL +KR+++
Sbjct: 208 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267
Query: 1053 SLAHPWLQDPATWSDL 1068
SL HPW++ T L
Sbjct: 268 SLQHPWIKPKDTQQAL 283
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 6e-51
Identities = 68/248 (27%), Positives = 117/248 (47%), Gaps = 27/248 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQE----AQLKNEVAILQNL--CHPGVVNLERMFETPG 884
G+ VAIK ++K R E ++ EV +L+ + GV+ L FE P
Sbjct: 23 GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82
Query: 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944
+++E+ + +E+G L E + Q+L A++H H+ ++H D+K EN+L
Sbjct: 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 142
Query: 945 LSTNSELPQVKLCDFGFARIIGEKSF----------PPEVLRNKGY-NRSLDMWSVGVIV 993
+ N ++KL DFG ++ + + PPE +R Y RS +WS+G+++
Sbjct: 143 IDLNR--GELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200
Query: 994 YVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053
Y + G PF D E+I + R +SS+ LI L ++ R + ++
Sbjct: 201 YDMVCGDIPFEHD----EEIIRGQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEI 252
Query: 1054 LAHPWLQD 1061
HPW+QD
Sbjct: 253 QNHPWMQD 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 176 bits (447), Expect = 2e-49
Identities = 80/262 (30%), Positives = 132/262 (50%), Gaps = 28/262 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
R +GR A+KV+ K KQ +E +L + HP ++ + F+ +IF++
Sbjct: 23 IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
M+ ++G L + + R KF ++ +AL++LHSK+I++ DLKPEN+LL N
Sbjct: 83 MDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG 141
Query: 950 ELPQVKLCDFGFARIIGEKSF---------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
+K+ DFGFA+ + + ++ PEV+ K YN+S+D WS G+++Y L+G
Sbjct: 142 ---HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 198
Query: 1001 FPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL-----SVDKS 1053
PF + E+I NA +PP + D DL++ L+ +RL +
Sbjct: 199 TPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 254
Query: 1054 LAHPWLQDPATWSDLRGLERQI 1075
HPW ++ W L L R I
Sbjct: 255 KNHPWFKE-VVWEKL--LSRNI 273
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 40.1 bits (93), Expect = 0.001
Identities = 16/39 (41%), Positives = 26/39 (66%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
K + + +AL++LHSK+I++ DLKPE N+ + IK
Sbjct: 107 KFYAAEVCLALEYLHSKDIIYRDLKPE-NILLDKNGHIK 144
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 177 bits (449), Expect = 2e-49
Identities = 59/252 (23%), Positives = 108/252 (42%), Gaps = 25/252 (9%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQL----KNEVAILQNLCHPGVVNLERMFETPGRI 886
+G+ A+K +DK R KQ L + ++++ P +V + F TP ++
Sbjct: 23 CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82
Query: 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLS 946
+++ + G L LS + G SE +F +I++ L+H+H++ +V+ DLKP N+LL
Sbjct: 83 SFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL- 140
Query: 947 TNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIVYV 995
E V++ D G A +K P + + Y+ S D +S+G +++
Sbjct: 141 --DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 198
Query: 996 SLSGTFPFNEDEDIN-EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS- 1053
L G PF + + + +I S + L+ LLQ +RL
Sbjct: 199 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 258
Query: 1054 ----LAHPWLQD 1061
P+ +
Sbjct: 259 AQEVKESPFFRS 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.9 bits (95), Expect = 8e-04
Identities = 10/39 (25%), Positives = 23/39 (58%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
+ + I++ L+H+H++ +V+ DLKP N+ ++
Sbjct: 110 RFYAAEIILGLEHMHNRFVVYRDLKPA-NILLDEHGHVR 147
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 7e-48
Identities = 70/254 (27%), Positives = 109/254 (42%), Gaps = 22/254 (8%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQ-LKNEVAILQNLC-HPGVVNLERMFETPGRIFV 888
+K+ + AIK + K + + E +L HP + ++ F+T +F
Sbjct: 21 AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
VME L G L + + F +I++ L+ LHSK IV+ DLK +N+LL +
Sbjct: 81 VMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD 139
Query: 949 SELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVS 996
+K+ DFG + PE+L + YN S+D WS GV++Y
Sbjct: 140 G---HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 196
Query: 997 LSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS-LA 1055
L G PF +D E + P P R + +A DL+ L + KRL V
Sbjct: 197 LIGQSPF-HGQDEEELFHSIRMDNPFYP-RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254
Query: 1056 HPWLQDPATWSDLR 1069
HP ++ W +L
Sbjct: 255 HPLFRE-INWEELE 267
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-47
Identities = 72/257 (28%), Positives = 120/257 (46%), Gaps = 25/257 (9%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
+ +GR A+K++ K K E A E +LQN HP + L+ F+T R+ V
Sbjct: 24 VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
ME G L LS + +E +F +I+ AL++LHS+++V+ D+K EN++L +
Sbjct: 84 MEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 142
Query: 950 ELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYVSL 997
+K+ DFG + PEVL + Y R++D W +GV++Y +
Sbjct: 143 ---HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 998 SGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS---- 1053
G PF + +E++ M R R +S +A L+ LL+ ++RL S
Sbjct: 200 CGRLPFYNQD--HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
Query: 1054 -LAHPWLQDPATWSDLR 1069
+ H + W D+
Sbjct: 258 VMEHRFFLS-INWQDVV 273
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 165 bits (418), Expect = 3e-46
Identities = 62/270 (22%), Positives = 114/270 (42%), Gaps = 44/270 (16%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
G A+K I + + E++IL+ L H +V L + T R+ +V E
Sbjct: 21 AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
L L+ +L +G L T K + Q+L + + H + ++H DLKP+N+L++
Sbjct: 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-- 137
Query: 952 PQVKLCDFGFARIIGEKSF------------PPEVLRNKG-YNRSLDMWSVGVIVYVSLS 998
++K+ DFG AR G P+VL Y+ ++D+WSVG I ++
Sbjct: 138 -ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 999 GTFPF--NEDEDINEQIQNAAFMYPPRPW-------------------------RDISSD 1031
GT F + D +I + W + +
Sbjct: 197 GTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256
Query: 1032 AIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
IDL++ +L++ +R++ ++L H + ++
Sbjct: 257 GIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-46
Identities = 61/273 (22%), Positives = 101/273 (36%), Gaps = 46/273 (16%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEA---QLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
+ + + VAIK I ++ E+ +LQ L HP ++ L F I
Sbjct: 17 ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 76
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+V + ++ D+ +I+ L+ K + L L++LH I+H DLKP N+LL
Sbjct: 77 LVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE 135
Query: 948 NSELPQVKLCDFGFARIIGEKSF-------------PPEVLRNKGYNRSLDMWSVGVIVY 994
N +KL DFG A+ G + P + + Y +DMW+VG I+
Sbjct: 136 NGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA 192
Query: 995 VSLSGTFPFNEDEDIN--EQIQNAAFMYPPRPWRD------------------------I 1028
L D D++ +I W D
Sbjct: 193 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA 252
Query: 1029 SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
D +DLI L R++ ++L + +
Sbjct: 253 GDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (415), Expect = 9e-46
Identities = 53/247 (21%), Positives = 106/247 (42%), Gaps = 26/247 (10%)
Query: 832 VHR-KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
V++ K VA+K+++ +Q KNEV +L+ H ++ + T ++ +V
Sbjct: 24 VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQLAIVT 82
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+ +G L L + + I Q + +LH+K+I+H DLK N+ L +
Sbjct: 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT 142
Query: 951 LPQVKLCDFGFARIIGEKS--------------FPPEVLRNKG---YNRSLDMWSVGVIV 993
VK+ DFG A + S PEV+R + Y+ D+++ G+++
Sbjct: 143 ---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199
Query: 994 YVSLSGTFPFNEDEDINE--QIQNAAFMYPPRP--WRDISSDAIDLINNLLQVKQRKRLS 1049
Y ++G P++ + ++ + ++ P + L+ L+ K+ +R
Sbjct: 200 YELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL 259
Query: 1050 VDKSLAH 1056
+ LA
Sbjct: 260 FPQILAS 266
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (94), Expect = 7e-04
Identities = 13/39 (33%), Positives = 20/39 (51%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
R + +LH+K+I+H DLK N+F L +K
Sbjct: 107 IDIARQTAQGMDYLHAKSIIHRDLKSN-NIFLHEDLTVK 144
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (421), Expect = 9e-46
Identities = 81/254 (31%), Positives = 129/254 (50%), Gaps = 22/254 (8%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889
H++SG A+K++DK + KQ NE ILQ + P +V LE F+ +++V
Sbjct: 60 VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
ME + G + L GR SE +F QI++ ++LHS ++++ DLKPEN+L+
Sbjct: 120 MEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG 178
Query: 950 ELPQVKLCDFGFARIIGEKSF---------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
+++ DFGFA+ + +++ PE++ +KGYN+++D W++GV++Y +G
Sbjct: 179 ---YIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 1001 FPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL-----SVDKSLA 1055
PF D+ I QI R SSD DL+ NLLQV KR V+
Sbjct: 236 PPFFADQPI--QIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
Query: 1056 HPWLQDPATWSDLR 1069
H W W +
Sbjct: 294 HKWFATT-DWIAIY 306
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 39.0 bits (90), Expect = 0.003
Identities = 11/31 (35%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLF 414
+ + I++ ++LHS ++++ DLKPE NL
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPE-NLL 173
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-45
Identities = 60/278 (21%), Positives = 104/278 (37%), Gaps = 55/278 (19%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR----- 885
SG VAIK + + + E+ I++ L H +V L F + G
Sbjct: 39 AKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92
Query: 886 -IFVVMEKLQGDMLEMIL--SSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
+ +V++ + + + S K L K + Q+ +L ++HS I H D+KP+N
Sbjct: 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 152
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSF------------PPEVLRNKGYNRSLDMWSVG 990
+LL ++ +KLCDFG A+ + P + Y S+D+WS G
Sbjct: 153 LLLDPDTA--VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 991 VIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYPPRPWR---------------------- 1026
++ L G F D ++ +I R
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 270
Query: 1027 ---DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+AI L + LL+ RL+ ++ AH + +
Sbjct: 271 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 3e-04
Identities = 11/39 (28%), Positives = 20/39 (51%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
K + + +L ++HS I H D+KP+ L + +K
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 163
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-45
Identities = 70/287 (24%), Positives = 120/287 (41%), Gaps = 57/287 (19%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG-----R 885
+ VAIK I T + + E+ IL H ++ + + P
Sbjct: 27 AYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85
Query: 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
+++V + D+ +++ + LS + + QIL LK++HS N++H DLKP N+LL
Sbjct: 86 VYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 142
Query: 946 STNSELPQVKLCDFGFARIIGEKSF---------------PPEVLRNK-GYNRSLDMWSV 989
+T +K+CDFG AR+ PE++ N GY +S+D+WSV
Sbjct: 143 NTTC---DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 199
Query: 990 GVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRP------------------------- 1024
G I+ LS F +++ + P
Sbjct: 200 GCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVP 259
Query: 1025 ----WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSD 1067
+ + S A+DL++ +L KR+ V+++LAHP+L+ SD
Sbjct: 260 WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (96), Expect = 5e-04
Identities = 16/39 (41%), Positives = 24/39 (61%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
F IL LK++HS N++H DLKP NL ++ ++K
Sbjct: 112 CYFLYQILRGLKYIHSANVLHRDLKP-SNLLLNTTCDLK 149
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-45
Identities = 46/234 (19%), Positives = 85/234 (36%), Gaps = 18/234 (7%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL-ERMFETPGRIFVVMEK 892
G VA+K I E +++ L H +V L + E G +++V E
Sbjct: 27 DYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82
Query: 893 LQ-GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ G +++ + S + L + A+++L N VH DL NVL+S ++
Sbjct: 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV- 141
Query: 952 PQVKLCDFGFARIIGEKS---------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFP 1002
K+ DFG + PE LR K ++ D+WS G++++ S
Sbjct: 142 --AKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 199
Query: 1003 FNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
+ + + Y +++ N + R S +
Sbjct: 200 PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 4e-45
Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 30/272 (11%)
Query: 823 AVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEA--QLKNEVAILQNLCH-PGVVNLERM 879
V +G+ A+KV+ K K + + E +L+++ P +V L
Sbjct: 38 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97
Query: 880 FETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLK 939
F+T ++ ++++ + G L LS ++ R +E + + +I++AL+HLH I++ D+K
Sbjct: 98 FQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIK 156
Query: 940 PENVLLSTNSELPQVKLCDFGFARIIGEK---------------SFPPEVLRNKGYNRSL 984
EN+LL +N V L DFG ++ + + G+++++
Sbjct: 157 LENILLDSNG---HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 213
Query: 985 DMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYPPRPWRDISSDAIDLINNLLQV 1042
D WS+GV++Y L+G PF D + N +I P +++S+ A DLI LL
Sbjct: 214 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMK 273
Query: 1043 KQRKRLS-----VDKSLAHPWLQDPATWSDLR 1069
+KRL D+ H + Q W DL
Sbjct: 274 DPKKRLGCGPRDADEIKEHLFFQK-INWDDLA 304
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-44
Identities = 66/271 (24%), Positives = 112/271 (41%), Gaps = 43/271 (15%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
++ +G VA+K I + E+++L+ L HP +V L + T ++++V
Sbjct: 21 ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E L D+ + + +S + K + Q+L L HS ++H DLKP+N+L++T
Sbjct: 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-- 138
Query: 951 LPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYN-RSLDMWSVGVIVYVSL 997
+KL DFG AR G PE+L Y ++D+WS+G I +
Sbjct: 139 -GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197
Query: 998 SGTFPFNEDEDIN--EQIQNAAFMYPPRPWRD-------------------------ISS 1030
+ F D +I+ +I W +
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDE 257
Query: 1031 DAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
D L++ +L KR+S +LAHP+ QD
Sbjct: 258 DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-44
Identities = 64/294 (21%), Positives = 110/294 (37%), Gaps = 59/294 (20%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP------- 883
HRK+G+ VA+K + E+ ILQ L H VVNL + T
Sbjct: 29 ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88
Query: 884 -GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
G I++V + + D+ ++ + + + K ++ +L L ++H I+H D+K N
Sbjct: 89 KGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 147
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKSF-----------------PPEVLRNKGYNRSLD 985
VL++ + +KL DFG AR P +L + Y +D
Sbjct: 148 VLITRDGV---LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPID 204
Query: 986 MWSVGVIVYVSLSGTFPF--NEDEDINEQIQNAAFMYPPRPWRDI--------------- 1028
+W G I+ + + N ++ I P W ++
Sbjct: 205 LWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQ 264
Query: 1029 -------------SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLR 1069
A+DLI+ LL + +R+ D +L H + SDL+
Sbjct: 265 KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLK 318
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 160 bits (405), Expect = 2e-44
Identities = 55/252 (21%), Positives = 95/252 (37%), Gaps = 26/252 (10%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQ-EAQLKNEVAILQNLCHPGVVNLERMFETP----GR 885
+ R VA+KV+ + + E L HP +V + E
Sbjct: 26 ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85
Query: 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLL 945
++VME + G L I+ +G ++ + +I AL H I+H D+KP N+++
Sbjct: 86 PYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 144
Query: 946 STNSELPQVKLCDFGFARIIGEKS---------------FPPEVLRNKGYNRSLDMWSVG 990
S VK+ DFG AR I + PE R + D++S+G
Sbjct: 145 SAT---NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 201
Query: 991 VIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
++Y L+G PF D ++ Q + P +S+D ++ L R
Sbjct: 202 CVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 261
Query: 1049 SVDKSLAHPWLQ 1060
+ ++
Sbjct: 262 QTAAEMRADLVR 273
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 5e-44
Identities = 72/276 (26%), Positives = 111/276 (40%), Gaps = 48/276 (17%)
Query: 831 GVHRKS-GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC---HPGVVNLERMFETP--- 883
K+ GR VA+K + EVA+L++L HP VV L +
Sbjct: 26 ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85
Query: 884 --GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
++ +V E + D+ + + + T K ++ Q+L L LHS +VH DLKP+
Sbjct: 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ 145
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVG 990
N+L++++ Q+KL DFG ARI + PEVL Y +D+WSVG
Sbjct: 146 NILVTSSG---QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 202
Query: 991 VIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYPPRPW----------------------- 1025
I F D++ +I + + W
Sbjct: 203 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV 262
Query: 1026 RDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
DI DL+ L KR+S +L+HP+ QD
Sbjct: 263 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 2e-04
Identities = 18/39 (46%), Positives = 23/39 (58%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
K +L L LHS +VH DLKP+ N+ TSS +IK
Sbjct: 119 KDMMFQLLRGLDFLHSHRVVHRDLKPQ-NILVTSSGQIK 156
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 4e-43
Identities = 64/272 (23%), Positives = 110/272 (40%), Gaps = 45/272 (16%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
+R++ VA+K + + E+ +L+ L H +V L + + ++ +V
Sbjct: 21 AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
E D+ S G L K + Q+L L HS+N++H DLKP+N+L++ N
Sbjct: 81 EFCDQDLK-KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG- 138
Query: 951 LPQVKLCDFGFARIIGEKS-------------FPPEVLRNKGYNRSLDMWSVGVIVYVSL 997
++KL +FG AR G P + K Y+ S+DMWS G I
Sbjct: 139 --ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196
Query: 998 SGTFPFNEDEDINEQ---IQNAAFMYPPRPWRD-------------------------IS 1029
+ P D+++Q I W ++
Sbjct: 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLN 256
Query: 1030 SDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+ DL+ NLL+ +R+S +++L HP+ D
Sbjct: 257 ATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 0.002
Identities = 14/31 (45%), Positives = 19/31 (61%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLF 414
KSF +L L HS+N++H DLKP+ L
Sbjct: 104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI 134
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-43
Identities = 60/282 (21%), Positives = 123/282 (43%), Gaps = 51/282 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGR----- 885
V ++G VAIK + + + E+ +L+++ H V+ L +F
Sbjct: 37 AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96
Query: 886 -IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944
++VM + D+ +++ + +L E +F++ Q+L L+++H+ I+H DLKP N+
Sbjct: 97 DFYLVMPFMGTDLGKLM---KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 153
Query: 945 LSTNSELPQVKLCDFGFARIIGEKSF----------PPEVLRNKGYNRSLDMWSVGVIVY 994
++ + E +K+ DFG AR + P +L Y +++D+WSVG I+
Sbjct: 154 VNEDCE---LKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210
Query: 995 VSLSGTFPF--NEDEDINEQIQNAAFMYPPRPWR-------------------------- 1026
++G F ++ D ++I P +
Sbjct: 211 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL 270
Query: 1027 -DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSD 1067
+ S A++L+ +L + +R++ ++LAHP+ + D
Sbjct: 271 TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-42
Identities = 48/238 (20%), Positives = 94/238 (39%), Gaps = 19/238 (7%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ + VAIK I + E E ++ L HP +V L + I +V E
Sbjct: 24 GYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
++ L L +++G + T + + + +L ++H DL N L+ N
Sbjct: 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-- 138
Query: 952 PQVKLCDFGFARIIGEKSF-------------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
+K+ DFG R + + + PEV Y+ D+WS GV+++ S
Sbjct: 139 -VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197
Query: 999 GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
E+ +E +++ + + R S+ ++N+ + + R + + L
Sbjct: 198 EGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (390), Expect = 2e-42
Identities = 49/235 (20%), Positives = 98/235 (41%), Gaps = 20/235 (8%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
GV +K VA+K + + T + + E A+++ + HP +V L + +++
Sbjct: 36 GVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92
Query: 891 EKL-QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
E + G++L+ + + +S ++ TQI A+++L KN +H DL N L+ N
Sbjct: 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH 152
Query: 950 ELPQVKLCDFGFARIIGEKSF-------------PPEVLRNKGYNRSLDMWSVGVIVYVS 996
VK+ DFG +R++ ++ PE L ++ D+W+ GV+++
Sbjct: 153 L---VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209
Query: 997 LSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVD 1051
+ D+++ + Y +L+ Q R S
Sbjct: 210 ATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFA 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-42
Identities = 51/243 (20%), Positives = 96/243 (39%), Gaps = 21/243 (8%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ VAIK+I + + E + E ++ NL H +V L + IF++ E
Sbjct: 23 GKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
+ L L + R + + + A+++L SK +H DL N L++
Sbjct: 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ--- 136
Query: 952 PQVKLCDFGFARIIGEKSF-------------PPEVLRNKGYNRSLDMWSVGVIVYVSLS 998
VK+ DFG +R + + + PPEVL ++ D+W+ GV+++ S
Sbjct: 137 GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196
Query: 999 GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPW 1058
E +E ++ A S ++ + K +R + L++
Sbjct: 197 LGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN-- 254
Query: 1059 LQD 1061
+ D
Sbjct: 255 ILD 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-41
Identities = 55/251 (21%), Positives = 102/251 (40%), Gaps = 27/251 (10%)
Query: 831 GVHRKSGRG--VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888
GV+R + VAIKV+ + E ++ E I+ L +P +V L + + + +
Sbjct: 28 GVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLIGVCQAEA-LML 85
Query: 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948
VME G L L ++ + ++ Q+ + +K+L KN VH DL NVLL
Sbjct: 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR 145
Query: 949 SELPQVKLCDFGFARIIGEKS---------------FPPEVLRNKGYNRSLDMWSVGVIV 993
K+ DFG ++ +G + PE + + ++ D+WS GV +
Sbjct: 146 ---HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 202
Query: 994 YVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS--- 1049
+ +LS G P+ + E + + + L+++ K R
Sbjct: 203 WEALSYGQKPY-KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLT 261
Query: 1050 VDKSLAHPWLQ 1060
V++ + +
Sbjct: 262 VEQRMRACYYS 272
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 151 bits (383), Expect = 5e-41
Identities = 56/282 (19%), Positives = 114/282 (40%), Gaps = 62/282 (21%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETP--GRIF 887
++ + V +K++ ++ ++K E+ IL+NL P ++ L + + P
Sbjct: 54 AINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+V E + + + L++ +F + +IL AL + HS I+H D+KP NV++
Sbjct: 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI-- 162
Query: 948 NSELPQVKLCDFGFARIIGEKS------------FPPEVLRNKGYNRSLDMWSVGVIVYV 995
+ E +++L D+G A P ++ + Y+ SLDMWS+G ++
Sbjct: 163 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222
Query: 996 SLSGTFPFNEDEDINEQIQNAAFM------------------------------------ 1019
+ PF D +Q+ A +
Sbjct: 223 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF 282
Query: 1020 YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+S +A+D ++ LL+ + RL+ +++ HP+
Sbjct: 283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (380), Expect = 8e-41
Identities = 52/254 (20%), Positives = 103/254 (40%), Gaps = 26/254 (10%)
Query: 831 GVHRKSGRG---VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
G + G+ VAIK + + KQ +E +I+ HP V++LE + +
Sbjct: 45 GHLKLPGKREIFVAIKTLKS-GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
++ E ++ L+ L G+ + ++ I +K+L N VH DL N+L+++
Sbjct: 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS 163
Query: 948 NSELPQVKLCDFGFARIIGEKS-----------------FPPEVLRNKGYNRSLDMWSVG 990
N K+ DFG +R + + + PE ++ + + + D+WS G
Sbjct: 164 NLV---CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYG 220
Query: 991 VIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSV 1050
++++ +S D + I Y P D S L+ + Q + R
Sbjct: 221 IVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 1051 DKSLAH--PWLQDP 1062
+ + +++P
Sbjct: 281 GQIVNTLDKMIRNP 294
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 48/246 (19%), Positives = 92/246 (37%), Gaps = 23/246 (9%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892
+K + VA+K++ + +L E ++Q L +P +V + + E + V ME
Sbjct: 30 MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLV-MEM 88
Query: 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELP 952
+ L L + + ++ ++ Q+ + +K+L N VH DL NVLL T
Sbjct: 89 AELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY-- 145
Query: 953 QVKLCDFGFARIIGEKS---------------FPPEVLRNKGYNRSLDMWSVGVIVYVSL 997
K+ DFG ++ + + PE + ++ D+WS GV+++ +
Sbjct: 146 -AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 204
Query: 998 SGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS---VDKSL 1054
S +E + DL+N R V+ L
Sbjct: 205 SYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
Query: 1055 AHPWLQ 1060
+ +
Sbjct: 265 RNYYYD 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-39
Identities = 49/263 (18%), Positives = 94/263 (35%), Gaps = 23/263 (8%)
Query: 831 GVHRKSGRGVAIKVIDK---LRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887
G+ G V I V K K ++ +E ++ ++ +P V L + T
Sbjct: 28 GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 87
Query: 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST 947
+ G +L+ + K + + QI + +L + +VH DL NVL+ T
Sbjct: 88 ITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 146
Query: 948 NSELPQVKLCDFGFARIIGEKS--------------FPPEVLRNKGYNRSLDMWSVGVIV 993
VK+ DFG A+++G + E + ++ Y D+WS GV V
Sbjct: 147 PQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 203
Query: 994 YVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKS 1053
+ ++ + +E + D ++ + R +
Sbjct: 204 WELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 263
Query: 1054 LAH--PWLQDPATWSDLRGLERQ 1074
+ +DP + ++G ER
Sbjct: 264 IIEFSKMARDPQRYLVIQGDERM 286
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 48/247 (19%), Positives = 93/247 (37%), Gaps = 23/247 (9%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ VA+K + + E +++ L H +V L T I+++ E
Sbjct: 32 GYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITE 87
Query: 892 KLQGDMLEMILSSEKG-RLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
++ L L + G +L+ + QI + + +N +H DL+ N+L+ S+
Sbjct: 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SD 144
Query: 951 LPQVKLCDFGFARIIGEKSF-------------PPEVLRNKGYNRSLDMWSVGVIVYVSL 997
K+ DFG AR+I + + PE + + D+WS G+++ +
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 998 SGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057
+ E IQN Y + + L+ + + R + D +
Sbjct: 205 THGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS-- 262
Query: 1058 WLQDPAT 1064
L+D T
Sbjct: 263 VLEDFFT 269
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-39
Identities = 61/276 (22%), Positives = 117/276 (42%), Gaps = 51/276 (18%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP------G 884
K+G VA+K + + + E+ +L+++ H V+ L +F
Sbjct: 37 AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96
Query: 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944
+++V + D+ ++ + +L++ +F+I QIL LK++HS +I+H DLKP N+
Sbjct: 97 DVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA 153
Query: 945 LSTNSELPQVKLCDFGFARIIGEKSF----------PPEVLRNKGYNRSLDMWSVGVIVY 994
+E ++K+ DFG AR ++ P +L YN+++D+WSVG I+
Sbjct: 154 ---VNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 995 VSLSGTFPF--NEDEDINEQIQNAAFMYPPRPWR-------------------------- 1026
L+G F + D + I +
Sbjct: 211 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF 270
Query: 1027 -DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061
+ A+DL+ +L + KR++ ++LAH +
Sbjct: 271 IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 4e-39
Identities = 43/265 (16%), Positives = 96/265 (36%), Gaps = 32/265 (12%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G +G VAIK+ + QL E I + + + R G V++
Sbjct: 26 GTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+L G LE + + + S +T + Q++ ++++HSKN +H D+KP+N L+ +
Sbjct: 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK 141
Query: 951 LPQVKLCDFGFARIIGEKSF-------------------PPEVLRNKGYNRSLDMWSVGV 991
V + DFG A+ + +R D+ S+G
Sbjct: 142 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 201
Query: 992 IVYVSLSGT--FPFNEDEDINEQIQNAAFMYPPRP----WRDISSDAIDLINNLLQVKQR 1045
++ G+ + + ++ + + P + S+ +N ++
Sbjct: 202 VLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFD 261
Query: 1046 KRLS---VDKSLAHPWLQDPATWSD 1067
+ + + + + + ++
Sbjct: 262 DKPDYSYLRQLFRNLFHRQGFSYDY 286
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 6e-39
Identities = 44/247 (17%), Positives = 83/247 (33%), Gaps = 22/247 (8%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890
G + R VAIK + T E +++ L H +V L + V
Sbjct: 36 GTWNGTTR-VAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE 91
Query: 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE 950
+G +L+ + L + QI + ++ N VH DL+ N+L+ N
Sbjct: 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 151
Query: 951 LPQVKLCDFGFARIIGEKSF-------------PPEVLRNKGYNRSLDMWSVGVIVYVSL 997
K+ DFG AR+I + + PE + D+WS G+++
Sbjct: 152 ---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208
Query: 998 SGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVD--KSLA 1055
+ E + Y + DL+ + + +R + + ++
Sbjct: 209 TKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
Query: 1056 HPWLQDP 1062
+
Sbjct: 269 EDYFTST 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 53/274 (19%), Positives = 92/274 (33%), Gaps = 35/274 (12%)
Query: 831 GVHRKSGRG--VAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIF 887
+K G AIK + + E+ +L L HP ++NL E G ++
Sbjct: 29 ARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87
Query: 888 VVMEKLQGDMLEMIL---------------SSEKGRLSERTTKFIITQILVALKHLHSKN 932
+ +E L L +S LS + + + +L K
Sbjct: 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 147
Query: 933 IVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS-----------FPPEVLRNKGYN 981
+H DL N+L+ N K+ DFG +R E L Y
Sbjct: 148 FIHRDLAARNILVGEN---YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT 204
Query: 982 RSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQ 1041
+ D+WS GV+++ +S E + Y + + DL+ +
Sbjct: 205 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWR 264
Query: 1042 VKQRKRLSVDKSLAH--PWLQDPATWSDLRGLER 1073
K +R S + L L++ T+ + E+
Sbjct: 265 EKPYERPSFAQILVSLNRMLEERKTYVNTTLYEK 298
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-38
Identities = 50/236 (21%), Positives = 85/236 (36%), Gaps = 18/236 (7%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKL 893
VAIK + +E + E ++ HP +V L + T ++++ME
Sbjct: 32 ENPALAVAIKTCKNCTSDSVRE-KFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELC 89
Query: 894 QGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953
L L K L + Q+ AL +L SK VH D+ NVL+S+N
Sbjct: 90 TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--- 146
Query: 954 VKLCDFGFARIIGEKSF-------------PPEVLRNKGYNRSLDMWSVGVIVYVSLSGT 1000
VKL DFG +R + + ++ PE + + + + D+W GV ++ L
Sbjct: 147 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 206
Query: 1001 FPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
+ N+ I + L+ +R + A
Sbjct: 207 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (87), Expect = 0.004
Identities = 14/63 (22%), Positives = 27/63 (42%), Gaps = 5/63 (7%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK----SNTEEEDEDEERGSTDG 439
+ + AL +L SK VH D+ RN+ +S+ +K + ++ ++ G
Sbjct: 111 ILYAYQLSTALAYLESKRFVHRDIAA-RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 169
Query: 440 GGP 442
P
Sbjct: 170 KLP 172
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 2e-37
Identities = 65/313 (20%), Positives = 124/313 (39%), Gaps = 64/313 (20%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL------ERMFETPG 884
R VAIK + + + E+ +++ + H +++L ++ E
Sbjct: 36 AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95
Query: 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVL 944
+++VME + ++ ++I + L +++ Q+L +KHLHS I+H DLKP N++
Sbjct: 96 DVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 945 LSTNSELPQVKLCDFGFARIIGEKSF-----------PPEVLRNKGYNRSLDMWSVGVIV 993
+ ++ +K+ DFG AR G PEV+ GY ++D+WSVG I+
Sbjct: 152 VKSDC---TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208
Query: 994 YVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRDI----------------------- 1028
+ F D ++ P + +
Sbjct: 209 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLF 268
Query: 1029 ---------------SSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPATWSDLRGLER 1073
+S A DL++ +L + KR+SVD +L HP++ +++
Sbjct: 269 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPP 328
Query: 1074 QIGTNKKKNPKRT 1086
QI + + T
Sbjct: 329 QIYDKQLDEREHT 341
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-37
Identities = 57/272 (20%), Positives = 100/272 (36%), Gaps = 53/272 (19%)
Query: 831 GVHRKSGRG-----VAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPG 884
+ VA+K++ + + + + L +E+ ++ L H +VNL G
Sbjct: 56 ATAYGISKTGVSIQVAVKMLKE-KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114
Query: 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKF----------------------IITQIL 922
I+++ E L L S++ + SE ++ Q+
Sbjct: 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 174
Query: 923 VALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS------------- 969
++ L K+ VH DL NVL++ VK+CDFG AR I S
Sbjct: 175 KGMEFLEFKSCVHRDLAARNVLVTHG---KVVKICDFGLARDIMSDSNYVVRGNARLPVK 231
Query: 970 -FPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPF---NEDEDINEQIQNAAFMYPPRP 1024
PE L Y D+WS G++++ S G P+ D + + IQN +
Sbjct: 232 WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG---FKMDQ 288
Query: 1025 WRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
+ + ++ + RKR S +
Sbjct: 289 PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (94), Expect = 8e-04
Identities = 9/38 (23%), Positives = 15/38 (39%), Gaps = 1/38 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEI 421
F + ++ L K+ VH DL N+ T +
Sbjct: 167 LCFAYQVAKGMEFLEFKSCVHRDLAAR-NVLVTHGKVV 203
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 6e-37
Identities = 46/257 (17%), Positives = 80/257 (31%), Gaps = 41/257 (15%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
+ + VA+K++ + +A + E A++ +P +V L + + ++ E
Sbjct: 38 LPYEPFTMVAVKMLKE-EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96
Query: 892 KLQGDMLEMILSSEKGR-----------------------LSERTTKFIITQILVALKHL 928
+ L L S LS I Q+ + +L
Sbjct: 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156
Query: 929 HSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS--------------FPPEV 974
+ VH DL N L+ N VK+ DFG +R I PPE
Sbjct: 157 SERKFVHRDLATRNCLVGENMV---VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES 213
Query: 975 LRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAID 1034
+ Y D+W+ GV+++ S E I + + +
Sbjct: 214 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYN 273
Query: 1035 LINNLLQVKQRKRLSVD 1051
L+ R S
Sbjct: 274 LMRLCWSKLPADRPSFC 290
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 50/246 (20%), Positives = 84/246 (34%), Gaps = 25/246 (10%)
Query: 823 AVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQE-AQLKNEVAILQNLCHPGVVNLERMFE 881
VV VA+K + + EV + +L H ++ L +
Sbjct: 22 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81
Query: 882 TPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPE 941
TP + +V E L L +G T Q+ + +L SK +H DL
Sbjct: 82 TP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR 140
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKS---------------FPPEVLRNKGYNRSLDM 986
N+LL+T VK+ DFG R + + PE L+ + ++ + D
Sbjct: 141 NLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 197
Query: 987 WSVGVIVYVSLS-GTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVK 1043
W GV ++ + G P+ I +I D D +++ K
Sbjct: 198 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG--ERLPRPEDCPQDIYNVMVQCWAHK 255
Query: 1044 QRKRLS 1049
R +
Sbjct: 256 PEDRPT 261
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-36
Identities = 47/251 (18%), Positives = 99/251 (39%), Gaps = 21/251 (8%)
Query: 835 KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894
K VAIK + + KQ E I+ H ++ LE + + ++ E ++
Sbjct: 34 KKEVPVAIKTLKA-GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 92
Query: 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQV 954
L+ L + G S ++ I +K+L + N VH DL N+L+++N
Sbjct: 93 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---C 149
Query: 955 KLCDFGFARIIGEKS---------------FPPEVLRNKGYNRSLDMWSVGVIVYVSLSG 999
K+ DFG +R++ + PE + + + + D+WS G++++ ++
Sbjct: 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 209
Query: 1000 TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA--HP 1057
+ +E ++ + D S L+ Q ++ +R ++
Sbjct: 210 GERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
Query: 1058 WLQDPATWSDL 1068
++ P + L
Sbjct: 270 LIRAPDSLKTL 280
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 6e-36
Identities = 46/241 (19%), Positives = 90/241 (37%), Gaps = 21/241 (8%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL-ERMFETPGRIFVVME 891
+ A+K ++++ + +Q E I+++ HP V++L + G VV+
Sbjct: 51 NDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109
Query: 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSEL 951
++ L + +E + + Q+ +K L SK VH DL N +L
Sbjct: 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK--- 166
Query: 952 PQVKLCDFGFARIIGEKSF----------------PPEVLRNKGYNRSLDMWSVGVIVYV 995
VK+ DFG AR + +K F E L+ + + D+WS GV+++
Sbjct: 167 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 226
Query: 996 SLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055
++ P D + + +++ K R S + ++
Sbjct: 227 LMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 1056 H 1056
Sbjct: 287 R 287
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 134 bits (339), Expect = 2e-35
Identities = 38/245 (15%), Positives = 85/245 (34%), Gaps = 33/245 (13%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCH-PGVVNLERMFETPGRIFVV 889
G + + + VAIK + QL++E + L G+ N+ + +V
Sbjct: 24 GTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949
++ L G LE +L + S +T Q+L ++ +H K++V+ D+KP+N L+ +
Sbjct: 80 ID-LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPN 138
Query: 950 ELP--QVKLCDFGFARIIGEKS-------------------FPPEVLRNKGYNRSLDMWS 988
+ + DFG + + + +R D+ +
Sbjct: 139 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA 198
Query: 989 VGVIVYVSLSGT--FPFNEDEDINEQIQNAAFMYPPRP----WRDISSDAIDLINNLLQV 1042
+G + L G+ + + ++ + P + ++ +
Sbjct: 199 LGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNL 258
Query: 1043 KQRKR 1047
Sbjct: 259 AFDAT 263
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 51/254 (20%), Positives = 86/254 (33%), Gaps = 37/254 (14%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVM 890
+ + VA+K++ T++E L +E+ +L L H +VNL G V+
Sbjct: 48 IKSDAAMTVAVKMLKPSAHLTERE-ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106
Query: 891 EKLQGDMLEMIL-----------------SSEKGRLSERTTKFIITQILVALKHLHSKNI 933
E L L ++ L Q+ + L SKN
Sbjct: 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166
Query: 934 VHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKS--------------FPPEVLRNKG 979
+H DL N+LL+ K+CDFG AR I S PE + N
Sbjct: 167 IHRDLAARNILLTHGR---ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223
Query: 980 YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM-YPPRPWRDISSDAIDLINN 1038
Y D+WS G+ ++ S ++ + + ++ D++
Sbjct: 224 YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT 283
Query: 1039 LLQVKQRKRLSVDK 1052
KR + +
Sbjct: 284 CWDADPLKRPTFKQ 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 0.001
Identities = 12/39 (30%), Positives = 16/39 (41%), Gaps = 1/39 (2%)
Query: 384 KSFRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422
SF + + L SKN +H DL N+ T K
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAAR-NILLTHGRITK 185
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 46/261 (17%), Positives = 92/261 (35%), Gaps = 33/261 (12%)
Query: 832 VHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891
V + VAIK +++ ++ + NE ++++ VV L + V+ME
Sbjct: 45 VKDEPETRVAIKTVNE-AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103
Query: 892 KLQGDMLEMILSSEKGR---------LSERTTKFIITQILVALKHLHSKNIVHCDLKPEN 942
+ L+ L S + S + +I + +L++ VH DL N
Sbjct: 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 163
Query: 943 VLLSTNSELPQVKLCDFGFARIIGEKS--------------FPPEVLRNKGYNRSLDMWS 988
+++ + VK+ DFG R I E PE L++ + D+WS
Sbjct: 164 CMVAED---FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 220
Query: 989 VGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRL 1048
GV+++ + + + ++ + +L+ Q + R
Sbjct: 221 FGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 280
Query: 1049 SVD------KSLAHPWLQDPA 1063
S K P ++ +
Sbjct: 281 SFLEIISSIKEEMEPGFREVS 301
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 44/248 (17%), Positives = 95/248 (38%), Gaps = 34/248 (13%)
Query: 835 KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVMEKL 893
VA+K++ K + L +E+ +++ + H ++NL G ++V++E
Sbjct: 43 NRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 101
Query: 894 QGDMLEMIL---------------SSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDL 938
L L + + +LS + Q+ +++L SK +H DL
Sbjct: 102 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 161
Query: 939 KPENVLLSTNSELPQVKLCDFGFARIIGEKS--------------FPPEVLRNKGYNRSL 984
NVL++ ++ +K+ DFG AR I PE L ++ Y
Sbjct: 162 AARNVLVTEDN---VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 218
Query: 985 DMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQ 1044
D+WS GV+++ + + E + + + +++ ++ +
Sbjct: 219 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 278
Query: 1045 RKRLSVDK 1052
+R + +
Sbjct: 279 SQRPTFKQ 286
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 51/255 (20%), Positives = 95/255 (37%), Gaps = 34/255 (13%)
Query: 833 HRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNL-ERMFETPGRIFVVME 891
+ R VA+K++ + ++ A + ++ H VVNL + G + V++E
Sbjct: 39 KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 98
Query: 892 KLQGDMLEMILSSE---------------KGRLSERTTKFIITQILVALKHLHSKNIVHC 936
+ L L S+ K L+ Q+ ++ L S+ +H
Sbjct: 99 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 158
Query: 937 DLKPENVLLSTNSELPQVKLCDFGFARIIGEKS--------------FPPEVLRNKGYNR 982
DL N+LLS + VK+CDFG AR I + PE + ++ Y
Sbjct: 159 DLAARNILLSEKNV---VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 215
Query: 983 SLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM-YPPRPWRDISSDAIDLINNLLQ 1041
D+WS GV+++ S I+E+ R + + + +
Sbjct: 216 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 275
Query: 1042 VKQRKRLSVDKSLAH 1056
+ +R + + + H
Sbjct: 276 GEPSQRPTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 126 bits (317), Expect = 4e-32
Identities = 69/327 (21%), Positives = 121/327 (37%), Gaps = 77/327 (23%)
Query: 831 GVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-----------CHPGVVNLERM 879
+ VA+K++ + T+ ++E+ +LQ + ++ L
Sbjct: 32 AKDMVNNTHVAMKIVRGDKVYTEA---AEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88
Query: 880 FETPG----RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIV 934
F G + +V E L ++L +I E + K I Q+L+ L ++H + I+
Sbjct: 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGII 148
Query: 935 HCDLKPENVLLSTNS---ELPQVKLCDFGFARIIGEKSF---------PPEVLRNKGYNR 982
H D+KPENVL+ L Q+K+ D G A E PEVL +
Sbjct: 149 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGC 208
Query: 983 SLDMWSVGVIVYVSLSGTFPF--------NEDEDINEQIQNAAFMYPPRPWR-------- 1026
D+WS +++ ++G F F +D+D QI P R
Sbjct: 209 GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTF 268
Query: 1027 ------------------------------DISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056
D + + D ++ +LQ+ RKR + H
Sbjct: 269 FNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328
Query: 1057 PWLQDPATWSDLRGLERQIGTNKKKNP 1083
PWL+D ++R +R++ + P
Sbjct: 329 PWLKDTLGMEEIRVPDRELYGSGSDIP 355
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-25
Identities = 40/270 (14%), Positives = 79/270 (29%), Gaps = 62/270 (22%)
Query: 834 RKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG----RIFVV 889
+ G VA+K+ ++ + E+ L H ++ ++++V
Sbjct: 23 KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79
Query: 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS--------KNIVHCDLKPE 941
+ + L L + ++ + L HLH I H DLK +
Sbjct: 80 SDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137
Query: 942 NVLLSTNSELPQVKLCDFGFARIIGEKS----------------FPPEVLRNKGYNRSL- 984
N+L+ N + D G A + PEVL + +
Sbjct: 138 NILVKKNG---TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 194
Query: 985 -----DMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF----------------MYPPR 1023
D++++G++ + ED + + P
Sbjct: 195 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI 254
Query: 1024 PWRDISSDA----IDLINNLLQVKQRKRLS 1049
P R S +A ++ RL+
Sbjct: 255 PNRWQSCEALRVMAKIMRECWYANGAARLT 284
|
| >d1xa6a3 g.49.1.1 (A:209-270) Beta-chimaerin, middle domain {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Beta-chimaerin, middle domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.1 bits (197), Expect = 4e-19
Identities = 24/51 (47%), Positives = 30/51 (58%)
Query: 265 PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315
H F +HT+ P C C + GL QG++C DCG NVHK+C VP DC
Sbjct: 4 THNFKVHTFRGPHWCEYCANFMWGLIAQGVRCSDCGLNVHKQCSKHVPNDC 54
|
| >d1xa6a3 g.49.1.1 (A:209-270) Beta-chimaerin, middle domain {Human (Homo sapiens) [TaxId: 9606]} Length = 62 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Beta-chimaerin, middle domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.1 bits (197), Expect = 4e-19
Identities = 24/51 (47%), Positives = 30/51 (58%)
Query: 529 PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579
H F +HT+ P C C + GL QG++C DCG NVHK+C VP DC
Sbjct: 4 THNFKVHTFRGPHWCEYCANFMWGLIAQGVRCSDCGLNVHKQCSKHVPNDC 54
|
| >d1ptqa_ g.49.1.1 (A:) Protein kinase C-delta (PKCdelta) {Mouse (Mus musculus) [TaxId: 10090]} Length = 50 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase C-delta (PKCdelta) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 79.0 bits (194), Expect = 7e-19
Identities = 27/50 (54%), Positives = 32/50 (64%)
Query: 266 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315
H F ++ Y PT C C LL GL KQGL+C+DCG NVH KC +KV C
Sbjct: 1 HRFKVYNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLC 50
|
| >d1ptqa_ g.49.1.1 (A:) Protein kinase C-delta (PKCdelta) {Mouse (Mus musculus) [TaxId: 10090]} Length = 50 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase C-delta (PKCdelta) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 79.0 bits (194), Expect = 7e-19
Identities = 27/50 (54%), Positives = 32/50 (64%)
Query: 530 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579
H F ++ Y PT C C LL GL KQGL+C+DCG NVH KC +KV C
Sbjct: 1 HRFKVYNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLC 50
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.1 bits (202), Expect = 2e-18
Identities = 32/184 (17%), Positives = 58/184 (31%), Gaps = 41/184 (22%)
Query: 832 VHRKSGRGVAIKVI----------------DKLRFPTKQEAQLKNEVAILQNLCHPGVVN 875
+ + +K L F +NE LQ L V
Sbjct: 19 CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVP- 77
Query: 876 LERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVH 935
+++ V+ME + L + ++ IL + + + IVH
Sbjct: 78 --KVYAW-EGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFYHRGIVH 126
Query: 936 CDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSFPPEVLR---------NKGYNRSLDM 986
DL NVL+S + + DF + +GE+ + + R ++ Y D+
Sbjct: 127 GDLSQYNVLVSEE----GIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEKDI 182
Query: 987 WSVG 990
S
Sbjct: 183 NSAI 186
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 37.5 bits (86), Expect = 0.004
Identities = 8/27 (29%), Positives = 11/27 (40%)
Query: 388 RSILVALKHLHSKNIVHCDLKPERNLF 414
IL + + + IVH DL L
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLV 136
|
| >d1tbna_ g.49.1.1 (A:) Protein kinase c-gamma {Rat (Rattus rattus) [TaxId: 10117]} Length = 66 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase c-gamma species: Rat (Rattus rattus) [TaxId: 10117]
Score = 76.2 bits (187), Expect = 9e-18
Identities = 24/52 (46%), Positives = 31/52 (59%)
Query: 264 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315
H F LH+Y+ PT C C LL GL QG++C C NVH++C+ VP C
Sbjct: 7 NKHKFRLHSYSSPTFCDHCGSLLYGLVHQGMKCSCCEMNVHRRCVRSVPSLC 58
|
| >d1tbna_ g.49.1.1 (A:) Protein kinase c-gamma {Rat (Rattus rattus) [TaxId: 10117]} Length = 66 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase c-gamma species: Rat (Rattus rattus) [TaxId: 10117]
Score = 76.2 bits (187), Expect = 9e-18
Identities = 24/52 (46%), Positives = 31/52 (59%)
Query: 528 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579
H F LH+Y+ PT C C LL GL QG++C C NVH++C+ VP C
Sbjct: 7 NKHKFRLHSYSSPTFCDHCGSLLYGLVHQGMKCSCCEMNVHRRCVRSVPSLC 58
|
| >d1tbna_ g.49.1.1 (A:) Protein kinase c-gamma {Rat (Rattus rattus) [TaxId: 10117]} Length = 66 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase c-gamma species: Rat (Rattus rattus) [TaxId: 10117]
Score = 37.3 bits (86), Expect = 5e-04
Identities = 10/26 (38%), Positives = 15/26 (57%)
Query: 177 GCSLNFHKRCVVKIPNNCSSGYKHRR 202
C +N H+RCV +P+ C + RR
Sbjct: 41 CCEMNVHRRCVRSVPSLCGVDHTERR 66
|
| >d1r79a_ g.49.1.1 (A:) Diacylglycerol kinase delta {Human (Homo sapiens) [TaxId: 9606]} Length = 84 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Diacylglycerol kinase delta species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.5 bits (185), Expect = 2e-17
Identities = 13/58 (22%), Positives = 21/58 (36%), Gaps = 1/58 (1%)
Query: 261 SVNIPHTFNLHTYTRPTLCGLCKKLLKGLF-KQGLQCKDCGFNVHKKCLDKVPKDCVG 317
+ +PH + C +C K + Q +C C VH C + + C G
Sbjct: 23 GIAMPHQWLEGNLPVSAKCTVCDKTCGSVLRLQDWRCLWCKAMVHTSCKESLLTKCSG 80
|
| >d1r79a_ g.49.1.1 (A:) Diacylglycerol kinase delta {Human (Homo sapiens) [TaxId: 9606]} Length = 84 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Diacylglycerol kinase delta species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.5 bits (185), Expect = 2e-17
Identities = 13/58 (22%), Positives = 21/58 (36%), Gaps = 1/58 (1%)
Query: 525 SVNIPHTFNLHTYTRPTLCGLCKKLLKGLF-KQGLQCKDCGFNVHKKCLDKVPKDCVG 581
+ +PH + C +C K + Q +C C VH C + + C G
Sbjct: 23 GIAMPHQWLEGNLPVSAKCTVCDKTCGSVLRLQDWRCLWCKAMVHTSCKESLLTKCSG 80
|
| >d1faqa_ g.49.1.1 (A:) RAF-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 52 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: RAF-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (171), Expect = 9e-16
Identities = 18/52 (34%), Positives = 26/52 (50%), Gaps = 4/52 (7%)
Query: 265 PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCV 316
H F T+ + C +C+K L G +C+ CG+ H+ C KVP CV
Sbjct: 3 THNFARKTFLKLAFCDICQKFLL----NGFRCQTCGYKFHEHCSTKVPTMCV 50
|
| >d1faqa_ g.49.1.1 (A:) RAF-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 52 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: RAF-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (171), Expect = 9e-16
Identities = 18/52 (34%), Positives = 26/52 (50%), Gaps = 4/52 (7%)
Query: 529 PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCV 580
H F T+ + C +C+K L G +C+ CG+ H+ C KVP CV
Sbjct: 3 THNFARKTFLKLAFCDICQKFLL----NGFRCQTCGYKFHEHCSTKVPTMCV 50
|
| >d1kbea_ g.49.1.1 (A:) Kinase suppressor of Ras, Ksr {Mouse (Mus musculus) [TaxId: 10090]} Length = 49 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Kinase suppressor of Ras, Ksr species: Mouse (Mus musculus) [TaxId: 10090]
Score = 69.5 bits (170), Expect = 1e-15
Identities = 13/50 (26%), Positives = 23/50 (46%), Gaps = 5/50 (10%)
Query: 264 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK 313
+ H F+ ++ C +C+K + G++CK C H KC + P
Sbjct: 3 VTHRFSTKSWLSQV-CNVCQKSMI----FGVKCKHCRLKCHNKCTKEAPA 47
|
| >d1kbea_ g.49.1.1 (A:) Kinase suppressor of Ras, Ksr {Mouse (Mus musculus) [TaxId: 10090]} Length = 49 | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Kinase suppressor of Ras, Ksr species: Mouse (Mus musculus) [TaxId: 10090]
Score = 69.5 bits (170), Expect = 1e-15
Identities = 13/50 (26%), Positives = 23/50 (46%), Gaps = 5/50 (10%)
Query: 528 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPK 577
+ H F+ ++ C +C+K + G++CK C H KC + P
Sbjct: 3 VTHRFSTKSWLSQV-CNVCQKSMI----FGVKCKHCRLKCHNKCTKEAPA 47
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1098 | |||
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.8 | |
| d1tbna_ | 66 | Protein kinase c-gamma {Rat (Rattus rattus) [TaxId | 99.44 | |
| d1tbna_ | 66 | Protein kinase c-gamma {Rat (Rattus rattus) [TaxId | 99.41 | |
| d1xa6a3 | 62 | Beta-chimaerin, middle domain {Human (Homo sapiens | 99.41 | |
| d1ptqa_ | 50 | Protein kinase C-delta (PKCdelta) {Mouse (Mus musc | 99.4 | |
| d1xa6a3 | 62 | Beta-chimaerin, middle domain {Human (Homo sapiens | 99.38 | |
| d1ptqa_ | 50 | Protein kinase C-delta (PKCdelta) {Mouse (Mus musc | 99.38 | |
| d1r79a_ | 84 | Diacylglycerol kinase delta {Human (Homo sapiens) | 99.19 | |
| d1kbea_ | 49 | Kinase suppressor of Ras, Ksr {Mouse (Mus musculus | 99.17 | |
| d1r79a_ | 84 | Diacylglycerol kinase delta {Human (Homo sapiens) | 99.15 | |
| d1faqa_ | 52 | RAF-1 {Human (Homo sapiens) [TaxId: 9606]} | 99.13 | |
| d1kbea_ | 49 | Kinase suppressor of Ras, Ksr {Mouse (Mus musculus | 99.11 | |
| d1faqa_ | 52 | RAF-1 {Human (Homo sapiens) [TaxId: 9606]} | 99.11 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 98.91 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 98.82 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 98.79 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 98.78 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 98.77 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 98.74 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 98.71 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 98.67 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 98.63 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 98.63 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 98.63 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 98.62 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 98.61 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 98.61 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 98.6 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 98.6 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 98.6 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 98.59 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 98.58 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 98.57 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 98.56 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 98.55 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 98.55 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 98.55 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 98.54 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 98.54 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 98.54 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 98.53 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 98.53 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 98.52 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 98.51 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 98.51 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 98.5 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 98.5 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 98.49 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 98.48 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 98.48 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 98.46 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 98.45 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 98.45 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 98.44 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 98.44 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 98.44 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 98.43 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 98.42 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 98.4 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 98.4 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 98.4 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 98.39 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 98.39 | |
| d1a25a_ | 132 | C2 domain from protein kinase c (beta) {Rat (Rattu | 98.39 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 98.38 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 98.34 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 98.34 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 98.31 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 98.3 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 98.3 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 98.24 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 98.2 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 98.18 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 98.11 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 98.05 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 97.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.84 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 97.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.22 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.74 | |
| d2bwqa1 | 125 | Regulating synaptic membrane exocytosis protein, r | 96.49 | |
| d1rh8a_ | 142 | Piccolo {Rat (Rattus norvegicus) [TaxId: 10116]} | 96.46 | |
| d1dqva2 | 145 | Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: | 96.45 | |
| d2cm5a1 | 137 | C2b-domain of rabphilin {Rat (Rattus norvegicus) [ | 96.17 | |
| d1w15a_ | 138 | Synaptotagmin IV {Rat (Rattus norvegicus) [TaxId: | 96.01 | |
| d1wmha_ | 83 | Protein kinase C, iota type {Human (Homo sapiens) | 95.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.2 | |
| d1dqva1 | 130 | Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: | 95.06 | |
| d1wfma_ | 138 | Synaptotagmin XIII {Human (Homo sapiens) [TaxId: 9 | 94.77 | |
| d1rsya_ | 143 | Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10 | 94.72 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.69 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.58 | |
| d1qasa2 | 131 | PI-specific phospholipase C isozyme D1 (PLC-D1), C | 94.09 | |
| d1rlwa_ | 126 | Domain from cytosolic phospholipase A2 {Human (Hom | 93.95 | |
| d1uowa_ | 157 | Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10 | 93.77 | |
| d1ugka_ | 138 | Synaptotagmin IV {Human (Homo sapiens) [TaxId: 960 | 93.64 | |
| d2ep6a1 | 126 | Multiple C2 and transmembrane domain-containing pr | 93.22 | |
| d1bdya_ | 123 | Domain from protein kinase C delta {Rat (Rattus no | 92.8 | |
| d1wfja_ | 136 | C2 domain protein At1g63220 {Thale cress (Arabidop | 91.88 | |
| d2nq3a1 | 133 | E3 ubiquitin-protein ligase Itchy {Human (Homo sap | 89.07 | |
| d1gmia_ | 136 | Domain from protein kinase C epsilon {Rat (Rattus | 85.92 | |
| d1v5na_ | 89 | Pdi-like hypothetical protein At1g60420 {Thale cre | 82.81 | |
| d1v5na_ | 89 | Pdi-like hypothetical protein At1g60420 {Thale cre | 82.21 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=425.32 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=221.4
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..|.+...||.|+||.||.|.++.+|+.||||++++.... ......+.+|+++|+.++||||++++++|.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4588999999999999999999999999999999764321 223467999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||++|++|..++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 88 Ey~~gg~L~~~~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~---~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS---CEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhh-ccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc---eEEecccccceecccCCc
Confidence 9999999988776 456799999999999999999999999999999999999999998 8999999999753
Q ss_pred ---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 966 ---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
+..|+|||++.+..|+.++|||||||+||||++|+.||.+... ....+...... .+..+++++.+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~----~p~~~s~~~~~ 239 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD----FPEKFFPKARD 239 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC----CCTTCCHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC----CCccCCHHHHH
Confidence 2246899999999999999999999999999999999987543 33334433332 33568999999
Q ss_pred HHHHhhhhcccCCCCHHH------HHcCCCcCCCCCcchhHHHHhhhCCC
Q psy48 1035 LINNLLQVKQRKRLSVDK------SLAHPWLQDPATWSDLRGLERQIGTN 1078 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~e------IL~HpfFk~~~~~~~~~~l~~~~~~~ 1078 (1098)
||.+||+.||++|||++| |++||||++ +||++|+++.+|+
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~----i~w~~l~~~~pP~ 285 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES----VTWENLHQQTPPK 285 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT----CCCTTGGGSCCCC
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC----CCHHHhhcCCCCC
Confidence 999999999999999987 689999998 6788887775444
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=428.93 Aligned_cols=261 Identities=27% Similarity=0.418 Sum_probs=227.9
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.+..|.+...||.|+||.||.+.++.+|+.||||++++.... ......+.+|+.+|+.++||||++++++|++.+.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 356789999999999999999999999999999999875321 2335778999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||++||+|..++. ..+.+++..++.+++||+.||+|||++||+||||||+|||++.+| ++||+|||+|+...
T Consensus 83 v~ey~~gg~L~~~~~-~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g---~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 83 VMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG---HIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---CEEECCCTTCBCSCCT
T ss_pred ceeccCCCchhhhhh-cccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC---CEEEeecccccccccC
Confidence 999999999988876 456799999999999999999999999999999999999999998 89999999997532
Q ss_pred ----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 967 ----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 967 ----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
..|+|||++.+..|+.++|||||||++|||++|++||.+.+. +.+.+.... ...+..+|+++.+
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~----~~~p~~~s~~~~d 234 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----IRFPRTLSPEAKS 234 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----CCCCTTSCHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC----CCCCccCCHHHHH
Confidence 235899999999999999999999999999999999987643 333443333 3334679999999
Q ss_pred HHHHhhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCC
Q psy48 1035 LINNLLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKN 1082 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~ 1082 (1098)
||.+||++||++|++ ++++++||||++ ++|+.+..+ +.||+.+.
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~----i~~~~l~~~~~~~p~~P~ 284 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS----INWQDVVQKKLLPPFKPQ 284 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT----CCHHHHHTTCSCCSCCCC
T ss_pred HHHhhccCCchhhcccccccHHHHHcCccccc----CCHHHHHhCCCCCCCCCC
Confidence 999999999999995 899999999998 788888877 88887643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.8e-47 Score=424.49 Aligned_cols=259 Identities=31% Similarity=0.496 Sum_probs=225.7
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
+..|.+...||.|+||.||.+.++.+|+.||||++++.... ......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 45688999999999999999999999999999999764321 22346789999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
|||+.|++|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+..
T Consensus 83 mE~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g---~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG---HIKITDFGFAKYVPDVT 158 (316)
T ss_dssp ECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS---CEEECCCSSCEECSSCB
T ss_pred eeecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC---CEEEecCccceEecccc
Confidence 99999999977765 556789999999999999999999999999999999999999998 8999999999754
Q ss_pred -----CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 966 -----GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 966 -----~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
+..|+|||++.+..|+.++|||||||+||||++|+.||.+... ....+......+ +..+|+++.++|.+
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~~ 234 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLSR 234 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC----CTTSCHHHHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHH
Confidence 3357899999999999999999999999999999999987643 333444433333 34689999999999
Q ss_pred hhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCC
Q psy48 1039 LLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKK 1081 (1098)
Q Consensus 1039 cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~ 1081 (1098)
||++||++|+ |++++++||||++ ++|+.|..+ +++|+.+
T Consensus 235 ~L~~dp~~R~~~~r~t~~~il~Hp~f~~----i~~~~l~~~~~~~p~~p 279 (316)
T d1fota_ 235 LITRDLSQRLGNLQNGTEDVKNHPWFKE----VVWEKLLSRNIETPYEP 279 (316)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS----CCHHHHHTTCSCCSCCC
T ss_pred HhhhCHHhccccchhhHHHHHcCccccc----CCHHHHHhCCCCcCCCC
Confidence 9999999996 8999999999999 788888776 8877754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=418.26 Aligned_cols=246 Identities=22% Similarity=0.393 Sum_probs=209.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.+...||.|+||.||.+.++.+|+.||||++++... .+..+.+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 4568899999999999999999999999999999976542 223467899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||++|++|..++. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 83 Ey~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~---~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 83 EYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNR 158 (271)
T ss_dssp ECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC---CEEECCCTTCEECEETTE
T ss_pred eccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC---CEEEccchhheeeccCCc
Confidence 9999999988875 456799999999999999999999999999999999999999988 8999999999743
Q ss_pred ---------CCCCCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCChhHHHHH-HHhhccCCCCCCCcCcHHHHH
Q psy48 966 ---------GEKSFPPEVLRNKGY-NRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI-QNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 ---------~~~~~APEvl~~~~y-s~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i-~~~~~~~p~~~~~~is~el~~ 1034 (1098)
+..|+|||++.+..| +.++|||||||+||||++|+.||....+..... ...........+..+|+++.+
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence 234689999998876 578999999999999999999997543221111 112222233446789999999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
||.+||+.||++|||++|+++||||++
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 999999999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-46 Score=428.72 Aligned_cols=262 Identities=32% Similarity=0.497 Sum_probs=227.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
+..|.....||.|+||.||.+.++.+|+.||||++++.... ......+.+|+.+|+.++||||++++++|.+...+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 45788999999999999999999999999999999764321 22346789999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||+.|++|..++. ..+.+++..++.++.||+.||.|||++|||||||||+|||++.++ ++||+|||+|+...
T Consensus 120 ~e~~~~g~l~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g---~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG---YIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EECCTTCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECSSCB
T ss_pred cccccccchhhhHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC---CEEeeeceeeeeccccc
Confidence 99999999988876 445799999999999999999999999999999999999999998 89999999997653
Q ss_pred ------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 967 ------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 967 ------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
..|||||++.+..|+.++|||||||+||||++|+.||.+.... ...+.... ...+..+|+++.+||.+
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~----~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK----VRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----CCCCTTCCHHHHHHHHH
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC----CCCCccCCHHHHHHHHH
Confidence 2368999999999999999999999999999999999876433 23333322 22345799999999999
Q ss_pred hhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcc
Q psy48 1039 LLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPK 1084 (1098)
Q Consensus 1039 cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~ 1084 (1098)
||..||.+|+ |++++++||||++ +||+.++++ +.+|+.+..+
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~----~~~~~~~~~~~~~p~~p~~~ 319 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT----TDWIAIYQRKVEAPFIPKFK 319 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTT----CCHHHHHTTCSCCSCCCCCC
T ss_pred HhhhCHHhccccccccHHHHHcCccccC----CCHHHHHhcCCCcCccCCCC
Confidence 9999999995 8999999999998 688888877 8888766543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=412.12 Aligned_cols=243 Identities=28% Similarity=0.457 Sum_probs=213.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
+..|.....||.|+||.||.+.++.+++.||||++.+.... ......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 45688999999999999999999999999999999764322 22346789999999999999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC--
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE-- 967 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~-- 967 (1098)
|||++||+|..++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 85 mEy~~~g~L~~~l~-~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~---~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG---ELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---CEEECCCCSCSCCCCCC
T ss_pred EeecCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC---CEeecccceeeecCCCc
Confidence 99999999988886 456799999999999999999999999999999999999999998 899999999975432
Q ss_pred --------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 968 --------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 968 --------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
.|+|||++.+..|+.++|||||||+||||++|+.||.+.. +....+...... .+..+|+++.+||.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----~p~~~s~~~~~li~ 236 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT----FPDFVTEGARDLIS 236 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC----CCTTSCHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----CCccCCHHHHHHHH
Confidence 4589999999999999999999999999999999998654 333333333322 33568999999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+||+.||++|||++|+++||||+.
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCC
Confidence 999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=415.31 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=213.4
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.+|.....||.|+||.||.+.++.+|+.||||++++.... ..+.+.+|+.+|+.++||||++++++|.+.+.+|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4688889999999999999999999999999999865432 34678999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-----
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG----- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~----- 966 (1098)
|++|++|..++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+...
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~---~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG---SVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---CEEECCCTTCEECCSTTCC
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC---cEeeccchhheeecccccc
Confidence 9999999887653 4699999999999999999999999999999999999999998 89999999997542
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc-cCCCCCCCcCcHHHHHHHHH
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF-MYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~-~~p~~~~~~is~el~~LL~~ 1038 (1098)
..|+|||++.+..|+.++|||||||++|+|++|+.||.+............. ..+...+..+|+++.+||.+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 2357999999999999999999999999999999999876543322222221 22333456799999999999
Q ss_pred hhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1039 LLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1039 cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
||+.||++|||++|+++||||+...
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HccCChhHCcCHHHHhcCHhhCCCC
Confidence 9999999999999999999998643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=414.13 Aligned_cols=244 Identities=23% Similarity=0.319 Sum_probs=212.8
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|.....||.|+||.||.+.++.+++.||||++++.. ....+.+.+|+++|+.++|||||++++++.+.+.+++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 46888899999999999999999999999999997643 3445778999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|++||+|..++.+..+.+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~---~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG---DIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC---CEEEEechhhhccCCCccc
Confidence 9999999988876677899999999999999999999999999999999999999998 8999999998532
Q ss_pred ------CCCCCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHH
Q psy48 966 ------GEKSFPPEVLR-----NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 966 ------~~~~~APEvl~-----~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
+..|+|||++. +..|+.++|||||||+||||++|+.||.+.. +....+..... .....+..+|+++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~ 245 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSNF 245 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC-CCCSSGGGSCHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCccccCCHHH
Confidence 34578999984 5668999999999999999999999998654 33333332221 1222346789999
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+||.+||+.||++|||++|+++||||+.
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=409.48 Aligned_cols=243 Identities=20% Similarity=0.378 Sum_probs=209.8
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec----CCcEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET----PGRIFV 888 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~----~~~l~L 888 (1098)
++++...||.|+||.||.+.++.+++.||||++............+.+|+++|+.++||||++++++|.+ ...+++
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 3478889999999999999999999999999998877677777889999999999999999999999865 356899
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecC-CCCCCcEEEeecCccccc
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKN--IVHCDLKPENVLLST-NSELPQVKLCDFGFARII 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~g--IvHrDLKp~NILld~-~g~~~~vKL~DFGla~~~ 965 (1098)
||||++|++|..++. +...+++..++.++.||+.||+|||++| |+||||||+|||++. ++ .+||+|||+|+..
T Consensus 90 vmE~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~---~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG---SVKIGDLGLATLK 165 (270)
T ss_dssp EEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS---CEEECCTTGGGGC
T ss_pred EEeCCCCCcHHHHHh-ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCC---CEEEeecCcceec
Confidence 999999999988886 4467999999999999999999999998 999999999999974 66 8999999999743
Q ss_pred ----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhcc-CCCCCCCcCcHHHHH
Q psy48 966 ----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFM-YPPRPWRDISSDAID 1034 (1098)
Q Consensus 966 ----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~-~p~~~~~~is~el~~ 1034 (1098)
+..|+|||++.+ .|+.++|||||||++|||++|+.||.+.............. .+...+..+++++.+
T Consensus 166 ~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 166 RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244 (270)
T ss_dssp CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred cCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence 345789999876 59999999999999999999999998654443333333222 233334568899999
Q ss_pred HHHHhhhhcccCCCCHHHHHcCCCcC
Q psy48 1035 LINNLLQVKQRKRLSVDKSLAHPWLQ 1060 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPSa~eIL~HpfFk 1060 (1098)
||.+||+.||++|||++|+++|||||
T Consensus 245 li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 245 IIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999999999999999997
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-46 Score=416.46 Aligned_cols=249 Identities=33% Similarity=0.595 Sum_probs=208.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.+...||.|+||.||.+.++.+++.||||++.+.... .....+.+|+.+|+.++||||++++++|.+++.+|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35689999999999999999999999999999999875433 23467889999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||++|++|..++. ..+.+++..+..++.||+.||+|||++||+||||||+|||+........+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 87 QLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp CCCCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred eccCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 9999999988886 4567999999999999999999999999999999999999964222228999999999643
Q ss_pred ------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 966 ------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
+..|+|||++.+..|+.++|||||||+||||++|+.||.+.. +....+.......+...+..+|+++.+||.
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 245 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245 (307)
T ss_dssp -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHH
Confidence 345689999999999999999999999999999999998764 444555555555565666789999999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+||++||++|||++|+++||||++
T Consensus 246 ~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 246 HLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.8e-46 Score=422.89 Aligned_cols=249 Identities=28% Similarity=0.477 Sum_probs=220.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
+.+|.+...||.|+||.||.+.++.+|+.||||++.+.. ....+.+.+|+.+|+.++||||++++++|.+.+.+|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 568999999999999999999999999999999997643 445678999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||++||+|..++....+++++..++.++.||+.||.|||++|||||||||+|||++.+.. ..+||+|||+|+..
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~-~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS-NELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTS-CCEEECCCTTCEECCTTSC
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCC-CeEEEeecchheecccccc
Confidence 999999998888766778999999999999999999999999999999999999975321 18999999999754
Q ss_pred ------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 966 ------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
+..|||||++.+..|+.++|||||||++|||++|..||.+.. +....+.......+...+..+|+++.+||.
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 261 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 345689999999999999999999999999999999998653 344555555555555556789999999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+||..||++|||++|+++||||+..
T Consensus 262 ~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 262 KLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-46 Score=415.00 Aligned_cols=254 Identities=22% Similarity=0.263 Sum_probs=217.1
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..|+....||.|+||.||.|.++.+++.||||++++..... .....+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999999999999999998765443 33477999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||+.+++|..++. ....+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 95 E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~---~~Kl~DFG~a~~~~~~~~ 170 (309)
T d1u5ra_ 95 EYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG---LVKLGDFGSASIMAPANS 170 (309)
T ss_dssp ECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT---EEEECCCTTCBSSSSBCC
T ss_pred EecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC---CEEEeecccccccCCCCc
Confidence 9999999966554 456799999999999999999999999999999999999999998 8999999999754
Q ss_pred ---CCCCCChhhhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHHh
Q psy48 966 ---GEKSFPPEVLRN---KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINNL 1039 (1098)
Q Consensus 966 ---~~~~~APEvl~~---~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~c 1039 (1098)
+..|+|||++.+ ..|+.++|||||||++|||++|..||.+...............+......+|+++.+||.+|
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 250 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 234689999964 45899999999999999999999999876544333333333334434456899999999999
Q ss_pred hhhcccCCCCHHHHHcCCCcCCCCCcchhH
Q psy48 1040 LQVKQRKRLSVDKSLAHPWLQDPATWSDLR 1069 (1098)
Q Consensus 1040 L~~dP~kRPSa~eIL~HpfFk~~~~~~~~~ 1069 (1098)
|+.||++|||++++++||||+.......+.
T Consensus 251 L~~dP~~Rpt~~ell~Hp~~~~~~~~~~~~ 280 (309)
T d1u5ra_ 251 LQKIPQDRPTSEVLLKHRFVLRERPPTVIM 280 (309)
T ss_dssp TCSSGGGSCCHHHHTTCHHHHSCCCTTHHH
T ss_pred CcCChhHCcCHHHHHhCHHhcCCCCchhhH
Confidence 999999999999999999998654433333
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.7e-46 Score=421.94 Aligned_cols=246 Identities=31% Similarity=0.520 Sum_probs=220.6
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.+...||.|+||.||.|.++.+|+.||||++++.. ......+.+|+.+|+.++||||++++++|.+++.+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 457999999999999999999999999999999997643 345578899999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC--CCCCCcEEEeecCcccccCC-
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLST--NSELPQVKLCDFGFARIIGE- 967 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~--~g~~~~vKL~DFGla~~~~~- 967 (1098)
||++|++|..++.....++++.+++.++.||+.||+|||++||+||||||+|||++. ++ ++||+|||+|+....
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~---~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS---SVKIIDFGLATKLNPD 182 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCC---CEEECCCTTCEECCTT
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCC---eEEEeecccceecCCC
Confidence 999999998887766678999999999999999999999999999999999999984 44 899999999976532
Q ss_pred ----------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 968 ----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 968 ----------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
.++|||++.+..|+.++|||||||+||||++|+.||.+.. +....+......++...+..+|+++.+|
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 3579999999999999999999999999999999998764 3445555656666666777899999999
Q ss_pred HHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1036 INNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
|.+||+.||++|||++|+++||||++
T Consensus 263 i~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.1e-46 Score=425.49 Aligned_cols=266 Identities=23% Similarity=0.361 Sum_probs=223.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH-HHHHHHH---HHHHHhccCCCCceeeeeeeecCCcE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK-QEAQLKN---EVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~-~~~~~~~---Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
+..|.+...||.|+||.||.+.++.+|+.||||++.+...... ....+.+ |+.+++.++||||++++++|.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 4568899999999999999999999999999999976432211 1233444 46677788899999999999999999
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG 966 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~ 966 (1098)
|+||||++|++|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g---~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG---HVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS---CEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC---cEEEeeeceeeecC
Confidence 999999999999888864 46789999999999999999999999999999999999999998 89999999997542
Q ss_pred ----------CCCCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-hHHHHHHHhhccCCCCCCCcCcHHHHH
Q psy48 967 ----------EKSFPPEVLR-NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-DINEQIQNAAFMYPPRPWRDISSDAID 1034 (1098)
Q Consensus 967 ----------~~~~APEvl~-~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-~~~~~i~~~~~~~p~~~~~~is~el~~ 1034 (1098)
..|+|||++. +..|+.++|||||||+||||++|+.||.+.. .....+.......+...+..+|+++.+
T Consensus 159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHH
Confidence 3357999997 5679999999999999999999999997642 122233334444455556789999999
Q ss_pred HHHHhhhhcccCCCC-----HHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcc
Q psy48 1035 LINNLLQVKQRKRLS-----VDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPK 1084 (1098)
Q Consensus 1035 LL~~cL~~dP~kRPS-----a~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~ 1084 (1098)
||.+||+.||++||| ++++++||||++ +||..++.+ +.||+.+...
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~----i~~~~~~~~~~~~p~~p~~~ 290 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS----LDWQMVFLQKYPPPLIPPRG 290 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT----CCHHHHHTTCSCCSCCCCCC
T ss_pred HHHHHcccCHHHhCCCcccCHHHHHcCccccC----CCHHHHhcCCCCcCcCCCCC
Confidence 999999999999999 799999999999 788888887 7777765443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=406.53 Aligned_cols=242 Identities=27% Similarity=0.417 Sum_probs=206.5
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec--CCcEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET--PGRIFVV 889 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~--~~~l~LV 889 (1098)
..|.+...||.|+||.||.+.++.+|+.||||++++..........+.+|+++|+.++||||+++++++.+ .+.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 45888899999999999999999999999999998877777777889999999999999999999999854 5679999
Q ss_pred EEeccCchHHHHHhh---ccCccchhHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceeecCCCCCCcEEEeecCc
Q psy48 890 MEKLQGDMLEMILSS---EKGRLSERTTKFIITQILVALKHLHSKN-----IVHCDLKPENVLLSTNSELPQVKLCDFGF 961 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~---~~~~lse~~~~~ia~qIa~gL~~LHs~g-----IvHrDLKp~NILld~~g~~~~vKL~DFGl 961 (1098)
|||++||+|..++.. ....+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~---~vkl~DFG~ 160 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ---NVKLGDFGL 160 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS---CEEECCHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC---cEEEeeccc
Confidence 999999999988763 2457999999999999999999999876 99999999999999998 899999999
Q ss_pred cccc------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCc
Q psy48 962 ARII------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 962 a~~~------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~ 1027 (1098)
|+.. +..|+|||++.+..|+.++|||||||++|||++|+.||.+.. ++...+..... ...+..
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~ 237 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIPYR 237 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---CCCCTT
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---CCCCcc
Confidence 9643 234789999999999999999999999999999999998653 33333333322 233457
Q ss_pred CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCc
Q psy48 1028 ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWL 1059 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRPSa~eIL~HpfF 1059 (1098)
+|+++.+||.+||+.||++|||++|+++|||+
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 89999999999999999999999999999995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-46 Score=411.98 Aligned_cols=250 Identities=30% Similarity=0.497 Sum_probs=218.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH----HHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK----QEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~----~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
..+|.....||.|+||.||.+.++.+|+.||||++++...... ..+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4579999999999999999999999999999999987554322 357899999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCC-CCcEEEeecCccccc
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE-LPQVKLCDFGFARII 965 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~-~~~vKL~DFGla~~~ 965 (1098)
|+||||++|++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ...+||+|||+|+..
T Consensus 89 ~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999888864 457999999999999999999999999999999999999987763 225999999999754
Q ss_pred C-----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHH
Q psy48 966 G-----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 966 ~-----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
. ..|+|||++.+..|+.++|||||||+||||++|+.||.+... ....+......++...+..+|+++
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 247 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHH
Confidence 2 235899999999999999999999999999999999987643 334444444444444456789999
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+||.+||+.||++|||++|+++||||+.
T Consensus 248 ~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 248 KDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999997
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-46 Score=417.52 Aligned_cols=246 Identities=23% Similarity=0.358 Sum_probs=210.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
...|.....||.|+||.||.+.++.+|+.||||++++.. .......+.+|+.+|+.++|||||+++++|.+.+++|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356888899999999999999999999999999997653 3445678999999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCCCCcEEEeecCccccc----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSK-NIVHCDLKPENVLLSTNSELPQVKLCDFGFARII---- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~-gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~---- 965 (1098)
||+.|++|..++.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++ ++||+|||+|+..
T Consensus 84 Ey~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~---~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG---EIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp ECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC---CEEECCCCCCHHHHHHT
T ss_pred EcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC---CEEEeeCCCccccCCCc
Confidence 99999999888864 45799999999999999999999975 999999999999999998 8999999998632
Q ss_pred ------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHH--------------------------
Q psy48 966 ------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQI-------------------------- 1013 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i-------------------------- 1013 (1098)
+..|+|||++.+..|+.++|||||||++|||++|+.||.+........
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 445789999999999999999999999999999999997542111100
Q ss_pred ---------------HHhhcc-CCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1014 ---------------QNAAFM-YPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1014 ---------------~~~~~~-~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
...... .+......+|.++.+||.+||..||++|||++|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000011 111112346899999999999999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=413.30 Aligned_cols=259 Identities=27% Similarity=0.377 Sum_probs=218.4
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHh-ccCCCCceeeeeeeecCCcEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQ-NLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~-~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
..|.+...||.|+||.||.+.++.+|+.||||++++.... ......+..|..++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 3588899999999999999999999999999999764321 223355666776664 68999999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||++||+|..++. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~-~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~---~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG---HIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---CEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC---ceeccccchhhhccccc
Confidence 99999999988876 456799999999999999999999999999999999999999998 89999999997432
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDL 1035 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~L 1035 (1098)
..|+|||++.+..|+.++|||||||++|||++|+.||.+.. ++...+..... ..+..+|+++.+|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~----~~p~~~s~~~~dl 233 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP----FYPRWLEKEAKDL 233 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----CCCTTSCHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----CCCccCCHHHHHH
Confidence 23579999999999999999999999999999999998754 33334443322 3345689999999
Q ss_pred HHHhhhhcccCCCCHH-HHHcCCCcCCCCCcchhHHHHhh-hCCCCCCC
Q psy48 1036 INNLLQVKQRKRLSVD-KSLAHPWLQDPATWSDLRGLERQ-IGTNKKKN 1082 (1098)
Q Consensus 1036 L~~cL~~dP~kRPSa~-eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~ 1082 (1098)
|.+||+.||++|||+. ++++||||++ ++|+.|+++ +.||+.+.
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~----~~~~~l~~~~~~pp~~p~ 278 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFRE----INWEELERKEIDPPFRPK 278 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTT----CCHHHHHTTCSCC-----
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhcc----CCHHHHHhcCCCCCCCCC
Confidence 9999999999999995 8999999998 788888877 77776543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=410.32 Aligned_cols=248 Identities=28% Similarity=0.467 Sum_probs=220.0
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..+|.+...||.|+||.||.+.++.+++.||||++++. ..+...+.+|+++|+.++||||++++++|.+.+.+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 46799999999999999999999999999999999764 344567889999999999999999999999999999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
||++|++|..++......+++.+++.|+.||+.||+|||++||+||||||+|||++.++. ..+||+|||+++...
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~-~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS-STIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC-CCEEECCCTTCEECCTTCE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCc-eEEEEcccchhhccccCCc
Confidence 999999999988766668999999999999999999999999999999999999986542 279999999997542
Q ss_pred -------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 967 -------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 -------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
..++|||++.+..|+.++|||||||++|+|++|..||.+.. +....+......++...+..+|+++.+||.
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 239 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHH
Confidence 33579999999999999999999999999999999998754 445555555555555556679999999999
Q ss_pred HhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1038 NLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+||..||++|||++|+++||||+..
T Consensus 240 ~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 240 RLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999763
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.3e-44 Score=395.25 Aligned_cols=247 Identities=32% Similarity=0.524 Sum_probs=216.9
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCCh-------HHHHHHHHHHHHHhccC-CCCceeeeeeeecC
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPT-------KQEAQLKNEVAILQNLC-HPGVVNLERMFETP 883 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~-------~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~ 883 (1098)
.+|.....||.|.||.||.+.++.+|+.||||++++..... .....+.+|+.++++++ ||||++++++|.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 46889999999999999999999999999999998754332 12356889999999997 99999999999999
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
+.+||||||++|++|..++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~---~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM---NIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC---CEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC---CeEEccchhee
Confidence 999999999999999999864 56799999999999999999999999999999999999999998 89999999997
Q ss_pred ccCC-----------CCCChhhhcc------CCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHHHHhhccCCCCC
Q psy48 964 IIGE-----------KSFPPEVLRN------KGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQIQNAAFMYPPRP 1024 (1098)
Q Consensus 964 ~~~~-----------~~~APEvl~~------~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i~~~~~~~p~~~ 1024 (1098)
.... .++|||++.+ ..++.++||||+||++|||++|+.||.+.. +..+.+......++...
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 6533 2369999863 457899999999999999999999998764 33445555555566666
Q ss_pred CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1025 WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1025 ~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
+..+|+++.+||.+||+.||++|||++|+++||||+.+
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 77899999999999999999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=394.52 Aligned_cols=214 Identities=23% Similarity=0.360 Sum_probs=180.8
Q ss_pred eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHH
Q psy48 839 GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFII 918 (1098)
Q Consensus 839 ~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia 918 (1098)
.||||+++...........|.+|+.+|+.++||||+++++++.. +.+++||||++||+|..++......+++..+..++
T Consensus 32 ~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~ 110 (276)
T d1uwha_ 32 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110 (276)
T ss_dssp EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHH
T ss_pred EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHH
Confidence 49999998776667777899999999999999999999998754 57899999999999999998777789999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--------------CCCCCChhhhcc---CCCC
Q psy48 919 TQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--------------GEKSFPPEVLRN---KGYN 981 (1098)
Q Consensus 919 ~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--------------~~~~~APEvl~~---~~ys 981 (1098)
.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.. +..|||||++.+ ..|+
T Consensus 111 ~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~---~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~ 187 (276)
T d1uwha_ 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187 (276)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEEETTS---SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCC
T ss_pred HHHHHHHHHHhcCCEeccccCHHHEEEcCCC---CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCC
Confidence 9999999999999999999999999999998 8999999998643 224689999974 3589
Q ss_pred chhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHh--hccCC--CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 982 RSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNA--AFMYP--PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 982 ~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~--~~~~p--~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.++|||||||+||||+||+.||.+........... ....| ...+.++|+++.+||.+||+.||++|||+++|+++
T Consensus 188 ~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999998654322222211 11111 12345689999999999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=394.04 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=205.8
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|.....||.|+||.||.|.++.+|+.||||+++...........+.+|+.+|++++||||++++++|.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 46888899999999999999999999999999997765444445789999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
|+.++++..........+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~---~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG---AIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS---CEEECSTTHHHHHCCCSBC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC---cceeccCCcceeccCCccc
Confidence 9999888666555667799999999999999999999999999999999999999988 8999999998643
Q ss_pred ------CCCCCChhhhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHH--HhhccCCCCC------------
Q psy48 966 ------GEKSFPPEVLRNKG-YNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ--NAAFMYPPRP------------ 1024 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~-ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~--~~~~~~p~~~------------ 1024 (1098)
+..++|||++.... ++.++|+|||||++|+|++|+.||.+......... ..........
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 23457999987766 57999999999999999999999987643322211 1111111000
Q ss_pred -------------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1025 -------------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1025 -------------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
...+|+++.+||.+||..||++|||++|+++||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 1256789999999999999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=394.70 Aligned_cols=240 Identities=26% Similarity=0.350 Sum_probs=198.9
Q ss_pred eeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHH---HHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEecc
Q psy48 818 VALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQ---EAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQ 894 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ 894 (1098)
..||.|+||.||.+.++.+|+.||||++++....... ...+.+|+.+|+.++||||++++++|.+++.+|+||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5799999999999999999999999999765432222 2568899999999999999999999999999999999999
Q ss_pred CchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---------
Q psy48 895 GDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--------- 965 (1098)
Q Consensus 895 ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--------- 965 (1098)
++++..+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 84 ~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~---~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 84 TDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG---VLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp EEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---CEEECCCGGGSTTTSCCCCCCC
T ss_pred chHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC---ccccccCccccccCCCcccccc
Confidence 99886554 4567799999999999999999999999999999999999999998 8999999999643
Q ss_pred ---CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhccCCCCC---------------
Q psy48 966 ---GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYPPRP--------------- 1024 (1098)
Q Consensus 966 ---~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~~p~~~--------------- 1024 (1098)
+..|+|||++.+ ..|+.++|||||||++|||++|..||.+..+.. ..+...........
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 234689999874 568999999999999999999999998765433 22222211111100
Q ss_pred ---------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1025 ---------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1025 ---------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
+..+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 1356889999999999999999999999999999997
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-44 Score=403.88 Aligned_cols=244 Identities=28% Similarity=0.500 Sum_probs=203.7
Q ss_pred hhheee-eeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhc-cCCCCceeeeeeeec----CC
Q psy48 811 LVFMTY-NVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQN-LCHPGVVNLERMFET----PG 884 (1098)
Q Consensus 811 l~~~~~-~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~L~~~f~~----~~ 884 (1098)
+..|.. +..||.|+||.||.|.++.+++.||||++++. ..+.+|+.++.+ .+||||++++++|.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 456665 45699999999999999999999999999642 457789988754 489999999999865 46
Q ss_pred cEEEEEEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
.+|+|||||+||+|..++.... ..|++.+++.|+.||+.||+|||++||+||||||+|||++.++....+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 7999999999999999987543 469999999999999999999999999999999999999975544489999999997
Q ss_pred cc-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh--hHHHHH----HHhhccCCCCCCC
Q psy48 964 II-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE--DINEQI----QNAAFMYPPRPWR 1026 (1098)
Q Consensus 964 ~~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~--~~~~~i----~~~~~~~p~~~~~ 1026 (1098)
.. +..|+|||++.+..|+.++|||||||+||+|++|+.||.+.. .....+ ......+|...+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 242 (335)
T d2ozaa1 163 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242 (335)
T ss_dssp ECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHH
T ss_pred eccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccc
Confidence 43 334689999999999999999999999999999999997543 222222 2222333444455
Q ss_pred cCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1027 DISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1027 ~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+|+++.+||.+||+.||++|||+.++++||||++
T Consensus 243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp HSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 78999999999999999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-43 Score=381.14 Aligned_cols=236 Identities=22% Similarity=0.332 Sum_probs=199.2
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEe
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEK 892 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy 892 (1098)
.|.+...||.|+||.||.+.++ +++.||||++++... ..+.+.+|+++++.++||||+++++++..++.+++||||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 5788899999999999999875 577899999976433 346799999999999999999999999999999999999
Q ss_pred ccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-------
Q psy48 893 LQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------- 965 (1098)
Q Consensus 893 ~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------- 965 (1098)
+++|+|..++......+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~---~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ---VIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG---CEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC---CeEecccchheeccCCCcee
Confidence 999999999887777899999999999999999999999999999999999999998 8999999998643
Q ss_pred ------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcC-CCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 966 ------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSG-TFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG-~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
+..|+|||++.+..|+.++|||||||+||||+|+ .+||.... ..+.+...........+..+++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-HHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-HHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 2347899999999999999999999999999995 55554432 222232222233333446789999999999
Q ss_pred hhhhcccCCCCHHHHHcC
Q psy48 1039 LLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1039 cL~~dP~kRPSa~eIL~H 1056 (1098)
||+.||++|||+++|++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=387.44 Aligned_cols=248 Identities=29% Similarity=0.376 Sum_probs=206.1
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecC-CceeEEEEEeccCCChHHHHHHHHHHHHHhcc---CCCCceeeeeeeec----
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKS-GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL---CHPGVVNLERMFET---- 882 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~t-g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~L~~~f~~---- 882 (1098)
..+|.....||.|+||.||.+.+..+ ++.||||+++...........+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 35789999999999999999999766 67899999987554443344566788877655 79999999999853
Q ss_pred -CCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCc
Q psy48 883 -PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGF 961 (1098)
Q Consensus 883 -~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGl 961 (1098)
...++++|||+.++++..........+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~---~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG---QIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---CEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC---Ceeecchhh
Confidence 3578999999999998766666677899999999999999999999999999999999999999998 899999999
Q ss_pred cccc-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhccCC-------
Q psy48 962 ARII-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYP------- 1021 (1098)
Q Consensus 962 a~~~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~~p------- 1021 (1098)
++.. +..|+|||++.+.+|+.++|||||||++|||++|+.||.+..+.. ..+........
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 8643 345789999999999999999999999999999999998764332 22222111000
Q ss_pred ----------------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1022 ----------------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1022 ----------------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
...+..+++++.+||.+||++||++|||++|+|+||||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0113457899999999999999999999999999999997
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=377.91 Aligned_cols=212 Identities=24% Similarity=0.370 Sum_probs=185.0
Q ss_pred CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHH
Q psy48 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTK 915 (1098)
Q Consensus 836 tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~ 915 (1098)
+++.||||++++.... ...+.+|+.+++.++||||+++++++.+++.+++||||+++|+|..++......+++..++
T Consensus 27 ~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~ 103 (258)
T d1k2pa_ 27 GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL 103 (258)
T ss_dssp TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHH
T ss_pred CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHH
Confidence 5668999999875433 4679999999999999999999999999999999999999999988887777789999999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-------------CCCChhhhccCCCCc
Q psy48 916 FIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE-------------KSFPPEVLRNKGYNR 982 (1098)
Q Consensus 916 ~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~-------------~~~APEvl~~~~ys~ 982 (1098)
+++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .|+|||++.+..|+.
T Consensus 104 ~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~---~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 180 (258)
T d1k2pa_ 104 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG---VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180 (258)
T ss_dssp HHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC---CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHhhcCcccccccceeEEEcCCC---cEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCc
Confidence 9999999999999999999999999999999988 899999999974321 257999999999999
Q ss_pred hhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 983 SLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 983 ~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
++|||||||++|||+| |+.||.+.. +....+.. ......+..+++++.+||.+||+.||++|||+++|++|
T Consensus 181 ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~---~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh---CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999998 899998654 33333332 23334456789999999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.6e-43 Score=386.56 Aligned_cols=244 Identities=21% Similarity=0.274 Sum_probs=209.3
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..+.+...||.|+||.||.|.++.+++.||||++++.. ...+.+.+|+++|+.++|||||+++++|.+.+.+++|||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 46788899999999999999999999999999997643 234679999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC---
Q psy48 892 KLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE--- 967 (1098)
Q Consensus 892 y~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~--- 967 (1098)
|+++|+|..++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+....
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~---~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH---LVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG---CEEECCCCCTTTCCSSSS
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC---cEEEccccceeecCCCCc
Confidence 99999998887643 45789999999999999999999999999999999999999998 899999999976432
Q ss_pred ----------CCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 968 ----------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 968 ----------~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
.|+|||++.+..|+.++|||||||++|||++|..||....+..+.............+..+|+++.+||.
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 250 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 250 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHH
Confidence 3579999999999999999999999999999877765443333333333334444556779999999999
Q ss_pred HhhhhcccCCCCHHHHHc--CCCcCC
Q psy48 1038 NLLQVKQRKRLSVDKSLA--HPWLQD 1061 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~--HpfFk~ 1061 (1098)
+||+.||++|||+++|++ ..++++
T Consensus 251 ~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 251 ACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999976 244444
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-42 Score=383.43 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=207.2
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.+|..-..||.|+||.||.+.++ +|+.||||+++...........+.+|+.+|+.++||||++++++|...+..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 57888999999999999999885 88999999997765444445789999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc------
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII------ 965 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~------ 965 (1098)
++.++++..+. ...+.+++..++.++.||+.||+|||+.|||||||||+|||++.++ .+||+|||++...
T Consensus 81 ~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~---~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 81 HLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG---ELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp CCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS---CEEECCTTHHHHHCC----
T ss_pred eehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC---CEEecccccceecccCccc
Confidence 99999886665 4567899999999999999999999999999999999999999998 8999999998643
Q ss_pred ------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhccCCC--------------
Q psy48 966 ------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYPP-------------- 1022 (1098)
Q Consensus 966 ------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~~p~-------------- 1022 (1098)
...++|||++.+ ..++.++|||||||++|||++|+.||.+..+.. ..+.......+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 234579999975 457999999999999999999999998654322 222221111110
Q ss_pred -----------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1023 -----------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1023 -----------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.....+++++.+||++||+.||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112357889999999999999999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-42 Score=384.57 Aligned_cols=241 Identities=22% Similarity=0.370 Sum_probs=200.8
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCc---eeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGR---GVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~---~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
...|.+...||.|+||.||.+.++.+++ .||||.+... ........|.+|+.+|+.++|||||++++++.+.+.++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 4678889999999999999999987765 5888887543 34555678999999999999999999999999999999
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC-
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG- 966 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~- 966 (1098)
+||||+++|+|..++....+.+++.++..++.||+.||+|||++||+||||||+||||+.++ ++||+|||+|+...
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~---~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL---VCKVSDFGLSRFLED 180 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC---CEEECCC--------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC---cEEECCcccceEccC
Confidence 99999999999998887777899999999999999999999999999999999999999998 89999999997431
Q ss_pred ----------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCc
Q psy48 967 ----------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDIS 1029 (1098)
Q Consensus 967 ----------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is 1029 (1098)
..|||||++.+..|+.++|||||||+||||+| |+.||.+.... +.+...........+..++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCccch
Confidence 23689999999999999999999999999998 89999865432 1222222223333456789
Q ss_pred HHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1030 SDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1030 ~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+++.+||.+||+.||++|||+.+|+++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-43 Score=393.73 Aligned_cols=266 Identities=26% Similarity=0.437 Sum_probs=224.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEe---ecCCceeEEEEEeccCCC--hHHHHHHHHHHHHHhccCC-CCceeeeeeeecCC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVH---RKSGRGVAIKVIDKLRFP--TKQEAQLKNEVAILQNLCH-PGVVNLERMFETPG 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~---k~tg~~VAVKvlkk~~~~--~~~~~~~~~Ei~iL~~l~H-pnIv~L~~~f~~~~ 884 (1098)
+..|.+...||.|+||.||.+.+ +.+|+.||||++++.... ......+.+|+.+|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 45699999999999999999987 457899999999764432 1234668899999999976 89999999999999
Q ss_pred cEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 885 RIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
.+++||||+.+++|..++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~-~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~---~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG---HVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---CEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHH-hcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC---CEEEeeccchhh
Confidence 9999999999999988876 455788999999999999999999999999999999999999998 899999999864
Q ss_pred c-------------CCCCCChhhhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCC--hhHHHHHHHhhccCCCCCCCc
Q psy48 965 I-------------GEKSFPPEVLRNK--GYNRSLDMWSVGVIVYVSLSGTFPFNED--EDINEQIQNAAFMYPPRPWRD 1027 (1098)
Q Consensus 965 ~-------------~~~~~APEvl~~~--~ys~~sDVwSLGvlLyELltG~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~ 1027 (1098)
. ...++|||.+.+. .++.++|||||||+||||++|+.||.+. .+....+...........+..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 3 3345799999764 4788999999999999999999999754 233344444444444445567
Q ss_pred CcHHHHHHHHHhhhhcccCCC-----CHHHHHcCCCcCCCCCcchhHHHHhh-hCCCCCCCcc
Q psy48 1028 ISSDAIDLINNLLQVKQRKRL-----SVDKSLAHPWLQDPATWSDLRGLERQ-IGTNKKKNPK 1084 (1098)
Q Consensus 1028 is~el~~LL~~cL~~dP~kRP-----Sa~eIL~HpfFk~~~~~~~~~~l~~~-~~~~~~~~~~ 1084 (1098)
+|+++.+||.+||++||++|| +++|+++||||++ ++|+.|+.+ +++|+++.-+
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~----i~~~~l~~~~~~~p~~p~~~ 317 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK----INWDDLAAKKVPAPFKPVIR 317 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT----CCHHHHHTTCSCCSCCCCCC
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC----CCHHHHHhCCCCcCCCCCCC
Confidence 999999999999999999999 4899999999998 788899998 9999986443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-43 Score=384.68 Aligned_cols=235 Identities=21% Similarity=0.313 Sum_probs=197.3
Q ss_pred eeeeeeeeeceEEEEee--cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccC
Q psy48 818 VALCIAVVAGAACGVHR--KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQG 895 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k--~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~g 895 (1098)
..||.|+||.||.|.++ .+++.||||+++...........+.+|+.+|++++||||+++++++.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 57999999999999865 4567899999977655555667899999999999999999999999654 67899999999
Q ss_pred chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---------
Q psy48 896 DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--------- 966 (1098)
Q Consensus 896 gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--------- 966 (1098)
|+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 92 g~L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~---~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHh-hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC---cccccchhhhhhccccccccccc
Confidence 99988876 456799999999999999999999999999999999999999998 89999999997431
Q ss_pred ------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 967 ------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 ------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
..|+|||++.+..|+.++|||||||++|||++ |+.||.+... +...+.. ...+..+..+|+++.+||.
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~---~~~~~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCPREMYDLMN 244 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc---CCCCCCCcccCHHHHHHHH
Confidence 24689999999999999999999999999998 8999987543 2333332 2333345678999999999
Q ss_pred HhhhhcccCCCCHHHHH---cCCCcC
Q psy48 1038 NLLQVKQRKRLSVDKSL---AHPWLQ 1060 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL---~HpfFk 1060 (1098)
+||+.||++|||+++|+ +|+|+.
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 99999999999999984 565543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=381.75 Aligned_cols=242 Identities=19% Similarity=0.242 Sum_probs=203.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..|.+...||.|+||.||.+.++ +++.||||+++.... ..+.+.+|+.+|++++|||||++++++.. +.+++|||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 46788999999999999999875 678899999976432 34679999999999999999999998754 56799999
Q ss_pred eccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 892 KLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
|+++|+|..++.... .++++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|+...
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~---~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL---SCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS---CEEECCCTTCEECSSSCE
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc---ceeeccccceEEccCCcc
Confidence 999999988765433 3699999999999999999999999999999999999999998 89999999997542
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
..|+|||++.+..|+.++|||||||+||||+||..|+.......+.+...........+..+++++.+||.
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 244 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHH
Confidence 23689999999999999999999999999999665554433333333333333444445679999999999
Q ss_pred HhhhhcccCCCCHHHHHc--CCCcCC
Q psy48 1038 NLLQVKQRKRLSVDKSLA--HPWLQD 1061 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~--HpfFk~ 1061 (1098)
+||+.||++|||+++|++ |+||..
T Consensus 245 ~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 245 LCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999998 788864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=384.61 Aligned_cols=240 Identities=28% Similarity=0.500 Sum_probs=204.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChH----HHHHHHHHHHHHhccC--CCCceeeeeeeecCC
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTK----QEAQLKNEVAILQNLC--HPGVVNLERMFETPG 884 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~----~~~~~~~Ei~iL~~l~--HpnIv~L~~~f~~~~ 884 (1098)
.++|.....||.|+||.||.|.++.+|+.||||++++...... ....+.+|+.+|+.++ ||||++++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4679999999999999999999999999999999987544322 1234678999999886 899999999999999
Q ss_pred cEEEEEEeccC-chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 885 RIFVVMEKLQG-DMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 885 ~l~LVmEy~~g-gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
.+++||||+.+ +++..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+|+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~--~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC--eEEECccccce
Confidence 99999999975 56766665 4567999999999999999999999999999999999999986532 89999999997
Q ss_pred ccC----------CCCCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHH
Q psy48 964 IIG----------EKSFPPEVLRNKGY-NRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 964 ~~~----------~~~~APEvl~~~~y-s~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
... ..|+|||++.+..+ +.++|||||||++|||++|+.||...+. +......+ ...+|+++
T Consensus 160 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----i~~~~~~~----~~~~s~~~ 231 (273)
T d1xwsa_ 160 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----IIRGQVFF----RQRVSSEC 231 (273)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HHHCCCCC----SSCCCHHH
T ss_pred ecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----HhhcccCC----CCCCCHHH
Confidence 442 23579999987765 6789999999999999999999987543 22222222 34689999
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+||.+||+.||++|||++|+++||||++
T Consensus 232 ~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999999999997
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=380.90 Aligned_cols=239 Identities=23% Similarity=0.339 Sum_probs=201.8
Q ss_pred heeeee-eeeeeeeeceEEEEeecC--CceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEE
Q psy48 813 FMTYNV-ALCIAVVAGAACGVHRKS--GRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 813 ~~~~~~-~Lg~G~~g~v~~a~~k~t--g~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LV 889 (1098)
.+.+.. .||.|+||.||.|.++.+ +..||||+++.. ........|.+|+.+|++++|||||++++++.+ +.+++|
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 455555 599999999999987644 557999999754 345556889999999999999999999999975 468999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||+++|+|..++......+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~---~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT---EEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC---ceeeccchhhhcccccc
Confidence 999999999998876777899999999999999999999999999999999999999998 89999999997542
Q ss_pred ------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHH
Q psy48 967 ------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 967 ------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
..|+|||++.+..|+.++|||||||++|||+| |+.||.+.. ++...+.. ...+..+..+|++
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~---~~~~~~p~~~~~~ 240 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPPECPPE 240 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---TCCCCCCTTCCHH
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCcCCHH
Confidence 23689999999999999999999999999998 999998653 33333333 2333445679999
Q ss_pred HHHHHHHhhhhcccCCCCHHHH---HcCCCc
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKS---LAHPWL 1059 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eI---L~HpfF 1059 (1098)
+.+||.+||+.||++|||+.+| |+|+|+
T Consensus 241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999888 455655
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=387.38 Aligned_cols=241 Identities=22% Similarity=0.274 Sum_probs=200.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCc-----eeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCc
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGR-----GVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGR 885 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~-----~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~ 885 (1098)
..+.+...||.|+||.||.|.++.+++ .||||++.... .......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 467889999999999999999887655 59999986532 233446789999999988 89999999999999999
Q ss_pred EEEEEEeccCchHHHHHhhcc----------------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy48 886 IFVVMEKLQGDMLEMILSSEK----------------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~----------------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NI 943 (1098)
+++||||+++|+|..++.... ..+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 999999999999999987543 3488999999999999999999999999999999999
Q ss_pred eecCCCCCCcEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChh
Q psy48 944 LLSTNSELPQVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDED 1008 (1098)
Q Consensus 944 Lld~~g~~~~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~ 1008 (1098)
|++.++ .+||+|||+|+.. +..|||||++.+..|+.++|||||||+||||+| |..||.+...
T Consensus 196 ll~~~~---~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 196 LVTHGK---VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp EEETTT---EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccCC---eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999998 9999999999643 234789999999999999999999999999998 8999986432
Q ss_pred HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1009 INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1009 ~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
................+..+|+++.+||.+||+.||++|||+++|++|
T Consensus 273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 211111122223333456789999999999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=372.47 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=210.7
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
.+|.....||.|+||.||.+.++.+++.||||+++...........+.+|+.+|+.++||||++++++|.+....++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47888999999999999999999999999999998776666667899999999999999999999999999999999999
Q ss_pred eccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCCC---
Q psy48 892 KLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEK--- 968 (1098)
Q Consensus 892 y~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~--- 968 (1098)
++.++++..++. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~---~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG---ELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---CEEECCCTTCEECCSCCSC
T ss_pred eccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC---ceeeeecchhhcccCCCcc
Confidence 999999976654 567899999999999999999999999999999999999999988 8999999999765322
Q ss_pred ---------CCChhhhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCChhHH---HHHHHhhccCC--------------
Q psy48 969 ---------SFPPEVLRNKG-YNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN---EQIQNAAFMYP-------------- 1021 (1098)
Q Consensus 969 ---------~~APEvl~~~~-ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~---~~i~~~~~~~p-------------- 1021 (1098)
++|||++.+.. ++.++|||||||++|||++|..||....+.. ..+........
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 25899987665 6899999999999999999999976443222 22222111111
Q ss_pred -----------CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1022 -----------PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1022 -----------~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
......+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 01123568899999999999999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=381.29 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=204.5
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec--------
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET-------- 882 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~-------- 882 (1098)
.++|.....||.|+||.||.|.++.+|+.||||++.+..........+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368999999999999999999999999999999997766555556788999999999999999999999855
Q ss_pred CCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcc
Q psy48 883 PGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFA 962 (1098)
Q Consensus 883 ~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla 962 (1098)
.+.+++||||+.++++..+ ......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~---~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG---VLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS---CEEECCCTTC
T ss_pred CceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC---cEEeeeccee
Confidence 3568999999999988544 34566799999999999999999999999999999999999999998 8999999999
Q ss_pred cccC----------------CCCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhH--HHHHHHhhccCCCC
Q psy48 963 RIIG----------------EKSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI--NEQIQNAAFMYPPR 1023 (1098)
Q Consensus 963 ~~~~----------------~~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~--~~~i~~~~~~~p~~ 1023 (1098)
+... ..|+|||++.+. .|+.++|||||||++|||++|+.||.+..+. ...+.......+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 6432 234799999865 6899999999999999999999999875433 23333333322222
Q ss_pred CCCc----------------------------CcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1024 PWRD----------------------------ISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1024 ~~~~----------------------------is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
.+.. .++++.+||.+||+.||++|||++|+++||||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 2111 26788999999999999999999999999999973
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.7e-42 Score=375.75 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=205.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC-hHHHHHHHHHHHHHhccCCCCceeeeeeeecCC----c
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP-TKQEAQLKNEVAILQNLCHPGVVNLERMFETPG----R 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~----~ 885 (1098)
..+|.+...||.|+||.||.+.+..+|+.||||++++.... ......+.+|+.+|+.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35689999999999999999999999999999999876553 344578999999999999999999999997654 3
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+|+||||++|++|..++. ..+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~---~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS---CEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc---cceeehhhhhhhh
Confidence 899999999999987775 456799999999999999999999999999999999999999998 8999999987532
Q ss_pred ---------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHH--HHHHhhccCCCCCCCcC
Q psy48 966 ---------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINE--QIQNAAFMYPPRPWRDI 1028 (1098)
Q Consensus 966 ---------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~--~i~~~~~~~p~~~~~~i 1028 (1098)
+..|+|||++.+..|+.++|||||||++|||+||++||.+...... .+.......+...+..+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 3456899999999999999999999999999999999987654332 22232223333445679
Q ss_pred cHHHHHHHHHhhhhcccCCC-CHHHHHcCCC
Q psy48 1029 SSDAIDLINNLLQVKQRKRL-SVDKSLAHPW 1058 (1098)
Q Consensus 1029 s~el~~LL~~cL~~dP~kRP-Sa~eIL~Hpf 1058 (1098)
|+++.+||.+||++||++|| |++++ .|+|
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l 271 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEM-RADL 271 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHH-HHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHH-HHHH
Confidence 99999999999999999999 55555 4444
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=372.55 Aligned_cols=239 Identities=20% Similarity=0.295 Sum_probs=201.1
Q ss_pred heeeeeeeeeeeeeceEEEEeecCC----ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSG----RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg----~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.++....||.|+||.||.|.++.++ ..||||+++.. ........|.+|+.+|+.++|||||++++++.+.+.+++
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4678889999999999999987665 46999999654 344556789999999999999999999999999999999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
||||+.++++..++......+++.+++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~---~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL---VCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC---CEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC---eEEEcccchhhcccCC
Confidence 9999999999888877777899999999999999999999999999999999999999998 8999999999743
Q ss_pred ------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 966 ------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 966 ------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
+..|+|||++.+..|+.++|||||||+||||++|..|+.......+.+........+..+..++.++.
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 243 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHH
Confidence 12368999999999999999999999999999976665543322233333333334444567999999
Q ss_pred HHHHHhhhhcccCCCCHHHHHc
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+||.+||+.||++|||+.+|++
T Consensus 244 ~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 244 QLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-41 Score=380.16 Aligned_cols=245 Identities=24% Similarity=0.424 Sum_probs=200.4
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC------c
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG------R 885 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~------~ 885 (1098)
.+|.....||.|+||.||.+.++.+|+.||||++++..........+.+|+.+|+.++|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 4688889999999999999999999999999999876666666788999999999999999999999997665 5
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
+|+||||+ +.+|..+.. ..++++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 98 ~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~---~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC---ELKILDFGLARQA 171 (346)
T ss_dssp CEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---CEEECCCTTCEEC
T ss_pred EEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc---ccccccccceecc
Confidence 79999999 556666653 35799999999999999999999999999999999999999998 8999999999755
Q ss_pred CC---------CCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHH--Hhhcc--------------
Q psy48 966 GE---------KSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQ--NAAFM-------------- 1019 (1098)
Q Consensus 966 ~~---------~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~--~~~~~-------------- 1019 (1098)
.. .|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....... .....
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T d1cm8a_ 172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251 (346)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence 32 3479999976 4578999999999999999999999987643322111 11100
Q ss_pred ---------CCC----CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCC
Q psy48 1020 ---------YPP----RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDP 1062 (1098)
Q Consensus 1020 ---------~p~----~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~ 1062 (1098)
... .....+++++.+||.+||..||++|||++|+|+||||++-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 011 1124578999999999999999999999999999999973
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=379.18 Aligned_cols=241 Identities=25% Similarity=0.356 Sum_probs=197.2
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec------CCcE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET------PGRI 886 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~------~~~l 886 (1098)
.|+....||.|+||.||.|.++.+|+.||||++++... .+.+|+++|+.++||||++++++|.. ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 47778889999999999999999999999999976432 23479999999999999999999843 2358
Q ss_pred EEEEEeccCchHHHHHh--hccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 887 FVVMEKLQGDMLEMILS--SEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~--~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
++||||++++++..+.. .....+++.+++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~--~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA--VLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC--CEEECCCTTCEE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC--ceeEecccchhh
Confidence 99999999887655543 34557999999999999999999999999999999999999997753 799999999975
Q ss_pred c-----------CCCCCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhh---------------
Q psy48 965 I-----------GEKSFPPEVLRN-KGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAA--------------- 1017 (1098)
Q Consensus 965 ~-----------~~~~~APEvl~~-~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~--------------- 1017 (1098)
. +..++|||++.+ ..|+.++|||||||++|||++|..||..............
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp CCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred ccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 4 234579999875 5699999999999999999999999987643322111110
Q ss_pred ----ccCCC--------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1018 ----FMYPP--------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1018 ----~~~p~--------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..++. .....+++++.+||.+||..||++|||+.|+|+||||++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 00110 012357899999999999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=365.94 Aligned_cols=237 Identities=23% Similarity=0.298 Sum_probs=197.5
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCC---ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSG---RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg---~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
..|.+...||.|+||.||.|.+..++ ..||||+++.. ........+.+|+.+|+.++||||+++++++. .+.+++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 46888999999999999999987554 45888887543 23445578999999999999999999999996 467899
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC--
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG-- 966 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~-- 966 (1098)
||||+++++|..++......+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+|+...
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~---~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC---cEEEccchhheeccCC
Confidence 9999999999888877777899999999999999999999999999999999999999998 89999999997532
Q ss_pred -----------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh--hHHHHHHHhhccCCCCCCCcCcHHH
Q psy48 967 -----------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE--DINEQIQNAAFMYPPRPWRDISSDA 1032 (1098)
Q Consensus 967 -----------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~--~~~~~i~~~~~~~p~~~~~~is~el 1032 (1098)
..|+|||++.+..|+.++|||||||++|||++ |.+||.... ++...+... .....+..+|+++
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~ 238 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPMPPNCPPTL 238 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---CCCCCCTTCCHHH
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHH
Confidence 23689999999999999999999999999998 899997643 444444332 2334456799999
Q ss_pred HHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1033 IDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1033 ~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.+||.+||+.||++|||+.+|++|
T Consensus 239 ~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 239 YSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-40 Score=374.72 Aligned_cols=239 Identities=24% Similarity=0.415 Sum_probs=199.4
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeec--CCcEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFET--PGRIFV 888 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~--~~~l~L 888 (1098)
.+|++...||.|+||.||.|.++.+|+.||||++++. ....+.+|+.+|+.++ ||||++++++|.. ...+++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 4789999999999999999999999999999999753 2467889999999995 9999999999974 456999
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC-
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE- 967 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~- 967 (1098)
||||+.+++|..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+|+....
T Consensus 110 v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~--~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCGGGCEECCTT
T ss_pred EEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC--eeeecccccceeccCC
Confidence 99999999985542 46999999999999999999999999999999999999997653 699999999975432
Q ss_pred ----------CCCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH---HHHh-------------hc--
Q psy48 968 ----------KSFPPEVLRNK-GYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ---IQNA-------------AF-- 1018 (1098)
Q Consensus 968 ----------~~~APEvl~~~-~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~---i~~~-------------~~-- 1018 (1098)
.++|||++.+. .|+.++||||+||++|||++|..||....+.... +... ..
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 24799998865 5899999999999999999999999754322111 1100 00
Q ss_pred ------------------cCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1019 ------------------MYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1019 ------------------~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
..+...+..+++++.+||++||..||++|||++|+|+||||++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0111123457899999999999999999999999999999997
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=368.09 Aligned_cols=242 Identities=20% Similarity=0.224 Sum_probs=204.0
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVME 891 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmE 891 (1098)
..+++...||.|+||.||.+.++.+ +.||||+++.... ..+.|.+|+.+|+.++|||||++++++.. +.+++|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 4689999999999999999988655 5699999976543 34679999999999999999999999865 56899999
Q ss_pred eccCchHHHHHhhc-cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----
Q psy48 892 KLQGDMLEMILSSE-KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---- 966 (1098)
Q Consensus 892 y~~ggsL~~~l~~~-~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---- 966 (1098)
|+.+|+|..++... ...+++.+++.++.||+.||+|||+.||+||||||+||||+.++ .+||+|||+++...
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~---~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL---VCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG---CEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC---cEEEcccchhhhccCCCc
Confidence 99999988777644 35699999999999999999999999999999999999999988 89999999996432
Q ss_pred ---------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHHHHHH
Q psy48 967 ---------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAIDLIN 1037 (1098)
Q Consensus 967 ---------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~~LL~ 1037 (1098)
..|+|||++.+..++.++|||||||+||||++|..|+.......+.+...........+..+++++.+||.
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHH
Confidence 23589999999999999999999999999999766665443333333333333344455679999999999
Q ss_pred HhhhhcccCCCCHHHHHc--CCCcCC
Q psy48 1038 NLLQVKQRKRLSVDKSLA--HPWLQD 1061 (1098)
Q Consensus 1038 ~cL~~dP~kRPSa~eIL~--HpfFk~ 1061 (1098)
+||+.||++||++++|++ ++||+.
T Consensus 249 ~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 249 QCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 999999999999999988 888876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=374.25 Aligned_cols=247 Identities=29% Similarity=0.453 Sum_probs=199.2
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC----cE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG----RI 886 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~----~l 886 (1098)
..+|.....||.|+||.||.+.++.+|+.||||++++.. .......+.+|+.+|+.++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 356889999999999999999999999999999997643 3444578899999999999999999999986653 23
Q ss_pred EEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-
Q psy48 887 FVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII- 965 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~- 965 (1098)
+++|+++.|++|..++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..
T Consensus 86 ~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~---~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC---DLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---CEEECCCTTCEECC
T ss_pred EEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC---CEEEcccCceeecc
Confidence 455566778889888753 4699999999999999999999999999999999999999988 8999999998643
Q ss_pred --------------CCCCCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhc------------
Q psy48 966 --------------GEKSFPPEVLR-NKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAF------------ 1018 (1098)
Q Consensus 966 --------------~~~~~APEvl~-~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~------------ 1018 (1098)
+..++|||++. +..|+.++||||+||++|+|++|+.||...............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 12357999984 566899999999999999999999999865432221111100
Q ss_pred ----------cCCC-------CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCC
Q psy48 1019 ----------MYPP-------RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPA 1063 (1098)
Q Consensus 1019 ----------~~p~-------~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~ 1063 (1098)
..+. ..+..+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0110 01245788999999999999999999999999999999643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=377.43 Aligned_cols=245 Identities=25% Similarity=0.425 Sum_probs=203.2
Q ss_pred HhhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec------C
Q psy48 810 MLVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET------P 883 (1098)
Q Consensus 810 ~l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~------~ 883 (1098)
++.+|.....||.|+||.||.+.++.+|+.||||++++..........+.+|+.+|+.++||||++++++|.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4567888999999999999999999999999999998877666777889999999999999999999999953 4
Q ss_pred CcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccc
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFAR 963 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~ 963 (1098)
..+|+||||+.++++..+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++
T Consensus 95 ~~~~iv~Ey~~~~l~~~~----~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~---~~kl~df~~~~ 167 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLAR 167 (355)
T ss_dssp CEEEEEEECCSEEHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC---CEEECCCCC--
T ss_pred ceeEEEEeccchHHHHhh----hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc---ceeeechhhhh
Confidence 679999999999888654 24689999999999999999999999999999999999999998 89999999876
Q ss_pred cc-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHH--HHHhhcc-----------
Q psy48 964 II-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQ--IQNAAFM----------- 1019 (1098)
Q Consensus 964 ~~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~--i~~~~~~----------- 1019 (1098)
.. +..++|||++.+..++.++||||+||++|+|++|+.||.+..+.... +......
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 43 34567999999999999999999999999999999999866433221 1111100
Q ss_pred --------CCCC---C----------------CCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCC
Q psy48 1020 --------YPPR---P----------------WRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQD 1061 (1098)
Q Consensus 1020 --------~p~~---~----------------~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~ 1061 (1098)
.+.. . ....++++.+||++||..||++|||++|+|+||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0000 0 0124678999999999999999999999999999996
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=374.35 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=204.7
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecC-----Cc
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETP-----GR 885 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~-----~~ 885 (1098)
..+|.....||.|+||.||.|.++.+|+.||||++++..........+.+|+.+|+.++||||++++++|... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 3578889999999999999999999999999999988766666677899999999999999999999998643 34
Q ss_pred EEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc
Q psy48 886 IFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII 965 (1098)
Q Consensus 886 l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~ 965 (1098)
.++||+|+.|++|..++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~---~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC---ELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---CEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc---cccccccchhccc
Confidence 5667778889999888753 4699999999999999999999999999999999999999998 8999999998654
Q ss_pred CC---------CCCChhhhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCChhHH--HHHHHhhccCC------------
Q psy48 966 GE---------KSFPPEVLRNKG-YNRSLDMWSVGVIVYVSLSGTFPFNEDEDIN--EQIQNAAFMYP------------ 1021 (1098)
Q Consensus 966 ~~---------~~~APEvl~~~~-ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~--~~i~~~~~~~p------------ 1021 (1098)
.. .++|||++.+.. ++.++|||||||++|+|++|+.||.+.+... ..+.......+
T Consensus 172 ~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 32 257999987654 6899999999999999999999998764332 22222111110
Q ss_pred -----------CC----CCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCCCcCCCCC
Q psy48 1022 -----------PR----PWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHPWLQDPAT 1064 (1098)
Q Consensus 1022 -----------~~----~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~HpfFk~~~~ 1064 (1098)
.. .+..+++++.+||.+||..||++|||++|+|+||||++..+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 00 12357899999999999999999999999999999997543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=370.08 Aligned_cols=213 Identities=20% Similarity=0.274 Sum_probs=179.7
Q ss_pred CCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhcc---------
Q psy48 836 SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEK--------- 906 (1098)
Q Consensus 836 tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~--------- 906 (1098)
++..||||++++.. .......+.+|+.++++++||||+++++++...+..++||||+.+|+|..++....
T Consensus 49 ~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~ 127 (308)
T d1p4oa_ 49 PETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127 (308)
T ss_dssp EEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTC
T ss_pred CCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhccccccccccc
Confidence 34679999997543 44555789999999999999999999999999999999999999999988876432
Q ss_pred CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc--------------CCCCCCh
Q psy48 907 GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--------------GEKSFPP 972 (1098)
Q Consensus 907 ~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--------------~~~~~AP 972 (1098)
..+++..+..++.||+.||.|||+++|+||||||+|||++.++ ++||+|||+|+.. +..|+||
T Consensus 128 ~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~---~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aP 204 (308)
T d1p4oa_ 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC---CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc---eEEEeecccceeccCCcceeeccceecccccCCH
Confidence 2368889999999999999999999999999999999999988 8999999999643 3346899
Q ss_pred hhhccCCCCchhHHHHHHHHHHHHHcCC-CCCCCChh--HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCC
Q psy48 973 EVLRNKGYNRSLDMWSVGVIVYVSLSGT-FPFNEDED--INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLS 1049 (1098)
Q Consensus 973 Evl~~~~ys~~sDVwSLGvlLyELltG~-~Pf~~~~~--~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPS 1049 (1098)
|.+.+..++.++||||||++||||+||. .||.+... ....+.. ......+..+++++.++|.+||+.||++|||
T Consensus 205 e~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~---~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs 281 (308)
T d1p4oa_ 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME---GGLLDKPDNCPDMLFELMRMCWQYNPKMRPS 281 (308)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---CCCCCCcccchHHHHHHHHHHcCCChhHCcC
Confidence 9999999999999999999999999985 67765432 2233322 2223334678999999999999999999999
Q ss_pred HHHHHc
Q psy48 1050 VDKSLA 1055 (1098)
Q Consensus 1050 a~eIL~ 1055 (1098)
+.+|++
T Consensus 282 ~~~il~ 287 (308)
T d1p4oa_ 282 FLEIIS 287 (308)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=362.28 Aligned_cols=240 Identities=20% Similarity=0.200 Sum_probs=194.2
Q ss_pred hheeeeeeeeeeeeeceEEEEeecC-C--ceeEEEEEeccCCCh-HHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKS-G--RGVAIKVIDKLRFPT-KQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIF 887 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~t-g--~~VAVKvlkk~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~ 887 (1098)
..|++...||.|+||.||.+.+..+ + ..||||++++..... ...+.|.+|+.+|+.++||||+++++++.+ +.++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 4588899999999999999986543 3 368999998755433 335789999999999999999999999976 4678
Q ss_pred EEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccCC
Q psy48 888 VVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGE 967 (1098)
Q Consensus 888 LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~ 967 (1098)
+||||++++++..++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~---~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc---ceeeccchhhhhccc
Confidence 99999999999888877777899999999999999999999999999999999999999988 899999999975421
Q ss_pred ---------------CCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHHHHhhccCCCCCCCcCcHH
Q psy48 968 ---------------KSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 968 ---------------~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
.++|||++.+..++.++|||||||++|||+| |..||.+................+..+..+|++
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence 3579999999999999999999999999998 899998764332222222223333445679999
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
+.+||.+||..||++|||+.+|++
T Consensus 244 l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=370.99 Aligned_cols=214 Identities=24% Similarity=0.329 Sum_probs=180.3
Q ss_pred cCCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEEEEEeccCchHHHHHhhcc-------
Q psy48 835 KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFVVMEKLQGDMLEMILSSEK------- 906 (1098)
Q Consensus 835 ~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~LVmEy~~ggsL~~~l~~~~------- 906 (1098)
.+++.||||++++.. .......+.+|+.++..+ +|||||++++++.+.+.+++||||+++++|..++....
T Consensus 51 ~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~ 129 (311)
T d1t46a_ 51 DAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129 (311)
T ss_dssp TCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC----
T ss_pred CCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccc
Confidence 456689999997654 345567899999999998 69999999999999999999999999999999886432
Q ss_pred ----------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC----------
Q psy48 907 ----------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG---------- 966 (1098)
Q Consensus 907 ----------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~---------- 966 (1098)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 130 ~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~---~~ki~DfG~~~~~~~~~~~~~~~~ 206 (311)
T d1t46a_ 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR---ITKICDFGLARDIKNDSNYVVKGN 206 (311)
T ss_dssp ----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT---EEEECCCGGGSCTTSCTTSEECSS
T ss_pred cccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC---cccccccchheeccCCCcceEeee
Confidence 2588999999999999999999999999999999999999988 89999999997542
Q ss_pred ----CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCh---hHHHHHHHhhccCCCCCCCcCcHHHHHHHHH
Q psy48 967 ----EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDE---DINEQIQNAAFMYPPRPWRDISSDAIDLINN 1038 (1098)
Q Consensus 967 ----~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~---~~~~~i~~~~~~~p~~~~~~is~el~~LL~~ 1038 (1098)
..|+|||++.+..++.++|||||||++|||+| |.+||.... .+.+.+.. ..++.....+++++.+||.+
T Consensus 207 ~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~Li~~ 283 (311)
T d1t46a_ 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE---GFRMLSPEHAPAEMYDIMKT 283 (311)
T ss_dssp SEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH---TCCCCCCTTSCHHHHHHHHH
T ss_pred cccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---CCCCCCcccccHHHHHHHHH
Confidence 23579999999999999999999999999998 556665432 22232322 23333445689999999999
Q ss_pred hhhhcccCCCCHHHHHc
Q psy48 1039 LLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1039 cL~~dP~kRPSa~eIL~ 1055 (1098)
||+.||++|||+++|++
T Consensus 284 cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 284 CWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcCCChhHCcCHHHHHH
Confidence 99999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-40 Score=365.35 Aligned_cols=240 Identities=21% Similarity=0.282 Sum_probs=201.5
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCce--eEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecCCcEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRG--VAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~--VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~~~l~L 888 (1098)
..+++...||.|+||.||.+.++.+|.. ||||.++... .....+.+.+|+.+|..+ +||||+++++++.+.+.+++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 5678899999999999999999999885 5666664322 334456899999999998 79999999999999999999
Q ss_pred EEEeccCchHHHHHhhc---------------cCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCc
Q psy48 889 VMEKLQGDMLEMILSSE---------------KGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQ 953 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~---------------~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~ 953 (1098)
||||+++|+|..++... ...+++.++..++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~---~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY---V 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG---C
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC---c
Confidence 99999999999988643 35689999999999999999999999999999999999999998 8
Q ss_pred EEEeecCccccc-----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCC-CCCCCChhHHHHHHHhhccCC
Q psy48 954 VKLCDFGFARII-----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGT-FPFNEDEDINEQIQNAAFMYP 1021 (1098)
Q Consensus 954 vKL~DFGla~~~-----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~-~Pf~~~~~~~~~i~~~~~~~p 1021 (1098)
+||+|||+|+.. +..|+|||.+.+..|+.++|||||||++|||++|. +||.+.. ..+.+........
T Consensus 166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGYR 244 (309)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHGGGTCC
T ss_pred eEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-HHHHHHHHHhcCC
Confidence 999999998632 34568999999999999999999999999999976 5665443 2233333333344
Q ss_pred CCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1022 PRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1022 ~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+..+..+++++.+||.+||+.||++|||+.+|+++
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 45567899999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-40 Score=357.82 Aligned_cols=234 Identities=22% Similarity=0.318 Sum_probs=195.3
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeee-cCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFE-TPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~-~~~~l~LV 889 (1098)
+..+.+...||.|+||.||.+.+ .|..||||+++++ ...+.+.+|+.++++++||||+++++++. ..+.+++|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 34678889999999999999987 4788999999753 33467999999999999999999999885 45678999
Q ss_pred EEeccCchHHHHHhhcc-CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 890 MEKLQGDMLEMILSSEK-GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~-~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
|||+++|+|..++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++..
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~---~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN---VAKVSDFGLTKEASST 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS---CEEECCCCC-------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC---CEeecccccceecCCC
Confidence 99999999999986443 3589999999999999999999999999999999999999998 8999999999754
Q ss_pred ------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHHHHHHH
Q psy48 966 ------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNED--EDINEQIQNAAFMYPPRPWRDISSDAIDLI 1036 (1098)
Q Consensus 966 ------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~el~~LL 1036 (1098)
+..++|||++.+..|+.++||||||+++|||+| |.+||... .+....+.. ...+..+..+++++.+||
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~li 233 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYEVM 233 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT---TCCCCCCTTCCHHHHHHH
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCCCCCccCCHHHHHHH
Confidence 234689999999999999999999999999998 68888754 233333332 233344567899999999
Q ss_pred HHhhhhcccCCCCHHHHHcC
Q psy48 1037 NNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1037 ~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.+||..||++|||+.+|+++
T Consensus 234 ~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 234 KNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcccCHhHCcCHHHHHHH
Confidence 99999999999999999873
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=365.83 Aligned_cols=236 Identities=19% Similarity=0.266 Sum_probs=197.9
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCce----eEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRG----VAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~----VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l~L 888 (1098)
.|.....||.|+||.||.+.+..+|+. ||||.++.. ........+.+|+.+|+.++|||||++++++.++ ..++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 478889999999999999999988874 677776542 2233457899999999999999999999999875 5678
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc---
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII--- 965 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~--- 965 (1098)
+|||+.+++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~---~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC---CeEeeccccceecccc
Confidence 8899988888888877778899999999999999999999999999999999999999998 8999999998743
Q ss_pred -----------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC--hhHHHHHHHhhccCCCCCCCcCcHH
Q psy48 966 -----------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNED--EDINEQIQNAAFMYPPRPWRDISSD 1031 (1098)
Q Consensus 966 -----------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~--~~~~~~i~~~~~~~p~~~~~~is~e 1031 (1098)
+..|+|||++.+..|+.++|||||||+||||+| |..||.+. .++...+.... ....+..++++
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~---~~~~p~~~~~~ 241 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICTID 241 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC---CCCCCTTBCHH
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---CCCCCcccCHH
Confidence 235789999999999999999999999999998 78999764 34444444432 22234578999
Q ss_pred HHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1032 AIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1032 l~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+.+||.+||+.||++|||+.+|++|
T Consensus 242 ~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 242 VYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999999988
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-39 Score=361.31 Aligned_cols=239 Identities=20% Similarity=0.220 Sum_probs=201.6
Q ss_pred hheeeeeeeeeeeeeceEEEEee-----cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCCcE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHR-----KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPGRI 886 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k-----~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~~l 886 (1098)
..+.+...||.|+||.||.|..+ .+++.||||+++... .......+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 46888999999999999999875 356789999997543 445567899999999999999999999999999999
Q ss_pred EEEEEeccCchHHHHHhhcc-----------------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy48 887 FVVMEKLQGDMLEMILSSEK-----------------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENV 943 (1098)
Q Consensus 887 ~LVmEy~~ggsL~~~l~~~~-----------------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NI 943 (1098)
++||||+.+++|..++.... ..+++..++.++.||+.||+|||++|||||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 99999999999999886432 2488999999999999999999999999999999999
Q ss_pred eecCCCCCCcEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCC-CCCCCChh
Q psy48 944 LLSTNSELPQVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGT-FPFNEDED 1008 (1098)
Q Consensus 944 Lld~~g~~~~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~-~Pf~~~~~ 1008 (1098)
|++.++ .+||+|||+|+.. +..|+|||++.+..|+.++|||||||+||||++|. +||.+...
T Consensus 172 Lld~~~---~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 172 LVGENM---VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EECGGG---CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EECCCC---cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999988 8999999998633 12368999999999999999999999999999986 56765533
Q ss_pred HHHHHHHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1009 INEQIQNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1009 ~~~~i~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
. +.+........+..+..+++++.+||.+||+.||++|||+.+|++
T Consensus 249 ~-e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 E-EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp H-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H-HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2 222222222233345679999999999999999999999999965
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-39 Score=359.35 Aligned_cols=241 Identities=23% Similarity=0.280 Sum_probs=190.6
Q ss_pred hheeeeeeeeeeeeeceEEEEeec-----CCceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecC-C
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRK-----SGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETP-G 884 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~-----tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~-~ 884 (1098)
..|.+...||.|+||.||.|.+.. +++.||||+++... .......+.+|..++.++ +|+||+.+++++... .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 568899999999999999999765 44689999997543 344456778888888766 689999999987654 5
Q ss_pred cEEEEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy48 885 RIFVVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNS 949 (1098)
Q Consensus 885 ~l~LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g 949 (1098)
.+++||||+++|+|..++.... ..+++.+++.++.||+.||+|||++||+||||||+||||+.++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence 6899999999999999986542 2488999999999999999999999999999999999999988
Q ss_pred CCCcEEEeecCccccc--------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcC-CCCCCCChhHHHHHH
Q psy48 950 ELPQVKLCDFGFARII--------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSG-TFPFNEDEDINEQIQ 1014 (1098)
Q Consensus 950 ~~~~vKL~DFGla~~~--------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG-~~Pf~~~~~~~~~i~ 1014 (1098)
.+||+|||+|+.. +..|+|||++.+..|+.++|||||||++|||++| ..||.+.........
T Consensus 172 ---~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 172 ---VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp ---CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred ---cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 8999999999643 1236899999999999999999999999999986 567865432222222
Q ss_pred HhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcC
Q psy48 1015 NAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1015 ~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
.......+..+..+++++.+||.+||+.||++|||+++|++|
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 222223334456789999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-39 Score=360.23 Aligned_cols=239 Identities=20% Similarity=0.235 Sum_probs=198.3
Q ss_pred eeeeeeeeeeeeeceEEEEeecCC---ceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeec-CCcEEEE
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSG---RGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFET-PGRIFVV 889 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg---~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~-~~~l~LV 889 (1098)
..|+..||.|+||.||.|.+..++ ..||||++++. ........|.+|+++|++++||||+++++++.. ++.+++|
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 345778999999999999986653 36999999753 345566889999999999999999999999765 5689999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCcccccC---
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIG--- 966 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~--- 966 (1098)
|||+++++|..++......+++..++.++.||+.||.|||+.+|+||||||+|||++.++ .+||+|||+++...
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~---~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF---TVKVADFGLARDMYDKE 184 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC---CEEECSSGGGCCTTTTT
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC---CEEEecccchhhccccc
Confidence 999999999999887777888999999999999999999999999999999999999888 89999999997532
Q ss_pred -------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhHHHHHHHhhccCCCCCCCcCcHHHH
Q psy48 967 -------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINEQIQNAAFMYPPRPWRDISSDAI 1033 (1098)
Q Consensus 967 -------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~~~~i~~~~~~~p~~~~~~is~el~ 1033 (1098)
..|+|||.+.+..++.++||||||++||||++|..||.......+..........+..+..+++++.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHH
Confidence 1257999999999999999999999999999988888755333222222222223333457899999
Q ss_pred HHHHHhhhhcccCCCCHHHHHcC
Q psy48 1034 DLINNLLQVKQRKRLSVDKSLAH 1056 (1098)
Q Consensus 1034 ~LL~~cL~~dP~kRPSa~eIL~H 1056 (1098)
+||.+||..||++||++.||++|
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=354.88 Aligned_cols=239 Identities=20% Similarity=0.274 Sum_probs=197.7
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCC-------ceeEEEEEeccCCChHHHHHHHHHHHHHhcc-CCCCceeeeeeeecC
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSG-------RGVAIKVIDKLRFPTKQEAQLKNEVAILQNL-CHPGVVNLERMFETP 883 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg-------~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~L~~~f~~~ 883 (1098)
..|.+...||.|+||.||.+.+..++ ..||||++++.. .......+.+|...+.++ +||||++++++|.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 46888999999999999999987665 379999997643 345567788898888877 799999999999999
Q ss_pred CcEEEEEEeccCchHHHHHhhcc---------------CccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy48 884 GRIFVVMEKLQGDMLEMILSSEK---------------GRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTN 948 (1098)
Q Consensus 884 ~~l~LVmEy~~ggsL~~~l~~~~---------------~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~ 948 (1098)
+.+++||||+.+|+|..++.... ..+++.+++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCC
Confidence 99999999999999999986443 358999999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCcccccC--------------CCCCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCChhHHHHH
Q psy48 949 SELPQVKLCDFGFARIIG--------------EKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS-GTFPFNEDEDINEQI 1013 (1098)
Q Consensus 949 g~~~~vKL~DFGla~~~~--------------~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt-G~~Pf~~~~~~~~~i 1013 (1098)
+ .+||+|||+++... ..|+|||.+.+..|+.++|||||||++|||++ |.+||.+.... +..
T Consensus 172 ~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-~~~ 247 (299)
T d1fgka_ 172 N---VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-ELF 247 (299)
T ss_dssp C---CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHH
T ss_pred C---CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-HHH
Confidence 8 89999999987431 23579999999999999999999999999998 68888755322 222
Q ss_pred HHhhccCCCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1014 QNAAFMYPPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1014 ~~~~~~~p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
........+..+..+++++.+||.+||+.||++|||+.||++
T Consensus 248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 222233444455679999999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-38 Score=348.96 Aligned_cols=244 Identities=17% Similarity=0.181 Sum_probs=195.4
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCC-ceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPG-VVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~L~~~f~~~~~l~LVm 890 (1098)
++|.....||.|+||.||.|.+..+|+.||||++..... ...+..|+++++.++|++ |+.+..++...+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 579999999999999999999999999999999876432 235788999999998766 555566667888899999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEeecCccccc-----
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLCDFGFARII----- 965 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~----- 965 (1098)
||++++++ ..+......+++..+..++.||+.||+|||++||+||||||+|||++..+....++|+|||+|+..
T Consensus 83 e~~~~~l~-~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 83 ELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp ECCCCBHH-HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEcCCchh-hhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 99977766 444456678999999999999999999999999999999999999876544447999999999743
Q ss_pred --------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChh--HHH---HHHHhhccCC-CCCC
Q psy48 966 --------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDED--INE---QIQNAAFMYP-PRPW 1025 (1098)
Q Consensus 966 --------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~--~~~---~i~~~~~~~p-~~~~ 1025 (1098)
+..|+|||++.+..|+.++|||||||++|||++|..||..... ... .........+ ....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence 2346899999999999999999999999999999999975421 111 1111111121 1123
Q ss_pred CcCcHHHHHHHHHhhhhcccCCCCHH---HHHcCCCcC
Q psy48 1026 RDISSDAIDLINNLLQVKQRKRLSVD---KSLAHPWLQ 1060 (1098)
Q Consensus 1026 ~~is~el~~LL~~cL~~dP~kRPSa~---eIL~HpfFk 1060 (1098)
..+|+++.++|..||+.||++||+++ ++|+|+|.+
T Consensus 242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 46899999999999999999999986 456777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-36 Score=335.04 Aligned_cols=240 Identities=18% Similarity=0.200 Sum_probs=196.4
Q ss_pred hhheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCC-CCceeeeeeeecCCcEEEE
Q psy48 811 LVFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCH-PGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 811 l~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~L~~~f~~~~~l~LV 889 (1098)
.++|++...||.|+||.||.|.+..+|+.||||+++.... ...+.+|+++++.+.| +|++.++.++......++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 4689999999999999999999999999999999865432 2346788889988865 8999999999999999999
Q ss_pred EEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCC--CCcEEEeecCccccc--
Q psy48 890 MEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSE--LPQVKLCDFGFARII-- 965 (1098)
Q Consensus 890 mEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~--~~~vKL~DFGla~~~-- 965 (1098)
|||++ ++|..++......+++..+..++.|++.||+|||++||+||||||+|||++.... ...+||+|||+|+..
T Consensus 80 me~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 99995 5666777766778999999999999999999999999999999999999975311 127999999999643
Q ss_pred -----------------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCh-----hHHHHHHHhhccCC-C
Q psy48 966 -----------------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDE-----DINEQIQNAAFMYP-P 1022 (1098)
Q Consensus 966 -----------------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~-----~~~~~i~~~~~~~p-~ 1022 (1098)
+..|||||++.+..|+.++|||||||++|||++|..||.+.. .....+.......+ .
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence 245789999999999999999999999999999999997431 11222222222221 1
Q ss_pred CCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1023 RPWRDISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1023 ~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.....+|+++.+++..|+..+|++||+.+.+.+
T Consensus 239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123468899999999999999999998766543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-36 Score=332.71 Aligned_cols=233 Identities=16% Similarity=0.170 Sum_probs=180.5
Q ss_pred heeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCceeeeeeeecCC----cEEE
Q psy48 813 FMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGVVNLERMFETPG----RIFV 888 (1098)
Q Consensus 813 ~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnIv~L~~~f~~~~----~l~L 888 (1098)
.+.....||.|+||.||.+.+ +|+.||||+++.. .........|+..+..++||||+++++++.+.+ .+++
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 467788999999999999975 6899999999643 122222334555556789999999999997653 5899
Q ss_pred EEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh--------CCccccCCCCCceeecCCCCCCcEEEeecC
Q psy48 889 VMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS--------KNIVHCDLKPENVLLSTNSELPQVKLCDFG 960 (1098)
Q Consensus 889 VmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs--------~gIvHrDLKp~NILld~~g~~~~vKL~DFG 960 (1098)
||||+++|+|..++.. ..+++..++.++.|++.||+|||+ +||+||||||+||||+.++ .+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~---~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG---TCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS---CEEECCCT
T ss_pred EEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC---CeEEEecC
Confidence 9999999999999864 358999999999999999999996 5999999999999999998 89999999
Q ss_pred ccccc----------------CCCCCChhhhccCC------CCchhHHHHHHHHHHHHHcCCCCCCCCh-----------
Q psy48 961 FARII----------------GEKSFPPEVLRNKG------YNRSLDMWSVGVIVYVSLSGTFPFNEDE----------- 1007 (1098)
Q Consensus 961 la~~~----------------~~~~~APEvl~~~~------ys~~sDVwSLGvlLyELltG~~Pf~~~~----------- 1007 (1098)
+++.. +..|+|||++.+.. ++.++|||||||+||||+||..||....
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 98643 23458999997653 5779999999999999999988763211
Q ss_pred --hHHHHHHHhhc--cCCCCCCC-----cCcHHHHHHHHHhhhhcccCCCCHHHHHc
Q psy48 1008 --DINEQIQNAAF--MYPPRPWR-----DISSDAIDLINNLLQVKQRKRLSVDKSLA 1055 (1098)
Q Consensus 1008 --~~~~~i~~~~~--~~p~~~~~-----~is~el~~LL~~cL~~dP~kRPSa~eIL~ 1055 (1098)
.....+..... ...+..+. ....++.+|+.+||..||++|||+.||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 01111111111 11111111 12356899999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-35 Score=335.89 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=190.4
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-----------CCCceeeeeee
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-----------HPGVVNLERMF 880 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~L~~~f 880 (1098)
++|+....||.|+||.||.|.++.+|+.||||++++. ......+.+|+.+++.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 5699999999999999999999999999999999764 334467788998887664 57899999888
Q ss_pred ecC--CcEEEEEEeccC--chHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCCC---C
Q psy48 881 ETP--GRIFVVMEKLQG--DMLEMILSSEKGRLSERTTKFIITQILVALKHLHS-KNIVHCDLKPENVLLSTNSEL---P 952 (1098)
Q Consensus 881 ~~~--~~l~LVmEy~~g--gsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs-~gIvHrDLKp~NILld~~g~~---~ 952 (1098)
... ...+++|+++.. +............+++..+..++.||+.||+|||+ .||+||||||+|||++.++.. .
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 543 456666666543 33333344455679999999999999999999997 899999999999999876522 1
Q ss_pred cEEEeecCccccc---------CCCCCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCChhH-----HHHHH-Hhh
Q psy48 953 QVKLCDFGFARII---------GEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDI-----NEQIQ-NAA 1017 (1098)
Q Consensus 953 ~vKL~DFGla~~~---------~~~~~APEvl~~~~ys~~sDVwSLGvlLyELltG~~Pf~~~~~~-----~~~i~-~~~ 1017 (1098)
.++|+|||.+... +..++|||++.+..|+.++|+||+||++++|++|+.||...... ...+. ...
T Consensus 170 ~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp EEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred eeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 4899999998643 22358999999999999999999999999999999999743210 00110 000
Q ss_pred c--------------------------cC--------------CCCCCCcCcHHHHHHHHHhhhhcccCCCCHHHHHcCC
Q psy48 1018 F--------------------------MY--------------PPRPWRDISSDAIDLINNLLQVKQRKRLSVDKSLAHP 1057 (1098)
Q Consensus 1018 ~--------------------------~~--------------p~~~~~~is~el~~LL~~cL~~dP~kRPSa~eIL~Hp 1057 (1098)
. .. ....+...++++.+||.+||..||.+|||++|+|+||
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp 329 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 329 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 00 0011123467899999999999999999999999999
Q ss_pred CcCCC
Q psy48 1058 WLQDP 1062 (1098)
Q Consensus 1058 fFk~~ 1062 (1098)
||++.
T Consensus 330 ~f~~~ 334 (362)
T d1q8ya_ 330 WLKDT 334 (362)
T ss_dssp GGTTC
T ss_pred ccCCC
Confidence 99963
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.80 E-value=6.4e-20 Score=189.21 Aligned_cols=162 Identities=20% Similarity=0.136 Sum_probs=124.6
Q ss_pred eeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCC----------------hHHHHHHHHHHHHHhccCCCCceeee
Q psy48 814 MTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFP----------------TKQEAQLKNEVAILQNLCHPGVVNLE 877 (1098)
Q Consensus 814 ~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~----------------~~~~~~~~~Ei~iL~~l~HpnIv~L~ 877 (1098)
+..+..||.|++|.||.|.+. +|+.||||+++..... ........+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 356889999999999999874 7899999997532110 11123456788899999999998877
Q ss_pred eeeecCCcEEEEEEeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCCCCcEEEe
Q psy48 878 RMFETPGRIFVVMEKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHSKNIVHCDLKPENVLLSTNSELPQVKLC 957 (1098)
Q Consensus 878 ~~f~~~~~l~LVmEy~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs~gIvHrDLKp~NILld~~g~~~~vKL~ 957 (1098)
++.. .+++|||+++..+. .++...+..++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 81 ~~~~----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~----~~~li 144 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE----GIWII 144 (191)
T ss_dssp EEET----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT----EEEEC
T ss_pred EecC----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC----CEEEE
Confidence 6532 37999999987652 35677788999999999999999999999999999999865 48999
Q ss_pred ecCcccccCCCCCChhhhc----------cCCCCchhHHHHHHHHH
Q psy48 958 DFGFARIIGEKSFPPEVLR----------NKGYNRSLDMWSVGVIV 993 (1098)
Q Consensus 958 DFGla~~~~~~~~APEvl~----------~~~ys~~sDVwSLGvlL 993 (1098)
|||+|.....+ .+.+.+. .+.|+..+|+||+.--+
T Consensus 145 DFG~a~~~~~~-~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEE-GWREILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTST-THHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99999876543 2333321 35688899999976544
|
| >d1tbna_ g.49.1.1 (A:) Protein kinase c-gamma {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase c-gamma species: Rat (Rattus rattus) [TaxId: 10117]
Probab=99.44 E-value=3.1e-14 Score=121.44 Aligned_cols=59 Identities=41% Similarity=0.893 Sum_probs=55.5
Q ss_pred CCcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCCCc
Q psy48 526 VNIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEPV 584 (1098)
Q Consensus 526 ~~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~~~ 584 (1098)
+..+|.|..++|..+++|++|+++|||+.+|||+|.+|++.||++|...|+..|+.+..
T Consensus 5 p~~~H~F~~~~~~~~~~C~~C~~~i~g~~~~g~~C~~C~~~~H~~C~~~v~~~C~~~~~ 63 (66)
T d1tbna_ 5 PRNKHKFRLHSYSSPTFCDHCGSLLYGLVHQGMKCSCCEMNVHRRCVRSVPSLCGVDHT 63 (66)
T ss_dssp CCCSCCEEECCSSSCCBCSSSCCBCCTTSSSCEEETTTCCEECTTTTTTSCCCSSCCCC
T ss_pred CCCCCceEEEeCCCCcCCcCCCCcccCcccCccccCcccCeEChHHhccccccCCCCcc
Confidence 45689999999999999999999999999999999999999999999999999987654
|
| >d1tbna_ g.49.1.1 (A:) Protein kinase c-gamma {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase c-gamma species: Rat (Rattus rattus) [TaxId: 10117]
Probab=99.41 E-value=6.9e-14 Score=119.23 Aligned_cols=57 Identities=42% Similarity=0.935 Sum_probs=53.8
Q ss_pred CCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCCCC
Q psy48 263 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGEP 319 (1098)
Q Consensus 263 ~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~~~ 319 (1098)
..+|+|..++|..|++|++|+++|||+++|||+|.+|++++|++|..+|+..|+...
T Consensus 6 ~~~H~F~~~~~~~~~~C~~C~~~i~g~~~~g~~C~~C~~~~H~~C~~~v~~~C~~~~ 62 (66)
T d1tbna_ 6 RNKHKFRLHSYSSPTFCDHCGSLLYGLVHQGMKCSCCEMNVHRRCVRSVPSLCGVDH 62 (66)
T ss_dssp CCSCCEEECCSSSCCBCSSSCCBCCTTSSSCEEETTTCCEECTTTTTTSCCCSSCCC
T ss_pred CCCCceEEEeCCCCcCCcCCCCcccCcccCccccCcccCeEChHHhccccccCCCCc
Confidence 468999999999999999999999999999999999999999999999999996543
|
| >d1xa6a3 g.49.1.1 (A:209-270) Beta-chimaerin, middle domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Beta-chimaerin, middle domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=5.6e-14 Score=118.29 Aligned_cols=56 Identities=43% Similarity=1.035 Sum_probs=53.3
Q ss_pred CCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCCCC
Q psy48 263 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGE 318 (1098)
Q Consensus 263 ~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~~~ 318 (1098)
..+|+|...+|..|++|++|.++|||+++||++|++|++++|++|..+|+..|+..
T Consensus 2 ~k~H~F~~~~~~~pt~C~~C~~~i~g~~~~g~~C~~C~~~~H~~C~~~v~~~C~~~ 57 (62)
T d1xa6a3 2 EKTHNFKVHTFRGPHWCEYCANFMWGLIAQGVRCSDCGLNVHKQCSKHVPNDCQPD 57 (62)
T ss_dssp CCCCCCCEECCSSCCBCTTTCCBCCTTTTCEECCSSSCCCBCTGGGTTSCSCCCTT
T ss_pred CCCCEEEEeeCCCCCCCcccCccccccccCeEEcCCCCchhhHHHHhhCCCcCCCC
Confidence 46899999999999999999999999999999999999999999999999999753
|
| >d1ptqa_ g.49.1.1 (A:) Protein kinase C-delta (PKCdelta) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase C-delta (PKCdelta) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.40 E-value=3.7e-14 Score=114.20 Aligned_cols=50 Identities=54% Similarity=1.115 Sum_probs=49.1
Q ss_pred eeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCC
Q psy48 266 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315 (1098)
Q Consensus 266 H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C 315 (1098)
|+|..++|.+|++|++|+++|||+++||++|++|++++|++|...|+..|
T Consensus 1 H~F~~~~~~~~~~C~~C~~~i~g~~~qg~~C~~C~~~~H~~C~~~v~~~C 50 (50)
T d1ptqa_ 1 HRFKVYNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLC 50 (50)
T ss_dssp CCEEEECCSSCCBCTTTCCBCCSSSSCEEEETTTCCEECHHHHTTSCSCC
T ss_pred CceEEecCCCCcCCcccCCcccCcccCcEECCCCCCeeChhHcccccCCC
Confidence 89999999999999999999999999999999999999999999999987
|
| >d1xa6a3 g.49.1.1 (A:209-270) Beta-chimaerin, middle domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Beta-chimaerin, middle domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=8.8e-14 Score=117.08 Aligned_cols=56 Identities=43% Similarity=1.035 Sum_probs=53.5
Q ss_pred CcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCCCC
Q psy48 527 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCVGE 582 (1098)
Q Consensus 527 ~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~~~ 582 (1098)
..+|+|+..+|..|++|++|.++|||+.+|||+|..|++.+|++|...|+..|+.+
T Consensus 2 ~k~H~F~~~~~~~pt~C~~C~~~i~g~~~~g~~C~~C~~~~H~~C~~~v~~~C~~~ 57 (62)
T d1xa6a3 2 EKTHNFKVHTFRGPHWCEYCANFMWGLIAQGVRCSDCGLNVHKQCSKHVPNDCQPD 57 (62)
T ss_dssp CCCCCCCEECCSSCCBCTTTCCBCCTTTTCEECCSSSCCCBCTGGGTTSCSCCCTT
T ss_pred CCCCEEEEeeCCCCCCCcccCccccccccCeEEcCCCCchhhHHHHhhCCCcCCCC
Confidence 46899999999999999999999999999999999999999999999999999864
|
| >d1ptqa_ g.49.1.1 (A:) Protein kinase C-delta (PKCdelta) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase C-delta (PKCdelta) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.38 E-value=6.6e-14 Score=112.70 Aligned_cols=50 Identities=54% Similarity=1.115 Sum_probs=49.0
Q ss_pred ceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCC
Q psy48 530 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579 (1098)
Q Consensus 530 H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C 579 (1098)
|+|+.++|.+|++|++|.++|||+++|||+|++|++++|++|...|+..|
T Consensus 1 H~F~~~~~~~~~~C~~C~~~i~g~~~qg~~C~~C~~~~H~~C~~~v~~~C 50 (50)
T d1ptqa_ 1 HRFKVYNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLC 50 (50)
T ss_dssp CCEEEECCSSCCBCTTTCCBCCSSSSCEEEETTTCCEECHHHHTTSCSCC
T ss_pred CceEEecCCCCcCCcccCCcccCcccCcEECCCCCCeeChhHcccccCCC
Confidence 89999999999999999999999999999999999999999999999887
|
| >d1r79a_ g.49.1.1 (A:) Diacylglycerol kinase delta {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Diacylglycerol kinase delta species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.19 E-value=5.3e-12 Score=112.37 Aligned_cols=56 Identities=23% Similarity=0.543 Sum_probs=52.7
Q ss_pred CCCCeeeeeeccCCCCccccccccccccc-ccceecCCCCCCccccccCCcCCCCCC
Q psy48 262 VNIPHTFNLHTYTRPTLCGLCKKLLKGLF-KQGLQCKDCGFNVHKKCLDKVPKDCVG 317 (1098)
Q Consensus 262 ~~~~H~f~~~~~~~pt~C~~C~~~l~Gl~-~qG~kC~~C~~~vHkkC~~~v~~~C~~ 317 (1098)
+.++|.|..++|..+++|++|++.|||++ +||++|..|+++||++|..+|+..|.+
T Consensus 24 ~~~~H~w~~~n~~~~~~C~~C~~~i~~~~~~qg~~C~~C~~~~H~~C~~~v~~~C~~ 80 (84)
T d1r79a_ 24 IAMPHQWLEGNLPVSAKCTVCDKTCGSVLRLQDWRCLWCKAMVHTSCKESLLTKCSG 80 (84)
T ss_dssp CCBCCCEEESCCCTTCBCSSSCCBCCCTTTCCCEEESSSCCEECHHHHHHCCSCBCC
T ss_pred CCCCceEEeCCCCCCCCCcccCcccCCccccCcEecCcCCchhhhhhcCCCCCcCcC
Confidence 55899999999999999999999999975 799999999999999999999999964
|
| >d1kbea_ g.49.1.1 (A:) Kinase suppressor of Ras, Ksr {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Kinase suppressor of Ras, Ksr species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.17 E-value=5.3e-12 Score=100.42 Aligned_cols=47 Identities=30% Similarity=0.893 Sum_probs=43.9
Q ss_pred CCCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCC
Q psy48 263 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 315 (1098)
Q Consensus 263 ~~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C 315 (1098)
.++|+|+.++|..+| |++|+++|| ||++|++|++++|++|.++|| .|
T Consensus 2 ~i~H~F~~~~~~~~t-C~~C~~~l~----qg~~C~~C~~~~Hk~C~~~~P-~C 48 (49)
T d1kbea_ 2 SVTHRFSTKSWLSQV-CNVCQKSMI----FGVKCKHCRLKCHNKCTKEAP-AC 48 (49)
T ss_dssp CCCCCEEEECCSSCC-CSSSCCSSC----CEEEETTTTEEESSSCTTTSC-CC
T ss_pred CCccEEeecCcCCCC-chhhchhhh----CcCCcCCCCChHhHhhcccCC-CC
Confidence 379999999999887 999999998 899999999999999999998 57
|
| >d1r79a_ g.49.1.1 (A:) Diacylglycerol kinase delta {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Diacylglycerol kinase delta species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.15 E-value=1.6e-11 Score=109.19 Aligned_cols=59 Identities=22% Similarity=0.488 Sum_probs=53.9
Q ss_pred CCCCcCceeeeeecCCCccccccccchhcc-cccceecCCCCccccccccccCCCCCCCC
Q psy48 524 SSVNIPHTFNLHTYTRPTLCGLCKKLLKGL-FKQGLQCKDCGFNVHKKCLDKVPKDCVGE 582 (1098)
Q Consensus 524 ~~~~~~H~F~~~~~~~~t~C~~C~~~l~Gl-~~qG~~C~~C~~~vH~~C~~~v~~~C~~~ 582 (1098)
....+||.|..++|..+++|++|.+.|||+ .+|||+|.+|+++||++|..+|+..|.+.
T Consensus 22 ~~~~~~H~w~~~n~~~~~~C~~C~~~i~~~~~~qg~~C~~C~~~~H~~C~~~v~~~C~~P 81 (84)
T d1r79a_ 22 DGIAMPHQWLEGNLPVSAKCTVCDKTCGSVLRLQDWRCLWCKAMVHTSCKESLLTKCSGP 81 (84)
T ss_dssp SCCCBCCCEEESCCCTTCBCSSSCCBCCCTTTCCCEEESSSCCEECHHHHHHCCSCBCCS
T ss_pred CCCCCCceEEeCCCCCCCCCcccCcccCCccccCcEecCcCCchhhhhhcCCCCCcCcCC
Confidence 345678999999999999999999999997 57999999999999999999999999653
|
| >d1faqa_ g.49.1.1 (A:) RAF-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: RAF-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=1.2e-11 Score=100.03 Aligned_cols=49 Identities=37% Similarity=0.994 Sum_probs=47.0
Q ss_pred CCeeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCCcCCCCC
Q psy48 264 IPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCV 316 (1098)
Q Consensus 264 ~~H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~v~~~C~ 316 (1098)
.+|+|+.++|..|++|++|+++|| ||++|++|++++|++|..+||..|.
T Consensus 2 ~~H~F~~~~f~~~~~C~~C~~~i~----~g~~C~~C~~~~H~~C~~~v~~~C~ 50 (52)
T d1faqa_ 2 TTHNFARKTFLKLAFCDICQKFLL----NGFRCQTCGYKFHEHCSTKVPTMCV 50 (52)
T ss_dssp CCCCCEEECCSSCEECTTSSSEEC----SEEECTTTTCCBCSTTSSSSSSCCC
T ss_pred CceEEEEeeCCCCcCCccCCCccc----cCCCcCCCCChhhhhhhcccccccc
Confidence 479999999999999999999998 7999999999999999999999995
|
| >d1kbea_ g.49.1.1 (A:) Kinase suppressor of Ras, Ksr {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Kinase suppressor of Ras, Ksr species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.11 E-value=1.1e-11 Score=98.47 Aligned_cols=47 Identities=30% Similarity=0.893 Sum_probs=43.8
Q ss_pred CcCceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCC
Q psy48 527 NIPHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDC 579 (1098)
Q Consensus 527 ~~~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C 579 (1098)
+++|+|+.++|..+| |++|.++|| |||+|++|++++|++|...|| .|
T Consensus 2 ~i~H~F~~~~~~~~t-C~~C~~~l~----qg~~C~~C~~~~Hk~C~~~~P-~C 48 (49)
T d1kbea_ 2 SVTHRFSTKSWLSQV-CNVCQKSMI----FGVKCKHCRLKCHNKCTKEAP-AC 48 (49)
T ss_dssp CCCCCEEEECCSSCC-CSSSCCSSC----CEEEETTTTEEESSSCTTTSC-CC
T ss_pred CCccEEeecCcCCCC-chhhchhhh----CcCCcCCCCChHhHhhcccCC-CC
Confidence 478999999998887 999999999 999999999999999999998 57
|
| >d1faqa_ g.49.1.1 (A:) RAF-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: RAF-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.11 E-value=1.1e-11 Score=100.15 Aligned_cols=48 Identities=38% Similarity=1.018 Sum_probs=46.6
Q ss_pred CceeeeeecCCCccccccccchhcccccceecCCCCccccccccccCCCCCC
Q psy48 529 PHTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDKVPKDCV 580 (1098)
Q Consensus 529 ~H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~v~~~C~ 580 (1098)
+|+|+.++|..|++|++|+++|| ||++|++|++++|++|..+||..|.
T Consensus 3 ~H~F~~~~f~~~~~C~~C~~~i~----~g~~C~~C~~~~H~~C~~~v~~~C~ 50 (52)
T d1faqa_ 3 THNFARKTFLKLAFCDICQKFLL----NGFRCQTCGYKFHEHCSTKVPTMCV 50 (52)
T ss_dssp CCCCEEECCSSCEECTTSSSEEC----SEEECTTTTCCBCSTTSSSSSSCCC
T ss_pred ceEEEEeeCCCCcCCccCCCccc----cCCCcCCCCChhhhhhhcccccccc
Confidence 69999999999999999999999 8999999999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.91 E-value=5.9e-11 Score=132.43 Aligned_cols=28 Identities=36% Similarity=0.517 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++|||||||||+|||||.+
T Consensus 114 il~al~ylH~~~iiHRDlKP~NILl~~~ 141 (337)
T d1o6la_ 114 IVSALEYLHSRDVVYRDIKLENLMLDKD 141 (337)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred HhhhhhhhhhcCccccccCHHHeEecCC
Confidence 9999999999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=1.8e-10 Score=123.82 Aligned_cols=28 Identities=39% Similarity=0.597 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||||.+
T Consensus 115 i~~al~~lH~~~ivHrDiKp~Nill~~~ 142 (263)
T d2j4za1 115 LANALSYCHSKRVIHRDIKPENLLLGSA 142 (263)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCeeeeeeccccceecCC
Confidence 9999999999999999999999999874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.79 E-value=2.7e-10 Score=125.75 Aligned_cols=28 Identities=46% Similarity=0.667 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++|||||||||+|||||.+
T Consensus 113 i~~al~~lH~~~iiHrDiKp~NILl~~~ 140 (316)
T d1fota_ 113 VCLALEYLHSKDIIYRDLKPENILLDKN 140 (316)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEECTT
T ss_pred HHHhhhhhccCcEEccccCchheeEcCC
Confidence 8999999999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.78 E-value=3.4e-10 Score=127.41 Aligned_cols=28 Identities=36% Similarity=0.640 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 116 i~~aL~ylH~~~iiHrDlKP~NILl~~~ 143 (364)
T d1omwa3 116 IILGLEHMHNRFVVYRDLKPANILLDEH 143 (364)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECSS
T ss_pred HHHHHHHHHHCCccceeeccceeEEcCC
Confidence 8999999999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.77 E-value=2.9e-10 Score=122.78 Aligned_cols=28 Identities=32% Similarity=0.534 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+++|||++|||||||||+|||||.+
T Consensus 112 i~~al~ylH~~~IiHrDiKp~NILl~~~ 139 (271)
T d1nvra_ 112 LMAGVVYLHGIGITHRDIKPENLLLDER 139 (271)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred HHHHHHHHHHcCCccCcccHHHEEECCC
Confidence 9999999999999999999999999863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.74 E-value=5.9e-10 Score=124.76 Aligned_cols=28 Identities=36% Similarity=0.571 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 150 i~~aL~yLH~~~iiHRDIKP~NILl~~~ 177 (350)
T d1rdqe_ 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQ 177 (350)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHhCCEecCcCCHHHcccCCC
Confidence 8999999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.71 E-value=7.4e-10 Score=120.78 Aligned_cols=29 Identities=38% Similarity=0.590 Sum_probs=27.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||+|.+.
T Consensus 111 il~~L~yLH~~~IiHrDiKpeNIl~~~~~ 139 (298)
T d1gz8a_ 111 LLQGLAFCHSHRVLHRDLKPQNLLINTEG 139 (298)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred HHHHHHHhhcCCEEccccCchheeecccC
Confidence 99999999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.67 E-value=1.8e-09 Score=117.30 Aligned_cols=28 Identities=32% Similarity=0.421 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||||.+
T Consensus 124 i~~gL~yLH~~~iiHrDlKp~NILl~~~ 151 (287)
T d1opja_ 124 ISSAMEYLEKKNFIHRDLAARNCLVGEN 151 (287)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred HHHHHHHHHHCCcccCccccCeEEECCC
Confidence 8889999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=98.63 E-value=1.5e-09 Score=117.30 Aligned_cols=29 Identities=28% Similarity=0.518 Sum_probs=27.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||||.+.
T Consensus 109 i~~~L~~LH~~~IvHrDiKp~NIll~~~~ 137 (286)
T d1ob3a_ 109 LLNGIAYCHDRRVLHRDLKPQNLLINREG 137 (286)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred HHHHHHHhccCcEEecCCCCceeeEcCCC
Confidence 89999999999999999999999998853
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.63 E-value=1.7e-09 Score=116.68 Aligned_cols=28 Identities=39% Similarity=0.638 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||++.+
T Consensus 110 ~~~aL~~lH~~~IvHrDiKP~NIli~~~ 137 (292)
T d1unla_ 110 LLKGLGFCHSRNVLHRDLKPQNLLINRN 137 (292)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHhhcCCEeeecccCcccccccC
Confidence 8899999999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.63 E-value=2e-09 Score=118.95 Aligned_cols=28 Identities=39% Similarity=0.590 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++|||||||||+|||||.+
T Consensus 138 i~~al~~lH~~~ivHrDiKp~Nill~~~ 165 (322)
T d1vzoa_ 138 IVLALEHLHKLGIIYRDIKLENILLDSN 165 (322)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred HHHHHHHhhcCCEEeccCCccceeecCC
Confidence 8899999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=1.5e-09 Score=119.39 Aligned_cols=29 Identities=28% Similarity=0.399 Sum_probs=27.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||||++.
T Consensus 120 i~~gl~yLH~~~iiHrDlKp~NIll~~~~ 148 (317)
T d1xkka_ 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQ 148 (317)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEEETT
T ss_pred HHHHHHHHHHcCcccCcchhhcceeCCCC
Confidence 88899999999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=1.6e-09 Score=120.83 Aligned_cols=29 Identities=31% Similarity=0.528 Sum_probs=27.2
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|+|||++|||||||||+|||||.+.
T Consensus 131 il~aL~yLH~~~IiHrDiKp~NILl~~~~ 159 (350)
T d1q5ka_ 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDT 159 (350)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEECTTT
T ss_pred HHHHHHHHHhcCCcccCCCcceEEEecCC
Confidence 89999999999999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=2.7e-09 Score=116.46 Aligned_cols=28 Identities=36% Similarity=0.574 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 125 i~~aL~yLH~~~iiHrDiKp~NILl~~~ 152 (293)
T d1yhwa1 125 CLQALEFLHSNQVIHRDIKSDNILLGMD 152 (293)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCCcccCCcHHHeEECCC
Confidence 9999999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.60 E-value=2.4e-09 Score=118.15 Aligned_cols=28 Identities=32% Similarity=0.528 Sum_probs=25.9
Q ss_pred HHHhhcccccc-ccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSK-NIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k-~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++ |||||||||+||||+.+
T Consensus 113 il~aL~yLH~~~~IiHRDiKP~NILl~~~ 141 (322)
T d1s9ja_ 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR 141 (322)
T ss_dssp HHHHHHHHHHHHCCCCSCCSGGGEEECTT
T ss_pred HHHHHHHHHHhCCEEccccCHHHeeECCC
Confidence 89999999986 89999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=98.60 E-value=1.8e-09 Score=119.00 Aligned_cols=30 Identities=37% Similarity=0.473 Sum_probs=27.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCCcc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSL 419 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~~ 419 (1098)
++.+|+|||++|||||||||+|||+|++..
T Consensus 138 il~aL~~LH~~gIvHrDiKp~NILi~~~~~ 167 (328)
T d3bqca1 138 ILKALDYCHSMGIMHRDVKPHNVMIDHEHR 167 (328)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETTTT
T ss_pred HHHHHHHHhhcccccccccccceEEcCCCC
Confidence 999999999999999999999999987443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.60 E-value=2.5e-09 Score=116.39 Aligned_cols=28 Identities=50% Similarity=0.729 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||++|||||||||+|||||.+
T Consensus 117 i~~al~ylH~~~iiHrDiKp~NIll~~~ 144 (288)
T d1uu3a_ 117 IVSALEYLHGKGIIHRDLKPENILLNED 144 (288)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred HHHHHHhhccccEEcCcCCccccccCCC
Confidence 8899999999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.59 E-value=2.5e-09 Score=118.02 Aligned_cols=28 Identities=43% Similarity=0.584 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 112 i~~al~ylH~~~iiHrDikp~NiL~~~~ 139 (320)
T d1xjda_ 112 IILGLQFLHSKGIVYRDLKLDNILLDKD 139 (320)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred HHHHHHHHHhCCeeeccCcccceeecCC
Confidence 8999999999999999999999999873
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=3.4e-09 Score=114.65 Aligned_cols=28 Identities=32% Similarity=0.386 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 119 i~~gl~~lH~~~iiHrDlKp~NILl~~~ 146 (283)
T d1mqba_ 119 IAAGMKYLANMNYVHRDLAARNILVNSN 146 (283)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred HHHhhhhccccccccCccccceEEECCC
Confidence 8889999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=98.57 E-value=2.6e-09 Score=119.41 Aligned_cols=27 Identities=48% Similarity=0.758 Sum_probs=25.9
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|+|||++|||||||||+||||+.
T Consensus 133 i~~aL~ylH~~~iiHrDiKp~NIll~~ 159 (350)
T d1koaa2 133 VCKGLCHMHENNYVHLDLKPENIMFTT 159 (350)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred HHHHHHHHHhcCCeeeeechhHeeecc
Confidence 999999999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=3.5e-09 Score=113.26 Aligned_cols=28 Identities=29% Similarity=0.381 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++||||||||++|||+|.+
T Consensus 109 i~~gl~~LH~~~iiH~dlk~~Nill~~~ 136 (258)
T d1k2pa_ 109 VCEAMEYLESKQFLHRDLAARNCLVNDQ 136 (258)
T ss_dssp HHHHHHHHHHTTBCCSCCSGGGEEECTT
T ss_pred HHHHHHHHhhcCcccccccceeEEEcCC
Confidence 8899999999999999999999999984
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=3e-09 Score=115.65 Aligned_cols=28 Identities=43% Similarity=0.568 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 119 i~~gL~ylH~~~ivHrDiKp~NIll~~~ 146 (288)
T d2jfla1 119 TLDALNYLHDNKIIHRDLKAGNILFTLD 146 (288)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred HHHHHHHHHHCCEEEeecChhheeECCC
Confidence 9999999999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.55 E-value=3.8e-09 Score=115.39 Aligned_cols=28 Identities=32% Similarity=0.381 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||||.+
T Consensus 137 ia~gl~yLH~~~iiHrDlKp~NILl~~~ 164 (299)
T d1jpaa_ 137 IAAGMKYLADMNYVHRDLAARNILVNSN 164 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred HHHHHHHHhhCCCccCccccceEEECCC
Confidence 8889999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=3.4e-09 Score=114.49 Aligned_cols=28 Identities=29% Similarity=0.458 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 113 i~~gl~yLH~~~ivHrDlKp~NiLl~~~ 140 (276)
T d1uwha_ 113 TAQGMDYLHAKSIIHRDLKSNNIFLHED 140 (276)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred HHHHHHHHhcCCEeccccCHHHEEEcCC
Confidence 8889999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.54 E-value=3.5e-09 Score=116.37 Aligned_cols=28 Identities=36% Similarity=0.513 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 124 i~~aL~yLH~~~iiHrDiKp~NILl~~~ 151 (309)
T d1u5ra_ 124 ALQGLAYLHSHNMIHRDVKAGNILLSEP 151 (309)
T ss_dssp HHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred HHHHHHHHHhCCEeccCCCcceEEECCC
Confidence 8999999999999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.54 E-value=4.6e-09 Score=112.42 Aligned_cols=29 Identities=17% Similarity=0.275 Sum_probs=27.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|+|||++|||||||||+|||||.+.
T Consensus 110 ia~gl~~lH~~~iiHrDlKp~Nill~~~~ 138 (263)
T d1sm2a_ 110 VCEGMAYLEEACVIHRDLAARNCLVGENQ 138 (263)
T ss_dssp HHHHHHHHHHTTCCCTTCSGGGEEECGGG
T ss_pred HHHHHHhhhccceeecccchhheeecCCC
Confidence 88899999999999999999999999743
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=98.54 E-value=3.6e-09 Score=118.33 Aligned_cols=27 Identities=44% Similarity=0.683 Sum_probs=25.9
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|+|||++|||||||||+|||||.
T Consensus 136 i~~aL~ylH~~~iiHRDiKp~NILl~~ 162 (352)
T d1koba_ 136 ACEGLKHMHEHSIVHLDIKPENIMCET 162 (352)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred HHHHHHHHHHCCeeecccccccccccc
Confidence 899999999999999999999999984
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=3.7e-09 Score=114.99 Aligned_cols=28 Identities=21% Similarity=0.385 Sum_probs=25.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||||.+
T Consensus 143 i~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 143 VAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred HHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 4578999999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=4.1e-09 Score=113.62 Aligned_cols=29 Identities=28% Similarity=0.385 Sum_probs=27.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||||.+.
T Consensus 120 i~~gl~ylH~~~iiHrDikp~NIll~~~~ 148 (273)
T d1u46a_ 120 VAEGMGYLESKRFIHRDLAARNLLLATRD 148 (273)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEEEETT
T ss_pred HHHHHHHhhhCCEeeeeecHHHhcccccc
Confidence 88999999999999999999999999854
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.52 E-value=4.1e-09 Score=116.34 Aligned_cols=28 Identities=25% Similarity=0.297 Sum_probs=25.0
Q ss_pred HHhhccccccccccccCCCCCccCCCCc
Q psy48 391 LVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 391 la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
+.+|+|||++|||||||||+|||+|.+.
T Consensus 174 ~~gl~yLH~~~IiHRDlKp~Nill~~~~ 201 (325)
T d1rjba_ 174 AKGMEFLEFKSCVHRDLAARNVLVTHGK 201 (325)
T ss_dssp HHHHHHHHHTTEEETTCSGGGEEEETTT
T ss_pred HHHHHHHHhCCeeeccCchhccccccCC
Confidence 4479999999999999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.51 E-value=5.4e-09 Score=115.36 Aligned_cols=28 Identities=43% Similarity=0.701 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+++|||++|||||||||+||||+.+
T Consensus 111 i~~al~yLH~~~iiHrDlKp~NIll~~~ 138 (321)
T d1tkia_ 111 VCEALQFLHSHNIGHFDIRPENIIYQTR 138 (321)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESSS
T ss_pred HHHHHHHHHHcCCCcccccccceeecCC
Confidence 8999999999999999999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.51 E-value=4.4e-09 Score=113.14 Aligned_cols=28 Identities=32% Similarity=0.593 Sum_probs=21.0
Q ss_pred HHHhhccccccc-----cccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKN-----IVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~-----IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++| ||||||||+|||||.+
T Consensus 118 i~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~ 150 (269)
T d2java1 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 150 (269)
T ss_dssp HHHHHHHHHHHCC---------CCGGGEEECTT
T ss_pred HHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC
Confidence 788999999987 9999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=4.8e-09 Score=112.90 Aligned_cols=29 Identities=31% Similarity=0.513 Sum_probs=26.9
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.++.|||++|||||||||+|||||.+.
T Consensus 119 i~~al~~lH~~~iiHrDiKp~NIll~~~~ 147 (273)
T d1xwsa_ 119 VLEAVRHCHNCGVLHRDIKDENILIDLNR 147 (273)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEETTT
T ss_pred HHHHHHHHHHCCCccccCcccceEEecCC
Confidence 88999999999999999999999998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=98.50 E-value=5.2e-09 Score=112.66 Aligned_cols=28 Identities=29% Similarity=0.484 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+||||+.+
T Consensus 120 i~~al~~lH~~~iiHrDiKP~NIll~~~ 147 (277)
T d1o6ya_ 120 ACQALNFSHQNGIIHRDVKPANIMISAT 147 (277)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred HHHHHHHHHhCCccCccccCcccccCcc
Confidence 8999999999999999999999999764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=6e-09 Score=113.24 Aligned_cols=28 Identities=43% Similarity=0.558 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||++.+
T Consensus 122 i~~al~yLH~~~ivHrDiKp~Nill~~~ 149 (293)
T d1jksa_ 122 ILNGVYYLHSLQIAHFDLKPENIMLLDR 149 (293)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEESCS
T ss_pred HHHHHHhhhhcceeecccccceEEEecC
Confidence 8899999999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.48 E-value=6.5e-09 Score=112.97 Aligned_cols=27 Identities=33% Similarity=0.634 Sum_probs=25.6
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||++.
T Consensus 112 i~~~l~~lH~~~iiHrDiKp~NIl~~~ 138 (299)
T d1ckia_ 112 MISRIEYIHSKNFIHRDVKPDNFLMGL 138 (299)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECC
T ss_pred HHHHHHHHHHCCeeeccCCHhhccccc
Confidence 899999999999999999999999876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=98.48 E-value=7.1e-09 Score=112.04 Aligned_cols=29 Identities=45% Similarity=0.600 Sum_probs=27.1
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+++|||++|||||||||+|||||.+.
T Consensus 119 i~~al~~lH~~~ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 119 LLEVICALHKLNIVHRDLKPENILLDDDM 147 (277)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred HHHHHHHHHHcCCcccccccceEEEcCCC
Confidence 89999999999999999999999998753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.46 E-value=1.3e-08 Score=110.63 Aligned_cols=32 Identities=38% Similarity=0.676 Sum_probs=28.3
Q ss_pred HHHhhccccccccccccCCCCCccCCC-Ccccc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT-SSLEI 421 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~-~~~~~ 421 (1098)
++.+|.|||++|||||||||+|||++. +.+.|
T Consensus 125 i~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred HHHHHHHHHhCCEEecCCCccEEEEcCCCCeee
Confidence 889999999999999999999999987 34444
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.45 E-value=8.1e-09 Score=111.09 Aligned_cols=28 Identities=21% Similarity=0.418 Sum_probs=26.5
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||||.+
T Consensus 118 i~~gl~~lH~~~ivHrDiKp~NIll~~~ 145 (272)
T d1qpca_ 118 IAEGMAFIEERNYIHRDLRAANILVSDT 145 (272)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred HHHHHHHHHhCCcccCccchhheeeecc
Confidence 8888999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.45 E-value=1.3e-08 Score=111.51 Aligned_cols=27 Identities=52% Similarity=0.707 Sum_probs=25.8
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||+.+
T Consensus 116 i~~al~ylH~~~iiHrDiKp~Nil~~~ 142 (307)
T d1a06a_ 116 VLDAVKYLHDLGIVHRDLKPENLLYYS 142 (307)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred HHHHHHhhhhceeeeEEecccceeecc
Confidence 999999999999999999999999965
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=1.2e-08 Score=113.32 Aligned_cols=28 Identities=50% Similarity=0.723 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||||.+
T Consensus 118 il~al~yLH~~~iiHRDIKp~NILl~~~ 145 (345)
T d1pmea_ 118 ILRGLKYIHSANVLHRDLKPSNLLLNTT 145 (345)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred HHHHHHHHHHCCCcCCCCCcceEEECCC
Confidence 8999999999999999999999999873
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=1.8e-08 Score=111.80 Aligned_cols=30 Identities=30% Similarity=0.471 Sum_probs=27.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCCcc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSL 419 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~~ 419 (1098)
++.+|+|||++|||||||||+|||+|.+..
T Consensus 130 i~~aL~~LH~~~IiHrDiKp~NIL~~~~~~ 159 (346)
T d1cm8a_ 130 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCE 159 (346)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred HHHHHHHHHhCCCcccccCcchhhcccccc
Confidence 899999999999999999999999987543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=1.2e-08 Score=112.93 Aligned_cols=28 Identities=43% Similarity=0.603 Sum_probs=26.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||+|.+
T Consensus 130 il~aL~~LH~~giiHrDiKp~NILi~~~ 157 (348)
T d2gfsa1 130 ILRGLKYIHSADIIHRDLKPSNLAVNED 157 (348)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred HHHHHHHHHhCCCcccccCCcccccccc
Confidence 9999999999999999999999999874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=2.1e-08 Score=111.11 Aligned_cols=27 Identities=48% Similarity=0.653 Sum_probs=26.2
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+++|||++|||||||||+||||+.
T Consensus 120 i~~al~ylH~~~iiHRDiKp~NIll~~ 146 (335)
T d2ozaa1 120 IGEAIQYLHSINIAHRDVKPENLLYTS 146 (335)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred HHHHHHHHHHcCCcccccccccccccc
Confidence 899999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.42 E-value=1.6e-08 Score=110.20 Aligned_cols=28 Identities=25% Similarity=0.348 Sum_probs=26.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+++|||++|||||||||+|||+|.+
T Consensus 144 i~~al~ylH~~~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 144 VARGMEYLASKKCIHRDLAARNVLVTED 171 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred HHHHHHHhhhCCEEeeeecccceeecCC
Confidence 6778899999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=1.1e-08 Score=109.83 Aligned_cols=28 Identities=32% Similarity=0.425 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||+|.+
T Consensus 117 i~~gl~ylH~~~iiHrDlKp~NIll~~~ 144 (273)
T d1mp8a_ 117 LSTALAYLESKRFVHRDIAARNVLVSSN 144 (273)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEEET
T ss_pred HHHHhhhhcccCeeccccchhheeecCC
Confidence 8889999999999999999999999884
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=1.5e-08 Score=110.95 Aligned_cols=29 Identities=28% Similarity=0.455 Sum_probs=27.0
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.++.|||++|||||||||+|||++.+.
T Consensus 126 il~~l~~lH~~~ivHrDlKp~NILl~~~~ 154 (318)
T d3blha1 126 LLNGLYYIHRNKILHRDMKAANVLITRDG 154 (318)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTS
T ss_pred HHHHHHHhccCCEEecCcCchheeecCCC
Confidence 88999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=1.8e-08 Score=110.17 Aligned_cols=29 Identities=21% Similarity=0.291 Sum_probs=26.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+++|||++|||||||||+|||+|.+.
T Consensus 136 ia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 136 VARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred HHHHHHhhhcCCccccccccceEEEcCCC
Confidence 57789999999999999999999999853
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.39 E-value=1.4e-08 Score=110.66 Aligned_cols=29 Identities=21% Similarity=0.319 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|.|||++|||||||||+|||||.+-
T Consensus 149 i~~gl~ylH~~~ivHrDlKp~NILld~~~ 177 (301)
T d1lufa_ 149 VAAGMAYLSERKFVHRDLATRNCLVGENM 177 (301)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred HHHHhhhcccCCeEeeEEcccceEECCCC
Confidence 67889999999999999999999999843
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=1.4e-08 Score=110.28 Aligned_cols=28 Identities=39% Similarity=0.548 Sum_probs=26.7
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||+|.+
T Consensus 109 il~aL~~lH~~~iiHrDiKp~NIli~~~ 136 (299)
T d1ua2a_ 109 TLQGLEYLHQHWILHRDLKPNNLLLDEN 136 (299)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred HHHHHHHhhccceecccCCcceEEecCC
Confidence 8999999999999999999999999873
|
| >d1a25a_ b.7.1.2 (A:) C2 domain from protein kinase c (beta) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2 domain from protein kinase c (beta) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.39 E-value=3.2e-09 Score=101.87 Aligned_cols=98 Identities=19% Similarity=0.189 Sum_probs=79.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCccccccccccccccCCCCCCeecccccEE--E
Q psy48 638 DTHSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSESEESRVTDMSQLYQISPDEVLGSGQFGI--V 715 (1098)
Q Consensus 638 ~~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~gsFG~--v 715 (1098)
+..+.+|||++....+......+.+|.+.+.+++|.|++.+.|.....+....+.+.+||.+.++.+++||+..++. +
T Consensus 31 d~~g~~DpYv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~v~~~~~~~~L~i~V~d~d~~~~d~~iG~~~i~l~~l 110 (132)
T d1a25a_ 31 DPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISEL 110 (132)
T ss_dssp STTSCCCEEEEEEEESCTTCSSCEECCCCSSCSSCEEEEEEEEECCSGGGGCEEEEEEEECCSSSCCEEEEEEEEEHHHH
T ss_pred CCCCCcCeEEEEEEccCCCCccccEEeeecCCCCCccceEEEEEeEccccCCEEeEEEEecCCCCCCcEeEEEEEeHHHc
Confidence 34566788887665554444456678888899999999999887665555667888899999999999999999987 6
Q ss_pred Eeeeehhhhhhhhhhccccc
Q psy48 716 YGASMVGIFFLAALYEGVKY 735 (1098)
Q Consensus 716 ~k~~~~g~~~l~~~~e~~~y 735 (1098)
..+..++||.|+..++|++|
T Consensus 111 ~~~~~~~W~~L~~~~~ge~~ 130 (132)
T d1a25a_ 111 QKAGVDGWFKLLSQEEGEYF 130 (132)
T ss_dssp TTCCEEEEEECBCHHHHTTC
T ss_pred CCCCCCeEEECCCCCCCccc
Confidence 67788999999999999988
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=2.3e-08 Score=111.52 Aligned_cols=29 Identities=41% Similarity=0.721 Sum_probs=27.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|+|||++|||||||||+|||++.+.
T Consensus 128 il~gl~~LH~~giiHrDlKP~Nil~~~~~ 156 (355)
T d2b1pa1 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDC 156 (355)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred HHHHHHHhhhcccccccCCcccccccccc
Confidence 99999999999999999999999999743
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.34 E-value=2.6e-08 Score=108.18 Aligned_cols=27 Identities=30% Similarity=0.561 Sum_probs=25.7
Q ss_pred HHHhhccccccccccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++|||||||||+|||++.
T Consensus 110 ~~~~l~~lH~~giiHrDiKp~Nili~~ 136 (293)
T d1csna_ 110 MLARVQSIHEKSLVYRDIKPDNFLIGR 136 (293)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEECC
T ss_pred HHHHHHHHHHCCceeccCCccceeecC
Confidence 788999999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.34 E-value=4e-08 Score=105.12 Aligned_cols=30 Identities=27% Similarity=0.403 Sum_probs=27.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCCcc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSL 419 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~~ 419 (1098)
++.+|.|||++|||||||||+|||+|.+-.
T Consensus 112 i~~al~ylH~~~ivH~dlkp~Nil~~~~~~ 141 (262)
T d1byga_ 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNV 141 (262)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred HHhhccccccCceeccccchHhheecCCCC
Confidence 889999999999999999999999997544
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=3.2e-08 Score=108.19 Aligned_cols=30 Identities=20% Similarity=0.265 Sum_probs=27.3
Q ss_pred HHHhhccccccccccccCCCCCccCCCCcc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSSL 419 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~~ 419 (1098)
++.+|+|||++|||||||||+|||||.+..
T Consensus 142 ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 142 IADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp HHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred HHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 677899999999999999999999998653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=2.9e-08 Score=108.65 Aligned_cols=29 Identities=28% Similarity=0.389 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCCc
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTSS 418 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~~ 418 (1098)
++.+|+|||++|||||||||+|||+|.+.
T Consensus 154 i~~gl~~LH~~~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 154 VAKGMAFLASKNCIHRDLAARNILLTHGR 182 (311)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred HHHHHHHHHhCCeeecccccccccccccC
Confidence 77889999999999999999999998744
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=3.2e-08 Score=107.21 Aligned_cols=28 Identities=25% Similarity=0.310 Sum_probs=26.8
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|+|||++|||||||||+|||||.+
T Consensus 122 i~~gl~~LH~~~ivH~DlKp~NIll~~~ 149 (285)
T d1fmka3 122 IASGMAYVERMNYVHRDLRAANILVGEN 149 (285)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred HHHHHHHHhhhheecccccceEEEECCC
Confidence 8999999999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.24 E-value=6.3e-08 Score=104.03 Aligned_cols=27 Identities=37% Similarity=0.603 Sum_probs=25.6
Q ss_pred HHHhhccccccc--cccccCCCCCccCCC
Q psy48 390 ILVALKHLHSKN--IVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~k~--IihRDLK~dNvLld~ 416 (1098)
++.+|.|||++| ||||||||+||||+.
T Consensus 121 i~~gl~yLH~~~~~IiHrDiKp~NILl~~ 149 (270)
T d1t4ha_ 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITG 149 (270)
T ss_dssp HHHHHHHHHTSSSCCCCSCCCGGGEEESS
T ss_pred HHHHHHHHHHCCCCEEeCCcChhhceeeC
Confidence 899999999999 999999999999964
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.20 E-value=7.4e-08 Score=104.24 Aligned_cols=28 Identities=32% Similarity=0.457 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 118 i~~gL~ylH~~~iiHrDlKp~Nill~~~ 145 (285)
T d1u59a_ 118 VSMGMKYLEEKNFVHRDLAARNVLLVNR 145 (285)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEEET
T ss_pred HHHHHHHHHhCCeecCcCchhheeeccC
Confidence 8899999999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.18 E-value=6.8e-08 Score=104.03 Aligned_cols=28 Identities=32% Similarity=0.449 Sum_probs=26.6
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 116 i~~gl~ylH~~~iiHrDlKp~Nill~~~ 143 (277)
T d1xbba_ 116 VSMGMKYLEESNFVHRDLAARNVLLVTQ 143 (277)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred HHHHHhhHHhCCcccCCCcchhhccccc
Confidence 8899999999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.11 E-value=1.4e-07 Score=103.29 Aligned_cols=28 Identities=29% Similarity=0.427 Sum_probs=26.4
Q ss_pred HHHhhccccccccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHSKNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~k~IihRDLK~dNvLld~~ 417 (1098)
++.+|.|||++|||||||||+|||||.+
T Consensus 139 ia~gL~~lH~~~iiHrDLK~~NILl~~~ 166 (311)
T d1r0pa_ 139 VAKGMKFLASKKFVHRDLAARNCMLDEK 166 (311)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred HHHhhhhhcccCcccCCccHHhEeECCC
Confidence 8888999999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.05 E-value=1.9e-07 Score=103.35 Aligned_cols=27 Identities=37% Similarity=0.675 Sum_probs=25.5
Q ss_pred HHHhhccccc-cccccccCCCCCccCCC
Q psy48 390 ILVALKHLHS-KNIVHCDLKPERNLFPT 416 (1098)
Q Consensus 390 ~la~lk~LH~-k~IihRDLK~dNvLld~ 416 (1098)
++.+|.|||+ +|||||||||+||||+.
T Consensus 134 il~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 134 LLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp HHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred HHHHHHHHhhhcCcccccCChhHeeeec
Confidence 8888999998 99999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=1e-06 Score=95.69 Aligned_cols=28 Identities=36% Similarity=0.458 Sum_probs=24.4
Q ss_pred HHHhhccccc--------cccccccCCCCCccCCCC
Q psy48 390 ILVALKHLHS--------KNIVHCDLKPERNLFPTS 417 (1098)
Q Consensus 390 ~la~lk~LH~--------k~IihRDLK~dNvLld~~ 417 (1098)
++.++.|||+ +|||||||||+|||||.+
T Consensus 109 ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~ 144 (303)
T d1vjya_ 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp HHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred HHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC
Confidence 6777888885 799999999999999764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.84 E-value=3.6e-05 Score=80.30 Aligned_cols=140 Identities=15% Similarity=0.085 Sum_probs=89.2
Q ss_pred hheeeeeeeeeeeeeceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEEE
Q psy48 812 VFMTYNVALCIAVVAGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVVM 890 (1098)
Q Consensus 812 ~~~~~~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LVm 890 (1098)
..++.....+.+....+|... .+++.+.||+...... .....+.+|..++..+. +--+.+++.+...++..++||
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 334444443444445666543 4566788898754321 11234677888877664 434677788888888999999
Q ss_pred EeccCchHHHHHhhccCccchhHHHHHHHHHHHHHHHHHh----------------------------------------
Q psy48 891 EKLQGDMLEMILSSEKGRLSERTTKFIITQILVALKHLHS---------------------------------------- 930 (1098)
Q Consensus 891 Ey~~ggsL~~~l~~~~~~lse~~~~~ia~qIa~gL~~LHs---------------------------------------- 930 (1098)
++++|..+..... +......++.+++..|+.||+
T Consensus 90 ~~l~G~~~~~~~~------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 90 SEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp ECCSSEEHHHHTT------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred Eeccccccccccc------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9999988754421 112223344444555555552
Q ss_pred -------------C------CccccCCCCCceeecCCCCCCcEEEeecCcccc
Q psy48 931 -------------K------NIVHCDLKPENVLLSTNSELPQVKLCDFGFARI 964 (1098)
Q Consensus 931 -------------~------gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~ 964 (1098)
. .++|+|+.|.|||++.++ .+.|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~---~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK---VSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE---EEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCc---eEEEeechhccc
Confidence 1 268999999999998765 557999998763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=97.54 E-value=6.7e-06 Score=82.68 Aligned_cols=37 Identities=24% Similarity=0.252 Sum_probs=32.8
Q ss_pred hhhHHHHhhccccccccccccCCCCCccCCCCccccc
Q psy48 386 FRRSILVALKHLHSKNIVHCDLKPERNLFPTSSLEIK 422 (1098)
Q Consensus 386 fgKV~la~lk~LH~k~IihRDLK~dNvLld~~~~~~~ 422 (1098)
+.+-++.++.|||++|||||||||+|||++.+.+.+-
T Consensus 108 i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~li 144 (191)
T d1zara2 108 VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWII 144 (191)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEEC
T ss_pred HHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEE
Confidence 5566899999999999999999999999998777763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.22 E-value=0.00024 Score=73.42 Aligned_cols=67 Identities=16% Similarity=0.106 Sum_probs=45.8
Q ss_pred eceEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC--CCCceeeeeeeecCCcEEEEEEeccCchH
Q psy48 826 AGAACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC--HPGVVNLERMFETPGRIFVVMEKLQGDML 898 (1098)
Q Consensus 826 g~v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~L~~~f~~~~~l~LVmEy~~ggsL 898 (1098)
..+|... ...+..+.+|...... ...+..|..+|+.+. .-.+.+++.+....+..++||+|++|..+
T Consensus 25 ~~v~r~~-~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 25 AAVFRLS-AQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CEEEEEE-CTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CeEEEEE-eCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455544 4557778899865432 234667777777653 23367778888888899999999988664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.74 E-value=0.0015 Score=72.61 Aligned_cols=79 Identities=14% Similarity=-0.030 Sum_probs=46.6
Q ss_pred eeeeeeeeeeceEEEEeecCCceeEEEEEecc-CC-C---hHHHHHHHHHHHHHhccC-C--CCceeeeeeeecCCcEEE
Q psy48 817 NVALCIAVVAGAACGVHRKSGRGVAIKVIDKL-RF-P---TKQEAQLKNEVAILQNLC-H--PGVVNLERMFETPGRIFV 888 (1098)
Q Consensus 817 ~~~Lg~G~~g~v~~a~~k~tg~~VAVKvlkk~-~~-~---~~~~~~~~~Ei~iL~~l~-H--pnIv~L~~~f~~~~~l~L 888 (1098)
-..+|.|....||......+++.|+||.-... +. . .....+...|.++|+.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 34678888888999888888889999975321 11 0 111234556888777553 2 345555544 3445679
Q ss_pred EEEeccCch
Q psy48 889 VMEKLQGDM 897 (1098)
Q Consensus 889 VmEy~~ggs 897 (1098)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d2bwqa1 b.7.1.2 (A:729-853) Regulating synaptic membrane exocytosis protein, rim2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Regulating synaptic membrane exocytosis protein, rim2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.49 E-value=3.2e-05 Score=72.40 Aligned_cols=87 Identities=11% Similarity=0.041 Sum_probs=57.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCc-CCCCcc-ccccccccccccCC--CCCCeecccccEE-
Q psy48 640 HSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKC-EDVSES-EESRVTDMSQLYQI--SPDEVLGSGQFGI- 714 (1098)
Q Consensus 640 ~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~--~~~~~lG~gsFG~- 714 (1098)
.+.+|||++....|......+.+|.+.+.+++|.|++.+.|. ....+. ...+.+.+|+.+.+ ..+++||+-.++.
T Consensus 32 ~~~~dpyVkv~l~~~~~~~~~~kT~~~~~t~~P~wne~f~f~~~~~~~l~~~~L~i~v~d~~~~~~~~~~~iG~~~i~l~ 111 (125)
T d2bwqa1 32 GRPRNPYVKIYFLPDRSDKNKRRTKTVKKTLEPKWNQTFIYSPVHRREFRERMLEITLWDQARVREEESEFLGEILIELE 111 (125)
T ss_dssp SCCBCEEEEEEEESSCSGGGEEECCCCSSBSSCEEEEEEEECSCCGGGGGGCEEEEEEEEC-------CEEEEEEEEEGG
T ss_pred CCCCCEEEEEEEeCCCCCccccccCEEcCCCCCEEccEEEEeeeChhhcCCCEEEEEEEECCCCCCCCCeeEEEEEEEch
Confidence 445677877666555555556788888999999999999886 333332 33566777887765 4567999999885
Q ss_pred -EEeeeehhhhhh
Q psy48 715 -VYGASMVGIFFL 726 (1098)
Q Consensus 715 -v~k~~~~g~~~l 726 (1098)
+.+....+||.|
T Consensus 112 ~~~~~~~~~Wy~L 124 (125)
T d2bwqa1 112 TALLDDEPHWYKL 124 (125)
T ss_dssp GCCCSSCEEEEEC
T ss_pred hcCCCCCCEEEeC
Confidence 454555567654
|
| >d1rh8a_ b.7.1.2 (A:) Piccolo {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Piccolo species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.46 E-value=1.7e-05 Score=75.86 Aligned_cols=92 Identities=12% Similarity=0.050 Sum_probs=61.5
Q ss_pred CCCCCCCCCCCCCCCCCCC---------CccccccccccCCCCCCCCCCCc-CCCCc-cccccccccccccCCCCCCeec
Q psy48 640 HSPSDGVETPVTAPESGLG---------ARAWELSLRQALMPVQEPSGTKC-EDVSE-SEESRVTDMSQLYQISPDEVLG 708 (1098)
Q Consensus 640 ~~~sd~~~~~~~~~~~~~~---------~~~~~~~~~~~l~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~lG 708 (1098)
.+.+|||++....+..+.. .+.+|++.+.+++|.|++.+.|. ....+ ....+.+.+||++.+..+++||
T Consensus 36 ~g~~DpyV~v~l~~~~~~~~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~~~~~~~~~~~L~i~V~d~d~~~~~~~lG 115 (142)
T d1rh8a_ 36 NGYSDPFVKVYLLPGRGQVMVVQNASAEYKRRTKYVQKSLNPEWNQTVIYKSISMEQLMKKTLEVTVWDYDRFSSNDFLG 115 (142)
T ss_dssp SSCSCCEEEEEETTSSCCCEECCCCCHHHHTTTTTTHHHHSCEEEEEEEECSCCHHHHTTCEEEEEEEEECSSSCEEEEE
T ss_pred CCCCCcCEEEEEecCcccccccccCCCceeeeccCCcCCCCceeEEEEEEeeecccccCCCEEEEEEEEecCCCCCeeeE
Confidence 4556777765444332221 23467778888999999998876 33222 2345778889999999999999
Q ss_pred ccccEE--E-Eeeeehhhhhhhhhhc
Q psy48 709 SGQFGI--V-YGASMVGIFFLAALYE 731 (1098)
Q Consensus 709 ~gsFG~--v-~k~~~~g~~~l~~~~e 731 (1098)
+-.++. + ......+||.|...++
T Consensus 116 ~~~i~L~~l~~~~~~~~W~~L~~~~~ 141 (142)
T d1rh8a_ 116 EVLIDLSSTSHLDNTPRWYPLKEQTE 141 (142)
T ss_dssp EEEEETTSCGGGTTCCEEEECBCCCC
T ss_pred EEEEEhHHcCCCCCceEEEECcCcCC
Confidence 998875 2 2334567887766543
|
| >d1dqva2 b.7.1.2 (A:425-569) Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin III species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.45 E-value=0.00019 Score=68.72 Aligned_cols=91 Identities=12% Similarity=-0.073 Sum_probs=66.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCcc-ccccccccccccCCCCCCeecccccEEEE-
Q psy48 639 THSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSES-EESRVTDMSQLYQISPDEVLGSGQFGIVY- 716 (1098)
Q Consensus 639 ~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~lG~gsFG~v~- 716 (1098)
..+.+|||++....+......+.+|.+.+.+++|.|++.+.|.....+. ...+.+.+++.+.+..+++||+-.+|.-.
T Consensus 37 ~~~~~dpyv~v~l~~~~~~~~~~kT~~~~~t~~P~wne~f~F~v~~~~~~~~~l~v~v~d~~~~~~~~~iG~~~i~l~~~ 116 (145)
T d1dqva2 37 LTGFSDPYVKASLISEGRRLKKRKTSIKKNTLNPTYNEALVFDVAPESVENVGLSIAVVDYDCIGHNEVIGVCRVGPEAA 116 (145)
T ss_dssp SSSCCCEEEEECCCTTCCTTSCEECCCCCSCSSCEEEECCCCCCCSGGGGSCCCCCEEEECCSSSCCEEEEECCCSSCTT
T ss_pred CCCCcCceEEEEEccCCccceeecCEEEeCCCCceecceEEEEEehhhcCCCEEEEEEEecCCCCCCcEEEEEEECchHc
Confidence 3456788888777766555556778888999999999999997655443 34567788899999999999999998621
Q ss_pred -eeeehhhhhhhhh
Q psy48 717 -GASMVGIFFLAAL 729 (1098)
Q Consensus 717 -k~~~~g~~~l~~~ 729 (1098)
......||.|+..
T Consensus 117 ~~~~~~~W~~l~~~ 130 (145)
T d1dqva2 117 DPHGREHWAEMLAN 130 (145)
T ss_dssp CHHHHHHHHTSSSS
T ss_pred CchhhHHHHHHHhC
Confidence 1223457666544
|
| >d2cm5a1 b.7.1.2 (A:541-677) C2b-domain of rabphilin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2b-domain of rabphilin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.17 E-value=0.00015 Score=68.45 Aligned_cols=94 Identities=15% Similarity=0.050 Sum_probs=66.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCcc-ccccccccccccCCCCCCeecccccEE-EE
Q psy48 639 THSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSES-EESRVTDMSQLYQISPDEVLGSGQFGI-VY 716 (1098)
Q Consensus 639 ~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~lG~gsFG~-v~ 716 (1098)
..+.+|||++....+..+...+.+|.+.+.+.+|.|++.+.|.....+. ...+.+.+++.+.+..+++||+..||. -.
T Consensus 32 ~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~~P~wne~f~f~v~~~~l~~~~l~v~v~~~~~~~~~~~iG~~~i~l~~~ 111 (137)
T d2cm5a1 32 ANGYSDPFVKLWLKPDMGKKAKHKTQIKKKTLNPEFNEEFFYDIKHSDLAKKSLDISVWDYDIGKSNDYIGGCQLGISAK 111 (137)
T ss_dssp TTSCCCEEEEEEEETC---CCEEECCCCCSCSSCEEEEEEEEECCGGGGGGCEEEEEEEECCSSSCCEEEEEEEEETTCC
T ss_pred CCCCcCeEEEEEEEcCCccceeecCEeEcCCCCCccceEEEEEeEHHHccccEEEEEeeeCCCCCCCCEEEEEEeCcccc
Confidence 3456788887766665555556788888999999999999888655543 345667788888999999999999986 11
Q ss_pred eeeehhhhhhhhhhcc
Q psy48 717 GASMVGIFFLAALYEG 732 (1098)
Q Consensus 717 k~~~~g~~~l~~~~e~ 732 (1098)
......||.|+.....
T Consensus 112 ~~~~~~W~~l~~~~~~ 127 (137)
T d2cm5a1 112 GERLKHWYECLKNKDK 127 (137)
T ss_dssp HHHHHHHHHHHHCTTC
T ss_pred CcchhhhhhHhhCCCC
Confidence 2234678887765443
|
| >d1w15a_ b.7.1.2 (A:) Synaptotagmin IV {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin IV species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.01 E-value=4.6e-05 Score=72.66 Aligned_cols=89 Identities=11% Similarity=-0.178 Sum_probs=60.7
Q ss_pred CCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCcc-ccccccccccccCCCCCCeecccccEEEEe-e
Q psy48 641 SPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSES-EESRVTDMSQLYQISPDEVLGSGQFGIVYG-A 718 (1098)
Q Consensus 641 ~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~lG~gsFG~v~k-~ 718 (1098)
+.+|||++....+......+.+|.+.+.+.+|.|++.+.|.....+. ...+.+.+++.+.+.++++||+-.+|.--. .
T Consensus 34 ~~~dpyvkv~l~~~~~~~~~~kT~~~~~t~~P~wne~f~F~v~~~~~~~~~l~i~v~d~~~~~~~~~iG~~~i~l~~~~~ 113 (138)
T d1w15a_ 34 GLSDPYVKVNLYHAKKRISKKKTHVKKCTPNAVFNELFVFDIPCESLEEISVEFLVLDSERGSRNEVIGRLVLGATAEGS 113 (138)
T ss_dssp -CCCEEEEEEEEETTEEEEEEECCCCCSCSSEEEEEEEEEECCSSSSTTEEEEEEEEECCTTSCCEEEEEEEESTTCCSH
T ss_pred CCcCEEEEEEEeCCcccCccccceeECCCCCCeECcEEEEEecHHHhCccEEEEEEEeCCCCCCCCEEEEEEEcchhCCc
Confidence 44567776555444434445677788889999999999887654443 345777889999999999999998885111 1
Q ss_pred eehhhhhhhhh
Q psy48 719 SMVGIFFLAAL 729 (1098)
Q Consensus 719 ~~~g~~~l~~~ 729 (1098)
....||.|+..
T Consensus 114 ~~~hW~~ll~~ 124 (138)
T d1w15a_ 114 GGGHWKEICDF 124 (138)
T ss_dssp HHHHHHHHHHS
T ss_pred hHHHHHHHHhC
Confidence 12347777654
|
| >d1wmha_ d.15.2.2 (A:) Protein kinase C, iota type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Protein kinase C, iota type species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.41 E-value=0.00011 Score=62.39 Aligned_cols=63 Identities=11% Similarity=0.133 Sum_probs=55.7
Q ss_pred CCCCchhhhhhhhhcccccCccccc-cCeEEeccCCCCCCCCCCCCCCCCCCCCcccCCCCCCC
Q psy48 456 SNNIPLMRVVQSIKHTKRRGSKVIK-EGWMIHYTSKDSMSSSFSTKPSSRSPSLTSRTDALSPT 518 (1098)
Q Consensus 456 ~~~ip~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (1098)
..+|.+..+++++|..++|...... .+|++.+|||+++|+|+++.++.|+.+..++++..+|.
T Consensus 18 ~~~it~e~l~~evr~~C~f~~~q~fT~KWiDeEGDPCTISSQmEL~EA~RLye~n~dseL~iHV 81 (83)
T d1wmha_ 18 EPSISFEGLCNEVRDMCSFDNEQLFTMKWIDEEGDPCTVSSQLELEEAFRLYELNKDSELLIHV 81 (83)
T ss_dssp CTTCCHHHHHHHHHHHTTCCTTCCCEEEEECTTSCEEECCSHHHHHHHHHHHHHTTCSCEEEEE
T ss_pred CCCccHHHHHHHHHHHhCCCcCCcEEEEEEcCCCCceeeecHHHHHHHHHHHHccCCcceEEEe
Confidence 4578899999999999999876544 99999999999999999999999999999988876643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.20 E-value=0.048 Score=58.26 Aligned_cols=66 Identities=17% Similarity=0.183 Sum_probs=40.2
Q ss_pred eEEEEeecCCceeEEEEEeccCCChHHHHHHHHHHHHHhccCCCCc--eeee-----eeeecCCcEEEEEEeccCch
Q psy48 828 AACGVHRKSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLCHPGV--VNLE-----RMFETPGRIFVVMEKLQGDM 897 (1098)
Q Consensus 828 v~~a~~k~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~HpnI--v~L~-----~~f~~~~~l~LVmEy~~ggs 897 (1098)
||.+. ..+|+.|++|+.+.... ...++..|...+..+....+ +..+ ..+...+..+.+++++.|..
T Consensus 38 vy~v~-~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 38 VYQFQ-DEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp EEEEC-CTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred eEEEE-cCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 44443 46788999999865432 24567778888876642221 1111 11244567889999998744
|
| >d1dqva1 b.7.1.2 (A:295-424) Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin III species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=95.06 E-value=0.0019 Score=60.43 Aligned_cols=73 Identities=12% Similarity=0.095 Sum_probs=54.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCcc-ccccccccccccCCCCCCeecccccE
Q psy48 639 THSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSES-EESRVTDMSQLYQISPDEVLGSGQFG 713 (1098)
Q Consensus 639 ~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~lG~gsFG 713 (1098)
..+.+|||++....+... .+.+|.+.+.+++|.|++.+.|.....+. ...+.+.+|+.+.+..+++||+-.++
T Consensus 35 ~~g~~dpyv~v~l~~~~~--~~~kT~v~~~t~~P~wne~f~f~v~~~~~~~~~L~v~V~d~~~~~~d~~iG~~~i~ 108 (130)
T d1dqva1 35 SNGFSDPYVKIYLLPDRK--KKFQTKVHRKTLNPIFNETFQFSVPLAELAQRKLHFSVYDFDRFSRHDLIGQVVLD 108 (130)
T ss_dssp TTSCCCEEEEEECTTSTT--SCEECCCCCSCSSCEEEEEEEEECCGGGGSSCCCEEEEEECCSSSCCCEEEEEECC
T ss_pred CCCCcceEEEEEEccCCC--ceEeceeEcCCCCeeeeeEEEEEEchHHcCCCeEEEEEEEcCCCCCCceEEEEEEC
Confidence 355678888766554332 24668888899999999999887654443 34567888999999999999987775
|
| >d1wfma_ b.7.1.2 (A:) Synaptotagmin XIII {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin XIII species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.77 E-value=0.00063 Score=64.51 Aligned_cols=87 Identities=14% Similarity=0.000 Sum_probs=61.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCcc-ccccccccccccCCCCCCeecccccEE--E-
Q psy48 640 HSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSES-EESRVTDMSQLYQISPDEVLGSGQFGI--V- 715 (1098)
Q Consensus 640 ~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~lG~gsFG~--v- 715 (1098)
.+.+|||++....+..+. ....|.+.+.+++|.|++.+.|.....+. ...+.+.+|++++++.+++||+-.|+. +
T Consensus 41 ~g~~dpyVkv~l~~~~~~-~~~kT~v~~~~~~P~wne~f~f~v~~~~l~~~~L~~~V~d~~~~~~~~~iG~~~i~L~~l~ 119 (138)
T d1wfma_ 41 DGGCDCYVQGSVANRTGS-VEAQTALKKRQLHTTWEEGLVLPLAEEELPTATLTLTLRTCDRFSRHSVAGELRLGLDGTS 119 (138)
T ss_dssp SSCCCEEEEEEEEETTEE-EEEECCCCCCCSSEECSSCEEEECCTTSSTTCEEEEEEEECCSSCTTSCSEEEEEESSSSS
T ss_pred CCCcCcEEEEEECCCCCc-cceeeeEECCCCCceEeeeEEEEeeehhccceEEEEEEeeecccccceeeeEEEEEhHHcc
Confidence 456788888776654332 23457778889999999999888654443 345778889999999999999999875 1
Q ss_pred Eeeeehhhhhhh
Q psy48 716 YGASMVGIFFLA 727 (1098)
Q Consensus 716 ~k~~~~g~~~l~ 727 (1098)
.....+.||.|.
T Consensus 120 ~~~~~~~W~~L~ 131 (138)
T d1wfma_ 120 VPLGAAQWGELK 131 (138)
T ss_dssp SCTTCCEEEECC
T ss_pred CCCCceEeEeCC
Confidence 122345566554
|
| >d1rsya_ b.7.1.2 (A:) Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptogamin I species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=94.72 E-value=0.00066 Score=64.69 Aligned_cols=75 Identities=19% Similarity=0.132 Sum_probs=55.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCcc-ccccccccccccCCCCCCeecccccEE
Q psy48 638 DTHSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSES-EESRVTDMSQLYQISPDEVLGSGQFGI 714 (1098)
Q Consensus 638 ~~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~lG~gsFG~ 714 (1098)
+..+.+|||++....+..+ ....|.+.+.+++|.|++.+.|.....+. ...+.+.+|+.+.+..+++||+..|..
T Consensus 50 ~~~g~~dpyV~v~l~~~~~--~~~kT~~~~~t~~P~wne~f~f~i~~~~l~~~~L~i~V~d~d~~~~~~~iG~~~i~L 125 (143)
T d1rsya_ 50 DMGGTSDPYVKVFLLPDKK--KKFETKVHRKTLNPVFNEQFTFKVPYSELGGKTLVMAVYDFDRFSKHDIIGEFKVPM 125 (143)
T ss_dssp STTSCCCEEEEEEEETTCC--SCEECCCCTTCSSCEEEEEEEECCCHHHHTTCEEEEEEEECCSSSCCEEEEEEEEEG
T ss_pred CCCCCCCeEEEEEEcCCCC--eeEEEEEeccccCcceeeeeEEEEEeeccCCceEEEEEEEcCCCCCCcEEEEEEEEc
Confidence 3456778888765544322 24567788899999999999887554332 345678889999999999999988874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.69 E-value=0.033 Score=61.27 Aligned_cols=73 Identities=15% Similarity=0.003 Sum_probs=46.6
Q ss_pred eeeeeeeeeceEEEEee-------cCCceeEEEEEeccCCChHHHHHHHHHHHHHhccC-CCCceeeeeeeecCCcEEEE
Q psy48 818 VALCIAVVAGAACGVHR-------KSGRGVAIKVIDKLRFPTKQEAQLKNEVAILQNLC-HPGVVNLERMFETPGRIFVV 889 (1098)
Q Consensus 818 ~~Lg~G~~g~v~~a~~k-------~tg~~VAVKvlkk~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~L~~~f~~~~~l~LV 889 (1098)
..++.|.--.+|..... ...+.|.+++.-.. .......+|..+++.+. +.-..++++++.. ++|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 35666776777776643 23456777776421 11234567888888774 4445577787753 689
Q ss_pred EEeccCchH
Q psy48 890 MEKLQGDML 898 (1098)
Q Consensus 890 mEy~~ggsL 898 (1098)
|||++|..+
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999988544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.58 E-value=0.17 Score=53.05 Aligned_cols=47 Identities=23% Similarity=0.234 Sum_probs=35.7
Q ss_pred CCccccCCCCCceeecCCCCCCcEEEeecCcccccCCCCCChhhhccCCCCchhHHHHHHHHHHHHHc
Q psy48 931 KNIVHCDLKPENVLLSTNSELPQVKLCDFGFARIIGEKSFPPEVLRNKGYNRSLDMWSVGVIVYVSLS 998 (1098)
Q Consensus 931 ~gIvHrDLKp~NILld~~g~~~~vKL~DFGla~~~~~~~~APEvl~~~~ys~~sDVwSLGvlLyELlt 998 (1098)
.|+||+|+.++||+++.+. ..-|+||+.+.... =+|=+++++..++.
T Consensus 183 ~giIHgDl~~dNvl~~~~~---v~gvIDF~~~~~~~------------------~~~DLAi~~~~~~~ 229 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE---LSGLIDFYFACNDL------------------LAYDVSICLNAWCF 229 (316)
T ss_dssp EEEECSCCCGGGEEEETTE---EEEECCCTTCEEEE------------------HHHHHHHHHHHHSB
T ss_pred cccccCCcchhhhhccccc---ceeEecccccccch------------------hhhhHHHHHHHHhh
Confidence 4799999999999999876 56899999875211 24556888877754
|
| >d1qasa2 b.7.1.1 (A:626-756) PI-specific phospholipase C isozyme D1 (PLC-D1), C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: PI-specific phospholipase C isozyme D1 (PLC-D1), C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=94.09 E-value=0.0028 Score=59.33 Aligned_cols=76 Identities=8% Similarity=-0.086 Sum_probs=49.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCcccccccc-ccCCCCCCCCCCCcCCCCccccccccccccccCCCCCCeecccccEE
Q psy48 638 DTHSPSDGVETPVTAPESGLGARAWELSLR-QALMPVQEPSGTKCEDVSESEESRVTDMSQLYQISPDEVLGSGQFGI 714 (1098)
Q Consensus 638 ~~~~~sd~~~~~~~~~~~~~~~~~~~~~~~-~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~gsFG~ 714 (1098)
+..+.+|||++....+......+..|.+.+ .+++|.|++.+++.....+ ...+.+.++|.|.++.+++||+-.+..
T Consensus 22 ~~~~~~DPyV~v~l~g~~~~~~~~~T~~v~~~~~nP~wne~f~f~~~~~~-~~~L~~~V~D~d~~~~d~~iG~~~i~l 98 (131)
T d1qasa2 22 NKNSIVDPKVIVEIHGVGRDTGSRQTAVITNNGFNPRWDMEFEFEVTVPD-LALVRFMVEDYDSSSKNDFIGQSTIPW 98 (131)
T ss_dssp ----CCCEEEEEEEESSTTTCEEEECCCCSSCSSSCEEEEEEEEEESCGG-GCEEEEEEEECCTTTCCEEEEEEEEEG
T ss_pred CCCCCcCeEEEEEEccCCCCcEEEEEEEEecccCCceEEEEEEEEEEcch-hceEEEEEEEecCCCCCcEEEEEEEEE
Confidence 345667888776554333333344555554 4589999999887654333 234677889999999999999877753
|
| >d1rlwa_ b.7.1.1 (A:) Domain from cytosolic phospholipase A2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from cytosolic phospholipase A2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.95 E-value=0.00083 Score=62.31 Aligned_cols=89 Identities=16% Similarity=0.136 Sum_probs=56.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCccccccccccccccCCCCCCeecccccEE---EE
Q psy48 640 HSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSESEESRVTDMSQLYQISPDEVLGSGQFGI---VY 716 (1098)
Q Consensus 640 ~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~gsFG~---v~ 716 (1098)
.+.+|||++....+... .+..|.+.+.+++|.|++.+.+..... ....+.+.+||++.. .+++||+..|.. ..
T Consensus 24 ~~~~Dpyv~v~l~~~~~--~~~~T~~~~~t~nP~wne~f~f~i~~~-~~~~L~v~V~d~d~~-~d~~lG~~~i~L~~l~~ 99 (126)
T d1rlwa_ 24 LDTPDPYVELFISTTPD--SRKRTRHFNNDINPVWNETFEFILDPN-QENVLEITLMDANYV-MDETLGTATFTVSSMKV 99 (126)
T ss_dssp HCCCCEEEEEECTTSTT--CCEECCCCTTCSSCEEEEEEEEEECTT-SCCEEEEEEEECCSS-CCEEEEEEEEEGGGSCT
T ss_pred CCCCCcEEEEEECCccc--ceeEeeecCCCccceeceeeeecccCc-ccCcEEEEEEECCCC-CCCeEEEEEEEHHHccC
Confidence 45667887655543221 235677778899999999888765422 233456777887665 478999988865 22
Q ss_pred eeeehhhhhhhhhhcc
Q psy48 717 GASMVGIFFLAALYEG 732 (1098)
Q Consensus 717 k~~~~g~~~l~~~~e~ 732 (1098)
....+.||.|-...+|
T Consensus 100 ~~~~~~~~~L~~~~~g 115 (126)
T d1rlwa_ 100 GEKKEVPFIFNQVTEM 115 (126)
T ss_dssp TCEEEEEEEETTTEEE
T ss_pred CCeEEEEEEccCCCeE
Confidence 3344567666444333
|
| >d1uowa_ b.7.1.2 (A:) Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptogamin I species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=93.77 E-value=0.0022 Score=61.94 Aligned_cols=76 Identities=12% Similarity=-0.005 Sum_probs=57.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCcc-ccccccccccccCCCCCCeecccccEE
Q psy48 639 THSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSES-EESRVTDMSQLYQISPDEVLGSGQFGI 714 (1098)
Q Consensus 639 ~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~lG~gsFG~ 714 (1098)
..+.+|||++....+........+|.+.+.+++|.|++.+.|.....+. ...+.+.+++.+.+.++++||+-.+|.
T Consensus 42 ~~~~~dpyV~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~F~v~~~~l~~~~l~i~v~d~~~~~~~~~iG~~~i~l 118 (157)
T d1uowa_ 42 VGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFEVPFEQIQKVQVVVTVLDYDKIGKNDAIGKVFVGY 118 (157)
T ss_dssp TTSCCCEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEEEECCGGGGGGCEEEEEEEECCSSSCCCEEEEEEEET
T ss_pred CCCCCCeeEEEEEecCCccccceecccccCCCCcccCCeEEEEecHHHcCccEEEEEEcccCCCCCCceeEEEEEec
Confidence 3456788888765554333344567888889999999999997655543 346778889999999999999988874
|
| >d1ugka_ b.7.1.2 (A:) Synaptotagmin IV {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin IV species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.64 E-value=0.0022 Score=60.58 Aligned_cols=71 Identities=18% Similarity=0.145 Sum_probs=50.7
Q ss_pred CCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCc-CCCCcc-ccccccccccccCCCCCCeecccccEE
Q psy48 642 PSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKC-EDVSES-EESRVTDMSQLYQISPDEVLGSGQFGI 714 (1098)
Q Consensus 642 ~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~lG~gsFG~ 714 (1098)
.+|||++....+... .+.+|++.+.+++|.|++.+.|. ....+. ...+.+.+|+.+++.++++||+-.|..
T Consensus 43 ~~dpyV~v~l~~~~~--~~~kT~v~~~t~nP~wne~f~f~~~~~~~l~~~~L~~~V~d~d~~~~~~~iG~~~i~L 115 (138)
T d1ugka_ 43 TSDPYIKMTILPEKK--HKVKTRVLRKTLDPAFDETFTFYGIPYTQIQELALHFTILSFDRFSRDDIIGEVLIPL 115 (138)
T ss_dssp BCEEEEEEEEETTTC--SEEECCCCSSCSSCEEEEEEEEECCCSTTGGGCEEEEEEEEECSSCCCCCCEEEEEEC
T ss_pred ccceEEEEEEcCCCC--EeEeCeeEeCCCCCceeeEEEEeeeCHHHcccceEEEEEEECCCCCCCcEEEEEEEEc
Confidence 357777765544322 24567888899999999999875 333332 345677889999999999999887754
|
| >d2ep6a1 b.7.1.1 (A:92-217) Multiple C2 and transmembrane domain-containing protein 2, MCTP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Multiple C2 and transmembrane domain-containing protein 2, MCTP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.22 E-value=0.0037 Score=57.82 Aligned_cols=69 Identities=14% Similarity=-0.044 Sum_probs=50.6
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCccccccccccccccCCCCCCeecccccE
Q psy48 638 DTHSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSESEESRVTDMSQLYQISPDEVLGSGQFG 713 (1098)
Q Consensus 638 ~~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~gsFG 713 (1098)
+..+.+|||++..... .+..|++.+.+++|.|++.+.|.... ....+.+++||.+.++.+++||+-.+.
T Consensus 22 d~~g~~Dpyv~v~~~~-----~~~~T~~~~~t~nP~wne~f~f~v~~--~~~~L~i~V~d~~~~~~d~~lG~~~i~ 90 (126)
T d2ep6a1 22 DFSGKSDPFCLLELGN-----DRLQTHTVYKNLNPEWNKVFTFPIKD--IHDVLEVTVFDEDGDKPPDFLGKVAIP 90 (126)
T ss_dssp SSSSCCCEEEEEEETT-----EEEECCCCSSCSSCCCCEEEEEEESC--TTCEEEEEEEEEETTEEEEECCBCEEE
T ss_pred CCCCCcCeEEEEEcCC-----eEEEEEeeCCceeEEEEEEEEEEEec--cCceeEEEEEEccCCcCcceEEEEEEE
Confidence 3455677887655432 24567777889999999999887543 234677888999999999999987764
|
| >d1bdya_ b.7.1.1 (A:) Domain from protein kinase C delta {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from protein kinase C delta species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=92.80 E-value=0.0072 Score=56.01 Aligned_cols=70 Identities=4% Similarity=-0.068 Sum_probs=47.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCccccccccccccccCCCCCCeecccccEE
Q psy48 638 DTHSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSESEESRVTDMSQLYQISPDEVLGSGQFGI 714 (1098)
Q Consensus 638 ~~~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~gsFG~ 714 (1098)
.+.+.+|||++....+.........+.+.+.+++|.||++|++..... ..+.+.++++| ++++|.-.+|.
T Consensus 19 ~~~~~~dPY~~v~l~~~~~~~~~~~t~~~kkT~nP~WnE~F~~~v~~~---~~l~i~V~d~d----d~~~g~~~i~l 88 (123)
T d1bdya_ 19 AEDDASQPFCAVKMKEALTTDRGKTLVQKKPTMYPEWKSTFDAHIYEG---RVIQIVLMRAA----EDPMSEVTVGV 88 (123)
T ss_dssp CCCCSCCCEEEEEEEEECCGGGTTBEEECSCCBCCCTTCEEEEECCTT---CEEEEEEEEET----TEEEEEEEEEH
T ss_pred CCCCCCCCEEEEEEcCccccccceEEEEeCCCCCcccceEEEEEEccc---cEEEEEEEEcc----ccccCccEEeh
Confidence 346778999876654332222234567778999999999988776543 34455566665 58999888876
|
| >d1wfja_ b.7.1.2 (A:) C2 domain protein At1g63220 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2 domain protein At1g63220 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=91.88 E-value=0.011 Score=55.21 Aligned_cols=69 Identities=7% Similarity=-0.088 Sum_probs=49.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCcccccccc-ccCCCCCCCCCCCcCCCCccccccccccccccCCCCCCeecccccE
Q psy48 638 DTHSPSDGVETPVTAPESGLGARAWELSLR-QALMPVQEPSGTKCEDVSESEESRVTDMSQLYQISPDEVLGSGQFG 713 (1098)
Q Consensus 638 ~~~~~sd~~~~~~~~~~~~~~~~~~~~~~~-~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~gsFG 713 (1098)
+..+.+|||+...... .+.++.+.+ .+++|.|++.+.+.... ....+.+++||++.++.+++||+..+-
T Consensus 26 d~~g~~Dpyv~v~~~~-----~~~~t~~~~~~~~nP~Wne~f~f~v~~--~~~~L~v~V~d~d~~~~d~~iG~~~i~ 95 (136)
T d1wfja_ 26 DFLNNMDPYVQLTCRT-----QDQKSNVAEGMGTTPEWNETFIFTVSE--GTTELKAKIFDKDVGTEDDAVGEATIP 95 (136)
T ss_dssp CSSCSSCCCEEEESSS-----CEEECCCCTTCCSSCEEEEEEEEEEES--SCCEEEEEECCSSSCTTTCCSEEEEEE
T ss_pred CCCCCCCccEEEEEee-----eeEEEEEEecCCCcEEEeeEEEEEEcC--ccceEEEEEEEecCCCCCCEEEEEEEE
Confidence 3457788888765432 234555555 58899999988776543 233477888999999999999987664
|
| >d2nq3a1 b.7.1.1 (A:13-145) E3 ubiquitin-protein ligase Itchy {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: E3 ubiquitin-protein ligase Itchy species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.07 E-value=0.017 Score=53.95 Aligned_cols=66 Identities=8% Similarity=-0.078 Sum_probs=48.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCccccccccccccccCCCCCCeecccccE
Q psy48 640 HSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSESEESRVTDMSQLYQISPDEVLGSGQFG 713 (1098)
Q Consensus 640 ~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~gsFG 713 (1098)
.+..|||++...... ...|.+.+.+++|.|++.+.+..... ..+.+.+||.+.+..+++||+..+-
T Consensus 24 ~~~~dpyv~v~~~~~-----~~kT~v~~~t~nP~wne~f~f~~~~~---~~l~~~V~d~d~~~~d~~iG~~~i~ 89 (133)
T d2nq3a1 24 WFGPSPYVEVTVDGQ-----SKKTEKCNNTNSPKWKQPLTVIVTPV---SKLHFRVWSHQTLKSDVLLGTAALD 89 (133)
T ss_dssp CCCCCEEEEEEETTE-----EEECCCCSSCSSCEEEEEEEEEECTT---CEEEEEEEECCSSSCCEEEEEEEEE
T ss_pred CCCcCeEEEEEECCe-----EEeeEEEEecccEEEcceEEEEEEec---ceeEEEEEEccCCCCCceEEEEEEE
Confidence 445678876554322 34566777889999999888775543 3567888999999999999987774
|
| >d1gmia_ b.7.1.1 (A:) Domain from protein kinase C epsilon {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from protein kinase C epsilon species: Rat (Rattus rattus) [TaxId: 10117]
Probab=85.92 E-value=0.023 Score=53.11 Aligned_cols=68 Identities=6% Similarity=-0.158 Sum_probs=48.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCCcCCCCccccccccccccccCCCCCCeecccccEE
Q psy48 640 HSPSDGVETPVTAPESGLGARAWELSLRQALMPVQEPSGTKCEDVSESEESRVTDMSQLYQISPDEVLGSGQFGI 714 (1098)
Q Consensus 640 ~~~sd~~~~~~~~~~~~~~~~~~~~~~~~~l~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~gsFG~ 714 (1098)
.+.+|||++..... .....|.+.+.+.+|.|++.+.+.... .+.+.+.+++++.++.+++||..++..
T Consensus 35 ~~~~DPYv~v~l~~----~~~~~T~~~~~t~~P~Wne~f~f~v~~---~~~l~i~V~d~~~~~~d~~iG~~~i~l 102 (136)
T d1gmia_ 35 TFLLDPYIALNVDD----SRIGQTATKQKTNSPAWHDEFVTDVCN---GRKIELAVFHDAPIGYDDFVANCTIQF 102 (136)
T ss_dssp CCCCCEEEEEEETT----EEEEECCCCSSCSSCEEEEEEEEEEEE---ECEEEEEEEECCSSSSCEEEEEEEEEH
T ss_pred CCCcCcEEEEEeCC----CcCcEeeEEcCCCCccCccEEEEEEec---CCceEEEEEEecCCCCceeEEEEEEEH
Confidence 45567777644421 112346667778899999999886542 345677888999999999999887764
|
| >d1v5na_ g.49.1.3 (A:) Pdi-like hypothetical protein At1g60420 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: C1-like domain domain: Pdi-like hypothetical protein At1g60420 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=82.81 E-value=0.2 Score=43.35 Aligned_cols=41 Identities=24% Similarity=0.608 Sum_probs=31.9
Q ss_pred eeeeeeccCCCCcccccccccccccccceecCCCCCCccccccCC
Q psy48 266 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDK 310 (1098)
Q Consensus 266 H~f~~~~~~~pt~C~~C~~~l~Gl~~qG~kC~~C~~~vHkkC~~~ 310 (1098)
|.+.... ..+..|+.|+..+.|+ .|+|..|++.+|..|+..
T Consensus 38 H~L~L~~-~~~~~C~~C~~~~~g~---~Y~C~~C~f~LH~~CA~~ 78 (89)
T d1v5na_ 38 HELELTR-VQVYTCDKCEEEGTIW---SYHCDECDFDLHAKCALN 78 (89)
T ss_dssp SCEEEEC-CSSCCCTTTSCCCCSC---EEECTTTCCCCCHHHHHC
T ss_pred CCeEEec-CCCCEeCCCCCCcCCc---EeEeccCCCEecHHHcCC
Confidence 4444332 3456899999988874 599999999999999865
|
| >d1v5na_ g.49.1.3 (A:) Pdi-like hypothetical protein At1g60420 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: C1-like domain domain: Pdi-like hypothetical protein At1g60420 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=82.21 E-value=0.33 Score=41.96 Aligned_cols=41 Identities=24% Similarity=0.608 Sum_probs=31.2
Q ss_pred ceeeeeecCCCccccccccchhcccccceecCCCCcccccccccc
Q psy48 530 HTFNLHTYTRPTLCGLCKKLLKGLFKQGLQCKDCGFNVHKKCLDK 574 (1098)
Q Consensus 530 H~F~~~~~~~~t~C~~C~~~l~Gl~~qG~~C~~C~~~vH~~C~~~ 574 (1098)
|.+.... ...-+|+.|++.+.|+ .|+|..|++.+|..|...
T Consensus 38 H~L~L~~-~~~~~C~~C~~~~~g~---~Y~C~~C~f~LH~~CA~~ 78 (89)
T d1v5na_ 38 HELELTR-VQVYTCDKCEEEGTIW---SYHCDECDFDLHAKCALN 78 (89)
T ss_dssp SCEEEEC-CSSCCCTTTSCCCCSC---EEECTTTCCCCCHHHHHC
T ss_pred CCeEEec-CCCCEeCCCCCCcCCc---EeEeccCCCEecHHHcCC
Confidence 4444332 3456899999988764 599999999999999863
|